Citrus Sinensis ID: 031702

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150----
Protein Sequence
MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS
Secondary Structure (PSIPRED)
ccccccHHHHHHHHHHHHHHHHccccccccEEEEEEEccEEEEEEEEccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccEEEEccccccccccccccccccccccccHHHHHcccccccccccccc
Secondary Structure Prediction (SSPRO)
ccEEEcHHHHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEccccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHHcEEcccccHHHEEEccEcccccEEEccccccEEccccccEccccccHHHccHHHHHHHHccccEEEEcc
Coil and Loop (DISEMBL)
MLKKLNKHLKSCLDCELNflssvnhpniiRLFDAFQAENCIFLVVEFCaggnlssyirlhgrvPEQTARKFLQQLGAGleilnshhiihrdlkpenillsgldddvMLKIADFglsctlypgnyaekvcgsplymapevlqfqrydekvnffvs
Flexible Loop (DISEMBL)
MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS
Low Complexity Region (SEG)
MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS
Disordered region (IsUnstruct)
*******HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDL***************LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF**
Disordered Region (DISOPRED)
************LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS
Disordered Region (DISEMBL)
MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS
Disordered Region (DISPRO)
MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	154	2.2.26 [Sep-21-2011]
Q9QY01	1037	Serine/threonine-protein	yes	no	0.889	0.132	0.440	4e-31
Q8IYT8	1036	Serine/threonine-protein	yes	no	0.889	0.132	0.440	7e-31
Q5ZJH6	468	Serine/threonine-protein	no	no	0.967	0.318	0.433	1e-29
Q86CS2	668	Serine/threonine-protein	yes	no	0.954	0.220	0.406	3e-29
O94168	619	Carbon catabolite-derepre	N/A	no	0.818	0.203	0.469	5e-29
A7KAL2	960	Serine/threonine-protein	yes	no	0.980	0.157	0.351	8e-29
O70405	1051	Serine/threonine-protein	no	no	0.928	0.136	0.409	1e-28
D3ZHP7	472	Serine/threonine-protein	no	no	0.961	0.313	0.443	1e-28
Q0CLX3	964	Serine/threonine-protein	N/A	no	0.980	0.156	0.356	1e-28
Q3U3Q1	472	Serine/threonine-protein	no	no	0.961	0.313	0.443	1e-28

>sp|Q9QY01|ULK2_MOUSE Serine/threonine-protein kinase ULK2 OS=Mus musculus GN=Ulk2 PE=1 SV=1

 Score =  133 bits (335), Expect = 4e-31,   Method: Composition-based stats.
 Identities = 63/143 (44%), Positives = 90/143 (62%), Gaps = 6/143 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  + H NI+ L+D  +  N +FLV+E+C GG+L+ Y++  G + E T R FL Q+
Sbjct: 56  EIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYLQAKGTLSEDTIRVFLHQI 115

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLD------DDVMLKIADFGLSCTLYPGNYAEKVC 129
            A + IL+S  IIHRDLKP+NILLS  +        + +KIADFG +  L+    A  +C
Sbjct: 116 AAAMRILHSKGIIHRDLKPQNILLSYANRRKSNVSGIRIKIADFGFARYLHSNTMAATLC 175

Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
           GSP+YMAPEV+  Q YD K + +
Sbjct: 176 GSPMYMAPEVIMSQHYDAKADLW 198

Serine/threonine-protein kinase involved in autophagy in response to starvation. Acts upstream of phosphatidylinositol 3-kinase PIK3C3 to regulate the formation of autophagophores, the precursors of autophagosomes. Part of regulatory feedback loops in autophagy: acts both as a downstream effector and negative regulator of mammalian target of rapamycin complex 1 (mTORC1) via interaction with RPTOR. Activated via phosphorylation by AMPK and also acts as a regulator of AMPK by mediating phosphorylation of AMPK subunits PRKAA1, PRKAB2 and PRKAG1, leading to negatively regulate AMPK activity. May phosphorylate ATG13/KIAA0652, FRS2, FRS3 and RPTOR; however such data need additional evidences. Not involved in ammonia-induced autophagy or in autophagic response of cerebellar granule neurons (CGN) to low potassium concentration. Plays a role early in neuronal differentiation and is required for granule cell axon formation: may govern axon formation via Ras-like GTPase signaling and through regulation of the Rab5-mediated endocytic pathways within developing axons.
Mus musculus (taxid: 10090)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8IYT8|ULK2_HUMAN Serine/threonine-protein kinase ULK2 OS=Homo sapiens GN=ULK2 PE=1 SV=3

 Score =  132 bits (333), Expect = 7e-31,   Method: Composition-based stats.
 Identities = 63/143 (44%), Positives = 90/143 (62%), Gaps = 6/143 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  + H NI+ L+D  +  N +FLV+E+C GG+L+ Y++  G + E T R FL Q+
Sbjct: 56  EIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYLQAKGTLSEDTIRVFLHQI 115

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLD------DDVMLKIADFGLSCTLYPGNYAEKVC 129
            A + IL+S  IIHRDLKP+NILLS  +        + +KIADFG +  L+    A  +C
Sbjct: 116 AAAMRILHSKGIIHRDLKPQNILLSYANRRKSSVSGIRIKIADFGFARYLHSNMMAATLC 175

Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
           GSP+YMAPEV+  Q YD K + +
Sbjct: 176 GSPMYMAPEVIMSQHYDAKADLW 198

Serine/threonine-protein kinase involved in autophagy in response to starvation. Acts upstream of phosphatidylinositol 3-kinase PIK3C3 to regulate the formation of autophagophores, the precursors of autophagosomes. Part of regulatory feedback loops in autophagy: acts both as a downstream effector and negative regulator of mammalian target of rapamycin complex 1 (mTORC1) via interaction with RPTOR. Activated via phosphorylation by AMPK and also acts as a regulator of AMPK by mediating phosphorylation of AMPK subunits PRKAA1, PRKAB2 and PRKAG1, leading to negatively regulate AMPK activity. May phosphorylate ATG13/KIAA0652, FRS2, FRS3 and RPTOR; however such data need additional evidences. Not involved in ammonia-induced autophagy or in autophagic response of cerebellar granule neurons (CGN) to low potassium concentration. Plays a role early in neuronal differentiation and is required for granule cell axon formation: may govern axon formation via Ras-like GTPase signaling and through regulation of the Rab5-mediated endocytic pathways within developing axons.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5ZJH6|ULK3_CHICK Serine/threonine-protein kinase ULK3 OS=Gallus gallus GN=ULK3 PE=2 SV=1

 Score =  128 bits (322), Expect = 1e-29,   Method: Composition-based stats.
 Identities = 65/150 (43%), Positives = 98/150 (65%), Gaps = 1/150 (0%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           + LN+     L  E+  L ++ HP+I+ L D     + I+L++EFCAGG+LS +IR+   
Sbjct: 49  RSLNRASVENLLTEIEILKTIRHPHIVELKDFQWDSDHIYLIMEFCAGGDLSRFIRMRRI 108

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE+ AR FLQQL   L+ L+ H+I H DLKP+NILLS   ++  LK+ADFG +  + P 
Sbjct: 109 LPEKVARIFLQQLACALKFLHDHNISHLDLKPQNILLS-TPENPQLKLADFGFAQYMSPW 167

Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           +    + GSPLYMAPE++  Q+YD +V+ +
Sbjct: 168 DEKHVLRGSPLYMAPEMVCRQQYDARVDLW 197

Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q86CS2|ATG1_DICDI Serine/threonine-protein kinase atg1 OS=Dictyostelium discoideum GN=atg1 PE=3 SV=1

 Score =  127 bits (319), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 61/150 (40%), Positives = 92/150 (61%), Gaps = 3/150 (2%)

Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN---CIFLVVEFCAGGNLSSYIRLHGR 62
           N  L   L+ E+  L  ++H NI+RL+D    E     I++++E C GG+ S YIR H +
Sbjct: 47  NSKLTENLNYEIRILKELSHTNIVRLYDVLNEETDPTFIYMIMECCEGGDFSKYIRTHKK 106

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           + E+ A  F++QL  GL+ L    I+HRDLKP+N+LLS   +  +LKI DFG +  + P 
Sbjct: 107 LTEEKALYFMKQLANGLKFLRQKQIVHRDLKPQNLLLSDDSEHPILKIGDFGFAKFIDPF 166

Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           + ++  CGSPLYMAPE+L  + Y  K + +
Sbjct: 167 SLSDTFCGSPLYMAPEILHRKNYTVKADLW 196

Serine/threonine protein kinase involved in autophagy. Involved in the control of autophagic vacuolar cell death.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O94168|SNF1_CANTR Carbon catabolite-derepressing protein kinase OS=Candida tropicalis GN=SNF1 PE=3 SV=1

 Score =  126 bits (317), Expect = 5e-29,   Method: Composition-based stats.
 Identities = 61/130 (46%), Positives = 89/130 (68%), Gaps = 4/130 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+++L  + HP+II+L+D  ++++ I +V+EF AG  L  YI   G++PE  AR+F QQ+
Sbjct: 100 EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEF-AGKELFDYIVQRGKMPEDEARRFFQQI 158

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            A +E  + H I+HRDLKPEN+L   LDD + +KIADFGLS  +  GN+ +  CGSP Y 
Sbjct: 159 IAAVEYCHRHKIVHRDLKPENLL---LDDQLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 215

Query: 136 APEVLQFQRY 145
           APEV+  + Y
Sbjct: 216 APEVISGKLY 225

Essential for release from glucose repression. It interacts and has functional relationship to the regulatory protein SNF4. Could phosphorylates CAT8.

Candida tropicalis (taxid: 5482)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A7KAL2|ATG1_PENCW Serine/threonine-protein kinase ATG1 OS=Penicillium chrysogenum (strain ATCC 28089 / DSM 1075 / Wisconsin 54-1255) GN=atg1 PE=3 SV=1

 Score =  125 bits (315), Expect = 8e-29,   Method: Composition-based stats.
 Identities = 70/199 (35%), Positives = 106/199 (53%), Gaps = 48/199 (24%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
           L KLNK LK  L  E++ L  ++HP+I+ L D  ++ + I LV+E+CA G+LS +I+   
Sbjct: 55  LSKLNKKLKENLSSEIDILKGLHHPHIVALIDCHESTSHIHLVMEYCALGDLSLFIKRRD 114

Query: 61  --------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL- 99
                               G + E   R FL+QL + L+ L   ++IHRD+KP+N+LL 
Sbjct: 115 TLGSHKYTRDMIAKYPNPPGGSLNEVVTRHFLKQLSSALKFLRDRNLIHRDIKPQNLLLC 174

Query: 100 --------------------------SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
                                     +GL+   MLKIADFG + +L   + AE +CGSPL
Sbjct: 175 PSPSSYRSGHAQVMPYKGSDDSYEPTTGLESLPMLKIADFGFARSLPATSLAETLCGSPL 234

Query: 134 YMAPEVLQFQRYDEKVNFF 152
           YMAPE+L++++YD K + +
Sbjct: 235 YMAPEILRYEKYDAKADLW 253

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Penicillium chrysogenum (strain ATCC 28089 / DSM 1075 / Wisconsin 54-1255) (taxid: 500485)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O70405|ULK1_MOUSE Serine/threonine-protein kinase ULK1 OS=Mus musculus GN=Ulk1 PE=1 SV=1

 Score =  125 bits (314), Expect = 1e-28,   Method: Composition-based stats.
 Identities = 61/149 (40%), Positives = 90/149 (60%), Gaps = 6/149 (4%)

Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           ++ L  E+  L  + H NI+ L+D  +  N ++LV+E+C GG+L+ Y+     + E T R
Sbjct: 57  QTLLGKEIKILKELKHENIVALYDFQEMANSVYLVMEYCNGGDLADYLHTMRTLSEDTVR 116

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD------DDVMLKIADFGLSCTLYPGN 123
            FLQQ+   + +L+S  IIHRDLKP+NILLS          ++ +KIADFG +  L    
Sbjct: 117 LFLQQIAGAMRLLHSKGIIHRDLKPQNILLSNPGGRRANPSNIRVKIADFGFARYLQSNM 176

Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
            A  +CGSP+YMAPEV+  Q YD K + +
Sbjct: 177 MAATLCGSPMYMAPEVIMSQHYDGKADLW 205

Serine/threonine-protein kinase involved in autophagy in response to starvation. Acts upstream of phosphatidylinositol 3-kinase PIK3C3 to regulate the formation of autophagophores, the precursors of autophagosomes. Part of regulatory feedback loops in autophagy: acts both as a downstream effector and negative regulator of mammalian target of rapamycin complex 1 (mTORC1) via interaction with RPTOR. Activated via phosphorylation by AMPK and also acts as a regulator of AMPK by mediating phosphorylation of AMPK subunits PRKAA1, PRKAB2 and PRKAG1, leading to negatively regulate AMPK activity. May phosphorylate ATG13/KIAA0652 and RPTOR; however such data need additional evidences. Plays a role early in neuronal differentiation and is required for granule cell axon formation.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|D3ZHP7|ULK3_RAT Serine/threonine-protein kinase ULK3 OS=Rattus norvegicus GN=Ulk3 PE=3 SV=1

 Score =  125 bits (313), Expect = 1e-28,   Method: Composition-based stats.
 Identities = 67/151 (44%), Positives = 99/151 (65%), Gaps = 3/151 (1%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHG 61
           K LNK     L  E+  L  + HP+I++L D FQ +N  I+L++EFCAGG+LS +I    
Sbjct: 49  KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDNDNIYLIMEFCAGGDLSRFIHTRR 107

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
            +PE+ AR F+QQL + L+ L+  +I H DLKP+NILLS L+    LK+ADFG +  + P
Sbjct: 108 ILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMSP 166

Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
            +    + GSPLYMAPE++  ++YD +V+ +
Sbjct: 167 WDEKHVLRGSPLYMAPEMVCRRQYDARVDLW 197

Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Acts as a negative regulator of SHH signaling in the absence of SHH ligand: interacts with SUFU, thereby inactivating the protein kinase activity and preventing phosphorylation of GLI proteins (GLI1, GLI2 and/or GLI3). Positively regulates SHH signaling in the presence of SHH: dissociates from SUFU, autophosphorylates and mediates phosphorylation of GLI2, activating it and promoting its nuclear translocation. Phosphorylates in vitro GLI2, as well as GLI1 and GLI3, although less efficiently. Also acts as a regulator of autophagy: following cellular senescence, able to induce autophagy.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q0CLX3|ATG1_ASPTN Serine/threonine-protein kinase atg1 OS=Aspergillus terreus (strain NIH 2624 / FGSC A1156) GN=atg1 PE=3 SV=1

 Score =  125 bits (313), Expect = 1e-28,   Method: Composition-based stats.
 Identities = 71/199 (35%), Positives = 104/199 (52%), Gaps = 48/199 (24%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
           L +LNK LK  L  E++ L  + HP+I+ L D  +  + I LV+E+CA G+LS +IR   
Sbjct: 59  LSQLNKKLKENLFSEIHILKGLYHPHIVALIDCHETTSHIHLVMEYCALGDLSQFIRHRN 118

Query: 61  --------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL- 99
                               G + E   R FL+QL + L+ L   ++IHRD+KP+N+LL 
Sbjct: 119 TLGEHRYTRDMIAKYPNPRGGALNEVVVRHFLKQLASALKFLRDRNLIHRDIKPQNLLLC 178

Query: 100 --------------------------SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
                                     +GLD   MLKIADFG + +L   + AE +CGSPL
Sbjct: 179 PSPTSYRAGVAQIVPFKGSEDSFSPATGLDSLPMLKIADFGFARSLPATSLAETLCGSPL 238

Query: 134 YMAPEVLQFQRYDEKVNFF 152
           YMAPE+L++++YD K + +
Sbjct: 239 YMAPEILRYEKYDAKADLW 257

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Aspergillus terreus (strain NIH 2624 / FGSC A1156) (taxid: 341663)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q3U3Q1|ULK3_MOUSE Serine/threonine-protein kinase ULK3 OS=Mus musculus GN=Ulk3 PE=2 SV=1

 Score =  125 bits (313), Expect = 1e-28,   Method: Composition-based stats.
 Identities = 67/151 (44%), Positives = 99/151 (65%), Gaps = 3/151 (1%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHG 61
           K LNK     L  E+  L  + HP+I++L D FQ +N  I+L++EFCAGG+LS +I    
Sbjct: 49  KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDNDNIYLIMEFCAGGDLSRFIHTRR 107

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
            +PE+ AR F+QQL + L+ L+  +I H DLKP+NILLS L+    LK+ADFG +  + P
Sbjct: 108 ILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMSP 166

Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
            +    + GSPLYMAPE++  ++YD +V+ +
Sbjct: 167 WDEKHVLRGSPLYMAPEMVCRRQYDARVDLW 197

Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Acts as a negative regulator of SHH signaling in the absence of SHH ligand: interacts with SUFU, thereby inactivating the protein kinase activity and preventing phosphorylation of GLI proteins (GLI1, GLI2 and/or GLI3). Positively regulates SHH signaling in the presence of SHH: dissociates from SUFU, autophosphorylates and mediates phosphorylation of GLI2, activating it and promoting its nuclear translocation. Phosphorylates in vitro GLI2, as well as GLI1 and GLI3, although less efficiently. Also acts as a regulator of autophagy: following cellular senescence, able to induce autophagy.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	154
255581995	321	serine/threonine-protein kinase, putativ	0.980	0.470	0.788	3e-63
225431573	275	PREDICTED: serine/threonine-protein kina	0.980	0.549	0.728	1e-60
359476946	260	PREDICTED: serine/threonine-protein kina	0.980	0.580	0.728	1e-60
224116060	266	predicted protein [Populus trichocarpa]	0.980	0.567	0.699	9e-57
357464547	290	Serine/threonine protein kinase GE16371	0.980	0.520	0.675	1e-54
297852566	266	hypothetical protein ARALYDRAFT_314341 [	0.980	0.567	0.635	2e-51
334183174	376	protein kinase-like protein [Arabidopsis	0.980	0.401	0.609	3e-50
7770326	392	F27J15.5 [Arabidopsis thaliana]	0.980	0.385	0.609	4e-50
30694500	408	protein kinase-like protein [Arabidopsis	0.980	0.370	0.609	4e-50
110736434	295	similar to MAP/ERK kinase kinase 3 [Arab	0.980	0.511	0.609	1e-49

>gi|255581995|ref|XP_002531795.1| serine/threonine-protein kinase, putative [Ricinus communis] gi|223528561|gb|EEF30583.1| serine/threonine-protein kinase, putative [Ricinus communis]

 Score =  246 bits (627), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 119/151 (78%), Positives = 132/151 (87%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLNKHLK+CLDCELNFLSSVNHPNIIRLF  FQAE+ IFLV+EFCAGG+LSSYIR HG
Sbjct: 53  LSKLNKHLKNCLDCELNFLSSVNHPNIIRLFHVFQAESSIFLVLEFCAGGSLSSYIRHHG 112

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
           RV E+ AR+ +QQLGAGLEIL+SHHIIHRDLKPENILLSG   DV+LKIADFGLS  + P
Sbjct: 113 RVQEEIARRLMQQLGAGLEILHSHHIIHRDLKPENILLSGQFADVVLKIADFGLSRRVQP 172

Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           G YAE VCGSPLYMAPEVLQFQ YD+K + +
Sbjct: 173 GKYAETVCGSPLYMAPEVLQFQSYDDKADMW 203

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225431573|ref|XP_002282420.1| PREDICTED: serine/threonine-protein kinase ULK3 isoform 1 [Vitis vinifera] gi|296088603|emb|CBI37594.3| unnamed protein product [Vitis vinifera]

 Score =  237 bits (604), Expect = 1e-60,   Method: Compositional matrix adjust.
 Identities = 110/151 (72%), Positives = 133/151 (88%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN++LK+ LDCE+NFLSSV+HPNIIRL   FQAE CIFLV+EFC+GG+L SYIR HG
Sbjct: 43  LSKLNRNLKTSLDCEINFLSSVSHPNIIRLLHVFQAEGCIFLVLEFCSGGDLESYIRHHG 102

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
           RV E  AR+F+QQLGAGLE+L+SHHIIHRDLKP NILLSG + DV+LKIADFGLS T++P
Sbjct: 103 RVQEWVARRFMQQLGAGLEVLHSHHIIHRDLKPGNILLSGPESDVLLKIADFGLSRTVHP 162

Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           G +AE VCG+PLYMAPEVL+F++YDEKV+ +
Sbjct: 163 GEHAETVCGTPLYMAPEVLRFKKYDEKVDMW 193

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359476946|ref|XP_003631917.1| PREDICTED: serine/threonine-protein kinase ULK3 isoform 2 [Vitis vinifera]

 Score =  237 bits (604), Expect = 1e-60,   Method: Compositional matrix adjust.
 Identities = 110/151 (72%), Positives = 133/151 (88%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN++LK+ LDCE+NFLSSV+HPNIIRL   FQAE CIFLV+EFC+GG+L SYIR HG
Sbjct: 43  LSKLNRNLKTSLDCEINFLSSVSHPNIIRLLHVFQAEGCIFLVLEFCSGGDLESYIRHHG 102

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
           RV E  AR+F+QQLGAGLE+L+SHHIIHRDLKP NILLSG + DV+LKIADFGLS T++P
Sbjct: 103 RVQEWVARRFMQQLGAGLEVLHSHHIIHRDLKPGNILLSGPESDVLLKIADFGLSRTVHP 162

Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           G +AE VCG+PLYMAPEVL+F++YDEKV+ +
Sbjct: 163 GEHAETVCGTPLYMAPEVLRFKKYDEKVDMW 193

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224116060|ref|XP_002332038.1| predicted protein [Populus trichocarpa] gi|222875263|gb|EEF12394.1| predicted protein [Populus trichocarpa]

 Score =  224 bits (571), Expect = 9e-57,   Method: Compositional matrix adjust.
 Identities = 107/153 (69%), Positives = 129/153 (84%), Gaps = 2/153 (1%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLNK+L++CLDCELNFLSSVNH NIIRL D F+ + C+FLV+EFC+GGNL+SY++ HG
Sbjct: 38  LSKLNKNLRNCLDCELNFLSSVNHTNIIRLLDVFEDDCCMFLVLEFCSGGNLASYLQQHG 97

Query: 62  RVPEQTARKFLQQLGAG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
           RV E+ A++F QQ+G+G  L+IL SHHIIHRDLKPENILLSG + DV+LKIADFGLS  +
Sbjct: 98  RVQEKIAKRFTQQMGSGDGLKILQSHHIIHRDLKPENILLSGKESDVVLKIADFGLSRRV 157

Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
            P NY E VCGSP YMAPEVLQFQRYD KV+ +
Sbjct: 158 LPDNYVETVCGSPFYMAPEVLQFQRYDYKVDMW 190

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357464547|ref|XP_003602555.1| Serine/threonine protein kinase GE16371 [Medicago truncatula] gi|355491603|gb|AES72806.1| Serine/threonine protein kinase GE16371 [Medicago truncatula]

 Score =  217 bits (552), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 102/151 (67%), Positives = 122/151 (80%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN HL++ LDCE+NFLSSVNHPNI+ L   FQ   C++LV+EFCAGGNL+SYIR H 
Sbjct: 58  LSKLNSHLRASLDCEINFLSSVNHPNIVHLLHFFQGNGCVYLVLEFCAGGNLASYIRCHE 117

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
           RV + TA+KF+QQLG+GL++L+SH IIHRDLKPENILLS    D +LKIADFGLS T+ P
Sbjct: 118 RVHQLTAKKFIQQLGSGLKVLHSHGIIHRDLKPENILLSSHGADAVLKIADFGLSRTVRP 177

Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           G Y E VCG+P YMAPEVLQFQRYD K + +
Sbjct: 178 GEYVETVCGTPSYMAPEVLQFQRYDHKADMW 208

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297852566|ref|XP_002894164.1| hypothetical protein ARALYDRAFT_314341 [Arabidopsis lyrata subsp. lyrata] gi|297340006|gb|EFH70423.1| hypothetical protein ARALYDRAFT_314341 [Arabidopsis lyrata subsp. lyrata]

 Score =  206 bits (524), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 96/151 (63%), Positives = 121/151 (80%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN++L++CL+ EL FLSSV+HPNIIRL   FQ E  + +V+E+C GG LSSYI+ HG
Sbjct: 39  LSKLNRNLRTCLNNELEFLSSVDHPNIIRLLHVFQDEEFLVMVMEYCDGGTLSSYIQRHG 98

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
           RV E  A++FL+Q+GAGLEI++ +HIIHRDLKPENIL+ G  DD++LKIADF L+  L P
Sbjct: 99  RVEEDIAKRFLKQIGAGLEIIHDNHIIHRDLKPENILIVGSGDDLVLKIADFSLARKLLP 158

Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           G Y E VCGSP YMAPEVLQFQRY+EK + +
Sbjct: 159 GKYLETVCGSPFYMAPEVLQFQRYNEKADMW 189

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|334183174|ref|NP_001185178.1| protein kinase-like protein [Arabidopsis thaliana] gi|332194280|gb|AEE32401.1| protein kinase-like protein [Arabidopsis thaliana]

 Score =  202 bits (514), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 92/151 (60%), Positives = 121/151 (80%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN++L+ CL+ EL FLSSV+HPNIIRL    Q ++ + +V+E+C GG LSSYI+ +G
Sbjct: 40  LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 99

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
           RV E  A++F++Q+GAGLEI++ +HIIHRDLKPENIL+ G  DD++LKIADF L+  L+P
Sbjct: 100 RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 159

Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           G Y E VCGSP YMAPEVLQFQRY+EK + +
Sbjct: 160 GKYLETVCGSPFYMAPEVLQFQRYNEKADMW 190

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|7770326|gb|AAF69696.1|AC016041_1 F27J15.5 [Arabidopsis thaliana]

 Score =  202 bits (514), Expect = 4e-50,   Method: Compositional matrix adjust.
 Identities = 92/151 (60%), Positives = 121/151 (80%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN++L+ CL+ EL FLSSV+HPNIIRL    Q ++ + +V+E+C GG LSSYI+ +G
Sbjct: 38  LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 97

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
           RV E  A++F++Q+GAGLEI++ +HIIHRDLKPENIL+ G  DD++LKIADF L+  L+P
Sbjct: 98  RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 157

Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           G Y E VCGSP YMAPEVLQFQRY+EK + +
Sbjct: 158 GKYLETVCGSPFYMAPEVLQFQRYNEKADMW 188

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|30694500|ref|NP_175344.2| protein kinase-like protein [Arabidopsis thaliana] gi|332194279|gb|AEE32400.1| protein kinase-like protein [Arabidopsis thaliana]

 Score =  202 bits (514), Expect = 4e-50,   Method: Compositional matrix adjust.
 Identities = 92/151 (60%), Positives = 121/151 (80%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN++L+ CL+ EL FLSSV+HPNIIRL    Q ++ + +V+E+C GG LSSYI+ +G
Sbjct: 40  LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 99

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
           RV E  A++F++Q+GAGLEI++ +HIIHRDLKPENIL+ G  DD++LKIADF L+  L+P
Sbjct: 100 RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 159

Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           G Y E VCGSP YMAPEVLQFQRY+EK + +
Sbjct: 160 GKYLETVCGSPFYMAPEVLQFQRYNEKADMW 190

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|110736434|dbj|BAF00185.1| similar to MAP/ERK kinase kinase 3 [Arabidopsis thaliana]

 Score =  201 bits (510), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 92/151 (60%), Positives = 121/151 (80%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN++L+ CL+ EL FLSSV+HPNIIRL    Q ++ + +V+E+C GG LSSYI+ +G
Sbjct: 68  LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 127

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
           RV E  A++F++Q+GAGLEI++ +HIIHRDLKPENIL+ G  DD++LKIADF L+  L+P
Sbjct: 128 RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 187

Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           G Y E VCGSP YMAPEVLQFQRY+EK + +
Sbjct: 188 GKYLETVCGSPFYMAPEVLQFQRYNEKADMW 218

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	154
TAIR|locus:2028496	408	AT1G49180 [Arabidopsis thalian	0.980	0.370	0.609	9.8e-48
TAIR|locus:2084440	712	AT3G53930 [Arabidopsis thalian	0.980	0.212	0.536	2.1e-39
TAIR|locus:2065680	733	AT2G37840 [Arabidopsis thalian	0.980	0.206	0.523	3.2e-39
TAIR|locus:2079527	626	AT3G61960 [Arabidopsis thalian	0.974	0.239	0.48	2.1e-36
MGI|MGI:1352758	1037	Ulk2 "unc-51 like kinase 2" [M	0.980	0.145	0.434	4.8e-28
RGD|1310181	1037	Ulk2 "Unc-51 like kinase 2 (C.	0.980	0.145	0.434	6.1e-28
UNIPROTKB|Q5ZJH6	468	ULK3 "Serine/threonine-protein	0.961	0.316	0.443	6.5e-28
UNIPROTKB|Q8IYT8	1036	ULK2 "Serine/threonine-protein	0.980	0.145	0.434	7.8e-28
UNIPROTKB|E2RF62	1037	ULK2 "Uncharacterized protein"	0.980	0.145	0.434	7.8e-28
UNIPROTKB|E1BH35	1037	ULK2 "Uncharacterized protein"	0.980	0.145	0.434	1e-27

TAIR|locus:2028496 AT1G49180 [Arabidopsis thaliana (taxid:3702)]

 Score = 499 (180.7 bits), Expect = 9.8e-48, P = 9.8e-48
 Identities = 92/151 (60%), Positives = 121/151 (80%)

Query:     2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
             L KLN++L+ CL+ EL FLSSV+HPNIIRL    Q ++ + +V+E+C GG LSSYI+ +G
Sbjct:    40 LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 99

Query:    62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
             RV E  A++F++Q+GAGLEI++ +HIIHRDLKPENIL+ G  DD++LKIADF L+  L+P
Sbjct:   100 RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 159

Query:   122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
             G Y E VCGSP YMAPEVLQFQRY+EK + +
Sbjct:   160 GKYLETVCGSPFYMAPEVLQFQRYNEKADMW 190

GO:0003676 "nucleic acid binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2084440 AT3G53930 [Arabidopsis thaliana (taxid:3702)]

 Score = 426 (155.0 bits), Expect = 2.1e-39, P = 2.1e-39
 Identities = 81/151 (53%), Positives = 107/151 (70%)

Query:     2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
             + +LNK L+  L  E+  L  +NHPNIIR  D  +A   I LV+E+C GG+LS YI  HG
Sbjct:    53 MARLNKKLQESLMSEIIILRKINHPNIIRFIDMIEAPGKINLVLEYCKGGDLSMYIHKHG 112

Query:    62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
              VPE TA+ F+ QL AGL++L  ++IIHRDLKP+N+LLS  D+D  LKIADFG + +L P
Sbjct:   113 SVPEATAKHFMLQLAAGLQVLRDNNIIHRDLKPQNLLLSTDDNDAALKIADFGFARSLQP 172

Query:   122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
                AE +CGSPLYMAPE++Q Q+YD K + +
Sbjct:   173 RGLAETLCGSPLYMAPEIMQLQKYDAKADLW 203

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2065680 AT2G37840 [Arabidopsis thaliana (taxid:3702)]

 Score = 425 (154.7 bits), Expect = 3.2e-39, P = 3.2e-39
 Identities = 79/151 (52%), Positives = 110/151 (72%)

Query:     2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
             + +LNK L+  L  E+  L  +NHPNIIRL D  ++   + LV+E+C GG+LS Y++ HG
Sbjct:    45 MDRLNKKLQESLMSEIFILRRINHPNIIRLIDMIKSPGKVHLVLEYCKGGDLSVYVQRHG 104

Query:    62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
              VPE TA+ F+QQL AGL++L  ++IIHRDLKP+N+LLS  ++D  LKIADFG + +L P
Sbjct:   105 IVPEATAKHFMQQLAAGLQVLRDNNIIHRDLKPQNLLLSTNENDADLKIADFGFARSLQP 164

Query:   122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
                AE +CGSPLYMAPE++Q Q+YD K + +
Sbjct:   165 RGLAETLCGSPLYMAPEIMQLQKYDAKADLW 195

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2079527 AT3G61960 [Arabidopsis thaliana (taxid:3702)]

 Score = 396 (144.5 bits), Expect = 2.1e-36, P = 2.1e-36
 Identities = 72/150 (48%), Positives = 108/150 (72%)

Query:     3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
             K L+  ++  L  E++ LS+++HPNIIR ++A +  + IFLV+E+C+GG+L+ YI  HG+
Sbjct:    44 KLLSPKVRDNLLKEISILSTIDHPNIIRFYEAIETGDRIFLVLEYCSGGDLAGYINRHGK 103

Query:    63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             VPE  A+ F++QL  GL++L   H IHRDLKP+N+LLS  +   +LKI DFG + +L P 
Sbjct:   104 VPEAVAKHFMRQLALGLQVLQEKHFIHRDLKPQNLLLSSKEVTPLLKIGDFGFARSLTPE 163

Query:   123 NYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
             + AE  CGSPLYMAPE+++ Q+YD K + +
Sbjct:   164 SMAETFCGSPLYMAPEIIRNQKYDAKADLW 193

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

MGI|MGI:1352758 Ulk2 "unc-51 like kinase 2" [Mus musculus (taxid:10090)]

 Score = 325 (119.5 bits), Expect = 4.8e-28, P = 4.8e-28
 Identities = 70/161 (43%), Positives = 100/161 (62%)

Query:     2 LKKLNK-HL-KS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
             +K +NK +L KS   L  E+  L  + H NI+ L+D  +  N +FLV+E+C GG+L+ Y+
Sbjct:    38 IKSINKKNLSKSQILLGKEIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYL 97

Query:    58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD------DDVMLKIA 111
             +  G + E T R FL Q+ A + IL+S  IIHRDLKP+NILLS  +        + +KIA
Sbjct:    98 QAKGTLSEDTIRVFLHQIAAAMRILHSKGIIHRDLKPQNILLSYANRRKSNVSGIRIKIA 157

Query:   112 DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
             DFG +  L+    A  +CGSP+YMAPEV+  Q YD K + +
Sbjct:   158 DFGFARYLHSNTMAATLCGSPMYMAPEVIMSQHYDAKADLW 198

GO:0000166 "nucleotide binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0006914 "autophagy" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0007399 "nervous system development" evidence=IEA

GO:0007409 "axonogenesis" evidence=IEA

GO:0010506 "regulation of autophagy" evidence=ISO;IMP

GO:0016020 "membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0031410 "cytoplasmic vesicle" evidence=IEA

GO:0034045 "pre-autophagosomal structure membrane" evidence=ISO;IDA

GO:0042594 "response to starvation" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=ISO

GO:0048671 "negative regulation of collateral sprouting" evidence=IMP

GO:0048675 "axon extension" evidence=IMP

RGD|1310181 Ulk2 "Unc-51 like kinase 2 (C. elegans)" [Rattus norvegicus (taxid:10116)]

 Score = 324 (119.1 bits), Expect = 6.1e-28, P = 6.1e-28
 Identities = 70/161 (43%), Positives = 99/161 (61%)

Query:     2 LKKLNK-HL-KS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
             +K +NK +L KS   L  E+  L  + H NI+ L+D  +  N +FLV+E+C GG+L+ Y+
Sbjct:    38 IKSINKKNLSKSQILLGKEIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYL 97

Query:    58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD------DDVMLKIA 111
             +  G + E T R FL Q+ A + IL+S  IIHRDLKP+NILLS           + +KIA
Sbjct:    98 QAKGTLSEDTIRVFLHQIAAAMRILHSKGIIHRDLKPQNILLSYASRRKSNVSGIRIKIA 157

Query:   112 DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
             DFG +  L+    A  +CGSP+YMAPEV+  Q YD K + +
Sbjct:   158 DFGFARYLHSNTMAATLCGSPMYMAPEVIMSQHYDAKADLW 198

GO:0003674 "molecular_function" evidence=ND

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISO

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0008150 "biological_process" evidence=ND

GO:0010506 "regulation of autophagy" evidence=IEA;ISO

GO:0034045 "pre-autophagosomal structure membrane" evidence=IEA;ISO

GO:0042594 "response to starvation" evidence=IEA;ISO

GO:0046777 "protein autophosphorylation" evidence=IEA;ISO

GO:0048671 "negative regulation of collateral sprouting" evidence=IEA;ISO

GO:0048675 "axon extension" evidence=IEA;ISO

UNIPROTKB|Q5ZJH6 ULK3 "Serine/threonine-protein kinase ULK3" [Gallus gallus (taxid:9031)]

 Score = 313 (115.2 bits), Expect = 6.5e-28, P = 6.5e-28
 Identities = 67/151 (44%), Positives = 101/151 (66%)

Query:     3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLHG 61
             + LN+     L  E+  L ++ HP+I+ L D FQ ++  I+L++EFCAGG+LS +IR+  
Sbjct:    49 RSLNRASVENLLTEIEILKTIRHPHIVELKD-FQWDSDHIYLIMEFCAGGDLSRFIRMRR 107

Query:    62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
              +PE+ AR FLQQL   L+ L+ H+I H DLKP+NILLS   ++  LK+ADFG +  + P
Sbjct:   108 ILPEKVARIFLQQLACALKFLHDHNISHLDLKPQNILLS-TPENPQLKLADFGFAQYMSP 166

Query:   122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
              +    + GSPLYMAPE++  Q+YD +V+ +
Sbjct:   167 WDEKHVLRGSPLYMAPEMVCRQQYDARVDLW 197

GO:0005524 "ATP binding" evidence=IEA

GO:0006914 "autophagy" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0045880 "positive regulation of smoothened signaling pathway" evidence=ISS

GO:0045879 "negative regulation of smoothened signaling pathway" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=ISS

UNIPROTKB|Q8IYT8 ULK2 "Serine/threonine-protein kinase ULK2" [Homo sapiens (taxid:9606)]

 Score = 323 (118.8 bits), Expect = 7.8e-28, P = 7.8e-28
 Identities = 70/161 (43%), Positives = 100/161 (62%)

Query:     2 LKKLNK-HL-KS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
             +K +NK +L KS   L  E+  L  + H NI+ L+D  +  N +FLV+E+C GG+L+ Y+
Sbjct:    38 IKSINKKNLSKSQILLGKEIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYL 97

Query:    58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD------DDVMLKIA 111
             +  G + E T R FL Q+ A + IL+S  IIHRDLKP+NILLS  +        + +KIA
Sbjct:    98 QAKGTLSEDTIRVFLHQIAAAMRILHSKGIIHRDLKPQNILLSYANRRKSSVSGIRIKIA 157

Query:   112 DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
             DFG +  L+    A  +CGSP+YMAPEV+  Q YD K + +
Sbjct:   158 DFGFARYLHSNMMAATLCGSPMYMAPEVIMSQHYDAKADLW 198

GO:0007165 "signal transduction" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006914 "autophagy" evidence=IEA

GO:0048671 "negative regulation of collateral sprouting" evidence=IEA

GO:0048675 "axon extension" evidence=IEA

GO:0030659 "cytoplasmic vesicle membrane" evidence=IEA

GO:0034045 "pre-autophagosomal structure membrane" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0010506 "regulation of autophagy" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042594 "response to starvation" evidence=ISS

UNIPROTKB|E2RF62 ULK2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 323 (118.8 bits), Expect = 7.8e-28, P = 7.8e-28
 Identities = 70/161 (43%), Positives = 100/161 (62%)

Query:     2 LKKLNK-HL-KS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
             +K +NK +L KS   L  E+  L  + H NI+ L+D  +  N +FLV+E+C GG+L+ Y+
Sbjct:    38 IKSINKKNLSKSQILLGKEIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYL 97

Query:    58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD------DDVMLKIA 111
             +  G + E T R FL Q+ A + IL+S  IIHRDLKP+NILLS  +        + +KIA
Sbjct:    98 QAKGTLSEDTIRVFLHQIAAAMRILHSKGIIHRDLKPQNILLSYANRRKSNVSGIRIKIA 157

Query:   112 DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
             DFG +  L+    A  +CGSP+YMAPEV+  Q YD K + +
Sbjct:   158 DFGFARYLHSNMMAATLCGSPMYMAPEVIMSQHYDAKADLW 198

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|E1BH35 ULK2 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 322 (118.4 bits), Expect = 1.0e-27, P = 1.0e-27
 Identities = 70/161 (43%), Positives = 99/161 (61%)

Query:     2 LKKLNK-HL-KS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
             +K +NK +L KS   L  E+  L  + H NI+ L+D  +  N +FLV+E+C GG+L+ Y+
Sbjct:    38 IKSINKKNLSKSQILLGKEIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYL 97

Query:    58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD------DDVMLKIA 111
             +  G + E T R FL Q+ A + IL+S  IIHRDLKP+NILLS           + +KIA
Sbjct:    98 QAKGTLSEDTIRVFLHQIAAAMRILHSKGIIHRDLKPQNILLSYASRKKSSVSGIRIKIA 157

Query:   112 DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
             DFG +  L+    A  +CGSP+YMAPEV+  Q YD K + +
Sbjct:   158 DFGFARYLHSNMMAATLCGSPMYMAPEVIMSQHYDAKADLW 198

GO:0048675 "axon extension" evidence=IEA

GO:0048671 "negative regulation of collateral sprouting" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0042594 "response to starvation" evidence=IEA

GO:0034045 "pre-autophagosomal structure membrane" evidence=IEA

GO:0010506 "regulation of autophagy" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00034887001 SubName- Full=Chromosome chr4 scaffold_73, whole genome shotgun sequence; (275 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	154
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-56
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-46
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	6e-46
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-41
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-40
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-39
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-38
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-36
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	9e-35
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-34
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-33
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-32
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-31
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-30
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-30
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-30
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-30
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-29
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-29
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-29
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-28
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-28
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-28
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-28
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-28
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	9e-28
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-27
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-26
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-26
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-26
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-25
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-25
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-25
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-25
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-25
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-25
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-25
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-25
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-25
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-24
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-24
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-23
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-23
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-23
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-23
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-23
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-23
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-23
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	6e-23
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	9e-23
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-22
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-22
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-22
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-22
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-21
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-21
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-21
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-21
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-21
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-21
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-21
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-21
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	8e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-21
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-20
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-20
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-20
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-20
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-20
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-20
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-20
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-20
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-20
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-20
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-20
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-20
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	8e-20
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	9e-20
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	9e-20
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-19
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-19
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-19
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-19
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-19
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-19
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-19
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-19
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-19
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-19
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-19
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	6e-19
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-19
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	9e-19
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-18
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-18
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-18
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-18
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-18
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	7e-18
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	8e-18
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	8e-18
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	8e-18
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	9e-18
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-17
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-17
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-17
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-17
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-17
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-17
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-17
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-17
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-17
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-17
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-17
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-17
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	8e-17
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	8e-17
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	9e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-16
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-16
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-16
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-16
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-16
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-16
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-16
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-16
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-16
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-16
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-16
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-16
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-16
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-16
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	6e-16
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	7e-16
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	8e-16
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	9e-16
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	9e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-15
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-15
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-15
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-15
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-15
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-15
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-15
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-15
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-15
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-15
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-15
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-15
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	7e-15
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	7e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	8e-15
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	9e-15
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-14
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-14
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-14
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-14
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-14
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-14
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-14
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-14
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-14
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-14
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	6e-14
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-14
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-14
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-14
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	9e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-13
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-13
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	3e-13
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-13
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-13
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-13
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-13
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-13
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-13
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-13
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-13
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-13
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	8e-13
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-12
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-12
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-12
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-12
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-12
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-12
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-12
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-12
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-12
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-12
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-12
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-12
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-12
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	7e-12
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-12
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-11
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-11
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-11
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-11
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-11
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	5e-11
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-11
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-11
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	7e-11
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	8e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	8e-11
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	8e-11
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	9e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-10
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-10
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-10
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-10
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-10
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	8e-10
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	9e-10
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-09
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-09
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-09
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-09
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-09
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	6e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	7e-09
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-08
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-08
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	6e-08
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-07
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	7e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	8e-07
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-07
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	9e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-06
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	4e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	7e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	7e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-05
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-04
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	4e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	7e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.001
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	0.003

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  175 bits (447), Expect = 4e-56
 Identities = 65/152 (42%), Positives = 94/152 (61%), Gaps = 7/152 (4%)

Query: 2   LKKLNKHLKSCLDC----ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K + K            E+  L  + HPNI+RL+D F+ E+ ++LV+E+C GG+L   +
Sbjct: 29  IKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLL 88

Query: 58  RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
           +  GR+ E  AR +L+Q+ + LE L+S  I+HRDLKPENIL   LD+D  +K+ADFGL+ 
Sbjct: 89  KKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENIL---LDEDGHVKLADFGLAR 145

Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149
            L PG       G+P YMAPEVL  + Y + V
Sbjct: 146 QLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAV 177

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  150 bits (381), Expect = 4e-46
 Identities = 66/155 (42%), Positives = 93/155 (60%), Gaps = 10/155 (6%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56
           +K L K  +          E+  L  ++HPNI+RL DAF+ ++ ++LV+E+C GG+L  Y
Sbjct: 29  VKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDY 88

Query: 57  IRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           +   G + E  A+K   Q+  GLE L+S+ IIHRDLKPENIL   LD++ ++KIADFGL+
Sbjct: 89  LSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENIL---LDENGVVKIADFGLA 145

Query: 117 CTLY-PGNYAEKVCGSPLYMAPEVLQFQR-YDEKV 149
             L    +      G+P YMAPEVL     Y  KV
Sbjct: 146 KKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKV 180

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  148 bits (376), Expect = 6e-46
 Identities = 65/155 (41%), Positives = 93/155 (60%), Gaps = 9/155 (5%)

Query: 2   LKKLNKHLKSCLDC----ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K + K   S L      E+  L  +NHPNI++L+  F+ EN ++LV+E+C GG+L   +
Sbjct: 23  IKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLL 82

Query: 58  -RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
               G++ E    + L Q+  GLE L+S+ IIHRDLKPENILL    D+  +K+ADFGLS
Sbjct: 83  KENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD--SDNGKVKLADFGLS 140

Query: 117 CTL-YPGNYAEKVCGSPLYMAPEVLQFQR-YDEKV 149
             L    +  + + G+P YMAPEVL  +  Y EK 
Sbjct: 141 KLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  136 bits (346), Expect = 6e-41
 Identities = 60/137 (43%), Positives = 84/137 (61%), Gaps = 4/137 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E N LS +NHP I++L  AFQ E  ++LV+E+  GG L S++   GR  E+ AR +  ++
Sbjct: 43  ERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEI 102

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLY 134
              LE L+S  II+RDLKPENIL   LD D  +K+ DFGL+  L          CG+P Y
Sbjct: 103 VLALEYLHSLGIIYRDLKPENIL---LDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY 159

Query: 135 MAPEVLQFQRYDEKVNF 151
           +APEVL  + Y + V++
Sbjct: 160 LAPEVLLGKGYGKAVDW 176

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  134 bits (340), Expect = 5e-40
 Identities = 53/144 (36%), Positives = 87/144 (60%), Gaps = 8/144 (5%)

Query: 11  SCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
             L+ E+  LSS+ HPNI+R + + + E  N + + +E+ +GG+LSS ++  G++PE   
Sbjct: 44  EALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI 103

Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---YPGNYA 125
           RK+ +Q+  GL  L+S+ I+HRD+K  NIL+     D ++K+ADFG +  L     G   
Sbjct: 104 RKYTRQILEGLAYLHSNGIVHRDIKGANILVDS---DGVVKLADFGCAKRLGDIETGEGT 160

Query: 126 EKVCGSPLYMAPEVLQFQRYDEKV 149
             V G+P +MAPEV++ + Y    
Sbjct: 161 GSVRGTPYWMAPEVIRGEEYGRAA 184

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  132 bits (334), Expect = 4e-39
 Identities = 48/138 (34%), Positives = 83/138 (60%), Gaps = 8/138 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----PEQTARKF 71
           E+  L  +NHPNII+ +++F+ +  + +V+E+  GG+LS  I+   +     PE+    +
Sbjct: 49  EVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW 108

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCG 130
             QL   L+ L+S  I+HRD+KP+NI    L  + ++K+ DFG+S  L    + A+ V G
Sbjct: 109 FVQLCLALKYLHSRKILHRDIKPQNIF---LTSNGLVKLGDFGISKVLSSTVDLAKTVVG 165

Query: 131 SPLYMAPEVLQFQRYDEK 148
           +P Y++PE+ Q + Y+ K
Sbjct: 166 TPYYLSPELCQNKPYNYK 183

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  129 bits (326), Expect = 6e-38
 Identities = 48/135 (35%), Positives = 78/135 (57%), Gaps = 4/135 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  L    HPNI++ + ++  ++ +++V+EFC+GG+L   ++   +   E       ++
Sbjct: 47  EIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKE 106

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
           L  GLE L+S+ IIHRD+K  NILL+    D  +K+ DFGLS  L        + G+P +
Sbjct: 107 LLKGLEYLHSNGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLSDTKARNTMVGTPYW 163

Query: 135 MAPEVLQFQRYDEKV 149
           MAPEV+  + YD K 
Sbjct: 164 MAPEVINGKPYDYKA 178

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  124 bits (314), Expect = 5e-36
 Identities = 52/159 (32%), Positives = 91/159 (57%), Gaps = 12/159 (7%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
             + K+    +  E + LS    P +++L+ +FQ +  ++LV+E+  GG+L+S +   G 
Sbjct: 30  DMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGS 89

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS------ 116
           + E  AR ++ ++   LE L+S+ IIHRDLKP+NIL   +D +  LK+ DFGLS      
Sbjct: 90  LDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNIL---IDSNGHLKLTDFGLSKVGLVR 146

Query: 117 --CTLYPGNYAE-KVCGSPLYMAPEVLQFQRYDEKVNFF 152
               L      + ++ G+P Y+APEV+  Q + + V+++
Sbjct: 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWW 185

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  122 bits (308), Expect = 9e-35
 Identities = 54/136 (39%), Positives = 85/136 (62%), Gaps = 5/136 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L S+ HP ++ L+ +FQ ++ ++LV+E+  GG L S++R  GR PE  AR +  Q+
Sbjct: 51  EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQV 110

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
              LE L+S  I++RDLKPEN+L   LD D  +KI DFG +  +    Y   +CG+P Y+
Sbjct: 111 VLALEYLHSLDIVYRDLKPENLL---LDSDGYIKITDFGFAKRVKGRTYT--LCGTPEYL 165

Query: 136 APEVLQFQRYDEKVNF 151
           APE++  + Y + V++
Sbjct: 166 APEIILSKGYGKAVDW 181

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  121 bits (305), Expect = 1e-34
 Identities = 48/137 (35%), Positives = 78/137 (56%), Gaps = 3/137 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L  +NHP ++ L+ +FQ E  ++LVV+   GG+L  ++    +  E+  + ++ ++
Sbjct: 50  ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEI 109

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
              LE L+S  IIHRD+KP+NIL   LD+   + I DF ++  + P        G+P YM
Sbjct: 110 VLALEYLHSKGIIHRDIKPDNIL---LDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYM 166

Query: 136 APEVLQFQRYDEKVNFF 152
           APEVL  Q Y   V+++
Sbjct: 167 APEVLCRQGYSVAVDWW 183

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  117 bits (295), Expect = 3e-33
 Identities = 53/156 (33%), Positives = 86/156 (55%), Gaps = 9/156 (5%)

Query: 2   LKKLNKH------LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           LK + K        +  +  E   L   NHP I++L+  F+ +  I++++E+C GG L +
Sbjct: 23  LKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWT 82

Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
            +R  G   E TAR ++  +    E L++  II+RDLKPEN+L   LD +  +K+ DFG 
Sbjct: 83  ILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLL---LDSNGYVKLVDFGF 139

Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNF 151
           +  L  G      CG+P Y+APE++  + YD  V++
Sbjct: 140 AKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDY 175

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  114 bits (289), Expect = 3e-32
 Identities = 46/137 (33%), Positives = 79/137 (57%), Gaps = 8/137 (5%)

Query: 16  ELNFLSSVNHPNIIRLF-DAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
           E   +  ++HPN+++L     + E  +++V+E+  GG+L SY+R +  ++       F  
Sbjct: 51  EARIMRKLDHPNVVKLLGVCTEEEP-LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFAL 109

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-SP 132
           Q+  G+E L S + IHRDL   N L   + +++++KI+DFGLS  LY  +Y  K  G  P
Sbjct: 110 QIARGMEYLESKNFIHRDLAARNCL---VGENLVVKISDFGLSRDLYDDDYYRKRGGKLP 166

Query: 133 L-YMAPEVLQFQRYDEK 148
           + +MAPE L+  ++  K
Sbjct: 167 IRWMAPESLKEGKFTSK 183

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  111 bits (280), Expect = 5e-31
 Identities = 45/138 (32%), Positives = 76/138 (55%), Gaps = 9/138 (6%)

Query: 16  ELNFLSSVNHPNIIRLF-DAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFL 72
           E   +  ++HPNI++L     + E  + +V+E+  GG+L  Y+R +    +       F 
Sbjct: 51  EARIMRKLDHPNIVKLLGVCTEEEP-LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFA 109

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-S 131
            Q+  G+E L S + IHRDL   N L+    +++++KI+DFGLS  LY  +Y +   G  
Sbjct: 110 LQIARGMEYLESKNFIHRDLAARNCLVG---ENLVVKISDFGLSRDLYDDDYYKVKGGKL 166

Query: 132 PL-YMAPEVLQFQRYDEK 148
           P+ +MAPE L+  ++  K
Sbjct: 167 PIRWMAPESLKEGKFTSK 184

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  110 bits (277), Expect = 2e-30
 Identities = 51/157 (32%), Positives = 80/157 (50%), Gaps = 15/157 (9%)

Query: 4   KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYI---- 57
            + +  K  L  E+N L  + HPNI+R +D    ++   +++V+E+C GG+L+  I    
Sbjct: 37  NMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCK 96

Query: 58  RLHGRVPEQTARKFLQQLGAGLE-----ILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
           +    + E+   + L QL   L          + ++HRDLKP NI    LD +  +K+ D
Sbjct: 97  KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIF---LDANNNVKLGD 153

Query: 113 FGLSCTLYPGNYAEKVC-GSPLYMAPEVLQFQRYDEK 148
           FGL+  L   +   K   G+P YM+PE L    YDEK
Sbjct: 154 FGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEK 190

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  110 bits (278), Expect = 2e-30
 Identities = 51/145 (35%), Positives = 72/145 (49%), Gaps = 26/145 (17%)

Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
           L  L+   HP II+L+  FQ E  ++ V+E+   G L  YIR +G + E+  R +  ++ 
Sbjct: 55  LTRLN--GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEIL 112

Query: 77  AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----------------- 119
             LE L+S  IIHRDLKPENIL   LD D+ +KI DFG +  L                 
Sbjct: 113 LALEYLHSKGIIHRDLKPENIL---LDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169

Query: 120 --YPGNYAEK--VCGSPLYMAPEVL 140
                N        G+  Y++PE+L
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELL 194

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  110 bits (278), Expect = 2e-30
 Identities = 47/137 (34%), Positives = 70/137 (51%), Gaps = 26/137 (18%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E++ L  + HPNI++L D    E  ++LV E+C   +L  Y+      +     +  + Q
Sbjct: 48  EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQ 106

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           L  GL   +SH I+HRDLKP+NIL   ++ D +LK+ADFGL+          +  G PL 
Sbjct: 107 LLRGLAYCHSHRILHRDLKPQNIL---INRDGVLKLADFGLA----------RAFGIPLR 153

Query: 134 ----------YMAPEVL 140
                     Y APE+L
Sbjct: 154 TYTHEVVTLWYRAPEIL 170

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  109 bits (276), Expect = 2e-30
 Identities = 44/137 (32%), Positives = 76/137 (55%), Gaps = 7/137 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E + +  ++HPNI+RL         +++V E+  GG+L  ++R HG  +  +   +   Q
Sbjct: 51  EASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQ 110

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +  G+E L S + +HRDL   N L   + +++++KI+DFGLS  +Y  +Y  K  G  L 
Sbjct: 111 IAKGMEYLESKNFVHRDLAARNCL---VTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167

Query: 134 --YMAPEVLQFQRYDEK 148
             +MAPE L+  ++  K
Sbjct: 168 IKWMAPESLKDGKFTSK 184

Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  108 bits (271), Expect = 1e-29
 Identities = 44/135 (32%), Positives = 76/135 (56%), Gaps = 5/135 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E++ L   + P I++ + ++     +++V+E+C  G++S  +++  +   E+     L Q
Sbjct: 48  EISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQ 107

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPL 133
              GLE L+S+  IHRD+K  NIL   L+++   K+ADFG+S  L         V G+P 
Sbjct: 108 TLKGLEYLHSNKKIHRDIKAGNIL---LNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPF 164

Query: 134 YMAPEVLQFQRYDEK 148
           +MAPEV+Q   Y+ K
Sbjct: 165 WMAPEVIQEIGYNNK 179

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  107 bits (269), Expect = 2e-29
 Identities = 55/137 (40%), Positives = 75/137 (54%), Gaps = 8/137 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E+  L+SVNHPNII   +AF   N + +V+E+   G+LS  I         +PEQ   + 
Sbjct: 49  EIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRI 108

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
             QL  GL+ L+   I+HRDLK  NILL   D    +KI D G+S  +   N A+   G+
Sbjct: 109 FIQLLRGLQALHEQKILHRDLKSANILLVANDL---VKIGDLGIS-KVLKKNMAKTQIGT 164

Query: 132 PLYMAPEVLQFQRYDEK 148
           P YMAPEV + + Y  K
Sbjct: 165 PHYMAPEVWKGRPYSYK 181

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  107 bits (270), Expect = 3e-29
 Identities = 51/137 (37%), Positives = 82/137 (59%), Gaps = 5/137 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L  V+HP IIRLF     +  +++++E+  GG L SY+R  GR    T   +  ++
Sbjct: 51  EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI 110

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
              LE L+S  I++RDLKPENIL   LD +  +K+ DFG +  L    +   +CG+P Y+
Sbjct: 111 VCALEYLHSKEIVYRDLKPENIL---LDKEGHIKLTDFGFAKKLRDRTWT--LCGTPEYL 165

Query: 136 APEVLQFQRYDEKVNFF 152
           APEV+Q + +++ V+++
Sbjct: 166 APEVIQSKGHNKAVDWW 182

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 2e-28
 Identities = 44/150 (29%), Positives = 82/150 (54%), Gaps = 8/150 (5%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
            +  K + + L+CE+  L ++ H  I++ +   + +  + + +E+  GG++   ++ +G 
Sbjct: 42  PETKKEVNA-LECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA 100

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP- 121
           + E   RK+ +Q+  G+E L+S+ I+HRD+K  NIL    D    +K+ DFG S  L   
Sbjct: 101 LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTI 157

Query: 122 ---GNYAEKVCGSPLYMAPEVLQFQRYDEK 148
              G   + V G+P +M+PEV+  + Y  K
Sbjct: 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRK 187

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  105 bits (263), Expect = 2e-28
 Identities = 48/142 (33%), Positives = 76/142 (53%), Gaps = 14/142 (9%)

Query: 16  ELNFLSSVNHPNIIRLF--DAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFL 72
           E+  L  + HPN+++ +  +  + +  IF+  E+C+GG L   +  HGR+  E   R + 
Sbjct: 49  EMKVLELLKHPNLVKYYGVEVHREKVYIFM--EYCSGGTLEELLE-HGRILDEHVIRVYT 105

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-----TLYPGNYAEK 127
            QL  GL  L+SH I+HRD+KP NI    LD + ++K+ DFG +      T   G   + 
Sbjct: 106 LQLLEGLAYLHSHGIVHRDIKPANIF---LDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS 162

Query: 128 VCGSPLYMAPEVLQFQRYDEKV 149
           + G+P YMAPEV+   +     
Sbjct: 163 LAGTPAYMAPEVITGGKGKGHG 184

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  105 bits (263), Expect = 2e-28
 Identities = 52/144 (36%), Positives = 84/144 (58%), Gaps = 12/144 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL---HGRVPEQTARKFL 72
           E+  +S  NHPN+++ + +F   + ++LV+ + +GG+L   ++     G + E      L
Sbjct: 49  EVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL 108

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKV--- 128
           +++  GLE L+S+  IHRD+K  NIL   L +D  +KIADFG+S +L   G+   KV   
Sbjct: 109 KEVLKGLEYLHSNGQIHRDIKAGNIL---LGEDGSVKIADFGVSASLADGGDRTRKVRKT 165

Query: 129 -CGSPLYMAPEVL-QFQRYDEKVN 150
             G+P +MAPEV+ Q   YD K +
Sbjct: 166 FVGTPCWMAPEVMEQVHGYDFKAD 189

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 3e-28
 Identities = 47/145 (32%), Positives = 71/145 (48%), Gaps = 15/145 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR---------LHGRVPEQ 66
           E   +  + HPN++RL      E  ++LV+E+  GG+L  Y+R             +  +
Sbjct: 46  EARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLK 105

Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
               F  Q+  G+E L S   +HRDL   N L+   +D V+ KI+DFGLS  +Y  +Y  
Sbjct: 106 DLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG--EDLVV-KISDFGLSRDVYDDDYYR 162

Query: 127 KVCGSPL---YMAPEVLQFQRYDEK 148
           K  G  L   +MAPE L+   +  K
Sbjct: 163 KKTGGKLPIRWMAPESLKDGIFTSK 187

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  105 bits (263), Expect = 4e-28
 Identities = 52/142 (36%), Positives = 80/142 (56%), Gaps = 7/142 (4%)

Query: 12  CLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           C   E   L+    HP + +L   FQ ++ +F V+E+  GG+L  +I+  GR  E  AR 
Sbjct: 41  CTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF 100

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKV 128
           +  ++  GL+ L+   II+RDLK +N+L   LD +  +KIADFG+ C   +  G      
Sbjct: 101 YAAEIVLGLQFLHERGIIYRDLKLDNVL---LDSEGHIKIADFGM-CKEGILGGVTTSTF 156

Query: 129 CGSPLYMAPEVLQFQRYDEKVN 150
           CG+P Y+APE+L +Q Y   V+
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVD 178

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  103 bits (260), Expect = 9e-28
 Identities = 48/139 (34%), Positives = 76/139 (54%), Gaps = 10/139 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E+  L +  HP +++L D F   +   LV+E+     LS  +R   R +PE   + +++ 
Sbjct: 49  EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRM 107

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGS 131
           L  G+  ++++ I+HRDLKP N+L+S    D +LKIADFGL+          Y+ +V  +
Sbjct: 108 LLKGVAYMHANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQV-AT 163

Query: 132 PLYMAPEVLQFQR-YDEKV 149
             Y APE+L   R YD  V
Sbjct: 164 RWYRAPELLYGARKYDPGV 182

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 3e-27
 Identities = 51/154 (33%), Positives = 77/154 (50%), Gaps = 29/154 (18%)

Query: 3   KKLNKHLKSCLDC----ELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           KK+ K   S  +C    E+  L  +N HPNI++L + F+  + ++ V E+  G NL   +
Sbjct: 30  KKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLM 88

Query: 58  RLHGRVP--EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +     P  E   R  + Q+  GL  ++ H   HRDLKPEN+L+SG +   ++KIADFGL
Sbjct: 89  KDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE---VVKIADFGL 145

Query: 116 SCTLYPGNYAEKVCGSP---------LYMAPEVL 140
                    A ++   P          Y APE+L
Sbjct: 146 ---------AREIRSRPPYTDYVSTRWYRAPEIL 170

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  101 bits (252), Expect = 2e-26
 Identities = 57/140 (40%), Positives = 81/140 (57%), Gaps = 13/140 (9%)

Query: 16  ELNFLSSVNHP-NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKF 71
           E+  L+S+NHP NI++L+D FQ E  ++LV+E+  GG+L   ++  GR   + E  A   
Sbjct: 47  EIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFI 106

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV--- 128
           L Q+ + LE L+S  IIHRD+KPENILL    D  ++K+ DFGL+  L        +   
Sbjct: 107 LAQILSALEYLHSKGIIHRDIKPENILLD--RDGRVVKLIDFGLAKLLPDPGSTSSIPAL 164

Query: 129 ----CGSPLYMAPEVLQFQR 144
                G+P YMAPEVL    
Sbjct: 165 PSTSVGTPGYMAPEVLLGLS 184

Length = 384

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 99.2 bits (248), Expect = 3e-26
 Identities = 44/140 (31%), Positives = 79/140 (56%), Gaps = 5/140 (3%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           K   + LKS +  E++ L ++ HPNI++   + +  + +++++E+   G+L   I+  G 
Sbjct: 37  KIKEEALKSIMQ-EIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP 95

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP- 121
            PE     ++ Q+  GL  L+   +IHRD+K  NIL +    D ++K+ADFG++  L   
Sbjct: 96  FPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK---DGVVKLADFGVATKLNDV 152

Query: 122 GNYAEKVCGSPLYMAPEVLQ 141
                 V G+P +MAPEV++
Sbjct: 153 SKDDASVVGTPYWMAPEVIE 172

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 99.2 bits (248), Expect = 5e-26
 Identities = 47/128 (36%), Positives = 76/128 (59%), Gaps = 5/128 (3%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEIL 82
            HPNI+  +D++   + +++V+E+  GG+L+  I  +  R+ E       +++  GLE L
Sbjct: 73  KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL 132

Query: 83  NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLYMAPEVLQ 141
           +S ++IHRD+K +NILLS  D  V  K+ADFG +  L         V G+P +MAPEV++
Sbjct: 133 HSQNVIHRDIKSDNILLS-KDGSV--KLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK 189

Query: 142 FQRYDEKV 149
            + Y  KV
Sbjct: 190 RKDYGPKV 197

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 98.3 bits (245), Expect = 7e-26
 Identities = 44/128 (34%), Positives = 80/128 (62%), Gaps = 3/128 (2%)

Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L+ E+  LS + HPNI++     + E+ +++ +E   GG+L+  ++ +G  PE   R + 
Sbjct: 49  LEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYT 108

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
           +Q+  GLE L+  + +HRD+K  NIL   +D + ++K+ADFG++  +   ++A+   GSP
Sbjct: 109 RQILLGLEYLHDRNTVHRDIKGANIL---VDTNGVVKLADFGMAKQVVEFSFAKSFKGSP 165

Query: 133 LYMAPEVL 140
            +MAPEV+
Sbjct: 166 YWMAPEVI 173

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 97.3 bits (243), Expect = 2e-25
 Identities = 49/135 (36%), Positives = 74/135 (54%), Gaps = 11/135 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L S   P +++ + AF  E  I +V+E+  GG+L+  ++  G++PE       +Q+
Sbjct: 49  ELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQI 108

Query: 76  GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFG----LSCTLYPGNYAEKVCG 130
             GL+ L    HIIHRD+KP N+L++    +V  KIADFG    L  TL   N      G
Sbjct: 109 LKGLDYLHTKRHIIHRDIKPSNLLIN-SKGEV--KIADFGISKVLENTLDQCNTF---VG 162

Query: 131 SPLYMAPEVLQFQRY 145
           +  YM+PE +Q + Y
Sbjct: 163 TVTYMSPERIQGESY 177

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 97.2 bits (242), Expect = 2e-25
 Identities = 51/153 (33%), Positives = 81/153 (52%), Gaps = 8/153 (5%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
               K +   L  E+  L  ++H NI++       E  + + +E+  GG++ S +R +GR
Sbjct: 45  DSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR 104

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL---SCTL 119
             EQ  R F +Q+  GL  L+S  I+HRDLK +N+L   +D D + KI+DFG+   S  +
Sbjct: 105 FEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLL---VDADGICKISDFGISKKSDDI 161

Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQR--YDEKVN 150
           Y  +    + GS  +MAPEV+      Y  KV+
Sbjct: 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVD 194

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 98.1 bits (245), Expect = 3e-25
 Identities = 50/166 (30%), Positives = 83/166 (50%), Gaps = 33/166 (19%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + L+  + P I++L+ +FQ E  ++LV+E+  GG+L + +      PE+TAR ++ +L
Sbjct: 51  ERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAEL 110

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-----------------CT 118
              L+ ++    IHRD+KP+NIL   +D D  +K+ADFGL                    
Sbjct: 111 VLALDSVHKLGFIHRDIKPDNIL---IDADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167

Query: 119 LYPGN-------------YAEKVCGSPLYMAPEVLQFQRYDEKVNF 151
           L+  N              A    G+P Y+APEVL+   Y  + ++
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDW 213

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 97.9 bits (244), Expect = 3e-25
 Identities = 53/156 (33%), Positives = 86/156 (55%), Gaps = 11/156 (7%)

Query: 2   LKKLNKHLKSCLD------CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           LK++ K L   L+       E + L++     +++L  AFQ +  ++L +E+  GG+  +
Sbjct: 31  LKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRT 90

Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
            +   G + E  AR ++ ++   ++ L+    IHRDLKPEN L   +D    +K+ DFGL
Sbjct: 91  LLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFL---IDASGHIKLTDFGL 147

Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNF 151
           S  +    YA  V GSP YMAPEVL+ + YD  V++
Sbjct: 148 SKGIV--TYANSVVGSPDYMAPEVLRGKGYDFTVDY 181

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 96.4 bits (240), Expect = 3e-25
 Identities = 45/151 (29%), Positives = 84/151 (55%), Gaps = 8/151 (5%)

Query: 2   LKKLNKHLKS-CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           L K+N+  +   +D E   L+ ++   IIR +++F  +  + +V+E+   G+L   +++ 
Sbjct: 35  LSKMNRREREEAID-EARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQ 93

Query: 61  G--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
               +PE    +F  Q+  GL  L+S  I+HRD+K  N+ L   D+   +KI D G++  
Sbjct: 94  RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN---VKIGDLGVAKL 150

Query: 119 LYPG-NYAEKVCGSPLYMAPEVLQFQRYDEK 148
           L    N+A  + G+P Y++PE+ + + Y+EK
Sbjct: 151 LSDNTNFANTIVGTPYYLSPELCEDKPYNEK 181

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 96.5 bits (240), Expect = 4e-25
 Identities = 46/135 (34%), Positives = 77/135 (57%), Gaps = 4/135 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   L  ++HPNII  ++ F  +  + +V+E+  GG L+ YI+      + E T   F  
Sbjct: 49  ECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV 108

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           Q+   L  +++  I+HRDLK +NILL      +++KI DFG+S  L   + A  V G+P 
Sbjct: 109 QILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSKAYTVVGTPC 166

Query: 134 YMAPEVLQFQRYDEK 148
           Y++PE+ + + Y++K
Sbjct: 167 YISPELCEGKPYNQK 181

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 96.0 bits (239), Expect = 5e-25
 Identities = 44/115 (38%), Positives = 75/115 (65%), Gaps = 6/115 (5%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
           P + +L+ +FQ+++ ++LV+E+  GG+ +S I+  G +PE  A++++ ++  G+E L+  
Sbjct: 57  PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR 116

Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL 140
            IIHRD+KPEN+L   +D    LK+ DFGLS     G   +K  G+P Y+APE +
Sbjct: 117 GIIHRDIKPENLL---IDQTGHLKLTDFGLSRN---GLENKKFVGTPDYLAPETI 165

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 97.2 bits (242), Expect = 7e-25
 Identities = 52/144 (36%), Positives = 85/144 (59%), Gaps = 19/144 (13%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + L  ++HP I+ +  +FQ EN ++ ++EF  GG L +++R  GR P   A+ +  +L
Sbjct: 68  EKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAEL 127

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV------- 128
               E L+S  II+RDLKPEN+L   LD+   +K+ DFG         +A+KV       
Sbjct: 128 VLAFEYLHSKDIIYRDLKPENLL---LDNKGHVKVTDFG---------FAKKVPDRTFTL 175

Query: 129 CGSPLYMAPEVLQFQRYDEKVNFF 152
           CG+P Y+APEV+Q + + + V+++
Sbjct: 176 CGTPEYLAPEVIQSKGHGKAVDWW 199

Length = 329

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 96.8 bits (241), Expect = 8e-25
 Identities = 51/129 (39%), Positives = 79/129 (61%), Gaps = 4/129 (3%)

Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84
           HP +  LF  FQ +  +F V+E+  GG+L  +I+  GR  E  AR +  ++  GL+ L+ 
Sbjct: 55  HPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK 114

Query: 85  HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT-LYPGNYAEKVCGSPLYMAPEVLQFQ 143
             II+RDLK +N+L   LD D  +KIADFG+    +     A   CG+P Y+APE+L+ Q
Sbjct: 115 KGIIYRDLKLDNVL---LDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ 171

Query: 144 RYDEKVNFF 152
           +Y+E V+++
Sbjct: 172 KYNESVDWW 180

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 96.4 bits (240), Expect = 1e-24
 Identities = 54/140 (38%), Positives = 86/140 (61%), Gaps = 8/140 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E + L+ VNHP I++L  AFQ E  ++L+++F  GG+L  + RL   V   E+  + +L 
Sbjct: 48  ERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLA 105

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSP 132
           +L   L+ L+S  II+RDLKPENIL   LD++  +K+ DFGLS  ++     A   CG+ 
Sbjct: 106 ELALALDHLHSLGIIYRDLKPENIL---LDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 162

Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            YMAPEV+  + + +  +++
Sbjct: 163 EYMAPEVVNRRGHTQSADWW 182

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 95.1 bits (237), Expect = 2e-24
 Identities = 53/139 (38%), Positives = 77/139 (55%), Gaps = 9/139 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E+  L  +NHPNII+L D F+ +  ++LV EF    +L   I+   R +PE   + +L Q
Sbjct: 48  EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQ 106

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSP 132
           L  GL   +SH I+HRDLKPEN+L++       LK+ADFGL+ +       Y   V  + 
Sbjct: 107 LLQGLAFCHSHGILHRDLKPENLLINTEGV---LKLADFGLARSFGSPVRPYTHYVV-TR 162

Query: 133 LYMAPEVLQFQR-YDEKVN 150
            Y APE+L   + Y   V+
Sbjct: 163 WYRAPELLLGDKGYSTPVD 181

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 92.9 bits (231), Expect = 1e-23
 Identities = 47/148 (31%), Positives = 79/148 (53%), Gaps = 22/148 (14%)

Query: 14  DC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGR-VPEQT 67
           DC  E++ L  ++HPN+I+   +F   N + +V+E    G+LS  I   +   R +PE+T
Sbjct: 48  DCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERT 107

Query: 68  ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--- 124
             K+  QL + LE ++S  I+HRD+KP N+ ++      ++K+ D GL      G +   
Sbjct: 108 IWKYFVQLCSALEHMHSKRIMHRDIKPANVFITA---TGVVKLGDLGL------GRFFSS 158

Query: 125 ----AEKVCGSPLYMAPEVLQFQRYDEK 148
               A  + G+P YM+PE +    Y+ K
Sbjct: 159 KTTAAHSLVGTPYYMSPERIHENGYNFK 186

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 92.0 bits (229), Expect = 2e-23
 Identities = 52/145 (35%), Positives = 77/145 (53%), Gaps = 20/145 (13%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPE-QTA---RK 70
           E++ L    HPNI+  F ++   + +++V+E+C GG+L   Y    G + E Q A   R+
Sbjct: 50  EISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRE 109

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--- 127
            L+    GL  L+    IHRD+K  NILL+   +D  +K+ADFG+S  L       K   
Sbjct: 110 TLK----GLAYLHETGKIHRDIKGANILLT---EDGDVKLADFGVSAQL--TATIAKRKS 160

Query: 128 VCGSPLYMAPEVLQFQR---YDEKV 149
             G+P +MAPEV   +R   YD K 
Sbjct: 161 FIGTPYWMAPEVAAVERKGGYDGKC 185

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 92.2 bits (229), Expect = 2e-23
 Identities = 54/139 (38%), Positives = 78/139 (56%), Gaps = 5/139 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   L  V+   I+ L  AF+ ++ + LV+    GG+L  +I   G    PE  A  +  
Sbjct: 43  EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA 102

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           Q+  GLE L+   I++RDLKPEN+LL   DD   ++I+D GL+  L  G   +   G+P 
Sbjct: 103 QIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPG 159

Query: 134 YMAPEVLQFQRYDEKVNFF 152
           YMAPEVLQ + YD  V++F
Sbjct: 160 YMAPEVLQGEVYDFSVDWF 178

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 91.7 bits (228), Expect = 4e-23
 Identities = 54/131 (41%), Positives = 77/131 (58%), Gaps = 13/131 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E++ LS   HPNI+ L++A+  EN +++++EFC GG L S +    R   E   R   +Q
Sbjct: 52  EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQ 111

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-----VC 129
           +   L  L+SH +IHRDLK  NILL+ LD DV  K+ADFG+S      N +         
Sbjct: 112 MLEALNFLHSHKVIHRDLKAGNILLT-LDGDV--KLADFGVSAK----NKSTLQKRDTFI 164

Query: 130 GSPLYMAPEVL 140
           G+P +MAPEV+
Sbjct: 165 GTPYWMAPEVV 175

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 92.2 bits (229), Expect = 4e-23
 Identities = 48/144 (33%), Positives = 77/144 (53%), Gaps = 7/144 (4%)

Query: 12  CLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           C   E   L+ +  HP +  L   FQ ++ +F V+E+  GG+L   I+   +  E  +R 
Sbjct: 41  CTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF 100

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKV 128
           +  ++   L  L+ H +I+RDLK +NIL   LD +   K+ADFG+ C   +  G      
Sbjct: 101 YAAEVTLALMFLHRHGVIYRDLKLDNIL---LDAEGHCKLADFGM-CKEGILNGVTTTTF 156

Query: 129 CGSPLYMAPEVLQFQRYDEKVNFF 152
           CG+P Y+APE+LQ   Y   V+++
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWW 180

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 92.1 bits (229), Expect = 5e-23
 Identities = 48/132 (36%), Positives = 74/132 (56%), Gaps = 7/132 (5%)

Query: 21  SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80
           +S  HP ++ LF  FQ E+ +  V+E+ AGG+L  +I       E  A  +   +  GL+
Sbjct: 57  NSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQ 115

Query: 81  ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMAPE 138
            L+ + I++RDLK +N+L   LD +  +KIADFGL C   +  G+     CG+P ++APE
Sbjct: 116 YLHENKIVYRDLKLDNLL---LDTEGFVKIADFGL-CKEGMGFGDRTSTFCGTPEFLAPE 171

Query: 139 VLQFQRYDEKVN 150
           VL    Y   V+
Sbjct: 172 VLTETSYTRAVD 183

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 92.2 bits (229), Expect = 5e-23
 Identities = 47/136 (34%), Positives = 84/136 (61%), Gaps = 6/136 (4%)

Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
           F ++ NHP ++ L   FQ E+ +F V+EF +GG+L  +++   ++PE+ AR +  ++   
Sbjct: 49  FETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA 108

Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMA 136
           L  L+   II+RDLK +N+L   LD +  +K+ D+G+ C   + PG+     CG+P Y+A
Sbjct: 109 LNFLHERGIIYRDLKLDNVL---LDAEGHIKLTDYGM-CKEGIRPGDTTSTFCGTPNYIA 164

Query: 137 PEVLQFQRYDEKVNFF 152
           PE+L+ + Y   V+++
Sbjct: 165 PEILRGEDYGFSVDWW 180

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 90.6 bits (225), Expect = 6e-23
 Identities = 45/138 (32%), Positives = 74/138 (53%), Gaps = 10/138 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQ 73
           E+  LS + HPNII  ++ F  +N + + +E+  GG L   I  +      E+    +L 
Sbjct: 49  EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---YPGNYAEKVCG 130
           Q+ + +  ++   I+HRD+K  NI L+      ++K+ DFG+S  L   Y    AE V G
Sbjct: 109 QIVSAVSYIHKAGILHRDIKTLNIFLT---KAGLIKLGDFGISKILGSEYSM--AETVVG 163

Query: 131 SPLYMAPEVLQFQRYDEK 148
           +P YM+PE+ Q  +Y+ K
Sbjct: 164 TPYYMSPELCQGVKYNFK 181

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 90.5 bits (224), Expect = 9e-23
 Identities = 51/127 (40%), Positives = 77/127 (60%), Gaps = 5/127 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQQ 74
           E++ L+S +HPNI++L DAF  EN +++++EFCAGG + +  + L   + E   R   +Q
Sbjct: 52  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQ 111

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 133
               L  L+ + IIHRDLK  NIL + LD D+  K+ADFG+S          +   G+P 
Sbjct: 112 TLEALNYLHENKIIHRDLKAGNILFT-LDGDI--KLADFGVSAKNTRTIQRRDSFIGTPY 168

Query: 134 YMAPEVL 140
           +MAPEV+
Sbjct: 169 WMAPEVV 175

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 90.9 bits (225), Expect = 1e-22
 Identities = 47/136 (34%), Positives = 82/136 (60%), Gaps = 6/136 (4%)

Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
           F  + NHP ++ L   FQ E+ +F V+E+  GG+L  +++   ++PE+ AR +  ++   
Sbjct: 49  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 108

Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMA 136
           L  L+   II+RDLK +N+L   LD +  +K+ D+G+ C   L PG+     CG+P Y+A
Sbjct: 109 LNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGM-CKEGLRPGDTTSTFCGTPNYIA 164

Query: 137 PEVLQFQRYDEKVNFF 152
           PE+L+ + Y   V+++
Sbjct: 165 PEILRGEDYGFSVDWW 180

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 90.6 bits (225), Expect = 2e-22
 Identities = 52/128 (40%), Positives = 74/128 (57%), Gaps = 6/128 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E N L +V HP I+ L  AFQ    ++L++E+ +GG L  ++   G   E TA  +L ++
Sbjct: 50  ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEI 109

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPL 133
              LE L+   II+RDLKPENIL   LD    +K+ DFGL C  +++ G      CG+  
Sbjct: 110 SLALEHLHQQGIIYRDLKPENIL---LDAQGHVKLTDFGL-CKESIHEGTVTHTFCGTIE 165

Query: 134 YMAPEVLQ 141
           YMAPE+L 
Sbjct: 166 YMAPEILM 173

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 88.9 bits (221), Expect = 4e-22
 Identities = 48/143 (33%), Positives = 72/143 (50%), Gaps = 27/143 (18%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E++ L  +NHPNI+RL D   +EN ++LV EF    +L  Y+             + +L 
Sbjct: 48  EISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLY 106

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           QL  G+   +SH ++HRDLKP+N+L   +D +  LK+ADFGL+          +  G P+
Sbjct: 107 QLLQGIAYCHSHRVLHRDLKPQNLL---IDREGALKLADFGLA----------RAFGVPV 153

Query: 134 -----------YMAPEVLQFQRY 145
                      Y APE+L   R 
Sbjct: 154 RTYTHEVVTLWYRAPEILLGSRQ 176

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 88.5 bits (220), Expect = 6e-22
 Identities = 49/129 (37%), Positives = 73/129 (56%), Gaps = 13/129 (10%)

Query: 20  LSSVNHPNIIRLFDAF---QAENC--IFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFL 72
           L S  HPNI+RL D     + +    + LV E     +L++Y+    +  +P +T +  +
Sbjct: 55  LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLM 113

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
           +QL  G++ L+SH I+HRDLKP+NIL++    D  +KIADFGL+  +Y    A       
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLKPQNILVT---SDGQVKIADFGLA-RIYSFEMALTSVVVT 169

Query: 133 L-YMAPEVL 140
           L Y APEVL
Sbjct: 170 LWYRAPEVL 178

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 88.1 bits (219), Expect = 1e-21
 Identities = 36/102 (35%), Positives = 59/102 (57%), Gaps = 5/102 (4%)

Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGA 77
           L++++HP +  L+ +FQ E  + LV+++C GG L   ++      + E+ AR +  ++  
Sbjct: 55  LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL 114

Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
            LE L+   I++RDLKPENILL      +ML  +DF LS   
Sbjct: 115 ALEYLHLLGIVYRDLKPENILLHE-SGHIML--SDFDLSKQS 153

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 87.9 bits (218), Expect = 1e-21
 Identities = 55/153 (35%), Positives = 86/153 (56%), Gaps = 11/153 (7%)

Query: 3   KKLNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           KK  KH+ +    E N  L +V HP ++ L  +FQ  + ++ V+++  GG L  +++   
Sbjct: 36  KKEQKHIMA----ERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRER 91

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--L 119
             PE  AR +  ++ + L  L+S +II+RDLKPENIL   LD    + + DFGL C   +
Sbjct: 92  SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENIL---LDSQGHVVLTDFGL-CKEGI 147

Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
                    CG+P Y+APEVL+ Q YD  V+++
Sbjct: 148 EHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWW 180

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 87.8 bits (217), Expect = 2e-21
 Identities = 46/136 (33%), Positives = 82/136 (60%), Gaps = 6/136 (4%)

Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
           F  + ++P ++ L   FQ  + +FLV+E+  GG+L  +++   ++PE+ AR +  ++   
Sbjct: 49  FEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA 108

Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMA 136
           L  L+   II+RDLK +N+L   LD D  +K+ D+G+ C   L PG+     CG+P Y+A
Sbjct: 109 LNFLHERGIIYRDLKLDNVL---LDADGHIKLTDYGM-CKEGLGPGDTTSTFCGTPNYIA 164

Query: 137 PEVLQFQRYDEKVNFF 152
           PE+L+ + Y   V+++
Sbjct: 165 PEILRGEEYGFSVDWW 180

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 86.5 bits (215), Expect = 3e-21
 Identities = 47/137 (34%), Positives = 78/137 (56%), Gaps = 9/137 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+ FLS    P I + + +F   + +++++E+C GG+    ++  G++ E      L+++
Sbjct: 49  EIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREV 107

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSP 132
             GLE L+    IHRD+K  NILLS   ++  +K+ADFG+S  L   +   K     G+P
Sbjct: 108 LLGLEYLHEEGKIHRDIKAANILLS---EEGDVKLADFGVSGQL--TSTMSKRNTFVGTP 162

Query: 133 LYMAPEVLQFQRYDEKV 149
            +MAPEV++   YDEK 
Sbjct: 163 FWMAPEVIKQSGYDEKA 179

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 86.6 bits (214), Expect = 5e-21
 Identities = 52/151 (34%), Positives = 84/151 (55%), Gaps = 7/151 (4%)

Query: 5   LNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV 63
           LN+  +  +  E N  L +V HP ++ L  +FQ    ++ V++F  GG L  +++     
Sbjct: 34  LNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSF 93

Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYP 121
           PE  AR +  ++ + L  L+S +I++RDLKPENILL      V+    DFGL C   +  
Sbjct: 94  PEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVL---TDFGL-CKEGIAQ 149

Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
            +     CG+P Y+APEV++ Q YD  V+++
Sbjct: 150 SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWW 180

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 86.4 bits (214), Expect = 5e-21
 Identities = 51/173 (29%), Positives = 98/173 (56%), Gaps = 25/173 (14%)

Query: 2   LKKLNKH---LKSCLD---CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +KK+NK    L++ +     E + L+   +P ++ +F +F+ +  + +V+E+  GG+ ++
Sbjct: 31  MKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCAT 90

Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
            ++  G +P   AR +  +    LE L+++ I+HRDLKP+N+L++ +     +K+ DFGL
Sbjct: 91  LLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH---IKLTDFGL 147

Query: 116 S--------CTLYPGNYA--------EKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           S          LY G+          ++VCG+P Y+APEV+  Q Y + V+++
Sbjct: 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWW 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 87.0 bits (215), Expect = 5e-21
 Identities = 46/125 (36%), Positives = 74/125 (59%), Gaps = 5/125 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L+ +NHP  + L+ +F+ E+ ++LV+EF  GG   +++R + R P      +  Q+
Sbjct: 81  ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L S +I++RDLKPEN+L   LD D  +K+ DFG +  +    Y   +CG+P Y+
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLL---LDKDGFIKMTDFGFAKVVDTRTYT--LCGTPEYI 195

Query: 136 APEVL 140
           APE+L
Sbjct: 196 APEIL 200

Length = 340

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 85.4 bits (212), Expect = 5e-21
 Identities = 48/135 (35%), Positives = 70/135 (51%), Gaps = 6/135 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQ 74
           EL+ L   N P I+  + AF     I + +E+  GG+L   ++   GR+PE+   K    
Sbjct: 49  ELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA 108

Query: 75  LGAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           +  GL  L   H IIHRD+KP NIL++       +K+ DFG+S  L   + A+   G+  
Sbjct: 109 VLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ---IKLCDFGVSGQLV-NSLAKTFVGTSS 164

Query: 134 YMAPEVLQFQRYDEK 148
           YMAPE +Q   Y  K
Sbjct: 165 YMAPERIQGNDYSVK 179

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 85.8 bits (212), Expect = 8e-21
 Identities = 49/131 (37%), Positives = 78/131 (59%), Gaps = 6/131 (4%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
            +P +  L+  FQ +  +F V+EF  GG+L  +I+  GR     A  +  ++  GL+ L+
Sbjct: 54  ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH 113

Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPLYMAPEVLQ 141
           S  II+RDLK +N++   LD D  +KIADFG+ C   ++  N A   CG+P Y+APE+LQ
Sbjct: 114 SKGIIYRDLKLDNVM---LDRDGHIKIADFGM-CKENVFGDNRASTFCGTPDYIAPEILQ 169

Query: 142 FQRYDEKVNFF 152
             +Y   V+++
Sbjct: 170 GLKYTFSVDWW 180

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 85.6 bits (212), Expect = 8e-21
 Identities = 48/139 (34%), Positives = 73/139 (52%), Gaps = 16/139 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
           EL    S   P I++ + AF  ++ + I + +E+C GG+L S   ++ +V ++  R   +
Sbjct: 49  ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS---IYKKVKKRGGRIGEK 105

Query: 74  QLG-------AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            LG        GL  L+S  IIHRD+KP NIL   L     +K+ DFG+S  L   + A 
Sbjct: 106 VLGKIAESVLKGLSYLHSRKIIHRDIKPSNIL---LTRKGQVKLCDFGVSGELV-NSLAG 161

Query: 127 KVCGSPLYMAPEVLQFQRY 145
              G+  YMAPE +Q + Y
Sbjct: 162 TFTGTSFYMAPERIQGKPY 180

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 85.0 bits (210), Expect = 2e-20
 Identities = 46/136 (33%), Positives = 77/136 (56%), Gaps = 6/136 (4%)

Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
            L ++ HP ++ L  +FQ    ++ V+++  GG L  +++      E  AR +  ++ + 
Sbjct: 49  LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASA 108

Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMA 136
           +  L+S +II+RDLKPENIL   LD    + + DFGL C   + P       CG+P Y+A
Sbjct: 109 IGYLHSLNIIYRDLKPENIL---LDSQGHVVLTDFGL-CKEGVEPEETTSTFCGTPEYLA 164

Query: 137 PEVLQFQRYDEKVNFF 152
           PEVL+ + YD  V+++
Sbjct: 165 PEVLRKEPYDRTVDWW 180

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 84.1 bits (208), Expect = 2e-20
 Identities = 46/135 (34%), Positives = 76/135 (56%), Gaps = 7/135 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  ++ +NHP+IIR+  A   ++   L VE+ AGG++S  +  +G   E     + +QL
Sbjct: 53  EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL 112

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-----GNYAEKVCG 130
             GL  L+ + IIHRD+K  N+L+        L+IADFG +  L       G +  ++ G
Sbjct: 113 LRGLSYLHENQIIHRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLG 170

Query: 131 SPLYMAPEVLQFQRY 145
           +  +MAPEVL+ ++Y
Sbjct: 171 TIAFMAPEVLRGEQY 185

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 84.8 bits (210), Expect = 2e-20
 Identities = 44/129 (34%), Positives = 77/129 (59%), Gaps = 6/129 (4%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
           P + +L   FQ  + ++ V+E+  GG+L  +I+  G+  E  A  +  ++  GL  L+S 
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPLYMAPEVLQFQ 143
            II+RDLK +N++   LD +  +KIADFG+ C   ++ G      CG+P Y+APE++ +Q
Sbjct: 121 GIIYRDLKLDNVM---LDAEGHIKIADFGM-CKENIFGGKTTRTFCGTPDYIAPEIIAYQ 176

Query: 144 RYDEKVNFF 152
            Y + V+++
Sbjct: 177 PYGKSVDWW 185

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 84.3 bits (208), Expect = 2e-20
 Identities = 46/127 (36%), Positives = 76/127 (59%), Gaps = 5/127 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQQ 74
           E+  L++ NHP I++L  AF  +  +++++EFC GG + +  + L   + E   +   +Q
Sbjct: 59  EIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQ 118

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 133
           +   L+ L+S  IIHRDLK  N+LL+ LD D+  K+ADFG+S   +      +   G+P 
Sbjct: 119 MLEALQYLHSMKIIHRDLKAGNVLLT-LDGDI--KLADFGVSAKNVKTLQRRDSFIGTPY 175

Query: 134 YMAPEVL 140
           +MAPEV+
Sbjct: 176 WMAPEVV 182

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 84.7 bits (209), Expect = 3e-20
 Identities = 54/153 (35%), Positives = 84/153 (54%), Gaps = 11/153 (7%)

Query: 3   KKLNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           KK  KH+ S    E N  L +V HP ++ L  +FQ  + ++ V+++  GG L  +++   
Sbjct: 36  KKEEKHIMS----ERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER 91

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TL 119
              E  AR +  ++ + L  L+S +I++RDLKPENIL   LD    + + DFGL C   +
Sbjct: 92  CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENIL---LDSQGHIVLTDFGL-CKENI 147

Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
                    CG+P Y+APEVL  Q YD  V+++
Sbjct: 148 EHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWW 180

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 83.5 bits (206), Expect = 3e-20
 Identities = 46/140 (32%), Positives = 79/140 (56%), Gaps = 5/140 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRV-PEQTARKFLQ 73
           E+  L+ + HPNI+  F +FQ    +F+V+E+C GG+L   I R  G +  E     +  
Sbjct: 49  EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV 108

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC-GSP 132
           Q+  GL+ ++   I+HRD+K +NI LS   + ++ K+ DFG++  L         C G+P
Sbjct: 109 QISLGLKHIHDRKILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDSMELAYTCVGTP 166

Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y++PE+ Q + Y+ K + +
Sbjct: 167 YYLSPEICQNRPYNNKTDIW 186

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 84.6 bits (209), Expect = 3e-20
 Identities = 48/131 (36%), Positives = 76/131 (58%), Gaps = 6/131 (4%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           NHP + +L+  FQ  + +F V+EF  GG+L  +I+   R  E  AR +  ++ + L  L+
Sbjct: 54  NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH 113

Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMAPEVLQ 141
              II+RDLK +N+L   LD +   K+ADFG+ C   ++ G      CG+P Y+APE+LQ
Sbjct: 114 DKGIIYRDLKLDNVL---LDHEGHCKLADFGM-CKEGIFNGKTTSTFCGTPDYIAPEILQ 169

Query: 142 FQRYDEKVNFF 152
              Y   V+++
Sbjct: 170 EMLYGPSVDWW 180

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 84.6 bits (209), Expect = 3e-20
 Identities = 47/129 (36%), Positives = 76/129 (58%), Gaps = 5/129 (3%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
           P I+ L  +FQ ++ ++LV ++ +GG L  +++  GR  E  A+ ++ +L   LE L+ +
Sbjct: 56  PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115

Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPLYMAPEVLQFQR 144
            I++RDLKPENIL   LD    + + DFGLS   L         CG+  Y+APEVL  ++
Sbjct: 116 DIVYRDLKPENIL---LDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEK 172

Query: 145 -YDEKVNFF 152
            Y + V+F+
Sbjct: 173 GYTKHVDFW 181

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 83.7 bits (207), Expect = 3e-20
 Identities = 54/142 (38%), Positives = 80/142 (56%), Gaps = 8/142 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----RLHGRVPEQTARKF 71
           E   L+ V+   I+ L  AFQ +  + LV+    GG+L  +I      +   PE  A  +
Sbjct: 43  EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY 102

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCG 130
             Q+ +GLE L+   II+RDLKPEN+L   LD+D  ++I+D GL+  L  G    K   G
Sbjct: 103 TAQIISGLEHLHQRRIIYRDLKPENVL---LDNDGNVRISDLGLAVELKDGQSKTKGYAG 159

Query: 131 SPLYMAPEVLQFQRYDEKVNFF 152
           +P +MAPE+LQ + YD  V++F
Sbjct: 160 TPGFMAPELLQGEEYDFSVDYF 181

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 83.4 bits (207), Expect = 5e-20
 Identities = 47/129 (36%), Positives = 69/129 (53%), Gaps = 10/129 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA--RKFLQ 73
           E+  L  + HPNII L D F  ++ I LV EF    +L   I+    +    A  + ++ 
Sbjct: 52  EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMET-DLEKVIK-DKSIVLTPADIKSYML 109

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPG-NYAEKVCGS 131
               GLE L+S+ I+HRDLKP N+L   +  D +LK+ADFGL+ +   P      +V  +
Sbjct: 110 MTLRGLEYLHSNWILHRDLKPNNLL---IASDGVLKLADFGLARSFGSPNRKMTHQVV-T 165

Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 166 RWYRAPELL 174

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 82.9 bits (205), Expect = 6e-20
 Identities = 37/102 (36%), Positives = 62/102 (60%), Gaps = 5/102 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
           E+  L  + H NI+RL+D   ++  + LV E+C   +L  Y    +G +  +  + F+ Q
Sbjct: 49  EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQ 107

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           L  GL   +SH+++HRDLKP+N+L++   +   LK+ADFGL+
Sbjct: 108 LLKGLAFCHSHNVLHRDLKPQNLLINKNGE---LKLADFGLA 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 82.8 bits (204), Expect = 7e-20
 Identities = 46/146 (31%), Positives = 81/146 (55%), Gaps = 10/146 (6%)

Query: 10  KSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
           K+  DC  E++ L  +NHPN+I+  D+F  +N + +V+E    G+LS  I+   +    +
Sbjct: 44  KARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLI 103

Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           PE+T  K+  QL + +E ++S  ++HRD+KP N+ ++      ++K+ D GL        
Sbjct: 104 PERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG---VVKLGDLGLGRFFSSKT 160

Query: 124 Y-AEKVCGSPLYMAPEVLQFQRYDEK 148
             A  + G+P YM+PE +    Y+ K
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGYNFK 186

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 82.5 bits (204), Expect = 8e-20
 Identities = 43/129 (33%), Positives = 67/129 (51%), Gaps = 8/129 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFL 72
           E++ +  + H NI+RL D    EN + LV E+    +L  Y+  HG    +   T + F 
Sbjct: 48  EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFT 106

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  G+   + + ++HRDLKP+N+L++       LK+ADFGL+     P N       +
Sbjct: 107 YQLLKGIAFCHENRVLHRDLKPQNLLINK---RGELKLADFGLARAFGIPVNTFSNEVVT 163

Query: 132 PLYMAPEVL 140
             Y AP+VL
Sbjct: 164 LWYRAPDVL 172

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 82.4 bits (203), Expect = 9e-20
 Identities = 46/150 (30%), Positives = 83/150 (55%), Gaps = 10/150 (6%)

Query: 10  KSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
           K+  DC  E++ L  +NHPN+I+ + +F  +N + +V+E    G+LS  I+   +    +
Sbjct: 44  KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI 103

Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           PE+T  K+  QL + LE ++S  ++HRD+KP N+ ++      ++K+ D GL        
Sbjct: 104 PEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG---VVKLGDLGLGRFFSSKT 160

Query: 124 Y-AEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
             A  + G+P YM+PE +    Y+ K + +
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIW 190

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 82.4 bits (203), Expect = 9e-20
 Identities = 45/146 (30%), Positives = 79/146 (54%), Gaps = 9/146 (6%)

Query: 11  SCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           S L+CE+  L ++ H  I++ +   +  AE  + + +E+  GG++   ++ +G + E   
Sbjct: 49  SALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVT 108

Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----YPGNY 124
           RK+ +Q+  G+  L+S+ I+HRD+K  NIL    D    +K+ DFG S  L      G  
Sbjct: 109 RKYTRQILEGMSYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTG 165

Query: 125 AEKVCGSPLYMAPEVLQFQRYDEKVN 150
              V G+P +M+PEV+  + Y  K +
Sbjct: 166 IRSVTGTPYWMSPEVISGEGYGRKAD 191

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 81.6 bits (202), Expect = 2e-19
 Identities = 48/136 (35%), Positives = 71/136 (52%), Gaps = 15/136 (11%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENC------IFLVVEFCAGG---NLSSYIRLHG-RVP 64
           E N L    NHPNI   + AF  +N       ++LV+E C GG   +L   +R  G R+ 
Sbjct: 52  EYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLK 111

Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
           E+     L++   GL  L+ + +IHRD+K +NILL+    +  +K+ DFG+S  L     
Sbjct: 112 EEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFGVSAQLDSTLG 168

Query: 125 AEKVC-GSPLYMAPEV 139
                 G+P +MAPEV
Sbjct: 169 RRNTFIGTPYWMAPEV 184

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 83.4 bits (206), Expect = 2e-19
 Identities = 39/112 (34%), Positives = 72/112 (64%), Gaps = 3/112 (2%)

Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           +NK++   +  E + L+    P I+ L+ + Q+ N ++LV+E+  GG++ S + ++G   
Sbjct: 43  INKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFD 102

Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           E+ A K++ ++   L+ L+ H IIHRDLKP+N+L+S   ++  +K+ DFGLS
Sbjct: 103 EEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS---NEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 81.7 bits (202), Expect = 2e-19
 Identities = 54/163 (33%), Positives = 76/163 (46%), Gaps = 28/163 (17%)

Query: 1   MLKKLNKHLKSCLD--CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           MLK  +   K   D   E+  +  +  H NII L      E  +++VVE+ A GNL  ++
Sbjct: 49  MLKD-DATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL 107

Query: 58  RLHGRVPEQTARK-----------------FLQQLGAGLEILNSHHIIHRDLKPENILLS 100
           R   R P + A                   F  Q+  G+E L S   IHRDL   N+L++
Sbjct: 108 RAR-RPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166

Query: 101 GLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVL 140
             +D VM KIADFGL+  ++  +Y  K     L   +MAPE L
Sbjct: 167 --EDHVM-KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL 206

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 81.6 bits (202), Expect = 2e-19
 Identities = 43/129 (33%), Positives = 68/129 (52%), Gaps = 9/129 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
           E+  L  + H NI+ L +AF+ +  ++LV E+     L   +    G +P    R ++ Q
Sbjct: 50  EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQ 108

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGS 131
           L   +   +SH+IIHRD+KPENIL+S   +  +LK+ DFG +  L         + V  +
Sbjct: 109 LLQAIAYCHSHNIIHRDIKPENILVS---ESGVLKLCDFGFARALRARPASPLTDYV-AT 164

Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 165 RWYRAPELL 173

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 81.2 bits (200), Expect = 2e-19
 Identities = 45/136 (33%), Positives = 82/136 (60%), Gaps = 6/136 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRV-PEQTARKFLQ 73
           E   L+ + HPNI+   ++F+A+  +++V+E+C GG+L   I+L  G++ PE T  ++  
Sbjct: 48  EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSP 132
           Q+  G++ ++   ++HRD+K +NI L+    +  +K+ DFG +  L  PG YA    G+P
Sbjct: 108 QMCLGVQHIHEKRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLTSPGAYACTYVGTP 164

Query: 133 LYMAPEVLQFQRYDEK 148
            Y+ PE+ +   Y+ K
Sbjct: 165 YYVPPEIWENMPYNNK 180

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 82.2 bits (203), Expect = 2e-19
 Identities = 46/139 (33%), Positives = 74/139 (53%), Gaps = 6/139 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++       E  AR +  ++
Sbjct: 45  ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 104

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 133
            + L  L+S  +++RDLK EN++   LD D  +KI DFGL C   +  G   +  CG+P 
Sbjct: 105 VSALGYLHSCDVVYRDLKLENLM---LDKDGHIKITDFGL-CKEGISDGATMKTFCGTPE 160

Query: 134 YMAPEVLQFQRYDEKVNFF 152
           Y+APEVL+   Y   V+++
Sbjct: 161 YLAPEVLEDNDYGRAVDWW 179

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 81.9 bits (202), Expect = 2e-19
 Identities = 51/139 (36%), Positives = 77/139 (55%), Gaps = 6/139 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L+ VN P I+ L  +FQ+   ++LV+ F  GG L  +++  GR     AR +  +L
Sbjct: 43  ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAEL 102

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPL 133
              LE L+  ++I+RDLKPENIL   LD    + + DFGL C L   +       CG+P 
Sbjct: 103 LCALENLHKFNVIYRDLKPENIL---LDYQGHIALCDFGL-CKLNMKDDDKTNTFCGTPE 158

Query: 134 YMAPEVLQFQRYDEKVNFF 152
           Y+APE+L    Y + V+++
Sbjct: 159 YLAPELLLGHGYTKAVDWW 177

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 83.0 bits (205), Expect = 3e-19
 Identities = 49/145 (33%), Positives = 72/145 (49%), Gaps = 13/145 (8%)

Query: 8   HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLHGRVP-E 65
           H ++    E    + + HPNI+ L D+ +A    +F V E+  G  L   +   G +P  
Sbjct: 20  HQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAG 79

Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--- 122
           +T R  LQ L A L   ++  I+HRDLKP+NI++S        K+ DFG+  TL PG   
Sbjct: 80  ETGRLMLQVLDA-LACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIG-TLLPGVRD 137

Query: 123 ------NYAEKVCGSPLYMAPEVLQ 141
                     +V G+P Y APE L+
Sbjct: 138 ADVATLTRTTEVLGTPTYCAPEQLR 162

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 80.8 bits (199), Expect = 3e-19
 Identities = 47/159 (29%), Positives = 88/159 (55%), Gaps = 16/159 (10%)

Query: 1   MLKKLN-----KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLS 54
           ++KKLN     +  +   + E   LS + HPNI+   ++++ E+  +++V+ FC GG+L 
Sbjct: 29  VIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDL- 87

Query: 55  SYIRLHGR----VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            Y +L  +    +PE    ++  Q+   L+ L+  HI+HRDLK +N+ L+  +   ++K+
Sbjct: 88  -YHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN---IIKV 143

Query: 111 ADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEK 148
            D G++  L      A  + G+P YM+PE+   + Y+ K
Sbjct: 144 GDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYK 182

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 81.0 bits (200), Expect = 3e-19
 Identities = 44/155 (28%), Positives = 78/155 (50%), Gaps = 10/155 (6%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           K   + +   L  E+  L  + H NI++   +    + + + +E+  GG++++ +  +G 
Sbjct: 43  KDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA 102

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP- 121
             E   R F++Q+  GL  L++  IIHRD+K  NIL   +D+   +KI+DFG+S  L   
Sbjct: 103 FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANIL---VDNKGGIKISDFGISKKLEAN 159

Query: 122 ------GNYAEKVCGSPLYMAPEVLQFQRYDEKVN 150
                       + GS  +MAPEV++   Y  K +
Sbjct: 160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKAD 194

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 80.8 bits (199), Expect = 3e-19
 Identities = 44/138 (31%), Positives = 70/138 (50%), Gaps = 9/138 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----VPEQTARKF 71
           E   LS ++HP I++   +F   +   ++ E+C G +L   +         + E    ++
Sbjct: 52  EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCG 130
             QL  G+  ++   I+HRDLK +NI L     + +LKI DFG+S  L    + A    G
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLLMGSCDLATTFTG 167

Query: 131 SPLYMAPEVLQFQRYDEK 148
           +P YM+PE L+ Q YD K
Sbjct: 168 TPYYMSPEALKHQGYDSK 185

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 81.0 bits (200), Expect = 5e-19
 Identities = 52/147 (35%), Positives = 78/147 (53%), Gaps = 27/147 (18%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+ FL  + HPN I     +  E+  +LV+E+C G + S  + +H        +K LQ++
Sbjct: 65  EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVH--------KKPLQEV 115

Query: 76  -------GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
                  GA  GL  L+SH  IHRD+K  NILL+   +   +K+ADFG +  + P N   
Sbjct: 116 EIAAICHGALQGLAYLHSHERIHRDIKAGNILLT---EPGTVKLADFGSASLVSPAN--- 169

Query: 127 KVCGSPLYMAPEVLQFQ---RYDEKVN 150
              G+P +MAPEV+      +YD KV+
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVD 196

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 80.7 bits (199), Expect = 5e-19
 Identities = 47/130 (36%), Positives = 75/130 (57%), Gaps = 11/130 (8%)

Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFLQQLGAGLEI 81
           HPNI+   D++   + +++V+E+ AGG+L+  +        Q A   R+ LQ     LE 
Sbjct: 75  HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ----ALEF 130

Query: 82  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVL 140
           L+S+ +IHRD+K +NILL G+D  V  K+ DFG    + P  +    + G+P +MAPEV+
Sbjct: 131 LHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187

Query: 141 QFQRYDEKVN 150
             + Y  KV+
Sbjct: 188 TRKAYGPKVD 197

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 80.2 bits (198), Expect = 6e-19
 Identities = 46/143 (32%), Positives = 74/143 (51%), Gaps = 27/143 (18%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++       +P    + +L 
Sbjct: 49  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLF 107

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+          +  G P+
Sbjct: 108 QLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLA----------RAFGVPV 154

Query: 134 -----------YMAPEVLQFQRY 145
                      Y APE+L   +Y
Sbjct: 155 RTYTHEVVTLWYRAPEILLGCKY 177

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 80.8 bits (199), Expect = 7e-19
 Identities = 45/129 (34%), Positives = 77/129 (59%), Gaps = 6/129 (4%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
           P + +L   FQ  + ++ V+E+  GG+L   I+  GR  E  A  +  ++  GL  L+S 
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPLYMAPEVLQFQ 143
            II+RDLK +N++   LD +  +KIADFG+ C   ++ G   +  CG+P Y+APE++ +Q
Sbjct: 121 GIIYRDLKLDNVM---LDSEGHIKIADFGM-CKENMWDGVTTKTFCGTPDYIAPEIIAYQ 176

Query: 144 RYDEKVNFF 152
            Y + V+++
Sbjct: 177 PYGKSVDWW 185

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 79.8 bits (197), Expect = 9e-19
 Identities = 45/134 (33%), Positives = 68/134 (50%), Gaps = 5/134 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  +     P I+  + AF  EN I + +EF   G+L    +  G +P +   K    +
Sbjct: 53  ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAV 112

Query: 76  GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L N H I+HRD+KP NIL++       +K+ DFG+S  L   + A+   G+  Y
Sbjct: 113 VEGLTYLYNVHRIMHRDIKPSNILVNSRGQ---IKLCDFGVSGELI-NSIADTFVGTSTY 168

Query: 135 MAPEVLQFQRYDEK 148
           M+PE +Q  +Y  K
Sbjct: 169 MSPERIQGGKYTVK 182

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 80.3 bits (199), Expect = 1e-18
 Identities = 49/166 (29%), Positives = 78/166 (46%), Gaps = 27/166 (16%)

Query: 3   KKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGN 52
           KK++      +D      E+  L  + H NII L D  +       N +++V E     +
Sbjct: 31  KKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTEL-METD 89

Query: 53  LSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
           L   I+    + +   + FL Q+  GL+ L+S ++IHRDLKP NIL   ++ +  LKI D
Sbjct: 90  LHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNIL---VNSNCDLKICD 146

Query: 113 FGLSCTLYPGNYAEKVCGSPL--------YMAPEV-LQFQRYDEKV 149
           FGL+  + P    ++     L        Y APE+ L   RY + +
Sbjct: 147 FGLARGVDP----DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAI 188

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 79.2 bits (196), Expect = 2e-18
 Identities = 53/150 (35%), Positives = 77/150 (51%), Gaps = 21/150 (14%)

Query: 3   KKLNKHLKSCLDCELNF-----LSSVN-HPNIIRL----FDAFQAENCIFLVVEFCAGGN 52
           K + KH KS L+   N      L  ++ HPNI+RL    FD  +    + LV E     N
Sbjct: 30  KCMKKHFKS-LEQVNNLREIQALRRLSPHPNILRLIEVLFD--RKTGRLALVFEL-MDMN 85

Query: 53  LSSYIRLHGR-VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
           L   I+   R +PE+  + ++ QL   L+ ++ + I HRD+KPENIL+     D +LK+A
Sbjct: 86  LYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI----KDDILKLA 141

Query: 112 DFGLSCTLYP-GNYAEKVCGSPLYMAPEVL 140
           DFG    +Y    Y E +  +  Y APE L
Sbjct: 142 DFGSCRGIYSKPPYTEYI-STRWYRAPECL 170

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.9 bits (194), Expect = 2e-18
 Identities = 43/144 (29%), Positives = 79/144 (54%), Gaps = 9/144 (6%)

Query: 13  LDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           L+CE+  L ++ H  I++ +   +   E  + + VE+  GG++   ++ +G + E   R+
Sbjct: 51  LECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRR 110

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS---CTLY-PGNYAE 126
           + +Q+  G+  L+S+ I+HRD+K  NIL    D    +K+ DFG S    T+   G   +
Sbjct: 111 YTRQILQGVSYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIK 167

Query: 127 KVCGSPLYMAPEVLQFQRYDEKVN 150
            V G+P +M+PEV+  + Y  K +
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKAD 191

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 80.6 bits (198), Expect = 2e-18
 Identities = 54/179 (30%), Positives = 87/179 (48%), Gaps = 29/179 (16%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYI--- 57
           + L +  KS L  E+N +  + H NI+R  D F  +A   +++++EFC  G+LS  I   
Sbjct: 49  RGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKC 108

Query: 58  -RLHGRVPEQTARKFLQQLGAGLEIL-------NSHHIIHRDLKPENILLS--------- 100
            ++ G++ E       +QL   L          N   ++HRDLKP+NI LS         
Sbjct: 109 YKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168

Query: 101 -----GLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL--QFQRYDEKVNFF 152
                 L+   + KI DFGLS  +   + A    G+P Y +PE+L  + + YD+K + +
Sbjct: 169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMW 227

Length = 1021

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 78.5 bits (193), Expect = 5e-18
 Identities = 43/129 (33%), Positives = 75/129 (58%), Gaps = 6/129 (4%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
           P + +L   FQ  + ++ V+E+  GG+L  +I+  G+  E  A  +  ++  GL  L+  
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120

Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPLYMAPEVLQFQ 143
            II+RDLK +N++   LD +  +KIADFG+ C   +  G      CG+P Y+APE++ +Q
Sbjct: 121 GIIYRDLKLDNVM---LDSEGHIKIADFGM-CKEHMVDGVTTRTFCGTPDYIAPEIIAYQ 176

Query: 144 RYDEKVNFF 152
            Y + V+++
Sbjct: 177 PYGKSVDWW 185

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 78.3 bits (193), Expect = 7e-18
 Identities = 47/138 (34%), Positives = 78/138 (56%), Gaps = 16/138 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNL----SSYIRLHGRVPEQTARKF 71
           E + ++  N   I++L  AFQ +  +++V+E+  GG+L    S+Y      +PE+ AR +
Sbjct: 93  ERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-----DIPEKWARFY 147

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKV 128
             ++   L+ ++S   IHRD+KP+N+L   LD    LK+ADFG +C     N     +  
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFG-TCMKMDANGMVRCDTA 203

Query: 129 CGSPLYMAPEVLQFQRYD 146
            G+P Y++PEVL+ Q  D
Sbjct: 204 VGTPDYISPEVLKSQGGD 221

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 77.0 bits (189), Expect = 8e-18
 Identities = 48/141 (34%), Positives = 75/141 (53%), Gaps = 7/141 (4%)

Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQT 67
           LK+    E   L   +HPNI+RL      +  I++V+E   GG+  +++R  G R+  + 
Sbjct: 36  LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKE 95

Query: 68  ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127
             + ++   AG+E L S H IHRDL   N L++   +  +LKI+DFG+S     G YA  
Sbjct: 96  LIQMVENAAAGMEYLESKHCIHRDLAARNCLVT---EKNVLKISDFGMSREEEDGVYAST 152

Query: 128 --VCGSPL-YMAPEVLQFQRY 145
             +   P+ + APE L + RY
Sbjct: 153 GGMKQIPVKWTAPEALNYGRY 173

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 77.7 bits (191), Expect = 8e-18
 Identities = 46/130 (35%), Positives = 75/130 (57%), Gaps = 4/130 (3%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
            HP +  L+  FQ +  +F V+E+  GG+L  +I+   +     A  +  ++  GL+ L+
Sbjct: 54  EHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH 113

Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQF 142
           S  I++RDLK +NILL   D D  +KIADFG+      G+      CG+P Y+APE+L  
Sbjct: 114 SKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170

Query: 143 QRYDEKVNFF 152
           Q+Y+  V+++
Sbjct: 171 QKYNTSVDWW 180

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 77.5 bits (191), Expect = 8e-18
 Identities = 42/138 (30%), Positives = 72/138 (52%), Gaps = 17/138 (12%)

Query: 16  ELNFLSSVNH-PNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGR-----VP 64
           E++ L  ++    I+RL D    E       ++LV E+    +L  ++  +GR     +P
Sbjct: 50  EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLP 108

Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--CTLYPG 122
            +T + F+ QL  G+   + H ++HRDLKP+N+L+       +LKIAD GL    ++   
Sbjct: 109 AKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLGRAFSIPVK 166

Query: 123 NYAEKVCGSPLYMAPEVL 140
           +Y  ++  +  Y APEVL
Sbjct: 167 SYTHEIV-TLWYRAPEVL 183

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 77.2 bits (190), Expect = 9e-18
 Identities = 46/132 (34%), Positives = 72/132 (54%), Gaps = 5/132 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   L  VN   ++ L  A++ ++ + LV+    GG+L  +I   G     E+ A  +  
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           ++  GLE L+   I++RDLKPENIL   LDD   ++I+D GL+  +  G       G+  
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENIL---LDDYGHIRISDLGLAVEIPEGETIRGRVGTVG 166

Query: 134 YMAPEVLQFQRY 145
           YMAPEV++ +RY
Sbjct: 167 YMAPEVVKNERY 178

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 76.6 bits (188), Expect = 1e-17
 Identities = 42/148 (28%), Positives = 80/148 (54%), Gaps = 9/148 (6%)

Query: 11  SCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           + L+CE+  L ++ H  I++ +   +   E  + + +E   GG++   ++ +G + E   
Sbjct: 49  NALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVT 108

Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----YPGNY 124
           RK+ +Q+  G+  L+S+ I+HRD+K  NIL   + +   +K+ DFG S  L      G  
Sbjct: 109 RKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN---VKLGDFGASKRLQTICLSGTG 165

Query: 125 AEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
            + V G+P +M+PEV+  + Y  K + +
Sbjct: 166 MKSVTGTPYWMSPEVISGEGYGRKADIW 193

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 75.8 bits (187), Expect = 2e-17
 Identities = 42/137 (30%), Positives = 69/137 (50%), Gaps = 8/137 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + ++ ++HP I+RL    + E  + LV+E    G L  Y++    +P    ++   Q+
Sbjct: 46  EASVMAQLDHPCIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV 104

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGS-P 132
             G+  L S H +HRDL   N+LL    +    KI+DFG+S  L  G+  Y     G  P
Sbjct: 105 AMGMAYLESKHFVHRDLAARNVLLV---NRHQAKISDFGMSRALGAGSDYYRATTAGRWP 161

Query: 133 L-YMAPEVLQFQRYDEK 148
           L + APE + + ++  K
Sbjct: 162 LKWYAPECINYGKFSSK 178

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 76.0 bits (187), Expect = 2e-17
 Identities = 40/138 (28%), Positives = 80/138 (57%), Gaps = 10/138 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----VPEQTARKF 71
           E+  LS++ HPNI++  ++F+    +++V+++C GG+L  Y +++ +     PE     +
Sbjct: 49  EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDL--YKKINAQRGVLFPEDQILDW 106

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC-G 130
             Q+   L+ ++   I+HRD+K +NI L+    D  +K+ DFG++  L       + C G
Sbjct: 107 FVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTIKLGDFGIARVLNSTVELARTCIG 163

Query: 131 SPLYMAPEVLQFQRYDEK 148
           +P Y++PE+ + + Y+ K
Sbjct: 164 TPYYLSPEICENRPYNNK 181

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 77.0 bits (189), Expect = 2e-17
 Identities = 47/139 (33%), Positives = 76/139 (54%), Gaps = 6/139 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  ++
Sbjct: 45  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 104

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 133
            + LE L+S  +++RD+K EN++   LD D  +KI DFGL C   +  G   +  CG+P 
Sbjct: 105 VSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGL-CKEGISDGATMKTFCGTPE 160

Query: 134 YMAPEVLQFQRYDEKVNFF 152
           Y+APEVL+   Y   V+++
Sbjct: 161 YLAPEVLEDNDYGRAVDWW 179

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 77.7 bits (191), Expect = 2e-17
 Identities = 46/146 (31%), Positives = 83/146 (56%), Gaps = 14/146 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RLHGRVP--EQTARKF 71
           EL+ L++ +H  I++ FD F++++ + L++E+ +GG+L+  I  RL   +P  E      
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILL--SGLDDDVMLKIADFGLSCTLYPG---NYAE 126
             Q+   L+ ++S  ++HRDLK  NI L  +G+     +K+ DFG S         + A 
Sbjct: 175 FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI-----IKLGDFGFSKQYSDSVSLDVAS 229

Query: 127 KVCGSPLYMAPEVLQFQRYDEKVNFF 152
             CG+P Y+APE+ + +RY +K + +
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMW 255

Length = 478

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 76.4 bits (188), Expect = 2e-17
 Identities = 38/118 (32%), Positives = 63/118 (53%), Gaps = 5/118 (4%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
           P ++ L  AFQ +  + L++++  GG L +++       E   R ++ ++   L+ L+  
Sbjct: 65  PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL 124

Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQ 141
            II+RD+K ENIL   LD +  + + DFGLS          A   CG+  YMAPEV++
Sbjct: 125 GIIYRDIKLENIL---LDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 76.2 bits (187), Expect = 2e-17
 Identities = 46/132 (34%), Positives = 72/132 (54%), Gaps = 5/132 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E   L  VN   ++ L  A++ ++ + LV+    GG+L  +I   G     E  A  +  
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           ++  GLE L+   I++RDLKPENIL   LDD   ++I+D GL+  +  G   +   G+  
Sbjct: 110 EICCGLEDLHQERIVYRDLKPENIL---LDDHGHIRISDLGLAVHVPEGQTIKGRVGTVG 166

Query: 134 YMAPEVLQFQRY 145
           YMAPEV++ +RY
Sbjct: 167 YMAPEVVKNERY 178

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 75.5 bits (186), Expect = 2e-17
 Identities = 35/118 (29%), Positives = 65/118 (55%), Gaps = 6/118 (5%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
            LK  +   ++ L  E + ++++ HPN+++L       N +++V E+ A G+L  Y+R  
Sbjct: 36  CLKDDSTAAQAFLA-EASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR 94

Query: 61  GR--VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           GR  +       F   +  G+E L   + +HRDL   N+L+S   +D++ K++DFGL+
Sbjct: 95  GRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS---EDLVAKVSDFGLA 149

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 76.2 bits (187), Expect = 2e-17
 Identities = 47/132 (35%), Positives = 71/132 (53%), Gaps = 5/132 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   L  VN   ++ L  A++ ++ + LV+    GG+L  +I   G     E+ A  +  
Sbjct: 50  EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           ++  GLE L+  + ++RDLKPENILL   DD   ++I+D GL+  +  G       G+  
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVG 166

Query: 134 YMAPEVLQFQRY 145
           YMAPEVL  QRY
Sbjct: 167 YMAPEVLNNQRY 178

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 75.9 bits (187), Expect = 2e-17
 Identities = 46/142 (32%), Positives = 78/142 (54%), Gaps = 17/142 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
           E+  +    HPNI+ ++ ++   + +++V+EF  GG L+  I  H R+ E Q A   L  
Sbjct: 66  EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAV 124

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV------ 128
           L A L  L++  +IHRD+K ++ILL+    D  +K++DFG  C       +++V      
Sbjct: 125 LKA-LSFLHAQGVIHRDIKSDSILLT---SDGRVKLSDFGF-C----AQVSKEVPRRKSL 175

Query: 129 CGSPLYMAPEVLQFQRYDEKVN 150
            G+P +MAPEV+    Y  +V+
Sbjct: 176 VGTPYWMAPEVISRLPYGTEVD 197

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 76.5 bits (189), Expect = 3e-17
 Identities = 48/137 (35%), Positives = 75/137 (54%), Gaps = 20/137 (14%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           E+ FL  + +HPNI++L +  +AEN   I+LV E+    +L + IR    + +   R  +
Sbjct: 56  EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEY-METDLHAVIR-ANILEDVHKRYIM 113

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            QL   L+ ++S ++IHRDLKP NIL   L+ D  +K+ADFGL+ +L           +P
Sbjct: 114 YQLLKALKYIHSGNVIHRDLKPSNIL---LNSDCRVKLADFGLARSLSELEENP---ENP 167

Query: 133 L---------YMAPEVL 140
           +         Y APE+L
Sbjct: 168 VLTDYVATRWYRAPEIL 184

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 76.6 bits (188), Expect = 3e-17
 Identities = 44/133 (33%), Positives = 79/133 (59%), Gaps = 6/133 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + ++  N P +++LF AFQ +  +++V+E+  GG+L + +  +  VPE+ A+ +  ++
Sbjct: 93  ERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEV 151

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPL 133
              L+ ++S  +IHRD+KP+N+L   LD    LK+ADFG    +        +   G+P 
Sbjct: 152 VLALDAIHSMGLIHRDVKPDNML---LDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPD 208

Query: 134 YMAPEVLQFQRYD 146
           Y++PEVL+ Q  D
Sbjct: 209 YISPEVLKSQGGD 221

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 75.8 bits (187), Expect = 4e-17
 Identities = 40/140 (28%), Positives = 70/140 (50%), Gaps = 19/140 (13%)

Query: 16  ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGR-----VPEQTA 68
           E+  L  + H N++ L + F   A+  ++L+ ++ A  +L   I+ H +     +P    
Sbjct: 52  EIALLRELKHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMV 110

Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLS-------CTLY 120
           +  L Q+  G+  L+S+ ++HRDLKP NIL+ G   +  ++KI D GL+         L 
Sbjct: 111 KSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170

Query: 121 PGNYAEKVCGSPLYMAPEVL 140
             +    V  +  Y APE+L
Sbjct: 171 DLD---PVVVTIWYRAPELL 187

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 75.5 bits (186), Expect = 5e-17
 Identities = 46/131 (35%), Positives = 68/131 (51%), Gaps = 5/131 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PE    K    +
Sbjct: 49  ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAV 108

Query: 76  GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 109 LRGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 164

Query: 135 MAPEVLQFQRY 145
           M+PE LQ   Y
Sbjct: 165 MSPERLQGTHY 175

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 75.8 bits (186), Expect = 6e-17
 Identities = 45/133 (33%), Positives = 78/133 (58%), Gaps = 6/133 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + ++  N P +++LF AFQ +  +++V+E+  GG+L + +  +  VPE+ AR +  ++
Sbjct: 93  ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEV 151

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPL 133
              L+ ++S   IHRD+KP+N+L   LD    LK+ADFG    +        +   G+P 
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 208

Query: 134 YMAPEVLQFQRYD 146
           Y++PEVL+ Q  D
Sbjct: 209 YISPEVLKSQGGD 221

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 75.5 bits (185), Expect = 7e-17
 Identities = 47/141 (33%), Positives = 83/141 (58%), Gaps = 8/141 (5%)

Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRV 63
           L +   +C   E + L + ++  I  L  AFQ EN ++LV+++  GG+L + + +   R+
Sbjct: 40  LKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL 99

Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYP 121
           PE  AR +L ++   ++ ++  H +HRD+KP+NIL   +D +  +++ADFG SC   +  
Sbjct: 100 PEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL---MDMNGHIRLADFG-SCLKLMED 155

Query: 122 GNYAEKVC-GSPLYMAPEVLQ 141
           G     V  G+P Y++PE+LQ
Sbjct: 156 GTVQSSVAVGTPDYISPEILQ 176

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 75.1 bits (184), Expect = 8e-17
 Identities = 51/140 (36%), Positives = 76/140 (54%), Gaps = 13/140 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+ FL  + HPN I     +  E+  +LV+E+C G + S  + +H + P Q         
Sbjct: 75  EVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKK-PLQEVEIAAITH 132

Query: 76  GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           GA  GL  L+SH++IHRD+K  NILL+   +   +K+ADFG +    P N      G+P 
Sbjct: 133 GALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASIASPAN---SFVGTPY 186

Query: 134 YMAPEVLQFQ---RYDEKVN 150
           +MAPEV+      +YD KV+
Sbjct: 187 WMAPEVILAMDEGQYDGKVD 206

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 74.5 bits (183), Expect = 8e-17
 Identities = 44/139 (31%), Positives = 68/139 (48%), Gaps = 9/139 (6%)

Query: 16  ELNFL-SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNL----SSYIRLHGRVPEQTARK 70
           E+  +   + HPNI+R +  F   + +++V++   G  L    +S      R  E+    
Sbjct: 58  EVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117

Query: 71  FLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
              Q+   L  L+    I+HRDL P NI+L G DD V   I DFGL+    P +    V 
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIML-GEDDKVT--ITDFGLAKQKQPESKLTSVV 174

Query: 130 GSPLYMAPEVLQFQRYDEK 148
           G+ LY  PE+++ + Y EK
Sbjct: 175 GTILYSCPEIVKNEPYGEK 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 75.2 bits (185), Expect = 9e-17
 Identities = 45/129 (34%), Positives = 73/129 (56%), Gaps = 6/129 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
           E + LS  N P I +L  AFQ ++ ++LV+E+  GG+L S + R   +  E  A+ +L +
Sbjct: 51  ERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAE 110

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSP 132
           L   +  ++    +HRD+KPEN+L   +D    +K+ADFG +  L       ++   G+P
Sbjct: 111 LVLAIHSVHQMGYVHRDIKPENVL---IDRTGHIKLADFGSAARLTANKMVNSKLPVGTP 167

Query: 133 LYMAPEVLQ 141
            Y+APEVL 
Sbjct: 168 DYIAPEVLT 176

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 74.7 bits (183), Expect = 1e-16
 Identities = 51/142 (35%), Positives = 77/142 (54%), Gaps = 13/142 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+ FL  + HPN I     +  E+  +LV+E+C G + S  + +H + P Q         
Sbjct: 71  EVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKK-PLQEVEIAAITH 128

Query: 76  GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           GA  GL  L+SH++IHRD+K  NILL+   +   +K+ADFG +    P N      G+P 
Sbjct: 129 GALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASKSSPAN---SFVGTPY 182

Query: 134 YMAPEVLQFQ---RYDEKVNFF 152
           +MAPEV+      +YD KV+ +
Sbjct: 183 WMAPEVILAMDEGQYDGKVDVW 204

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 74.7 bits (184), Expect = 1e-16
 Identities = 44/154 (28%), Positives = 68/154 (44%), Gaps = 32/154 (20%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC----IFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           EL  L    H NII + D  +        +++V++     +L   I     + E+  R F
Sbjct: 54  ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL-MESDLHHIIHSDQPLTEEHIRYF 112

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
           L QL  GL+ ++S ++IHRDLKP N+L++    D  L+I DFG+         A  +  S
Sbjct: 113 LYQLLRGLKYIHSANVIHRDLKPSNLLVNE---DCELRIGDFGM---------ARGLSSS 160

Query: 132 PL--------------YMAPEVL-QFQRYDEKVN 150
           P               Y APE+L     Y   ++
Sbjct: 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAID 194

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 74.1 bits (182), Expect = 1e-16
 Identities = 41/127 (32%), Positives = 65/127 (51%), Gaps = 8/127 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           EL+ L     P I+  + AF  E  +++ +E+   G+L            +PE   R+  
Sbjct: 49  ELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRIT 108

Query: 73  QQLGAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
             +  GL+ L   H+IIHRD+KP N+L++G   +  +K+ DFG+S  L   + A+   G 
Sbjct: 109 YAVVKGLKFLKEEHNIIHRDVKPTNVLVNG---NGQVKLCDFGVSGNLV-ASLAKTNIGC 164

Query: 132 PLYMAPE 138
             YMAPE
Sbjct: 165 QSYMAPE 171

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 74.0 bits (182), Expect = 1e-16
 Identities = 47/136 (34%), Positives = 73/136 (53%), Gaps = 4/136 (2%)

Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           +K +K     E+  L  + H N++ L + F+ +  ++LV EF     L    +    + E
Sbjct: 40  DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDE 99

Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNY 124
              RK+L Q+  G+E  +SH+IIHRD+KPENIL+S      ++K+ DFG + TL  PG  
Sbjct: 100 SRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEV 156

Query: 125 AEKVCGSPLYMAPEVL 140
                 +  Y APE+L
Sbjct: 157 YTDYVATRWYRAPELL 172

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 74.4 bits (182), Expect = 1e-16
 Identities = 47/141 (33%), Positives = 79/141 (56%), Gaps = 11/141 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
           E+  +  + +PNI+   D+F   + +F+V+E+ AGG+L+  +        Q A   R+ L
Sbjct: 66  EILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL 125

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGS 131
           Q     LE L+++ +IHRD+K +N+LL G+D  V  K+ DFG    + P       + G+
Sbjct: 126 Q----ALEFLHANQVIHRDIKSDNVLL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGT 178

Query: 132 PLYMAPEVLQFQRYDEKVNFF 152
           P +MAPEV+  + Y  KV+ +
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIW 199

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 74.1 bits (183), Expect = 1e-16
 Identities = 42/132 (31%), Positives = 73/132 (55%), Gaps = 13/132 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFL 72
           E+  L  + HPNI+RL +    + +  I++V E+    +L+  +     +  E   + ++
Sbjct: 48  EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYM 106

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---YPGNYAEKVC 129
           +QL  GL+ L+S+ I+HRD+K  NIL   +++D +LK+ADFGL+         +Y  +V 
Sbjct: 107 KQLLEGLQYLHSNGILHRDIKGSNIL---INNDGVLKLADFGLARPYTKRNSADYTNRVI 163

Query: 130 GSPL-YMAPEVL 140
              L Y  PE+L
Sbjct: 164 --TLWYRPPELL 173

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 74.3 bits (182), Expect = 1e-16
 Identities = 49/145 (33%), Positives = 82/145 (56%), Gaps = 11/145 (7%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RL 59
           MLK+      +C   E N L + +   I  L  AFQ EN ++LV+++  GG+L + + + 
Sbjct: 39  MLKRAET---ACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKF 95

Query: 60  HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-- 117
             R+PE  AR ++ ++   +  ++  H +HRD+KP+N+L   LD +  +++ADFG SC  
Sbjct: 96  EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVL---LDMNGHIRLADFG-SCLK 151

Query: 118 TLYPGNYAEKVC-GSPLYMAPEVLQ 141
               G     V  G+P Y++PE+LQ
Sbjct: 152 MNQDGTVQSSVAVGTPDYISPEILQ 176

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 73.6 bits (181), Expect = 2e-16
 Identities = 43/149 (28%), Positives = 70/149 (46%), Gaps = 22/149 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK----- 70
           E   +S + HPNI+ L      E    ++ E+ A G+L  ++  +    +  A       
Sbjct: 58  EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117

Query: 71  --------FLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
                   FL    Q+ AG+E L+SHH +HRDL   N L+    + + +KI+DFGLS  +
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG---EGLTVKISDFGLSRDI 174

Query: 120 YPGNYAEKVCGSPL---YMAPEVLQFQRY 145
           Y  +Y      S L   +M PE + + ++
Sbjct: 175 YSADYYRVQSKSLLPVRWMPPEAILYGKF 203

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 73.9 bits (181), Expect = 2e-16
 Identities = 51/144 (35%), Positives = 75/144 (52%), Gaps = 13/144 (9%)

Query: 17  LNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTAR 69
           L  L +  HPN++RLFD         E  + LV E     +L++Y+       VP +T +
Sbjct: 55  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIK 113

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             + QL  GL+ L+SH ++HRDLKP+NIL++       +K+ADFGL+  +Y    A    
Sbjct: 114 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLA-RIYSFQMALTSV 169

Query: 130 GSPL-YMAPEVLQFQRYDEKVNFF 152
              L Y APEVL    Y   V+ +
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLW 193

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 73.6 bits (180), Expect = 2e-16
 Identities = 47/141 (33%), Positives = 79/141 (56%), Gaps = 11/141 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
           E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +        Q A   R+ L
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGS 131
           Q     LE L+S+ +IHRD+K +NILL G+D  V  K+ DFG    + P  +    + G+
Sbjct: 127 Q----ALEFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGT 179

Query: 132 PLYMAPEVLQFQRYDEKVNFF 152
           P +MAPEV+  + Y  KV+ +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIW 200

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 73.9 bits (181), Expect = 2e-16
 Identities = 51/140 (36%), Positives = 78/140 (55%), Gaps = 13/140 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+ FL  + HPN I+    +  E+  +LV+E+C G + S  + +H + P Q         
Sbjct: 65  EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKK-PLQEVEIAAVTH 122

Query: 76  GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           GA  GL  L+SH++IHRD+K  NILLS   +  ++K+ DFG +  + P N      G+P 
Sbjct: 123 GALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPAN---XFVGTPY 176

Query: 134 YMAPEVLQFQ---RYDEKVN 150
           +MAPEV+      +YD KV+
Sbjct: 177 WMAPEVILAMDEGQYDGKVD 196

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 73.5 bits (180), Expect = 2e-16
 Identities = 48/146 (32%), Positives = 79/146 (54%), Gaps = 15/146 (10%)

Query: 13  LDCELNFLSSV-NHPNIIRLFDAF-QAENCI----FLVVEFCAGGNLSSYI----RLHGR 62
           ++ E N L S+ NHPN+++ +  F +A+  +    +LV+E C GG+++  +        R
Sbjct: 65  IEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR 124

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           + E      L     GL+ L+++ IIHRD+K  NILL+    +  +K+ DFG+S  L   
Sbjct: 125 LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT---EGGVKLVDFGVSAQLTST 181

Query: 123 NYAEKV-CGSPLYMAPEVLQF-QRYD 146
                   G+P +MAPEV+   Q+YD
Sbjct: 182 RLRRNTSVGTPFWMAPEVIACEQQYD 207

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 73.1 bits (179), Expect = 3e-16
 Identities = 47/132 (35%), Positives = 70/132 (53%), Gaps = 5/132 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   L  VN   ++ L  A++ ++ + LV+    GG+L  +I   G     EQ A  +  
Sbjct: 50  EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           +L  GLE L    I++RDLKPENIL   LDD   ++I+D GL+  +  G       G+  
Sbjct: 110 ELCCGLEDLQRERIVYRDLKPENIL---LDDRGHIRISDLGLAVQIPEGETVRGRVGTVG 166

Query: 134 YMAPEVLQFQRY 145
           YMAPEV+  ++Y
Sbjct: 167 YMAPEVINNEKY 178

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 73.5 bits (180), Expect = 3e-16
 Identities = 47/131 (35%), Positives = 69/131 (52%), Gaps = 5/131 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112

Query: 76  GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 113 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 168

Query: 135 MAPEVLQFQRY 145
           M+PE LQ   Y
Sbjct: 169 MSPERLQGTHY 179

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 72.4 bits (178), Expect = 3e-16
 Identities = 47/149 (31%), Positives = 65/149 (43%), Gaps = 19/149 (12%)

Query: 9   LKSCLD---CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRV 63
           L   +D    E   + S++H N+IRL+        + +V E    G+L   +R    G  
Sbjct: 36  LSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHF 94

Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---- 119
              T   +  Q+  G+  L S   IHRDL   NILL+  DD V  KI DFGL   L    
Sbjct: 95  LISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLAS-DDKV--KIGDFGLMRALPQNE 151

Query: 120 --YPGNYAEKVCGSPL-YMAPEVLQFQRY 145
             Y      KV   P  + APE L+ + +
Sbjct: 152 DHYVMEEHLKV---PFAWCAPESLRTRTF 177

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 72.6 bits (178), Expect = 4e-16
 Identities = 41/140 (29%), Positives = 75/140 (53%), Gaps = 10/140 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L S+ H NI++       +N I + +EF  GG++SS +   G +PE    K+ +Q+
Sbjct: 52  EVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI 111

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG-------LSCTLYPGNYAEKV 128
             G+  L+++ ++HRD+K  N++L     + ++K+ DFG       +       N  + +
Sbjct: 112 LDGVAYLHNNCVVHRDIKGNNVMLM---PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM 168

Query: 129 CGSPLYMAPEVLQFQRYDEK 148
            G+P +MAPEV+    Y  K
Sbjct: 169 HGTPYWMAPEVINESGYGRK 188

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 72.4 bits (177), Expect = 5e-16
 Identities = 42/138 (30%), Positives = 74/138 (53%), Gaps = 5/138 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P I R + ++     +++++E+  GG+    ++  G + E      L+++
Sbjct: 52  EITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREI 110

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 134
             GL+ L+S   IHRD+K  N+LLS   D   +K+ADFG++  L           G+P +
Sbjct: 111 LKGLDYLHSERKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFW 167

Query: 135 MAPEVLQFQRYDEKVNFF 152
           MAPEV++   YD K + +
Sbjct: 168 MAPEVIKQSAYDFKADIW 185

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 72.1 bits (177), Expect = 5e-16
 Identities = 43/134 (32%), Positives = 70/134 (52%), Gaps = 7/134 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   L   +HPNI++L      +  I++V+E   GG+L +++R    R+  +   +    
Sbjct: 42  EAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLD 101

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSP 132
             AG+E L S + IHRDL   N L   + ++ +LKI+DFG+S     G Y   + +   P
Sbjct: 102 AAAGMEYLESKNCIHRDLAARNCL---VGENNVLKISDFGMSREEEGGIYTVSDGLKQIP 158

Query: 133 L-YMAPEVLQFQRY 145
           + + APE L + RY
Sbjct: 159 IKWTAPEALNYGRY 172

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 72.3 bits (177), Expect = 6e-16
 Identities = 47/139 (33%), Positives = 75/139 (53%), Gaps = 5/139 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
           E   L  VN P I+ L  AF+++  + LV+    GG+L  +I   G    +  R   +  
Sbjct: 43  EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           Q+  G+  L+S  I++RD+KPEN+LL   DD    +++D GL+  L  G    +  G+  
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNG 159

Query: 134 YMAPEVLQFQRYDEKVNFF 152
           YMAPE+L+ + Y   V++F
Sbjct: 160 YMAPEILKEEPYSYPVDWF 178

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 72.1 bits (177), Expect = 7e-16
 Identities = 43/145 (29%), Positives = 73/145 (50%), Gaps = 29/145 (20%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY---IRLHGRVPEQTARKFL 72
           E++ L  + HPNI+ L D    E+ ++L+ EF +  +L  Y   +     +  +  + +L
Sbjct: 49  EISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYL 107

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+  G+   +S  ++HRDLKP+N+L   +D+  ++K+ADFGL+          +  G P
Sbjct: 108 YQILQGILFCHSRRVLHRDLKPQNLL---IDNKGVIKLADFGLA----------RAFGIP 154

Query: 133 L-----------YMAPEVL-QFQRY 145
           +           Y APEVL    RY
Sbjct: 155 VRVYTHEVVTLWYRAPEVLLGSPRY 179

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 71.4 bits (175), Expect = 8e-16
 Identities = 39/137 (28%), Positives = 68/137 (49%), Gaps = 8/137 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
           E   +  ++H  +++L+     +  I++V E+ + G L +Y+R HG+  +     +  + 
Sbjct: 49  EAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKD 108

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +  G+  L S   IHRDL   N L   +DD   +K++DFGLS  +    Y   V GS   
Sbjct: 109 VCEGMAYLESKQFIHRDLAARNCL---VDDQGCVKVSDFGLSRYVLDDEYTSSV-GSKFP 164

Query: 134 --YMAPEVLQFQRYDEK 148
             +  PEVL + ++  K
Sbjct: 165 VRWSPPEVLLYSKFSSK 181

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 72.4 bits (178), Expect = 9e-16
 Identities = 50/144 (34%), Positives = 69/144 (47%), Gaps = 18/144 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRL---HGRVPEQ 66
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   H R+   
Sbjct: 65  ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMEL-MDANLCQVIQMDLDHERM--- 120

Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
                L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T        
Sbjct: 121 --SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTSFMMT 175

Query: 127 KVCGSPLYMAPEVLQFQRYDEKVN 150
               +  Y APEV+    Y E V+
Sbjct: 176 PYVVTRYYRAPEVILGMGYKENVD 199

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 72.2 bits (177), Expect = 9e-16
 Identities = 48/137 (35%), Positives = 72/137 (52%), Gaps = 9/137 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
           EL  L  + H NII L D F      I+ V E   G +L   +     + +Q  + FL Q
Sbjct: 59  ELKLLKHLRHENIISLSDIFISPLEDIYFVTEL-LGTDLHRLLT-SRPLEKQFIQYFLYQ 116

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
           +  GL+ ++S  ++HRDLKP NIL   ++++  LKI DFGL+    P         +  Y
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNIL---INENCDLKICDFGLARIQDP--QMTGYVSTRYY 171

Query: 135 MAPEV-LQFQRYDEKVN 150
            APE+ L +Q+YD +V+
Sbjct: 172 RAPEIMLTWQKYDVEVD 188

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 71.6 bits (175), Expect = 9e-16
 Identities = 42/138 (30%), Positives = 73/138 (52%), Gaps = 5/138 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P + + + ++     +++++E+  GG+    +R  G   E      L+++
Sbjct: 52  EITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEI 110

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVCGSPLY 134
             GL+ L+S   IHRD+K  N+LLS   D   +K+ADFG++  L           G+P +
Sbjct: 111 LKGLDYLHSEKKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFW 167

Query: 135 MAPEVLQFQRYDEKVNFF 152
           MAPEV+Q   YD K + +
Sbjct: 168 MAPEVIQQSAYDSKADIW 185

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 72.1 bits (176), Expect = 1e-15
 Identities = 46/141 (32%), Positives = 78/141 (55%), Gaps = 11/141 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
           E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +        Q A   R+ L
Sbjct: 66  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 125

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGS 131
           Q     L+ L+S+ +IHRD+K +NILL G+D  V  K+ DFG    + P       + G+
Sbjct: 126 Q----ALDFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGT 178

Query: 132 PLYMAPEVLQFQRYDEKVNFF 152
           P +MAPEV+  + Y  KV+ +
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIW 199

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 71.6 bits (175), Expect = 1e-15
 Identities = 41/130 (31%), Positives = 68/130 (52%), Gaps = 4/130 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +    H NI+  F ++   + +++ +EFC GG+L     + G + E       ++ 
Sbjct: 56  EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRET 115

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
             GL  L+S   +HRD+K  NILL+   D+  +K+ADFG+S  +       K   G+P +
Sbjct: 116 LQGLYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSFIGTPYW 172

Query: 135 MAPEVLQFQR 144
           MAPEV   +R
Sbjct: 173 MAPEVAAVER 182

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 72.0 bits (176), Expect = 1e-15
 Identities = 45/139 (32%), Positives = 74/139 (53%), Gaps = 6/139 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +  HP +  L  +FQ ++ +  V+E+  GG L  ++       E   R +  ++
Sbjct: 45  ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEI 104

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 133
            + L+ L+S  I++RDLK EN++   LD D  +KI DFGL C   +      +  CG+P 
Sbjct: 105 VSALDYLHSGKIVYRDLKLENLM---LDKDGHIKITDFGL-CKEGITDAATMKTFCGTPE 160

Query: 134 YMAPEVLQFQRYDEKVNFF 152
           Y+APEVL+   Y   V+++
Sbjct: 161 YLAPEVLEDNDYGRAVDWW 179

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 71.8 bits (176), Expect = 1e-15
 Identities = 44/127 (34%), Positives = 68/127 (53%), Gaps = 14/127 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  VNHPN+++  D F     I +++EF  GG+L        +     AR+ L   
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQIL--- 178

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG----LSCTLYPGNYAEKVCGS 131
            +G+  L+  HI+HRD+KP N+L   ++    +KIADFG    L+ T+ P N +    G+
Sbjct: 179 -SGIAYLHRRHIVHRDIKPSNLL---INSAKNVKIADFGVSRILAQTMDPCNSS---VGT 231

Query: 132 PLYMAPE 138
             YM+PE
Sbjct: 232 IAYMSPE 238

Length = 353

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 71.2 bits (175), Expect = 1e-15
 Identities = 40/127 (31%), Positives = 66/127 (51%), Gaps = 6/127 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  + HPN++ L + F+ +  + LV E+C    L+   +    VPE   +K + Q 
Sbjct: 50  EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQT 109

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--NYAEKVCGSPL 133
              +   + H+ IHRD+KPENIL++       +K+ DFG +  L     +Y + V  +  
Sbjct: 110 LQAVNFCHKHNCIHRDVKPENILIT---KQGQIKLCDFGFARILTGPGDDYTDYV-ATRW 165

Query: 134 YMAPEVL 140
           Y APE+L
Sbjct: 166 YRAPELL 172

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 71.8 bits (176), Expect = 1e-15
 Identities = 35/111 (31%), Positives = 67/111 (60%), Gaps = 8/111 (7%)

Query: 8   HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQT 67
           H+K+    E + L+  ++  +++L+ +FQ ++ ++ V+++  GG++ S +   G   E  
Sbjct: 47  HVKA----ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL 102

Query: 68  ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
           AR ++ +L   +E ++    IHRD+KP+NIL   +D D  +K+ DFGL CT
Sbjct: 103 ARFYIAELTCAIESVHKMGFIHRDIKPDNIL---IDRDGHIKLTDFGL-CT 149

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 70.7 bits (174), Expect = 2e-15
 Identities = 35/131 (26%), Positives = 64/131 (48%), Gaps = 19/131 (14%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           ++PN I+L+ +        L++++   G+L   ++  G++ E   +K ++QL   L  L+
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH 126

Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-------YMA 136
            H+IIH D+K EN+L     D +   + D+GL           K+ G+P        Y +
Sbjct: 127 KHNIIHNDIKLENVLYDRAKDRI--YLCDYGLC----------KIIGTPSCYDGTLDYFS 174

Query: 137 PEVLQFQRYDE 147
           PE ++   YD 
Sbjct: 175 PEKIKGHNYDV 185

Length = 267

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 71.3 bits (175), Expect = 2e-15
 Identities = 43/118 (36%), Positives = 72/118 (61%), Gaps = 8/118 (6%)

Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQLGAGLEILNSHH 86
           I  L  AFQ EN ++LV+++  GG+L + + +   R+PE  AR +L ++   ++ ++   
Sbjct: 63  ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122

Query: 87  IIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVC-GSPLYMAPEVLQ 141
            +HRD+KP+N+L   LD +  +++ADFG SC   L  G     V  G+P Y++PE+LQ
Sbjct: 123 YVHRDIKPDNVL---LDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQ 176

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 71.2 bits (174), Expect = 2e-15
 Identities = 45/131 (34%), Positives = 68/131 (51%), Gaps = 5/131 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++   R+PE+   K    +
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 112

Query: 76  GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 113 LRGLAYLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 168

Query: 135 MAPEVLQFQRY 145
           M+PE LQ   Y
Sbjct: 169 MSPERLQGTHY 179

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 70.9 bits (174), Expect = 2e-15
 Identities = 49/130 (37%), Positives = 72/130 (55%), Gaps = 10/130 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFL 72
           E+  L ++ HPNI+ L +    +  + IFLV+E+C   +L+S +  +     E   +  +
Sbjct: 56  EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLM 114

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCG 130
            QL  GL+ L+ + IIHRDLK  N+LL+   D   LKIADFGL+ T  L       KV  
Sbjct: 115 LQLLRGLQYLHENFIIHRDLKVSNLLLT---DKGCLKIADFGLARTYGLPAKPMTPKVV- 170

Query: 131 SPLYMAPEVL 140
           +  Y APE+L
Sbjct: 171 TLWYRAPELL 180

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 70.7 bits (173), Expect = 2e-15
 Identities = 45/130 (34%), Positives = 67/130 (51%), Gaps = 8/130 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   + P II  + AF  EN I +  EF  GG+L  Y     ++PE    +    +
Sbjct: 49  ELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAV 104

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
             GL  L S  I+HRD+KP N+L++       +K+ DFG+S  L   + A+   G+  YM
Sbjct: 105 VKGLTYLWSLKILHRDVKPSNMLVNTRGQ---VKLCDFGVSTQLV-NSIAKTYVGTNAYM 160

Query: 136 APEVLQFQRY 145
           APE +  ++Y
Sbjct: 161 APERISGEQY 170

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 70.3 bits (172), Expect = 3e-15
 Identities = 43/137 (31%), Positives = 75/137 (54%), Gaps = 5/137 (3%)

Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
           L+ +S+ + P I+ +  AF   + +  +++   GG+L  ++  HG   E   R +  ++ 
Sbjct: 48  LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEII 107

Query: 77  AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 136
            GLE +++  +++RDLKP NIL   LD+   ++I+D GL+C  +         G+  YMA
Sbjct: 108 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 163

Query: 137 PEVLQFQ-RYDEKVNFF 152
           PEVLQ    YD   ++F
Sbjct: 164 PEVLQKGVAYDSSADWF 180

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 69.7 bits (171), Expect = 4e-15
 Identities = 41/140 (29%), Positives = 68/140 (48%), Gaps = 20/140 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +V+E  A G+L SY+R   R PE          
Sbjct: 59  EASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLR--SRRPEAENNPGLGPP 116

Query: 67  TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           T +KF+Q   ++  G+  L +   +HRDL   N +++   +D+ +KI DFG++  +Y  +
Sbjct: 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGMTRDIYETD 173

Query: 124 YAEKVCGSPL---YMAPEVL 140
           Y  K     L   +MAPE L
Sbjct: 174 YYRKGGKGLLPVRWMAPESL 193

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 69.6 bits (170), Expect = 5e-15
 Identities = 43/137 (31%), Positives = 76/137 (55%), Gaps = 5/137 (3%)

Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
           L+ +S+ + P I+ +  AF   + +  +++   GG+L  ++  HG   E+  R +  ++ 
Sbjct: 48  LSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEII 107

Query: 77  AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 136
            GLE +++  +++RDLKP NIL   LD+   ++I+D GL+C  +         G+  YMA
Sbjct: 108 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 163

Query: 137 PEVLQF-QRYDEKVNFF 152
           PEVLQ    YD   ++F
Sbjct: 164 PEVLQKGTAYDSSADWF 180

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 69.5 bits (170), Expect = 5e-15
 Identities = 40/137 (29%), Positives = 65/137 (47%), Gaps = 7/137 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  V          
Sbjct: 52  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 111

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 132
           Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y A      P
Sbjct: 112 QISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFP 168

Query: 133 L-YMAPEVLQFQRYDEK 148
           + + APE L + ++  K
Sbjct: 169 IKWTAPESLAYNKFSIK 185

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 69.4 bits (170), Expect = 6e-15
 Identities = 37/148 (25%), Positives = 70/148 (47%), Gaps = 22/148 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------- 61
           E   L++  H NI++ +      +   +V E+   G+L+ ++R HG              
Sbjct: 58  EAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMG 117

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
            +      +   Q+ +G+  L S H +HRDL   N L+     D+++KI DFG+S  +Y 
Sbjct: 118 ELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG---YDLVVKIGDFGMSRDVYT 174

Query: 122 GNYAEKVCGSPL----YMAPEVLQFQRY 145
            +Y  +V G  +    +M PE + ++++
Sbjct: 175 TDYY-RVGGHTMLPIRWMPPESIMYRKF 201

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 70.1 bits (171), Expect = 7e-15
 Identities = 50/143 (34%), Positives = 68/143 (47%), Gaps = 12/143 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  L  VNH NII L + F  +        ++LV+E     NL   I  H  +  +   
Sbjct: 70  ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL-MDANLCQVI--HMELDHERMS 126

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 127 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTACTNFMMTPYV 183

Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 184 VTRYYRAPEVILGMGYKENVDIW 206

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 69.7 bits (170), Expect = 7e-15
 Identities = 46/140 (32%), Positives = 76/140 (54%), Gaps = 7/140 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++       E  AR +  ++
Sbjct: 45  ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 104

Query: 76  GAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSP 132
            + L+ L+S  ++++RDLK EN++L   D D  +KI DFGL C   +  G   +  CG+P
Sbjct: 105 VSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGL-CKEGIKDGATMKTFCGTP 160

Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+APEVL+   Y   V+++
Sbjct: 161 EYLAPEVLEDNDYGRAVDWW 180

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 69.6 bits (170), Expect = 8e-15
 Identities = 51/139 (36%), Positives = 73/139 (52%), Gaps = 23/139 (16%)

Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPE-QTARKFL 72
           H NII L      E  ++++VE+ A GNL  ++R              +VPE Q + K L
Sbjct: 77  HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136

Query: 73  ----QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
                Q+  G+E L S   IHRDL   N+L++  +D+VM KIADFGL+  ++  +Y +K 
Sbjct: 137 VSCAYQVARGMEYLESRRCIHRDLAARNVLVT--EDNVM-KIADFGLARGVHDIDYYKKT 193

Query: 129 CGSPL---YMAPEVLQFQR 144
               L   +MAPE L F R
Sbjct: 194 SNGRLPVKWMAPEAL-FDR 211

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 69.6 bits (171), Expect = 9e-15
 Identities = 36/107 (33%), Positives = 60/107 (56%), Gaps = 11/107 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAF----QAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  L  ++H N+I L D F      E+   ++LV     G +L++ ++   ++ +   +
Sbjct: 64  ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHL-MGADLNNIVK-CQKLSDDHIQ 121

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
             + Q+  GL+ ++S  IIHRDLKP NI    +++D  LKI DFGL+
Sbjct: 122 FLVYQILRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLA 165

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 69.3 bits (170), Expect = 9e-15
 Identities = 43/143 (30%), Positives = 67/143 (46%), Gaps = 26/143 (18%)

Query: 16  ELNFLSSVNHPNIIRLFD-----AFQAENC---IFLVVEFC----AGGNLSSYIRLHGRV 63
           E+  L  + H N++ L +     A          +LV EFC    AG  L S   +   +
Sbjct: 61  EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAG--LLSNKNVKFTL 118

Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY--- 120
            E   +K ++ L  GL  ++ + I+HRD+K  NIL++    D +LK+ADFGL+       
Sbjct: 119 SE--IKKVMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFGLARAFSLSK 173

Query: 121 ---PGNYAEKVCGSPLYMAPEVL 140
              P  Y  +V  +  Y  PE+L
Sbjct: 174 NSKPNRYTNRVV-TLWYRPPELL 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 68.9 bits (168), Expect = 1e-14
 Identities = 48/139 (34%), Positives = 73/139 (52%), Gaps = 23/139 (16%)

Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPEQ--TARKF 71
           H NII L  A   +  ++++VE+ + GNL  Y+R              RVP++  T +  
Sbjct: 80  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139

Query: 72  LQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
           +    Q+  G+E L S   IHRDL   N+L++  +++VM KIADFGL+  +   +Y +K 
Sbjct: 140 VSCTYQVARGMEYLASQKCIHRDLAARNVLVT--ENNVM-KIADFGLARDVNNIDYYKKT 196

Query: 129 CGSPL---YMAPEVLQFQR 144
               L   +MAPE L F R
Sbjct: 197 TNGRLPVKWMAPEAL-FDR 214

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 68.9 bits (168), Expect = 1e-14
 Identities = 47/150 (31%), Positives = 77/150 (51%), Gaps = 7/150 (4%)

Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           N+ +K     EL  L ++   NI+ L +AF+    ++LV E+     L     +   VP 
Sbjct: 40  NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP 99

Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--- 122
           +  R ++ QL   +   + + I+HRD+KPEN+L+S  D   +LK+ DFG +  L  G   
Sbjct: 100 EKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND---VLKLCDFGFARNLSEGSNA 156

Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           NY E V  +  Y +PE+L    Y + V+ +
Sbjct: 157 NYTEYV-ATRWYRSPELLLGAPYGKAVDMW 185

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 69.3 bits (169), Expect = 1e-14
 Identities = 48/139 (34%), Positives = 74/139 (53%), Gaps = 23/139 (16%)

Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------RVPEQ--TARKF 71
           H NII L  A   +  ++++VE+ + GNL  Y+R              ++PE+  T +  
Sbjct: 77  HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136

Query: 72  LQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
           +    Q+  G+E L S   IHRDL   N+L++  +D+VM KIADFGL+  ++  +Y +K 
Sbjct: 137 VSCAYQVARGMEYLASQKCIHRDLAARNVLVT--EDNVM-KIADFGLARDVHNIDYYKKT 193

Query: 129 CGSPL---YMAPEVLQFQR 144
               L   +MAPE L F R
Sbjct: 194 TNGRLPVKWMAPEAL-FDR 211

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 68.2 bits (167), Expect = 1e-14
 Identities = 36/140 (25%), Positives = 75/140 (53%), Gaps = 9/140 (6%)

Query: 16  ELNFLSSVNH---PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           E+  LS +     PNI + + ++     +++++E+  GG++ + ++  G + E+     +
Sbjct: 49  EVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVII 107

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGS 131
           +++   L+ ++   +IHRD+K  NIL++    +V L   DFG++  L   +       G+
Sbjct: 108 REVLVALKYIHKVGVIHRDIKAANILVT-NTGNVKL--CDFGVAALLNQNSSKRSTFVGT 164

Query: 132 PLYMAPEVLQ-FQRYDEKVN 150
           P +MAPEV+   + YD K +
Sbjct: 165 PYWMAPEVITEGKYYDTKAD 184

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 68.1 bits (167), Expect = 2e-14
 Identities = 38/139 (27%), Positives = 72/139 (51%), Gaps = 13/139 (9%)

Query: 17  LNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTAR 69
           L+FL+        +HPNIIRL         + ++ E+   G+L  ++R + G+       
Sbjct: 50  LDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLV 109

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP--GNYAEK 127
             L+ + +G++ L+  + +HRDL   NIL++    +++ K++DFGLS  L      Y  K
Sbjct: 110 GMLRGIASGMKYLSEMNYVHRDLAARNILVN---SNLVCKVSDFGLSRRLEDSEATYTTK 166

Query: 128 VCGSPL-YMAPEVLQFQRY 145
               P+ + APE + ++++
Sbjct: 167 GGKIPIRWTAPEAIAYRKF 185

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 68.2 bits (166), Expect = 2e-14
 Identities = 39/138 (28%), Positives = 74/138 (53%), Gaps = 5/138 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P + + + ++  +  +++++E+  GG+    +   G + E      L+++
Sbjct: 52  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 110

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 134
             GL+ L+S   IHRD+K  N+LLS   +   +K+ADFG++  L           G+P +
Sbjct: 111 LKGLDYLHSEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFW 167

Query: 135 MAPEVLQFQRYDEKVNFF 152
           MAPEV++   YD K + +
Sbjct: 168 MAPEVIKQSAYDSKADIW 185

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 68.9 bits (168), Expect = 2e-14
 Identities = 38/118 (32%), Positives = 71/118 (60%), Gaps = 8/118 (6%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +L+    H+K+    E + L+  ++  ++RL+ +FQ ++ ++ V+++  GG++ S +   
Sbjct: 40  LLRNQVAHVKA----ERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM 95

Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
           G  PE  AR ++ +L   +E ++    IHRD+KP+NIL   +D D  +K+ DFGL CT
Sbjct: 96  GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNIL---IDRDGHIKLTDFGL-CT 149

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 68.9 bits (168), Expect = 2e-14
 Identities = 35/114 (30%), Positives = 69/114 (60%), Gaps = 4/114 (3%)

Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           LN++  + +  E + L+  ++  +++L+ +FQ ++ ++ V+++  GG++ S +      P
Sbjct: 40  LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFP 99

Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
           E  AR ++ +L   +E ++    IHRD+KP+NIL   +D D  +K+ DFGL CT
Sbjct: 100 EVLARFYIAELTLAIESVHKMGFIHRDIKPDNIL---IDLDGHIKLTDFGL-CT 149

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 68.1 bits (166), Expect = 2e-14
 Identities = 45/152 (29%), Positives = 76/152 (50%), Gaps = 30/152 (19%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV------------ 63
           E N L  VNHP++I+L+ A   +  + L+VE+   G+L S++R   +V            
Sbjct: 53  EFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112

Query: 64  ------PEQTAR------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
                 P++ A        F  Q+  G++ L    ++HRDL   N+L++   +   +KI+
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA---EGRKMKIS 169

Query: 112 DFGLSCTLYPGN-YAEKVCGS-PL-YMAPEVL 140
           DFGLS  +Y  + Y ++  G  P+ +MA E L
Sbjct: 170 DFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL 201

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 68.1 bits (166), Expect = 3e-14
 Identities = 48/139 (34%), Positives = 74/139 (53%), Gaps = 23/139 (16%)

Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPEQ--TARKF 71
           H NII L  A   +  ++++VE+ + GNL  Y+R              +VPE+  + +  
Sbjct: 83  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142

Query: 72  LQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
           +    Q+  G+E L S   IHRDL   N+L++  +D+VM KIADFGL+  ++  +Y +K 
Sbjct: 143 VSCAYQVARGMEYLASKKCIHRDLAARNVLVT--EDNVM-KIADFGLARDIHHIDYYKKT 199

Query: 129 CGSPL---YMAPEVLQFQR 144
               L   +MAPE L F R
Sbjct: 200 TNGRLPVKWMAPEAL-FDR 217

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 67.8 bits (166), Expect = 3e-14
 Identities = 36/102 (35%), Positives = 54/102 (52%), Gaps = 5/102 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E + L  + H NI+ L D    +  + LV E+    +L  Y+   G  +     R FL Q
Sbjct: 53  EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQ 111

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           L  GL   +   ++HRDLKP+N+L+S   +   LK+ADFGL+
Sbjct: 112 LLRGLAYCHQRRVLHRDLKPQNLLISERGE---LKLADFGLA 150

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 67.9 bits (166), Expect = 4e-14
 Identities = 36/126 (28%), Positives = 71/126 (56%), Gaps = 19/126 (15%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--------------NCIFLVVEFCAGGNLSSYIRLHG 61
           E+  +  ++H NI+++++                   N +++V E     +L++ +   G
Sbjct: 52  EIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQE-YMETDLANVLE-QG 109

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
            + E+ AR F+ QL  GL+ ++S +++HRDLKP N+ ++   +D++LKI DFGL+  + P
Sbjct: 110 PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVLKIGDFGLARIVDP 167

Query: 122 GNYAEK 127
            +Y+ K
Sbjct: 168 -HYSHK 172

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 67.2 bits (164), Expect = 5e-14
 Identities = 34/110 (30%), Positives = 58/110 (52%), Gaps = 19/110 (17%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFC---------AGGNLSSYIRLHGRVPEQ 66
           E++ L  + H NI+RL D   +E  ++LV E+          +  + +   RL       
Sbjct: 51  EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRL------- 103

Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
             + +L Q+  G+   +SH ++HRDLKP+N+L+    +   LK+ADFGL+
Sbjct: 104 -IKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLA 150

Length = 294

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 67.0 bits (163), Expect = 6e-14
 Identities = 42/154 (27%), Positives = 81/154 (52%), Gaps = 19/154 (12%)

Query: 13  LDCELNFLSSV-NHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSS----YIRLHGR 62
           ++ E N L ++ +HPN+++ +  +  ++      ++LV+E C GG+++     +++   R
Sbjct: 61  IEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER 120

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           + E      L +   GL+ L+ +  IHRD+K  NILL+    +  +K+ DFG+S  L   
Sbjct: 121 MEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT---TEGGVKLVDFGVSAQLTST 177

Query: 123 NYAEKV-CGSPLYMAPEVLQFQR-----YDEKVN 150
                   G+P +MAPEV+  ++     YD + +
Sbjct: 178 RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCD 211

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 66.7 bits (163), Expect = 6e-14
 Identities = 40/125 (32%), Positives = 62/125 (49%), Gaps = 13/125 (10%)

Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           E +FL      S  NH NI+RL          F+++E  AGG+L S++R +   PE+ + 
Sbjct: 53  ESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSS 112

Query: 70  KFLQQL-------GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             ++ L         G + L  +H IHRD+   N LL+      + KIADFG++  +Y  
Sbjct: 113 LTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRA 172

Query: 123 NYAEK 127
           +Y  K
Sbjct: 173 SYYRK 177

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 66.8 bits (163), Expect = 6e-14
 Identities = 41/132 (31%), Positives = 73/132 (55%), Gaps = 18/132 (13%)

Query: 24  NHPNIIRLFD-AFQAENC-----IFLVVEFCAGGNLSSYI---RLHG---RVPEQTARKF 71
           +HPN+++L    F+A +        +++ F   G+L S++   RL G   ++P QT  KF
Sbjct: 59  DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
           +  +  G+E L++ + IHRDL   N +   L +D+ + +ADFGLS  +Y G+Y  +   +
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCM---LREDMTVCVADFGLSKKIYSGDYYRQGRIA 175

Query: 132 PL---YMAPEVL 140
            +   ++A E L
Sbjct: 176 KMPVKWIAIESL 187

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 67.0 bits (164), Expect = 7e-14
 Identities = 35/119 (29%), Positives = 71/119 (59%), Gaps = 9/119 (7%)

Query: 1   MLKKLN-KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           ML+K    H+++    E + L+  ++P +++L+ +FQ EN ++L++E+  GG++ + +  
Sbjct: 39  MLEKEQVAHVRA----ERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK 94

Query: 60  HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
                E+  R ++ +    ++ ++    IHRD+KP+N+L   LD    +K++DFGL CT
Sbjct: 95  KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLL---LDAKGHIKLSDFGL-CT 149

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 66.2 bits (161), Expect = 9e-14
 Identities = 39/131 (29%), Positives = 69/131 (52%), Gaps = 7/131 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
           E N + ++ H  ++RL+     E  I+++ E+ A G+L  +++    G+V       F  
Sbjct: 51  EANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 110

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 132
           Q+  G+  +   + IHRDL+  N+L+S   + +M KIADFGL+  +    Y A +    P
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNEYTAREGAKFP 167

Query: 133 L-YMAPEVLQF 142
           + + APE + F
Sbjct: 168 IKWTAPEAINF 178

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 65.7 bits (160), Expect = 1e-13
 Identities = 42/136 (30%), Positives = 74/136 (54%), Gaps = 10/136 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   ++ ++H N++RL       N +++V+E  + GNL +++R  GR  V      +F  
Sbjct: 49  ETAVMTKLHHKNLVRLLGVI-LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL 107

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
            +  G+E L S  ++HRDL   NIL+S   +D + K++DFGL+     G    K+   P+
Sbjct: 108 DVAEGMEYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGSMGVDNSKL---PV 161

Query: 134 -YMAPEVLQFQRYDEK 148
            + APE L+ +++  K
Sbjct: 162 KWTAPEALKHKKFSSK 177

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 66.1 bits (161), Expect = 1e-13
 Identities = 38/102 (37%), Positives = 58/102 (56%), Gaps = 5/102 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + L  + H NI+ L D    +  +  V E+    +L+ Y+  H G +     R F+ Q
Sbjct: 53  EASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQ 111

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           L  GL  ++  HI+HRDLKP+N+L+S L +   LK+ADFGL+
Sbjct: 112 LLRGLAYIHGQHILHRDLKPQNLLISYLGE---LKLADFGLA 150

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 65.4 bits (159), Expect = 2e-13
 Identities = 49/144 (34%), Positives = 75/144 (52%), Gaps = 13/144 (9%)

Query: 17  LNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTAR 69
           L  L + +HPNI+RL D         E  + LV E     +L +Y+       +P +T +
Sbjct: 53  LKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEH-VDQDLRTYLDKVPPPGLPAETIK 111

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKV 128
             ++Q   GL+ L+++ I+HRDLKPENIL++       +K+ADFGL+  +Y    A   V
Sbjct: 112 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG---QVKLADFGLA-RIYSCQMALTPV 167

Query: 129 CGSPLYMAPEVLQFQRYDEKVNFF 152
             +  Y APEVL    Y   V+ +
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMW 191

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 65.1 bits (158), Expect = 3e-13
 Identities = 39/144 (27%), Positives = 75/144 (52%), Gaps = 22/144 (15%)

Query: 21  SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL---HGRV----PEQTARKFLQ 73
           S + HPNI+ L      E  + ++  +C+  +L  ++ +   H  V     ++T +  L+
Sbjct: 63  SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122

Query: 74  ---------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
                    Q+ AG+E L+SHH++H+DL   N+L+    D + +KI+D GL   +Y  +Y
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF---DKLNVKISDLGLFREVYAADY 179

Query: 125 AEKVCGSPL---YMAPEVLQFQRY 145
            + +  S L   +M+PE + + ++
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKF 203

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 64.5 bits (157), Expect = 3e-13
 Identities = 39/135 (28%), Positives = 66/135 (48%), Gaps = 7/135 (5%)

Query: 7   KHLKSCLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           K L+   +     L+ + H  PN++ L     +E+ +FLV++   GG L S+I     +P
Sbjct: 24  KGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP 83

Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
           E+  +++  ++   L+ L+   I+ RDL P NIL   LDD   +++  F     +     
Sbjct: 84  EECVKRWAAEMVVALDALHREGIVCRDLNPNNIL---LDDRGHIQLTYFSRWSEVEDSCD 140

Query: 125 AEKVCGSPLYMAPEV 139
            E V    +Y APEV
Sbjct: 141 GEAV--ENMYCAPEV 153

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 64.7 bits (158), Expect = 3e-13
 Identities = 36/133 (27%), Positives = 61/133 (45%), Gaps = 8/133 (6%)

Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAG 78
           ++SV+HP+++RL     +   + L+ +    G L  Y+R H   +  Q    +  Q+  G
Sbjct: 63  MASVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKG 121

Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--PL-YM 135
           +  L    ++HRDL   N+L+        +KI DFGL+  L          G   P+ +M
Sbjct: 122 MSYLEEKRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178

Query: 136 APEVLQFQRYDEK 148
           A E +  + Y  K
Sbjct: 179 ALESILHRIYTHK 191

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 64.7 bits (158), Expect = 3e-13
 Identities = 39/158 (24%), Positives = 70/158 (44%), Gaps = 19/158 (12%)

Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           + + +     E+  LS ++ PNI RL      +  + +++E+   G+L+ +++ H     
Sbjct: 59  SDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETS 118

Query: 66  QTARKFLQ-----------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
             A                Q+ +G+  L S + +HRDL   N L+        +KIADFG
Sbjct: 119 GLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKN---YTIKIADFG 175

Query: 115 LSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEK 148
           +S  LY  +Y  +V G       +MA E +   ++  K
Sbjct: 176 MSRNLYSSDYY-RVQGRAPLPIRWMAWESVLLGKFTTK 212

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 64.6 bits (157), Expect = 4e-13
 Identities = 38/118 (32%), Positives = 65/118 (55%), Gaps = 5/118 (4%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
           P ++ L  AFQ +  + L++++  GG L +++    R  EQ  + +  ++   LE L+  
Sbjct: 65  PFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL 124

Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ 141
            II+RD+K ENIL   LD +  + + DFGLS   +      A   CG+  YMAP++++
Sbjct: 125 GIIYRDIKLENIL---LDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR 179

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 63.9 bits (155), Expect = 5e-13
 Identities = 46/144 (31%), Positives = 70/144 (48%), Gaps = 6/144 (4%)

Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRV 63
           L + LK     E   L   +HPNI++L         I++V+E   GG+  S++R     +
Sbjct: 31  LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDEL 90

Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
             +   KF     AG+  L S + IHRDL   N L+    ++ +LKI+DFG+S     G 
Sbjct: 91  KTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSRQEDDGI 147

Query: 124 YAEKVCGS-PL-YMAPEVLQFQRY 145
           Y+       P+ + APE L + RY
Sbjct: 148 YSSSGLKQIPIKWTAPEALNYGRY 171

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 64.0 bits (156), Expect = 5e-13
 Identities = 39/137 (28%), Positives = 70/137 (51%), Gaps = 8/137 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HPN+++L+     +  IF+V E+ A G L +Y+R   G++  +        
Sbjct: 49  EAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSD 108

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--P 132
           +   +E L S+  IHRDL   N L+    +D ++K++DFGL+  +    Y     G+  P
Sbjct: 109 VCEAMEYLESNGFIHRDLAARNCLVG---EDNVVKVSDFGLARYVLDDQYTSSQ-GTKFP 164

Query: 133 L-YMAPEVLQFQRYDEK 148
           + +  PEV  + R+  K
Sbjct: 165 VKWAPPEVFDYSRFSSK 181

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 64.7 bits (157), Expect = 5e-13
 Identities = 47/143 (32%), Positives = 69/143 (48%), Gaps = 12/143 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQME--LDHERMS 129

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTSFMMTPYV 186

Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 64.1 bits (156), Expect = 5e-13
 Identities = 43/158 (27%), Positives = 70/158 (44%), Gaps = 34/158 (21%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQT-------- 67
           E   ++  +HPNI++L         + L+ E+ A G+L+ ++R   R P           
Sbjct: 58  EAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR--HRSPRAQCSLSHSTS 115

Query: 68  -ARKFLQ---------------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
            ARK                  Q+ AG+  L+    +HRDL   N L+     ++++KIA
Sbjct: 116 SARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGE---NMVVKIA 172

Query: 112 DFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRY 145
           DFGLS  +Y  +Y  K   +      +M PE + + RY
Sbjct: 173 DFGLSRNIYSADYY-KASENDAIPIRWMPPESIFYNRY 209

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 64.3 bits (156), Expect = 6e-13
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 12/143 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL-MDANLCQVIQM--ELDHERMS 122

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTSFMMTPYV 179

Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIW 202

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 64.3 bits (157), Expect = 6e-13
 Identities = 43/146 (29%), Positives = 69/146 (47%), Gaps = 15/146 (10%)

Query: 16  ELNFLSSV-NHPNIIRLFDA----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           EL  L     H NI  L+D         N ++L  E     +L   IR    + +   + 
Sbjct: 51  ELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQS 109

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYA 125
           F+ Q+  GL+ ++S +++HRDLKP N+L++    D  LKI DFGL+            + 
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNA---DCELKICDFGLARGFSENPGENAGFM 166

Query: 126 EKVCGSPLYMAPEV-LQFQRYDEKVN 150
            +   +  Y APE+ L FQ Y + ++
Sbjct: 167 TEYVATRWYRAPEIMLSFQSYTKAID 192

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 63.9 bits (155), Expect = 7e-13
 Identities = 39/135 (28%), Positives = 70/135 (51%), Gaps = 4/135 (2%)

Query: 11  SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           S +  E+  +    H NI+  F ++ +   +++ +E+C GG+L     + G + E     
Sbjct: 51  SLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY 110

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VC 129
             ++   GL  L+S   +HRD+K  NILL+   D+  +K+ADFG++  +       K   
Sbjct: 111 VCRETLQGLAYLHSKGKMHRDIKGANILLT---DNGDVKLADFGVAAKITATIAKRKSFI 167

Query: 130 GSPLYMAPEVLQFQR 144
           G+P +MAPEV   ++
Sbjct: 168 GTPYWMAPEVAAVEK 182

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 64.0 bits (156), Expect = 7e-13
 Identities = 36/129 (27%), Positives = 60/129 (46%), Gaps = 9/129 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  ++ + H NI+ L D +   + I LV++  A  +L   +    R+ E   +  L Q+
Sbjct: 70  ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQI 128

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS----CTLYPGNYAEKVCGS 131
             GL +L+  + +HRDL P NI    ++   + KIADFGL+       Y    ++     
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIF---INSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185

Query: 132 P-LYMAPEV 139
               M  +V
Sbjct: 186 RREEMTSKV 194

Length = 335

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 63.9 bits (155), Expect = 7e-13
 Identities = 37/147 (25%), Positives = 74/147 (50%), Gaps = 21/147 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------R 62
           E   L+++ H +I++ +      + + +V E+   G+L+ ++R HG              
Sbjct: 57  EAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE 116

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           + +       QQ+ AG+  L S H +HRDL   N L+    +++++KI DFG+S  +Y  
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMSRDVYST 173

Query: 123 NYAEKVCGSPL----YMAPEVLQFQRY 145
           +Y  +V G  +    +M PE + ++++
Sbjct: 174 DYY-RVGGHTMLPIRWMPPESIMYRKF 199

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 64.1 bits (156), Expect = 8e-13
 Identities = 42/140 (30%), Positives = 67/140 (47%), Gaps = 13/140 (9%)

Query: 16  ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFL 72
           E   L +VNHP++IR+ D     A  C+ L        +L +Y+ +    +P   A    
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS---DLYTYLTKRSRPLPIDQALIIE 163

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLY-PGNYAEKVCG 130
           +Q+  GL  L++  IIHRD+K ENI    ++D   + I D G +   +  P      + G
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIF---INDVDQVCIGDLGAAQFPVVAPAFLG--LAG 218

Query: 131 SPLYMAPEVLQFQRYDEKVN 150
           +    APEVL   +Y+ K +
Sbjct: 219 TVETNAPEVLARDKYNSKAD 238

Length = 357

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 63.3 bits (154), Expect = 1e-12
 Identities = 43/132 (32%), Positives = 70/132 (53%), Gaps = 12/132 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFL 72
           E+   S + H NI++   +        + +E   GG+LS+ +R      +  EQT   + 
Sbjct: 55  EIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT 114

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILL---SGLDDDVMLKIADFGLSCTLYPGN-YAEKV 128
           +Q+  GL+ L+ + I+HRD+K +N+L+   SG+     +KI+DFG S  L   N   E  
Sbjct: 115 KQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGV-----VKISDFGTSKRLAGINPCTETF 169

Query: 129 CGSPLYMAPEVL 140
            G+  YMAPEV+
Sbjct: 170 TGTLQYMAPEVI 181

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 63.0 bits (153), Expect = 1e-12
 Identities = 46/137 (33%), Positives = 66/137 (48%), Gaps = 12/137 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S+ NHPNI++L          ++++E   GG+L SY+R             L++L
Sbjct: 49  EAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKEL 108

Query: 76  GA-------GLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSCTLYPGNYAE 126
                    G   L   H IHRDL   N L+S  G D D ++KI DFGL+  +Y  +Y  
Sbjct: 109 LDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR 168

Query: 127 KVCGSPL---YMAPEVL 140
           K     L   +MAPE L
Sbjct: 169 KEGEGLLPVRWMAPESL 185

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 63.1 bits (153), Expect = 1e-12
 Identities = 37/138 (26%), Positives = 75/138 (54%), Gaps = 5/138 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +    H N++ +++++   + +++V+EF  GG L+  I  H R+ E+        +
Sbjct: 67  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAV 125

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
              L +L++  +IHRD+K ++ILL+    D  +K++DFG    +       K + G+P +
Sbjct: 126 LKALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYW 182

Query: 135 MAPEVLQFQRYDEKVNFF 152
           MAPE++    Y  +V+ +
Sbjct: 183 MAPELISRLPYGPEVDIW 200

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 62.8 bits (152), Expect = 1e-12
 Identities = 42/135 (31%), Positives = 72/135 (53%), Gaps = 13/135 (9%)

Query: 16  ELNFLSSVNH-PNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIR--LHGRVPEQ 66
           E+N L   +H  NI   + AF  +N       ++LV+EFC  G+++  I+      + E+
Sbjct: 52  EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 111

Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYA 125
                 +++  GL  L+ H +IHRD+K +N+LL+   ++  +K+ DFG+S  L       
Sbjct: 112 WIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRR 168

Query: 126 EKVCGSPLYMAPEVL 140
               G+P +MAPEV+
Sbjct: 169 NTFIGTPYWMAPEVI 183

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 63.2 bits (154), Expect = 1e-12
 Identities = 36/114 (31%), Positives = 54/114 (47%), Gaps = 4/114 (3%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
           P I++ +  F  ++ +F+ +E  +        R+ G +PE    K    +   L  L   
Sbjct: 74  PYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK 133

Query: 86  H-IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPE 138
           H +IHRD+KP NIL   LD    +K+ DFG+S  L       +  G   YMAPE
Sbjct: 134 HGVIHRDVKPSNIL---LDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPE 184

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 62.6 bits (152), Expect = 2e-12
 Identities = 39/131 (29%), Positives = 68/131 (51%), Gaps = 17/131 (12%)

Query: 16  ELNFLSSVNHPNIIRLFD------AFQAENCIFLVVEFCAGGNLSSYIRLHGR------- 62
           E   +   +HPN+I+L        A        +++ F   G+L +++ L  R       
Sbjct: 51  EAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFL-LMSRIGEEPFT 109

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +P QT  +F+  + +G+E L+S + IHRDL   N +   L++++ + +ADFGLS  +Y G
Sbjct: 110 LPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCM---LNENMTVCVADFGLSKKIYSG 166

Query: 123 NYAEKVCGSPL 133
           +Y  + C S L
Sbjct: 167 DYYRQGCASKL 177

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 62.6 bits (152), Expect = 2e-12
 Identities = 38/140 (27%), Positives = 71/140 (50%), Gaps = 16/140 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNII L         + ++ EF   G L S++R + G+         L+ 
Sbjct: 55  EASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRG 114

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL--------YPGNYAE 126
           + AG++ L+  + +HRDL   NIL   ++ +++ K++DFGLS  L        Y  +   
Sbjct: 115 IAAGMKYLSEMNYVHRDLAARNIL---VNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGG 171

Query: 127 KVCGSPL-YMAPEVLQFQRY 145
           K+   P+ + APE + ++++
Sbjct: 172 KI---PIRWTAPEAIAYRKF 188

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 62.7 bits (152), Expect = 2e-12
 Identities = 43/139 (30%), Positives = 78/139 (56%), Gaps = 7/139 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  +   +H N++ +++++   + +++V+EF  GG L+  I  H R+  EQ A   L  
Sbjct: 69  EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSV 127

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPL 133
           L A L  L++  +IHRD+K ++ILL+    D  +K++DFG    +       K + G+P 
Sbjct: 128 LRA-LSYLHNQGVIHRDIKSDSILLT---SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPY 183

Query: 134 YMAPEVLQFQRYDEKVNFF 152
           +MAPEV+    Y  +V+ +
Sbjct: 184 WMAPEVISRLPYGTEVDIW 202

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 62.1 bits (151), Expect = 2e-12
 Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 18/156 (11%)

Query: 4   KLNKHLKSC-LDCEL----NFLS------SVNHPNIIRLFDAFQAENCIFLVVEFCAGGN 52
           K+   +K+C           FL         +HP+I++L      EN +++V+E    G 
Sbjct: 34  KIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT-ENPVWIVMELAPLGE 92

Query: 53  LSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
           L SY++++   +   +   +  QL   L  L S   +HRD+   N+L+S  D    +K+ 
Sbjct: 93  LRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD---CVKLG 149

Query: 112 DFGLSCTL-YPGNYAEKVCGSPL-YMAPEVLQFQRY 145
           DFGLS  L     Y       P+ +MAPE + F+R+
Sbjct: 150 DFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 61.9 bits (150), Expect = 3e-12
 Identities = 43/147 (29%), Positives = 75/147 (51%), Gaps = 8/147 (5%)

Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           +  LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ +++ +  V E
Sbjct: 36  DPALKDELLREANVMQQLDNPYIVRMIGICEAESWM-LVMELAELGPLNKFLQKNKHVTE 94

Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-- 123
           +   + + Q+  G++ L   + +HRDL   N+LL         KI+DFGLS  L      
Sbjct: 95  KNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV---TQHYAKISDFGLSKALGADENY 151

Query: 124 YAEKVCGS-PL-YMAPEVLQFQRYDEK 148
           Y  K  G  P+ + APE + + ++  K
Sbjct: 152 YKAKTHGKWPVKWYAPECMNYYKFSSK 178

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 62.3 bits (151), Expect = 3e-12
 Identities = 40/150 (26%), Positives = 73/150 (48%), Gaps = 23/150 (15%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL---HGRV-----PEQT 67
           E + ++ ++HPNI+ L      E  + ++ E+   G+L  ++ +   H  V      + T
Sbjct: 57  EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116

Query: 68  ARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
            +  L          Q+ AG+E L+SH  +H+DL   NIL+    + + +KI+D GLS  
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG---EQLHVKISDLGLSRE 173

Query: 119 LYPGNYAEKVCGSPL---YMAPEVLQFQRY 145
           +Y  +Y      S L   +M PE + + ++
Sbjct: 174 IYSADYYRVQPKSLLPIRWMPPEAIMYGKF 203

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 62.0 bits (151), Expect = 3e-12
 Identities = 30/104 (28%), Positives = 56/104 (53%), Gaps = 6/104 (5%)

Query: 16  ELNFLSSVNHPNIIRL--FDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFL 72
           E+  L +++H NI++            + L++E+   G+L  Y++ H  ++  +    F 
Sbjct: 56  EIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFS 115

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
            Q+  G++ L S   IHRDL   NIL   ++ + ++KI+DFGL+
Sbjct: 116 SQICKGMDYLGSQRYIHRDLAARNIL---VESEDLVKISDFGLA 156

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 62.3 bits (151), Expect = 3e-12
 Identities = 40/135 (29%), Positives = 75/135 (55%), Gaps = 13/135 (9%)

Query: 16  ELNFLSSVNH-PNIIRLFDAF------QAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQT 67
           E+N L   +H  NI   + AF        ++ ++LV+EFC  G+++  ++   G   ++ 
Sbjct: 62  EINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKED 121

Query: 68  ARKFL-QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYA 125
              ++ +++  GL  L++H +IHRD+K +N+LL+   ++  +K+ DFG+S  L       
Sbjct: 122 WIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRR 178

Query: 126 EKVCGSPLYMAPEVL 140
               G+P +MAPEV+
Sbjct: 179 NTFIGTPYWMAPEVI 193

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 61.8 bits (150), Expect = 3e-12
 Identities = 36/136 (26%), Positives = 69/136 (50%), Gaps = 8/136 (5%)

Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +   +HPNII L         + +V E+   G+L +++R H G+         L+
Sbjct: 54  SEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR 113

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCG 130
            + +G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +   
Sbjct: 114 GIASGMKYLSDMGYVHRDLAARNIL---VNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 170

Query: 131 SPL-YMAPEVLQFQRY 145
            P+ + APE + ++++
Sbjct: 171 IPIRWTAPEAIAYRKF 186

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 61.7 bits (150), Expect = 3e-12
 Identities = 39/150 (26%), Positives = 67/150 (44%), Gaps = 6/150 (4%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-H 60
           LK  +   +     E+  L  + H ++I LF        ++++ E    G+L +++R   
Sbjct: 38  LKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPE 97

Query: 61  GRV-PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
           G+V P  +      Q+  G+  L   + IHRDL   NIL   + +D++ K+ADFGL+  +
Sbjct: 98  GQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNIL---VGEDLVCKVADFGLARLI 154

Query: 120 YPGNYAEKVCGSPL-YMAPEVLQFQRYDEK 148
               Y       P  + APE      +  K
Sbjct: 155 KEDVYLSSDKKIPYKWTAPEAASHGTFSTK 184

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 62.6 bits (152), Expect = 3e-12
 Identities = 36/121 (29%), Positives = 66/121 (54%), Gaps = 8/121 (6%)

Query: 1   MLKKLN-KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           M KK    H+K+    E + L+  + P ++ L+ +FQ    ++L++EF  GG+L + +  
Sbjct: 39  MFKKDQLAHVKA----ERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK 94

Query: 60  HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
           +    E   R ++ +    +E ++    IHRD+KP+NIL   +D    +K++DFGLS   
Sbjct: 95  YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNIL---IDRGGHIKLSDFGLSTGF 151

Query: 120 Y 120
           +
Sbjct: 152 H 152

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 61.9 bits (150), Expect = 3e-12
 Identities = 38/137 (27%), Positives = 68/137 (49%), Gaps = 8/137 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+      + I LV EF   G LS Y+R   G+  ++T       
Sbjct: 49  EAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLD 108

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +  G+  L S ++IHRDL   N L+    ++ ++K++DFG++  +    Y     G+   
Sbjct: 109 VCEGMAYLESSNVIHRDLAARNCLVG---ENQVVKVSDFGMTRFVLDDQYTSST-GTKFP 164

Query: 134 --YMAPEVLQFQRYDEK 148
             + +PEV  F +Y  K
Sbjct: 165 VKWSSPEVFSFSKYSSK 181

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 62.3 bits (151), Expect = 4e-12
 Identities = 50/166 (30%), Positives = 83/166 (50%), Gaps = 25/166 (15%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL +  +S L       EL  L  + H N+I L D F  +      +  +LV+ F  G
Sbjct: 45  IKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPF-MG 103

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L   ++ H ++ E   +  + Q+  GL+ +++  IIHRDLKP N+    +++D  LKI
Sbjct: 104 TDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNL---AVNEDCELKI 159

Query: 111 ADFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+          ++ G   +  Y APEV L +  Y + V+ +
Sbjct: 160 LDFGLA-----RQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIW 200

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 61.5 bits (150), Expect = 5e-12
 Identities = 46/141 (32%), Positives = 70/141 (49%), Gaps = 32/141 (22%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL- 72
           E+N L  + HPNI+ + +     N   I++V+E+    +L S +    +   Q+  K L 
Sbjct: 54  EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLM 112

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSCTLYPGNYAEKVCG 130
            QL +G+  L+ + I+HRDLK  N+LL+  G+     LKI DFGL+          +  G
Sbjct: 113 LQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI-----LKICDFGLA----------REYG 157

Query: 131 SPL-----------YMAPEVL 140
           SPL           Y APE+L
Sbjct: 158 SPLKPYTQLVVTLWYRAPELL 178

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 61.5 bits (149), Expect = 5e-12
 Identities = 34/121 (28%), Positives = 62/121 (51%), Gaps = 15/121 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR---------LHGRVPEQ 66
           E+  +S + +PNIIRL     +++ + ++ E+   G+L+ ++              +P  
Sbjct: 67  EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126

Query: 67  TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           +    L    Q+ +G++ L S + +HRDL   N L   + +   +KIADFG+S  LY G+
Sbjct: 127 SIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL---VGNHYTIKIADFGMSRNLYSGD 183

Query: 124 Y 124
           Y
Sbjct: 184 Y 184

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 61.6 bits (149), Expect = 5e-12
 Identities = 38/102 (37%), Positives = 58/102 (56%), Gaps = 5/102 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + L  + H NI+ L D    +  + LV E+    +L  Y+  H G +  +  + FL Q
Sbjct: 53  EASLLKGLKHANIVLLHDIIHTKETLTLVFEY-VHTDLCQYMDKHPGGLHPENVKLFLFQ 111

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           L  GL  ++  +I+HRDLKP+N+L+S   D   LK+ADFGL+
Sbjct: 112 LLRGLSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 61.2 bits (149), Expect = 5e-12
 Identities = 29/103 (28%), Positives = 54/103 (52%), Gaps = 5/103 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGR-VPEQTARKFLQ 73
           E   +  + H  +++L+     E  I++V E+ + G+L  +++   G+ +          
Sbjct: 51  EAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA 110

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           Q+  G+  L S + IHRDL   NIL+    ++++ KIADFGL+
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVG---ENLVCKIADFGLA 150

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 61.1 bits (148), Expect = 7e-12
 Identities = 44/132 (33%), Positives = 70/132 (53%), Gaps = 10/132 (7%)

Query: 16  ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
           E+N L ++ H NI++     + Q    + L++E+   G+L  Y+  H     Q    F Q
Sbjct: 56  EINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL-FAQ 114

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC---G 130
           Q+  G+  L+S H IHRDL   N+L   LD+D ++KI DFGL+  +  G+   +V     
Sbjct: 115 QICEGMAYLHSQHYIHRDLAARNVL---LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171

Query: 131 SPLY-MAPEVLQ 141
           SP++  A E L+
Sbjct: 172 SPVFWYAVECLK 183

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 61.2 bits (148), Expect = 7e-12
 Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 28/154 (18%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-------------HG 61
           EL  L  + +HPNII L  A +    +++ +E+   GNL  ++R              HG
Sbjct: 52  ELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHG 111

Query: 62  RVPEQTARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
                T+++ LQ    +  G++ L+    IHRDL   N+L+    +++  KIADFGLS  
Sbjct: 112 TASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG---ENLASKIADFGLS-- 166

Query: 119 LYPGN--YAEKVCGS-PL-YMAPEVLQFQRYDEK 148
              G   Y +K  G  P+ +MA E L +  Y  K
Sbjct: 167 --RGEEVYVKKTMGRLPVRWMAIESLNYSVYTTK 198

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 60.8 bits (147), Expect = 9e-12
 Identities = 40/163 (24%), Positives = 78/163 (47%), Gaps = 23/163 (14%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           LK+ ++  +     E   L+ + H +I+R +        + +V E+   G+L+ ++R HG
Sbjct: 43  LKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHG 102

Query: 62  ---RVPEQ---------TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDV 106
              ++            T  + L    Q+ +G+  L S H +HRDL   N L+      +
Sbjct: 103 PDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG---QGL 159

Query: 107 MLKIADFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRY 145
           ++KI DFG+S  +Y  +Y  +V G  +    +M PE + ++++
Sbjct: 160 VVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILYRKF 201

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 60.8 bits (147), Expect = 1e-11
 Identities = 47/166 (28%), Positives = 86/166 (51%), Gaps = 25/166 (15%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 47  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-MG 105

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 106 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 161

Query: 111 ADFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+      +  +++ G   +  Y APE+ L +  Y++ V+ +
Sbjct: 162 LDFGLA-----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 202

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 60.3 bits (146), Expect = 1e-11
 Identities = 39/138 (28%), Positives = 68/138 (49%), Gaps = 22/138 (15%)

Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----- 60
           NK+ ++    E+  LS +  PNIIRL      E+ + ++ E+   G+L+ ++  H     
Sbjct: 59  NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDK 118

Query: 61  -----------GRVPEQTARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDV 106
                        +P  +    L    Q+ +G++ L+S + +HRDL   N L+     ++
Sbjct: 119 EENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGE---NL 175

Query: 107 MLKIADFGLSCTLYPGNY 124
            +KIADFG+S  LY G+Y
Sbjct: 176 TIKIADFGMSRNLYAGDY 193

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 60.0 bits (145), Expect = 1e-11
 Identities = 37/118 (31%), Positives = 65/118 (55%), Gaps = 17/118 (14%)

Query: 20  LSSVNHPNIIRLFDA-FQ-AENCIF----LVVEFCAGGNLSSYIRLHGRV-------PEQ 66
           +   +HPN++RL     Q  E+  +    +++ F   G+L S++ L+ R+       P Q
Sbjct: 54  MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFL-LYSRLGDCPQYLPTQ 112

Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
              KF+  + +G+E L+S   IHRDL   N +   L++++ + +ADFGLS  +Y G+Y
Sbjct: 113 MLVKFMTDIASGMEYLSSKSFIHRDLAARNCM---LNENMNVCVADFGLSKKIYNGDY 167

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 60.0 bits (145), Expect = 1e-11
 Identities = 38/137 (27%), Positives = 72/137 (52%), Gaps = 10/137 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFL 72
           E + ++ + H N+++L      E   +++V E+ A G+L  Y+R  GR  +      KF 
Sbjct: 49  EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 108

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
             +   +E L +++ +HRDL   N+L+S   +D + K++DFGL+          K+   P
Sbjct: 109 LDVCEAMEYLEANNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL---P 162

Query: 133 L-YMAPEVLQFQRYDEK 148
           + + APE L+ +++  K
Sbjct: 163 VKWTAPEALREKKFSTK 179

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 60.0 bits (145), Expect = 2e-11
 Identities = 40/140 (28%), Positives = 72/140 (51%), Gaps = 13/140 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFL 72
           E   +  +++P I+R+    +AE  + LV+E  +GG L+ +  L G+   +      + +
Sbjct: 45  EAEIMHQLDNPYIVRMIGVCEAEA-LMLVMEMASGGPLNKF--LSGKKDEITVSNVVELM 101

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCG 130
            Q+  G++ L   + +HRDL   N+LL    +    KI+DFGLS  L   +  Y  +  G
Sbjct: 102 HQVSMGMKYLEGKNFVHRDLAARNVLLV---NQHYAKISDFGLSKALGADDSYYKARSAG 158

Query: 131 S-PL-YMAPEVLQFQRYDEK 148
             PL + APE + F+++  +
Sbjct: 159 KWPLKWYAPECINFRKFSSR 178

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 60.0 bits (145), Expect = 2e-11
 Identities = 36/102 (35%), Positives = 57/102 (55%), Gaps = 5/102 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
           E++ L ++ H NI+ L D    E C+ LV E+    +L  Y+   G +      + F+ Q
Sbjct: 53  EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQ 111

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           L  GL   +   I+HRDLKP+N+L   +++   LK+ADFGL+
Sbjct: 112 LLRGLSYCHKRKILHRDLKPQNLL---INEKGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 59.3 bits (143), Expect = 3e-11
 Identities = 39/137 (28%), Positives = 69/137 (50%), Gaps = 8/137 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
           E N + ++ H  +++L  A   +  I+++ EF A G+L  +++     + P      F  
Sbjct: 51  EANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 109

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 132
           Q+  G+  +   + IHRDL+  NIL+S     ++ KIADFGL+  +    Y A +    P
Sbjct: 110 QIAEGMAFIEQRNYIHRDLRAANILVSAS---LVCKIADFGLARVIEDNEYTAREGAKFP 166

Query: 133 L-YMAPEVLQFQRYDEK 148
           + + APE + F  +  K
Sbjct: 167 IKWTAPEAINFGSFTIK 183

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 59.9 bits (145), Expect = 3e-11
 Identities = 53/160 (33%), Positives = 81/160 (50%), Gaps = 32/160 (20%)

Query: 13  LDCELN--FLSSVN-HPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQT 67
           + C LN  F S V  H +  +  D    EN   I LV+++   G+L   I+   +    T
Sbjct: 82  VCCLLNCDFFSIVKCHEDFAKK-DPRNPENVLMIALVLDYANAGDLRQEIKSRAK----T 136

Query: 68  ARKFLQQLGAGL---EIL------NSHHIIHRDLKPENILL--SGLDDDVMLKIADFGLS 116
            R F +   AGL   ++L      +S H+IHRD+K  NILL  +GL     +K+ DFG S
Sbjct: 137 NRTFREH-EAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL-----VKLGDFGFS 190

Query: 117 CTLYPGNYAEKV----CGSPLYMAPEVLQFQRYDEKVNFF 152
             +Y    ++ V    CG+P Y+APE+ + + Y +K + F
Sbjct: 191 -KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMF 229

Length = 496

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 59.2 bits (143), Expect = 4e-11
 Identities = 36/120 (30%), Positives = 63/120 (52%), Gaps = 5/120 (4%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
           P ++ L  AFQ E  + L++++ +GG + +++       E   R +  ++   LE L+  
Sbjct: 65  PFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL 124

Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQ 143
            I++RD+K ENIL   LD +  + + DFGLS              CG+  YMAPE+++ +
Sbjct: 125 GIVYRDIKLENIL---LDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK 181

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 59.0 bits (143), Expect = 4e-11
 Identities = 48/154 (31%), Positives = 73/154 (47%), Gaps = 28/154 (18%)

Query: 1   MLK-KLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
           MLK   +   +  L  EL  +S + NH NI+ L  A      I ++ E+C  G+L +++R
Sbjct: 72  MLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR 131

Query: 59  LHGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLK 109
                  +    FL          Q+  G+  L S + IHRDL   N+LL+      ++K
Sbjct: 132 -------RKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT---HGKIVK 181

Query: 110 IADFGLSC-TLYPGNYAEKVCGS---PL-YMAPE 138
           I DFGL+   +   NY  K  G+   P+ +MAPE
Sbjct: 182 ICDFGLARDIMNDSNYVVK--GNARLPVKWMAPE 213

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 58.9 bits (142), Expect = 5e-11
 Identities = 47/166 (28%), Positives = 86/166 (51%), Gaps = 25/166 (15%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 45  VKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNL-MG 103

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ ++  +  + QL  GL+ ++S  IIHRDLKP N+    +++D  L+I
Sbjct: 104 ADLNNIVKCQ-KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNV---AVNEDCELRI 159

Query: 111 ADFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+         +++ G   +  Y APE+ L +  Y++ V+ +
Sbjct: 160 LDFGLA-----RQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 200

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 58.7 bits (142), Expect = 5e-11
 Identities = 38/127 (29%), Positives = 65/127 (51%), Gaps = 11/127 (8%)

Query: 23  VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ-----LGA 77
           +NHPN+++            LV+EFC  G+L +Y+R +  +  Q A+K + Q     + +
Sbjct: 52  LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111

Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLY 134
           GL  L+    IH DL   N  L+    D+ +KI D+GL+   YP +Y    +       +
Sbjct: 112 GLLWLHQADFIHSDLALRNCQLTA---DLSVKIGDYGLALEQYPEDYYITKDCHAVPLRW 168

Query: 135 MAPEVLQ 141
           +APE+++
Sbjct: 169 LAPELVE 175

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 58.4 bits (141), Expect = 6e-11
 Identities = 40/130 (30%), Positives = 67/130 (51%), Gaps = 8/130 (6%)

Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAG 78
           + S++H  I+RL       + + LV +    G+L  ++R H   +  Q    +  Q+  G
Sbjct: 63  MGSLDHAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKG 121

Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPL-YM 135
           +  L  H ++HR+L   NILL     D +++IADFG++  LYP +  Y      +P+ +M
Sbjct: 122 MYYLEEHRMVHRNLAARNILLK---SDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178

Query: 136 APEVLQFQRY 145
           A E + F RY
Sbjct: 179 ALESILFGRY 188

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 58.2 bits (141), Expect = 7e-11
 Identities = 36/140 (25%), Positives = 67/140 (47%), Gaps = 13/140 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + HP +I+L+     E  I++V E    G+L  Y++       ++P+      
Sbjct: 51  EAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI--DM 108

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
             Q+ +G+  L + + IHRDL   N+L+    ++ + K+ADFGL+  +    Y  +  G+
Sbjct: 109 AAQVASGMAYLEAQNYIHRDLAARNVLVG---ENNICKVADFGLARVIKEDIYEARE-GA 164

Query: 132 PL---YMAPEVLQFQRYDEK 148
                + APE   + R+  K
Sbjct: 165 KFPIKWTAPEAALYNRFSIK 184

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 58.4 bits (141), Expect = 8e-11
 Identities = 37/131 (28%), Positives = 64/131 (48%), Gaps = 16/131 (12%)

Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           NK+ ++    E+  +S +  PNIIRL       + + ++ E+   G+L+ ++  H    E
Sbjct: 59  NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRH-EPQE 117

Query: 66  Q------------TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
                        T      Q+ +G++ L+S + +HRDL   N L+     +  +KIADF
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG---KNYTIKIADF 174

Query: 114 GLSCTLYPGNY 124
           G+S  LY G+Y
Sbjct: 175 GMSRNLYSGDY 185

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 58.2 bits (141), Expect = 8e-11
 Identities = 46/153 (30%), Positives = 71/153 (46%), Gaps = 20/153 (13%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
           LKK+    ++ + C     EL  L    H N++   D  Q  +      I++V E     
Sbjct: 30  LKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQS- 88

Query: 52  NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
           +L   I     +     + FL Q+  GL+ L+S  I+HRD+KP N+L   ++ + +LKI 
Sbjct: 89  DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLL---VNSNCVLKIC 145

Query: 112 DFGLSCTLYPGN----YAEKVCGSPLYMAPEVL 140
           DFGL+    P        E V  +  Y APE+L
Sbjct: 146 DFGLARVEEPDESKHMTQEVV--TQYYRAPEIL 176

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 57.9 bits (140), Expect = 8e-11
 Identities = 36/137 (26%), Positives = 66/137 (48%), Gaps = 8/137 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  +++V EF   G L +Y+R   G++ +       Q 
Sbjct: 49  EAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD 108

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +  G+E L  +  IHRDL   N L+S      ++K++DFG++  +    Y     G+   
Sbjct: 109 VCEGMEYLERNSFIHRDLAARNCLVS---STGVVKVSDFGMTRYVLDDEYTSS-SGAKFP 164

Query: 134 --YMAPEVLQFQRYDEK 148
             +  PEV  F +Y  K
Sbjct: 165 VKWSPPEVFNFSKYSSK 181

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 58.1 bits (140), Expect = 9e-11
 Identities = 37/150 (24%), Positives = 73/150 (48%), Gaps = 24/150 (16%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--------VPEQT 67
           E   L+++ H +I++ +      + + +V E+   G+L+ ++R HG          P Q 
Sbjct: 57  EAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 116

Query: 68  ARKF--------LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
             +           Q+ +G+  L S H +HRDL   N L+     ++++KI DFG+S  +
Sbjct: 117 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFGMSRDV 173

Query: 120 YPGNYAEKVCGSPL----YMAPEVLQFQRY 145
           Y  +Y  +V G  +    +M PE + ++++
Sbjct: 174 YSTDYY-RVGGHTMLPIRWMPPESIMYRKF 202

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 58.3 bits (141), Expect = 1e-10
 Identities = 33/106 (31%), Positives = 57/106 (53%), Gaps = 8/106 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
           E++ L +++H  II L  A++ ++  C+ +    C   +L +Y+   G +P + A    +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC---DLFTYVDRSGPLPLEQAITIQR 192

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
           +L   L  L+   IIHRD+K ENI L   ++ V+    DFG +C L
Sbjct: 193 RLLEALAYLHGRGIIHRDVKTENIFLDEPENAVL---GDFGAACKL 235

Length = 392

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 1e-10
 Identities = 44/141 (31%), Positives = 67/141 (47%), Gaps = 17/141 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           E+  L    H NII + D  +       N +++V E     +L   I+    +     + 
Sbjct: 53  EIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ-HLSNDHIQY 110

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-----SCTLYPGNYA 125
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL         + G   
Sbjct: 111 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD---LKICDFGLARIADPEHDHTGFLT 167

Query: 126 EKVCGSPLYMAPEV-LQFQRY 145
           E V  +  Y APE+ L  + Y
Sbjct: 168 EYV-ATRWYRAPEIMLNSKGY 187

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 57.7 bits (139), Expect = 1e-10
 Identities = 38/139 (27%), Positives = 75/139 (53%), Gaps = 7/139 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +    H N++ ++ ++     +++++EF  GG L+  +    R+ E+      + +
Sbjct: 68  EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QTRLNEEQIATVCESV 126

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSPL 133
              L  L+S  +IHRD+K ++ILL+ LD  V  K++DFG  C     +  ++  + G+P 
Sbjct: 127 LQALCYLHSQGVIHRDIKSDSILLT-LDGRV--KLSDFGF-CAQISKDVPKRKSLVGTPY 182

Query: 134 YMAPEVLQFQRYDEKVNFF 152
           +MAPEV+    Y  +V+ +
Sbjct: 183 WMAPEVISRTPYGTEVDIW 201

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 57.6 bits (139), Expect = 1e-10
 Identities = 35/131 (26%), Positives = 66/131 (50%), Gaps = 8/131 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQ 73
           E N +  + HP ++RL+ A   +  I+++ E+   G+L  +++     ++          
Sbjct: 51  EANLMKQLQHPRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAA 109

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 132
           Q+  G+  +   + IHRDL+  NIL+S   + +  KIADFGL+  +    Y A +    P
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDNEYTAREGAKFP 166

Query: 133 L-YMAPEVLQF 142
           + + APE + +
Sbjct: 167 IKWTAPEAINY 177

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 57.2 bits (138), Expect = 2e-10
 Identities = 33/125 (26%), Positives = 59/125 (47%), Gaps = 10/125 (8%)

Query: 23  VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ----QLGAG 78
           + HPNI++            LV E+C  G+L SY+         +    LQ    ++ AG
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111

Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYM 135
           +  ++ H+ +H DL   N  L+    D+ +K+ D+G+  + Y  +Y E     C    ++
Sbjct: 112 VTHMHKHNFLHSDLALRNCFLTS---DLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL 168

Query: 136 APEVL 140
           APE++
Sbjct: 169 APELV 173

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 57.3 bits (139), Expect = 2e-10
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 15/110 (13%)

Query: 16  ELNFLSSVNHPNIIRLFDAF-------QAENCIFLVVEFCAGGNLSSYIRLHG---RVPE 65
           E+  L  + HPN++ L D         + +     +V      +LS    L     ++ E
Sbjct: 57  EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGL--LENPSVKLTE 114

Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
              + ++ QL  G+  L+ +HI+HRD+K  NIL   +D+  +LKIADFGL
Sbjct: 115 SQIKCYMLQLLEGINYLHENHILHRDIKAANIL---IDNQGILKIADFGL 161

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 56.6 bits (136), Expect = 2e-10
 Identities = 45/154 (29%), Positives = 70/154 (45%), Gaps = 28/154 (18%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-------------HG 61
           EL  L  + +HPNII L  A +    ++L +E+   GNL  ++R              + 
Sbjct: 45  ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 104

Query: 62  RVPEQTAR---KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
                +++    F   +  G++ L+    IHRDL   NIL+    ++ + KIADFGLS  
Sbjct: 105 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS-- 159

Query: 119 LYPGN--YAEKVCGS-PL-YMAPEVLQFQRYDEK 148
              G   Y +K  G  P+ +MA E L +  Y   
Sbjct: 160 --RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN 191

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 55.8 bits (134), Expect = 5e-10
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 5/102 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E++ L  + H NI+ L D    E  + LV E+    +L  Y+   G  +     + FL Q
Sbjct: 54  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQ 112

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           L  GL   +   ++HRDLKP+N+L   +++   LK+ADFGL+
Sbjct: 113 LLRGLNYCHRRKVLHRDLKPQNLL---INERGELKLADFGLA 151

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 55.2 bits (133), Expect = 8e-10
 Identities = 39/167 (23%), Positives = 77/167 (46%), Gaps = 18/167 (10%)

Query: 1   MLKKLNK----HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56
           ++K L K    +L+S    EL+    ++H N++RL    +     ++++E+   G+L  +
Sbjct: 39  LVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQF 98

Query: 57  IRLHGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVM 107
           +R      E+     L          Q+  G++ L++   +HRDL   N L+S       
Sbjct: 99  LRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSS---QRE 155

Query: 108 LKIADFGLSCTLYPGNYAE-KVCGSPL-YMAPEVLQFQRYDEKVNFF 152
           +K++   LS  +Y   Y + +    PL ++APE +Q   +  K + +
Sbjct: 156 VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVW 202

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 55.4 bits (133), Expect = 9e-10
 Identities = 46/142 (32%), Positives = 65/142 (45%), Gaps = 29/142 (20%)

Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----------------QT 67
           HPNII L  A +    ++L +E+   GNL  ++R   RV E                 Q 
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQQ 125

Query: 68  ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YA 125
              F   +  G++ L+    IHRDL   NIL+    ++ + KIADFGLS     G   Y 
Sbjct: 126 LLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS----RGQEVYV 178

Query: 126 EKVCGS-PL-YMAPEVLQFQRY 145
           +K  G  P+ +MA E L +  Y
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVY 200

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 55.4 bits (133), Expect = 1e-09
 Identities = 30/114 (26%), Positives = 64/114 (56%), Gaps = 4/114 (3%)

Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L K   + +  E + L   +   ++++F +FQ +  ++L++EF  GG++ + +     + 
Sbjct: 40  LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLS 99

Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
           E+  + ++ +    ++ ++    IHRD+KP+N+L   LD    +K++DFGL CT
Sbjct: 100 EEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLL---LDAKGHVKLSDFGL-CT 149

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 54.7 bits (132), Expect = 1e-09
 Identities = 38/108 (35%), Positives = 60/108 (55%), Gaps = 9/108 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAF-----QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           E+  L  ++H N+I + D       +A N +++V E     +L   IR    + +   + 
Sbjct: 54  EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYEL-MDTDLHQIIRSSQTLSDDHCQY 112

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
           FL QL  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+ T
Sbjct: 113 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLART 157

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 54.3 bits (130), Expect = 2e-09
 Identities = 35/139 (25%), Positives = 73/139 (52%), Gaps = 12/139 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 51  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DM 107

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 108 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 164

Query: 131 SPL-YMAPEVLQFQRYDEK 148
            P+ + APE   + R+  K
Sbjct: 165 FPIKWTAPEAALYGRFTIK 183

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 53.8 bits (129), Expect = 2e-09
 Identities = 39/135 (28%), Positives = 66/135 (48%), Gaps = 8/135 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +H NIIRL           ++ E+   G L  Y+R H G          L+ 
Sbjct: 56  EASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRG 115

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL--YP-GNYAEKVCGS 131
           + AG++ L+  + +HRDL   NIL   ++ ++  K++DFGLS  L   P G Y       
Sbjct: 116 IAAGMKYLSDMNYVHRDLAARNIL---VNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172

Query: 132 PL-YMAPEVLQFQRY 145
           P+ + APE + ++++
Sbjct: 173 PIRWTAPEAIAYRKF 187

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 53.9 bits (130), Expect = 2e-09
 Identities = 40/145 (27%), Positives = 66/145 (45%), Gaps = 15/145 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E+     + HPNI+    +F  ++ +++V    A G+    ++ H     PE      L+
Sbjct: 49  EIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK 108

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSP 132
            +   L+ ++S   IHR +K  +ILLSG D  V+L  +    S ++   G     V   P
Sbjct: 109 DVLNALDYIHSKGFIHRSVKASHILLSG-DGKVVL--SGLRYSVSMIKHGKRQRVVHDFP 165

Query: 133 LY-------MAPEVLQ--FQRYDEK 148
                    ++PEVLQ   Q Y+EK
Sbjct: 166 KSSVKNLPWLSPEVLQQNLQGYNEK 190

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 53.9 bits (129), Expect = 2e-09
 Identities = 38/139 (27%), Positives = 70/139 (50%), Gaps = 12/139 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  ++ L+ A  +E  I++V EF   G+L  +++     + ++P+      
Sbjct: 51  EAQIMKKLRHDKLVPLY-AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLV--DM 107

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+  G+  +   + IHRDL+  NIL+    D+++ KIADFGL+  +    Y A +   
Sbjct: 108 AAQIADGMAYIERMNYIHRDLRAANILVG---DNLVCKIADFGLARLIEDNEYTARQGAK 164

Query: 131 SPL-YMAPEVLQFQRYDEK 148
            P+ + APE   + R+  K
Sbjct: 165 FPIKWTAPEAALYGRFTIK 183

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 53.9 bits (129), Expect = 3e-09
 Identities = 26/91 (28%), Positives = 56/91 (61%), Gaps = 4/91 (4%)

Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87
           ++++F +FQ +  ++L++EF  GG++ + +     + E+  + ++ +    ++ ++    
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122

Query: 88  IHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
           IHRD+KP+N+L   LD    +K++DFGL CT
Sbjct: 123 IHRDIKPDNLL---LDSKGHVKLSDFGL-CT 149

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 53.5 bits (128), Expect = 4e-09
 Identities = 44/149 (29%), Positives = 73/149 (48%), Gaps = 17/149 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHG---------RVP 64
           E+  L  + HPN+I L   F   A+  ++L+ ++ A  +L   I+ H          ++P
Sbjct: 48  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLP 106

Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLS----CTL 119
               +  L Q+  G+  L+++ ++HRDLKP NIL+ G   +   +KIAD G +      L
Sbjct: 107 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166

Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEK 148
            P    + V  +  Y APE+L   R+  K
Sbjct: 167 KPLADLDPVVVTFWYRAPELLLGARHYTK 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 53.5 bits (128), Expect = 4e-09
 Identities = 33/102 (32%), Positives = 55/102 (53%), Gaps = 5/102 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
           E++ L  + H NI+ L D    +  + LV E+    +L  Y+   G +      + FL Q
Sbjct: 54  EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQ 112

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           +  GL   +   ++HRDLKP+N+L++   +   LK+ADFGL+
Sbjct: 113 ILRGLAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLA 151

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 53.4 bits (128), Expect = 4e-09
 Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 23/148 (15%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  L  + H N+I L D F +          +LV+ +    +L   +     + E   +
Sbjct: 64  ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHP--LSEDKVQ 120

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-KV 128
             + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI DFGL+       +A+ ++
Sbjct: 121 YLVYQMLCGLKYIHSAGIIHRDLKPGNL---AVNEDCELKILDFGLA------RHADAEM 171

Query: 129 CG---SPLYMAPEV-LQFQRYDEKVNFF 152
            G   +  Y APEV L +  Y++ V+ +
Sbjct: 172 TGYVVTRWYRAPEVILNWMHYNQTVDIW 199

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 53.1 bits (127), Expect = 6e-09
 Identities = 43/149 (28%), Positives = 73/149 (48%), Gaps = 17/149 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHG---------RVP 64
           E+  L  + HPN+I L   F   ++  ++L+ ++ A  +L   I+ H          ++P
Sbjct: 48  EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLP 106

Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLS----CTL 119
               +  L Q+  G+  L+++ ++HRDLKP NIL+ G   +   +KIAD G +      L
Sbjct: 107 RSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166

Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEK 148
            P    + V  +  Y APE+L   R+  K
Sbjct: 167 KPLADLDPVVVTFWYRAPELLLGARHYTK 195

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 52.7 bits (126), Expect = 6e-09
 Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 18/140 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQT 67
           E + +      +++RL           +V+E  A G+L SY+R          GR P  T
Sbjct: 59  EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPT 117

Query: 68  ARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
            ++ +Q   ++  G+  LN+   +HRDL   N +++    D  +KI DFG++  +Y  +Y
Sbjct: 118 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETDY 174

Query: 125 AEKVCGSPL---YMAPEVLQ 141
             K     L   +MAPE L+
Sbjct: 175 YRKGGKGLLPVRWMAPESLK 194

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 52.7 bits (126), Expect = 7e-09
 Identities = 44/137 (32%), Positives = 68/137 (49%), Gaps = 15/137 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAF------QAENCIFL--VVEFCAGGNLSSYIRLHGR----V 63
           EL  + ++NH NII L D +      + E  IFL  V+EF     +  Y++ + R    +
Sbjct: 109 ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHAL 167

Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           P    + +  QL   L  ++S  I HRDLKP+N+L+    +   LK+ DFG +  L  G 
Sbjct: 168 PLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHTLKLCDFGSAKNLLAGQ 225

Query: 124 YAEKVCGSPLYMAPEVL 140
            +     S  Y APE++
Sbjct: 226 RSVSYICSRFYRAPELM 242

Length = 440

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 52.1 bits (125), Expect = 1e-08
 Identities = 42/138 (30%), Positives = 67/138 (48%), Gaps = 14/138 (10%)

Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK---FLQQL 75
           +   +HPN++ L      +E    +V+ +   G+L ++IR     P  T +    F  Q+
Sbjct: 50  MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP--TVKDLIGFGLQV 107

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL 133
             G+E L S   +HRDL   N +   LD+   +K+ADFGL+  +Y   Y       G+ L
Sbjct: 108 AKGMEYLASKKFVHRDLAARNCM---LDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL 164

Query: 134 ---YMAPEVLQFQRYDEK 148
              +MA E LQ Q++  K
Sbjct: 165 PVKWMALESLQTQKFTTK 182

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 51.5 bits (123), Expect = 2e-08
 Identities = 40/139 (28%), Positives = 71/139 (51%), Gaps = 12/139 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGR---VPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++   GR   +P       
Sbjct: 51  EAQIMKKLRHDKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLV--DM 107

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ AG+  +   + IHRDL+  NIL+    D ++ KIADFGL+  +    Y A +   
Sbjct: 108 AAQVAAGMAYIERMNYIHRDLRSANILVG---DGLVCKIADFGLARLIEDNEYTARQGAK 164

Query: 131 SPL-YMAPEVLQFQRYDEK 148
            P+ + APE   + R+  K
Sbjct: 165 FPIKWTAPEAALYGRFTIK 183

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 51.5 bits (123), Expect = 2e-08
 Identities = 31/108 (28%), Positives = 52/108 (48%), Gaps = 6/108 (5%)

Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTA 68
           K  LD E   ++SV++P++ RL       + + L+ +    G L  Y+R H   +  Q  
Sbjct: 54  KEILD-EAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL 111

Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
             +  Q+  G+  L    ++HRDL   N+L+        +KI DFGL+
Sbjct: 112 LNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH---VKITDFGLA 156

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 50.8 bits (121), Expect = 3e-08
 Identities = 36/140 (25%), Positives = 66/140 (47%), Gaps = 18/140 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------T 67
           E + +   N  +++RL           +++E    G+L SY+R   R   +        +
Sbjct: 59  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR-SLRPEMENNPVQAPPS 117

Query: 68  ARKFLQQLGA---GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
            +K +Q  G    G+  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +Y
Sbjct: 118 LKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDY 174

Query: 125 AEKVCGSPL---YMAPEVLQ 141
             K     L   +M+PE L+
Sbjct: 175 YRKGGKGLLPVRWMSPESLK 194

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 50.4 bits (121), Expect = 4e-08
 Identities = 33/95 (34%), Positives = 42/95 (44%), Gaps = 7/95 (7%)

Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
           Y  L   +PE+   K        L  L     IIHRD+KP NIL   LD +  +K+ DFG
Sbjct: 97  YEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNIL---LDRNGNIKLCDFG 153

Query: 115 LSCTLYPGNYAEKVCGSPLYMAPEVL---QFQRYD 146
           +S  L       +  G   YMAPE +       YD
Sbjct: 154 ISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYD 188

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 49.9 bits (119), Expect = 6e-08
 Identities = 36/137 (26%), Positives = 62/137 (45%), Gaps = 6/137 (4%)

Query: 12  CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARK 70
               E   L   +H NI+RL       N + +V E+ + G L S++R H G++       
Sbjct: 52  GFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMG 111

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG-LSCTLYPGNYAEKVC 129
            L  L +G++ L+    +H+ L    +L++    D++ KI+ F  L        Y     
Sbjct: 112 MLPGLASGMKYLSEMGYVHKGLAAHKVLVN---SDLVCKISGFRRLQEDKSEAIYTTMSG 168

Query: 130 GSP-LYMAPEVLQFQRY 145
            SP L+ APE +Q+  +
Sbjct: 169 KSPVLWAAPEAIQYHHF 185

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 49.5 bits (118), Expect = 8e-08
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 6/104 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFL 72
           E+  L ++ H NI++       +  N I L++EF   G+L  Y+ R   ++  +   K+ 
Sbjct: 56  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYA 115

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
            Q+  G++ L S   +HRDL   N+L   ++ +  +KI DFGL+
Sbjct: 116 VQICKGMDYLGSRQYVHRDLAARNVL---VESEHQVKIGDFGLT 156

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 49.1 bits (117), Expect = 1e-07
 Identities = 31/70 (44%), Positives = 41/70 (58%), Gaps = 10/70 (14%)

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS- 131
           Q+  G+E L S   IHRDL   NILLS   ++ ++KI DFGL+  +Y   +Y  K  G  
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRK--GDA 235

Query: 132 --PL-YMAPE 138
             PL +MAPE
Sbjct: 236 RLPLKWMAPE 245

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 49.0 bits (117), Expect = 2e-07
 Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 9/106 (8%)

Query: 16  ELNFLSSVNHPNI-----IRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           E+  L  + HP+I     I L  + +    I++V E     +L   I+ +  +  +  + 
Sbjct: 49  EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDDLTPEHHQF 107

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           FL QL   L+ +++ ++ HRDLKP+NIL +    D  LKI DFGL+
Sbjct: 108 FLYQLLRALKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLA 150

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 48.5 bits (115), Expect = 3e-07
 Identities = 33/70 (47%), Positives = 43/70 (61%), Gaps = 10/70 (14%)

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS- 131
           Q+  G+E L S   IHRDL   NILLS  +++V +KI DFGL+  +Y   +Y  K  GS 
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLS--ENNV-VKICDFGLARDIYKDPDYVRK--GSA 236

Query: 132 --PL-YMAPE 138
             PL +MAPE
Sbjct: 237 RLPLKWMAPE 246

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 48.2 bits (115), Expect = 3e-07
 Identities = 33/106 (31%), Positives = 55/106 (51%), Gaps = 10/106 (9%)

Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARK 70
           E+  L S+ H NI++     + A      + LV+E+   G+L  Y++ H  R+  +    
Sbjct: 55  EIEILKSLQHDNIVKYKGVCYSA--GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLL 112

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           +  Q+  G+E L S   +HRDL   NIL   ++ +  +KI DFGL+
Sbjct: 113 YASQICKGMEYLGSKRYVHRDLATRNIL---VESENRVKIGDFGLT 155

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 47.3 bits (112), Expect = 6e-07
 Identities = 30/70 (42%), Positives = 41/70 (58%), Gaps = 6/70 (8%)

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS- 131
           Q+  G+E L S   IHRDL   NILLS   ++ ++KI DFGL+  +Y   +Y  K     
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARL 243

Query: 132 PL-YMAPEVL 140
           PL +MAPE +
Sbjct: 244 PLKWMAPETI 253

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 47.2 bits (112), Expect = 7e-07
 Identities = 39/149 (26%), Positives = 67/149 (44%), Gaps = 28/149 (18%)

Query: 16  ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARK 70
           E   L  ++HP ++ L D        C+ L        +L +Y+    R   + + TA  
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS---DLYTYLGARLRPLGLAQVTA-- 264

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG 130
             +QL + ++ ++   IIHRD+K EN+L++G +D   + + DFG +C      +A     
Sbjct: 265 VARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED---ICLGDFGAAC------FARGSWS 315

Query: 131 SPLYM---------APEVLQFQRYDEKVN 150
           +P +          APEVL    Y   V+
Sbjct: 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVD 344

Length = 461

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 46.9 bits (111), Expect = 8e-07
 Identities = 38/128 (29%), Positives = 62/128 (48%), Gaps = 13/128 (10%)

Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA--RKFLQQLG--- 76
           S+ H N+++            LV+EFC  G+L  Y+R   R  E        LQ++    
Sbjct: 51  SLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLR-SCRKAELMTPDPTTLQRMACEI 109

Query: 77  -AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSP 132
             GL  L+ ++ IH DL   N LL+    D+ +KI D+GLS   Y  +Y    +++    
Sbjct: 110 ALGLLHLHKNNFIHSDLALRNCLLTA---DLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL 166

Query: 133 LYMAPEVL 140
            ++APE++
Sbjct: 167 RWIAPELV 174

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 46.7 bits (111), Expect = 8e-07
 Identities = 45/144 (31%), Positives = 66/144 (45%), Gaps = 29/144 (20%)

Query: 16  ELNFLSSVNHPNIIRL----------FDAFQAENCIFLVVEFCAG---GNLSSYIRLHGR 62
           E+  L  +NH NI+ L           D  + +   +LV E+      G L S     G 
Sbjct: 56  EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLES-----GL 110

Query: 63  V--PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
           V   E   + F++QL  GL   +  + +HRD+K  NIL   L++   +K+ADFGL+  LY
Sbjct: 111 VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNIL---LNNKGQIKLADFGLA-RLY 166

Query: 121 PGN----YAEKVCGSPLYMAPEVL 140
                  Y  KV  +  Y  PE+L
Sbjct: 167 NSEESRPYTNKVI-TLWYRPPELL 189

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 46.6 bits (111), Expect = 9e-07
 Identities = 33/152 (21%), Positives = 63/152 (41%), Gaps = 21/152 (13%)

Query: 11  SCLDCELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           + L  E   L  ++H NI+ +     +     F++  +   GNL  +++          +
Sbjct: 53  TLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQ 112

Query: 70  KFLQ--------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
                       Q+  G+  L+   +IH+D+   N ++   D+++ +KI D  LS  L+P
Sbjct: 113 ALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKITDNALSRDLFP 169

Query: 122 GNYAEKVC-----GSPL-YMAPEVLQFQRYDE 147
            +Y    C       P+ +MA E L  + Y  
Sbjct: 170 MDYH---CLGDNENRPVKWMALESLVNKEYSS 198

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 46.2 bits (109), Expect = 1e-06
 Identities = 33/133 (24%), Positives = 62/133 (46%), Gaps = 8/133 (6%)

Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAG 78
           ++S++HP+++RL     +   I LV +    G L  Y+  H   +  Q    +  Q+  G
Sbjct: 63  MASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKG 121

Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YM 135
           +  L    ++HRDL   N+L+   +    +KI DFGL+  L          G  +   +M
Sbjct: 122 MMYLEERRLVHRDLAARNVLVKSPNH---VKITDFGLARLLEGDEKEYNADGGKMPIKWM 178

Query: 136 APEVLQFQRYDEK 148
           A E + ++++  +
Sbjct: 179 ALECIHYRKFTHQ 191

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 46.1 bits (109), Expect = 1e-06
 Identities = 46/154 (29%), Positives = 70/154 (45%), Gaps = 19/154 (12%)

Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARK 70
           L  EL+     NHPNI+     F A+N +++V  F A G+    I  H    + E     
Sbjct: 46  LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAY 105

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--- 127
            LQ +   L+ ++    +HR +K  +IL+S +D  V L     GL   L   N+ ++   
Sbjct: 106 ILQGVLKALDYIHHMGYVHRSVKASHILIS-VDGKVYLS----GLRSNLSMINHGQRLRV 160

Query: 128 VCGSPLY-------MAPEVLQ--FQRYDEKVNFF 152
           V   P Y       ++PEVLQ   Q YD K + +
Sbjct: 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIY 194

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 45.5 bits (108), Expect = 2e-06
 Identities = 27/78 (34%), Positives = 39/78 (50%), Gaps = 4/78 (5%)

Query: 62  RVPEQTARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
            +PE    K    +   LE L+S   +IHRD+KP N+L   ++ +  +K+ DFG+S  L 
Sbjct: 99  TIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVL---INRNGQVKLCDFGISGYLV 155

Query: 121 PGNYAEKVCGSPLYMAPE 138
                    G   YMAPE
Sbjct: 156 DSVAKTIDAGCKPYMAPE 173

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.8 bits (106), Expect = 4e-06
 Identities = 27/72 (37%), Positives = 39/72 (54%), Gaps = 4/72 (5%)

Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEK 127
           +  ++Q+   L+ L+S  I+HRD+KP+NI+ S  +     KI D G +  L  G NY  K
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFS--EGSGSFKIIDLGAAADLRVGINYIPK 315

Query: 128 -VCGSPLYMAPE 138
                P Y APE
Sbjct: 316 EFLLDPRYAAPE 327

Length = 566

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 44.2 bits (104), Expect = 7e-06
 Identities = 28/73 (38%), Positives = 40/73 (54%), Gaps = 10/73 (13%)

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVC 129
           F  Q+  G+E L S + +HRDL   N+LL+      ++KI DFGL+   ++  NY  K  
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLA---QGKIVKICDFGLARDIMHDSNYVSK-- 296

Query: 130 GSPL----YMAPE 138
           GS      +MAPE
Sbjct: 297 GSTFLPVKWMAPE 309

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 44.3 bits (104), Expect = 7e-06
 Identities = 29/101 (28%), Positives = 48/101 (47%), Gaps = 14/101 (13%)

Query: 51  GNLSSYIRLHGRVPEQTA---------RKFLQQLGAGLEILNSHHIIHRDLKPENILLSG 101
           G L  ++    ++P+            +  ++Q+  GL  L+   I+HRD+KPEN+L++ 
Sbjct: 285 GCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV 344

Query: 102 LDDDVMLKIADFGLSCTLYPGNYAEKVCG--SPLYMAPEVL 140
              D  +KI DFG +  +  G     + G   P Y  PE L
Sbjct: 345 ---DGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382

Length = 507

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 43.7 bits (103), Expect = 1e-05
 Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 14/155 (9%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           ++K++N  + S    E+  +  + HPNI++L    ++E   +L+ E+  G NLS  +R  
Sbjct: 719 VVKEIND-VNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-- 775

Query: 61  GRVPEQTARKFLQQLGAGLEILNSH---HIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
             +  +  RK    +   L  L+      ++  +L PE I++ G  D+  L+++  GL C
Sbjct: 776 -NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG-KDEPHLRLSLPGLLC 833

Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           T        K   S  Y+APE  + +   EK + +
Sbjct: 834 T------DTKCFISSAYVAPETRETKDITEKSDIY 862

Length = 968

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 43.6 bits (103), Expect = 1e-05
 Identities = 29/85 (34%), Positives = 41/85 (48%), Gaps = 26/85 (30%)

Query: 77  AGLEILNSHHIIHRDLKPENILLS----------------GLDDDVMLKIADFGLSCTLY 120
           A +E ++S  ++HRDLKP+NILL                  L+++ +L I D       Y
Sbjct: 124 ATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI-DVDERNICY 182

Query: 121 -----PGNYAEKVCGSPLYMAPEVL 140
                PG    K+ G+P YMAPE L
Sbjct: 183 SSMTIPG----KIVGTPDYMAPERL 203

Length = 932

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 43.1 bits (101), Expect = 2e-05
 Identities = 36/141 (25%), Positives = 63/141 (44%), Gaps = 10/141 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + L ++NHP+II+L   F       L++      +L  Y+     +         + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSV 191

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP----GNYAEKVCGS 131
              ++ L+ + IIHRD+K ENI ++   D   + + DFG +C  +P     N      G+
Sbjct: 192 LRAIQYLHENRIIHRDIKAENIFINHPGD---VCLGDFGAAC--FPVDINANKYYGWAGT 246

Query: 132 PLYMAPEVLQFQRYDEKVNFF 152
               APE+L    Y   V+ +
Sbjct: 247 IATNAPELLARDPYGPAVDIW 267

Length = 391

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 42.3 bits (99), Expect = 3e-05
 Identities = 29/73 (39%), Positives = 41/73 (56%), Gaps = 10/73 (13%)

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVC 129
           F  Q+  G+E L S + +HRDL   N+L+    +  ++KI DFGL+   +   NY  K  
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLIC---EGKLVKICDFGLARDIMRDSNYISK-- 298

Query: 130 GS---PL-YMAPE 138
           GS   PL +MAPE
Sbjct: 299 GSTFLPLKWMAPE 311

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 41.9 bits (98), Expect = 3e-05
 Identities = 31/108 (28%), Positives = 50/108 (46%), Gaps = 6/108 (5%)

Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTA 68
           K  LD E   ++ V  P + RL       + + LV +    G L  Y+R +  R+  Q  
Sbjct: 54  KEILD-EAYVMAGVGSPYVCRLL-GICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDL 111

Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
             +  Q+  G+  L    ++HRDL   N+L+   +    +KI DFGL+
Sbjct: 112 LNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH---VKITDFGLA 156

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 40.2 bits (94), Expect = 2e-04
 Identities = 28/74 (37%), Positives = 42/74 (56%), Gaps = 10/74 (13%)

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKV 128
           +F  Q+  G++ L S + IHRD+   N+LL+   D  + KI DFGL+  +    NY  K 
Sbjct: 216 RFSSQVAQGMDFLASKNCIHRDVAARNVLLT---DGRVAKICDFGLARDIMNDSNYVVK- 271

Query: 129 CGS---PL-YMAPE 138
            G+   P+ +MAPE
Sbjct: 272 -GNARLPVKWMAPE 284

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 40.1 bits (93), Expect = 2e-04
 Identities = 29/119 (24%), Positives = 57/119 (47%), Gaps = 15/119 (12%)

Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVV---EFCAGGNLSSYI-----RLH 60
               L+ E+  L  +NH NI+++ +  ++E   +++    +F    +L S++        
Sbjct: 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWK 261

Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
            R   +  R  ++QL   +E ++   +IHRD+K ENI L+    D  + + DFG +   
Sbjct: 262 DRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC---DGKIVLGDFGTAMPF 317

Length = 501

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 39.9 bits (93), Expect = 2e-04
 Identities = 28/104 (26%), Positives = 53/104 (50%), Gaps = 13/104 (12%)

Query: 9   LKSCLDCELNFLSS-------VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L++C +  L  L +         HPNI+  +  F   + ++++  F A G+ +S ++ + 
Sbjct: 35  LENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTY- 93

Query: 62  RVPEQTARKFLQQL--GA--GLEILNSHHIIHRDLKPENILLSG 101
             PE  +   +  +  GA  GL  L+ +  IHR++K  +IL+SG
Sbjct: 94  -FPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISG 136

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 39.1 bits (91), Expect = 4e-04
 Identities = 20/46 (43%), Positives = 26/46 (56%), Gaps = 3/46 (6%)

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           F  Q+  G+  L S + IHRDL   NILL+      + KI DFGL+
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILLT---HGRITKICDFGLA 261

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 38.7 bits (91), Expect = 4e-04
 Identities = 29/94 (30%), Positives = 44/94 (46%), Gaps = 13/94 (13%)

Query: 23  VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82
           VN P  +   D         +V+E+  G  L   I  +G    + +R+  + +G     L
Sbjct: 61  VNVP-AVYFVD----PENFIIVMEYIEGEPLKDLINSNGMEELELSREIGRLVG----KL 111

Query: 83  NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           +S  IIH DL   N++LSG    + L I DFGL+
Sbjct: 112 HSAGIIHGDLTTSNMILSG--GKIYL-I-DFGLA 141

Length = 211

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 38.4 bits (89), Expect = 7e-04
 Identities = 33/120 (27%), Positives = 50/120 (41%), Gaps = 16/120 (13%)

Query: 35  FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH-HIIHRDLK 93
           FQ E     +V    G  L  +I  HG    +   + + Q G  L+  ++  H++H DLK
Sbjct: 200 FQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLK 259

Query: 94  PENILLSGLD-------------DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL 140
           PENIL+   D             D   ++I D G  C       A  +  +  Y +PEV+
Sbjct: 260 PENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTA--IVSTRHYRSPEVV 317

Length = 467

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 36.6 bits (85), Expect = 0.001
 Identities = 26/108 (24%), Positives = 45/108 (41%), Gaps = 15/108 (13%)

Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
           L  L+    P + ++  + +++   +L++E+  G  L         V E+      +QL 
Sbjct: 45  LQLLARKGLP-VPKVLASGESDGWSYLLMEWIEGETLDE-------VSEEEKEDIAEQLA 96

Query: 77  AGLEILNSH---HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
             L  L+      + H DL P NIL   +DD  +L I D+       P
Sbjct: 97  ELLAKLHQLPLLVLCHGDLHPGNIL---VDDGKILGIIDWE-YAGYGP 140

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 36.4 bits (84), Expect = 0.003
 Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 8/104 (7%)

Query: 43  LVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS- 100
           +V EF   G L   +R   GRVP        QQL + L  L   +++H ++  +NILL+ 
Sbjct: 93  MVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLAR 152

Query: 101 -GLDDDVM--LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 141
            GL +     +K++D G+S T    +  E+V   P ++APE + 
Sbjct: 153 LGLAEGTSPFIKLSDPGVSFTAL--SREERVERIP-WIAPECVP 193

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	154
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	99.98
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.98
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.98
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.98
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.98
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.98
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.98
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.98
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.98
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.98
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.98
KOG0610	459	consensus Putative serine/threonine protein kinase	99.98
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.98
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.98
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.98
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.98
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.98
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.97
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.97
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.97
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.97
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.97
PHA02988	283	hypothetical protein; Provisional	99.97
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.97
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.97
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.97
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.97
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.97
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.97
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.97
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.97
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.97
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.97
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.97
PHA03207	392	serine/threonine kinase US3; Provisional	99.97
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.97
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.97
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.97
PHA03209	357	serine/threonine kinase US3; Provisional	99.97
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.97
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.97
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.97
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.97
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.97
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.97
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.97
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.97
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.97
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.97
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.97
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.97
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.97
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.97
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.97
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.97
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.97
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.97
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.97
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.97
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.97
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.97
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.97
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.97
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.97
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.97
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.97
PHA03211	461	serine/threonine kinase US3; Provisional	99.97
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.97
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.97
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.97
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.97
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.97
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.97
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.97
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.97
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.97
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.97
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.97
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.97
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.97
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.97
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.97
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.97
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.97
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.97
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.97
PTZ00036	440	glycogen synthase kinase; Provisional	99.97
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.97
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.97
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.97
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.97
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.97
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.97
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.97
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.97
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.97
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.97
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.97
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.97
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.97
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.97
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.97
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.97
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.97
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.96
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.96
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.96
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.96
PTZ00283	496	serine/threonine protein kinase; Provisional	99.96
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.96
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.96
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.96
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.96
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.96
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.96
PHA03210	501	serine/threonine kinase US3; Provisional	99.96
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.96
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.96
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.96
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.96
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.96
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.96
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.96
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.96
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.96
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.96
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.96
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.96
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.96
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.96
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.96
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.96
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.96
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.96
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.96
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.96
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.96
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.96
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.96
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.96
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.96
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.96
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.96
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.96
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.96
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.96
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.96
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.96
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.96
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.96
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.96
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.96
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.96
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.96
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.96
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.96
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.96
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.96
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.96
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.96
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.96
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.96
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.96
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.96
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.96
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.96
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.96
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.96
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.96
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.96
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.96
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.96
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.96
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.96
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.96
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.96
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.96
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.96
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.96
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.96
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.96
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.96
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.96
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.96
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.96
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.96
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.96
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.96
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.96
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.96
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.96
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.96
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.96
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.96
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.96
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.96
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.96
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.96
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.96
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.96
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.96
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.96
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.96
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.96
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.96
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.96
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.96
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.96
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.96
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.96
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.96
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.95
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.95
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.95
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.95
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.95
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.95
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.95
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.95
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.95
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.95
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.95
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.95
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.95
PTZ00284	467	protein kinase; Provisional	99.95
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.95
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.95
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.95
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.95
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.95
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.95
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.95
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.95
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.95
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.95
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.95
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.95
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.95
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.95
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.95
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.95
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.95
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.95
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.95
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.95
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.95
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.95
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.95
PLN00009	294	cyclin-dependent kinase A; Provisional	99.95
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.95
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.95
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.95
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.95
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.95
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.95
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.95
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.95
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.95
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.95
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.94
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.94
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.94
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.94
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.94
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.94
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.94
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.94
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.94
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.94
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.94
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.94
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.94
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.94
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.94
PHA02882	294	putative serine/threonine kinase; Provisional	99.94
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.94
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.94
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.94
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.94
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.94
KOG3653	534	consensus Transforming growth factor beta/activin	99.94
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.94
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.94
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.93
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.93
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.93
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.93
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.93
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.93
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.93
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.93
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.92
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.92
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.92
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.92
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.92
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.9
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.9
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.89
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.88
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.88
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.86
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.86
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.85
PRK10345	210	hypothetical protein; Provisional	99.82
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.82
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.82
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.82
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.82
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.81
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.8
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.8
PRK12274	218	serine/threonine protein kinase; Provisional	99.78
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.76
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.74
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.72
PRK14879	211	serine/threonine protein kinase; Provisional	99.72
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.72
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.7
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.7
smart00090	237	RIO RIO-like kinase.	99.69
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.68
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.67
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.65
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.62
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.58
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.57
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.55
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.47
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.44
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.43
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.41
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.39
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.38
KOG3087	229	consensus Serine/threonine protein kinase [General	99.37
KOG1243	690	consensus Protein kinase [General function predict	99.34
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.31
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.3
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.28
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.27
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.26
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.22
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.2
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.16
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.13
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.0
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.92
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.84
PRK09902	216	hypothetical protein; Provisional	98.77
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.75
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.6
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.56
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.5
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.38
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.35
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.32
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.27
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.18
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.1
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.04
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	97.95
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.86
PLN02876	822	acyl-CoA dehydrogenase	97.76
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.69
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.68
PF01636	239	APH: Phosphotransferase enzyme family This family	97.66
COG4248	637	Uncharacterized protein with protein kinase and he	97.64
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.36
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	96.95
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.91
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.78
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.08
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	96.02
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.02
KOG2270	520	consensus Serine/threonine protein kinase involved	95.92
PTZ00384	383	choline kinase; Provisional	95.76
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	95.52
PRK05231	319	homoserine kinase; Provisional	95.5
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	95.5
PRK10593	297	hypothetical protein; Provisional	95.46
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.29
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	95.14
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	95.08
PHA03111	444	Ser/Thr kinase; Provisional	94.98
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	94.88
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	94.82
KOG4720	391	consensus Ethanolamine kinase [Lipid transport and	94.75
PRK10271	188	thiK thiamine kinase; Provisional	94.6
PLN02236	344	choline kinase	93.77
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	93.63
COG2334	331	Putative homoserine kinase type II (protein kinase	93.58
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	93.5
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	93.36
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	93.13
KOG1236	565	consensus Predicted unusual protein kinase [Genera	92.93
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	92.84
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	92.73
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	92.54
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	92.46

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3e-45  Score=255.70  Aligned_cols=151  Identities=53%  Similarity=0.928  Sum_probs=141.9

Q ss_pred             hhhhhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 031702            4 KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         4 ~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      +++....+.+..|+.+|+.++|||||++++++.+++.+|+|||||.||+|.+|+.+.+.+++..++.++.|++.|+++||
T Consensus        47 ~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~  126 (429)
T KOG0595|consen   47 KLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLH  126 (429)
T ss_pred             ccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            34666889999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCC---eeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           84 SHHIIHRDLKPENILLSGLDDD---VMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~---~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||||||+||++......   ..+||+|||+|+...+.....+.||+|.|||||++...+|+.|+|+||+
T Consensus       127 ~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSi  200 (429)
T KOG0595|consen  127 ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSI  200 (429)
T ss_pred             HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHH
Confidence            9999999999999999754222   6889999999999998888999999999999999999999999999994

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-43  Score=245.94  Aligned_cols=144  Identities=36%  Similarity=0.642  Sum_probs=134.7

Q ss_pred             HhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 031702           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR   90 (154)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~   90 (154)
                      ....+|+++|++|+|||||+++++|+.+...|||+||++||+|.+++-.++.+.+...+.+++|++.|+.|||++||+||
T Consensus       221 ~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HR  300 (475)
T KOG0615|consen  221 RDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHR  300 (475)
T ss_pred             hhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccc
Confidence            34679999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCC---CcccceecC
Q 031702           91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY---DEKVNFFVS  154 (154)
Q Consensus        91 ~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Diwsl  154 (154)
                      ||||+||++.++.....+||+|||+|..........+.||||.|.|||++.++.+   ..++||||+
T Consensus       301 DiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSl  367 (475)
T KOG0615|consen  301 DIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSL  367 (475)
T ss_pred             cCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeec
Confidence            9999999998766789999999999999988889999999999999999987653   348899996

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=240.48  Aligned_cols=145  Identities=32%  Similarity=0.553  Sum_probs=137.3

Q ss_pred             hhhhHHhHHHHHHHHhhCCCCccchhhhheecCCc-EEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh
Q 031702            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ++..++++.+|++++++.+||+||+++++|..++. ++++||||.+|+|.++++..+++++.....++.++++|+.|||.
T Consensus       117 ~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~  196 (364)
T KOG0581|consen  117 DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHE  196 (364)
T ss_pred             CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            68889999999999999999999999999999984 99999999999999999988999999999999999999999996


Q ss_pred             -CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           85 -HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        85 -~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                       .+|+||||||+|+++   +..+.+||+|||.+..+... ...+..||..|||||.+.+..|+.++|||||
T Consensus       197 ~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSL  263 (364)
T KOG0581|consen  197 ERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSL  263 (364)
T ss_pred             ccCeeeccCCHHHeee---ccCCCEEeccccccHHhhhh-hcccccccccccChhhhcCCcCCcccceecc
Confidence             899999999999999   78999999999998876555 7788899999999999999999999999997

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5e-41  Score=232.10  Aligned_cols=144  Identities=39%  Similarity=0.645  Sum_probs=135.9

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+....|..||..++||+||+++..|+++..+|+|+||+.||.|...+.+++.+++..+.-|+.+|+.|+.|||+.||
T Consensus        67 ~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gI  146 (357)
T KOG0598|consen   67 KEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGI  146 (357)
T ss_pred             hhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCe
Confidence            45778899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeeccccccc-CCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|||+||+||++   +..++++|.|||++... ..++...+.|||+.|||||++.+.+|+..+|+|||
T Consensus       147 iyRDlKPENILL---d~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsL  211 (357)
T KOG0598|consen  147 IYRDLKPENILL---DEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSL  211 (357)
T ss_pred             eeccCCHHHeee---cCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhH
Confidence            999999999999   89999999999999864 34456777899999999999999999999999996

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.9e-40  Score=237.57  Aligned_cols=146  Identities=34%  Similarity=0.607  Sum_probs=139.3

Q ss_pred             hhhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      +...++.+.+|++|.+.|+|||||++++.|++++++|++.|+|..++|..+++..+.+++.+++.+++||+.|+.|||+.
T Consensus        58 k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~  137 (592)
T KOG0575|consen   58 KPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL  137 (592)
T ss_pred             CcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc
Confidence            56778999999999999999999999999999999999999999999999999889999999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+|||||..|+++   ++..++||+|||+|...... +...+.||||-|+|||++...+++..+||||+
T Consensus       138 ~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSl  204 (592)
T KOG0575|consen  138 GIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSL  204 (592)
T ss_pred             Cceecccchhheee---cCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhh
Confidence            99999999999999   78889999999999988755 67788999999999999999999999999995

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=219.94  Aligned_cols=142  Identities=36%  Similarity=0.670  Sum_probs=135.2

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+...+|..+|+.+.||+++++++.+.+.+.+||+|||++||.|..++++.+++++..++-+++||+.|++|||+.++
T Consensus        86 KQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~i  165 (355)
T KOG0616|consen   86 KQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDI  165 (355)
T ss_pred             HHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCe
Confidence            44677889999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++||+||+||++   +..+.+|+.|||+|.+....  ..+.||||.|+|||++..++|..++|+|||
T Consensus       166 iYRDLKPENiLl---D~~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~sk~ynkavDWWal  227 (355)
T KOG0616|consen  166 IYRDLKPENLLL---DQNGHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQSKGYNKAVDWWAL  227 (355)
T ss_pred             eeccCChHHeee---ccCCcEEEEeccceEEecCc--EEEecCCccccChHHhhcCCCCcchhHHHH
Confidence            999999999999   89999999999999887554  677999999999999999999999999996

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-39  Score=230.43  Aligned_cols=142  Identities=35%  Similarity=0.569  Sum_probs=129.4

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCC-cEEEEEEecCCCCchHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      .+.|.+|+.+|++++|||||+++|++.++. ..++||||+++|+|.+++..  ...++...+..++.||+.|++|||+++
T Consensus        83 ~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~  162 (362)
T KOG0192|consen   83 RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEG  162 (362)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence            679999999999999999999999999988 79999999999999999977  578999999999999999999999999


Q ss_pred             -ceeecCCCCcEEeecCCCCe-eEEEeecccccccCCC-CccccccCCccccCccccc--ccCCCcccceecC
Q 031702           87 -IIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ--FQRYDEKVNFFVS  154 (154)
Q Consensus        87 -~~h~~i~p~nil~~~~~~~~-~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~--~~~~~~~~Diwsl  154 (154)
                       ++|+||||+|+++   +... ++||+|||+++..... .......||+.|||||++.  ...|+.++|||||
T Consensus       163 ~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySF  232 (362)
T KOG0192|consen  163 PIIHRDLKSDNILV---DLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSF  232 (362)
T ss_pred             CeeecccChhhEEE---cCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhH
Confidence             9999999999999   6775 9999999999876544 3334478999999999999  5689999999997

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-39  Score=217.79  Aligned_cols=147  Identities=32%  Similarity=0.602  Sum_probs=130.8

Q ss_pred             hhhhhHHhHHHHHHHHhhCCCCccchhhh-heecCCc-EEEEEEecCCCCchHHHHH----cCCCCHHHHHHHHHHHHHH
Q 031702            5 LNKHLKSCLDCELNFLSSVNHPNIIRLFD-AFQAENC-IFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAG   78 (154)
Q Consensus         5 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~-~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~   78 (154)
                      ++...++++..|+.+|++|+||||+++++ .|.+++. ++++||++.+|+|.+.++.    +..+++..+++++.|++.|
T Consensus        57 md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~A  136 (375)
T KOG0591|consen   57 MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRA  136 (375)
T ss_pred             ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHH
Confidence            34667889999999999999999999998 6666555 8999999999999998853    3459999999999999999


Q ss_pred             HHHHHh--CC--ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceec
Q 031702           79 LEILNS--HH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFV  153 (154)
Q Consensus        79 l~~lh~--~~--~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diws  153 (154)
                      +.++|.  .+  +.||||||.||++   +..+.+||+|||+++...+.. ...+..|||.||+||.+...+|+.+|||||
T Consensus       137 L~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWs  213 (375)
T KOG0591|consen  137 LYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWS  213 (375)
T ss_pred             HHHHhccccccceeeccCcchheEE---cCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHH
Confidence            999999  45  9999999999999   788999999999999876543 456788999999999999999999999999


Q ss_pred             C
Q 031702          154 S  154 (154)
Q Consensus       154 l  154 (154)
                      +
T Consensus       214 l  214 (375)
T KOG0591|consen  214 L  214 (375)
T ss_pred             H
Confidence            6

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-38  Score=224.45  Aligned_cols=143  Identities=42%  Similarity=0.738  Sum_probs=133.7

Q ss_pred             hHHhHHHHHHHHhhCC-CCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+.+++.+. ||||+++++++.+...+|++|||+.||+|.+++.+.+++.+..+..+++|++.|++|+|+.|+
T Consensus        62 ~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi  141 (370)
T KOG0583|consen   62 LDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGI  141 (370)
T ss_pred             cchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCE
Confidence            4667779999999998 999999999999999999999999999999999988999999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCC-eeEEEeeccccccc-CCCCccccccCCccccCcccccccC-CC-cccceecC
Q 031702           88 IHRDLKPENILLSGLDDD-VMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQFQR-YD-EKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~-~~~kl~df~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~Diwsl  154 (154)
                      +||||||+|+++   +.. +++||+|||++... ...+...+.|||+.|+|||++.+.. |+ .++||||+
T Consensus       142 ~HRDLK~ENill---d~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~  209 (370)
T KOG0583|consen  142 VHRDLKPENILL---DGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSL  209 (370)
T ss_pred             eeCCCCHHHEEe---cCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhh
Confidence            999999999999   566 89999999999887 5677888999999999999999877 87 78999996

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-37  Score=221.48  Aligned_cols=142  Identities=27%  Similarity=0.506  Sum_probs=126.3

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      .+.|.+|+++|++|+|++||++++++..+..+|+|||||+.|+|.+|++.  +..+...+.+.++.|||+|++||.++++
T Consensus       245 ~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~  324 (468)
T KOG0197|consen  245 PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNY  324 (468)
T ss_pred             hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCc
Confidence            47889999999999999999999999998899999999999999999987  4569999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccc--cCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV--CGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~--~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |||||...|||+   +....+||+|||+|+...++......  .-...|.|||.+..+.+|.+||||||
T Consensus       325 IHRDLAARNiLV---~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSF  390 (468)
T KOG0197|consen  325 IHRDLAARNILV---DEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSF  390 (468)
T ss_pred             cchhhhhhheee---ccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeeh
Confidence            999999999999   78889999999999954444332222  12344999999999999999999998

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=211.75  Aligned_cols=142  Identities=35%  Similarity=0.610  Sum_probs=124.1

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCC--cEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      .+.+.+|+.+|++++|||||++++......  .++++|||+++|+|.+++.+.+ .+++..++.+++|+++|+.|||++|
T Consensus        58 ~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g  137 (313)
T KOG0198|consen   58 SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG  137 (313)
T ss_pred             HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            667999999999999999999999754444  6999999999999999998877 7999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCC-CeeEEEeecccccccCC----CCccccccCCccccCcccccccCC-CcccceecC
Q 031702           87 IIHRDLKPENILLSGLDD-DVMLKIADFGLSCTLYP----GNYAEKVCGSPLYMAPEVLQFQRY-DEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~-~~~~kl~df~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Diwsl  154 (154)
                      ++|+||||+||++   +. .+.+||+|||.+.....    ........||+.|||||++.++.. ..++|||||
T Consensus       138 ~vH~DiK~~NiLl---~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSl  208 (313)
T KOG0198|consen  138 IVHCDIKPANILL---DPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSL  208 (313)
T ss_pred             EeccCcccceEEE---eCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhc
Confidence            9999999999999   56 68999999999987653    223445789999999999996433 349999997

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-37  Score=220.46  Aligned_cols=142  Identities=30%  Similarity=0.576  Sum_probs=131.3

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      .++-+.+|+.+|+..+|+|||++++.|..++.+++|||||+||+|.+.+. +..+++.++..++++++.||+|||.+||+
T Consensus       313 ~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt-~~~~~E~qIA~Icre~l~aL~fLH~~gIi  391 (550)
T KOG0578|consen  313 KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVT-KTRMTEGQIAAICREILQGLKFLHARGII  391 (550)
T ss_pred             chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhh-cccccHHHHHHHHHHHHHHHHHHHhccee
Confidence            46778999999999999999999999999999999999999999999886 45599999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |||||..||++   ...+.+||+|||++..+.... ...+..|||+|||||++....|.+++|||||
T Consensus       392 HrDIKSDnILL---~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSL  455 (550)
T KOG0578|consen  392 HRDIKSDNILL---TMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSL  455 (550)
T ss_pred             eeccccceeEe---ccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhh
Confidence            99999999999   678889999999998876544 5667889999999999999999999999997

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-37  Score=219.69  Aligned_cols=145  Identities=34%  Similarity=0.563  Sum_probs=132.3

Q ss_pred             hhhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      +...+.+.+|-.+|..| .||+|++++..|.+...+|+++||+++|+|.+++++.+.|++...+.++++|+.|++|||++
T Consensus       114 e~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~  193 (604)
T KOG0592|consen  114 EKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN  193 (604)
T ss_pred             hcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc
Confidence            34457788899999999 99999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--------------ccccccCCccccCcccccccCCCcccce
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------------YAEKVCGSPLYMAPEVLQFQRYDEKVNF  151 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di  151 (154)
                      ||+||||||+|||+   +.+++++|.|||.|..+.+..              ...+..||..|++||++..+..+..+||
T Consensus       194 GIIHRDlKPENILL---d~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDi  270 (604)
T KOG0592|consen  194 GIIHRDLKPENILL---DKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDL  270 (604)
T ss_pred             CceeccCChhheeE---cCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccch
Confidence            99999999999999   899999999999997664321              1144789999999999999999999999


Q ss_pred             ecC
Q 031702          152 FVS  154 (154)
Q Consensus       152 wsl  154 (154)
                      |+|
T Consensus       271 WAl  273 (604)
T KOG0592|consen  271 WAL  273 (604)
T ss_pred             HHH
Confidence            997

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=201.16  Aligned_cols=151  Identities=35%  Similarity=0.546  Sum_probs=139.9

Q ss_pred             hhhhhhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHH
Q 031702            3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL   82 (154)
Q Consensus         3 k~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l   82 (154)
                      |+++....+.+.+|+.|-+.|+||||++++..+.+.+..|+|+|+|.|++|-.-+-...-+++..+-.+++||++|+.|+
T Consensus        47 ~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yC  126 (355)
T KOG0033|consen   47 KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYC  126 (355)
T ss_pred             hhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            55667788999999999999999999999999999999999999999999986665556688899999999999999999


Q ss_pred             HhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceec
Q 031702           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFV  153 (154)
Q Consensus        83 h~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws  153 (154)
                      |.++|+|||+||.|.++.+.+..--+||+|||+|....++.......|||.|||||++...+|+..+||||
T Consensus       127 H~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~  197 (355)
T KOG0033|consen  127 HSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWA  197 (355)
T ss_pred             HhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhh
Confidence            99999999999999999988888899999999999998777788899999999999999999999999997

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-36  Score=211.94  Aligned_cols=145  Identities=36%  Similarity=0.679  Sum_probs=138.4

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      +.+--.+.+|++||+.|+||+|+.++++|++++.+.+||||..+|.|++|+.+.+.+++.+...+++||+.|+.|+|+++
T Consensus        94 eqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr  173 (668)
T KOG0611|consen   94 EQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR  173 (668)
T ss_pred             HHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc
Confidence            45567889999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCC-cccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD-EKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Diwsl  154 (154)
                      ++|||+|.+||++   |.++++||+|||++-.+.......+.||+|.|.+||++.+.+|. +.+|-|||
T Consensus       174 VvHRDLKLENILL---D~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsL  239 (668)
T KOG0611|consen  174 VVHRDLKLENILL---DQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSL  239 (668)
T ss_pred             ceecccchhheee---cCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhH
Confidence            9999999999999   89999999999999988888888999999999999999999986 88999996

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-36  Score=216.21  Aligned_cols=145  Identities=31%  Similarity=0.502  Sum_probs=128.8

Q ss_pred             hhhhHHhHHHHHHHHhhCCCCccchhhhheecC--CcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHH
Q 031702            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEIL   82 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~l   82 (154)
                      ++.......+|+.||++|.||||+++.+...+.  +.+|||+|||++ +|.-++.+.+ +|++.++..+++|++.|++|+
T Consensus       156 ~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~c  234 (560)
T KOG0600|consen  156 KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYC  234 (560)
T ss_pred             CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHH
Confidence            356677889999999999999999999999877  689999999976 9988887643 699999999999999999999


Q ss_pred             HhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCccccccc-CCCcccceecC
Q 031702           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        83 h~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      |.+|++|||||.+|||+   +.++.+||+|||+|+.+....  .......|.||.|||.+.+. .|++.+|+||.
T Consensus       235 H~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~  306 (560)
T KOG0600|consen  235 HSRGVLHRDIKGSNILI---DNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSV  306 (560)
T ss_pred             hhcCeeeccccccceEE---cCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhh
Confidence            99999999999999999   899999999999999776544  34556679999999999875 69999999984

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-36  Score=216.32  Aligned_cols=146  Identities=34%  Similarity=0.619  Sum_probs=135.8

Q ss_pred             hhhhHHhHHHHHHHHhhCCCCccchhhhheecCCc-EEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHH
Q 031702            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEIL   82 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~l   82 (154)
                      ++..++...+|+.++++++||||+.+.+.|.+++. ++++|+|++||++.+.+.+.+  .++++.+..|+.|++.|+.||
T Consensus        43 t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~yl  122 (426)
T KOG0589|consen   43 TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYL  122 (426)
T ss_pred             CchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence            45667789999999999999999999999999988 999999999999999997554  599999999999999999999


Q ss_pred             HhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        83 h~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+++|+|||||+.|||+   .....++|+|||+|+...+.. ...+..||+.|++||.+.+.+|..++|||||
T Consensus       123 H~~~iLHRDlK~~Nifl---tk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsL  192 (426)
T KOG0589|consen  123 HENRVLHRDLKCANIFL---TKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSL  192 (426)
T ss_pred             Hhhhhhcccchhhhhhc---cccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhh
Confidence            99999999999999999   567778999999999988776 7888999999999999999999999999997

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.1e-36  Score=220.89  Aligned_cols=143  Identities=34%  Similarity=0.642  Sum_probs=133.5

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      .+.+.+.+|++|++.++||||+.+++.|++..++++|+||+.| +|..++...+.++++.+..++.+++.|+.|||+.++
T Consensus        43 k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~ri  121 (808)
T KOG0597|consen   43 KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRI  121 (808)
T ss_pred             HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCc
Confidence            4456799999999999999999999999999999999999966 999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+|+||+||++   +.++.+|++|||+|+....+. ...+..|||.|||||.+.+.+|+..+|+|||
T Consensus       122 lhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWsl  186 (808)
T KOG0597|consen  122 LHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSL  186 (808)
T ss_pred             ccccCCcceeee---cCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHH
Confidence            999999999999   789999999999998876654 3456789999999999999999999999996

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3e-36  Score=204.53  Aligned_cols=145  Identities=30%  Similarity=0.543  Sum_probs=128.5

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      +..++...+|+.+|++|+|+|+|.+.++|......++|+||++..-|.++-+....++...+..+++|++.|+.|+|+++
T Consensus        42 ~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n  121 (396)
T KOG0593|consen   42 PVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN  121 (396)
T ss_pred             HHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC
Confidence            34467788999999999999999999999999999999999988666665555567999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccC-CCCccccccCCccccCcccccc-cCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      ++||||||+||++   ...+.+||+|||+|+.+. +++...-...|.||.|||.+.+ -.|...+||||.
T Consensus       122 ~IHRDIKPENILi---t~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAi  188 (396)
T KOG0593|consen  122 CIHRDIKPENILI---TQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAI  188 (396)
T ss_pred             eecccCChhheEE---ecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhh
Confidence            9999999999999   688899999999999876 4555555667999999999987 589999999984

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-36  Score=214.09  Aligned_cols=137  Identities=33%  Similarity=0.523  Sum_probs=124.3

Q ss_pred             HHHHHHHhhCC-CCccchhhhheecCC-cEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 031702           14 DCELNFLSSVN-HPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHIIHR   90 (154)
Q Consensus        14 ~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~~h~   90 (154)
                      .+|+..|++|. ||||+++.+++.+.. .+|+|||||+. +|.++++.++ .|++..++.|+.||++|++|+|.+|+.||
T Consensus        56 LREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHR  134 (538)
T KOG0661|consen   56 LREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHR  134 (538)
T ss_pred             HHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccc
Confidence            46999999997 999999999999887 99999999965 9999987654 59999999999999999999999999999


Q ss_pred             cCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc-cCCCcccceecC
Q 031702           91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        91 ~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      |+||+||++   .....+||+|||+|+.+.+..+......|+||.|||++.. +-|+.+.||||+
T Consensus       135 DlKPENiLi---~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~  196 (538)
T KOG0661|consen  135 DLKPENILI---SGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAV  196 (538)
T ss_pred             cCChhheEe---cccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHH
Confidence            999999999   4577899999999999988877777788999999999764 568899999985

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-36  Score=220.64  Aligned_cols=145  Identities=36%  Similarity=0.712  Sum_probs=137.7

Q ss_pred             hhhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ++.....+.+|+-+|+.+.|||+++++++|+++.++|++.||+++|.|.+++.+++++++.+...+++||+.|+.|+|..
T Consensus        52 s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~  131 (786)
T KOG0588|consen   52 SSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF  131 (786)
T ss_pred             ccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh
Confidence            44557789999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCC-cccceec
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD-EKVNFFV  153 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Diws  153 (154)
                      +++|||+||+|+++   +.++++||+|||.|..-.++...++-||+|-|.|||++.+.+|+ .++||||
T Consensus       132 ~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWS  197 (786)
T KOG0588|consen  132 NICHRDLKPENLLL---DVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWS  197 (786)
T ss_pred             cceeccCCchhhhh---hcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccch
Confidence            99999999999999   77888999999999887788888999999999999999999997 7899998

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-36  Score=214.81  Aligned_cols=142  Identities=29%  Similarity=0.399  Sum_probs=126.7

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCC-cEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ..+|.+|+.++.+++|||+++++|+|.+.+ ..++|+|||++|+|.+.+....  .+++....+|+.++++|++|||...
T Consensus       115 ~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~  194 (361)
T KOG1187|consen  115 EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGC  194 (361)
T ss_pred             hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCC
Confidence            456999999999999999999999999998 5999999999999999986544  7899999999999999999999853


Q ss_pred             ---ceeecCCCCcEEeecCCCCeeEEEeecccccccCC-CCccccc-cCCccccCcccccccCCCcccceecC
Q 031702           87 ---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKV-CGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ---~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~-~~~~~~~-~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                         ++||||||+||++   |.+..+|++|||+|...+. ....... .||.+|+|||+...+..+.++|||||
T Consensus       195 ~~~iiHrDiKssNILL---D~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySF  264 (361)
T KOG1187|consen  195 PPPIIHRDIKSSNILL---DEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSF  264 (361)
T ss_pred             CCCEecCCCCHHHeeE---CCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccc
Confidence               9999999999999   8999999999999965544 3322233 79999999999998899999999997

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=209.17  Aligned_cols=142  Identities=33%  Similarity=0.567  Sum_probs=127.5

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      -+.+.+|++.++.+.||||++++..|..+..+|+||.||.+|++.+.++..  ..+++..+..+.+++++|+.|||.+|.
T Consensus        68 ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~  147 (516)
T KOG0582|consen   68 LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGH  147 (516)
T ss_pred             HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCc
Confidence            688999999999999999999999999999999999999999999999765  349999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-cc----ccccCCccccCcccccc--cCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YA----EKVCGSPLYMAPEVLQF--QRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~----~~~~~~~~y~aPE~~~~--~~~~~~~Diwsl  154 (154)
                      +|||+|+.||++   +.++.+||+|||.+..+...+ ..    .+..|+++|||||++..  .+|+.|+|||||
T Consensus       148 IHRdvKAgnILi---~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSf  218 (516)
T KOG0582|consen  148 IHRDVKAGNILI---DSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSF  218 (516)
T ss_pred             eecccccccEEE---cCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhh
Confidence            999999999999   899999999999876654433 22    44578999999999643  479999999997

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.7e-36  Score=201.65  Aligned_cols=145  Identities=37%  Similarity=0.742  Sum_probs=135.6

Q ss_pred             hhhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      .+..+.-.+|+.||+++ .||+|+++.++++++..+++|+|.|+.|.|.+++.+.-.+++.....+++|+.+++.|||.+
T Consensus        63 ~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~  142 (411)
T KOG0599|consen   63 YEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR  142 (411)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh
Confidence            34567778899999998 89999999999999999999999999999999999888999999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc------cCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF------QRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Diwsl  154 (154)
                      +|+|||+||+||++   +++.+++|+|||+++.+.++......||||+|+|||.+.-      .+|+..+|+||.
T Consensus       143 ~IVHRDLKpENILl---ddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~  214 (411)
T KOG0599|consen  143 NIVHRDLKPENILL---DDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWAC  214 (411)
T ss_pred             hhhhcccChhheee---ccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHH
Confidence            99999999999999   7888999999999999999999999999999999999853      368899999984

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.3e-34  Score=204.48  Aligned_cols=143  Identities=31%  Similarity=0.480  Sum_probs=128.9

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ....+.+|+.+++.++||||+++.+.+.+++..|++|||+++++|.+++.....+++..+..++.|++.|++|||+.|++
T Consensus        38 ~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iv  117 (323)
T cd05571          38 EVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVV  117 (323)
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence            44567889999999999999999999999999999999999999999998888899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCC-CCccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||||+||++   +..+.+||+|||++..... .......+|++.|+|||++.+..++.++|||||
T Consensus       118 HrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  181 (323)
T cd05571         118 YRDLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL  181 (323)
T ss_pred             eCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCccc
Confidence            99999999999   6788899999999875322 233445678999999999998899999999997

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2e-34  Score=207.72  Aligned_cols=143  Identities=25%  Similarity=0.512  Sum_probs=127.9

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|..+++.++|++|+++++.+.+...+|++|||+++|+|.+++.+.+.+++..+..++.|++.|++|||+.|++
T Consensus        44 ~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~giv  123 (363)
T cd05628          44 QVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFI  123 (363)
T ss_pred             HHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence            44678889999999999999999999999999999999999999999998888999999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCC------------------------------------ccccccCCc
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------------------------------------YAEKVCGSP  132 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~------------------------------------~~~~~~~~~  132 (154)
                      ||||||+||++   +..+.+||+|||++.......                                    .....+||+
T Consensus       124 HrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~  200 (363)
T cd05628         124 HRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTP  200 (363)
T ss_pred             ecCCCHHHeEE---CCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCc
Confidence            99999999999   677899999999986542211                                    012357899


Q ss_pred             cccCcccccccCCCcccceecC
Q 031702          133 LYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus       133 ~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .|+|||++.+..++.++|||||
T Consensus       201 ~Y~aPE~~~~~~~~~~~DvwSl  222 (363)
T cd05628         201 DYIAPEVFMQTGYNKLCDWWSL  222 (363)
T ss_pred             cccCHHHHcCCCCCCchhhhhh
Confidence            9999999998899999999996

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.5e-34  Score=205.52  Aligned_cols=142  Identities=32%  Similarity=0.588  Sum_probs=129.2

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++||||+++++++.+++..|++|||+++|+|.+++.+...+++..+..++.|++.|+.|||+.++
T Consensus        73 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i  152 (340)
T PTZ00426         73 KQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNI  152 (340)
T ss_pred             hhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34567889999999999999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +||||||+||++   +..+.+||+|||++......  .....||+.|+|||++.+..++.++|||||
T Consensus       153 vHrDLkp~NILl---~~~~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  214 (340)
T PTZ00426        153 VYRDLKPENLLL---DKDGFIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEILLNVGHGKAADWWTL  214 (340)
T ss_pred             EccCCCHHHEEE---CCCCCEEEecCCCCeecCCC--cceecCChhhcCHHHHhCCCCCccccccch
Confidence            999999999999   67889999999998765332  344678999999999998889999999997

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.2e-34  Score=208.35  Aligned_cols=145  Identities=28%  Similarity=0.570  Sum_probs=130.0

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ....+.+..|-.+|....+|+||+++.+|.++.++|+||||++||++..++.+.+.+++..++.++.+++.|++-+|+.|
T Consensus       182 ~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g  261 (550)
T KOG0605|consen  182 KNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG  261 (550)
T ss_pred             hhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC
Confidence            44567788899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCC----------------------CCcc-------------------
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP----------------------GNYA-------------------  125 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~----------------------~~~~-------------------  125 (154)
                      ++||||||+|+|+   |..|++||+|||++.-...                      .+..                   
T Consensus       262 yIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~  338 (550)
T KOG0605|consen  262 YIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWK  338 (550)
T ss_pred             cccccCChhheee---cCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHH
Confidence            9999999999999   8999999999999842110                      0000                   


Q ss_pred             -------ccccCCccccCcccccccCCCcccceecC
Q 031702          126 -------EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus       126 -------~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                             .+..|||.|+|||++.+.+|+..+|+|||
T Consensus       339 ~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  339 RNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                   12479999999999999999999999996

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1e-34  Score=217.81  Aligned_cols=143  Identities=27%  Similarity=0.551  Sum_probs=129.3

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC----------C----CCHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------R----VPEQTARKFLQQ   74 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----------~----~~~~~~~~~~~~   74 (154)
                      .+++|++|++++..|+|||||+++|+|.+++..|||+|||..|+|.+|++.+.          .    ++..+.+.++.|
T Consensus       532 ~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~Q  611 (774)
T KOG1026|consen  532 ARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQ  611 (774)
T ss_pred             HHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHH
Confidence            78899999999999999999999999999999999999999999999996442          2    778899999999


Q ss_pred             HHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccc---cCCccccCcccccccCCCcccce
Q 031702           75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV---CGSPLYMAPEVLQFQRYDEKVNF  151 (154)
Q Consensus        75 i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~---~~~~~y~aPE~~~~~~~~~~~Di  151 (154)
                      |+.|+.||-++.+|||||..+|+++   .++..+||+|||+++.+.+.+.....   .-..+|||||.+..++||++|||
T Consensus       612 IAaGM~YLs~~~FVHRDLATRNCLV---ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDV  688 (774)
T KOG1026|consen  612 IAAGMEYLSSHHFVHRDLATRNCLV---GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDV  688 (774)
T ss_pred             HHHHHHHHHhCcccccchhhhhcee---ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhh
Confidence            9999999999999999999999999   78899999999999987776644322   22466999999999999999999


Q ss_pred             ecC
Q 031702          152 FVS  154 (154)
Q Consensus       152 wsl  154 (154)
                      |||
T Consensus       689 Ws~  691 (774)
T KOG1026|consen  689 WSF  691 (774)
T ss_pred             hhh
Confidence            997

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-34  Score=201.75  Aligned_cols=144  Identities=34%  Similarity=0.517  Sum_probs=129.4

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++||||+++++.+.+++..|++|||+++++|.+++...+.+++..+..++.|++.|+.|||+.++
T Consensus        35 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  114 (312)
T cd05585          35 SEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNV  114 (312)
T ss_pred             hHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            34567788999999999999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCC-CCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||||+||++   +..+.++|+|||++..... ........||+.|+|||++.+..++.++|||||
T Consensus       115 ~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  179 (312)
T cd05585         115 IYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTL  179 (312)
T ss_pred             EeCCCCHHHeEE---CCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceech
Confidence            999999999999   6788999999999875332 223345678999999999998899999999996

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-34  Score=206.99  Aligned_cols=144  Identities=28%  Similarity=0.538  Sum_probs=126.7

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+++++.++||||+++++++.+++.+|++|||+++++|.+++.....+++..+..++.|++.|++|||+.|+
T Consensus        43 ~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi  122 (377)
T cd05629          43 DQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGF  122 (377)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            34567889999999999999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--------------------------------------------
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------------------------------------------  123 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--------------------------------------------  123 (154)
                      +||||||+||++   +..+.++|+|||++.......                                            
T Consensus       123 vHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (377)
T cd05629         123 IHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKK  199 (377)
T ss_pred             eccCCCHHHEEE---CCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhh
Confidence            999999999999   678889999999985321100                                            


Q ss_pred             ----ccccccCCccccCcccccccCCCcccceecC
Q 031702          124 ----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus       124 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                          ......||+.|+|||++.+..++.++|||||
T Consensus       200 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         200 NRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence                0012468999999999998899999999997

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-34  Score=201.32  Aligned_cols=141  Identities=36%  Similarity=0.632  Sum_probs=128.2

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++.+.+.+++..+..++.|++.|++|||++|++
T Consensus        44 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  123 (291)
T cd05612          44 QEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIV  123 (291)
T ss_pred             HHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            45678899999999999999999999999999999999999999999998888899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||+|+||++   +..+.+||+|||++......  .....|++.|+|||++.+..++.++|||||
T Consensus       124 H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  184 (291)
T cd05612         124 YRDLKPENILL---DKEGHIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQSKGHNKAVDWWAL  184 (291)
T ss_pred             ecCCCHHHeEE---CCCCCEEEEecCcchhccCC--cccccCChhhcCHHHHcCCCCCchhhHHHH
Confidence            99999999999   67788999999998765432  234568999999999998889999999996

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.5e-34  Score=203.00  Aligned_cols=143  Identities=31%  Similarity=0.483  Sum_probs=128.1

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ....+.+|+.+++.++||||+++++.+...+..|++|||+++++|..++.....+++..+..++.|++.|+.|||+.+++
T Consensus        38 ~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv  117 (323)
T cd05595          38 EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV  117 (323)
T ss_pred             HHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            45567789999999999999999999999999999999999999999998888899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||||+||++   +..+.+||+|||++...... .......|++.|+|||++.+..++.++|||||
T Consensus       118 H~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  181 (323)
T cd05595         118 YRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL  181 (323)
T ss_pred             ecCCCHHHEEE---cCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhh
Confidence            99999999999   67788999999988653222 23344678999999999998899999999996

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.5e-34  Score=203.97  Aligned_cols=141  Identities=35%  Similarity=0.620  Sum_probs=129.0

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++||||+++++++.+++..|++|||+.+++|.+++.+.+.+++..+..++.|++.|++|||+.+++
T Consensus        61 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv  140 (329)
T PTZ00263         61 QVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDII  140 (329)
T ss_pred             hHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            35678899999999999999999999999999999999999999999998888899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||||+||++   +..+.+||+|||++......  .....|++.|+|||++.+..++.++|||||
T Consensus       141 H~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  201 (329)
T PTZ00263        141 YRDLKPENLLL---DNKGHVKVTDFGFAKKVPDR--TFTLCGTPEYLAPEVIQSKGHGKAVDWWTM  201 (329)
T ss_pred             ecCCCHHHEEE---CCCCCEEEeeccCceEcCCC--cceecCChhhcCHHHHcCCCCCCcceeech
Confidence            99999999999   67889999999998765433  234578999999999998889999999997

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-34  Score=203.71  Aligned_cols=141  Identities=34%  Similarity=0.595  Sum_probs=128.7

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++||||+++++++.+++..|++|||+++++|.+++...+.+++..+..++.|++.|+.|||+.+++
T Consensus        44 ~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv  123 (333)
T cd05600          44 EVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYI  123 (333)
T ss_pred             HHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            35678889999999999999999999999999999999999999999998888899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||+|+||++   +..+.+||+|||++.....  ......|++.|+|||++.+..++.++|||||
T Consensus       124 H~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  184 (333)
T cd05600         124 HRDLKPENFLI---DASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGKGYDFTVDYWSL  184 (333)
T ss_pred             ccCCCHHHEEE---CCCCCEEEEeCcCCccccc--ccCCcccCccccChhHhcCCCCCCccceecc
Confidence            99999999999   6788999999999875533  3345678999999999998899999999997

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=7.9e-34  Score=202.13  Aligned_cols=144  Identities=31%  Similarity=0.470  Sum_probs=128.8

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      .....+.+|+.+++.++||||+++.+.+.+.+..|++|||+++++|..++.....+++..+..++.|++.|++|||+.++
T Consensus        37 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~i  116 (328)
T cd05593          37 DEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKI  116 (328)
T ss_pred             hHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            34567788999999999999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCC-CCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||||+||++   +..+.+||+|||++..... ........|++.|+|||++.+..++.++|||||
T Consensus       117 vHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  181 (328)
T cd05593         117 VYRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL  181 (328)
T ss_pred             EecccCHHHeEE---CCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCcccc
Confidence            999999999999   6788899999999875332 223344678999999999998889999999997

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-34  Score=205.10  Aligned_cols=144  Identities=27%  Similarity=0.564  Sum_probs=127.8

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      .....+.+|+.+++.++||||+++++.+.+++.+|++|||+++|+|.+++.+.+.+++..+..++.|++.|++|||+.++
T Consensus        43 ~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i  122 (364)
T cd05599          43 EQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY  122 (364)
T ss_pred             hHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34566788999999999999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---------------------------------------ccccc
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---------------------------------------YAEKV  128 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---------------------------------------~~~~~  128 (154)
                      +|+||||+||++   +..+.++|+|||++.......                                       .....
T Consensus       123 vH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (364)
T cd05599         123 IHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYST  199 (364)
T ss_pred             EeccCCHHHeEE---CCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhccccccccc
Confidence            999999999999   678899999999986542211                                       01124


Q ss_pred             cCCccccCcccccccCCCcccceecC
Q 031702          129 CGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus       129 ~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .||+.|+|||++.+..++.++|||||
T Consensus       200 ~gt~~y~aPE~~~~~~~~~~~DiwSl  225 (364)
T cd05599         200 VGTPDYIAPEVFLQTGYNKECDWWSL  225 (364)
T ss_pred             ccCccccCHHHHcCCCCCCeeeeecc
Confidence            68999999999998899999999997

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-34  Score=204.22  Aligned_cols=145  Identities=35%  Similarity=0.634  Sum_probs=134.3

Q ss_pred             hHHhHHHHHHHHhhCC-CCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+.+|+++. |||++.+.++|++...+++|||++.||.|.+.+... .+++..+..+++|++.++.|||..|+
T Consensus        78 ~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gv  156 (382)
T KOG0032|consen   78 DREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGV  156 (382)
T ss_pred             cHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            4578999999999997 999999999999999999999999999999999766 59999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCC-CeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDD-DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~-~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+|+||+|+++...+. .+.+|++|||++............+||+.|+|||++....|+..+||||+
T Consensus       157 vHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~  224 (382)
T KOG0032|consen  157 VHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSI  224 (382)
T ss_pred             eeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHH
Confidence            99999999999976543 45899999999998888667788999999999999999999999999995

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.3e-33  Score=204.60  Aligned_cols=144  Identities=30%  Similarity=0.577  Sum_probs=126.6

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++||||+++++.+.+++.+|++|||+++|+|.+++.+.+.+++..+..++.|++.|++|||+.++
T Consensus        43 ~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~i  122 (382)
T cd05625          43 NQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF  122 (382)
T ss_pred             HHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            34567889999999999999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCC---------------------------------------------
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---------------------------------------------  122 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~---------------------------------------------  122 (154)
                      +||||||+||++   +..+.+||+|||++......                                             
T Consensus       123 vHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (382)
T cd05625         123 IHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQ  199 (382)
T ss_pred             ecCCCCHHHEEE---CCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccc
Confidence            999999999999   67889999999987432100                                             


Q ss_pred             ---CccccccCCccccCcccccccCCCcccceecC
Q 031702          123 ---NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus       123 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                         .......||+.|+|||++.+..++.++|||||
T Consensus       200 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         200 HQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             cccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence               00123468999999999998899999999997

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.3e-33  Score=204.29  Aligned_cols=143  Identities=29%  Similarity=0.559  Sum_probs=126.0

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++|+||+++++.+.+++.+|++|||+++|+|.+++...+.+++..+..++.|++.|++|||+.+++
T Consensus        44 ~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv  123 (376)
T cd05598          44 QAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFI  123 (376)
T ss_pred             hHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            35678899999999999999999999999999999999999999999998888899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCC--------------------------------------------Cc
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--------------------------------------------NY  124 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~--------------------------------------------~~  124 (154)
                      ||||||+||++   +..+.++|+|||++......                                            ..
T Consensus       124 HrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (376)
T cd05598         124 HRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCL  200 (376)
T ss_pred             eCCCCHHHEEE---CCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhccccc
Confidence            99999999999   67889999999987422100                                            00


Q ss_pred             cccccCCccccCcccccccCCCcccceecC
Q 031702          125 AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus       125 ~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .....||+.|+|||++.+..++.++|||||
T Consensus       201 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  230 (376)
T cd05598         201 AHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  230 (376)
T ss_pred             ccccCCCccccCHHHHcCCCCCcceeeeec
Confidence            113468999999999998899999999997

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.3e-33  Score=204.69  Aligned_cols=144  Identities=28%  Similarity=0.544  Sum_probs=126.9

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++||||+++++.+.+++.+|++|||+++|+|.+++.+...+++..+..++.|++.|++|||+.++
T Consensus        43 ~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~gi  122 (381)
T cd05626          43 NQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF  122 (381)
T ss_pred             HHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            34567889999999999999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCC---------------------------------------------
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---------------------------------------------  122 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~---------------------------------------------  122 (154)
                      +||||||+||++   +..+.+||+|||++......                                             
T Consensus       123 vHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (381)
T cd05626         123 IHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQ  199 (381)
T ss_pred             eecCCcHHHEEE---CCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccc
Confidence            999999999999   67889999999987532100                                             


Q ss_pred             ---CccccccCCccccCcccccccCCCcccceecC
Q 031702          123 ---NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus       123 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                         .......||+.|+|||++.+..++.++|||||
T Consensus       200 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         200 HQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             ccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence               00123468999999999998889999999997

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.1e-33  Score=199.72  Aligned_cols=143  Identities=31%  Similarity=0.488  Sum_probs=127.5

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCc
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-HHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~   87 (154)
                      ....+.+|+.+++.++||||+++.+.+.+.+..|++|||+++++|..++.....+++..+..++.|++.|+.|||+ .++
T Consensus        38 ~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~i  117 (325)
T cd05594          38 EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV  117 (325)
T ss_pred             HHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCE
Confidence            3456778999999999999999999999999999999999999999999888889999999999999999999997 799


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCC-CCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||||+||++   +..+.+||+|||++..... ........|++.|+|||++.+..++.++|||||
T Consensus       118 vHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  182 (325)
T cd05594         118 VYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL  182 (325)
T ss_pred             EecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccc
Confidence            999999999999   6778999999999865332 223344678999999999998899999999997

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.4e-33  Score=199.97  Aligned_cols=143  Identities=36%  Similarity=0.559  Sum_probs=128.5

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ....+.+|+.++++++||||+++++++.+++..|++|||+++++|.+++.+...+++..+..++.|++.|++|||+.+++
T Consensus        41 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~  120 (318)
T cd05582          41 DRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII  120 (318)
T ss_pred             hHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            34567789999999999999999999999999999999999999999998888899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||+|+||++   +..+.++|+|||++...... .......|++.|+|||++.+..++.++|||||
T Consensus       121 H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl  184 (318)
T cd05582         121 YRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSF  184 (318)
T ss_pred             cCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceecc
Confidence            99999999999   67788999999998765433 23345678999999999998889999999997

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.1e-33  Score=199.53  Aligned_cols=142  Identities=37%  Similarity=0.574  Sum_probs=127.4

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (154)
                      ...+.+|+.+++.++||||+++++.+..++..|++|||+++++|.+++.+.+.+++..+..++.|++.|+.|||+.+++|
T Consensus        44 ~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH  123 (323)
T cd05584          44 TAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIY  123 (323)
T ss_pred             HHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            45677899999999999999999999999999999999999999999988888999999999999999999999999999


Q ss_pred             ecCCCCcEEeecCCCCeeEEEeecccccccCC-CCccccccCCccccCcccccccCCCcccceecC
Q 031702           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        90 ~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +||||+||++   +..+.+||+|||++..... ........|++.|+|||++.+..++.++|||||
T Consensus       124 ~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  186 (323)
T cd05584         124 RDLKPENILL---DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSL  186 (323)
T ss_pred             CCCCHHHeEE---CCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceeccc
Confidence            9999999999   6788999999999865432 223344578999999999998889999999997

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-34  Score=193.71  Aligned_cols=145  Identities=31%  Similarity=0.563  Sum_probs=131.7

Q ss_pred             HHhHHHHHHHHhhC-CCCccchhhhheecC----CcEEEEEEecCCCCchHHHHHcCC--CCHHHHHHHHHHHHHHHHHH
Q 031702           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEIL   82 (154)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~----~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~l   82 (154)
                      ....++|+++.-.. .|||||+++++|++.    .++.+|||.|+||.|...+..++.  +++.++..+++||+.|+.||
T Consensus        98 s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~l  177 (400)
T KOG0604|consen   98 SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYL  177 (400)
T ss_pred             CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHH
Confidence            45567888887666 899999999999764    568999999999999999987765  99999999999999999999


Q ss_pred             HhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        83 h~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+.+|.|||+||+|++..++..+..+||+|||+|.....+....++|-||.|.|||++...+|+.++|+||+
T Consensus       178 H~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSl  249 (400)
T KOG0604|consen  178 HSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSL  249 (400)
T ss_pred             HhcchhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccch
Confidence            999999999999999999888888999999999998777777788999999999999999999999999996

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=7.7e-34  Score=189.54  Aligned_cols=143  Identities=31%  Similarity=0.479  Sum_probs=127.1

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      +.......+|+..|+.++|+||+.+.++|...+.+.+|+|||+ .+|...++... .+++..+..|+.++++|++|+|.+
T Consensus        42 dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~  120 (318)
T KOG0659|consen   42 DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK  120 (318)
T ss_pred             cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh
Confidence            4446678899999999999999999999999999999999995 59999987654 589999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc-ccccCCccccCccccccc-CCCcccceec
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVCGSPLYMAPEVLQFQ-RYDEKVNFFV  153 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~-~~~~~~Diws  153 (154)
                      .++|||+||.|+++   ++++.+|++|||+|+.+.+.... .....|.||.|||.+.+. .|...+||||
T Consensus       121 ~IlHRDlKPnNLLi---s~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWa  187 (318)
T KOG0659|consen  121 WILHRDLKPNNLLI---SSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWA  187 (318)
T ss_pred             hhhcccCCccceEE---cCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhh
Confidence            99999999999999   78999999999999988765433 333679999999998764 6999999998

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-34  Score=212.00  Aligned_cols=145  Identities=36%  Similarity=0.618  Sum_probs=132.1

Q ss_pred             hhhhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh
Q 031702            6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      .+.+.+....|..|+... +||+++++++.|.+++++|++|||+.||++.... ..+.+++..+.-|++.++.||.|||+
T Consensus       408 ~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~-~~~~F~e~rarfyaAev~l~L~fLH~  486 (694)
T KOG0694|consen  408 QRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHI-HTDVFSEPRARFYAAEVVLGLQFLHE  486 (694)
T ss_pred             ccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEE-ecccccHHHHHHHHHHHHHHHHHHHh
Confidence            456678888899999888 6999999999999999999999999999965543 35779999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccC-CCCccccccCCccccCcccccccCCCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +||++||||.+||++   |..|++||+|||+++.-- ......+.||||.|+|||++.+..|+.++|||||
T Consensus       487 ~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~l  554 (694)
T KOG0694|consen  487 NGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGL  554 (694)
T ss_pred             cCceeeecchhheEE---cccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHH
Confidence            999999999999999   899999999999998743 5567788999999999999999999999999996

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2e-33  Score=202.31  Aligned_cols=144  Identities=25%  Similarity=0.528  Sum_probs=127.9

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|..++..++||+++++++.+.+++.+|++|||+++|+|.+++.+.+.+++..+..++.|++.|++|||+.|+
T Consensus        43 ~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~gi  122 (360)
T cd05627          43 EQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF  122 (360)
T ss_pred             hhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34567888999999999999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC------------------------------------ccccccCC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------------------------------------YAEKVCGS  131 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~------------------------------------~~~~~~~~  131 (154)
                      +|+||||+||++   +..+.++|+|||++.......                                    ......||
T Consensus       123 vHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt  199 (360)
T cd05627         123 IHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGT  199 (360)
T ss_pred             EccCCCHHHEEE---CCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCC
Confidence            999999999999   678899999999986442110                                    01134689


Q ss_pred             ccccCcccccccCCCcccceecC
Q 031702          132 PLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus       132 ~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +.|+|||++.+..++.++|||||
T Consensus       200 ~~Y~APE~~~~~~~~~~~DiwSl  222 (360)
T cd05627         200 PDYIAPEVFMQTGYNKLCDWWSL  222 (360)
T ss_pred             ccccCHHHHcCCCCCCcceeccc
Confidence            99999999998999999999997

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-33  Score=201.91  Aligned_cols=144  Identities=33%  Similarity=0.605  Sum_probs=129.8

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++||||+++++++.+++..|++|||+++++|.+++.+.+.+++..++.++.|++.|++|||+.|+
T Consensus        43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi  122 (350)
T cd05573          43 NQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF  122 (350)
T ss_pred             cHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34567889999999999999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC------------------------------ccccccCCccccCc
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------------------------------YAEKVCGSPLYMAP  137 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~------------------------------~~~~~~~~~~y~aP  137 (154)
                      +|+||||+||++   +..+.+||+|||++.......                              ......||+.|+||
T Consensus       123 iH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  199 (350)
T cd05573         123 IHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAP  199 (350)
T ss_pred             eccCCCHHHeEE---CCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCH
Confidence            999999999999   678899999999987654332                              22345689999999


Q ss_pred             ccccccCCCcccceecC
Q 031702          138 EVLQFQRYDEKVNFFVS  154 (154)
Q Consensus       138 E~~~~~~~~~~~Diwsl  154 (154)
                      |++.+..++.++|||||
T Consensus       200 E~~~~~~~~~~~DiwSl  216 (350)
T cd05573         200 EVLRGTPYGLECDWWSL  216 (350)
T ss_pred             HHHcCCCCCCceeeEec
Confidence            99998899999999997

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.7e-33  Score=199.44  Aligned_cols=143  Identities=32%  Similarity=0.622  Sum_probs=128.1

Q ss_pred             hHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|..+++.+ +||||+++++++.+.+.+|++|||+++++|.+++.+.+.+++..+..++.|++.|+.|||++++
T Consensus        38 ~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i  117 (329)
T cd05588          38 DIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGI  117 (329)
T ss_pred             HHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345688899999998 7999999999999999999999999999999998888889999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccC-CCCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.+||+|||++.... ........+||+.|+|||++.+..++.++|+|||
T Consensus       118 vH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  182 (329)
T cd05588         118 IYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL  182 (329)
T ss_pred             EecCCCHHHeEE---CCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceech
Confidence            999999999999   677889999999986532 2333445678999999999998899999999996

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-34  Score=205.47  Aligned_cols=146  Identities=31%  Similarity=0.551  Sum_probs=134.8

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR--LHGRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ...+.+++|+.||+.+.||+||.+..-|++++.+++|||-+ .|++.+.+-  +.+++++...+.++.||+.|+.|||-+
T Consensus       605 kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k  683 (888)
T KOG4236|consen  605 KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK  683 (888)
T ss_pred             chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc
Confidence            44588999999999999999999999999999999999988 456666653  346799999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+|+|+||+|+++.+.+....+||+|||+|+.+++.....++.|||.|+|||++.++.|..+-||||.
T Consensus       684 nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSV  752 (888)
T KOG4236|consen  684 NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSV  752 (888)
T ss_pred             ceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceee
Confidence            999999999999999888888999999999999999999999999999999999999999999999984

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=204.97  Aligned_cols=147  Identities=29%  Similarity=0.450  Sum_probs=128.9

Q ss_pred             hhhhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH
Q 031702            5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         5 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      ........+.+|+++++.++||||++++|+......++++||+|.||+|.+++++.+. ++..+...++.+.+.|++|||
T Consensus       200 ~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh  279 (474)
T KOG0194|consen  200 LTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH  279 (474)
T ss_pred             ccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH
Confidence            3467788999999999999999999999999999999999999999999999998774 999999999999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccc-cccCCccccCcccccccCCCcccceecC
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-KVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++++||||..+|+++   +.+..+||+|||+++.-..-.... ...-...|+|||.+..+.|+.++|||||
T Consensus       280 ~k~~IHRDIAARNcL~---~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sf  348 (474)
T KOG0194|consen  280 SKNCIHRDIAARNCLY---SKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSF  348 (474)
T ss_pred             HCCCcchhHhHHHhee---cCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhhe
Confidence            9999999999999999   667778999999986543111111 1123466999999999999999999997

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5.6e-33  Score=197.84  Aligned_cols=143  Identities=31%  Similarity=0.591  Sum_probs=127.6

Q ss_pred             hHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|..++..+ +||||+++++++.+++..+++|||+++++|..++.....+++..+..++.|++.|++|||++++
T Consensus        38 ~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i  117 (329)
T cd05618          38 DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGI  117 (329)
T ss_pred             HHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            445678899998887 8999999999999999999999999999999998888889999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCC-CCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||||+||++   +..+.+||+|||++..... ........||+.|+|||++.+..++.++|||||
T Consensus       118 vH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  182 (329)
T cd05618         118 IYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL  182 (329)
T ss_pred             eeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecc
Confidence            999999999999   6788999999999865322 223345678999999999998899999999997

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2e-33  Score=193.89  Aligned_cols=142  Identities=35%  Similarity=0.568  Sum_probs=124.8

Q ss_pred             hHHhHHHHHHHHhhCCCCc-cchhhhheecCC------cEEEEEEecCCCCchHHHHHcC----CCCHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSVNHPN-IIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQLGA   77 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~------~~~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~   77 (154)
                      ......+|+.++++++|+| |+++++++.+.+      .+++++||+. .+|..++....    .++...++.+++|++.
T Consensus        53 ~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~  131 (323)
T KOG0594|consen   53 VPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLR  131 (323)
T ss_pred             CCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHH
Confidence            3456689999999999999 999999998776      7899999995 59999998655    4788899999999999


Q ss_pred             HHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccC-CCCccccccCCccccCccccccc-CCCcccceecC
Q 031702           78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        78 ~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      |++|||+++|+||||||+||++   +..+.+||+|||+|+... +........+|.+|.|||++.+. .|++..||||+
T Consensus       132 gl~~~H~~~IlHRDLKPQNlLi---~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~  207 (323)
T KOG0594|consen  132 GLAFLHSHGILHRDLKPQNLLI---SSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSL  207 (323)
T ss_pred             HHHHHHhCCeecccCCcceEEE---CCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhH
Confidence            9999999999999999999999   679999999999998765 33345556779999999999876 79999999995

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-34  Score=206.94  Aligned_cols=139  Identities=31%  Similarity=0.542  Sum_probs=130.1

Q ss_pred             HHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecC
Q 031702           13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDL   92 (154)
Q Consensus        13 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i   92 (154)
                      -+.++.-|++|+||||+.+.++|...+.+|++||||..|-|...++....+.+.....|.++|+.++.|||.+.|+||||
T Consensus       159 kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDL  238 (904)
T KOG4721|consen  159 KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDL  238 (904)
T ss_pred             hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhcc
Confidence            34578889999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           93 KPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        93 ~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |.-||++   .....+||+|||-+.........-..+||..|||||++.+.+.+.|+|||||
T Consensus       239 KSPNiLI---s~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSf  297 (904)
T KOG4721|consen  239 KSPNILI---SYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSF  297 (904)
T ss_pred             CCCceEe---eccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehh
Confidence            9999999   5677899999999988777666667899999999999999999999999997

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-33  Score=205.94  Aligned_cols=144  Identities=35%  Similarity=0.581  Sum_probs=130.9

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCc--EEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      +...++|.+|+.+|+.|+||||++++.+|.+...  +-+++|.+..|+|..|+++.+++....++.|++||++||.|||+
T Consensus        82 ~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs  161 (632)
T KOG0584|consen   82 PEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHS  161 (632)
T ss_pred             hHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhc
Confidence            5567999999999999999999999999987654  88999999999999999999999999999999999999999999


Q ss_pred             C--CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           85 H--HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        85 ~--~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +  .|+|||||..|||++  ...+.+||+|+|+|....... .....|||.|||||+.. ..|+..+|||||
T Consensus       162 ~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~r~s~-aksvIGTPEFMAPEmYE-E~YnE~VDVYaF  229 (632)
T KOG0584|consen  162 QDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLLRKSH-AKSVIGTPEFMAPEMYE-ENYNELVDVYAF  229 (632)
T ss_pred             CCCCccccccccceEEEc--CCcCceeecchhHHHHhhccc-cceeccCccccChHHHh-hhcchhhhhhhh
Confidence            8  599999999999996  578899999999998765544 33488999999999988 789999999998

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6.4e-33  Score=193.91  Aligned_cols=142  Identities=32%  Similarity=0.461  Sum_probs=126.2

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+|+.+++.++|++++++.+++.+.+..++++||+++|+|.+.+...  ..+++..+..++.|++.|++|||+.++
T Consensus        44 ~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  123 (285)
T cd05631          44 EAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERI  123 (285)
T ss_pred             HHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            345788999999999999999999999999999999999999998877543  358999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||||+||++   +..+.++|+|||++.............|++.|+|||++.+..++.++|||||
T Consensus       124 iH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvwsl  187 (285)
T cd05631         124 VYRDLKPENILL---DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGL  187 (285)
T ss_pred             EeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhH
Confidence            999999999999   6778899999999877644444445678999999999998899999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.4e-33  Score=200.68  Aligned_cols=142  Identities=31%  Similarity=0.562  Sum_probs=125.1

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++||||+++++.+.++..+|++|||+++|+|.+++.. ..+++..+..++.|++.|++|||+.+++
T Consensus        86 ~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~Iv  164 (370)
T cd05621          86 DSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLI  164 (370)
T ss_pred             hHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            456688999999999999999999999999999999999999999998864 4689999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCccccccc----CCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ----RYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~----~~~~~~Diwsl  154 (154)
                      ||||||+||++   +..+.+||+|||++.......  ......||+.|+|||++.+.    .++.++|||||
T Consensus       165 HrDLKp~NILl---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSl  233 (370)
T cd05621         165 HRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV  233 (370)
T ss_pred             ecCCCHHHEEE---CCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEee
Confidence            99999999999   678899999999987654332  23456789999999998754    37889999996

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.5e-34  Score=194.95  Aligned_cols=141  Identities=29%  Similarity=0.416  Sum_probs=124.3

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecC--CcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      .-.-.+|+.+|.+++|||||.+.++...+  +.+|+|||||+. +|..++.+.. +|.+.+++.++.|+++|++|||++.
T Consensus       119 PItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w  197 (419)
T KOG0663|consen  119 PITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW  197 (419)
T ss_pred             cchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce
Confidence            34457899999999999999999988655  569999999976 9999997765 8999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCccccccc-CCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      |+|||+||+|+++   +..+.+|++|||+|+.+.+.. .......|.||.|||.+.+. .|+++.||||+
T Consensus       198 ilHRDLK~SNLLm---~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSv  264 (419)
T KOG0663|consen  198 ILHRDLKTSNLLL---SHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSV  264 (419)
T ss_pred             eEecccchhheee---ccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhH
Confidence            9999999999999   788999999999999987653 33445569999999999865 69999999995

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.7e-33  Score=206.77  Aligned_cols=144  Identities=30%  Similarity=0.566  Sum_probs=127.2

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      .....+.+|+.+++.++||||+++++.+..++..|++|||+++|+|.+++..    ...+++..+..++.|++.|+.|||
T Consensus       107 ~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH  186 (478)
T PTZ00267        107 RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH  186 (478)
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4456788899999999999999999999999999999999999999987753    345899999999999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCCCcccceecC
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +.+++||||||+||++   +..+.+||+|||++.......   .....+||+.|+|||++.+..++.++|||||
T Consensus       187 ~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~sl  257 (478)
T PTZ00267        187 SRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSL  257 (478)
T ss_pred             hCCEEECCcCHHhEEE---CCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHH
Confidence            9999999999999999   677889999999998654332   2345678999999999998899999999996

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=9.3e-33  Score=196.02  Aligned_cols=142  Identities=32%  Similarity=0.555  Sum_probs=123.4

Q ss_pred             HHhHHHHH-HHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           10 KSCLDCEL-NFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        10 ~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ...+..|. .+++.++||||+++++.+.+.+..|++|||+++++|...+.....+++..+..++.|++.|+.|||+.+++
T Consensus        39 ~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iv  118 (321)
T cd05603          39 QNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNII  118 (321)
T ss_pred             HHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            34444554 46788999999999999999999999999999999999888778899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCC-CCccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||||+||++   +..+.+||+|||++..... ........|++.|+|||++.+..++.++|||||
T Consensus       119 H~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  182 (321)
T cd05603         119 YRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCL  182 (321)
T ss_pred             eccCCHHHeEE---CCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCccccc
Confidence            99999999999   6788999999999865322 223344578999999999998889999999997

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.1e-32  Score=195.93  Aligned_cols=141  Identities=35%  Similarity=0.614  Sum_probs=123.1

Q ss_pred             HhHHHHHH-HHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 031702           11 SCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (154)
Q Consensus        11 ~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (154)
                      ..+.+|.. +++.++||||+++++.+.+++..|++|||+++++|..++.+...+++..+..++.|++.|++|||+.|++|
T Consensus        40 ~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH  119 (323)
T cd05575          40 KHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIY  119 (323)
T ss_pred             HHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            34444544 56788999999999999999999999999999999999988888999999999999999999999999999


Q ss_pred             ecCCCCcEEeecCCCCeeEEEeecccccccCC-CCccccccCCccccCcccccccCCCcccceecC
Q 031702           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        90 ~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +||||+||++   +..+.+||+|||++..... ........|++.|+|||++.+..++.++|||||
T Consensus       120 ~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  182 (323)
T cd05575         120 RDLKPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCL  182 (323)
T ss_pred             CCCCHHHeEE---CCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCcccccccc
Confidence            9999999999   6788999999999865322 223344578999999999998899999999997

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=7.7e-33  Score=196.97  Aligned_cols=144  Identities=31%  Similarity=0.591  Sum_probs=128.4

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|..++..+ +||+|+++++.+.+.+.+|++|||+++++|..++.....+++..+..++.|++.|++|||+.+
T Consensus        37 ~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~  116 (327)
T cd05617          37 EDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG  116 (327)
T ss_pred             hHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3456688999999998 799999999999999999999999999999999888888999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccC-CCCccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||||+||++   +..+.+||+|||++.... ........+|++.|+|||++.+..++.++|||||
T Consensus       117 ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  182 (327)
T cd05617         117 IIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWAL  182 (327)
T ss_pred             eeccCCCHHHEEE---eCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehh
Confidence            9999999999999   677889999999987532 2333445678999999999998899999999997

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-33  Score=201.00  Aligned_cols=147  Identities=33%  Similarity=0.607  Sum_probs=137.0

Q ss_pred             hhhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh
Q 031702            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      +......+.+|+..|+.++|||||+++++..+...+|++.|.-.+|+|.+|+.++. .+.+...++|+.||+.|+.|+|+
T Consensus        57 D~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq  136 (864)
T KOG4717|consen   57 DTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ  136 (864)
T ss_pred             chhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh
Confidence            45556788899999999999999999999999999999999999999999997664 59999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCC-cccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD-EKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Diwsl  154 (154)
                      ..++|||+||+|+++.  ..-+.+||.|||++-.+.++....+.||+..|.|||++.+..|+ +.+|||||
T Consensus       137 LHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSL  205 (864)
T KOG4717|consen  137 LHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSL  205 (864)
T ss_pred             hhhhcccCCcceeEEe--eecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHH
Confidence            9999999999999986  57889999999999999998889999999999999999999998 78999996

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.1e-32  Score=195.99  Aligned_cols=140  Identities=34%  Similarity=0.572  Sum_probs=122.5

Q ss_pred             hHHHHH-HHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 031702           12 CLDCEL-NFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR   90 (154)
Q Consensus        12 ~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~   90 (154)
                      .+..|. .+++.++||||+++++++.+.+..|++|||+++++|.+++.....+++..+..++.|++.|+.|||+.|++|+
T Consensus        41 ~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHr  120 (325)
T cd05602          41 HIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR  120 (325)
T ss_pred             HHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            344444 4567789999999999999999999999999999999999888889999999999999999999999999999


Q ss_pred             cCCCCcEEeecCCCCeeEEEeecccccccCC-CCccccccCCccccCcccccccCCCcccceecC
Q 031702           91 DLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        91 ~i~p~nil~~~~~~~~~~kl~df~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ||||+||++   +..+.++|+|||++..... ........|++.|+|||++.+..++.++|||||
T Consensus       121 Dlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  182 (325)
T cd05602         121 DLKPENILL---DSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCL  182 (325)
T ss_pred             CCCHHHeEE---CCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccc
Confidence            999999999   6778899999999875432 223445678999999999998899999999997

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.2e-32  Score=195.72  Aligned_cols=142  Identities=35%  Similarity=0.614  Sum_probs=124.1

Q ss_pred             HHhHHHHHH-HHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           10 KSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        10 ~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      .+.+..|.. +++.++||||+++++.+..++..|++|||+++++|..++.+...+++..+..++.|++.|+.|||+.|++
T Consensus        39 ~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~giv  118 (325)
T cd05604          39 QKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIV  118 (325)
T ss_pred             HHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            344555554 4677899999999999999999999999999999999998888899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCC-CCccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||||+||++   +..+.+||+|||++..... ........|++.|+|||++.+..++.++|||||
T Consensus       119 H~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  182 (325)
T cd05604         119 YRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCL  182 (325)
T ss_pred             ecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccc
Confidence            99999999999   6788999999999865322 223345678999999999998899999999997

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.4e-34  Score=198.15  Aligned_cols=141  Identities=33%  Similarity=0.516  Sum_probs=124.1

Q ss_pred             HhHHHHHHHHhhCCCCccchhhhheecC-----CcEEEEEEecCCCCchHHHHH----cCCCCHHHHHHHHHHHHHHHHH
Q 031702           11 SCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEI   81 (154)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~   81 (154)
                      +.-.+|+++|+.+.|||||++..+|...     -+..+|||||+. +|.+.++.    +..++.-.++-++.|+.+|+.|
T Consensus        62 r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~y  140 (364)
T KOG0658|consen   62 RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAY  140 (364)
T ss_pred             CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHH
Confidence            3557799999999999999999888432     256789999976 99988874    5678889999999999999999


Q ss_pred             HHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCccccccc-CCCcccceecC
Q 031702           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        82 lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      ||..|++||||||+|+++.  ...+.+||+|||.|+....+++..+...|+.|.|||.+.+. .|+.+.||||.
T Consensus       141 Lh~~~IcHRDIKPqNlLvD--~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSa  212 (364)
T KOG0658|consen  141 LHSHGICHRDIKPQNLLVD--PDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSA  212 (364)
T ss_pred             HHhcCcccCCCChheEEEc--CCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhh
Confidence            9999999999999999994  46689999999999999888888888889999999998864 69999999993

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.4e-32  Score=195.22  Aligned_cols=143  Identities=33%  Similarity=0.539  Sum_probs=127.0

Q ss_pred             hHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+..|..+++.+ +||||+++++++.+++..|++|||+++++|...+.....+++..+..++.|++.|+.|||+.++
T Consensus        38 ~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i  117 (321)
T cd05591          38 DVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGV  117 (321)
T ss_pred             HHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345677889999876 8999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCC-CCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||||+||++   +..+.++|+|||++..... ........|++.|+|||++.+..++.++|||||
T Consensus       118 vHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  182 (321)
T cd05591         118 IYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWAL  182 (321)
T ss_pred             eccCCCHHHeEE---CCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceech
Confidence            999999999999   6788999999999875432 223344678999999999998889999999996

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.2e-32  Score=195.52  Aligned_cols=143  Identities=36%  Similarity=0.571  Sum_probs=126.9

Q ss_pred             hHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+..|..+++.+ +||||+++++++.+.+.+|++|||+++++|.+++.....+++..+..++.|++.|++|||+.++
T Consensus        38 ~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~i  117 (320)
T cd05590          38 DVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGI  117 (320)
T ss_pred             HHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345677888888877 7999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCC-CCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||||+||++   +..+.++|+|||++..... ........|++.|+|||++.+..++.++|||||
T Consensus       118 vH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  182 (320)
T cd05590         118 IYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAM  182 (320)
T ss_pred             EeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhh
Confidence            999999999999   6778899999999865332 223345678999999999998889999999996

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.6e-32  Score=198.37  Aligned_cols=143  Identities=31%  Similarity=0.561  Sum_probs=125.0

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|..+++.++||||+++++.+.+++..|++|||+++++|.+++.. ..+++..+..++.|++.|++|||+.++
T Consensus        85 ~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~i  163 (371)
T cd05622          85 SDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGF  163 (371)
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            3456688999999999999999999999999999999999999999998864 468999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCccccccc----CCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ----RYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~----~~~~~~Diwsl  154 (154)
                      +|+||||+||++   +..+.+||+|||++.......  ......||+.|+|||++.+.    .++.++|||||
T Consensus       164 vHrDLkp~NIll---~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSl  233 (371)
T cd05622         164 IHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV  233 (371)
T ss_pred             EeCCCCHHHEEE---CCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeeh
Confidence            999999999999   677889999999987654332  23356789999999998754    37899999997

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.3e-33  Score=202.18  Aligned_cols=144  Identities=40%  Similarity=0.733  Sum_probs=136.0

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+++|+.+.||||++++.+.+++..+|+||||+.+|.+.+++.++++..+.....++.|++.|++|+|++++
T Consensus        97 ~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~i  176 (596)
T KOG0586|consen   97 SKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNI  176 (596)
T ss_pred             HHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcce
Confidence            34455899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCC-cccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD-EKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Diwsl  154 (154)
                      +|+|||++|+++   +...++||+|||++..+.......+.||++.|.|||+..+..|+ +.+|+||+
T Consensus       177 vHrdLk~eNilL---~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wsl  241 (596)
T KOG0586|consen  177 VHRDLKAENILL---DENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSL  241 (596)
T ss_pred             eccccchhhccc---ccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhh
Confidence            999999999999   78888999999999999888888999999999999999998886 79999996

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-33  Score=200.00  Aligned_cols=142  Identities=32%  Similarity=0.597  Sum_probs=120.3

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecC--CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      .+...+|+.+|+++.|||||+++++..++  +.+|||+|||..|.+...-.....+++.+.+.++++++.||+|||.+|+
T Consensus       152 ~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qgi  231 (576)
T KOG0585|consen  152 IEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGI  231 (576)
T ss_pred             HHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCe
Confidence            36889999999999999999999999765  6799999999998887654333338999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCC------CccccccCCccccCccccccc---CC-CcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG------NYAEKVCGSPLYMAPEVLQFQ---RY-DEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~---~~-~~~~Diwsl  154 (154)
                      +||||||+|+++   ++.+++||+|||.+......      .......|||.|+|||...++   .+ +.+.||||+
T Consensus       232 iHRDIKPsNLLl---~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWal  305 (576)
T KOG0585|consen  232 IHRDIKPSNLLL---SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWAL  305 (576)
T ss_pred             eccccchhheEE---cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhh
Confidence            999999999999   67899999999998765222      223347899999999998763   23 378999996

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.6e-32  Score=194.50  Aligned_cols=142  Identities=39%  Similarity=0.657  Sum_probs=124.9

Q ss_pred             HHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      .+.+..|..++... +||||+++++++..++..|++|||+++++|.+++.....+++..+..++.|++.|+.|||+.+++
T Consensus        39 ~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~iv  118 (316)
T cd05592          39 VECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGII  118 (316)
T ss_pred             HHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence            44556677777655 89999999999999999999999999999999998888899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||||+||++   +..+.+||+|||++...... ......+||+.|+|||++.+..++.++|||||
T Consensus       119 H~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  182 (316)
T cd05592         119 YRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSF  182 (316)
T ss_pred             eCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhH
Confidence            99999999999   67789999999998754332 23345678999999999998889999999996

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.6e-32  Score=195.91  Aligned_cols=144  Identities=31%  Similarity=0.492  Sum_probs=120.8

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheecC-CcEEEEEEecCCCCchHHHHHc-------------------------
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLH-------------------------   60 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~-------------------------   60 (154)
                      ...+.+.+|+.+++.+ +||||+++++++... +.++++|||+++|+|.+++...                         
T Consensus        52 ~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  131 (338)
T cd05102          52 SEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQS  131 (338)
T ss_pred             HHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhh
Confidence            3456789999999999 899999999988764 4689999999999999998643                         


Q ss_pred             -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEeecCC
Q 031702           61 -------------------------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD  103 (154)
Q Consensus        61 -------------------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~  103 (154)
                                                           ..++...+..++.|++.|++|||+.+++|+||||+||++   +
T Consensus       132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~  208 (338)
T cd05102         132 RVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---S  208 (338)
T ss_pred             ccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---c
Confidence                                                 236677889999999999999999999999999999999   6


Q ss_pred             CCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCCCcccceecC
Q 031702          104 DDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus       104 ~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ..+.+||+|||++.......   ......+++.|+|||++.+..++.++|||||
T Consensus       209 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwsl  262 (338)
T cd05102         209 ENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSF  262 (338)
T ss_pred             CCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHH
Confidence            77889999999987653321   1122344577999999998889999999996

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.4e-32  Score=194.53  Aligned_cols=143  Identities=32%  Similarity=0.517  Sum_probs=126.6

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+.+++.++|+||+++.+.+.+.+..+++|||+++++|.+++.+. ..+++..+..++.|++.|+.|||+.++
T Consensus        44 ~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i  123 (330)
T cd05601          44 TVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY  123 (330)
T ss_pred             HHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            4567889999999999999999999999999999999999999999999876 679999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--cccccCCccccCccccc------ccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ------FQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~y~aPE~~~------~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.+||+|||++........  .....||+.|+|||++.      ...++.++|||||
T Consensus       124 ~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diwsl  195 (330)
T cd05601         124 VHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSL  195 (330)
T ss_pred             EcccCchHheEE---CCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecc
Confidence            999999999999   6788999999999976544332  23356899999999986      4567899999997

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-33  Score=186.03  Aligned_cols=144  Identities=33%  Similarity=0.567  Sum_probs=133.0

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHh
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR--LHGRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      .....++.+|++|.+.|+||||++++++|.++..+|+++||.+.|++...+.  ....+++.....+++|++.|+.|+|.
T Consensus        63 ~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~  142 (281)
T KOG0580|consen   63 TQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL  142 (281)
T ss_pred             hcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc
Confidence            4556789999999999999999999999999999999999999999999998  55679999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .+++||||||+|+++   +..+..|++|||-+..-+ .....+.|||..|.+||...+..++..+|+|++
T Consensus       143 k~VIhRdiKpenlLl---g~~~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~l  208 (281)
T KOG0580|consen  143 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSL  208 (281)
T ss_pred             CCcccCCCCHHHhcc---CCCCCeeccCCCceeecC-CCCceeeecccccCCHhhcCCCCccchhhHHHH
Confidence            999999999999999   788899999999887554 556778999999999999999999999999985

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.6e-32  Score=194.50  Aligned_cols=143  Identities=29%  Similarity=0.459  Sum_probs=126.3

Q ss_pred             hHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+.+++.+ +|++|+++++++.+.+.++++|||+++++|.+++..+..+++..+..++.|++.|+.|||+.++
T Consensus        47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  126 (332)
T cd05614          47 TVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGI  126 (332)
T ss_pred             HHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            346688899999999 6999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCccccccc-CCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      +||||||+||++   +..+.+||+|||++.......  ......||+.|+|||++.+. .++.++|||||
T Consensus       127 vHrDlkp~Nili---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  193 (332)
T cd05614         127 VYRDIKLENILL---DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSL  193 (332)
T ss_pred             EecCCCHHHeEE---CCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccc
Confidence            999999999999   677899999999987653332  23345789999999998765 47889999997

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.2e-32  Score=195.14  Aligned_cols=143  Identities=36%  Similarity=0.558  Sum_probs=125.7

Q ss_pred             hHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+..|..++... +||+++++++++.+.+.+|++|||+++++|..++..+..+++..+..++.|++.|++|||+.|+
T Consensus        38 ~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  117 (316)
T cd05620          38 DVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGI  117 (316)
T ss_pred             hHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345667788888765 8999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCC-CCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||||+||++   +..+.++|+|||++..... ........|++.|+|||++.+..++.++|||||
T Consensus       118 vHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  182 (316)
T cd05620         118 IYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSF  182 (316)
T ss_pred             EecCCCHHHeEE---CCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhh
Confidence            999999999999   6778899999998864322 223345678999999999998899999999996

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-33  Score=196.80  Aligned_cols=141  Identities=38%  Similarity=0.550  Sum_probs=133.4

Q ss_pred             HhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      .-..+|-++|+++..++||.+-.+|++++.+|+|+..|.||+|.-.+.+.+  .+++..+..++++|+.|+++||..+||
T Consensus       230 ~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iV  309 (591)
T KOG0986|consen  230 TMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIV  309 (591)
T ss_pred             HHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhccee
Confidence            445679999999999999999999999999999999999999998887666  699999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +||+||+||++   |++++++|+|+|+|..+....+.....||.+|||||++.++.|+.++|+|||
T Consensus       310 YRDLKPeNILL---Dd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~l  372 (591)
T KOG0986|consen  310 YRDLKPENILL---DDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSL  372 (591)
T ss_pred             eccCChhheee---ccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHH
Confidence            99999999999   8999999999999999998888888899999999999999999999999996

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=9.3e-33  Score=202.50  Aligned_cols=144  Identities=34%  Similarity=0.485  Sum_probs=126.9

Q ss_pred             hhhHHhHHHHHHHHhhCC-CC-----ccchhhhheecCCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVN-HP-----NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAG   78 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~   78 (154)
                      ....++-..|+.+|..|+ |.     |+|+++++|...+++|+|+|.+ ..+|.++++.+.  .++...++.++.||+.|
T Consensus       223 k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~  301 (586)
T KOG0667|consen  223 KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTA  301 (586)
T ss_pred             hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHH
Confidence            455677788999999996 43     8999999999999999999988 569999998764  58999999999999999


Q ss_pred             HHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        79 l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |.+||+.+++|+||||+|||+.. .....+|++|||.|+.....-.  +...+..|.|||++.+.+|+.+.|||||
T Consensus       302 L~~L~~l~IIHcDLKPENILL~~-~~r~~vKVIDFGSSc~~~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSL  374 (586)
T KOG0667|consen  302 LLFLHELGIIHCDLKPENILLKD-PKRSRIKVIDFGSSCFESQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSL  374 (586)
T ss_pred             HHHHHhCCeeeccCChhheeecc-CCcCceeEEecccccccCCcce--eeeeccccccchhhccCCCCCccceeeh
Confidence            99999999999999999999975 3455899999999987644333  6677899999999999999999999997

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.1e-32  Score=196.72  Aligned_cols=142  Identities=30%  Similarity=0.541  Sum_probs=124.2

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++||||+++++++.+++..|++|||+++|+|.+++.. ..+++..+..++.|++.|++|||+.+++
T Consensus        86 ~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iv  164 (370)
T cd05596          86 DSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFI  164 (370)
T ss_pred             hHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            345678899999999999999999999999999999999999999998864 4688999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCccccccc----CCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ----RYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~----~~~~~~Diwsl  154 (154)
                      |+||||+||++   +..+.+||+|||++.......  ......||+.|+|||++.+.    .++.++|||||
T Consensus       165 HrDLkp~NILl---~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSl  233 (370)
T cd05596         165 HRDVKPDNMLL---DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV  233 (370)
T ss_pred             ccCCCHHHEEE---cCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeeh
Confidence            99999999999   678899999999987654332  22346789999999998653    47899999996

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=1.9e-32  Score=199.05  Aligned_cols=141  Identities=24%  Similarity=0.366  Sum_probs=125.0

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (154)
                      .+.+.+|+.+++.++||||+++++++..+...++++|++. ++|..++.....+++..++.++.|++.|+.|||+.+++|
T Consensus       127 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvH  205 (391)
T PHA03212        127 RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIH  205 (391)
T ss_pred             hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            4567899999999999999999999999999999999985 689888887788999999999999999999999999999


Q ss_pred             ecCCCCcEEeecCCCCeeEEEeecccccccCCC--CccccccCCccccCcccccccCCCcccceecC
Q 031702           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        90 ~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +||||+||++   +..+.+||+|||++......  .......||+.|+|||++.+..++.++|||||
T Consensus       206 rDiKP~NIll---~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  269 (391)
T PHA03212        206 RDIKAENIFI---NHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSA  269 (391)
T ss_pred             CCCChHhEEE---cCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHH
Confidence            9999999999   67788999999998654322  22334578999999999998899999999996

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=5.2e-32  Score=192.98  Aligned_cols=144  Identities=31%  Similarity=0.585  Sum_probs=125.3

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|..+++.++|+||+++++++.+++.+|++|||+++++|.+++.+ ...+++..+..++.|++.|++|||+++
T Consensus        43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  122 (331)
T cd05597          43 AETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG  122 (331)
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            3456688999999999999999999999999999999999999999999976 457999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--cccccCCccccCcccccc-----cCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQF-----QRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-----~~~~~~~Diwsl  154 (154)
                      ++|+||||+||++   +..+.+||+|||++........  .....||+.|+|||++..     ..++.++|||||
T Consensus       123 ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diwsl  194 (331)
T cd05597         123 YVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSL  194 (331)
T ss_pred             eEECCCCHHHEEE---CCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehh
Confidence            9999999999999   6778899999999876544322  223468999999999863     457889999996

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.98  E-value=3.4e-32  Score=192.99  Aligned_cols=143  Identities=36%  Similarity=0.618  Sum_probs=127.2

Q ss_pred             hHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|..+++.+ +||||+++++++.+.+.+|++|||+++++|..++.+.+.+++..+..++.|++.|+.|||+.++
T Consensus        38 ~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i  117 (318)
T cd05570          38 DVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGI  117 (318)
T ss_pred             HHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            456677899999888 7999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCC-CCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||++..... .......+|++.|+|||++.+..++.++|+|||
T Consensus       118 vH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl  182 (318)
T cd05570         118 IYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWAL  182 (318)
T ss_pred             EccCCCHHHeEE---CCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhH
Confidence            999999999999   6778999999998865322 223344568999999999998899999999996

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.98  E-value=4e-32  Score=193.57  Aligned_cols=144  Identities=31%  Similarity=0.516  Sum_probs=128.8

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH-   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-   85 (154)
                      +...+.+.+|+++++.++||||+++++++..++..+++|||+++++|.+++.....+++..+..++.|++.|+.|||+. 
T Consensus        44 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  123 (331)
T cd06649          44 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH  123 (331)
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC
Confidence            3456789999999999999999999999999999999999999999999998888899999999999999999999986 


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||||+||++   +..+.++|+|||++...... ......|++.|+|||++.+..++.++|||||
T Consensus       124 ~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl  188 (331)
T cd06649         124 QIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSM  188 (331)
T ss_pred             CEEcCCCChhhEEE---cCCCcEEEccCccccccccc-ccccCCCCcCcCCHhHhcCCCCCchHhHHHH
Confidence            69999999999999   67788999999998765332 2334568999999999998889999999996

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.98  E-value=5.8e-32  Score=192.75  Aligned_cols=144  Identities=30%  Similarity=0.578  Sum_probs=126.0

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|..+++.++|++|+++++.+.+++..|++|||+++|+|.+++.+ ...+++..+..++.|++.|++|||+.+
T Consensus        43 ~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~  122 (331)
T cd05624          43 AETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH  122 (331)
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3456688899999999999999999999999999999999999999999976 457899999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--cccccCCccccCcccccc-----cCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQF-----QRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-----~~~~~~~Diwsl  154 (154)
                      ++|+||||+||++   +..+.+||+|||++........  .....|++.|+|||++.+     +.++.++|||||
T Consensus       123 iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSl  194 (331)
T cd05624         123 YVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSL  194 (331)
T ss_pred             eeeccCchHHEEE---cCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEee
Confidence            9999999999999   6778899999999876544322  223568999999999875     467899999996

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.98  E-value=5.6e-32  Score=192.23  Aligned_cols=142  Identities=33%  Similarity=0.586  Sum_probs=125.8

Q ss_pred             HHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      .+.+..|..++..+ +|++++++++++.+.+..|++|||+++|+|.+++.....+++..+..++.|++.|++|||+.+++
T Consensus        44 ~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv  123 (323)
T cd05616          44 VECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGII  123 (323)
T ss_pred             HHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence            44567788888887 68999999999999999999999999999999998888899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCC-CCccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||||+||++   +..+.+||+|||++..... ........||+.|+|||++.+..++.++|||||
T Consensus       124 HrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  187 (323)
T cd05616         124 YRDLKLDNVML---DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF  187 (323)
T ss_pred             ecCCCHHHeEE---CCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhch
Confidence            99999999999   6788999999999875432 223345678999999999999999999999997

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.98  E-value=5.1e-32  Score=190.80  Aligned_cols=144  Identities=26%  Similarity=0.503  Sum_probs=123.7

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-------------------CCCHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------------RVPEQTA   68 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-------------------~~~~~~~   68 (154)
                      .....+.+|+.++++++||||+++++++.+.+..+++|||+++++|.+++....                   .++...+
T Consensus        61 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  140 (304)
T cd05096          61 NARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSL  140 (304)
T ss_pred             HHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHH
Confidence            345678999999999999999999999999999999999999999999986432                   2567788


Q ss_pred             HHHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCC
Q 031702           69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRY  145 (154)
Q Consensus        69 ~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~  145 (154)
                      ..++.|++.|+.|||+.+++|+||||+||++   +..+.+||+|||++........   .....++..|+|||++.++.+
T Consensus       141 ~~i~~~i~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  217 (304)
T cd05096         141 LHVALQIASGMKYLSSLNFVHRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF  217 (304)
T ss_pred             HHHHHHHHHHHHHHHHCCccccCcchhheEE---cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC
Confidence            9999999999999999999999999999999   6778899999999876543321   222344678999999988889


Q ss_pred             CcccceecC
Q 031702          146 DEKVNFFVS  154 (154)
Q Consensus       146 ~~~~Diwsl  154 (154)
                      +.++|||||
T Consensus       218 ~~~~Dv~sl  226 (304)
T cd05096         218 TTASDVWAF  226 (304)
T ss_pred             CchhhhHHH
Confidence            999999996

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.98  E-value=4.2e-32  Score=200.64  Aligned_cols=148  Identities=30%  Similarity=0.511  Sum_probs=132.4

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCC------cEEEEEEecCCCCchHHHHHc---CCCCHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQLGA   77 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~   77 (154)
                      ....+...+|++++++|+|+|||+++++-++..      ...++||||.||+|...+++.   ..+++.+++.+..+++.
T Consensus        52 ~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~  131 (732)
T KOG4250|consen   52 LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVS  131 (732)
T ss_pred             cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHH
Confidence            356788899999999999999999999876654      468999999999999999644   35999999999999999


Q ss_pred             HHHHHHhCCceeecCCCCcEEeecCC-CCeeEEEeecccccccCCCCccccccCCccccCcccccc-cCCCcccceecC
Q 031702           78 GLEILNSHHIIHRDLKPENILLSGLD-DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        78 ~l~~lh~~~~~h~~i~p~nil~~~~~-~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      |+.|||.+||+||||||.||++.... +....||+|||.|+...++....+..||..|++||.... +.|+..+|.|||
T Consensus       132 al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~  210 (732)
T KOG4250|consen  132 ALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSF  210 (732)
T ss_pred             HHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhh
Confidence            99999999999999999999986533 556779999999999999888899999999999999984 789999999997

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.98  E-value=8.8e-32  Score=191.88  Aligned_cols=144  Identities=31%  Similarity=0.585  Sum_probs=125.3

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|..++..++|++|+++++.+.+.+.+|++|||+++|+|.+++.+ ...+++..+..++.|++.|+.|||+.+
T Consensus        43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~  122 (332)
T cd05623          43 AETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH  122 (332)
T ss_pred             hHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3345688899999999999999999999999999999999999999999976 457899999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--cccccCCccccCccccc-----ccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ-----FQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~y~aPE~~~-----~~~~~~~~Diwsl  154 (154)
                      ++||||||+||++   +..+.++|+|||++........  .....||+.|+|||++.     ...++.++|||||
T Consensus       123 iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSl  194 (332)
T cd05623         123 YVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSL  194 (332)
T ss_pred             eEecCCCHHHEEE---CCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEee
Confidence            9999999999999   6778899999999876533322  23357899999999986     3468899999996

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.98  E-value=4.6e-32  Score=189.16  Aligned_cols=141  Identities=38%  Similarity=0.540  Sum_probs=124.3

Q ss_pred             HhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      +.+..|+.+++.++|+|++++.+++..++..+++|||+++++|.+.+..    +..+++..+..++.|++.|++|||+.+
T Consensus        38 ~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~  117 (280)
T cd05608          38 EGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR  117 (280)
T ss_pred             HHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            5677899999999999999999999999999999999999999887642    345899999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.++|+|||.+....... ......|++.|+|||++.+..++.++|+|||
T Consensus       118 i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvwsl  183 (280)
T cd05608         118 IIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFAL  183 (280)
T ss_pred             cccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHH
Confidence            9999999999999   677889999999987654432 2334568899999999999999999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.98  E-value=5.1e-32  Score=189.26  Aligned_cols=144  Identities=28%  Similarity=0.498  Sum_probs=125.6

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++||||+++++++.+++..+++|||++++++..+......+++..+..++.|++.|+.|||+.++
T Consensus        42 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i  121 (287)
T cd07848          42 EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDI  121 (287)
T ss_pred             cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34567889999999999999999999999999999999999987777665555679999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.+||+|||++.......  ......+++.|+|||++.+..++.++|+|||
T Consensus       122 ~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  187 (287)
T cd07848         122 VHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSV  187 (287)
T ss_pred             ecCCCCHHHEEE---cCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhH
Confidence            999999999999   677889999999987654322  2233568899999999998889999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.98  E-value=1.1e-31  Score=188.30  Aligned_cols=143  Identities=31%  Similarity=0.490  Sum_probs=123.9

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.|.+||+.+.||.++.++..|+++...|++||||+||+|..++.++.  .+++..++-++++++.||+|||-.|
T Consensus       120 Kl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG  199 (459)
T KOG0610|consen  120 KLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG  199 (459)
T ss_pred             HHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc
Confidence            34566779999999999999999999999999999999999999999887653  5999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCC---------------------------------C-C---------
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP---------------------------------G-N---------  123 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~---------------------------------~-~---------  123 (154)
                      |++|||||+||++   .+++++.|+||.++.....                                 . .         
T Consensus       200 ivYRDLKPENILv---redGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~  276 (459)
T KOG0610|consen  200 IVYRDLKPENILV---REDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESA  276 (459)
T ss_pred             eeeccCCcceeEE---ecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccc
Confidence            9999999999999   6899999999988743210                                 0 0         


Q ss_pred             --------------ccccccCCccccCcccccccCCCcccceecC
Q 031702          124 --------------YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus       124 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                                    ...+..||-.|+|||++.+.+++.++|||+|
T Consensus       277 ~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtf  321 (459)
T KOG0610|consen  277 SRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTF  321 (459)
T ss_pred             cccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHH
Confidence                          0112357888999999999999999999986

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.98  E-value=8.1e-32  Score=191.46  Aligned_cols=144  Identities=32%  Similarity=0.570  Sum_probs=126.2

Q ss_pred             hhHHhHHHHHHHHhhCCC-CccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+..|..+++.+.| ++++++++++.+.+.+|++|||+++++|.+++.....+++..+..++.|++.|+.|||+.+
T Consensus        42 ~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~  121 (324)
T cd05587          42 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG  121 (324)
T ss_pred             hHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            345677889999999965 5688899999999999999999999999999988888999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCC-CCccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||||+||++   +..+.++|+|||++..... ........|++.|+|||++.+..++.++|||||
T Consensus       122 ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  187 (324)
T cd05587         122 IIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAF  187 (324)
T ss_pred             eEecCCCHHHeEE---cCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhh
Confidence            9999999999999   6778899999999864322 223345678999999999998899999999996

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.2e-31  Score=187.54  Aligned_cols=142  Identities=32%  Similarity=0.459  Sum_probs=125.8

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+|+.+++.++||||+++++.+.+++..+++|||+++++|.+++...  ..+++..+..++.|++.|+.|||+.++
T Consensus        44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  123 (285)
T cd05605          44 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERI  123 (285)
T ss_pred             HHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            345778999999999999999999999999999999999999999887543  358999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||++.............|++.|+|||++.+..++.++|+|||
T Consensus       124 vH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~  187 (285)
T cd05605         124 VYRDLKPENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGL  187 (285)
T ss_pred             EecCCCHHHEEE---CCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhH
Confidence            999999999999   6778899999999876544444345578899999999988889999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.98  E-value=6.2e-32  Score=192.77  Aligned_cols=144  Identities=32%  Similarity=0.536  Sum_probs=128.0

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH-   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-   85 (154)
                      ....+.+.+|+++++.++||||+++++++.+++..+++|||+++++|.+++...+.+++..+..++.+++.|+.|||+. 
T Consensus        44 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~  123 (333)
T cd06650          44 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH  123 (333)
T ss_pred             HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC
Confidence            3456779999999999999999999999999999999999999999999998888899999999999999999999985 


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||||+||++   +..+.+||+|||++...... ......++..|+|||++.+..++.++|+|||
T Consensus       124 ~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  188 (333)
T cd06650         124 KIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSM  188 (333)
T ss_pred             CEEecCCChhhEEE---cCCCCEEEeeCCcchhhhhh-ccccCCCCccccCHHHhcCCCCCcHHHHHHH
Confidence            79999999999999   56778999999998654332 2234568889999999998889999999996

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.2e-32  Score=190.16  Aligned_cols=150  Identities=33%  Similarity=0.523  Sum_probs=128.6

Q ss_pred             Chhhhh-----hhhHHhHHHHHHHHhhCCCCccchhhhheec-----CCcEEEEEEecCCCCchHHHHHcCCCCHHHHHH
Q 031702            1 MLKKLN-----KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK   70 (154)
Q Consensus         1 ~~k~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~   70 (154)
                      |+|++.     ....++..+|+.+|+.++|+||+.+.+++..     -+.+|+++|+| +.+|.+.+++++.+++..++.
T Consensus        51 AIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~  129 (359)
T KOG0660|consen   51 AIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQY  129 (359)
T ss_pred             ehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcCccccHHHHHH
Confidence            455555     3446778899999999999999999999865     25699999999 669999999888899999999


Q ss_pred             HHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCC---CCccccccCCccccCccccc-ccCCC
Q 031702           71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP---GNYAEKVCGSPLYMAPEVLQ-FQRYD  146 (154)
Q Consensus        71 ~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~---~~~~~~~~~~~~y~aPE~~~-~~~~~  146 (154)
                      +++|++.|+.|+|+.+++|||+||+|+++   +.+...|++|||+|+...+   .+.......|.||.|||++. ...|+
T Consensus       130 f~YQiLrgLKyiHSAnViHRDLKPsNll~---n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt  206 (359)
T KOG0660|consen  130 FLYQILRGLKYIHSANVIHRDLKPSNLLL---NADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYT  206 (359)
T ss_pred             HHHHHHHhcchhhcccccccccchhheee---ccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhcccccc
Confidence            99999999999999999999999999999   6788889999999987753   22334456799999999976 45799


Q ss_pred             cccceecC
Q 031702          147 EKVNFFVS  154 (154)
Q Consensus       147 ~~~Diwsl  154 (154)
                      ...||||.
T Consensus       207 ~aiDiWSv  214 (359)
T KOG0660|consen  207 KAIDIWSV  214 (359)
T ss_pred             chhhhhhh
Confidence            99999994

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.98  E-value=7.3e-32  Score=191.17  Aligned_cols=142  Identities=35%  Similarity=0.558  Sum_probs=124.9

Q ss_pred             HHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      .+.+..|..+++.. +||||+++++++.+++.++++|||+++|+|.+++.+...+++..+..++.|++.|+.|||+.+++
T Consensus        39 ~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~iv  118 (316)
T cd05619          39 VECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIV  118 (316)
T ss_pred             HHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence            45566778888765 99999999999999999999999999999999998878899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCC-CCccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||||+||++   +..+.+||+|||++..... ........||+.|+|||++.+..++.++|+|||
T Consensus       119 Hrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  182 (316)
T cd05619         119 YRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSF  182 (316)
T ss_pred             eCCCCHHHEEE---CCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhH
Confidence            99999999999   6778899999999865322 223345678999999999998889999999996

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.97  E-value=1e-31  Score=190.93  Aligned_cols=143  Identities=31%  Similarity=0.561  Sum_probs=125.7

Q ss_pred             hHHhHHHHHHHHhhCC-CCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+..|..+++.+. |++++++.+.+.+.+.+|++|||+++++|.+++...+.+++..+..++.|++.|++|||+.++
T Consensus        43 ~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~i  122 (323)
T cd05615          43 DVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGI  122 (323)
T ss_pred             HHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            3456778999998884 678888999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||||+||++   +.++.++|+|||++...... .......||+.|+|||++.+..++.++|||||
T Consensus       123 vHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  187 (323)
T cd05615         123 IYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAY  187 (323)
T ss_pred             eccCCCHHHeEE---CCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhh
Confidence            999999999999   67788999999998754332 23345668999999999998889999999996

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-33  Score=200.09  Aligned_cols=145  Identities=31%  Similarity=0.565  Sum_probs=140.2

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ....+.+.+|-.||...+.|+||+++..|.++.++||+||-|-||.++..++..+.|+..+.+.++..+++|++|||.+|
T Consensus       461 tkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~  540 (732)
T KOG0614|consen  461 TKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG  540 (732)
T ss_pred             hhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC
Confidence            45678889999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |++||+||+|.++   +..+.+||.|||+|..+.++....+.||||.|+|||++.++.++.++|.|||
T Consensus       541 iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaL  605 (732)
T KOG0614|consen  541 IIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWAL  605 (732)
T ss_pred             ceeccCChhheee---ccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHH
Confidence            9999999999999   8999999999999999999999999999999999999999999999999996

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.4e-31  Score=190.58  Aligned_cols=140  Identities=35%  Similarity=0.553  Sum_probs=121.5

Q ss_pred             hHHHHHHHHhhC---CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           12 CLDCELNFLSSV---NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        12 ~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ....|..++...   +||+|++++..+.+++..|++|||+++++|.+++.+.+.+++..+..++.|++.|++|||+++++
T Consensus        39 ~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~iv  118 (330)
T cd05586          39 HTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIV  118 (330)
T ss_pred             HHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            344566666655   69999999999999999999999999999999998888899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCC-CCccccccCCccccCccccccc-CCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      |+||||+||++   +..+.++|+|||++..... .......+||+.|+|||++.+. .++.++|||||
T Consensus       119 HrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvwsl  183 (330)
T cd05586         119 YRDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSL  183 (330)
T ss_pred             eccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceecc
Confidence            99999999999   6778899999999875433 2334456789999999998754 47899999997

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.97  E-value=1.1e-31  Score=187.03  Aligned_cols=142  Identities=32%  Similarity=0.503  Sum_probs=125.0

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      .+.+..|++++++++||||+++.+.+.++...+++|||+++++|.+++....  .++...+..++.|++.|++|||+.++
T Consensus        37 ~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i  116 (277)
T cd05607          37 EKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI  116 (277)
T ss_pred             hHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            3455679999999999999999999999999999999999999998875443  48889999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||++.............+++.|+|||++.+..++.++|+|||
T Consensus       117 vH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  180 (277)
T cd05607         117 VYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAM  180 (277)
T ss_pred             EEccCChHhEEE---cCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHH
Confidence            999999999999   6778899999999877655444444568899999999998889999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=5.1e-32  Score=193.13  Aligned_cols=142  Identities=26%  Similarity=0.469  Sum_probs=121.3

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecC-----CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      ....+.+|+.+++.++||||+++++++...     ..+|++|||++ ++|.+++.....+++..+..++.|++.|+.|||
T Consensus        42 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH  120 (338)
T cd07859          42 DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH  120 (338)
T ss_pred             hHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHH
Confidence            345688999999999999999999988543     35899999995 689999988888999999999999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC----ccccccCCccccCcccccc--cCCCcccceecC
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQF--QRYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Diwsl  154 (154)
                      +++++|+||||+||++   +..+.+||+|||++.......    ......+++.|+|||++.+  ..++.++|||||
T Consensus       121 ~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSl  194 (338)
T cd07859         121 TANVFHRDLKPKNILA---NADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSI  194 (338)
T ss_pred             HCCeecCCCCHHHeEE---CCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHH
Confidence            9999999999999999   678899999999987543222    1233568899999999865  578999999996

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.97  E-value=1.4e-31  Score=190.22  Aligned_cols=142  Identities=35%  Similarity=0.593  Sum_probs=122.5

Q ss_pred             hHHhHHHHHHHH---hhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            9 LKSCLDCELNFL---SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         9 ~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ..+.+.+|..++   +.++||||+++++++.+++..|++|||+++++|...+. .+.+++..+..++.|++.|++|||+.
T Consensus        42 ~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~  120 (324)
T cd05589          42 EVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHEN  120 (324)
T ss_pred             HHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            345677777665   45679999999999999999999999999999988775 45799999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCC-CCccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||||+||++   +..+.+||+|||++..... ........|++.|+|||.+.+..++.++|||||
T Consensus       121 ~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl  187 (324)
T cd05589         121 KIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGL  187 (324)
T ss_pred             CeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhH
Confidence            99999999999999   6788999999998865322 223345678999999999998899999999996

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-33  Score=198.71  Aligned_cols=145  Identities=28%  Similarity=0.536  Sum_probs=133.5

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      +...+.+.+|+.++..++++||.++++.+..+..++++|||+.||++.+.++....+.+..+..++++++.|+.|+|.++
T Consensus        52 ~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~  131 (467)
T KOG0201|consen   52 EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK  131 (467)
T ss_pred             chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc
Confidence            34567899999999999999999999999999999999999999999999987777799999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .+|+|||+.||++   ...+.+|++|||.+....... ...+..|||.|||||++....|+.++|||||
T Consensus       132 kiHrDIKaanil~---s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSL  197 (467)
T KOG0201|consen  132 KIHRDIKAANILL---SESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSL  197 (467)
T ss_pred             eecccccccceeE---eccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhh
Confidence            9999999999999   566999999999998876544 3477899999999999998899999999997

>PHA02988 hypothetical protein; Provisional

Probab=99.97  E-value=1.8e-31  Score=186.57  Aligned_cols=140  Identities=19%  Similarity=0.248  Sum_probs=123.2

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheec----CCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-   84 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-   84 (154)
                      .+.+.+|+.++++++||||+++++++.+    ...++++|||+++|+|.+++.+...++......++.+++.|+.+||+ 
T Consensus        62 ~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~  141 (283)
T PHA02988         62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY  141 (283)
T ss_pred             HHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhc
Confidence            4778899999999999999999999876    35789999999999999999888889999999999999999999998 


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc--cCCCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF--QRYDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Diwsl  154 (154)
                      .+++|+||+|+||++   +.++.+|++|||++......  .....++..|+|||++.+  ..++.++|||||
T Consensus       142 ~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~Sl  208 (283)
T PHA02988        142 TNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSL  208 (283)
T ss_pred             CCCCCCcCChhhEEE---CCCCcEEEcccchHhhhccc--cccccCcccccCHHHhhhccccccchhhhhHH
Confidence            489999999999999   67789999999998754332  223457889999999976  678999999996

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.97  E-value=6.2e-32  Score=189.20  Aligned_cols=141  Identities=29%  Similarity=0.489  Sum_probs=121.4

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ...+.+|+.+++.++||||+++++++.+.+..++++||+++ +|.+++...+ .++...+..++.|++.|++|||+++++
T Consensus        47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv  125 (288)
T cd07871          47 PCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKIL  125 (288)
T ss_pred             chhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            45678999999999999999999999999999999999975 8988886554 478999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccc-cCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      |+||||+||++   +..+.+||+|||++....... ......+++.|+|||++.+ ..++.++|||||
T Consensus       126 H~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  190 (288)
T cd07871         126 HRDLKPQNLLI---NEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGV  190 (288)
T ss_pred             cCCCCHHHEEE---CCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHH
Confidence            99999999999   677889999999986543322 2334567889999999865 568899999996

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.4e-32  Score=206.79  Aligned_cols=147  Identities=31%  Similarity=0.562  Sum_probs=134.4

Q ss_pred             hhhhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh
Q 031702            5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         5 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ++......|+.|-.+|..-..+.|++++.+|.+..++|+|||||+||+|..++.+.+++++..++.|++.|+.|+.-+|+
T Consensus       114 lKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~  193 (1317)
T KOG0612|consen  114 LKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHS  193 (1317)
T ss_pred             hhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHh
Confidence            34566788999999999999999999999999999999999999999999999988899999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCcccccc-----cCCCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQF-----QRYDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-----~~~~~~~Diwsl  154 (154)
                      .|+|||||||.||++   +..|++||+|||.+..+..++  .+....|||.|++||++..     +.|.+.+||||+
T Consensus       194 mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSl  267 (1317)
T KOG0612|consen  194 MGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSL  267 (1317)
T ss_pred             ccceeccCCcceeEe---cccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhh
Confidence            999999999999999   899999999999887776444  4566789999999999852     468899999996

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.97  E-value=1.9e-31  Score=184.69  Aligned_cols=144  Identities=22%  Similarity=0.384  Sum_probs=124.2

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|+.+++.++|||++++++++..++..+++|||+++++|.+++... ..+++..++.++.|++.|++|||+++
T Consensus        48 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~  127 (266)
T cd05064          48 KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG  127 (266)
T ss_pred             HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            44567899999999999999999999999999999999999999999998764 46899999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc--ccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +.++.++++|||.+.........  ....++..|+|||.+.+..++.++|||||
T Consensus       128 iiH~dikp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  194 (266)
T cd05064         128 YVHKGLAAHKVLV---NSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSF  194 (266)
T ss_pred             EeeccccHhhEEE---cCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHH
Confidence            9999999999999   67788999999987554322211  12234567999999998899999999996

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.97  E-value=1.3e-31  Score=193.84  Aligned_cols=143  Identities=27%  Similarity=0.452  Sum_probs=122.1

Q ss_pred             hHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc---------------------------
Q 031702            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---------------------------   60 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~---------------------------   60 (154)
                      ..+.+.+|+.+++.+ +|+||+++++.+.+.+..+++|||+++|+|.+++...                           
T Consensus        84 ~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (374)
T cd05106          84 EREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLE  163 (374)
T ss_pred             HHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchh
Confidence            456788999999999 8999999999999999999999999999999988542                           


Q ss_pred             -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcE
Q 031702           61 -------------------------------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENI   97 (154)
Q Consensus        61 -------------------------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~ni   97 (154)
                                                                 ..+++..+..++.|++.|+.|||+++++|+||||+||
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Ni  243 (374)
T cd05106         164 KKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNV  243 (374)
T ss_pred             cccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheE
Confidence                                                       1367788999999999999999999999999999999


Q ss_pred             EeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCcccceecC
Q 031702           98 LLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        98 l~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++   +....++|+|||++........   .....++..|+|||++.+..++.++|||||
T Consensus       244 l~---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSl  300 (374)
T cd05106         244 LL---TDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSY  300 (374)
T ss_pred             EE---eCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHH
Confidence            99   5677899999999876543221   112234567999999988899999999996

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.3e-32  Score=208.80  Aligned_cols=146  Identities=28%  Similarity=0.463  Sum_probs=128.7

Q ss_pred             hhhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc------C-CCCHHHHHHHHHHHHHH
Q 031702            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------G-RVPEQTARKFLQQLGAG   78 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~------~-~~~~~~~~~~~~~i~~~   78 (154)
                      +.+....|.+|..+|+.+.|||||+++|++.+....++++|||+||+|..|+++.      . .++......++.||++|
T Consensus       735 ~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G  814 (1025)
T KOG1095|consen  735 SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKG  814 (1025)
T ss_pred             CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhh
Confidence            4677899999999999999999999999999999999999999999999999876      2 38889999999999999


Q ss_pred             HHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccc-c-c-cCCccccCcccccccCCCcccceecC
Q 031702           79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-K-V-CGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        79 l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~-~-~-~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +.||++++++||||..+|+|+   +.+..+|++|||+|+.+...+... . . .-...|||||.+..+.++.++|||||
T Consensus       815 ~~YLe~~~fvHRDLAaRNCLL---~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsF  890 (1025)
T KOG1095|consen  815 MNYLESKHFVHRDLAARNCLL---DERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSF  890 (1025)
T ss_pred             hHHHHhCCCcCcchhhhheee---cccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhh
Confidence            999999999999999999999   678999999999998554433221 1 1 12345999999999999999999997

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.97  E-value=3.6e-31  Score=185.26  Aligned_cols=145  Identities=24%  Similarity=0.554  Sum_probs=125.7

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-------------CCCHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------RVPEQTARKFLQ   73 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~   73 (154)
                      ....+.+.+|++++++++|||++++++.+...+..++++||+++++|.+++...+             .+++.++..++.
T Consensus        48 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  127 (288)
T cd05093          48 DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ  127 (288)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHH
Confidence            3456679999999999999999999999999999999999999999999987543             389999999999


Q ss_pred             HHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCcccc
Q 031702           74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVN  150 (154)
Q Consensus        74 ~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~D  150 (154)
                      |++.|++|||+.+++|+||+|+||++   +..+.++|+|||.+........   .....++..|+|||++.+..++.++|
T Consensus       128 ql~~aL~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sD  204 (288)
T cd05093         128 QIAAGMVYLASQHFVHRDLATRNCLV---GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESD  204 (288)
T ss_pred             HHHHHHHHHHhCCeeecccCcceEEE---ccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhh
Confidence            99999999999999999999999999   6778899999999876533221   12233466799999999888999999


Q ss_pred             eecC
Q 031702          151 FFVS  154 (154)
Q Consensus       151 iwsl  154 (154)
                      +|||
T Consensus       205 iwsl  208 (288)
T cd05093         205 VWSL  208 (288)
T ss_pred             HHHH
Confidence            9996

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.97  E-value=5.7e-31  Score=184.41  Aligned_cols=142  Identities=37%  Similarity=0.663  Sum_probs=128.7

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+++++.++||||+++++++.+++..++++||+++++|.+++.+.+.+++..+..++.|++.|+.+||+.++
T Consensus        43 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i  122 (290)
T cd05580          43 KQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI  122 (290)
T ss_pred             hHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            34577889999999999999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|.||++   +..+.++|+|||++......  .....+++.|+|||.+.+..++.++|+|||
T Consensus       123 ~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  184 (290)
T cd05580         123 VYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSKGYGKAVDWWAL  184 (290)
T ss_pred             ecCCCCHHHEEE---CCCCCEEEeeCCCccccCCC--CCCCCCCccccChhhhcCCCCCccccHHHH
Confidence            999999999999   66788999999998765443  334567889999999988888999999996

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.97  E-value=1.7e-31  Score=193.26  Aligned_cols=144  Identities=28%  Similarity=0.430  Sum_probs=122.5

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-------------------------
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------------------   61 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-------------------------   61 (154)
                      ...+.+.+|+.+++.+ +||||+++++++.+++..+++|||+++|+|.+++....                         
T Consensus        80 ~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (375)
T cd05104          80 TEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQRE  159 (375)
T ss_pred             HHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhc
Confidence            3456788999999999 89999999999999999999999999999999886421                         


Q ss_pred             --------------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeec
Q 031702           62 --------------------------------------------------RVPEQTARKFLQQLGAGLEILNSHHIIHRD   91 (154)
Q Consensus        62 --------------------------------------------------~~~~~~~~~~~~~i~~~l~~lh~~~~~h~~   91 (154)
                                                                        .+++..+..++.|++.|+.|||+.+++|+|
T Consensus       160 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~D  239 (375)
T cd05104         160 MSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRD  239 (375)
T ss_pred             ccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence                                                              367788899999999999999999999999


Q ss_pred             CCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCcccceecC
Q 031702           92 LKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        92 i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |||+||++   +....+||+|||++........   .....++..|+|||++.+..++.++|||||
T Consensus       240 lkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~sl  302 (375)
T cd05104         240 LAARNILL---THGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY  302 (375)
T ss_pred             CchhhEEE---ECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHH
Confidence            99999999   5677899999999876543321   112234567999999998899999999996

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-31  Score=181.80  Aligned_cols=148  Identities=31%  Similarity=0.483  Sum_probs=130.5

Q ss_pred             hhhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      -..+.++.+|++++... .|+||+++++.|+++..+|+|||-|.||+|...+.++..+++.+...++++|+.|+.+||.+
T Consensus       116 gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k  195 (463)
T KOG0607|consen  116 GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTK  195 (463)
T ss_pred             chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc
Confidence            35678899999999999 79999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--------ccccccCCccccCcccccc-----cCCCccccee
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQF-----QRYDEKVNFF  152 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-----~~~~~~~Diw  152 (154)
                      ||.|||+||+||+....+.-..+||+||.++..+..+.        ..-+++|+..|||||++.-     ..|+.++|.|
T Consensus       196 gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlw  275 (463)
T KOG0607|consen  196 GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLW  275 (463)
T ss_pred             CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHH
Confidence            99999999999999877778889999998875432211        2245788899999999742     3589999999


Q ss_pred             cC
Q 031702          153 VS  154 (154)
Q Consensus       153 sl  154 (154)
                      ||
T Consensus       276 SL  277 (463)
T KOG0607|consen  276 SL  277 (463)
T ss_pred             HH
Confidence            96

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.97  E-value=5.2e-31  Score=183.77  Aligned_cols=144  Identities=26%  Similarity=0.496  Sum_probs=124.9

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc----------------CCCCHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARKF   71 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~   71 (154)
                      ...+.+.+|+.+++.++|||++++++++......++++||+++++|.+++...                ..+++..+..+
T Consensus        50 ~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  129 (283)
T cd05048          50 KVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI  129 (283)
T ss_pred             HHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHH
Confidence            44567899999999999999999999999989999999999999999999764                34788899999


Q ss_pred             HHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCCCcc
Q 031702           72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEK  148 (154)
Q Consensus        72 ~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~  148 (154)
                      +.|++.|+.|||+.+++|+||+|+||++   +..+.++|+|||++.......   ......+++.|+|||.+.+..++.+
T Consensus       130 ~~~l~~al~~lH~~~i~H~dlkp~Nil~---~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  206 (283)
T cd05048         130 AIQIAAGMEYLSSHHFVHRDLAARNCLV---GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE  206 (283)
T ss_pred             HHHHHHHHHHHHhCCeeccccccceEEE---cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchh
Confidence            9999999999999999999999999999   567789999999987543322   1223445778999999988889999


Q ss_pred             cceecC
Q 031702          149 VNFFVS  154 (154)
Q Consensus       149 ~Diwsl  154 (154)
                      +|||||
T Consensus       207 sDv~sl  212 (283)
T cd05048         207 SDIWSF  212 (283)
T ss_pred             hhHHHH
Confidence            999996

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.97  E-value=6.6e-31  Score=183.78  Aligned_cols=142  Identities=32%  Similarity=0.476  Sum_probs=125.6

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      .+.+.+|+.+++.++|++++++.+.+.+.+..+++|||+++++|.+++...  ..+++..+..++.|++.|+.|||+.++
T Consensus        44 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i  123 (285)
T cd05630          44 ESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERI  123 (285)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            345778999999999999999999999999999999999999999988543  358999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||++.............|+..|+|||++.+..++.++|+|||
T Consensus       124 iH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl  187 (285)
T cd05630         124 VYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWAL  187 (285)
T ss_pred             EeCCCCHHHEEE---CCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHH
Confidence            999999999999   6778899999999876544433344578999999999998889999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.97  E-value=9.5e-31  Score=179.86  Aligned_cols=146  Identities=28%  Similarity=0.539  Sum_probs=129.3

Q ss_pred             hhhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH
Q 031702            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      .....+.+.+|+.+++.++|||++++++.+.+.+..++++||+++++|.+++...  ..+++..+..++.+++.|+.|||
T Consensus        39 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH  118 (256)
T cd08529          39 NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH  118 (256)
T ss_pred             CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            3566788999999999999999999999999999999999999999999998764  46899999999999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +.+++|+||+|+||++   +..+.++|+|||++....... ......+++.|+|||+..+..++.++|+|||
T Consensus       119 ~~~i~h~dl~~~nili---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  187 (256)
T cd08529         119 SKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWAL  187 (256)
T ss_pred             HCCcccCCCCcceEEE---eCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHH
Confidence            9999999999999999   567889999999987654433 2334567889999999998889999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=197.24  Aligned_cols=146  Identities=32%  Similarity=0.517  Sum_probs=129.3

Q ss_pred             hhhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 031702            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      +...-+++.-|+.||..+.||+|++++++|--.+.++++.|||+||.....+-.- ..+.+.++..+++|+++|+.|||+
T Consensus        69 seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs  148 (1187)
T KOG0579|consen   69 SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHS  148 (1187)
T ss_pred             chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhh
Confidence            4566788889999999999999999999999999999999999999999887554 459999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccC-CCCccccccCCccccCccccc-----ccCCCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQ-----FQRYDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~-~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Diwsl  154 (154)
                      ++++|||+|..||++   ...|.++|+|||.+.... ......+..|||+|||||++.     ..+|+.++|||||
T Consensus       149 ~~iIHRDLKAGNiL~---TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSl  221 (1187)
T KOG0579|consen  149 QNIIHRDLKAGNILL---TLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSL  221 (1187)
T ss_pred             cchhhhhccccceEE---EecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhh
Confidence            999999999999999   577889999999876533 234566789999999999985     3579999999997

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=8e-31  Score=180.94  Aligned_cols=142  Identities=30%  Similarity=0.585  Sum_probs=126.6

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (154)
                      .+.+.+|+.+++.++||||+++++++.++...++++||+++++|.+++.....+++..+..++.|++.|+.+||+.+++|
T Consensus        48 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H  127 (263)
T cd06625          48 VNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH  127 (263)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            46789999999999999999999999999999999999999999999988888999999999999999999999999999


Q ss_pred             ecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc----ccccCCccccCcccccccCCCcccceecC
Q 031702           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        90 ~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +||+|+||++   +..+.++|+|||.+.........    ....++..|+|||...+..++.++|||||
T Consensus       128 ~dl~p~nilv---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  193 (263)
T cd06625         128 RDIKGANILR---DSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSV  193 (263)
T ss_pred             CCCCHHHEEE---cCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHH
Confidence            9999999999   56778999999998765332211    23457788999999998889999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.97  E-value=2.5e-31  Score=187.26  Aligned_cols=141  Identities=30%  Similarity=0.458  Sum_probs=120.1

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ...+.+|+.+++.++||||+++++++.++...+++|||++ ++|.+++... +.+++..+..++.|++.|++|||+.+++
T Consensus        47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv  125 (303)
T cd07869          47 PFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYIL  125 (303)
T ss_pred             chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            3467789999999999999999999999999999999995 5777777554 5689999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCcccccc-cCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      |+||||+||++   +..+.+||+|||++...... .......+++.|+|||++.+ ..++.++|||||
T Consensus       126 H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  190 (303)
T cd07869         126 HRDLKPQNLLI---SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGV  190 (303)
T ss_pred             cCCCCHHHEEE---CCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHH
Confidence            99999999999   67788999999998654322 22334567899999999865 457889999996

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2.2e-31  Score=193.67  Aligned_cols=140  Identities=27%  Similarity=0.439  Sum_probs=124.3

Q ss_pred             HhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 031702           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR   90 (154)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~   90 (154)
                      +...+|+.+++.++||||+++++.+......|++||++. ++|.+++.....+++..+..++.|++.|+.|||+.+++|+
T Consensus       131 ~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHr  209 (392)
T PHA03207        131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHR  209 (392)
T ss_pred             ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            345789999999999999999999999999999999985 6888888777889999999999999999999999999999


Q ss_pred             cCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCcccceecC
Q 031702           91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        91 ~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ||||+||++   +..+.++|+|||++........   .....||+.|+|||++.+..++.++|||||
T Consensus       210 Dlkp~Nill---~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  273 (392)
T PHA03207        210 DVKTENIFL---DEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSA  273 (392)
T ss_pred             CCCHHHEEE---cCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHH
Confidence            999999999   6788999999999876544322   234568999999999998899999999996

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.97  E-value=3.6e-32  Score=185.46  Aligned_cols=145  Identities=28%  Similarity=0.508  Sum_probs=132.5

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      +.+-+.+..|+.++++++.|++|++++.+.....+++|||||+.|+..+.++- +.++++.++..+.++.+++++|||..
T Consensus        69 ~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~  148 (502)
T KOG0574|consen   69 DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL  148 (502)
T ss_pred             cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH
Confidence            45578889999999999999999999999999999999999999999999864 45799999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .-+|||||..||++   +..+..||+|||.|..+.+. ....++.|||.|||||++..-.|+.++|||||
T Consensus       149 ~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSL  215 (502)
T KOG0574|consen  149 KKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSL  215 (502)
T ss_pred             HHHHhhcccccEEE---cccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhh
Confidence            99999999999999   78899999999999766442 35677899999999999999999999999997

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.97  E-value=1.2e-30  Score=182.46  Aligned_cols=142  Identities=33%  Similarity=0.458  Sum_probs=125.6

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      .+.+.+|+++++.++|++++++.+.+.+++..++++||+++++|.+++...  ..+++..+..++.|++.|+.|||+.++
T Consensus        44 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i  123 (285)
T cd05632          44 ESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENT  123 (285)
T ss_pred             HHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            455788999999999999999999999999999999999999999887543  359999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||++.............|+..|+|||.+.+..++.++|+|||
T Consensus       124 iH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~sl  187 (285)
T cd05632         124 VYRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGL  187 (285)
T ss_pred             eecCCCHHHEEE---CCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHH
Confidence            999999999999   5677899999999876544333345578999999999988889999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.97  E-value=8.2e-31  Score=184.73  Aligned_cols=144  Identities=28%  Similarity=0.442  Sum_probs=122.1

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC----------------CCCHHHHHH
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK   70 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----------------~~~~~~~~~   70 (154)
                      ...+.+.+|+.++.++ +|+|++++++++.+++..++++||+++++|.+++....                .+++..++.
T Consensus        49 ~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  128 (303)
T cd05088          49 DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH  128 (303)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHH
Confidence            3456788999999999 89999999999999999999999999999999986543                478889999


Q ss_pred             HHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccc
Q 031702           71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVN  150 (154)
Q Consensus        71 ~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  150 (154)
                      ++.|++.|++|||+.|++|+||+|+||++   +..+.++|+|||++..............+..|+|||...+..++.++|
T Consensus       129 ~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  205 (303)
T cd05088         129 FAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSD  205 (303)
T ss_pred             HHHHHHHHHHHHHhCCccccccchheEEe---cCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCccccc
Confidence            99999999999999999999999999999   677889999999886432111111222356699999998888899999


Q ss_pred             eecC
Q 031702          151 FFVS  154 (154)
Q Consensus       151 iwsl  154 (154)
                      ||||
T Consensus       206 i~sl  209 (303)
T cd05088         206 VWSY  209 (303)
T ss_pred             chhh
Confidence            9997

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=6.1e-31  Score=189.23  Aligned_cols=139  Identities=28%  Similarity=0.404  Sum_probs=121.9

Q ss_pred             hHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 031702           12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHIIHR   90 (154)
Q Consensus        12 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~   90 (154)
                      ....|+.+++.++||||+++++++...+..++++|++. ++|.+++.+ ...+++..+..++.|++.|+.|||+.+++||
T Consensus       103 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr  181 (357)
T PHA03209        103 TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR  181 (357)
T ss_pred             ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            44679999999999999999999999999999999995 588887754 4568999999999999999999999999999


Q ss_pred             cCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        91 ~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ||||+||++   +..+.++|+|||++.............||+.|+|||++.+..++.++|||||
T Consensus       182 Dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  242 (357)
T PHA03209        182 DVKTENIFI---NDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSA  242 (357)
T ss_pred             CCCHHHEEE---CCCCCEEEecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHH
Confidence            999999999   6778899999999875443333445678999999999998899999999996

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=8e-31  Score=180.50  Aligned_cols=141  Identities=17%  Similarity=0.276  Sum_probs=121.0

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      .+.+.+|+.+++.++|||++++++.+.. +..++++||+++++|.+++.... .++...+..++.|++.|+.|||+++++
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~  123 (259)
T cd05037          45 SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLV  123 (259)
T ss_pred             HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence            6788999999999999999999999988 77899999999999999998766 689999999999999999999999999


Q ss_pred             eecCCCCcEEeecCC----CCeeEEEeecccccccCCCCccccccCCccccCccccccc--CCCcccceecC
Q 031702           89 HRDLKPENILLSGLD----DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ--RYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~----~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Diwsl  154 (154)
                      |+||+|+||++....    ....++++|||++.....   .....++..|+|||++...  .++.++|||||
T Consensus       124 H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~sl  192 (259)
T cd05037         124 HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSF  192 (259)
T ss_pred             cccCccceEEEecCccccCCceeEEeCCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHH
Confidence            999999999995321    122799999999876543   2233456779999998876  78899999996

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.97  E-value=1.1e-30  Score=183.00  Aligned_cols=143  Identities=23%  Similarity=0.527  Sum_probs=124.8

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC----------------CCCHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARKFL   72 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~   72 (154)
                      ..+.+.+|+.+++.++|+|++++++.+.+.+..+++|||+++++|.+++..+.                .+++..++.++
T Consensus        50 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  129 (291)
T cd05094          50 ARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA  129 (291)
T ss_pred             HHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHH
Confidence            34678999999999999999999999999999999999999999999997542                37889999999


Q ss_pred             HHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCccc
Q 031702           73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKV  149 (154)
Q Consensus        73 ~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~  149 (154)
                      .|++.|++|||+++++|+||+|+||++   +..+.++|+|||++........   .....++..|+|||.+.+..++.++
T Consensus       130 ~~i~~al~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  206 (291)
T cd05094         130 SQIASGMVYLASQHFVHRDLATRNCLV---GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES  206 (291)
T ss_pred             HHHHHHHHHHHhCCeeecccCcceEEE---ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchh
Confidence            999999999999999999999999999   6778999999999876543321   2233456779999999988899999


Q ss_pred             ceecC
Q 031702          150 NFFVS  154 (154)
Q Consensus       150 Diwsl  154 (154)
                      |||||
T Consensus       207 Di~sl  211 (291)
T cd05094         207 DVWSF  211 (291)
T ss_pred             hHHHH
Confidence            99996

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.97  E-value=1.3e-30  Score=180.00  Aligned_cols=144  Identities=35%  Similarity=0.643  Sum_probs=130.0

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++|||++++.+.+.+++..++++||+++++|.+++.+...++...+..++.|++.|++|+|++++
T Consensus        35 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~  114 (262)
T cd05572          35 GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGI  114 (262)
T ss_pred             hHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCc
Confidence            44578999999999999999999999999999999999999999999999887789999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||.+.............+++.|+|||.+.+..++.++|+|||
T Consensus       115 ~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~sl  178 (262)
T cd05572         115 IYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSL  178 (262)
T ss_pred             ccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhh
Confidence            999999999999   6678899999999887655433444567889999999988889999999996

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.97  E-value=7.9e-31  Score=190.93  Aligned_cols=144  Identities=27%  Similarity=0.457  Sum_probs=122.7

Q ss_pred             hhHHhHHHHHHHHhhCC-CCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--------------------------
Q 031702            8 HLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------------------------   60 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--------------------------   60 (154)
                      ...+.+.+|+.+++.+. ||||+++++++.+.+..|++|||+++|+|.+++..+                          
T Consensus        82 ~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (400)
T cd05105          82 SEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADE  161 (400)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccc
Confidence            44578999999999995 999999999999999999999999999999887542                          


Q ss_pred             ----------------------------------------------------------------------CCCCHHHHHH
Q 031702           61 ----------------------------------------------------------------------GRVPEQTARK   70 (154)
Q Consensus        61 ----------------------------------------------------------------------~~~~~~~~~~   70 (154)
                                                                                            ..+++..+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~  241 (400)
T cd05105         162 STRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLS  241 (400)
T ss_pred             cccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHH
Confidence                                                                                  1366778889


Q ss_pred             HHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCCCc
Q 031702           71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDE  147 (154)
Q Consensus        71 ~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~  147 (154)
                      ++.|++.|+.|||+.+++|+||+|+||++   +....+||+|||++.......   ......+++.|+|||.+.+..++.
T Consensus       242 ~~~qi~~aL~~LH~~~ivH~dikp~Nill---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  318 (400)
T cd05105         242 FTYQVARGMEFLASKNCVHRDLAARNVLL---AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT  318 (400)
T ss_pred             HHHHHHHHHHHHHhCCeeCCCCChHhEEE---eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCc
Confidence            99999999999999999999999999999   567789999999987653322   122334567899999998888999


Q ss_pred             ccceecC
Q 031702          148 KVNFFVS  154 (154)
Q Consensus       148 ~~Diwsl  154 (154)
                      ++|||||
T Consensus       319 ~~DiwSl  325 (400)
T cd05105         319 LSDVWSY  325 (400)
T ss_pred             hhhHHHH
Confidence            9999996

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.97  E-value=1e-30  Score=181.38  Aligned_cols=144  Identities=28%  Similarity=0.442  Sum_probs=122.3

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC----------------CCCHHHHHH
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK   70 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----------------~~~~~~~~~   70 (154)
                      ...+.+.+|+.+++++ +|||++++++.+...+..+++|||+++++|.+++....                .++..++..
T Consensus        37 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  116 (270)
T cd05047          37 DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH  116 (270)
T ss_pred             HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHH
Confidence            4456788999999999 89999999999999999999999999999999986543                378899999


Q ss_pred             HHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccc
Q 031702           71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVN  150 (154)
Q Consensus        71 ~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  150 (154)
                      ++.|++.|++|||+.+++|+||+|+||++   +..+.+|++|||++..............+..|+|||+.....++.++|
T Consensus       117 ~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~D  193 (270)
T cd05047         117 FAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSD  193 (270)
T ss_pred             HHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhh
Confidence            99999999999999999999999999999   678899999999885332211112223356699999998888999999


Q ss_pred             eecC
Q 031702          151 FFVS  154 (154)
Q Consensus       151 iwsl  154 (154)
                      +|||
T Consensus       194 i~sl  197 (270)
T cd05047         194 VWSY  197 (270)
T ss_pred             HHHH
Confidence            9996

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.97  E-value=1.7e-30  Score=179.00  Aligned_cols=144  Identities=33%  Similarity=0.563  Sum_probs=130.9

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|++++++++|||++++++.+.++...++++||+++++|.+++.+...+++..+..++.|++.|+.|||+.++
T Consensus        42 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i  121 (258)
T cd05578          42 GSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI  121 (258)
T ss_pred             hHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            44678999999999999999999999999999999999999999999999877789999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||.+.............++..|+|||.+.+..++.++|+|||
T Consensus       122 ~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  185 (258)
T cd05578         122 IHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSL  185 (258)
T ss_pred             eccCCCHHHeEE---cCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhh
Confidence            999999999999   6778899999999877655544455667888999999988889999999996

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.97  E-value=1.3e-30  Score=182.76  Aligned_cols=144  Identities=25%  Similarity=0.436  Sum_probs=126.8

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-----------CCCHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------RVPEQTARKFLQQLG   76 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~i~   76 (154)
                      ...+.+.+|+++++.++|||++++++++..++..++++|++++++|.+++....           .+++..++.++.|++
T Consensus        61 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  140 (296)
T cd05051          61 NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIA  140 (296)
T ss_pred             HHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHH
Confidence            456788999999999999999999999999999999999999999999997665           689999999999999


Q ss_pred             HHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCCCcccceec
Q 031702           77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFV  153 (154)
Q Consensus        77 ~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws  153 (154)
                      .|+.|||+.+++|+||+|+||++   +..+.++|+|||.+.......   ......+++.|+|||...+..++.++||||
T Consensus       141 ~al~~LH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s  217 (296)
T cd05051         141 SGMRYLESLNFVHRDLATRNCLV---GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWA  217 (296)
T ss_pred             HHHHHHHHcCccccccchhceee---cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhh
Confidence            99999999999999999999999   567899999999987654332   222344567899999998888999999999


Q ss_pred             C
Q 031702          154 S  154 (154)
Q Consensus       154 l  154 (154)
                      |
T Consensus       218 l  218 (296)
T cd05051         218 F  218 (296)
T ss_pred             h
Confidence            6

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.97  E-value=1.3e-30  Score=184.18  Aligned_cols=144  Identities=32%  Similarity=0.543  Sum_probs=127.6

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-H   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~   85 (154)
                      ....+.+.+|++++++++||||+++++.+.+++.+++++||+++++|.+++.+.+.+++..+..++.|++.|+.|||+ .
T Consensus        40 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  119 (308)
T cd06615          40 PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH  119 (308)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC
Confidence            344567889999999999999999999999999999999999999999999888889999999999999999999997 5


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||+|.||++   +..+.++|+|||.+...... ......+++.|+|||.+.+..++.++|+|||
T Consensus       120 ~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Diwsl  184 (308)
T cd06615         120 KIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYTVQSDIWSL  184 (308)
T ss_pred             CEEECCCChHHEEE---ecCCcEEEccCCCccccccc-ccccCCCCcCccChhHhcCCCCCccchHHHH
Confidence            89999999999999   56778999999988654332 2234567889999999988889999999996

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.97  E-value=1.9e-30  Score=178.56  Aligned_cols=146  Identities=30%  Similarity=0.492  Sum_probs=128.6

Q ss_pred             hhhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH
Q 031702            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      +....+.+.+|++++++++|+|++++++.+.+.+..++++||+++++|.+++.+.  ..+++..+..++.|++.++.|||
T Consensus        39 ~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh  118 (256)
T cd08221          39 SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH  118 (256)
T ss_pred             chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            3455677899999999999999999999999999999999999999999999765  45899999999999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +.+++|+||+|+||++   +..+.+|++|||.+....... ......+++.|+|||...+..++.++|+|||
T Consensus       119 ~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~sl  187 (256)
T cd08221         119 KAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWAL  187 (256)
T ss_pred             hCCccccCCChHhEEE---eCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHH
Confidence            9999999999999999   567789999999987654433 3344567889999999988888999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.97  E-value=1.3e-30  Score=180.48  Aligned_cols=143  Identities=28%  Similarity=0.508  Sum_probs=126.0

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ....+.+|+.+++.++|||++++++.+...+..++++||+++++|.+++...+.+++.+++.++.|++.|+.|||+.|++
T Consensus        49 ~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  128 (267)
T cd06645          49 DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKM  128 (267)
T ss_pred             HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            34567889999999999999999999999999999999999999999998888899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCccccc---ccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ---FQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~---~~~~~~~~Diwsl  154 (154)
                      |+||+|+||++   +..+.++|+|||++....... ......|++.|+|||++.   ...++.++|+|||
T Consensus       129 H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSl  195 (267)
T cd06645         129 HRDIKGANILL---TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAV  195 (267)
T ss_pred             cCCCCHHHEEE---CCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHH
Confidence            99999999999   677889999999986553322 223456889999999974   4568899999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.97  E-value=1.5e-30  Score=181.42  Aligned_cols=145  Identities=23%  Similarity=0.519  Sum_probs=125.2

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC---------------CCCHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---------------RVPEQTARKF   71 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~   71 (154)
                      ....+.+.+|+++++.++|+||+++++++.+++..++++||+++++|.+++....               .+++..+..+
T Consensus        48 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  127 (280)
T cd05092          48 ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI  127 (280)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHH
Confidence            4556789999999999999999999999999999999999999999999987543               3788999999


Q ss_pred             HHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCcc
Q 031702           72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEK  148 (154)
Q Consensus        72 ~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~  148 (154)
                      +.|++.|++|||+.+++|+||+|+||++   +..+.++|+|||++........   .....+++.|+|||.+.+..++.+
T Consensus       128 ~~qi~~al~~LH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  204 (280)
T cd05092         128 ASQIASGMVYLASLHFVHRDLATRNCLV---GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE  204 (280)
T ss_pred             HHHHHHHHHHHHHCCeecccccHhhEEE---cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCch
Confidence            9999999999999999999999999999   5678899999999875533221   122234577999999998899999


Q ss_pred             cceecC
Q 031702          149 VNFFVS  154 (154)
Q Consensus       149 ~Diwsl  154 (154)
                      +|||||
T Consensus       205 ~Di~sl  210 (280)
T cd05092         205 SDIWSF  210 (280)
T ss_pred             hhHHHH
Confidence            999996

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.97  E-value=1.3e-30  Score=187.51  Aligned_cols=141  Identities=35%  Similarity=0.490  Sum_probs=119.9

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCC------cEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~   81 (154)
                      ...+.+.+|+.+++.++||||+++++++...+      .+|++|||+++ ++.+.+.  ..++...+..++.|++.|+.|
T Consensus        62 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~  138 (359)
T cd07876          62 THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKH  138 (359)
T ss_pred             hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHH
Confidence            34567789999999999999999999886443      47999999965 6665553  358889999999999999999


Q ss_pred             HHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        82 lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ||+.+++|+||||+||++   +..+.+||+|||++.............+|+.|+|||++.+..++.++|||||
T Consensus       139 LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl  208 (359)
T cd07876         139 LHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV  208 (359)
T ss_pred             HHhCCcccCCCCHHHEEE---CCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHH
Confidence            999999999999999999   6788999999999876544444445577899999999998899999999996

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=2.5e-30  Score=178.93  Aligned_cols=143  Identities=30%  Similarity=0.533  Sum_probs=126.9

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++||||+++.+.+.+.+..++++||+++++|.+++...+.++...+..++.|++.|+++||+.+++
T Consensus        49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~iv  128 (267)
T cd06628          49 MLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGII  128 (267)
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcc
Confidence            34678999999999999999999999999999999999999999999998888899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCC-------ccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-------YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||+|+||++   +..+.++|+|||.+.......       ......++..|+|||.+.+..++.++|+|||
T Consensus       129 H~di~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl  198 (267)
T cd06628         129 HRDIKGANILV---DNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSL  198 (267)
T ss_pred             cccCCHHHEEE---cCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHH
Confidence            99999999999   677889999999987664221       1122357788999999988889999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.97  E-value=2.8e-30  Score=181.46  Aligned_cols=144  Identities=28%  Similarity=0.437  Sum_probs=121.5

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC----------------CCCHHHHHH
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK   70 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----------------~~~~~~~~~   70 (154)
                      ...+.+.+|+.+++++ +|||++++++.+.+.+..++++||+++++|.+++.+..                .+++..+..
T Consensus        44 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  123 (297)
T cd05089          44 NDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ  123 (297)
T ss_pred             HHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHH
Confidence            3456789999999999 79999999999999999999999999999999986542                478889999


Q ss_pred             HHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccc
Q 031702           71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVN  150 (154)
Q Consensus        71 ~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  150 (154)
                      ++.|++.|++|||+.+++|+||+|+||++   +..+.+||+|||++..............+..|+|||...+..++.++|
T Consensus       124 i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  200 (297)
T cd05089         124 FASDVATGMQYLSEKQFIHRDLAARNVLV---GENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSD  200 (297)
T ss_pred             HHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhh
Confidence            99999999999999999999999999999   667889999999886432211111122245699999998888999999


Q ss_pred             eecC
Q 031702          151 FFVS  154 (154)
Q Consensus       151 iwsl  154 (154)
                      ||||
T Consensus       201 vwSl  204 (297)
T cd05089         201 VWSF  204 (297)
T ss_pred             HHHH
Confidence            9996

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.97  E-value=2.8e-30  Score=179.77  Aligned_cols=143  Identities=24%  Similarity=0.521  Sum_probs=124.6

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC--------------CCCHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--------------RVPEQTARKFLQQ   74 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~   74 (154)
                      ..+.+.+|+++++.++|+|++++++.+..++..+++|||+++++|.+++...+              .+++..+..++.|
T Consensus        51 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  130 (280)
T cd05049          51 ARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ  130 (280)
T ss_pred             HHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHH
Confidence            45789999999999999999999999999999999999999999999997543              3778899999999


Q ss_pred             HHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCcccce
Q 031702           75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNF  151 (154)
Q Consensus        75 i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di  151 (154)
                      ++.|+.+||+.+++|+||+|+||++   +..+.++|+|||.+........   .....+++.|+|||++.+..++.++||
T Consensus       131 i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  207 (280)
T cd05049         131 IASGMVYLASQHFVHRDLATRNCLV---GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV  207 (280)
T ss_pred             HHHHHHHHhhCCeeccccccceEEE---cCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhH
Confidence            9999999999999999999999999   6778999999999875433221   223344677999999998999999999


Q ss_pred             ecC
Q 031702          152 FVS  154 (154)
Q Consensus       152 wsl  154 (154)
                      |||
T Consensus       208 ~sl  210 (280)
T cd05049         208 WSF  210 (280)
T ss_pred             HHH
Confidence            996

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=3.3e-30  Score=179.98  Aligned_cols=144  Identities=24%  Similarity=0.434  Sum_probs=123.6

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecC--CcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ...+.+.+|+++++.++|||++++.+++.+.  ...++++||+++++|.+++.+.. .+++..+..++.|++.|++|||+
T Consensus        48 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~  127 (284)
T cd05079          48 NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS  127 (284)
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3457899999999999999999999988765  56899999999999999986553 58999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc----cccccCCccccCcccccccCCCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|++|+||+|+||++   +..+.++|+|||++........    .....++..|+|||...+..++.++|||||
T Consensus       128 ~gi~H~dlkp~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl  198 (284)
T cd05079         128 RQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSF  198 (284)
T ss_pred             CCeeecccchheEEE---cCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhh
Confidence            999999999999999   5677899999999876543321    123345667999999988889999999997

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.97  E-value=3.3e-30  Score=177.79  Aligned_cols=143  Identities=22%  Similarity=0.466  Sum_probs=121.0

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|+.++++++||||+++++++. .+..++++||+++++|.+++.. ...+++..+..++.|++.|+.|||+++
T Consensus        37 ~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  115 (257)
T cd05115          37 SVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN  115 (257)
T ss_pred             HHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Confidence            34567899999999999999999999875 4568999999999999999875 446899999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc----ccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.+||+|||++.........    ....++..|+|||.+.+..++.++|||||
T Consensus       116 i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  184 (257)
T cd05115         116 FVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSY  184 (257)
T ss_pred             eeecccchheEEE---cCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHH
Confidence            9999999999999   67788999999998754333211    11223467999999988889999999996

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.97  E-value=3.1e-30  Score=177.18  Aligned_cols=145  Identities=32%  Similarity=0.547  Sum_probs=123.7

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ......+.+|+.+++.++||||+++++++......++++||+++++|.+++.+.. .+++..++.++.|++.|+.|||+.
T Consensus        34 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~  113 (252)
T cd05084          34 PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK  113 (252)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3456789999999999999999999999999999999999999999999987544 589999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc---ccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||+|.||++   +..+.++|+|||.+.........   .....+..|+|||.+.++.++.++|+|||
T Consensus       114 ~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  182 (252)
T cd05084         114 HCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSF  182 (252)
T ss_pred             CccccccchheEEE---cCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHH
Confidence            99999999999999   56778999999998654322111   11122456999999988889999999996

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-30  Score=193.78  Aligned_cols=146  Identities=31%  Similarity=0.475  Sum_probs=131.0

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRV--PEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~--~~~~~~~~~~~i~~~l~~lh   83 (154)
                      ++..+-++.|+.+.++|+|.|||+++|.+.+++++-++||-++||+|..++++. +++  .+.++..+.+||++|+.|||
T Consensus       613 sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLH  692 (1226)
T KOG4279|consen  613 SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLH  692 (1226)
T ss_pred             chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhh
Confidence            455677899999999999999999999999999999999999999999999865 456  78999999999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCccccccc--CCCcccceecC
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ--RYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Diwsl  154 (154)
                      ++.|+|||||-.|++++  .-.+.+||+|||-+++.-.- ....+..||..|||||++..+  +|...+|||||
T Consensus       693 en~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~  764 (1226)
T KOG4279|consen  693 ENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSF  764 (1226)
T ss_pred             hcceeeccccCCcEEEe--eccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhc
Confidence            99999999999999996  56789999999998876543 455778899999999999865  58899999997

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.97  E-value=4.7e-30  Score=176.39  Aligned_cols=146  Identities=32%  Similarity=0.589  Sum_probs=128.5

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ....+.+.+|+.+++.++|||++++++.+..++..++++||+++++|.+++...  ..+++..+..++.+++.++++||+
T Consensus        40 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~  119 (256)
T cd08220          40 KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT  119 (256)
T ss_pred             cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            445678999999999999999999999999999999999999999999999764  348999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++++|+||+|+||++.  +....++++|||.+.............++..|+|||.+....++.++|+|||
T Consensus       120 ~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  187 (256)
T cd08220         120 KLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWAL  187 (256)
T ss_pred             CCeecCCCCHHHEEEc--CCCCEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHH
Confidence            9999999999999994  3455789999999987665544455667889999999988888999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.97  E-value=2e-31  Score=194.17  Aligned_cols=145  Identities=26%  Similarity=0.500  Sum_probs=128.0

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ...+..|.+|+.+|.+|+||||++++++|..++.+++++|||++|+|.+|+..+.  .........++.||+.|++||.+
T Consensus       576 ~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes  655 (807)
T KOG1094|consen  576 KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES  655 (807)
T ss_pred             hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh
Confidence            4557889999999999999999999999999999999999999999999998774  34567788899999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcccc---ccCCccccCcccccccCCCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .+++|||+.+.|+++   +...++|++|||.++.+.+.+....   ..-...|||||.+..+++++++|+|+|
T Consensus       656 ~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWaf  725 (807)
T KOG1094|consen  656 LNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAF  725 (807)
T ss_pred             hchhhccccccceee---cCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhh
Confidence            999999999999999   8999999999999987655543221   223567999999999999999999987

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.97  E-value=4.1e-31  Score=182.55  Aligned_cols=145  Identities=32%  Similarity=0.543  Sum_probs=122.8

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ....+.+.+|++.+++++||||+++++++...+..++++||+++|+|.+++...  ..+++..+..++.|++.|+.|||+
T Consensus        42 ~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~  121 (259)
T PF07714_consen   42 EEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS  121 (259)
T ss_dssp             HHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH
T ss_pred             cccceeeeeccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            345789999999999999999999999999888899999999999999999876  679999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCCCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .+++|++|+++||++   +..+.+||+|||++.......   ..........|+|||.+.+..++.++|||||
T Consensus       122 ~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysf  191 (259)
T PF07714_consen  122 NNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSF  191 (259)
T ss_dssp             TTEEEST-SGGGEEE---ETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHH
T ss_pred             ccccccccccccccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999999999   567899999999987663222   1223345677999999998889999999996

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.4e-30  Score=177.65  Aligned_cols=143  Identities=31%  Similarity=0.561  Sum_probs=127.2

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+.+++.++|||++++++.+.+++.++++|||+++++|.+++... ..+++..+..++.|++.|+.|||+.++
T Consensus        43 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i  122 (262)
T cd06613          43 DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGK  122 (262)
T ss_pred             hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            4678999999999999999999999999999999999999999999998776 679999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCccccccc---CCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ---RYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~---~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||.+....... ......++..|+|||...+.   .++.++|+|||
T Consensus       123 ~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~sl  190 (262)
T cd06613         123 IHRDIKGANILL---TEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWAL  190 (262)
T ss_pred             eecCCChhhEEE---CCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHH
Confidence            999999999999   677889999999987654432 23345678889999999776   78899999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.97  E-value=3.4e-30  Score=179.31  Aligned_cols=143  Identities=22%  Similarity=0.395  Sum_probs=122.1

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC----------CCCHHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------RVPEQTARKFLQQLGAG   78 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~i~~~   78 (154)
                      ....+.+|+.+++.++|||++++++++.++...++++||+++++|.+++.+..          .++...+..++.|++.|
T Consensus        52 ~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  131 (277)
T cd05062          52 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG  131 (277)
T ss_pred             HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHH
Confidence            45668899999999999999999999999999999999999999999986532          24677889999999999


Q ss_pred             HHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCcccceecC
Q 031702           79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        79 l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +.|||+.+++|+||+|+||++   +..+.++|+|||++........   .....+++.|+|||.+.+..++.++|||||
T Consensus       132 l~~lH~~~~vH~dlkp~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  207 (277)
T cd05062         132 MAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF  207 (277)
T ss_pred             HHHHHHCCcccCCcchheEEE---cCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHH
Confidence            999999999999999999999   6778899999999875543221   112344677999999998889999999996

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.97  E-value=2.5e-30  Score=186.91  Aligned_cols=142  Identities=30%  Similarity=0.461  Sum_probs=122.2

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCC-----cEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      ..+.+.+|+.+++.++|+||+++++++...+     ..|+++||+. ++|.+.+.....+++..+..++.|++.|+.|||
T Consensus        42 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH  120 (372)
T cd07853          42 SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH  120 (372)
T ss_pred             HHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            3467889999999999999999999998776     7899999995 588888877788999999999999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCccccccc-CCCcccceecC
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      +.+++|+||||+||++   +..+.+||+|||++.......  ......+++.|+|||.+.+. .++.++|||||
T Consensus       121 ~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  191 (372)
T cd07853         121 SAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSV  191 (372)
T ss_pred             hCCeeCCCCChHHEEE---CCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhH
Confidence            9999999999999999   678899999999987543322  22234568889999998764 47899999996

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.97  E-value=4.6e-31  Score=192.50  Aligned_cols=145  Identities=28%  Similarity=0.498  Sum_probs=127.3

Q ss_pred             hhhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh
Q 031702            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      +++..+.|.+|+.++++-+|.||+-++|++..++. .+|+.+|+|.+|+.++.- ..+|...+...|++|+++|+.|||.
T Consensus       428 t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA  506 (678)
T KOG0193|consen  428 TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA  506 (678)
T ss_pred             CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh
Confidence            46778999999999999999999999999999887 999999999999999853 3569999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccc---cCCCCccccccCCccccCcccccc---cCCCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT---LYPGNYAEKVCGSPLYMAPEVLQF---QRYDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~---~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Diwsl  154 (154)
                      ++|+|+|||..|||+   .+++.+||.|||++..   +..........|+..|||||++..   .+|+..+|||||
T Consensus       507 K~IIHrDLKSnNIFl---~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaF  579 (678)
T KOG0193|consen  507 KNIIHRDLKSNNIFL---HEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAF  579 (678)
T ss_pred             hhhhhhhccccceEE---ccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhh
Confidence            999999999999999   6779999999999853   222234455677888999999873   379999999997

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=5.7e-30  Score=178.18  Aligned_cols=143  Identities=23%  Similarity=0.317  Sum_probs=120.3

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+.+++.++||||+++++++.+++..+++|||+++++|..++.+ .+.+++..+..++.|++.|++|||++++
T Consensus        59 ~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  138 (274)
T cd05076          59 IALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNL  138 (274)
T ss_pred             HHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCc
Confidence            346788899999999999999999999999999999999999999998865 4568999999999999999999999999


Q ss_pred             eeecCCCCcEEeecC----CCCeeEEEeecccccccCCCCccccccCCccccCcccccc-cCCCcccceecC
Q 031702           88 IHRDLKPENILLSGL----DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~----~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++...    .....++++|||.+......   ....++..|+|||.+.+ ..++.++|+|||
T Consensus       139 iH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~sl  207 (274)
T cd05076         139 VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSF  207 (274)
T ss_pred             cCCCCCcccEEEeccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHH
Confidence            999999999999531    12345899999987543222   22346778999998865 468899999996

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.97  E-value=2.3e-30  Score=181.19  Aligned_cols=141  Identities=35%  Similarity=0.529  Sum_probs=119.2

Q ss_pred             HHhHHHHHHHHhhC---CCCccchhhhhee-----cCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHH
Q 031702           10 KSCLDCELNFLSSV---NHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGL   79 (154)
Q Consensus        10 ~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l   79 (154)
                      ...+.+|+.+++.+   +||||+++++++.     ....+++++||++ ++|.+++...  ..+++..+..++.|++.|+
T Consensus        45 ~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL  123 (290)
T cd07862          45 PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGL  123 (290)
T ss_pred             hHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHH
Confidence            34566777777766   6999999999875     3456899999996 5899888654  3489999999999999999


Q ss_pred             HHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        80 ~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .|||+.+++|+||||+||++   +..+.+||+|||++.............+++.|+|||++.+..++.++|||||
T Consensus       124 ~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  195 (290)
T cd07862         124 DFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSV  195 (290)
T ss_pred             HHHHHCCeeeCCCCHHHEEE---cCCCCEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHH
Confidence            99999999999999999999   6778899999999876655444455678999999999988889999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=1.3e-30  Score=192.20  Aligned_cols=141  Identities=23%  Similarity=0.363  Sum_probs=122.7

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ...+.+|++++++++|+||+++++++..++..++++|++. ++|.+++... ..+++..++.++.|++.||.|||+.+++
T Consensus       204 ~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIv  282 (461)
T PHA03211        204 YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGII  282 (461)
T ss_pred             ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence            3456789999999999999999999999999999999995 6888887654 4699999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||||+||++   +..+.++|+|||++.......   ......||..|+|||++.+..++.++|||||
T Consensus       283 HrDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSl  348 (461)
T PHA03211        283 HRDIKTENVLV---NGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSA  348 (461)
T ss_pred             ECcCCHHHEEE---CCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHH
Confidence            99999999999   677789999999987653322   1223568999999999998899999999996

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.97  E-value=4.8e-30  Score=180.81  Aligned_cols=144  Identities=29%  Similarity=0.467  Sum_probs=123.6

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC----------------CCCHHHHHH
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK   70 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----------------~~~~~~~~~   70 (154)
                      ...+.+.+|+.+++.+ +||||+++++.+...+..++++||+++++|.+++.+..                .++...+..
T Consensus        62 ~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  141 (304)
T cd05101          62 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS  141 (304)
T ss_pred             HHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHH
Confidence            4456789999999999 89999999999999999999999999999999987542                367788999


Q ss_pred             HHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCc
Q 031702           71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE  147 (154)
Q Consensus        71 ~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~  147 (154)
                      ++.|++.|+.|||+.|++|+||+|+||++   +..+.++|+|||.+........   .....+++.|+|||++.+..++.
T Consensus       142 ~~~qi~~al~~LH~~givH~dlkp~Nili---~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  218 (304)
T cd05101         142 CTYQVARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTH  218 (304)
T ss_pred             HHHHHHHHHHHHHHCCeeecccccceEEE---cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCc
Confidence            99999999999999999999999999999   5678899999999876643321   22233456799999998888999


Q ss_pred             ccceecC
Q 031702          148 KVNFFVS  154 (154)
Q Consensus       148 ~~Diwsl  154 (154)
                      ++|||||
T Consensus       219 ~~Di~sl  225 (304)
T cd05101         219 QSDVWSF  225 (304)
T ss_pred             hhhHHHH
Confidence            9999996

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.97  E-value=5.1e-30  Score=176.35  Aligned_cols=143  Identities=29%  Similarity=0.499  Sum_probs=127.8

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc---------CCCCHHHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---------GRVPEQTARKFLQQLGAGL   79 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~i~~~l   79 (154)
                      ..+.+.+|+..++.++|+|++++++++.++...++++||+++++|.+++...         ..+++..+..++.|++.|+
T Consensus        39 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al  118 (262)
T cd00192          39 ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM  118 (262)
T ss_pred             HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHH
Confidence            3678899999999999999999999999999999999999999999999875         6799999999999999999


Q ss_pred             HHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCCCcccceecC
Q 031702           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        80 ~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .+||+++++|+||+|+||++   +..+.++|+|||.+.......   ......++..|+|||......++.++|+|||
T Consensus       119 ~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  193 (262)
T cd00192         119 EYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSF  193 (262)
T ss_pred             HHHHcCCcccCccCcceEEE---CCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHH
Confidence            99999999999999999999   677899999999987765432   2333456788999999988889999999996

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.97  E-value=3.3e-30  Score=199.65  Aligned_cols=144  Identities=24%  Similarity=0.364  Sum_probs=123.1

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-----------CCCCHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPEQTARKFLQQLG   76 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~~i~   76 (154)
                      ...+.+.+|+.+++.++|||++++++++.+++..+++|||++|++|.+++...           ...+...+..++.|++
T Consensus        44 ~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa  123 (932)
T PRK13184         44 LLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC  123 (932)
T ss_pred             HHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHH
Confidence            34677899999999999999999999999999999999999999999988642           1245567889999999


Q ss_pred             HHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCC-------------------CccccccCCccccCc
Q 031702           77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-------------------NYAEKVCGSPLYMAP  137 (154)
Q Consensus        77 ~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-------------------~~~~~~~~~~~y~aP  137 (154)
                      .|++|||+.|++||||||+||++   +..+.++|+|||++......                   .......||+.|+||
T Consensus       124 ~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAP  200 (932)
T PRK13184        124 ATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAP  200 (932)
T ss_pred             HHHHHHHHCCccccCCchheEEE---cCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCH
Confidence            99999999999999999999999   67788999999998765211                   011124689999999


Q ss_pred             ccccccCCCcccceecC
Q 031702          138 EVLQFQRYDEKVNFFVS  154 (154)
Q Consensus       138 E~~~~~~~~~~~Diwsl  154 (154)
                      |++.+..++.++|||||
T Consensus       201 E~l~g~~~S~kSDIWSL  217 (932)
T PRK13184        201 ERLLGVPASESTDIYAL  217 (932)
T ss_pred             HHhcCCCCCcHhHHHHH
Confidence            99998899999999996

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=5e-30  Score=177.37  Aligned_cols=144  Identities=18%  Similarity=0.279  Sum_probs=120.4

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      .....+.+|+.+++.++||||+++++++.++...++++||+++++|..++... ..+++..+..++.|++.|++|||+.+
T Consensus        46 ~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  125 (262)
T cd05077          46 DISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD  125 (262)
T ss_pred             hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC
Confidence            34457888999999999999999999999998999999999999999888654 56899999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCC----CCeeEEEeecccccccCCCCccccccCCccccCccccc-ccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLD----DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~----~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++....    ....++++|||.+......   ....++..|+|||.+. +..++.++|||||
T Consensus       126 ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  195 (262)
T cd05077         126 LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSF  195 (262)
T ss_pred             eECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHH
Confidence            99999999999995311    1224899999988654322   2234677899999986 4568899999996

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.97  E-value=2.2e-30  Score=178.50  Aligned_cols=142  Identities=25%  Similarity=0.463  Sum_probs=123.4

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      .+.+.+|+.++++++||||+++++++.+....+++|||+++++|.+++... ..+++..++.++.|++.|++|||+.+++
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  122 (256)
T cd05113          43 EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI  122 (256)
T ss_pred             HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            467899999999999999999999999888999999999999999998764 3689999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc--ccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||+|.||++   +..+.+||+|||.+.........  ....++..|+|||...+..++.++|+|||
T Consensus       123 H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~sl  187 (256)
T cd05113         123 HRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAF  187 (256)
T ss_pred             ccccCcceEEE---cCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHH
Confidence            99999999999   66778999999988765433221  12234567999999988889999999996

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.3e-30  Score=178.33  Aligned_cols=142  Identities=26%  Similarity=0.493  Sum_probs=122.4

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      .+.+.+|+.+++.++|||++++++++.+.+..++++||+++++|.+++... ..+++..+..++.|++.|+.|||+.+++
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~  122 (256)
T cd05059          43 EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI  122 (256)
T ss_pred             HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            457888999999999999999999999999999999999999999998754 4689999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc--ccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||+|+||++   +..+.+||+|||.+.........  ....++..|+|||.+.+..++.++|+|||
T Consensus       123 H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~sl  187 (256)
T cd05059         123 HRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSF  187 (256)
T ss_pred             cccccHhhEEE---CCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHH
Confidence            99999999999   67788999999988765433211  11123346999999998889999999996

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.97  E-value=2.1e-30  Score=186.21  Aligned_cols=140  Identities=30%  Similarity=0.496  Sum_probs=118.5

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++|+||+++++++...+.+++++||+.+++|.+.    ....+..+..++.|++.|++|||+.++
T Consensus       114 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~i  189 (353)
T PLN00034        114 TVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHI  189 (353)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            4467889999999999999999999999999999999999999998653    335678888999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCccccccc-----CCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-----RYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Diwsl  154 (154)
                      +|+||||+||++   +..+.+||+|||++...... .......|+..|+|||++...     ..+.++|||||
T Consensus       190 vHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dvwsl  259 (353)
T PLN00034        190 VHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSL  259 (353)
T ss_pred             eecCCCHHHEEE---cCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHH
Confidence            999999999999   67789999999998765432 223445789999999987432     23468999996

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.97  E-value=5.9e-30  Score=176.37  Aligned_cols=143  Identities=27%  Similarity=0.451  Sum_probs=122.7

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++||||+++++.+.. ...++++||+++++|.+++.....+++..+..++.|++.|++++|++++
T Consensus        38 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i  116 (257)
T cd05116          38 ALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF  116 (257)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            456788999999999999999999988754 4578999999999999999877889999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc----cccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|.||++   +..+.++|+|||.+........    .....++..|+|||.+....++.++|+|||
T Consensus       117 ~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  184 (257)
T cd05116         117 VHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSF  184 (257)
T ss_pred             eecccchhhEEE---cCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHH
Confidence            999999999999   5678899999999876543321    111223467999999988889999999996

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.97  E-value=2.5e-30  Score=186.41  Aligned_cols=141  Identities=33%  Similarity=0.476  Sum_probs=120.4

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecC------CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~   81 (154)
                      ...+.+.+|+.+++.++||||+++++++...      ..+|++|||+++ +|.+.+.  ..++...+..++.|++.|+.|
T Consensus        65 ~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~  141 (364)
T cd07875          65 THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKH  141 (364)
T ss_pred             hhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHH
Confidence            3456778899999999999999999987543      357999999965 7777664  358889999999999999999


Q ss_pred             HHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        82 lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ||+++++|+||||+||++   +..+.+||+|||++.............+++.|+|||++.+..++.++|||||
T Consensus       142 LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl  211 (364)
T cd07875         142 LHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV  211 (364)
T ss_pred             HhhCCeecCCCCHHHEEE---CCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhH
Confidence            999999999999999999   6778899999999976654444445578899999999998899999999996

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=5.3e-30  Score=179.87  Aligned_cols=144  Identities=25%  Similarity=0.472  Sum_probs=123.3

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC------------CCCHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------RVPEQTARKFLQQL   75 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~i   75 (154)
                      ...+.+.+|+++++.++|+|++++++.+...+..+++|||+++++|.+++....            .++...+..++.|+
T Consensus        59 ~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i  138 (295)
T cd05097          59 TARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQI  138 (295)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHH
Confidence            345678999999999999999999999999999999999999999999986432            36788899999999


Q ss_pred             HHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCccccee
Q 031702           76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFF  152 (154)
Q Consensus        76 ~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diw  152 (154)
                      +.|++|||+.+++|+||+|+||++   +..+.+||+|||++........   .....++..|+|||...++.++.++|+|
T Consensus       139 ~~al~~lH~~~i~H~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw  215 (295)
T cd05097         139 ASGMKYLASLNFVHRDLATRNCLV---GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVW  215 (295)
T ss_pred             HHHHHHHHhcCeeccccChhhEEE---cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHH
Confidence            999999999999999999999999   5677899999999876543321   1223346679999999888899999999


Q ss_pred             cC
Q 031702          153 VS  154 (154)
Q Consensus       153 sl  154 (154)
                      ||
T Consensus       216 Sl  217 (295)
T cd05097         216 AF  217 (295)
T ss_pred             HH
Confidence            96

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.5e-31  Score=193.49  Aligned_cols=139  Identities=33%  Similarity=0.542  Sum_probs=124.2

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      .=.++..|+..|+.+.|||.+.+.++|-.....++|||||- |+-.+++.- ..++.+..+..++.+.+.|++|||+.+.
T Consensus        69 KWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~  147 (948)
T KOG0577|consen   69 KWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNR  147 (948)
T ss_pred             HHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhH
Confidence            34678899999999999999999999998888999999995 588887754 4579999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCccccc---ccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Diwsl  154 (154)
                      +|||||..||++   ...+.+||+|||.|...   .+..+..|||.|||||++.   .+.|+-++|||||
T Consensus       148 IHRDiKAGNILL---se~g~VKLaDFGSAsi~---~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSL  211 (948)
T KOG0577|consen  148 IHRDIKAGNILL---SEPGLVKLADFGSASIM---APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL  211 (948)
T ss_pred             HhhhccccceEe---cCCCeeeeccccchhhc---CchhcccCCccccchhHheeccccccCCccceeec
Confidence            999999999999   78999999999988654   3456788999999999975   5689999999997

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.97  E-value=5.4e-30  Score=177.16  Aligned_cols=143  Identities=30%  Similarity=0.523  Sum_probs=126.9

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+++++.++|+|++++.+++.+.+..++++||+++++|.+++.+...+++..+..++.|++.|+++||+.+++
T Consensus        45 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  124 (265)
T cd06631          45 EYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVV  124 (265)
T ss_pred             HHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            34678999999999999999999999999999999999999999999998878899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCC-------CccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-------NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||+|+||++   +..+.++|+|||.+......       .......++..|+|||...+..++.++|+|||
T Consensus       125 H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~sl  194 (265)
T cd06631         125 HRDIKGNNVML---MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSI  194 (265)
T ss_pred             cCCcCHHhEEE---CCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHH
Confidence            99999999999   67889999999988654221       11223457888999999998889999999996

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.97  E-value=4.6e-30  Score=176.44  Aligned_cols=142  Identities=31%  Similarity=0.561  Sum_probs=126.9

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      .+.+.+|+++++.++|+|++++.+.+.++...|+++||+++++|.+++.. ...+++..+..++.|++.|+.|||+.+++
T Consensus        42 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~  121 (256)
T cd06612          42 LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKI  121 (256)
T ss_pred             HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            67899999999999999999999999999999999999999999999875 34689999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+|++|.||++   +..+.++|+|||++....... ......++..|+|||++.+..++.++|||||
T Consensus       122 H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~  185 (256)
T cd06612         122 HRDIKAGNILL---NEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSL  185 (256)
T ss_pred             cCCCCcceEEE---CCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHH
Confidence            99999999999   567789999999987665433 2334457888999999988889999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.97  E-value=4.9e-30  Score=181.65  Aligned_cols=144  Identities=27%  Similarity=0.479  Sum_probs=118.2

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheec--CCcEEEEEEecCCCCchHHHHHc---------CCCCHHHHHHHHHHHHHH
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH---------GRVPEQTARKFLQQLGAG   78 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~i~~~   78 (154)
                      ...+.+|+.+++.++||||+++++.+..  +..+++++||++ ++|.+++...         ..+++..+..++.|++.|
T Consensus        42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a  120 (317)
T cd07868          42 SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG  120 (317)
T ss_pred             cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHH
Confidence            4567889999999999999999998854  456899999985 5888877532         248899999999999999


Q ss_pred             HHHHHhCCceeecCCCCcEEeecC-CCCeeEEEeecccccccCCCC----ccccccCCccccCccccccc-CCCccccee
Q 031702           79 LEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFF  152 (154)
Q Consensus        79 l~~lh~~~~~h~~i~p~nil~~~~-~~~~~~kl~df~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~Diw  152 (154)
                      +.|||+++++|+||||+||++... +..+.+||+|||++.......    ......+|+.|+|||++.+. .++.++|||
T Consensus       121 l~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  200 (317)
T cd07868         121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW  200 (317)
T ss_pred             HHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHH
Confidence            999999999999999999999542 355789999999997654322    12345678999999998764 588999999


Q ss_pred             cC
Q 031702          153 VS  154 (154)
Q Consensus       153 sl  154 (154)
                      ||
T Consensus       201 sl  202 (317)
T cd07868         201 AI  202 (317)
T ss_pred             HH
Confidence            96

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.97  E-value=3.9e-30  Score=178.27  Aligned_cols=144  Identities=26%  Similarity=0.450  Sum_probs=119.6

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-----CCCHHHHHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----RVPEQTARKFLQQLGAGLEIL   82 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~l   82 (154)
                      .....+.+|+.+++.++||||+++++.+.+....+++|||+++++|.+++....     ..++..+..++.|++.|++||
T Consensus        37 ~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l  116 (269)
T cd05042          37 DEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL  116 (269)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHH
Confidence            345678899999999999999999999999999999999999999999987643     246778899999999999999


Q ss_pred             HhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccc-------cCCCccccee
Q 031702           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQF-------QRYDEKVNFF  152 (154)
Q Consensus        83 h~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-------~~~~~~~Diw  152 (154)
                      |+.+++|+||||+||++   +..+.+|++|||++........   .....++..|+|||+...       ..++.++|||
T Consensus       117 H~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diw  193 (269)
T cd05042         117 HQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIW  193 (269)
T ss_pred             HhcCEecccccHhheEe---cCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHH
Confidence            99999999999999999   6788899999999865433221   122334567999999743       3567899999


Q ss_pred             cC
Q 031702          153 VS  154 (154)
Q Consensus       153 sl  154 (154)
                      ||
T Consensus       194 sl  195 (269)
T cd05042         194 SL  195 (269)
T ss_pred             HH
Confidence            96

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.97  E-value=8.1e-30  Score=176.36  Aligned_cols=144  Identities=32%  Similarity=0.551  Sum_probs=126.4

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++|+|++++++.+.+++..++++||+++++|.+++.+.+.+++..+..++.|++.|+.+||+++++
T Consensus        46 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~  125 (268)
T cd06630          46 VVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQII  125 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            45788999999999999999999999999999999999999999999998888899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCC-----ccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||+|.||++.  .....++|+|||.+.......     ......++..|+|||...+..++.++|+|||
T Consensus       126 H~~i~~~nil~~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~sl  194 (268)
T cd06630         126 HRDVKGANLLID--STGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSV  194 (268)
T ss_pred             cCCCCHHHEEEc--CCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHH
Confidence            999999999993  233468999999987654332     1223457888999999988889999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.97  E-value=8.5e-30  Score=178.51  Aligned_cols=144  Identities=31%  Similarity=0.498  Sum_probs=123.3

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc----------------CCCCHHHHHH
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARK   70 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----------------~~~~~~~~~~   70 (154)
                      .....+.+|+.+++.+ +|+|++++++++..++.++++|||+++++|.+++...                ..+++..+..
T Consensus        57 ~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  136 (293)
T cd05053          57 KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS  136 (293)
T ss_pred             HHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHH
Confidence            3446688999999999 8999999999999999999999999999999998642                3578899999


Q ss_pred             HHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCc
Q 031702           71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE  147 (154)
Q Consensus        71 ~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~  147 (154)
                      ++.|++.|+.|||+.+++|+||+|+||++   +..+.++|+|||++........   .....++..|+|||...+..++.
T Consensus       137 i~~qi~~al~~LH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  213 (293)
T cd05053         137 FAYQVARGMEFLASKKCIHRDLAARNVLV---TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTH  213 (293)
T ss_pred             HHHHHHHHHHHHHHCCccccccceeeEEE---cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCc
Confidence            99999999999999999999999999999   5778899999999876543321   11223456799999998888999


Q ss_pred             ccceecC
Q 031702          148 KVNFFVS  154 (154)
Q Consensus       148 ~~Diwsl  154 (154)
                      ++|||||
T Consensus       214 ~~Di~sl  220 (293)
T cd05053         214 QSDVWSF  220 (293)
T ss_pred             ccceeeh
Confidence            9999997

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.97  E-value=7.7e-30  Score=175.63  Aligned_cols=142  Identities=24%  Similarity=0.492  Sum_probs=123.2

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      .+.+.+|+.+++.++||||+++++++.+....+++|||+++++|.+++... ..+++..+..++.|++.|++|||+.+++
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  122 (256)
T cd05114          43 EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI  122 (256)
T ss_pred             HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            467889999999999999999999999999999999999999999998653 4689999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc--ccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||+|+||++   +..+.++++|||.+.........  ....++..|+|||...+..++.++|+|||
T Consensus       123 H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~  187 (256)
T cd05114         123 HRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSF  187 (256)
T ss_pred             ccccCcceEEE---cCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHH
Confidence            99999999999   66778999999988765433221  12234557999999988889999999996

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.97  E-value=6.9e-30  Score=176.57  Aligned_cols=142  Identities=26%  Similarity=0.448  Sum_probs=123.4

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      .+.+.+|+.+++.++|+|++++++++...+.+++++||+++++|.+++....  .+++..++.++.|++.+++|||+.++
T Consensus        46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i  125 (263)
T cd05052          46 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF  125 (263)
T ss_pred             HHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            4678899999999999999999999999999999999999999999986543  58899999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccc--cccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.+||+|||.+..........  ....+..|+|||...+..++.++|||||
T Consensus       126 ~H~dlkp~nil~---~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  191 (263)
T cd05052         126 IHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF  191 (263)
T ss_pred             eecccCcceEEE---cCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHH
Confidence            999999999999   677889999999987654432221  1223557999999988889999999996

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.97  E-value=5e-30  Score=176.94  Aligned_cols=143  Identities=27%  Similarity=0.501  Sum_probs=124.1

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ..+.+.+|+.+++.++|+|++++++.+.+++..++++||+++++|.+++.+.  ..++...+..++.|++.|++|||+.+
T Consensus        44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~  123 (261)
T cd05072          44 SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN  123 (261)
T ss_pred             hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3578899999999999999999999999999999999999999999998653  45888999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--cccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.++|+|||.+........  .....++..|+|||......++.++|+|||
T Consensus       124 i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  190 (261)
T cd05072         124 YIHRDLRAANVLV---SESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF  190 (261)
T ss_pred             eeccccchhhEEe---cCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhh
Confidence            9999999999999   6778899999999876543221  122234567999999988889999999996

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.97  E-value=1.4e-30  Score=191.86  Aligned_cols=141  Identities=29%  Similarity=0.457  Sum_probs=115.9

Q ss_pred             HhHHHHHHHHhhCCCCccchhhhheecC--------CcEEEEEEecCCCCchHHHH----HcCCCCHHHHHHHHHHHHHH
Q 031702           11 SCLDCELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKFLQQLGAG   78 (154)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~~v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~   78 (154)
                      ....+|+.+++.++||||+++.+++...        ..++++|||+++ ++.+++.    ....+++..++.++.|++.|
T Consensus       104 ~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~g  182 (440)
T PTZ00036        104 QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRA  182 (440)
T ss_pred             chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHH
Confidence            3456799999999999999998876332        247799999965 7766654    34568999999999999999


Q ss_pred             HHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCccccccc-CCCcccceecC
Q 031702           79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        79 l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      ++|||+.+++||||||+||++.  .....+||+|||++.............+|+.|+|||++.+. .|+.++|||||
T Consensus       183 L~yLH~~~IiHrDLKp~NILl~--~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl  257 (440)
T PTZ00036        183 LAYIHSKFICHRDLKPQNLLID--PNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSL  257 (440)
T ss_pred             HHHHHHCCEecCCcCHHHEEEc--CCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHH
Confidence            9999999999999999999993  23457999999999876555545556789999999998654 68999999996

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-30  Score=191.28  Aligned_cols=151  Identities=27%  Similarity=0.463  Sum_probs=132.7

Q ss_pred             Chhhhhhh--hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCC--CCHHHHHHHHHHHH
Q 031702            1 MLKKLNKH--LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLG   76 (154)
Q Consensus         1 ~~k~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~   76 (154)
                      ++|.+++.  ..+.|..|+.+|+.++|||+|+++++|..+..+|+|+|||.+|+|.+|+++..+  ++.-..+.++.||.
T Consensus       296 AVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIs  375 (1157)
T KOG4278|consen  296 AVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQIS  375 (1157)
T ss_pred             ehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHH
Confidence            35666654  368899999999999999999999999999999999999999999999987654  77778889999999


Q ss_pred             HHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcccc--ccCCccccCcccccccCCCcccceecC
Q 031702           77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        77 ~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~--~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .|++||..++++||||...|+++   .++..+|++|||+++.+..++....  ..-...|.|||-+....++.++|+|+|
T Consensus       376 SaMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAF  452 (1157)
T KOG4278|consen  376 SAMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAF  452 (1157)
T ss_pred             HHHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHH
Confidence            99999999999999999999999   6888999999999998877654432  222455999999999999999999997

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.97  E-value=6e-30  Score=178.13  Aligned_cols=142  Identities=38%  Similarity=0.536  Sum_probs=125.6

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      .+.+.+|+.+++.++|||++++.+++...+..|+++||+++++|.+++.+..  .+++..+..++.|++.|+.|||+.++
T Consensus        37 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i  116 (277)
T cd05577          37 EQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI  116 (277)
T ss_pred             hHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            4556789999999999999999999999999999999999999999987665  69999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||.+.............++..|+|||...+..++.++|+|||
T Consensus       117 ~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  180 (277)
T cd05577         117 VYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFAL  180 (277)
T ss_pred             ccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHH
Confidence            999999999999   6777899999998876544333344556788999999988889999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.97  E-value=7.2e-30  Score=178.16  Aligned_cols=144  Identities=24%  Similarity=0.502  Sum_probs=123.2

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-----------------CCCCHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------------GRVPEQTARK   70 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-----------------~~~~~~~~~~   70 (154)
                      ...+.+.+|+.+++.++|||++++++.+..+...|++|||+++++|.+++...                 ..+++..+..
T Consensus        49 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  128 (283)
T cd05090          49 QQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH  128 (283)
T ss_pred             HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHH
Confidence            33467889999999999999999999999999999999999999999998532                 2367888999


Q ss_pred             HHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCc
Q 031702           71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE  147 (154)
Q Consensus        71 ~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~  147 (154)
                      ++.|++.|+.|||+++++|+||+|+||++   +....++|+|||++........   .....++..|+|||++.+..++.
T Consensus       129 i~~~i~~al~~lH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  205 (283)
T cd05090         129 IAIQIAAGMEYLSSHFFVHKDLAARNILI---GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSS  205 (283)
T ss_pred             HHHHHHHHHHHHHhcCeehhccccceEEE---cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCc
Confidence            99999999999999999999999999999   5677899999999876543321   22233456799999998888999


Q ss_pred             ccceecC
Q 031702          148 KVNFFVS  154 (154)
Q Consensus       148 ~~Diwsl  154 (154)
                      ++|+|||
T Consensus       206 ~~Dv~sl  212 (283)
T cd05090         206 DSDIWSF  212 (283)
T ss_pred             hhhhHHH
Confidence            9999996

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.97  E-value=4.1e-30  Score=182.93  Aligned_cols=144  Identities=25%  Similarity=0.384  Sum_probs=120.8

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ...+.+.+|+.+++.++||||+++++++.+++..++++||+++++|.+++..+  ..+++..+..++.|++.|++|||+.
T Consensus        41 ~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~  120 (327)
T cd08227          41 EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM  120 (327)
T ss_pred             HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            34567888999999999999999999999999999999999999999998653  4589999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--------ccccccCCccccCcccccc--cCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQF--QRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~--~~~~~~~Diwsl  154 (154)
                      +++|+||||+||++   +..+.+++.||+.........        ......++..|+|||++.+  ..++.++|||||
T Consensus       121 ~iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diwsl  196 (327)
T cd08227         121 GYVHRSVKASHILI---SVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV  196 (327)
T ss_pred             CEecCCCChhhEEE---ecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHH
Confidence            99999999999999   567789999997654332111        1122345677999999875  358899999996

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.97  E-value=1.1e-29  Score=174.73  Aligned_cols=144  Identities=29%  Similarity=0.589  Sum_probs=126.4

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ...+.+.+|+.+++.++|+|++++.+.+.+++.+++++||+++++|.+++...  ..+++..+..++.|++.|+.+||+.
T Consensus        40 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~  119 (255)
T cd08219          40 SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK  119 (255)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence            45677889999999999999999999999999999999999999999988643  3588999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||+|+||++   +..+.++++|||.+....... ......+++.|+|||++.+..++.++|+|||
T Consensus       120 ~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~sl  186 (255)
T cd08219         120 RVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSL  186 (255)
T ss_pred             CcccCCCCcceEEE---CCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhh
Confidence            99999999999999   677889999999987654322 2334567888999999988889999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.97  E-value=6.2e-30  Score=178.05  Aligned_cols=147  Identities=27%  Similarity=0.405  Sum_probs=123.8

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-------CCCHHHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------RVPEQTARKFLQQLGAGLE   80 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~i~~~l~   80 (154)
                      .....+.+|+.+++.++|+||+++++++.+.+..++++||+++++|.+++....       .+++..+..++.|++.|++
T Consensus        51 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~  130 (277)
T cd05036          51 QDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK  130 (277)
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHH
Confidence            345678899999999999999999999999989999999999999999987553       4888999999999999999


Q ss_pred             HHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCcccceecC
Q 031702           81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        81 ~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |||+.+++|+||+|+||++........+||+|||++........   ......+..|+|||++.+..++.++|||||
T Consensus       131 ~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  207 (277)
T cd05036         131 YLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSF  207 (277)
T ss_pred             HHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHH
Confidence            99999999999999999996433455789999999876533221   112223457999999988889999999996

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.97  E-value=9.9e-30  Score=176.23  Aligned_cols=145  Identities=24%  Similarity=0.454  Sum_probs=124.1

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      +...+.+..|+.+++.++|||++++.+.+.++...++++||+++++|.+++... +.++..++..++.|++.|++|||+.
T Consensus        46 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~  125 (269)
T cd05065          46 EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM  125 (269)
T ss_pred             HHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            445678999999999999999999999999999999999999999999998754 4589999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcccc---cc---CCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VC---GSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~---~~---~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||+|+||++   +....++++|||.+...........   ..   .+..|+|||...+..++.++|+|||
T Consensus       126 g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dvwsl  197 (269)
T cd05065         126 NYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSY  197 (269)
T ss_pred             CEeecccChheEEE---cCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhh
Confidence            99999999999999   6778899999998865433221111   11   1346999999998899999999996

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.97  E-value=4.2e-30  Score=176.91  Aligned_cols=140  Identities=38%  Similarity=0.666  Sum_probs=125.7

Q ss_pred             hHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCceeec
Q 031702           12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRD   91 (154)
Q Consensus        12 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~~   91 (154)
                      ...+|+.+++.++||||+++.+++......+++||++++++|.+++.....++...+..++.|++.|+.+||+.+++|+|
T Consensus        44 ~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~d  123 (260)
T PF00069_consen   44 ENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRD  123 (260)
T ss_dssp             HHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESS
T ss_pred             hhhhhhhccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            44559999999999999999999999999999999999999999999888999999999999999999999999999999


Q ss_pred             CCCCcEEeecCCCCeeEEEeeccccccc-CCCCccccccCCccccCccccc-ccCCCcccceecC
Q 031702           92 LKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVNFFVS  154 (154)
Q Consensus        92 i~p~nil~~~~~~~~~~kl~df~~~~~~-~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Diwsl  154 (154)
                      |+|+||++   +..+.++|+|||.+... ..........+++.|+|||+.. +..++.++|+|||
T Consensus       124 ikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl  185 (260)
T PF00069_consen  124 IKPENILL---DENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSL  185 (260)
T ss_dssp             BSGGGEEE---STTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHH
T ss_pred             cccccccc---cccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999   67889999999998753 2233444567788999999998 7788999999995

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.97  E-value=5.7e-30  Score=181.37  Aligned_cols=144  Identities=24%  Similarity=0.355  Sum_probs=122.8

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ....+.+.+|+.+++.++||||+++++.+... ..++++||+++|+|.+++.... .++...+..++.|++.|++|||+.
T Consensus        50 ~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~  128 (316)
T cd05108          50 PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER  128 (316)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc
Confidence            34567888999999999999999999998765 4678999999999999997644 588999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc---ccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||||+||++   +..+.+||+|||++.........   ....++..|+|||.+.+..++.++|||||
T Consensus       129 ~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl  197 (316)
T cd05108         129 RLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY  197 (316)
T ss_pred             CeeccccchhheEe---cCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHH
Confidence            99999999999999   56778999999999866543322   22233567999999998899999999996

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.97  E-value=7.2e-30  Score=179.91  Aligned_cols=144  Identities=28%  Similarity=0.445  Sum_probs=124.4

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ...+.+.+|+.+++++ +||||+++++.+...+..++++||+++++|.+++....  .+++.++..++.|++.|++|||+
T Consensus        80 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~  159 (302)
T cd05055          80 SEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS  159 (302)
T ss_pred             HHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3456789999999999 79999999999999999999999999999999987543  38999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++++|+||+|+||++   +....++++|||++........   .....++..|+|||.+.+..++.++|||||
T Consensus       160 ~~ivH~dlkp~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  229 (302)
T cd05055         160 KNCIHRDLAARNVLL---THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY  229 (302)
T ss_pred             CCeehhhhccceEEE---cCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHH
Confidence            999999999999999   5777899999999876543321   122334677999999998889999999996

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.97  E-value=4.9e-30  Score=177.43  Aligned_cols=145  Identities=30%  Similarity=0.575  Sum_probs=125.6

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH----cCCCCHHHHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEIL   82 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~l   82 (154)
                      ......+.+|+.+++.++|||++++++.+.+.+..++++||+++++|.+++..    ...+++..+..++.|++.|+.||
T Consensus        43 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L  122 (267)
T cd08228          43 AKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM  122 (267)
T ss_pred             HHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            34456788999999999999999999999999999999999999999988753    23488999999999999999999


Q ss_pred             HhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc-cccccCCccccCcccccccCCCcccceecC
Q 031702           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        83 h~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+++++|+||+|+||++   +..+.++++|||.+........ .....+++.|+|||.+.+..++.++|+|||
T Consensus       123 H~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~sl  192 (267)
T cd08228         123 HSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSL  192 (267)
T ss_pred             hhCCeeCCCCCHHHEEE---cCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHH
Confidence            99999999999999999   5677899999998876544322 233467888999999988888999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=1e-29  Score=177.39  Aligned_cols=142  Identities=28%  Similarity=0.444  Sum_probs=121.2

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecC--CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ..+.+.+|+++++.++|||++++.+++...  ...+++|||+++++|.+++.. ..+++.++..++.|++.|+.|||+.+
T Consensus        49 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~  127 (283)
T cd05080          49 NTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQH  127 (283)
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            457788999999999999999999987653  468999999999999999875 45999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc----cccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.++|+|||++........    .....++..|+|||...+..++.++|||||
T Consensus       128 i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~sl  196 (283)
T cd05080         128 YIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSF  196 (283)
T ss_pred             eeccccChheEEE---cCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHH
Confidence            9999999999999   5678899999999876543221    122334566999999988889999999996

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.97  E-value=1e-29  Score=175.87  Aligned_cols=143  Identities=29%  Similarity=0.526  Sum_probs=124.2

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecC--CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ..+.+.+|+.+++.++|||++++++.+.++  ..+++++||+++++|.+++.+...+++..+..++.|++.|+++||+.+
T Consensus        47 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~  126 (265)
T cd06652          47 EVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM  126 (265)
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            356888999999999999999999988764  468899999999999999987778899999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC----ccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.++|+|||.+.......    ......++..|+|||+..+..++.++|+|||
T Consensus       127 i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  195 (265)
T cd06652         127 IVHRDIKGANILR---DSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSV  195 (265)
T ss_pred             EecCCCCHHHEEe---cCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHH
Confidence            9999999999999   677889999999887543211    1233457888999999988888999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.97  E-value=1.1e-29  Score=179.79  Aligned_cols=144  Identities=29%  Similarity=0.461  Sum_probs=122.3

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc----------------CCCCHHHHHH
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARK   70 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----------------~~~~~~~~~~   70 (154)
                      ...+.+.+|+.+++.+ +||||+++++++...+..++++||+++++|.+++...                ..++..++..
T Consensus        59 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  138 (314)
T cd05099          59 KDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS  138 (314)
T ss_pred             HHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHH
Confidence            3456788999999999 6999999999999999999999999999999999653                2378889999


Q ss_pred             HHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCc
Q 031702           71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE  147 (154)
Q Consensus        71 ~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~  147 (154)
                      ++.|++.|+.|||+.|++|+||+|+||++   +..+.+||+|||.+........   .....++..|+|||++.+..++.
T Consensus       139 ~~~qi~~aL~~lH~~gi~H~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  215 (314)
T cd05099         139 CAYQVARGMEYLESRRCIHRDLAARNVLV---TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTH  215 (314)
T ss_pred             HHHHHHHHHHHHHHCCeeeccccceeEEE---cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCc
Confidence            99999999999999999999999999999   5677899999999976543221   11122345699999998888999


Q ss_pred             ccceecC
Q 031702          148 KVNFFVS  154 (154)
Q Consensus       148 ~~Diwsl  154 (154)
                      ++|||||
T Consensus       216 ~~Diwsl  222 (314)
T cd05099         216 QSDVWSF  222 (314)
T ss_pred             cchhhHH
Confidence            9999996

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.97  E-value=1.3e-29  Score=175.76  Aligned_cols=144  Identities=21%  Similarity=0.382  Sum_probs=120.8

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      ...+.+.+|+.+++.++|||++++++.+.+....|++|||+++++|.+++.+.    ...+...+..++.|++.|++|||
T Consensus        37 ~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH  116 (268)
T cd05086          37 KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH  116 (268)
T ss_pred             HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence            45678999999999999999999999999999999999999999999998754    23567788899999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccc-------cCCCcccceec
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQF-------QRYDEKVNFFV  153 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-------~~~~~~~Diws  153 (154)
                      +.+++|+||+|+||++   +..+.++|+|||++.......   ......++..|+|||++..       ..++.++||||
T Consensus       117 ~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws  193 (268)
T cd05086         117 KHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWA  193 (268)
T ss_pred             HCCeeccCCccceEEE---cCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHH
Confidence            9999999999999999   677889999999875432221   2234567788999999753       23578899999


Q ss_pred             C
Q 031702          154 S  154 (154)
Q Consensus       154 l  154 (154)
                      |
T Consensus       194 l  194 (268)
T cd05086         194 L  194 (268)
T ss_pred             H
Confidence            6

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.97  E-value=1.4e-29  Score=175.19  Aligned_cols=144  Identities=30%  Similarity=0.574  Sum_probs=126.1

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      ...+.+.+|+.+++.++|||++++++.+.+++..++++||+++++|.+++..    ...+++..+..++.|++.|+.|||
T Consensus        44 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH  123 (267)
T cd08229          44 KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH  123 (267)
T ss_pred             HHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4456888999999999999999999999999999999999999999998863    345899999999999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +.+++|+||+|+||++   +..+.++++|||.+....... ......++..|+|||...+..++.++|+|||
T Consensus       124 ~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~sl  192 (267)
T cd08229         124 SRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSL  192 (267)
T ss_pred             HCCeecCCCCHHHEEE---cCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHH
Confidence            9999999999999999   677789999999887654332 2234567888999999988889999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.97  E-value=6.8e-30  Score=176.82  Aligned_cols=143  Identities=27%  Similarity=0.491  Sum_probs=125.2

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++|||++++++++..++..++++||+++++|.+++.....+++..+..++.|++.|+.|||+.+++
T Consensus        49 ~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  128 (267)
T cd06646          49 DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKM  128 (267)
T ss_pred             hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            34568889999999999999999999999999999999999999999998778899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCccccc---ccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ---FQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~---~~~~~~~~Diwsl  154 (154)
                      |+|++|+||++   +..+.++|+|||++....... ......+++.|+|||.+.   ...++.++|+|||
T Consensus       129 H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~  195 (267)
T cd06646         129 HRDIKGANILL---TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAV  195 (267)
T ss_pred             ccCCCHHHEEE---CCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHH
Confidence            99999999999   677789999999987654332 233456788999999974   3457889999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.96  E-value=2.1e-29  Score=175.73  Aligned_cols=144  Identities=35%  Similarity=0.564  Sum_probs=123.8

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|+.+++.++|||++++++.+...+..++++||+++++|..++.+ ...+++..+..++.|++.|+.|||+.+
T Consensus        44 ~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~  123 (282)
T cd06643          44 EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK  123 (282)
T ss_pred             HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4456788899999999999999999999999999999999999999987754 456899999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCccccc-----ccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.++++|||++...... .......+++.|+|||++.     +..++.++|+|||
T Consensus       124 i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl  194 (282)
T cd06643         124 IIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSL  194 (282)
T ss_pred             eeecCCCcccEEE---ccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhH
Confidence            9999999999999   67788999999998664332 2233456788999999984     3457889999996

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.96  E-value=1.1e-29  Score=174.63  Aligned_cols=143  Identities=32%  Similarity=0.596  Sum_probs=128.3

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+++++.++|+|++++.+.+.++...++++||+++++|.+++.+...+++..+..++.|++.|+++||+.+++
T Consensus        45 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  124 (258)
T cd06632          45 AVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTV  124 (258)
T ss_pred             HHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            45788999999999999999999999999999999999999999999998877899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccC-CCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diwsl  154 (154)
                      |+||+|+||++   +..+.+||+|||.+.............++..|+|||...... ++.++|+|||
T Consensus       125 H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~sl  188 (258)
T cd06632         125 HRDIKGANILV---DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSL  188 (258)
T ss_pred             cCCCCHHHEEE---CCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHH
Confidence            99999999999   677899999999987654444344566788899999987666 8999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.96  E-value=6.6e-30  Score=198.92  Aligned_cols=149  Identities=34%  Similarity=0.586  Sum_probs=124.3

Q ss_pred             hhhhHHhHHHHHHHHhhCCCCccchhhhheec--CCcEEEEEEecCCCCchHHHHHc----CCCCHHHHHHHHHHHHHHH
Q 031702            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGL   79 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l   79 (154)
                      .....+.+..|+.+++.++||||+++++.|..  ...+|++|||+++++|.+++...    ..+++..++.++.||+.||
T Consensus        52 ~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~AL  131 (1021)
T PTZ00266         52 KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL  131 (1021)
T ss_pred             CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHH
Confidence            34556788999999999999999999998854  35689999999999999988642    5699999999999999999


Q ss_pred             HHHHhC-------CceeecCCCCcEEeecC--------------CCCeeEEEeecccccccCCCCccccccCCccccCcc
Q 031702           80 EILNSH-------HIIHRDLKPENILLSGL--------------DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPE  138 (154)
Q Consensus        80 ~~lh~~-------~~~h~~i~p~nil~~~~--------------~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE  138 (154)
                      .|||..       +|+|+||||+||++...              +....+||+|||++.............||+.|+|||
T Consensus       132 aYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPE  211 (1021)
T PTZ00266        132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPE  211 (1021)
T ss_pred             HHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHH
Confidence            999984       49999999999999531              234468999999997765444445567899999999


Q ss_pred             cccc--cCCCcccceecC
Q 031702          139 VLQF--QRYDEKVNFFVS  154 (154)
Q Consensus       139 ~~~~--~~~~~~~Diwsl  154 (154)
                      ++..  ..++.++|||||
T Consensus       212 vL~ge~~~~s~KSDVWSL  229 (1021)
T PTZ00266        212 LLLHETKSYDDKSDMWAL  229 (1021)
T ss_pred             HHhccCCCCCchhHHHHH
Confidence            9864  458899999996

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=6.8e-30  Score=175.83  Aligned_cols=141  Identities=26%  Similarity=0.488  Sum_probs=124.3

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ..+.+.+|+.+++.++|+|++++++.+.+.+..++++||+++++|.+++....  .+++..+..++.|++.|+.|||+.+
T Consensus        43 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~  122 (256)
T cd05039          43 AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN  122 (256)
T ss_pred             HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            35788999999999999999999999998999999999999999999997665  6899999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.++|+|||.+........  ....+..|+|||.+..+.++.++|+|||
T Consensus       123 i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~sl  185 (256)
T cd05039         123 FVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQGQD--SGKLPVKWTAPEALREKKFSTKSDVWSF  185 (256)
T ss_pred             ccchhcccceEEE---eCCCCEEEcccccccccccccc--cCCCcccccCchhhcCCcCCcHHHHHHH
Confidence            9999999999999   6788899999999876532222  2334567999999988889999999996

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.96  E-value=6.7e-30  Score=190.46  Aligned_cols=145  Identities=28%  Similarity=0.494  Sum_probs=124.2

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCC--------cEEEEEEecCCCCchHHHHHc----CCCCHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN--------CIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQ   74 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~   74 (154)
                      ......+.+|+.++..++|+|+++++..+....        .+++++||+++|+|.+++...    ..+++..+..++.|
T Consensus        72 ~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~q  151 (496)
T PTZ00283         72 EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ  151 (496)
T ss_pred             HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHH
Confidence            455677889999999999999999988775332        368999999999999988643    35899999999999


Q ss_pred             HHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCC---CccccccCCccccCcccccccCCCcccce
Q 031702           75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQRYDEKVNF  151 (154)
Q Consensus        75 i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  151 (154)
                      ++.|+.|+|+.+++|+||||+||++   +..+.+||+|||++......   .......||+.|+|||++.+..++.++||
T Consensus       152 ll~aL~~lH~~~IiHrDLKP~NILl---~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DV  228 (496)
T PTZ00283        152 VLLAVHHVHSKHMIHRDIKSANILL---CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADM  228 (496)
T ss_pred             HHHHHHHHHhCCEecCCCCHHHEEE---eCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHH
Confidence            9999999999999999999999999   67788999999998765432   23345678999999999998899999999


Q ss_pred             ecC
Q 031702          152 FVS  154 (154)
Q Consensus       152 wsl  154 (154)
                      |||
T Consensus       229 wSl  231 (496)
T PTZ00283        229 FSL  231 (496)
T ss_pred             HHH
Confidence            996

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.96  E-value=8e-30  Score=178.93  Aligned_cols=143  Identities=26%  Similarity=0.519  Sum_probs=125.5

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++|+|++++++.+..++..++++||+++++|.+++. .+.+++..+..++.|++.|+.|||+.++
T Consensus        61 ~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i  139 (292)
T cd06658          61 QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGV  139 (292)
T ss_pred             HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            446678899999999999999999999999999999999999999999875 4568999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +.++.++|+|||++....... ......++..|+|||...+..++.++|+|||
T Consensus       140 vH~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  204 (292)
T cd06658         140 IHRDIKSDSILL---TSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSL  204 (292)
T ss_pred             eecCCCHHHEEE---cCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHH
Confidence            999999999999   667889999999886543222 2234567889999999988889999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.96  E-value=4.8e-30  Score=184.38  Aligned_cols=141  Identities=34%  Similarity=0.481  Sum_probs=120.4

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecC------CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~   81 (154)
                      ...+.+.+|+.+++.++||||+++++++...      ...|++|||+++ ++.+.+.  ..++...+..++.|++.|+.|
T Consensus        58 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~  134 (355)
T cd07874          58 THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKH  134 (355)
T ss_pred             HHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHH
Confidence            3456778899999999999999999988543      357999999965 6666654  358889999999999999999


Q ss_pred             HHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        82 lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ||+.|++|+||||+||++   +..+.+||+|||++.............+++.|+|||++.+..++.++|||||
T Consensus       135 LH~~givHrDikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diwsl  204 (355)
T cd07874         135 LHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV  204 (355)
T ss_pred             HHhCCcccCCCChHHEEE---CCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHH
Confidence            999999999999999999   6778899999999976655444455678999999999998889999999996

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.96  E-value=8.9e-31  Score=195.63  Aligned_cols=151  Identities=24%  Similarity=0.461  Sum_probs=132.1

Q ss_pred             Chhhhh----hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHH
Q 031702            1 MLKKLN----KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL   75 (154)
Q Consensus         1 ~~k~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i   75 (154)
                      |||.++    +..+.+|..|+.||-++.||||+++.|+......+++++|||++|+|..|++.+. .|..-++..+.+.|
T Consensus       661 AIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGI  740 (996)
T KOG0196|consen  661 AIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGI  740 (996)
T ss_pred             EEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHH
Confidence            355554    5678899999999999999999999999999999999999999999999998764 58889999999999


Q ss_pred             HHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc--ccc--cCCccccCcccccccCCCcccce
Q 031702           76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKV--CGSPLYMAPEVLQFQRYDEKVNF  151 (154)
Q Consensus        76 ~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~--~~~--~~~~~y~aPE~~~~~~~~~~~Di  151 (154)
                      +.|+.||.+.++|||||...|||+   +.+..+|++|||+++.+.++...  .+.  .-...|.|||.+...+++.+||+
T Consensus       741 AsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDV  817 (996)
T KOG0196|consen  741 ASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDV  817 (996)
T ss_pred             HHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhc
Confidence            999999999999999999999999   78999999999999866444311  111  11356999999999999999999


Q ss_pred             ecC
Q 031702          152 FVS  154 (154)
Q Consensus       152 wsl  154 (154)
                      |||
T Consensus       818 WSy  820 (996)
T KOG0196|consen  818 WSY  820 (996)
T ss_pred             ccc
Confidence            997

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.96  E-value=2.3e-30  Score=176.82  Aligned_cols=145  Identities=28%  Similarity=0.495  Sum_probs=124.3

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheec-CCcEEEEEEecCCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH-----GRVPEQTARKFLQQLGAGLEIL   82 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~l   82 (154)
                      ......+|+.+++.++|||++.+..+|.+ +..+++++||.+. +|.+.++.+     ..++...+..++.||+.|+.||
T Consensus        70 iS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YL  148 (438)
T KOG0666|consen   70 ISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYL  148 (438)
T ss_pred             cCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHH
Confidence            45667889999999999999999999977 7889999999976 999988644     3489999999999999999999


Q ss_pred             HhCCceeecCCCCcEEeecC-CCCeeEEEeecccccccCCCC----ccccccCCccccCccccccc-CCCcccceecC
Q 031702           83 NSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        83 h~~~~~h~~i~p~nil~~~~-~~~~~~kl~df~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      |++.++|||+||.||++..+ ..++.+||+|+|+++.+.+.-    ....+..|.+|.|||.+.+. .|+.+.||||.
T Consensus       149 H~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAi  226 (438)
T KOG0666|consen  149 HSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAI  226 (438)
T ss_pred             hhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHH
Confidence            99999999999999999643 356999999999998775432    23446679999999999875 58999999983

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.96  E-value=1.6e-29  Score=174.91  Aligned_cols=144  Identities=23%  Similarity=0.450  Sum_probs=124.9

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      .....+.+|+.+++.++|||++++++.+.+.+..++++||+++++|.+++... +.++...+..++.|++.|++|||+.+
T Consensus        47 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~  126 (266)
T cd05033          47 KQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN  126 (266)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            44567889999999999999999999999999999999999999999998764 46899999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-c--cccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-Y--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.++++|||++....... .  .....++..|+|||...+..++.++|+|||
T Consensus       127 i~H~di~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~sl  194 (266)
T cd05033         127 YVHRDLAARNILV---NSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSF  194 (266)
T ss_pred             cccCCCCcceEEE---cCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHH
Confidence            9999999999999   677889999999988764211 1  112234567999999998889999999996

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.96  E-value=6.3e-30  Score=178.39  Aligned_cols=143  Identities=24%  Similarity=0.517  Sum_probs=122.5

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc----------------CCCCHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARKFL   72 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~   72 (154)
                      ..+.+.+|+.+++.++||||+++++++.+.+..++++||+.+++|.+++...                ..+++..+..++
T Consensus        51 ~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  130 (283)
T cd05091          51 LREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV  130 (283)
T ss_pred             HHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHH
Confidence            4577889999999999999999999999999999999999999999998532                247888899999


Q ss_pred             HHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCccc
Q 031702           73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKV  149 (154)
Q Consensus        73 ~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~  149 (154)
                      .|++.|+.|+|+.+++|+||||.||++   +..+.+||+|||++........   .....+++.|+|||...++.++.++
T Consensus       131 ~ql~~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  207 (283)
T cd05091         131 TQIAAGMEFLSSHHVVHKDLATRNVLV---FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDS  207 (283)
T ss_pred             HHHHHHHHHHHHcCccccccchhheEe---cCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcch
Confidence            999999999999999999999999999   5677899999999876543221   1223446789999999888899999


Q ss_pred             ceecC
Q 031702          150 NFFVS  154 (154)
Q Consensus       150 Diwsl  154 (154)
                      |||||
T Consensus       208 Dv~sl  212 (283)
T cd05091         208 DIWSY  212 (283)
T ss_pred             hHHHH
Confidence            99996

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=8.6e-30  Score=190.19  Aligned_cols=142  Identities=24%  Similarity=0.372  Sum_probs=120.3

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----GRVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      ..+.+.+|+.+++.++||||+++++++.+.+..|++++++. +++.+++...     .......+..++.|++.|+.|||
T Consensus       206 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH  284 (501)
T PHA03210        206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH  284 (501)
T ss_pred             HHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            45678899999999999999999999999999999999985 5777766432     12345677889999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCcccccccCCCcccceecC
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++++|+||||+||++   +..+.+||+|||++.......  ......|+..|+|||++.+..++.++|||||
T Consensus       285 ~~gIiHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  354 (501)
T PHA03210        285 DKKLIHRDIKLENIFL---NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSC  354 (501)
T ss_pred             hCCeecCCCCHHHEEE---CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHH
Confidence            9999999999999999   677889999999997664432  2234578999999999998899999999996

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=3.8e-30  Score=193.73  Aligned_cols=146  Identities=26%  Similarity=0.460  Sum_probs=121.0

Q ss_pred             hhhhHHhHHHHHHHHhhC-CCCccchhhhhe-e---cCC---cEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHH
Q 031702            6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAF-Q---AEN---CIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL   75 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~---~~~---~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i   75 (154)
                      ++..-+.+.+|+++|+.| .|+|||.+++.. .   ..+   .++++||||+||.|-++++.+  ..|++.++++|+.|+
T Consensus        74 de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv  153 (738)
T KOG1989|consen   74 DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDV  153 (738)
T ss_pred             CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHH
Confidence            456678899999999999 599999999943 1   112   378999999999999999743  469999999999999


Q ss_pred             HHHHHHHHhCC--ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-c---------cccccCCccccCccccc--
Q 031702           76 GAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-Y---------AEKVCGSPLYMAPEVLQ--  141 (154)
Q Consensus        76 ~~~l~~lh~~~--~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~---------~~~~~~~~~y~aPE~~~--  141 (154)
                      ++|+++||...  ++|||||-+|+|+   +.++..||||||.++...... .         ......|+.|+|||++.  
T Consensus       154 ~~AVa~mH~~~pPiIHRDLKiENvLl---s~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDly  230 (738)
T KOG1989|consen  154 CEAVAAMHYLKPPIIHRDLKIENVLL---SADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLY  230 (738)
T ss_pred             HHHHHHHhcCCCccchhhhhhhheEE---cCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhh
Confidence            99999999987  9999999999999   788899999999987532221 1         11245688999999974  


Q ss_pred             -ccCCCcccceecC
Q 031702          142 -FQRYDEKVNFFVS  154 (154)
Q Consensus       142 -~~~~~~~~Diwsl  154 (154)
                       +.+++.|+|||||
T Consensus       231 sg~pI~eKsDIWAL  244 (738)
T KOG1989|consen  231 SGLPIGEKSDIWAL  244 (738)
T ss_pred             cCCCCcchhHHHHH
Confidence             5678999999996

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.96  E-value=1.4e-29  Score=174.35  Aligned_cols=143  Identities=27%  Similarity=0.416  Sum_probs=125.0

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ...+.+.+|+.++++++|||++++++.+.+ ...++++||+++++|.+++.+..  .+++..+..++.|++.|+++||+.
T Consensus        38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~  116 (257)
T cd05040          38 DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK  116 (257)
T ss_pred             HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC
Confidence            456788999999999999999999999988 88999999999999999997654  589999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC----ccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||+|+||++   +..+.+||+|||.+.......    ......++..|+|||.+.+..++.++|||||
T Consensus       117 ~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~sl  186 (257)
T cd05040         117 RFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMF  186 (257)
T ss_pred             CccccccCcccEEE---ecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHH
Confidence            99999999999999   567899999999987664422    1123445678999999988889999999996

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.96  E-value=1.3e-29  Score=175.53  Aligned_cols=144  Identities=24%  Similarity=0.451  Sum_probs=124.3

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|+.+++.++||||+++++.+.+++..+++|||+++++|.+++.+. ..++..++..++.|++.|+++||+.+
T Consensus        47 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~  126 (267)
T cd05066          47 KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG  126 (267)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34678899999999999999999999999999999999999999999999765 45899999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc----ccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.++++|||.+.........    ....++..|+|||...+..++.++|+|||
T Consensus       127 i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl  195 (267)
T cd05066         127 YVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSY  195 (267)
T ss_pred             EeehhhchhcEEE---CCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHH
Confidence            9999999999999   66788999999998765443211    11122456999999998889999999996

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=1.4e-29  Score=176.06  Aligned_cols=144  Identities=24%  Similarity=0.414  Sum_probs=123.6

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC----------CCCHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------RVPEQTARKFLQQLGA   77 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~i~~   77 (154)
                      .....+.+|+.+++.++|||++++++++..+...++++||+++++|.+++....          .+++..+..++.|++.
T Consensus        51 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  130 (277)
T cd05032          51 RERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD  130 (277)
T ss_pred             HHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHH
Confidence            345678899999999999999999999999999999999999999999986432          3677889999999999


Q ss_pred             HHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCcccceecC
Q 031702           78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        78 ~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+.|||+.+++|+||+|+||++   +..+.++|+|||++........   .....++..|+|||.+.++.++.++|||||
T Consensus       131 ~l~~lH~~~i~H~di~p~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  207 (277)
T cd05032         131 GMAYLAAKKFVHRDLAARNCMV---AEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSF  207 (277)
T ss_pred             HHHHHHhCCccccccChheEEE---cCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHH
Confidence            9999999999999999999999   6778899999999876544321   122345678999999988889999999996

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.96  E-value=1.9e-29  Score=177.20  Aligned_cols=144  Identities=25%  Similarity=0.481  Sum_probs=123.0

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-----------CCCHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------RVPEQTARKFLQQLG   76 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~i~   76 (154)
                      ...+.+.+|+.+++.++|+|++++++++...+..++++||+++++|.+++....           .+++.++..++.|++
T Consensus        61 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  140 (296)
T cd05095          61 NARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIA  140 (296)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHH
Confidence            345688999999999999999999999999999999999999999999987543           256778999999999


Q ss_pred             HHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCcccceec
Q 031702           77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFV  153 (154)
Q Consensus        77 ~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws  153 (154)
                      .|++|||+.+++|+||+|+||++   +..+.++|+|||++........   .....++..|+|||...++.++.++|+||
T Consensus       141 ~al~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwS  217 (296)
T cd05095         141 SGMKYLSSLNFVHRDLATRNCLV---GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWA  217 (296)
T ss_pred             HHHHHHHHCCeecccCChheEEE---cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhH
Confidence            99999999999999999999999   5678899999999876543321   12233356799999988888999999999


Q ss_pred             C
Q 031702          154 S  154 (154)
Q Consensus       154 l  154 (154)
                      |
T Consensus       218 l  218 (296)
T cd05095         218 F  218 (296)
T ss_pred             H
Confidence            6

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.96  E-value=1.6e-29  Score=176.43  Aligned_cols=144  Identities=26%  Similarity=0.418  Sum_probs=120.9

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheec--CCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ...+.+.+|+++++.++|||++++.+++..  ....++++||+++++|.+++.+. ..+++..+..++.|++.|++|||+
T Consensus        47 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~  126 (284)
T cd05081          47 EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS  126 (284)
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH
Confidence            445678999999999999999999987643  35689999999999999998654 458999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc----ccccCCccccCcccccccCCCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .|++|+||+|+||++   +..+.++|+|||++.........    ....++..|+|||++.+..++.++|||||
T Consensus       127 ~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  197 (284)
T cd05081         127 KRYVHRDLATRNILV---ESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSF  197 (284)
T ss_pred             CCceeccCCHhhEEE---CCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHH
Confidence            999999999999999   67788999999998865433211    11123345999999988889999999996

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.96  E-value=1.1e-29  Score=177.92  Aligned_cols=144  Identities=29%  Similarity=0.451  Sum_probs=123.0

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc------------------------CCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------------------------GRV   63 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~------------------------~~~   63 (154)
                      ...+.+.+|+.+++.++||||+++++.+...+..++++||+.+++|.+++...                        ..+
T Consensus        45 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  124 (290)
T cd05045          45 SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL  124 (290)
T ss_pred             HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCcccccc
Confidence            34567889999999999999999999999999999999999999999988642                        236


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccc
Q 031702           64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVL  140 (154)
Q Consensus        64 ~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~  140 (154)
                      +...+..++.|++.|+.|||+.+++|+||+|+||++   +..+.++|+|||++........   .....++..|+|||..
T Consensus       125 ~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~  201 (290)
T cd05045         125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV---AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL  201 (290)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE---cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHH
Confidence            788999999999999999999999999999999999   5677899999999875433221   2223446679999999


Q ss_pred             cccCCCcccceecC
Q 031702          141 QFQRYDEKVNFFVS  154 (154)
Q Consensus       141 ~~~~~~~~~Diwsl  154 (154)
                      .+..++.++|||||
T Consensus       202 ~~~~~~~~~Di~sl  215 (290)
T cd05045         202 FDHIYTTQSDVWSF  215 (290)
T ss_pred             ccCCcchHhHHHHH
Confidence            88889999999996

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.4e-29  Score=175.87  Aligned_cols=143  Identities=31%  Similarity=0.567  Sum_probs=127.4

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+++++.++|+|++++.+.+.++...++++||+++++|.+++... .+++..+..++.|++.|+.+||+.++
T Consensus        41 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i  119 (274)
T cd06609          41 DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGK  119 (274)
T ss_pred             hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            34567889999999999999999999999999999999999999999998755 78999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++++|||++...... .......+++.|+|||.+.+..++.++|||||
T Consensus       120 ~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~sl  184 (274)
T cd06609         120 IHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSL  184 (274)
T ss_pred             ccCCCCHHHEEE---CCCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHH
Confidence            999999999999   67888999999998776543 23334567888999999998889999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=2e-29  Score=174.07  Aligned_cols=142  Identities=25%  Similarity=0.428  Sum_probs=123.1

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      .+.+.+|+.++++++|||++++++++...+..++++||+++++|.+++....  .++...+..++.|++.|+.+||+.++
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i  124 (261)
T cd05068          45 PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY  124 (261)
T ss_pred             HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            5678899999999999999999999999999999999999999999987654  68999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc--ccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||++.........  .....+..|+|||...+..++.++|+|||
T Consensus       125 ~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  190 (261)
T cd05068         125 IHRDLAARNVLV---GENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSF  190 (261)
T ss_pred             eeccCCcceEEE---cCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHH
Confidence            999999999999   67788999999998765432211  11122356999999988889999999996

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.96  E-value=2.2e-29  Score=177.53  Aligned_cols=143  Identities=30%  Similarity=0.562  Sum_probs=124.3

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++||||+++++.+.+++..++++||+++++|.+++...+.+++..+..++.|++.|++|||+.+++
T Consensus        44 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  123 (305)
T cd05609          44 QIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIV  123 (305)
T ss_pred             HHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            35678899999999999999999999999999999999999999999998888899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCC----------------ccccccCCccccCcccccccCCCccccee
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----------------YAEKVCGSPLYMAPEVLQFQRYDEKVNFF  152 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Diw  152 (154)
                      |+||+|.||++   +..+.++++|||.+.......                ......++..|+|||.+.+..++.++|+|
T Consensus       124 H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  200 (305)
T cd05609         124 HRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWW  200 (305)
T ss_pred             ccCCchHHEEE---CCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHH
Confidence            99999999999   677889999999875311000                01123567789999999888899999999


Q ss_pred             cC
Q 031702          153 VS  154 (154)
Q Consensus       153 sl  154 (154)
                      ||
T Consensus       201 sl  202 (305)
T cd05609         201 AM  202 (305)
T ss_pred             HH
Confidence            96

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.96  E-value=2e-29  Score=173.86  Aligned_cols=144  Identities=17%  Similarity=0.278  Sum_probs=121.7

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|+.+++.++|||++++++.+..+...+++|||+++|+|.+++..++ .+++..+..++.|++.|++|||+.+
T Consensus        41 ~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  120 (258)
T cd05078          41 NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG  120 (258)
T ss_pred             HHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            345678889999999999999999999999999999999999999999997654 5899999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCC-----CCeeEEEeecccccccCCCCccccccCCccccCccccccc-CCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLD-----DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~-----~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++....     ..+.++++|||.+......   ....++..|+|||++.+. .++.++|||||
T Consensus       121 iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  191 (258)
T cd05078         121 LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSF  191 (258)
T ss_pred             eecCCCccceEEEecccccccCCCceEEecccccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHH
Confidence            99999999999995321     1234799999988654332   234567889999999864 57899999996

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.96  E-value=2.6e-29  Score=172.34  Aligned_cols=144  Identities=31%  Similarity=0.511  Sum_probs=123.0

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      .....+.+|+.+++.++|||++++.+.+.+.+..+++|||+++++|.+++... ..+++..+..++.+++.++.|+|+.+
T Consensus        34 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  113 (250)
T cd05085          34 ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN  113 (250)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            34567889999999999999999999999999999999999999999988654 45789999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc--ccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.++++|||++.........  ....++..|+|||++.+..++.++|||||
T Consensus       114 ~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  180 (250)
T cd05085         114 CIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSY  180 (250)
T ss_pred             eeecccChheEEE---cCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHH
Confidence            9999999999999   67778999999988654332211  11233566999999988889999999996

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.96  E-value=2e-29  Score=175.69  Aligned_cols=139  Identities=33%  Similarity=0.554  Sum_probs=122.5

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.++++++|||++++++.+...+..++++||+++++|..+    ..+++..+..++.|++.|+.|||+.++
T Consensus        41 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i  116 (279)
T cd06619          41 ELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKI  116 (279)
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            4456788999999999999999999999999999999999999998654    357888999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||++...... ......++..|+|||++.+..++.++|+|||
T Consensus       117 ~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  179 (279)
T cd06619         117 LHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGEQYGIHSDVWSL  179 (279)
T ss_pred             eeCCCCHHHEEE---CCCCCEEEeeCCcceecccc-cccCCCCChhhcCceeecCCCCCCcchHHHH
Confidence            999999999999   67889999999998765332 2334568889999999998889999999996

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.96  E-value=1.3e-29  Score=176.36  Aligned_cols=143  Identities=28%  Similarity=0.529  Sum_probs=125.7

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++|||++++++.+..++..++++||+++++|.+++. ...+++..+..++.|++.|+.|||+.++
T Consensus        44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i  122 (277)
T cd06642          44 DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERK  122 (277)
T ss_pred             HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence            345678999999999999999999999999999999999999999999876 4568999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++++|||++....... ......++..|+|||.+.+..++.++|+|||
T Consensus       123 vH~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  187 (277)
T cd06642         123 IHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSL  187 (277)
T ss_pred             eccCCChheEEE---eCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHH
Confidence            999999999999   567789999999987654332 2223457888999999998889999999996

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.96  E-value=2e-29  Score=173.85  Aligned_cols=143  Identities=24%  Similarity=0.417  Sum_probs=124.5

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ..+.+.+|+.+++.++|+|++++++.+.+....++++||+++++|.+++.+.  ..++...+..++.|++.|+.|||+.+
T Consensus        45 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~  124 (261)
T cd05148          45 KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN  124 (261)
T ss_pred             hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4677899999999999999999999999999999999999999999999753  35899999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc-cccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.++|+|||.+........ .....++..|+|||...+..++.++|+|||
T Consensus       125 i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Diwsl  190 (261)
T cd05148         125 SIHRDLAARNILV---GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSF  190 (261)
T ss_pred             eeccccCcceEEE---cCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHH
Confidence            9999999999999   6778899999999876543321 122334567999999988889999999996

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.96  E-value=2.8e-29  Score=174.04  Aligned_cols=143  Identities=26%  Similarity=0.411  Sum_probs=119.1

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----RVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      ....+.+|+.+++.++|||++++++.+.+....+++|||+++++|.+++....     ..+...+..++.|++.|++|||
T Consensus        38 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH  117 (269)
T cd05087          38 EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH  117 (269)
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence            34578889999999999999999999999999999999999999999986432     3566778889999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCccccccc-------CCCcccceec
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQ-------RYDEKVNFFV  153 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~-------~~~~~~Diws  153 (154)
                      +.+++|+||||+||++   +..+.++|+|||.+........   .....++..|+|||+..+.       .++.++||||
T Consensus       118 ~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws  194 (269)
T cd05087         118 KNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWS  194 (269)
T ss_pred             HCCEeccccCcceEEE---cCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHH
Confidence            9999999999999999   5678899999998865433221   1234567789999998642       3578999999


Q ss_pred             C
Q 031702          154 S  154 (154)
Q Consensus       154 l  154 (154)
                      |
T Consensus       195 l  195 (269)
T cd05087         195 L  195 (269)
T ss_pred             H
Confidence            6

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.96  E-value=2.4e-29  Score=175.62  Aligned_cols=144  Identities=31%  Similarity=0.494  Sum_probs=126.6

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+++++.++|+|++++.+.+.+++..++++||++++.+..+..+...+++..+..++.|++.|+.|||+.++
T Consensus        42 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i  121 (288)
T cd07833          42 DVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNI  121 (288)
T ss_pred             cchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34578899999999999999999999999999999999999987777766666779999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCccccccc-CCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      +|+|++|+||++   +..+.++|+|||.+.......  ......++..|+|||++.+. .++.++|+|||
T Consensus       122 ~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~sl  188 (288)
T cd07833         122 IHRDIKPENILV---SESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAI  188 (288)
T ss_pred             ecCCCCHHHeEE---CCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHH
Confidence            999999999999   678899999999987665443  23345678889999999877 78899999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.96  E-value=2.8e-29  Score=175.02  Aligned_cols=142  Identities=27%  Similarity=0.442  Sum_probs=120.9

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ....+..|+..++.+.||||+++++++.. ...++++||+++|+|.+++... ..+++..+..++.|++.|++|||+.++
T Consensus        52 ~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  130 (279)
T cd05111          52 TFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRM  130 (279)
T ss_pred             HHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            34677888889999999999999998754 4578899999999999999754 468999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +.++.+||+|||.+........   .....++..|+|||...++.++.++|||||
T Consensus       131 iH~dlkp~nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~sl  197 (279)
T cd05111         131 VHRNLAARNILL---KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSY  197 (279)
T ss_pred             eccccCcceEEE---cCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHH
Confidence            999999999999   6778899999999876543321   123345677999999988889999999996

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.96  E-value=5.6e-30  Score=180.85  Aligned_cols=141  Identities=27%  Similarity=0.454  Sum_probs=120.0

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ...+.+|+.+++.++|||++++++++.+++..+++|||+++ +|.+++...+ .++...+..++.|++.|+.|||+++++
T Consensus        48 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~iv  126 (309)
T cd07872          48 PCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVL  126 (309)
T ss_pred             chhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            34677899999999999999999999999999999999965 8888776543 488999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccc-cCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      |+||+|+||++   +..+.+||+|||++....... ......+++.|+|||.+.+ ..++.++|||||
T Consensus       127 H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  191 (309)
T cd07872         127 HRDLKPQNLLI---NERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGV  191 (309)
T ss_pred             cCCCCHHHEEE---CCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHH
Confidence            99999999999   677889999999986543322 2233457889999999865 468899999996

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.96  E-value=1.4e-29  Score=177.04  Aligned_cols=140  Identities=34%  Similarity=0.519  Sum_probs=117.6

Q ss_pred             HhHHHHHHHHhhC---CCCccchhhhheec-----CCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHH
Q 031702           11 SCLDCELNFLSSV---NHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLE   80 (154)
Q Consensus        11 ~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~   80 (154)
                      ..+.+|+.+++.+   +||||+++++++.+     ....++++|++++ +|.+++....  .+++..+..++.|++.|+.
T Consensus        44 ~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~  122 (288)
T cd07863          44 LSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLD  122 (288)
T ss_pred             hHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Confidence            3556778777766   69999999998864     2458999999964 8888886543  4899999999999999999


Q ss_pred             HHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        81 ~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |||+.+++|+||+|+||++   +..+.+||+|||++.............++..|+|||++.+..++.++|||||
T Consensus       123 ~lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  193 (288)
T cd07863         123 FLHANCIVHRDLKPENILV---TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSV  193 (288)
T ss_pred             HHHhCCeecCCCCHHHEEE---CCCCCEEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhH
Confidence            9999999999999999999   6778899999999876654433444567889999999988889999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=3e-29  Score=172.81  Aligned_cols=142  Identities=27%  Similarity=0.460  Sum_probs=122.2

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+++++.+.|+|++++++++. .+..++++||+++++|.+++.....+++..+..++.|++.|+++||..+++
T Consensus        39 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~  117 (257)
T cd05060          39 GKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV  117 (257)
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCee
Confidence            4567889999999999999999998775 456899999999999999998877899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc----ccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||+|+||++   +..+.++|+|||.+.........    ....++..|+|||...+..++.++|||||
T Consensus       118 H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  184 (257)
T cd05060         118 HRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSY  184 (257)
T ss_pred             ccCcccceEEE---cCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHH
Confidence            99999999999   67788999999998765443321    11122456999999988889999999996

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.96  E-value=1.5e-29  Score=176.44  Aligned_cols=143  Identities=29%  Similarity=0.483  Sum_probs=124.5

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++|+|++++++++..+...++++||++++++..+......+++..+..++.|++.++.|||+.+++
T Consensus        43 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~  122 (286)
T cd07847          43 IKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCI  122 (286)
T ss_pred             ccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence            34567899999999999999999999999999999999999988888877667799999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccc-cCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      |+||+|+||++   +..+.++|+|||++....... ......++..|+|||.+.+ ..++.++|+|||
T Consensus       123 H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~sl  187 (286)
T cd07847         123 HRDVKPENILI---TKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAI  187 (286)
T ss_pred             ecCCChhhEEE---cCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHH
Confidence            99999999999   667789999999987664433 2233456788999999865 457889999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7.3e-30  Score=175.64  Aligned_cols=141  Identities=33%  Similarity=0.523  Sum_probs=130.8

Q ss_pred             HhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 031702           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR   90 (154)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~   90 (154)
                      ..-..|-.+|+..+||.+..+...|++.+.+|+||||..||.|.-.+.+...+++...+.+...|+.|+.|||++++++|
T Consensus       213 AHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYR  292 (516)
T KOG0690|consen  213 AHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYR  292 (516)
T ss_pred             hhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeee
Confidence            34456889999999999999999999999999999999999999999888889999999999999999999999999999


Q ss_pred             cCCCCcEEeecCCCCeeEEEeecccccc-cCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           91 DLKPENILLSGLDDDVMLKIADFGLSCT-LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        91 ~i~p~nil~~~~~~~~~~kl~df~~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+|.+|.++   +.++++||.|||++.. +.......+.||||.|+|||++....|..++|+|.+
T Consensus       293 DlKLENLlL---DkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~  354 (516)
T KOG0690|consen  293 DLKLENLLL---DKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGV  354 (516)
T ss_pred             echhhhhee---ccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhh
Confidence            999999999   8999999999999875 445667888999999999999999999999999974

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.96  E-value=2.9e-29  Score=179.28  Aligned_cols=143  Identities=30%  Similarity=0.483  Sum_probs=120.2

Q ss_pred             hHHhHHHHHHHHhhC-CCCccchhhhheecC-CcEEEEEEecCCCCchHHHHHc--------------------------
Q 031702            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLH--------------------------   60 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~--------------------------   60 (154)
                      ..+.+.+|+.+++++ +|+||+++++.+... ..+++++||+++++|.+++...                          
T Consensus        53 ~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  132 (337)
T cd05054          53 EYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQR  132 (337)
T ss_pred             HHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccc
Confidence            346678899999999 899999999988644 6789999999999999988542                          


Q ss_pred             -----------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCC
Q 031702           61 -----------------------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDD  105 (154)
Q Consensus        61 -----------------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~  105 (154)
                                                         ..++...+..++.|++.|++|||+++++|+||||+||++   +..
T Consensus       133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill---~~~  209 (337)
T cd05054         133 LDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL---SEN  209 (337)
T ss_pred             cccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---eCC
Confidence                                               257888999999999999999999999999999999999   567


Q ss_pred             eeEEEeecccccccCCCC---ccccccCCccccCcccccccCCCcccceecC
Q 031702          106 VMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus       106 ~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +.++|+|||++..+....   ......++..|+|||++.+..++.++|||||
T Consensus       210 ~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~Sl  261 (337)
T cd05054         210 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSF  261 (337)
T ss_pred             CcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHH
Confidence            789999999997653322   1122344567999999998999999999996

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.96  E-value=3.9e-29  Score=171.98  Aligned_cols=144  Identities=28%  Similarity=0.602  Sum_probs=124.0

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheec-CCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ...+.+.+|+.+++.++|+|++++.+.+.. .+.+++++||+++++|.+++...  ..+++.++..++.+++.++++||+
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~  120 (257)
T cd08223          41 RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE  120 (257)
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            445678999999999999999999988764 44689999999999999988753  358999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .+++|+||+|+||++   +..+.++|+|||++....... ......+++.|+|||+..+..++.++|+|||
T Consensus       121 ~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  188 (257)
T cd08223         121 KHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWAL  188 (257)
T ss_pred             CCeeccCCCchhEEE---ecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHH
Confidence            999999999999999   677889999999987654322 2334567888999999998889999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.96  E-value=3.4e-29  Score=173.39  Aligned_cols=143  Identities=29%  Similarity=0.555  Sum_probs=124.0

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecC--CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ..+.+.+|+.+++.++|||++++++.+.+.  ..+++++||+++++|.+++.....+++...+.++.|++.|+.+||+.+
T Consensus        47 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~  126 (266)
T cd06651          47 EVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM  126 (266)
T ss_pred             HHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            456789999999999999999999988653  568999999999999999988788999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC----ccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.++|+|||++.......    ......++..|+|||...+..++.++|+|||
T Consensus       127 i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  195 (266)
T cd06651         127 IVHRDIKGANILR---DSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSL  195 (266)
T ss_pred             eeeCCCCHHHEEE---CCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHH
Confidence            9999999999999   677789999999987543211    1123457888999999988889999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.96  E-value=3.3e-29  Score=173.13  Aligned_cols=144  Identities=30%  Similarity=0.557  Sum_probs=126.3

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      ...+.+.+|+.+++.++|++++++++.+.+++..++++||+++++|.+++..    ...+++.++..++.+++.|+.+||
T Consensus        44 ~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh  123 (267)
T cd08224          44 KARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH  123 (267)
T ss_pred             hhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH
Confidence            3467899999999999999999999999999999999999999999998864    234899999999999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +.|++|+||+|+||++   +..+.++++|||.+....... ......+++.|+|||.+.+..++.++|+|||
T Consensus       124 ~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl  192 (267)
T cd08224         124 SKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSL  192 (267)
T ss_pred             hCCEecCCcChhhEEE---CCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHH
Confidence            9999999999999999   677889999999887654332 2233567888999999988889999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2.1e-29  Score=175.55  Aligned_cols=145  Identities=36%  Similarity=0.568  Sum_probs=125.1

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ....+.+.+|+.+++.++|||++++++.+.+++..+++|||+++++|.+++.+. ..+++..+..++.|++.++.|||+.
T Consensus        43 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~  122 (280)
T cd06611          43 EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH  122 (280)
T ss_pred             HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            345567889999999999999999999999999999999999999999998764 4699999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCccccc-----ccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ-----FQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~Diwsl  154 (154)
                      +++|+||+|+||++   +..+.++|+|||.+....... ......+++.|+|||.+.     ...++.++|+|||
T Consensus       123 ~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~sl  194 (280)
T cd06611         123 KVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSL  194 (280)
T ss_pred             CcccCCCChhhEEE---CCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHH
Confidence            99999999999999   678889999999876543322 233456788999999975     2356789999996

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.96  E-value=2.2e-29  Score=174.97  Aligned_cols=143  Identities=21%  Similarity=0.403  Sum_probs=124.1

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC---------CCCHHHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---------RVPEQTARKFLQQLGAGL   79 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l   79 (154)
                      ..+.+.+|+.++++++|+|++++++.+.+....++++||+++++|.+++....         .+++..+..++.|++.|+
T Consensus        51 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l  130 (275)
T cd05046          51 LQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM  130 (275)
T ss_pred             HHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHH
Confidence            45678999999999999999999999999899999999999999999997655         689999999999999999


Q ss_pred             HHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCcccccccCCCcccceecC
Q 031702           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        80 ~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|||+.+++|+||+|+||++   +..+.++++|||++.......  ......++..|+|||.+.+..++.++|||||
T Consensus       131 ~~LH~~~i~H~dlkp~Nili---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  204 (275)
T cd05046         131 DHLSNARFVHRDLAARNCLV---SSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSF  204 (275)
T ss_pred             HHhhhcCcccCcCccceEEE---eCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHH
Confidence            99999999999999999999   567789999999876443222  1223345667999999988888899999996

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.96  E-value=3.6e-29  Score=179.08  Aligned_cols=139  Identities=29%  Similarity=0.525  Sum_probs=118.5

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecC------CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL   82 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l   82 (154)
                      ..+.+.+|+.+++.++||||+++++++...      ...|++++++ +++|.+++. ...+++..+..++.|++.|+.||
T Consensus        57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~L  134 (343)
T cd07878          57 HARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYI  134 (343)
T ss_pred             HHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH
Confidence            345677899999999999999999988543      3478999988 779988765 45799999999999999999999


Q ss_pred             HhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc-cCCCcccceecC
Q 031702           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        83 h~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      |+.+++|+||||+||++   +..+.+||+|||++......  .....+++.|+|||++.+ ..++.++|||||
T Consensus       135 H~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  202 (343)
T cd07878         135 HSAGIIHRDLKPSNVAV---NEDCELRILDFGLARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSV  202 (343)
T ss_pred             HHCCeecccCChhhEEE---CCCCCEEEcCCccceecCCC--cCCccccccccCchHhcCCccCCchhhhHhH
Confidence            99999999999999999   67788999999998765332  234567899999999876 468899999996

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.96  E-value=3.4e-29  Score=178.67  Aligned_cols=144  Identities=30%  Similarity=0.468  Sum_probs=122.5

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC----------------CCCHHHHHH
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK   70 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----------------~~~~~~~~~   70 (154)
                      ...+.+.+|+.+++++ +||||+++++.+...+..++++||+++++|.+++.+..                .++...+..
T Consensus        59 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  138 (334)
T cd05100          59 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS  138 (334)
T ss_pred             HHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHH
Confidence            3456889999999999 89999999999999999999999999999999987532                367788899


Q ss_pred             HHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCc
Q 031702           71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE  147 (154)
Q Consensus        71 ~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~  147 (154)
                      ++.|++.|+.|||+.+++|+||+|+||++   +..+.++|+|||++........   .....++..|+|||++.+..++.
T Consensus       139 ~~~qi~~al~~LH~~givH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  215 (334)
T cd05100         139 CAYQVARGMEYLASQKCIHRDLAARNVLV---TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTH  215 (334)
T ss_pred             HHHHHHHHHHHHHHCCeeccccccceEEE---cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCc
Confidence            99999999999999999999999999999   5677899999999876543221   11223345699999999888999


Q ss_pred             ccceecC
Q 031702          148 KVNFFVS  154 (154)
Q Consensus       148 ~~Diwsl  154 (154)
                      ++|||||
T Consensus       216 ~~Di~sl  222 (334)
T cd05100         216 QSDVWSF  222 (334)
T ss_pred             hhhhHHH
Confidence            9999996

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.96  E-value=2.6e-29  Score=173.05  Aligned_cols=141  Identities=23%  Similarity=0.459  Sum_probs=120.9

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhhe-ecCCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ..+.+.+|+.+++.++|++++++++.+ .+++..++++||+++++|.+++.+..  .+++..+..++.|++.|++|||++
T Consensus        42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~  121 (256)
T cd05082          42 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN  121 (256)
T ss_pred             hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            356789999999999999999999876 45567899999999999999987654  378899999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||+|+||++   +..+.+||+|||++.......  .....+..|+|||+..+..++.++|||||
T Consensus       122 ~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  185 (256)
T cd05082         122 NFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSF  185 (256)
T ss_pred             CEeccccchheEEE---cCCCcEEecCCccceeccccC--CCCccceeecCHHHHccCCCCchhhhHHH
Confidence            99999999999999   677889999999887543322  22334567999999988889999999996

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.96  E-value=2e-29  Score=177.31  Aligned_cols=142  Identities=25%  Similarity=0.498  Sum_probs=125.3

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++|||++++++.+..++..++++||+++++|..++. ...+++..++.++.|++.|+++||+.+++
T Consensus        61 ~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~iv  139 (297)
T cd06659          61 RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQGVI  139 (297)
T ss_pred             hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            45678899999999999999999999999999999999999999998775 45689999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||+|+||++   +..+.++|+|||++....... ......++..|+|||.+.+..++.++|+|||
T Consensus       140 H~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  203 (297)
T cd06659         140 HRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSL  203 (297)
T ss_pred             cCCCCHHHeEE---ccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHH
Confidence            99999999999   678899999999886543322 2334567889999999988889999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.96  E-value=5.8e-29  Score=174.36  Aligned_cols=145  Identities=32%  Similarity=0.528  Sum_probs=123.8

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ....+.+.+|+.+++.++|+|++++.+.+..++..+++|||+++++|..++.+ ...+++..+..++.|++.++.+||+.
T Consensus        50 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~  129 (292)
T cd06644          50 EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM  129 (292)
T ss_pred             HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence            34567788999999999999999999999999999999999999999887754 45689999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCccccc-----ccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Diwsl  154 (154)
                      +++|+||+|+||++   +..+.++|+|||.+...... .......+++.|+|||++.     ...++.++|+|||
T Consensus       130 ~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl  201 (292)
T cd06644         130 KIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSL  201 (292)
T ss_pred             CeeecCCCcceEEE---cCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhH
Confidence            99999999999999   56788999999988654332 2234456788899999985     3456789999996

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.96  E-value=5.2e-29  Score=171.71  Aligned_cols=144  Identities=35%  Similarity=0.593  Sum_probs=127.1

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+++++.++|||++++++.+.++...|+++||+++++|.+++.+.+.+++..+..++.|++.|+++||+.++
T Consensus        35 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i  114 (265)
T cd05579          35 NQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGI  114 (265)
T ss_pred             hHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCe
Confidence            34678899999999999999999999999999999999999999999999887789999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---------ccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---------YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||++.......         ......++..|+|||......++.++|+|||
T Consensus       115 ~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~sl  187 (265)
T cd05579         115 IHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSL  187 (265)
T ss_pred             ecCCCCHHHeEE---cCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHH
Confidence            999999999999   678899999999886543321         1223456788999999988888999999996

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.96  E-value=2e-29  Score=174.18  Aligned_cols=143  Identities=33%  Similarity=0.552  Sum_probs=126.9

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh-C
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS-H   85 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~-~   85 (154)
                      ...+.+.+|+++++.++|||++++++.+..++..++++||+++++|.+++... ..+++..+..++.|++.|+.++|+ .
T Consensus        41 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~  120 (265)
T cd06605          41 AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH  120 (265)
T ss_pred             HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC
Confidence            45677889999999999999999999999999999999999999999999876 779999999999999999999999 9


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||+|+||++   +..+.++|+|||.+........ ....++..|+|||.+.+..++.++|+|||
T Consensus       121 ~i~H~dl~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl  185 (265)
T cd06605         121 KIIHRDVKPSNILV---NSRGQIKLCDFGVSGQLVNSLA-KTFVGTSSYMAPERIQGNDYSVKSDIWSL  185 (265)
T ss_pred             CeecCCCCHHHEEE---CCCCCEEEeecccchhhHHHHh-hcccCChhccCHHHHcCCCCCchhhHHHH
Confidence            99999999999999   5678899999998865533221 22667888999999988889999999996

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.96  E-value=2.1e-29  Score=177.03  Aligned_cols=142  Identities=30%  Similarity=0.539  Sum_probs=124.8

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.+.|+|++++++.+..+...++++||+++++|.+++. ...+++.++..++.|++.|++|||+.+++
T Consensus        60 ~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~ql~~aL~~LH~~gi~  138 (296)
T cd06654          60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVI  138 (296)
T ss_pred             hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            35678899999999999999999999999999999999999999999886 34688999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||+|+||++   +..+.++|+|||.+....... ......+++.|+|||.+.+..++.++|+|||
T Consensus       139 H~dLkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~  202 (296)
T cd06654         139 HRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL  202 (296)
T ss_pred             cCCCCHHHEEE---cCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHH
Confidence            99999999999   567789999999887644332 2233467889999999988888999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.96  E-value=2.9e-29  Score=177.05  Aligned_cols=144  Identities=30%  Similarity=0.469  Sum_probs=122.5

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC----------------CCCHHHHHH
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK   70 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----------------~~~~~~~~~   70 (154)
                      ...+.+.+|+.+++.+ +|||++++++++...+..++++||+++++|.+++....                .++..++..
T Consensus        65 ~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  144 (307)
T cd05098          65 KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS  144 (307)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHH
Confidence            3456788899999999 89999999999999999999999999999999997542                378889999


Q ss_pred             HHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCc
Q 031702           71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE  147 (154)
Q Consensus        71 ~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~  147 (154)
                      ++.|++.|++|||+.+++|+||+|+||++   +..+.++|+|||.+........   .....++..|+|||.+.+..++.
T Consensus       145 ~~~qi~~aL~~lH~~gi~H~dlkp~Nill---~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  221 (307)
T cd05098         145 CAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH  221 (307)
T ss_pred             HHHHHHHHHHHHHHCCcccccccHHheEE---cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCc
Confidence            99999999999999999999999999999   5678899999999875543221   11122346799999998888999


Q ss_pred             ccceecC
Q 031702          148 KVNFFVS  154 (154)
Q Consensus       148 ~~Diwsl  154 (154)
                      ++|+|||
T Consensus       222 ~~Dvwsl  228 (307)
T cd05098         222 QSDVWSF  228 (307)
T ss_pred             HHHHHHH
Confidence            9999996

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.96  E-value=6.1e-29  Score=172.30  Aligned_cols=144  Identities=27%  Similarity=0.479  Sum_probs=121.0

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCc------EEEEEEecCCCCchHHHHHc------CCCCHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLH------GRVPEQTARKFLQQL   75 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~i   75 (154)
                      ...+.+.+|+..++.++|||++++++.+.+...      .++++||+++++|..++...      ..+++..+..++.|+
T Consensus        43 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i  122 (273)
T cd05035          43 SEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI  122 (273)
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHH
Confidence            345678999999999999999999998765443      79999999999999888432      258899999999999


Q ss_pred             HHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCccccee
Q 031702           76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFF  152 (154)
Q Consensus        76 ~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diw  152 (154)
                      +.|+.|||+.+++|+||+|+||++   +..+.+||+|||.+........   .....++..|+|||.+.+..++.++|||
T Consensus       123 ~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~  199 (273)
T cd05035         123 ALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVW  199 (273)
T ss_pred             HHHHHHHHhCCeeccccchheEEE---CCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchH
Confidence            999999999999999999999999   6778999999999876544321   1122345679999999888899999999


Q ss_pred             cC
Q 031702          153 VS  154 (154)
Q Consensus       153 sl  154 (154)
                      ||
T Consensus       200 Sl  201 (273)
T cd05035         200 AF  201 (273)
T ss_pred             HH
Confidence            96

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=9e-29  Score=172.81  Aligned_cols=144  Identities=28%  Similarity=0.512  Sum_probs=123.3

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      +...+.+.+|+.+++.++|||++++++.+...+..++++||+++++|.+++...   ..+++..+..++.+++.|+.|||
T Consensus        40 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH  119 (286)
T cd06622          40 ESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK  119 (286)
T ss_pred             HHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            344578899999999999999999999999999999999999999999988753   36899999999999999999999


Q ss_pred             h-CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCccccccc------CCCcccceecC
Q 031702           84 S-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ------RYDEKVNFFVS  154 (154)
Q Consensus        84 ~-~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Diwsl  154 (154)
                      . .+++|+||+|+||++   +..+.++|+|||.+...... ......+++.|+|||.+.+.      .++.++|+|||
T Consensus       120 ~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Diwsl  193 (286)
T cd06622         120 EEHNIIHRDVKPTNVLV---NGNGQVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSL  193 (286)
T ss_pred             hcCCEeeCCCCHHHEEE---CCCCCEEEeecCCcccccCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhH
Confidence            7 599999999999999   56788999999988655322 23344578889999998543      35789999996

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.96  E-value=2.6e-29  Score=173.68  Aligned_cols=141  Identities=21%  Similarity=0.418  Sum_probs=119.9

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      .+.+.+|+++++.++|||++++++.+.+ ...++++||+++++|.+++.+.  ..++...+..++.|++.|++++|+.++
T Consensus        45 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i  123 (262)
T cd05071          45 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY  123 (262)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            4678999999999999999999987754 5579999999999999999753  347889999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc--ccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||.+.........  ....++..|+|||...+..++.++|+|||
T Consensus       124 ~H~dl~p~Nill---~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dvwsl  189 (262)
T cd05071         124 VHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF  189 (262)
T ss_pred             cccccCcccEEE---cCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHH
Confidence            999999999999   56778999999998765433221  22345567999999988889999999996

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=4.9e-29  Score=176.46  Aligned_cols=143  Identities=29%  Similarity=0.474  Sum_probs=124.0

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ..+.+.+|+.+++.++|+||+++++.+.++...|+++||+.+++|.+++...  ..+++..+..++.|++.|++|||+.+
T Consensus        44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~  123 (316)
T cd05574          44 KVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG  123 (316)
T ss_pred             HHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4567889999999999999999999999999999999999999999998754  46899999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc------------------------------cccccCCccccC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY------------------------------AEKVCGSPLYMA  136 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~------------------------------~~~~~~~~~y~a  136 (154)
                      ++|+||+|+||++   +..+.++|+|||++........                              .....|+..|+|
T Consensus       124 i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~a  200 (316)
T cd05574         124 IVYRDLKPENILL---HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIA  200 (316)
T ss_pred             eeccCCChHHeEE---cCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcC
Confidence            9999999999999   5677899999998765422110                              112356788999


Q ss_pred             cccccccCCCcccceecC
Q 031702          137 PEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus       137 PE~~~~~~~~~~~Diwsl  154 (154)
                      ||++.+..++.++|||||
T Consensus       201 PE~~~~~~~~~~~Di~sl  218 (316)
T cd05574         201 PEVISGDGHGSAVDWWTL  218 (316)
T ss_pred             HHHHcCCCCCchHHHHHH
Confidence            999998889999999996

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=6.6e-29  Score=172.98  Aligned_cols=143  Identities=24%  Similarity=0.368  Sum_probs=122.7

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|+.+++.++|||++++++++.+ ...++++||+++++|.+++.+. ..+++..+..++.|++.|++|||+.+
T Consensus        51 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~  129 (279)
T cd05057          51 KANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR  129 (279)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            345778899999999999999999999887 7789999999999999998764 46899999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccc---cccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.++|+|||.+..........   ...++..|+|||......++.++|+|||
T Consensus       130 i~H~di~p~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  197 (279)
T cd05057         130 LVHRDLAARNVLV---KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSY  197 (279)
T ss_pred             EEecccCcceEEE---cCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHH
Confidence            9999999999999   567789999999987654332211   1223457999999988889999999996

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=2.6e-29  Score=175.53  Aligned_cols=144  Identities=31%  Similarity=0.530  Sum_probs=127.6

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-H   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~   85 (154)
                      +...+.+.+|+++++.++|||++++++.+...+.+++++||+++++|.+++.+.+.++...+..++.+++.++.|||+ .
T Consensus        44 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~  123 (284)
T cd06620          44 SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH  123 (284)
T ss_pred             chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence            345678899999999999999999999999999999999999999999999887889999999999999999999997 5


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||+|+||++   +..+.++|+|||++...... ......++..|+|||++.+..++.++|+|||
T Consensus       124 ~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~sl  188 (284)
T cd06620         124 RIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINS-IADTFVGTSTYMSPERIQGGKYTVKSDVWSL  188 (284)
T ss_pred             CeeccCCCHHHEEE---CCCCcEEEccCCcccchhhh-ccCccccCcccCCHHHHccCCCCccchHHHH
Confidence            89999999999999   67788999999987654222 2234568899999999988889999999996

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.96  E-value=6.9e-29  Score=172.21  Aligned_cols=142  Identities=35%  Similarity=0.535  Sum_probs=124.7

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (154)
                      .+.+.+|+.+++.++|||++++++.+...+..++++||+++++|.+++.+.+.++...+..++.|++.|+.+||+.+++|
T Consensus        52 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H  131 (272)
T cd06629          52 VKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILH  131 (272)
T ss_pred             HHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeee
Confidence            45788899999999999999999999999999999999999999999988888999999999999999999999999999


Q ss_pred             ecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccC--CCcccceecC
Q 031702           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQR--YDEKVNFFVS  154 (154)
Q Consensus        90 ~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~--~~~~~Diwsl  154 (154)
                      +||+|+||++   +..+.++++|||.+.......   ......++..|+|||......  ++.++|+|||
T Consensus       132 ~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~sl  198 (272)
T cd06629         132 RDLKADNLLV---DADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSL  198 (272)
T ss_pred             cCCChhhEEE---cCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHH
Confidence            9999999999   678899999999987543221   122345788899999987654  7899999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.96  E-value=4.5e-29  Score=173.81  Aligned_cols=144  Identities=23%  Similarity=0.345  Sum_probs=121.7

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ....+.+.+|+.+++.++|||++++++.+... ..++++||+++|+|.+++..+ +.+++..+..++.|++.|++|||++
T Consensus        50 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~  128 (279)
T cd05109          50 PKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV  128 (279)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            34567788999999999999999999988754 467899999999999998764 4689999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc---ccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||+|+||++   ...+.+||+|||++.........   ....+++.|+|||...+..++.++|||||
T Consensus       129 ~iiH~dlkp~Nil~---~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  197 (279)
T cd05109         129 RLVHRDLAARNVLV---KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSY  197 (279)
T ss_pred             CeeccccccceEEE---cCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHH
Confidence            99999999999999   56677999999998765432221   12234567999999988889999999996

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=3.4e-29  Score=181.36  Aligned_cols=144  Identities=24%  Similarity=0.441  Sum_probs=125.7

Q ss_pred             hhhhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH
Q 031702            6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      ++...+-+.+|+..|.+| +|.+|++++++-..++.+|||||+ +..+|.+.+++... .+...++.+++||+.|+.++|
T Consensus       399 D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~-Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH  477 (677)
T KOG0596|consen  399 DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC-GDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH  477 (677)
T ss_pred             CHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec-ccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH
Confidence            456678899999999999 799999999999999999999995 46799999987765 444688999999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCccccccc-----------CCCccc
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQ-----------RYDEKV  149 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~-----------~~~~~~  149 (154)
                      +.||||.||||.|+++    ..|.+||+|||.|..+.+++.   ..+.+||+-||+||.+...           +.++++
T Consensus       478 ~~gIVHSDLKPANFLl----VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~S  553 (677)
T KOG0596|consen  478 QHGIVHSDLKPANFLL----VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKS  553 (677)
T ss_pred             HhceeecCCCcccEEE----EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCcc
Confidence            9999999999999998    578999999999998877653   4668999999999998543           256889


Q ss_pred             ceecC
Q 031702          150 NFFVS  154 (154)
Q Consensus       150 Diwsl  154 (154)
                      |||||
T Consensus       554 DvWSL  558 (677)
T KOG0596|consen  554 DVWSL  558 (677)
T ss_pred             chhhh
Confidence            99996

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.96  E-value=3.1e-29  Score=182.61  Aligned_cols=142  Identities=27%  Similarity=0.461  Sum_probs=120.9

Q ss_pred             HHhHHHHHHHHhhCC-CCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC---------------------------
Q 031702           10 KSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---------------------------   61 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---------------------------   61 (154)
                      .+.+.+|+.++..+. ||||+++++++.+.+..++++||+++|+|.+++....                           
T Consensus        84 ~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (401)
T cd05107          84 KQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQ  163 (401)
T ss_pred             HHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccc
Confidence            457889999999996 9999999999999999999999999999999986432                           


Q ss_pred             -----------------------------------------------------------------------CCCHHHHHH
Q 031702           62 -----------------------------------------------------------------------RVPEQTARK   70 (154)
Q Consensus        62 -----------------------------------------------------------------------~~~~~~~~~   70 (154)
                                                                                             .++...+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  243 (401)
T cd05107         164 RKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVG  243 (401)
T ss_pred             cccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHH
Confidence                                                                                   245667888


Q ss_pred             HHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCCCc
Q 031702           71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDE  147 (154)
Q Consensus        71 ~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~  147 (154)
                      ++.|++.|+.|||+.+++|+||+|+||++   +....++|+|||++.......   ......++..|+|||.+.+..++.
T Consensus       244 ~~~qi~~aL~~LH~~~ivHrdlkp~NiLl---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  320 (401)
T cd05107         244 FSYQVANGMEFLASKNCVHRDLAARNVLI---CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT  320 (401)
T ss_pred             HHHHHHHHHHHHhcCCcCcccCCcceEEE---eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCc
Confidence            99999999999999999999999999999   567789999999987643322   122334577899999998888999


Q ss_pred             ccceecC
Q 031702          148 KVNFFVS  154 (154)
Q Consensus       148 ~~Diwsl  154 (154)
                      ++|||||
T Consensus       321 ~~Dvwsl  327 (401)
T cd05107         321 LSDVWSF  327 (401)
T ss_pred             HhHHHHH
Confidence            9999996

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.96  E-value=6.6e-29  Score=175.61  Aligned_cols=145  Identities=24%  Similarity=0.391  Sum_probs=124.1

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ....+.+.+|+.+++.++|+||+++++++.+.+..++++||+++++|.+++...  ..+++..+..++.|++.|++|||+
T Consensus        40 ~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~  119 (314)
T cd08216          40 KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS  119 (314)
T ss_pred             hhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            445678999999999999999999999999999999999999999999998754  458899999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--------cccccCCccccCcccccc--cCCCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQF--QRYDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~--~~~~~~~Diwsl  154 (154)
                      .+++|+||+|+||++   +..+.++++||+.+........        .....++..|+|||++..  ..++.++|+|||
T Consensus       120 ~~ivH~dlk~~Nili---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~  196 (314)
T cd08216         120 KGFIHRSVKASHILL---SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSV  196 (314)
T ss_pred             CCeecCCCCcceEEE---ecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHH
Confidence            999999999999999   5677899999998865432211        223345678999999875  358899999996

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.96  E-value=5e-29  Score=174.43  Aligned_cols=143  Identities=24%  Similarity=0.400  Sum_probs=120.8

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC----------CCCHHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------RVPEQTARKFLQQLGAG   78 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~i~~~   78 (154)
                      ....+.+|+.+++.++|||++++++++.+++..+++|||+++|+|.+++....          ..+...+..++.|++.|
T Consensus        52 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  131 (288)
T cd05061          52 ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG  131 (288)
T ss_pred             HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHH
Confidence            34567889999999999999999999999999999999999999999997532          24566788999999999


Q ss_pred             HHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCcccceecC
Q 031702           79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        79 l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +.|||+.+++|+||+|+||++   +..+.++|+|||++........   .....++..|+|||.+.++.++.++|+|||
T Consensus       132 l~~lH~~~i~H~dikp~nili---~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dvwsl  207 (288)
T cd05061         132 MAYLNAKKFVHRDLAARNCMV---AHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSF  207 (288)
T ss_pred             HHHHHhCCCcCCCCChheEEE---cCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHH
Confidence            999999999999999999999   5678899999999876543221   112234567999999988889999999996

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=5.8e-29  Score=172.04  Aligned_cols=144  Identities=28%  Similarity=0.545  Sum_probs=124.5

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecC--CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      .....+.+|+.+++.++|+|++++++.+.+.  +.+++++||+++++|.+++.+.+.+++..+..++.|++.|+.|||+.
T Consensus        46 ~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~  125 (264)
T cd06653          46 KEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN  125 (264)
T ss_pred             HHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4456889999999999999999999988664  46889999999999999998777899999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC----ccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||+|+||++   +..+.++|+|||++.......    ......++..|+|||.+.+..++.++|+|||
T Consensus       126 ~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  195 (264)
T cd06653         126 MIVHRDIKGANILR---DSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSV  195 (264)
T ss_pred             CEecCCCCHHHEEE---cCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHH
Confidence            99999999999999   567789999999987653211    1123457888999999988888999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.96  E-value=3.7e-29  Score=173.50  Aligned_cols=145  Identities=27%  Similarity=0.464  Sum_probs=120.7

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecC------CcEEEEEEecCCCCchHHHHHc------CCCCHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLH------GRVPEQTARKFLQQ   74 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~   74 (154)
                      ....+.+.+|+.+++.++|+||+++++.+...      ...++++||+++++|.+++...      ..+++..+..++.|
T Consensus        41 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  120 (272)
T cd05075          41 RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD  120 (272)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHH
Confidence            44567889999999999999999999876322      3578999999999999887422      24789999999999


Q ss_pred             HHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCcccce
Q 031702           75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNF  151 (154)
Q Consensus        75 i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di  151 (154)
                      ++.|++|||+.+++|+||||+||++   +..+.++|+|||++........   .....+++.|+|||...+..++.++||
T Consensus       121 i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di  197 (272)
T cd05075         121 IASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDV  197 (272)
T ss_pred             HHHHHHHHHHCCeeccccchhheEE---cCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHH
Confidence            9999999999999999999999999   6778899999999876544321   122345677999999998889999999


Q ss_pred             ecC
Q 031702          152 FVS  154 (154)
Q Consensus       152 wsl  154 (154)
                      |||
T Consensus       198 ~sl  200 (272)
T cd05075         198 WSF  200 (272)
T ss_pred             HHH
Confidence            996

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.96  E-value=5.3e-29  Score=172.47  Aligned_cols=147  Identities=28%  Similarity=0.440  Sum_probs=122.9

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-------CCCCHHHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-------GRVPEQTARKFLQQLGAGLE   80 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~l~   80 (154)
                      .....+.+|+++++.++||||+++++++......++++||+++++|.+++...       ..++...+..++.|++.|+.
T Consensus        41 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~  120 (269)
T cd05044          41 QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV  120 (269)
T ss_pred             hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHH
Confidence            34667889999999999999999999999999999999999999999998643       23778899999999999999


Q ss_pred             HHHhCCceeecCCCCcEEeecCC--CCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCcccceecC
Q 031702           81 ILNSHHIIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        81 ~lh~~~~~h~~i~p~nil~~~~~--~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |||+.+++|+||+|+||++...+  ....++++|||++........   .....++..|+|||.+.++.++.++|||||
T Consensus       121 ~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  199 (269)
T cd05044         121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSF  199 (269)
T ss_pred             HHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHH
Confidence            99999999999999999995322  223799999999876543221   122334677999999998889999999996

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.96  E-value=6.5e-29  Score=170.88  Aligned_cols=145  Identities=28%  Similarity=0.572  Sum_probs=126.4

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ....+.+.+|+.+++.++|||++++.+.+.+.+..++++||+.+++|.+++....  .+++.++..++.|++.|+.+||+
T Consensus        40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~  119 (256)
T cd08218          40 PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD  119 (256)
T ss_pred             hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            4456688999999999999999999999999999999999999999999887543  57899999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc-cccccCCccccCcccccccCCCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++++|+||+|+||++   +..+.++++|||.+........ .....+++.|+|||++.+..++.++|+|||
T Consensus       120 ~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~sl  187 (256)
T cd08218         120 RKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWAL  187 (256)
T ss_pred             CCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHH
Confidence            999999999999999   6677899999999876544322 223457788999999988888999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.96  E-value=2.3e-29  Score=175.59  Aligned_cols=141  Identities=30%  Similarity=0.546  Sum_probs=120.3

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      .+.+.+|+.+++.++|||++++++++.+.+..++++||++ ++|.+++.+ ...+++..++.++.|++.|+.|||+.+++
T Consensus        43 ~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~  121 (284)
T cd07839          43 PSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVL  121 (284)
T ss_pred             ccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            3567889999999999999999999999999999999996 478777754 45799999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCccccccc-CCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      |+||+|+||++   +..+.++|+|||++....... ......+++.|+|||++.+. .++.++|||||
T Consensus       122 H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  186 (284)
T cd07839         122 HRDLKPQNLLI---NKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA  186 (284)
T ss_pred             cCCCCHHHEEE---cCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHH
Confidence            99999999999   677889999999987553322 22234567889999998764 47899999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.96  E-value=4e-29  Score=174.80  Aligned_cols=144  Identities=26%  Similarity=0.536  Sum_probs=122.7

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC----------------------CCCH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------------RVPE   65 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----------------------~~~~   65 (154)
                      ...+.+.+|+.+++.+.|||++++++++.++...++++||+++++|.+++....                      .+++
T Consensus        50 ~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  129 (288)
T cd05050          50 DMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC  129 (288)
T ss_pred             HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCH
Confidence            345778999999999999999999999999999999999999999999986432                      3677


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccc
Q 031702           66 QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQF  142 (154)
Q Consensus        66 ~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~  142 (154)
                      ..++.++.|++.|+.+||+.+++|+||+|+||++   +..+.++++|||.+........   ......+..|+|||...+
T Consensus       130 ~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  206 (288)
T cd05050         130 TEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY  206 (288)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeecccccHhheEe---cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc
Confidence            8889999999999999999999999999999999   6778899999998875433221   122234567999999988


Q ss_pred             cCCCcccceecC
Q 031702          143 QRYDEKVNFFVS  154 (154)
Q Consensus       143 ~~~~~~~Diwsl  154 (154)
                      ..++.++|+|||
T Consensus       207 ~~~~~~~Dv~sl  218 (288)
T cd05050         207 NRYTTESDVWAY  218 (288)
T ss_pred             CCCCchhHHHHH
Confidence            889999999996

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.96  E-value=5.7e-29  Score=174.91  Aligned_cols=142  Identities=30%  Similarity=0.557  Sum_probs=125.4

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++|||++++++.+...+..++++||+++++|.+++.. ..+++.++..++.+++.|+++||+.+++
T Consensus        59 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~  137 (296)
T cd06655          59 KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVI  137 (296)
T ss_pred             hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            356788999999999999999999999999999999999999999998864 4689999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCCc-cccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||+|+||++   +..+.++|+|||++........ .....++..|+|||.+.+..++.++|+|||
T Consensus       138 H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  201 (296)
T cd06655         138 HRDIKSDNVLL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL  201 (296)
T ss_pred             cCCCCHHHEEE---CCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHH
Confidence            99999999999   6778899999998876544322 233467888999999988889999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.96  E-value=5e-29  Score=170.09  Aligned_cols=137  Identities=26%  Similarity=0.397  Sum_probs=118.5

Q ss_pred             HHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecC
Q 031702           13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDL   92 (154)
Q Consensus        13 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i   92 (154)
                      ..+|...+....|||++++++.+.+....+++|||+++++|.+++.+...+++..+..++.|++.|+.|+|+.+++|+||
T Consensus        32 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dl  111 (237)
T cd05576          32 YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDL  111 (237)
T ss_pred             hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence            34555666666899999999999999999999999999999999987778999999999999999999999999999999


Q ss_pred             CCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           93 KPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        93 ~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||++   +..+.++++|||.+......  .....++..|+|||...+..++.++|+|||
T Consensus       112 kp~Nil~---~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  168 (237)
T cd05576         112 NPNNILL---DDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGISEETEACDWWSL  168 (237)
T ss_pred             CHHHEEE---cCCCCEEEecccchhccccc--cccCCcCccccCCcccCCCCCCchhhHHHH
Confidence            9999999   67788999999977554332  223445677999999988888999999995

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.96  E-value=6.2e-29  Score=172.10  Aligned_cols=144  Identities=24%  Similarity=0.413  Sum_probs=123.5

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|+.+++.++|+|++++.+++.+.+..+++|||+++++|.+++... ..+++.++..++.|++.|++|||+.+
T Consensus        48 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~  127 (268)
T cd05063          48 KQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN  127 (268)
T ss_pred             HHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34677899999999999999999999999999999999999999999998754 46899999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc----ccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.++++|||++.........    .....+..|+|||++.+..++.++|+|||
T Consensus       128 i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl  196 (268)
T cd05063         128 YVHRDLAARNILV---NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSF  196 (268)
T ss_pred             eeccccchhhEEE---cCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHH
Confidence            9999999999999   56778999999998755432211    11122356999999988889999999996

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.96  E-value=4.5e-29  Score=176.61  Aligned_cols=144  Identities=27%  Similarity=0.480  Sum_probs=117.1

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhhee--cCCcEEEEEEecCCCCchHHHHHc---------CCCCHHHHHHHHHHHHHH
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLH---------GRVPEQTARKFLQQLGAG   78 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~i~~~   78 (154)
                      ...+.+|+.+++.++|||++++.+++.  .+...++++||++ ++|.+++...         ..+++..+..++.|++.|
T Consensus        42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a  120 (317)
T cd07867          42 SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG  120 (317)
T ss_pred             cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHH
Confidence            346788999999999999999999885  3567899999986 4777776422         247889999999999999


Q ss_pred             HHHHHhCCceeecCCCCcEEeecC-CCCeeEEEeecccccccCCCC----ccccccCCccccCccccccc-CCCccccee
Q 031702           79 LEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFF  152 (154)
Q Consensus        79 l~~lh~~~~~h~~i~p~nil~~~~-~~~~~~kl~df~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~Diw  152 (154)
                      +.|||+.+++|+||||+||++... +..+.+||+|||++.......    ......+|+.|+|||++.+. .++.++|||
T Consensus       121 L~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  200 (317)
T cd07867         121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW  200 (317)
T ss_pred             HHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHH
Confidence            999999999999999999999543 356789999999997654332    12334678899999998764 578999999


Q ss_pred             cC
Q 031702          153 VS  154 (154)
Q Consensus       153 sl  154 (154)
                      ||
T Consensus       201 Sl  202 (317)
T cd07867         201 AI  202 (317)
T ss_pred             hH
Confidence            96

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.96  E-value=6.8e-29  Score=171.22  Aligned_cols=144  Identities=33%  Similarity=0.553  Sum_probs=129.7

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-HH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~   86 (154)
                      ...+.+.+|+..++.++|+|++++++.+..++..++++||+++++|.+++.....+++..+..++.|++.|+++||+ .+
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~  120 (264)
T cd06623          41 EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH  120 (264)
T ss_pred             HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC
Confidence            34678999999999999999999999999999999999999999999999888889999999999999999999999 99


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc-ccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.++|+|||.+......... ....++..|+|||...+..++.++|+|||
T Consensus       121 ~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~sl  186 (264)
T cd06623         121 IIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSL  186 (264)
T ss_pred             CccCCCCHHHEEE---CCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHH
Confidence            9999999999999   67889999999998766544332 24567888999999998889999999996

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.96  E-value=6.5e-29  Score=173.69  Aligned_cols=143  Identities=27%  Similarity=0.520  Sum_probs=125.7

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++|||++++++.+..++..++++||+++++|.+++.. ..++...+..++.|++.|+++||+.++
T Consensus        58 ~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i  136 (285)
T cd06648          58 QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGV  136 (285)
T ss_pred             hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            3456688999999999999999999999999999999999999999999876 678999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||.+....... ......+++.|+|||...+..++.++|+|||
T Consensus       137 ~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  201 (285)
T cd06648         137 IHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSL  201 (285)
T ss_pred             ecCCCChhhEEE---cCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHH
Confidence            999999999999   677899999999876543322 2233457889999999988889999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.96  E-value=1.7e-29  Score=185.54  Aligned_cols=145  Identities=27%  Similarity=0.480  Sum_probs=128.2

Q ss_pred             hhhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh
Q 031702            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      .+...+.|..|..+|+.++||+|+++.|++.+.+ .++|||.++.|.|..|+..+. .++......++.|++.|+.|||+
T Consensus       431 t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeS  509 (974)
T KOG4257|consen  431 TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLES  509 (974)
T ss_pred             ChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHh
Confidence            3577999999999999999999999999998765 799999999999999997654 69999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccC--CccccCcccccccCCCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG--SPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~--~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .+++||||...||++   .+...+||+|||+++.+..........|  ...|||||.+....++.++|+|.|
T Consensus       510 krfVHRDIAaRNiLV---sSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMF  578 (974)
T KOG4257|consen  510 KRFVHRDIAARNILV---SSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMF  578 (974)
T ss_pred             hchhhhhhhhhheee---cCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHH
Confidence            999999999999999   6777899999999998776654433222  345999999999999999999976

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.96  E-value=6.9e-29  Score=172.11  Aligned_cols=144  Identities=25%  Similarity=0.448  Sum_probs=121.6

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ....+.+.+|+.+++.++|||++++++++.++ ..++++||+++++|.+++.+.. .++...+..++.+++.|+.|||+.
T Consensus        48 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~  126 (270)
T cd05056          48 PSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK  126 (270)
T ss_pred             HHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            34567899999999999999999999988754 4689999999999999997644 589999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc--ccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||+|+||++   +..+.++++|||++.........  ....++..|+|||.+....++.++|||||
T Consensus       127 ~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  194 (270)
T cd05056         127 RFVHRDIAARNVLV---SSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMF  194 (270)
T ss_pred             CeeccccChheEEE---ecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHH
Confidence            99999999999999   56778999999998765433211  12223457999999988889999999996

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.96  E-value=1.1e-28  Score=170.24  Aligned_cols=144  Identities=29%  Similarity=0.566  Sum_probs=127.4

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+++++.++|+||+++++.+.+.+..++++||+++++|.+++.+...+++..+..++.+++.|++|||+.++
T Consensus        41 ~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i  120 (264)
T cd06626          41 KTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGI  120 (264)
T ss_pred             HHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCc
Confidence            35778999999999999999999999999999999999999999999999877778999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc-----ccccCCccccCcccccccC---CCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-----EKVCGSPLYMAPEVLQFQR---YDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~---~~~~~Diwsl  154 (154)
                      +|+||+|.||++   +..+.++|+|||.+.........     ....++..|+|||.+.+..   ++.++|||||
T Consensus       121 ~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~  192 (264)
T cd06626         121 VHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSL  192 (264)
T ss_pred             ccCCCCHHHEEE---CCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHH
Confidence            999999999999   56788999999998766443321     1345678899999998766   7899999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.96  E-value=1.1e-28  Score=170.99  Aligned_cols=145  Identities=30%  Similarity=0.461  Sum_probs=122.8

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHHh
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRV--PEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~--~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ...+.+.+|+.+++.++|+||+++++.+..++..++++||+++++|.+++... ..+  ++..+..++.|++.|++|||+
T Consensus        47 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~  126 (268)
T cd06624          47 RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD  126 (268)
T ss_pred             HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH
Confidence            45568899999999999999999999999999999999999999999998754 445  788899999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccC--CCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR--YDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~~Diwsl  154 (154)
                      .+++|+||+|+||++.  ...+.++|+|||.+....... ......+++.|+|||.+.+..  ++.++|+|||
T Consensus       127 ~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~sl  197 (268)
T cd06624         127 NQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSL  197 (268)
T ss_pred             CCEeecCCCHHHEEEc--CCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHH
Confidence            9999999999999993  235689999999987654322 223345788899999986543  7889999996

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.96  E-value=7.4e-29  Score=171.13  Aligned_cols=144  Identities=26%  Similarity=0.398  Sum_probs=120.4

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhhee-cCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ...+.+.+|+.+++.++|||++++++.+. .++..++++||+.+++|.+++.+. ...+...+..++.|++.|+.|||+.
T Consensus        38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~  117 (262)
T cd05058          38 EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK  117 (262)
T ss_pred             HHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            34568889999999999999999999765 455689999999999999998754 3467788889999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-----ccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||+|+||++   +..+.+||+|||++.......     ......++..|+|||.+.+..++.++|||||
T Consensus       118 ~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  188 (262)
T cd05058         118 KFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSF  188 (262)
T ss_pred             CccccccCcceEEE---cCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHH
Confidence            99999999999999   667789999999987543321     1122344667999999988889999999996

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=5.7e-29  Score=183.21  Aligned_cols=145  Identities=30%  Similarity=0.596  Sum_probs=127.4

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      .........|-+||..-..+.||+++..|.+++.+|+||||++||++..++-+.+-|++...+.+++++..|+++.|..|
T Consensus       670 rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG  749 (1034)
T KOG0608|consen  670 RNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG  749 (1034)
T ss_pred             hhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc
Confidence            33445667799999999999999999999999999999999999999999998999999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccC---------CCC--------c-------------------------
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---------PGN--------Y-------------------------  124 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~---------~~~--------~-------------------------  124 (154)
                      ++||||||.||||   |.++++||.|||++.-+.         .++        .                         
T Consensus       750 FIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~  826 (1034)
T KOG0608|consen  750 FIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRI  826 (1034)
T ss_pred             ceecccCccceEE---ccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhh
Confidence            9999999999999   899999999999985221         000        0                         


Q ss_pred             -cccccCCccccCcccccccCCCcccceecC
Q 031702          125 -AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus       125 -~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                       .....||+-|+|||++...+|+..+|+||.
T Consensus       827 ~ahslvgt~nyiapevl~r~g~~q~cdwws~  857 (1034)
T KOG0608|consen  827 LAHSLVGTPNYIAPEVLARTGYTQLCDWWSV  857 (1034)
T ss_pred             hhhhhcCCCcccChHHhcccCccccchhhHh
Confidence             012468999999999999999999999983

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.96  E-value=8.1e-29  Score=172.45  Aligned_cols=143  Identities=28%  Similarity=0.535  Sum_probs=126.2

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.+.|||++++.+.+.+++..++++||+++++|.+++.. ..+++.++..++.|++.|++++|+.++
T Consensus        44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i  122 (277)
T cd06640          44 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKK  122 (277)
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            4457889999999999999999999999999999999999999999998864 568999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++++|||++....... ......++..|+|||.+.+..++.++|+|||
T Consensus       123 vH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~sl  187 (277)
T cd06640         123 IHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSL  187 (277)
T ss_pred             cCcCCChhhEEE---cCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHH
Confidence            999999999999   677789999999987654433 2233457788999999988889999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.96  E-value=9.7e-29  Score=169.85  Aligned_cols=143  Identities=30%  Similarity=0.520  Sum_probs=125.5

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ..+.+.+|+.+++.++|+|++++++.+.+.+..++++||+++++|.+++.....  +++..+..++.|++.|+++||+.+
T Consensus        44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~  123 (258)
T smart00219       44 QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN  123 (258)
T ss_pred             HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC
Confidence            467889999999999999999999999999999999999999999999876554  999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccc--cccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.++|+|||.+..........  ...+++.|+|||...+..++.++|+|||
T Consensus       124 ~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~sl  190 (258)
T smart00219      124 FIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSF  190 (258)
T ss_pred             eeecccccceEEE---ccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHH
Confidence            9999999999999   677799999999987665432211  1235678999999988889999999996

Phosphotransferases. Tyrosine-specific kinase subfamily.

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.96  E-value=5e-29  Score=172.84  Aligned_cols=125  Identities=26%  Similarity=0.493  Sum_probs=112.5

Q ss_pred             CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEeecCC
Q 031702           24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD  103 (154)
Q Consensus        24 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~  103 (154)
                      +|||++++++.+..++..+++|||+++++|.+++.++..+++..+..++.|++.|+.+||+.+++|+||+|+||++.   
T Consensus        67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---  143 (267)
T PHA03390         67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD---  143 (267)
T ss_pred             cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---
Confidence            79999999999999999999999999999999998877899999999999999999999999999999999999994   


Q ss_pred             CCe-eEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702          104 DDV-MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus       104 ~~~-~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ..+ .++++|||.+......   ....++..|+|||++.+..++.++|+|||
T Consensus       144 ~~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  192 (267)
T PHA03390        144 RAKDRIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAV  192 (267)
T ss_pred             CCCCeEEEecCccceecCCC---ccCCCCCcccChhhhcCCCCCchhhHHHH
Confidence            444 8999999988755332   23457889999999998889999999996

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=4.8e-29  Score=172.00  Aligned_cols=142  Identities=25%  Similarity=0.455  Sum_probs=123.3

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      .+.+.+|+.+++.++|+|++++++++.+....++++||+++++|.+++....  .++...+..++.+++.|+.|||++++
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i  124 (261)
T cd05034          45 PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNY  124 (261)
T ss_pred             HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            4678999999999999999999999998889999999999999999987543  58999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc--ccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++++|||.+.........  .....+..|+|||...+..++.++|+|||
T Consensus       125 ~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  190 (261)
T cd05034         125 IHRDLAARNILV---GENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSF  190 (261)
T ss_pred             ccCCcchheEEE---cCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHH
Confidence            999999999999   67789999999998765432211  12233567999999998889999999996

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.96  E-value=9.3e-29  Score=172.59  Aligned_cols=143  Identities=31%  Similarity=0.539  Sum_probs=124.1

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++|||++++++++.+++..++++||++++++..+......+++..+..++.|++.|+.|||+.+++
T Consensus        43 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~  122 (286)
T cd07846          43 VKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNII  122 (286)
T ss_pred             hhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            35678899999999999999999999999999999999999999988877666799999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccc-cCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      |+|++|+||++   +.++.++|+|||++....... ......++..|+|||+..+ ..++.++|||||
T Consensus       123 h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl  187 (286)
T cd07846         123 HRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAV  187 (286)
T ss_pred             ccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHH
Confidence            99999999999   678899999999987654332 2223456788999999865 347789999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.96  E-value=6e-29  Score=174.82  Aligned_cols=143  Identities=29%  Similarity=0.524  Sum_probs=125.7

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++|+|++++++.+..++..++++||+++++|.+++.+ ..+++.++..++.|++.++.+||+.++
T Consensus        58 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i  136 (297)
T cd06656          58 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQV  136 (297)
T ss_pred             chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            3456788999999999999999999999999999999999999999998864 568899999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc-cccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++++|||++........ .....+++.|+|||.+.+..++.++|+|||
T Consensus       137 ~H~dL~p~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  201 (297)
T cd06656         137 IHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL  201 (297)
T ss_pred             ccCCCCHHHEEE---CCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHH
Confidence            999999999999   6778899999999876543322 233467888999999998889999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.96  E-value=7.1e-29  Score=173.40  Aligned_cols=143  Identities=33%  Similarity=0.589  Sum_probs=126.7

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+++++.++|+|++++++.+...+..++++||+++++|.+++.... .++...+..++.+++.|+.+||+.|+
T Consensus        58 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi  137 (286)
T cd06614          58 NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNV  137 (286)
T ss_pred             hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            36778899999999999999999999999999999999999999999998776 79999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+|++|+||++   +..+.++|+|||.+....... ......+++.|+|||.+.+..++.++|+|||
T Consensus       138 ~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl  202 (286)
T cd06614         138 IHRDIKSDNILL---SKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSL  202 (286)
T ss_pred             eeCCCChhhEEE---cCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHH
Confidence            999999999999   677789999999876543322 2233456788999999988889999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=2.5e-29  Score=163.15  Aligned_cols=146  Identities=28%  Similarity=0.462  Sum_probs=125.1

Q ss_pred             hhhhhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHH----HHcCCCCHHHHHHHHHHHHHHH
Q 031702            5 LNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----RLHGRVPEQTARKFLQQLGAGL   79 (154)
Q Consensus         5 ~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~----~~~~~~~~~~~~~~~~~i~~~l   79 (154)
                      ++.....++.+|+++..+- .+|++|.+++.......+++.||.| ..||..|.    ++++.+++..+.+++-.++.|+
T Consensus        83 vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al  161 (282)
T KOG0984|consen   83 VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHAL  161 (282)
T ss_pred             cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHH
Confidence            3566788888999988776 8999999999999999999999999 45887765    4557799999999999999999


Q ss_pred             HHHHhC-CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc----cCCCcccceecC
Q 031702           80 EILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF----QRYDEKVNFFVS  154 (154)
Q Consensus        80 ~~lh~~-~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Diwsl  154 (154)
                      .|||++ .++|||+||+||++   +..+++|++|||.+..+.++-....-.|+..|+|||.+..    ..|+.++|||||
T Consensus       162 ~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSL  238 (282)
T KOG0984|consen  162 EFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSL  238 (282)
T ss_pred             HHHHHHhhhhhccCCcceEEE---ccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhh
Confidence            999986 89999999999999   8999999999999876655433333568889999999853    479999999997

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.96  E-value=8.9e-29  Score=173.73  Aligned_cols=141  Identities=33%  Similarity=0.498  Sum_probs=122.5

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ...+.+|+++++.++|+|++++++++.+.+..++++||+ +++|.+++.... .+++..+..++.|+++|+.|||+.+++
T Consensus        46 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~  124 (298)
T cd07841          46 NFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWIL  124 (298)
T ss_pred             hHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            456778999999999999999999999999999999999 889999998766 799999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccc-cCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      |+||+|+||++   +..+.++|+|||++....... ......+++.|+|||.+.+ ..++.++|+|||
T Consensus       125 H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl  189 (298)
T cd07841         125 HRDLKPNNLLI---ASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSV  189 (298)
T ss_pred             ecCCChhhEEE---cCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHH
Confidence            99999999999   677889999999987664432 2223345778999999854 457899999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.96  E-value=3.3e-28  Score=166.73  Aligned_cols=143  Identities=42%  Similarity=0.645  Sum_probs=128.0

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++|+|++++++.+.+++..+++|||+++++|.+++.....+++..+..++.|++.|+.++|+.+++
T Consensus        36 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~  115 (250)
T cd05123          36 EVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGII  115 (250)
T ss_pred             HHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence            45688999999999999999999999999999999999999999999998887899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||+|.||++   +..+.++|+|||.+...... .......++..|+|||...+...+.++|+|||
T Consensus       116 H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~sl  179 (250)
T cd05123         116 YRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSL  179 (250)
T ss_pred             ecCCCcceEEE---cCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHH
Confidence            99999999999   56778999999998765443 23344567888999999988888899999996

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.96  E-value=1.5e-28  Score=168.71  Aligned_cols=143  Identities=31%  Similarity=0.505  Sum_probs=123.2

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+++++.++|+||+++++++.+....++++||+++++|.+++.+. ..++...+..++.+++.++.+||++++
T Consensus        35 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i  114 (251)
T cd05041          35 LKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNC  114 (251)
T ss_pred             HHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            4578899999999999999999999999999999999999999999998653 468899999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc---ccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||.+.........   .....+..|+|||.+.++.++.++|+|||
T Consensus       115 ~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  181 (251)
T cd05041         115 IHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSY  181 (251)
T ss_pred             ehhhcCcceEEE---cCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHH
Confidence            999999999999   67788999999998754322211   11223456999999988889999999996

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.96  E-value=1.1e-28  Score=172.22  Aligned_cols=142  Identities=30%  Similarity=0.602  Sum_probs=119.1

Q ss_pred             HHhHHHHHHHHhhC-CCCccchhhhhee-----cCCcEEEEEEecCCCCchHHHHH----cCCCCHHHHHHHHHHHHHHH
Q 031702           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGL   79 (154)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~-----~~~~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l   79 (154)
                      .+.+.+|+.+++.+ +|||++++++++.     .++.++++|||+++++|.+++..    ...+++..+..++.|++.|+
T Consensus        58 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l  137 (286)
T cd06638          58 DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL  137 (286)
T ss_pred             HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHH
Confidence            46788999999999 7999999999873     44678999999999999988753    24588899999999999999


Q ss_pred             HHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccc-----cCCCcccceec
Q 031702           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-----QRYDEKVNFFV  153 (154)
Q Consensus        80 ~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~Diws  153 (154)
                      .|||+.+++|+||+|+||++   +..+.++|+|||++....... ......|++.|+|||++..     ..++.++|+||
T Consensus       138 ~~lH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~s  214 (286)
T cd06638         138 QHLHVNKTIHRDVKGNNILL---TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWS  214 (286)
T ss_pred             HHHHhCCccccCCCHHhEEE---CCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhh
Confidence            99999999999999999999   567779999999987654332 2234568889999999753     45788999999


Q ss_pred             C
Q 031702          154 S  154 (154)
Q Consensus       154 l  154 (154)
                      |
T Consensus       215 l  215 (286)
T cd06638         215 L  215 (286)
T ss_pred             H
Confidence            6

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.96  E-value=2.5e-28  Score=170.19  Aligned_cols=133  Identities=32%  Similarity=0.558  Sum_probs=115.9

Q ss_pred             HHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcE
Q 031702           18 NFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENI   97 (154)
Q Consensus        18 ~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~ni   97 (154)
                      ..++...||+++++.+.+.+.+..++++||+.|++|.+++.+.+.+++..+..++.|++.|+.|||+.+++|+||+|+||
T Consensus        49 ~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~ni  128 (278)
T cd05606          49 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANI  128 (278)
T ss_pred             HHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHE
Confidence            34445679999999999999999999999999999999998778899999999999999999999999999999999999


Q ss_pred             EeecCCCCeeEEEeecccccccCCCCccccccCCccccCccccccc-CCCcccceecC
Q 031702           98 LLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        98 l~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      ++   +.++.++|+|||++...... ......|+..|+|||.+.++ .++.++|+|||
T Consensus       129 li---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~  182 (278)
T cd05606         129 LL---DEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSL  182 (278)
T ss_pred             EE---CCCCCEEEccCcCccccCcc-CCcCcCCCcCCcCcHHhcCCCCCCcccchHhH
Confidence            99   66778999999998755332 22345688999999998754 68999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.96  E-value=9.7e-29  Score=174.18  Aligned_cols=141  Identities=24%  Similarity=0.406  Sum_probs=120.1

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ...+.+|+.+++.++|||++++++.+..+ ..++++||+++|+|.+++..+. .+++..+..++.|++.|+.|||+++++
T Consensus        53 ~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iv  131 (303)
T cd05110          53 NVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLV  131 (303)
T ss_pred             HHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCee
Confidence            45688999999999999999999988654 4678999999999999987654 588999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||+|+||++   +..+.+||+|||++........   .....++..|+|||.+.+..++.++|||||
T Consensus       132 H~dikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Diwsl  197 (303)
T cd05110         132 HRDLAARNVLV---KSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSY  197 (303)
T ss_pred             ccccccceeee---cCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHH
Confidence            99999999999   5677899999999976543322   122334667999999988889999999996

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.96  E-value=2.3e-28  Score=167.88  Aligned_cols=144  Identities=38%  Similarity=0.545  Sum_probs=126.8

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH----cCCCCHHHHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEIL   82 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~l   82 (154)
                      ......+.+|+++++.++|+|++++.+++.++...++++||+++++|.+++..    ...+++..+..++.|++.|+++|
T Consensus        40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l  119 (256)
T cd08530          40 QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL  119 (256)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Confidence            34566788899999999999999999999999999999999999999998865    34589999999999999999999


Q ss_pred             HhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        83 h~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+.|++|+||+|.||++   +..+.++|+|||.+...... ......+++.|+|||...+..++.++|+|||
T Consensus       120 h~~~i~h~~l~~~ni~~---~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~sl  187 (256)
T cd08530         120 HEQKILHRDLKSANILL---VANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSL  187 (256)
T ss_pred             hhCCcccCCCCcceEEE---ecCCcEEEeeccchhhhccC-CcccccCCccccCHHHHCCCCCCchhhHHHH
Confidence            99999999999999999   55778999999998766544 3334567888999999998889999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.96  E-value=1.3e-28  Score=169.36  Aligned_cols=140  Identities=26%  Similarity=0.491  Sum_probs=119.4

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ..+.+.+|+.+++.++|||++++.+.+...+ .++++||+++++|.+++....  .++...+..++.|++.|+.|||+.|
T Consensus        42 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~  120 (254)
T cd05083          42 TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK  120 (254)
T ss_pred             hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            4567889999999999999999999886654 799999999999999987654  4789999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.++|+|||.+......  ......+..|+|||.+.++.++.++|+|||
T Consensus       121 ~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl  183 (254)
T cd05083         121 LVHRDLAARNILV---SEDGVAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKHKKFSSKSDVWSY  183 (254)
T ss_pred             eeccccCcceEEE---cCCCcEEECCCccceecccc--CCCCCCCceecCHHHhccCCcCchhhHHHH
Confidence            9999999999999   56778999999988653322  112233567999999988889999999996

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.96  E-value=1.9e-28  Score=170.68  Aligned_cols=145  Identities=22%  Similarity=0.364  Sum_probs=123.1

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheec-CCcEEEEEEecCCCCchHHHHHc--------CCCCHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH--------GRVPEQTARKFLQQLGA   77 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~i~~   77 (154)
                      ....+.+.+|+.+++.++|+|++++++++.. +...+++++|+++++|.+++...        ..+++..+..++.|++.
T Consensus        49 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~  128 (280)
T cd05043          49 EIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC  128 (280)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHH
Confidence            4456778999999999999999999998765 46789999999999999998653        35889999999999999


Q ss_pred             HHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCcccceecC
Q 031702           78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        78 ~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |++|||+.+++|+||+|+||++   +..+.+|++|||+++.......   .....++..|+|||++.+..++.++|||||
T Consensus       129 ~l~~LH~~~i~H~di~p~nil~---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl  205 (280)
T cd05043         129 GMSYLHKRGVIHKDIAARNCVI---DEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSF  205 (280)
T ss_pred             HHHHHHHCCEeecccCHhhEEE---cCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHh
Confidence            9999999999999999999999   5678999999999876543321   122345667999999988889999999996

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2.4e-28  Score=168.45  Aligned_cols=137  Identities=33%  Similarity=0.597  Sum_probs=118.7

Q ss_pred             hHHHHHHHHh-hCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 031702           12 CLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR   90 (154)
Q Consensus        12 ~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~   90 (154)
                      .+..|..++. ..+|+|++++++.+.+++..|+++||+++++|.+++...+.+++..+..++.|++.|+.|||+.+++|+
T Consensus        42 ~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~  121 (260)
T cd05611          42 NVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHR  121 (260)
T ss_pred             HHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            3444555444 458999999999999999999999999999999999888889999999999999999999999999999


Q ss_pred             cCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        91 ~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ||+|.||++   +..+.++|+|||++.....   .....+++.|+|||...+..++.++|+|||
T Consensus       122 dl~p~nil~---~~~~~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl  179 (260)
T cd05611         122 DIKPENLLI---DQTGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVGDDKMSDWWSL  179 (260)
T ss_pred             CCCHHHeEE---CCCCcEEEeecccceeccc---cccCCCCcCccChhhhcCCCCcchhhhHHH
Confidence            999999999   6678899999998865432   233457788999999988888999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.96  E-value=2.1e-28  Score=171.35  Aligned_cols=143  Identities=29%  Similarity=0.466  Sum_probs=124.7

Q ss_pred             hHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+.+++.+ +|++|+++++.+..++..|+++||+++++|.+++.....+++..+..++.|++.|+.+||+.++
T Consensus        47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i  126 (290)
T cd05613          47 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGI  126 (290)
T ss_pred             HHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            346788899999999 6999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCccccccc--CCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ--RYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||++.......  ......++..|+|||.....  .++.++|+|||
T Consensus       127 ~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~sl  194 (290)
T cd05613         127 IYRDIKLENILL---DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSM  194 (290)
T ss_pred             eccCCCHHHeEE---CCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHH
Confidence            999999999999   667899999999987654332  22335678889999998753  46789999996

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.96  E-value=1.6e-28  Score=169.23  Aligned_cols=146  Identities=35%  Similarity=0.621  Sum_probs=126.0

Q ss_pred             hhhhHHhHHHHHHHHhhCCCCccchhhhheec--CCcEEEEEEecCCCCchHHHHH----cCCCCHHHHHHHHHHHHHHH
Q 031702            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGL   79 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l   79 (154)
                      +....+.+.+|+++++.++|+|++++++.+..  +...++++||+++++|.+++..    ...+++..++.++.|++.|+
T Consensus        39 ~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l  118 (265)
T cd08217          39 TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL  118 (265)
T ss_pred             CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHH
Confidence            34556788999999999999999999987754  4568999999999999999865    35689999999999999999


Q ss_pred             HHHH-----hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc-cccccCCccccCcccccccCCCcccceec
Q 031702           80 EILN-----SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVNFFV  153 (154)
Q Consensus        80 ~~lh-----~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Diws  153 (154)
                      .+||     +.+++|+||+|+||++   +..+.++++|||.+........ .....+++.|+|||...+..++.++|+||
T Consensus       119 ~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~s  195 (265)
T cd08217         119 YECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWS  195 (265)
T ss_pred             HHHhcCccccCcceecCCCHHHEEE---ecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHH
Confidence            9999     8999999999999999   5678999999999876654432 34456788999999998888999999999


Q ss_pred             C
Q 031702          154 S  154 (154)
Q Consensus       154 l  154 (154)
                      |
T Consensus       196 l  196 (265)
T cd08217         196 L  196 (265)
T ss_pred             H
Confidence            6

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.96  E-value=3.4e-28  Score=167.87  Aligned_cols=142  Identities=25%  Similarity=0.478  Sum_probs=121.2

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ..+.+.+|+.+++.++|+|++++.+.+.+ ...++++||+++++|.+++.+.  ..++...+..++.|++.|+.+||+.+
T Consensus        44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~  122 (260)
T cd05073          44 SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN  122 (260)
T ss_pred             HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence            35678899999999999999999999887 7789999999999999998753  34788899999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--cccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.++|+|||.+........  .....++..|+|||++....++.++|+|||
T Consensus       123 i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  189 (260)
T cd05073         123 YIHRDLRAANILV---SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF  189 (260)
T ss_pred             ccccccCcceEEE---cCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHH
Confidence            9999999999999   6788999999998876543221  112234567999999988889999999996

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=9.2e-30  Score=198.04  Aligned_cols=142  Identities=31%  Similarity=0.564  Sum_probs=126.8

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (154)
                      .+.+.+|..++..++|||+|+++++=.....+++.||||.+|+|.+.+...+..++.....+..|++.|++|||+.||||
T Consensus      1278 ~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVH 1357 (1509)
T KOG4645|consen 1278 FKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVH 1357 (1509)
T ss_pred             CcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCcee
Confidence            35677899999999999999999999999999999999999999999998888999999999999999999999999999


Q ss_pred             ecCCCCcEEeecCCCCeeEEEeecccccccCCCC-----ccccccCCccccCccccccc---CCCcccceecC
Q 031702           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQ---RYDEKVNFFVS  154 (154)
Q Consensus        90 ~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~---~~~~~~Diwsl  154 (154)
                      |||||.||++   +.++.+|++|||.|..+..+.     ......||+.|||||++.+.   +...++|||||
T Consensus      1358 RDIK~aNI~L---d~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWsl 1427 (1509)
T KOG4645|consen 1358 RDIKPANILL---DFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSL 1427 (1509)
T ss_pred             cCCCccceee---ecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcc
Confidence            9999999999   678899999999998876653     12346799999999999753   45678999997

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.96  E-value=2.2e-28  Score=170.63  Aligned_cols=138  Identities=32%  Similarity=0.532  Sum_probs=117.1

Q ss_pred             HHHHHHHHhh---CCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 031702           13 LDCELNFLSS---VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (154)
Q Consensus        13 ~~~e~~~l~~---l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (154)
                      +.+|..+++.   ..||+++.+.+.+..++..+++|||+++++|.+++..++.+++..+..++.|++.|++|||+.+++|
T Consensus        41 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH  120 (279)
T cd05633          41 ALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY  120 (279)
T ss_pred             HHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCC
Confidence            3444444333   4799999999999999999999999999999999988888999999999999999999999999999


Q ss_pred             ecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc-cCCCcccceecC
Q 031702           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        90 ~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      +||+|+||++   +..+.++++|||++....... .....++..|+|||...+ ..++.++|+|||
T Consensus       121 ~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl  182 (279)
T cd05633         121 RDLKPANILL---DEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSL  182 (279)
T ss_pred             CCCCHHHEEE---CCCCCEEEccCCcceeccccC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHH
Confidence            9999999999   677889999999986543322 233468899999999864 568899999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.96  E-value=1e-28  Score=172.33  Aligned_cols=141  Identities=30%  Similarity=0.494  Sum_probs=119.8

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      .+.+.+|+.+++.++|||++++++++.+++..++++||++ ++|.+++...   ..+++..++.++.|++.|++|||+.+
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~  121 (285)
T cd07861          43 PSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR  121 (285)
T ss_pred             hHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            4678899999999999999999999999999999999996 5888877543   45899999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCccccccc-CCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.++|+|||++....... ......+++.|+|||++.+. .++.++|+|||
T Consensus       122 i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl  188 (285)
T cd07861         122 VLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSI  188 (285)
T ss_pred             eeecCCCHHHEEE---cCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHH
Confidence            9999999999999   678889999999986543222 22234567889999988654 57889999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.96  E-value=2.6e-28  Score=171.32  Aligned_cols=143  Identities=30%  Similarity=0.537  Sum_probs=124.8

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++|||++++++.+..++..++++||+++++|.+++.+ ..++...+..++.|++.|+.+||+.++
T Consensus        58 ~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi  136 (293)
T cd06647          58 PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQV  136 (293)
T ss_pred             hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            3456788999999999999999999999999999999999999999998864 458889999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+|++|+||++   +..+.++|+|||++....... ......+++.|+|||.+....++.++|+|||
T Consensus       137 ~H~dL~p~Nili---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl  201 (293)
T cd06647         137 IHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL  201 (293)
T ss_pred             eeccCCHHHEEE---cCCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHH
Confidence            999999999999   567789999999886554332 2233457888999999988888999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.96  E-value=1.9e-28  Score=175.98  Aligned_cols=141  Identities=34%  Similarity=0.488  Sum_probs=120.5

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecC------CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~   81 (154)
                      ...+.+.+|+.+++.++|+|++++++++...      ...|+++||+. ++|.+.+...  ++...+..++.|++.|++|
T Consensus        57 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~  133 (353)
T cd07850          57 THAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKH  133 (353)
T ss_pred             hHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHH
Confidence            3456677899999999999999999988543      35799999995 5888877543  8899999999999999999


Q ss_pred             HHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        82 lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ||+.|++|+||+|+||++   +..+.++|+|||++.............+++.|+|||.+.+..++.++|||||
T Consensus       134 LH~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  203 (353)
T cd07850         134 LHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV  203 (353)
T ss_pred             HHhCCeeeCCCCHHHEEE---CCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhH
Confidence            999999999999999999   6778899999999976654444444567888999999998899999999996

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.96  E-value=2.4e-28  Score=168.54  Aligned_cols=141  Identities=24%  Similarity=0.435  Sum_probs=119.8

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      .+.+.+|+.++++++|++++++++.+. ....+++|||+++++|.+++...  ..+++..+..++.+++.|+.|||+.++
T Consensus        45 ~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i  123 (260)
T cd05070          45 PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY  123 (260)
T ss_pred             HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            467899999999999999999998875 45679999999999999998753  358999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc--ccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|.||++   +..+.++|+|||.+.........  ....++..|+|||...+..++.++|+|||
T Consensus       124 ~H~di~p~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  189 (260)
T cd05070         124 IHRDLRSANILV---GDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF  189 (260)
T ss_pred             ccCCCccceEEE---eCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHH
Confidence            999999999999   56778999999998765443221  12234567999999988889999999996

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.96  E-value=2.6e-28  Score=167.90  Aligned_cols=142  Identities=26%  Similarity=0.497  Sum_probs=123.0

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      .+.+.+|+++++.++||+++++++++......++++||+++++|.+++... ..+++..+..++.+++.++++||+.+++
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~  122 (256)
T cd05112          43 EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVI  122 (256)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            467889999999999999999999999999999999999999999998754 4589999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--cccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||+|+||++   +..+.++|+|||.+........  .....++..|+|||...++.++.++|+|||
T Consensus       123 h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~sl  187 (256)
T cd05112         123 HRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSF  187 (256)
T ss_pred             ccccccceEEE---cCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHH
Confidence            99999999999   6777899999998876543321  112234567999999988889999999996

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.96  E-value=1.7e-28  Score=168.37  Aligned_cols=144  Identities=37%  Similarity=0.636  Sum_probs=129.9

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecC--CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ...+.+.+|+.++++++|+|++++.+.+.+.  ...++++|++++++|.+++.+...+++..+..++.+++.+++|||+.
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~  120 (260)
T cd06606          41 EELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN  120 (260)
T ss_pred             HHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4478899999999999999999999999888  88999999999999999998877899999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+|++|+||++   +..+.++|+|||.+........   .....++..|+|||......++.++|+|||
T Consensus       121 ~~~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~sl  189 (260)
T cd06606         121 GIVHRDIKGANILV---DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSL  189 (260)
T ss_pred             CccccCCCHHHEEE---cCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHH
Confidence            99999999999999   5678899999999887665543   445667888999999988889999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.96  E-value=2.7e-28  Score=170.14  Aligned_cols=143  Identities=30%  Similarity=0.523  Sum_probs=123.9

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|+.+++.++|||++++++++..+...++++||+ +++|.+++.. ...+++.++..++.|++.|++|||+.+
T Consensus        41 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  119 (286)
T cd07832          41 GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG  119 (286)
T ss_pred             hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34578899999999999999999999999999999999999 9999998864 356899999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--cccccCCccccCccccccc-CCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.++++|||.+........  .....++..|+|||.+.+. .++.++|||||
T Consensus       120 i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl  187 (286)
T cd07832         120 IMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAV  187 (286)
T ss_pred             eecCCcCHHHEEE---cCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHH
Confidence            9999999999999   5678899999999876544331  2334678889999998654 46899999995

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.96  E-value=3.6e-28  Score=166.18  Aligned_cols=143  Identities=34%  Similarity=0.613  Sum_probs=128.7

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+.+++.++|++++++.+.+..+...++++||+++++|.+++... ..+++..+..++.+++.|+.+||..++
T Consensus        40 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i  119 (253)
T cd05122          40 KKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGI  119 (253)
T ss_pred             HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCE
Confidence            5678999999999999999999999999999999999999999999998766 579999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||.+.............++..|+|||.+....++.++|+|||
T Consensus       120 ~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~sl  183 (253)
T cd05122         120 IHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSL  183 (253)
T ss_pred             ecCCCCHHHEEE---ccCCeEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHH
Confidence            999999999999   5678899999999877655443445667888999999988888999999996

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.95  E-value=2.9e-28  Score=171.04  Aligned_cols=143  Identities=25%  Similarity=0.520  Sum_probs=125.3

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++|+|++++++.+...+..++++||+++++|.+++. ...+++..+..++.|++.+++|||+.|+
T Consensus        59 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~gi  137 (292)
T cd06657          59 QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGV  137 (292)
T ss_pred             hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            456678999999999999999999999999999999999999999998765 4568999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++++|||.+....... ......+++.|+|||...+..++.++|+|||
T Consensus       138 vH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~sl  202 (292)
T cd06657         138 IHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSL  202 (292)
T ss_pred             ecCCCCHHHEEE---CCCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHH
Confidence            999999999999   677789999999876554332 2233567888999999988888999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.95  E-value=3.9e-28  Score=173.84  Aligned_cols=143  Identities=31%  Similarity=0.479  Sum_probs=118.3

Q ss_pred             hHHhHHHHHHHHhhC-CCCccchhhhheecC-CcEEEEEEecCCCCchHHHHHcC-------------------------
Q 031702            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLHG-------------------------   61 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~-------------------------   61 (154)
                      ..+.+.+|+.++..+ +|||++++++++... ...++++||+++|+|.+++....                         
T Consensus        53 ~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  132 (343)
T cd05103          53 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISE  132 (343)
T ss_pred             HHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhh
Confidence            356788999999999 789999999988654 56899999999999999886431                         


Q ss_pred             ------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe
Q 031702           62 ------------------------------------------RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL   99 (154)
Q Consensus        62 ------------------------------------------~~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~   99 (154)
                                                                .++...+..++.|++.|++|||+.+++|+||||+||++
T Consensus       133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~  212 (343)
T cd05103         133 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL  212 (343)
T ss_pred             hhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE
Confidence                                                      25677888899999999999999999999999999999


Q ss_pred             ecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCcccceecC
Q 031702          100 SGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus       100 ~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                         +..+.++++|||++........   .....+++.|+|||.+.+..++.++|||||
T Consensus       213 ---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  267 (343)
T cd05103         213 ---SENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF  267 (343)
T ss_pred             ---cCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHH
Confidence               6778899999999876533211   112334567999999988889999999996

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.95  E-value=3.5e-28  Score=167.78  Aligned_cols=141  Identities=24%  Similarity=0.434  Sum_probs=119.7

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      .+.+.+|+.+++.++|+|++++++.+. .+..+++|||+++++|.+++.+..  .++...+..++.|++.|+.|||+.++
T Consensus        45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i  123 (260)
T cd05069          45 PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY  123 (260)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            467889999999999999999998775 456789999999999999987543  47889999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--cccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|.||++   +..+.++|+|||.+........  .....++..|+|||...+..++.++|+|||
T Consensus       124 ~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~sl  189 (260)
T cd05069         124 IHRDLRAANILV---GDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF  189 (260)
T ss_pred             eecccCcceEEE---cCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHH
Confidence            999999999999   6788899999999876543321  122334567999999988889999999996

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.95  E-value=3e-28  Score=168.96  Aligned_cols=143  Identities=31%  Similarity=0.561  Sum_probs=121.0

Q ss_pred             hHHhHHHHHHHHhhC-CCCccchhhhheecC------CcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGL   79 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l   79 (154)
                      ..+.+.+|+.+++.+ +|+|++++.+.+...      ...++++||+++++|.+++...  ..+++..+..++.|++.|+
T Consensus        45 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l  124 (272)
T cd06637          45 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL  124 (272)
T ss_pred             cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHH
Confidence            356788999999999 799999999998653      4589999999999999998764  3589999999999999999


Q ss_pred             HHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCccccc-----ccCCCcccceec
Q 031702           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVNFFV  153 (154)
Q Consensus        80 ~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Diws  153 (154)
                      +|||+.+++|+|++|+||++   +..+.++|+|||++...... .......|++.|+|||++.     +..++.++|+||
T Consensus       125 ~~LH~~~ivh~dl~~~nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~s  201 (272)
T cd06637         125 SHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWS  201 (272)
T ss_pred             HHHHHCCCccCCCCHHHEEE---CCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHH
Confidence            99999999999999999999   67778999999998754332 2334456888999999986     345888999999


Q ss_pred             C
Q 031702          154 S  154 (154)
Q Consensus       154 l  154 (154)
                      |
T Consensus       202 l  202 (272)
T cd06637         202 L  202 (272)
T ss_pred             H
Confidence            6

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=5.7e-28  Score=165.69  Aligned_cols=144  Identities=28%  Similarity=0.565  Sum_probs=128.7

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|++++++++|+|++++.+.+.+++..++++|++++++|.+++.....+++..+..++.|++.++.+||+.|+
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i  120 (254)
T cd06627          41 EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV  120 (254)
T ss_pred             HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCc
Confidence            45678999999999999999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc-cccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|.||++   +..+.++|+|||.+........ .....++..|+|||...+..++.++|+|||
T Consensus       121 ~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~l  185 (254)
T cd06627         121 IHRDIKAANILT---TKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSL  185 (254)
T ss_pred             ccCCCCHHHEEE---CCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHH
Confidence            999999999999   5678899999999877654432 234567888999999987778999999985

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.95  E-value=4.2e-28  Score=167.51  Aligned_cols=143  Identities=35%  Similarity=0.590  Sum_probs=125.6

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ..+.+.+|+.+++.++|+|++++++.+..++..++++|++++++|.+++...   ..+++..+..++.|++.|+.+||+.
T Consensus        42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~  121 (267)
T cd06610          42 SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN  121 (267)
T ss_pred             HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            5678999999999999999999999999999999999999999999999764   3589999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc-----ccccCCccccCccccccc-CCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-----EKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      +++|+||+|+||++   +..+.++|+|||++.........     ....++..|+|||.+... .++.++|+|||
T Consensus       122 ~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~sl  193 (267)
T cd06610         122 GQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSF  193 (267)
T ss_pred             CeecCCCCHHhEEE---cCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhH
Confidence            99999999999999   56778999999998765543221     334578889999998766 78899999996

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.95  E-value=1.8e-28  Score=172.62  Aligned_cols=141  Identities=27%  Similarity=0.448  Sum_probs=120.0

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ...+.+|+.+++.++||||+++++++.+++..++++||++ ++|.+++... ..+++..+..++.|++.|++|||+.+++
T Consensus        48 ~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~  126 (301)
T cd07873          48 PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVL  126 (301)
T ss_pred             hhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            4567789999999999999999999999999999999996 5888887654 4689999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCccccccc-CCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      |+||+|+||++   +..+.++|+|||++....... ......+++.|+|||++.+. .++.++|||||
T Consensus       127 H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl  191 (301)
T cd07873         127 HRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGV  191 (301)
T ss_pred             CCCCCHHHEEE---CCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHH
Confidence            99999999999   677889999999986543222 22334568889999998654 57889999996

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.95  E-value=5.4e-28  Score=166.24  Aligned_cols=145  Identities=31%  Similarity=0.611  Sum_probs=124.5

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ...+.+.+|+++++.++|+|++++++.+.+.+..++++||+++++|.+++....  .+++..+..++.+++.|+.|||+.
T Consensus        41 ~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~  120 (257)
T cd08225          41 KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR  120 (257)
T ss_pred             hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            456788899999999999999999999999999999999999999999987543  478999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc-cccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||+|.||++.  +....++++|||.+........ .....+++.|+|||+..+..++.++|+|||
T Consensus       121 ~i~H~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~sl  188 (257)
T cd08225         121 KILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSL  188 (257)
T ss_pred             CcccccCCHHHEEEc--CCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHH
Confidence            999999999999994  2334679999998876544322 223457888999999988889999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.95  E-value=3.2e-28  Score=170.63  Aligned_cols=141  Identities=27%  Similarity=0.433  Sum_probs=120.0

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecC--CcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+|+.++++++|||++++.+++..+  +..|+++||++ ++|.+++.... .+++..+..++.|++.|++|||+.+
T Consensus        48 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  126 (293)
T cd07843          48 PITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW  126 (293)
T ss_pred             hhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34567899999999999999999998777  88999999996 48988886544 4899999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCccccccc-CCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.++|+|||.+...... .......+++.|+|||.+.+. .++.++|+|||
T Consensus       127 i~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~sl  193 (293)
T cd07843         127 ILHRDLKTSNLLL---NNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSV  193 (293)
T ss_pred             eeeccCCHHHEEE---CCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHH
Confidence            9999999999999   67788999999998766543 223334567889999998754 46889999996

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.95  E-value=6e-28  Score=165.70  Aligned_cols=144  Identities=33%  Similarity=0.618  Sum_probs=127.9

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      ...+.+.+|+++++.++|+|++++.+.+..++..++++|++++++|.+++.+.    ..+++..+..++.+++.|+.+||
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh  120 (258)
T cd08215          41 KEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH  120 (258)
T ss_pred             HHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH
Confidence            55678899999999999999999999999999999999999999999998764    66999999999999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +.+++|+||+|+||++   +..+.++|+|||.+....... ......+++.|+|||...+..++.++|+|||
T Consensus       121 ~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl  189 (258)
T cd08215         121 SRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSL  189 (258)
T ss_pred             hCCEecccCChHHeEE---cCCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHH
Confidence            9999999999999999   567889999999987654433 3344567888999999988889999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.95  E-value=2.7e-28  Score=168.34  Aligned_cols=141  Identities=23%  Similarity=0.487  Sum_probs=120.0

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      .+.+.+|+.+++.++|+|++++++.+. ....++++||+++++|.+++...  ..++..++..++.|++.|++|||+.++
T Consensus        45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i  123 (260)
T cd05067          45 PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY  123 (260)
T ss_pred             HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence            467889999999999999999998764 45689999999999999988653  358899999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--cccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++++|||.+........  .....++..|+|||++....++.++|||||
T Consensus       124 ~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~sl  189 (260)
T cd05067         124 IHRDLRAANILV---SETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF  189 (260)
T ss_pred             ecccccHHhEEE---cCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHH
Confidence            999999999999   6778899999999876542221  122344567999999988889999999996

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.95  E-value=4.1e-28  Score=169.87  Aligned_cols=140  Identities=29%  Similarity=0.442  Sum_probs=118.8

Q ss_pred             HhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 031702           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (154)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (154)
                      ..+.+|+.+++.++|+||+++++++.+++..++++||+++ +|.+++... ..+++..+..++.|++.|+.|||+.+++|
T Consensus        48 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H  126 (291)
T cd07844          48 FTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLH  126 (291)
T ss_pred             hhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            4567899999999999999999999999999999999975 899888654 45899999999999999999999999999


Q ss_pred             ecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccc-cCCCcccceecC
Q 031702           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        90 ~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      +||+|+||++   +..+.++|+|||++....... ......++..|+|||+..+ ..++.++|||||
T Consensus       127 ~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~sl  190 (291)
T cd07844         127 RDLKPQNLLI---SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGV  190 (291)
T ss_pred             ccCCHHHEEE---cCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHH
Confidence            9999999999   677889999999886543221 1222345788999999865 457899999996

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.95  E-value=5.1e-28  Score=167.59  Aligned_cols=143  Identities=28%  Similarity=0.534  Sum_probs=123.9

Q ss_pred             hHHhHHHHHHHHhh-CCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSS-VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         9 ~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      ..+++.+|+.++++ ++|||++++++.+.+++..++++||+++++|.+++..    ...+++..++.++.|++.++.+||
T Consensus        51 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh  130 (269)
T cd08528          51 SIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH  130 (269)
T ss_pred             HHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc
Confidence            44567788888876 6999999999999999999999999999999988743    346899999999999999999999


Q ss_pred             h-CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           84 S-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        84 ~-~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      + .+++|+||+|.||++   +..+.++|+|||.+.............++..|+|||.+.+..++.++|+|||
T Consensus       131 ~~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~sl  199 (269)
T cd08528         131 KEKRIVHRDLTPNNIML---GEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAF  199 (269)
T ss_pred             cCCceeecCCCHHHEEE---CCCCcEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHH
Confidence            6 689999999999999   6778899999999876655444445667888999999998889999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PTZ00284 protein kinase; Provisional

Probab=99.95  E-value=2.1e-28  Score=181.53  Aligned_cols=142  Identities=25%  Similarity=0.431  Sum_probs=115.3

Q ss_pred             HHhHHHHHHHHhhCCCC------ccchhhhheecC-CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHH
Q 031702           10 KSCLDCELNFLSSVNHP------NIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL   82 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l   82 (154)
                      .+.+..|+++++.++|.      +++++.+++... +++|+++|++ +++|.+++.+.+.+++..+..++.|++.|+.||
T Consensus       169 ~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yL  247 (467)
T PTZ00284        169 TRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYF  247 (467)
T ss_pred             HHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH
Confidence            44567788888887654      477888887654 5789999988 678999888888899999999999999999999


Q ss_pred             Hh-CCceeecCCCCcEEeecCC-------------CCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcc
Q 031702           83 NS-HHIIHRDLKPENILLSGLD-------------DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEK  148 (154)
Q Consensus        83 h~-~~~~h~~i~p~nil~~~~~-------------~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  148 (154)
                      |. .|++||||||+||++...+             ....+||+|||.+....  .......||+.|+|||++.+..|+.+
T Consensus       248 H~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~  325 (467)
T PTZ00284        248 HTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYS  325 (467)
T ss_pred             HhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcH
Confidence            98 5999999999999995321             11259999999875432  22334678999999999999999999


Q ss_pred             cceecC
Q 031702          149 VNFFVS  154 (154)
Q Consensus       149 ~Diwsl  154 (154)
                      +|||||
T Consensus       326 ~DiwSl  331 (467)
T PTZ00284        326 TDMWSM  331 (467)
T ss_pred             HHHHHH
Confidence            999996

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=7.8e-29  Score=175.17  Aligned_cols=142  Identities=32%  Similarity=0.623  Sum_probs=129.0

Q ss_pred             HHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      .+--..|-.+|..- +-|.+++++..|++-+.+|+||||+.||+|...+..-+++.+..+..++.+|+-|+.+||++||+
T Consensus       393 vectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIi  472 (683)
T KOG0696|consen  393 VECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGII  472 (683)
T ss_pred             ccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCee
Confidence            34445577778777 67899999999999999999999999999999999889999999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccc-cCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCT-LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +||+|..|+++   +..+++||.|||++.. +.......+.||||.|+|||++...+|..++|+|||
T Consensus       473 YRDLKLDNvmL---d~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~  536 (683)
T KOG0696|consen  473 YRDLKLDNVML---DSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF  536 (683)
T ss_pred             eeeccccceEe---ccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHH
Confidence            99999999999   8999999999999875 344556788999999999999999999999999996

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.95  E-value=8.9e-28  Score=168.04  Aligned_cols=143  Identities=35%  Similarity=0.565  Sum_probs=121.6

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecC--CcEEEEEEecCCCCchHHHHH----cCCCCHHHHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEI   81 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~   81 (154)
                      ...+.+.+|+++++.++||||+++++.+.+.  +.++++|||+++++|.+++..    ...+++..+..++.|++.|+.|
T Consensus        41 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~  120 (287)
T cd06621          41 DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY  120 (287)
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            3567789999999999999999999988653  468999999999999987653    3458899999999999999999


Q ss_pred             HHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        82 lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ||+.+++|+||+|.||++   +..+.++|+|||++....... .....++..|+|||.+.+..++.++|+|||
T Consensus       121 lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~sl  189 (287)
T cd06621         121 LHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSL  189 (287)
T ss_pred             HHHCCcccCCCCHHHEEE---ecCCeEEEeeccccccccccc-cccccCCccccCHHHhcCCCCCchhhHHHH
Confidence            999999999999999999   567789999999986543322 123456788999999988889999999985

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.95  E-value=9e-28  Score=167.30  Aligned_cols=143  Identities=26%  Similarity=0.472  Sum_probs=122.5

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheec--CCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ..+.+.+|+.+++.++|+|++++.+++..  ....++++||+++++|.+++.... .++...+..++.|++.|+++||+.
T Consensus        49 ~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~  128 (284)
T cd05038          49 HRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ  128 (284)
T ss_pred             HHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC
Confidence            46789999999999999999999998876  567999999999999999997654 589999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc----cccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||+|.||++   +..+.++|+|||.+........    .....++..|+|||...+..++.++|+|||
T Consensus       129 ~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~sl  198 (284)
T cd05038         129 RYIHRDLAARNILV---ESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSF  198 (284)
T ss_pred             CeecCCCCHHhEEE---cCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHH
Confidence            99999999999999   6678999999999876653221    111233456999999988889999999996

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=5.5e-28  Score=168.10  Aligned_cols=144  Identities=25%  Similarity=0.517  Sum_probs=124.6

Q ss_pred             hhhHHhHHHHHHHHhhCC---CCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      ....+.+.+|+.+++.++   |||++++++++.+++..++++||+++++|.+++.. ..+++..+..++.|++.++.|||
T Consensus        40 ~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh  118 (277)
T cd06917          40 DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIH  118 (277)
T ss_pred             chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHH
Confidence            344567889999999996   99999999999999999999999999999998865 47899999999999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCccccccc-CCCcccceecC
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      +.+++|+||+|+||++   +..+.++++|||.+....... ......|+..|+|||.+.++ .++.++|+|||
T Consensus       119 ~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl  188 (277)
T cd06917         119 KVGVIHRDIKAANILV---TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSL  188 (277)
T ss_pred             hCCcccCCcCHHHEEE---cCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHH
Confidence            9999999999999999   568889999999987665443 23345678889999998654 46889999996

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.95  E-value=9.6e-28  Score=167.82  Aligned_cols=143  Identities=30%  Similarity=0.479  Sum_probs=124.5

Q ss_pred             hHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+++++.+ +||+++++++.+..+...++++||+++++|.+++..+..+++..+..++.|++.++.+||+.++
T Consensus        47 ~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~  126 (288)
T cd05583          47 TAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGI  126 (288)
T ss_pred             HHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            356788999999999 6999999999999999999999999999999999877789999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--cccccCCccccCcccccccC--CCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQR--YDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~--~~~~~Diwsl  154 (154)
                      +|+||+|.||++   +..+.++++|||++........  .....++..|+|||...+..  .+.++|+|||
T Consensus       127 ~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~sl  194 (288)
T cd05583         127 IYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSL  194 (288)
T ss_pred             eccCCCHHHeEE---CCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHH
Confidence            999999999999   5677899999999876543321  22345788899999987654  6889999996

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.95  E-value=2.6e-28  Score=172.49  Aligned_cols=145  Identities=26%  Similarity=0.486  Sum_probs=118.8

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecC--CcEEEEEEecCCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-----GRVPEQTARKFLQQLGAGLEI   81 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~   81 (154)
                      ..+.+.+|+.+++.++|||++++++.+.+.  ..+++++||+++ ++.+.+...     ..+++..++.++.|++.|++|
T Consensus        45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~  123 (316)
T cd07842          45 ISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHY  123 (316)
T ss_pred             ccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHH
Confidence            346778899999999999999999999888  789999999965 677666432     258899999999999999999


Q ss_pred             HHhCCceeecCCCCcEEeec-CCCCeeEEEeecccccccCCCC----ccccccCCccccCccccccc-CCCcccceecC
Q 031702           82 LNSHHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        82 lh~~~~~h~~i~p~nil~~~-~~~~~~~kl~df~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      ||+.+++|+||+|+||++.. .+..+.+||+|||++.......    ......+++.|+|||+..+. .++.++|||||
T Consensus       124 lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl  202 (316)
T cd07842         124 LHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAI  202 (316)
T ss_pred             HHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHH
Confidence            99999999999999999932 1128899999999987653322    12334678889999987654 57899999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.95  E-value=8.5e-28  Score=167.04  Aligned_cols=144  Identities=36%  Similarity=0.617  Sum_probs=126.8

Q ss_pred             hhHHhHHHHHHHHhhCC-CCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|+.++++++ ||||+++++++.+++..+++||++++++|.+++.+...+++..+..++.|++.|+.+||+.+
T Consensus        43 ~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~  122 (280)
T cd05581          43 KKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG  122 (280)
T ss_pred             HHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34577889999999998 99999999999999999999999999999999988888999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---------------------cccccCCccccCcccccccCC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---------------------AEKVCGSPLYMAPEVLQFQRY  145 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~  145 (154)
                      ++|+||+|+||++   +..+.++++|||++........                     .....++..|+|||......+
T Consensus       123 ~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~  199 (280)
T cd05581         123 IIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA  199 (280)
T ss_pred             eeecCCCHHHeEE---CCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCC
Confidence            9999999999999   6778899999999876543221                     122346778999999988888


Q ss_pred             CcccceecC
Q 031702          146 DEKVNFFVS  154 (154)
Q Consensus       146 ~~~~Diwsl  154 (154)
                      +.++|+|||
T Consensus       200 ~~~~Di~sl  208 (280)
T cd05581         200 GKSSDLWAL  208 (280)
T ss_pred             ChhhhHHHH
Confidence            999999986

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=8.2e-29  Score=181.58  Aligned_cols=140  Identities=30%  Similarity=0.485  Sum_probs=121.9

Q ss_pred             HHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+-.+|..++... +|||++++.+++.++.+.|+|||.+.|+-+.+.+.....+. ..+..|+++|+.|+.|||.+|++
T Consensus       359 ~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvv  437 (612)
T KOG0603|consen  359 ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVV  437 (612)
T ss_pred             ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCee
Confidence            34456677777776 89999999999999999999999999988888777665555 78888999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |||+||+||++.  ++.++++|+|||.+......  ..+++-|..|.|||++....|+.++|||||
T Consensus       438 hRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSL  499 (612)
T KOG0603|consen  438 HRDLKPGNILLD--GSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSL  499 (612)
T ss_pred             ecCCChhheeec--CCCCcEEEEEechhhhCchh--hcccchhhcccChhhhccCCCCcchhhHHH
Confidence            999999999994  47788999999999876554  555677888999999999999999999997

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.95  E-value=5e-28  Score=169.48  Aligned_cols=140  Identities=29%  Similarity=0.429  Sum_probs=117.3

Q ss_pred             HhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 031702           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (154)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (154)
                      ..+.+|+.+++.++|+|++++.+++.++...|+++||+. +++.+++.. ...+++..+..++.|++.|+.|||+.+++|
T Consensus        48 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H  126 (291)
T cd07870          48 FTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH  126 (291)
T ss_pred             HHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            467789999999999999999999999999999999996 577666644 345788889999999999999999999999


Q ss_pred             ecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCccccccc-CCCcccceecC
Q 031702           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        90 ~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      +||+|+||++   +..+.++|+|||++....... ......+++.|+|||...+. .++.++|+|||
T Consensus       127 ~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl  190 (291)
T cd07870         127 RDLKPQNLLI---SYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGA  190 (291)
T ss_pred             CCCChHHEEE---cCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHH
Confidence            9999999999   677889999999886543221 22334568889999998754 57889999996

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.95  E-value=9.3e-28  Score=167.12  Aligned_cols=142  Identities=27%  Similarity=0.543  Sum_probs=124.7

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.++++++|||++++++.+.+++..++++||+++++|.+++. ...++...+..++.+++.++.+||+.+++
T Consensus        45 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~  123 (277)
T cd06641          45 EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKI  123 (277)
T ss_pred             HHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHccCCee
Confidence            35678899999999999999999999999999999999999999999886 45689999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||+|.||++   +..+.++++|||++....... ......++..|+|||.+.+...+.++|+|||
T Consensus       124 h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl  187 (277)
T cd06641         124 HRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL  187 (277)
T ss_pred             cCCCCHHhEEE---CCCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHH
Confidence            99999999999   667889999999886654332 1233457888999999988888999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=7.8e-28  Score=166.74  Aligned_cols=143  Identities=33%  Similarity=0.587  Sum_probs=120.8

Q ss_pred             hHHhHHHHHHHHhhC-CCCccchhhhheecCC------cEEEEEEecCCCCchHHHHH----cCCCCHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGA   77 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~------~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~   77 (154)
                      ..+.+.+|+.+++++ +|+|++++++.+.+..      ..++++||+++++|.+++..    ...+++..+..++.|++.
T Consensus        45 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~  124 (275)
T cd06608          45 EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLR  124 (275)
T ss_pred             hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHH
Confidence            457799999999999 7999999999996644      48999999999999998864    346899999999999999


Q ss_pred             HHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccc-----cCCCcccce
Q 031702           78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-----QRYDEKVNF  151 (154)
Q Consensus        78 ~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di  151 (154)
                      |+.|||+.+++|+||+|+||++   +..+.++|+|||.+....... ......++..|+|||++..     ..++.++||
T Consensus       125 al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv  201 (275)
T cd06608         125 GLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDV  201 (275)
T ss_pred             HHHHHhcCCcccCCCCHHHEEE---ccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccH
Confidence            9999999999999999999999   667889999999887654322 2334567888999998753     346788999


Q ss_pred             ecC
Q 031702          152 FVS  154 (154)
Q Consensus       152 wsl  154 (154)
                      |||
T Consensus       202 ~sl  204 (275)
T cd06608         202 WSL  204 (275)
T ss_pred             HHh
Confidence            996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.95  E-value=6.5e-28  Score=171.69  Aligned_cols=144  Identities=20%  Similarity=0.346  Sum_probs=119.2

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ...+.+.+|+.+++.++||||+++++++..++..++++||+.++++.+++.+.  ..+++..+..++.|++.|++|||+.
T Consensus        41 ~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~  120 (328)
T cd08226          41 EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN  120 (328)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            34578899999999999999999999999999999999999999999988764  3488999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-c-------cccccCCccccCccccccc--CCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-Y-------AEKVCGSPLYMAPEVLQFQ--RYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~-------~~~~~~~~~y~aPE~~~~~--~~~~~~Diwsl  154 (154)
                      +++|+||||+||++   +..+.+++.||+.+....... .       .....++..|+|||++.+.  .++.++|||||
T Consensus       121 ~ivHrDlkp~Nill---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diwsl  196 (328)
T cd08226         121 GYIHRNIKASHILI---SGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSV  196 (328)
T ss_pred             CeecCCCCHHHEEE---eCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHH
Confidence            99999999999999   567789999997543322111 0       1112345669999998764  47899999996

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.95  E-value=1.2e-27  Score=166.80  Aligned_cols=144  Identities=29%  Similarity=0.560  Sum_probs=120.5

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheec------CCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAG   78 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~   78 (154)
                      .....+..|+.+++.+ +|+|++++++.+..      ....|++|||+++++|.+++...  ..+++..+..++.|++.|
T Consensus        54 ~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~a  133 (282)
T cd06636          54 DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG  133 (282)
T ss_pred             HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHH
Confidence            3456788999999999 79999999998853      45789999999999999998753  348888999999999999


Q ss_pred             HHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCccccc-----ccCCCccccee
Q 031702           79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVNFF  152 (154)
Q Consensus        79 l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Diw  152 (154)
                      +.|||+.+++|+|++|+||++   +..+.++|+|||++...... .......+++.|+|||.+.     ...++.++|+|
T Consensus       134 l~~LH~~~ivH~dl~~~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~Dvw  210 (282)
T cd06636         134 LAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIW  210 (282)
T ss_pred             HHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchh
Confidence            999999999999999999999   56778999999998754322 2234456788999999976     34678899999


Q ss_pred             cC
Q 031702          153 VS  154 (154)
Q Consensus       153 sl  154 (154)
                      ||
T Consensus       211 sl  212 (282)
T cd06636         211 SL  212 (282)
T ss_pred             HH
Confidence            96

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.95  E-value=1.2e-27  Score=165.06  Aligned_cols=142  Identities=31%  Similarity=0.590  Sum_probs=122.2

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ....+..|+.+++.++|||++++++.+.+....++++||+++++|.+++..    ...+++..++.++.|++.|+.+||+
T Consensus        45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~  124 (260)
T cd08222          45 ETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ  124 (260)
T ss_pred             hHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH
Confidence            445677899999999999999999999999999999999999999988753    3468999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCcccccccCCCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .+++|+|++|+||++.    .+.++++|||.+...... .......+++.|+|||...+..++.++|+|||
T Consensus       125 ~~i~h~~l~~~nili~----~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~sl  191 (260)
T cd08222         125 RRILHRDLKAKNIFLK----NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSL  191 (260)
T ss_pred             cCccccCCChhheEee----cCCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHH
Confidence            9999999999999993    345999999988765433 23334567888999999988888999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.95  E-value=1.4e-27  Score=168.57  Aligned_cols=139  Identities=33%  Similarity=0.544  Sum_probs=119.0

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+.+++.++|||++++.+++.+++..++++||+. +++.+++.. ...+++..+..++.|++.|+.|||+.++
T Consensus        58 ~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i  136 (307)
T cd06607          58 KWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER  136 (307)
T ss_pred             HHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            34678899999999999999999999999999999999996 577766653 4568999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCccccc---ccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||++......   ....+++.|+|||++.   ...++.++|||||
T Consensus       137 ~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~  200 (307)
T cd06607         137 IHRDIKAGNILL---TEPGTVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL  200 (307)
T ss_pred             eecCCCcccEEE---CCCCCEEEeecCcceecCCC---CCccCCccccCceeeeccCCCCCCcccchHHH
Confidence            999999999999   67788999999988654322   2345778899999874   3568899999996

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.95  E-value=6.3e-28  Score=171.70  Aligned_cols=143  Identities=31%  Similarity=0.519  Sum_probs=124.9

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCC-----cEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL   82 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l   82 (154)
                      ...+.+.+|+.+++.++|+|++++.+++....     .+|+++||++ ++|.+++.+...+++..+..++.+++.|+++|
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~L  119 (330)
T cd07834          41 IDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYL  119 (330)
T ss_pred             hhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH
Confidence            34578899999999999999999999998775     7899999996 58999888777899999999999999999999


Q ss_pred             HhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC----ccccccCCccccCccccccc-CCCcccceecC
Q 031702           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        83 h~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      |+.|++|+||+|.||++   +..+.++|+|||.+.......    ......+++.|+|||.+.+. .++.++|+|||
T Consensus       120 H~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~sl  193 (330)
T cd07834         120 HSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSV  193 (330)
T ss_pred             HhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHH
Confidence            99999999999999999   667899999999988765442    23344578889999999877 78999999996

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.95  E-value=1.4e-27  Score=166.56  Aligned_cols=141  Identities=34%  Similarity=0.536  Sum_probs=120.8

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      .+.+.+|+++++.++|||++++++++.+++..++++||++ ++|.+++....  .+++..+..++.|++.|++|||+.++
T Consensus        42 ~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~  120 (283)
T cd07835          42 PSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRV  120 (283)
T ss_pred             hhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            4568889999999999999999999999999999999995 68999887665  68999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCccccccc-CCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +.++.++|+|||.+....... ......++..|+|||++.+. .++.++|+|||
T Consensus       121 ~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~sl  186 (283)
T cd07835         121 LHRDLKPQNLLI---DREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSI  186 (283)
T ss_pred             eCCCCCHHHEEE---cCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHH
Confidence            999999999999   568889999999986543222 12223457889999987654 57899999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.95  E-value=1.6e-27  Score=166.96  Aligned_cols=143  Identities=32%  Similarity=0.614  Sum_probs=119.6

Q ss_pred             hHHhHHHHHHHHhhC-CCCccchhhhheecC-----CcEEEEEEecCCCCchHHHHH----cCCCCHHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAG   78 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~   78 (154)
                      ..+.+.+|+.+++++ +|||++++++++...     +..++++||+++++|.++++.    ...+++..++.++.|++.|
T Consensus        61 ~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~a  140 (291)
T cd06639          61 VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG  140 (291)
T ss_pred             HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHH
Confidence            356778899999999 899999999998643     358999999999999988753    3568999999999999999


Q ss_pred             HHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCccccccc-----CCCccccee
Q 031702           79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-----RYDEKVNFF  152 (154)
Q Consensus        79 l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-----~~~~~~Diw  152 (154)
                      +++||+.+++|+||+|+||++   +..+.++|+|||++....... ......++..|+|||.+...     .++.++|||
T Consensus       141 l~~lH~~~ivH~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~  217 (291)
T cd06639         141 LQHLHNNRIIHRDVKGNNILL---TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVW  217 (291)
T ss_pred             HHHHHhCCeeccCCCHHHEEE---cCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchH
Confidence            999999999999999999999   567789999999987654332 22334678889999997543     368899999


Q ss_pred             cC
Q 031702          153 VS  154 (154)
Q Consensus       153 sl  154 (154)
                      ||
T Consensus       218 sl  219 (291)
T cd06639         218 SL  219 (291)
T ss_pred             HH
Confidence            96

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.95  E-value=8.6e-28  Score=171.46  Aligned_cols=142  Identities=30%  Similarity=0.500  Sum_probs=120.6

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheec----CCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ..+.+.+|+.+++.++||||+++++++..    ....++++||++ ++|.+++.....+++..+..++.|++.|+.|||+
T Consensus        47 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~  125 (334)
T cd07855          47 LAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHS  125 (334)
T ss_pred             chHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            45667889999999999999999998863    356899999995 5899998877789999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc-----cccccCCccccCcccccc-cCCCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      .+++|+||+|+||++   +..+.+||+|||.+........     .....++..|+|||.+.+ ..++.++|||||
T Consensus       126 ~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~sl  198 (334)
T cd07855         126 ANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSV  198 (334)
T ss_pred             CCeecCCCCHHHEEE---cCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHH
Confidence            999999999999999   6788999999999876533221     123467888999999765 458899999996

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=3.7e-28  Score=176.99  Aligned_cols=138  Identities=30%  Similarity=0.540  Sum_probs=124.6

Q ss_pred             HHHHHHHHhhCC---CCccchhhhheecCCcEEEEEEecC-CCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           13 LDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCA-GGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        13 ~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~v~e~~~-~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      +-.|++||..++   |+||+++++.|++.+++|++||-.+ |.+|.+++..+..+++.....+++|++.|+++||++||+
T Consensus       613 Vp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~iv  692 (772)
T KOG1152|consen  613 VPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIV  692 (772)
T ss_pred             cchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCce
Confidence            456999999997   9999999999999999999999753 678999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCC-cccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD-EKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Diwsl  154 (154)
                      |||||-+|+++   +.++.+||+|||.+.. ..+++-....||..|.|||++.+.+|- ..-|||+|
T Consensus       693 hrdikdenviv---d~~g~~klidfgsaa~-~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwal  755 (772)
T KOG1152|consen  693 HRDIKDENVIV---DSNGFVKLIDFGSAAY-TKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWAL  755 (772)
T ss_pred             ecccccccEEE---ecCCeEEEeeccchhh-hcCCCcceeeeeccccchhhhCCCccCCCcchhhhh
Confidence            99999999999   8999999999997764 445566778899999999999998885 56799986

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.95  E-value=6.7e-28  Score=167.89  Aligned_cols=142  Identities=35%  Similarity=0.569  Sum_probs=122.9

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+++++.++|++++++++.+..++..++++||+++ ++.+++.. ...+++..+..++.|++.|+.+||+.++
T Consensus        41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i  119 (283)
T cd05118          41 IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI  119 (283)
T ss_pred             hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            456788999999999999999999999999999999999965 88877765 3578999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCccccccc-CCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||.+....... ......++..|+|||.+.+. .++.++|+|||
T Consensus       120 ~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~sl  185 (283)
T cd05118         120 LHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSV  185 (283)
T ss_pred             eecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHH
Confidence            999999999999   677889999999987665443 22234567789999998776 78899999996

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.95  E-value=1.3e-27  Score=166.49  Aligned_cols=138  Identities=32%  Similarity=0.491  Sum_probs=116.4

Q ss_pred             hHHHHHHHHhhC-CCCccchhhhheecC--CcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702           12 CLDCELNFLSSV-NHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus        12 ~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+|+.+++++ +|+|++++++++.++  +..++++||+++ ++.+.+... ..+++..+..++.|++.|++|||+.++
T Consensus        43 ~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i  121 (282)
T cd07831          43 NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGI  121 (282)
T ss_pred             hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            445788999998 599999999999887  889999999964 777777653 568999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc-cCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +. +.++|+|||.+.............+++.|+|||.+.. +.++.++|+|||
T Consensus       122 ~H~dl~p~ni~l---~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl  185 (282)
T cd07831         122 FHRDIKPENILI---KD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAV  185 (282)
T ss_pred             eecccCHHHEEE---cC-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHH
Confidence            999999999999   45 8999999999877654444344557888999997653 457889999996

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.95  E-value=1.3e-27  Score=166.71  Aligned_cols=141  Identities=33%  Similarity=0.550  Sum_probs=119.9

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      .+.+.+|++++++++|||++++++++.+++..++++||+. ++|.+++...  ..+++..+..++.|++.|++|||+.++
T Consensus        43 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i  121 (284)
T cd07860          43 PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV  121 (284)
T ss_pred             chHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            4578899999999999999999999999999999999995 5888887653  458999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccC-CCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||++....... ......+++.|+|||...+.. ++.++|+|||
T Consensus       122 ~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl  187 (284)
T cd07860         122 LHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL  187 (284)
T ss_pred             ecCCCCHHHEEE---CCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHH
Confidence            999999999999   677889999999987553322 222334678899999887544 5888999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=4.2e-27  Score=164.04  Aligned_cols=140  Identities=31%  Similarity=0.515  Sum_probs=121.5

Q ss_pred             HhHHHHHHHHhhCC-CCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702           11 SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus        11 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ....+|+..+++++ |+|++++++++.+++..+++|||+ +++|.+++....  .+++..+..++.|++.++.|||++++
T Consensus        42 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i  120 (283)
T cd07830          42 CMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGF  120 (283)
T ss_pred             HHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            34557999999998 999999999999999999999999 779998887654  68999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCccccc-ccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Diwsl  154 (154)
                      +|+||+|.||++   +..+.++|+|||.+.............++..|+|||++. +..++.++|+|||
T Consensus       121 ~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~  185 (283)
T cd07830         121 FHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWAL  185 (283)
T ss_pred             ccCCCChhhEEE---cCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhH
Confidence            999999999999   678899999999987665544434455788899999875 3457899999996

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=6.9e-28  Score=166.83  Aligned_cols=145  Identities=31%  Similarity=0.601  Sum_probs=135.1

Q ss_pred             hhhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      +++.+..+.|-.++..- +||.+|-++..|.++..+++|.||++||+|.-.+.++.+++++.++.+...|+.|+.|||++
T Consensus       291 dedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r  370 (593)
T KOG0695|consen  291 DEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER  370 (593)
T ss_pred             cccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc
Confidence            45577888899999888 89999999999999999999999999999998888888999999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccc-cCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT-LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+++||+|..|+++   +..+++||.|+|.... +.+.+...+.||||-|.|||++.+..|..++|+|+|
T Consensus       371 giiyrdlkldnvll---daeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwal  437 (593)
T KOG0695|consen  371 GIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWAL  437 (593)
T ss_pred             CeeeeeccccceEE---ccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHH
Confidence            99999999999999   8999999999999865 456678888999999999999999999999999986

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.95  E-value=5.6e-28  Score=172.41  Aligned_cols=139  Identities=29%  Similarity=0.427  Sum_probs=120.0

Q ss_pred             hHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCceeec
Q 031702           12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRD   91 (154)
Q Consensus        12 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~~   91 (154)
                      .+.+|+.+++.++|+|++++++++..++..++++||+. ++|.+++.....+++.....++.|++.|+++||+.+++|+|
T Consensus        66 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~d  144 (335)
T PTZ00024         66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRD  144 (335)
T ss_pred             hHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence            57789999999999999999999999999999999996 59999998778899999999999999999999999999999


Q ss_pred             CCCCcEEeecCCCCeeEEEeecccccccCCC---------------CccccccCCccccCccccccc-CCCcccceecC
Q 031702           92 LKPENILLSGLDDDVMLKIADFGLSCTLYPG---------------NYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        92 i~p~nil~~~~~~~~~~kl~df~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      |+|+||++   +..+.++|+|||.+......               .......+++.|+|||.+.+. .++.++|+|||
T Consensus       145 l~~~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl  220 (335)
T PTZ00024        145 LSPANIFI---NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSV  220 (335)
T ss_pred             ccHHHeEE---CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHH
Confidence            99999999   67788999999988755411               111223457789999998754 46899999996

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.95  E-value=1.5e-27  Score=158.23  Aligned_cols=145  Identities=24%  Similarity=0.296  Sum_probs=120.1

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecC-----CcEEEEEEecCCCCchHHHHHc----CCCCHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGA   77 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~   77 (154)
                      .+..+...+|++..++++|||++++++....+     ...|++++|...|+|.+.+...    ..+++.+++.|+.++++
T Consensus        59 ~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~  138 (302)
T KOG2345|consen   59 QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICR  138 (302)
T ss_pred             hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHH
Confidence            36678889999999999999999999877433     3489999999999999998643    35999999999999999


Q ss_pred             HHHHHHhCC--ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc----------cccccCCccccCccccccc--
Q 031702           78 GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----------AEKVCGSPLYMAPEVLQFQ--  143 (154)
Q Consensus        78 ~l~~lh~~~--~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~--  143 (154)
                      |+++||+..  +.|+||||.||++   ++.+.+++.|||.++...-.-.          ......|..|.|||.+.-+  
T Consensus       139 gL~~lH~~~~~yAH~DiKP~NILl---s~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~  215 (302)
T KOG2345|consen  139 GLEALHEKEPPYAHRDIKPANILL---SDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSH  215 (302)
T ss_pred             HHHHHhccCCcccccCCCcceeEe---cCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccC
Confidence            999999998  9999999999999   5678999999998865432111          1123568889999998744  


Q ss_pred             -CCCcccceecC
Q 031702          144 -RYDEKVNFFVS  154 (154)
Q Consensus       144 -~~~~~~Diwsl  154 (154)
                       ..+.++|||||
T Consensus       216 ~ti~ertDIWSL  227 (302)
T KOG2345|consen  216 CTITERTDIWSL  227 (302)
T ss_pred             cccccccchhhh
Confidence             35789999997

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.95  E-value=2e-27  Score=166.68  Aligned_cols=142  Identities=29%  Similarity=0.439  Sum_probs=118.0

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      .+.+.+|+.+++.++|||++++++++.++...++++||++ +++.+++.....  +++..+..++.|++.|++|||+.++
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i  123 (294)
T PLN00009         45 PSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRV  123 (294)
T ss_pred             hHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            4678899999999999999999999999999999999995 588877765443  5788889999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccc-cCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++.  ..+..+|++|||++....... ......+++.|+|||.+.+ ..++.++|+|||
T Consensus       124 ~H~dl~p~nill~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl  190 (294)
T PLN00009        124 LHRDLKPQNLLID--RRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSV  190 (294)
T ss_pred             eCCCCCcceEEEE--CCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHH
Confidence            9999999999994  245678999999987553322 1223456788999998865 357899999996

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.95  E-value=1.9e-27  Score=169.95  Aligned_cols=141  Identities=30%  Similarity=0.499  Sum_probs=120.6

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecC-----CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ...+.+|+.+++.++|+|++++.+++...     ...|+++||+. ++|.+++...+.+++..+..++.|++.|+.|||+
T Consensus        48 ~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  126 (337)
T cd07858          48 AKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS  126 (337)
T ss_pred             hHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            45677899999999999999999988654     35899999995 6899988878889999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCcccccc-cCCCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      .+++|+||+|+||++   +..+.++|+|||++...... .......++..|+|||.+.+ ..++.++|+|||
T Consensus       127 ~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  195 (337)
T cd07858         127 ANVLHRDLKPSNLLL---NANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSV  195 (337)
T ss_pred             CCEecCCCCHHHEEE---cCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHH
Confidence            999999999999999   66788999999998765443 22334467888999998765 468899999996

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.95  E-value=2.8e-27  Score=164.85  Aligned_cols=150  Identities=22%  Similarity=0.332  Sum_probs=124.2

Q ss_pred             hhhhh--hhhHHhHHHHHHHHhhC-CCC-----ccchhhhheecCCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHH
Q 031702            2 LKKLN--KHLKSCLDCELNFLSSV-NHP-----NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKF   71 (154)
Q Consensus         2 ~k~~~--~~~~~~~~~e~~~l~~l-~h~-----~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~   71 (154)
                      ||.++  ...++...-|+++++++ ++.     .++++.++|.-.++.|+++|.+ |.|+.+++.++.  +++...++.+
T Consensus       119 lKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m  197 (415)
T KOG0671|consen  119 LKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHM  197 (415)
T ss_pred             HHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHH
Confidence            44444  34477788899999999 332     3778888899999999999988 779999998654  6999999999


Q ss_pred             HHHHHHHHHHHHhCCceeecCCCCcEEeecC-----------------CCCeeEEEeecccccccCCCCccccccCCccc
Q 031702           72 LQQLGAGLEILNSHHIIHRDLKPENILLSGL-----------------DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY  134 (154)
Q Consensus        72 ~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~-----------------~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y  134 (154)
                      .+|++.++++||+.+++|.|+||+||++.+.                 .....++++|||.|......  ..+...|.-|
T Consensus       198 ~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHY  275 (415)
T KOG0671|consen  198 GYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHY  275 (415)
T ss_pred             HHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC--cceeeecccc
Confidence            9999999999999999999999999999621                 12447899999998764333  2456678889


Q ss_pred             cCcccccccCCCcccceecC
Q 031702          135 MAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus       135 ~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .|||++.+-+++..+||||+
T Consensus       276 RAPEViLgLGwS~pCDvWSi  295 (415)
T KOG0671|consen  276 RAPEVILGLGWSQPCDVWSI  295 (415)
T ss_pred             CCchheeccCcCCccCceee
Confidence            99999999999999999996

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.95  E-value=1.5e-28  Score=165.51  Aligned_cols=145  Identities=28%  Similarity=0.496  Sum_probs=126.3

Q ss_pred             hhhhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH
Q 031702            6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      +.++.+++..++.++..- .+|+||+++++|..+..+++.||.| +..+..+++. .+++++..+..+...+++|+.||-
T Consensus       130 Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLK  208 (391)
T KOG0983|consen  130 NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLK  208 (391)
T ss_pred             CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHH
Confidence            456778888899888776 5999999999999999999999988 4566666653 467999999999999999999998


Q ss_pred             h-CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCccccc---ccCCCcccceecC
Q 031702           84 S-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVNFFVS  154 (154)
Q Consensus        84 ~-~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Diwsl  154 (154)
                      . .+++|||+||+||++   |..+++|++|||.+.++.++.......|++.|||||.+.   ...|+..+|+|||
T Consensus       209 eKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSl  280 (391)
T KOG0983|consen  209 EKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSL  280 (391)
T ss_pred             HhcceeecccCccceEE---ccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhh
Confidence            7 589999999999999   899999999999999887776666677899999999986   3479999999997

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=3.1e-27  Score=164.47  Aligned_cols=143  Identities=34%  Similarity=0.562  Sum_probs=123.7

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|+.+++.++|+|++++++++.+.+..++++||++ ++|.+++.+. ..+++..+..++.+++.|+++||+.+
T Consensus        40 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~  118 (282)
T cd07829          40 GIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR  118 (282)
T ss_pred             cccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            345677889999999999999999999999999999999997 5899999876 57999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCccccccc-CCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.++|+|||.+....... ......++..|+|||.+.+. .++.++|+|||
T Consensus       119 i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~sl  185 (282)
T cd07829         119 ILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSV  185 (282)
T ss_pred             cccCCCChheEEE---cCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHH
Confidence            9999999999999   668889999999887654332 22234456789999998766 78899999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.95  E-value=2.5e-27  Score=164.43  Aligned_cols=144  Identities=25%  Similarity=0.424  Sum_probs=118.6

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCC------cEEEEEEecCCCCchHHHHHc------CCCCHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLH------GRVPEQTARKFLQQL   75 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~i   75 (154)
                      ...+.+.+|+++++.++|||++++++++....      ..+++++|+.+++|.+++...      ..++...+..++.|+
T Consensus        43 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i  122 (273)
T cd05074          43 SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI  122 (273)
T ss_pred             HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Confidence            44667889999999999999999999875432      347889999999998886422      247889999999999


Q ss_pred             HHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCCCccccee
Q 031702           76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFF  152 (154)
Q Consensus        76 ~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diw  152 (154)
                      +.|++|||+.+++|+||+|+||++   +..+.++++|||.+.......   ......+++.|++||...+..++.++|||
T Consensus       123 ~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~  199 (273)
T cd05074         123 ASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVW  199 (273)
T ss_pred             HHHHHHHHhCCEeecccchhhEEE---cCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhH
Confidence            999999999999999999999999   567789999999987654322   12223345679999999888899999999


Q ss_pred             cC
Q 031702          153 VS  154 (154)
Q Consensus       153 sl  154 (154)
                      ||
T Consensus       200 sl  201 (273)
T cd05074         200 AF  201 (273)
T ss_pred             HH
Confidence            96

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=6.8e-28  Score=170.78  Aligned_cols=150  Identities=26%  Similarity=0.395  Sum_probs=128.6

Q ss_pred             ChhhhhhhhHHhHHHHHHHHhhC--CCCccchhhhheecC----CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHH
Q 031702            1 MLKKLNKHLKSCLDCELNFLSSV--NHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ   74 (154)
Q Consensus         1 ~~k~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~   74 (154)
                      |+|.++..+.+...+|.+|.+..  +|+||+.+.++-..+    ..++++++|.+.|||.+|+.+ ..++.+...+++..
T Consensus       238 AVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS  316 (513)
T KOG2052|consen  238 AVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALS  316 (513)
T ss_pred             EEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHH
Confidence            57888999999999999999874  999999999876443    368999999999999999986 67999999999999


Q ss_pred             HHHHHHHHHhC--------CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-----ccccccCCccccCccccc
Q 031702           75 LGAGLEILNSH--------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQ  141 (154)
Q Consensus        75 i~~~l~~lh~~--------~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~  141 (154)
                      ++.|+++||..        .|.|||||..||++   .+++.+.|+|+|+|.+.....     ......||..|||||++.
T Consensus       317 ~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLd  393 (513)
T KOG2052|consen  317 IASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLD  393 (513)
T ss_pred             HhhhHHHHHHHHhcCCCCchhhccccccccEEE---ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhh
Confidence            99999999974        48999999999999   578899999999998765542     345678999999999997


Q ss_pred             ccC----C--CcccceecC
Q 031702          142 FQR----Y--DEKVNFFVS  154 (154)
Q Consensus       142 ~~~----~--~~~~Diwsl  154 (154)
                      ...    +  -..+|||||
T Consensus       394 etin~~~Fesyk~ADIYaf  412 (513)
T KOG2052|consen  394 ETINMKHFESYKRADIYAF  412 (513)
T ss_pred             hhcChhhhhhhhHHHHHHH
Confidence            532    2  256999997

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.95  E-value=3.3e-27  Score=165.09  Aligned_cols=143  Identities=28%  Similarity=0.454  Sum_probs=119.9

Q ss_pred             hhHHhHHHHHHHHhhCC-CCccchhhhheecCCcEEEEEEecCCCCchHHHH-----HcCCCCHHHHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-----LHGRVPEQTARKFLQQLGAGLEI   81 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~   81 (154)
                      .....+.+|+.++.++. |+||+++++++..++..++++||++ +++.++..     ....+++..+..++.+++.|++|
T Consensus        44 ~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~  122 (288)
T cd06616          44 KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNY  122 (288)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Confidence            34567889999999995 9999999999999999999999985 46655432     23569999999999999999999


Q ss_pred             HHhC-CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCccccccc---CCCcccceecC
Q 031702           82 LNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ---RYDEKVNFFVS  154 (154)
Q Consensus        82 lh~~-~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Diwsl  154 (154)
                      ||+. +++|+||+|+||++   +..+.++|+|||++.............+++.|+|||++.+.   .++.++|||||
T Consensus       123 lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~sl  196 (288)
T cd06616         123 LKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSL  196 (288)
T ss_pred             HhhcCCeeccCCCHHHEEE---ccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHH
Confidence            9975 99999999999999   56788999999998765544444445678889999998765   68899999996

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.95  E-value=5.1e-27  Score=166.41  Aligned_cols=140  Identities=34%  Similarity=0.556  Sum_probs=119.3

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|+.+++.++|||++++.+++.+++..++++||+.+ ++.+.+.. ...+++.++..++.+++.|+.|||+.+
T Consensus        67 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~  145 (317)
T cd06635          67 EKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN  145 (317)
T ss_pred             HHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3446788999999999999999999999999999999999965 77776643 456899999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCccccc---ccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.++|+|||++.....   .....+++.|+|||.+.   .+.++.++|+|||
T Consensus       146 i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~sl  210 (317)
T cd06635         146 MIHRDIKAGNILL---TEPGQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL  210 (317)
T ss_pred             cccCCCCcccEEE---CCCCCEEEecCCCccccCC---cccccCCccccChhhhhcCCCCCCCccccHHHH
Confidence            9999999999999   5678899999998764432   23346788899999974   4568899999996

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.95  E-value=2.9e-27  Score=164.85  Aligned_cols=142  Identities=30%  Similarity=0.501  Sum_probs=121.4

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecC--CcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ..+.+.+|+++++.++|+|++++++++.+.  +..++++||+++ +|.+++.+. ..+++..++.++.|++.|+++||+.
T Consensus        41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~  119 (287)
T cd07840          41 FPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN  119 (287)
T ss_pred             chHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            356788999999999999999999999888  889999999965 888888655 5799999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCcccccc-cCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      +++|+||+|+||++   +..+.++++|||.+.......  ......++..|+|||.+.+ ..++.++|||||
T Consensus       120 ~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl  188 (287)
T cd07840         120 GILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSV  188 (287)
T ss_pred             CceeccCcHHHeEE---cCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHH
Confidence            99999999999999   678899999999987654432  1233456778999998764 457899999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.95  E-value=4.2e-27  Score=164.11  Aligned_cols=141  Identities=30%  Similarity=0.511  Sum_probs=119.8

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      .+.+.+|+.+++.++|+|++++++.+.+.+..++++||+++ +|.+++....   .+++..+..++.|++.|+.|||+.+
T Consensus        42 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  120 (284)
T cd07836          42 PSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR  120 (284)
T ss_pred             hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence            46677899999999999999999999999999999999975 8888876543   5899999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCccccccc-CCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.++++|||.+....... ......++..|+|||++.+. .++.++|+|||
T Consensus       121 i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl  187 (284)
T cd07836         121 VLHRDLKPQNLLI---NKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSV  187 (284)
T ss_pred             eeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHH
Confidence            9999999999999   677889999999886543322 12234567889999998653 56889999996

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.94  E-value=8.6e-28  Score=153.52  Aligned_cols=141  Identities=32%  Similarity=0.543  Sum_probs=123.7

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ......+|+.+++.++|.|||+++++..++..+.+++|||. .+|..+..+ ++.++.+.++.++.|+++++.++|+.++
T Consensus        44 vpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnv  122 (292)
T KOG0662|consen   44 VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNV  122 (292)
T ss_pred             CcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhh
Confidence            34567889999999999999999999999999999999995 489988865 4569999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc-ccccCCccccCccccccc-CCCcccceec
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVCGSPLYMAPEVLQFQ-RYDEKVNFFV  153 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~-~~~~~~Diws  153 (154)
                      +|||+||+|.++   +.++..|++|||+++..+-.-.+ .....|.+|.+|+++.+. .|+++.||||
T Consensus       123 lhrdlkpqnlli---n~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmws  187 (292)
T KOG0662|consen  123 LHRDLKPQNLLI---NRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS  187 (292)
T ss_pred             hhccCCcceEEe---ccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhh
Confidence            999999999999   78899999999999876554322 334568999999998865 5899999998

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.94  E-value=4.6e-27  Score=159.68  Aligned_cols=142  Identities=44%  Similarity=0.785  Sum_probs=128.6

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (154)
                      .+.+.+|++.++.++|++++++.+.+......++++|++++++|.+++.....++...+..++.+++.++.+||+.+++|
T Consensus        31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h  110 (244)
T smart00220       31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIH  110 (244)
T ss_pred             HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeec
Confidence            68899999999999999999999999999999999999999999999987666899999999999999999999999999


Q ss_pred             ecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        90 ~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +||+|.||++   +..+.++++|||.+.............++..|+|||...+..++.++|+|||
T Consensus       111 ~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~sl  172 (244)
T smart00220      111 RDLKPENILL---DEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSL  172 (244)
T ss_pred             CCcCHHHeEE---CCCCcEEEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHH
Confidence            9999999999   5668999999999887665544455667888999999988888999999985

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.94  E-value=3.1e-27  Score=166.52  Aligned_cols=141  Identities=26%  Similarity=0.462  Sum_probs=115.6

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCC--------cEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHH
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN--------CIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLE   80 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~   80 (154)
                      ...+.+|+.++++++|||++++++++...+        ..++++||++ +++.+.+.... .+++.++..++.|++.|++
T Consensus        55 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~  133 (310)
T cd07865          55 PITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLY  133 (310)
T ss_pred             hhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHH
Confidence            345678999999999999999999876543        4599999996 47877776443 6899999999999999999


Q ss_pred             HHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc-----cccccCCccccCccccccc-CCCcccceecC
Q 031702           81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        81 ~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      |||+.+++|+||+|+||++   +..+.++|+|||.+........     .....++..|+|||.+.+. .++.++|+|||
T Consensus       134 ~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl  210 (310)
T cd07865         134 YIHRNKILHRDMKAANILI---TKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGA  210 (310)
T ss_pred             HHHHCCeeccCCCHHHEEE---CCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHH
Confidence            9999999999999999999   6778999999999876533221     1234567789999998654 46889999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.94  E-value=3.7e-27  Score=168.33  Aligned_cols=141  Identities=28%  Similarity=0.516  Sum_probs=117.2

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecC-----CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      ..+.+.+|+.+++.++|+|++++++++...     ...++++||++ +++.+.+. ...+++..+..++.|++.|+++||
T Consensus        46 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH  123 (336)
T cd07849          46 FCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIK-TQHLSNDHIQYFLYQILRGLKYIH  123 (336)
T ss_pred             hHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH
Confidence            456678899999999999999999887544     35899999996 48877764 457999999999999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC----ccccccCCccccCcccccc-cCCCcccceecC
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      +.+++|+||+|+||++   +..+.++|+|||++.......    ......+++.|+|||.+.+ ..++.++|+|||
T Consensus       124 ~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl  196 (336)
T cd07849         124 SANVLHRDLKPSNLLL---NTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSV  196 (336)
T ss_pred             hCCeeccCCCHHHEEE---CCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHH
Confidence            9999999999999999   677889999999987653322    1123467888999998654 468899999996

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.94  E-value=6.3e-27  Score=163.29  Aligned_cols=141  Identities=35%  Similarity=0.542  Sum_probs=119.9

Q ss_pred             HHhHHHHHHHHhhC---CCCccchhhhheecCCc-----EEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHH
Q 031702           10 KSCLDCELNFLSSV---NHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL   79 (154)
Q Consensus        10 ~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~-----~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l   79 (154)
                      ...+.+|+.+++.+   .|+|++++.+.+.+...     .++++||+. ++|.+++....  .+++..++.++.|++.|+
T Consensus        42 ~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al  120 (287)
T cd07838          42 PLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGV  120 (287)
T ss_pred             hhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHH
Confidence            45667788887766   59999999999987766     999999996 48888886643  489999999999999999


Q ss_pred             HHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        80 ~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .+||+.+++|+|++|+||++   +..+.++|+|||.+.............++..|+|||.+.+..++.++|+|||
T Consensus       121 ~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~  192 (287)
T cd07838         121 DFLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSV  192 (287)
T ss_pred             HHHHHCCeeeccCChhhEEE---ccCCCEEEeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhH
Confidence            99999999999999999999   6678999999999877654443334456788999999998889999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.94  E-value=1e-26  Score=164.64  Aligned_cols=139  Identities=33%  Similarity=0.534  Sum_probs=118.5

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+.+++.++|||++++++++.+....|+++||+. +++.+++.. ...+++.++..++.|++.|+.|||+.|+
T Consensus        64 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi  142 (313)
T cd06633          64 KWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM  142 (313)
T ss_pred             HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34678889999999999999999999999999999999996 577776654 4568999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCccccc---ccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||++....   ......++..|+|||.+.   ...++.++|+|||
T Consensus       143 ~H~dl~p~nili---~~~~~~kL~dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~sl  206 (313)
T cd06633         143 IHRDIKAGNILL---TEPGQVKLADFGSASKSS---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL  206 (313)
T ss_pred             ecCCCChhhEEE---CCCCCEEEeecCCCcccC---CCCCccccccccChhhccccCCCCCCchhhHHHH
Confidence            999999999999   567789999999875432   223456788899999974   3567889999996

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=4.4e-27  Score=177.54  Aligned_cols=149  Identities=30%  Similarity=0.592  Sum_probs=128.9

Q ss_pred             hhhhhhhHHhHHHHHHHHhhC-CCCccchhhhhee-----cCCcEEEEEEecCCCCchHHHHH--cCCCCHHHHHHHHHH
Q 031702            3 KKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQ   74 (154)
Q Consensus         3 k~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-----~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~   74 (154)
                      +.......+.++.|..+++.. .|||++.+++++.     .++.+++|||||.|||..++++.  ..++.+..+..+++.
T Consensus        52 ~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re  131 (953)
T KOG0587|consen   52 MDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILRE  131 (953)
T ss_pred             ecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHH
Confidence            334566788999999999999 7999999999984     34679999999999999999864  346899999999999


Q ss_pred             HHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCccccccc-----CCCcc
Q 031702           75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-----RYDEK  148 (154)
Q Consensus        75 i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-----~~~~~  148 (154)
                      ++.|+.+||.+.++|||||-.||++   ...+.+||.|||.+..+... ....+..|||.|||||+....     .|+..
T Consensus       132 ~lrgl~HLH~nkviHRDikG~NiLL---T~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R  208 (953)
T KOG0587|consen  132 ILRGLAHLHNNKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYR  208 (953)
T ss_pred             HHHHHHHHhhcceeeecccCceEEE---eccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccc
Confidence            9999999999999999999999999   57889999999998776543 456677899999999999743     47789


Q ss_pred             cceecC
Q 031702          149 VNFFVS  154 (154)
Q Consensus       149 ~Diwsl  154 (154)
                      +|+|||
T Consensus       209 ~D~WsL  214 (953)
T KOG0587|consen  209 SDLWSL  214 (953)
T ss_pred             cchhhc
Confidence            999997

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.94  E-value=8.4e-27  Score=162.51  Aligned_cols=140  Identities=28%  Similarity=0.457  Sum_probs=115.6

Q ss_pred             HhHHHHHHH-HhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702           11 SCLDCELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus        11 ~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ..+..|..+ ++.++|||++++++.+..++..|+++||++ ++|.+++...    ..+++..++.++.|++.|++|||++
T Consensus        44 ~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  122 (283)
T cd06617          44 KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK  122 (283)
T ss_pred             HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc
Confidence            445556665 566799999999999999999999999996 5888777542    3589999999999999999999997


Q ss_pred             -CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc----cCCCcccceecC
Q 031702           86 -HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF----QRYDEKVNFFVS  154 (154)
Q Consensus        86 -~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Diwsl  154 (154)
                       +++|+||+|+||++   +..+.+||+|||.+.............++..|+|||.+.+    ..++.++|+|||
T Consensus       123 ~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~sl  193 (283)
T cd06617         123 LSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSL  193 (283)
T ss_pred             CCeecCCCCHHHEEE---CCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhh
Confidence             99999999999999   6788999999999876544333333567888999998864    456889999996

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.94  E-value=9e-27  Score=164.56  Aligned_cols=139  Identities=32%  Similarity=0.564  Sum_probs=118.6

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+.+++.++|+|++++.+++..++..++++||+. +++.+.+.. ...+++..+..++.|++.|+.|||+.++
T Consensus        58 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i  136 (308)
T cd06634          58 KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM  136 (308)
T ss_pred             HHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            34567889999999999999999999999999999999996 577776653 4468999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCccccc---ccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++++|||++......   ....+++.|+|||.+.   ...++.++|||||
T Consensus       137 ~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~sl  200 (308)
T cd06634         137 IHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSL  200 (308)
T ss_pred             ccCCCCHHhEEE---CCCCcEEECCcccceeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHH
Confidence            999999999999   56788999999988654332   2345788899999974   3467889999996

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.94  E-value=5.1e-27  Score=165.74  Aligned_cols=140  Identities=34%  Similarity=0.489  Sum_probs=116.9

Q ss_pred             HhHHHHHHHHhhCCCCccchhhhheecC--CcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702           11 SCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+|+.+++.++|+|++++.+++.+.  +..++++||++ ++|.+++... ..+++..+..++.|++.|+.|||+.++
T Consensus        51 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i  129 (309)
T cd07845          51 ISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFI  129 (309)
T ss_pred             chhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            3466899999999999999999998755  56899999996 4888887653 568999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccc-cCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||.+....... ......+++.|+|||.+.+ ..++.++|+|||
T Consensus       130 ~H~dl~p~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl  195 (309)
T cd07845         130 IHRDLKVSNLLL---TDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAV  195 (309)
T ss_pred             ecCCCCHHHEEE---CCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHH
Confidence            999999999999   677889999999987665432 2222334677999999865 457899999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.94  E-value=9.2e-27  Score=163.25  Aligned_cols=142  Identities=29%  Similarity=0.464  Sum_probs=116.1

Q ss_pred             HHhHHHHHHHHhhC-CCCccchhhhheecCCc-----EEEEEEecCCCCchHHHHHc-----CCCCHHHHHHHHHHHHHH
Q 031702           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLH-----GRVPEQTARKFLQQLGAG   78 (154)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-----~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~   78 (154)
                      .+.+.+|+.+++.+ +|+|++++++++...+.     .|+++||+++ +|.+++...     ..+++..++.++.|++.|
T Consensus        44 ~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~  122 (295)
T cd07837          44 PPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG  122 (295)
T ss_pred             chHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHH
Confidence            35688899999999 56999999999876655     8999999975 888887543     347999999999999999


Q ss_pred             HHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCcccccc-cCCCcccceecC
Q 031702           79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        79 l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      +.|||+.+++|+||+|+||++.  ...+.++|+|||.+...... .......+++.|+|||.+.+ ..++.++|+|||
T Consensus       123 L~~LH~~~i~H~dl~~~nil~~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~sl  198 (295)
T cd07837         123 VAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSV  198 (295)
T ss_pred             HHHHHHCCeeecCCChHHEEEe--cCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHH
Confidence            9999999999999999999993  22788999999998754332 22223356788999998864 457899999996

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.94  E-value=7.2e-27  Score=175.64  Aligned_cols=153  Identities=33%  Similarity=0.507  Sum_probs=128.1

Q ss_pred             ChhhhhhhhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCC---CHHHHHHHHHHH
Q 031702            1 MLKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRV---PEQTARKFLQQL   75 (154)
Q Consensus         1 ~~k~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~---~~~~~~~~~~~i   75 (154)
                      |+|.+-.+..+...+|++.|+.- +||||+++++.-.+..+.|+..|.|. -+|.+++... ...   ..-.......|+
T Consensus       537 AVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~  615 (903)
T KOG1027|consen  537 AVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQI  615 (903)
T ss_pred             hHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhHHHHHhccccchhhcccccHHHHHHHH
Confidence            46667777888899999999998 89999999999999999999999995 5999999864 111   113346678899


Q ss_pred             HHHHHHHHhCCceeecCCCCcEEeecC--CCCeeEEEeecccccccCCCC----ccccccCCccccCcccccccCCCccc
Q 031702           76 GAGLEILNSHHIIHRDLKPENILLSGL--DDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKV  149 (154)
Q Consensus        76 ~~~l~~lh~~~~~h~~i~p~nil~~~~--~~~~~~kl~df~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~  149 (154)
                      ++|+++||+.+++||||||+||++...  +...+++|+|||++.++..+.    ...+..||-+|+|||++....-+.++
T Consensus       616 ~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~av  695 (903)
T KOG1027|consen  616 ASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAV  695 (903)
T ss_pred             HHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCccc
Confidence            999999999999999999999999754  244688999999999876543    23456789999999999988888899


Q ss_pred             ceecC
Q 031702          150 NFFVS  154 (154)
Q Consensus       150 Diwsl  154 (154)
                      ||+||
T Consensus       696 DiFsl  700 (903)
T KOG1027|consen  696 DIFSL  700 (903)
T ss_pred             chhhc
Confidence            99986

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.94  E-value=1.2e-26  Score=176.37  Aligned_cols=145  Identities=31%  Similarity=0.533  Sum_probs=126.9

Q ss_pred             hhhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC----------------CCCHHHHH
Q 031702            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR   69 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----------------~~~~~~~~   69 (154)
                      ..+.+.+..|+.+++.+ +|+|++.+.+++..++.++++.||+..|+|.++++.+.                .++.....
T Consensus       342 ~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLl  421 (609)
T KOG0200|consen  342 SSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLL  421 (609)
T ss_pred             cHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHH
Confidence            45678999999999999 79999999999999999999999999999999998665                38888999


Q ss_pred             HHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcccc--ccC--CccccCcccccccCC
Q 031702           70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCG--SPLYMAPEVLQFQRY  145 (154)
Q Consensus        70 ~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~--~~~--~~~y~aPE~~~~~~~  145 (154)
                      .++.||+.|++||++..++|||+..+||++   ..+..+|++|||+++..........  -.+  ...|||||.+....|
T Consensus       422 sfa~QIa~GMe~L~~~~~vHRDLAaRNVLi---~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~f  498 (609)
T KOG0200|consen  422 SFAYQIANGMEYLASVPCVHRDLAARNVLI---TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVF  498 (609)
T ss_pred             HHHHHHHHHHHHHhhCCccchhhhhhhEEe---cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcc
Confidence            999999999999999999999999999999   5778999999999986555443321  111  334999999999999


Q ss_pred             CcccceecC
Q 031702          146 DEKVNFFVS  154 (154)
Q Consensus       146 ~~~~Diwsl  154 (154)
                      +.++|+|||
T Consensus       499 t~kSDVWSf  507 (609)
T KOG0200|consen  499 TSKSDVWSF  507 (609)
T ss_pred             cccchhhHH
Confidence            999999997

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.94  E-value=1.2e-26  Score=165.53  Aligned_cols=141  Identities=29%  Similarity=0.452  Sum_probs=117.8

Q ss_pred             HHhHHHHHHHHhhC-CCCccchhhhheec----CCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh
Q 031702           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      .+.+.+|+.+++++ +||||+++++.+..    ....++++++++ ++|.+.+.....+++..+..++.|++.|++|||+
T Consensus        45 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~  123 (332)
T cd07857          45 AKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHS  123 (332)
T ss_pred             HHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            45678899999999 69999999986532    245789999885 6899988877889999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc-----cccccCCccccCcccccc-cCCCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      .|++|+||+|+||++   +..+.++|+|||.+........     .....|++.|+|||.+.+ ..++.++|||||
T Consensus       124 ~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~sl  196 (332)
T cd07857         124 ANVLHRDLKPGNLLV---NADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSV  196 (332)
T ss_pred             CCcccCCCCHHHeEE---cCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHH
Confidence            999999999999999   6778899999999876543221     223467888999998765 468899999996

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.94  E-value=1.5e-26  Score=165.29  Aligned_cols=141  Identities=35%  Similarity=0.546  Sum_probs=118.2

Q ss_pred             hHHhHHHHHHHHhhC-CCCccchhhhheecC--CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ....+.+|+.+++.+ +||||+++++++...  ...++++||++ ++|.+++... .+++.....++.|++.|+.|||+.
T Consensus        49 ~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~  126 (337)
T cd07852          49 DAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSG  126 (337)
T ss_pred             hhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            345677899999999 999999999988654  46899999996 5998888755 788899999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC------ccccccCCccccCcccccc-cCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------YAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      |++|+||+|+||++   +..+.++|+|||.+.......      ......+++.|+|||.+.+ ..++.++|+|||
T Consensus       127 ~i~H~dl~p~nill---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~sl  199 (337)
T cd07852         127 NVIHRDLKPSNILL---NSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSV  199 (337)
T ss_pred             CeecCCCCHHHEEE---cCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHH
Confidence            99999999999999   678899999999987654332      1123457888999998764 457889999996

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.94  E-value=1.7e-26  Score=162.27  Aligned_cols=136  Identities=16%  Similarity=0.224  Sum_probs=109.2

Q ss_pred             HHHHHHhhCCCCccchhhhheecCC----cEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 031702           15 CELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR   90 (154)
Q Consensus        15 ~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~   90 (154)
                      .+...+..+.|++++++++......    ..++++++. ..++.+.+......++..+..++.|++.|++|||+.+++||
T Consensus        72 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHr  150 (294)
T PHA02882         72 ALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHG  150 (294)
T ss_pred             HHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            3445566778999999998765443    346777876 44777777655567888899999999999999999999999


Q ss_pred             cCCCCcEEeecCCCCeeEEEeecccccccCCCC--------ccccccCCccccCcccccccCCCcccceecC
Q 031702           91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        91 ~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ||||+||++   +..+.++|+|||++.......        ......||+.|+|||+..+..++.++|||||
T Consensus       151 DiKp~Nill---~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSl  219 (294)
T PHA02882        151 DIKPENIMV---DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESL  219 (294)
T ss_pred             CCCHHHEEE---cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHH
Confidence            999999999   667789999999987653321        1223468999999999999999999999996

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.94  E-value=3.1e-26  Score=160.87  Aligned_cols=142  Identities=27%  Similarity=0.500  Sum_probs=117.0

Q ss_pred             hHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 031702            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNS-H   85 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~-~   85 (154)
                      ....+..|+.++... .||||+++++++.+++..|+++||++ +++.++... ...+++..+..++.|++.|++|||+ .
T Consensus        56 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~  134 (296)
T cd06618          56 ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH  134 (296)
T ss_pred             HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC
Confidence            345566677777666 59999999999999999999999985 477777654 3568999999999999999999997 5


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccC----CCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR----YDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Diwsl  154 (154)
                      +++|+||+|+||++   +..+.++|+|||.+.............++..|+|||.+.+..    ++.++|+|||
T Consensus       135 ~i~H~dl~p~nill---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~sl  204 (296)
T cd06618         135 GVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSL  204 (296)
T ss_pred             CEecCCCcHHHEEE---cCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHH
Confidence            99999999999999   677899999999987654433333445678899999987543    7889999996

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.94  E-value=1.2e-26  Score=163.08  Aligned_cols=141  Identities=26%  Similarity=0.422  Sum_probs=116.9

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCC----------cEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHH
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN----------CIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAG   78 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----------~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~   78 (154)
                      ...+.+|+++++.++|||++++++++.+..          .+++++||+++ ++.+.+.+. ..+++..+..++.|++.|
T Consensus        50 ~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~a  128 (302)
T cd07864          50 PITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEG  128 (302)
T ss_pred             hHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHH
Confidence            356778999999999999999999887654          78999999976 677666543 468999999999999999


Q ss_pred             HHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCcccccc-cCCCcccceecC
Q 031702           79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        79 l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      ++|||+.+++|+||+|+||++   +..+.+||+|||.+.......  ......++..|+|||.+.+ ..++.++|||||
T Consensus       129 L~~LH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~sl  204 (302)
T cd07864         129 LNYCHKKNFLHRDIKCSNILL---NNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC  204 (302)
T ss_pred             HHHHHhCCeecCCCCHHHEEE---CCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHH
Confidence            999999999999999999999   678899999999987654332  1222345778999998864 357889999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.94  E-value=7.9e-27  Score=180.97  Aligned_cols=111  Identities=32%  Similarity=0.598  Sum_probs=92.3

Q ss_pred             EEEEEEecCCCCchHHHHHcCCC-CHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeeccccccc
Q 031702           41 IFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  119 (154)
Q Consensus        41 ~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~  119 (154)
                      +|+-||||+..++.++++.+... .....++++++|++|++|+|++|++||||||.|||+   +....+||+|||+|...
T Consensus       671 LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~  747 (1351)
T KOG1035|consen  671 LYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFL---DSRNSVKIGDFGLATDL  747 (1351)
T ss_pred             EEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEE---cCCCCeeecccccchhh
Confidence            58999999887777777655433 478899999999999999999999999999999999   78999999999999762


Q ss_pred             C----C--------------CC-ccccccCCccccCcccccccC---CCcccceecC
Q 031702          120 Y----P--------------GN-YAEKVCGSPLYMAPEVLQFQR---YDEKVNFFVS  154 (154)
Q Consensus       120 ~----~--------------~~-~~~~~~~~~~y~aPE~~~~~~---~~~~~Diwsl  154 (154)
                      .    .              +. ...+..||..|+|||++.+..   |+.|+|||||
T Consensus       748 ~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSL  804 (1351)
T KOG1035|consen  748 KENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSL  804 (1351)
T ss_pred             hhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHH
Confidence            1    0              01 223457888999999998654   9999999996

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.94  E-value=1.5e-26  Score=163.07  Aligned_cols=141  Identities=28%  Similarity=0.481  Sum_probs=114.5

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecC--------CcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHH
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLE   80 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~   80 (154)
                      ...+.+|+++++.++||||+++++.+.+.        ..+++++||+.+ ++...+.. ...+++..+..++.|+++|++
T Consensus        51 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~  129 (311)
T cd07866          51 PITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGIN  129 (311)
T ss_pred             chhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHH
Confidence            34677899999999999999999987543        346999999965 66666653 347999999999999999999


Q ss_pred             HHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc------------ccccCCccccCccccccc-CCCc
Q 031702           81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA------------EKVCGSPLYMAPEVLQFQ-RYDE  147 (154)
Q Consensus        81 ~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~------------~~~~~~~~y~aPE~~~~~-~~~~  147 (154)
                      |||+.+++|+|++|+||++   +..+.++|+|||++.........            ....+++.|+|||...+. .++.
T Consensus       130 ~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  206 (311)
T cd07866         130 YLHENHILHRDIKAANILI---DNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTT  206 (311)
T ss_pred             HHHhCCeecCCCCHHHEEE---CCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCc
Confidence            9999999999999999999   67889999999998754332211            123457789999987653 5789


Q ss_pred             ccceecC
Q 031702          148 KVNFFVS  154 (154)
Q Consensus       148 ~~Diwsl  154 (154)
                      ++|||||
T Consensus       207 ~~Dv~sl  213 (311)
T cd07866         207 AVDIWGI  213 (311)
T ss_pred             hhHhHHH
Confidence            9999996

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.94  E-value=3.5e-26  Score=163.89  Aligned_cols=138  Identities=30%  Similarity=0.527  Sum_probs=116.1

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecC------CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      .+.+.+|+.+++.++||||+++.+++...      ...|++++++ +++|.+++. ...+++..+..++.|++.|++|||
T Consensus        60 ~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH  137 (345)
T cd07877          60 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH  137 (345)
T ss_pred             HHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH
Confidence            46688899999999999999999988543      3478888877 779988775 446999999999999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc-cCCCcccceecC
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      +.+++|+||+|+||++   +..+.++|+|||++.....  ......++..|+|||.+.+ ..++.++|+|||
T Consensus       138 ~~~ivH~dlkp~NIll---~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl  204 (345)
T cd07877         138 SADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV  204 (345)
T ss_pred             HCCeeecCCChHHEEE---cCCCCEEEecccccccccc--cccccccCCCccCHHHHhCccCCCchhhHHHH
Confidence            9999999999999999   6777899999999875432  2233467888999999865 467899999996

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-26  Score=165.60  Aligned_cols=150  Identities=30%  Similarity=0.490  Sum_probs=127.9

Q ss_pred             ChhhhhhhhHHhHHHHHHHHhhC--CCCccchhhhheecCC----cEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHH
Q 031702            1 MLKKLNKHLKSCLDCELNFLSSV--NHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ   74 (154)
Q Consensus         1 ~~k~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~~----~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~   74 (154)
                      |+|.+..+..+.+.+|-.|++..  +|+||++++++-+..+    .+++|++|.+.|+|.++++ ...+++....+++..
T Consensus       237 AVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~-~ntisw~~~cria~S  315 (534)
T KOG3653|consen  237 AVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLK-ANTISWNSLCRIAES  315 (534)
T ss_pred             EEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHH-hccccHHHHHHHHHH
Confidence            57889999999999999999875  8999999998876555    7899999999999999998 456899999999999


Q ss_pred             HHHHHHHHHhC---------CceeecCCCCcEEeecCCCCeeEEEeecccccccCCC---CccccccCCccccCcccccc
Q 031702           75 LGAGLEILNSH---------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQF  142 (154)
Q Consensus        75 i~~~l~~lh~~---------~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~  142 (154)
                      +++|++|||+.         .|.|||||.+||++   ..+..+.|+|||+|.++.+.   +......||.+|||||++.+
T Consensus       316 marGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEg  392 (534)
T KOG3653|consen  316 MARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEG  392 (534)
T ss_pred             HHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhh
Confidence            99999999974         49999999999999   57889999999999887643   23345789999999999975


Q ss_pred             cCC-C-----cccceecC
Q 031702          143 QRY-D-----EKVNFFVS  154 (154)
Q Consensus       143 ~~~-~-----~~~Diwsl  154 (154)
                      ... .     .+.||||+
T Consensus       393 ainl~d~~Afkr~DvYam  410 (534)
T KOG3653|consen  393 AINLQDRDAFKRIDVYAM  410 (534)
T ss_pred             hcccccHHHHHHHHHHHH
Confidence            421 1     35788874

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.94  E-value=2.6e-26  Score=164.47  Aligned_cols=139  Identities=31%  Similarity=0.522  Sum_probs=117.6

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCC------cEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL   82 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l   82 (154)
                      ..+.+.+|+.+++.++||||+++.+++....      ..++++|++ +++|.+++. ...+++..+..++.|++.|++||
T Consensus        57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~L  134 (343)
T cd07880          57 FAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYI  134 (343)
T ss_pred             HHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH
Confidence            3567889999999999999999999987553      358999998 678988776 45799999999999999999999


Q ss_pred             HhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc-cCCCcccceecC
Q 031702           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        83 h~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      |+.+++|+||+|+||++   +..+.++++|||.+......  .....+++.|+|||.+.+ ..++.++|+|||
T Consensus       135 H~~gi~H~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl  202 (343)
T cd07880         135 HAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSV  202 (343)
T ss_pred             HhCCeecCCCCHHHEEE---cCCCCEEEeecccccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHH
Confidence            99999999999999999   56778999999998754332  233456888999999875 357899999996

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=5.4e-26  Score=162.20  Aligned_cols=147  Identities=31%  Similarity=0.516  Sum_probs=127.5

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheec-CCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH-   85 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-   85 (154)
                      ...+...+|..|.+.|.||.||+++++|.- .+.+|-|.|||+|.+|.-|++.+..+++.+++.|+.||+.|+.||... 
T Consensus       509 NYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEik  588 (775)
T KOG1151|consen  509 NYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIK  588 (775)
T ss_pred             hHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccC
Confidence            334667789999999999999999999964 467999999999999999999999999999999999999999999975 


Q ss_pred             -CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--------ccccccCCccccCccccccc----CCCccccee
Q 031702           86 -HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQ----RYDEKVNFF  152 (154)
Q Consensus        86 -~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~----~~~~~~Diw  152 (154)
                       .|+|-|+||.||++.+...-+.+||.|||++..+....        ......||.||++||.+.-+    +.+.++|+|
T Consensus       589 pPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVW  668 (775)
T KOG1151|consen  589 PPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVW  668 (775)
T ss_pred             CCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeE
Confidence             69999999999999877778899999999998765432        23456789999999997643    468999999


Q ss_pred             cC
Q 031702          153 VS  154 (154)
Q Consensus       153 sl  154 (154)
                      |.
T Consensus       669 Sv  670 (775)
T KOG1151|consen  669 SV  670 (775)
T ss_pred             ee
Confidence            94

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.93  E-value=3.7e-26  Score=163.56  Aligned_cols=143  Identities=27%  Similarity=0.577  Sum_probs=116.2

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecC--------------CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--------------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ   73 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~   73 (154)
                      ...+.+.+|+.+++.++|||++++++.+...              ...|+++||++ ++|.+++. ...+++..++.++.
T Consensus        44 ~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~  121 (342)
T cd07854          44 QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMY  121 (342)
T ss_pred             chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHH
Confidence            3456788999999999999999999887654              35799999996 58888775 45689999999999


Q ss_pred             HHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC----ccccccCCccccCcccccc-cCCCcc
Q 031702           74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQF-QRYDEK  148 (154)
Q Consensus        74 ~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~  148 (154)
                      |++.|+.|||+.|++|+||+|+||++.  ..+..++++|||.+.......    ......++..|+|||.+.. ..++.+
T Consensus       122 qi~~aL~~LH~~givH~dikp~Nili~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  199 (342)
T cd07854         122 QLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKA  199 (342)
T ss_pred             HHHHHHHHHHhCCcccCCCCHHHEEEc--CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCch
Confidence            999999999999999999999999994  345678999999987543221    1122356788999998754 467889


Q ss_pred             cceecC
Q 031702          149 VNFFVS  154 (154)
Q Consensus       149 ~Diwsl  154 (154)
                      +|||||
T Consensus       200 ~DiwSl  205 (342)
T cd07854         200 IDMWAA  205 (342)
T ss_pred             hhHHHH
Confidence            999996

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.93  E-value=4.3e-26  Score=163.32  Aligned_cols=139  Identities=29%  Similarity=0.521  Sum_probs=118.2

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCc------EEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL   82 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l   82 (154)
                      ..+.+.+|+.+++.++|+|++++.+++...+.      .++++||+ +++|.+++.. ..+++..+..++.|++.|+++|
T Consensus        57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~L  134 (343)
T cd07851          57 HAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYI  134 (343)
T ss_pred             HHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Confidence            44667789999999999999999998876554      89999998 6699988864 5799999999999999999999


Q ss_pred             HhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc-cCCCcccceecC
Q 031702           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        83 h~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      |+.|++|+||+|+||++   +..+.++|+|||.+......  .....++..|+|||.+.+ ..++.++|+|||
T Consensus       135 H~~gi~H~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl  202 (343)
T cd07851         135 HSAGIIHRDLKPSNIAV---NEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSV  202 (343)
T ss_pred             HHCCeecCCCCHHHeEE---CCCCCEEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHH
Confidence            99999999999999999   56788999999998765332  233456788999999865 367899999996

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.93  E-value=4.7e-26  Score=162.25  Aligned_cols=139  Identities=35%  Similarity=0.545  Sum_probs=117.2

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheec-CCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+.+++.++|||++++.+++.. ....++++||+ +++|.++++ ...+++..+..++.|++.|+.+||+.++
T Consensus        52 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i  129 (328)
T cd07856          52 LAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGV  129 (328)
T ss_pred             hhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            45678889999999999999999999865 46789999998 568888776 4568888999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc-cCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||.+.....  ......++..|+|||.+.+ ..++.++|+|||
T Consensus       130 iH~dl~p~Nili---~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl  192 (328)
T cd07856         130 VHRDLKPSNILI---NENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSA  192 (328)
T ss_pred             ccCCCCHHHEeE---CCCCCEEeCccccccccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHH
Confidence            999999999999   6778899999998865422  2223456778999999765 568899999996

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.93  E-value=9.4e-27  Score=153.53  Aligned_cols=149  Identities=25%  Similarity=0.425  Sum_probs=129.7

Q ss_pred             ChhhhhhhhHHhHHHHHHHHhhC-CCCccchhhhheecC--CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHH
Q 031702            1 MLKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGA   77 (154)
Q Consensus         1 ~~k~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~   77 (154)
                      ++|.+++-..+.+.+|+.||+.| .||||++++++..++  ....+++||+.+.+...+.   ..++.-.++.++.+++.
T Consensus        67 ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLk  143 (338)
T KOG0668|consen   67 VIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLK  143 (338)
T ss_pred             EEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHH
Confidence            46888899999999999999999 599999999999765  4578999999888777654   35788899999999999


Q ss_pred             HHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc-cCCCcccceecC
Q 031702           78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        78 ~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      |+.|+|+.||.|||+||.|+++.  ...-..+|+|+|+|.++.+.........+..|--||.+-. ..|+.+-|||||
T Consensus       144 ALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~  219 (338)
T KOG0668|consen  144 ALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSL  219 (338)
T ss_pred             HHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHH
Confidence            99999999999999999999994  4566789999999998877766666777889999999864 568899999997

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.93  E-value=2.7e-26  Score=182.68  Aligned_cols=131  Identities=26%  Similarity=0.427  Sum_probs=109.7

Q ss_pred             HHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCceee
Q 031702           14 DCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN---SHHIIHR   90 (154)
Q Consensus        14 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~~~h~   90 (154)
                      ..|++.+++++||||+++++++.+++..++||||+++|+|.++++   .+++.....++.|++.|++|||   +.+++||
T Consensus       731 ~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~  807 (968)
T PLN00113        731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVG  807 (968)
T ss_pred             HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecC
Confidence            457899999999999999999999999999999999999999986   3788999999999999999999   6699999


Q ss_pred             cCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        91 ~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||+||++   +.....++. ++.+.....   .....+++.|+|||+..+..++.++|||||
T Consensus       808 dlkp~Nil~---~~~~~~~~~-~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~  864 (968)
T PLN00113        808 NLSPEKIII---DGKDEPHLR-LSLPGLLCT---DTKCFISSAYVAPETRETKDITEKSDIYGF  864 (968)
T ss_pred             CCCHHhEEE---CCCCceEEE-ecccccccc---CCCccccccccCcccccCCCCCcccchhhH
Confidence            999999999   444445543 443322211   122357889999999998899999999996

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=6.9e-27  Score=159.85  Aligned_cols=139  Identities=35%  Similarity=0.499  Sum_probs=119.6

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecC------CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      .++..+|..++..++|+|+++++.+|.-.      ..+|++||+| ..+|.+.+.  -.++=..+..+..|++.|++|||
T Consensus        59 akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lh  135 (369)
T KOG0665|consen   59 AKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLH  135 (369)
T ss_pred             chhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHH
Confidence            35677899999999999999999999533      3589999999 558888775  44667889999999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +.||+||||||+||++   .....+|+.|||+|+.-...-...-...|..|.|||+..+..|...+||||+
T Consensus       136 s~~IihRdLkPsnivv---~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSv  203 (369)
T KOG0665|consen  136 SAGIIHRDLKPSNIVV---NSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV  203 (369)
T ss_pred             hcceeecccCccccee---cchhheeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhh
Confidence            9999999999999999   6888999999999987655533444556888999999999889999999995

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.93  E-value=1.1e-25  Score=161.07  Aligned_cols=137  Identities=30%  Similarity=0.475  Sum_probs=114.1

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCC------cEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      ...+.+|+.+++.++||||+++.+++....      ..++++||+. .++.++.  ...+++..+..++.|++.|++|||
T Consensus        58 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH  134 (342)
T cd07879          58 AKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIH  134 (342)
T ss_pred             hhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH
Confidence            456789999999999999999999986543      4699999985 4676654  346899999999999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc-cCCCcccceecC
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      +.+++|+||+|+||++   +..+.++|+|||++.....  ......+++.|+|||.+.+ ..++.++|+|||
T Consensus       135 ~~~i~H~dlkp~NIll---~~~~~~kL~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl  201 (342)
T cd07879         135 SAGIIHRDLKPGNLAV---NEDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSV  201 (342)
T ss_pred             HCCcccCCCCHHHEEE---CCCCCEEEeeCCCCcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHH
Confidence            9999999999999999   6778999999999865432  2223456788999999875 458899999996

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.93  E-value=3.7e-25  Score=170.05  Aligned_cols=143  Identities=27%  Similarity=0.442  Sum_probs=120.6

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ....+..|+.+++.++||||++++..+...+.+|++|||+.+++|.+++...+.+++..++.++.|++.||.|||..+++
T Consensus        47 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIi  126 (669)
T cd05610          47 MVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGII  126 (669)
T ss_pred             HHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence            35788999999999999999999999999999999999999999999998778899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccC-CCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Diwsl  154 (154)
                      |+||||+||++   +..+.++|+|||++....... ......+++.|++||...... -...+++||+
T Consensus       127 HrDLKP~NILl---~~~g~vkL~DFGls~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~  191 (669)
T cd05610         127 HRDLKPDNMLI---SNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKNDYSRTPGQVLSLISSL  191 (669)
T ss_pred             eCCccHHHEEE---cCCCCEEEEeCCCCccccCCcccccccccCccccCccccccCCCCceeeeeeec
Confidence            99999999999   567889999999998654433 233456788999999764332 2234555553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=2.4e-26  Score=153.53  Aligned_cols=144  Identities=24%  Similarity=0.452  Sum_probs=120.3

Q ss_pred             hhhhHHhHHHHHHHHhhCCCCccchhhhheecC--------CcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHH
Q 031702            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLG   76 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~   76 (154)
                      ++..-....+|+.+|+.++|+|++.+.++|.+.        ..+|+|+++|+. +|..++... .+++...+..++++++
T Consensus        56 KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm  134 (376)
T KOG0669|consen   56 KEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLM  134 (376)
T ss_pred             ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHH
Confidence            344556678899999999999999999988543        348999999965 888888655 5799999999999999


Q ss_pred             HHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-----ccccccCCccccCccccccc-CCCcccc
Q 031702           77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQ-RYDEKVN  150 (154)
Q Consensus        77 ~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~D  150 (154)
                      .|+.|+|...++|||+||.|+++   +.++.+||+|||+++......     .......|.+|.+||.+.+. .|+++.|
T Consensus       135 ~GL~~iHr~kilHRDmKaaNvLI---t~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iD  211 (376)
T KOG0669|consen  135 NGLYYIHRNKILHRDMKAANVLI---TKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPID  211 (376)
T ss_pred             HHHHHHHHhhHHhhcccHhhEEE---cCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcch
Confidence            99999999999999999999999   788999999999996554322     12234458999999998764 6899999


Q ss_pred             eec
Q 031702          151 FFV  153 (154)
Q Consensus       151 iws  153 (154)
                      ||+
T Consensus       212 iWg  214 (376)
T KOG0669|consen  212 IWG  214 (376)
T ss_pred             hHh
Confidence            996

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.93  E-value=1.5e-26  Score=155.24  Aligned_cols=144  Identities=28%  Similarity=0.426  Sum_probs=121.0

Q ss_pred             hhhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHH-----HcCCCCHHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-----LHGRVPEQTARKFLQQLGAGLE   80 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~~i~~~l~   80 (154)
                      ..+++++..|.+...+- +.||||+++|+...++..++-||.| ..|+..+.+     ....++++.+..+.--.++|+.
T Consensus       103 ~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~  181 (361)
T KOG1006|consen  103 EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALD  181 (361)
T ss_pred             hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHH
Confidence            35677888888877665 8999999999999999999999999 557776653     3356999999999989999999


Q ss_pred             HHHhC-CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc--cCCCcccceecC
Q 031702           81 ILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF--QRYDEKVNFFVS  154 (154)
Q Consensus        81 ~lh~~-~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Diwsl  154 (154)
                      ||-.. .++|||+||+||++   +..+.+||+|||.+..+..+-....-.|+..|||||.+..  .+|+.+||+|||
T Consensus       182 yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSL  255 (361)
T KOG1006|consen  182 YLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSL  255 (361)
T ss_pred             HHHHHhhhhhccCChhheEE---ecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhh
Confidence            99874 89999999999999   8999999999999877655544445578899999999863  469999999997

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.92  E-value=4.5e-25  Score=148.63  Aligned_cols=143  Identities=41%  Similarity=0.712  Sum_probs=126.3

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+..++.++|+|++++++.+......++++|++++++|.+++..... +++..+..++.+++.++.+||+.++
T Consensus        40 ~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i  119 (225)
T smart00221       40 QREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGI  119 (225)
T ss_pred             HHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            567899999999999999999999999998999999999999999999987666 8999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCcccc-cccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVL-QFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~-~~~~~~~~~Diwsl  154 (154)
                      +|+|++|.||++   +....++|+|||.+.......  ......++..|++||.. ....++.++|+|||
T Consensus       120 ~h~di~~~ni~v---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~l  186 (225)
T smart00221      120 VHRDLKPENILL---GMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSL  186 (225)
T ss_pred             ecCCCCHHHEEE---cCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHH
Confidence            999999999999   566899999999987765443  33445677889999998 66677889999985

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1e-26  Score=157.06  Aligned_cols=142  Identities=30%  Similarity=0.479  Sum_probs=121.8

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCC-----cEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      ..+.+-+|+.++..++|.|++..+++..-.+     .+|+++|.| ..+|...+-+.++++...++-+.+||++|+.|||
T Consensus        95 s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLH  173 (449)
T KOG0664|consen   95 SCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLH  173 (449)
T ss_pred             HHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHh
Confidence            3567788999999999999999999886553     368899988 5599988888889999999999999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--cccccCCccccCccccccc-CCCcccceecC
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      +.+|+||||||.|.++   +++...||+|||+++....++.  ......|..|.|||++.+. .|+...||||.
T Consensus       174 sA~ILHRDIKPGNLLV---NSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSV  244 (449)
T KOG0664|consen  174 TANILHRDIKPGNLLV---NSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSV  244 (449)
T ss_pred             hcchhhccCCCccEEe---ccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehh
Confidence            9999999999999999   6888999999999987654432  2234457889999999865 68999999994

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.92  E-value=1.1e-25  Score=167.44  Aligned_cols=142  Identities=23%  Similarity=0.369  Sum_probs=124.5

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ..++|.+|+.+|.+|+|+++++++|+..+ ....||+|.++.|+|.+.+++  ...|.....-.|+.||+.|+.||..++
T Consensus       154 ~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr  232 (1039)
T KOG0199|consen  154 IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR  232 (1039)
T ss_pred             hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh
Confidence            56899999999999999999999999988 567899999999999999976  235788889999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc----ccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|||+...|+++   ...-.+||+|||+.+.+..++..    ....-...|.|||.+....++.++|+|+|
T Consensus       233 lvHRDLAARNlll---asprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmy  301 (1039)
T KOG0199|consen  233 LVHRDLAARNLLL---ASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMY  301 (1039)
T ss_pred             hhhhhhhhhhhee---cccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhh
Confidence            9999999999999   45778999999999887765432    22333556999999999999999999986

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.92  E-value=8.8e-26  Score=170.14  Aligned_cols=144  Identities=26%  Similarity=0.411  Sum_probs=127.1

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ....+.+..|+.+|.+++|||++++++++..+. +.++++|+++|+|.++++.+ .++.....+.|+.||++|+.|||++
T Consensus       739 ~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q  817 (1177)
T KOG1025|consen  739 PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ  817 (1177)
T ss_pred             chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc
Confidence            455788999999999999999999999998876 78999999999999999765 4689999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccc---cCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV---CGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~---~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++||||..+|+++   .+...+|+.|||++......+..-..   .-.+.|||-|......|+.++|||||
T Consensus       818 rlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsf  886 (1177)
T KOG1025|consen  818 RLVHRDLAARNVLV---KSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSF  886 (1177)
T ss_pred             chhhhhhhhhheee---cCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhh
Confidence            99999999999999   57789999999999877665533222   22456999999999999999999997

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.92  E-value=1.9e-24  Score=143.58  Aligned_cols=142  Identities=44%  Similarity=0.747  Sum_probs=124.3

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      .+.+.+|++.++.++|++++++++.+......++++|++++++|.+++... ..++...+..++.+++.++.+||+.+++
T Consensus        35 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~  114 (215)
T cd00180          35 LEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII  114 (215)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            478999999999999999999999999999999999999989999998765 4789999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCC-CeeEEEeecccccccCCCC-ccccccCCccccCccccccc-CCCcccceecC
Q 031702           89 HRDLKPENILLSGLDD-DVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~-~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      |+|++|.||++   +. ...++|+||+.+....... ......+...|++||..... .++.++|+|||
T Consensus       115 H~dl~~~ni~~---~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~l  180 (215)
T cd00180         115 HRDLKPENILL---DSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSL  180 (215)
T ss_pred             ccCCCHhhEEE---eCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHH
Confidence            99999999999   45 6789999999887654432 12334567789999999876 78899999985

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=3.1e-25  Score=173.47  Aligned_cols=134  Identities=15%  Similarity=0.152  Sum_probs=102.8

Q ss_pred             HhhCCC-Cccchhhhhee-------cCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 031702           20 LSSVNH-PNIIRLFDAFQ-------AENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIHR   90 (154)
Q Consensus        20 l~~l~h-~~i~~~~~~~~-------~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~   90 (154)
                      .+.++| +||+++++++.       ....++.++|++ +++|.+++... ..+++..++.+++||+.|+.|||++||+||
T Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHr  104 (793)
T PLN00181         26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVH  104 (793)
T ss_pred             cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            355667 68888999882       224567778887 66999999753 459999999999999999999999999999


Q ss_pred             cCCCCcEEeec----------------CCCCeeEEEeecccccccCCCC-----------------ccccccCCccccCc
Q 031702           91 DLKPENILLSG----------------LDDDVMLKIADFGLSCTLYPGN-----------------YAEKVCGSPLYMAP  137 (154)
Q Consensus        91 ~i~p~nil~~~----------------~~~~~~~kl~df~~~~~~~~~~-----------------~~~~~~~~~~y~aP  137 (154)
                      ||||+||++..                .+....+|++|||+++......                 ......||++|+||
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            99999999942                1234456777888775421100                 00113578889999


Q ss_pred             ccccccCCCcccceecC
Q 031702          138 EVLQFQRYDEKVNFFVS  154 (154)
Q Consensus       138 E~~~~~~~~~~~Diwsl  154 (154)
                      |++.+..|+.++|||||
T Consensus       185 E~~~~~~~~~~sDVwSl  201 (793)
T PLN00181        185 EEDNGSSSNCASDVYRL  201 (793)
T ss_pred             hhhccCCCCchhhhhhH
Confidence            99998899999999996

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.90  E-value=8.6e-24  Score=153.04  Aligned_cols=145  Identities=28%  Similarity=0.429  Sum_probs=126.0

Q ss_pred             hhhhHHhHHHHHHHHhhCCC------CccchhhhheecCCcEEEEEEecCCCCchHHHHHcC---CCCHHHHHHHHHHHH
Q 031702            6 NKHLKSCLDCELNFLSSVNH------PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLG   76 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~   76 (154)
                      ++-+.+.=..|+++|++|..      -++++++..|...+++|+|+|.. ..+|.+.+++-+   .+....+..|+.|+.
T Consensus       468 NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLf  546 (752)
T KOG0670|consen  468 NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLF  546 (752)
T ss_pred             chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHH
Confidence            35566777889999999953      27899999999999999999977 669999998655   378889999999999


Q ss_pred             HHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        77 ~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .||..|-.+|++|.||||.|||++  .....+||||||.|.....+....... +..|.|||++.+.+|+...|+||.
T Consensus       547 lALklLK~c~vlHaDIKPDNiLVN--E~k~iLKLCDfGSA~~~~eneitPYLV-SRFYRaPEIiLG~~yd~~iD~WSv  621 (752)
T KOG0670|consen  547 LALKLLKKCGVLHADIKPDNILVN--ESKNILKLCDFGSASFASENEITPYLV-SRFYRAPEIILGLPYDYPIDTWSV  621 (752)
T ss_pred             HHHHHHHhcCeeecccCccceEec--cCcceeeeccCccccccccccccHHHH-HHhccCcceeecCcccCCccceee
Confidence            999999999999999999999995  567788999999998887776655443 677999999999999999999994

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.90  E-value=1.3e-24  Score=160.70  Aligned_cols=144  Identities=30%  Similarity=0.529  Sum_probs=128.6

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ....-++.|+-+++..+||||+.+++.+.....+++.|||+.+|+|.+...--+++++.++...++..+.+++|||+.|-
T Consensus        54 dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk  133 (829)
T KOG0576|consen   54 DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGK  133 (829)
T ss_pred             ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCc
Confidence            44566788999999999999999999999999999999999999999987666789999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCC-CCccccccCCccccCccccc---ccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQ---FQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~-~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Diwsl  154 (154)
                      +|||||-.||++   .+.+.+|++|||.+..+.. -.......||+.|||||+..   .+.|...+|+|++
T Consensus       134 ~hRdiKGanill---td~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~  201 (829)
T KOG0576|consen  134 IHRDIKGANILL---TDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAL  201 (829)
T ss_pred             ccccccccceee---cccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhccccccccccccc
Confidence            999999999999   6888999999999876643 23566788999999999964   5679999999985

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.89  E-value=9.4e-23  Score=153.97  Aligned_cols=104  Identities=27%  Similarity=0.414  Sum_probs=81.5

Q ss_pred             ecCCcEEEEEEecCCCCchHHHHHcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCC
Q 031702           36 QAENCIFLVVEFCAGGNLSSYIRLHGR--------------------VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPE   95 (154)
Q Consensus        36 ~~~~~~~~v~e~~~~~~L~~~~~~~~~--------------------~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~   95 (154)
                      ......++++||+++++|.+++.....                    .....+..++.|++.|+.|||+.+++||||||+
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~  284 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ  284 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence            345678999999999999998864321                    123446689999999999999999999999999


Q ss_pred             cEEeecCCCCeeEEEeecccccccCCC--CccccccCCccccCccccc
Q 031702           96 NILLSGLDDDVMLKIADFGLSCTLYPG--NYAEKVCGSPLYMAPEVLQ  141 (154)
Q Consensus        96 nil~~~~~~~~~~kl~df~~~~~~~~~--~~~~~~~~~~~y~aPE~~~  141 (154)
                      ||++.  +..+.+||+|||++......  .......+++.|+|||.+.
T Consensus       285 NILl~--~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~  330 (566)
T PLN03225        285 NIIFS--EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYI  330 (566)
T ss_pred             HEEEe--CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhh
Confidence            99994  24578999999999765332  2234567889999999754

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.88  E-value=3.8e-22  Score=148.19  Aligned_cols=127  Identities=25%  Similarity=0.348  Sum_probs=95.8

Q ss_pred             HHHHHHHHhhCCCCcc-----chhhhheec--------CCcEEEEEEecCCCCchHHHHHcC------------------
Q 031702           13 LDCELNFLSSVNHPNI-----IRLFDAFQA--------ENCIFLVVEFCAGGNLSSYIRLHG------------------   61 (154)
Q Consensus        13 ~~~e~~~l~~l~h~~i-----~~~~~~~~~--------~~~~~~v~e~~~~~~L~~~~~~~~------------------   61 (154)
                      ...|+..+.+++|.++     +++.++|..        .+..++|+||+++++|.+++....                  
T Consensus       219 ~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~  298 (507)
T PLN03224        219 GMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIP  298 (507)
T ss_pred             hHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchh
Confidence            3446777777766554     566666642        356899999999999998875321                  


Q ss_pred             ------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcccc--ccCCcc
Q 031702           62 ------RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSPL  133 (154)
Q Consensus        62 ------~~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~--~~~~~~  133 (154)
                            .++...+..++.|++.++.|+|+.+++|+||||+||++   +..+.+||+|||++...........  ..+++.
T Consensus       299 ~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~  375 (507)
T PLN03224        299 DNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPR  375 (507)
T ss_pred             hhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCccCccccCCCcc
Confidence                  13456788899999999999999999999999999999   5677899999999865543322222  234788


Q ss_pred             ccCcccccc
Q 031702          134 YMAPEVLQF  142 (154)
Q Consensus       134 y~aPE~~~~  142 (154)
                      |+|||.+..
T Consensus       376 Y~aPE~l~~  384 (507)
T PLN03224        376 YSPPEELVM  384 (507)
T ss_pred             eeChhhhcC
Confidence            999999753

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.88  E-value=2e-22  Score=142.03  Aligned_cols=140  Identities=27%  Similarity=0.417  Sum_probs=116.6

Q ss_pred             hHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ....+.+|+++|..+ .+.||+++.+.+..++.+.+++||++.....++..   .++...++.+++.++.|+.++|.+||
T Consensus        77 ~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GI  153 (418)
T KOG1167|consen   77 SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGI  153 (418)
T ss_pred             CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCc
Confidence            356789999999999 79999999999999999999999999988888876   46789999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccC-----------------C-C----------------Cc---------
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-----------------P-G----------------NY---------  124 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~-----------------~-~----------------~~---------  124 (154)
                      +||||||+|++..  -..+.-.|+|||+|....                 . .                ..         
T Consensus       154 vHRDiKpsNFL~n--~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~  231 (418)
T KOG1167|consen  154 VHRDIKPSNFLYN--RRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRP  231 (418)
T ss_pred             cccCCCccccccc--cccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCcc
Confidence            9999999999995  345566899999996210                 0 0                00         


Q ss_pred             --cccccCCccccCccccccc-CCCcccceec
Q 031702          125 --AEKVCGSPLYMAPEVLQFQ-RYDEKVNFFV  153 (154)
Q Consensus       125 --~~~~~~~~~y~aPE~~~~~-~~~~~~Diws  153 (154)
                        .-...||++|.|||++... .-++++||||
T Consensus       232 ~~~anrAGT~GfRaPEvL~k~~~QttaiDiws  263 (418)
T KOG1167|consen  232 SERANRAGTPGFRAPEVLFRCPRQTTAIDIWS  263 (418)
T ss_pred             ceecccCCCCCCCchHHHhhccCcCCccceee
Confidence              0114689999999998754 4578999998

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=2.5e-22  Score=143.77  Aligned_cols=121  Identities=21%  Similarity=0.227  Sum_probs=94.7

Q ss_pred             hHHhHHHHHHHHhhCCCCccch-hhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVNHPNIIR-LFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+.+++.++|+|++. ++.    .+..|++|||++|++|... .   ...   ...++.+++.++.+||+.|+
T Consensus        64 ~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~LVmE~~~G~~L~~~-~---~~~---~~~~~~~i~~aL~~lH~~gI  132 (365)
T PRK09188         64 ARHLAAREIRALKTVRGIGVVPQLLA----TGKDGLVRGWTEGVPLHLA-R---PHG---DPAWFRSAHRALRDLHRAGI  132 (365)
T ss_pred             HHHHHHHHHHHHHhccCCCCCcEEEE----cCCcEEEEEccCCCCHHHh-C---ccc---hHHHHHHHHHHHHHHHHCCC
Confidence            4667999999999999999885 433    2457999999999999632 1   111   14678899999999999999


Q ss_pred             eeecC-CCCcEEeecCCCCeeEEEeecccccccCCCCcc---------ccccCCccccCccccccc
Q 031702           88 IHRDL-KPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---------EKVCGSPLYMAPEVLQFQ  143 (154)
Q Consensus        88 ~h~~i-~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~  143 (154)
                      +|||| ||+||++   +..+.++|+|||++.........         .+..+++.|+|||.+...
T Consensus       133 iHrDL~KP~NILv---~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        133 THNDLAKPQNWLM---GPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             eeCCCCCcceEEE---cCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            99999 9999999   56678999999999866443211         245677889999998643

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=1.1e-21  Score=140.85  Aligned_cols=92  Identities=32%  Similarity=0.525  Sum_probs=78.5

Q ss_pred             hhHHhHHHHHHHHhhCC-----C---Cccchhhhhee----cCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVN-----H---PNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ   73 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~-----h---~~i~~~~~~~~----~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~   73 (154)
                      ...+....|+.+|++++     |   ..||++++-|.    ++.++|||+|+. |.+|..++...  +.++...++.|++
T Consensus       116 hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~  194 (590)
T KOG1290|consen  116 HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICR  194 (590)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHH
Confidence            45788889999999983     2   25999999985    446899999988 66888888654  3599999999999


Q ss_pred             HHHHHHHHHHh-CCceeecCCCCcEEee
Q 031702           74 QLGAGLEILNS-HHIIHRDLKPENILLS  100 (154)
Q Consensus        74 ~i~~~l~~lh~-~~~~h~~i~p~nil~~  100 (154)
                      |++.||.|||. +||+|.||||+|||+.
T Consensus       195 qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  195 QVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             HHHHHHHHHHHhcCccccCCCcceeeee
Confidence            99999999997 5999999999999995

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.86  E-value=1.8e-21  Score=137.09  Aligned_cols=145  Identities=25%  Similarity=0.411  Sum_probs=124.8

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecC-CcEEEEEEecCCCCchHHHHHc--------CCCCHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLH--------GRVPEQTARKFLQQLGA   77 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~i~~   77 (154)
                      +-.-..+..|...+..+.|||+..+.+++.+. ...++++.++.-|+|+.|+...        +.++..+...++.|++.
T Consensus       328 ~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~  407 (563)
T KOG1024|consen  328 QIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAM  407 (563)
T ss_pred             HHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHH
Confidence            44456788899999999999999999998654 5678999999999999999732        23667788889999999


Q ss_pred             HHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCcccceecC
Q 031702           78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        78 ~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |++|||..+++|.||...|+++   ++..++||+|-.+++...+.+.   .........||+||.+.+..|+..+|+|||
T Consensus       408 am~hlh~~~ViHkDiAaRNCvI---dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsf  484 (563)
T KOG1024|consen  408 AMEHLHNHGVIHKDIAARNCVI---DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSF  484 (563)
T ss_pred             HHHHHHhcCcccchhhhhccee---hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHH
Confidence            9999999999999999999999   7889999999999988766553   345566677999999999999999999997

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.85  E-value=2.9e-21  Score=130.42  Aligned_cols=141  Identities=26%  Similarity=0.429  Sum_probs=111.0

Q ss_pred             HHhHHHHHHHHhhC-CCCccchhhhh-eecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702           10 KSCLDCELNFLSSV-NHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~-~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+|.+|...--.| .|.+|+.-+++ |++.+.+.+++||++.|+|..-+.. ..+.+.....++.|+++|+.|||++++
T Consensus        64 ~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknl  142 (378)
T KOG1345|consen   64 QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNL  142 (378)
T ss_pred             HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccch
Confidence            56788888776677 58899888765 6777888999999999999876653 458889999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc---cC--CCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---QR--YDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~--~~~~~Diwsl  154 (154)
                      +|||||.+||++.+ .+..++||+|||.++..+.  .-.....+..|.+||....   +.  ..+++|+|.|
T Consensus       143 VHRdlK~eNiLif~-~df~rvKlcDFG~t~k~g~--tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~Wqf  211 (378)
T KOG1345|consen  143 VHRDLKAENILIFD-ADFYRVKLCDFGLTRKVGT--TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQF  211 (378)
T ss_pred             hhcccccceEEEec-CCccEEEeeecccccccCc--eehhhhhhcccCCcHHHhhccccceEecccccchhe
Confidence            99999999999986 3445999999998865432  2222333556889988642   33  4688999986

>PRK10345 hypothetical protein; Provisional

Probab=99.82  E-value=4.3e-20  Score=123.49  Aligned_cols=106  Identities=23%  Similarity=0.388  Sum_probs=84.7

Q ss_pred             hHHhHHHHHHHHhhC-----CCCccchhhhheecCC---cEE-EEEEe--cCCCCchHHHHHcCCCCHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSV-----NHPNIIRLFDAFQAEN---CIF-LVVEF--CAGGNLSSYIRLHGRVPEQTARKFLQQLGA   77 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~~~-~v~e~--~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~   77 (154)
                      ..+.+.+|+.+++.+     .||||+++++++.++.   .++ +++||  +.+++|.+++++ +.+++.  ..++.+++.
T Consensus        39 ~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~  115 (210)
T PRK10345         39 GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLK  115 (210)
T ss_pred             hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHH
Confidence            467899999999999     5799999999998873   434 78999  447999999975 356655  356778887


Q ss_pred             HH-HHHHhCCceeecCCCCcEEeecCC-CCeeEEEee-ccccc
Q 031702           78 GL-EILNSHHIIHRDLKPENILLSGLD-DDVMLKIAD-FGLSC  117 (154)
Q Consensus        78 ~l-~~lh~~~~~h~~i~p~nil~~~~~-~~~~~kl~d-f~~~~  117 (154)
                      ++ +|||+++++|+||||+||++...+ ....++|+| ||.+.
T Consensus       116 ~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~~  158 (210)
T PRK10345        116 KLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGEST  158 (210)
T ss_pred             HHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCcc
Confidence            77 999999999999999999996433 445899999 45443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.82  E-value=1e-19  Score=127.78  Aligned_cols=143  Identities=40%  Similarity=0.613  Sum_probs=123.5

Q ss_pred             hHHhHHHHHHHHhhCCCC-ccchhhhheecCCcEEEEEEecCCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh
Q 031702            9 LKSCLDCELNFLSSVNHP-NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ....+.+|..+++.+.|+ +++++.+.+......+++++++.++++.++.....   .++......+..|++.++.++|.
T Consensus        40 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~  119 (384)
T COG0515          40 EVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS  119 (384)
T ss_pred             HHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            467789999999999888 79999999977777899999999999998877665   79999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCe-eEEEeecccccccCCCC-------ccccccCCccccCcccccc---cCCCcccceec
Q 031702           85 HHIIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPGN-------YAEKVCGSPLYMAPEVLQF---QRYDEKVNFFV  153 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~-~~kl~df~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~---~~~~~~~Diws  153 (154)
                      .+++|+|+||+||++   +... .+++.|||.+.......       ......++..|+|||...+   ..++...|+||
T Consensus       120 ~~~~hrd~kp~nil~---~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s  196 (384)
T COG0515         120 KGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWS  196 (384)
T ss_pred             CCeeccCCCHHHeee---cCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHH
Confidence            999999999999999   4555 79999999987554432       2356788999999999987   57788999997


Q ss_pred             C
Q 031702          154 S  154 (154)
Q Consensus       154 l  154 (154)
                      +
T Consensus       197 ~  197 (384)
T COG0515         197 L  197 (384)
T ss_pred             H
Confidence            4

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=7.2e-20  Score=130.24  Aligned_cols=142  Identities=24%  Similarity=0.307  Sum_probs=116.5

Q ss_pred             hHHHHHHHHhhCCC----Cccchhhhhe-ecCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh
Q 031702           12 CLDCELNFLSSVNH----PNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus        12 ~~~~e~~~l~~l~h----~~i~~~~~~~-~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      .+..|..++..+..    ++++.+.+.. ..+...++||+.. |.+|.++.+..  +.++..+...++.|++.+|+++|+
T Consensus        62 ~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~  140 (322)
T KOG1164|consen   62 VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS  140 (322)
T ss_pred             cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh
Confidence            68889999999963    5888888888 5777899999977 88999988554  469999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCC--eeEEEeecccccccC--CCC-----c----cccccCCccccCcccccccCCCcccce
Q 031702           85 HHIIHRDLKPENILLSGLDDD--VMLKIADFGLSCTLY--PGN-----Y----AEKVCGSPLYMAPEVLQFQRYDEKVNF  151 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~--~~~kl~df~~~~~~~--~~~-----~----~~~~~~~~~y~aPE~~~~~~~~~~~Di  151 (154)
                      .|++||||||.|+.+......  ..+.+.|||++++..  ...     .    .....||..|.++++..+...+.+.|+
T Consensus       141 ~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDl  220 (322)
T KOG1164|consen  141 KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDL  220 (322)
T ss_pred             cCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhh
Confidence            999999999999999643212  578999999998322  111     0    112348999999999999999999999


Q ss_pred             ecC
Q 031702          152 FVS  154 (154)
Q Consensus       152 wsl  154 (154)
                      ||+
T Consensus       221 es~  223 (322)
T KOG1164|consen  221 ESL  223 (322)
T ss_pred             hhH
Confidence            985

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.82  E-value=1.7e-19  Score=119.30  Aligned_cols=102  Identities=23%  Similarity=0.211  Sum_probs=82.0

Q ss_pred             hHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HhCCceee
Q 031702           12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL-NSHHIIHR   90 (154)
Q Consensus        12 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~~~h~   90 (154)
                      ...+|+.++..+.++++.........  ..+++|||++++++.........++...+..++.|++.++.++ |+.|++|+
T Consensus        65 ~~~~E~~~l~~l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHr  142 (190)
T cd05147          65 WAEKEMRNLKRLVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHA  142 (190)
T ss_pred             HHHHHHHHHHHHHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            34569999999988877544332222  2389999999887766544456799999999999999999999 79999999


Q ss_pred             cCCCCcEEeecCCCCeeEEEeeccccccc
Q 031702           91 DLKPENILLSGLDDDVMLKIADFGLSCTL  119 (154)
Q Consensus        91 ~i~p~nil~~~~~~~~~~kl~df~~~~~~  119 (154)
                      ||||+||++.    .+.++|+|||+|...
T Consensus       143 DlkP~NIli~----~~~v~LiDFG~a~~~  167 (190)
T cd05147         143 DLSEYNLLYH----DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCCHHHEEEE----CCcEEEEEccccccC
Confidence            9999999993    357999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.82  E-value=4.5e-20  Score=124.21  Aligned_cols=119  Identities=16%  Similarity=0.201  Sum_probs=91.5

Q ss_pred             HHHHHHHHhhCCCCccchhhhheecC--------CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh
Q 031702           13 LDCELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus        13 ~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      +.+|+..+.++.|++|+.+...+...        +..+++|||++|.+|.++..    +++    ....+++.++..+|.
T Consensus        82 ~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~  153 (232)
T PRK10359         82 YENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQ  153 (232)
T ss_pred             HHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHH
Confidence            68999999999999999998876533        35789999999999988732    333    245689999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .|++|+|++|+||++.   ..+ ++++|||...........           ...+....|..++|+|||
T Consensus       154 ~gi~H~Dikp~Nili~---~~g-i~liDfg~~~~~~e~~a~-----------d~~vler~y~~~~di~~l  208 (232)
T PRK10359        154 HGMVSGDPHKGNFIVS---KNG-LRIIDLSGKRCTAQRKAK-----------DRIDLERHYGIKNEIKDL  208 (232)
T ss_pred             cCCccCCCChHHEEEe---CCC-EEEEECCCcccccchhhH-----------HHHHHHhHhcccccccce
Confidence            9999999999999994   445 999999977544221111           113444557788999997

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=4e-20  Score=139.98  Aligned_cols=137  Identities=35%  Similarity=0.549  Sum_probs=117.9

Q ss_pred             HHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecC
Q 031702           13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDL   92 (154)
Q Consensus        13 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i   92 (154)
                      +..|+.+-..|.|+|++.....+.+....+-.|||+++ +|..++.+.+.+....+-.+++|++.|+.|+|+.|+.|+|+
T Consensus       368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~Giahrdl  446 (601)
T KOG0590|consen  368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDL  446 (601)
T ss_pred             hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccC
Confidence            77788888999999998888887766555455999999 99999988778999999999999999999999999999999


Q ss_pred             CCCcEEeecCCCCeeEEEeecccccccCCC-----CccccccCCccccCcccccccCCCc-ccceec
Q 031702           93 KPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYAEKVCGSPLYMAPEVLQFQRYDE-KVNFFV  153 (154)
Q Consensus        93 ~p~nil~~~~~~~~~~kl~df~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~-~~Diws  153 (154)
                      ||+|+++   ...+.+|++|||.+.-....     ......+|+..|+|||++.+..|++ ..||||
T Consensus       447 K~enll~---~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS  510 (601)
T KOG0590|consen  447 KLENLLV---TENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWS  510 (601)
T ss_pred             ccccEEE---ecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhh
Confidence            9999999   67779999999987544322     2345578999999999999999985 689998

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.80  E-value=1.1e-19  Score=118.68  Aligned_cols=89  Identities=29%  Similarity=0.336  Sum_probs=76.5

Q ss_pred             CCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcccccc
Q 031702           51 GNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC  129 (154)
Q Consensus        51 ~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~  129 (154)
                      |+|.+++.+. ..+++..++.++.|++.|+.|||+.+      ||+||++   +..+.+++  ||.+.......    ..
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~~----~~   65 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPEQ----SR   65 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeecccc----CC
Confidence            6899999764 45999999999999999999999998      9999999   67778888  99886543322    25


Q ss_pred             CCccccCcccccccCCCcccceecC
Q 031702          130 GSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus       130 ~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |++.|+|||++.+..++.++|||||
T Consensus        66 g~~~y~aPE~~~~~~~~~~~DiwSl   90 (176)
T smart00750       66 VDPYFMAPEVIQGQSYTEKADIYSL   90 (176)
T ss_pred             CcccccChHHhcCCCCcchhhHHHH
Confidence            7899999999999999999999996

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.80  E-value=6e-19  Score=116.81  Aligned_cols=104  Identities=19%  Similarity=0.165  Sum_probs=83.9

Q ss_pred             HhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCcee
Q 031702           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-HHIIH   89 (154)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~h   89 (154)
                      ..+..|...+.++.++++..........  .+++|||++|+++.........++......++.|++.++.++|. .|++|
T Consensus        64 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givH  141 (190)
T cd05145          64 AWAEKEFRNLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVH  141 (190)
T ss_pred             HHHHHHHHHHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEec
Confidence            4456899999999999875554443332  48999999887655443334568888999999999999999999 99999


Q ss_pred             ecCCCCcEEeecCCCCeeEEEeecccccccC
Q 031702           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLY  120 (154)
Q Consensus        90 ~~i~p~nil~~~~~~~~~~kl~df~~~~~~~  120 (154)
                      +||||.||++   + .+.++|+|||++....
T Consensus       142 rDlkP~NIll---~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         142 GDLSEYNILY---H-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCChhhEEE---E-CCCEEEEEcccceecC
Confidence            9999999999   4 5789999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=1.4e-18  Score=115.19  Aligned_cols=96  Identities=22%  Similarity=0.222  Sum_probs=78.6

Q ss_pred             hHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 031702           12 CLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR   90 (154)
Q Consensus        12 ~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~   90 (154)
                      .+.+|+++|++| +++++++++++    +..+++|||+.|.+|.+....       ....+..|++.++.++|++|++|+
T Consensus        47 l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHr  115 (218)
T PRK12274         47 LARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHN  115 (218)
T ss_pred             HHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccC
Confidence            588999999999 45889998875    346999999999898754321       123567899999999999999999


Q ss_pred             cC-CCCcEEeecCCCCeeEEEeecccccccCC
Q 031702           91 DL-KPENILLSGLDDDVMLKIADFGLSCTLYP  121 (154)
Q Consensus        91 ~i-~p~nil~~~~~~~~~~kl~df~~~~~~~~  121 (154)
                      || ||.||++   +..+.++|+|||++.....
T Consensus       116 DL~kp~NILv---~~~g~i~LIDFG~A~~~~~  144 (218)
T PRK12274        116 DLAKEANWLV---QEDGSPAVIDFQLAVRGNP  144 (218)
T ss_pred             CCCCcceEEE---cCCCCEEEEECCCceecCC
Confidence            99 7999999   5667899999999975443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.76  E-value=4.2e-18  Score=113.61  Aligned_cols=145  Identities=18%  Similarity=0.185  Sum_probs=119.1

Q ss_pred             hhHHhHHHHHHHHhhCC-CCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            8 HLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      .....+.-|..+.+.|+ ...|+.+..+..+..+-.+|||.. |.||.++++-. .+++..+++-++.|++.-++|+|.+
T Consensus        52 a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r  130 (341)
T KOG1163|consen   52 AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR  130 (341)
T ss_pred             CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh
Confidence            33567888999999995 579999999999999999999988 88999998755 4699999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--------ccccccCCccccCcccccccCCCcccceec
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVNFFV  153 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws  153 (154)
                      +++||||||+|++.+-.-....+.++|||+|..+.+..        ......||..|.+-....+..-+..-|+=|
T Consensus       131 ~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeS  206 (341)
T KOG1163|consen  131 NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMES  206 (341)
T ss_pred             ccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhh
Confidence            99999999999999654456678999999998775543        234467888999887776655566666544

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.74  E-value=9.6e-18  Score=116.32  Aligned_cols=145  Identities=20%  Similarity=0.287  Sum_probs=123.1

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ...-+++.|....+.| ..++|+.++..-.++-+..+|+|.. |.||.+++.-++ +|+..++..++.|++.-++++|++
T Consensus        65 S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k  143 (449)
T KOG1165|consen   65 SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK  143 (449)
T ss_pred             CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc
Confidence            3456788899999999 7899999998888888899999988 889999998665 599999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCC--CCeeEEEeecccccccCCCCc--------cccccCCccccCcccccccCCCcccceec
Q 031702           86 HIIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVNFFV  153 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~--~~~~~kl~df~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Diws  153 (154)
                      .+++|||||+|++|....  ....+.++|||+|..+.+...        ..+..||..||+-....+..-|..-|+=|
T Consensus       144 ~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEa  221 (449)
T KOG1165|consen  144 DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEA  221 (449)
T ss_pred             ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHH
Confidence            999999999999997543  355788999999998765432        34568999999999988887777777644

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.72  E-value=9.6e-19  Score=129.11  Aligned_cols=135  Identities=29%  Similarity=0.426  Sum_probs=121.0

Q ss_pred             hHHHHHHHHhhCC-CCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 031702           12 CLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR   90 (154)
Q Consensus        12 ~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~   90 (154)
                      .-..|-.++...+ ||.+++++..+++++..+++.++..||.+...+.+...+.+.....+...++-+++++|+.+++++
T Consensus        42 ~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyr  121 (612)
T KOG0603|consen   42 HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYR  121 (612)
T ss_pred             ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHh
Confidence            4455778888885 999999999999999999999999999999888877888899999999999999999999999999


Q ss_pred             cCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        91 ~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+|++||++   +..|++++.|||+++........   |||..|||||+..  +++..+|+|||
T Consensus       122 d~k~enill---d~~Ghi~~tdfglske~v~~~~~---cgt~eymApEI~~--gh~~a~D~ws~  177 (612)
T KOG0603|consen  122 DYKLENVLL---LLEGHIKLTDFGLSKEAVKEKIA---CGTYEYRAPEIIN--GHLSAADWWSF  177 (612)
T ss_pred             cccccceee---cccCccccCCchhhhHhHhhhhc---ccchhhhhhHhhh--ccCCcccchhh
Confidence            999999999   89999999999998876544433   9999999999998  67889999996

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.72  E-value=5e-17  Score=109.11  Aligned_cols=101  Identities=23%  Similarity=0.322  Sum_probs=88.2

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (154)
                      .+.+.+|+.++..+.|++++....++...+..+++|||++|++|.+++.....    ....++.+++.++.++|..+++|
T Consensus        43 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H  118 (211)
T PRK14879         43 RERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIH  118 (211)
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCccc
Confidence            45688899999999999988887777777788999999999999998864332    77889999999999999999999


Q ss_pred             ecCCCCcEEeecCCCCeeEEEeecccccc
Q 031702           90 RDLKPENILLSGLDDDVMLKIADFGLSCT  118 (154)
Q Consensus        90 ~~i~p~nil~~~~~~~~~~kl~df~~~~~  118 (154)
                      +|++|.||++   + .+.++++|||.+..
T Consensus       119 ~Dl~p~Nil~---~-~~~~~liDf~~a~~  143 (211)
T PRK14879        119 GDLTTSNMIL---S-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCCCcccEEE---E-CCCEEEEECCcccC
Confidence            9999999999   3 56789999998865

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.72  E-value=3.5e-18  Score=115.99  Aligned_cols=143  Identities=21%  Similarity=0.357  Sum_probs=112.0

Q ss_pred             hhhhhhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCC--CCHHHHHHHHHHHHHHHH
Q 031702            3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLE   80 (154)
Q Consensus         3 k~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~   80 (154)
                      +.+..+..++|..|.-.|+-+.||||+.+++.|.+++.+.++..||+.|+|...+.....  .+..+..+++.+++++++
T Consensus       224 r~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargma  303 (448)
T KOG0195|consen  224 REVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMA  303 (448)
T ss_pred             hhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHH
Confidence            445567788999999999999999999999999999999999999999999999976554  677899999999999999


Q ss_pred             HHHhCC--ceeecCCCCcEEeecCCCCeeEEEe--ecccccccCCCCccccccCCccccCcccccccCCC---cccceec
Q 031702           81 ILNSHH--IIHRDLKPENILLSGLDDDVMLKIA--DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD---EKVNFFV  153 (154)
Q Consensus        81 ~lh~~~--~~h~~i~p~nil~~~~~~~~~~kl~--df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~Diws  153 (154)
                      |||+..  +.---+....+++   ++..+.+|+  |--++      .......-+|.|++||.++..+-+   .++||||
T Consensus       304 flhslep~ipr~~lns~hvmi---dedltarismad~kfs------fqe~gr~y~pawmspealqrkped~n~raadmws  374 (448)
T KOG0195|consen  304 FLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFS------FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWS  374 (448)
T ss_pred             HHhhcchhhhhhhcccceEEe---cchhhhheecccceee------eeccccccCcccCCHHHHhcCchhcchhhhhHHH
Confidence            999963  3333567777888   566555544  32111      112233447889999999876543   6799999


Q ss_pred             C
Q 031702          154 S  154 (154)
Q Consensus       154 l  154 (154)
                      |
T Consensus       375 f  375 (448)
T KOG0195|consen  375 F  375 (448)
T ss_pred             H
Confidence            7

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.70  E-value=7.9e-17  Score=121.65  Aligned_cols=98  Identities=20%  Similarity=0.279  Sum_probs=86.0

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (154)
                      .+.+.+|+.+++.++|++++....+..+....+++|||+++++|.+++.        ....++.+++.++.+||+.+++|
T Consensus       380 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiH  451 (535)
T PRK09605        380 TERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVH  451 (535)
T ss_pred             HHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCcc
Confidence            4678899999999999999888777777777899999999999998875        34678899999999999999999


Q ss_pred             ecCCCCcEEeecCCCCeeEEEeeccccccc
Q 031702           90 RDLKPENILLSGLDDDVMLKIADFGLSCTL  119 (154)
Q Consensus        90 ~~i~p~nil~~~~~~~~~~kl~df~~~~~~  119 (154)
                      +|+||+||++    ....++++|||++...
T Consensus       452 rDlkp~NILl----~~~~~~liDFGla~~~  477 (535)
T PRK09605        452 GDLTTSNFIV----RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCCChHHEEE----ECCcEEEEeCcccccC
Confidence            9999999999    2457899999998764

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.70  E-value=8.4e-17  Score=107.14  Aligned_cols=99  Identities=23%  Similarity=0.291  Sum_probs=83.4

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (154)
                      .+.+.+|+.+++.++|+++......+...+..+++|||++|++|.+++.....       .++.+++.++.++|+.+++|
T Consensus        41 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H  113 (199)
T TIGR03724        41 RERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVH  113 (199)
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeec
Confidence            46778899999999988776666566666777999999999999988754321       78899999999999999999


Q ss_pred             ecCCCCcEEeecCCCCeeEEEeeccccccc
Q 031702           90 RDLKPENILLSGLDDDVMLKIADFGLSCTL  119 (154)
Q Consensus        90 ~~i~p~nil~~~~~~~~~~kl~df~~~~~~  119 (154)
                      +|++|.||++   + .+.++++|||++...
T Consensus       114 ~Dl~~~Nil~---~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724       114 GDLTTSNIIV---R-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCCCcceEEE---E-CCcEEEEECCCCcCC
Confidence            9999999999   4 678999999988653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>smart00090 RIO RIO-like kinase

Probab=99.69  E-value=1.8e-16  Score=108.26  Aligned_cols=103  Identities=20%  Similarity=0.201  Sum_probs=81.0

Q ss_pred             HhHHHHHHHHhhCCCCc--cchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC-c
Q 031702           11 SCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH-I   87 (154)
Q Consensus        11 ~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~-~   87 (154)
                      ..+..|+.+++++.+..  ++++++   .. ..+++|||++|.++.................++.|++.++.+||+.| +
T Consensus        95 ~~~~~E~~~L~~L~~~~i~~p~~~~---~~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~i  170 (237)
T smart00090       95 LWAEKEFRNLQRLYEAGVPVPKPIA---WR-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGEL  170 (237)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCeeeE---ec-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCE
Confidence            45678999999997533  333332   22 34899999999888776544455667778899999999999999999 9


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP  121 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~  121 (154)
                      +|+|++|+||++   + .+.++++|||.+.....
T Consensus       171 iH~Dikp~NIli---~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      171 VHGDLSEYNILV---H-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             EeCCCChhhEEE---E-CCCEEEEEChhhhccCC
Confidence            999999999999   4 66899999999875433

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.68  E-value=3.8e-17  Score=127.51  Aligned_cols=138  Identities=26%  Similarity=0.334  Sum_probs=113.0

Q ss_pred             HHHHhhCC---CCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCC
Q 031702           17 LNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLK   93 (154)
Q Consensus        17 ~~~l~~l~---h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~   93 (154)
                      .+++.+|+   -+.|..+..+..-.+.-++++||.+.|+|.++++..+..++..+..++.|++..++.||..+|+|+|||
T Consensus       742 ~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiK  821 (974)
T KOG1166|consen  742 LQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIK  821 (974)
T ss_pred             HHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCC
Confidence            34455554   245666666667777778999999999999999977889999999999999999999999999999999


Q ss_pred             CCcEEeec----CCCCeeEEEeeccccccc---CCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           94 PENILLSG----LDDDVMLKIADFGLSCTL---YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        94 p~nil~~~----~~~~~~~kl~df~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |.|+++..    ......++|+|||.+..+   .++..-...++|-.+-++|+..|.+++..+|.|.|
T Consensus       822 PDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGl  889 (974)
T KOG1166|consen  822 PDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGL  889 (974)
T ss_pred             cceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHH
Confidence            99999964    223557899999998653   23335566778889999999999999999998864

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.67  E-value=5.3e-16  Score=106.05  Aligned_cols=104  Identities=20%  Similarity=0.257  Sum_probs=81.2

Q ss_pred             hHHhHHHHHHHHhhCCCCcc--chhhhheecC-Cc---EEEEEEecCC-CCchHHHHHcCCCCHHHHHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSVNHPNI--IRLFDAFQAE-NC---IFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~-~~---~~~v~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~   81 (154)
                      ....+.+|+.++..++|+++  ++.++..... ..   .++++|+++| .+|.+++.. ..+++..    +.+++.++.+
T Consensus        83 ~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~  157 (239)
T PRK01723         83 ERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIAR  157 (239)
T ss_pred             hhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHH
Confidence            35678899999999998885  5666554332 22   2599999987 688888764 4555543    5689999999


Q ss_pred             HHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccC
Q 031702           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY  120 (154)
Q Consensus        82 lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~  120 (154)
                      ||+.|++|+||+|.||++   +..+.++|+|||.+....
T Consensus       158 lH~~GI~HrDlkp~NILv---~~~~~v~LIDfg~~~~~~  193 (239)
T PRK01723        158 FHDAGVYHADLNAHNILL---DPDGKFWLIDFDRGELRT  193 (239)
T ss_pred             HHHCCCCCCCCCchhEEE---cCCCCEEEEECCCcccCC
Confidence            999999999999999999   455689999999887643

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.65  E-value=4e-16  Score=114.51  Aligned_cols=132  Identities=24%  Similarity=0.389  Sum_probs=108.7

Q ss_pred             HhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCc-eeecCCCCcE
Q 031702           20 LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI-IHRDLKPENI   97 (154)
Q Consensus        20 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~-~h~~i~p~ni   97 (154)
                      |+.+.|.|+.++.+.+.+++..+.+.+|+..|+|.+.+.. ...++......++++++.+++|+|.-.+ .|+.+++.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            4678999999999999999999999999999999999976 3468888999999999999999998765 9999999999


Q ss_pred             EeecCCCCeeEEEeecccccccCCC---CccccccCCccccCcccccccC-------CCcccceecC
Q 031702           98 LLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQR-------YDEKVNFFVS  154 (154)
Q Consensus        98 l~~~~~~~~~~kl~df~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Diwsl  154 (154)
                      ++   +..+.+|+.|||+.......   ..........-|.|||.+.+..       -+.++|+|||
T Consensus        81 lv---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~  144 (484)
T KOG1023|consen   81 LV---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSF  144 (484)
T ss_pred             ee---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehH
Confidence            99   89999999999998665321   1111111234499999998641       3677999996

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.62  E-value=3e-17  Score=119.22  Aligned_cols=109  Identities=32%  Similarity=0.580  Sum_probs=93.2

Q ss_pred             cEEEEEEecCCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccc
Q 031702           40 CIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS  116 (154)
Q Consensus        40 ~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~  116 (154)
                      ++|+.|+++...+|.+++....   ..+....+.+..|+..++.|   ++.+|+|++|.||++.   ....+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchhhhhhhhhhe
Confidence            5899999999999999997443   36678899999999999999   9999999999999994   4558999999998


Q ss_pred             cccCCCC-------ccccccCCccccCcccccccCCCcccceecC
Q 031702          117 CTLYPGN-------YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus       117 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .......       ......||.+||+||.+.+..|+.++|||||
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaL  448 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYAL  448 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhH
Confidence            7654443       2344678999999999999999999999986

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.58  E-value=1.1e-14  Score=103.67  Aligned_cols=128  Identities=31%  Similarity=0.414  Sum_probs=92.9

Q ss_pred             CCCccchhhhheecC---------------------------CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHH
Q 031702           24 NHPNIIRLFDAFQAE---------------------------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG   76 (154)
Q Consensus        24 ~h~~i~~~~~~~~~~---------------------------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~   76 (154)
                      +||||+++.+.|.++                           ..+|++|.-.+. +|.+++-.+ ..+.....-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence            699999999887441                           246899887754 899888643 466667777889999


Q ss_pred             HHHHHHHhCCceeecCCCCcEEeecC-CCCeeEEEeecccccccCCCC-------ccccccCCccccCcccccccC----
Q 031702           77 AGLEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTLYPGN-------YAEKVCGSPLYMAPEVLQFQR----  144 (154)
Q Consensus        77 ~~l~~lh~~~~~h~~i~p~nil~~~~-~~~~~~kl~df~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~----  144 (154)
                      +|+.|||++|+.|||+|..||++.-+ |.-....++|||++-.-...+       .....-|.-..||||+....+    
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            99999999999999999999999743 344566889999864322211       111223445589999986432    


Q ss_pred             --CCcccceec
Q 031702          145 --YDEKVNFFV  153 (154)
Q Consensus       145 --~~~~~Diws  153 (154)
                        ...++|.|+
T Consensus       432 vvny~kAD~WA  442 (598)
T KOG4158|consen  432 VVNYEKADTWA  442 (598)
T ss_pred             eeccchhhhhh
Confidence              236789996

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.57  E-value=1.2e-14  Score=96.76  Aligned_cols=98  Identities=23%  Similarity=0.240  Sum_probs=76.7

Q ss_pred             HhHHHHHHHHhhCCCCc--cchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           11 SCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        11 ~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      .....|..++..+.+++  ++...+    ....+++|||++|++|.....      ......++.+++.++.++|..+++
T Consensus        78 ~~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~  147 (198)
T cd05144          78 LAAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGII  147 (198)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCC
Confidence            34678999999997774  333332    234589999999998876532      134567888999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP  121 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~  121 (154)
                      |+||+|.||++   +..+.++|+|||.+.....
T Consensus       148 H~Dl~p~Nill---~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         148 HGDLSEFNILV---DDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             cCCCCcccEEE---cCCCcEEEEECCccccCCC
Confidence            99999999999   5678999999999865433

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.55  E-value=1.2e-14  Score=92.03  Aligned_cols=99  Identities=23%  Similarity=0.364  Sum_probs=84.6

Q ss_pred             HHhHHHHHHHHhhCCC--CccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC--
Q 031702           10 KSCLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH--   85 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~--   85 (154)
                      ...+.+|...++.+++  ..+++++.....++..++++||++++++..+       +......+..+++.++..+|..  
T Consensus        35 ~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~  107 (155)
T cd05120          35 GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPL  107 (155)
T ss_pred             hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCc
Confidence            4678999999999976  5888988888888889999999988877654       5566777889999999999985  


Q ss_pred             -CceeecCCCCcEEeecCCCCeeEEEeecccccc
Q 031702           86 -HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  118 (154)
Q Consensus        86 -~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~  118 (154)
                       +++|+|++|.||++   +..+.++++||+.+..
T Consensus       108 ~~i~H~Dl~~~Nil~---~~~~~~~l~Df~~~~~  138 (155)
T cd05120         108 LVLCHGDLHPGNILV---DDGKILGIIDWEYAGY  138 (155)
T ss_pred             eEEEecCCCcceEEE---ECCcEEEEEecccccC
Confidence             69999999999999   4567899999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.47  E-value=6.7e-15  Score=111.86  Aligned_cols=143  Identities=31%  Similarity=0.537  Sum_probs=119.6

Q ss_pred             hHHhHHHHHHHHhhCC-CCccchhhhheecCCcEEEEEEecCCCCchHHH-HHcC-CCCHHHHHHHHHHHHHHHHHHH-h
Q 031702            9 LKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHG-RVPEQTARKFLQQLGAGLEILN-S   84 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~-~~~~-~~~~~~~~~~~~~i~~~l~~lh-~   84 (154)
                      ..+.+..|..+-+.+. |+|++++.+...+....++.++|..|+++.... .... ..+......+..|+..++.|+| .
T Consensus        63 ~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~  142 (601)
T KOG0590|consen   63 SSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE  142 (601)
T ss_pred             hhhhcCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc
Confidence            3455666888888885 999999999999999999999999999999887 4443 5777888999999999999999 9


Q ss_pred             CCceeecCCCCcEEeecCCCCe-eEEEeecccccccCC-CC---ccccccC-CccccCcccccccCC-CcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYP-GN---YAEKVCG-SPLYMAPEVLQFQRY-DEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~-~~kl~df~~~~~~~~-~~---~~~~~~~-~~~y~aPE~~~~~~~-~~~~Diwsl  154 (154)
                      .++.|+|++|+|.++   +..+ ..+++|||+|..... .+   .....+| ++.|+|||...+..| .+..|+||.
T Consensus       143 ~~~~h~~ikP~n~~l---~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~  216 (601)
T KOG0590|consen  143 NGVTHRDIKPSNSLL---DESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSL  216 (601)
T ss_pred             cccccCCCCCccchh---ccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccc
Confidence            999999999999999   5566 899999999987665 33   2344678 999999999987544 478899984

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.44  E-value=7.9e-13  Score=85.52  Aligned_cols=99  Identities=21%  Similarity=0.250  Sum_probs=81.7

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (154)
                      .++-.+|+.++..++--.++...-+..+++...++|||++|..|.+.+...       ...+++.+-..+.-||..|++|
T Consensus        43 r~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givH  115 (204)
T COG3642          43 RERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVH  115 (204)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeec
Confidence            566778999999997777777777777888888999999999999888755       2456666777788899999999


Q ss_pred             ecCCCCcEEeecCCCCeeEEEeeccccccc
Q 031702           90 RDLKPENILLSGLDDDVMLKIADFGLSCTL  119 (154)
Q Consensus        90 ~~i~p~nil~~~~~~~~~~kl~df~~~~~~  119 (154)
                      +|+.++||++.    ...+.++|||++...
T Consensus       116 GDLTtsNiIl~----~~~i~~IDfGLg~~s  141 (204)
T COG3642         116 GDLTTSNIILS----GGRIYFIDFGLGEFS  141 (204)
T ss_pred             CCCccceEEEe----CCcEEEEECCccccc
Confidence            99999999993    344899999998743

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.43  E-value=1.7e-12  Score=85.86  Aligned_cols=101  Identities=15%  Similarity=0.152  Sum_probs=74.8

Q ss_pred             HhHHHHHHHHhhCCC--CccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HhCCc
Q 031702           11 SCLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL-NSHHI   87 (154)
Q Consensus        11 ~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~~   87 (154)
                      ....+|+..|+++..  -++++++..    ...+++|||+++..+....-+...++......+..+++.++..+ |..|+
T Consensus        71 ~wa~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~gl  146 (197)
T cd05146          71 MWAEKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNL  146 (197)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCe
Confidence            344589999999954  455666643    34579999997654432222233456666777889999999988 89999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeeccccccc
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTL  119 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~  119 (154)
                      +|+|+++.||++.    .+.+.++|||.+...
T Consensus       147 VHGDLs~~NIL~~----~~~v~iIDF~qav~~  174 (197)
T cd05146         147 VHADLSEYNMLWH----DGKVWFIDVSQSVEP  174 (197)
T ss_pred             ecCCCCHHHEEEE----CCcEEEEECCCceeC
Confidence            9999999999993    356899999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.41  E-value=7.6e-13  Score=92.31  Aligned_cols=136  Identities=17%  Similarity=0.291  Sum_probs=99.5

Q ss_pred             HHHHHhhCCCCccchhhhheecC-----CcEEEEEEecCCCCchHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC-
Q 031702           16 ELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEILNSH-   85 (154)
Q Consensus        16 e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~-   85 (154)
                      -..-+-.+-|.||++++.+|.+.     ....+++|||..|++.+++++.    ..+......+|+.||+.|+.|||+. 
T Consensus       117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~  196 (458)
T KOG1266|consen  117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence            34445566799999999999655     4578999999999999999654    3488889999999999999999997 


Q ss_pred             -CceeecCCCCcEEeecCCCCeeEEEeecccccccCC----CC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           86 -HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP----GN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 -~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~----~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                       -++|+++....|++   ...+.+|+..-.....-..    .. ......+-++|.+||.=.....+..+|||+|
T Consensus       197 PpiihgnlTc~tifi---q~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~f  268 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFI---QHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKF  268 (458)
T ss_pred             CccccCCcchhheee---cCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhh
Confidence             59999999999999   5666677653211111000    00 1112234577899987655556678899886

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.39  E-value=7.7e-14  Score=109.32  Aligned_cols=139  Identities=20%  Similarity=0.225  Sum_probs=103.6

Q ss_pred             HhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 031702           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR   90 (154)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~   90 (154)
                      .+-..|++ ...+++||.+.+.-+..+....|++-+|.. .+|.+.+..+.=+...+.+.++-|++.|+..+|..|+.||
T Consensus        67 ~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHG  144 (1431)
T KOG1240|consen   67 KQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHG  144 (1431)
T ss_pred             HHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCcccc
Confidence            33344555 666799999999999888888899999985 4999988765557788899999999999999999999999


Q ss_pred             cCCCCcEEeecCCCCeeEEEeecccccc--cCCCCcc------ccccCCccccCcccccccC-----------CCcccce
Q 031702           91 DLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYA------EKVCGSPLYMAPEVLQFQR-----------YDEKVNF  151 (154)
Q Consensus        91 ~i~p~nil~~~~~~~~~~kl~df~~~~~--~~~~~~~------~~~~~~~~y~aPE~~~~~~-----------~~~~~Di  151 (154)
                      |||.+||+++   +-+.+.|.||..-+.  ++.+.+.      .+-..-.+|.|||-+-...           .+++-||
T Consensus       145 DIKsENILiT---SWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDI  221 (1431)
T KOG1240|consen  145 DIKSENILIT---SWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDI  221 (1431)
T ss_pred             ccccceEEEe---eechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhh
Confidence            9999999994   566788999975321  1222221      1112234599999875321           4567788


Q ss_pred             ecC
Q 031702          152 FVS  154 (154)
Q Consensus       152 wsl  154 (154)
                      ||+
T Consensus       222 FS~  224 (1431)
T KOG1240|consen  222 FSA  224 (1431)
T ss_pred             hhh
Confidence            874

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.38  E-value=3.1e-12  Score=84.29  Aligned_cols=75  Identities=24%  Similarity=0.317  Sum_probs=58.2

Q ss_pred             cEEEEEEecCCCCchHH-HHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEeecCCCCeeEEEeeccccc
Q 031702           40 CIFLVVEFCAGGNLSSY-IRLHGRVPEQTARKFLQQLGAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (154)
Q Consensus        40 ~~~~v~e~~~~~~L~~~-~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~  117 (154)
                      ..+++|||++++++... +... .. ......++.+++.++.++|. .+++|+|++|.||++   + .+.++++|||.+.
T Consensus        89 ~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili---~-~~~~~liDfg~a~  162 (187)
T cd05119          89 RHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILV---D-DGKVYIIDVPQAV  162 (187)
T ss_pred             CCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE---E-CCcEEEEECcccc
Confidence            35899999998543321 1111 11 16778899999999999999 999999999999999   4 6789999999986


Q ss_pred             ccC
Q 031702          118 TLY  120 (154)
Q Consensus       118 ~~~  120 (154)
                      ...
T Consensus       163 ~~~  165 (187)
T cd05119         163 EID  165 (187)
T ss_pred             ccc
Confidence            543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.37  E-value=5.9e-12  Score=81.48  Aligned_cols=109  Identities=22%  Similarity=0.285  Sum_probs=87.9

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCC-CCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~-~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      +.+..+|+..+.++.--.|....-++.+.....+.|||++| .++.+++.+..  .........+++++-..+.-||.++
T Consensus        54 r~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd  133 (229)
T KOG3087|consen   54 RKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND  133 (229)
T ss_pred             HHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC
Confidence            56677899999988766777777778888888899999976 57888886543  2333444788899999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccc
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCT  118 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~  118 (154)
                      ++|+|+..+||++.+.+....+.++|||++..
T Consensus       134 iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen  134 IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99999999999998766666779999999853

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.34  E-value=1.1e-11  Score=93.11  Aligned_cols=102  Identities=21%  Similarity=0.351  Sum_probs=87.7

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-hCCce
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN-SHHII   88 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~~~   88 (154)
                      .+...+-+..|+.++||||++++..+++++..|+++|-+.  .|..++++.+   ...+..-+.||+.|+.+|| +++++
T Consensus        53 ~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lv  127 (690)
T KOG1243|consen   53 TELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLV  127 (690)
T ss_pred             hHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCee
Confidence            4567788899999999999999999999999999999873  6776676443   5666677889999999997 67899


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeeccccccc
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTL  119 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~  119 (154)
                      |+++.-..+++   +..+..||++|.+....
T Consensus       128 HgNv~~~SVfV---n~~GeWkLggle~v~~~  155 (690)
T KOG1243|consen  128 HGNVCKDSVFV---NESGEWKLGGLELVSKA  155 (690)
T ss_pred             eccEeeeeEEE---cCCCcEEEeeeEEEecc
Confidence            99999999999   78999999999887554

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.31  E-value=4.3e-13  Score=93.19  Aligned_cols=108  Identities=20%  Similarity=0.233  Sum_probs=71.1

Q ss_pred             EEEEEEecCCCCchHHHHH---cCC----CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeec
Q 031702           41 IFLVVEFCAGGNLSSYIRL---HGR----VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF  113 (154)
Q Consensus        41 ~~~v~e~~~~~~L~~~~~~---~~~----~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df  113 (154)
                      .+++|+-+ .++|.+++..   ...    +.......+..|+++.+++||..|++|+||+|+|+++   +.++.++|+||
T Consensus       114 ~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll---~~~G~v~Lg~F  189 (288)
T PF14531_consen  114 RFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLL---DQDGGVFLGDF  189 (288)
T ss_dssp             EEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE----TTS-EEE--G
T ss_pred             hhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEE---cCCCCEEEcCh
Confidence            36777766 5688887642   222    2234456677899999999999999999999999999   78999999999


Q ss_pred             ccccccCCCCccccccCCccccCccccccc--------CCCcccceecC
Q 031702          114 GLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ--------RYDEKVNFFVS  154 (154)
Q Consensus       114 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~Diwsl  154 (154)
                      +...+.+.....  ...+..|.+||.....        .++.+.|.|+|
T Consensus       190 ~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~L  236 (288)
T PF14531_consen  190 SSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQL  236 (288)
T ss_dssp             GGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHH
T ss_pred             HHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHH
Confidence            877655443322  2334669999987432        46788898874

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.30  E-value=7.7e-13  Score=103.38  Aligned_cols=78  Identities=38%  Similarity=0.649  Sum_probs=66.2

Q ss_pred             HHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC----------------ccccccCCccccCc
Q 031702           74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----------------YAEKVCGSPLYMAP  137 (154)
Q Consensus        74 ~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~----------------~~~~~~~~~~y~aP  137 (154)
                      +++.+++|+|.-+++|+|+||.|.++   ..-+++|+.|||++.......                ....++|||.|.||
T Consensus       151 dmvla~Eylh~ygivhrdlkpdnllI---T~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaP  227 (1205)
T KOG0606|consen  151 DMVLAVEYLHSYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAP  227 (1205)
T ss_pred             hhhHHhHhhccCCeecCCCCCCccee---eecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccCh
Confidence            34789999999999999999999999   578899999999986532210                22457999999999


Q ss_pred             ccccccCCCcccceecC
Q 031702          138 EVLQFQRYDEKVNFFVS  154 (154)
Q Consensus       138 E~~~~~~~~~~~Diwsl  154 (154)
                      |++....|...+|||++
T Consensus       228 eVilrqgygkpvdwwam  244 (1205)
T KOG0606|consen  228 EVILRQGYGKPVDWWAM  244 (1205)
T ss_pred             hhhhhhccCCCccHHHH
Confidence            99999999999999985

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.28  E-value=2.5e-11  Score=89.77  Aligned_cols=102  Identities=23%  Similarity=0.271  Sum_probs=70.3

Q ss_pred             hHHHHHHHHhhCC-----CCc--cchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHH-HHHHH
Q 031702           12 CLDCELNFLSSVN-----HPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGA-GLEIL   82 (154)
Q Consensus        12 ~~~~e~~~l~~l~-----h~~--i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~-~l~~l   82 (154)
                      ++.+|+..+.++.     +++  +++++..  ..+..+++|||++|++|.+..... ....   ...++..++. .+..+
T Consensus       199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~--~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql  273 (437)
T TIGR01982       199 DLRREAANASELGENFKNDPGVYVPEVYWD--RTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQV  273 (437)
T ss_pred             CHHHHHHHHHHHHHhcCCCCCEEeCCEehh--hcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHH
Confidence            4566776666652     233  2333322  233468999999999999876532 1222   2345555555 46788


Q ss_pred             HhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCC
Q 031702           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP  121 (154)
Q Consensus        83 h~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~  121 (154)
                      |..|++|+|++|.||++   ..++.++++|||++....+
T Consensus       274 ~~~g~~H~D~hPgNilv---~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       274 LRDGFFHADLHPGNIFV---LKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HhCCceeCCCCcccEEE---CCCCcEEEEeCCCeeECCH
Confidence            99999999999999999   5678899999999976653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.27  E-value=7.4e-12  Score=81.19  Aligned_cols=94  Identities=23%  Similarity=0.251  Sum_probs=69.7

Q ss_pred             HhHHHHHHHHhhCCCCcc-chhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc--
Q 031702           11 SCLDCELNFLSSVNHPNI-IRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI--   87 (154)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~--   87 (154)
                      ..+.+|+.+++.+.+.++ ++++....  ...+++|||++|.++...    .    ........+++.+++.||..++  
T Consensus        37 ~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~----~----~~~~~~~~~l~~~l~~LH~~~~~~  106 (170)
T cd05151          37 INRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTE----D----FSDPENLEKIAKLLKKLHSSPLPD  106 (170)
T ss_pred             cCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccccc----c----ccCHHHHHHHHHHHHHHhCCCCCC
Confidence            457889999999865443 44544332  335799999999888643    1    1123456789999999999885  


Q ss_pred             ---eeecCCCCcEEeecCCCCeeEEEeecccccc
Q 031702           88 ---IHRDLKPENILLSGLDDDVMLKIADFGLSCT  118 (154)
Q Consensus        88 ---~h~~i~p~nil~~~~~~~~~~kl~df~~~~~  118 (154)
                         +|+|++|.||++.    .+.++++||+.+..
T Consensus       107 ~~~~HgD~~~~Nil~~----~~~~~liDf~~a~~  136 (170)
T cd05151         107 LVPCHNDLLPGNFLLD----DGRLWLIDWEYAGM  136 (170)
T ss_pred             ceeecCCCCcCcEEEE----CCeEEEEecccccC
Confidence               9999999999993    45689999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.26  E-value=8.4e-11  Score=81.62  Aligned_cols=107  Identities=16%  Similarity=0.165  Sum_probs=82.1

Q ss_pred             hHHHHHHHHhhCCCCccchh--hhheec-----CCcEEEEEEecCCC-CchHHHHH--cCCCCHHHHHHHHHHHHHHHHH
Q 031702           12 CLDCELNFLSSVNHPNIIRL--FDAFQA-----ENCIFLVVEFCAGG-NLSSYIRL--HGRVPEQTARKFLQQLGAGLEI   81 (154)
Q Consensus        12 ~~~~e~~~l~~l~h~~i~~~--~~~~~~-----~~~~~~v~e~~~~~-~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~   81 (154)
                      .+.+|...+..|...+|...  .++.+.     ...-++++|++++. +|.+++..  ....+......++.+++..+.-
T Consensus        74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~  153 (268)
T PRK15123         74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD  153 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence            47789999998865555444  334432     23468999999875 78888764  2345667788999999999999


Q ss_pred             HHhCCceeecCCCCcEEeecC----CCCeeEEEeecccccc
Q 031702           82 LNSHHIIHRDLKPENILLSGL----DDDVMLKIADFGLSCT  118 (154)
Q Consensus        82 lh~~~~~h~~i~p~nil~~~~----~~~~~~kl~df~~~~~  118 (154)
                      ||..|++|+|+++.||++...    +....+.++||+.+..
T Consensus       154 LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        154 MHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            999999999999999999631    2356889999998753

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.22  E-value=1.7e-10  Score=77.43  Aligned_cols=110  Identities=20%  Similarity=0.228  Sum_probs=85.8

Q ss_pred             HHhHHHHHHHHhhCCCCcc--chhhhheecC----CcEEEEEEecCC-CCchHHHHHcCCCCHHHHHHHHHHHHHHHHHH
Q 031702           10 KSCLDCELNFLSSVNHPNI--IRLFDAFQAE----NCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL   82 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~----~~~~~v~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l   82 (154)
                      .....+|...+..|...+|  ++++++....    ...++++|++++ .+|.+++......+......++.+++..+.-|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            4567888888888865554  3444444432    235899999987 47999988655577888899999999999999


Q ss_pred             HhCCceeecCCCCcEEeecCCCCeeEEEeeccccccc
Q 031702           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  119 (154)
Q Consensus        83 h~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~  119 (154)
                      |..|++|+|++|.||++...+....+.++||+.+...
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999999999999975445568999999977654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.20  E-value=1.5e-11  Score=91.05  Aligned_cols=136  Identities=29%  Similarity=0.457  Sum_probs=111.6

Q ss_pred             HHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCC-CCHHHHHHHHHHHHH----HHHHHHhCCc
Q 031702           14 DCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGA----GLEILNSHHI   87 (154)
Q Consensus        14 ~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~i~~----~l~~lh~~~~   87 (154)
                      .+|+...+.+ .|++.++.+..|.+++..++-+|.+ +.+|..+...... ++...++....+...    |+.++|..++
T Consensus       165 ~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~  243 (524)
T KOG0601|consen  165 LREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNI  243 (524)
T ss_pred             cchhhcccccCccccccccCcccccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcc
Confidence            4566666777 6999999999999999999999988 5688887765444 888999999999999    9999999999


Q ss_pred             eeecCCCCcEEeecCCCC-eeEEEeecccccccCCCCccc------cccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDD-VMLKIADFGLSCTLYPGNYAE------KVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~-~~~kl~df~~~~~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|.+++|.||+..   .. ..+++.|||+...+.+.....      ...+...|++||... +.++..+|++||
T Consensus       244 ~~~~~kp~~i~~~---~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl  313 (524)
T KOG0601|consen  244 VHDDLKPANIFTT---SDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSL  313 (524)
T ss_pred             cccccchhheecc---cccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcch
Confidence            9999999999994   44 778999999988776655322      224566799999987 567888899886

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.16  E-value=8.2e-11  Score=88.52  Aligned_cols=104  Identities=24%  Similarity=0.347  Sum_probs=67.0

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCc-------------EEEEEEecCCCCchHHH--HHcC----CCCHHHHH
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-------------IFLVVEFCAGGNLSSYI--RLHG----RVPEQTAR   69 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-------------~~~v~e~~~~~~L~~~~--~~~~----~~~~~~~~   69 (154)
                      ..+.+.+|++..+..  +|+.++...|.+.+.             .+++|||+.|+.+.+..  ...+    .+.+..+.
T Consensus       193 ~~~~l~~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~  270 (537)
T PRK04750        193 FEKTLHDELDLMREA--ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVE  270 (537)
T ss_pred             HHHHHHHhhCHHHHH--HHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHH
Confidence            345555566655555  456666555544433             35999999999998753  2222    13333444


Q ss_pred             HHHHHHHHHHHHHHhCCceeecCCCCcEEeecC-CCCeeEEEeecccccccCC
Q 031702           70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTLYP  121 (154)
Q Consensus        70 ~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~-~~~~~~kl~df~~~~~~~~  121 (154)
                      .++.|+       ...|++|+|++|.||++..+ ...+.++++|||+......
T Consensus       271 ~~~~Qi-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        271 VFFTQV-------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHH-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            444444       35899999999999999421 1123899999999876644

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.13  E-value=2.7e-10  Score=75.04  Aligned_cols=103  Identities=20%  Similarity=0.331  Sum_probs=67.6

Q ss_pred             hhHHhHHHHHHHHhhCCCC--ccchhhhheecCCcEEEEEEecC--CCCchHHHHHcCCCCHHHHHHHHHHHHHHHHH-H
Q 031702            8 HLKSCLDCELNFLSSVNHP--NIIRLFDAFQAENCIFLVVEFCA--GGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI-L   82 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~~v~e~~~--~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~-l   82 (154)
                      ..+....+|...|..+...  ++++++.+  +.  ..++|||++  |..+..+....  ++......+..+++..+.. +
T Consensus        50 ~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--~~--~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~  123 (188)
T PF01163_consen   50 LIREWAKKEFRNLKRLYEAGVPVPKPYDY--NR--NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKML  123 (188)
T ss_dssp             HHHHHHHHHHHHHHHCCCTT-SS--EEEE--ET--TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHCCccCCcEEEE--eC--CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHH
Confidence            4467788999999999766  45665533  22  369999998  66665544321  2244556667777775554 5


Q ss_pred             HhCCceeecCCCCcEEeecCCCCeeEEEeecccccccC
Q 031702           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY  120 (154)
Q Consensus        83 h~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~  120 (154)
                      |..|++|+|+++.||++.   .+ .+.++|||.+....
T Consensus       124 ~~~givHGDLs~~NIlv~---~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  124 HKAGIVHGDLSEYNILVD---DG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             HCTTEEESS-STTSEEEE---TT-CEEE--GTTEEETT
T ss_pred             HhcCceecCCChhhEEee---cc-eEEEEecCcceecC
Confidence            799999999999999994   33 89999999886543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.00  E-value=2.8e-10  Score=84.45  Aligned_cols=138  Identities=21%  Similarity=0.231  Sum_probs=104.7

Q ss_pred             HHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCceeec
Q 031702           13 LDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRD   91 (154)
Q Consensus        13 ~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~~   91 (154)
                      -..|+.+...+ .|.+.++....|......|+-.||++++++.....-...+.+...+....|++.++.++|+..++|+|
T Consensus       312 sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d  391 (524)
T KOG0601|consen  312 SLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLD  391 (524)
T ss_pred             chhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhccc
Confidence            34567777776 68999999999988888889999999999988776666788999999999999999999999999999


Q ss_pred             CCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCcccc--CcccccccCCCcccceecC
Q 031702           92 LKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM--APEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        92 i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~--aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||++.++  ++..++.||+......-.. . ...+..++.  +|.......+..++|++||
T Consensus       392 ~~psni~i~~~--~~~~~~~~~~~~t~~~~~~-~-~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl  452 (524)
T KOG0601|consen  392 VKPSNILISND--GFFSKLGDFGCWTRLAFSS-G-VFHHIDRLYPIAEILLEDYPHLSKADIFSL  452 (524)
T ss_pred             ccccceeeccc--hhhhhccccccccccceec-c-cccccccccccchhhccccccccccccccc
Confidence            99999999532  2777899999876421111 1 111222333  4555555667788888876

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.92  E-value=6.7e-09  Score=69.95  Aligned_cols=106  Identities=17%  Similarity=0.258  Sum_probs=74.8

Q ss_pred             HHhHHHHHHHHhhCCCC--ccchhhhheecC---CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh
Q 031702           10 KSCLDCELNFLSSVNHP--NIIRLFDAFQAE---NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ...+.+|+.+++.+.+.  .+++++......   +..+++|||++|.++.+.... ..+++.....++.+++.++..||+
T Consensus        39 ~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~  117 (223)
T cd05154          39 AHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHS  117 (223)
T ss_pred             cccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhC
Confidence            56789999999999653  456677666554   357899999999888765421 345555556666666666666653


Q ss_pred             --------------------------------------------------------CCceeecCCCCcEEeecCCCCeeE
Q 031702           85 --------------------------------------------------------HHIIHRDLKPENILLSGLDDDVML  108 (154)
Q Consensus        85 --------------------------------------------------------~~~~h~~i~p~nil~~~~~~~~~~  108 (154)
                                                                              ..++|+|+.|.||++... ....+
T Consensus       118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~  196 (223)
T cd05154         118 VDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVV  196 (223)
T ss_pred             CChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEE
Confidence                                                                    236899999999999421 14567


Q ss_pred             EEeeccccc
Q 031702          109 KIADFGLSC  117 (154)
Q Consensus       109 kl~df~~~~  117 (154)
                      .++||+.+.
T Consensus       197 ~iID~e~~~  205 (223)
T cd05154         197 AVLDWELAT  205 (223)
T ss_pred             EEEeccccc
Confidence            899998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.84  E-value=2.8e-08  Score=73.61  Aligned_cols=104  Identities=18%  Similarity=0.298  Sum_probs=84.1

Q ss_pred             HHHHHHhhCCCCccchhhhheecC----CcEEEEEEecCC-CCchHHHH---------------HcCCCCHHHHHHHHHH
Q 031702           15 CELNFLSSVNHPNIIRLFDAFQAE----NCIFLVVEFCAG-GNLSSYIR---------------LHGRVPEQTARKFLQQ   74 (154)
Q Consensus        15 ~e~~~l~~l~h~~i~~~~~~~~~~----~~~~~v~e~~~~-~~L~~~~~---------------~~~~~~~~~~~~~~~~   74 (154)
                      .-++.++++.|.|+|++.++|.+.    ..+++|++|.++ ++|.++.-               .+...+++.+|.++-|
T Consensus       322 ~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~Q  401 (655)
T KOG3741|consen  322 SLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQ  401 (655)
T ss_pred             HHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHH
Confidence            347889999999999999999743    458999999875 56666531               1224778999999999


Q ss_pred             HHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCC
Q 031702           75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP  121 (154)
Q Consensus        75 i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~  121 (154)
                      +..|+.++|+.|+..+-+.|.+|++   .+..+++|+..|......+
T Consensus       402 LtaaL~sIHssGLAck~L~~~kIlv---~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  402 LTAALYSIHSSGLACKTLDLKKILV---TGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HHHHHHHHHhcCceeecccHhHeEe---eCcceEEEecccceeeecC
Confidence            9999999999999999999999999   4555889888776654433

>PRK09902 hypothetical protein; Provisional

Probab=98.77  E-value=8.5e-08  Score=64.07  Aligned_cols=109  Identities=11%  Similarity=0.104  Sum_probs=80.3

Q ss_pred             hHHhHHHHHHHHhhCCCCcc--chhhhheecC----CcEEEEEEecC-CCCchHHHHHc--CCCCHHHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSVNHPNI--IRLFDAFQAE----NCIFLVVEFCA-GGNLSSYIRLH--GRVPEQTARKFLQQLGAGL   79 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~----~~~~~v~e~~~-~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l   79 (154)
                      -...|.+|...++.|..-++  +++...-...    -.-++|+|-++ ..+|.+++...  .+.+......+..+++.++
T Consensus        62 g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~i  141 (216)
T PRK09902         62 GRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAF  141 (216)
T ss_pred             CchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHH
Confidence            45778999999999955444  4444111111    23578888664 36888887643  2457788889999999999


Q ss_pred             HHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccc
Q 031702           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  118 (154)
Q Consensus        80 ~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~  118 (154)
                      .-||+.|+.|+|+.+.||++.. +....++++||.-++.
T Consensus       142 a~LH~~Gv~Hgdly~khIll~~-~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        142 KKMHSVNRQHGCCYVRHIYVKT-EGKAEAGFLDLEKSRR  179 (216)
T ss_pred             HHHHHCCCcCCCCCHhheeecC-CCCeeEEEEEhhccch
Confidence            9999999999999999999942 2234599999987654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.75  E-value=1.2e-07  Score=63.70  Aligned_cols=66  Identities=23%  Similarity=0.360  Sum_probs=51.2

Q ss_pred             cEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeeccccc
Q 031702           40 CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (154)
Q Consensus        40 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~  117 (154)
                      ..++++||++|..|.++..    +++    .+...+.+++.-+|+.|++|+|.+|.|+++.    .+.++++|++...
T Consensus       117 ~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~----~~~i~iID~~~k~  182 (229)
T PF06176_consen  117 SYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS----NNGIRIIDTQGKR  182 (229)
T ss_pred             EEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----CCcEEEEECcccc
Confidence            4568999999988877543    332    2345677889999999999999999999983    3448999997654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.60  E-value=8.3e-09  Score=81.50  Aligned_cols=129  Identities=29%  Similarity=0.452  Sum_probs=101.2

Q ss_pred             CCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEeecC
Q 031702           23 VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGL  102 (154)
Q Consensus        23 l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~  102 (154)
                      -.+|.++.....+......+++++|..+++|...+.+.+..+.+-...+...+..+.++||...+.|++++|.|.+.   
T Consensus       861 p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---  937 (1205)
T KOG0606|consen  861 PRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---  937 (1205)
T ss_pred             CCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhh---
Confidence            34566666666666667789999999999999988877777777888888899999999999999999999999998   


Q ss_pred             CCCeeEEEeecccccccCC---------------------C-----------CccccccCCccccCcccccccCCCcccc
Q 031702          103 DDDVMLKIADFGLSCTLYP---------------------G-----------NYAEKVCGSPLYMAPEVLQFQRYDEKVN  150 (154)
Q Consensus       103 ~~~~~~kl~df~~~~~~~~---------------------~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~D  150 (154)
                      ...+..++.+|+......-                     .           .......+|+.|.+||.+.+......+|
T Consensus       938 ~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad 1017 (1205)
T KOG0606|consen  938 AYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAAD 1017 (1205)
T ss_pred             cccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcch
Confidence            5777888888873321100                     0           0012346789999999999998889999


Q ss_pred             eecC
Q 031702          151 FFVS  154 (154)
Q Consensus       151 iwsl  154 (154)
                      +|++
T Consensus      1018 ~~~~ 1021 (1205)
T KOG0606|consen 1018 WWSS 1021 (1205)
T ss_pred             hhhh
Confidence            9974

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.56  E-value=6.9e-07  Score=61.65  Aligned_cols=99  Identities=17%  Similarity=0.209  Sum_probs=74.6

Q ss_pred             hhHHhHHHHHHHHhhCCCC--ccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            8 HLKSCLDCELNFLSSVNHP--NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      -.+...++|.+.|++|...  .+++.++    -+...++||+++|..|....     +.....-.++..|+..+.-.-..
T Consensus       151 ~sRl~A~rEf~~L~~L~~~G~~VP~P~~----~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~  221 (304)
T COG0478         151 VSRLAAEREFEALQRLYPEGVKVPKPIA----WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRR  221 (304)
T ss_pred             hHHHHHHHHHHHHHHhhhcCCCCCCccc----cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHc
Confidence            3456778899999999655  6666653    35567999999987776432     23445555666677777777789


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccc
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  118 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~  118 (154)
                      |++|+|+++=||++   +.++.+.++||-.+..
T Consensus       222 GiVHGDlSefNIlV---~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         222 GIVHGDLSEFNILV---TEDGDIVVIDWPQAVP  251 (304)
T ss_pred             CccccCCchheEEE---ecCCCEEEEeCccccc
Confidence            99999999999999   6778899999977654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.50  E-value=9e-08  Score=72.68  Aligned_cols=136  Identities=23%  Similarity=0.315  Sum_probs=101.9

Q ss_pred             HhHHHHHHHHhhCCCCc-cchhhhheecCCcEEEEEEecCCC-Cch-HHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702           11 SCLDCELNFLSSVNHPN-IIRLFDAFQAENCIFLVVEFCAGG-NLS-SYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus        11 ~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~v~e~~~~~-~L~-~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ....-++++|.+++||| .+...+-+..+....+.++++.++ +-. ..-...-.+..-+.....+.-.++++++|+..-
T Consensus       278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~  357 (829)
T KOG0576|consen  278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYK  357 (829)
T ss_pred             hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccc
Confidence            34456889999999999 666677777778889999998766 222 111122235556667777888889999999877


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+|    ||+.    .....+..+|+....+.......+..+++.|+|||+.....++.+.|.||+
T Consensus       358 ~~~d----~~l~----s~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~  416 (829)
T KOG0576|consen  358 VHRD----NILG----SEEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSL  416 (829)
T ss_pred             cCcc----cccc----cccccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCC
Confidence            7887    7775    446778899988776655545666778999999999998899999999875

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.38  E-value=5.7e-06  Score=55.13  Aligned_cols=102  Identities=27%  Similarity=0.386  Sum_probs=75.5

Q ss_pred             HHhHHHHHHHHhhCC------CCccchhhhheecCCcEEEEEEecCC------CCchHHHHHcCCCCHHHHHHHHHHHHH
Q 031702           10 KSCLDCELNFLSSVN------HPNIIRLFDAFQAENCIFLVVEFCAG------GNLSSYIRLHGRVPEQTARKFLQQLGA   77 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~~v~e~~~~------~~L~~~~~~~~~~~~~~~~~~~~~i~~   77 (154)
                      .+...+|+.-...+.      +..|.+++|..+++-..-+++|.+..      .+|.+++. .+.+++ ..   ...+-+
T Consensus        55 ~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~-~~---~~~L~~  129 (199)
T PF10707_consen   55 YRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLK-EGGLTE-EL---RQALDE  129 (199)
T ss_pred             hHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHH-cCCccH-HH---HHHHHH
Confidence            567777877777776      78899999999999888888887642      47778775 344555 33   333444


Q ss_pred             HHHHHHhCCceeecCCCCcEEeecCCCCe-eEEEee-cccc
Q 031702           78 GLEILNSHHIIHRDLKPENILLSGLDDDV-MLKIAD-FGLS  116 (154)
Q Consensus        78 ~l~~lh~~~~~h~~i~p~nil~~~~~~~~-~~kl~d-f~~~  116 (154)
                      -..+|-+.+|+.+|++|.||++...+++. .+.++| ||..
T Consensus       130 f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  130 FKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             HHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEeCCCCc
Confidence            56788889999999999999998766555 677776 5543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.35  E-value=2.4e-06  Score=56.53  Aligned_cols=98  Identities=24%  Similarity=0.283  Sum_probs=76.7

Q ss_pred             HHHHHHHhhCCC-CccchhhhheecCCcEEEEEEecCCCCchHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 031702           14 DCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSY---IRLHGRVPEQTARKFLQQLGAGLEILNS---HH   86 (154)
Q Consensus        14 ~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~---~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~   86 (154)
                      ..|.-+++.+++ +++++++|+|..    +.+.||.+.+++...   +..-...++.....++.++++.+++++.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            458889999965 699999999953    578899987655421   1112236789999999999999999998   45


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccc
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCT  118 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~  118 (154)
                      +.-+|++|+|+.+   +.++.+|++|......
T Consensus        83 ~~lcDv~~~nfgv---~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGV---NDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEE---eCCCcEEEEechhcch
Confidence            8889999999999   5677899999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.32  E-value=6e-07  Score=68.52  Aligned_cols=81  Identities=20%  Similarity=0.295  Sum_probs=62.0

Q ss_pred             HHHHHHHHHHHHHhC-CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc-c---------ccccCCccccCccc
Q 031702           71 FLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-A---------EKVCGSPLYMAPEV  139 (154)
Q Consensus        71 ~~~~i~~~l~~lh~~-~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~-~---------~~~~~~~~y~aPE~  139 (154)
                      =..++++|+.++|.. ++||++|.|++|.+   +..+.+|+++|+++....+... .         ........|.|||+
T Consensus       104 nl~~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~  180 (700)
T KOG2137|consen  104 NLGNVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEY  180 (700)
T ss_pred             hhhcccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchh
Confidence            344677999999974 89999999999999   7888999999988765444211 0         01122445999999


Q ss_pred             ccccCCCcccceecC
Q 031702          140 LQFQRYDEKVNFFVS  154 (154)
Q Consensus       140 ~~~~~~~~~~Diwsl  154 (154)
                      +.+...+..+|++||
T Consensus       181 ~~~~~~~~~sd~fSl  195 (700)
T KOG2137|consen  181 LLGTTNTPASDVFSL  195 (700)
T ss_pred             hccccccccccceee
Confidence            998777899999986

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.27  E-value=3.5e-06  Score=57.88  Aligned_cols=46  Identities=13%  Similarity=0.088  Sum_probs=34.8

Q ss_pred             HHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchH
Q 031702           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS   55 (154)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~   55 (154)
                      ...+.+|+.+++.+ ++--+++++.....++..+++||+++|.++..
T Consensus        35 ~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150          35 TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            34678899999998 34456677777766667889999999877764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.18  E-value=2.2e-05  Score=53.47  Aligned_cols=43  Identities=19%  Similarity=0.188  Sum_probs=33.2

Q ss_pred             HHhHHHHHHHHhhCCCCc--cchhhhheecCCcEEEEEEecCCCC
Q 031702           10 KSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGN   52 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~~v~e~~~~~~   52 (154)
                      ...+.+|.++++.+..-+  +++++.+...++...++||+++|.+
T Consensus        36 ~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172        36 KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            456789999999996444  4677777777777889999998863

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.10  E-value=1.1e-05  Score=61.07  Aligned_cols=105  Identities=21%  Similarity=0.256  Sum_probs=64.6

Q ss_pred             HHHHHHHHhhCC-----CCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702           13 LDCELNFLSSVN-----HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus        13 ~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      +.+|...+.+++     .+++.-..-+++-.+.-.++|||+.|..+.+.... ....+...+.....++  -+..+-..|
T Consensus       208 y~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dg  285 (517)
T COG0661         208 YRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcC
Confidence            344555544442     34333223233333445799999999999888532 2335533332222211  123334489


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG  122 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~  122 (154)
                      +.|.|.+|.||++   +..+.+.+.|||....+.+.
T Consensus       286 ffHaDpHpGNi~v---~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         286 FFHADPHPGNILV---RSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             ccccCCCccceEE---ecCCcEEEEcCcceecCCHH
Confidence            9999999999999   67789999999998776554

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.04  E-value=4.5e-05  Score=52.28  Aligned_cols=101  Identities=19%  Similarity=0.134  Sum_probs=64.4

Q ss_pred             hHHHHHHHHhhCCCC--ccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCce
Q 031702           12 CLDCELNFLSSVNHP--NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-HHII   88 (154)
Q Consensus        12 ~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~   88 (154)
                      ....|+.-|+++...  .+++.+...    ...++|||++......-.-+.-.+.......+..++++.+.-|-. .+++
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LV  189 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLV  189 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcc
Confidence            344566666665322  223323222    246999999653111110011123333677778888888888887 8999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLY  120 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~  120 (154)
                      |+||+.=||++   . .+.+.++|++.|....
T Consensus       190 HgDLSEyNiL~---~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         190 HGDLSEYNILV---H-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             cccchhhheEE---E-CCeEEEEECccccccC
Confidence            99999999999   3 6788999999986543

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=97.95  E-value=3.2e-06  Score=66.16  Aligned_cols=64  Identities=19%  Similarity=0.310  Sum_probs=43.9

Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++...|.+.++.  ......++.||+.+.......   ......||+.|+|||++.+..++.++|||||
T Consensus       500 ~~~~~p~~~~~~--~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~DiwSl  566 (669)
T cd05610         500 TQKPRPHGNLYQ--TPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVDWWAL  566 (669)
T ss_pred             CCCCCCCCceeE--CCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHHHHHHH
Confidence            455556544432  334455777888776543221   2234578999999999998889999999996

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.86  E-value=8.6e-05  Score=50.79  Aligned_cols=45  Identities=9%  Similarity=0.073  Sum_probs=30.1

Q ss_pred             HHhHHHHHHHHhhCCCC---ccchhhhheecC---CcEEEEEEecCCCCch
Q 031702           10 KSCLDCELNFLSSVNHP---NIIRLFDAFQAE---NCIFLVVEFCAGGNLS   54 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~---~~~~~v~e~~~~~~L~   54 (154)
                      ...+.+|..+++.+...   .++++++.....   +..+++|++++|.++.
T Consensus        32 ~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G~~l~   82 (235)
T cd05155          32 AGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEGETAT   82 (235)
T ss_pred             HHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecCCCCC
Confidence            45799999999988532   344444433322   2358899999987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PLN02876 acyl-CoA dehydrogenase

Probab=97.76  E-value=0.00028  Score=56.77  Aligned_cols=44  Identities=14%  Similarity=0.375  Sum_probs=33.4

Q ss_pred             HHhHHHHHHHHhhCC-CCcc--chhhhheecC---CcEEEEEEecCCCCc
Q 031702           10 KSCLDCELNFLSSVN-HPNI--IRLFDAFQAE---NCIFLVVEFCAGGNL   53 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~~~v~e~~~~~~L   53 (154)
                      ...+.+|+.+++.+. |+++  ++++..+.+.   +..|++||+++|..+
T Consensus        82 ~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~  131 (822)
T PLN02876         82 AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIF  131 (822)
T ss_pred             HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCccc
Confidence            357889999999995 6765  6667766554   457899999988653

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.69  E-value=0.00012  Score=59.64  Aligned_cols=145  Identities=23%  Similarity=0.209  Sum_probs=103.7

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCC----cEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      .....-|...+....|+|++.++.+-.+.-    ...+..+++..-++...+.+-+..+.+..+.+..+..+++.++|+.
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            444556777888889999999887764432    2335567888888888888888899999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEe--ecccccccCCCCccccccCCccccCcccccccCCCc--ccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIA--DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDE--KVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~--df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~~Diwsl  154 (154)
                      ...|.-+......-...+..+.....  ||+................+..+.+||.......+.  ..|+|.+
T Consensus       306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCL  378 (1351)
T ss_pred             ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHH
Confidence            76666555553333323455555555  888777666665555555566688888887655443  3688863

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.68  E-value=0.00057  Score=52.03  Aligned_cols=89  Identities=18%  Similarity=0.305  Sum_probs=58.4

Q ss_pred             cchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHH-HHHHhCCceeecCCCCcEEeecC-CC
Q 031702           28 IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGL-EILNSHHIIHRDLKPENILLSGL-DD  104 (154)
Q Consensus        28 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l-~~lh~~~~~h~~i~p~nil~~~~-~~  104 (154)
                      |++++..+.++  -.++||||+|..+.+.-.- ...++...+   +..+.++. +-+-..|++|+|-+|.||++..+ ..
T Consensus       266 VP~Vy~~~st~--RVLtME~~~G~~i~Dl~~i~~~gi~~~~i---~~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~  340 (538)
T KOG1235|consen  266 VPKVYWDLSTK--RVLTMEYVDGIKINDLDAIDKRGISPHDI---LNKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEG  340 (538)
T ss_pred             CCeehhhcCcc--eEEEEEecCCccCCCHHHHHHcCCCHHHH---HHHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCC
Confidence            66666555444  5799999999888765421 223555433   33333322 23335789999999999999643 24


Q ss_pred             CeeEEEeecccccccCC
Q 031702          105 DVMLKIADFGLSCTLYP  121 (154)
Q Consensus       105 ~~~~kl~df~~~~~~~~  121 (154)
                      ...+.+-|||+...+..
T Consensus       341 ~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  341 DEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CccEEEEcccccccccH
Confidence            67888999999876544

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.66  E-value=0.0003  Score=47.52  Aligned_cols=47  Identities=17%  Similarity=0.226  Sum_probs=32.5

Q ss_pred             hHHhHHHHHHHHhhCCCC--ccchhhhhee---cCCcEEEEEEecCCCCchH
Q 031702            9 LKSCLDCELNFLSSVNHP--NIIRLFDAFQ---AENCIFLVVEFCAGGNLSS   55 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~--~i~~~~~~~~---~~~~~~~v~e~~~~~~L~~   55 (154)
                      ....+.+|..+++.+...  .+++++....   .....++++++++|.++..
T Consensus        33 ~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~   84 (239)
T PF01636_consen   33 AAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDD   84 (239)
T ss_dssp             HHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred             CHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccc
Confidence            567888999999998533  3566665332   2345799999999987777

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=97.64  E-value=0.00023  Score=52.58  Aligned_cols=110  Identities=14%  Similarity=0.145  Sum_probs=73.8

Q ss_pred             EEEEEEecCCC-CchHHH------HHcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeec
Q 031702           41 IFLVVEFCAGG-NLSSYI------RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF  113 (154)
Q Consensus        41 ~~~v~e~~~~~-~L~~~~------~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df  113 (154)
                      .-+.|..+.+. ....+.      .+.....+...++..+.++.+.+-||..|.+-+|+.++|+++   ++.+.+.|.|-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lV---sd~~~V~LVds  161 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLV---SDDSKVVLVDS  161 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceee---ecCceEEEEcc
Confidence            56777766553 112222      112236778899999999999999999999999999999999   56777888764


Q ss_pred             ccccccCCCCccccccCCccccCccccccc-----CCCcccceec
Q 031702          114 GLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-----RYDEKVNFFV  153 (154)
Q Consensus       114 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Diws  153 (154)
                      ..-..-..+.....+.|...|.+||.-.-+     .-+...|-|.
T Consensus       162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FG  206 (637)
T COG4248         162 DSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFG  206 (637)
T ss_pred             cceeeccCCceEecccCccccCCHHHhccccccccCCCccccchh
Confidence            321111222334456788899999986522     2244556554

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.36  E-value=0.0011  Score=46.78  Aligned_cols=113  Identities=25%  Similarity=0.297  Sum_probs=63.3

Q ss_pred             hhhhhhhhHHhHHHHHHHHhhCCCCc--cchhhhhe------ecCCcEEEEEEecCCCCchH----HHH-----------
Q 031702            2 LKKLNKHLKSCLDCELNFLSSVNHPN--IIRLFDAF------QAENCIFLVVEFCAGGNLSS----YIR-----------   58 (154)
Q Consensus         2 ~k~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~------~~~~~~~~v~e~~~~~~L~~----~~~-----------   58 (154)
                      +|.......+.+..|+.+++.+.+.+  +++++...      ...+..++++++++|..+..    ...           
T Consensus        42 Lr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~  121 (296)
T cd05153          42 LTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHL  121 (296)
T ss_pred             EEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHH
Confidence            34333344567888999999885433  44544321      22345689999999876532    100           


Q ss_pred             HcCCCCH--------HHHH------------HHHHHHHHHHHHHHh-------CCceeecCCCCcEEeecCCCCeeEEEe
Q 031702           59 LHGRVPE--------QTAR------------KFLQQLGAGLEILNS-------HHIIHRDLKPENILLSGLDDDVMLKIA  111 (154)
Q Consensus        59 ~~~~~~~--------~~~~------------~~~~~i~~~l~~lh~-------~~~~h~~i~p~nil~~~~~~~~~~kl~  111 (154)
                      ....+..        ....            .....+..++..+..       .+++|+|+.|.|+++   +....+.++
T Consensus       122 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~---~~~~~~~iI  198 (296)
T cd05153         122 AAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLF---DGDELSGVI  198 (296)
T ss_pred             HhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEE---eCCceEEEe
Confidence            0000100        0000            001112233444443       369999999999999   455556899


Q ss_pred             eccccc
Q 031702          112 DFGLSC  117 (154)
Q Consensus       112 df~~~~  117 (154)
                      ||+.+.
T Consensus       199 Dfe~a~  204 (296)
T cd05153         199 DFYFAC  204 (296)
T ss_pred             ehhhhc
Confidence            998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=96.95  E-value=0.0033  Score=43.53  Aligned_cols=28  Identities=21%  Similarity=0.417  Sum_probs=22.9

Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeeccccc
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~  117 (154)
                      .++|+|+.|.||++.   ..+ +.++||..+.
T Consensus       147 ~l~H~Dl~~~Nil~~---~~~-~~lIDwE~a~  174 (256)
T TIGR02721       147 APLHMDVHAYNLVVT---PQG-LKLIDWEYAS  174 (256)
T ss_pred             eeecCCCCcCcEEEe---CCC-CEEEeccccC
Confidence            489999999999994   333 6899998775

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.91  E-value=5.1e-05  Score=63.63  Aligned_cols=146  Identities=14%  Similarity=0.039  Sum_probs=101.7

Q ss_pred             hhhhhHHhHHHHHHHHhhCCCCccchhhhheec--CCcEEEEEEecCCCCchHHHHHcC----CCCHHHHHHHHHHHHHH
Q 031702            5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQLGAG   78 (154)
Q Consensus         5 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~   78 (154)
                      +.+..++-...|..-.+..+|+++.....-...  +...+..++++.+|.+...+-++-    .+.+..+....++.+.+
T Consensus      1268 LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~ 1347 (2724)
T KOG1826|consen 1268 LSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLN 1347 (2724)
T ss_pred             HhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhc
Confidence            445556666667777777899988777655532  344678889999999998886542    23344444444443555


Q ss_pred             HHHHHhC-----CceeecCCCCcEEeecCCCCeeEEEeeccccc-ccCCCCccccccCCccccCcccccccCCCccccee
Q 031702           79 LEILNSH-----HIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF  152 (154)
Q Consensus        79 l~~lh~~-----~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~-~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw  152 (154)
                      ..-.|..     --+|+++++.|-++   ....++++.++|+.+ .-..........+++.|++|++...-.++.++|+|
T Consensus      1348 ~~~~ls~tnlg~T~v~~~Lkf~lpmI---Vtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdil 1424 (2724)
T KOG1826|consen 1348 RNVILSLTNLGNTNVSKSLKFTLPMI---VTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDIL 1424 (2724)
T ss_pred             cchhhhcccCCccchhhhhhhhccce---ecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHH
Confidence            5555543     25799999999999   577789999999988 32223334445667789999998888888889998


Q ss_pred             c
Q 031702          153 V  153 (154)
Q Consensus       153 s  153 (154)
                      +
T Consensus      1425 r 1425 (2724)
T KOG1826|consen 1425 R 1425 (2724)
T ss_pred             H
Confidence            6

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.78  E-value=0.007  Score=44.26  Aligned_cols=73  Identities=25%  Similarity=0.288  Sum_probs=55.3

Q ss_pred             CCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEeecCCCCeeEEEeecccc
Q 031702           38 ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLS  116 (154)
Q Consensus        38 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~~~h~~i~p~nil~~~~~~~~~~kl~df~~~  116 (154)
                      ..+.|+++++. |+++.-.    .....++...++.+.+..+.-+... .+-|+++.-.||++   + .|++.|+||.++
T Consensus       298 ~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI---d-~GnvtLIDfkls  368 (488)
T COG5072         298 TLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI---D-EGNVTLIDFKLS  368 (488)
T ss_pred             ceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee---e-cCceEEEEeeee
Confidence            34678888876 5566532    2245677888888887777777664 68899999999999   5 889999999998


Q ss_pred             ccc
Q 031702          117 CTL  119 (154)
Q Consensus       117 ~~~  119 (154)
                      +.-
T Consensus       369 Rl~  371 (488)
T COG5072         369 RLS  371 (488)
T ss_pred             ecc
Confidence            743

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.08  E-value=0.056  Score=38.89  Aligned_cols=43  Identities=16%  Similarity=0.179  Sum_probs=29.8

Q ss_pred             hHHhHHHHHHHHhhCCC--CccchhhhheecCC--cEEEEEEecCCC
Q 031702            9 LKSCLDCELNFLSSVNH--PNIIRLFDAFQAEN--CIFLVVEFCAGG   51 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~--~~~~v~e~~~~~   51 (154)
                      ......+|+.+++.+.-  --++..++.+.++.  ..+.+|+|++|.
T Consensus        64 ~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe  110 (321)
T COG3173          64 SAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGE  110 (321)
T ss_pred             hhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecce
Confidence            34566788999988843  33444566665554  679999999883

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=96.02  E-value=0.024  Score=37.30  Aligned_cols=97  Identities=19%  Similarity=0.203  Sum_probs=64.7

Q ss_pred             hhhHHhHHHHHHHHhhCCCCcc-chhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNI-IRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      +..+..+..|++++..++..++ ++++.+-.+    ++.|||+.|..|.+.....   +..    -...++++..-|-..
T Consensus        56 ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L~~~~~~~---~rk----~l~~vlE~a~~LD~~  124 (201)
T COG2112          56 DSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPLGKLEIGG---DRK----HLLRVLEKAYKLDRL  124 (201)
T ss_pred             CcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcchhhhhhcc---cHH----HHHHHHHHHHHHHHh
Confidence            5567899999999999876554 333332222    3459999988887754421   222    233456666667778


Q ss_pred             CceeecCCC--CcEEeecCCCCeeEEEeecccccc
Q 031702           86 HIIHRDLKP--ENILLSGLDDDVMLKIADFGLSCT  118 (154)
Q Consensus        86 ~~~h~~i~p--~nil~~~~~~~~~~kl~df~~~~~  118 (154)
                      ||-|+.++-  .|+++    ....+.|+||..|..
T Consensus       125 GI~H~El~~~~k~vlv----~~~~~~iIDFd~At~  155 (201)
T COG2112         125 GIEHGELSRPWKNVLV----NDRDVYIIDFDSATF  155 (201)
T ss_pred             ccchhhhcCCceeEEe----cCCcEEEEEccchhh
Confidence            999998874  45554    344789999998863

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.02  E-value=0.013  Score=42.33  Aligned_cols=93  Identities=20%  Similarity=0.281  Sum_probs=63.2

Q ss_pred             hHHHHHHHHhhCCCCc--cchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 031702           12 CLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (154)
Q Consensus        12 ~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (154)
                      ...+|...|+.|....  +++.+    +.+..++|||++.|-.|.+...-   ..+   ..+...+..-+--|...|++|
T Consensus       156 aa~kEfafmkaL~e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v---~d~---~~ly~~lm~~Iv~la~~GlIH  225 (465)
T KOG2268|consen  156 AATKEFAFMKALYERGFPVPKPI----DHNRHCVVMELVDGYPLRQVRHV---EDP---PTLYDDLMGLIVRLANHGLIH  225 (465)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCcc----cccceeeHHHhhcccceeeeeec---CCh---HHHHHHHHHHHHHHHHcCcee
Confidence            4456777777774333  22222    34557899999998888764321   112   223445556677788899999


Q ss_pred             ecCCCCcEEeecCCCCeeEEEeeccccc
Q 031702           90 RDLKPENILLSGLDDDVMLKIADFGLSC  117 (154)
Q Consensus        90 ~~i~p~nil~~~~~~~~~~kl~df~~~~  117 (154)
                      +|..-=||++   .....++++||-...
T Consensus       226 gDFNEFNimv---~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  226 GDFNEFNIMV---KDDDKIVVIDFPQMV  250 (465)
T ss_pred             cccchheeEE---ecCCCEEEeechHhh
Confidence            9999999999   467789999996543

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=95.92  E-value=0.062  Score=39.68  Aligned_cols=100  Identities=23%  Similarity=0.201  Sum_probs=64.8

Q ss_pred             hHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-hCCceee
Q 031702           12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN-SHHIIHR   90 (154)
Q Consensus        12 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~~~h~   90 (154)
                      ....|..-|++|....|+..--+..-  ...+||++++...-..-.-+...++...+..+-.+++.-+.-|. .+++||.
T Consensus       212 WAEKE~RNLkRl~~aGIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHA  289 (520)
T KOG2270|consen  212 WAEKEMRNLKRLNNAGIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHA  289 (520)
T ss_pred             HHHHHHHHHHHHHhcCCCCCCceeee--cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceecc
Confidence            44557777777766665533222221  23689999854222222222345676777777777777776664 5799999


Q ss_pred             cCCCCcEEeecCCCCeeEEEeeccccc
Q 031702           91 DLKPENILLSGLDDDVMLKIADFGLSC  117 (154)
Q Consensus        91 ~i~p~nil~~~~~~~~~~kl~df~~~~  117 (154)
                      ||+-=|+++    ..+.+.++|-+.+.
T Consensus       290 DLSEfN~Ly----hdG~lyiIDVSQSV  312 (520)
T KOG2270|consen  290 DLSEFNLLY----HDGKLYIIDVSQSV  312 (520)
T ss_pred             chhhhhheE----ECCEEEEEEccccc
Confidence            999999998    46778899987664

>PTZ00384 choline kinase; Provisional

Probab=95.76  E-value=0.037  Score=40.89  Aligned_cols=37  Identities=16%  Similarity=0.323  Sum_probs=26.9

Q ss_pred             HHHHHHHhhCC-CCccchhhhheecCCcEEEEEEecCCCCch
Q 031702           14 DCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLS   54 (154)
Q Consensus        14 ~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   54 (154)
                      .+|..+++.+. +..-+++++.+..    +++.||++|.++.
T Consensus       100 ~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efIeGr~l~  137 (383)
T PTZ00384        100 DLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWVEGNTMG  137 (383)
T ss_pred             HHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEeccccCC
Confidence            56889999984 4455666666653    4899999987765

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=95.52  E-value=0.02  Score=38.99  Aligned_cols=31  Identities=23%  Similarity=0.347  Sum_probs=24.8

Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccc
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  118 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~  118 (154)
                      .++|+|+.|.||++.+  .+..+.++||..+..
T Consensus       171 ~l~H~Dl~~~Nil~~~--~~~~~~lIDwe~a~~  201 (235)
T cd05157         171 VFCHNDLLSGNIIYNE--EKNSVKFIDYEYAGY  201 (235)
T ss_pred             EEEcCCCCcCcEEEeC--CCCCEEEEEcccCCc
Confidence            5899999999999942  135799999987753

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK05231 homoserine kinase; Provisional

Probab=95.50  E-value=0.012  Score=42.11  Aligned_cols=30  Identities=33%  Similarity=0.660  Sum_probs=24.5

Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeeccccc
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~  117 (154)
                      .+++|+|+.|.||++   +.+....++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~---~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLF---EGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEE---ECCceEEEEeccccc
Confidence            379999999999999   444455899998875

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=95.50  E-value=0.035  Score=39.59  Aligned_cols=30  Identities=37%  Similarity=0.751  Sum_probs=24.8

Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeeccccc
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~  117 (154)
                      .+++|+|+.+.|+++.   .+....++||+.+.
T Consensus       187 ~~l~HgD~~~~Nvl~~---~~~~~~vIDfd~~~  216 (307)
T TIGR00938       187 RGVIHADLFPDNVLFD---GDSVKGVIDFYFAC  216 (307)
T ss_pred             CccCCCCCCcCcEEEE---CCceEEEeeccccc
Confidence            5799999999999994   44556899998874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK10593 hypothetical protein; Provisional

Probab=95.46  E-value=0.042  Score=39.14  Aligned_cols=70  Identities=13%  Similarity=0.078  Sum_probs=47.4

Q ss_pred             HHhHHHHHHHHhhCCC---Cccchhhhheec---CCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 031702           10 KSCLDCELNFLSSVNH---PNIIRLFDAFQA---ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h---~~i~~~~~~~~~---~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      ...+..|...++.+..   -.++++++.+..   .+..+++||+++|.++.+.     .........+..++++++.-||
T Consensus        51 ~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH  125 (297)
T PRK10593         51 PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWH  125 (297)
T ss_pred             chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHh
Confidence            4689999999999943   367888877654   3668999999999877541     1223334444555556666666


Q ss_pred             h
Q 031702           84 S   84 (154)
Q Consensus        84 ~   84 (154)
                      +
T Consensus       126 ~  126 (297)
T PRK10593        126 R  126 (297)
T ss_pred             C
Confidence            5

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.29  E-value=0.06  Score=38.27  Aligned_cols=29  Identities=31%  Similarity=0.438  Sum_probs=23.4

Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeeccccc
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~  117 (154)
                      .+++|+|+.+.|+++.   . +.+.++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~---~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLK---D-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEe---C-CcEEEEECcccc
Confidence            4789999999999994   3 457899998653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=95.14  E-value=0.053  Score=38.47  Aligned_cols=33  Identities=30%  Similarity=0.400  Sum_probs=24.8

Q ss_pred             CceeecCCCCcEEeecC-CCCeeEEEeecccccc
Q 031702           86 HIIHRDLKPENILLSGL-DDDVMLKIADFGLSCT  118 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~-~~~~~~kl~df~~~~~  118 (154)
                      .++|+|+.|.||++... +....+.++||..+..
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            57999999999999410 0035789999988753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=95.08  E-value=0.13  Score=34.68  Aligned_cols=86  Identities=21%  Similarity=0.322  Sum_probs=57.2

Q ss_pred             HHhHHHHHHHHhhCC---CCcc--chhhhheecC------------------CcEEEEEEecCCCCchHHHHHcCCCCHH
Q 031702           10 KSCLDCELNFLSSVN---HPNI--IRLFDAFQAE------------------NCIFLVVEFCAGGNLSSYIRLHGRVPEQ   66 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~---h~~i--~~~~~~~~~~------------------~~~~~v~e~~~~~~L~~~~~~~~~~~~~   66 (154)
                      .+-|..|.....+|+   +.++  ++++|+..-.                  ...-+|.||++...         .+..+
T Consensus        98 ~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~  168 (207)
T PF13095_consen   98 ADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR  168 (207)
T ss_pred             cChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh
Confidence            456778888877774   3455  7777776211                  12356777765533         22223


Q ss_pred             HHHHHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccc
Q 031702           67 TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS  116 (154)
Q Consensus        67 ~~~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~  116 (154)
                      .    +.+|.+-+..+|..||+-+|+++.|..        .-+|+|||.+
T Consensus       169 ~----~~~~~~dl~~~~k~gI~~~Dv~~~ny~--------~G~lvDfs~~  206 (207)
T PF13095_consen  169 D----IPQMLRDLKILHKLGIVPRDVKPRNYR--------GGKLVDFSSS  206 (207)
T ss_pred             H----HHHHHHHHHHHHHCCeeeccCcccccc--------CCEEEecccC
Confidence            3    345677778899999999999998886        2378999854

>PHA03111 Ser/Thr kinase; Provisional

Probab=94.98  E-value=0.11  Score=37.85  Aligned_cols=45  Identities=22%  Similarity=0.390  Sum_probs=28.6

Q ss_pred             HHHHHHHHHHHHHHHHHHh----CCceeecCCCCcEEeecCCCCeeEEE
Q 031702           66 QTARKFLQQLGAGLEILNS----HHIIHRDLKPENILLSGLDDDVMLKI  110 (154)
Q Consensus        66 ~~~~~~~~~i~~~l~~lh~----~~~~h~~i~p~nil~~~~~~~~~~kl  110 (154)
                      +-++-+..||+.-.-.+-.    .+++|-||||.||++.+.+....+++
T Consensus       279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~  327 (444)
T PHA03111        279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITL  327 (444)
T ss_pred             HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEE
Confidence            4455566677665433322    36999999999999975443343333

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=94.88  E-value=0.086  Score=37.43  Aligned_cols=49  Identities=16%  Similarity=0.182  Sum_probs=31.1

Q ss_pred             hhhhhhhHHhHHHHHHHHhhCC---CCccchhhhheecCCcEEEEEEecCCC
Q 031702            3 KKLNKHLKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGG   51 (154)
Q Consensus         3 k~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~v~e~~~~~   51 (154)
                      |.......+.|..|..-|+.|.   --.+++++++....+.-++++||++.+
T Consensus        46 K~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   46 KVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             EecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            4444455678999999999993   345788888877777779999998765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=94.82  E-value=0.072  Score=37.43  Aligned_cols=44  Identities=32%  Similarity=0.397  Sum_probs=31.6

Q ss_pred             HHHHHHHHHHHHHhC--CceeecCCCCcEEeecCCCCeeEEEeeccccc
Q 031702           71 FLQQLGAGLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (154)
Q Consensus        71 ~~~~i~~~l~~lh~~--~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~  117 (154)
                      ....+-.++.-.+..  -++|+|+.|.|++.   .+.+.++|+||..|.
T Consensus       137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~---t~~~~l~LIDWEyAg  182 (269)
T COG0510         137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLL---TDKGGLFLIDWEYAG  182 (269)
T ss_pred             HHHHHHHHhhhcCCCceeeecCCCCccceEE---cCCCcEEEEecccCC
Confidence            333444444444433  48899999999999   456899999998775

>KOG4720 consensus Ethanolamine kinase [Lipid transport and metabolism]

Probab=94.75  E-value=0.26  Score=35.33  Aligned_cols=37  Identities=24%  Similarity=0.337  Sum_probs=30.5

Q ss_pred             HHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCch
Q 031702           14 DCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLS   54 (154)
Q Consensus        14 ~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   54 (154)
                      .+|+..++.| .|-.-+++++.|.++    +++||++|.+|.
T Consensus       126 e~Ev~afk~L~a~G~ap~Ly~tF~NG----Lvyefi~g~tL~  163 (391)
T KOG4720|consen  126 ENEVIAFKLLAAYGFAPKLYGTFNNG----LVYEFIQGKTLE  163 (391)
T ss_pred             HHHHHHHHHHHHcCcChhhhheecCc----eEEeeecCcccC
Confidence            4577777777 578888999999887    899999998876

>PRK10271 thiK thiamine kinase; Provisional

Probab=94.60  E-value=0.031  Score=37.01  Aligned_cols=28  Identities=21%  Similarity=0.373  Sum_probs=22.8

Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeeccccc
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~  117 (154)
                      -.+|+|+.|.|+++.   +++ ++++||+.+.
T Consensus        78 ~p~H~D~~~~N~~~~---~~~-~~lIDwe~a~  105 (188)
T PRK10271         78 APLHMDVHAGNLVHS---ASG-LRLIDWEYAG  105 (188)
T ss_pred             eeecCCCCCccEEEE---CCC-EEEEeCCccc
Confidence            358999999999983   333 8899999875

>PLN02236 choline kinase

Probab=93.77  E-value=0.14  Score=37.35  Aligned_cols=31  Identities=23%  Similarity=0.454  Sum_probs=25.1

Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccc
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  118 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~  118 (154)
                      .++|+|+++.||++.  +....+.++||..+..
T Consensus       201 ~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMID--EETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEe--CCCCcEEEEeehhccc
Confidence            589999999999994  2345799999988753

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=93.63  E-value=0.064  Score=37.81  Aligned_cols=30  Identities=27%  Similarity=0.479  Sum_probs=23.1

Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeeccccc
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~  117 (154)
                      .++|+|++|.||++.+  ......++||+.+.
T Consensus       186 ~lvHGD~~~~Nilv~~--~~~~~gviDWe~a~  215 (276)
T cd05152         186 VLVHGDLHPGHILIDE--DARVTGLIDWTEAK  215 (276)
T ss_pred             eeEeCCCCCCcEEEeC--CCCEEEEECcHhcc
Confidence            4899999999999941  13345799999775

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=93.58  E-value=0.16  Score=36.85  Aligned_cols=28  Identities=46%  Similarity=0.775  Sum_probs=23.4

Q ss_pred             ceeecCCCCcEEeecCCCCe-eEEEeeccccc
Q 031702           87 IIHRDLKPENILLSGLDDDV-MLKIADFGLSC  117 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~-~~kl~df~~~~  117 (154)
                      ++|+|+.|.||++   +... .+.++||+.+.
T Consensus       199 iIH~D~~~~NVl~---d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLF---DDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeE---cCCCCeeeEEEccccc
Confidence            8999999999999   4443 47899998875

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=93.50  E-value=0.045  Score=36.78  Aligned_cols=30  Identities=37%  Similarity=0.613  Sum_probs=19.8

Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeeccccc
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~  117 (154)
                      .+.|+|+.|.||++.  ...+.++++||..+.
T Consensus       144 v~cHnDl~~~Nil~~--~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILIN--NKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEET--SSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEec--cCCCeEEEecHHHHh
Confidence            478999999999993  467789999998875

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=93.36  E-value=0.3  Score=32.54  Aligned_cols=34  Identities=29%  Similarity=0.337  Sum_probs=24.8

Q ss_pred             CCceeecCCCCcEEeecCCC--CeeEEEeecccccc
Q 031702           85 HHIIHRDLKPENILLSGLDD--DVMLKIADFGLSCT  118 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~--~~~~kl~df~~~~~  118 (154)
                      ..++|||+.+.|+++.....  ...+.++||..+..
T Consensus       120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~  155 (196)
T smart00587      120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY  155 (196)
T ss_pred             eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence            35899999999999953211  12688999987753

subfamily of choline kinases

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=93.13  E-value=0.099  Score=38.17  Aligned_cols=18  Identities=44%  Similarity=0.768  Sum_probs=15.5

Q ss_pred             CceeecCCCCcEEeecCC
Q 031702           86 HIIHRDLKPENILLSGLD  103 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~  103 (154)
                      +++|-||||.||++.+.+
T Consensus       299 nF~H~DLKPdNILiFds~  316 (434)
T PF05445_consen  299 NFLHVDLKPDNILIFDSK  316 (434)
T ss_pred             eeeecccCcCcEEEecCC
Confidence            699999999999997533

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=92.93  E-value=0.48  Score=35.71  Aligned_cols=60  Identities=22%  Similarity=0.335  Sum_probs=44.7

Q ss_pred             EEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-hCCceeecCCCCcEEeec
Q 031702           41 IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN-SHHIIHRDLKPENILLSG  101 (154)
Q Consensus        41 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~~~h~~i~p~nil~~~  101 (154)
                      ..++-+|++|.++..+++ ....+++....++.-.+.|+--+- -.+++|.|++|.||++.-
T Consensus       320 ~vl~E~~~~Gl~v~~~v~-~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVK-WKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             ceeeeeccccccHHhhhh-cccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence            356668888999998886 445666667777776666655443 468999999999999963

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=92.84  E-value=0.23  Score=35.46  Aligned_cols=30  Identities=17%  Similarity=0.207  Sum_probs=25.2

Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccc
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  118 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~  118 (154)
                      +++|+|+.+.|+++   +.++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~---~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLY---DETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEE---cCCCCEEEEEhhhccc
Confidence            69999999999999   5666788899987753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=92.73  E-value=0.12  Score=35.52  Aligned_cols=85  Identities=20%  Similarity=0.234  Sum_probs=51.7

Q ss_pred             HhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh--CCce
Q 031702           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS--HHII   88 (154)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~--~~~~   88 (154)
                      ..+.++..+++++.  +|+++..=  +...+.++.|.|-.... .+        ...   +.+ =++++.-.|+  .+.+
T Consensus       103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-~~--------~N~---i~a-gi~~L~~fH~~~~~~l  165 (308)
T PF07387_consen  103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-NF--------SNF---ITA-GIKDLMDFHSENQHCL  165 (308)
T ss_pred             hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-ch--------hHH---HHH-hHHHHHHhhccCCCee
Confidence            34456677776653  34444411  33346788888732111 11        111   111 1345667774  4799


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeeccc
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGL  115 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~  115 (154)
                      |+|-.|+||+-   ++.+.+||.|-+.
T Consensus       166 HGD~np~NiM~---D~~G~lKlVDP~~  189 (308)
T PF07387_consen  166 HGDCNPDNIMC---DKFGYLKLVDPVC  189 (308)
T ss_pred             cCCCChhheee---cCCCCEEecChhh
Confidence            99999999999   8999999999654

The function of this family is unknown.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=92.54  E-value=0.12  Score=37.43  Aligned_cols=29  Identities=31%  Similarity=0.528  Sum_probs=24.3

Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeeccccc
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~  117 (154)
                      +.|+|+.+.||++.  +..+.++++||..|.
T Consensus       184 ~CHnDl~~~NiL~~--~~~~~l~lID~EYag  212 (330)
T PLN02421        184 FAHNDLLSGNLMLN--EDEGKLYFIDFEYGS  212 (330)
T ss_pred             EEECCCCcccEEEe--CCCCcEEEEcccccC
Confidence            68999999999994  245679999998875

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=92.46  E-value=0.61  Score=32.38  Aligned_cols=48  Identities=17%  Similarity=0.256  Sum_probs=37.8

Q ss_pred             hhhHHhHHHHHHHHhhCCC---CccchhhhheecCCcEEEEEEecCCCCch
Q 031702            7 KHLKSCLDCELNFLSSVNH---PNIIRLFDAFQAENCIFLVVEFCAGGNLS   54 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   54 (154)
                      ......|..|+.-|+.|.-   -.+++++.+-.+.++.|+|+||.+-+.+.
T Consensus        49 ~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          49 REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            4445778889888888843   45788888888889999999999876655

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	154
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-28
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-27
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-27
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-27
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-27
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-27
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-27
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		8e-27
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-26
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-26
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-26
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-26
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-26
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-26
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-26
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		7e-25
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-25
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-24
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-23
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-23
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-22
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-22
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-22
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-22
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-22
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-22
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-22
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-22
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-22
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-22
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-22
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-22
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-22
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-21
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-21
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-21
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-21
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-21
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-21
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-21
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-21
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-21
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-21
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-21
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-21
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-21
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-21
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-20
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-20
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-20
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-20
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-20
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-20
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-20
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-20
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-20
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-20
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		9e-20
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-19
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-19
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-19
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-19
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-19
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-19
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-19
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-19
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-19
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-19
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-19
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-19
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-19
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-19
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-19
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-19
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-19
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-19
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-19
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-19
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-19
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		7e-19
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		7e-19
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-19
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		8e-19
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-19
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		9e-19
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		9e-19
3g51_A	325	Structural Diversity Of The Active Conformation Of		9e-19
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-18
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-18
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-18
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-18
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-18
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-18
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-18
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-18
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-18
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-18
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-18
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-18
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-18
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-18
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-18
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-18
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-18
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-18
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-18
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-18
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-18
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-18
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-18
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-18
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-18
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-18
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-18
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-18
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-18
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-18
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-18
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-18
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-18
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-18
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-18
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-18
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-18
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-18
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-18
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-18
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-18
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-18
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-18
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-18
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-18
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-18
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-18
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-18
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-18
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-18
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-18
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-18
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-18
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-18
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-18
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-18
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-18
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-18
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-18
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-18
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-18
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-18
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-18
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-18
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-18
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-18
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-18
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-18
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-18
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-18
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-18
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-18
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-18
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-18
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-18
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-18
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-18
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-18
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-18
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-18
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		6e-18
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-18
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-18
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-18
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		7e-18
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-18
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		7e-18
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-18
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		7e-18
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		7e-18
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-18
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		7e-18
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		7e-18
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		7e-18
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		7e-18
2oza_A	356	Structure Of P38alpha Complex Length = 356		7e-18
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-18
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-18
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		8e-18
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		8e-18
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		8e-18
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		8e-18
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		8e-18
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		8e-18
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		8e-18
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		8e-18
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		8e-18
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		8e-18
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		9e-18
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		9e-18
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-18
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		9e-18
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-18
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		9e-18
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		9e-18
4ae9_A	343	Structure And Function Of The Human Sperm-specific		9e-18
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-17
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-17
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-17
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-17
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-17
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-17
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-17
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-17
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-17
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-17
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-17
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-17
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-17
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-17
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-17
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-17
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-17
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-17
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-17
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-17
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-17
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-17
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		7e-17
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		8e-17
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-17
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		9e-17
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-16
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-16
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-16
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-16
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-16
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-16
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-16
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-16
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-16
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-16
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-16
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-16
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-16
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-16
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-16
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-16
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-16
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-16
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-16
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-16
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-16
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-16
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-16
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-16
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-16
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-16
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-16
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-16
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-16
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-16
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		7e-16
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-16
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-16
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-16
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		8e-16
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-16
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		8e-16
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		8e-16
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		9e-16
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-15
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-15
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-15
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-15
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-15
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-15
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-15
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-15
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-15
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-15
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-15
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-15
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-15
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-15
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-15
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-15
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-15
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-15
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-15
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-15
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-15
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-15
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		9e-15
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-14
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-14
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-14
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-14
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-14
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-14
3soa_A	444	Full-Length Human Camkii Length = 444		1e-14
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-14
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-14
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-14
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-14
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-14
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-14
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-14
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-14
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-14
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-14
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-14
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		6e-14
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-14
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-14
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-14
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		7e-14
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		8e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		8e-14
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		9e-14
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		9e-14
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		9e-14
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-13
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-13
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-13
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-13
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-13
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-13
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-13
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-13
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-13
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-13
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-13
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-13
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-13
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-13
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-13
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-13
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-13
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-13
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-13
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		8e-13
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		8e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		9e-13
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-12
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-12
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-12
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-12
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-12
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-12
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-12
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-12
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-12
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		7e-12
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-12
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		8e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-12
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		8e-12
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		8e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-12
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		9e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-11
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		1e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-11
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-11
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-11
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-11
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-11
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-11
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-11
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-11
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-11
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-11
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-11
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-11
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-11
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-11
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-11
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-11
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-11
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-11
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-11
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-11
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-11
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		6e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-11
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		6e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		7e-11
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		8e-11
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		9e-11
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-10
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-10
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-10
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-10
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-10
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-10
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-10
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-10
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-10
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-10
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-10
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-10
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-10
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-10
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-10
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-10
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-10
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-10
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-10
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-10
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-10
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-10
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-10
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-10
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-10
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-10
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-10
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-10
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-10
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-10
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-10
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-10
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-10
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-10
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-10
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-10
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-10
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-10
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-10
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-10
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-10
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-10
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-10
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-10
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-10
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-10
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-10
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-10
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-10
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-10
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-10
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-10
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-10
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-10
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-10
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-10
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-10
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-10
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-10
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-10
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-10
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-10
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-10
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-10
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-10
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-10
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-10
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-10
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-10
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-10
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		5e-10
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-10
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-10
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		6e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-10
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-10
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		7e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		7e-10
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-10
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		8e-10
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		9e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		9e-10
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		9e-10
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		9e-10
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		9e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		9e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-10
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		9e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-09
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-09
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-09
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-09
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-09
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-09
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-09
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-09
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-09
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-09
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-09
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-09
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-09
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-09
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-09
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-09
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-09
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-09
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-09
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-09
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-09
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-09
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-09
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-09
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-09
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-09
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-09
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-09
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-09
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-09
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-09
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-09
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-09
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-09
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-09
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-09
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		7e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		7e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		8e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-09
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		8e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		8e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-08
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-08
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-08
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-08
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-08
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-08
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-08
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-08
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-08
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-08
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-08
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-08
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-08
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-08
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-08
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-08
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		5e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-08
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-08
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-08
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		5e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-08
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		6e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-08
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		8e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		8e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		9e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		9e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		9e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		9e-08
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		9e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		9e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-07
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-07
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-07
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-07
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-07
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-07
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-07
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-07
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-07
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-07
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-07
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-07
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-07
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-07
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-07
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-07
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-07
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-07
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-07
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-07
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-07
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-07
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-07
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-07
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-07
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-07
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-07
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-07
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		3e-07
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-07
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-07
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-07
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		4e-07
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-07
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		4e-07
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-07
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		5e-07
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-07
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-07
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		7e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-07
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		8e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		9e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		9e-07
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-06
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-06
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-06
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-06
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-06
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-06
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-06
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-06
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-06
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-06
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-06
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-06
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-06
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-06
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-06
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-06
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-06
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-06
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-06
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-06
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-06
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-06
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-06
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		2e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-06
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-06
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		4e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-06
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-06
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-06
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		5e-06
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		6e-06
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		6e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		6e-06
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-06
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		6e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-06
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		6e-06
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		6e-06
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		6e-06
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		6e-06
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		6e-06
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		6e-06
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		6e-06
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		7e-06
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		7e-06
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		7e-06
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		8e-06
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		8e-06
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-05
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-05
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-05
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-05

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  119 bits (299), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 54/131 (41%), Positives = 85/131 (64%), Gaps = 3/131 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++LV+E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 123
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            + ++  +  +I+HRDLK EN+LL G   D+ +KIADFG S     GN  +  CGSP Y 
Sbjct: 124 VSAVQYCHQKYIVHRDLKAENLLLDG---DMNIKIADFGFSNEFTVGNKLDTFCGSPPYA 180
Query: 136 APEVLQFQRYD 146
           APE+ Q ++YD
Sbjct: 181 APELFQGKKYD 191

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  118 bits (296), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 62/145 (42%), Positives = 93/145 (64%), Gaps = 6/145 (4%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +LKK + H++  ++ E+++L  + HP+II+L+D       I +V+E+ AGG L  YI   
Sbjct: 46  LLKKSDMHMR--VEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEK 102
Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
            R+ E   R+F QQ+   +E  + H I+HRDLKPEN+L   LDD++ +KIADFGLS  + 
Sbjct: 103 KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLL---LDDNLNVKIADFGLSNIMT 159
Query: 121 PGNYAEKVCGSPLYMAPEVLQFQRY 145
            GN+ +  CGSP Y APEV+  + Y
Sbjct: 160 DGNFLKTSCGSPNYAAPEVINGKLY 184

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  117 bits (294), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 54/131 (41%), Positives = 85/131 (64%), Gaps = 3/131 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++LV+E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            + ++  +   I+HRDLK EN+L   LD D+ +KIADFG S     GN  ++ CGSP Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLL---LDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYA 179
Query: 136 APEVLQFQRYD 146
           APE+ Q ++YD
Sbjct: 180 APELFQGKKYD 190

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  117 bits (293), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 54/131 (41%), Positives = 84/131 (64%), Gaps = 3/131 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++LV+E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            + ++  +   I+HRDLK EN+L   LD D+ +KIADFG S     GN  +  CGSP Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLL---LDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYA 179
Query: 136 APEVLQFQRYD 146
           APE+ Q ++YD
Sbjct: 180 APELFQGKKYD 190

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  117 bits (293), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 54/131 (41%), Positives = 84/131 (64%), Gaps = 3/131 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++LV+E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            + ++  +   I+HRDLK EN+L   LD D+ +KIADFG S     GN  +  CGSP Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLL---LDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYA 179
Query: 136 APEVLQFQRYD 146
           APE+ Q ++YD
Sbjct: 180 APELFQGKKYD 190

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  117 bits (293), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 54/131 (41%), Positives = 84/131 (64%), Gaps = 3/131 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++LV+E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            + ++  +   I+HRDLK EN+L   LD D+ +KIADFG S     GN  +  CGSP Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLL---LDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYA 179
Query: 136 APEVLQFQRYD 146
           APE+ Q ++YD
Sbjct: 180 APELFQGKKYD 190

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  115 bits (289), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 53/131 (40%), Positives = 84/131 (64%), Gaps = 3/131 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++LV+E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            + ++  +   I+HRDLK EN+L   LD D+ +KIADFG S     GN  +  CG+P Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLL---LDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYA 179
Query: 136 APEVLQFQRYD 146
           APE+ Q ++YD
Sbjct: 180 APELFQGKKYD 190

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  115 bits (289), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 52/131 (39%), Positives = 83/131 (63%), Gaps = 3/131 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++L++E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 61  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 120
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            + ++  +   I+HRDLK EN+L   LD D+ +KIADFG S     G   +  CGSP Y 
Sbjct: 121 VSAVQYCHQKRIVHRDLKAENLL---LDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYA 177
Query: 136 APEVLQFQRYD 146
           APE+ Q ++YD
Sbjct: 178 APELFQGKKYD 188

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  115 bits (288), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 57/137 (41%), Positives = 92/137 (67%), Gaps = 4/137 (2%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           ++  ++ E+++L  + HP+II+L+D  ++++ I +V+E+ AG  L  YI    ++ EQ A
Sbjct: 57  MQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEA 115
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
           R+F QQ+ + +E  + H I+HRDLKPEN+L   LD+ + +KIADFGLS  +  GN+ +  
Sbjct: 116 RRFFQQIISAVEYCHRHKIVHRDLKPENLL---LDEHLNVKIADFGLSNIMTDGNFLKTS 172
Query: 129 CGSPLYMAPEVLQFQRY 145
           CGSP Y APEV+  + Y
Sbjct: 173 CGSPNYAAPEVISGKLY 189

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  115 bits (288), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 57/137 (41%), Positives = 92/137 (67%), Gaps = 4/137 (2%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           ++  ++ E+++L  + HP+II+L+D  ++++ I +V+E+ AG  L  YI    ++ EQ A
Sbjct: 56  MQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEA 114
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
           R+F QQ+ + +E  + H I+HRDLKPEN+L   LD+ + +KIADFGLS  +  GN+ +  
Sbjct: 115 RRFFQQIISAVEYCHRHKIVHRDLKPENLL---LDEHLNVKIADFGLSNIMTDGNFLKTS 171
Query: 129 CGSPLYMAPEVLQFQRY 145
           CGSP Y APEV+  + Y
Sbjct: 172 CGSPNYAAPEVISGKLY 188

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  115 bits (287), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 57/137 (41%), Positives = 92/137 (67%), Gaps = 4/137 (2%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           ++  ++ E+++L  + HP+II+L+D  ++++ I +V+E+ AG  L  YI    ++ EQ A
Sbjct: 47  MQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEA 105
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
           R+F QQ+ + +E  + H I+HRDLKPEN+L   LD+ + +KIADFGLS  +  GN+ +  
Sbjct: 106 RRFFQQIISAVEYCHRHKIVHRDLKPENLL---LDEHLNVKIADFGLSNIMTDGNFLKTS 162
Query: 129 CGSPLYMAPEVLQFQRY 145
           CGSP Y APEV+  + Y
Sbjct: 163 CGSPNYAAPEVISGKLY 179

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  114 bits (286), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 57/137 (41%), Positives = 92/137 (67%), Gaps = 4/137 (2%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           ++  ++ E+++L  + HP+II+L+D  ++++ I +V+E+ AG  L  YI    ++ EQ A
Sbjct: 51  MQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEA 109
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
           R+F QQ+ + +E  + H I+HRDLKPEN+L   LD+ + +KIADFGLS  +  GN+ +  
Sbjct: 110 RRFFQQIISAVEYCHRHKIVHRDLKPENLL---LDEHLNVKIADFGLSNIMTDGNFLKTS 166
Query: 129 CGSPLYMAPEVLQFQRY 145
           CGSP Y APEV+  + Y
Sbjct: 167 CGSPNYAAPEVISGKLY 183

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  114 bits (285), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 53/131 (40%), Positives = 83/131 (63%), Gaps = 3/131 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++LV+E+ +GG +  Y+  HG + E+ AR   +Q+
Sbjct: 56  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQI 115
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            + ++  +   I+HRDLK EN+L   LD D+ +KIADFG S     GN  +  CGSP Y 
Sbjct: 116 VSAVQYCHQKFIVHRDLKAENLL---LDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYA 172
Query: 136 APEVLQFQRYD 146
           APE+ Q ++YD
Sbjct: 173 APELFQGKKYD 183

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  114 bits (285), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 51/131 (38%), Positives = 83/131 (63%), Gaps = 3/131 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++L++E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 123
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            + ++  +   I+HRDLK EN+L   LD D+ +KIADFG S     G   +  CG+P Y 
Sbjct: 124 VSAVQYCHQKRIVHRDLKAENLL---LDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYA 180
Query: 136 APEVLQFQRYD 146
           APE+ Q ++YD
Sbjct: 181 APELFQGKKYD 191

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  112 bits (281), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 53/131 (40%), Positives = 80/131 (61%), Gaps = 3/131 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+     +NHPNI++LF+  + E  ++LV E+ +GG +  Y+  HGR  E+ AR   +Q+
Sbjct: 63  EVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQI 122
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            + ++  +   I+HRDLK EN+L   LD D  +KIADFG S     GN  +  CG+P Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLL---LDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYA 179
Query: 136 APEVLQFQRYD 146
           APE+ Q ++YD
Sbjct: 180 APELFQGKKYD 190

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  109 bits (272), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 60/150 (40%), Positives = 84/150 (56%), Gaps = 9/150 (6%)
Query: 2   LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K LN+     LD       E+  L    HP+II+L+         F+V+E+ +GG L  
Sbjct: 41  VKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFD 100
Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           YI  HGRV E  AR+  QQ+ + ++  + H ++HRDLKPEN+L   LD  +  KIADFGL
Sbjct: 101 YICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVL---LDAHMNAKIADFGL 157
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
           S  +  G +    CGSP Y APEV+  + Y
Sbjct: 158 SNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  109 bits (272), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 60/150 (40%), Positives = 84/150 (56%), Gaps = 9/150 (6%)
Query: 2   LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K LN+     LD       E+  L    HP+II+L+         F+V+E+ +GG L  
Sbjct: 41  VKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFD 100
Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           YI  HGRV E  AR+  QQ+ + ++  + H ++HRDLKPEN+L   LD  +  KIADFGL
Sbjct: 101 YICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVL---LDAHMNAKIADFGL 157
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
           S  +  G +    CGSP Y APEV+  + Y
Sbjct: 158 SNMMSDGEFLRDSCGSPNYAAPEVISGRLY 187

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  108 bits (269), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 59/150 (39%), Positives = 88/150 (58%), Gaps = 9/150 (6%)
Query: 2   LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K LN+     LD       E+  L    HP+II+L+      + IF+V+E+ +GG L  
Sbjct: 46  VKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFD 105
Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           YI  +GR+ E+ +R+  QQ+ +G++  + H ++HRDLKPEN+L   LD  +  KIADFGL
Sbjct: 106 YICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVL---LDAHMNAKIADFGL 162
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
           S  +  G +    CGSP Y APEV+  + Y
Sbjct: 163 SNMMSDGEFLRXSCGSPNYAAPEVISGRLY 192

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  104 bits (260), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 53/137 (38%), Positives = 84/137 (61%), Gaps = 1/137 (0%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNI++L++ F+ +   +LV+E   GG L   I L  +  E  A   ++Q+
Sbjct: 54  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQV 113
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            +G   L+ H+I+HRDLKPEN+LL     D ++KI DFGLS     G   ++  G+  Y+
Sbjct: 114 LSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYI 173
Query: 136 APEVLQFQRYDEKVNFF 152
           APEVL+ ++YDEK + +
Sbjct: 174 APEVLR-KKYDEKCDVW 189

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  104 bits (259), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 53/137 (38%), Positives = 84/137 (61%), Gaps = 1/137 (0%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNI++L++ F+ +   +LV+E   GG L   I L  +  E  A   ++Q+
Sbjct: 71  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQV 130
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            +G   L+ H+I+HRDLKPEN+LL     D ++KI DFGLS     G   ++  G+  Y+
Sbjct: 131 LSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYI 190
Query: 136 APEVLQFQRYDEKVNFF 152
           APEVL+ ++YDEK + +
Sbjct: 191 APEVLR-KKYDEKCDVW 206

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  102 bits (253), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 54/136 (39%), Positives = 81/136 (59%), Gaps = 4/136 (2%)
Query: 7   KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           + L+     E++ L  V+ HPNII+L D ++     FLV +    G L  Y+     + E
Sbjct: 51  QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 110
Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
           +  RK ++ L   +  L+  +I+HRDLKPENIL   LDDD+ +K+ DFG SC L PG   
Sbjct: 111 KETRKIMRALLEVICALHKLNIVHRDLKPENIL---LDDDMNIKLTDFGFSCQLDPGEKL 167
Query: 126 EKVCGSPLYMAPEVLQ 141
            +VCG+P Y+APE+++
Sbjct: 168 REVCGTPSYLAPEIIE 183

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  102 bits (253), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 54/136 (39%), Positives = 81/136 (59%), Gaps = 4/136 (2%)
Query: 7   KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           + L+     E++ L  V+ HPNII+L D ++     FLV +    G L  Y+     + E
Sbjct: 64  QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123
Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
           +  RK ++ L   +  L+  +I+HRDLKPENIL   LDDD+ +K+ DFG SC L PG   
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENIL---LDDDMNIKLTDFGFSCQLDPGEKL 180
Query: 126 EKVCGSPLYMAPEVLQ 141
            +VCG+P Y+APE+++
Sbjct: 181 REVCGTPSYLAPEIIE 196

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  101 bits (252), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 54/137 (39%), Positives = 83/137 (60%), Gaps = 1/137 (0%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L S++HPNII+LFD F+ +   +LV EF  GG L   I    +  E  A   ++Q+
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            +G+  L+ H+I+HRD+KPENILL   +  + +KI DFGLS             G+  Y+
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215
Query: 136 APEVLQFQRYDEKVNFF 152
           APEVL+ ++Y+EK + +
Sbjct: 216 APEVLK-KKYNEKCDVW 231

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  101 bits (252), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 54/136 (39%), Positives = 80/136 (58%), Gaps = 4/136 (2%)
Query: 7   KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           + L+     E++ L  V+ HPNII+L D ++     FLV +    G L  Y+     + E
Sbjct: 64  QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123
Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
           +  RK ++ L   +  L+  +I+HRDLKPENIL   LDDD+ +K+ DFG SC L PG   
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENIL---LDDDMNIKLTDFGFSCQLDPGEKL 180
Query: 126 EKVCGSPLYMAPEVLQ 141
             VCG+P Y+APE+++
Sbjct: 181 RSVCGTPSYLAPEIIE 196

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  101 bits (251), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 51/137 (37%), Positives = 79/137 (57%), Gaps = 1/137 (0%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNI++LF+  +  +  ++V E   GG L   I    R  E  A + ++Q+
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV 130
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            +G+  ++ H+I+HRDLKPENILL   + D  +KI DFGLS         +   G+  Y+
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 136 APEVLQFQRYDEKVNFF 152
           APEVL+   YDEK + +
Sbjct: 191 APEVLR-GTYDEKCDVW 206

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 51/137 (37%), Positives = 79/137 (57%), Gaps = 1/137 (0%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNI++LF+  +  +  ++V E   GG L   I    R  E  A + ++Q+
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV 130
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            +G+  ++ H+I+HRDLKPENILL   + D  +KI DFGLS         +   G+  Y+
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 136 APEVLQFQRYDEKVNFF 152
           APEVL+   YDEK + +
Sbjct: 191 APEVLR-GTYDEKCDVW 206

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  100 bits (250), Expect = 3e-22,   Method: Composition-based stats.
 Identities = 51/137 (37%), Positives = 79/137 (57%), Gaps = 1/137 (0%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNI++LF+  +  +  ++V E   GG L   I    R  E  A + ++Q+
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV 130
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            +G+  ++ H+I+HRDLKPENILL   + D  +KI DFGLS         +   G+  Y+
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 136 APEVLQFQRYDEKVNFF 152
           APEVL+   YDEK + +
Sbjct: 191 APEVLR-GTYDEKCDVW 206

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  100 bits (249), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 87/150 (58%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           + KK  +  +  ++ E+  L  + HPNI+ L D +++   ++L+++  +GG L   I   
Sbjct: 51  IAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK 110
Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
           G   E+ A + + Q+   ++ L+   I+HRDLKPEN+L   LD+D  + I+DFGLS    
Sbjct: 111 GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 170
Query: 121 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVN 150
           PG+     CG+P Y+APEVL  + Y + V+
Sbjct: 171 PGSVLSTACGTPGYVAPEVLAQKPYSKAVD 200

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  100 bits (249), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 49/136 (36%), Positives = 84/136 (61%), Gaps = 4/136 (2%)
Query: 7   KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           + ++     E + L  V  HP+II L D++++ + +FLV +    G L  Y+     + E
Sbjct: 140 EEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSE 199
Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
           +  R  ++ L   +  L++++I+HRDLKPENIL   LDD++ ++++DFG SC L PG   
Sbjct: 200 KETRSIMRSLLEAVSFLHANNIVHRDLKPENIL---LDDNMQIRLSDFGFSCHLEPGEKL 256
Query: 126 EKVCGSPLYMAPEVLQ 141
            ++CG+P Y+APE+L+
Sbjct: 257 RELCGTPGYLAPEILK 272

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  100 bits (249), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 50/141 (35%), Positives = 83/141 (58%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E+  L  + HPNI+ L D +++   ++L+++  +GG L   I   G   E+ A 
Sbjct: 60  EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS 119
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
           + + Q+   ++ L+   I+HRDLKPEN+L   LD+D  + I+DFGLS    PG+     C
Sbjct: 120 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC 179
Query: 130 GSPLYMAPEVLQFQRYDEKVN 150
           G+P Y+APEVL  + Y + V+
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVD 200

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  100 bits (248), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 50/141 (35%), Positives = 83/141 (58%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E+  L  + HPNI+ L D +++   ++L+++  +GG L   I   G   E+ A 
Sbjct: 60  EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS 119
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
           + + Q+   ++ L+   I+HRDLKPEN+L   LD+D  + I+DFGLS    PG+     C
Sbjct: 120 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC 179
Query: 130 GSPLYMAPEVLQFQRYDEKVN 150
           G+P Y+APEVL  + Y + V+
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVD 200

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  100 bits (248), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 52/137 (37%), Positives = 84/137 (61%), Gaps = 1/137 (0%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNI++L+D F+ +   +LV+E   GG L   I    +  E  A   ++Q+
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQV 145
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            +G+  L+ H+I+HRDLKPEN+LL   + D ++KI DFGLS         ++  G+  Y+
Sbjct: 146 LSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYI 205
Query: 136 APEVLQFQRYDEKVNFF 152
           APEVL+ ++YDEK + +
Sbjct: 206 APEVLR-KKYDEKCDVW 221

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 50/141 (35%), Positives = 83/141 (58%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E+  L  + HPNI+ L D +++   ++L+++  +GG L   I   G   E+ A 
Sbjct: 60  EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS 119
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
           + + Q+   ++ L+   I+HRDLKPEN+L   LD+D  + I+DFGLS    PG+     C
Sbjct: 120 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC 179
Query: 130 GSPLYMAPEVLQFQRYDEKVN 150
           G+P Y+APEVL  + Y + V+
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVD 200

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 50/128 (39%), Positives = 80/128 (62%), Gaps = 1/128 (0%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + + 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+   ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 133 LYMAPEVL 140
            Y+APEVL
Sbjct: 181 TYLAPEVL 188

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 50/128 (39%), Positives = 80/128 (62%), Gaps = 1/128 (0%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + + 
Sbjct: 201 VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 259
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+   ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P
Sbjct: 260 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 319
Query: 133 LYMAPEVL 140
            Y+APEVL
Sbjct: 320 TYLAPEVL 327

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 50/128 (39%), Positives = 80/128 (62%), Gaps = 1/128 (0%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + + 
Sbjct: 61  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 119
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+   ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P
Sbjct: 120 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 179
Query: 133 LYMAPEVL 140
            Y+APEVL
Sbjct: 180 TYLAPEVL 187

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 50/128 (39%), Positives = 80/128 (62%), Gaps = 1/128 (0%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + + 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+   ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 133 LYMAPEVL 140
            Y+APEVL
Sbjct: 181 TYLAPEVL 188

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 50/128 (39%), Positives = 80/128 (62%), Gaps = 1/128 (0%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + + 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+   ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 133 LYMAPEVL 140
            Y+APEVL
Sbjct: 181 TYLAPEVL 188

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 52/133 (39%), Positives = 81/133 (60%), Gaps = 5/133 (3%)
Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL 79
           LS V HP IIR++  FQ    IF+++++  GG L S +R   R P   A+ +  ++   L
Sbjct: 60  LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL 119
Query: 80  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 139
           E L+S  II+RDLKPENIL   LD +  +KI DFG +   Y  +    +CG+P Y+APEV
Sbjct: 120 EYLHSKDIIYRDLKPENIL---LDKNGHIKITDFGFAK--YVPDVTYXLCGTPDYIAPEV 174
Query: 140 LQFQRYDEKVNFF 152
           +  + Y++ ++++
Sbjct: 175 VSTKPYNKSIDWW 187

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 50/128 (39%), Positives = 80/128 (62%), Gaps = 1/128 (0%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + + 
Sbjct: 187 VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 245
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+   ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P
Sbjct: 246 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 305
Query: 133 LYMAPEVL 140
            Y+APEVL
Sbjct: 306 TYLAPEVL 313

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 50/128 (39%), Positives = 80/128 (62%), Gaps = 1/128 (0%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + + 
Sbjct: 68  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 126
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+   ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P
Sbjct: 127 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 186
Query: 133 LYMAPEVL 140
            Y+APEVL
Sbjct: 187 TYLAPEVL 194

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 50/140 (35%), Positives = 81/140 (57%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+R+++ F     I+L++EF   G L   ++ HGR  EQ +  F+
Sbjct: 61  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
           ++L   L   +   +IHRD+KPEN+L+    +   LKIADFG S    P      +CG+ 
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGE---LKIADFGWSVHA-PSLRRRXMCGTL 176
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 177 DYLPPEMIEGKTHDEKVDLW 196

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 50/140 (35%), Positives = 81/140 (57%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+R+++ F     I+L++EF   G L   ++ HGR  EQ +  F+
Sbjct: 62  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 121
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
           ++L   L   +   +IHRD+KPEN+L+    +   LKIADFG S    P      +CG+ 
Sbjct: 122 EELADALHYCHERKVIHRDIKPENLLMGYKGE---LKIADFGWSVHA-PSLRRRXMCGTL 177
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 178 DYLPPEMIEGKTHDEKVDLW 197

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 58/152 (38%), Positives = 85/152 (55%), Gaps = 1/152 (0%)
Query: 2   LKKLNKHL-KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           LK L K + K  +  E+  L  ++HPNII+L + F+    I LV+E   GG L   I   
Sbjct: 83  LKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEK 142
Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
           G   E+ A   ++Q+   +  L+ + I+HRDLKPEN+L +    D  LKIADFGLS  + 
Sbjct: 143 GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202
Query: 121 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
                + VCG+P Y APE+L+   Y  +V+ +
Sbjct: 203 HQVLMKTVCGTPGYCAPEILRGCAYGPEVDMW 234

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 84/148 (56%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KK  K  +S ++ E+  L  + H NI+ L D +++ N ++LV++  +GG L   I   G 
Sbjct: 57  KKALKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGF 116
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E+ A   ++Q+   +  L+   I+HRDLKPEN+L    D++  + I+DFGLS     G
Sbjct: 117 YTEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKG 176
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVN 150
           +     CG+P Y+APEVL  + Y + V+
Sbjct: 177 DVMSTACGTPGYVAPEVLAQKPYSKAVD 204

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 80/145 (55%), Gaps = 1/145 (0%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           K  L  E+  L  ++HPNI++L++ F+ +   +LV E   GG L   I    R  E  A 
Sbjct: 76  KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA 135
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
           + ++Q+ +G+  ++ + I+HRDLKPEN+LL     D  ++I DFGLS         +   
Sbjct: 136 RIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 195
Query: 130 GSPLYMAPEVLQFQRYDEKVNFFVS 154
           G+  Y+APEVL    YDEK + + +
Sbjct: 196 GTAYYIAPEVLH-GTYDEKCDVWST 219

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 51/143 (35%), Positives = 81/143 (56%), Gaps = 5/143 (3%)
Query: 3   KKLNKHLKSCLD---CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           KK+ K+    +D    E+  + S++HPNIIRL++ F+    I+LV+E C GG L   + +
Sbjct: 40  KKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV-V 98
Query: 60  HGRV-PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
           H RV  E  A + ++ + + +   +  ++ HRDLKPEN L      D  LK+ DFGL+  
Sbjct: 99  HKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158
Query: 119 LYPGNYAEKVCGSPLYMAPEVLQ 141
             PG       G+P Y++P+VL+
Sbjct: 159 FKPGKMMRTKVGTPYYVSPQVLE 181

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 51/143 (35%), Positives = 81/143 (56%), Gaps = 5/143 (3%)
Query: 3   KKLNKHLKSCLD---CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           KK+ K+    +D    E+  + S++HPNIIRL++ F+    I+LV+E C GG L   + +
Sbjct: 57  KKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV-V 115
Query: 60  HGRV-PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
           H RV  E  A + ++ + + +   +  ++ HRDLKPEN L      D  LK+ DFGL+  
Sbjct: 116 HKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 175
Query: 119 LYPGNYAEKVCGSPLYMAPEVLQ 141
             PG       G+P Y++P+VL+
Sbjct: 176 FKPGKMMRTKVGTPYYVSPQVLE 198

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 48/137 (35%), Positives = 83/137 (60%), Gaps = 5/137 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E+N L  + HPNII L D F+ +  + L++E  +GG L  ++     + E  A 
Sbjct: 52  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT 111
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +K+ DFG++  +  GN  +
Sbjct: 112 QFLKQILDGVHYLHSKRIAHFDLKPENIML--LDKNVPNPRIKLIDFGIAHKIEAGNEFK 169
Query: 127 KVCGSPLYMAPEVLQFQ 143
            + G+P ++APE++ ++
Sbjct: 170 NIFGTPEFVAPEIVNYE 186

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 48/137 (35%), Positives = 83/137 (60%), Gaps = 5/137 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E+N L  + HPNII L D F+ +  + L++E  +GG L  ++     + E  A 
Sbjct: 59  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT 118
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +K+ DFG++  +  GN  +
Sbjct: 119 QFLKQILDGVHYLHSKRIAHFDLKPENIML--LDKNVPNPRIKLIDFGIAHKIEAGNEFK 176
Query: 127 KVCGSPLYMAPEVLQFQ 143
            + G+P ++APE++ ++
Sbjct: 177 NIFGTPEFVAPEIVNYE 193

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 48/137 (35%), Positives = 83/137 (60%), Gaps = 5/137 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E+N L  + HPNII L D F+ +  + L++E  +GG L  ++     + E  A 
Sbjct: 73  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT 132
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +K+ DFG++  +  GN  +
Sbjct: 133 QFLKQILDGVHYLHSKRIAHFDLKPENIML--LDKNVPNPRIKLIDFGIAHKIEAGNEFK 190
Query: 127 KVCGSPLYMAPEVLQFQ 143
            + G+P ++APE++ ++
Sbjct: 191 NIFGTPEFVAPEIVNYE 207

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-20,   Method: Composition-based stats.
 Identities = 51/143 (35%), Positives = 79/143 (55%), Gaps = 1/143 (0%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           K  L  E+  L  ++HPNI++L++ F+ +   +LV E   GG L   I    R  E  A 
Sbjct: 93  KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA 152
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
           + ++Q+ +G+  ++ + I+HRDLKPEN+LL     D  ++I DFGLS         +   
Sbjct: 153 RIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 212
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
           G+  Y+APEVL    YDEK + +
Sbjct: 213 GTAYYIAPEVLH-GTYDEKCDVW 234

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-20,   Method: Composition-based stats.
 Identities = 51/143 (35%), Positives = 79/143 (55%), Gaps = 1/143 (0%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           K  L  E+  L  ++HPNI++L++ F+ +   +LV E   GG L   I    R  E  A 
Sbjct: 70  KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
           + ++Q+ +G+  ++ + I+HRDLKPEN+LL     D  ++I DFGLS         +   
Sbjct: 130 RIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 189
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
           G+  Y+APEVL    YDEK + +
Sbjct: 190 GTAYYIAPEVLH-GTYDEKCDVW 211

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-20,   Method: Composition-based stats.
 Identities = 51/143 (35%), Positives = 79/143 (55%), Gaps = 1/143 (0%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           K  L  E+  L  ++HPNI++L++ F+ +   +LV E   GG L   I    R  E  A 
Sbjct: 94  KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA 153
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
           + ++Q+ +G+  ++ + I+HRDLKPEN+LL     D  ++I DFGLS         +   
Sbjct: 154 RIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 213
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
           G+  Y+APEVL    YDEK + +
Sbjct: 214 GTAYYIAPEVLH-GTYDEKCDVW 235

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 83/149 (55%), Gaps = 8/149 (5%)
Query: 1   MLKKLNKHLKSC----LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56
           ++K +NK         ++ E+  L S++HPNII++F+ F+  + +++V+E C GG L   
Sbjct: 51  VIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLER 110
Query: 57  I---RLHGR-VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
           I   +  G+ + E    + ++Q+   L   +S H++H+DLKPENIL         +KI D
Sbjct: 111 IVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIID 170
Query: 113 FGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 141
           FGL+       ++    G+ LYMAPEV +
Sbjct: 171 FGLAELFKSDEHSTNAAGTALYMAPEVFK 199

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-20,   Method: Composition-based stats.
 Identities = 51/143 (35%), Positives = 77/143 (53%), Gaps = 1/143 (0%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           K  L  E+  L  ++HPNI +L++ F+ +   +LV E   GG L   I    R  E  A 
Sbjct: 70  KESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
           + ++Q+ +G+   + + I+HRDLKPEN+LL     D  ++I DFGLS         +   
Sbjct: 130 RIIRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKI 189
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
           G+  Y+APEVL    YDEK + +
Sbjct: 190 GTAYYIAPEVLH-GTYDEKCDVW 211

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 52/139 (37%), Positives = 83/139 (59%), Gaps = 4/139 (2%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E + L+ VNHP +++L  AFQ E  ++L+++F  GG+L + +       E+  + +L +
Sbjct: 79  MERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 138
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 133
           L  GL+ L+S  II+RDLKPENIL   LD++  +K+ DFGLS   +     A   CG+  
Sbjct: 139 LALGLDHLHSLGIIYRDLKPENIL---LDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVE 195
Query: 134 YMAPEVLQFQRYDEKVNFF 152
           YMAPEV+  Q +    +++
Sbjct: 196 YMAPEVVNRQGHSHSADWW 214

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 87/157 (55%), Gaps = 10/157 (6%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIR 58
           +KL K  +     E   L  + HPNI+R +D++++    + CI LV E    G L +Y++
Sbjct: 62  RKLTKSERQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLK 121
Query: 59  LHGRVPEQTARKFLQQLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLS 116
                  +  R + +Q+  GL+ L++    IIHRDLK +NI ++G    V  KI D GL+
Sbjct: 122 RFKVXKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSV--KIGDLGLA 179
Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFV 153
            TL   ++A+ V G+P + APE  + ++YDE V+ + 
Sbjct: 180 -TLKRASFAKAVIGTPEFXAPEXYE-EKYDESVDVYA 214

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 47/134 (35%), Positives = 83/134 (61%), Gaps = 5/134 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A +FL
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAEKVC 129
           +Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  + + 
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178
Query: 130 GSPLYMAPEVLQFQ 143
           G+P ++APE++ ++
Sbjct: 179 GTPAFVAPEIVNYE 192

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 84/137 (61%), Gaps = 5/137 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 KVCGSPLYMAPEVLQFQ 143
            + G+P ++APE++ ++
Sbjct: 176 NIFGTPEFVAPEIVNYE 192

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 84/137 (61%), Gaps = 5/137 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 KVCGSPLYMAPEVLQFQ 143
            + G+P ++APE++ ++
Sbjct: 176 NIFGTPEFVAPEIVNYE 192

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 84/137 (61%), Gaps = 5/137 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 KVCGSPLYMAPEVLQFQ 143
            + G+P ++APE++ ++
Sbjct: 176 NIFGTPEFVAPEIVNYE 192

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 47/134 (35%), Positives = 83/134 (61%), Gaps = 5/134 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A +FL
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAEKVC 129
           +Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  + + 
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178
Query: 130 GSPLYMAPEVLQFQ 143
           G+P ++APE++ ++
Sbjct: 179 GTPEFVAPEIVNYE 192

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 84/137 (61%), Gaps = 5/137 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 KVCGSPLYMAPEVLQFQ 143
            + G+P ++APE++ ++
Sbjct: 176 NIFGTPEFVAPEIVNYE 192

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 84/137 (61%), Gaps = 5/137 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 KVCGSPLYMAPEVLQFQ 143
            + G+P ++APE++ ++
Sbjct: 176 NIFGTPEFVAPEIVNYE 192

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 46/136 (33%), Positives = 81/136 (59%), Gaps = 4/136 (2%)
Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
           F  + NHP ++ L   FQ E+ +F V+E+  GG+L  +++   ++PE+ AR +  ++   
Sbjct: 106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 165
Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPLYMAP 137
           L  L+   II+RDLK +N+L   LD +  +K+ D+G+    L PG+     CG+P Y+AP
Sbjct: 166 LNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 222
Query: 138 EVLQFQRYDEKVNFFV 153
           E+L+ + Y   V+++ 
Sbjct: 223 EILRGEDYGFSVDWWA 238

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 84/137 (61%), Gaps = 5/137 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 KVCGSPLYMAPEVLQFQ 143
            + G+P ++APE++ ++
Sbjct: 176 NIFGTPEFVAPEIVNYE 192

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 84/137 (61%), Gaps = 5/137 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 KVCGSPLYMAPEVLQFQ 143
            + G+P ++APE++ ++
Sbjct: 176 NIFGTPEFVAPEIVNYE 192

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 84/137 (61%), Gaps = 5/137 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 57  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 116
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 117 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 174
Query: 127 KVCGSPLYMAPEVLQFQ 143
            + G+P ++APE++ ++
Sbjct: 175 NIFGTPEFVAPEIVNYE 191

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 84/137 (61%), Gaps = 5/137 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 57  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 116
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 117 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 174
Query: 127 KVCGSPLYMAPEVLQFQ 143
            + G+P ++APE++ ++
Sbjct: 175 NIFGTPEFVAPEIVNYE 191

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 84/137 (61%), Gaps = 5/137 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 KVCGSPLYMAPEVLQFQ 143
            + G+P ++APE++ ++
Sbjct: 176 NIFGTPEFVAPEIVNYE 192

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 84/137 (61%), Gaps = 5/137 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 KVCGSPLYMAPEVLQFQ 143
            + G+P ++APE++ ++
Sbjct: 176 NIFGTPEFVAPEIVNYE 192

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 46/136 (33%), Positives = 81/136 (59%), Gaps = 4/136 (2%)
Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
           F  + NHP ++ L   FQ E+ +F V+E+  GG+L  +++   ++PE+ AR +  ++   
Sbjct: 74  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 133
Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPLYMAP 137
           L  L+   II+RDLK +N+L   LD +  +K+ D+G+    L PG+     CG+P Y+AP
Sbjct: 134 LNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAP 190
Query: 138 EVLQFQRYDEKVNFFV 153
           E+L+ + Y   V+++ 
Sbjct: 191 EILRGEDYGFSVDWWA 206

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 46/136 (33%), Positives = 81/136 (59%), Gaps = 4/136 (2%)
Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
           F  + NHP ++ L   FQ E+ +F V+E+  GG+L  +++   ++PE+ AR +  ++   
Sbjct: 59  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 118
Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPLYMAP 137
           L  L+   II+RDLK +N+L   LD +  +K+ D+G+    L PG+     CG+P Y+AP
Sbjct: 119 LNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAP 175
Query: 138 EVLQFQRYDEKVNFFV 153
           E+L+ + Y   V+++ 
Sbjct: 176 EILRGEDYGFSVDWWA 191

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 46/136 (33%), Positives = 81/136 (59%), Gaps = 4/136 (2%)
Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
           F  + NHP ++ L   FQ E+ +F V+E+  GG+L  +++   ++PE+ AR +  ++   
Sbjct: 63  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 122
Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPLYMAP 137
           L  L+   II+RDLK +N+L   LD +  +K+ D+G+    L PG+     CG+P Y+AP
Sbjct: 123 LNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAP 179
Query: 138 EVLQFQRYDEKVNFFV 153
           E+L+ + Y   V+++ 
Sbjct: 180 EILRGEDYGFSVDWWA 195

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 82/149 (55%), Gaps = 1/149 (0%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           +KK      S L+ E+  L  + H NI+ L D +++    +LV++  +GG L   I   G
Sbjct: 42  IKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG 101
Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
              E+ A   +QQ+ + ++ L+ + I+HRDLKPEN+L    +++  + I DFGLS  +  
Sbjct: 102 VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLS-KMEQ 160
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVN 150
                  CG+P Y+APEVL  + Y + V+
Sbjct: 161 NGIMSTACGTPGYVAPEVLAQKPYSKAVD 189

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 79/140 (56%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   R  EQ    ++
Sbjct: 59  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYI 118
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +  + +CG+ 
Sbjct: 119 TELANALSYCHSKRVIHRDIKPENLLLGSNGE---LKIADFGWSVHA-PSSRRDTLCGTL 174
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 175 DYLPPEMIEGRMHDEKVDLW 194

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 84/138 (60%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q+
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 171
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 172 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGATWT--LCGTPEYL 226
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 227 APEIILSKGYNKAVDWWA 244

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 51/139 (36%), Positives = 83/139 (59%), Gaps = 4/139 (2%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E + L  VNHP I++L  AFQ E  ++L+++F  GG+L + +       E+  + +L +
Sbjct: 76  MERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 135
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 133
           L   L+ L+S  II+RDLKPENIL   LD++  +K+ DFGLS  ++     A   CG+  
Sbjct: 136 LALALDHLHSLGIIYRDLKPENIL---LDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 192
Query: 134 YMAPEVLQFQRYDEKVNFF 152
           YMAPEV+  + + +  +++
Sbjct: 193 YMAPEVVNRRGHTQSADWW 211

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 51/139 (36%), Positives = 83/139 (59%), Gaps = 4/139 (2%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E + L  VNHP I++L  AFQ E  ++L+++F  GG+L + +       E+  + +L +
Sbjct: 75  MERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 134
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 133
           L   L+ L+S  II+RDLKPENIL   LD++  +K+ DFGLS  ++     A   CG+  
Sbjct: 135 LALALDHLHSLGIIYRDLKPENIL---LDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 191
Query: 134 YMAPEVLQFQRYDEKVNFF 152
           YMAPEV+  + + +  +++
Sbjct: 192 YMAPEVVNRRGHTQSADWW 210

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 85/138 (61%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+  GG++ S++R  GR  E  AR +  Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQI 150
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN+L   +D    +K+ADFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIKVADFGFAKRVKGRTWX--LCGTPEYL 205
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYI 119
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 175
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 176 DYLPPEMIEGRMHDEKVDLW 195

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 85/138 (61%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+  GG++ S++R  GR  E  AR +  Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQI 150
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN+L   +D    +K+ADFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIKVADFGFAKRVKGRTWX--LCGTPEYL 205
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 79/140 (56%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 56  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 115
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +  + +CG+ 
Sbjct: 116 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRDTLCGTL 171
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 172 DYLPPEMIEGRMHDEKVDLW 191

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 89/147 (60%), Gaps = 6/147 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +K+ADFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIKVADFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVNFFV 153
            +CG+P Y+APE++  + Y++ V+++ 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 51/139 (36%), Positives = 83/139 (59%), Gaps = 4/139 (2%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E + L  VNHP I++L  AFQ E  ++L+++F  GG+L + +       E+  + +L +
Sbjct: 75  MERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 134
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 133
           L   L+ L+S  II+RDLKPENIL   LD++  +K+ DFGLS  ++     A   CG+  
Sbjct: 135 LALALDHLHSLGIIYRDLKPENIL---LDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 191
Query: 134 YMAPEVLQFQRYDEKVNFF 152
           YMAPEV+  + + +  +++
Sbjct: 192 YMAPEVVNRRGHTQSADWW 210

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 83/137 (60%), Gaps = 5/137 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L+ E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 KVCGSPLYMAPEVLQFQ 143
            + G+P ++APE++ ++
Sbjct: 176 NIFGTPEFVAPEIVNYE 192

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 51/146 (34%), Positives = 80/146 (54%), Gaps = 12/146 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRY 145
           N      K+CG+  Y+APE+L+ + +
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREF 183

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 85/138 (61%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q+
Sbjct: 78  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 137
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN+L   +D+   +++ DFG +  +    +   +CG+P Y+
Sbjct: 138 VLTFEYLHSLDLIYRDLKPENLL---IDEQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 192
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 193 APEIILSKGYNKAVDWWA 210

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 51/146 (34%), Positives = 80/146 (54%), Gaps = 12/146 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRY 145
           N      K+CG+  Y+APE+L+ + +
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREF 183

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 78/140 (55%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   R  EQ    ++
Sbjct: 59  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYI 118
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 119 TELANALSYCHSKRVIHRDIKPENLLLGSNGE---LKIADFGWSVHA-PSSRRTTLCGTL 174
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 175 DYLPPEMIEGRMHDEKVDLW 194

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 51/146 (34%), Positives = 80/146 (54%), Gaps = 12/146 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRY 145
           N      K+CG+  Y+APE+L+ + +
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREF 183

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 51/146 (34%), Positives = 80/146 (54%), Gaps = 12/146 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRY 145
           N      K+CG+  Y+APE+L+ + +
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREF 183

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 51/146 (34%), Positives = 80/146 (54%), Gaps = 12/146 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRY 145
           N      K+CG+  Y+APE+L+ + +
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREF 184

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 79/140 (56%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +  + +CG+ 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRDDLCGTL 173
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 174 DYLPPEMIEGRMHDEKVDLW 193

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 51/146 (34%), Positives = 80/146 (54%), Gaps = 12/146 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRY 145
           N      K+CG+  Y+APE+L+ + +
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREF 184

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 51/146 (34%), Positives = 80/146 (54%), Gaps = 12/146 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRY 145
           N      K+CG+  Y+APE+L+ + +
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREF 183

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 51/146 (34%), Positives = 80/146 (54%), Gaps = 12/146 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 40  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 99
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 100 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 156
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRY 145
           N      K+CG+  Y+APE+L+ + +
Sbjct: 157 NRERLLNKMCGTLPYVAPELLKRREF 182

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 51/146 (34%), Positives = 80/146 (54%), Gaps = 12/146 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRY 145
           N      K+CG+  Y+APE+L+ + +
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREF 184

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 51/146 (34%), Positives = 80/146 (54%), Gaps = 12/146 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRY 145
           N      K+CG+  Y+APE+L+ + +
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREF 183

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 51/146 (34%), Positives = 80/146 (54%), Gaps = 12/146 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRY 145
           N      K+CG+  Y+APE+L+ + +
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREF 184

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 51/146 (34%), Positives = 80/146 (54%), Gaps = 12/146 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRY 145
           N      K+CG+  Y+APE+L+ + +
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREF 183

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 52/128 (40%), Positives = 70/128 (54%), Gaps = 1/128 (0%)
Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81
           S+ HPNI+R  +       + +++E+ +GG L   I   GR  E  AR F QQL +G+  
Sbjct: 72  SLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSY 131
Query: 82  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 141
            +S  I HRDLK EN LL G      LKI DFG S +    +  +   G+P Y+APEVL 
Sbjct: 132 CHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 190
Query: 142 FQRYDEKV 149
            Q YD K+
Sbjct: 191 RQEYDGKI 198

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 51/146 (34%), Positives = 80/146 (54%), Gaps = 12/146 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRY 145
           N      K+CG+  Y+APE+L+ + +
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREF 183

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 51/146 (34%), Positives = 80/146 (54%), Gaps = 12/146 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRY 145
           N      K+CG+  Y+APE+L+ + +
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREF 184

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 79/140 (56%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 81  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 140
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +  + +CG+ 
Sbjct: 141 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRDDLCGTL 196
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 197 DYLPPEMIEGRMHDEKVDLW 216

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 51/146 (34%), Positives = 80/146 (54%), Gaps = 12/146 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRY 145
           N      K+CG+  Y+APE+L+ + +
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREF 184

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 51/146 (34%), Positives = 80/146 (54%), Gaps = 12/146 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRY 145
           N      K+CG+  Y+APE+L+ + +
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREF 184

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 79/140 (56%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +   ++CG+ 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTELCGTL 170
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 171 DYLPPEMIEGRMHDEKVDLW 190

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 173
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 174 DYLPPEMIEGRMHDEKVDLW 193

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 52/128 (40%), Positives = 70/128 (54%), Gaps = 1/128 (0%)
Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81
           S+ HPNI+R  +       + +V+E+ +GG L   I   GR  E  AR F QQL +G+  
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 130
Query: 82  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 141
            ++  + HRDLK EN LL G      LKIADFG S      +  +   G+P Y+APEVL 
Sbjct: 131 AHAMQVAHRDLKLENTLLDG-SPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLL 189
Query: 142 FQRYDEKV 149
            + YD KV
Sbjct: 190 KKEYDGKV 197

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 56  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 115
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG SC   P +    + G+ 
Sbjct: 116 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSCHA-PSSRRTTLSGTL 171
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 172 DYLPPEMIEGRMHDEKVDLW 191

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 173
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 174 DYLPPEMIEGRMHDEKVDLW 193

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 84/138 (60%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN++   +D    +K+ DFGL+  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLM---IDQQGYIKVTDFGLAKRVKGRTWX--LCGTPEYL 205
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 59  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 118
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 119 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 174
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 175 DYLPPEMIEGRMHDEKVDLW 194

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 54  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 113
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 114 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 169
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 170 DYLPPEMIEGRMHDEKVDLW 189

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 52  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 111
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 112 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 167
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 168 DYLPPEMIEGRMHDEKVDLW 187

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 119
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 175
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 176 DYLPPEMIEGRMHDEKVDLW 195

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 119
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTDLCGTL 175
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 176 DYLPPEMIEGRMHDEKVDLW 195

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTXLCGTL 170
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 171 DYLPPEMIEGRMHDEKVDLW 190

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRXXLCGTL 173
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 174 DYLPPEMIEGRMHDEKVDLW 193

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 89/147 (60%), Gaps = 6/147 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVNFFV 153
            +CG+P Y+APE++  + Y++ V+++ 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 84/138 (60%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 84/138 (60%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 170
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 171 DYLPPEMIEGRMHDEKVDLW 190

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 115 TELANALSYCHSKKVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRAALCGTL 170
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 171 DYLPPEMIEGRMHDEKVDLW 190

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 84/138 (60%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 84/138 (60%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q+
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 206
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 207 APEIILSKGYNKAVDWWA 224

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTDLCGTL 170
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 171 DYLPPEMIEGRMHDEKVDLW 190

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 72  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 131
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 132 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 187
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 188 DYLPPEMIEGRMHDEKVDLW 207

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRAALCGTL 170
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 171 DYLPPEMIEGRMHDEKVDLW 190

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTDLCGTL 170
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 171 DYLPPEMIEGRMHDEKVDLW 190

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 57  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 116
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 117 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRXXLCGTL 172
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 173 DYLPPEMIEGRMHDEKVDLW 192

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 84/138 (60%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 56  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 115
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 116 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTDLCGTL 171
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 172 DYLPPEMIEGRMHDEKVDLW 191

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 84/138 (60%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRAALCGTL 173
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 174 DYLPPEMIEGRMHDEKVDLW 193

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 84/138 (60%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQI 150
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 84/138 (60%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRXXLCGTL 170
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 171 DYLPPEMIEGRMHDEKVDLW 190

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 84/138 (60%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q+
Sbjct: 86  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 145
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 146 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 200
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 201 APEIILSKGYNKAVDWWA 218

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 81  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 140
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 141 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 196
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 197 DYLPPEMIEGRMHDEKVDLW 216

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 53/145 (36%), Positives = 84/145 (57%), Gaps = 10/145 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQ 73
            E++ L+S +HPNI++L DAF  EN +++++EFCAGG + +  + L   + E   +   +
Sbjct: 83  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 142
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSP 132
           Q    L  L+ + IIHRDLK  NIL + LD D+  K+ADFG+S          +   G+P
Sbjct: 143 QTLDALNYLHDNKIIHRDLKAGNILFT-LDGDI--KLADFGVSAKNTRTIQRRDSFIGTP 199
Query: 133 LYMAPEVL-----QFQRYDEKVNFF 152
            +MAPEV+     + + YD K + +
Sbjct: 200 YWMAPEVVMCETSKDRPYDYKADVW 224

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 77/140 (55%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 119
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 175
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE ++ + +DEKV+ +
Sbjct: 176 DYLPPEXIEGRXHDEKVDLW 195

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 84/138 (60%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 150
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 84/138 (60%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 150
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 89/147 (60%), Gaps = 6/147 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 104 KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP 162
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 163 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 218
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVNFFV 153
            +CG+P Y+APE++  + Y++ V+++ 
Sbjct: 219 -LCGTPEYLAPEIILSKGYNKAVDWWA 244

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 84/138 (60%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 150
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 53/145 (36%), Positives = 84/145 (57%), Gaps = 10/145 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQ 73
            E++ L+S +HPNI++L DAF  EN +++++EFCAGG + +  + L   + E   +   +
Sbjct: 83  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 142
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSP 132
           Q    L  L+ + IIHRDLK  NIL + LD D+  K+ADFG+S          +   G+P
Sbjct: 143 QTLDALNYLHDNKIIHRDLKAGNILFT-LDGDI--KLADFGVSAKNTRXIQRRDSFIGTP 199
Query: 133 LYMAPEVL-----QFQRYDEKVNFF 152
            +MAPEV+     + + YD K + +
Sbjct: 200 YWMAPEVVMCETSKDRPYDYKADVW 224

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 78/151 (51%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+ Q E+  +LV +   GG L   I     
Sbjct: 42  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 101
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E  A   +QQ+   +   +S+ I+HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 102 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFV 153
                  G+P Y++PEVL+   Y + V+ + 
Sbjct: 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWA 192

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 78/151 (51%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+ Q E+  +LV +   GG L   I     
Sbjct: 41  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 100
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E  A   +QQ+   +   +S+ I+HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 101 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 160
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFV 153
                  G+P Y++PEVL+   Y + V+ + 
Sbjct: 161 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWA 191

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 78/151 (51%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+ Q E+  +LV +   GG L   I     
Sbjct: 65  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 124
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E  A   +QQ+   +   +S+ I+HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 125 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFV 153
                  G+P Y++PEVL+   Y + V+ + 
Sbjct: 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWA 215

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 78/151 (51%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+ Q E+  +LV +   GG L   I     
Sbjct: 42  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 101
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E  A   +QQ+   +   +S+ I+HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 102 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFV 153
                  G+P Y++PEVL+   Y + V+ + 
Sbjct: 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWA 192

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 89/147 (60%), Gaps = 6/147 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN++   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLI---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVNFFV 153
            +CG+P Y+APE++  + Y++ V+++ 
Sbjct: 198 -LCGTPEYLAPEIIISKGYNKAVDWWA 223

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 53/145 (36%), Positives = 84/145 (57%), Gaps = 10/145 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQ 73
            E++ L+S +HPNI++L DAF  EN +++++EFCAGG + +  + L   + E   +   +
Sbjct: 83  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 142
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSP 132
           Q    L  L+ + IIHRDLK  NIL + LD D+  K+ADFG+S          +   G+P
Sbjct: 143 QTLDALNYLHDNKIIHRDLKAGNILFT-LDGDI--KLADFGVSAKNTRXIQRRDXFIGTP 199
Query: 133 LYMAPEVL-----QFQRYDEKVNFF 152
            +MAPEV+     + + YD K + +
Sbjct: 200 YWMAPEVVMCETSKDRPYDYKADVW 224

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 83/138 (60%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q+
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN++   +D    +K+ DFG +  +    +   +CG+P Y+
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLM---IDQQGYIKVTDFGFAKRVKGRTWX--LCGTPEYL 206
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 207 APEIILSKGYNKAVDWWA 224

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 88/147 (59%), Gaps = 6/147 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN++   +D    +K+ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLM---IDQQGYIKVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVNFFV 153
            +CG+P Y+APE++  + Y++ V+++ 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 83/138 (60%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E     +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q+
Sbjct: 92  EKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN+L   +D    +K+ADFG +  +    +   +CG+P Y+
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIKVADFGFAKRVKGRTWX--LCGTPEYL 206
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 207 APEIILSKGYNKAVDWWA 224

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 84/138 (60%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN++   +D    +++ DFGL+  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLM---IDQQGYIQVTDFGLAKRVKGRTWX--LCGTPEYL 205
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 88/147 (59%), Gaps = 6/147 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN++   +D    +K+ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLM---IDQQGYIKVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVNFFV 153
            +CG+P Y+APE++  + Y++ V+++ 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 88/157 (56%), Gaps = 7/157 (4%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 46  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 104
Query: 58  RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 105 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 164
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           +      N   + C +P Y+APEVL  ++YD+  + +
Sbjct: 165 AKETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMW 201

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 83/138 (60%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q+
Sbjct: 77  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 136
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 137 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWT--LCGTPEYL 191
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 192 APEIILSKGYNKAVDWWA 209

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 88/147 (59%), Gaps = 6/147 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 84  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 142
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWT- 198
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVNFFV 153
            +CG+P Y+APE++  + Y++ V+++ 
Sbjct: 199 -LCGTPEYLAPEIILSKGYNKAVDWWA 224

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 86/155 (55%), Gaps = 15/155 (9%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
           K  L  E+N L  + HPNI+R +D    +    +++V+E+C GG+L+S I    +    +
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 64  PEQTARKFLQQLGAGLEILN-----SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
            E+   + + QL   L+  +      H ++HRDLKP N+ L G  +   +K+ DFGL+  
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARI 165
Query: 119 L-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           L +  ++A++  G+P YM+PE +    Y+EK + +
Sbjct: 166 LNHDEDFAKEFVGTPYYMSPEQMNRMSYNEKSDIW 200

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 78/140 (55%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIA+FG S    P +    +CG+ 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIANFGWSVHA-PSSRRTTLCGTL 173
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 174 DYLPPEMIEGRMHDEKVDLW 193

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 78/140 (55%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 57  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 116
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIA+FG S    P +    +CG+ 
Sbjct: 117 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIANFGWSVHA-PSSRRTTLCGTL 172
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 173 DYLPPEMIEGRMHDEKVDLW 192

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 83/138 (60%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q+
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 83/138 (60%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q+
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 83/138 (60%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q+
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 85/155 (54%), Gaps = 15/155 (9%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
           K  L  E+N L  + HPNI+R +D    +    +++V+E+C GG+L+S I    +    +
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 64  PEQTARKFLQQLGAGLEILN-----SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
            E+   + + QL   L+  +      H ++HRDLKP N+ L G  +   +K+ DFGL+  
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARI 165
Query: 119 L-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           L +  ++A+   G+P YM+PE +    Y+EK + +
Sbjct: 166 LNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIW 200

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 88/147 (59%), Gaps = 6/147 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 104 KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 162
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 163 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 218
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVNFFV 153
            +CG+P Y+APE++  + Y++ V+++ 
Sbjct: 219 -LCGTPEYLAPEIILSKGYNKAVDWWA 244

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 88/147 (59%), Gaps = 6/147 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 84  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 142
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 198
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVNFFV 153
            +CG+P Y+APE++  + Y++ V+++ 
Sbjct: 199 -LCGTPEYLAPEIILSKGYNKAVDWWA 224

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 88/147 (59%), Gaps = 6/147 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVNFFV 153
            +CG+P Y+APE++  + Y++ V+++ 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 87/157 (55%), Gaps = 7/157 (4%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 46  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 104
Query: 58  RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 105 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 164
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           +      N     C +P Y+APEVL  ++YD+  + +
Sbjct: 165 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 201

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 83/138 (60%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q+
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 206
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 207 APEIILSKGYNKAVDWWA 224

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 87/157 (55%), Gaps = 7/157 (4%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 48  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 106
Query: 58  RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 107 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           +      N     C +P Y+APEVL  ++YD+  + +
Sbjct: 167 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 203

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 85/155 (54%), Gaps = 15/155 (9%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
           K  L  E+N L  + HPNI+R +D    +    +++V+E+C GG+L+S I    +    +
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 64  PEQTARKFLQQLGAGLEILN-----SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
            E+   + + QL   L+  +      H ++HRDLKP N+ L G  +   +K+ DFGL+  
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARI 165
Query: 119 L-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           L +  ++A+   G+P YM+PE +    Y+EK + +
Sbjct: 166 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIW 200

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 88/147 (59%), Gaps = 6/147 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 84  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 142
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 198
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVNFFV 153
            +CG+P Y+APE++  + Y++ V+++ 
Sbjct: 199 -LCGTPEYLAPEIILSKGYNKAVDWWA 224

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 88/147 (59%), Gaps = 6/147 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVNFFV 153
            +CG+P Y+APE++  + Y++ V+++ 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 87/157 (55%), Gaps = 7/157 (4%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 48  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 106
Query: 58  RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 107 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           +      N     C +P Y+APEVL  ++YD+  + +
Sbjct: 167 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 203

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 83/138 (60%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q+
Sbjct: 84  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 143
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 144 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 198
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 199 APEIILSKGYNKAVDWWA 216

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 83/138 (60%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q+
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 206
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 207 APEIILSKGYNKAVDWWA 224

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 83/138 (60%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 87/157 (55%), Gaps = 7/157 (4%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 47  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 105
Query: 58  RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 106 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 165
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           +      N     C +P Y+APEVL  ++YD+  + +
Sbjct: 166 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 202

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 87/157 (55%), Gaps = 7/157 (4%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 98  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 156
Query: 58  RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 157 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 216
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           +      N     C +P Y+APEVL  ++YD+  + +
Sbjct: 217 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 253

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 87/157 (55%), Gaps = 7/157 (4%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 92  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 150
Query: 58  RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 151 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           +      N     C +P Y+APEVL  ++YD+  + +
Sbjct: 211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 247

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 87/157 (55%), Gaps = 7/157 (4%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 52  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 110
Query: 58  RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 111 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 170
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           +      N     C +P Y+APEVL  ++YD+  + +
Sbjct: 171 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 207

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 51/128 (39%), Positives = 70/128 (54%), Gaps = 1/128 (0%)
Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81
           S+ HPNI+R  +       + +V+E+ +GG L   I   GR  E  AR F QQL +G+  
Sbjct: 70  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 129
Query: 82  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 141
            ++  + HRDLK EN LL G      LKI DFG S +    +  +   G+P Y+APEVL 
Sbjct: 130 CHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 188
Query: 142 FQRYDEKV 149
            + YD KV
Sbjct: 189 KKEYDGKV 196

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 87/157 (55%), Gaps = 7/157 (4%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 62  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 120
Query: 58  RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 121 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 180
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           +      N     C +P Y+APEVL  ++YD+  + +
Sbjct: 181 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 217

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 82/138 (59%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P + +L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q+
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN++   +D    +K+ DFG +  +    +   +CG+P Y+
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLM---IDQQGYIKVTDFGFAKRVKGRTWX--LCGTPEYL 206
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 207 APEIILSKGYNKAVDWWA 224

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 87/157 (55%), Gaps = 7/157 (4%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 53  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 111
Query: 58  RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 112 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 171
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           +      N     C +P Y+APEVL  ++YD+  + +
Sbjct: 172 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 208

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 87/157 (55%), Gaps = 7/157 (4%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 54  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 112
Query: 58  RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 113 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 172
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           +      N     C +P Y+APEVL  ++YD+  + +
Sbjct: 173 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 209

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 51/128 (39%), Positives = 70/128 (54%), Gaps = 1/128 (0%)
Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81
           S+ HPNI+R  +       + +V+E+ +GG L   I   GR  E  AR F QQL +G+  
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 130
Query: 82  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 141
            ++  + HRDLK EN LL G      LKI DFG S +    +  +   G+P Y+APEVL 
Sbjct: 131 CHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 189
Query: 142 FQRYDEKV 149
            + YD KV
Sbjct: 190 KKEYDGKV 197

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 82/138 (59%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P + +L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q+
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN++   +D    +K+ DFG +  +    +   +CG+P Y+
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLM---IDQQGYIKVTDFGFAKRVKGRTWX--LCGTPEYL 206
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 207 APEIILSKGYNKAVDWWA 224

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 88/147 (59%), Gaps = 6/147 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVNFFV 153
            +CG+P Y+APE++  + Y++ V+++ 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 88/147 (59%), Gaps = 6/147 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVNFFV 153
            +CG+P Y+APE++  + Y++ V+++ 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 88/147 (59%), Gaps = 6/147 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 84  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP 142
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 198
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVNFFV 153
            +CG+P Y+APE++  + Y++ V+++ 
Sbjct: 199 -LCGTPEYLAPEIILSKGYNKAVDWWA 224

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 83/138 (60%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 136 APEVLQFQRYDEKVNFFV 153
           AP ++  + Y++ V+++ 
Sbjct: 206 APAIILSKGYNKAVDWWA 223

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 88/147 (59%), Gaps = 6/147 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN++   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLM---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVNFFV 153
            +CG+P Y+APE++  + Y++ V+++ 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 83/138 (60%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q+
Sbjct: 84  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQI 143
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 144 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 198
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 199 APEIILSKGYNKAVDWWA 216

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 47/128 (36%), Positives = 77/128 (60%), Gaps = 9/128 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV---PEQTARKFL 72
           E+     + HP+I+ L++ F+  N ++LV+E C  G ++ Y++   RV    E  AR F+
Sbjct: 61  EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEARHFM 118
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            Q+  G+  L+SH I+HRDL   N+LL+    ++ +KIADFGL+  L  P      +CG+
Sbjct: 119 HQIITGMLYLHSHGILHRDLTLSNLLLT---RNMNIKIADFGLATQLKMPHEKHYTLCGT 175
Query: 132 PLYMAPEV 139
           P Y++PE+
Sbjct: 176 PNYISPEI 183

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 82/138 (59%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P + +L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q+
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQI 151
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN++   +D    +K+ DFG +  +    +   +CG+P Y+
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLM---IDQQGYIKVTDFGFAKRVKGRTWX--LCGTPEYL 206
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 207 APEIILSKGYNKAVDWWA 224

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 80/134 (59%), Gaps = 5/134 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E++ L  V HPNII L D ++    + L++E  +GG L  ++     + E+ A  F+
Sbjct: 62  IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAEKVC 129
           +Q+  G+  L++  I H DLKPENI+L  LD ++    +K+ DFGL+  +  G   + + 
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 130 GSPLYMAPEVLQFQ 143
           G+P ++APE++ ++
Sbjct: 180 GTPEFVAPEIVNYE 193

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 77/140 (55%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYI 119
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    + G+ 
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRXXLXGTL 175
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + +DEKV+ +
Sbjct: 176 DYLPPEMIEGRMHDEKVDLW 195

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 79/146 (54%), Gaps = 12/146 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRY 145
           N      K+ G+  Y+APE+L+ + +
Sbjct: 158 NRERLLNKMXGTLPYVAPELLKRREF 183

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 79/146 (54%), Gaps = 12/146 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRY 145
           N      K+ G+  Y+APE+L+ + +
Sbjct: 158 NRERLLNKMXGTLPYVAPELLKRREF 183

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 79/146 (54%), Gaps = 12/146 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRY 145
           N      K+ G+  Y+APE+L+ + +
Sbjct: 159 NRERLLNKMXGTLPYVAPELLKRREF 184

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 88/147 (59%), Gaps = 6/147 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVNFFV 153
            + G+P Y+APE++  + Y++ V+++ 
Sbjct: 198 -LAGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 79/146 (54%), Gaps = 12/146 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRY 145
           N      K+ G+  Y+APE+L+ + +
Sbjct: 158 NRERLLNKMXGTLPYVAPELLKRREF 183

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 78/133 (58%), Gaps = 7/133 (5%)
Query: 26  PNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL 79
           P+I+ + D ++     + C+ +++E   GG L S I+  G     E+ A + ++ +G  +
Sbjct: 63  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 122
Query: 80  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 139
           + L+SH+I HRD+KPEN+L +  + D +LK+ DFG +      N  +  C +P Y+APEV
Sbjct: 123 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-QNALQTPCYTPYYVAPEV 181
Query: 140 LQFQRYDEKVNFF 152
           L  ++YD+  + +
Sbjct: 182 LGPEKYDKSCDMW 194

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 79/146 (54%), Gaps = 12/146 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           +PE  A++F  QL AG+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 123 NYAE---KVCGSPLYMAPEVLQFQRY 145
           N      K+ G+  Y+APE+L+ + +
Sbjct: 158 NRERLLNKMXGTLPYVAPELLKRREF 183

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 78/133 (58%), Gaps = 7/133 (5%)
Query: 26  PNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL 79
           P+I+ + D ++     + C+ +++E   GG L S I+  G     E+ A + ++ +G  +
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 80  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 139
           + L+SH+I HRD+KPEN+L +  + D +LK+ DFG +      N  +  C +P Y+APEV
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-QNALQTPCYTPYYVAPEV 200
Query: 140 LQFQRYDEKVNFF 152
           L  ++YD+  + +
Sbjct: 201 LGPEKYDKSCDMW 213

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 83/138 (60%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
               E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P  +
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEAL 205
Query: 136 APEVLQFQRYDEKVNFFV 153
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 88/147 (59%), Gaps = 6/147 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVNFFV 153
            + G+P Y+APE++  + Y++ V+++ 
Sbjct: 198 -LXGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 78/139 (56%), Gaps = 5/139 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++  S ++H NI+ + D  + ++C +LV+E+  G  LS YI  HG +   TA  F  Q+
Sbjct: 61  EVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQI 120
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSPL 133
             G++  +   I+HRD+KP+NIL   +D +  LKI DFG++  L   +  +   V G+  
Sbjct: 121 LDGIKHAHDMRIVHRDIKPQNIL---IDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ 177
Query: 134 YMAPEVLQFQRYDEKVNFF 152
           Y +PE  + +  DE  + +
Sbjct: 178 YFSPEQAKGEATDECTDIY 196

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 76/139 (54%), Gaps = 4/139 (2%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N L  V HP I+ L  AFQ    ++L++E+ +GG L   +   G   E TA  +L +
Sbjct: 70  AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAE 129
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 133
           +   L  L+   II+RDLKPENI+   L+    +K+ DFGL   +++ G      CG+  
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIM---LNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIE 186
Query: 134 YMAPEVLQFQRYDEKVNFF 152
           YMAPE+L    ++  V+++
Sbjct: 187 YMAPEILMRSGHNRAVDWW 205

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 76/139 (54%), Gaps = 4/139 (2%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N L  V HP I+ L  AFQ    ++L++E+ +GG L   +   G   E TA  +L +
Sbjct: 70  AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAE 129
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 133
           +   L  L+   II+RDLKPENI+   L+    +K+ DFGL   +++ G      CG+  
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIM---LNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIE 186
Query: 134 YMAPEVLQFQRYDEKVNFF 152
           YMAPE+L    ++  V+++
Sbjct: 187 YMAPEILMRSGHNRAVDWW 205

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 48/140 (34%), Positives = 83/140 (59%), Gaps = 10/140 (7%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-- 62
           L  H K  +  E+    S+++P+++     F+ ++ +++V+E C      S + LH R  
Sbjct: 81  LKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEIC---RRRSLLELHKRRK 137
Query: 63  -VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-Y 120
            V E  AR F++Q   G++ L+++ +IHRDLK  N+    L+DD+ +KI DFGL+  + +
Sbjct: 138 AVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLF---LNDDMDVKIGDFGLATKIEF 194
Query: 121 PGNYAEKVCGSPLYMAPEVL 140
            G   + +CG+P Y+APEVL
Sbjct: 195 DGERKKTLCGTPNYIAPEVL 214

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 81/137 (59%), Gaps = 4/137 (2%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H K  +  E+    S+++P+++     F+ ++ +++V+E C   +L    +    V 
Sbjct: 65  LKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVT 124
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 123
           E  AR F++Q   G++ L+++ +IHRDLK  N+    L+DD+ +KI DFGL+  + + G 
Sbjct: 125 EPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLF---LNDDMDVKIGDFGLATKIEFDGE 181
Query: 124 YAEKVCGSPLYMAPEVL 140
             + +CG+P Y+APEVL
Sbjct: 182 RKKDLCGTPNYIAPEVL 198

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 48/140 (34%), Positives = 83/140 (59%), Gaps = 10/140 (7%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-- 62
           L  H K  +  E+    S+++P+++     F+ ++ +++V+E C      S + LH R  
Sbjct: 81  LKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEIC---RRRSLLELHKRRK 137
Query: 63  -VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-Y 120
            V E  AR F++Q   G++ L+++ +IHRDLK  N+    L+DD+ +KI DFGL+  + +
Sbjct: 138 AVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLF---LNDDMDVKIGDFGLATKIEF 194
Query: 121 PGNYAEKVCGSPLYMAPEVL 140
            G   + +CG+P Y+APEVL
Sbjct: 195 DGERKKDLCGTPNYIAPEVL 214

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 48/140 (34%), Positives = 83/140 (59%), Gaps = 10/140 (7%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-- 62
           L  H K  +  E+    S+++P+++     F+ ++ +++V+E C      S + LH R  
Sbjct: 81  LKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEIC---RRRSLLELHKRRK 137
Query: 63  -VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-Y 120
            V E  AR F++Q   G++ L+++ +IHRDLK  N+    L+DD+ +KI DFGL+  + +
Sbjct: 138 AVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLF---LNDDMDVKIGDFGLATKIEF 194
Query: 121 PGNYAEKVCGSPLYMAPEVL 140
            G   + +CG+P Y+APEVL
Sbjct: 195 DGERKKXLCGTPNYIAPEVL 214

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 85/157 (54%), Gaps = 7/157 (4%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V E   GG L S I
Sbjct: 92  LKXLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRI 150
Query: 58  RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G     E+ A +  + +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 151 QDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           +      N     C +P Y+APEVL  ++YD+  + +
Sbjct: 211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXW 247

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 83/150 (55%), Gaps = 10/150 (6%)
Query: 10  KSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
           K+  DC  E++ L  +NHPN+I+ + +F  +N + +V+E    G+LS  I+   +    +
Sbjct: 74  KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI 133
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           PE+T  K+  QL + LE ++S  ++HRD+KP N+ ++      ++K+ D GL        
Sbjct: 134 PERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG---VVKLGDLGLGRFFSSKT 190
Query: 124 Y-AEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
             A  + G+P YM+PE +    Y+ K + +
Sbjct: 191 TAAHSLVGTPYYMSPERIHENGYNFKSDIW 220

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 50/128 (39%), Positives = 69/128 (53%), Gaps = 1/128 (0%)
Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81
           S+ HPNI+R  +       + +V+E+ +GG L   I   GR  E  AR F QQL +G+  
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 130
Query: 82  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 141
            ++  + HRDLK EN LL G      LKI  FG S +    +  +   G+P Y+APEVL 
Sbjct: 131 CHAMQVCHRDLKLENTLLDG-SPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 189
Query: 142 FQRYDEKV 149
            + YD KV
Sbjct: 190 KKEYDGKV 197

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 50/128 (39%), Positives = 69/128 (53%), Gaps = 1/128 (0%)
Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81
           S+ HPNI+R  +       + +V+E+ +GG L   I   GR  E  AR F QQL +G+  
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 130
Query: 82  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 141
            ++  + HRDLK EN LL G      LKI  FG S +    +  +   G+P Y+APEVL 
Sbjct: 131 CHAMQVCHRDLKLENTLLDG-SPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLL 189
Query: 142 FQRYDEKV 149
            + YD KV
Sbjct: 190 KKEYDGKV 197

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 76/152 (50%), Gaps = 1/152 (0%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+   E   +LV +   GG L   I     
Sbjct: 67  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY 126
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E  A   + Q+   +  ++ H I+HRDLKPEN+LL+       +K+ADFGL+  +   
Sbjct: 127 YSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGE 186
Query: 123 NYAE-KVCGSPLYMAPEVLQFQRYDEKVNFFV 153
             A     G+P Y++PEVL+   Y + V+ + 
Sbjct: 187 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWA 218

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 76/129 (58%), Gaps = 4/129 (3%)
Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
           P + +L   FQ  + ++ V+E+  GG+L  +I+  GR  E  A  +  ++  GL  L S 
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPLYMAPEVLQFQR 144
            II+RDLK +N++   LD +  +KIADFG+    ++ G   +  CG+P Y+APE++ +Q 
Sbjct: 141 GIIYRDLKLDNVM---LDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP 197
Query: 145 YDEKVNFFV 153
           Y + V+++ 
Sbjct: 198 YGKSVDWWA 206

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 76/129 (58%), Gaps = 4/129 (3%)
Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
           P + +L   FQ  + ++ V+E+  GG+L  +I+  GR  E  A  +  ++  GL  L S 
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPLYMAPEVLQFQR 144
            II+RDLK +N++   LD +  +KIADFG+    ++ G   +  CG+P Y+APE++ +Q 
Sbjct: 462 GIIYRDLKLDNVM---LDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP 518
Query: 145 YDEKVNFFV 153
           Y + V+++ 
Sbjct: 519 YGKSVDWWA 527

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/155 (34%), Positives = 78/155 (50%), Gaps = 7/155 (4%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+   E   +LV +   GG L   I     
Sbjct: 40  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY 99
Query: 63  VPEQTARKFLQQLGAGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
             E  A   +QQ+   LE +N  H   I+HRDLKPEN+LL+       +K+ADFGL+  +
Sbjct: 100 YSEADASHCIQQI---LESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEV 156
Query: 120 YPGNYAE-KVCGSPLYMAPEVLQFQRYDEKVNFFV 153
                A     G+P Y++PEVL+   Y + V+ + 
Sbjct: 157 QGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWA 191

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/155 (34%), Positives = 78/155 (50%), Gaps = 7/155 (4%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+   E   +LV +   GG L   I     
Sbjct: 40  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY 99
Query: 63  VPEQTARKFLQQLGAGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
             E  A   +QQ+   LE +N  H   I+HRDLKPEN+LL+       +K+ADFGL+  +
Sbjct: 100 YSEADASHCIQQI---LESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEV 156
Query: 120 YPGNYAE-KVCGSPLYMAPEVLQFQRYDEKVNFFV 153
                A     G+P Y++PEVL+   Y + V+ + 
Sbjct: 157 QGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWA 191

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 83/151 (54%), Gaps = 7/151 (4%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KK  KH+ S  +     L +V HP ++ L  +FQ  + ++ V+++  GG L  +++    
Sbjct: 79  KKEEKHIMSERNV---LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC 135
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYP 121
             E  AR +  ++ + L  L+S +I++RDLKPENIL   LD    + + DFGL    +  
Sbjct: 136 FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENIL---LDSQGHIVLTDFGLCKENIEH 192
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
            +     CG+P Y+APEVL  Q YD  V+++
Sbjct: 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWW 223

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 80/137 (58%), Gaps = 5/137 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  V H N+I L D ++    + L++E  +GG L  ++     + E+ A 
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
            F++Q+  G+  L++  I H DLKPENI+L  LD ++    +K+ DFGL+  +  G   +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 127 KVCGSPLYMAPEVLQFQ 143
            + G+P ++APE++ ++
Sbjct: 177 NIFGTPEFVAPEIVNYE 193

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 80/137 (58%), Gaps = 5/137 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  V H N+I L D ++    + L++E  +GG L  ++     + E+ A 
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
            F++Q+  G+  L++  I H DLKPENI+L  LD ++    +K+ DFGL+  +  G   +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 127 KVCGSPLYMAPEVLQFQ 143
            + G+P ++APE++ ++
Sbjct: 177 NIFGTPEFVAPEIVNYE 193

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 72/128 (56%), Gaps = 6/128 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 138
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 139 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 195
Query: 133 LYMAPEVL 140
            Y++PE+L
Sbjct: 196 QYVSPELL 203

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 80/137 (58%), Gaps = 5/137 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  V H N+I L D ++    + L++E  +GG L  ++     + E+ A 
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
            F++Q+  G+  L++  I H DLKPENI+L  LD ++    +K+ DFGL+  +  G   +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 127 KVCGSPLYMAPEVLQFQ 143
            + G+P ++APE++ ++
Sbjct: 177 NIFGTPEFVAPEIVNYE 193

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 80/137 (58%), Gaps = 5/137 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  V H N+I L D ++    + L++E  +GG L  ++     + E+ A 
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
            F++Q+  G+  L++  I H DLKPENI+L  LD ++    +K+ DFGL+  +  G   +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 127 KVCGSPLYMAPEVLQFQ 143
            + G+P ++APE++ ++
Sbjct: 177 NIFGTPEFVAPEIVNYE 193

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 80/137 (58%), Gaps = 5/137 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  V H N+I L D ++    + L++E  +GG L  ++     + E+ A 
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 126
            F++Q+  G+  L++  I H DLKPENI+L  LD ++    +K+ DFGL+  +  G   +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 127 KVCGSPLYMAPEVLQFQ 143
            + G+P ++APE++ ++
Sbjct: 177 NIFGTPEFVAPEIVNYE 193

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 72/128 (56%), Gaps = 6/128 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 64  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 123
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 124 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 180
Query: 133 LYMAPEVL 140
            Y++PE+L
Sbjct: 181 QYVSPELL 188

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 72/128 (56%), Gaps = 6/128 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 58  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 117
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 118 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 174
Query: 133 LYMAPEVL 140
            Y++PE+L
Sbjct: 175 QYVSPELL 182

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 72/128 (56%), Gaps = 6/128 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 138
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 139 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 195
Query: 133 LYMAPEVL 140
            Y++PE+L
Sbjct: 196 QYVSPELL 203

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 72/128 (56%), Gaps = 6/128 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 57  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 116
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 117 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 173
Query: 133 LYMAPEVL 140
            Y++PE+L
Sbjct: 174 QYVSPELL 181

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 72/128 (56%), Gaps = 6/128 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 59  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 118
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 119 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 175
Query: 133 LYMAPEVL 140
            Y++PE+L
Sbjct: 176 QYVSPELL 183

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 72/128 (56%), Gaps = 6/128 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 142
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 143 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 199
Query: 133 LYMAPEVL 140
            Y++PE+L
Sbjct: 200 QYVSPELL 207

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 72/128 (56%), Gaps = 6/128 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 140 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 133 LYMAPEVL 140
            Y++PE+L
Sbjct: 197 QYVSPELL 204

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 72/128 (56%), Gaps = 6/128 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 140 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANAFVGTA 196
Query: 133 LYMAPEVL 140
            Y++PE+L
Sbjct: 197 QYVSPELL 204

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/145 (40%), Positives = 77/145 (53%), Gaps = 16/145 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP-----EQTARK 70
           EL  LS VNHPNI++L+ A    N + LV+E+  GG+L  Y  LHG  P        A  
Sbjct: 52  ELRQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSL--YNVLHGAEPLPYYTAAHAMS 107
Query: 71  FLQQLGAGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127
           +  Q   G+  L+S     +IHRDLKP N+LL  +    +LKI DFG +C +       K
Sbjct: 108 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL--VAGGTVLKICDFGTACDIQTHMTNNK 165
Query: 128 VCGSPLYMAPEVLQFQRYDEKVNFF 152
             GS  +MAPEV +   Y EK + F
Sbjct: 166 --GSAAWMAPEVFEGSNYSEKCDVF 188

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 72/128 (56%), Gaps = 6/128 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 133 LYMAPEVL 140
            Y++PE+L
Sbjct: 199 QYVSPELL 206

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 72/128 (56%), Gaps = 6/128 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 133 LYMAPEVL 140
            Y++PE+L
Sbjct: 199 QYVSPELL 206

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 71/125 (56%), Gaps = 3/125 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  +  + HP ++ L+ +FQ E  +F+VV+   GG+L  +++ +    E+T + F+ +L
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICEL 124
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
              L+ L +  IIHRD+KP+NIL   LD+   + I DF ++  L        + G+  YM
Sbjct: 125 VMALDYLQNQRIIHRDMKPDNIL---LDEHGHVHITDFNIAAMLPRETQITTMAGTKPYM 181
Query: 136 APEVL 140
           APE+ 
Sbjct: 182 APEMF 186

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 52/145 (35%), Positives = 79/145 (54%), Gaps = 5/145 (3%)
Query: 11  SCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
            C   E   LS + NHP + +LF  FQ  + +F V+EF  GG+L  +I+   R  E  AR
Sbjct: 68  ECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARAR 127
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKV 128
            +  ++ + L  L+   II+RDLK +N+L   LD +   K+ADFG+    +  G      
Sbjct: 128 FYAAEIISALMFLHDKGIIYRDLKLDNVL---LDHEGHCKLADFGMCKEGICNGVTTATF 184
Query: 129 CGSPLYMAPEVLQFQRYDEKVNFFV 153
           CG+P Y+APE+LQ   Y   V+++ 
Sbjct: 185 CGTPDYIAPEILQEMLYGPAVDWWA 209

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 72/128 (56%), Gaps = 6/128 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 140 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 133 LYMAPEVL 140
            Y++PE+L
Sbjct: 197 QYVSPELL 204

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 72/128 (56%), Gaps = 6/128 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 60  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 119
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 120 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 176
Query: 133 LYMAPEVL 140
            Y++PE+L
Sbjct: 177 QYVSPELL 184

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 72/128 (56%), Gaps = 6/128 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 133 LYMAPEVL 140
            Y++PE+L
Sbjct: 199 QYVSPELL 206

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/145 (40%), Positives = 77/145 (53%), Gaps = 16/145 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP-----EQTARK 70
           EL  LS VNHPNI++L+ A    N + LV+E+  GG+L  Y  LHG  P        A  
Sbjct: 51  ELRQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSL--YNVLHGAEPLPYYTAAHAMS 106
Query: 71  FLQQLGAGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127
           +  Q   G+  L+S     +IHRDLKP N+LL  +    +LKI DFG +C +       K
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL--VAGGTVLKICDFGTACDIQTHMTNNK 164
Query: 128 VCGSPLYMAPEVLQFQRYDEKVNFF 152
             GS  +MAPEV +   Y EK + F
Sbjct: 165 --GSAAWMAPEVFEGSNYSEKCDVF 187

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 72/128 (56%), Gaps = 6/128 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 133 LYMAPEVL 140
            Y++PE+L
Sbjct: 199 QYVSPELL 206

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 72/128 (56%), Gaps = 6/128 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 140 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 133 LYMAPEVL 140
            Y++PE+L
Sbjct: 197 QYVSPELL 204

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 72/128 (56%), Gaps = 6/128 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 142
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 143 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 199
Query: 133 LYMAPEVL 140
            Y++PE+L
Sbjct: 200 QYVSPELL 207

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 72/128 (56%), Gaps = 6/128 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 133 LYMAPEVL 140
            Y++PE+L
Sbjct: 199 QYVSPELL 206

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 70/129 (54%), Gaps = 1/129 (0%)
Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84
           HPNI++L + F  +   FLV+E   GG L   I+      E  A   +++L + +  ++ 
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 85  HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLYMAPEVLQFQ 143
             ++HRDLKPEN+L +  +D++ +KI DFG +    P N   K  C +  Y APE+L   
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 144 RYDEKVNFF 152
            YDE  + +
Sbjct: 185 GYDESCDLW 193

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 72/128 (56%), Gaps = 6/128 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 85  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 144
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 145 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 201
Query: 133 LYMAPEVL 140
            Y++PE+L
Sbjct: 202 QYVSPELL 209

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 81/144 (56%), Gaps = 5/144 (3%)
Query: 11  SCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
            C   E   LS +  HP +  +F  FQ +  +F V+E+  GG+L  +I+   +     A 
Sbjct: 63  ECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRAT 122
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKV 128
            +  ++  GL+ L+S  I++RDLK +NIL   LD D  +KIADFG+      G+    + 
Sbjct: 123 FYAAEIILGLQFLHSKGIVYRDLKLDNIL---LDKDGHIKIADFGMCKENMLGDAKTNEF 179
Query: 129 CGSPLYMAPEVLQFQRYDEKVNFF 152
           CG+P Y+APE+L  Q+Y+  V+++
Sbjct: 180 CGTPDYIAPEILLGQKYNHSVDWW 203

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 44/130 (33%), Positives = 77/130 (59%), Gaps = 6/130 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + ++  N P +++LF AFQ +  +++V+E+  GG+L + +  +  VPE+ AR +  ++
Sbjct: 124 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEV 182
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPL 133
              L+ ++S   IHRD+KP+N+L   LD    LK+ADFG    +        +   G+P 
Sbjct: 183 VLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 239
Query: 134 YMAPEVLQFQ 143
           Y++PEVL+ Q
Sbjct: 240 YISPEVLKSQ 249

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 80/144 (55%), Gaps = 5/144 (3%)
Query: 11  SCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
            C   E   LS +  HP +  +F  FQ +  +F V+E+  GG+L  +I+   +     A 
Sbjct: 62  ECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRAT 121
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKV 128
            +  ++  GL+ L+S  I++RDLK +NIL   LD D  +KIADFG+      G+      
Sbjct: 122 FYAAEIILGLQFLHSKGIVYRDLKLDNIL---LDKDGHIKIADFGMCKENMLGDAKTNXF 178
Query: 129 CGSPLYMAPEVLQFQRYDEKVNFF 152
           CG+P Y+APE+L  Q+Y+  V+++
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWW 202

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 84/149 (56%), Gaps = 4/149 (2%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H +  +  E++   S+ H +++     F+  + +F+V+E C   +L    +    + 
Sbjct: 56  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT 115
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 123
           E  AR +L+Q+  G + L+ + +IHRDLK  N+    L++D+ +KI DFGL+  + Y G 
Sbjct: 116 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF---LNEDLEVKIGDFGLATKVEYDGE 172
Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
             + +CG+P Y+APEVL  + +  +V+ +
Sbjct: 173 RKKTLCGTPNYIAPEVLSKKGHSFEVDVW 201

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 84/149 (56%), Gaps = 4/149 (2%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H +  +  E++   S+ H +++     F+  + +F+V+E C   +L    +    + 
Sbjct: 56  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT 115
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 123
           E  AR +L+Q+  G + L+ + +IHRDLK  N+    L++D+ +KI DFGL+  + Y G 
Sbjct: 116 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF---LNEDLEVKIGDFGLATKVEYDGE 172
Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
             + +CG+P Y+APEVL  + +  +V+ +
Sbjct: 173 RKKTLCGTPNYIAPEVLSKKGHSFEVDVW 201

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 44/130 (33%), Positives = 77/130 (59%), Gaps = 6/130 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + ++  N P +++LF AFQ +  +++V+E+  GG+L + +  +  VPE+ AR +  ++
Sbjct: 124 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEV 182
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPL 133
              L+ ++S   IHRD+KP+N+L   LD    LK+ADFG    +        +   G+P 
Sbjct: 183 VLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 239
Query: 134 YMAPEVLQFQ 143
           Y++PEVL+ Q
Sbjct: 240 YISPEVLKSQ 249

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 72/128 (56%), Gaps = 6/128 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 87  ERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 146
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 147 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 203
Query: 133 LYMAPEVL 140
            Y++PE+L
Sbjct: 204 QYVSPELL 211

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 84/149 (56%), Gaps = 4/149 (2%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H +  +  E++   S+ H +++     F+  + +F+V+E C   +L    +    + 
Sbjct: 60  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT 119
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 123
           E  AR +L+Q+  G + L+ + +IHRDLK  N+    L++D+ +KI DFGL+  + Y G 
Sbjct: 120 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF---LNEDLEVKIGDFGLATKVEYDGE 176
Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
             + +CG+P Y+APEVL  + +  +V+ +
Sbjct: 177 RKKTLCGTPNYIAPEVLSKKGHSFEVDVW 205

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 44/130 (33%), Positives = 77/130 (59%), Gaps = 6/130 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + ++  N P +++LF AFQ +  +++V+E+  GG+L + +  +  VPE+ AR +  ++
Sbjct: 119 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEV 177
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPL 133
              L+ ++S   IHRD+KP+N+L   LD    LK+ADFG    +        +   G+P 
Sbjct: 178 VLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 234
Query: 134 YMAPEVLQFQ 143
           Y++PEVL+ Q
Sbjct: 235 YISPEVLKSQ 244

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 46/134 (34%), Positives = 78/134 (58%), Gaps = 2/134 (1%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNL-SSYIRLHGRVPEQTA 68
           K  +  E++ ++ ++H N+I+L+DAF+++N I LV+E+  GG L    I     + E   
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT 189
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
             F++Q+  G+  ++  +I+H DLKPENIL    D    +KI DFGL+    P    +  
Sbjct: 190 ILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVN 248
Query: 129 CGSPLYMAPEVLQF 142
            G+P ++APEV+ +
Sbjct: 249 FGTPEFLAPEVVNY 262

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 41/127 (32%), Positives = 74/127 (58%), Gaps = 2/127 (1%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E+  +S + HP ++ L DAF+ +N + ++ EF +GG L   +   H ++ E  A ++++Q
Sbjct: 98  EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 157
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
           +  GL  ++ ++ +H DLKPENI+ +    +  LK+ DFGL+  L P    +   G+  +
Sbjct: 158 VCKGLCHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQSVKVTTGTAEF 216
Query: 135 MAPEVLQ 141
            APEV +
Sbjct: 217 AAPEVAE 223

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 41/127 (32%), Positives = 74/127 (58%), Gaps = 2/127 (1%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E+  +S + HP ++ L DAF+ +N + ++ EF +GG L   +   H ++ E  A ++++Q
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 263
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
           +  GL  ++ ++ +H DLKPENI+ +    +  LK+ DFGL+  L P    +   G+  +
Sbjct: 264 VCKGLCHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQSVKVTTGTAEF 322
Query: 135 MAPEVLQ 141
            APEV +
Sbjct: 323 AAPEVAE 329

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 72/128 (56%), Gaps = 6/128 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEI 141
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 198
Query: 133 LYMAPEVL 140
            Y++PE+L
Sbjct: 199 QYVSPELL 206

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 84/149 (56%), Gaps = 4/149 (2%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H +  +  E++   S+ H +++     F+  + +F+V+E C   +L    +    + 
Sbjct: 54  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT 113
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 123
           E  AR +L+Q+  G + L+ + +IHRDLK  N+    L++D+ +KI DFGL+  + Y G 
Sbjct: 114 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF---LNEDLEVKIGDFGLATKVEYDGE 170
Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
             + +CG+P Y+APEVL  + +  +V+ +
Sbjct: 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVW 199

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 18/152 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR--------LHGRVPEQT 67
           E+  +S  +HPNI+  + +F  ++ ++LV++  +GG++   I+          G + E T
Sbjct: 58  EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 117
Query: 68  ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----- 122
               L+++  GLE L+ +  IHRD+K  NILL    +D  ++IADFG+S  L  G     
Sbjct: 118 IATILREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITR 174
Query: 123 NYAEKV-CGSPLYMAPEVL-QFQRYDEKVNFF 152
           N   K   G+P +MAPEV+ Q + YD K + +
Sbjct: 175 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIW 206

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 18/152 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR--------LHGRVPEQT 67
           E+  +S  +HPNI+  + +F  ++ ++LV++  +GG++   I+          G + E T
Sbjct: 63  EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 68  ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----- 122
               L+++  GLE L+ +  IHRD+K  NILL    +D  ++IADFG+S  L  G     
Sbjct: 123 IATILREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITR 179
Query: 123 NYAEKV-CGSPLYMAPEVL-QFQRYDEKVNFF 152
           N   K   G+P +MAPEV+ Q + YD K + +
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIW 211

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 84/149 (56%), Gaps = 4/149 (2%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H +  +  E++   S+ H +++     F+  + +F+V+E C   +L    +    + 
Sbjct: 78  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT 137
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 123
           E  AR +L+Q+  G + L+ + +IHRDLK  N+    L++D+ +KI DFGL+  + Y G 
Sbjct: 138 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF---LNEDLEVKIGDFGLATKVEYDGE 194
Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
             + +CG+P Y+APEVL  + +  +V+ +
Sbjct: 195 RKKVLCGTPNYIAPEVLSKKGHSFEVDVW 223

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 75/139 (53%), Gaps = 4/139 (2%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  +
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 133
           + + LE L+S  +++RD+K EN++   LD D  +KI DFGL    +  G   +  CG+P 
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 170
Query: 134 YMAPEVLQFQRYDEKVNFF 152
           Y+APEVL+   Y   V+++
Sbjct: 171 YLAPEVLEDNDYGRAVDWW 189

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 75/139 (53%), Gaps = 4/139 (2%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  +
Sbjct: 57  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 116
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 133
           + + LE L+S  +++RD+K EN++   LD D  +KI DFGL    +  G   +  CG+P 
Sbjct: 117 IVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 173
Query: 134 YMAPEVLQFQRYDEKVNFF 152
           Y+APEVL+   Y   V+++
Sbjct: 174 YLAPEVLEDNDYGRAVDWW 192

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 75/139 (53%), Gaps = 4/139 (2%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  +
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 133
           + + LE L+S  +++RD+K EN++   LD D  +KI DFGL    +  G   +  CG+P 
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKEGISDGATMKXFCGTPE 170
Query: 134 YMAPEVLQFQRYDEKVNFF 152
           Y+APEVL+   Y   V+++
Sbjct: 171 YLAPEVLEDNDYGRAVDWW 189

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 75/139 (53%), Gaps = 4/139 (2%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  +
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 133
           + + LE L+S  +++RD+K EN++   LD D  +KI DFGL    +  G   +  CG+P 
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 170
Query: 134 YMAPEVLQFQRYDEKVNFF 152
           Y+APEVL+   Y   V+++
Sbjct: 171 YLAPEVLEDNDYGRAVDWW 189

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 49/150 (32%), Positives = 79/150 (52%), Gaps = 11/150 (7%)
Query: 12  CLDCELNFLSSVNHPNII---RLFDAFQ--AENCI-FLVVEFCAGGNLSSYIRLHGR--- 62
           CL  E+  +  +NHPN++    + D  Q  A N +  L +E+C GG+L  Y+        
Sbjct: 61  CL--EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG 118
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           + E   R  L  + + L  L+ + IIHRDLKPENI+L      ++ KI D G +  L  G
Sbjct: 119 LKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG 178
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
               +  G+  Y+APE+L+ ++Y   V+++
Sbjct: 179 ELCTEFVGTLQYLAPELLEQKKYTVTVDYW 208

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 49/150 (32%), Positives = 79/150 (52%), Gaps = 11/150 (7%)
Query: 12  CLDCELNFLSSVNHPNII---RLFDAFQ--AENCI-FLVVEFCAGGNLSSYIRLHGR--- 62
           CL  E+  +  +NHPN++    + D  Q  A N +  L +E+C GG+L  Y+        
Sbjct: 60  CL--EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG 117
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           + E   R  L  + + L  L+ + IIHRDLKPENI+L      ++ KI D G +  L  G
Sbjct: 118 LKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG 177
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
               +  G+  Y+APE+L+ ++Y   V+++
Sbjct: 178 ELCTEFVGTLQYLAPELLEQKKYTVTVDYW 207

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 84/149 (56%), Gaps = 4/149 (2%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H +  +  E++   S+ H +++     F+  + +F+V+E C   +L    +    + 
Sbjct: 80  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT 139
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 123
           E  AR +L+Q+  G + L+ + +IHRDLK  N+    L++D+ +KI DFGL+  + Y G 
Sbjct: 140 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF---LNEDLEVKIGDFGLATKVEYDGE 196
Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
             + +CG+P Y+APEVL  + +  +V+ +
Sbjct: 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVW 225

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 75/139 (53%), Gaps = 4/139 (2%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  +
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 133
           + + LE L+S  +++RD+K EN++   LD D  +KI DFGL    +  G   +  CG+P 
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKEGISDGATMKXFCGTPE 170
Query: 134 YMAPEVLQFQRYDEKVNFF 152
           Y+APEVL+   Y   V+++
Sbjct: 171 YLAPEVLEDNDYGRAVDWW 189

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 75/139 (53%), Gaps = 4/139 (2%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  +
Sbjct: 59  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 118
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 133
           + + LE L+S  +++RD+K EN++   LD D  +KI DFGL    +  G   +  CG+P 
Sbjct: 119 IVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKEGISDGATMKXFCGTPE 175
Query: 134 YMAPEVLQFQRYDEKVNFF 152
           Y+APEVL+   Y   V+++
Sbjct: 176 YLAPEVLEDNDYGRAVDWW 194

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/142 (35%), Positives = 79/142 (55%), Gaps = 13/142 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+ FL  + HPN I+    +  E+  +LV+E+C G + S  + +H + P Q         
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKK-PLQEVEIAAVTH 161
Query: 76  GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           GA  GL  L+SH++IHRD+K  NILLS   +  ++K+ DFG +  + P N      G+P 
Sbjct: 162 GALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPAN---XFVGTPY 215
Query: 134 YMAPEV---LQFQRYDEKVNFF 152
           +MAPEV   +   +YD KV+ +
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVW 237

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 75/139 (53%), Gaps = 4/139 (2%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  +
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 133
           + + LE L+S  +++RD+K EN++   LD D  +KI DFGL    +  G   +  CG+P 
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKEGISDGATMKXFCGTPE 170
Query: 134 YMAPEVLQFQRYDEKVNFF 152
           Y+APEVL+   Y   V+++
Sbjct: 171 YLAPEVLEDNDYGRAVDWW 189

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/142 (35%), Positives = 79/142 (55%), Gaps = 13/142 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+ FL  + HPN I+    +  E+  +LV+E+C G + S  + +H + P Q         
Sbjct: 65  EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKK-PLQEVEIAAVTH 122
Query: 76  GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           GA  GL  L+SH++IHRD+K  NILLS   +  ++K+ DFG +  + P N      G+P 
Sbjct: 123 GALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPAN---XFVGTPY 176
Query: 134 YMAPEV---LQFQRYDEKVNFF 152
           +MAPEV   +   +YD KV+ +
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVW 198

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 81/145 (55%), Gaps = 5/145 (3%)
Query: 11  SCLDCELNFLSSVNHPN-IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
            C   E   L+ ++ P  + +L   FQ  + ++ V+E+  GG+L  +I+  G+  E  A 
Sbjct: 64  ECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAV 123
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT-LYPGNYAEKV 128
            +  ++  GL  L+   II+RDLK +N++   LD +  +KIADFG+    +  G    + 
Sbjct: 124 FYAAEISIGLFFLHKRGIIYRDLKLDNVM---LDSEGHIKIADFGMCKEHMMDGVTTREF 180
Query: 129 CGSPLYMAPEVLQFQRYDEKVNFFV 153
           CG+P Y+APE++ +Q Y + V+++ 
Sbjct: 181 CGTPDYIAPEIIAYQPYGKSVDWWA 205

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 79/145 (54%), Gaps = 5/145 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----PEQTA 68
           L  E +    + HP+I+ L + + ++  +++V EF  G +L   I           E  A
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEK 127
             +++Q+   L   + ++IIHRD+KPEN+LL+  ++   +K+ DFG++  L   G  A  
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGG 192
Query: 128 VCGSPLYMAPEVLQFQRYDEKVNFF 152
             G+P +MAPEV++ + Y + V+ +
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVW 217

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 44/133 (33%), Positives = 80/133 (60%), Gaps = 6/133 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + ++  N P +++LF AFQ +  +++V+E+  GG+L + +  +  VPE+ A+ +  ++
Sbjct: 125 ERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEV 183
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPL 133
              L+ ++S  +IHRD+KP+N+L   LD    LK+ADFG    +      + +   G+P 
Sbjct: 184 VLALDAIHSMGLIHRDVKPDNML---LDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPD 240
Query: 134 YMAPEVLQFQRYD 146
           Y++PEVL+ Q  D
Sbjct: 241 YISPEVLKSQGGD 253

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 75/152 (49%), Gaps = 1/152 (0%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+   E   +L+ +   GG L   I     
Sbjct: 58  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY 117
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E  A   +QQ+   +   +   ++HRDLKPEN+LL+       +K+ADFGL+  +   
Sbjct: 118 YSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGE 177
Query: 123 NYAE-KVCGSPLYMAPEVLQFQRYDEKVNFFV 153
             A     G+P Y++PEVL+   Y + V+ + 
Sbjct: 178 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWA 209

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 51/142 (35%), Positives = 79/142 (55%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----RLHGRVPEQTARKF 71
           E   L+ V+   I+ L  AF+ +  + LV+    GG++  +I      +    E  A  +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCG 130
             Q+ +GLE L+  +II+RDLKPEN+L   LDDD  ++I+D GL+  L  G    K   G
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVL---LDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 131 SPLYMAPEVLQFQRYDEKVNFF 152
           +P +MAPE+L  + YD  V++F
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYF 373

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 51/142 (35%), Positives = 79/142 (55%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----RLHGRVPEQTARKF 71
           E   L+ V+   I+ L  AF+ +  + LV+    GG++  +I      +    E  A  +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCG 130
             Q+ +GLE L+  +II+RDLKPEN+L   LDDD  ++I+D GL+  L  G    K   G
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVL---LDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 131 SPLYMAPEVLQFQRYDEKVNFF 152
           +P +MAPE+L  + YD  V++F
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYF 373

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 51/142 (35%), Positives = 79/142 (55%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----RLHGRVPEQTARKF 71
           E   L+ V+   I+ L  AF+ +  + LV+    GG++  +I      +    E  A  +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCG 130
             Q+ +GLE L+  +II+RDLKPEN+L   LDDD  ++I+D GL+  L  G    K   G
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVL---LDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 131 SPLYMAPEVLQFQRYDEKVNFF 152
           +P +MAPE+L  + YD  V++F
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYF 373

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 51/142 (35%), Positives = 79/142 (55%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----RLHGRVPEQTARKF 71
           E   L+ V+   I+ L  AF+ +  + LV+    GG++  +I      +    E  A  +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCG 130
             Q+ +GLE L+  +II+RDLKPEN+L   LDDD  ++I+D GL+  L  G    K   G
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVL---LDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 131 SPLYMAPEVLQFQRYDEKVNFF 152
           +P +MAPE+L  + YD  V++F
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYF 373

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 75/152 (49%), Gaps = 1/152 (0%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + H NI+RL D+   E   +LV +   GG L   I     
Sbjct: 40  KKLSARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY 99
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E  A   +QQ+   +   +   ++HRDLKPEN+LL+       +K+ADFGL+  +   
Sbjct: 100 YSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGD 159
Query: 123 NYAE-KVCGSPLYMAPEVLQFQRYDEKVNFFV 153
             A     G+P Y++PEVL+ + Y + V+ + 
Sbjct: 160 QQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWA 191

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 80/141 (56%), Gaps = 11/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
           E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +        Q A   R+ L
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGS 131
           Q     LE L+S+ +IHRD+K +NILL G+D  V  K+ DFG    + P  +   ++ G+
Sbjct: 127 Q----ALEFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSEMVGT 179
Query: 132 PLYMAPEVLQFQRYDEKVNFF 152
           P +MAPEV+  + Y  KV+ +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIW 200

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 77/140 (55%), Gaps = 5/140 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E   L  VN   ++ L  A++ ++ + LV+    GG+L  +I   G+   PE  A  +  
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           ++  GLE L+   I++RDLKPENIL   LDD   ++I+D GL+  +  G   +   G+  
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENIL---LDDHGHIRISDLGLAVHVPEGQTIKGRVGTVG 350
Query: 134 YMAPEVLQFQRYDEKVNFFV 153
           YMAPEV++ +RY    +++ 
Sbjct: 351 YMAPEVVKNERYTFSPDWWA 370

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 80/140 (57%), Gaps = 6/140 (4%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRV 63
           L +   +C   E + L + +   I  L  AFQ +N ++LV+++  GG+L + + +   R+
Sbjct: 113 LKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRL 172
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           PE+ AR +L ++   ++ ++  H +HRD+KP+NIL   +D +  +++ADFG    L    
Sbjct: 173 PEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL---MDMNGHIRLADFGSCLKLMEDG 229
Query: 124 YAEK--VCGSPLYMAPEVLQ 141
             +     G+P Y++PE+LQ
Sbjct: 230 TVQSSVAVGTPDYISPEILQ 249

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 77/140 (55%), Gaps = 5/140 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E   L  VN   ++ L  A++ ++ + LV+    GG+L  +I   G+   PE  A  +  
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           ++  GLE L+   I++RDLKPENIL   LDD   ++I+D GL+  +  G   +   G+  
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENIL---LDDHGHIRISDLGLAVHVPEGQTIKGRVGTVG 350
Query: 134 YMAPEVLQFQRYDEKVNFFV 153
           YMAPEV++ +RY    +++ 
Sbjct: 351 YMAPEVVKNERYTFSPDWWA 370

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 78/141 (55%), Gaps = 11/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
           E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +        Q A   R+ L
Sbjct: 68  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 127
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGS 131
           Q     LE L+S+ +IHRD+K +NILL G+D  V  K+ DFG    + P       + G+
Sbjct: 128 Q----ALEFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSXMVGT 180
Query: 132 PLYMAPEVLQFQRYDEKVNFF 152
           P +MAPEV+  + Y  KV+ +
Sbjct: 181 PYWMAPEVVTRKAYGPKVDIW 201

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 78/141 (55%), Gaps = 11/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
           E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +        Q A   R+ L
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGS 131
           Q     LE L+S+ +IHRD+K +NILL G+D  V  K+ DFG    + P       + G+
Sbjct: 127 Q----ALEFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGT 179
Query: 132 PLYMAPEVLQFQRYDEKVNFF 152
           P +MAPEV+  + Y  KV+ +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIW 200

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 78/141 (55%), Gaps = 11/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
           E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +        Q A   R+ L
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGS 131
           Q     LE L+S+ +IHRD+K +NILL G+D  V  K+ DFG    + P       + G+
Sbjct: 127 Q----ALEFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSXMVGT 179
Query: 132 PLYMAPEVLQFQRYDEKVNFF 152
           P +MAPEV+  + Y  KV+ +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIW 200

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 48/131 (36%), Positives = 70/131 (53%), Gaps = 4/131 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG-NLSSYIRLHGRVPEQTARKFLQQ 74
           E+  LS V H NII++ D F+ +    LV+E    G +L ++I  H R+ E  A    +Q
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
           L + +  L    IIHRD+K ENI+++   +D  +K+ DFG +  L  G      CG+  Y
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIA---EDFTIKLIDFGSAAYLERGKLFYTFCGTIEY 195
Query: 135 MAPEVLQFQRY 145
            APEVL    Y
Sbjct: 196 CAPEVLMGNPY 206

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 132
Query: 76  GAGLEILN-SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 133 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLID-SMANSFVGTRSY 188
Query: 135 MAPEVLQFQRYDEKVNFF 152
           M+PE LQ   Y  + + +
Sbjct: 189 MSPERLQGTHYSVQSDIW 206

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 81/145 (55%), Gaps = 10/145 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQ 73
            E+  L++ +HP I++L  A+  +  +++++EFC GG + +  + L   + E   +   +
Sbjct: 57  VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR 116
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSP 132
           Q+   L  L+S  IIHRDLK  N+L++ L+ D+  ++ADFG+S   L      +   G+P
Sbjct: 117 QMLEALNFLHSKRIIHRDLKAGNVLMT-LEGDI--RLADFGVSAKNLKTLQKRDSFIGTP 173
Query: 133 LYMAPEVLQFQR-----YDEKVNFF 152
            +MAPEV+  +      YD K + +
Sbjct: 174 YWMAPEVVMCETMKDTPYDYKADIW 198

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 75/152 (49%), Gaps = 1/152 (0%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+   E   +L+ +   GG L   I     
Sbjct: 47  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY 106
Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E  A   +QQ+   +   +   ++HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 107 YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166
Query: 123 NYAE-KVCGSPLYMAPEVLQFQRYDEKVNFFV 153
             A     G+P Y++PEVL+   Y + V+ + 
Sbjct: 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWA 198

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 74/138 (53%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P I R F ++     +++++E+  GG+    ++  G + E      L+++
Sbjct: 67  EITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREI 125
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 134
             GL+ L+S   IHRD+K  N+LLS   D   +K+ADFG++  L           G+P +
Sbjct: 126 LKGLDYLHSERKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNXFVGTPFW 182
Query: 135 MAPEVLQFQRYDEKVNFF 152
           MAPEV++   YD K + +
Sbjct: 183 MAPEVIKQSAYDFKADIW 200

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 81/145 (55%), Gaps = 10/145 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQ 73
            E+  L++ +HP I++L  A+  +  +++++EFC GG + +  + L   + E   +   +
Sbjct: 65  VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR 124
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSP 132
           Q+   L  L+S  IIHRDLK  N+L++ L+ D+  ++ADFG+S   L      +   G+P
Sbjct: 125 QMLEALNFLHSKRIIHRDLKAGNVLMT-LEGDI--RLADFGVSAKNLKTLQKRDSFIGTP 181
Query: 133 LYMAPEVLQFQR-----YDEKVNFF 152
            +MAPEV+  +      YD K + +
Sbjct: 182 YWMAPEVVMCETMKDTPYDYKADIW 206

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 76  GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 169
Query: 135 MAPEVLQFQRYDEKVNFF 152
           M+PE LQ   Y  + + +
Sbjct: 170 MSPERLQGTHYSVQSDIW 187

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 76  GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 169
Query: 135 MAPEVLQFQRYDEKVNFF 152
           M+PE LQ   Y  + + +
Sbjct: 170 MSPERLQGTHYSVQSDIW 187

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 76  GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 169
Query: 135 MAPEVLQFQRYDEKVNFF 152
           M+PE LQ   Y  + + +
Sbjct: 170 MSPERLQGTHYSVQSDIW 187

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 76  GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 169
Query: 135 MAPEVLQFQRYDEKVNFF 152
           M+PE LQ   Y  + + +
Sbjct: 170 MSPERLQGTHYSVQSDIW 187

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 57  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 116
Query: 76  GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L     A +  G+  Y
Sbjct: 117 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DEMANEFVGTRSY 172
Query: 135 MAPEVLQFQRYDEKVNFF 152
           M+PE LQ   Y  + + +
Sbjct: 173 MSPERLQGTHYSVQSDIW 190

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 76  GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 169
Query: 135 MAPEVLQFQRYDEKVNFF 152
           M+PE LQ   Y  + + +
Sbjct: 170 MSPERLQGTHYSVQSDIW 187

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 175
Query: 76  GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 176 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 231
Query: 135 MAPEVLQFQRYDEKVNFF 152
           M+PE LQ   Y  + + +
Sbjct: 232 MSPERLQGTHYSVQSDIW 249

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 140
Query: 76  GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 196
Query: 135 MAPEVLQFQRYDEKVNFF 152
           M+PE LQ   Y  + + +
Sbjct: 197 MSPERLQGTHYSVQSDIW 214

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/129 (36%), Positives = 73/129 (56%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF +  +L  ++    L G +P    + +L
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTG-IPLPLIKSYL 110
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKPEN+L   ++ +  +K+ADFGL+     P         +
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPENLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 167
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 168 LWYRAPEIL 176

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/129 (36%), Positives = 73/129 (56%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF +  +L  ++    L G +P    + +L
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTG-IPLPLIKSYL 112
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKPEN+L   ++ +  +K+ADFGL+     P         +
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPENLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 170 LWYRAPEIL 178

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 64/117 (54%), Gaps = 5/117 (4%)
Query: 39  NCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPEN 96
            C+F+ +EFC  G L  +I  R   ++ +  A +  +Q+  G++ ++S  +IHRDLKP N
Sbjct: 107 KCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSN 166
Query: 97  ILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFV 153
           I L    D   +KI DFGL  +L       +  G+  YM+PE +  Q Y ++V+ + 
Sbjct: 167 IFLV---DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYA 220

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 76/145 (52%), Gaps = 6/145 (4%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTA 68
           K  +  E++ ++ ++HP +I L DAF+ +  + L++EF +GG L   I     ++ E   
Sbjct: 92  KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV 151
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
             +++Q   GL+ ++ H I+H D+KPENI+         +KI DFGL+  L P    +  
Sbjct: 152 INYMRQACEGLKHMHEHSIVHLDIKPENIMCE-TKKASSVKIIDFGLATKLNPDEIVKVT 210
Query: 129 CGSPLYMAPEVLQFQRYDEKVNFFV 153
             +  + APE++      E V F+ 
Sbjct: 211 TATAEFAAPEIVD----REPVGFYT 231

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/134 (35%), Positives = 74/134 (55%), Gaps = 9/134 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 166
Query: 132 PLYMAPEVLQFQRY 145
             Y APE+L   +Y
Sbjct: 167 LWYRAPEILLGXKY 180

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 78/141 (55%), Gaps = 11/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
           E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +        Q A   R+ L
Sbjct: 68  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 127
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGS 131
           Q     LE L+S+ +IHR++K +NILL G+D  V  K+ DFG    + P       + G+
Sbjct: 128 Q----ALEFLHSNQVIHRNIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGT 180
Query: 132 PLYMAPEVLQFQRYDEKVNFF 152
           P +MAPEV+  + Y  KV+ +
Sbjct: 181 PYWMAPEVVTRKAYGPKVDIW 201

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 79/154 (51%), Gaps = 7/154 (4%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG- 61
           + L   LK+    E   L   +HPNI+RL      +  I++V+E   GG+  +++R  G 
Sbjct: 149 ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA 208
Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
           R+  +T  + +    AG+E L S   IHRDL   N L++   +  +LKI+DFG+S     
Sbjct: 209 RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEAD 265
Query: 122 GNYAEK--VCGSPL-YMAPEVLQFQRYDEKVNFF 152
           G YA    +   P+ + APE L + RY  + + +
Sbjct: 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVW 299

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 47/129 (36%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 110
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKPEN+L   ++ +  +K+ADFGL+     P         +
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPENLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 167
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 168 LWYRAPEIL 176

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 47/129 (36%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTG-IPLPLIKSYL 109
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKPEN+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPENLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 166
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 167 LWYRAPEIL 175

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/135 (36%), Positives = 77/135 (57%), Gaps = 11/135 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 116
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YP-GNYAEKVCG 130
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P   Y  +V  
Sbjct: 117 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVV- 172
Query: 131 SPLYMAPEVLQFQRY 145
           +  Y APE+L   +Y
Sbjct: 173 TLWYRAPEILLGXKY 187

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 47/129 (36%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 111
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKPEN+L   ++ +  +K+ADFGL+     P         +
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPENLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 168
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 169 LWYRAPEIL 177

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 21/156 (13%)
Query: 16  ELNFLSSVNHPNIIRL---FDAFQAE-------------NCIFLVVEFCAGGNLSSYI-- 57
           E+  L+ ++H NI+     +D F  +              C+F+ +EFC  G L  +I  
Sbjct: 54  EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113
Query: 58  RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
           R   ++ +  A +  +Q+  G++ ++S  +I+RDLKP NI L    D   +KI DFGL  
Sbjct: 114 RRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVT 170
Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFV 153
           +L       +  G+  YM+PE +  Q Y ++V+ + 
Sbjct: 171 SLKNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYA 206

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 40/119 (33%), Positives = 69/119 (57%), Gaps = 2/119 (1%)
Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQLGAGLEILN 83
           P +I L + ++  + I L++E+ AGG + S     L   V E    + ++Q+  G+  L+
Sbjct: 89  PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF 142
            ++I+H DLKP+NILLS +     +KI DFG+S  +       ++ G+P Y+APE+L +
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNY 207

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 73/129 (56%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF +  +L  ++    L G +P    + +L
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTG-IPLPLIKSYL 111
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 168
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 169 LWYRAPEIL 177

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 73/129 (56%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF +  +L  ++    L G +P    + +L
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTG-IPLPLIKSYL 112
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 170 LWYRAPEIL 178

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 6/140 (4%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           L +   SC   E + L + +   I +L  AFQ EN ++LV+E+  GG+L + +   G R+
Sbjct: 100 LKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERI 159
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           P + AR +L ++   ++ ++    +HRD+KP+NIL   LD    +++ADFG    L    
Sbjct: 160 PAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNIL---LDRCGHIRLADFGSCLKLRADG 216
Query: 124 YAEKV--CGSPLYMAPEVLQ 141
               +   G+P Y++PE+LQ
Sbjct: 217 TVRSLVAVGTPDYLSPEILQ 236

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 73/129 (56%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L +++    L G +P    + +L
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKTFMDASALTG-IPLPLIKSYL 112
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 170 LWYRAPEIL 178

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLSFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 166
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 167 LWYRAPEIL 175

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 47/131 (35%), Positives = 66/131 (50%), Gaps = 2/131 (1%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
            HPNII L D +     ++LV E   GG L   I       E+ A   L  +G  +E L+
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLH 138
Query: 84  SHHIIHRDLKPENIL-LSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ 141
           S  ++HRDLKP NIL +    +   L+I DFG +  L   N      C +  ++APEVL+
Sbjct: 139 SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLK 198
Query: 142 FQRYDEKVNFF 152
            Q YDE  + +
Sbjct: 199 RQGYDEGCDIW 209

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 71/139 (51%), Gaps = 13/139 (9%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86
           NI+ L + F+ +   +LV E   GG++ ++I+      E+ A + ++ + A L+ L++  
Sbjct: 72  NILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKG 131
Query: 87  IIHRDLKPENILLSGLDDDVMLKIADFGL--------SCTLYPGNYAEKVCGSPLYMAPE 138
           I HRDLKPENIL    +    +KI DF L        SCT          CGS  YMAPE
Sbjct: 132 IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPE 191
Query: 139 VL-----QFQRYDEKVNFF 152
           V+     Q   YD++ + +
Sbjct: 192 VVEVFTDQATFYDKRCDLW 210

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 47/131 (35%), Positives = 66/131 (50%), Gaps = 2/131 (1%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
            HPNII L D +     ++LV E   GG L   I       E+ A   L  +G  +E L+
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLH 138
Query: 84  SHHIIHRDLKPENIL-LSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ 141
           S  ++HRDLKP NIL +    +   L+I DFG +  L   N      C +  ++APEVL+
Sbjct: 139 SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLK 198
Query: 142 FQRYDEKVNFF 152
            Q YDE  + +
Sbjct: 199 RQGYDEGCDIW 209

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 77/140 (55%), Gaps = 4/140 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   + ++HPNI+RL++ F     I+L++E+   G L   ++      EQ     +
Sbjct: 70  LRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIM 129
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
           ++L   L   +   +IHRD+KPEN+LL        LKIADFG S    P    + +CG+ 
Sbjct: 130 EELADALMYCHGKKVIHRDIKPENLLLGLK---GELKIADFGWSVHA-PSLRRKTMCGTL 185
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+ PE+++ + ++EKV+ +
Sbjct: 186 DYLPPEMIEGRMHNEKVDLW 205

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 110
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 167
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 168 LWYRAPEIL 176

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 166
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 167 LWYRAPEIL 175

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 108
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 165
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 166 LWYRAPEIL 174

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 166
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 167 LWYRAPEIL 175

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 108
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 165
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 166 LWYRAPEIL 174

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 108
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 165
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 166 LWYRAPEIL 174

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 166
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 167 LWYRAPEIL 175

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 166
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 167 LWYRAPEIL 175

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 108
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 165
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 166 LWYRAPEIL 174

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 166
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 167 LWYRAPEIL 175

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 110
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 167
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 168 LWYRAPEIL 176

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 108
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 165
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 166 LWYRAPEIL 174

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 113
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 114 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 170
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 171 LWYRAPEIL 179

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 166
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 167 LWYRAPEIL 175

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 73/129 (56%), Gaps = 7/129 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E++ +   + P++++ + ++     +++V+E+C  G++S  IRL  +   E      LQ 
Sbjct: 74  EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQS 133
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSP 132
              GLE L+    IHRD+K  NIL   L+ +   K+ADFG++  L     A++  V G+P
Sbjct: 134 TLKGLEYLHFMRKIHRDIKAGNIL---LNTEGHAKLADFGVAGQLT-DXMAKRNXVIGTP 189
Query: 133 LYMAPEVLQ 141
            +MAPEV+Q
Sbjct: 190 FWMAPEVIQ 198

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 116
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 117 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 173
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 174 LWYRAPEIL 182

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 112
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 170 LWYRAPEIL 178

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 111
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 168
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 169 LWYRAPEIL 177

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 166
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 167 LWYRAPEIL 175

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/144 (35%), Positives = 76/144 (52%), Gaps = 13/144 (9%)
Query: 17  LNFLSSVNHPNIIRLFDA-----FQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTAR 69
           L  L +  HPN++RLFD         E  + LV E     +L++Y+       VP +T +
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK 123
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKV 128
             + QL  GL+ L+SH ++HRDLKP+NIL++       +K+ADFGL+  +Y    A   V
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLA-RIYSFQMALTSV 179
Query: 129 CGSPLYMAPEVLQFQRYDEKVNFF 152
             +  Y APEVL    Y   V+ +
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLW 203

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 78/141 (55%), Gaps = 6/141 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E+  L+++ HPNI++  ++F+    +++V+++C GG+L   I     V   E     +  
Sbjct: 73  EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV 132
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC-GSP 132
           Q+   L+ ++   I+HRD+K +NI L+    D  +++ DFG++  L       + C G+P
Sbjct: 133 QICLALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIARVLNSTVELARACIGTP 189
Query: 133 LYMAPEVLQFQRYDEKVNFFV 153
            Y++PE+ + + Y+ K + + 
Sbjct: 190 YYLSPEICENKPYNNKSDIWA 210

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 113
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 114 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 170
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 171 LWYRAPEIL 179

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/144 (35%), Positives = 76/144 (52%), Gaps = 13/144 (9%)
Query: 17  LNFLSSVNHPNIIRLFDA-----FQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTAR 69
           L  L +  HPN++RLFD         E  + LV E     +L++Y+       VP +T +
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK 123
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKV 128
             + QL  GL+ L+SH ++HRDLKP+NIL++       +K+ADFGL+  +Y    A   V
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLA-RIYSFQMALTSV 179
Query: 129 CGSPLYMAPEVLQFQRYDEKVNFF 152
             +  Y APEVL    Y   V+ +
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLW 203

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 111
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 168
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 169 LWYRAPEIL 177

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/144 (35%), Positives = 76/144 (52%), Gaps = 13/144 (9%)
Query: 17  LNFLSSVNHPNIIRLFDA-----FQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTAR 69
           L  L +  HPN++RLFD         E  + LV E     +L++Y+       VP +T +
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK 123
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKV 128
             + QL  GL+ L+SH ++HRDLKP+NIL++       +K+ADFGL+  +Y    A   V
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLA-RIYSFQMALTSV 179
Query: 129 CGSPLYMAPEVLQFQRYDEKVNFF 152
             +  Y APEVL    Y   V+ +
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLW 203

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 74/138 (53%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P + + + ++  +  +++++E+  GG+    +   G + E      L+++
Sbjct: 75  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 133
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 134
             GL+ L+S   IHRD+K  N+LLS   +   +K+ADFG++  L           G+P +
Sbjct: 134 LKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFW 190
Query: 135 MAPEVLQFQRYDEKVNFF 152
           MAPEV++   YD K + +
Sbjct: 191 MAPEVIKQSAYDSKADIW 208

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 74/138 (53%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P + + + ++  +  +++++E+  GG+    +   G + E      L+++
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 113
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 134
             GL+ L+S   IHRD+K  N+LLS   +   +K+ADFG++  L           G+P +
Sbjct: 114 LKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFW 170
Query: 135 MAPEVLQFQRYDEKVNFF 152
           MAPEV++   YD K + +
Sbjct: 171 MAPEVIKQSAYDSKADIW 188

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 112
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 170 LWYRAPEIL 178

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYL 110
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 167
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 168 LWYRAPEIL 176

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 74/145 (51%), Gaps = 8/145 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL   + ++ P I+ L+ A +    + + +E   GG+L   I+  G +PE  A  +L Q 
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQA 159
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------VC 129
             GLE L++  I+H D+K +N+LLS   D     + DFG +  L P    +       + 
Sbjct: 160 LEGLEYLHTRRILHGDVKADNVLLS--SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 130 GSPLYMAPEVLQFQRYDEKVNFFVS 154
           G+  +MAPEV+  +  D KV+ + S
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSS 242

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 73/138 (52%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  +   + + + ++   + +++++E+  GG+    +R  G   E      L+++
Sbjct: 71  EITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEI 129
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 134
             GL+ L+S   IHRD+K  N+LLS   D   +K+ADFG++  L           G+P +
Sbjct: 130 LKGLDYLHSEKKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFW 186
Query: 135 MAPEVLQFQRYDEKVNFF 152
           MAPEV+Q   YD K + +
Sbjct: 187 MAPEVIQQSAYDSKADIW 204

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/134 (34%), Positives = 75/134 (55%), Gaps = 12/134 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E+  L    H NI+ LF  +  +  + +V ++C G +L  Y  LH    +   +K +   
Sbjct: 70  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL--YHHLHASETKFEMKKLIDIA 126
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 129
           +Q   G++ L++  IIHRDLK  NI L    +D  +KI DFGL+   + + G++  E++ 
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATEKSRWSGSHQFEQLS 183
Query: 130 GSPLYMAPEVLQFQ 143
           GS L+MAPEV++ Q
Sbjct: 184 GSILWMAPEVIRMQ 197

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 74/145 (51%), Gaps = 8/145 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL   + ++ P I+ L+ A +    + + +E   GG+L   I+  G +PE  A  +L Q 
Sbjct: 114 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQA 173
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------VC 129
             GLE L++  I+H D+K +N+LLS   D     + DFG +  L P    +       + 
Sbjct: 174 LEGLEYLHTRRILHGDVKADNVLLS--SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 231
Query: 130 GSPLYMAPEVLQFQRYDEKVNFFVS 154
           G+  +MAPEV+  +  D KV+ + S
Sbjct: 232 GTETHMAPEVVMGKPCDAKVDIWSS 256

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 64/126 (50%), Gaps = 4/126 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  + HPN++ L + F+ +  + LV E+C    L    R    VPE   +    Q 
Sbjct: 52  EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT 111
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLY 134
              +   + H+ IHRD+KPENIL++      ++K+ DFG +  L  P +Y +    +  Y
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILIT---KHSVIKLCDFGFARLLTGPSDYYDDEVATRWY 168
Query: 135 MAPEVL 140
            +PE+L
Sbjct: 169 RSPELL 174

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 74/145 (51%), Gaps = 8/145 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL   + ++ P I+ L+ A +    + + +E   GG+L   I+  G +PE  A  +L Q 
Sbjct: 116 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQA 175
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------VC 129
             GLE L++  I+H D+K +N+LLS   D     + DFG +  L P    +       + 
Sbjct: 176 LEGLEYLHTRRILHGDVKADNVLLS--SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 233
Query: 130 GSPLYMAPEVLQFQRYDEKVNFFVS 154
           G+  +MAPEV+  +  D KV+ + S
Sbjct: 234 GTETHMAPEVVMGKPCDAKVDIWSS 258

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 73/145 (50%), Gaps = 8/145 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL   + +  P I+ L+ A +    + + +E   GG+L   ++  G +PE  A  +L Q 
Sbjct: 135 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQA 194
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------VC 129
             GLE L+S  I+H D+K +N+LLS   D     + DFG +  L P    +       + 
Sbjct: 195 LEGLEYLHSRRILHGDVKADNVLLS--SDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIP 252
Query: 130 GSPLYMAPEVLQFQRYDEKVNFFVS 154
           G+  +MAPEV+  +  D KV+ + S
Sbjct: 253 GTETHMAPEVVLGRSCDAKVDVWSS 277

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 14/148 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL   + +  P I+ L+ A +    + + +E   GG+L   ++  G +PE  A  +L Q 
Sbjct: 116 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQA 175
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP---------GNYAE 126
             GLE L+S  I+H D+K +N+LLS   D     + DFG +  L P         G+Y  
Sbjct: 176 LEGLEYLHSRRILHGDVKADNVLLS--SDGSHAALCDFGHAVCLQPDGLGKDLLTGDY-- 231
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVNFFVS 154
            + G+  +MAPEV+  +  D KV+ + S
Sbjct: 232 -IPGTETHMAPEVVLGRSCDAKVDVWSS 258

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/134 (34%), Positives = 75/134 (55%), Gaps = 12/134 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E+  L    H NI+ LF  +  +  + +V ++C G +L  Y  LH    +   +K +   
Sbjct: 58  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL--YHHLHASETKFEMKKLIDIA 114
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 129
           +Q   G++ L++  IIHRDLK  NI L    +D  +KI DFGL+   + + G++  E++ 
Sbjct: 115 RQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATVKSRWSGSHQFEQLS 171
Query: 130 GSPLYMAPEVLQFQ 143
           GS L+MAPEV++ Q
Sbjct: 172 GSILWMAPEVIRMQ 185

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/133 (34%), Positives = 72/133 (54%), Gaps = 9/133 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
           E+  L  ++HPN+++L +      E+ +++V E    G +     L   + E  AR + Q
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK-PLSEDQARFYFQ 144
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGS 131
            L  G+E L+   IIHRD+KP N+L+    +D  +KIADFG+S   + G+ A      G+
Sbjct: 145 DLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKIADFGVSNE-FKGSDALLSNTVGT 200
Query: 132 PLYMAPEVLQFQR 144
           P +MAPE L   R
Sbjct: 201 PAFMAPESLSETR 213

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 74/138 (53%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P + + + ++  +  +++++E+  GG+    +   G + E      L+++
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 113
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 134
             GL+ L+S   IHRD+K  N+LLS   +   +K+ADFG++  L           G+P +
Sbjct: 114 LKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFW 170
Query: 135 MAPEVLQFQRYDEKVNFF 152
           MAPEV++   YD K + +
Sbjct: 171 MAPEVIKQSAYDSKADIW 188

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 79/140 (56%), Gaps = 6/140 (4%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRV 63
           L +   +C   E + L + +   I  L  AFQ EN ++LV+++  GG+L + + +   ++
Sbjct: 129 LKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKL 188
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           PE  AR ++ ++   ++ ++  H +HRD+KP+N+L   LD +  +++ADFG    +    
Sbjct: 189 PEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVL---LDVNGHIRLADFGSCLKMNDDG 245
Query: 124 YAEK--VCGSPLYMAPEVLQ 141
             +     G+P Y++PE+LQ
Sbjct: 246 TVQSSVAVGTPDYISPEILQ 265

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 79/140 (56%), Gaps = 6/140 (4%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRV 63
           L +   +C   E + L + +   I  L  AFQ EN ++LV+++  GG+L + + +   ++
Sbjct: 113 LKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKL 172
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           PE  AR ++ ++   ++ ++  H +HRD+KP+N+L   LD +  +++ADFG    +    
Sbjct: 173 PEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVL---LDVNGHIRLADFGSCLKMNDDG 229
Query: 124 YAEK--VCGSPLYMAPEVLQ 141
             +     G+P Y++PE+LQ
Sbjct: 230 TVQSSVAVGTPDYISPEILQ 249

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 74/138 (53%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P + + + ++  +  +++++E+  GG+    +   G + E      L+++
Sbjct: 70  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 128
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 134
             GL+ L+S   IHRD+K  N+LLS   +   +K+ADFG++  L           G+P +
Sbjct: 129 LKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFW 185
Query: 135 MAPEVLQFQRYDEKVNFF 152
           MAPEV++   YD K + +
Sbjct: 186 MAPEVIKQSAYDSKADIW 203

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 71/138 (51%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++   R+PE+   K    +
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 123
Query: 76  GAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 124 LRGLAYLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 179
Query: 135 MAPEVLQFQRYDEKVNFF 152
           MAPE LQ   Y  + + +
Sbjct: 180 MAPERLQGTHYSVQSDIW 197

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/134 (34%), Positives = 74/134 (55%), Gaps = 12/134 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E+  L    H NI+ LF  +     + +V ++C G +L  Y  LH    +   +K +   
Sbjct: 70  EVGVLRKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSL--YHHLHASETKFEMKKLIDIA 126
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 129
           +Q   G++ L++  IIHRDLK  NI L    +D  +KI DFGL+   + + G++  E++ 
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATEKSRWSGSHQFEQLS 183
Query: 130 GSPLYMAPEVLQFQ 143
           GS L+MAPEV++ Q
Sbjct: 184 GSILWMAPEVIRMQ 197

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/129 (34%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV E     +L +++    L G +P    + +L
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEHVHQ-DLKTFMDASALTG-IPLPLIKSYL 108
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 165
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 166 LWYRAPEIL 174

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 75/140 (53%), Gaps = 5/140 (3%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++       E  AR +  +
Sbjct: 200 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 259
Query: 75  LGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSP 132
           + + L+ L+S  ++++RDLK EN++   LD D  +KI DFGL    +  G   +  CG+P
Sbjct: 260 IVSALDYLHSEKNVVYRDLKLENLM---LDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 316
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+APEVL+   Y   V+++
Sbjct: 317 EYLAPEVLEDNDYGRAVDWW 336

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 75/140 (53%), Gaps = 5/140 (3%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++       E  AR +  +
Sbjct: 197 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 256
Query: 75  LGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSP 132
           + + L+ L+S  ++++RDLK EN++   LD D  +KI DFGL    +  G   +  CG+P
Sbjct: 257 IVSALDYLHSEKNVVYRDLKLENLM---LDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 313
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+APEVL+   Y   V+++
Sbjct: 314 EYLAPEVLEDNDYGRAVDWW 333

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 78/154 (50%), Gaps = 7/154 (4%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG- 61
           + L   LK+    E   L   +HPNI+RL      +  I++V+E   GG+  +++R  G 
Sbjct: 149 ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA 208
Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
           R+  +T  + +    AG+E L S   IHRDL   N L++   +  +LKI+DFG+S     
Sbjct: 209 RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEAD 265
Query: 122 GNYAEK--VCGSPL-YMAPEVLQFQRYDEKVNFF 152
           G  A    +   P+ + APE L + RY  + + +
Sbjct: 266 GVXAASGGLRQVPVKWTAPEALNYGRYSSESDVW 299

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 75/140 (53%), Gaps = 5/140 (3%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++       E  AR +  +
Sbjct: 58  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 117
Query: 75  LGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSP 132
           + + L+ L+S  ++++RDLK EN++   LD D  +KI DFGL    +  G   +  CG+P
Sbjct: 118 IVSALDYLHSEKNVVYRDLKLENLM---LDKDGHIKITDFGLCKEGIKDGATMKXFCGTP 174
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+APEVL+   Y   V+++
Sbjct: 175 EYLAPEVLEDNDYGRAVDWW 194

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 75/140 (53%), Gaps = 5/140 (3%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++       E  AR +  +
Sbjct: 57  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 116
Query: 75  LGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSP 132
           + + L+ L+S  ++++RDLK EN++   LD D  +KI DFGL    +  G   +  CG+P
Sbjct: 117 IVSALDYLHSEKNVVYRDLKLENLM---LDKDGHIKITDFGLCKEGIKDGATMKXFCGTP 173
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+APEVL+   Y   V+++
Sbjct: 174 EYLAPEVLEDNDYGRAVDWW 193

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 75/140 (53%), Gaps = 5/140 (3%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++       E  AR +  +
Sbjct: 59  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 118
Query: 75  LGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSP 132
           + + L+ L+S  ++++RDLK EN++   LD D  +KI DFGL    +  G   +  CG+P
Sbjct: 119 IVSALDYLHSEKNVVYRDLKLENLM---LDKDGHIKITDFGLCKEGIKDGATMKXFCGTP 175
Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            Y+APEVL+   Y   V+++
Sbjct: 176 EYLAPEVLEDNDYGRAVDWW 195

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/129 (40%), Positives = 73/129 (56%), Gaps = 10/129 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E+  L  ++HPNII L DAF  ++ I LV +F    +L   I+ +  V  P       L 
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGS 131
            L  GLE L+ H I+HRDLKP N+L   LD++ +LK+ADFGL+ +    N  Y  +V  +
Sbjct: 121 TL-QGLEYLHQHWILHRDLKPNNLL---LDENGVLKLADFGLAKSFGSPNRAYXHQVV-T 175
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 176 RWYRAPELL 184

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 45/129 (34%), Positives = 71/129 (55%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV E     +L  ++    L G +P    + +L
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTG-IPLPLIKSYL 112
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 132 PLYMAPEVL 140
             Y APE+L
Sbjct: 170 LWYRAPEIL 178

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 76/145 (52%), Gaps = 5/145 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----PEQTA 68
           L  E +    + HP+I+ L + + ++  +++V EF  G +L   I           E  A
Sbjct: 75  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 134
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEK 127
             +++Q+   L   + ++IIHRD+KP  +LL+  ++   +K+  FG++  L   G  A  
Sbjct: 135 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 194
Query: 128 VCGSPLYMAPEVLQFQRYDEKVNFF 152
             G+P +MAPEV++ + Y + V+ +
Sbjct: 195 RVGTPHFMAPEVVKREPYGKPVDVW 219

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 76/145 (52%), Gaps = 5/145 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----PEQTA 68
           L  E +    + HP+I+ L + + ++  +++V EF  G +L   I           E  A
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEK 127
             +++Q+   L   + ++IIHRD+KP  +LL+  ++   +K+  FG++  L   G  A  
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 192
Query: 128 VCGSPLYMAPEVLQFQRYDEKVNFF 152
             G+P +MAPEV++ + Y + V+ +
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVW 217

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 70/136 (51%), Gaps = 4/136 (2%)
Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           +K +K     E+  L  + H N++ L +  + +   +LV EF     L         +  
Sbjct: 64  DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDY 123
Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNY 124
           Q  +K+L Q+  G+   +SH+IIHRD+KPENIL+S      ++K+ DFG + TL  PG  
Sbjct: 124 QVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEV 180
Query: 125 AEKVCGSPLYMAPEVL 140
            +    +  Y APE+L
Sbjct: 181 YDDEVATRWYRAPELL 196

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 75/137 (54%), Gaps = 5/137 (3%)
Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
           L+ +S+ + P I+ +  AF   + +  +++   GG+L  ++  HG   E   R +  ++ 
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 77  AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 136
            GLE +++  +++RDLKP NIL   LD+   ++I+D GL+C  +         G+  YMA
Sbjct: 303 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 358
Query: 137 PEVLQFQ-RYDEKVNFF 152
           PEVLQ    YD   ++F
Sbjct: 359 PEVLQKGVAYDSSADWF 375

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 75/137 (54%), Gaps = 5/137 (3%)
Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
           L+ +S+ + P I+ +  AF   + +  +++   GG+L  ++  HG   E   R +  ++ 
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 77  AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 136
            GLE +++  +++RDLKP NIL   LD+   ++I+D GL+C  +         G+  YMA
Sbjct: 303 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 358
Query: 137 PEVLQFQ-RYDEKVNFF 152
           PEVLQ    YD   ++F
Sbjct: 359 PEVLQKGVAYDSSADWF 375

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 75/137 (54%), Gaps = 5/137 (3%)
Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
           L+ +S+ + P I+ +  AF   + +  +++   GG+L  ++  HG   E   R +  ++ 
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 77  AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 136
            GLE +++  +++RDLKP NIL   LD+   ++I+D GL+C  +         G+  YMA
Sbjct: 303 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 358
Query: 137 PEVLQFQ-RYDEKVNFF 152
           PEVLQ    YD   ++F
Sbjct: 359 PEVLQKGVAYDSSADWF 375

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 75/137 (54%), Gaps = 5/137 (3%)
Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
           L+ +S+ + P I+ +  AF   + +  +++   GG+L  ++  HG   E   R +  ++ 
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 301
Query: 77  AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 136
            GLE +++  +++RDLKP NIL   LD+   ++I+D GL+C  +         G+  YMA
Sbjct: 302 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 357
Query: 137 PEVLQFQ-RYDEKVNFF 152
           PEVLQ    YD   ++F
Sbjct: 358 PEVLQKGVAYDSSADWF 374

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 72/141 (51%), Gaps = 6/141 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA-RKFLQQ 74
           E   +  ++HP +++ +     E  I++V E+ + G L +Y+R HG+  E +   +    
Sbjct: 53  EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-PL 133
           +  G+  L SH  IHRDL   N L   +D D+ +K++DFG++  +    Y   V    P+
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCL---VDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV 169
Query: 134 -YMAPEVLQFQRYDEKVNFFV 153
            + APEV  + +Y  K + + 
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWA 190

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 24/154 (15%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQ--TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
              RVPE+  T +  +    QL  G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 114 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 144
           GL+  +   +Y +K     L   +MAPE L F R
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDR 234

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 24/154 (15%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQ--TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
              RVPE+  T +  +    QL  G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 114 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 144
           GL+  +   +Y +K     L   +MAPE L F R
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDR 234

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 24/154 (15%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQ--TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
              RVPE+  T +  +    QL  G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 114 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 144
           GL+  +   +Y +K     L   +MAPE L F R
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDR 234

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 24/154 (15%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 131 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 190
Query: 61  --GRVPEQ--TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
              RVPE+  T +  +    QL  G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 247
Query: 114 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 144
           GL+  +   +Y +K     L   +MAPE L F R
Sbjct: 248 GLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDR 280

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 24/154 (15%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 72  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 131
Query: 61  --GRVPEQ--TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
              RVPE+  T +  +    QL  G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 132 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVT---ENNVMKIADF 188
Query: 114 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 144
           GL+  +   +Y +K     L   +MAPE L F R
Sbjct: 189 GLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDR 221

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 73/141 (51%), Gaps = 7/141 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
           E N + ++ H  ++RL+     E  I+++ EF A G+L  +++    G+V       F  
Sbjct: 57  EANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSA 116
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 132
           Q+  G+  +   + IHRDL+  N+L+S   + +M KIADFGL+  +    Y A +    P
Sbjct: 117 QIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNEYTAREGAKFP 173
Query: 133 L-YMAPEVLQFQRYDEKVNFF 152
           + + APE + F  +  K N +
Sbjct: 174 IKWTAPEAINFGCFTIKSNVW 194

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 24/154 (15%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 77  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 136
Query: 61  --GRVPEQ--TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
              RVPE+  T +  +    QL  G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 137 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 193
Query: 114 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 144
           GL+  +   +Y +K     L   +MAPE L F R
Sbjct: 194 GLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDR 226

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/134 (34%), Positives = 75/134 (55%), Gaps = 12/134 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E+  L    H NI+ LF  +  +  + +V ++C G +L  Y  LH    +    K +   
Sbjct: 74  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIA 130
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 129
           +Q   G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 131 RQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATEKSRWSGSHQFEQLS 187
Query: 130 GSPLYMAPEVLQFQ 143
           GS L+MAPEV++ Q
Sbjct: 188 GSILWMAPEVIRMQ 201

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/134 (34%), Positives = 75/134 (55%), Gaps = 12/134 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E+  L    H NI+ LF  +  +  + +V ++C G +L  Y  LH    +    K +   
Sbjct: 81  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIA 137
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 129
           +Q   G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 138 RQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLS 194
Query: 130 GSPLYMAPEVLQFQ 143
           GS L+MAPEV++ Q
Sbjct: 195 GSILWMAPEVIRMQ 208

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/134 (34%), Positives = 75/134 (55%), Gaps = 12/134 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E+  L    H NI+ LF  +  +  + +V ++C G +L  Y  LH    +    K +   
Sbjct: 82  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIA 138
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 129
           +Q   G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 139 RQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLS 195
Query: 130 GSPLYMAPEVLQFQ 143
           GS L+MAPEV++ Q
Sbjct: 196 GSILWMAPEVIRMQ 209

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 24/154 (15%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 74  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 133
Query: 61  --GRVPEQ--TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
              RVPE+  T +  +    QL  G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 134 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 190
Query: 114 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 144
           GL+  +   +Y +K     L   +MAPE L F R
Sbjct: 191 GLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDR 223

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/134 (34%), Positives = 75/134 (55%), Gaps = 12/134 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E+  L    H NI+ LF  +  +  + +V ++C G +L  Y  LH    +    K +   
Sbjct: 82  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIA 138
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 129
           +Q   G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 139 RQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATEKSRWSGSHQFEQLS 195
Query: 130 GSPLYMAPEVLQFQ 143
           GS L+MAPEV++ Q
Sbjct: 196 GSILWMAPEVIRMQ 209

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/134 (34%), Positives = 75/134 (55%), Gaps = 12/134 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E+  L    H NI+ LF  +  +  + +V ++C G +L  Y  LH    +    K +   
Sbjct: 59  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIA 115
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 129
           +Q   G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 116 RQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLS 172
Query: 130 GSPLYMAPEVLQFQ 143
           GS L+MAPEV++ Q
Sbjct: 173 GSILWMAPEVIRMQ 186

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/134 (34%), Positives = 75/134 (55%), Gaps = 12/134 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E+  L    H NI+ LF  +  +  + +V ++C G +L  Y  LH    +    K +   
Sbjct: 56  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIA 112
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 129
           +Q   G++ L++  IIHRDLK  NI    L +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 113 RQTAQGMDYLHAKSIIHRDLKSNNIF---LHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 169
Query: 130 GSPLYMAPEVLQFQ 143
           GS L+MAPEV++ Q
Sbjct: 170 GSILWMAPEVIRMQ 183

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/134 (34%), Positives = 75/134 (55%), Gaps = 12/134 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E+  L    H NI+ LF  +  +  + +V ++C G +L  Y  LH    +    K +   
Sbjct: 59  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIA 115
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 129
           +Q   G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 116 RQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLS 172
Query: 130 GSPLYMAPEVLQFQ 143
           GS L+MAPEV++ Q
Sbjct: 173 GSILWMAPEVIRMQ 186

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/134 (34%), Positives = 75/134 (55%), Gaps = 12/134 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E+  L    H NI+ LF  +  +  + +V ++C G +L  Y  LH    +    K +   
Sbjct: 54  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIA 110
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 129
           +Q   G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 111 RQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLS 167
Query: 130 GSPLYMAPEVLQFQ 143
           GS L+MAPEV++ Q
Sbjct: 168 GSILWMAPEVIRMQ 181

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/134 (34%), Positives = 75/134 (55%), Gaps = 12/134 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E+  L    H NI+ LF  +  +  + +V ++C G +L  Y  LH    +    K +   
Sbjct: 54  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIA 110
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 129
           +Q   G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 111 RQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATEKSRWSGSHQFEQLS 167
Query: 130 GSPLYMAPEVLQFQ 143
           GS L+MAPEV++ Q
Sbjct: 168 GSILWMAPEVIRMQ 181

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 73/153 (47%), Gaps = 19/153 (12%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E+  +  + HPN+++       +  +  + E+  GG L   I+ +  + P      F + 
Sbjct: 57  EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------- 127
           + +G+  L+S +IIHRDL   N L+    ++  + +ADFGL+  +       +       
Sbjct: 117 IASGMAYLHSMNIIHRDLNSHNCLVR---ENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 128 --------VCGSPLYMAPEVLQFQRYDEKVNFF 152
                   V G+P +MAPE++  + YDEKV+ F
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVF 206

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 74/140 (52%), Gaps = 7/140 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  ++HPNI+ L D   +E C+ LV EF               + +   + +L QL
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 133
             G+   + H I+HRDLKP+N+L   ++ D  LK+ADFGL+    +   +Y  +V  +  
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLL---INSDGALKLADFGLARAFGIPVRSYTHEVV-TLW 184
Query: 134 YMAPEVLQ-FQRYDEKVNFF 152
           Y AP+VL   ++Y   V+ +
Sbjct: 185 YRAPDVLMGSKKYSTSVDIW 204

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 78/154 (50%), Gaps = 24/154 (15%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQ--TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
              RVPE+  T +  +    QL  G+E L S   IHRDL   N+L++   ++ +++IADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMRIADF 201
Query: 114 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 144
           GL+  +   +Y +K     L   +MAPE L F R
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDR 234

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 74/140 (52%), Gaps = 7/140 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  ++HPNI+ L D   +E C+ LV EF               + +   + +L QL
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 133
             G+   + H I+HRDLKP+N+L   ++ D  LK+ADFGL+    +   +Y  +V  +  
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLL---INSDGALKLADFGLARAFGIPVRSYTHEVV-TLW 184
Query: 134 YMAPEVLQ-FQRYDEKVNFF 152
           Y AP+VL   ++Y   V+ +
Sbjct: 185 YRAPDVLMGSKKYSTSVDIW 204

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/134 (34%), Positives = 74/134 (55%), Gaps = 12/134 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E+  L    H NI+ LF  +     + +V ++C G +L  Y  LH    +    K +   
Sbjct: 54  EVGVLRKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSL--YHHLHIIETKFEMIKLIDIA 110
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 129
           +Q   G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 111 RQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLS 167
Query: 130 GSPLYMAPEVLQFQ 143
           GS L+MAPEV++ Q
Sbjct: 168 GSILWMAPEVIRMQ 181

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/136 (33%), Positives = 75/136 (55%), Gaps = 16/136 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF---- 71
           E+  L    H NI+ LF  +  ++ + +V ++C G +L  Y  LH  V E   + F    
Sbjct: 82  EVAVLRKTRHVNIL-LFMGYMTKDNLAIVTQWCEGSSL--YKHLH--VQETKFQMFQLID 136
Query: 72  -LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGN-YAEK 127
             +Q   G++ L++ +IIHRD+K  NI    L + + +KI DFGL+   + + G+   E+
Sbjct: 137 IARQTAQGMDYLHAKNIIHRDMKSNNIF---LHEGLTVKIGDFGLATVKSRWSGSQQVEQ 193
Query: 128 VCGSPLYMAPEVLQFQ 143
             GS L+MAPEV++ Q
Sbjct: 194 PTGSVLWMAPEVIRMQ 209

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 69/131 (52%), Gaps = 7/131 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
           E N + ++ H  ++RL+     E  I+++ E+ A G+L  +++    G+V       F  
Sbjct: 58  EANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 117
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 132
           Q+  G+  +   + IHRDL+  N+L+S   + +M KIADFGL+  +    Y A +    P
Sbjct: 118 QIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNEYTAREGAKFP 174
Query: 133 L-YMAPEVLQF 142
           + + APE + F
Sbjct: 175 IKWTAPEAINF 185

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 77/154 (50%), Gaps = 24/154 (15%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQ--TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
              RVPE+  T +  +    QL  G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 114 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 144
           GL+  +   +Y +      L   +MAPE L F R
Sbjct: 202 GLARDINNIDYYKNTTNGRLPVKWMAPEAL-FDR 234

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 70/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NLS  I++   +  +   
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 70/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NLS  I++   +  +   
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 70/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NLS  I++   +  +   
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 77/154 (50%), Gaps = 24/154 (15%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++V + + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQ--TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
              RVPE+  T +  +    QL  G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 114 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 144
           GL+  +   +Y +K     L   +MAPE L F R
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDR 234

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 80/184 (43%), Gaps = 46/184 (25%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR--- 58
           ++++N      +  E+  +  ++HPNI RL++ ++ E  I LV+E C GG+L   +    
Sbjct: 64  IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123
Query: 59  ------------------------------LHG-------RVPEQTARKFLQQLGAGLEI 81
                                         +HG          E+     ++Q+ + L  
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183
Query: 82  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-----KVCGSPLYMA 136
           L++  I HRD+KPEN L S  +    +K+ DFGLS   Y  N  E        G+P ++A
Sbjct: 184 LHNQGICHRDIKPENFLFS-TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242
Query: 137 PEVL 140
           PEVL
Sbjct: 243 PEVL 246

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/133 (33%), Positives = 65/133 (48%), Gaps = 6/133 (4%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
            HPNII L D +     +++V E   GG L   I       E+ A   L  +   +E L+
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH 133
Query: 84  SHHIIHRDLKPENILL---SGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEV 139
           +  ++HRDLKP NIL    SG  + +  +I DFG +  L   N      C +  ++APEV
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESI--RICDFGFAKQLRAENGLLXTPCYTANFVAPEV 191
Query: 140 LQFQRYDEKVNFF 152
           L+ Q YD   + +
Sbjct: 192 LERQGYDAACDIW 204

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 8/143 (5%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +   +HPNIIRL           +V E+   G+L +++R H G+         L+
Sbjct: 99  SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR 158
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSP 132
            +GAG+  L+    +HRDL   N+L   +D +++ K++DFGLS  L    + A    G  
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVL---VDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGK 215
Query: 133 L---YMAPEVLQFQRYDEKVNFF 152
           +   + APE + F+ +    + +
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVW 238

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/133 (33%), Positives = 65/133 (48%), Gaps = 6/133 (4%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
            HPNII L D +     +++V E   GG L   I       E+ A   L  +   +E L+
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH 133
Query: 84  SHHIIHRDLKPENILL---SGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEV 139
           +  ++HRDLKP NIL    SG  + +  +I DFG +  L   N      C +  ++APEV
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESI--RICDFGFAKQLRAENGLLMTPCYTANFVAPEV 191
Query: 140 LQFQRYDEKVNFF 152
           L+ Q YD   + +
Sbjct: 192 LERQGYDAACDIW 204

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 77/156 (49%), Gaps = 28/156 (17%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 71  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEY 128
Query: 65  ---------EQTARKFL----QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
                    EQ + K L     Q+  G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 129 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 185
Query: 112 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 144
           DFGL+  ++  +Y +K     L   +MAPE L F R
Sbjct: 186 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDR 220

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 71/145 (48%), Gaps = 12/145 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RLHGRVPE----QTAR 69
           E++ +  + H NI+RL+D    EN + LV EF    +L  Y+  R  G  P        +
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVK 111
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKV 128
            F  QL  GL   + + I+HRDLKP+N+L   ++    LK+ DFGL+     P N     
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLL---INKRGQLKLGDFGLARAFGIPVNTFSSE 168
Query: 129 CGSPLYMAPEVLQFQR-YDEKVNFF 152
             +  Y AP+VL   R Y   ++ +
Sbjct: 169 VVTLWYRAPDVLMGSRTYSTSIDIW 193

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 77/154 (50%), Gaps = 24/154 (15%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSY 144
Query: 61  --GRVPEQ--TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
              RVPE+  T +  +    QL  G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 114 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 144
           GL+  +   +  +K     L   +MAPE L F R
Sbjct: 202 GLARDINNIDXXKKTTNGRLPVKWMAPEAL-FDR 234

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 77/156 (49%), Gaps = 28/156 (17%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 70  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEY 127
Query: 65  ---------EQTARKFL----QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
                    EQ + K L     Q+  G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 128 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 184
Query: 112 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 144
           DFGL+  ++  +Y +K     L   +MAPE L F R
Sbjct: 185 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDR 219

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 77/156 (49%), Gaps = 28/156 (17%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 67  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEY 124
Query: 65  ---------EQTARKFL----QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
                    EQ + K L     Q+  G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 125 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 181
Query: 112 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 144
           DFGL+  ++  +Y +K     L   +MAPE L F R
Sbjct: 182 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDR 216

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 77/156 (49%), Gaps = 28/156 (17%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEY 135
Query: 65  ---------EQTARKFL----QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
                    EQ + K L     Q+  G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 136 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 192
Query: 112 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 144
           DFGL+  ++  +Y +K     L   +MAPE L F R
Sbjct: 193 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDR 227

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 77/154 (50%), Gaps = 24/154 (15%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQ--TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
              RVPE+  T +  +    QL  G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 114 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 144
           GL+  +   +  +K     L   +MAPE L F R
Sbjct: 202 GLARDINNIDXXKKTTNGRLPVKWMAPEAL-FDR 234

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 77/156 (49%), Gaps = 28/156 (17%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQAREPPGLEY 135
Query: 65  ---------EQTARKFL----QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
                    EQ + K L     Q+  G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 136 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 192
Query: 112 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 144
           DFGL+  ++  +Y +K     L   +MAPE L F R
Sbjct: 193 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDR 227

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 77/156 (49%), Gaps = 28/156 (17%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 63  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEY 120
Query: 65  ---------EQTARKFL----QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
                    EQ + K L     Q+  G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 121 CYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 177
Query: 112 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 144
           DFGL+  ++  +Y +K     L   +MAPE L F R
Sbjct: 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDR 212

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 69/121 (57%), Gaps = 7/121 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 48  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 106
Query: 58  RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 107 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
Query: 116 S 116
           +
Sbjct: 167 A 167

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 77/156 (49%), Gaps = 28/156 (17%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEY 135
Query: 65  ---------EQTARKFL----QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
                    EQ + K L     Q+  G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 136 CYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 192
Query: 112 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 144
           DFGL+  ++  +Y +K     L   +MAPE L F R
Sbjct: 193 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDR 227

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 77/154 (50%), Gaps = 24/154 (15%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++V + + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQ--TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
              RVPE+  T +  +    QL  G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 114 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 144
           GL+  +   +Y +K     L   +MAPE L F R
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDR 234

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 70/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NLS  I++   +  +   
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 77/156 (49%), Gaps = 28/156 (17%)
Query: 11  SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 119 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEY 176
Query: 65  ---------EQTARKFL----QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
                    EQ + K L     Q+  G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 177 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 233
Query: 112 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 144
           DFGL+  ++  +Y +K     L   +MAPE L F R
Sbjct: 234 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDR 268

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/143 (34%), Positives = 68/143 (47%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  L  VNH NII L + F  +        ++LV+E     NL   I  H  +  +   
Sbjct: 71  ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--HMELDHERMS 127
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 128 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTASTNFMMTPYV 184
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 185 VTRYYRAPEVILGMGYKENVDIW 207

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 8/143 (5%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +   +HPNIIRL           +V E+   G+L +++R H G+         L+
Sbjct: 99  SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR 158
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSP 132
            +GAG+  L+    +HRDL   N+L   +D +++ K++DFGLS  L    + A    G  
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVL---VDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGK 215
Query: 133 L---YMAPEVLQFQRYDEKVNFF 152
           +   + APE + F+ +    + +
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVW 238

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 84/168 (50%), Gaps = 21/168 (12%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           LK  + + +     E   L+++ H +I++ +      + + +V E+   G+L+ ++R HG
Sbjct: 51  LKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHG 110
Query: 62  ----------RVPEQTARKFL---QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVML 108
                        E T  + L   QQ+ AG+  L S H +HRDL   N L+    +++++
Sbjct: 111 PDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLV 167
Query: 109 KIADFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVNFF 152
           KI DFG+S  +Y  +Y  +V G  +    +M PE + ++++  + + +
Sbjct: 168 KIGDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVW 214

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 70/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NLS  I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 75/138 (54%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +    H N++ +++++   + +++V+EF  GG L+  +  H R+ E+        +
Sbjct: 71  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAV 129
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
              L +L++  +IHRD+K ++ILL+    D  +K++DFG    +       K + G+P +
Sbjct: 130 LQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYW 186
Query: 135 MAPEVLQFQRYDEKVNFF 152
           MAPE++    Y  +V+ +
Sbjct: 187 MAPELISRLPYGPEVDIW 204

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 69/127 (54%), Gaps = 2/127 (1%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQ 74
           E++ L+   H NI+ L ++F++   + ++ EF +G ++   I      + E+    ++ Q
Sbjct: 51  EISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ 110
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
           +   L+ L+SH+I H D++PENI+         +KI +FG +  L PG+    +  +P Y
Sbjct: 111 VCEALQFLHSHNIGHFDIRPENIIYQTRRSST-IKIIEFGQARQLKPGDNFRLLFTAPEY 169
Query: 135 MAPEVLQ 141
            APEV Q
Sbjct: 170 YAPEVHQ 176

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 75/138 (54%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +    H N++ +++++   + +++V+EF  GG L+  +  H R+ E+        +
Sbjct: 67  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAV 125
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
              L +L++  +IHRD+K ++ILL+    D  +K++DFG    +       K + G+P +
Sbjct: 126 LQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYW 182
Query: 135 MAPEVLQFQRYDEKVNFF 152
           MAPE++    Y  +V+ +
Sbjct: 183 MAPELISRLPYGPEVDIW 200

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME--LDHERMS 122
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 123 YLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYV 179
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIW 202

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 78/168 (46%), Gaps = 36/168 (21%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 423 IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 481
Query: 58  RLHGRVPEQTARKF----------LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVM 107
           ++         RKF            QL   L  L S   +HRD+   N+L+S  D    
Sbjct: 482 QV---------RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATD---C 529
Query: 108 LKIADFGLSCTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVNFFV 153
           +K+ DFGLS  +    Y +   G  P+ +MAPE + F+R+    + ++
Sbjct: 530 VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 577

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 75/138 (54%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +    H N++ +++++   + +++V+EF  GG L+  +  H R+ E+        +
Sbjct: 76  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAV 134
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
              L +L++  +IHRD+K ++ILL+    D  +K++DFG    +       K + G+P +
Sbjct: 135 LQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYW 191
Query: 135 MAPEVLQFQRYDEKVNFF 152
           MAPE++    Y  +V+ +
Sbjct: 192 MAPELISRLPYGPEVDIW 209

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 78/159 (49%), Gaps = 18/159 (11%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 43  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 101
Query: 58  RLHG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           ++    +   +   +  QL   L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 102 QVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATD---CVKLGDFGLS 158
Query: 117 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVNFFV 153
             +    Y +   G  P+ +MAPE + F+R+    + ++
Sbjct: 159 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 197

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 75/138 (54%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +    H N++ +++++   + +++V+EF  GG L+  +  H R+ E+        +
Sbjct: 78  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAV 136
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
              L +L++  +IHRD+K ++ILL+    D  +K++DFG    +       K + G+P +
Sbjct: 137 LQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYW 193
Query: 135 MAPEVLQFQRYDEKVNFF 152
           MAPE++    Y  +V+ +
Sbjct: 194 MAPELISRLPYGPEVDIW 211

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 76/165 (46%), Gaps = 31/165 (18%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------------IFLVVEFCAGGNLSSYIRLHGRV 63
           E+  L+ + HP I+R F+A+  +N             +++ ++ C   NL  ++     +
Sbjct: 53  EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI 112
Query: 64  PEQTARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
            E+     L    Q+   +E L+S  ++HRDLKP NI  + +DD  ++K+ DFGL   + 
Sbjct: 113 EERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT-MDD--VVKVGDFGLVTAMD 169
Query: 121 PGNYAEKV-------------CGSPLYMAPEVLQFQRYDEKVNFF 152
                + V              G+ LYM+PE +    Y  KV+ F
Sbjct: 170 QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIF 214

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 74/138 (53%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +   +H N++ ++ ++   + +++V+EF  GG L+  +  H R+ E+        +
Sbjct: 92  EVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIATVCLSV 150
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
              L  L++  +IHRD+K ++ILL+    D  +K++DFG    +       K + G+P +
Sbjct: 151 LRALSYLHNQGVIHRDIKSDSILLTS---DGRIKLSDFGFCAQVSKEVPKRKXLVGTPYW 207
Query: 135 MAPEVLQFQRYDEKVNFF 152
           MAPEV+    Y  +V+ +
Sbjct: 208 MAPEVISRLPYGTEVDIW 225

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 70/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NLS  I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 70/129 (54%), Gaps = 6/129 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFL 72
           E+     + H NI++   +F     I + +E   GG+LS+ +R      +  EQT   + 
Sbjct: 69  EIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT 128
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGS 131
           +Q+  GL+ L+ + I+HRD+K +N+L++      +LKI+DFG S  L   N   E   G+
Sbjct: 129 KQILEGLKYLHDNQIVHRDIKGDNVLINTYSG--VLKISDFGTSKRLAGINPCTETFTGT 186
Query: 132 PLYMAPEVL 140
             YMAPE++
Sbjct: 187 LQYMAPEII 195

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 75/138 (54%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +    H N++ +++++   + +++V+EF  GG L+  +  H R+ E+        +
Sbjct: 121 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAV 179
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
              L +L++  +IHRD+K ++ILL+    D  +K++DFG    +       K + G+P +
Sbjct: 180 LQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYW 236
Query: 135 MAPEVLQFQRYDEKVNFF 152
           MAPE++    Y  +V+ +
Sbjct: 237 MAPELISRLPYGPEVDIW 254

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 70/129 (54%), Gaps = 6/129 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFL 72
           E+     + H NI++   +F     I + +E   GG+LS+ +R      +  EQT   + 
Sbjct: 55  EIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT 114
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGS 131
           +Q+  GL+ L+ + I+HRD+K +N+L++      +LKI+DFG S  L   N   E   G+
Sbjct: 115 KQILEGLKYLHDNQIVHRDIKGDNVLINTYSG--VLKISDFGTSKRLAGINPCTETFTGT 172
Query: 132 PLYMAPEVL 140
             YMAPE++
Sbjct: 173 LQYMAPEII 181

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 58/101 (57%), Gaps = 3/101 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  + H NI+RL D   ++  + LV EFC       +   +G +  +  + FL QL
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL 110
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
             GL   +S +++HRDLKP+N+L   ++ +  LK+ADFGL+
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLL---INRNGELKLADFGLA 148

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 70/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T       E   
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMEPEV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDLW 209

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 72/135 (53%), Gaps = 13/135 (9%)
Query: 16  ELNFLSSVNH-PNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIR--LHGRVPEQ 66
           E+N L   +H  NI   + AF  +N       ++LV+EFC  G+++  I+      + E+
Sbjct: 70  EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 129
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYA 125
                 +++  GL  L+ H +IHRD+K +N+LL+   ++  +K+ DFG+S  L       
Sbjct: 130 WIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRR 186
Query: 126 EKVCGSPLYMAPEVL 140
               G+P +MAPEV+
Sbjct: 187 NTFIGTPYWMAPEVI 201

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 70/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T       E   
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMEPEV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 74  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 130
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 131 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 187
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIW 210

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANLCQVIQME--LDHERMS 167
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 224
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIW 247

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 122
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 179
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIW 202

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 78/152 (51%), Gaps = 28/152 (18%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP---------EQ 66
           E    + + HPN++ L      +  + ++  +C+ G+L  ++ +  R P         ++
Sbjct: 79  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVM--RSPHSDVGSTDDDR 136
Query: 67  TARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
           T +  L+         Q+ AG+E L+SHH++H+DL   N+L+    D + +KI+D GL  
Sbjct: 137 TVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY---DKLNVKISDLGLFR 193
Query: 118 TLYPGNYAEKVCGSPL----YMAPEVLQFQRY 145
            +Y  +Y  K+ G+ L    +MAPE + + ++
Sbjct: 194 EVYAADYY-KLLGNSLLPIRWMAPEAIMYGKF 224

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 74  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 130
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 131 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 187
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIW 210

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 72  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 128
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 129 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 185
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 186 VTRYYRAPEVILGMGYKENVDIW 208

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 67  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 123
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 124 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 180
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 181 VTRYYRAPEVILGMGYKENVDIW 203

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 67  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 123
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 124 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 180
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 181 VTRYYRAPEVILGMGYKENVDIW 203

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 167
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 224
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIW 247

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 78/152 (51%), Gaps = 28/152 (18%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP---------EQ 66
           E    + + HPN++ L      +  + ++  +C+ G+L  ++ +  R P         ++
Sbjct: 62  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVM--RSPHSDVGSTDDDR 119
Query: 67  TARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
           T +  L+         Q+ AG+E L+SHH++H+DL   N+L+    D + +KI+D GL  
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY---DKLNVKISDLGLFR 176
Query: 118 TLYPGNYAEKVCGSPL----YMAPEVLQFQRY 145
            +Y  +Y  K+ G+ L    +MAPE + + ++
Sbjct: 177 EVYAADYY-KLLGNSLLPIRWMAPEAIMYGKF 207

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 75/138 (54%), Gaps = 5/138 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +    H N++ +++++   + +++V+EF  GG L+  +  H R+ E+        +
Sbjct: 198 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAV 256
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
              L +L++  +IHRD+K ++ILL+    D  +K++DFG    +       K + G+P +
Sbjct: 257 LQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYW 313
Query: 135 MAPEVLQFQRYDEKVNFF 152
           MAPE++    Y  +V+ +
Sbjct: 314 MAPELISRLPYGPEVDIW 331

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 78/159 (49%), Gaps = 18/159 (11%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 43  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 101
Query: 58  RLHGRVPEQTARK-FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           ++     +  +   +  QL   L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 102 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 158
Query: 117 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVNFFV 153
             +    Y +   G  P+ +MAPE + F+R+    + ++
Sbjct: 159 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 197

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 78/159 (49%), Gaps = 18/159 (11%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 43  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 101
Query: 58  RLHGRVPEQTARK-FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           ++     +  +   +  QL   L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 102 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 158
Query: 117 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVNFFV 153
             +    Y +   G  P+ +MAPE + F+R+    + ++
Sbjct: 159 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 197

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 78/168 (46%), Gaps = 36/168 (21%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 423 IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 481
Query: 58  RLHGRVPEQTARKF----------LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVM 107
           ++         RKF            QL   L  L S   +HRD+   N+L+S  D    
Sbjct: 482 QV---------RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---C 529
Query: 108 LKIADFGLSCTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVNFFV 153
           +K+ DFGLS  +    Y +   G  P+ +MAPE + F+R+    + ++
Sbjct: 530 VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 577

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 78/159 (49%), Gaps = 18/159 (11%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 71  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 129
Query: 58  RLHGRVPEQTARK-FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           ++     +  +   +  QL   L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 130 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 186
Query: 117 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVNFFV 153
             +    Y +   G  P+ +MAPE + F+R+    + ++
Sbjct: 187 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 225

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 78/159 (49%), Gaps = 18/159 (11%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 40  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 98
Query: 58  RLHGRVPEQTARK-FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           ++     +  +   +  QL   L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 99  QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 155
Query: 117 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVNFFV 153
             +    Y +   G  P+ +MAPE + F+R+    + ++
Sbjct: 156 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 194

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 78/159 (49%), Gaps = 18/159 (11%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 46  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 104
Query: 58  RLHGRVPEQTARK-FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           ++     +  +   +  QL   L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 105 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 161
Query: 117 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVNFFV 153
             +    Y +   G  P+ +MAPE + F+R+    + ++
Sbjct: 162 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 200

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 19/149 (12%)
Query: 20  LSSVNHPNIIRLFD-----AFQAENCIFLVVEFCAGGNLSSYIRLHGR-------VPEQT 67
           +   +HPN+IRL       + Q      +++ F   G+L +Y+ L+ R       +P QT
Sbjct: 90  MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL-LYSRLETGPKHIPLQT 148
Query: 68  ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE- 126
             KF+  +  G+E L++ + +HRDL   N +L    DD+ + +ADFGLS  +Y G+Y   
Sbjct: 149 LLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR---DDMTVCVADFGLSKKIYSGDYYRQ 205
Query: 127 -KVCGSPL-YMAPEVLQFQRYDEKVNFFV 153
            ++   P+ ++A E L  + Y  K + + 
Sbjct: 206 GRIAKMPVKWIAIESLADRVYTSKSDVWA 234

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 78/159 (49%), Gaps = 18/159 (11%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 45  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 103
Query: 58  RLHGRVPEQTARK-FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           ++     +  +   +  QL   L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 104 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 160
Query: 117 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVNFFV 153
             +    Y +   G  P+ +MAPE + F+R+    + ++
Sbjct: 161 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 199

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 78/159 (49%), Gaps = 18/159 (11%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 48  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 106
Query: 58  RLHGRVPEQTARK-FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           ++     +  +   +  QL   L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 107 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 163
Query: 117 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVNFFV 153
             +    Y +   G  P+ +MAPE + F+R+    + ++
Sbjct: 164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 202

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 76/156 (48%), Gaps = 28/156 (17%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEF 135
Query: 65  ---------EQTARKFL----QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
                    EQ + K L     Q+  G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 136 SFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 192
Query: 112 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 144
           DFGL+  ++  +  +K     L   +MAPE L F R
Sbjct: 193 DFGLARDIHHIDXXKKTTNGRLPVKWMAPEAL-FDR 227

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 78/162 (48%), Gaps = 25/162 (15%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 66  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 125
Query: 58  RL-------HGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSG 101
           R        +   PE   + FL          Q+  G+E L S   IHRDL   NILLS 
Sbjct: 126 RSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 184
Query: 102 LDDDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-YMAPEVL 140
             +  ++KI DFGL+  +Y  P    +     PL +MAPE +
Sbjct: 185 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 224

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 64/137 (46%), Gaps = 7/137 (5%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           K+ NK +   LD     L S + P I++ F  F     +F+ +E           R+ G 
Sbjct: 64  KEENKRILMDLDV---VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGP 120
Query: 63  VPEQTARKFLQQLGAGLEILNSHH-IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
           +PE+   K    +   L  L   H +IHRD+KP NILL   D+   +K+ DFG+S  L  
Sbjct: 121 IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISGRLVD 177
Query: 122 GNYAEKVCGSPLYMAPE 138
               ++  G   YMAPE
Sbjct: 178 DKAKDRSAGCAAYMAPE 194

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKXQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDXELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 167 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 71/142 (50%), Gaps = 9/142 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY-IRLHGRVPEQTARKFLQQ 74
           E   +  +++P I+RL    QAE  + LV+E   GG L  + +     +P     + L Q
Sbjct: 60  EAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGS- 131
           +  G++ L   + +HRDL   N+LL    +    KI+DFGLS  L   +  Y  +  G  
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKW 175
Query: 132 PL-YMAPEVLQFQRYDEKVNFF 152
           PL + APE + F+++  + + +
Sbjct: 176 PLKWYAPECINFRKFSSRSDVW 197

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 75/153 (49%), Gaps = 30/153 (19%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----------- 63
            E N L  VNHP++I+L+ A   +  + L+VE+   G+L  ++R   +V           
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 64  -------PEQTAR------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
                  P++ A        F  Q+  G++ L    ++HRDL   NIL++   +   +KI
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMKI 191
Query: 111 ADFGLSCTLY-PGNYAEKVCGS-PL-YMAPEVL 140
           +DFGLS  +Y   +Y ++  G  P+ +MA E L
Sbjct: 192 SDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESL 224

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/143 (34%), Positives = 67/143 (46%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  L  VNH NII L + F  +        ++LV+E     NL   I  H  +  +   
Sbjct: 73  ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--HMELDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTACTNFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y   V+ +
Sbjct: 187 VTRYYRAPEVILGMGYAANVDIW 209

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 67  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQME--LDHERMS 123
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 124 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 180
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 181 VTRYYRAPEVILGMGYKENVDLW 203

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 63/130 (48%), Gaps = 27/130 (20%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----------- 63
            E N L  VNHP++I+L+ A   +  + L+VE+   G+L  ++R   +V           
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 64  -------PEQTAR------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
                  P++ A        F  Q+  G++ L    ++HRDL   NIL++   +   +KI
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMKI 191
Query: 111 ADFGLSCTLY 120
           +DFGLS  +Y
Sbjct: 192 SDFGLSRDVY 201

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 75/148 (50%), Gaps = 17/148 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E    +++NHP I+ ++D  +AE       ++V+E+  G  L   +   G +   T ++ 
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM---TPKRA 118
Query: 72  LQQLGAGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEK 127
           ++ +    + LN  H   IIHRD+KP NIL+S  +    +K+ DFG++  +   GN   +
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANILISATN---AVKVVDFGIARAIADSGNSVXQ 175
Query: 128 ---VCGSPLYMAPEVLQFQRYDEKVNFF 152
              V G+  Y++PE  +    D + + +
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVY 203

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 71/143 (49%), Gaps = 8/143 (5%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
           CE + +   +HPN++ L         + +V+EF   G L +++R H G+         L+
Sbjct: 93  CEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLR 152
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY--PGNYAEKVCGS 131
            + AG+  L     +HRDL   NIL   ++ +++ K++DFGLS  +   P        G 
Sbjct: 153 GIAAGMRYLADMGYVHRDLAARNIL---VNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGK 209
Query: 132 -PL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE +Q++++    + +
Sbjct: 210 IPVRWTAPEAIQYRKFTSASDVW 232

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 78/162 (48%), Gaps = 25/162 (15%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 64  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 58  RL-------HGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSG 101
           R        +   PE   + FL          Q+  G+E L S   IHRDL   NILLS 
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 182
Query: 102 LDDDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-YMAPEVL 140
             +  ++KI DFGL+  +Y  P    +     PL +MAPE +
Sbjct: 183 --EKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETI 222

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 78  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQME--LDHERMS 134
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 135 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 191
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 192 VTRYYRAPEVILGMGYKENVDLW 214

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 63/130 (48%), Gaps = 27/130 (20%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----------- 63
            E N L  VNHP++I+L+ A   +  + L+VE+   G+L  ++R   +V           
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 64  -------PEQTAR------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
                  P++ A        F  Q+  G++ L    ++HRDL   NIL++   +   +KI
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVA---EGRKMKI 191
Query: 111 ADFGLSCTLY 120
           +DFGLS  +Y
Sbjct: 192 SDFGLSRDVY 201

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 58/101 (57%), Gaps = 3/101 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  + H NI+RL D   ++  + LV EFC       +   +G +  +  + FL QL
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL 110
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
             GL   +S +++HRDLKP+N+L   ++ +  LK+A+FGL+
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLL---INRNGELKLANFGLA 148

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL+K  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 64  VKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 122
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 123 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 178
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 179 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 219

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 71/144 (49%), Gaps = 11/144 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   ++++EF   GNL  Y+R   R  E +A   L   
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 115
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  L  G+      G+ 
Sbjct: 116 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS-RLMTGDTXTAHAGAK 171
Query: 133 L---YMAPEVLQFQRYDEKVNFFV 153
               + APE L + ++  K + + 
Sbjct: 172 FPIKWTAPESLAYNKFSIKSDVWA 195

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 78/162 (48%), Gaps = 25/162 (15%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 101 MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 160
Query: 58  RL-------HGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSG 101
           R        +   PE   + FL          Q+  G+E L S   IHRDL   NILLS 
Sbjct: 161 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 219
Query: 102 LDDDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-YMAPEVL 140
             +  ++KI DFGL+  +Y  P    +     PL +MAPE +
Sbjct: 220 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 259

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 87/166 (52%), Gaps = 25/166 (15%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 59  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 117
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 118 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 173
Query: 111 ADFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+      + A+++ G   +  Y APE+ L +  Y++ V+ +
Sbjct: 174 LDFGLA-----RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 9/143 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   ++++EF   GNL  Y+R   R  E +A   L   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 117
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 132 PL-YMAPEVLQFQRYDEKVNFFV 153
           P+ + APE L + ++  K + + 
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWA 197

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKXQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 167 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 9/143 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   ++++EF   GNL  Y+R   R  E +A   L   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 117
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 132 PL-YMAPEVLQFQRYDEKVNFFV 153
           P+ + APE L + ++  K + + 
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWA 197

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 87/166 (52%), Gaps = 25/166 (15%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 59  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 117
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 118 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 173
Query: 111 ADFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+      + A+++ G   +  Y APE+ L +  Y++ V+ +
Sbjct: 174 LDFGLA-----RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 74  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMS 130
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 131 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 187
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIW 210

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 87/166 (52%), Gaps = 25/166 (15%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 59  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 117
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 118 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 173
Query: 111 ADFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+      + A+++ G   +  Y APE+ L +  Y++ V+ +
Sbjct: 174 LDFGLA-----RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 78/162 (48%), Gaps = 25/162 (15%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 64  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 58  RL-------HGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSG 101
           R        +   PE   + FL          Q+  G+E L S   IHRDL   NILLS 
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 182
Query: 102 LDDDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-YMAPEVL 140
             +  ++KI DFGL+  +Y  P    +     PL +MAPE +
Sbjct: 183 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 222

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 63  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 121
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 122 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDXELKI 177
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 178 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 218

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 57  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 115
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 116 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDXELKI 171
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 172 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 212

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 78/150 (52%), Gaps = 9/150 (6%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +++K   H++S +  E+  L     H N++ L + F+ E+  +LV E   GG++ S+I  
Sbjct: 45  IIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK 104
Query: 60  HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
                E  A   +Q + + L+ L++  I HRDLKPENIL    +    +KI DFGL   +
Sbjct: 105 RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGI 164
Query: 120 ------YPGNYAE--KVCGSPLYMAPEVLQ 141
                  P +  E    CGS  YMAPEV++
Sbjct: 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVE 194

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 57  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 115
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 116 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDXELKI 171
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 172 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 212

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 77/167 (46%), Gaps = 31/167 (18%)
Query: 2   LKKLNKHLKSCLDCELNFLSSV-------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLS 54
           +K+  K L   +D E N L  V        H +++R F A+  ++ + +  E+C GG+L+
Sbjct: 39  IKRSKKPLAGSVD-EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLA 97
Query: 55  SYIRLHGRV----PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS---------- 100
             I  + R+     E   +  L Q+G GL  ++S  ++H D+KP NI +S          
Sbjct: 98  DAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASE 157
Query: 101 -GLDDD-----VMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 141
            G +DD     VM KI D G    +      E   G   ++A EVLQ
Sbjct: 158 EGDEDDWASNKVMFKIGDLGHVTRISSPQVEE---GDSRFLANEVLQ 201

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 58  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 116
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 117 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDSELKI 172
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 173 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 213

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 77/167 (46%), Gaps = 31/167 (18%)
Query: 2   LKKLNKHLKSCLDCELNFLSSV-------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLS 54
           +K+  K L   +D E N L  V        H +++R F A+  ++ + +  E+C GG+L+
Sbjct: 39  IKRSKKPLAGSVD-EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLA 97
Query: 55  SYIRLHGRV----PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS---------- 100
             I  + R+     E   +  L Q+G GL  ++S  ++H D+KP NI +S          
Sbjct: 98  DAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASE 157
Query: 101 -GLDDD-----VMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 141
            G +DD     VM KI D G    +      E   G   ++A EVLQ
Sbjct: 158 EGDEDDWASNKVMFKIGDLGHVTRISSPQVEE---GDSRFLANEVLQ 201

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 48  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 106
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 107 ADLNNIVKC-AKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 162
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 163 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 203

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 77/167 (46%), Gaps = 31/167 (18%)
Query: 2   LKKLNKHLKSCLDCELNFLSSV-------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLS 54
           +K+  K L   +D E N L  V        H +++R F A+  ++ + +  E+C GG+L+
Sbjct: 37  IKRSKKPLAGSVD-EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLA 95
Query: 55  SYIRLHGRV----PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS---------- 100
             I  + R+     E   +  L Q+G GL  ++S  ++H D+KP NI +S          
Sbjct: 96  DAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASE 155
Query: 101 -GLDDD-----VMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 141
            G +DD     VM KI D G    +      E   G   ++A EVLQ
Sbjct: 156 EGDEDDWASNKVMFKIGDLGHVTRISSPQVEE---GDSRFLANEVLQ 199

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 72/143 (50%), Gaps = 11/143 (7%)
Query: 17  LNFLSSVNHPNIIRLFDA-----FQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTAR 69
           L  L +  HPN++RL D         E  + LV E     +L +Y+       +P +T +
Sbjct: 57  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIK 115
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             ++Q   GL+ L+++ I+HRDLKPENIL++       +K+ADFGL+         + V 
Sbjct: 116 DLMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQMALDPVV 172
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEVL    Y   V+ +
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMW 195

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 167 LDFGLA--RHTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPEV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 77/167 (46%), Gaps = 31/167 (18%)
Query: 2   LKKLNKHLKSCLDCELNFLSSV-------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLS 54
           +K+  K L   +D E N L  V        H +++R F A+  ++ + +  E+C GG+L+
Sbjct: 41  IKRSKKPLAGSVD-EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLA 99
Query: 55  SYIRLHGRV----PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS---------- 100
             I  + R+     E   +  L Q+G GL  ++S  ++H D+KP NI +S          
Sbjct: 100 DAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASE 159
Query: 101 -GLDDD-----VMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 141
            G +DD     VM KI D G    +      E   G   ++A EVLQ
Sbjct: 160 EGDEDDWASNKVMFKIGDLGHVTRISSPQVEE---GDSRFLANEVLQ 203

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 82/155 (52%), Gaps = 9/155 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-H 60
           L+K ++ + S    E++ L  + H NI++L+D    +  + LV E     +L   + +  
Sbjct: 36  LEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCE 94
Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT-- 118
           G +   TA+ FL QL  G+   +   ++HRDLKP+N+L   ++ +  LKIADFGL+    
Sbjct: 95  GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL---INREGELKIADFGLARAFG 151
Query: 119 LYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVNFF 152
           +    Y  +V  +  Y AP+VL   ++Y   ++ +
Sbjct: 152 IPVRKYTHEVV-TLWYRAPDVLMGSKKYSTTIDIW 185

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 167 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 54  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 112
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 113 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDSELKI 168
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 169 LDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 209

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 82/155 (52%), Gaps = 9/155 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-H 60
           L+K ++ + S    E++ L  + H NI++L+D    +  + LV E     +L   + +  
Sbjct: 36  LEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCE 94
Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT-- 118
           G +   TA+ FL QL  G+   +   ++HRDLKP+N+L   ++ +  LKIADFGL+    
Sbjct: 95  GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL---INREGELKIADFGLARAFG 151
Query: 119 LYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVNFF 152
           +    Y  +V  +  Y AP+VL   ++Y   ++ +
Sbjct: 152 IPVRKYTHEVV-TLWYRAPDVLMGSKKYSTTIDIW 185

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 48  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 106
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 107 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 162
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 163 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 203

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 58  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 116
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 117 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 172
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 173 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 213

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/142 (26%), Positives = 71/142 (50%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E   + +++H  +++L+     +  IF++ E+ A G L +Y+R +  R   Q   +  + 
Sbjct: 54  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 113
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  +    Y   V GS   
Sbjct: 114 VCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 169
Query: 134 --YMAPEVLQFQRYDEKVNFFV 153
             +  PEVL + ++  K + + 
Sbjct: 170 VRWSPPEVLMYSKFSSKSDIWA 191

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/142 (26%), Positives = 71/142 (50%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E   + +++H  +++L+     +  IF++ E+ A G L +Y+R +  R   Q   +  + 
Sbjct: 49  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 108
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  +    Y   V GS   
Sbjct: 109 VCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 164
Query: 134 --YMAPEVLQFQRYDEKVNFFV 153
             +  PEVL + ++  K + + 
Sbjct: 165 VRWSPPEVLMYSKFSSKSDIWA 186

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 57  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 115
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 116 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 171
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 172 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 212

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 75/148 (50%), Gaps = 17/148 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E    +++NHP I+ ++D  +AE       ++V+E+  G  L   +   G +   T ++ 
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM---TPKRA 118
Query: 72  LQQLGAGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEK 127
           ++ +    + LN  H   IIHRD+KP NI++S  +    +K+ DFG++  +   GN   +
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQ 175
Query: 128 ---VCGSPLYMAPEVLQFQRYDEKVNFF 152
              V G+  Y++PE  +    D + + +
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVY 203

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 54  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 112
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 113 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 168
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 169 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 209

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 167 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 167 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 62  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 120
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 121 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 176
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 177 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 217

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 75/148 (50%), Gaps = 17/148 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E    +++NHP I+ ++D  +AE       ++V+E+  G  L   +   G +   T ++ 
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM---TPKRA 118
Query: 72  LQQLGAGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEK 127
           ++ +    + LN  H   IIHRD+KP NI++S  +    +K+ DFG++  +   GN   +
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQ 175
Query: 128 ---VCGSPLYMAPEVLQFQRYDEKVNFF 152
              V G+  Y++PE  +    D + + +
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVY 203

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/142 (25%), Positives = 71/142 (50%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL         + +V E+   G+L S++R H  +         L+ 
Sbjct: 84  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 143
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + +G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +    
Sbjct: 144 IASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 200
Query: 132 PL-YMAPEVLQFQRYDEKVNFF 152
           P+ + +PE + ++++    + +
Sbjct: 201 PIRWTSPEAIAYRKFTSASDVW 222

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 75/148 (50%), Gaps = 17/148 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E    +++NHP I+ ++D  +AE       ++V+E+  G  L   +   G +   T ++ 
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM---TPKRA 118
Query: 72  LQQLGAGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEK 127
           ++ +    + LN  H   IIHRD+KP NI++S  +    +K+ DFG++  +   GN   +
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQ 175
Query: 128 ---VCGSPLYMAPEVLQFQRYDEKVNFF 152
              V G+  Y++PE  +    D + + +
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVY 203

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 49  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 107
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 108 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 163
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 164 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 204

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/142 (26%), Positives = 71/142 (50%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E   + +++H  +++L+     +  IF++ E+ A G L +Y+R +  R   Q   +  + 
Sbjct: 60  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 119
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  +    Y   V GS   
Sbjct: 120 VCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 175
Query: 134 --YMAPEVLQFQRYDEKVNFFV 153
             +  PEVL + ++  K + + 
Sbjct: 176 VRWSPPEVLMYSKFSSKSDIWA 197

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/142 (26%), Positives = 71/142 (50%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E   + +++H  +++L+     +  IF++ E+ A G L +Y+R +  R   Q   +  + 
Sbjct: 53  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 112
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  +    Y   V GS   
Sbjct: 113 VCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 168
Query: 134 --YMAPEVLQFQRYDEKVNFFV 153
             +  PEVL + ++  K + + 
Sbjct: 169 VRWSPPEVLMYSKFSSKSDIWA 190

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 50  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 108
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 109 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 164
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 165 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 205

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/142 (25%), Positives = 71/142 (50%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL         + +V E+   G+L S++R H  +         L+ 
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 126
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + +G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +    
Sbjct: 127 IASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 183
Query: 132 PL-YMAPEVLQFQRYDEKVNFF 152
           P+ + +PE + ++++    + +
Sbjct: 184 PIRWTSPEAIAYRKFTSASDVW 205

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 83/174 (47%), Gaps = 37/174 (21%)
Query: 11  SCLDCELNFLSSVNHPNIIRLFDAF-------------QAENCIFLVVEFCAGGNLSSYI 57
           S +  E+  L+S+NH  ++R + A+             + ++ +F+ +E+C  G L  Y 
Sbjct: 47  STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL--YD 104
Query: 58  RLHGRVPEQTARKF---LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
            +H     Q   ++    +Q+   L  ++S  IIHRDLKP NI    +D+   +KI DFG
Sbjct: 105 LIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIF---IDESRNVKIGDFG 161
Query: 115 LSCTLY-------------PGNYA--EKVCGSPLYMAPEVLQFQ-RYDEKVNFF 152
           L+  ++             PG+        G+ +Y+A EVL     Y+EK++ +
Sbjct: 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMY 215

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 58  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 116
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 117 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 172
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 173 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 213

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 49  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 107
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 108 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 163
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 164 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 204

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 75  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 133
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 134 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 189
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 190 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 230

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 59  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 117
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 118 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 173
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 174 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 167 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 167 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 63  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 121
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 122 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 177
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 178 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 218

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 48  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 106
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 107 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 162
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 163 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 203

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 54  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 112
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 113 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 168
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 169 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 209

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 167 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 167 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 58  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 116
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 117 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 172
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 173 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 213

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 72  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 130
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 131 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 186
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 187 LDFGLA--RHTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIW 227

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 9/143 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E +A   L   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 117
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 132 PL-YMAPEVLQFQRYDEKVNFFV 153
           P+ + APE L + ++  K + + 
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWA 197

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 9/143 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E +A   L   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 117
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 132 PL-YMAPEVLQFQRYDEKVNFFV 153
           P+ + APE L + ++  K + + 
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWA 197

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 57  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 115
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 116 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 171
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 172 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 212

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 167 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 9/143 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   ++++EF   GNL  Y+R   R  E  A   L   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 122
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 132 PL-YMAPEVLQFQRYDEKVNFFV 153
           P+ + APE L + ++  K + + 
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWA 202

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 51  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 109
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 110 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 165
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 166 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 206

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 167 LDFGLA--RHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 72  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 130
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 131 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 186
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 187 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 227

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 64  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 122
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 123 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 178
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 179 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 219

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 72  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 130
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 131 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 186
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 187 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 227

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 64  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 122
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 123 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 178
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 179 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 219

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/142 (25%), Positives = 71/142 (50%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL         + +V E+   G+L S++R H  +         L+ 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + +G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +    
Sbjct: 156 IASGMKYLSDMGFVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 132 PL-YMAPEVLQFQRYDEKVNFF 152
           P+ + +PE + ++++    + +
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVW 234

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 48  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 106
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 107 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 162
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 163 LDFGLA--RHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIW 203

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 54  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 112
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 113 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 168
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 169 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 209

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 167 LDFGLA--RHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/142 (26%), Positives = 71/142 (50%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E   + +++H  +++L+     +  IF++ E+ A G L +Y+R +  R   Q   +  + 
Sbjct: 69  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 128
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  +    Y   V GS   
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 184
Query: 134 --YMAPEVLQFQRYDEKVNFFV 153
             +  PEVL + ++  K + + 
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWA 206

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 74/148 (50%), Gaps = 17/148 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E    +++NHP I+ ++D  +AE       ++V+E+  G  L   +   G     T ++ 
Sbjct: 79  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRA 135
Query: 72  LQQLGAGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEK 127
           ++ +    + LN  H   IIHRD+KP NI++S  +    +K+ DFG++  +   GN   +
Sbjct: 136 IEVIADACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQ 192
Query: 128 ---VCGSPLYMAPEVLQFQRYDEKVNFF 152
              V G+  Y++PE  +    D + + +
Sbjct: 193 TAAVIGTAQYLSPEQARGDSVDARSDVY 220

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 70/144 (48%), Gaps = 11/144 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   ++++EF   GNL  Y+R   R  E  A   L   
Sbjct: 60  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 118
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  L  G+      G+ 
Sbjct: 119 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS-RLMTGDTXTAHAGAK 174
Query: 133 L---YMAPEVLQFQRYDEKVNFFV 153
               + APE L + ++  K + + 
Sbjct: 175 FPIKWTAPESLAYNKFSIKSDVWA 198

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 71  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 129
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 130 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 185
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 186 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 226

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 9/143 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E +A   L   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 122
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 132 PL-YMAPEVLQFQRYDEKVNFFV 153
           P+ + APE L + ++  K + + 
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWA 202

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 71  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 129
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 130 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 185
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 186 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 226

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 82/155 (52%), Gaps = 9/155 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-H 60
           L+K ++ + S    E++ L  + H NI++L+D    +  + LV E     +L   + +  
Sbjct: 36  LEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCE 94
Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT-- 118
           G +   TA+ FL QL  G+   +   ++HRDLKP+N+L   ++ +  LKIADFGL+    
Sbjct: 95  GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL---INREGELKIADFGLARAFG 151
Query: 119 LYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVNFF 152
           +    Y  ++  +  Y AP+VL   ++Y   ++ +
Sbjct: 152 IPVRKYTHEIV-TLWYRAPDVLMGSKKYSTTIDIW 185

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 70/144 (48%), Gaps = 11/144 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E +A   L   
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 115
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  L  G+      G+ 
Sbjct: 116 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS-RLMTGDTXTAHAGAK 171
Query: 133 L---YMAPEVLQFQRYDEKVNFFV 153
               + APE L + ++  K + + 
Sbjct: 172 FPIKWTAPESLAYNKFSIKSDVWA 195

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 75  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 133
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 134 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 189
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 190 LDFGLA--RHTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIW 230

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 83/165 (50%), Gaps = 23/165 (13%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI-----FLVVEFCAGG 51
           +KKL++  +S +       EL  L  + H N+I L D F     I       +V    G 
Sbjct: 58  VKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGA 117
Query: 52  NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
           +L++ ++    + ++  +  + QL  GL+ ++S  IIHRDLKP N+    +++D  L+I 
Sbjct: 118 DLNNIVKSQA-LSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNV---AVNEDSELRIL 173
Query: 112 DFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVNFF 152
           DFGL+         E++ G   +  Y APE+ L +  Y++ V+ +
Sbjct: 174 DFGLAR-----QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 213

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/142 (25%), Positives = 71/142 (50%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL         + +V E+   G+L S++R H  +         L+ 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + +G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +    
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 132 PL-YMAPEVLQFQRYDEKVNFF 152
           P+ + +PE + ++++    + +
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVW 234

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 78/153 (50%), Gaps = 5/153 (3%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           M+    +  +  L  E+  +    H N++ ++ ++     +++++EF  GG L+  +   
Sbjct: 77  MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-Q 135
Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
            R+ E+      + +   L  L++  +IHRD+K ++ILL+ LD  V  K++DFG    + 
Sbjct: 136 VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT-LDGRV--KLSDFGFCAQIS 192
Query: 121 PGNYAEK-VCGSPLYMAPEVLQFQRYDEKVNFF 152
                 K + G+P +MAPEV+    Y  +V+ +
Sbjct: 193 KDVPKRKXLVGTPYWMAPEVISRSLYATEVDIW 225

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 76/148 (51%), Gaps = 21/148 (14%)
Query: 17  LNFLSSVNHPNIIRLFDA-----FQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTAR 69
           L  L +  HPN++RL D         E  + LV E     +L +Y+       +P +T +
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIK 123
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             ++Q   GL+ L+++ I+HRDLKPENIL++       +K+ADFGL+       Y+ ++ 
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARI-----YSYQMA 175
Query: 130 GSPL-----YMAPEVLQFQRYDEKVNFF 152
            +P+     Y APEVL    Y   V+ +
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTYATPVDMW 203

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 71/142 (50%), Gaps = 17/142 (11%)
Query: 11  SCLDCELNFL-SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----GRVP 64
           S  D E+  L  S  HPN+IR F   +     ++ +E CA   L  Y+        G  P
Sbjct: 62  SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA-TLQEYVEQKDFAHLGLEP 120
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLK--IADFGLSCTLYPG 122
                  LQQ  +GL  L+S +I+HRDLKP NIL+S  +    +K  I+DFGL   L  G
Sbjct: 121 ----ITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176
Query: 123 NYA----EKVCGSPLYMAPEVL 140
            ++      V G+  ++APE+L
Sbjct: 177 RHSFSRRSGVPGTEGWIAPEML 198

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 74/132 (56%), Gaps = 9/132 (6%)
Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
           P ++ L  AFQ E  + L++++  GG L +++    R  E   + ++ ++   LE L+  
Sbjct: 119 PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL 178
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV---CGSPLYMAPEVLQF 142
            II+RD+K ENIL   LD +  + + DFGLS   +  +  E+    CG+  YMAP++++ 
Sbjct: 179 GIIYRDIKLENIL---LDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIEYMAPDIVRG 234
Query: 143 --QRYDEKVNFF 152
               +D+ V+++
Sbjct: 235 GDSGHDKAVDWW 246

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 75  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMS 131
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 132 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMVPFV 188
Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEV+    Y E V+ +
Sbjct: 189 VTRYYRAPEVILGMGYKENVDIW 211

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 76/148 (51%), Gaps = 21/148 (14%)
Query: 17  LNFLSSVNHPNIIRLFDA-----FQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTAR 69
           L  L +  HPN++RL D         E  + LV E     +L +Y+       +P +T +
Sbjct: 57  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIK 115
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             ++Q   GL+ L+++ I+HRDLKPENIL++       +K+ADFGL+       Y+ ++ 
Sbjct: 116 DLMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARI-----YSYQMA 167
Query: 130 GSPL-----YMAPEVLQFQRYDEKVNFF 152
            +P+     Y APEVL    Y   V+ +
Sbjct: 168 LAPVVVTLWYRAPEVLLQSTYATPVDMW 195

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/142 (25%), Positives = 71/142 (50%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL         + +V E+   G+L S++R H  +         L+ 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + +G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +    
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 132 PL-YMAPEVLQFQRYDEKVNFF 152
           P+ + +PE + ++++    + +
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVW 234

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/142 (25%), Positives = 71/142 (50%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL         + +V E+   G+L S++R H  +         L+ 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + +G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +    
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 132 PL-YMAPEVLQFQRYDEKVNFF 152
           P+ + +PE + ++++    + +
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVW 234

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 8/148 (5%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 51  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 109
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NY--A 125
            + + Q+  G++ L   + +HRDL   N+LL         KI+DFGLS  L    NY  A
Sbjct: 110 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 166
Query: 126 EKVCGSPL-YMAPEVLQFQRYDEKVNFF 152
           +     P+ + APE + + ++  K + +
Sbjct: 167 QTHGKWPVKWYAPECINYYKFSSKSDVW 194

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/142 (25%), Positives = 71/142 (50%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL         + +V E+   G+L S++R H  +         L+ 
Sbjct: 94  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 153
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + +G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +    
Sbjct: 154 IASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 210
Query: 132 PL-YMAPEVLQFQRYDEKVNFF 152
           P+ + +PE + ++++    + +
Sbjct: 211 PIRWTSPEAIAYRKFTSASDVW 232

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 78/162 (48%), Gaps = 25/162 (15%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++ EFC  GNLS+Y+
Sbjct: 55  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL 114
Query: 58  RL-------HGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSG 101
           R        +   PE   + FL          Q+  G+E L S   IHRDL   NILLS 
Sbjct: 115 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 173
Query: 102 LDDDVMLKIADFGLSCTLYPG-NYAEKVCGS-PL-YMAPEVL 140
             +  ++KI DFGL+  +Y   +Y  K     PL +MAPE +
Sbjct: 174 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 213

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKSQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDSELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL C  +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 167 LDFGL-CR-HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/142 (25%), Positives = 71/142 (50%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL         + +V E+   G+L S++R H  +         L+ 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + +G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +    
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 132 PL-YMAPEVLQFQRYDEKVNFF 152
           P+ + +PE + ++++    + +
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVW 234

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 78/161 (48%), Gaps = 24/161 (14%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 65  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 124
Query: 58  R------LHGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSGL 102
           R      +  + PE   + FL          Q+  G+E L S   IHRDL   NILLS  
Sbjct: 125 RSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-- 182
Query: 103 DDDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-YMAPEVL 140
            +  ++KI DFGL+  +   P    +     PL +MAPE +
Sbjct: 183 -EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETI 222

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 8/148 (5%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 49  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 107
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NY--A 125
            + + Q+  G++ L   + +HRDL   N+LL         KI+DFGLS  L    NY  A
Sbjct: 108 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 164
Query: 126 EKVCGSPL-YMAPEVLQFQRYDEKVNFF 152
           +     P+ + APE + + ++  K + +
Sbjct: 165 QTHGKWPVKWYAPECINYYKFSSKSDVW 192

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 77/159 (48%), Gaps = 18/159 (11%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 43  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 101
Query: 58  RLHG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           ++    +   +   +  QL   L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 102 QVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 158
Query: 117 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVNFFV 153
             +      +   G  P+ +MAPE + F+R+    + ++
Sbjct: 159 RYMEDSTXXKASKGKLPIKWMAPESINFRRFTSASDVWM 197

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 8/148 (5%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 61  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 119
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NY--A 125
            + + Q+  G++ L   + +HRDL   N+LL         KI+DFGLS  L    NY  A
Sbjct: 120 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 176
Query: 126 EKVCGSPL-YMAPEVLQFQRYDEKVNFF 152
           +     P+ + APE + + ++  K + +
Sbjct: 177 QTHGKWPVKWYAPECINYYKFSSKSDVW 204

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 8/148 (5%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 55  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 113
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NY--A 125
            + + Q+  G++ L   + +HRDL   N+LL         KI+DFGLS  L    NY  A
Sbjct: 114 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 170
Query: 126 EKVCGSPL-YMAPEVLQFQRYDEKVNFF 152
           +     P+ + APE + + ++  K + +
Sbjct: 171 QTHGKWPVKWYAPECINYYKFSSKSDVW 198

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 68/143 (47%), Gaps = 9/143 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 119
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 120 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAPAGAKF 176
Query: 132 PL-YMAPEVLQFQRYDEKVNFFV 153
           P+ + APE L + ++  K + + 
Sbjct: 177 PIKWTAPESLAYNKFSIKSDVWA 199

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 78/162 (48%), Gaps = 25/162 (15%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++ EFC  GNLS+Y+
Sbjct: 55  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL 114
Query: 58  RL-------HGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSG 101
           R        +   PE   + FL          Q+  G+E L S   IHRDL   NILLS 
Sbjct: 115 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 173
Query: 102 LDDDVMLKIADFGLSCTLYPG-NYAEKVCGS-PL-YMAPEVL 140
             +  ++KI DFGL+  +Y   +Y  K     PL +MAPE +
Sbjct: 174 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 213

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 76/148 (51%), Gaps = 8/148 (5%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 55  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 113
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAE 126
            + + Q+  G++ L   + +HRDL   N+LL         KI+DFGLS  L      Y  
Sbjct: 114 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENXYKA 170
Query: 127 KVCGS-PL-YMAPEVLQFQRYDEKVNFF 152
           +  G  P+ + APE + + ++  K + +
Sbjct: 171 QTHGKWPVKWYAPECINYYKFSSKSDVW 198

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 8/148 (5%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 71  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 129
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NY--A 125
            + + Q+  G++ L   + +HRDL   N+LL         KI+DFGLS  L    NY  A
Sbjct: 130 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 186
Query: 126 EKVCGSPL-YMAPEVLQFQRYDEKVNFF 152
           +     P+ + APE + + ++  K + +
Sbjct: 187 QTHGKWPVKWYAPECINYYKFSSKSDVW 214

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 8/148 (5%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 71  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 129
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NY--A 125
            + + Q+  G++ L   + +HRDL   N+LL         KI+DFGLS  L    NY  A
Sbjct: 130 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 186
Query: 126 EKVCGSPL-YMAPEVLQFQRYDEKVNFF 152
           +     P+ + APE + + ++  K + +
Sbjct: 187 QTHGKWPVKWYAPECINYYKFSSKSDVW 214

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 68/143 (47%), Gaps = 9/143 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 119
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 120 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 176
Query: 132 PL-YMAPEVLQFQRYDEKVNFFV 153
           P+ + APE L + ++  K + + 
Sbjct: 177 PIKWTAPESLAYNKFSIKSDVWA 199

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 68/143 (47%), Gaps = 9/143 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 60  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 118
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 119 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAPAGAKF 175
Query: 132 PL-YMAPEVLQFQRYDEKVNFFV 153
           P+ + APE L + ++  K + + 
Sbjct: 176 PIKWTAPESLAYNKFSIKSDVWA 198

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 83/165 (50%), Gaps = 23/165 (13%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI-----FLVVEFCAGG 51
           +KKL++  +S +       EL  L  + H N+I L D F     I       +V    G 
Sbjct: 58  VKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGA 117
Query: 52  NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
           +L++ ++    + ++  +  + QL  GL+ ++S  IIHRDLKP N+    +++D  L+I 
Sbjct: 118 DLNNIVKCQA-LSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNV---AVNEDSELRIL 173
Query: 112 DFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVNFF 152
           DFGL+         E++ G   +  Y APE+ L +  Y++ V+ +
Sbjct: 174 DFGLA-----RQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 213

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 8/148 (5%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 69  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 127
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NY--A 125
            + + Q+  G++ L   + +HRDL   N+LL         KI+DFGLS  L    NY  A
Sbjct: 128 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 184
Query: 126 EKVCGSPL-YMAPEVLQFQRYDEKVNFF 152
           +     P+ + APE + + ++  K + +
Sbjct: 185 QTHGKWPVKWYAPECINYYKFSSKSDVW 212

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 41/138 (29%), Positives = 69/138 (50%), Gaps = 9/138 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY-IRLHGRVPEQTARKFLQQ 74
           E   +  +++P I+RL    QAE  + LV+E   GG L  + +     +P     + L Q
Sbjct: 386 EAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 444
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGS- 131
           +  G++ L   + +HR+L   N+LL    +    KI+DFGLS  L   +  Y  +  G  
Sbjct: 445 VSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKW 501
Query: 132 PL-YMAPEVLQFQRYDEK 148
           PL + APE + F+++  +
Sbjct: 502 PLKWYAPECINFRKFSSR 519

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 68/143 (47%), Gaps = 9/143 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 122
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 132 PL-YMAPEVLQFQRYDEKVNFFV 153
           P+ + APE L + ++  K + + 
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWA 202

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/117 (28%), Positives = 62/117 (52%), Gaps = 8/117 (6%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 90  IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 148
Query: 88  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQ 141
           +H DLKP N L+     D MLK+ DFG++  + P   +   +   G+  YM PE ++
Sbjct: 149 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 68/143 (47%), Gaps = 9/143 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 119
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 120 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 176
Query: 132 PL-YMAPEVLQFQRYDEKVNFFV 153
           P+ + APE L + ++  K + + 
Sbjct: 177 PIKWTAPESLAYNKFSIKSDVWA 199

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 81/163 (49%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAG 50
           +KKL +  +S L       EL  L  + H N+I L D F  +  +      +LV+ F  G
Sbjct: 55  IKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-G 113
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L   ++ H ++ E   +  + Q+  GL  +++  IIHRDLKP N+    +++D  LKI
Sbjct: 114 TDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNL---AVNEDCELKI 169
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+           V  +  Y APEV L + RY + V+ +
Sbjct: 170 LDFGLARQADSEMXGXVV--TRWYRAPEVILNWMRYTQTVDIW 210

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 68/143 (47%), Gaps = 9/143 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 117
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 132 PL-YMAPEVLQFQRYDEKVNFFV 153
           P+ + APE L + ++  K + + 
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWA 197

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 83/165 (50%), Gaps = 23/165 (13%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI-----FLVVEFCAGG 51
           +KKL++  +S +       EL  L  + H N+I L D F     I       +V    G 
Sbjct: 50  VKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGA 109
Query: 52  NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
           +L++ ++    + ++  +  + QL  GL+ ++S  IIHRDLKP N+    +++D  L+I 
Sbjct: 110 DLNNIVKCQA-LSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNV---AVNEDCELRIL 165
Query: 112 DFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVNFF 152
           DFGL+         E++ G   +  Y APE+ L +  Y++ V+ +
Sbjct: 166 DFGLA-----RQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 205

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 79/158 (50%), Gaps = 21/158 (13%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 64  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 58  RLHGR--VPEQTARK-FLQ---------QLGAGLEILNSHHIIHRDLKPENILLSGLDDD 105
           R      VP +   K FL          Q+  G+E L S   IHRDL   NILLS   + 
Sbjct: 124 RSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLS---EK 180
Query: 106 VMLKIADFGLSCTLYPG-NYAEKVCGS-PL-YMAPEVL 140
            ++KI DFGL+  +Y   +Y  K     PL +MAPE +
Sbjct: 181 NVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 218

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 68/143 (47%), Gaps = 9/143 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 63  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 121
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 122 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 132 PL-YMAPEVLQFQRYDEKVNFFV 153
           P+ + APE L + ++  K + + 
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWA 201

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 68/143 (47%), Gaps = 9/143 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 117
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 132 PL-YMAPEVLQFQRYDEKVNFFV 153
           P+ + APE L + ++  K + + 
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWA 197

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 68/143 (47%), Gaps = 9/143 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 72  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 130
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 131 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 187
Query: 132 PL-YMAPEVLQFQRYDEKVNFFV 153
           P+ + APE L + ++  K + + 
Sbjct: 188 PIKWTAPESLAYNKFSIKSDVWA 210

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 68/143 (47%), Gaps = 9/143 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 122
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 132 PL-YMAPEVLQFQRYDEKVNFFV 153
           P+ + APE L + ++  K + + 
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWA 202

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 69/144 (47%), Gaps = 11/144 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 122
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  L  G+      G+ 
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS-RLMTGDTXTAHAGAK 178
Query: 133 L---YMAPEVLQFQRYDEKVNFFV 153
               + APE L + ++  K + + 
Sbjct: 179 FPIKWTAPESLAYNKFSIKSDVWA 202

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 73/145 (50%), Gaps = 10/145 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +   +HPN+I L         + ++ EF   G+L S++R + G+         L+
Sbjct: 83  SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR 142
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----NYAEKVC 129
            + AG++ L   + +HRDL   NIL   ++ +++ K++DFGLS  L        Y   + 
Sbjct: 143 GIAAGMKYLADMNYVHRDLAARNIL---VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 199
Query: 130 GS-PL-YMAPEVLQFQRYDEKVNFF 152
           G  P+ + APE +Q++++    + +
Sbjct: 200 GKIPIRWTAPEAIQYRKFTSASDVW 224

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/131 (32%), Positives = 68/131 (51%), Gaps = 11/131 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFL 72
           E+  L  + H N+I+L D    + +  +++V+E+C  G       +   R P   A  + 
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF 115
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC--- 129
            QL  GLE L+S  I+H+D+KP N+LL+       LKI+  G++  L+P   A+  C   
Sbjct: 116 CQLIDGLEYLHSQGIVHKDIKPGNLLLT---TGGTLKISALGVAEALHP-FAADDTCRTS 171
Query: 130 -GSPLYMAPEV 139
            GSP +  PE+
Sbjct: 172 QGSPAFQPPEI 182

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/117 (28%), Positives = 62/117 (52%), Gaps = 8/117 (6%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 71  IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 129
Query: 88  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQ 141
           +H DLKP N L+     D MLK+ DFG++  + P   +   +   G+  YM PE ++
Sbjct: 130 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 70/144 (48%), Gaps = 11/144 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E +A   L   
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 115
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  L  G+      G+ 
Sbjct: 116 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS-RLMTGDTFTAHAGAK 171
Query: 133 L---YMAPEVLQFQRYDEKVNFFV 153
               + APE L + ++  K + + 
Sbjct: 172 FPIKWTAPESLAYNKFSIKSDVWA 195

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            D+GL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 167 LDYGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/117 (28%), Positives = 62/117 (52%), Gaps = 8/117 (6%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 118 IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 176
Query: 88  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQ 141
           +H DLKP N L+     D MLK+ DFG++  + P   +   +   G+  YM PE ++
Sbjct: 177 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 229

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 74/149 (49%), Gaps = 23/149 (15%)
Query: 17  LNFLSSVNHPNIIRLFDA-----FQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTAR 69
           L  L +  HPN++RL D         E  + LV E     +L +Y+       +P +T +
Sbjct: 57  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIK 115
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS------CTLYPGN 123
             ++Q   GL+ L+++ I+HRDLKPENIL++       +K+ADFGL+        L+P  
Sbjct: 116 DLMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQMALFP-- 170
Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
               V  +  Y APEVL    Y   V+ +
Sbjct: 171 ----VVVTLWYRAPEVLLQSTYATPVDMW 195

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/117 (28%), Positives = 62/117 (52%), Gaps = 8/117 (6%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 74  IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 132
Query: 88  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQ 141
           +H DLKP N L+     D MLK+ DFG++  + P   +   +   G+  YM PE ++
Sbjct: 133 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 185

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 9/143 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   ++V E+   GNL  Y+R   R  E TA   L   
Sbjct: 78  EAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNR-EEVTAVVLLYMA 136
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 137 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHVVKVADFGLSRLMTGDTYTAHAGAKF 193
Query: 132 PL-YMAPEVLQFQRYDEKVNFFV 153
           P+ + APE L +  +  K + + 
Sbjct: 194 PIKWTAPESLAYNTFSIKSDVWA 216

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/117 (28%), Positives = 62/117 (52%), Gaps = 8/117 (6%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 118 IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 176
Query: 88  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQ 141
           +H DLKP N L+     D MLK+ DFG++  + P   +   +   G+  YM PE ++
Sbjct: 177 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 229

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 76/157 (48%), Gaps = 24/157 (15%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--------RVPEQT 67
           E   L+++ H +I++ +      + + +V E+   G+L+ ++R HG          P Q 
Sbjct: 67  EAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 126
Query: 68  ARKF--------LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
             +           Q+ +G+  L S H +HRDL   N L+     ++++KI DFG+S  +
Sbjct: 127 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA---NLLVKIGDFGMSRDV 183
Query: 120 YPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVNFF 152
           Y  +Y  +V G  +    +M PE + ++++  + + +
Sbjct: 184 YSTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVW 219

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/117 (28%), Positives = 62/117 (52%), Gaps = 8/117 (6%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 70  IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 128
Query: 88  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQ 141
           +H DLKP N L+     D MLK+ DFG++  + P   +   +   G+  YM PE ++
Sbjct: 129 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 181

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/117 (28%), Positives = 62/117 (52%), Gaps = 8/117 (6%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 118 IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 176
Query: 88  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQ 141
           +H DLKP N L+     D MLK+ DFG++  + P   +   +   G+  YM PE ++
Sbjct: 177 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 8/148 (5%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 414 LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 472
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NY--A 125
            + + Q+  G++ L   + +HRDL   N+LL         KI+DFGLS  L    NY  A
Sbjct: 473 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 529
Query: 126 EKVCGSPL-YMAPEVLQFQRYDEKVNFF 152
           +     P+ + APE + + ++  K + +
Sbjct: 530 QTHGKWPVKWYAPECINYYKFSSKSDVW 557

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/142 (24%), Positives = 71/142 (50%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL         + +V E+   G+L S++R H  +         L+ 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + +G++ L+    +HRDL   NIL   ++ +++ K++DFGL+  L       Y  +    
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLARVLEDDPEAAYTTRGGKI 212
Query: 132 PL-YMAPEVLQFQRYDEKVNFF 152
           P+ + +PE + ++++    + +
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVW 234

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 8/148 (5%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 413 LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 471
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NY--A 125
            + + Q+  G++ L   + +HRDL   N+LL         KI+DFGLS  L    NY  A
Sbjct: 472 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 528
Query: 126 EKVCGSPL-YMAPEVLQFQRYDEKVNFF 152
           +     P+ + APE + + ++  K + +
Sbjct: 529 QTHGKWPVKWYAPECINYYKFSSKSDVW 556

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 16/153 (10%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S +NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 78  ELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 70  KFL-------QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             +       + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 138 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 197
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVNFF 152
           +Y  K   + L   +M PE      +  K + +
Sbjct: 198 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 230

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 76/160 (47%), Gaps = 23/160 (14%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 66  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 125
Query: 58  RLHGR-----VPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSGLD 103
           R          PE   + FL          Q+  G+E L S   IHRDL   NILLS   
Sbjct: 126 RSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLS--- 182
Query: 104 DDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-YMAPEVL 140
           +  ++KI DFGL+  +   P    +     PL +MAPE +
Sbjct: 183 EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETI 222

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/142 (25%), Positives = 70/142 (49%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL         + +V E    G+L S++R H  +         L+ 
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRG 126
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + +G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +    
Sbjct: 127 IASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 183
Query: 132 PL-YMAPEVLQFQRYDEKVNFF 152
           P+ + +PE + ++++    + +
Sbjct: 184 PIRWTSPEAIAYRKFTSASDVW 205

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 77/162 (47%), Gaps = 25/162 (15%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 55  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 114
Query: 58  RL-------HGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSG 101
           R        +   PE   + FL          Q+  G+E L S   IHRDL   NILLS 
Sbjct: 115 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 173
Query: 102 LDDDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-YMAPEVL 140
             +  ++KI DFGL+  +   P    +     PL +MAPE +
Sbjct: 174 --EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETI 213

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 79/158 (50%), Gaps = 21/158 (13%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 64  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 58  RLHGR--VPEQTARK-FLQ---------QLGAGLEILNSHHIIHRDLKPENILLSGLDDD 105
           R      VP +   K FL          Q+  G+E L S   IHRDL   NILLS   + 
Sbjct: 124 RSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLS---EK 180
Query: 106 VMLKIADFGLSCTLYPG-NYAEKVCGS-PL-YMAPEVL 140
            ++KI DFGL+  +Y   +Y  K     PL +MAPE +
Sbjct: 181 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 218

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L    Y++ V+ +
Sbjct: 167 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIW 207

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 11/144 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ-- 73
           E+  +  + HPNI+    A      + +V E+ + G+L   +   G   +   R+ L   
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 74  -QLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKV 128
             +  G+  L++ +  I+HRDLK  N+L   +D    +K+ DFGLS  L    +  ++  
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRDLKSPNLL---VDKKYTVKVCDFGLS-RLKASXFLXSKXA 199
Query: 129 CGSPLYMAPEVLQFQRYDEKVNFF 152
            G+P +MAPEVL+ +  +EK + +
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKSDVY 223

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 73/138 (52%), Gaps = 10/138 (7%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQT 67
           +S    E++ L ++ H +II+       Q E  + LV+E+   G+L  Y+  H     Q 
Sbjct: 60  RSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL 119
Query: 68  ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127
              F QQ+  G+  L+S H IHR+L   N+L   LD+D ++KI DFGL+  +  G+   +
Sbjct: 120 LL-FAQQICEGMAYLHSQHYIHRNLAARNVL---LDNDRLVKIGDFGLAKAVPEGHEYYR 175
Query: 128 V---CGSPL-YMAPEVLQ 141
           V     SP+ + APE L+
Sbjct: 176 VREDGDSPVFWYAPECLK 193

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 69/145 (47%), Gaps = 10/145 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E    + + HPNII L      E  + LV+EF  GG L+  +    R+P      +  Q+
Sbjct: 56  EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQI 114
Query: 76  GAGLEILNSHH---IIHRDLKPENILL-----SGLDDDVMLKIADFGLSCTLYPGNYAEK 127
             G+  L+      IIHRDLK  NIL+     +G   + +LKI DFGL+   +       
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-RTTKMS 173
Query: 128 VCGSPLYMAPEVLQFQRYDEKVNFF 152
             G+  +MAPEV++   + +  + +
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVW 198

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 16/153 (10%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S +NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 92  ELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 151
Query: 70  KFL-------QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             +       + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 152 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 211
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVNFF 152
           +Y  K   + L   +M PE      +  K + +
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 244

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 40/119 (33%), Positives = 56/119 (47%), Gaps = 5/119 (4%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEIL 82
            HP  +RL  A++    ++L  E C G +L  +    G  +PE     +L+     L  L
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 83  NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 141
           +S  ++H D+KP NI L         K+ DFGL   L      E   G P YMAPE+LQ
Sbjct: 174 HSQGLVHLDVKPANIFLG---PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ 229

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 35/142 (24%), Positives = 72/142 (50%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNII L         + ++ E+   G+L +++R + GR         L+ 
Sbjct: 59  EASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRG 118
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           +G+G++ L+    +HRDL   NIL   ++ +++ K++DFG+S  L       Y  +    
Sbjct: 119 IGSGMKYLSDMSYVHRDLAARNIL---VNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI 175
Query: 132 PL-YMAPEVLQFQRYDEKVNFF 152
           P+ + APE + ++++    + +
Sbjct: 176 PIRWTAPEAIAYRKFTSASDVW 197

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 40/138 (28%), Positives = 67/138 (48%), Gaps = 9/138 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E +A   L   
Sbjct: 266 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 324
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHR+L   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 325 TQISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 381
Query: 132 PL-YMAPEVLQFQRYDEK 148
           P+ + APE L + ++  K
Sbjct: 382 PIKWTAPESLAYNKFSIK 399

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 36/142 (25%), Positives = 70/142 (49%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL         + +V E    G+L S++R H  +         L+ 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + +G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +    
Sbjct: 156 IASGMKYLSDMGAVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 132 PL-YMAPEVLQFQRYDEKVNFF 152
           P+ + +PE + ++++    + +
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVW 234

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 35/142 (24%), Positives = 70/142 (49%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL         + +V E+   G+L S++R H  +         L+ 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + +G++ L+    +HRDL   NIL   ++ +++ K++DFGL   L       Y  +    
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212
Query: 132 PL-YMAPEVLQFQRYDEKVNFF 152
           P+ + +PE + ++++    + +
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVW 234

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 77/162 (47%), Gaps = 25/162 (15%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 64  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 58  RL-------HGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSG 101
           R        +   PE   + FL          Q+  G+E L S   IHRDL   NILLS 
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 182
Query: 102 LDDDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-YMAPEVL 140
             +  ++KI DFGL+  +   P    +     PL +MAPE +
Sbjct: 183 --EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETI 222

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/142 (24%), Positives = 72/142 (50%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNII L         + ++ E+   G+L +++R + GR         L+ 
Sbjct: 65  EASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRG 124
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           +G+G++ L+    +HRDL   NIL   ++ +++ K++DFG+S  L       Y  +    
Sbjct: 125 IGSGMKYLSDMSYVHRDLAARNIL---VNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI 181
Query: 132 PL-YMAPEVLQFQRYDEKVNFF 152
           P+ + APE + ++++    + +
Sbjct: 182 PIRWTAPEAIAYRKFTSASDVW 203

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/142 (24%), Positives = 72/142 (50%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNII L         + ++ E+   G+L +++R + GR         L+ 
Sbjct: 80  EASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRG 139
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           +G+G++ L+    +HRDL   NIL   ++ +++ K++DFG+S  L       Y  +    
Sbjct: 140 IGSGMKYLSDMSAVHRDLAARNIL---VNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI 196
Query: 132 PL-YMAPEVLQFQRYDEKVNFF 152
           P+ + APE + ++++    + +
Sbjct: 197 PIRWTAPEAIAYRKFTSASDVW 218

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/117 (28%), Positives = 61/117 (52%), Gaps = 8/117 (6%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 90  IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 148
Query: 88  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQ 141
           +H DLKP N L+     D MLK+ DFG++  + P       +   G+  YM PE ++
Sbjct: 149 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIK 201

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/142 (25%), Positives = 70/142 (49%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL         + +V E    G+L S++R H  +         L+ 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + +G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +    
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 132 PL-YMAPEVLQFQRYDEKVNFF 152
           P+ + +PE + ++++    + +
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVW 234

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 81  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLM-G 139
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 140 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 195
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +  +       +  Y APE+ L +  Y+  V+ +
Sbjct: 196 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIW 236

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 69/138 (50%), Gaps = 10/138 (7%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +    HPNIIRL         + ++ EF   G L S++RL+ G+         L+
Sbjct: 64  SEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR 123
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVC 129
            + +G+  L     +HRDL   NIL   ++ +++ K++DFGLS  L   +    Y   + 
Sbjct: 124 GIASGMRYLAEMSYVHRDLAARNIL---VNSNLVCKVSDFGLSRFLEENSSDPTYTSSLG 180
Query: 130 GS-PL-YMAPEVLQFQRY 145
           G  P+ + APE + F+++
Sbjct: 181 GKIPIRWTAPEAIAFRKF 198

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 77/150 (51%), Gaps = 9/150 (6%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +++K   H++S +  E+  L     H N++ L + F+ E+  +LV E   GG++ S+I  
Sbjct: 45  IIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK 104
Query: 60  HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
                E  A   +Q + + L+ L++  I HRDLKPENIL    +    +KI DF L   +
Sbjct: 105 RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164
Query: 120 ------YPGNYAE--KVCGSPLYMAPEVLQ 141
                  P +  E    CGS  YMAPEV++
Sbjct: 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVE 194

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/142 (26%), Positives = 70/142 (49%), Gaps = 8/142 (5%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL 72
            E N + ++ H  +++L  A   +  I+++ EF A G+L  +++     + P      F 
Sbjct: 232 AEANVMKTLQHDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 290
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+  G+  +   + IHRDL+  NIL+S     ++ KIADFGL+  +    Y  +     
Sbjct: 291 AQIAEGMAFIEQRNYIHRDLRAANILVSA---SLVCKIADFGLARVIEDNEYTAREGAKF 347
Query: 132 PL-YMAPEVLQFQRYDEKVNFF 152
           P+ + APE + F  +  K + +
Sbjct: 348 PIKWTAPEAINFGSFTIKSDVW 369

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 16/153 (10%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 77  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS 136
Query: 70  KFL-------QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             +       + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 137 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVNFF 152
           +Y  K   + L   +M PE      +  K + +
Sbjct: 197 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 229

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 70/142 (49%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E   + +++H  +++L+     +  IF++ E+ A G L +Y+R +  R   Q   +  + 
Sbjct: 54  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 113
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  +    Y     GS   
Sbjct: 114 VCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEYTSSR-GSKFP 169
Query: 134 --YMAPEVLQFQRYDEKVNFFV 153
             +  PEVL + ++  K + + 
Sbjct: 170 VRWSPPEVLMYSKFSSKSDIWA 191

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 71/142 (50%), Gaps = 8/142 (5%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL 72
            E N + ++ H  +++L  A   +  I+++ EF A G+L  +++     + P      F 
Sbjct: 59  AEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 117
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGS 131
            Q+  G+  +   + IHRDL+  NIL+S     ++ KIADFGL+  +    Y A +    
Sbjct: 118 AQIAEGMAFIEQRNYIHRDLRAANILVSA---SLVCKIADFGLARVIEDNEYTAREGAKF 174
Query: 132 PL-YMAPEVLQFQRYDEKVNFF 152
           P+ + APE + F  +  K + +
Sbjct: 175 PIKWTAPEAINFGSFTIKSDVW 196

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 16/153 (10%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 78  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 70  KFL-------QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             +       + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 138 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRA 197
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVNFF 152
           +Y  K   + L   +M PE      +  K + +
Sbjct: 198 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 230

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 16/153 (10%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 94  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 153
Query: 70  KFL-------QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             +       + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 154 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 213
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVNFF 152
           +Y  K   + L   +M PE      +  K + +
Sbjct: 214 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 246

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 80/144 (55%), Gaps = 24/144 (16%)
Query: 16  ELNFLSSVNHPNIIRLFD--------------AFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           E+  +  ++H NI+++F+              +    N +++V E+    +L++ +   G
Sbjct: 58  EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLE-QG 115
Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
            + E+ AR F+ QL  GL+ ++S +++HRDLKP N+ ++   +D++LKI DFGL+  + P
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN--TEDLVLKIGDFGLARIMDP 173
Query: 122 -----GNYAEKVCGSPLYMAPEVL 140
                G+ +E +  +  Y +P +L
Sbjct: 174 HYSHKGHLSEGLV-TKWYRSPRLL 196

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 16/153 (10%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 84  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 143
Query: 70  KFL-------QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             +       + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 144 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 203
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVNFF 152
           +Y  K   + L   +M PE      +  K + +
Sbjct: 204 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 236

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 16/153 (10%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 69  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 128
Query: 70  KFL-------QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             +       + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 129 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 188
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVNFF 152
           +Y  K   + L   +M PE      +  K + +
Sbjct: 189 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 221

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 16/153 (10%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 104 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 163
Query: 70  KFL-------QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             +       + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 164 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 223
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVNFF 152
           +Y  K   + L   +M PE      +  K + +
Sbjct: 224 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 256

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 16/153 (10%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 77  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 136
Query: 70  KFL-------QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             +       + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 137 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVNFF 152
           +Y  K   + L   +M PE      +  K + +
Sbjct: 197 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 229

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 16/153 (10%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 92  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS 151
Query: 70  KFL-------QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             +       + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 152 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 211
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVNFF 152
           +Y  K   + L   +M PE      +  K + +
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 244

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 16/153 (10%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 78  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 70  KFL-------QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             +       + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 138 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 197
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVNFF 152
           +Y  K   + L   +M PE      +  K + +
Sbjct: 198 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 230

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 40/138 (28%), Positives = 66/138 (47%), Gaps = 9/138 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--- 72
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 305 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 363
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 131
            Q+ + +E L   + IHR+L   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 364 TQISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 420
Query: 132 PL-YMAPEVLQFQRYDEK 148
           P+ + APE L + ++  K
Sbjct: 421 PIKWTAPESLAYNKFSIK 438

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 72/143 (50%), Gaps = 10/143 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ- 73
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 63  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 120
Query: 74  --QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +    Y A +   
Sbjct: 121 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAK 177
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE + +  +  K + +
Sbjct: 178 FPIKWTAPEAINYGTFTIKSDVW 200

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 72/143 (50%), Gaps = 10/143 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ- 73
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 57  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 114
Query: 74  --QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +    Y A +   
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAK 171
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE + +  +  K + +
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVW 194

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 72/143 (50%), Gaps = 10/143 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ- 73
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 62  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 119
Query: 74  --QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +    Y A +   
Sbjct: 120 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAK 176
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE + +  +  K + +
Sbjct: 177 FPIKWTAPEAINYGTFTIKSDVW 199

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 78/146 (53%), Gaps = 15/146 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFL 72
           E+  +S++NHPNI++L+      N   +V+EF   G+L  Y RL  +   +      + +
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDL--YHRLLDKAHPIKWSVKLRLM 128
Query: 73  QQLGAGLEILNSHH--IIHRDLKPENILLSGLDDD--VMLKIADFGLSCTLYPGNYAEKV 128
             +  G+E + + +  I+HRDL+  NI L  LD++  V  K+ADFGLS      +    +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGL 186
Query: 129 CGSPLYMAPEVL--QFQRYDEKVNFF 152
            G+  +MAPE +  + + Y EK + +
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTY 212

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 73/145 (50%), Gaps = 16/145 (11%)
Query: 15  CELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKF 71
            E + ++ + H N+++L     + +  +++V E+ A G+L  Y+R  GR  +      KF
Sbjct: 63  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 122
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL----SCTLYPGNYAEK 127
              +   +E L  ++ +HRDL   N+L+S   +D + K++DFGL    S T   G    K
Sbjct: 123 SLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 179
Query: 128 VCGSPLYMAPEVLQFQRYDEKVNFF 152
                 + APE L+ +++  K + +
Sbjct: 180 ------WTAPEALREKKFSTKSDVW 198

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 68/153 (44%), Gaps = 16/153 (10%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 95  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 154
Query: 70  KFL-------QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             +       + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 155 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 214
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVNFF 152
            Y  K   + L   +M PE      +  K + +
Sbjct: 215 GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 247

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 73/145 (50%), Gaps = 16/145 (11%)
Query: 15  CELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKF 71
            E + ++ + H N+++L     + +  +++V E+ A G+L  Y+R  GR  +      KF
Sbjct: 48  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 107
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL----SCTLYPGNYAEK 127
              +   +E L  ++ +HRDL   N+L+S   +D + K++DFGL    S T   G    K
Sbjct: 108 SLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 164
Query: 128 VCGSPLYMAPEVLQFQRYDEKVNFF 152
                 + APE L+ +++  K + +
Sbjct: 165 ------WTAPEALREKKFSTKSDVW 183

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 68/153 (44%), Gaps = 16/153 (10%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 118 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 177
Query: 70  KFL-------QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             +       + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 178 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVNFF 152
            Y  K   + L   +M PE      +  K + +
Sbjct: 238 GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 270

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 72/143 (50%), Gaps = 10/143 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ- 73
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 52  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 109
Query: 74  --QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +    Y A +   
Sbjct: 110 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAK 166
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE + +  +  K + +
Sbjct: 167 FPIKWTAPEAINYGTFTIKSDVW 189

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 16/153 (10%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 92  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 151
Query: 70  KFL-------QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             +       + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 152 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 211
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVNFF 152
           +Y  K   + L   +M PE      +  K + +
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 244

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 73/144 (50%), Gaps = 11/144 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ-- 73
           E+  +  + HPNI+    A      + +V E+ + G+L   +   G   +   R+ L   
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 74  -QLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKV 128
             +  G+  L++ +  I+HR+LK  N+L+   D    +K+ DFGLS  L    +  ++  
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLS-RLKASTFLSSKSA 199
Query: 129 CGSPLYMAPEVLQFQRYDEKVNFF 152
            G+P +MAPEVL+ +  +EK + +
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKSDVY 223

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 72/143 (50%), Gaps = 10/143 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ- 73
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 67  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 124
Query: 74  --QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +    Y A +   
Sbjct: 125 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAK 181
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE + +  +  K + +
Sbjct: 182 FPIKWTAPEAINYGTFTIKSDVW 204

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/142 (25%), Positives = 71/142 (50%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNII L         + +V E+   G+L ++++ + G+         L+ 
Sbjct: 73  EASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRG 132
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + AG++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +    
Sbjct: 133 ISAGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 189
Query: 132 PL-YMAPEVLQFQRYDEKVNFF 152
           P+ + APE + F+++    + +
Sbjct: 190 PIRWTAPEAIAFRKFTSASDVW 211

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
             FGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 167 LGFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 73/138 (52%), Gaps = 10/138 (7%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQT 67
           +S    E++ L ++ H +II+       Q E  + LV+E+   G+L  Y+  H     Q 
Sbjct: 60  RSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL 119
Query: 68  ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127
              F QQ+  G+  L++ H IHR+L   N+L   LD+D ++KI DFGL+  +  G+   +
Sbjct: 120 LL-FAQQICEGMAYLHAQHYIHRNLAARNVL---LDNDRLVKIGDFGLAKAVPEGHEYYR 175
Query: 128 V---CGSPL-YMAPEVLQ 141
           V     SP+ + APE L+
Sbjct: 176 VREDGDSPVFWYAPECLK 193

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 83/174 (47%), Gaps = 37/174 (21%)
Query: 11  SCLDCELNFLSSVNHPNIIRLFDAF-------------QAENCIFLVVEFCAGGNLSSYI 57
           S +  E+  L+S+NH  ++R + A+             + ++ +F+ +E+C   N + Y 
Sbjct: 47  STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCE--NRTLYD 104
Query: 58  RLHGRVPEQTARKF---LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
            +H     Q   ++    +Q+   L  ++S  IIHRDLKP NI    +D+   +KI DFG
Sbjct: 105 LIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIF---IDESRNVKIGDFG 161
Query: 115 LSCTLY-------------PGNYAE--KVCGSPLYMAPEVLQFQ-RYDEKVNFF 152
           L+  ++             PG+        G+ +Y+A EVL     Y+EK++ +
Sbjct: 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMY 215

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 76/162 (46%), Gaps = 25/162 (15%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++ EFC  GNLS+Y+
Sbjct: 55  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL 114
Query: 58  RL-------HGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSG 101
           R        +   PE   + FL          Q+  G+E L S   IHRDL   NILLS 
Sbjct: 115 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 173
Query: 102 LDDDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-YMAPEVL 140
             +  ++KI DFGL+  +   P    +     PL +MAPE +
Sbjct: 174 --EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETI 213

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 74/148 (50%), Gaps = 17/148 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E    +++NHP I+ ++   +AE       ++V+E+  G  L   +   G +   T ++ 
Sbjct: 62  EAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM---TPKRA 118
Query: 72  LQQLGAGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEK 127
           ++ +    + LN  H   IIHRD+KP NI++S  +    +K+ DFG++  +   GN   +
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQ 175
Query: 128 ---VCGSPLYMAPEVLQFQRYDEKVNFF 152
              V G+  Y++PE  +    D + + +
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVY 203

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            D GL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 167 LDAGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 73/145 (50%), Gaps = 16/145 (11%)
Query: 15  CELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKF 71
            E + ++ + H N+++L     + +  +++V E+ A G+L  Y+R  GR  +      KF
Sbjct: 235 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 294
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL----SCTLYPGNYAEK 127
              +   +E L  ++ +HRDL   N+L+S   +D + K++DFGL    S T   G    K
Sbjct: 295 SLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 351
Query: 128 VCGSPLYMAPEVLQFQRYDEKVNFF 152
                 + APE L+ +++  K + +
Sbjct: 352 ------WTAPEALREKKFSTKSDVW 370

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            D GL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 167 LDRGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DF L+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 167 LDFYLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 19/163 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 111 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 166
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            D GL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 167 LDGGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 77/170 (45%), Gaps = 23/170 (13%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           LK+ ++  +     E   L+ + H +I+R F        + +V E+   G+L+ ++R HG
Sbjct: 79  LKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHG 138
Query: 62  RVPEQTAR---------------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV 106
              +  A                    Q+ AG+  L   H +HRDL   N L+      +
Sbjct: 139 PDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGL 195
Query: 107 MLKIADFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVNFF 152
           ++KI DFG+S  +Y  +Y  +V G  +    +M PE + ++++  + + +
Sbjct: 196 VVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILYRKFTTESDVW 244

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 68/139 (48%), Gaps = 12/139 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +    HPNIIRL         + ++ EF   G L S++RL+ G+         L+
Sbjct: 66  SEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR 125
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
            + +G+  L     +HRDL   NIL   ++ +++ K++DFGLS  L   N ++    S L
Sbjct: 126 GIASGMRYLAEMSYVHRDLAARNIL---VNSNLVCKVSDFGLSRFLEE-NSSDPTETSSL 181
Query: 134 -------YMAPEVLQFQRY 145
                  + APE + F+++
Sbjct: 182 GGKIPIRWTAPEAIAFRKF 200

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 77/170 (45%), Gaps = 23/170 (13%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           LK+ ++  +     E   L+ + H +I+R F        + +V E+   G+L+ ++R HG
Sbjct: 50  LKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHG 109
Query: 62  RVPEQTAR---------------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV 106
              +  A                    Q+ AG+  L   H +HRDL   N L+      +
Sbjct: 110 PDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGL 166
Query: 107 MLKIADFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVNFF 152
           ++KI DFG+S  +Y  +Y  +V G  +    +M PE + ++++  + + +
Sbjct: 167 VVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILYRKFTTESDVW 215

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 77/170 (45%), Gaps = 23/170 (13%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           LK+ ++  +     E   L+ + H +I+R F        + +V E+   G+L+ ++R HG
Sbjct: 56  LKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHG 115
Query: 62  RVPEQTAR---------------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV 106
              +  A                    Q+ AG+  L   H +HRDL   N L+      +
Sbjct: 116 PDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGL 172
Query: 107 MLKIADFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVNFF 152
           ++KI DFG+S  +Y  +Y  +V G  +    +M PE + ++++  + + +
Sbjct: 173 VVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILYRKFTTESDVW 221

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 70/142 (49%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E   + +++H  +++L+     +  IF++ E+ A G L +Y+R +  R   Q   +  + 
Sbjct: 69  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 128
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  +        V GS   
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEETSSV-GSKFP 184
Query: 134 --YMAPEVLQFQRYDEKVNFFV 153
             +  PEVL + ++  K + + 
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWA 206

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/145 (25%), Positives = 72/145 (49%), Gaps = 10/145 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +   +HPN+I L         + ++ EF   G+L S++R + G+         L+
Sbjct: 57  SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR 116
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----NYAEKVC 129
            + AG++ L   + +HR L   NIL   ++ +++ K++DFGLS  L        Y   + 
Sbjct: 117 GIAAGMKYLADMNYVHRALAARNIL---VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 173
Query: 130 GS-PL-YMAPEVLQFQRYDEKVNFF 152
           G  P+ + APE +Q++++    + +
Sbjct: 174 GKIPIRWTAPEAIQYRKFTSASDVW 198

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 69/141 (48%), Gaps = 5/141 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  + H NII L       + + L+ E+ A  +L  Y+  +  V  +  + FL QL
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLHLIFEY-AENDLKKYMDKNPDVSMRVIKSFLYQL 141
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLD--DDVMLKIADFGLSCTL-YPGNYAEKVCGSP 132
             G+   +S   +HRDLKP+N+LLS  D  +  +LKI DFGL+     P         + 
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITL 201
Query: 133 LYMAPEVLQFQR-YDEKVNFF 152
            Y  PE+L   R Y   V+ +
Sbjct: 202 WYRPPEILLGSRHYSTSVDIW 222

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 69/140 (49%), Gaps = 10/140 (7%)
Query: 20  LSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLGA 77
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 103 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 162
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 133
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 163 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 219
Query: 134 -YMAPEVLQFQRYDEKVNFF 152
            +MA E LQ Q++  K + +
Sbjct: 220 KWMALESLQTQKFTTKSDVW 239

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 66/140 (47%), Gaps = 6/140 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  I LV EF   G LS Y+R   G    +T       
Sbjct: 52  EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 111
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-PL 133
           +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  +    Y        P+
Sbjct: 112 VCEGMAYLEEASVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 168
Query: 134 -YMAPEVLQFQRYDEKVNFF 152
            + +PEV  F RY  K + +
Sbjct: 169 KWASPEVFSFSRYSSKSDVW 188

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 69/140 (49%), Gaps = 10/140 (7%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLGA 77
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 144
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 133
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 145 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 201
Query: 134 -YMAPEVLQFQRYDEKVNFF 152
            +MA E LQ Q++  K + +
Sbjct: 202 KWMALESLQTQKFTTKSDVW 221

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 69/140 (49%), Gaps = 10/140 (7%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLGA 77
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 77  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 136
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 133
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 137 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 193
Query: 134 -YMAPEVLQFQRYDEKVNFF 152
            +MA E LQ Q++  K + +
Sbjct: 194 KWMALESLQTQKFTTKSDVW 213

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 72/140 (51%), Gaps = 10/140 (7%)
Query: 8   HLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
            L+S    E+  L ++ H +I++       Q E  + LV+E+   G+L  Y+  H  V  
Sbjct: 53  QLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC-VGL 111
Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
                F QQ+  G+  L++ H IHR L   N+L   LD+D ++KI DFGL+  +  G+  
Sbjct: 112 AQLLLFAQQICEGMAYLHAQHYIHRALAARNVL---LDNDRLVKIGDFGLAKAVPEGHEY 168
Query: 126 EKV---CGSPL-YMAPEVLQ 141
            +V     SP+ + APE L+
Sbjct: 169 YRVREDGDSPVFWYAPECLK 188

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 69/140 (49%), Gaps = 10/140 (7%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLGA 77
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 83  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 142
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 133
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 143 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 199
Query: 134 -YMAPEVLQFQRYDEKVNFF 152
            +MA E LQ Q++  K + +
Sbjct: 200 KWMALESLQTQKFTTKSDVW 219

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 72/140 (51%), Gaps = 10/140 (7%)
Query: 8   HLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
            L+S    E+  L ++ H +I++       Q E  + LV+E+   G+L  Y+  H  V  
Sbjct: 52  QLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC-VGL 110
Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
                F QQ+  G+  L++ H IHR L   N+L   LD+D ++KI DFGL+  +  G+  
Sbjct: 111 AQLLLFAQQICEGMAYLHAQHYIHRALAARNVL---LDNDRLVKIGDFGLAKAVPEGHEY 167
Query: 126 EKV---CGSPL-YMAPEVLQ 141
            +V     SP+ + APE L+
Sbjct: 168 YRVREDGDSPVFWYAPECLK 187

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 69/140 (49%), Gaps = 10/140 (7%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLGA 77
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 80  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 139
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 133
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 140 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196
Query: 134 -YMAPEVLQFQRYDEKVNFF 152
            +MA E LQ Q++  K + +
Sbjct: 197 KWMALESLQTQKFTTKSDVW 216

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 66/141 (46%), Gaps = 8/141 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  I LV EF   G LS Y+R   G    +T       
Sbjct: 53  EAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 112
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  +    Y     G+   
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFP 168
Query: 134 --YMAPEVLQFQRYDEKVNFF 152
             + +PEV  F RY  K + +
Sbjct: 169 VKWASPEVFSFSRYSSKSDVW 189

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 69/140 (49%), Gaps = 10/140 (7%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLGA 77
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 82  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 141
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 133
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 142 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 198
Query: 134 -YMAPEVLQFQRYDEKVNFF 152
            +MA E LQ Q++  K + +
Sbjct: 199 KWMALESLQTQKFTTKSDVW 218

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 69/140 (49%), Gaps = 10/140 (7%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLGA 77
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 144
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 133
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 145 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 201
Query: 134 -YMAPEVLQFQRYDEKVNFF 152
            +MA E LQ Q++  K + +
Sbjct: 202 KWMALESLQTQKFTTKSDVW 221

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 69/140 (49%), Gaps = 10/140 (7%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLGA 77
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 104 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 163
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 133
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 164 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 220
Query: 134 -YMAPEVLQFQRYDEKVNFF 152
            +MA E LQ Q++  K + +
Sbjct: 221 KWMALESLQTQKFTTKSDVW 240

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 69/140 (49%), Gaps = 10/140 (7%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLGA 77
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 84  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 143
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 133
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 144 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 200
Query: 134 -YMAPEVLQFQRYDEKVNFF 152
            +MA E LQ Q++  K + +
Sbjct: 201 KWMALESLQTQKFTTKSDVW 220

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 63/126 (50%), Gaps = 10/126 (7%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEF-CAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82
            HP +IRL D F+ +    LV+E      +L  YI   G + E  +R F  Q+ A ++  
Sbjct: 96  GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 83  NSHHIIHRDLKPENILLSGLDDDVM---LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 139
           +S  ++HRD+K ENIL+     D+     K+ DFG    L+   Y +   G+ +Y  PE 
Sbjct: 156 HSRGVVHRDIKDENILI-----DLRRGCAKLIDFGSGALLHDEPYTD-FDGTRVYSPPEW 209
Query: 140 LQFQRY 145
           +   +Y
Sbjct: 210 ISRHQY 215

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 56/99 (56%), Gaps = 11/99 (11%)
Query: 42  FLVVEFCAGGNLSSYIRLHGRV-------PEQTARKFLQQLGAGLEILNSHHIIHRDLKP 94
            +++ F   G+L +++ L  R+       P QT  +F+  +  G+E L+S + IHRDL  
Sbjct: 107 MVILPFMKHGDLHAFL-LASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAA 165
Query: 95  ENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
            N +L+   +D+ + +ADFGLS  +Y G+Y  + C S L
Sbjct: 166 RNCMLA---EDMTVCVADFGLSRKIYSGDYYRQGCASKL 201

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 74/173 (42%), Gaps = 42/173 (24%)
Query: 14  DCELNFLSSVNHPNI-IRLFDAFQAENCI------------FLVVEFCAGGNLSSYI--- 57
           D  L+  S ++ P++ IR  D F  +N +            ++ ++ C   NL  ++   
Sbjct: 96  DWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155
Query: 58  -----RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
                R HG            Q+   +E L+S  ++HRDLKP NI  + +DD  ++K+ D
Sbjct: 156 CSLEDREHG-----VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT-MDD--VVKVGD 207
Query: 113 FGLSCTLYPGNYAEKV-------------CGSPLYMAPEVLQFQRYDEKVNFF 152
           FGL   +      + V              G+ LYM+PE +    Y  KV+ F
Sbjct: 208 FGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIF 260

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 77/146 (52%), Gaps = 15/146 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFL 72
           E+  +S++NHPNI++L+      N   +V+EF   G+L  Y RL  +   +      + +
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDL--YHRLLDKAHPIKWSVKLRLM 128
Query: 73  QQLGAGLEILNSHH--IIHRDLKPENILLSGLDDD--VMLKIADFGLSCTLYPGNYAEKV 128
             +  G+E + + +  I+HRDL+  NI L  LD++  V  K+ADFG S      +    +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSV--HSVSGL 186
Query: 129 CGSPLYMAPEVL--QFQRYDEKVNFF 152
            G+  +MAPE +  + + Y EK + +
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTY 212

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 74/140 (52%), Gaps = 14/140 (10%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLF----DAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           +S    E++ L ++ H +II+      DA  A   + LV+E+   G+L  Y+  H     
Sbjct: 77  RSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS--LQLVMEYVPLGSLRDYLPRHSIGLA 134
Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
           Q    F QQ+  G+  L++ H IHRDL   N+L   LD+D ++KI DFGL+  +  G+  
Sbjct: 135 QLLL-FAQQICEGMAYLHAQHYIHRDLAARNVL---LDNDRLVKIGDFGLAKAVPEGHEX 190
Query: 126 EKV---CGSPL-YMAPEVLQ 141
            +V     SP+ + APE L+
Sbjct: 191 YRVREDGDSPVFWYAPECLK 210

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 66/140 (47%), Gaps = 6/140 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  I LV EF   G LS Y+R   G    +T       
Sbjct: 72  EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 131
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-PL 133
           +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  +    Y        P+
Sbjct: 132 VCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 188
Query: 134 -YMAPEVLQFQRYDEKVNFF 152
            + +PEV  F RY  K + +
Sbjct: 189 KWASPEVFSFSRYSSKSDVW 208

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 66/141 (46%), Gaps = 8/141 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  I LV EF   G LS Y+R   G    +T       
Sbjct: 50  EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 109
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  +    Y     G+   
Sbjct: 110 VCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFP 165
Query: 134 --YMAPEVLQFQRYDEKVNFF 152
             + +PEV  F RY  K + +
Sbjct: 166 VKWASPEVFSFSRYSSKSDVW 186

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 66/141 (46%), Gaps = 8/141 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  I LV EF   G LS Y+R   G    +T       
Sbjct: 52  EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 111
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  +    Y     G+   
Sbjct: 112 VCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFP 167
Query: 134 --YMAPEVLQFQRYDEKVNFF 152
             + +PEV  F RY  K + +
Sbjct: 168 VKWASPEVFSFSRYSSKSDVW 188

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 66/141 (46%), Gaps = 8/141 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  I LV EF   G LS Y+R   G    +T       
Sbjct: 55  EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 114
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  +    Y     G+   
Sbjct: 115 VCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFP 170
Query: 134 --YMAPEVLQFQRYDEKVNFF 152
             + +PEV  F RY  K + +
Sbjct: 171 VKWASPEVFSFSRYSSKSDVW 191

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 70/145 (48%), Gaps = 16/145 (11%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKF 71
            E + ++ + H N+++L      E   +++V E+ A G+L  Y+R  GR  +      KF
Sbjct: 54  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 113
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL----SCTLYPGNYAEK 127
              +   +E L  ++ +HRDL   N+L+S   +D + K++DFGL    S T   G    K
Sbjct: 114 SLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 170
Query: 128 VCGSPLYMAPEVLQFQRYDEKVNFF 152
                 + APE L+   +  K + +
Sbjct: 171 ------WTAPEALREAAFSTKSDVW 189

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 72/143 (50%), Gaps = 10/143 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ- 73
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 53  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 110
Query: 74  --QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+  G+  +   + IHR+L+  NIL+S   D +  KIADFGL+  +    Y A +   
Sbjct: 111 AAQIAEGMAFIEERNYIHRNLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAK 167
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE + +  +  K + +
Sbjct: 168 FPIKWTAPEAINYGTFTIKSDVW 190

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 10/140 (7%)
Query: 20  LSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLGA 77
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 86  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 145
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 133
           G++ L S   +HRDL   N +   LD+   +K+ADFGL+  +Y   +       G+ L  
Sbjct: 146 GMKFLASKKFVHRDLAARNCM---LDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 202
Query: 134 -YMAPEVLQFQRYDEKVNFF 152
            +MA E LQ Q++  K + +
Sbjct: 203 KWMALESLQTQKFTTKSDVW 222

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 10/140 (7%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLGA 77
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 144
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 133
           G++ L S   +HRDL   N +   LD+   +K+ADFGL+  +Y   +       G+ L  
Sbjct: 145 GMKFLASKKFVHRDLAARNCM---LDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 201
Query: 134 -YMAPEVLQFQRYDEKVNFF 152
            +MA E LQ Q++  K + +
Sbjct: 202 KWMALESLQTQKFTTKSDVW 221

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 10/140 (7%)
Query: 20  LSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLGA 77
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 90  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 149
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 133
           G++ L S   +HRDL   N +   LD+   +K+ADFGL+  +Y   +       G+ L  
Sbjct: 150 GMKFLASKKFVHRDLAARNCM---LDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 206
Query: 134 -YMAPEVLQFQRYDEKVNFF 152
            +MA E LQ Q++  K + +
Sbjct: 207 KWMALESLQTQKFTTKSDVW 226

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 10/140 (7%)
Query: 20  LSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLGA 77
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 83  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 142
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 133
           G++ L S   +HRDL   N +   LD+   +K+ADFGL+  +Y   +       G+ L  
Sbjct: 143 GMKFLASKKFVHRDLAARNCM---LDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 199
Query: 134 -YMAPEVLQFQRYDEKVNFF 152
            +MA E LQ Q++  K + +
Sbjct: 200 KWMALESLQTQKFTTKSDVW 219

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 77/146 (52%), Gaps = 15/146 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFL 72
           E+  +S++NHPNI++L+      N   +V+EF   G+L  Y RL  +   +      + +
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDL--YHRLLDKAHPIKWSVKLRLM 128
Query: 73  QQLGAGLEILNSHH--IIHRDLKPENILLSGLDDD--VMLKIADFGLSCTLYPGNYAEKV 128
             +  G+E + + +  I+HRDL+  NI L  LD++  V  K+ADF LS      +    +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSV--HSVSGL 186
Query: 129 CGSPLYMAPEVL--QFQRYDEKVNFF 152
            G+  +MAPE +  + + Y EK + +
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTY 212

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 10/140 (7%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLGA 77
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 144
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 133
           G++ L S   +HRDL   N +   LD+   +K+ADFGL+  +Y   +       G+ L  
Sbjct: 145 GMKFLASKKFVHRDLAARNCM---LDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 201
Query: 134 -YMAPEVLQFQRYDEKVNFF 152
            +MA E LQ Q++  K + +
Sbjct: 202 KWMALESLQTQKFTTKSDVW 221

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 10/140 (7%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLGA 77
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 203
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 133
           G++ L S   +HRDL   N +   LD+   +K+ADFGL+  +Y   +       G+ L  
Sbjct: 204 GMKFLASKKFVHRDLAARNCM---LDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 260
Query: 134 -YMAPEVLQFQRYDEKVNFF 152
            +MA E LQ Q++  K + +
Sbjct: 261 KWMALESLQTQKFTTKSDVW 280

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 65/147 (44%), Gaps = 9/147 (6%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           M+    + LK   D E+  ++   H N++ L       + + LV  +   G+L   +   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 61  GRVPEQTAR---KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-- 115
              P  +     K  Q    G+  L+ +H IHRD+K  NIL   LD+    KI+DFGL  
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL---LDEAFTAKISDFGLAR 181
Query: 116 -SCTLYPGNYAEKVCGSPLYMAPEVLQ 141
            S          ++ G+  YMAPE L+
Sbjct: 182 ASEKFAQTVMXSRIVGTTAYMAPEALR 208

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 71/143 (49%), Gaps = 10/143 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ- 73
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 57  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 114
Query: 74  --QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +      A +   
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDAEXTAREGAK 171
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE + +  +  K + +
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVW 194

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 65/147 (44%), Gaps = 9/147 (6%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           M+    + LK   D E+  ++   H N++ L       + + LV  +   G+L   +   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 61  GRVPEQTAR---KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-- 115
              P  +     K  Q    G+  L+ +H IHRD+K  NIL   LD+    KI+DFGL  
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL---LDEAFTAKISDFGLAR 181
Query: 116 -SCTLYPGNYAEKVCGSPLYMAPEVLQ 141
            S          ++ G+  YMAPE L+
Sbjct: 182 ASEKFAQTVMXXRIVGTTAYMAPEALR 208

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 71/143 (49%), Gaps = 10/143 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ- 73
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 57  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 114
Query: 74  --QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +      A +   
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEXTAREGAK 171
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE + +  +  K + +
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVW 194

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 71/143 (49%), Gaps = 10/143 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ- 73
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 58  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 115
Query: 74  --QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +      A +   
Sbjct: 116 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEXTAREGAK 172
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE + +  +  K + +
Sbjct: 173 FPIKWTAPEAINYGTFTIKSDVW 195

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 65/147 (44%), Gaps = 9/147 (6%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           M+    + LK   D E+  ++   H N++ L       + + LV  +   G+L   +   
Sbjct: 59  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 118
Query: 61  GRVPEQTAR---KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-- 115
              P  +     K  Q    G+  L+ +H IHRD+K  NIL   LD+    KI+DFGL  
Sbjct: 119 DGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL---LDEAFTAKISDFGLAR 175
Query: 116 -SCTLYPGNYAEKVCGSPLYMAPEVLQ 141
            S          ++ G+  YMAPE L+
Sbjct: 176 ASEKFAQXVMXXRIVGTTAYMAPEALR 202

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 71/143 (49%), Gaps = 10/143 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ- 73
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 59  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 116
Query: 74  --QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +      A +   
Sbjct: 117 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEXTAREGAK 173
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE + +  +  K + +
Sbjct: 174 FPIKWTAPEAINYGTFTIKSDVW 196

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 71/143 (49%), Gaps = 10/143 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ- 73
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 57  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 114
Query: 74  --QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +      A +   
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEXTAREGAK 171
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE + +  +  K + +
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVW 194

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 17/150 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHG---------RVP 64
           E+  L  + HPN+I L   F   A+  ++L+ ++ A  +L   I+ H          ++P
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLP 126
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLS----CTL 119
               +  L Q+  G+  L+++ ++HRDLKP NIL+ G   +   +KIAD G +      L
Sbjct: 127 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 186
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149
            P    + V  +  Y APE+L   R+  K 
Sbjct: 187 KPLADLDPVVVTFWYRAPELLLGARHYTKA 216

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 77/165 (46%), Gaps = 30/165 (18%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----------------L 59
           E   ++  ++PNI++L         + L+ E+ A G+L+ ++R                 
Sbjct: 100 EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 159
Query: 60  HGRV------PEQTARKF--LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
             RV      P   A +    +Q+ AG+  L+    +HRDL   N L+    +++++KIA
Sbjct: 160 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIA 216
Query: 112 DFGLSCTLYPGNY--AEKVCGSPL-YMAPEVLQFQRYDEKVNFFV 153
           DFGLS  +Y  +Y  A+     P+ +M PE + + RY  + + + 
Sbjct: 217 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWA 261

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 71/143 (49%), Gaps = 10/143 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ- 73
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 66  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 123
Query: 74  --QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +      A +   
Sbjct: 124 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEXTAREGAK 180
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE + +  +  K + +
Sbjct: 181 FPIKWTAPEAINYGTFTIKSDVW 203

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 71/143 (49%), Gaps = 10/143 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ- 73
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 65  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 122
Query: 74  --QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +      A +   
Sbjct: 123 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEXTAREGAK 179
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE + +  +  K + +
Sbjct: 180 FPIKWTAPEAINYGTFTIKSDVW 202

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 71/143 (49%), Gaps = 10/143 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ- 73
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 63  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 120
Query: 74  --QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +      A +   
Sbjct: 121 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEXTAREGAK 177
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE + +  +  K + +
Sbjct: 178 FPIKWTAPEAINYGTFTIKSDVW 200

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 63/127 (49%), Gaps = 6/127 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
           E++ L  + H NI+ L D    E  + LV E+    +L  Y+   G +      + FL Q
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQ 108
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPL 133
           L  GL   +   ++HRDLKP+N+L++   +   LK+ADFGL+     P    +    +  
Sbjct: 109 LLRGLAYCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYDNEVVTLW 165
Query: 134 YMAPEVL 140
           Y  P++L
Sbjct: 166 YRPPDIL 172

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 72/146 (49%), Gaps = 11/146 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++EF   G+L  Y++ H  R+
Sbjct: 56  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERI 114
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 115 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 171
Query: 124 YAEKV---CGSPL-YMAPEVLQFQRY 145
              KV     SP+ + APE L   ++
Sbjct: 172 EXXKVKEPGESPIFWYAPESLTESKF 197

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 63/129 (48%), Gaps = 18/129 (13%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQ---QL 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q   ++
Sbjct: 80  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 138
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 133
             G+  LN+   +HRDL   N +++    D  +KI DFG++  +Y  +Y  K     L  
Sbjct: 139 ADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 195
Query: 134 -YMAPEVLQ 141
            +MAPE L+
Sbjct: 196 RWMAPESLK 204

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 81/174 (46%), Gaps = 37/174 (21%)
Query: 11  SCLDCELNFLSSVNHPNIIRLFDAF-------------QAENCIFLVVEFCAGGNLSSYI 57
           S +  E+  L+S+NH  ++R + A+             + ++ +F+  E+C   N + Y 
Sbjct: 47  STILSEVXLLASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCE--NRTLYD 104
Query: 58  RLHGRVPEQTARKF---LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
            +H     Q   ++    +Q+   L  ++S  IIHR+LKP NI    +D+   +KI DFG
Sbjct: 105 LIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRNLKPXNIF---IDESRNVKIGDFG 161
Query: 115 LSCTLY-------------PGNYAE--KVCGSPLYMAPEVLQFQ-RYDEKVNFF 152
           L+  ++             PG+        G+  Y+A EVL     Y+EK++ +
Sbjct: 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXY 215

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 63/129 (48%), Gaps = 18/129 (13%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQ---QL 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q   ++
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 139
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 133
             G+  LN+   +HRDL   N +++    D  +KI DFG++  +Y  +Y  K     L  
Sbjct: 140 ADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 196
Query: 134 -YMAPEVLQ 141
            +MAPE L+
Sbjct: 197 RWMAPESLK 205

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 67/148 (45%), Gaps = 25/148 (16%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----------------Q 66
           +HPNII L  A +    ++L +E+   GNL  ++R   RV E                 Q
Sbjct: 74  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQ 132
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
               F   +  G++ L+    IHRDL   NIL+    ++ + KIADFGLS       Y +
Sbjct: 133 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRG--QEVYVK 187
Query: 127 KVCGS-PL-YMAPEVLQFQRYDEKVNFF 152
           K  G  P+ +MA E L +  Y    + +
Sbjct: 188 KTMGRLPVRWMAIESLNYSVYTTNSDVW 215

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 67/148 (45%), Gaps = 25/148 (16%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----------------Q 66
           +HPNII L  A +    ++L +E+   GNL  ++R   RV E                 Q
Sbjct: 84  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQ 142
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
               F   +  G++ L+    IHRDL   NIL+    ++ + KIADFGLS       Y +
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRG--QEVYVK 197
Query: 127 KVCGS-PL-YMAPEVLQFQRYDEKVNFF 152
           K  G  P+ +MA E L +  Y    + +
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVW 225

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 11/146 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 56  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERI 114
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 115 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 171
Query: 124 YAEKV---CGSPL-YMAPEVLQFQRY 145
              KV     SP+ + APE L   ++
Sbjct: 172 EXXKVKEPGESPIFWYAPESLTESKF 197

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 68/140 (48%), Gaps = 10/140 (7%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLGA 77
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 84  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 143
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 133
           G++ L S   +HRDL   N +   LD+   +K+ADFGL+  +Y           G+ L  
Sbjct: 144 GMKYLASKKFVHRDLAARNCM---LDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPV 200
Query: 134 -YMAPEVLQFQRYDEKVNFF 152
            +MA E LQ Q++  K + +
Sbjct: 201 KWMALESLQTQKFTTKSDVW 220

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 66/133 (49%), Gaps = 8/133 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI---FLVVEFCAGGNLSSYIRLHGR---VPEQTAR 69
           E   L  +NH NI++LF A + E       L++EFC  G+L + +        +PE    
Sbjct: 57  EFEVLKKLNHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL 115
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENIL-LSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
             L+ +  G+  L  + I+HR++KP NI+ + G D   + K+ DFG +  L        +
Sbjct: 116 IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL 175
Query: 129 CGSPLYMAPEVLQ 141
            G+  Y+ P++ +
Sbjct: 176 YGTEEYLHPDMYE 188

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 66/133 (49%), Gaps = 8/133 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI---FLVVEFCAGGNLSSYIRLHGR---VPEQTAR 69
           E   L  +NH NI++LF A + E       L++EFC  G+L + +        +PE    
Sbjct: 57  EFEVLKKLNHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL 115
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENIL-LSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
             L+ +  G+  L  + I+HR++KP NI+ + G D   + K+ DFG +  L        +
Sbjct: 116 IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXL 175
Query: 129 CGSPLYMAPEVLQ 141
            G+  Y+ P++ +
Sbjct: 176 YGTEEYLHPDMYE 188

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 62/129 (48%), Gaps = 18/129 (13%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQ---QL 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q   ++
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 139
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 133
             G+  LN+   +HRDL   N +++    D  +KI DFG++  +Y   Y  K     L  
Sbjct: 140 ADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETAYYRKGGKGLLPV 196
Query: 134 -YMAPEVLQ 141
            +MAPE L+
Sbjct: 197 RWMAPESLK 205

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 11/146 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 58  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 116
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 117 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 173
Query: 124 YAEKV---CGSPL-YMAPEVLQFQRY 145
              KV     SP+ + APE L   ++
Sbjct: 174 EXXKVKEPGESPIFWYAPESLTESKF 199

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 11/146 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 59  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 117
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 118 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 174
Query: 124 YAEKV---CGSPL-YMAPEVLQFQRY 145
              KV     SP+ + APE L   ++
Sbjct: 175 EXXKVKEPGESPIFWYAPESLTESKF 200

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 11/146 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 56  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 114
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 115 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 171
Query: 124 YAEKV---CGSPL-YMAPEVLQFQRY 145
              KV     SP+ + APE L   ++
Sbjct: 172 EXXKVKEPGESPIFWYAPESLTESKF 197

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 11/146 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 60  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 118
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 119 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 175
Query: 124 YAEKV---CGSPL-YMAPEVLQFQRY 145
              KV     SP+ + APE L   ++
Sbjct: 176 EXXKVKEPGESPIFWYAPESLTESKF 201

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 11/146 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 84  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 142
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 143 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 199
Query: 124 YAEKV---CGSPL-YMAPEVLQFQRY 145
              KV     SP+ + APE L   ++
Sbjct: 200 EXXKVKEPGESPIFWYAPESLTESKF 225

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 11/146 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 71  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 129
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 130 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 186
Query: 124 YAEKV---CGSPL-YMAPEVLQFQRY 145
              KV     SP+ + APE L   ++
Sbjct: 187 EXXKVKEPGESPIFWYAPESLTESKF 212

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 11/146 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 71  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 129
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 130 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 186
Query: 124 YAEKV---CGSPL-YMAPEVLQFQRY 145
              KV     SP+ + APE L   ++
Sbjct: 187 EXXKVKEPGESPIFWYAPESLTESKF 212

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 11/146 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 57  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 115
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 116 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 172
Query: 124 YAEKV---CGSPL-YMAPEVLQFQRY 145
              KV     SP+ + APE L   ++
Sbjct: 173 EXXKVKEPGESPIFWYAPESLTESKF 198

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 11/146 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 51  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 109
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 110 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 166
Query: 124 YAEKV---CGSPL-YMAPEVLQFQRY 145
              KV     SP+ + APE L   ++
Sbjct: 167 EXXKVKEPGESPIFWYAPESLTESKF 192

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 11/146 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 53  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 111
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 112 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 168
Query: 124 YAEKV---CGSPL-YMAPEVLQFQRY 145
              KV     SP+ + APE L   ++
Sbjct: 169 EXXKVKEPGESPIFWYAPESLTESKF 194

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 11/146 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 52  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 110
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 111 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 167
Query: 124 YAEKV---CGSPL-YMAPEVLQFQRY 145
              KV     SP+ + APE L   ++
Sbjct: 168 EXXKVKEPGESPIFWYAPESLTESKF 193

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 67/141 (47%), Gaps = 16/141 (11%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL 72
            E N + ++ H  +++L  A   +  I+++ EF A G+L  +++     + P      F 
Sbjct: 226 AEANVMKTLQHDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 284
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+  G+  +   + IHRDL+  NIL+S     ++ KIADFGL         A      P
Sbjct: 285 AQIAEGMAFIEQRNYIHRDLRAANILVSA---SLVCKIADFGL---------ARVGAKFP 332
Query: 133 L-YMAPEVLQFQRYDEKVNFF 152
           + + APE + F  +  K + +
Sbjct: 333 IKWTAPEAINFGSFTIKSDVW 353

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 11/146 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 53  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 111
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 112 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 168
Query: 124 YAEKV---CGSPL-YMAPEVLQFQRY 145
              KV     SP+ + APE L   ++
Sbjct: 169 EXXKVKEPGESPIFWYAPESLTESKF 194

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 37/129 (28%), Positives = 70/129 (54%), Gaps = 16/129 (12%)
Query: 19  FLSSVNHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFL 72
           FL+ V HP+I+++F+  +      +   ++V+E+  G +L    R  G ++P   A  +L
Sbjct: 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLK---RSKGQKLPVAEAIAYL 188
Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            ++   L  L+S  +++ DLKPENI+L+    +  LK+ D G    +    Y   + G+P
Sbjct: 189 LEILPALSYLHSIGLVYNDLKPENIMLT----EEQLKLIDLGAVSRINSFGY---LYGTP 241
Query: 133 LYMAPEVLQ 141
            + APE+++
Sbjct: 242 GFQAPEIVR 250

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/128 (32%), Positives = 65/128 (50%), Gaps = 14/128 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI-----FLVVEFCAGG 51
           +KK+N+  +  +DC     E+  L+ +    IIRL D    E+ +     ++V+E  A  
Sbjct: 58  IKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEI-ADS 116
Query: 52  NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
           +L    +    + EQ  +  L  L  G + ++   IIHRDLKP N L   L+ D  +KI 
Sbjct: 117 DLKKLFKTPIFLTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCL---LNQDCSVKIC 173
Query: 112 DFGLSCTL 119
           DFGL+ T+
Sbjct: 174 DFGLARTI 181

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 18/150 (12%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  L    H NII + D  +          +++V++     +L   I     +  +  R
Sbjct: 103 ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVR 161
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS---CTLYPGN--- 123
            FL QL  GL+ ++S  +IHRDLKP N+L   ++++  LKI DFG++   CT  P     
Sbjct: 162 YFLYQLLRGLKYMHSAQVIHRDLKPSNLL---VNENCELKIGDFGMARGLCT-SPAEHQY 217
Query: 124 YAEKVCGSPLYMAPE-VLQFQRYDEKVNFF 152
           +  +   +  Y APE +L    Y + ++ +
Sbjct: 218 FMTEYVATRWYRAPELMLSLHEYTQAIDLW 247

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 69/142 (48%), Gaps = 23/142 (16%)
Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK-------FLQQ 74
           S +HPN+IR + +   +  +++ +E C   NL   +       E    +        L+Q
Sbjct: 65  SDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLD----------DDVMLKIADFGLSCTLYPGNY 124
           + +G+  L+S  IIHRDLKP+NIL+S             +++ + I+DFGL   L  G  
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 125 AEKV-----CGSPLYMAPEVLQ 141
           + +       G+  + APE+L+
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLE 205

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNX 129
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 130 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 186

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 68/140 (48%), Gaps = 10/140 (7%)
Query: 20  LSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLGA 77
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 86  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 145
Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 133
           G++ L S   +HRDL   N +   LD+   +K+ADFGL+  +    +       G+ L  
Sbjct: 146 GMKFLASKKFVHRDLAARNCM---LDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPV 202
Query: 134 -YMAPEVLQFQRYDEKVNFF 152
            +MA E LQ Q++  K + +
Sbjct: 203 KWMALESLQTQKFTTKSDVW 222

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 18/129 (13%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQ---QL 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q   ++
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 139
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 133
             G+  LN+   +HR+L   N +++    D  +KI DFG++  +Y  +Y  K     L  
Sbjct: 140 ADGMAYLNAKKFVHRNLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 196
Query: 134 -YMAPEVLQ 141
            +MAPE L+
Sbjct: 197 RWMAPESLK 205

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 69/144 (47%), Gaps = 11/144 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--- 131
           +  G+  L S   IHRDL   N+LL+  D   ++KI DFGL   L P N    V      
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRAL-PQNDDHXVMQEHRK 175
Query: 132 -PL-YMAPEVLQFQRYDEKVNFFV 153
            P  + APE L+ + +    + ++
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWM 199

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 5/101 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G+  L S   IHRDL   N+LL+  D   ++KI DFGL
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGL 157

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 21/149 (14%)
Query: 10  KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE--- 65
           K  L  EL  +S +  H NI+ L  A      + ++ E+C  G+L +++R   RV E   
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 66  ------QTARK-----FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
                  TA       F  Q+  G+  L S + IHRD+   N+LL+   +  + KI DFG
Sbjct: 153 AFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFG 209
Query: 115 LSCTLY-PGNYAEKVCGS-PL-YMAPEVL 140
           L+  +    NY  K     P+ +MAPE +
Sbjct: 210 LARDIMNDSNYIVKGNARLPVKWMAPESI 238

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 81/163 (49%), Gaps = 20/163 (12%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F   + +      +LV+ F   
Sbjct: 54  IKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT 113
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L   + L  +  E+  +  + Q+  GL+ ++S  ++HRDLKP N+    +++D  LKI
Sbjct: 114 -DLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNL---AVNEDCELKI 167
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+   +          +  Y APEV L +  Y++ V+ +
Sbjct: 168 LDFGLA--RHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIW 208

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 67/148 (45%), Gaps = 25/148 (16%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----------------Q 66
           +HPNII L  A +    ++L +E+   GNL  ++R   RV E                 Q
Sbjct: 81  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQ 139
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
               F   +  G++ L+    IHR+L   NIL+    ++ + KIADFGLS       Y +
Sbjct: 140 QLLHFAADVARGMDYLSQKQFIHRNLAARNILVG---ENYVAKIADFGLSRG--QEVYVK 194
Query: 127 KVCGS-PL-YMAPEVLQFQRYDEKVNFF 152
           K  G  P+ +MA E L +  Y    + +
Sbjct: 195 KTMGRLPVRWMAIESLNYSVYTTNSDVW 222

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 18/129 (13%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQ---QL 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q   ++
Sbjct: 82  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 140
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 133
             G+  LN+   +HR+L   N +++    D  +KI DFG++  +Y  +Y  K     L  
Sbjct: 141 ADGMAYLNAKKFVHRNLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 197
Query: 134 -YMAPEVLQ 141
            +MAPE L+
Sbjct: 198 RWMAPESLK 206

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/142 (24%), Positives = 66/142 (46%), Gaps = 8/142 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +   +H NIIRL         + ++ E+   G L  ++R   G          L+ 
Sbjct: 96  EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 131
           + AG++ L + + +HRDL   NIL   ++ +++ K++DFGLS  L       Y       
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNIL---VNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212
Query: 132 PL-YMAPEVLQFQRYDEKVNFF 152
           P+ + APE + ++++    + +
Sbjct: 213 PIRWTAPEAISYRKFTSASDVW 234

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 5/101 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G+  L S   IHRDL   N+LL+  D   ++KI DFGL
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGL 157

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 18/150 (12%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  L    H NII + D  +          +++V++     +L   I     +  +  R
Sbjct: 104 ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVR 162
Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS---CTLYPGN--- 123
            FL QL  GL+ ++S  +IHRDLKP N+L   ++++  LKI DFG++   CT  P     
Sbjct: 163 YFLYQLLRGLKYMHSAQVIHRDLKPSNLL---VNENCELKIGDFGMARGLCT-SPAEHQY 218
Query: 124 YAEKVCGSPLYMAPE-VLQFQRYDEKVNFF 152
           +  +   +  Y APE +L    Y + ++ +
Sbjct: 219 FMTEYVATRWYRAPELMLSLHEYTQAIDLW 248

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 74  GVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 133
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 134 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 190

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 5/101 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 65  EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 123
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G+  L S   IHRDL   N+LL+  D   ++KI DFGL
Sbjct: 124 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGL 161

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 5/101 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 71  EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G+  L S   IHRDL   N+LL+  D   ++KI DFGL
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGL 167

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 76/143 (53%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V+E+ + G+L  +++     + R+P+      
Sbjct: 63  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLV--DM 119
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 120 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE   + R+  K + +
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVW 199

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 5/101 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 71  EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G+  L S   IHRDL   N+LL+  D   ++KI DFGL
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGL 167

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 5/101 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 65  EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 123
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G+  L S   IHRDL   N+LL+  D   ++KI DFGL
Sbjct: 124 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGL 161

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 75/143 (52%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 63  EAQVMKKIRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DM 119
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 120 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE   + R+  K + +
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVW 199

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 117 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 177 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 233

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 70/149 (46%), Gaps = 21/149 (14%)
Query: 10  KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ-- 66
           K  L  EL  +S +  H NI+ L  A      + ++ E+C  G+L +++R   RV E   
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 67  ---------TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
                    + R  L    Q+  G+  L S + IHRD+   N+LL+   +  + KI DFG
Sbjct: 153 AFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFG 209
Query: 115 LSCTLY-PGNYAEKVCGS-PL-YMAPEVL 140
           L+  +    NY  K     P+ +MAPE +
Sbjct: 210 LARDIMNDSNYIVKGNARLPVKWMAPESI 238

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 28/151 (18%)
Query: 16  ELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFC--------AGGNLSSY-IRLHGRVPE 65
           E+  L+ S +HPN+IR + +   +  +++ +E C           N+S   ++L     E
Sbjct: 76  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQK---E 132
Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD----------DDVMLKIADFGL 115
                 L+Q+ +G+  L+S  IIHRDLKP+NIL+S             +++ + I+DFGL
Sbjct: 133 YNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 192
Query: 116 SCTLYPGNYAEKV-----CGSPLYMAPEVLQ 141
              L  G    +       G+  + APE+L+
Sbjct: 193 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLE 223

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 75  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 134
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 135 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 191

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 28/151 (18%)
Query: 16  ELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFC--------AGGNLSSY-IRLHGRVPE 65
           E+  L+ S +HPN+IR + +   +  +++ +E C           N+S   ++L     E
Sbjct: 76  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQK---E 132
Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD----------DDVMLKIADFGL 115
                 L+Q+ +G+  L+S  IIHRDLKP+NIL+S             +++ + I+DFGL
Sbjct: 133 YNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 192
Query: 116 SCTLYPGNYAEKV-----CGSPLYMAPEVLQ 141
              L  G    +       G+  + APE+L+
Sbjct: 193 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLE 223

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 73  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 132
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 133 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 189

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 74  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 133
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 134 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 190

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 129
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 130 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 186

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 68/142 (47%), Gaps = 23/142 (16%)
Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK-------FLQQ 74
           S +HPN+IR + +   +  +++ +E C   NL   +       E    +        L+Q
Sbjct: 65  SDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLD----------DDVMLKIADFGLSCTLYPGNY 124
           + +G+  L+S  IIHRDLKP+NIL+S             +++ + I+DFGL   L  G  
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQX 183
Query: 125 AEKV-----CGSPLYMAPEVLQ 141
             +       G+  + APE+L+
Sbjct: 184 XFRXNLNNPSGTSGWRAPELLE 205

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 75  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 134
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 135 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 191

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 71/156 (45%), Gaps = 23/156 (14%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 122
Query: 67  TARKFLQQLGA---GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           +  K +Q  G    G+  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +
Sbjct: 123 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETD 179
Query: 124 YAEKVCGSPL---YMAPEVLQ---FQRYDEKVNFFV 153
           Y  K     L   +M+PE L+   F  Y +  +F V
Sbjct: 180 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 215

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 71/156 (45%), Gaps = 23/156 (14%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 69  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 126
Query: 67  TARKFLQQLGA---GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           +  K +Q  G    G+  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +
Sbjct: 127 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETD 183
Query: 124 YAEKVCGSPL---YMAPEVLQ---FQRYDEKVNFFV 153
           Y  K     L   +M+PE L+   F  Y +  +F V
Sbjct: 184 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 219

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 71/156 (45%), Gaps = 23/156 (14%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 128
Query: 67  TARKFLQQLGA---GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           +  K +Q  G    G+  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +
Sbjct: 129 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETD 185
Query: 124 YAEKVCGSPL---YMAPEVLQ---FQRYDEKVNFFV 153
           Y  K     L   +M+PE L+   F  Y +  +F V
Sbjct: 186 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 221

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 102 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 161
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 162 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 218

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 129
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 130 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 186

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 117 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 177 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 233

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 74/143 (51%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++       R+P+      
Sbjct: 229 EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DM 285
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 286 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 342
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE   + R+  K + +
Sbjct: 343 FPIKWTAPEAALYGRFTIKSDVW 365

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 117 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 177 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 233

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 71/156 (45%), Gaps = 23/156 (14%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 129
Query: 67  TARKFLQQLGA---GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           +  K +Q  G    G+  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +
Sbjct: 130 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETD 186
Query: 124 YAEKVCGSPL---YMAPEVLQ---FQRYDEKVNFFV 153
           Y  K     L   +M+PE L+   F  Y +  +F V
Sbjct: 187 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 222

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 102 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 161
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 162 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 218

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 162
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 163 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 219

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 63/147 (42%), Gaps = 9/147 (6%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           M+    + LK   D E+   +   H N++ L       + + LV  +   G+L   +   
Sbjct: 56  MVDITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCL 115
Query: 61  GRVPEQTAR---KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-- 115
              P  +     K  Q    G+  L+ +H IHRD+K  NIL   LD+    KI+DFGL  
Sbjct: 116 DGTPPLSWHXRCKIAQGAANGINFLHENHHIHRDIKSANIL---LDEAFTAKISDFGLAR 172
Query: 116 -SCTLYPGNYAEKVCGSPLYMAPEVLQ 141
            S          ++ G+  Y APE L+
Sbjct: 173 ASEKFAQXVXXSRIVGTTAYXAPEALR 199

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 102 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 161
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 162 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 218

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 75  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 134
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 135 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 191

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 97  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 156
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 157 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 213

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 162
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 163 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 219

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 74/143 (51%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++       R+P+      
Sbjct: 229 EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DM 285
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 286 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 342
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE   + R+  K + +
Sbjct: 343 FPIKWTAPEAALYGRFTIKSDVW 365

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 71/156 (45%), Gaps = 23/156 (14%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 100 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 157
Query: 67  TARKFLQQLGA---GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           +  K +Q  G    G+  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +
Sbjct: 158 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETD 214
Query: 124 YAEKVCGSPL---YMAPEVLQ---FQRYDEKVNFFV 153
           Y  K     L   +M+PE L+   F  Y +  +F V
Sbjct: 215 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 250

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 162
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 163 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 219

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 102 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 161
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 162 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 218

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 89  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 148
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 149 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 205

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 89  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 148
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 149 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 205

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 90  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 149
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 150 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 206

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 168
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 169 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 225

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 90  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 149
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 150 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 206

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 162
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 163 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 219

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 122 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 181
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 182 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 238

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   +   ++ 
Sbjct: 90  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 149
Query: 86  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 150 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 206

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 71/156 (45%), Gaps = 23/156 (14%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 128
Query: 67  TARKFLQQLGA---GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           +  K +Q  G    G+  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +
Sbjct: 129 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETD 185
Query: 124 YAEKVCGSPL---YMAPEVLQ---FQRYDEKVNFFV 153
           Y  K     L   +M+PE L+   F  Y +  +F V
Sbjct: 186 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 221

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 74/143 (51%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++       R+P+      
Sbjct: 56  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DM 112
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 113 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 169
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE   + R+  K + +
Sbjct: 170 FPIKWTAPEAALYGRFTIKSDVW 192

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 71/154 (46%), Gaps = 19/154 (12%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-------HGRVPEQTA 68
           E + +   N  +++RL           +++E    G+L SY+R        +  +   + 
Sbjct: 68  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 127
Query: 69  RKFLQQLGA---GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
            K +Q  G    G+  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +Y 
Sbjct: 128 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYY 184
Query: 126 EKVCGSPL---YMAPEVLQ---FQRYDEKVNFFV 153
            K     L   +M+PE L+   F  Y +  +F V
Sbjct: 185 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 218

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 11/146 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 53  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 111
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 112 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 168
Query: 124 YAEKV---CGSPL-YMAPEVLQFQRY 145
              KV     SP+ + APE L   ++
Sbjct: 169 EFFKVKEPGESPIFWYAPESLTESKF 194

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 75/143 (52%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 54  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DM 110
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 111 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 167
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE   + R+  K + +
Sbjct: 168 FPIKWTAPEAALYGRFTIKSDVW 190

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 75/143 (52%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 63  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DM 119
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 120 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE   + R+  K + +
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVW 199

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 65/134 (48%), Gaps = 14/134 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           E+  L    H NII + D  +A        ++LV     G +L   ++      +     
Sbjct: 91  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQHLSNDHICY- 148
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 149 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLT 205
Query: 127 KVCGSPLYMAPEVL 140
           +   +  Y APE++
Sbjct: 206 EYVATRWYRAPEIM 219

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 75/143 (52%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 52  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DM 108
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 109 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 165
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE   + R+  K + +
Sbjct: 166 FPIKWTAPEAALYGRFTIKSDVW 188

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 71/156 (45%), Gaps = 23/156 (14%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 135
Query: 67  TARKFLQQLGA---GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           +  K +Q  G    G+  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +
Sbjct: 136 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETD 192
Query: 124 YAEKVCGSPL---YMAPEVLQ---FQRYDEKVNFFV 153
           Y  K     L   +M+PE L+   F  Y +  +F V
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 228

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 72/139 (51%), Gaps = 12/139 (8%)
Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAG 78
           + S++H +I+RL       + + LV ++   G+L  ++R H G +  Q    +  Q+  G
Sbjct: 69  IGSLDHAHIVRLL-GLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 127
Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPL- 133
           +  L  H ++HR+L   N+LL        +++ADFG++  L P +    Y+E    +P+ 
Sbjct: 128 MYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVADLLPPDDKQLLYSE--AKTPIK 182
Query: 134 YMAPEVLQFQRYDEKVNFF 152
           +MA E + F +Y  + + +
Sbjct: 183 WMALESIHFGKYTHQSDVW 201

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 71/154 (46%), Gaps = 19/154 (12%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-------HGRVPEQTA 68
           E + +   N  +++RL           +++E    G+L SY+R        +  +   + 
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 69  RKFLQQLGA---GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
            K +Q  G    G+  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +Y 
Sbjct: 138 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYY 194
Query: 126 EKVCGSPL---YMAPEVLQ---FQRYDEKVNFFV 153
            K     L   +M+PE L+   F  Y +  +F V
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 228

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 83/165 (50%), Gaps = 18/165 (10%)
Query: 3   KKLNKHLKSCL-DCELN----------FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG 51
           +K+N  +K+C  DC L+           + +++HP+I++L    + E   ++++E    G
Sbjct: 35  EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYG 93
Query: 52  NLSSYI-RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            L  Y+ R    +   T   +  Q+   +  L S + +HRD+   NIL++  +    +K+
Sbjct: 94  ELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE---CVKL 150
Query: 111 ADFGLSCTLYPGNYAE-KVCGSPL-YMAPEVLQFQRYDEKVNFFV 153
            DFGLS  +   +Y +  V   P+ +M+PE + F+R+    + ++
Sbjct: 151 GDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWM 195

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 85/167 (50%), Gaps = 28/167 (16%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F   + +      +LV+ F   
Sbjct: 72  IKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT 131
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L   + +     E+  +  + Q+  GL+ ++S  ++HRDLKP N+    +++D  LKI
Sbjct: 132 -DLQKIMGME--FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNL---AVNEDCELKI 185
Query: 111 ADFGLSCTLYPGNYAE-KVCG---SPLYMAPEV-LQFQRYDEKVNFF 152
            DFGL+       +A+ ++ G   +  Y APEV L +  Y++ V+ +
Sbjct: 186 LDFGLA------RHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIW 226

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 72/139 (51%), Gaps = 12/139 (8%)
Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAG 78
           + S++H +I+RL       + + LV ++   G+L  ++R H G +  Q    +  Q+  G
Sbjct: 87  IGSLDHAHIVRLL-GLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 145
Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPL- 133
           +  L  H ++HR+L   N+LL        +++ADFG++  L P +    Y+E    +P+ 
Sbjct: 146 MYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVADLLPPDDKQLLYSE--AKTPIK 200
Query: 134 YMAPEVLQFQRYDEKVNFF 152
           +MA E + F +Y  + + +
Sbjct: 201 WMALESIHFGKYTHQSDVW 219

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 69/142 (48%), Gaps = 14/142 (9%)
Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL---- 75
           LS   HP+++ L       N + L+ ++   GNL  +  L+G      +  + Q+L    
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH--LYGSDLPTMSMSWEQRLEICI 146
Query: 76  GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS---CTLYPGNYAEKVCG 130
           GA  GL  L++  IIHRD+K  NIL   LD++ + KI DFG+S     L   +    V G
Sbjct: 147 GAARGLHYLHTRAIIHRDVKSINIL---LDENFVPKITDFGISKKGTELGQTHLXXVVKG 203
Query: 131 SPLYMAPEVLQFQRYDEKVNFF 152
           +  Y+ PE     R  EK + +
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVY 225

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 83/165 (50%), Gaps = 18/165 (10%)
Query: 3   KKLNKHLKSCL-DCELN----------FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG 51
           +K+N  +K+C  DC L+           + +++HP+I++L    + E   ++++E    G
Sbjct: 51  EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYG 109
Query: 52  NLSSYI-RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            L  Y+ R    +   T   +  Q+   +  L S + +HRD+   NIL++  +    +K+
Sbjct: 110 ELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE---CVKL 166
Query: 111 ADFGLSCTLYPGNYAE-KVCGSPL-YMAPEVLQFQRYDEKVNFFV 153
            DFGLS  +   +Y +  V   P+ +M+PE + F+R+    + ++
Sbjct: 167 GDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWM 211

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 74/143 (51%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 230 EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DM 286
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL   +    Y A +   
Sbjct: 287 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLGRLIEDNEYTARQGAK 343
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE   + R+  K + +
Sbjct: 344 FPIKWTAPEAALYGRFTIKSDVW 366

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 74/142 (52%), Gaps = 15/142 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
           +KK+ +  +  +DC     E+  L+ +NH +++++ D    ++      +++V+E  A  
Sbjct: 83  IKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEI-ADS 141
Query: 52  NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
           +     R    + E   +  L  L  G++ ++S  I+HRDLKP N L   ++ D  +K+ 
Sbjct: 142 DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL---VNQDCSVKVC 198
Query: 112 DFGLSCTL-YPGNYAEKVCGSP 132
           DFGL+ T+ YP N   ++  SP
Sbjct: 199 DFGLARTVDYPENGNSQLPISP 220

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 83/165 (50%), Gaps = 18/165 (10%)
Query: 3   KKLNKHLKSCL-DCELN----------FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG 51
           +K+N  +K+C  DC L+           + +++HP+I++L    + E   ++++E    G
Sbjct: 39  EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYG 97
Query: 52  NLSSYI-RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            L  Y+ R    +   T   +  Q+   +  L S + +HRD+   NIL++  +    +K+
Sbjct: 98  ELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE---CVKL 154
Query: 111 ADFGLSCTLYPGNYAE-KVCGSPL-YMAPEVLQFQRYDEKVNFFV 153
            DFGLS  +   +Y +  V   P+ +M+PE + F+R+    + ++
Sbjct: 155 GDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWM 199

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 69/142 (48%), Gaps = 14/142 (9%)
Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL---- 75
           LS   HP+++ L       N + L+ ++   GNL  +  L+G      +  + Q+L    
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH--LYGSDLPTMSMSWEQRLEICI 146
Query: 76  GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS---CTLYPGNYAEKVCG 130
           GA  GL  L++  IIHRD+K  NIL   LD++ + KI DFG+S     L   +    V G
Sbjct: 147 GAARGLHYLHTRAIIHRDVKSINIL---LDENFVPKITDFGISKKGTELDQTHLXXVVKG 203
Query: 131 SPLYMAPEVLQFQRYDEKVNFF 152
           +  Y+ PE     R  EK + +
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVY 225

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 73/142 (51%), Gaps = 13/142 (9%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 54  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 112
Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                 ++  Q+  G+E L +   IHR+L   NIL   ++++  +KI DFGL+  L P +
Sbjct: 113 DHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNIL---VENENRVKIGDFGLTKVL-PQD 168
Query: 124 ---YAEKVCG-SPL-YMAPEVL 140
              Y  K  G SP+ + APE L
Sbjct: 169 KEYYKVKEPGESPIFWYAPESL 190

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/128 (29%), Positives = 65/128 (50%), Gaps = 14/128 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI-----FLVVEFCAGG 51
           +KK+N+  +  +DC     E+  L+ +    IIRL+D    ++ +     ++V+E  A  
Sbjct: 56  IKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI-ADS 114
Query: 52  NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
           +L    +    + E+  +  L  L  G   ++   IIHRDLKP N L   L+ D  +K+ 
Sbjct: 115 DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCL---LNQDCSVKVC 171
Query: 112 DFGLSCTL 119
           DFGL+ T+
Sbjct: 172 DFGLARTI 179

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 71/157 (45%), Gaps = 22/157 (14%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-- 58
           +L+ +NKH     D E+ +        I+ L   F   N + LV E  +  NL   +R  
Sbjct: 103 LLELMNKH-----DTEMKYY-------IVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNT 149
Query: 59  -LHGRVPEQTARKFLQQLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGL 115
              G V     RKF QQ+   L  L +    IIH DLKPENILL        +KI DFG 
Sbjct: 150 NFRG-VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGS 207
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           SC L  G    +   S  Y +PEVL    YD  ++ +
Sbjct: 208 SCQL--GQRIYQXIQSRFYRSPEVLLGMPYDLAIDMW 242

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 70/156 (44%), Gaps = 23/156 (14%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 122
Query: 67  TARKFLQQLGA---GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           +  K +Q  G    G+  LN++  +HRDL   N  ++   +D  +KI DFG++  +Y  +
Sbjct: 123 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVA---EDFTVKIGDFGMTRDIYETD 179
Query: 124 YAEKVCGSPL---YMAPEVLQ---FQRYDEKVNFFV 153
           Y  K     L   +M+PE L+   F  Y +  +F V
Sbjct: 180 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 215

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 35/139 (25%), Positives = 73/139 (52%), Gaps = 12/139 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 312 EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DM 368
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 369 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 425
Query: 131 SPL-YMAPEVLQFQRYDEK 148
            P+ + APE   + R+  K
Sbjct: 426 FPIKWTAPEAALYGRFTIK 444

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 75/143 (52%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 63  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLV--DM 119
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 120 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE   + R+  K + +
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVW 199

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 71/157 (45%), Gaps = 22/157 (14%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-- 58
           +L+ +NKH     D E+ +        I+ L   F   N + LV E  +  NL   +R  
Sbjct: 103 LLELMNKH-----DTEMKYY-------IVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNT 149
Query: 59  -LHGRVPEQTARKFLQQLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGL 115
              G V     RKF QQ+   L  L +    IIH DLKPENILL        +KI DFG 
Sbjct: 150 NFRG-VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRXAIKIVDFGS 207
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           SC L  G    +   S  Y +PEVL    YD  ++ +
Sbjct: 208 SCQL--GQRIYQXIQSRFYRSPEVLLGMPYDLAIDMW 242

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 74/143 (51%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++       R+P+      
Sbjct: 229 EAQVMKKLRHEKLVQLY-AVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLV--DM 285
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 286 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 342
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE   + R+  K + +
Sbjct: 343 FPIKWTAPEAALYGRFTIKSDVW 365

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 71/157 (45%), Gaps = 22/157 (14%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-- 58
           +L+ +NKH     D E+ +        I+ L   F   N + LV E  +  NL   +R  
Sbjct: 84  LLELMNKH-----DTEMKYY-------IVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNT 130
Query: 59  -LHGRVPEQTARKFLQQLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGL 115
              G V     RKF QQ+   L  L +    IIH DLKPENILL        +KI DFG 
Sbjct: 131 NFRG-VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGS 188
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           SC L  G    +   S  Y +PEVL    YD  ++ +
Sbjct: 189 SCQL--GQRIYQXIQSRFYRSPEVLLGMPYDLAIDMW 223

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 74/143 (51%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 63  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DM 119
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL   NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 120 AAQIASGMAYVERMNYVHRDLAAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE   + R+  K + +
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVW 199

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 23/149 (15%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHG-------RVP 64
           E+  L  + H NI++   A +    +    +L+  F   G+LS +++ +         + 
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIA 127
Query: 65  EQTAR--KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           E  AR   +L +   GL+  +   I HRD+K +N+LL    +++   IADFGL+     G
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK---NNLTACIADFGLALKFEAG 184
Query: 123 NYAEKV---CGSPLYMAPEVLQ----FQR 144
             A       G+  YMAPEVL+    FQR
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQR 213

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 11/134 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL   F +      E  + LV+++           Y R    +P  
Sbjct: 142 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 201
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 202 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 259
Query: 127 KVCGSPLYMAPEVL 140
               S  Y APE++
Sbjct: 260 SYICSRYYRAPELI 273

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 75/143 (52%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V+E+ + G L  +++     + R+P+      
Sbjct: 63  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLV--DM 119
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 120 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE   + R+  K + +
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVW 199

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 73/143 (51%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+   G+L  +++       R+P+      
Sbjct: 60  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLV--DM 116
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 117 SAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 173
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE   + R+  K + +
Sbjct: 174 FPIKWTAPEAALYGRFTIKSDVW 196

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 7/74 (9%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKIXDFGLARVADPDHDHTGFLT 185
Query: 127 KVCGSPLYMAPEVL 140
           +   +  Y APE++
Sbjct: 186 EYVATRWYRAPEIM 199

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 74/143 (51%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G L  +++     + R+P+      
Sbjct: 63  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLV--DM 119
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 120 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE   + R+  K + +
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVW 199

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 7/74 (9%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 131 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSD---LKICDFGLARVADPDHDHTGFLT 187
Query: 127 KVCGSPLYMAPEVL 140
           +   +  Y APE++
Sbjct: 188 EYVATRWYRAPEIM 201

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 74/144 (51%), Gaps = 14/144 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V+E+ + G+L  +++     + R+P+      
Sbjct: 63  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLV--DM 119
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  L   N      G+
Sbjct: 120 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLA-RLIEDNEXTARQGA 175
Query: 132 PL---YMAPEVLQFQRYDEKVNFF 152
                + APE   + R+  K + +
Sbjct: 176 KFPIKWTAPEAALYGRFTIKSDVW 199

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 7/74 (9%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLT 185
Query: 127 KVCGSPLYMAPEVL 140
           +   +  Y APE++
Sbjct: 186 EYVATRWYRAPEIM 199

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 7/74 (9%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLT 185
Query: 127 KVCGSPLYMAPEVL 140
           +   +  Y APE++
Sbjct: 186 EYVATRWYRAPEIM 199

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 11/134 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 127 KVCGSPLYMAPEVL 140
               S  Y APE++
Sbjct: 181 SXICSRYYRAPELI 194

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 61/129 (47%), Gaps = 18/129 (13%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQ---QL 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q   ++
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 139
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 133
             G+  LN+   +HRDL   N +++    D  +KI DFG++  +   +   K     L  
Sbjct: 140 ADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 196
Query: 134 -YMAPEVLQ 141
            +MAPE L+
Sbjct: 197 RWMAPESLK 205

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 71/146 (48%), Gaps = 15/146 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAF-----QAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQT 67
           E+  L+  +HPNI+ L D F      A + ++LV E     +L+  I  H +   +  Q 
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIVISPQH 135
Query: 68  ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127
            + F+  +  GL +L+   ++HRDL P NILL+  +D   + I DF L+           
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND---ITICDFNLAREDTADANKTH 192
Query: 128 VCGSPLYMAPE-VLQFQRYDEKVNFF 152
                 Y APE V+QF+ + + V+ +
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMW 218

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 7/74 (9%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLT 189
Query: 127 KVCGSPLYMAPEVL 140
           +   +  Y APE++
Sbjct: 190 EYVATRWYRAPEIM 203

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 71/146 (48%), Gaps = 15/146 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAF-----QAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQT 67
           E+  L+  +HPNI+ L D F      A + ++LV E     +L+  I  H +   +  Q 
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIVISPQH 135
Query: 68  ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127
            + F+  +  GL +L+   ++HRDL P NILL+  +D   + I DF L+           
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND---ITICDFNLAREDTADANKTH 192
Query: 128 VCGSPLYMAPE-VLQFQRYDEKVNFF 152
                 Y APE V+QF+ + + V+ +
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMW 218

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 7/74 (9%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLT 189
Query: 127 KVCGSPLYMAPEVL 140
           +   +  Y APE++
Sbjct: 190 EYVATRWYRAPEIM 203

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 61/129 (47%), Gaps = 18/129 (13%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQ---QL 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q   ++
Sbjct: 78  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 136
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 133
             G+  LN+   +HRDL   N +++    D  +KI DFG++  +   +   K     L  
Sbjct: 137 ADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 193
Query: 134 -YMAPEVLQ 141
            +MAPE L+
Sbjct: 194 RWMAPESLK 202

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 69/141 (48%), Gaps = 12/141 (8%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAE---NCIFLVVEFCAGGNLSSYI-RLHGRVPEQTA 68
           L  E+  L ++ H NI++ +     E   N I L++EF   G+L  Y+ +   ++  +  
Sbjct: 58  LKKEIEILRNLYHENIVK-YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ 116
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
            K+  Q+  G++ L S   +HRDL   N+L   ++ +  +KI DFGL+  +        V
Sbjct: 117 LKYAVQICKGMDYLGSRQYVHRDLAARNVL---VESEHQVKIGDFGLTKAIETDKEXXTV 173
Query: 129 C---GSPL-YMAPEVLQFQRY 145
                SP+ + APE L   ++
Sbjct: 174 KDDRDSPVFWYAPECLMQSKF 194

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 61/129 (47%), Gaps = 18/129 (13%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQ---QL 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q   ++
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 139
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 133
             G+  LN+   +HRDL   N +++    D  +KI DFG++  +   +   K     L  
Sbjct: 140 ADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 196
Query: 134 -YMAPEVLQ 141
            +MAPE L+
Sbjct: 197 RWMAPESLK 205

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 69/145 (47%), Gaps = 17/145 (11%)
Query: 10  KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQ 66
           K  L  EL  +S +  H NI+ L  A      + ++ E+C  G+L +++R      + ++
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKE 152
Query: 67  TARK--------FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
             R         F  Q+  G+  L S + IHRD+   N+LL+   +  + KI DFGL+  
Sbjct: 153 DGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLARD 209
Query: 119 LY-PGNYAEKVCGS-PL-YMAPEVL 140
           +    NY  K     P+ +MAPE +
Sbjct: 210 IMNDSNYIVKGNARLPVKWMAPESI 234

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 69/141 (48%), Gaps = 12/141 (8%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAE---NCIFLVVEFCAGGNLSSYI-RLHGRVPEQTA 68
           L  E+  L ++ H NI++ +     E   N I L++EF   G+L  Y+ +   ++  +  
Sbjct: 70  LKKEIEILRNLYHENIVK-YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ 128
Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
            K+  Q+  G++ L S   +HRDL   N+L   ++ +  +KI DFGL+  +        V
Sbjct: 129 LKYAVQICKGMDYLGSRQYVHRDLAARNVL---VESEHQVKIGDFGLTKAIETDKEXXTV 185
Query: 129 C---GSPL-YMAPEVLQFQRY 145
                SP+ + APE L   ++
Sbjct: 186 KDDRDSPVFWYAPECLMQSKF 206

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 69/145 (47%), Gaps = 17/145 (11%)
Query: 10  KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQ 66
           K  L  EL  +S +  H NI+ L  A      + ++ E+C  G+L +++R      + ++
Sbjct: 85  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKE 144
Query: 67  TARK--------FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
             R         F  Q+  G+  L S + IHRD+   N+LL+   +  + KI DFGL+  
Sbjct: 145 DGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLARD 201
Query: 119 LY-PGNYAEKVCGS-PL-YMAPEVL 140
           +    NY  K     P+ +MAPE +
Sbjct: 202 IMNDSNYIVKGNARLPVKWMAPESI 226

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 74/143 (51%), Gaps = 11/143 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEF-CAGGNLSSYIRL--HG 61
           K L+   D +     S+   +I++L D F  +  N + +V+ F   G NL + I+   H 
Sbjct: 67  KLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR 126
Query: 62  RVPEQTARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDDD---VMLKIADFGLSC 117
            +P    ++  +QL  GL+ ++    IIH D+KPEN+L+  +D     + +KIAD G +C
Sbjct: 127 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186
Query: 118 TLYPGNYAEKVCGSPLYMAPEVL 140
             Y  +Y   +  +  Y +PEVL
Sbjct: 187 -WYDEHYTNSIQ-TREYRSPEVL 207

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 74/143 (51%), Gaps = 11/143 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEF-CAGGNLSSYIRL--HG 61
           K L+   D +     S+   +I++L D F  +  N + +V+ F   G NL + I+   H 
Sbjct: 67  KLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR 126
Query: 62  RVPEQTARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDDD---VMLKIADFGLSC 117
            +P    ++  +QL  GL+ ++    IIH D+KPEN+L+  +D     + +KIAD G +C
Sbjct: 127 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186
Query: 118 TLYPGNYAEKVCGSPLYMAPEVL 140
             Y  +Y   +  +  Y +PEVL
Sbjct: 187 -WYDEHYTNSIQ-TREYRSPEVL 207

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 11/134 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVI 122
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 127 KVCGSPLYMAPEVL 140
               S  Y APE++
Sbjct: 181 SXICSRYYRAPELI 194

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/143 (23%), Positives = 73/143 (51%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+   G+L  +++       R+P+      
Sbjct: 60  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLV--DM 116
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    + A +   
Sbjct: 117 SAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEWTARQGAK 173
Query: 131 SPL-YMAPEVLQFQRYDEKVNFF 152
            P+ + APE   + R+  K + +
Sbjct: 174 FPIKWTAPEAALYGRFTIKSDVW 196

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 66/131 (50%), Gaps = 10/131 (7%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 84  SHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-Q 141
           S  I+HRD+KP N++   +D ++  L++ D+GL+   +PG        S  +  PE+L  
Sbjct: 143 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 199
Query: 142 FQRYDEKVNFF 152
            Q YD  ++ +
Sbjct: 200 LQDYDYSLDMW 210

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 66/131 (50%), Gaps = 10/131 (7%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 88  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 144
Query: 84  SHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-Q 141
           S  I+HRD+KP N++   +D ++  L++ D+GL+   +PG        S  +  PE+L  
Sbjct: 145 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 201
Query: 142 FQRYDEKVNFF 152
            Q YD  ++ +
Sbjct: 202 LQDYDYSLDMW 212

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 66/131 (50%), Gaps = 10/131 (7%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 84  SHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-Q 141
           S  I+HRD+KP N++   +D ++  L++ D+GL+   +PG        S  +  PE+L  
Sbjct: 143 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 199
Query: 142 FQRYDEKVNFF 152
            Q YD  ++ +
Sbjct: 200 LQDYDYSLDMW 210

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 66/131 (50%), Gaps = 10/131 (7%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 84  SHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-Q 141
           S  I+HRD+KP N++   +D ++  L++ D+GL+   +PG        S  +  PE+L  
Sbjct: 143 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 199
Query: 142 FQRYDEKVNFF 152
            Q YD  ++ +
Sbjct: 200 LQDYDYSLDMW 210

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 66/131 (50%), Gaps = 10/131 (7%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 84  SHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-Q 141
           S  I+HRD+KP N++   +D ++  L++ D+GL+   +PG        S  +  PE+L  
Sbjct: 143 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 199
Query: 142 FQRYDEKVNFF 152
            Q YD  ++ +
Sbjct: 200 LQDYDYSLDMW 210

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 66/131 (50%), Gaps = 10/131 (7%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 143
Query: 84  SHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-Q 141
           S  I+HRD+KP N++   +D ++  L++ D+GL+   +PG        S  +  PE+L  
Sbjct: 144 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 200
Query: 142 FQRYDEKVNFF 152
            Q YD  ++ +
Sbjct: 201 LQDYDYSLDMW 211

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 66/131 (50%), Gaps = 10/131 (7%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 143
Query: 84  SHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-Q 141
           S  I+HRD+KP N++   +D ++  L++ D+GL+   +PG        S  +  PE+L  
Sbjct: 144 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 200
Query: 142 FQRYDEKVNFF 152
            Q YD  ++ +
Sbjct: 201 LQDYDYSLDMW 211

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 66/131 (50%), Gaps = 10/131 (7%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 84  SHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-Q 141
           S  I+HRD+KP N++   +D ++  L++ D+GL+   +PG        S  +  PE+L  
Sbjct: 143 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 199
Query: 142 FQRYDEKVNFF 152
            Q YD  ++ +
Sbjct: 200 LQDYDYSLDMW 210

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 66/131 (50%), Gaps = 10/131 (7%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 107 PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 163
Query: 84  SHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-Q 141
           S  I+HRD+KP N++   +D ++  L++ D+GL+   +PG        S  +  PE+L  
Sbjct: 164 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 220
Query: 142 FQRYDEKVNFF 152
            Q YD  ++ +
Sbjct: 221 LQDYDYSLDMW 231

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 66/131 (50%), Gaps = 10/131 (7%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 84  SHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-Q 141
           S  I+HRD+KP N++   +D ++  L++ D+GL+   +PG        S  +  PE+L  
Sbjct: 143 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 199
Query: 142 FQRYDEKVNFF 152
            Q YD  ++ +
Sbjct: 200 LQDYDYSLDMW 210

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 75/168 (44%), Gaps = 31/168 (18%)
Query: 1   MLK-KLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
           MLK K +   +  L  EL  ++ + +H NI+ L  A      I+L+ E+C  G+L +Y+R
Sbjct: 82  MLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 141
Query: 59  L--------------HGRVPEQTARK---------FLQQLGAGLEILNSHHIIHRDLKPE 95
                            R+ E+             F  Q+  G+E L     +HRDL   
Sbjct: 142 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201
Query: 96  NILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGS-PL-YMAPEVL 140
           N+L++      ++KI DFGL+  +    NY  +     P+ +MAPE L
Sbjct: 202 NVLVT---HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 246

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 61/133 (45%), Gaps = 10/133 (7%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQLGAGL 79
           N  N+I + + F   N I +  E  +  NL   I+ +      +P    RKF   +   L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLP--LVRKFAHSILQCL 213
Query: 80  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 139
           + L+ + IIH DLKPENILL        +K+ DFG SC  Y          S  Y APEV
Sbjct: 214 DALHKNRIIHCDLKPENILLK-QQGRSGIKVIDFGSSC--YEHQRVYTXIQSRFYRAPEV 270
Query: 140 LQFQRYDEKVNFF 152
           +   RY   ++ +
Sbjct: 271 ILGARYGMPIDMW 283

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 25/152 (16%)
Query: 10  KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP---- 64
           K  L  EL  +S +  H NI+ L  A      + ++ E+C  G+L +++R   R P    
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR-RKRPPGLEY 151
Query: 65  ---------EQTARK----FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
                    EQ + +    F  Q+  G+  L S + IHRD+   N+LL+   +  + KI 
Sbjct: 152 SYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIG 208
Query: 112 DFGLSCTLY-PGNYAEKVCGS-PL-YMAPEVL 140
           DFGL+  +    NY  K     P+ +MAPE +
Sbjct: 209 DFGLARDIMNDSNYIVKGNARLPVKWMAPESI 240

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 70/146 (47%), Gaps = 24/146 (16%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCA---GGNLSSYIRLHGRVP 64
           E+  L  + H N++ L +  + +          I+LV +FC     G LS+ +    +  
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFT 122
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----- 119
               ++ +Q L  GL  ++ + I+HRD+K  N+L++    D +LK+ADFGL+        
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKN 179
Query: 120 -YPGNYAEKVCGSPLYMAPEVLQFQR 144
             P  Y  +V  +  Y  PE+L  +R
Sbjct: 180 SQPNRYXNRVV-TLWYRPPELLLGER 204

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 61/133 (45%), Gaps = 10/133 (7%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQLGAGL 79
           N  N+I + + F   N I +  E  +  NL   I+ +      +P    RKF   +   L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLP--LVRKFAHSILQCL 213
Query: 80  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 139
           + L+ + IIH DLKPENILL        +K+ DFG SC  Y          S  Y APEV
Sbjct: 214 DALHKNRIIHCDLKPENILLK-QQGRSGIKVIDFGSSC--YEHQRVYTXIQSRFYRAPEV 270
Query: 140 LQFQRYDEKVNFF 152
           +   RY   ++ +
Sbjct: 271 ILGARYGMPIDMW 283

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 11/134 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 127 KVCGSPLYMAPEVL 140
               S  Y APE++
Sbjct: 181 SXICSRYYRAPELI 194

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 11/134 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 127 KVCGSPLYMAPEVL 140
               S  Y APE++
Sbjct: 181 SYICSRYYRAPELI 194

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 7/74 (9%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 185
Query: 127 KVCGSPLYMAPEVL 140
           +   +  Y APE++
Sbjct: 186 EYVATRWYRAPEIM 199

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 61/133 (45%), Gaps = 10/133 (7%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQLGAGL 79
           N  N+I + + F   N I +  E  +  NL   I+ +      +P    RKF   +   L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLP--LVRKFAHSILQCL 213
Query: 80  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 139
           + L+ + IIH DLKPENILL        +K+ DFG SC  Y          S  Y APEV
Sbjct: 214 DALHKNRIIHCDLKPENILLK-QQGRSGIKVIDFGSSC--YEHQRVYXXIQSRFYRAPEV 270
Query: 140 LQFQRYDEKVNFF 152
           +   RY   ++ +
Sbjct: 271 ILGARYGMPIDMW 283

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 11/134 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 127 KVCGSPLYMAPEVL 140
               S  Y APE++
Sbjct: 181 SXICSRYYRAPELI 194

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 11/134 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 64  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 123
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 124 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 181
Query: 127 KVCGSPLYMAPEVL 140
               S  Y APE++
Sbjct: 182 SXICSRYYRAPELI 195

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 47/88 (53%), Gaps = 2/88 (2%)
Query: 53  LSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
           L S+IR    +P      ++ QL   +  ++S  I HRD+KP+N+L++  D+   LK+ D
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN--TLKLCD 185
Query: 113 FGLSCTLYPGNYAEKVCGSPLYMAPEVL 140
           FG +  L P   +     S  Y APE++
Sbjct: 186 FGSAKKLIPSEPSVAXICSRFYRAPELM 213

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 70/146 (47%), Gaps = 24/146 (16%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCA---GGNLSSYIRLHGRVP 64
           E+  L  + H N++ L +  + +          I+LV +FC     G LS+ +    +  
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFT 123
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----- 119
               ++ +Q L  GL  ++ + I+HRD+K  N+L++    D +LK+ADFGL+        
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKN 180
Query: 120 -YPGNYAEKVCGSPLYMAPEVLQFQR 144
             P  Y  +V  +  Y  PE+L  +R
Sbjct: 181 SQPNRYXNRVV-TLWYRPPELLLGER 205

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 7/74 (9%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 189
Query: 127 KVCGSPLYMAPEVL 140
           +   +  Y APE++
Sbjct: 190 EYVATRWYRAPEIM 203

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 7/74 (9%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 127 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 183
Query: 127 KVCGSPLYMAPEVL 140
           +   +  Y APE++
Sbjct: 184 EYVATRWYRAPEIM 197

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 7/74 (9%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 127 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 183
Query: 127 KVCGSPLYMAPEVL 140
           +   +  Y APE++
Sbjct: 184 EYVATRWYRAPEIM 197

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 7/74 (9%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 189
Query: 127 KVCGSPLYMAPEVL 140
           +   +  Y APE++
Sbjct: 190 EYVATRWYRAPEIM 203

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 7/74 (9%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 134 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 190
Query: 127 KVCGSPLYMAPEVL 140
           +   +  Y APE++
Sbjct: 191 EYVATRWYRAPEIM 204

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 11/134 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 67  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 126
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 127 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 184
Query: 127 KVCGSPLYMAPEVL 140
               S  Y APE++
Sbjct: 185 SXICSRYYRAPELI 198

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 7/74 (9%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 135 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 191
Query: 127 KVCGSPLYMAPEVL 140
           +   +  Y APE++
Sbjct: 192 EYVATRWYRAPEIM 205

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 7/74 (9%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 126 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 182
Query: 127 KVCGSPLYMAPEVL 140
           +   +  Y APE++
Sbjct: 183 EYVATRWYRAPEIM 196

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 7/74 (9%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 189
Query: 127 KVCGSPLYMAPEVL 140
           +   +  Y APE++
Sbjct: 190 EYVATRWYRAPEIM 203

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 7/74 (9%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 131 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 187
Query: 127 KVCGSPLYMAPEVL 140
           +   +  Y APE++
Sbjct: 188 EYVATRWYRAPEIM 201

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 11/134 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 127 KVCGSPLYMAPEVL 140
               S  Y APE++
Sbjct: 181 SYICSRYYRAPELI 194

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 7/74 (9%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 131 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 187
Query: 127 KVCGSPLYMAPEVL 140
           +   +  Y APE++
Sbjct: 188 EYVATRWYRAPEIM 201

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 7/74 (9%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLX 189
Query: 127 KVCGSPLYMAPEVL 140
           +   +  Y APE++
Sbjct: 190 EXVATRWYRAPEIM 203

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 7/74 (9%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 134 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLX 190
Query: 127 KVCGSPLYMAPEVL 140
           +   +  Y APE++
Sbjct: 191 EXVATRWYRAPEIM 204

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 11/134 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 82  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 142 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 199
Query: 127 KVCGSPLYMAPEVL 140
               S  Y APE++
Sbjct: 200 SXICSRYYRAPELI 213

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 7/74 (9%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 137 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 193
Query: 127 KVCGSPLYMAPEVL 140
           +   +  Y APE++
Sbjct: 194 EYVATRWYRAPEIM 207

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 7/74 (9%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 185
Query: 127 KVCGSPLYMAPEVL 140
           +   +  Y APE++
Sbjct: 186 EYVATRWYRAPEIM 199

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 11/134 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 134
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 135 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 192
Query: 127 KVCGSPLYMAPEVL 140
               S  Y APE++
Sbjct: 193 SXICSRYYRAPELI 206

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 7/74 (9%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 126
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 149 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 205
Query: 127 KVCGSPLYMAPEVL 140
           +   +  Y APE++
Sbjct: 206 EYVATRWYRAPEIM 219

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 11/134 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 71  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 130
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 131 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 188
Query: 127 KVCGSPLYMAPEVL 140
               S  Y APE++
Sbjct: 189 SXICSRYYRAPELI 202

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 11/134 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 76  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 135
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 136 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 193
Query: 127 KVCGSPLYMAPEVL 140
               S  Y APE++
Sbjct: 194 SYICSRYYRAPELI 207

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 11/134 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 127 KVCGSPLYMAPEVL 140
               S  Y APE++
Sbjct: 181 SYICSRYYRAPELI 194

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 11/134 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 134
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 135 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 192
Query: 127 KVCGSPLYMAPEVL 140
               S  Y APE++
Sbjct: 193 SXICSRYYRAPELI 206

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 11/134 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSS---YIRLHGRVPEQ 66
           EL  +  V HPN++ L   F      + E  + LV+E+       +   Y +L   +P  
Sbjct: 82  ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML 141
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL       +LK+ DFG +  L  G    
Sbjct: 142 LIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG--VLKLIDFGSAKILIAGEPNV 199
Query: 127 KVCGSPLYMAPEVL 140
               S  Y APE++
Sbjct: 200 SXICSRYYRAPELI 213

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 70/146 (47%), Gaps = 24/146 (16%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC--------IFLVVEFCA---GGNLSSYIRLHGRVP 64
           E+  L  + H N++ L +  + +          I+LV +FC     G LS+ +    +  
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLV---KFT 123
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----- 119
               ++ +Q L  GL  ++ + I+HRD+K  N+L++    D +LK+ADFGL+        
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKN 180
Query: 120 -YPGNYAEKVCGSPLYMAPEVLQFQR 144
             P  Y  +V  +  Y  PE+L  +R
Sbjct: 181 SQPNRYXNRVV-TLWYRPPELLLGER 205

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 70/146 (47%), Gaps = 24/146 (16%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCA---GGNLSSYIRLHGRVP 64
           E+  L  + H N++ L +  + +          I+LV +FC     G LS+ +    +  
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFT 123
Query: 65  EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----- 119
               ++ +Q L  GL  ++ + I+HRD+K  N+L++    D +LK+ADFGL+        
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKN 180
Query: 120 -YPGNYAEKVCGSPLYMAPEVLQFQR 144
             P  Y  +V  +  Y  PE+L  +R
Sbjct: 181 SQPNRYXNRVV-TLWYRPPELLLGER 205

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 64/141 (45%), Gaps = 10/141 (7%)
Query: 19  FLSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQLG 76
            +  +NHPN++ L       E    +++ +   G+L  +IR   R P  +    F  Q+ 
Sbjct: 75  LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVA 134
Query: 77  AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSP 132
            G+E L     +HRDL   N +   LD+   +K+ADFGL+  +    Y      +    P
Sbjct: 135 RGMEYLAEQKFVHRDLAARNCM---LDESFTVKVADFGLARDILDREYYSVQQHRHARLP 191
Query: 133 L-YMAPEVLQFQRYDEKVNFF 152
           + + A E LQ  R+  K + +
Sbjct: 192 VKWTALESLQTYRFTTKSDVW 212

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 70/147 (47%), Gaps = 12/147 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL 72
            E+  +S   H N++RL           LV  + A G+++S +R     + P    ++  
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 143
Query: 73  QQLGA--GLEILNSH---HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYA- 125
             LG+  GL  L+ H    IIHRD+K  NIL   LD++    + DFGL+  + Y   +  
Sbjct: 144 IALGSARGLAYLHDHCDPKIIHRDVKAANIL---LDEEFEAVVGDFGLAKLMDYKDXHVX 200
Query: 126 EKVCGSPLYMAPEVLQFQRYDEKVNFF 152
             V G+  ++APE L   +  EK + F
Sbjct: 201 XAVRGTIGHIAPEYLSTGKSSEKTDVF 227

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 11/134 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 157 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 214
Query: 127 KVCGSPLYMAPEVL 140
               S  Y APE++
Sbjct: 215 SXICSRYYRAPELI 228

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 11/134 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 68  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 127
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 128 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 185
Query: 127 KVCGSPLYMAPEVL 140
               S  Y APE++
Sbjct: 186 SYICSRYYRAPELI 199

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 64/130 (49%), Gaps = 8/130 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+L+    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVLIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 143 QRYDEKVNFF 152
           Q YD  ++ +
Sbjct: 207 QMYDYSLDMW 216

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 11/134 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 91  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 150
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 151 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 208
Query: 127 KVCGSPLYMAPEVL 140
               S  Y APE++
Sbjct: 209 SYICSRYYRAPELI 222

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 30/158 (18%)
Query: 10  KSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-------- 60
           K  L  EL  +S +  H NI+ L  A      + ++ E+C  G+L +++R          
Sbjct: 78  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPS 137
Query: 61  ---GRVPEQTARK------------FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDD 105
              G+ PE   ++            F  Q+  G+  L S + IHRD+   N+LL+   + 
Sbjct: 138 LAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NG 194
Query: 106 VMLKIADFGLSCTLY-PGNYAEKVCGS-PL-YMAPEVL 140
            + KI DFGL+  +    NY  K     P+ +MAPE +
Sbjct: 195 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI 232

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/142 (26%), Positives = 69/142 (48%), Gaps = 10/142 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPE-QTARKFLQ 73
           E   +  + H  +++L+ A  +E  I++V E+   G+L  +++   GR  +         
Sbjct: 54  EAQIMKKLKHDKLVQLY-AVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAA 112
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           Q+ AG+  +   + IHRDL+  NIL+    + ++ KIADFGL+  L   N      G+  
Sbjct: 113 QVAAGMAYIERMNYIHRDLRSANILVG---NGLICKIADFGLA-RLIEDNEXTARQGAKF 168
Query: 134 ---YMAPEVLQFQRYDEKVNFF 152
              + APE   + R+  K + +
Sbjct: 169 PIKWTAPEAALYGRFTIKSDVW 190

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 11/134 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 99  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 158
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 159 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 216
Query: 127 KVCGSPLYMAPEVL 140
               S  Y APE++
Sbjct: 217 SYICSRYYRAPELI 230

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 20/148 (13%)
Query: 24  NHPNIIRL----FDAFQAENCIFLVVEFCAGGNLSSYI-RLHGR---VPEQTARKFLQQL 75
           NHPNI+RL         A++  +L++ F   G L + I RL  +   + E      L  +
Sbjct: 84  NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--------NYAEK 127
             GLE +++    HRDLKP NILL      V++ +     +C    G        ++A +
Sbjct: 144 CRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 128 VCGSPLYMAPEVLQFQRY---DEKVNFF 152
            C +  Y APE+   Q +   DE+ + +
Sbjct: 204 RC-TISYRAPELFSVQSHCVIDERTDVW 230

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 11/134 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 157 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 214
Query: 127 KVCGSPLYMAPEVL 140
               S  Y APE++
Sbjct: 215 SYICSRYYRAPELI 228

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 73/144 (50%), Gaps = 14/144 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I +V E+ + G+L  +++       R+P+      
Sbjct: 53  EAQVMKKLRHEKLVQLY-AVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DM 109
Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
             Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  L   N      G+
Sbjct: 110 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLA-RLIEDNEXTARQGA 165
Query: 132 --PL-YMAPEVLQFQRYDEKVNFF 152
             P+ + APE   + R+  K + +
Sbjct: 166 KFPIKWTAPEAALYGRFTIKSDVW 189

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 11/134 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 101 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 160
Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 161 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 218
Query: 127 KVCGSPLYMAPEVL 140
               S  Y APE++
Sbjct: 219 SYICSRYYRAPELI 232

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 8/130 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 143 QRYDEKVNFF 152
           Q YD  ++ +
Sbjct: 207 QMYDYSLDMW 216

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 8/130 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 143 QRYDEKVNFF 152
           Q YD  ++ +
Sbjct: 207 QMYDYSLDMW 216

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 8/130 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 143 QRYDEKVNFF 152
           Q YD  ++ +
Sbjct: 207 QMYDYSLDMW 216

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/125 (24%), Positives = 59/125 (47%), Gaps = 5/125 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E      +  P+++ + D  + +  +++      G +L++ +R  G +    A   ++Q+
Sbjct: 84  EARTAGRLQEPHVVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQI 143
Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPL 133
           G+ L+  ++    HRD+KPENIL+S    D    + DFG++         +     G+  
Sbjct: 144 GSALDAAHAAGATHRDVKPENILVSA---DDFAYLVDFGIASATTDEKLTQLGNTVGTLY 200
Query: 134 YMAPE 138
           Y APE
Sbjct: 201 YXAPE 205

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 38/120 (31%), Positives = 57/120 (47%), Gaps = 13/120 (10%)
Query: 43  LVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSG 101
           LV+E+   G L  +++ H  R+       +  Q+  G+E L S   +HRDL   NIL   
Sbjct: 87  LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL--- 143
Query: 102 LDDDVMLKIADFGLSCTLYPGNYAEKVCGSP-----LYMAPEVLQ---FQRYDEKVNFFV 153
           ++ +  +KIADFGL+  L P +    V   P      + APE L    F R  +  +F V
Sbjct: 144 VESEAHVKIADFGLA-KLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGV 202

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 8/130 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 143 QRYDEKVNFF 152
           Q YD  ++ +
Sbjct: 207 QMYDYSLDMW 216

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 27/74 (36%), Positives = 43/74 (58%), Gaps = 7/74 (9%)
Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP----GNYAE 126
           FL Q+  GL+ ++S +++HRDLKP N+L++   D   LKI DFGL+    P      +  
Sbjct: 149 FLYQILRGLKYIHSANVLHRDLKPSNLLINTTCD---LKICDFGLARIADPEHDHTGFLT 205
Query: 127 KVCGSPLYMAPEVL 140
           +   +  Y APE++
Sbjct: 206 EXVATRWYRAPEIM 219

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 8/130 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 147
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 148 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 205
Query: 143 QRYDEKVNFF 152
           Q YD  ++ +
Sbjct: 206 QMYDYSLDMW 215

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 8/130 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 143 QRYDEKVNFF 152
           Q YD  ++ +
Sbjct: 207 QMYDYSLDMW 216

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 8/130 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 97  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 153
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 154 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 211
Query: 143 QRYDEKVNFF 152
           Q YD  ++ +
Sbjct: 212 QMYDYSLDMW 221

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 8/130 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 147
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 148 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 205
Query: 143 QRYDEKVNFF 152
           Q YD  ++ +
Sbjct: 206 QMYDYSLDMW 215

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 8/130 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 143 QRYDEKVNFF 152
           Q YD  ++ +
Sbjct: 207 QMYDYSLDMW 216

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 8/130 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 143 QRYDEKVNFF 152
           Q YD  ++ +
Sbjct: 207 QMYDYSLDMW 216

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 8/130 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 143 QRYDEKVNFF 152
           Q YD  ++ +
Sbjct: 207 QMYDYSLDMW 216

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 8/130 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 146
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 147 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 143 QRYDEKVNFF 152
           Q YD  ++ +
Sbjct: 205 QMYDYSLDMW 214

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 8/130 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 143 QRYDEKVNFF 152
           Q YD  ++ +
Sbjct: 207 QMYDYSLDMW 216

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 69/147 (46%), Gaps = 12/147 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL 72
            E+  +S   H N++RL           LV  + A G+++S +R     + P    ++  
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 73  QQLGA--GLEILNSH---HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYA- 125
             LG+  GL  L+ H    IIHRD+K  NIL   LD++    + DFGL+  + Y   +  
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANIL---LDEEFEAVVGDFGLAKLMDYKDXHVX 192
Query: 126 EKVCGSPLYMAPEVLQFQRYDEKVNFF 152
             V G   ++APE L   +  EK + F
Sbjct: 193 XAVRGXIGHIAPEYLSTGKSSEKTDVF 219

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 69/156 (44%), Gaps = 23/156 (14%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 120
Query: 67  TARKFLQQLGA---GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           +  K +Q  G    G+  LN++  +HRDL   N +++   +D  +KI DFG++  +   +
Sbjct: 121 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIXETD 177
Query: 124 YAEKVCGSPL---YMAPEVLQ---FQRYDEKVNFFV 153
              K     L   +M+PE L+   F  Y +  +F V
Sbjct: 178 XXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 213

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 69/156 (44%), Gaps = 23/156 (14%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 129
Query: 67  TARKFLQQLGA---GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           +  K +Q  G    G+  LN++  +HRDL   N +++   +D  +KI DFG++  +   +
Sbjct: 130 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIXETD 186
Query: 124 YAEKVCGSPL---YMAPEVLQ---FQRYDEKVNFFV 153
              K     L   +M+PE L+   F  Y +  +F V
Sbjct: 187 XXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 222

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 63/130 (48%), Gaps = 8/130 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
           PNII L D  +        LV E     N + + +L   + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLRQTLTDYDIRFYMYEILKALDYCH 148
Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 142
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 143 QRYDEKVNFF 152
           Q YD  ++ +
Sbjct: 207 QMYDYSLDMW 216

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/82 (37%), Positives = 46/82 (56%), Gaps = 6/82 (7%)
Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY--PGNYAEKVCGS 131
           Q+  G+E L+S   IHRDL   NILLS   ++ ++KI DFGL+  +Y  P    +     
Sbjct: 207 QVARGMEFLSSRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKNPDYVRKGDTRL 263
Query: 132 PL-YMAPEVLQFQRYDEKVNFF 152
           PL +MAPE +  + Y  K + +
Sbjct: 264 PLKWMAPESIFDKIYSTKSDVW 285

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/120 (31%), Positives = 57/120 (47%), Gaps = 13/120 (10%)
Query: 43  LVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSG 101
           LV+E+   G L  +++ H  R+       +  Q+  G+E L S   +HRDL   NIL   
Sbjct: 90  LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL--- 146
Query: 102 LDDDVMLKIADFGLSCTLYPGNYAEKVCGSP-----LYMAPEVLQ---FQRYDEKVNFFV 153
           ++ +  +KIADFGL+  L P +    V   P      + APE L    F R  +  +F V
Sbjct: 147 VESEAHVKIADFGLA-KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGV 205

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 57/95 (60%), Gaps = 9/95 (9%)
Query: 25  HPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL-QQLGAGLEI 81
           H NI+ L +  +A+N   ++LV ++    +L + IR    + E   ++++  QL   ++ 
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIR--ANILEPVHKQYVVYQLIKVIKY 124
Query: 82  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           L+S  ++HRD+KP NILL+    +  +K+ADFGLS
Sbjct: 125 LHSGGLLHRDMKPSNILLNA---ECHVKVADFGLS 156

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/120 (31%), Positives = 57/120 (47%), Gaps = 13/120 (10%)
Query: 43  LVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSG 101
           LV+E+   G L  +++ H  R+       +  Q+  G+E L S   +HRDL   NIL   
Sbjct: 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL--- 159
Query: 102 LDDDVMLKIADFGLSCTLYPGNYAEKVCGSP-----LYMAPEVLQ---FQRYDEKVNFFV 153
           ++ +  +KIADFGL+  L P +    V   P      + APE L    F R  +  +F V
Sbjct: 160 VESEAHVKIADFGLA-KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGV 218
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	154
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-55
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-52
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-52
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-51
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-51
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-51
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-51
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	7e-51
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-51
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-50
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-50
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-50
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-50
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-49
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-49
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-48
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-48
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-47
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-47
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-47
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-47
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-47
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-47
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-47
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-47
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-47
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-47
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	7e-47
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	8e-47
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	8e-47
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-47
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-46
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-46
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-46
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-46
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-46
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-46
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-46
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-46
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-46
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	7e-46
2a19_B	284	Interferon-induced, double-stranded RNA-activated	8e-46
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-45
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-45
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-45
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-45
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-44
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-44
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-44
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	9e-44
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-43
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-43
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-43
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-43
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-43
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-43
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-42
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-42
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-42
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-42
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-42
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-41
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-41
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-40
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-39
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-39
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-39
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-39
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-39
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-38
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-38
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-38
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-37
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-37
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-36
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-36
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-36
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-36
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	6e-36
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-35
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-35
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-35
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-35
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	8e-35
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-34
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-34
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-34
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-34
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	9e-34
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-33
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-33
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-33
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-33
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-33
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-33
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-33
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-32
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-32
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-32
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-32
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-32
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	9e-32
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-31
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-31
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-31
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-31
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-30
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-30
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-30
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-30
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-29
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-29
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-29
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-29
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-29
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-29
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-29
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-28
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-28
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-28
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-28
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-28
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	7e-28
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-27
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-27
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-27
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-27
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-27
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-27
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-27
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-27
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-27
3q4u_A	301	Activin receptor type-1; structural genomics conso	7e-27
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-27
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-26
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-26
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-26
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-26
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-26
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-26
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-26
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-26
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-26
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-26
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-26
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-26
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-26
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-26
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-26
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-26
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	9e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-25
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-25
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-25
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-25
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	9e-25
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-24
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-24
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-24
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-24
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-24
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-24
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-24
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-24
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-24
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-24
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-24
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-24
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-24
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-23
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-23
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-23
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-23
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-23
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-23
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-23
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-23
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-23
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-23
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-23
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-23
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-23
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-23
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-23
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	8e-23
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-22
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-22
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-22
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-22
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-22
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-22
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-22
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-22
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-21
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-21
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-21
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-21
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-21
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-21
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-21
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-21
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-21
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-21
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	8e-21
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-20
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-20
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	9e-20
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-19
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-19
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-19
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-19
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-18
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-18
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-18
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-17
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-15
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-15
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-15
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-15
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-07
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-07
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-06

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  183 bits (465), Expect = 2e-55
 Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 9/156 (5%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAGGNLSSY 56
           ++L+   +     E+  +  +NHPN++   +       +       L +E+C GG+L  Y
Sbjct: 49  QELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKY 108

Query: 57  IRLHGR---VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
           +        + E   R  L  + + L  L+ + IIHRDLKPENI+L      ++ KI D 
Sbjct: 109 LNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168

Query: 114 GLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149
           G +  L  G    +  G+  Y+APE+L+ ++Y   V
Sbjct: 169 GYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTV 204

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  168 bits (428), Expect = 1e-52
 Identities = 38/161 (23%), Positives = 69/161 (42%), Gaps = 15/161 (9%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLH 60
               + +      E   L  +NH NI++LF   +        L++EFC  G+L + +   
Sbjct: 45  ISFLRPVDV-QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP 103

Query: 61  GR---VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS-GLDDDVMLKIADFGLS 116
                +PE      L+ +  G+  L  + I+HR++KP NI+   G D   + K+ DFG +
Sbjct: 104 SNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163

Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQF--------QRYDEKV 149
             L        + G+  Y+ P++ +         ++Y   V
Sbjct: 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATV 204

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  165 bits (419), Expect = 7e-52
 Identities = 46/146 (31%), Positives = 77/146 (52%), Gaps = 8/146 (5%)

Query: 4   KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV 63
            +   L+     E+   S + HPNI+RL+  F     ++L++E+   G +   ++   + 
Sbjct: 51  GVEHQLRR----EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF 106

Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
            EQ    ++ +L   L   +S  +IHRD+KPEN+L   L     LKIADFG S    P +
Sbjct: 107 DEQRTATYITELANALSYCHSKRVIHRDIKPENLL---LGSAGELKIADFGWS-VHAPSS 162

Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKV 149
               +CG+  Y+ PE+++ + +DEKV
Sbjct: 163 RRTDLCGTLDYLPPEMIEGRMHDEKV 188

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  164 bits (417), Expect = 2e-51
 Identities = 50/146 (34%), Positives = 80/146 (54%), Gaps = 8/146 (5%)

Query: 4   KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV 63
            +   L+     E+   S + HPNI+R+++ F     I+L++EF   G L   ++ HGR 
Sbjct: 56  GVEHQLRR----EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF 111

Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
            EQ +  F+++L   L   +   +IHRD+KPEN+L   +     LKIADFG S    P  
Sbjct: 112 DEQRSATFMEELADALHYCHERKVIHRDIKPENLL---MGYKGELKIADFGWS-VHAPSL 167

Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKV 149
               +CG+  Y+ PE+++ + +DEKV
Sbjct: 168 RRRTMCGTLDYLPPEMIEGKTHDEKV 193

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  165 bits (419), Expect = 3e-51
 Identities = 52/137 (37%), Positives = 81/137 (59%), Gaps = 4/137 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + +  Q+
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
              ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P Y+
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 183

Query: 136 APEVLQ---FQRYDEKV 149
           APEVL       Y+  V
Sbjct: 184 APEVLVSVGTAGYNRAV 200

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  165 bits (419), Expect = 3e-51
 Identities = 43/135 (31%), Positives = 78/135 (57%), Gaps = 4/135 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++   S+ H +++     F+  + +F+V+E C   +L    +    + E  AR +L+Q+
Sbjct: 91  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 150

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLY 134
             G + L+ + +IHRDLK  N+    L++D+ +KI DFGL+  + Y G   + +CG+P Y
Sbjct: 151 VLGCQYLHRNRVIHRDLKLGNLF---LNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 207

Query: 135 MAPEVLQFQRYDEKV 149
           +APEVL  + +  +V
Sbjct: 208 IAPEVLSKKGHSFEV 222

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  163 bits (415), Expect = 5e-51
 Identities = 43/135 (31%), Positives = 78/135 (57%), Gaps = 4/135 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++   S+ H +++     F+  + +F+V+E C   +L    +    + E  AR +L+Q+
Sbjct: 65  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 124

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLY 134
             G + L+ + +IHRDLK  N+    L++D+ +KI DFGL+  + Y G   + +CG+P Y
Sbjct: 125 VLGCQYLHRNRVIHRDLKLGNLF---LNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 181

Query: 135 MAPEVLQFQRYDEKV 149
           +APEVL  + +  +V
Sbjct: 182 IAPEVLSKKGHSFEV 196

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  162 bits (413), Expect = 7e-51
 Identities = 45/134 (33%), Positives = 72/134 (53%), Gaps = 1/134 (0%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  + S++HPNIIRL++ F+    I+LV+E C GG L   +       E  A + ++ +
Sbjct: 56  EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDV 115

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            + +   +  ++ HRDLKPEN L      D  LK+ DFGL+    PG       G+P Y+
Sbjct: 116 LSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYV 175

Query: 136 APEVLQFQRYDEKV 149
           +P+VL+   Y  + 
Sbjct: 176 SPQVLE-GLYGPEC 188

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  165 bits (420), Expect = 7e-51
 Identities = 38/148 (25%), Positives = 67/148 (45%), Gaps = 14/148 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGR---VPEQTARK 70
           E   L  +NH NI++LF   +        L++EFC  G+L + +        +PE     
Sbjct: 57  EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLS-GLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
            L+ +  G+  L  + I+HR++KP NI+   G D   + K+ DFG +  L        + 
Sbjct: 117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176

Query: 130 GSPLYMAPEVLQF--------QRYDEKV 149
           G+  Y+ P++ +         ++Y   V
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATV 204

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  162 bits (412), Expect = 1e-50
 Identities = 50/147 (34%), Positives = 76/147 (51%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+ Q E+  +LV +   GG L   I     
Sbjct: 42  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 101

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E  A   +QQ+   +   +S+ I+HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 102 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161

Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKV 149
                  G+P Y++PEVL+   Y + V
Sbjct: 162 EAWHGFAGTPGYLSPEVLKKDPYSKPV 188

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  165 bits (420), Expect = 1e-50
 Identities = 52/137 (37%), Positives = 81/137 (59%), Gaps = 4/137 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + +  Q+
Sbjct: 190 EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
              ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P Y+
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 308

Query: 136 APEVLQ---FQRYDEKV 149
           APEVL       Y+  V
Sbjct: 309 APEVLVSVGTAGYNRAV 325

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  163 bits (414), Expect = 3e-50
 Identities = 50/147 (34%), Positives = 76/147 (51%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+ Q E+  +LV +   GG L   I     
Sbjct: 65  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 124

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E  A   +QQ+   +   +S+ I+HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 125 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184

Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKV 149
                  G+P Y++PEVL+   Y + V
Sbjct: 185 EAWHGFAGTPGYLSPEVLKKDPYSKPV 211

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  160 bits (407), Expect = 7e-50
 Identities = 52/147 (35%), Positives = 79/147 (53%), Gaps = 1/147 (0%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
                   S +  E+  L  ++HPNI++LF+  +  +  ++V E   GG L   I    R
Sbjct: 58  ASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR 117

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E  A + ++Q+ +G+  ++ H+I+HRDLKPENILL   + D  +KI DFGLS      
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177

Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKV 149
              +   G+  Y+APEVL+   YDEK 
Sbjct: 178 TKMKDRIGTAYYIAPEVLR-GTYDEKC 203

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  160 bits (406), Expect = 2e-49
 Identities = 54/144 (37%), Positives = 87/144 (60%), Gaps = 3/144 (2%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
            +LN      L  E+  +  +NHPNI++LF+  + E  ++L++E+ +GG +  Y+  HGR
Sbjct: 51  TQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR 110

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           + E+ AR   +Q+ + ++  +   I+HRDLK EN+L   LD D+ +KIADFG S     G
Sbjct: 111 MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLL---LDADMNIKIADFGFSNEFTVG 167

Query: 123 NYAEKVCGSPLYMAPEVLQFQRYD 146
              +  CG+P Y APE+ Q ++YD
Sbjct: 168 GKLDAFCGAPPYAAPELFQGKKYD 191

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  158 bits (401), Expect = 5e-49
 Identities = 47/151 (31%), Positives = 79/151 (52%), Gaps = 5/151 (3%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----R 58
           K  ++     ++ E+  L S++HPNII++F+ F+  + +++V+E C GG L   I     
Sbjct: 57  KDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQA 116

Query: 59  LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
               + E    + ++Q+   L   +S H++H+DLKPENIL         +KI DFGL+  
Sbjct: 117 RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176

Query: 119 LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149
                ++    G+ LYMAPEV + +    K 
Sbjct: 177 FKSDEHSTNAAGTALYMAPEVFK-RDVTFKC 206

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  156 bits (396), Expect = 3e-48
 Identities = 55/131 (41%), Positives = 77/131 (58%), Gaps = 3/131 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L    HP+II+L+         F+V+E+ +GG L  YI  HGRV E  AR+  QQ+
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI 120

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            + ++  + H ++HRDLKPEN+L   LD  +  KIADFGLS  +  G +    CGSP Y 
Sbjct: 121 LSAVDYCHRHMVVHRDLKPENVL---LDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA 177

Query: 136 APEVLQFQRYD 146
           APEV+  + Y 
Sbjct: 178 APEVISGRLYA 188

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  155 bits (395), Expect = 7e-48
 Identities = 51/149 (34%), Positives = 82/149 (55%), Gaps = 1/149 (0%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
            +KK      S L+ E+  L  + H NI+ L D +++    +LV++  +GG L   I   
Sbjct: 41  CIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER 100

Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
           G   E+ A   +QQ+ + ++ L+ + I+HRDLKPEN+L    +++  + I DFGLS    
Sbjct: 101 GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160

Query: 121 PGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149
            G  +   CG+P Y+APEVL  + Y + V
Sbjct: 161 NGIMST-ACGTPGYVAPEVLAQKPYSKAV 188

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  154 bits (392), Expect = 1e-47
 Identities = 45/136 (33%), Positives = 76/136 (55%), Gaps = 5/136 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+     + HP+I+ L++ F+  N ++LV+E C  G ++ Y++       E  AR F+ Q
Sbjct: 61  EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ 120

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPL 133
           +  G+  L+SH I+HRDL   N+L   L  ++ +KIADFGL+  L  P      +CG+P 
Sbjct: 121 IITGMLYLHSHGILHRDLTLSNLL---LTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN 177

Query: 134 YMAPEVLQFQRYDEKV 149
           Y++PE+     +  + 
Sbjct: 178 YISPEIATRSAHGLES 193

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  159 bits (404), Expect = 1e-47
 Identities = 52/147 (35%), Positives = 79/147 (53%), Gaps = 1/147 (0%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
                   S +  E+  L  ++HPNI++LF+  +  +  ++V E   GG L   I    R
Sbjct: 58  ASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR 117

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E  A + ++Q+ +G+  ++ H+I+HRDLKPENILL   + D  +KI DFGLS      
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177

Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKV 149
              +   G+  Y+APEVL+   YDEK 
Sbjct: 178 TKMKDRIGTAYYIAPEVLR-GTYDEKC 203

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  156 bits (396), Expect = 1e-47
 Identities = 53/134 (39%), Positives = 76/134 (56%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNII+L + F+    I LV+E   GG L   I   G   E+ A   ++Q+
Sbjct: 98  EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI 157

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
              +  L+ + I+HRDLKPEN+L +    D  LKIADFGLS  +      + VCG+P Y 
Sbjct: 158 LEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYC 217

Query: 136 APEVLQFQRYDEKV 149
           APE+L+   Y  +V
Sbjct: 218 APEILRGCAYGPEV 231

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  159 bits (404), Expect = 1e-47
 Identities = 54/147 (36%), Positives = 86/147 (58%), Gaps = 1/147 (0%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
             ++    S L  E+  L  ++HPNI++L+D F+ +   +LV+E   GG L   I    +
Sbjct: 73  TSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK 132

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E  A   ++Q+ +G+  L+ H+I+HRDLKPEN+LL   + D ++KI DFGLS      
Sbjct: 133 FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192

Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKV 149
              ++  G+  Y+APEVL+ ++YDEK 
Sbjct: 193 KKMKERLGTAYYIAPEVLR-KKYDEKC 218

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  159 bits (403), Expect = 2e-47
 Identities = 49/134 (36%), Positives = 75/134 (55%), Gaps = 1/134 (0%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNI++L++ F+ +   +LV E   GG L   I    R  E  A + ++Q+
Sbjct: 76  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQV 135

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            +G+  ++ + I+HRDLKPEN+LL     D  ++I DFGLS         +   G+  Y+
Sbjct: 136 LSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYI 195

Query: 136 APEVLQFQRYDEKV 149
           APEVL    YDEK 
Sbjct: 196 APEVLH-GTYDEKC 208

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  155 bits (393), Expect = 2e-47
 Identities = 36/151 (23%), Positives = 72/151 (47%), Gaps = 10/151 (6%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           L++ +         E+ +L+ +   +  IIRL+D    +  I++V+E C   +L+S+++ 
Sbjct: 62  LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 120

Query: 60  HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
              +     + + + +   +  ++ H I+H DLKP N L+     D MLK+ DFG++  +
Sbjct: 121 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQM 176

Query: 120 YPG---NYAEKVCGSPLYMAPEVLQFQRYDE 147
            P       +   G+  YM PE ++      
Sbjct: 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  155 bits (394), Expect = 2e-47
 Identities = 36/151 (23%), Positives = 72/151 (47%), Gaps = 10/151 (6%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           L++ +         E+ +L+ +   +  IIRL+D    +  I++V+E C   +L+S+++ 
Sbjct: 43  LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 101

Query: 60  HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
              +     + + + +   +  ++ H I+H DLKP N L+     D MLK+ DFG++  +
Sbjct: 102 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQM 157

Query: 120 YPG---NYAEKVCGSPLYMAPEVLQFQRYDE 147
            P       +   G+  YM PE ++      
Sbjct: 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  153 bits (390), Expect = 2e-47
 Identities = 48/134 (35%), Positives = 76/134 (56%), Gaps = 6/134 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+     +NH N+++ +   +  N  +L +E+C+GG L   I     +PE  A++F  QL
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSP 132
            AG+  L+   I HRD+KPEN+L   LD+   LKI+DFGL+      N      K+CG+ 
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLL---LDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

Query: 133 LYMAPEVLQFQRYD 146
            Y+APE+L+ + + 
Sbjct: 172 PYVAPELLKRREFH 185

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  159 bits (403), Expect = 2e-47
 Identities = 54/134 (40%), Positives = 81/134 (60%), Gaps = 1/134 (0%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L S++HPNII+LFD F+ +   +LV EF  GG L   I    +  E  A   ++Q+
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            +G+  L+ H+I+HRD+KPENILL   +  + +KI DFGLS             G+  Y+
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215

Query: 136 APEVLQFQRYDEKV 149
           APEVL+ ++Y+EK 
Sbjct: 216 APEVLK-KKYNEKC 228

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  155 bits (393), Expect = 5e-47
 Identities = 52/131 (39%), Positives = 70/131 (53%), Gaps = 1/131 (0%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+    S+ HPNI+R  +       + +++E+ +GG L   I   GR  E  AR F QQL
Sbjct: 66  EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL 125

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            +G+   +S  I HRDLK EN LL G      LKI DFG S +    +  +   G+P Y+
Sbjct: 126 LSGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 184

Query: 136 APEVLQFQRYD 146
           APEVL  Q YD
Sbjct: 185 APEVLLRQEYD 195

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  153 bits (389), Expect = 7e-47
 Identities = 48/134 (35%), Positives = 76/134 (56%), Gaps = 6/134 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+     +NH N+++ +   +  N  +L +E+C+GG L   I     +PE  A++F  QL
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSP 132
            AG+  L+   I HRD+KPEN+L   LD+   LKI+DFGL+      N      K+CG+ 
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLL---LDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

Query: 133 LYMAPEVLQFQRYD 146
            Y+APE+L+ + + 
Sbjct: 172 PYVAPELLKRREFH 185

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  155 bits (393), Expect = 8e-47
 Identities = 36/151 (23%), Positives = 72/151 (47%), Gaps = 10/151 (6%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           L++ +         E+ +L+ +   +  IIRL+D    +  I++V+E C   +L+S+++ 
Sbjct: 90  LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 148

Query: 60  HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
              +     + + + +   +  ++ H I+H DLKP N L+     D MLK+ DFG++  +
Sbjct: 149 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQM 204

Query: 120 YPG---NYAEKVCGSPLYMAPEVLQFQRYDE 147
            P       +   G+  YM PE ++      
Sbjct: 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR 235

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  153 bits (389), Expect = 9e-47
 Identities = 47/150 (31%), Positives = 79/150 (52%), Gaps = 2/150 (1%)

Query: 2   LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +K ++K +++    E+  L     HPNI++L + F  +   FLV+E   GG L   I+  
Sbjct: 41  VKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK 100

Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
               E  A   +++L + +  ++   ++HRDLKPEN+L +  +D++ +KI DFG +    
Sbjct: 101 KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160

Query: 121 PGNYA-EKVCGSPLYMAPEVLQFQRYDEKV 149
           P N   +  C +  Y APE+L    YDE  
Sbjct: 161 PDNQPLKTPCFTLHYAAPELLNQNGYDESC 190

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  152 bits (387), Expect = 1e-46
 Identities = 55/141 (39%), Positives = 82/141 (58%), Gaps = 10/141 (7%)

Query: 16  ELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
           E++ L  V+ HPNII+L D ++     FLV +    G L  Y+     + E+  RK ++ 
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
           L   +  L+  +I+HRDLKPENIL   LDDD+ +K+ DFG SC L PG    +VCG+P Y
Sbjct: 133 LLEVICALHKLNIVHRDLKPENIL---LDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSY 189

Query: 135 MAPEVLQ------FQRYDEKV 149
           +APE+++         Y ++V
Sbjct: 190 LAPEIIECSMNDNHPGYGKEV 210

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  154 bits (391), Expect = 1e-46
 Identities = 48/132 (36%), Positives = 81/132 (61%), Gaps = 9/132 (6%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
            HP+II L D++++ + +FLV +    G L  Y+     + E+  R  ++ L   +  L+
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH 217

Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-- 141
           +++I+HRDLKPENIL   LDD++ ++++DFG SC L PG    ++CG+P Y+APE+L+  
Sbjct: 218 ANNIVHRDLKPENIL---LDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCS 274

Query: 142 ----FQRYDEKV 149
                  Y ++V
Sbjct: 275 MDETHPGYGKEV 286

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  153 bits (388), Expect = 1e-46
 Identities = 48/132 (36%), Positives = 70/132 (53%), Gaps = 4/132 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEF-CAGGNLSSYIRLHGRVPEQTARKFLQQ 74
           E+  LS V H NII++ D F+ +    LV+E   +G +L ++I  H R+ E  A    +Q
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
           L + +  L    IIHRD+K ENI+   + +D  +K+ DFG +  L  G      CG+  Y
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIV---IAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEY 195

Query: 135 MAPEVLQFQRYD 146
            APEVL    Y 
Sbjct: 196 CAPEVLMGNPYR 207

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  155 bits (395), Expect = 1e-46
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 1/148 (0%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+   E   +L+ +   GG L   I     
Sbjct: 47  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY 106

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
             E  A   +QQ+   +   +   ++HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 107 YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166

Query: 123 NYA-EKVCGSPLYMAPEVLQFQRYDEKV 149
             A     G+P Y++PEVL+   Y + V
Sbjct: 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPV 194

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  156 bits (395), Expect = 2e-46
 Identities = 54/131 (41%), Positives = 81/131 (61%), Gaps = 3/131 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L    HP+II+L+      + IF+V+E+ +GG L  YI  +GR+ E+ +R+  QQ+
Sbjct: 66  EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI 125

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
            +G++  + H ++HRDLKPEN+L   LD  +  KIADFGLS  +  G +    CGSP Y 
Sbjct: 126 LSGVDYCHRHMVVHRDLKPENVL---LDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA 182

Query: 136 APEVLQFQRYD 146
           APEV+  + Y 
Sbjct: 183 APEVISGRLYA 193

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  150 bits (382), Expect = 3e-46
 Identities = 45/135 (33%), Positives = 78/135 (57%), Gaps = 1/135 (0%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+N L  + HPNII L D F+ +  + L++E  +GG L  ++     + E  A +FL+Q+
Sbjct: 58  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 117

Query: 76  GAGLEILNSHHIIHRDLKPENILL-SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             G+  L+S  I H DLKPENI+L      +  +K+ DFG++  +  GN  + + G+P +
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEF 177

Query: 135 MAPEVLQFQRYDEKV 149
           +APE++ ++    + 
Sbjct: 178 VAPEIVNYEPLGLEA 192

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  151 bits (384), Expect = 5e-46
 Identities = 42/150 (28%), Positives = 78/150 (52%), Gaps = 3/150 (2%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RL 59
           ++  +  ++ +  E+  L      P +I L + ++  + I L++E+ AGG + S     L
Sbjct: 65  RRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL 124

Query: 60  HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
              V E    + ++Q+  G+  L+ ++I+H DLKP+NILLS +     +KI DFG+S  +
Sbjct: 125 AEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184

Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149
                  ++ G+P Y+APE+L +       
Sbjct: 185 GHACELREIMGTPEYLAPEILNYDPITTAT 214

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  151 bits (384), Expect = 5e-46
 Identities = 44/135 (32%), Positives = 78/135 (57%), Gaps = 1/135 (0%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A +FL+Q+
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123

Query: 76  GAGLEILNSHHIIHRDLKPENILL-SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             G+  L+S  I H DLKPENI+L         +KI DFGL+  +  GN  + + G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183

Query: 135 MAPEVLQFQRYDEKV 149
           +APE++ ++    + 
Sbjct: 184 VAPEIVNYEPLGLEA 198

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  152 bits (385), Expect = 6e-46
 Identities = 39/139 (28%), Positives = 73/139 (52%), Gaps = 5/139 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----EQTARKF 71
           E +    + HP+I+ L + + ++  +++V EF  G +L   I           E  A  +
Sbjct: 76  EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 135

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCG 130
           ++Q+   L   + ++IIHRD+KP  +LL+  ++   +K+  FG++  L   G  A    G
Sbjct: 136 MRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVG 195

Query: 131 SPLYMAPEVLQFQRYDEKV 149
           +P +MAPEV++ + Y + V
Sbjct: 196 TPHFMAPEVVKREPYGKPV 214

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  151 bits (383), Expect = 7e-46
 Identities = 40/135 (29%), Positives = 74/135 (54%), Gaps = 1/135 (0%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  V H N+I L D ++    + L++E  +GG L  ++     + E+ A  F++Q+
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124

Query: 76  GAGLEILNSHHIIHRDLKPENILL-SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             G+  L++  I H DLKPENI+L         +K+ DFGL+  +  G   + + G+P +
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184

Query: 135 MAPEVLQFQRYDEKV 149
           +APE++ ++    + 
Sbjct: 185 VAPEIVNYEPLGLEA 199

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  149 bits (379), Expect = 8e-46
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 22/166 (13%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE----------------NCIFLVV 45
           +K++  + +     E+  L+ ++H NI+     +                    C+F+ +
Sbjct: 41  IKRVKYNNEKAER-EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQM 99

Query: 46  EFCAGGNLSSYI--RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103
           EFC  G L  +I  R   ++ +  A +  +Q+  G++ ++S  +I+RDLKP NI L    
Sbjct: 100 EFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL---V 156

Query: 104 DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149
           D   +KI DFGL  +L       +  G+  YM+PE +  Q Y ++V
Sbjct: 157 DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEV 202

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  150 bits (382), Expect = 1e-45
 Identities = 58/131 (44%), Positives = 83/131 (63%), Gaps = 4/131 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+++L  + HP+II+L+D       I +V+E+ AGG L  YI    R+ E   R+F QQ+
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQI 117

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
              +E  + H I+HRDLKPEN+L   LDD++ +KIADFGLS  +  GN+ +  CGSP Y 
Sbjct: 118 ICAIEYCHRHKIVHRDLKPENLL---LDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 174

Query: 136 APEVLQFQRYD 146
           APEV+  + Y 
Sbjct: 175 APEVINGKLYA 185

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  151 bits (383), Expect = 1e-45
 Identities = 42/135 (31%), Positives = 75/135 (55%), Gaps = 1/135 (0%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  V HPNII L D ++    + L++E  +GG L  ++     + E+ A  F++Q+
Sbjct: 65  EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124

Query: 76  GAGLEILNSHHIIHRDLKPENILL-SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             G+  L++  I H DLKPENI+L         +K+ DFGL+  +  G   + + G+P +
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184

Query: 135 MAPEVLQFQRYDEKV 149
           +APE++ ++    + 
Sbjct: 185 VAPEIVNYEPLGLEA 199

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  151 bits (382), Expect = 1e-45
 Identities = 37/150 (24%), Positives = 78/150 (52%), Gaps = 6/150 (4%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
           + +++   +     E+  L+++ HPNI++  ++F+    +++V+++C GG+L   I    
Sbjct: 59  ISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQK 118

Query: 61  -GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
                E     +  Q+   L+ ++   I+HRD+K +NI    L  D  +++ DFG++  L
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIF---LTKDGTVQLGDFGIARVL 175

Query: 120 YPG-NYAEKVCGSPLYMAPEVLQFQRYDEK 148
                 A    G+P Y++PE+ + + Y+ K
Sbjct: 176 NSTVELARACIGTPYYLSPEICENKPYNNK 205

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  150 bits (380), Expect = 2e-45
 Identities = 42/129 (32%), Positives = 61/129 (47%), Gaps = 2/129 (1%)

Query: 23  VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82
             HPNII L D +     +++V E   GG L   I       E+ A   L  +   +E L
Sbjct: 73  GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYL 132

Query: 83  NSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPGNYA-EKVCGSPLYMAPEVL 140
           ++  ++HRDLKP NIL      +   ++I DFG +  L   N      C +  ++APEVL
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL 192

Query: 141 QFQRYDEKV 149
           + Q YD   
Sbjct: 193 ERQGYDAAC 201

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  148 bits (375), Expect = 2e-44
 Identities = 26/145 (17%), Positives = 59/145 (40%), Gaps = 15/145 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--------RVPEQT 67
           EL  ++ + +   +         + ++++ E+    ++  +              +P Q 
Sbjct: 93  ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152

Query: 68  ARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
            +  ++ +      +++  +I HRD+KP NIL   +D +  +K++DFG S         +
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL---MDKNGRVKLSDFGES-EYMVDKKIK 208

Query: 127 KVCGSPLYMAPEVLQFQR--YDEKV 149
              G+  +M PE    +      KV
Sbjct: 209 GSRGTYEFMPPEFFSNESSYNGAKV 233

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  147 bits (372), Expect = 2e-44
 Identities = 39/135 (28%), Positives = 65/135 (48%), Gaps = 8/135 (5%)

Query: 16  ELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFL 72
           E+  L  V+     +IRL D F+  +   L++E      +L  +I   G + E+ AR F 
Sbjct: 96  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 155

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGS 131
            Q+   +   ++  ++HRD+K ENIL   +D +   LK+ DFG    L          G+
Sbjct: 156 WQVLEAVRHCHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 211

Query: 132 PLYMAPEVLQFQRYD 146
            +Y  PE +++ RY 
Sbjct: 212 RVYSPPEWIRYHRYH 226

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  147 bits (374), Expect = 7e-44
 Identities = 43/132 (32%), Positives = 72/132 (54%), Gaps = 6/132 (4%)

Query: 24  NHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQLGA 77
             P+I+R+ D ++       C+ +V+E   GG L S I  R      E+ A + ++ +G 
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172

Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAP 137
            ++ L+S +I HRD+KPEN+L +    + +LK+ DFG +      N     C +P Y+AP
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232

Query: 138 EVLQFQRYDEKV 149
           EVL  ++YD+  
Sbjct: 233 EVLGPEKYDKSC 244

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  145 bits (367), Expect = 9e-44
 Identities = 43/136 (31%), Positives = 69/136 (50%), Gaps = 9/136 (6%)

Query: 16  ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
           E+  L  ++HPN+++L +      E+ +++V E    G +         + E  AR + Q
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQ 144

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSP 132
            L  G+E L+   IIHRD+KP N+L   + +D  +KIADFG+S      +       G+P
Sbjct: 145 DLIKGIEYLHYQKIIHRDIKPSNLL---VGEDGHIKIADFGVSNEFKGSDALLSNTVGTP 201

Query: 133 LYMAPEVLQFQR--YD 146
            +MAPE L   R  + 
Sbjct: 202 AFMAPESLSETRKIFS 217

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  144 bits (365), Expect = 2e-43
 Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 4/127 (3%)

Query: 21  SSVNHPNIIRLFDAFQAENCIFLVVEF-CAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL 79
           +   HP +IRL D F+ +    LV+E      +L  YI   G + E  +R F  Q+ A +
Sbjct: 93  AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAI 152

Query: 80  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 139
           +  +S  ++HRD+K ENIL+         K+ DFG    L          G+ +Y  PE 
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCA--KLIDFGSG-ALLHDEPYTDFDGTRVYSPPEW 209

Query: 140 LQFQRYD 146
           +   +Y 
Sbjct: 210 ISRHQYH 216

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  144 bits (365), Expect = 2e-43
 Identities = 44/139 (31%), Positives = 67/139 (48%), Gaps = 13/139 (9%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
            H N++ L + F+ E+  +LV E   GG++ S+I       E  A   +Q + + L+ L+
Sbjct: 69  GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128

Query: 84  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV--------CGSPLYM 135
           +  I HRDLKPENIL    +    +KI DF L   +        +        CGS  YM
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188

Query: 136 APEVL-----QFQRYDEKV 149
           APEV+     +   YD++ 
Sbjct: 189 APEVVEAFSEEASIYDKRC 207

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  144 bits (365), Expect = 3e-43
 Identities = 46/158 (29%), Positives = 67/158 (42%), Gaps = 12/158 (7%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K+     +   D      E+     V  HP  +RL  A++    ++L  E C G +L  
Sbjct: 87  VKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQ 145

Query: 56  YIRLHG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
           +    G  +PE     +L+     L  L+S  ++H D+KP NI    L      K+ DFG
Sbjct: 146 HCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIF---LGPRGRCKLGDFG 202

Query: 115 LSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           L   L      E   G P YMAPE+LQ   Y    + F
Sbjct: 203 LLVELGTAGAGEVQEGDPRYMAPELLQ-GSYGTAADVF 239

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  149 bits (377), Expect = 3e-43
 Identities = 41/135 (30%), Positives = 75/135 (55%), Gaps = 2/135 (1%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
           E+  +S + HP ++ L DAF+ +N + ++ EF +GG L   +   H ++ E  A ++++Q
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 263

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
           +  GL  ++ ++ +H DLKPENI+ +    +  LK+ DFGL+  L P    +   G+  +
Sbjct: 264 VCKGLCHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQSVKVTTGTAEF 322

Query: 135 MAPEVLQFQRYDEKV 149
            APEV + +      
Sbjct: 323 AAPEVAEGKPVGYYT 337

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  145 bits (368), Expect = 3e-43
 Identities = 45/135 (33%), Positives = 76/135 (56%), Gaps = 2/135 (1%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQ 74
           E++ ++ ++H N+I+L+DAF+++N I LV+E+  GG L   I      + E     F++Q
Sbjct: 136 EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQ 195

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
           +  G+  ++  +I+H DLKPENIL    D    +KI DFGL+    P    +   G+P +
Sbjct: 196 ICEGIRHMHQMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVNFGTPEF 254

Query: 135 MAPEVLQFQRYDEKV 149
           +APEV+ +       
Sbjct: 255 LAPEVVNYDFVSFPT 269

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  145 bits (368), Expect = 4e-43
 Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 2/135 (1%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E++ ++ ++HP +I L DAF+ +  + L++EF +GG L   I        E     +++Q
Sbjct: 98  EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ 157

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
              GL+ ++ H I+H D+KPENI+         +KI DFGL+  L P    +    +  +
Sbjct: 158 ACEGLKHMHEHSIVHLDIKPENIMCETKKAS-SVKIIDFGLATKLNPDEIVKVTTATAEF 216

Query: 135 MAPEVLQFQRYDEKV 149
            APE++  +      
Sbjct: 217 AAPEIVDREPVGFYT 231

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  142 bits (360), Expect = 2e-42
 Identities = 38/135 (28%), Positives = 69/135 (51%), Gaps = 2/135 (1%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQ 74
           E++ L+   H NI+ L ++F++   + ++ EF +G ++   I      + E+    ++ Q
Sbjct: 51  EISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ 110

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
           +   L+ L+SH+I H D++PENI+         +KI +FG +  L PG+    +  +P Y
Sbjct: 111 VCEALQFLHSHNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQLKPGDNFRLLFTAPEY 169

Query: 135 MAPEVLQFQRYDEKV 149
            APEV Q        
Sbjct: 170 YAPEVHQHDVVSTAT 184

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  140 bits (356), Expect = 3e-42
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 15/160 (9%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRL 59
              + +  K  L  E+N L  + HPNI+R +D         +++V+E+C GG+L+S I  
Sbjct: 41  YGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK 100

Query: 60  HGR----VPEQTARKFLQQLGAGLEIL-----NSHHIIHRDLKPENILLSGLDDDVMLKI 110
             +    + E+   + + QL   L+         H ++HRDLKP N+ L   D    +K+
Sbjct: 101 GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKL 157

Query: 111 ADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKV 149
            DFGL+  L     +A+   G+P YM+PE +    Y+EK 
Sbjct: 158 GDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKS 197

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  141 bits (357), Expect = 3e-42
 Identities = 42/164 (25%), Positives = 69/164 (42%), Gaps = 33/164 (20%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAEN-------------CIFLVVEFCAGGNLSSYIRLHGR 62
           E+  L+S+NH  ++R + A+                  +F+ +E+C  G L   I     
Sbjct: 52  EVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL 111

Query: 63  -VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-- 119
                   +  +Q+   L  ++S  IIHRDLKP NI    +D+   +KI DFGL+  +  
Sbjct: 112 NQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIF---IDESRNVKIGDFGLAKNVHR 168

Query: 120 -------------YPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKV 149
                           +      G+ +Y+A EVL     Y+EK+
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKI 212

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  141 bits (357), Expect = 3e-42
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 12/139 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGN--LSSYIRLHGRVPEQTARKF 71
           E+  L  + H N+I+L D    E    +++V+E+C  G   +   +    R P   A  +
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGY 114

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP---GNYAEKV 128
             QL  GLE L+S  I+H+D+KP N+L   L     LKI+  G++  L+P    +     
Sbjct: 115 FCQLIDGLEYLHSQGIVHKDIKPGNLL---LTTGGTLKISALGVAEALHPFAADDTCRTS 171

Query: 129 CGSPLYMAPEVLQFQR-YD 146
            GSP +  PE+      + 
Sbjct: 172 QGSPAFQPPEIANGLDTFS 190

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  141 bits (358), Expect = 4e-42
 Identities = 43/132 (32%), Positives = 75/132 (56%), Gaps = 7/132 (5%)

Query: 24  NHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQLGA 77
             P+I+ + D ++     + C+ +++E   GG L S I  R      E+ A + ++ +G 
Sbjct: 80  GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 139

Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAP 137
            ++ L+SH+I HRD+KPEN+L +  + D +LK+ DFG +      N  +  C +P Y+AP
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA-KETTQNALQTPCYTPYYVAP 198

Query: 138 EVLQFQRYDEKV 149
           EVL  ++YD+  
Sbjct: 199 EVLGPEKYDKSC 210

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  139 bits (353), Expect = 1e-41
 Identities = 43/139 (30%), Positives = 76/139 (54%), Gaps = 8/139 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----VPEQTARKF 71
           E++ L  +NHPN+I+ + +F  +N + +V+E    G+LS  I+   +    +PE+T  K+
Sbjct: 82  EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY 141

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCG 130
             QL + LE ++S  ++HRD+KP N+    +    ++K+ D GL          A  + G
Sbjct: 142 FVQLCSALEHMHSRRVMHRDIKPANVF---ITATGVVKLGDLGLGRFFSSKTTAAHSLVG 198

Query: 131 SPLYMAPEVLQFQRYDEKV 149
           +P YM+PE +    Y+ K 
Sbjct: 199 TPYYMSPERIHENGYNFKS 217

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  139 bits (352), Expect = 4e-41
 Identities = 49/195 (25%), Positives = 81/195 (41%), Gaps = 48/195 (24%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           ++++N      +  E+  +  ++HPNI RL++ ++ E  I LV+E C GG+L   + +  
Sbjct: 64  IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123

Query: 62  RVP----------------------------------------EQTARKFLQQLGAGLEI 81
                                                      E+     ++Q+ + L  
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183

Query: 82  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-----KVCGSPLYMA 136
           L++  I HRD+KPEN L S  +    +K+ DFGLS   Y  N  E        G+P ++A
Sbjct: 184 LHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242

Query: 137 PEVLQF--QRYDEKV 149
           PEVL    + Y  K 
Sbjct: 243 PEVLNTTNESYGPKC 257

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  136 bits (345), Expect = 9e-40
 Identities = 42/129 (32%), Positives = 73/129 (56%), Gaps = 3/129 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  +  + HP ++ L+ +FQ E  +F+VV+   GG+L  +++ +    E+T + F+ +L
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICEL 124

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
              L+ L +  IIHRD+KP+NIL   LD+   + I DF ++  L        + G+  YM
Sbjct: 125 VMALDYLQNQRIIHRDMKPDNIL---LDEHGHVHITDFNIAAMLPRETQITTMAGTKPYM 181

Query: 136 APEVLQFQR 144
           APE+   ++
Sbjct: 182 APEMFSSRK 190

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  134 bits (338), Expect = 2e-39
 Identities = 40/176 (22%), Positives = 69/176 (39%), Gaps = 32/176 (18%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC------------IFLVVEFCA 49
           L       +  +  E+  L+ + HP I+R F+A+  +N             +++ ++ C 
Sbjct: 40  LPNRELAREKVMR-EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCR 98

Query: 50  GGNLSSYIRLHGRV---PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV 106
             NL  ++     +             Q+   +E L+S  ++HRDLKP NI       D 
Sbjct: 99  KENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIF---FTMDD 155

Query: 107 MLKIADFGLSCTL-------------YPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149
           ++K+ DFGL   +                       G+ LYM+PE +    Y  KV
Sbjct: 156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKV 211

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  136 bits (345), Expect = 2e-39
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 12/158 (7%)

Query: 3   KKLNKHLKSCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           K++     S  D E+  L  S  HPN+IR F   +     ++ +E C    L  Y+    
Sbjct: 54  KRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKD 112

Query: 62  RV-PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSCT 118
                      LQQ  +GL  L+S +I+HRDLKP NIL+S       +   I+DFGL   
Sbjct: 113 FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172

Query: 119 LYPGNYAEK----VCGSPLYMAPEVLQ---FQRYDEKV 149
           L  G ++      V G+  ++APE+L     +     V
Sbjct: 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTV 210

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  133 bits (337), Expect = 4e-39
 Identities = 43/137 (31%), Positives = 74/137 (54%), Gaps = 6/137 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSP 132
            + LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +   +     G+ 
Sbjct: 140 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196

Query: 133 LYMAPEVLQFQRYDEKV 149
            Y++PE+L  +   +  
Sbjct: 197 QYVSPELLTEKSACKSS 213

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  135 bits (342), Expect = 6e-39
 Identities = 44/177 (24%), Positives = 78/177 (44%), Gaps = 31/177 (17%)

Query: 3   KKLNKHLKSCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           K++          E+  L+ S +HPN+IR + +   +  +++ +E C   NL   +    
Sbjct: 45  KRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKN 103

Query: 62  -------RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS----------GLDD 104
                     E      L+Q+ +G+  L+S  IIHRDLKP+NIL+S             +
Sbjct: 104 VSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE 163

Query: 105 DVMLKIADFGLSCTLYPGNYAEK-----VCGSPLYMAPEVLQ-------FQRYDEKV 149
           ++ + I+DFGL   L  G  + +       G+  + APE+L+        +R    +
Sbjct: 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSI 220

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  133 bits (336), Expect = 7e-39
 Identities = 45/147 (30%), Positives = 73/147 (49%), Gaps = 8/147 (5%)

Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           L+     EL   + ++ P I+ L+ A +    + + +E   GG+L   I+  G +PE  A
Sbjct: 93  LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA 152

Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK- 127
             +L Q   GLE L++  I+H D+K +N+LLS   D     + DFG +  L P    +  
Sbjct: 153 LYYLGQALEGLEYLHTRRILHGDVKADNVLLS--SDGSRAALCDFGHALCLQPDGLGKSL 210

Query: 128 -----VCGSPLYMAPEVLQFQRYDEKV 149
                + G+  +MAPEV+  +  D KV
Sbjct: 211 LTGDYIPGTETHMAPEVVMGKPCDAKV 237

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  130 bits (330), Expect = 4e-38
 Identities = 42/172 (24%), Positives = 66/172 (38%), Gaps = 27/172 (15%)

Query: 2   LKKLNKHLKSCLDC---ELNFLSSVNHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLS 54
           LK++  H +   +    E +     NHPNI+RL      E    +  +L++ F   G L 
Sbjct: 59  LKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLW 118

Query: 55  SYI----RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
           + I         + E      L  +  GLE +++    HRDLKP NIL   L D+    +
Sbjct: 119 NEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNIL---LGDEGQPVL 175

Query: 111 ADFGLSCTL--YPGNYAE--------KVCGSPLYMAPEVLQFQRY---DEKV 149
            D G       +     +            +  Y APE+   Q +   DE+ 
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERT 227

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  132 bits (332), Expect = 4e-38
 Identities = 32/165 (19%), Positives = 61/165 (36%), Gaps = 16/165 (9%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           + K  N          +  L        ++ + A   +N   LV E  + G L + I L+
Sbjct: 102 VQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLY 161

Query: 61  GR-----VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL--------SGLDDDVM 107
                  +P+     F  ++   +E ++   IIH D+KP+N +L           D    
Sbjct: 162 KNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221

Query: 108 LKIADFGLSCTLY---PGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149
           L + D G S  +     G      C +  +   E+L  + ++ ++
Sbjct: 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQI 266

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  129 bits (326), Expect = 8e-38
 Identities = 54/154 (35%), Positives = 86/154 (55%), Gaps = 10/154 (6%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF----QAENCIFLVVEFCAGGNLSSYI 57
            +KL K  +     E   L  + HPNI+R +D++    + + CI LV E    G L +Y+
Sbjct: 61  DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 120

Query: 58  RLHGRVPEQTARKFLQQLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +    +  +  R + +Q+  GL+ L++    IIHRDLK +NI ++G    V  KI D GL
Sbjct: 121 KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSV--KIGDLGL 178

Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149
             TL   ++A+ V G+P +MAPE+ + ++YDE V
Sbjct: 179 -ATLKRASFAKAVIGTPEFMAPEMYE-EKYDESV 210

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  128 bits (323), Expect = 3e-37
 Identities = 38/140 (27%), Positives = 68/140 (48%), Gaps = 9/140 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFL 72
           E+  +  + HPNI+    A      + +V E+ + G+L   +   G    + E+      
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143

Query: 73  QQLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVC 129
             +  G+  L++ +  I+HR+LK  N+L   +D    +K+ DFGLS         ++   
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLL---VDKKYTVKVCDFGLSRLKASTFLSSKSAA 200

Query: 130 GSPLYMAPEVLQFQRYDEKV 149
           G+P +MAPEVL+ +  +EK 
Sbjct: 201 GTPEWMAPEVLRDEPSNEKS 220

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  126 bits (319), Expect = 7e-37
 Identities = 45/143 (31%), Positives = 67/143 (46%), Gaps = 12/143 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E    + + HPNII L      E  + LV+EF  GG L+    L G+ +P      +  Q
Sbjct: 56  EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRV--LSGKRIPPDILVNWAVQ 113

Query: 75  LGAGLEILNSHH---IIHRDLKPENILLS-----GLDDDVMLKIADFGLSCTLYPGNYAE 126
           +  G+  L+      IIHRDLK  NIL+      G   + +LKI DFGL+   +      
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-RTTKM 172

Query: 127 KVCGSPLYMAPEVLQFQRYDEKV 149
              G+  +MAPEV++   + +  
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGS 195

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  127 bits (320), Expect = 1e-36
 Identities = 52/140 (37%), Positives = 73/140 (52%), Gaps = 12/140 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR---KFL 72
           EL  LS VNHPNI++L+ A     C+  V+E+  GG+L + +     +P  TA     + 
Sbjct: 51  ELRQLSRVNHPNIVKLYGACLNPVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC 108

Query: 73  QQLGAGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
            Q   G+  L+S     +IHRDLKP N+LL       +LKI DFG +C +    +     
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTACDIQ--THMTNNK 164

Query: 130 GSPLYMAPEVLQFQRYDEKV 149
           GS  +MAPEV +   Y EK 
Sbjct: 165 GSAAWMAPEVFEGSNYSEKC 184

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  127 bits (321), Expect = 1e-36
 Identities = 54/141 (38%), Positives = 78/141 (55%), Gaps = 19/141 (13%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   LS V HP IIR++  FQ    IF+++++  GG L S +R   R P   A+ +  ++
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV 115

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-------CTLYPGNYAEKV 128
              LE L+S  II+RDLKPENIL   LD +  +KI DFG +        TL         
Sbjct: 116 CLALEYLHSKDIIYRDLKPENIL---LDKNGHIKITDFGFAKYVPDVTYTL--------- 163

Query: 129 CGSPLYMAPEVLQFQRYDEKV 149
           CG+P Y+APEV+  + Y++ +
Sbjct: 164 CGTPDYIAPEVVSTKPYNKSI 184

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  127 bits (320), Expect = 2e-36
 Identities = 48/158 (30%), Positives = 86/158 (54%), Gaps = 19/158 (12%)

Query: 2   LKKLNK----------HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG 51
           +K L+K          H  +    E   L +VN P +++L  +F+  + +++V+E+ AGG
Sbjct: 71  MKILDKQKVVKLKQIEHTLN----EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126

Query: 52  NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
            + S++R  GR  E  AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ 
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVT 183

Query: 112 DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149
           DFG +  +        +CG+P  +APE++  + Y++ V
Sbjct: 184 DFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYNKAV 219

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  126 bits (318), Expect = 4e-36
 Identities = 49/152 (32%), Positives = 78/152 (51%), Gaps = 7/152 (4%)

Query: 2   LKK---LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
           L+K   + K   +    E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++ 
Sbjct: 38  LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS 97

Query: 59  LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-C 117
                 E+ AR +  ++ + LE L+S  +++RD+K EN++   LD D  +KI DFGL   
Sbjct: 98  RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKE 154

Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149
            +  G   +  CG+P Y+APEVL+   Y   V
Sbjct: 155 GISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 186

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  129 bits (325), Expect = 6e-36
 Identities = 52/159 (32%), Positives = 83/159 (52%), Gaps = 11/159 (6%)

Query: 2   LKKLNK-HLKS-----CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
            KKL K  +K          E   L  VN   ++ L  A++ ++ + LV+    GG+L  
Sbjct: 214 CKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKF 273

Query: 56  YIRLHGRV--PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
           +I   G+   PE  A  +  ++  GLE L+   I++RDLKPENILL   DD   ++I+D 
Sbjct: 274 HIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDL 330

Query: 114 GLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           GL+  +  G   +   G+  YMAPEV++ +RY    +++
Sbjct: 331 GLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWW 369

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  124 bits (313), Expect = 1e-35
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 19/150 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E+  +  + HPN+++       +  +  + E+  GG L   I+      P      F + 
Sbjct: 57  EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------- 127
           + +G+  L+S +IIHRDL   N L   + ++  + +ADFGL+  +       +       
Sbjct: 117 IASGMAYLHSMNIIHRDLNSHNCL---VRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173

Query: 128 --------VCGSPLYMAPEVLQFQRYDEKV 149
                   V G+P +MAPE++  + YDEKV
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKV 203

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  123 bits (311), Expect = 1e-35
 Identities = 41/141 (29%), Positives = 69/141 (48%), Gaps = 11/141 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E+  +S++NHPNI++L+        +  V+EF   G+L   +      +      + +  
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130

Query: 75  LGAGLEILNSHH--IIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGNYAEKVCG 130
           +  G+E + + +  I+HRDL+  NI L  LD    V  K+ADFGLS      +    + G
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLG 188

Query: 131 SPLYMAPEVLQFQ--RYDEKV 149
           +  +MAPE +  +   Y EK 
Sbjct: 189 NFQWMAPETIGAEEESYTEKA 209

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  124 bits (314), Expect = 1e-35
 Identities = 49/139 (35%), Positives = 73/139 (52%), Gaps = 4/139 (2%)

Query: 12  CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
               E N L  V HP I+ L  AFQ    ++L++E+ +GG L   +   G   E TA  +
Sbjct: 67  HTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY 126

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCG 130
           L ++   L  L+   II+RDLKPENI+   L+    +K+ DFGL   +++ G      CG
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIM---LNHQGHVKLTDFGLCKESIHDGTVTHTFCG 183

Query: 131 SPLYMAPEVLQFQRYDEKV 149
           +  YMAPE+L    ++  V
Sbjct: 184 TIEYMAPEILMRSGHNRAV 202

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  123 bits (310), Expect = 4e-35
 Identities = 51/135 (37%), Positives = 80/135 (59%), Gaps = 4/135 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + L  VNHP I++L  AFQ E  ++L+++F  GG+L + +       E+  + +L +L
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL 135

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPLY 134
              L+ L+S  II+RDLKPENIL   LD++  +K+ DFGLS  ++     A   CG+  Y
Sbjct: 136 ALALDHLHSLGIIYRDLKPENIL---LDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 192

Query: 135 MAPEVLQFQRYDEKV 149
           MAPEV+  + + +  
Sbjct: 193 MAPEVVNRRGHTQSA 207

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  124 bits (314), Expect = 8e-35
 Identities = 49/154 (31%), Positives = 78/154 (50%), Gaps = 8/154 (5%)

Query: 1   MLKK---LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +LKK   + K   +    E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++
Sbjct: 180 ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL 239

Query: 58  RLHGRVPEQTARKFLQQLGAGLEILNSHH-IIHRDLKPENILLSGLDDDVMLKIADFGLS 116
                  E  AR +  ++ + L+ L+S   +++RDLK EN++   LD D  +KI DFGL 
Sbjct: 240 SRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM---LDKDGHIKITDFGLC 296

Query: 117 -CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149
              +  G   +  CG+P Y+APEVL+   Y   V
Sbjct: 297 KEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAV 330

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  121 bits (305), Expect = 1e-34
 Identities = 42/142 (29%), Positives = 66/142 (46%), Gaps = 13/142 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQ 73
           E+  L    H NI+       A    I  V ++C G +L  ++     +   +      +
Sbjct: 70  EVGVLRKTRHVNILLFMGYSTAPQLAI--VTQWCEGSSLYHHLHASETKFEMKKLIDIAR 127

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC---TLYPGNYAEKVCG 130
           Q   G++ L++  IIHRDLK  NI    L +D  +KI DFGL+         +  E++ G
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIF---LHEDNTVKIGDFGLATEKSRWSGSHQFEQLSG 184

Query: 131 SPLYMAPEVLQFQ---RYDEKV 149
           S L+MAPEV++ Q    Y  + 
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQS 206

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  120 bits (304), Expect = 1e-34
 Identities = 39/156 (25%), Positives = 70/156 (44%), Gaps = 25/156 (16%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----PEQTARK 70
           E+   + +  H +++R F A+  ++ + +  E+C GG+L+  I  + R+     E   + 
Sbjct: 60  EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119

Query: 71  FLQQLGAGLEILNSHHIIHRDLKPENILLS----------------GLDDDVMLKIADFG 114
            L Q+G GL  ++S  ++H D+KP NI +S                   + VM KI D G
Sbjct: 120 LLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179

Query: 115 LSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKV 149
               +   +  +   G   ++A EVLQ    +  K 
Sbjct: 180 HVTRI---SSPQVEEGDSRFLANEVLQENYTHLPKA 212

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  121 bits (306), Expect = 3e-34
 Identities = 51/153 (33%), Positives = 78/153 (50%), Gaps = 8/153 (5%)

Query: 2   LKK---LNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           LKK   L      C   E      +  HP +  +F  FQ +  +F V+E+  GG+L  +I
Sbjct: 50  LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI 109

Query: 58  RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 116
           +   +     A  +  ++  GL+ L+S  I++RDLK +NIL   LD D  +KIADFG+  
Sbjct: 110 QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL---LDKDGHIKIADFGMCK 166

Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149
             +         CG+P Y+APE+L  Q+Y+  V
Sbjct: 167 ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSV 199

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  121 bits (304), Expect = 5e-34
 Identities = 47/134 (35%), Positives = 70/134 (52%), Gaps = 5/134 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 140

Query: 76  GAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 196

Query: 135 MAPEVLQFQRYDEK 148
           M+PE LQ   Y  +
Sbjct: 197 MSPERLQGTHYSVQ 210

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  122 bits (309), Expect = 9e-34
 Identities = 50/159 (31%), Positives = 80/159 (50%), Gaps = 11/159 (6%)

Query: 2   LKK---LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI- 57
           L K     +        E   L+ V+   I+ L  AF+ +  + LV+    GG++  +I 
Sbjct: 218 LNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY 277

Query: 58  ---RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
                +    E  A  +  Q+ +GLE L+  +II+RDLKPEN+L   LDDD  ++I+D G
Sbjct: 278 NVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVL---LDDDGNVRISDLG 334

Query: 115 LSC-TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           L+          +   G+P +MAPE+L  + YD  V++F
Sbjct: 335 LAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYF 373

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  120 bits (303), Expect = 1e-33
 Identities = 52/153 (33%), Positives = 82/153 (53%), Gaps = 8/153 (5%)

Query: 2   LKK---LNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           L+K   L K  +  +  E N  L +V HP ++ L  +FQ  + ++ V+++  GG L  ++
Sbjct: 71  LQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHL 130

Query: 58  RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 116
           +      E  AR +  ++ + L  L+S +I++RDLKPENIL   LD    + + DFGL  
Sbjct: 131 QRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENIL---LDSQGHIVLTDFGLCK 187

Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149
             +   +     CG+P Y+APEVL  Q YD  V
Sbjct: 188 ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTV 220

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  118 bits (299), Expect = 2e-33
 Identities = 30/150 (20%), Positives = 58/150 (38%), Gaps = 20/150 (13%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+       H N++    A  +   + ++   C G  L S +R    V      R+  Q+
Sbjct: 79  EVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQE 138

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------V 128
           +  G+  L++  I+H+DLK +N+      D+  + I DFGL           +       
Sbjct: 139 IVKGMGYLHAKGILHKDLKSKNVFY----DNGKVVITDFGLFSISGVLQAGRREDKLRIQ 194

Query: 129 CGSPLYMAPEVLQFQR---------YDEKV 149
            G   ++APE+++            + +  
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHS 224

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  118 bits (299), Expect = 4e-33
 Identities = 51/154 (33%), Positives = 82/154 (53%), Gaps = 10/154 (6%)

Query: 2   LKK---LNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           LKK   +      C   E   L+     P + +L   FQ  + ++ V+E+  GG+L  +I
Sbjct: 53  LKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI 112

Query: 58  RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
           +  GR  E  A  +  ++  GL  L S  II+RDLK +N++   LD +  +KIADFG+ C
Sbjct: 113 QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM---LDSEGHIKIADFGM-C 168

Query: 118 --TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149
              ++ G   +  CG+P Y+APE++ +Q Y + V
Sbjct: 169 KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSV 202

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  121 bits (306), Expect = 5e-33
 Identities = 49/161 (30%), Positives = 80/161 (49%), Gaps = 14/161 (8%)

Query: 2   LKKLNK-HLKS-----CLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGN 52
           +K L+K  +K          E   LS V+    P I+ +  AF   + +  +++   GG+
Sbjct: 219 MKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGD 278

Query: 53  LSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
           L  ++  HG   E   R +  ++  GLE +++  +++RDLKP NIL   LD+   ++I+D
Sbjct: 279 LHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISD 335

Query: 113 FGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFF 152
            GL+C            G+  YMAPEVLQ    YD   ++F
Sbjct: 336 LGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWF 375

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  118 bits (297), Expect = 6e-33
 Identities = 46/132 (34%), Positives = 78/132 (59%), Gaps = 4/132 (3%)

Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
           F  + NHP ++ L   FQ E+ +F V+E+  GG+L  +++   ++PE+ AR +  ++   
Sbjct: 63  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 122

Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPLYMAP 137
           L  L+   II+RDLK +N+L   LD +  +K+ D+G+    L PG+     CG+P Y+AP
Sbjct: 123 LNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 179

Query: 138 EVLQFQRYDEKV 149
           E+L+ + Y   V
Sbjct: 180 EILRGEDYGFSV 191

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  118 bits (297), Expect = 6e-33
 Identities = 56/153 (36%), Positives = 79/153 (51%), Gaps = 8/153 (5%)

Query: 2   LKK---LNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           LKK   L      C   E   LS   NHP + +LF  FQ  + +F V+EF  GG+L  +I
Sbjct: 56  LKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI 115

Query: 58  RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 116
           +   R  E  AR +  ++ + L  L+   II+RDLK +N+L   LD +   K+ADFG+  
Sbjct: 116 QKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVL---LDHEGHCKLADFGMCK 172

Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149
             +  G      CG+P Y+APE+LQ   Y   V
Sbjct: 173 EGICNGVTTATFCGTPDYIAPEILQEMLYGPAV 205

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  118 bits (298), Expect = 1e-32
 Identities = 48/150 (32%), Positives = 84/150 (56%), Gaps = 12/150 (8%)

Query: 2   LKKLNKH--LK----SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K L+K   +K    +    E + ++  N P +++LF AFQ +  +++V+E+  GG+L +
Sbjct: 99  MKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN 158

Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
            +  +  VPE+ AR +  ++   L+ ++S   IHRD+KP+N+L   LD    LK+ADFG 
Sbjct: 159 LMS-NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFGT 214

Query: 116 S--CTLYPGNYAEKVCGSPLYMAPEVLQFQ 143
                       +   G+P Y++PEVL+ Q
Sbjct: 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 244

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  116 bits (293), Expect = 1e-32
 Identities = 31/162 (19%), Positives = 57/162 (35%), Gaps = 19/162 (11%)

Query: 4   KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLH 60
             +         ++  +   +  N +        +  +++ ++ C   NL  ++      
Sbjct: 99  LSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158

Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL- 119
                        Q+   +E L+S  ++HRDLKP NI       D ++K+ DFGL   + 
Sbjct: 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIF---FTMDDVVKVGDFGLVTAMD 215

Query: 120 ------------YPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149
                                 G+ LYM+PE +    Y  KV
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  117 bits (296), Expect = 1e-32
 Identities = 46/132 (34%), Positives = 78/132 (59%), Gaps = 4/132 (3%)

Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
           F  + NHP ++ L   FQ E+ +F V+E+  GG+L  +++   ++PE+ AR +  ++   
Sbjct: 106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 165

Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPLYMAP 137
           L  L+   II+RDLK +N+L   LD +  +K+ D+G+    L PG+     CG+P Y+AP
Sbjct: 166 LNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 222

Query: 138 EVLQFQRYDEKV 149
           E+L+ + Y   V
Sbjct: 223 EILRGEDYGFSV 234

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  115 bits (290), Expect = 2e-32
 Identities = 42/133 (31%), Positives = 71/133 (53%), Gaps = 6/133 (4%)

Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVP--EQTAR 69
           L  E+     + H NI++   +F     I + +E   GG+LS+ +R   G +   EQT  
Sbjct: 66  LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG 125

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-V 128
            + +Q+  GL+ L+ + I+HRD+K +N+L++     +  KI+DFG S  L   N   +  
Sbjct: 126 FYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVL--KISDFGTSKRLAGINPCTETF 183

Query: 129 CGSPLYMAPEVLQ 141
            G+  YMAPE++ 
Sbjct: 184 TGTLQYMAPEIID 196

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  117 bits (295), Expect = 4e-32
 Identities = 48/157 (30%), Positives = 87/157 (55%), Gaps = 14/157 (8%)

Query: 2   LKKLNKH--LK----SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K LNK   LK    +C   E + L + +   I  L  AFQ +N ++LV+++  GG+L +
Sbjct: 104 MKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLT 163

Query: 56  YI-RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
            + +   R+PE+ AR +L ++   ++ ++  H +HRD+KP+NIL   +D +  +++ADFG
Sbjct: 164 LLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL---MDMNGHIRLADFG 220

Query: 115 LSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEK 148
             C     +   +     G+P Y++PE+LQ     + 
Sbjct: 221 S-CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKG 256

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  115 bits (289), Expect = 8e-32
 Identities = 40/133 (30%), Positives = 67/133 (50%), Gaps = 6/133 (4%)

Query: 16  ELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
           E   L  +   P ++ L  AFQ E  + L++++  GG L +++    R  E   + ++ +
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 167

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--CTLYPGNYAEKVCGSP 132
           +   LE L+   II+RD+K ENIL   LD +  + + DFGLS          A   CG+ 
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENIL---LDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224

Query: 133 LYMAPEVLQFQRY 145
            YMAP++++    
Sbjct: 225 EYMAPDIVRGGDS 237

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  114 bits (288), Expect = 9e-32
 Identities = 40/180 (22%), Positives = 67/180 (37%), Gaps = 35/180 (19%)

Query: 2   LKKLNKHLKSCLDC---ELNFLSSV-NHPNIIRLFDAF-------QAENCIFLVVEFCAG 50
           LK+L  + +        E+ F+  +  HPNI++   A              FL++     
Sbjct: 58  LKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK 117

Query: 51  GNLSSYI---RLHGRVPEQTARKFLQQLGAGLEILNSHH--IIHRDLKPENILLSGLDDD 105
           G L  ++      G +   T  K   Q    ++ ++     IIHRDLK EN+L   L + 
Sbjct: 118 GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLL---LSNQ 174

Query: 106 VMLKIADFGLSCTLYPGNYAEK-------------VCGSPLYMAPEVLQFQR---YDEKV 149
             +K+ DFG + T+                        +P+Y  PE++         EK 
Sbjct: 175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQ 234

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  117 bits (295), Expect = 1e-31
 Identities = 51/154 (33%), Positives = 82/154 (53%), Gaps = 10/154 (6%)

Query: 2   LKK---LNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           LKK   +      C   E   L+     P + +L   FQ  + ++ V+E+  GG+L  +I
Sbjct: 374 LKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI 433

Query: 58  RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
           +  GR  E  A  +  ++  GL  L S  II+RDLK +N++   LD +  +KIADFG+ C
Sbjct: 434 QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM---LDSEGHIKIADFGM-C 489

Query: 118 --TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149
              ++ G   +  CG+P Y+APE++ +Q Y + V
Sbjct: 490 KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSV 523

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  113 bits (284), Expect = 2e-31
 Identities = 36/132 (27%), Positives = 62/132 (46%), Gaps = 27/132 (20%)

Query: 24  NHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQLGA 77
             P+I+R+ D ++       C+ +V+E   GG L S I  R      E+ A + ++ +G 
Sbjct: 69  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128

Query: 78  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAP 137
            ++ L+S +I HRD+KPEN+L +    + +LK+ DFG                     A 
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AK 168

Query: 138 EVLQFQRYDEKV 149
           E    ++YD+  
Sbjct: 169 ETTG-EKYDKSC 179

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  115 bits (289), Expect = 2e-31
 Identities = 47/151 (31%), Positives = 82/151 (54%), Gaps = 12/151 (7%)

Query: 2   LKKLNKHL---KSCLDC---ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K +NK     +  + C   E + L + +   I +L  AFQ EN ++LV+E+  GG+L +
Sbjct: 91  MKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLT 150

Query: 56  YIRLHG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
            +   G R+P + AR +L ++   ++ ++    +HRD+KP+NIL   LD    +++ADFG
Sbjct: 151 LLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNIL---LDRCGHIRLADFG 207

Query: 115 LSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ 143
               L       +    G+P Y++PE+LQ  
Sbjct: 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAV 238

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  111 bits (280), Expect = 6e-31
 Identities = 43/123 (34%), Positives = 67/123 (54%), Gaps = 11/123 (8%)

Query: 21  SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80
           S ++H NI+ + D  + ++C +LV+E+  G  LS YI  HG +   TA  F  Q+  G++
Sbjct: 66  SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125

Query: 81  ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-----SCTLYPGNYAEKVCGSPLYM 135
             +   I+HRD+KP+NIL   +D +  LKI DFG+       +L        V G+  Y 
Sbjct: 126 HAHDMRIVHRDIKPQNIL---IDSNKTLKIFDFGIAKALSETSL---TQTNHVLGTVQYF 179

Query: 136 APE 138
           +PE
Sbjct: 180 SPE 182

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  109 bits (275), Expect = 3e-30
 Identities = 28/143 (19%), Positives = 57/143 (39%), Gaps = 16/143 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKF 71
           E   L   +HPN++ +  A Q+       L+  +   G+L + +       V +  A KF
Sbjct: 57  ECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKF 116

Query: 72  LQQLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
              +  G+  L++    I    L   +++   +D+D+  +I+   +  +           
Sbjct: 117 ALDMARGMAFLHTLEPLIPRHALNSRSVM---IDEDMTARISMADVKFSFQSPG----RM 169

Query: 130 GSPLYMAPEVLQFQRYD---EKV 149
            +P ++APE LQ +  D      
Sbjct: 170 YAPAWVAPEALQKKPEDTNRRSA 192

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  110 bits (276), Expect = 3e-30
 Identities = 40/140 (28%), Positives = 62/140 (44%), Gaps = 10/140 (7%)

Query: 16  ELNFL-SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
           +L+ +  S + P I++ F  F     +F+ +E           R+ G +PE+   K    
Sbjct: 73  DLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVA 132

Query: 75  LGAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           +   L  L   H +IHRD+KP NILL        +K+ DFG+S  L      ++  G   
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLDERGQ---IKLCDFGISGRLVDDKAKDRSAGCAA 189

Query: 134 YMAPEVLQFQR-----YDEK 148
           YMAPE +         YD +
Sbjct: 190 YMAPERIDPPDPTKPDYDIR 209

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  110 bits (276), Expect = 4e-30
 Identities = 42/136 (30%), Positives = 72/136 (52%), Gaps = 5/136 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E++ +   + P++++ + ++     +++V+E+C  G++S  IRL    + E      LQ 
Sbjct: 74  EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQS 133

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPL 133
              GLE L+    IHRD+K  NILL+  +     K+ADFG++  L         V G+P 
Sbjct: 134 TLKGLEYLHFMRKIHRDIKAGNILLN-TEGHA--KLADFGVAGQLTDTMAKRNTVIGTPF 190

Query: 134 YMAPEVLQFQRYDEKV 149
           +MAPEV+Q   Y+   
Sbjct: 191 WMAPEVIQEIGYNCVA 206

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  109 bits (275), Expect = 5e-30
 Identities = 37/135 (27%), Positives = 71/135 (52%), Gaps = 5/135 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +    H N++ ++ ++     +++++EF  GG L+  +    R+ E+      + +
Sbjct: 92  EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAV 150

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
              L  L++  +IHRD+K ++ILL+ LD  V  K++DFG    +       K + G+P +
Sbjct: 151 LQALAYLHAQGVIHRDIKSDSILLT-LDGRV--KLSDFGFCAQISKDVPKRKSLVGTPYW 207

Query: 135 MAPEVLQFQRYDEKV 149
           MAPEV+    Y  +V
Sbjct: 208 MAPEVISRSLYATEV 222

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  109 bits (274), Expect = 5e-30
 Identities = 42/135 (31%), Positives = 73/135 (54%), Gaps = 5/135 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +     + E       ++ 
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCREC 125

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
              LE L+S+ +IHRD+K +NILL  +D  V  K+ DFG    + P       + G+P +
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLG-MDGSV--KLTDFGFCAQITPEQSKRSTMVGTPYW 182

Query: 135 MAPEVLQFQRYDEKV 149
           MAPEV+  + Y  KV
Sbjct: 183 MAPEVVTRKAYGPKV 197

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  107 bits (269), Expect = 3e-29
 Identities = 39/135 (28%), Positives = 72/135 (53%), Gaps = 5/135 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P + + + ++  +  +++++E+  GG+    +   G + E      L+++
Sbjct: 70  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 128

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLY 134
             GL+ L+S   IHRD+K  N+LLS   +   +K+ADFG++  L           G+P +
Sbjct: 129 LKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFW 185

Query: 135 MAPEVLQFQRYDEKV 149
           MAPEV++   YD K 
Sbjct: 186 MAPEVIKQSAYDSKA 200

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  106 bits (268), Expect = 4e-29
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 27/138 (19%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++        P    + +L 
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 110

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+          +  G P+
Sbjct: 111 QLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLA----------RAFGVPV 157

Query: 134 -----------YMAPEVL 140
                      Y APE+L
Sbjct: 158 RTYTHEVVTLWYRAPEIL 175

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  107 bits (270), Expect = 4e-29
 Identities = 47/137 (34%), Positives = 66/137 (48%), Gaps = 9/137 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+ FL  + HPN I+    +  E+  +LV+E+C G            + E          
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGA 163

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
             GL  L+SH++IHRD+K  NILLS     V  K+ DFG +  + P N      G+P +M
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLS-EPGLV--KLGDFGSASIMAPAN---SFVGTPYWM 217

Query: 136 APEVLQFQR---YDEKV 149
           APEV+       YD KV
Sbjct: 218 APEVILAMDEGQYDGKV 234

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  108 bits (270), Expect = 5e-29
 Identities = 20/139 (14%), Positives = 42/139 (30%), Gaps = 14/139 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCA------GGNLSSYIRLHGRVPEQT 67
             + +       +IR+    +       F +           G  L S+   H  +    
Sbjct: 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA 207

Query: 68  ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127
             +   Q+   L  L+ + ++H  L+P +I+   LD    + +  F              
Sbjct: 208 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIV---LDQRGGVFLTGFEHLV---RDGARVV 261

Query: 128 VCGSPLYMAPEVLQFQRYD 146
              S  +  PE+   +   
Sbjct: 262 SSVSRGFEPPELEARRATI 280

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  107 bits (269), Expect = 5e-29
 Identities = 41/138 (29%), Positives = 64/138 (46%), Gaps = 24/138 (17%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  + H NII L       + + L+ E+    +L  Y+  +  V  +  + FL QL
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL 141

Query: 76  GAGLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
             G+   +S   +HRDLKP+N+LLS     +  +LKI DFGL+          +  G P+
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA----------RAFGIPI 191

Query: 134 -----------YMAPEVL 140
                      Y  PE+L
Sbjct: 192 RQFTHEIITLWYRPPEIL 209

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  106 bits (268), Expect = 6e-29
 Identities = 36/137 (26%), Positives = 62/137 (45%), Gaps = 26/137 (18%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E+  L  + HPN++ L + F+ +  + LV E+C    +   +  + R VPE   +    Q
Sbjct: 52  EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQ 110

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
               +   + H+ IHRD+KPENIL   +    ++K+ DFG +          ++   P  
Sbjct: 111 TLQAVNFCHKHNCIHRDVKPENIL---ITKHSVIKLCDFGFA----------RLLTGPSD 157

Query: 134 ----------YMAPEVL 140
                     Y +PE+L
Sbjct: 158 YYDDEVATRWYRSPELL 174

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  106 bits (266), Expect = 8e-29
 Identities = 45/143 (31%), Positives = 78/143 (54%), Gaps = 14/143 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  L++ +HP I++L  A+  +  +++++EFC GG + + +    R   E   +   +Q
Sbjct: 66  EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQ 125

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGS 131
           +   L  L+S  IIHRDLK  N+L++ L+ D+  ++ADFG+S         +K     G+
Sbjct: 126 MLEALNFLHSKRIIHRDLKAGNVLMT-LEGDI--RLADFGVSAKN--LKTLQKRDSFIGT 180

Query: 132 PLYMAPEV-----LQFQRYDEKV 149
           P +MAPEV     ++   YD K 
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKA 203

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  104 bits (263), Expect = 3e-28
 Identities = 44/137 (32%), Positives = 69/137 (50%), Gaps = 26/137 (18%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E++ L  ++HPNI+ L D   +E C+ LV EF    +L   +  +     +   + +L Q
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           L  G+   + H I+HRDLKP+N+L   ++ D  LK+ADFGL+          +  G P+ 
Sbjct: 128 LLRGVAHCHQHRILHRDLKPQNLL---INSDGALKLADFGLA----------RAFGIPVR 174

Query: 134 ----------YMAPEVL 140
                     Y AP+VL
Sbjct: 175 SYTHEVVTLWYRAPDVL 191

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  104 bits (262), Expect = 4e-28
 Identities = 32/126 (25%), Positives = 60/126 (47%), Gaps = 11/126 (8%)

Query: 21  SSVNHPNIIRLFD----AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
           +++NHP I+ ++D       A    ++V+E+  G  L   +   G +  + A + +    
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 126

Query: 77  AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL----SCTLYPGNYAEKVCGSP 132
             L   + + IIHRD+KP NI++S       +K+ DFG+    + +         V G+ 
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183

Query: 133 LYMAPE 138
            Y++PE
Sbjct: 184 QYLSPE 189

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  104 bits (263), Expect = 5e-28
 Identities = 38/137 (27%), Positives = 64/137 (46%), Gaps = 26/137 (18%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E+  L  + H N++ L +  + +   +LV EF     +   + L    +  Q  +K+L Q
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQ 132

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +  G+   +SH+IIHRD+KPENIL   +    ++K+ DFG +          +   +P  
Sbjct: 133 IINGIGFCHSHNIIHRDIKPENIL---VSQSGVVKLCDFGFA----------RTLAAPGE 179

Query: 134 ----------YMAPEVL 140
                     Y APE+L
Sbjct: 180 VYDDEVATRWYRAPELL 196

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  103 bits (260), Expect = 6e-28
 Identities = 42/137 (30%), Positives = 66/137 (48%), Gaps = 26/137 (18%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  L  + H NI+RL D   ++  + LV EFC   +L  Y          +  + FL Q
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ 109

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           L  GL   +S +++HRDLKP+N+L   ++ +  LK+A+FGL+          +  G P+ 
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLL---INRNGELKLANFGLA----------RAFGIPVR 156

Query: 134 ----------YMAPEVL 140
                     Y  P+VL
Sbjct: 157 CYSAEVVTLWYRPPDVL 173

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  104 bits (262), Expect = 6e-28
 Identities = 50/137 (36%), Positives = 71/137 (51%), Gaps = 26/137 (18%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  L  ++HPNII L DAF  ++ I LV +F    +L   I+ +  V      + ++  
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM 120

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
              GLE L+ H I+HRDLKP N+L   LD++ +LK+ADFGL+          K  GSP  
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLL---LDENGVLKLADFGLA----------KSFGSPNR 167

Query: 134 ----------YMAPEVL 140
                     Y APE+L
Sbjct: 168 AYTHQVVTRWYRAPELL 184

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  103 bits (259), Expect = 7e-28
 Identities = 41/137 (29%), Positives = 66/137 (48%), Gaps = 26/137 (18%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E++ L  + H NI++L+D    +  + LV E     +L   + +        TA+ FL Q
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ 108

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           L  G+   +   ++HRDLKP+N+L   ++ +  LKIADFGL+          +  G P+ 
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLL---INREGELKIADFGLA----------RAFGIPVR 155

Query: 134 ----------YMAPEVL 140
                     Y AP+VL
Sbjct: 156 KYTHEIVTLWYRAPDVL 172

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  106 bits (266), Expect = 1e-27
 Identities = 34/128 (26%), Positives = 69/128 (53%), Gaps = 14/128 (10%)

Query: 19  FLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
           FL+ V HP+I+++F+  +  +       ++V+E+  G +L        ++P   A  +L 
Sbjct: 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLL 189

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           ++   L  L+S  +++ DLKPENI+L+  ++ +  K+ D G    +   N    + G+P 
Sbjct: 190 EILPALSYLHSIGLVYNDLKPENIMLT--EEQL--KLIDLGAVSRI---NSFGYLYGTPG 242

Query: 134 YMAPEVLQ 141
           + APE+++
Sbjct: 243 FQAPEIVR 250

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  103 bits (258), Expect = 1e-27
 Identities = 47/149 (31%), Positives = 79/149 (53%), Gaps = 18/149 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF---- 71
           E+  +S  +HPNI+  + +F  ++ ++LV++  +GG++   I+      E  +       
Sbjct: 63  EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122

Query: 72  ----LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127
               L+++  GLE L+ +  IHRD+K  NIL   L +D  ++IADFG+S  L  G    +
Sbjct: 123 IATILREVLEGLEYLHKNGQIHRDVKAGNIL---LGEDGSVQIADFGVSAFLATGGDITR 179

Query: 128 ------VCGSPLYMAPEVL-QFQRYDEKV 149
                   G+P +MAPEV+ Q + YD K 
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKA 208

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  103 bits (258), Expect = 2e-27
 Identities = 33/127 (25%), Positives = 62/127 (48%), Gaps = 13/127 (10%)

Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81
            +  P+++ + D  + +  +++ +    G +L++ +R  G +    A   ++Q+G+ L+ 
Sbjct: 90  RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149

Query: 82  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-----SCTLYPGNYAEKVCGSPLYMA 136
            ++    HRD+KPENIL+S  DD     + DFG+        L          G+  YMA
Sbjct: 150 AHAAGATHRDVKPENILVSA-DDFA--YLVDFGIASATTDEKL---TQLGNTVGTLYYMA 203

Query: 137 PEVLQFQ 143
           PE  +F 
Sbjct: 204 PE--RFS 208

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  102 bits (256), Expect = 2e-27
 Identities = 39/142 (27%), Positives = 62/142 (43%), Gaps = 12/142 (8%)

Query: 16  ELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY---IRLHGRVPEQTARKF 71
           +L+  + +V+ P  +  + A   E  +++ +E         Y   I     +PE    K 
Sbjct: 55  DLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKI 114

Query: 72  LQQLGAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG 130
              +   LE L+S   +IHRD+KP N+L++     V  K+ DFG+S  L      +   G
Sbjct: 115 AVSIVKALEHLHSKLSVIHRDVKPSNVLIN-ALGQV--KMCDFGISGYLVDDVAKDIDAG 171

Query: 131 SPLYMAPEV----LQFQRYDEK 148
              YMAPE     L  + Y  K
Sbjct: 172 CKPYMAPERINPELNQKGYSVK 193

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  103 bits (259), Expect = 3e-27
 Identities = 38/146 (26%), Positives = 64/146 (43%), Gaps = 15/146 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
           EL+     NHPNI+     F A+N +++V  F A G+    I  H    + E      LQ
Sbjct: 76  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ 135

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC---- 129
            +   L+ ++    +HR +K  +IL+S  D  V   ++    + ++      ++V     
Sbjct: 136 GVLKALDYIHHMGYVHRSVKASHILISV-DGKV--YLSGLRSNLSMISHGQRQRVVHDFP 192

Query: 130 ----GSPLYMAPEVLQ--FQRYDEKV 149
                   +++PEVLQ   Q YD K 
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKS 218

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  103 bits (257), Expect = 4e-27
 Identities = 20/137 (14%), Positives = 33/137 (24%), Gaps = 15/137 (10%)

Query: 24  NHPNIIRLFDAFQAENC--IFLVVEFCAG------GNLSSYIRLHGRVPEQTARKFLQQL 75
           + P   +L             L++   +         L       G            QL
Sbjct: 144 SQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQL 203

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
                 L S  ++H    P+N+    +  D  L + D         G           Y 
Sbjct: 204 IRLAANLQSKGLVHGHFTPDNLF---IMPDGRLMLGDVSAL--WKVGTRGPASSVPVTYA 258

Query: 136 APEVLQFQR--YDEKVN 150
             E L      +   +N
Sbjct: 259 PREFLNASTATFTHALN 275

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  101 bits (254), Expect = 4e-27
 Identities = 40/141 (28%), Positives = 67/141 (47%), Gaps = 10/141 (7%)

Query: 15  CELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVP-EQTARKFL 72
            E   +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F 
Sbjct: 75  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 134

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCG 130
            Q+  G++ L S   +HRDL   N +L   +   + K+ADFGL+  +Y   Y       G
Sbjct: 135 LQVAKGMKYLASKKFVHRDLAARNCMLD--EKFTV-KVADFGLARDMYDKEYYSVHNKTG 191

Query: 131 SPL---YMAPEVLQFQRYDEK 148
           + L   +MA E LQ Q++  K
Sbjct: 192 AKLPVKWMALESLQTQKFTTK 212

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  101 bits (254), Expect = 6e-27
 Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 19/164 (11%)

Query: 1   MLKKLNKHLKSCLD--CELNFLSSVNHPNIIRLF-----DAFQAENCIFLVVEFCAGGNL 53
            +K  N   +   +   E   +   +HPN+IRL       + Q      +++ F   G+L
Sbjct: 69  TMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDL 128

Query: 54  SSYIRLH------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVM 107
            +Y+           +P QT  KF+  +  G+E L++ + +HRDL   N +L   DD  +
Sbjct: 129 HTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR--DDMTV 186

Query: 108 LKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEK 148
             +ADFGLS  +Y G+Y  +   + +   ++A E L  + Y  K
Sbjct: 187 -CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK 229

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  101 bits (255), Expect = 6e-27
 Identities = 35/134 (26%), Positives = 60/134 (44%), Gaps = 8/134 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   ++SV++P++ RL       + + L+ +    G L  Y+R H   +  Q    +  Q
Sbjct: 67  EAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--P 132
           +  G+  L    ++HRDL   N+L+        +KI DFGL+  L          G   P
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182

Query: 133 L-YMAPEVLQFQRY 145
           + +MA E +  + Y
Sbjct: 183 IKWMALESILHRIY 196

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  101 bits (253), Expect = 7e-27
 Identities = 37/157 (23%), Positives = 62/157 (39%), Gaps = 27/157 (17%)

Query: 16  ELNFLSSVNHPNIIRLFDA----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           EL     + H NI+    +      +   ++L+  +   G+L  Y++L   +   +  + 
Sbjct: 52  ELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRI 110

Query: 72  LQQLGAGLEILNSHH--------IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
           +  + +GL  L+           I HRDLK +NIL   +  +    IAD GL+       
Sbjct: 111 VLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNIL---VKKNGQCCIADLGLAVMHSQST 167

Query: 124 YAEKV-----CGSPLYMAPEVL------QFQRYDEKV 149
               V      G+  YMAPEVL            ++V
Sbjct: 168 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRV 204

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  102 bits (255), Expect = 8e-27
 Identities = 39/140 (27%), Positives = 67/140 (47%), Gaps = 10/140 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVP-EQTARKFLQ 73
           E   +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  
Sbjct: 140 EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL 199

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGS 131
           Q+  G++ L S   +HRDL   N +L   +   + K+ADFGL+  +Y   +       G+
Sbjct: 200 QVAKGMKFLASKKFVHRDLAARNCMLD--EKFTV-KVADFGLARDMYDKEFDSVHNKTGA 256

Query: 132 PL---YMAPEVLQFQRYDEK 148
            L   +MA E LQ Q++  K
Sbjct: 257 KLPVKWMALESLQTQKFTTK 276

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  101 bits (253), Expect = 1e-26
 Identities = 39/149 (26%), Positives = 68/149 (45%), Gaps = 20/149 (13%)

Query: 16  ELNFLSSVNHPNIIRLF------DAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           E   +   +HP++ +L        A        +++ F   G+L +++    R+ E    
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS-RIGENPFN 133

Query: 70  -------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
                  +F+  +  G+E L+S + IHRDL   N +L+  +D  +  +ADFGLS  +Y G
Sbjct: 134 LPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA--EDMTV-CVADFGLSRKIYSG 190

Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEK 148
           +Y  + C S L   ++A E L    Y   
Sbjct: 191 DYYRQGCASKLPVKWLALESLADNLYTVH 219

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  100 bits (251), Expect = 1e-26
 Identities = 38/140 (27%), Positives = 63/140 (45%), Gaps = 10/140 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVP-EQTARKFLQ 73
           E   +  +NHPN++ L       E    +++ +   G+L  +IR   R P  +    F  
Sbjct: 72  EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL 131

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGS 131
           Q+  G+E L     +HRDL   N +L    +   +K+ADFGL+  +    Y   ++   +
Sbjct: 132 QVARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLARDILDREYYSVQQHRHA 188

Query: 132 PL---YMAPEVLQFQRYDEK 148
            L   + A E LQ  R+  K
Sbjct: 189 RLPVKWTALESLQTYRFTTK 208

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  101 bits (253), Expect = 1e-26
 Identities = 39/137 (28%), Positives = 62/137 (45%), Gaps = 26/137 (18%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E++ L  + H NI+ L D    E  + LV E+    +L  Y+   G +      + FL Q
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQ 108

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           L  GL   +   ++HRDLKP+N+L   +++   LK+ADFGL+          +    P  
Sbjct: 109 LLRGLAYCHRQKVLHRDLKPQNLL---INERGELKLADFGLA----------RAKSIPTK 155

Query: 134 ----------YMAPEVL 140
                     Y  P++L
Sbjct: 156 TYDNEVVTLWYRPPDIL 172

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  101 bits (252), Expect = 1e-26
 Identities = 37/157 (23%), Positives = 59/157 (37%), Gaps = 27/157 (17%)

Query: 16  ELNFLSSVNHPNIIRLFDA----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E+     + H NI+    A          ++LV ++   G+L  Y+  +  V  +   K 
Sbjct: 86  EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKL 144

Query: 72  LQQLGAGLEILNSHH--------IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                +GL  L+           I HRDLK +NIL   +  +    IAD GL+       
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL---VKKNGTCCIADLGLAVRHDSAT 201

Query: 124 YAEKV-----CGSPLYMAPEVL------QFQRYDEKV 149
               +      G+  YMAPEVL      +     ++ 
Sbjct: 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 238

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =   99 bits (250), Expect = 2e-26
 Identities = 42/142 (29%), Positives = 64/142 (45%), Gaps = 31/142 (21%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV------PEQTAR 69
           E++ +  + H NI+RL+D    EN + LV EF    +L  Y+                 +
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK 111

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
            F  QL  GL   + + I+HRDLKP+N+L   ++    LK+ DFGL+          +  
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLL---INKRGQLKLGDFGLA----------RAF 158

Query: 130 GSPL-----------YMAPEVL 140
           G P+           Y AP+VL
Sbjct: 159 GIPVNTFSSEVVTLWYRAPDVL 180

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =   99 bits (250), Expect = 2e-26
 Identities = 46/147 (31%), Positives = 69/147 (46%), Gaps = 31/147 (21%)

Query: 20  LSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFL 72
           L +  HPN++RLFD         E  + LV E     +L++Y+        P +T +  +
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            QL  GL+ L+SH ++HRDLKP+NIL   +     +K+ADFGL+          ++    
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNIL---VTSSGQIKLADFGLA----------RIYSFQ 173

Query: 133 L----------YMAPEVLQFQRYDEKV 149
           +          Y APEVL    Y   V
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPV 200

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  100 bits (250), Expect = 3e-26
 Identities = 34/137 (24%), Positives = 66/137 (48%), Gaps = 8/137 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
            +  + S++H +I+RL       + + LV ++   G+L  ++R H G +  Q    +  Q
Sbjct: 65  HMLAIGSLDHAHIVRLL-GLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +  G+  L  H ++HR+L   N+LL        +++ADFG++  L P +       +   
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180

Query: 134 --YMAPEVLQFQRYDEK 148
             +MA E + F +Y  +
Sbjct: 181 IKWMALESIHFGKYTHQ 197

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  100 bits (250), Expect = 3e-26
 Identities = 40/143 (27%), Positives = 63/143 (44%), Gaps = 10/143 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR------ 69
           E   +S  NH NI+R           F+++E  AGG+L S++R     P Q +       
Sbjct: 83  EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142

Query: 70  -KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
               + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y  +Y  K 
Sbjct: 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 202

Query: 129 CGSPL---YMAPEVLQFQRYDEK 148
             + L   +M PE      +  K
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSK 225

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 99.7 bits (249), Expect = 3e-26
 Identities = 39/143 (27%), Positives = 60/143 (41%), Gaps = 13/143 (9%)

Query: 16  ELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARK 70
           +L+  + S + P I++ + A   E   ++ +E  +      Y      L   +PE+   K
Sbjct: 70  DLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGK 129

Query: 71  FLQQLGAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
                   L  L     IIHRD+KP NILL     ++  K+ DFG+S  L       +  
Sbjct: 130 ITLATVKALNHLKENLKIIHRDIKPSNILLD-RSGNI--KLCDFGISGQLVDSIAKTRDA 186

Query: 130 GSPLYMAPEVLQFQR----YDEK 148
           G   YMAPE +        YD +
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVR 209

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 99.8 bits (249), Expect = 4e-26
 Identities = 35/157 (22%), Positives = 60/157 (38%), Gaps = 27/157 (17%)

Query: 16  ELNFLSSVNHPNIIRLFDA----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E+     + H NI+    A      +   ++L+ ++   G+L  Y++    +  ++  K 
Sbjct: 81  EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKL 139

Query: 72  LQQLGAGL-----EILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
                +GL     EI ++     I HRDLK +NIL   +  +    IAD GL+       
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNIL---VKKNGTCCIADLGLAVKFISDT 196

Query: 124 YAEKV-----CGSPLYMAPEVL------QFQRYDEKV 149
               +      G+  YM PEVL         +     
Sbjct: 197 NEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMA 233

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  100 bits (250), Expect = 4e-26
 Identities = 39/140 (27%), Positives = 61/140 (43%), Gaps = 10/140 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR------ 69
           E   +S  NH NI+R           F+++E  AGG+L S++R     P Q +       
Sbjct: 124 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183

Query: 70  -KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
               + +  G + L  +H IHRD+   N LL+      + KI DFG++  +Y   Y  K 
Sbjct: 184 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKG 243

Query: 129 CGSPL---YMAPEVLQFQRY 145
             + L   +M PE      +
Sbjct: 244 GCAMLPVKWMPPEAFMEGIF 263

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 99.3 bits (248), Expect = 6e-26
 Identities = 32/146 (21%), Positives = 62/146 (42%), Gaps = 16/146 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR------ 69
           E + +   N  +++RL           +++E    G+L SY+R                 
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137

Query: 70  ----KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
               +   ++  G+  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +Y 
Sbjct: 138 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYY 194

Query: 126 EKVCGSPL---YMAPEVLQFQRYDEK 148
            K     L   +M+PE L+   +   
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTY 220

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  100 bits (250), Expect = 6e-26
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 37/152 (24%)

Query: 15  CELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGR---------V 63
            E+  L  + HPN+I L   F   A+  ++L+ ++    +L   I+ H           +
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQL 125

Query: 64  PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPG 122
           P    +  L Q+  G+  L+++ ++HRDLKP NIL+ G   +   +KIAD G +      
Sbjct: 126 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA------ 179

Query: 123 NYAEKVCGSPL--------------YMAPEVL 140
               ++  SPL              Y APE+L
Sbjct: 180 ----RLFNSPLKPLADLDPVVVTFWYRAPELL 207

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 98.0 bits (245), Expect = 6e-26
 Identities = 37/137 (27%), Positives = 71/137 (51%), Gaps = 10/137 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFL 72
           E + ++ + H N+++L     + +  +++V E+ A G+L  Y+R  GR         KF 
Sbjct: 64  EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 123

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
             +   +E L  ++ +HRDL   N+L+S   +D + K++DFGL+          K+   P
Sbjct: 124 LDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL---P 177

Query: 133 L-YMAPEVLQFQRYDEK 148
           + + APE L+ +++  K
Sbjct: 178 VKWTAPEALREKKFSTK 194

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 98.8 bits (247), Expect = 7e-26
 Identities = 44/150 (29%), Positives = 67/150 (44%), Gaps = 31/150 (20%)

Query: 17  LNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGRV--PEQTAR 69
           L  L +  HPN++RL D            + LV E     +L +Y+        P +T +
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             ++Q   GL+ L+++ I+HRDLKPENIL   +     +K+ADFGL+          ++ 
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENIL---VTSGGTVKLADFGLA----------RIY 170

Query: 130 GSPL----------YMAPEVLQFQRYDEKV 149
              +          Y APEVL    Y   V
Sbjct: 171 SYQMALTPVVVTLWYRAPEVLLQSTYATPV 200

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 98.9 bits (247), Expect = 7e-26
 Identities = 34/134 (25%), Positives = 59/134 (44%), Gaps = 8/134 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   ++SV++P++ RL       + + L+ +    G L  Y+R H   +  Q    +  Q
Sbjct: 67  EAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +  G+  L    ++HRDL   N+L+        +KI DFGL+  L          G  + 
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182

Query: 134 --YMAPEVLQFQRY 145
             +MA E +  + Y
Sbjct: 183 IKWMALESILHRIY 196

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  100 bits (250), Expect = 9e-26
 Identities = 37/137 (27%), Positives = 72/137 (52%), Gaps = 10/137 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFL 72
           E + ++ + H N+++L     + +  +++V E+ A G+L  Y+R  GR  +      KF 
Sbjct: 236 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 295

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
             +   +E L  ++ +HRDL   N+L+S   +D + K++DFGL+          K+   P
Sbjct: 296 LDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL---P 349

Query: 133 L-YMAPEVLQFQRYDEK 148
           + + APE L+ +++  K
Sbjct: 350 VKWTAPEALREKKFSTK 366

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 97.1 bits (242), Expect = 3e-25
 Identities = 45/149 (30%), Positives = 75/149 (50%), Gaps = 18/149 (12%)

Query: 16  ELNFLSSV-NHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQ 66
           E+N L    +H NI   + AF        ++ ++LV+EFC  G+++  I+      + E+
Sbjct: 70  EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 129

Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
                 +++  GL  L+ H +IHRD+K +N+LL+  + +V  K+ DFG+S  L       
Sbjct: 130 WIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT-ENAEV--KLVDFGVSAQLDRTVGRR 186

Query: 127 K-VCGSPLYMAPEVLQFQR-----YDEKV 149
               G+P +MAPEV+         YD K 
Sbjct: 187 NTFIGTPYWMAPEVIACDENPDATYDFKS 215

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 96.2 bits (240), Expect = 5e-25
 Identities = 38/135 (28%), Positives = 63/135 (46%), Gaps = 9/135 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R             
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           Q+ + +E L   + IHRDL   N L+    ++ ++K+ADFGLS  L  G+      G+  
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS-RLMTGDTYTAHAGAKF 174

Query: 134 ---YMAPEVLQFQRY 145
              + APE L + ++
Sbjct: 175 PIKWTAPESLAYNKF 189

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 96.6 bits (241), Expect = 5e-25
 Identities = 39/166 (23%), Positives = 73/166 (43%), Gaps = 21/166 (12%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
            LK+ ++  +     E   L+ + H +I+R F        + +V E+   G+L+ ++R H
Sbjct: 78  ALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH 137

Query: 61  GRVPEQTAR---------------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDD 105
           G   +  A                    Q+ AG+  L   H +HRDL   N L+      
Sbjct: 138 GPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QG 194

Query: 106 VMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEK 148
           +++KI DFG+S  +Y  +Y      + L   +M PE + ++++  +
Sbjct: 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE 240

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 97.9 bits (244), Expect = 5e-25
 Identities = 44/160 (27%), Positives = 74/160 (46%), Gaps = 17/160 (10%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSS 55
           +KK+ +  +     EL  +  ++H NI+RL   F      + E  + LV+++     +  
Sbjct: 84  IKKVLQDKRFKNR-ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYR 141

Query: 56  YIRLHGR----VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
             R + R    +P    + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ 
Sbjct: 142 VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLC 199

Query: 112 DFGLSCTLYPGN-YAEKVCGSPLYMAPEV-LQFQRYDEKV 149
           DFG +  L  G      +C S  Y APE+      Y   +
Sbjct: 200 DFGSAKQLVRGEPNVSYIC-SRYYRAPELIFGATDYTSSI 238

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 96.2 bits (240), Expect = 9e-25
 Identities = 41/151 (27%), Positives = 68/151 (45%), Gaps = 21/151 (13%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ-------- 66
           EL  +S +  H NI+ L  A      + ++ E+C  G+L +++R   RV E         
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158

Query: 67  ---TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
              + R  L    Q+  G+  L S + IHRD+   N+LL+   +  + KI DFGL+  + 
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLARDIM 215

Query: 121 PGNYAEKVCGSPL---YMAPEVLQFQRYDEK 148
             +       + L   +MAPE +    Y  +
Sbjct: 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQ 246

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 95.0 bits (237), Expect = 1e-24
 Identities = 36/167 (21%), Positives = 72/167 (43%), Gaps = 22/167 (13%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
            LK      +     E   L+++ H +I++ +      + + +V E+   G+L+ ++R H
Sbjct: 52  ALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAH 111

Query: 61  GRVPEQTAR----------------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDD 104
           G                            Q+ +G+  L S H +HRDL   N L+     
Sbjct: 112 GPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---A 168

Query: 105 DVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEK 148
           ++++KI DFG+S  +Y  +Y      + L   +M PE + ++++  +
Sbjct: 169 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE 215

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 96.2 bits (240), Expect = 2e-24
 Identities = 42/129 (32%), Positives = 67/129 (51%), Gaps = 7/129 (5%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEIL 82
           +HPNI+RL      +  I++V+E   GG+  +++R  G  +  +T  + +    AG+E L
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229

Query: 83  NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEV 139
            S   IHRDL   N L++   +  +LKI+DFG+S     G YA       +   + APE 
Sbjct: 230 ESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEA 286

Query: 140 LQFQRYDEK 148
           L + RY  +
Sbjct: 287 LNYGRYSSE 295

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 94.6 bits (236), Expect = 2e-24
 Identities = 38/168 (22%), Positives = 76/168 (45%), Gaps = 23/168 (13%)

Query: 1   MLKK-LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
            LK      L+     E    + + HPN++ L      +  + ++  +C+ G+L  ++ +
Sbjct: 46  TLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVM 105

Query: 60  HGRVPEQTAR----------------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103
                +  +                   + Q+ AG+E L+SHH++H+DL   N+L+    
Sbjct: 106 RSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY--- 162

Query: 104 DDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEK 148
           D + +KI+D GL   +Y  +Y + +  S L   +MAPE + + ++   
Sbjct: 163 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID 210

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 95.3 bits (237), Expect = 2e-24
 Identities = 39/150 (26%), Positives = 57/150 (38%), Gaps = 27/150 (18%)

Query: 15  CELNFLSSVNHPNIIRLFDA-----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
             +  +  + H NI R                 LV+E+   G+L  Y+ LH      ++ 
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSC 114

Query: 70  KFLQQLGAGL-----EILNSHH----IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
           +    +  GL     E+    H    I HRDL   N+L   + +D    I+DFGLS  L 
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVL---VKNDGTCVISDFGLSMRLT 171

Query: 121 PGNYAEK---------VCGSPLYMAPEVLQ 141
                             G+  YMAPEVL+
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLE 201

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 94.8 bits (236), Expect = 2e-24
 Identities = 39/143 (27%), Positives = 64/143 (44%), Gaps = 21/143 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E+  L  + H NI++   A +    +    +L+  F   G+LS +++ +  V        
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHI 126

Query: 72  LQQLGAGLEILNSH----------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
            + +  GL  L+             I HRD+K +N+L   L +++   IADFGL+     
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVL---LKNNLTACIADFGLALKFEA 183

Query: 122 GNYAEK---VCGSPLYMAPEVLQ 141
           G  A       G+  YMAPEVL+
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLE 206

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 95.5 bits (238), Expect = 3e-24
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 15/136 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSSYIRLHGR----VPE 65
           EL  +  V HPN++ L   F      + E  + LV+E+     +    R + +    +P 
Sbjct: 82  ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPM 140

Query: 66  QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-Y 124
              + ++ QL   L  ++S  I HRD+KP+N+LL       +LK+ DFG +  L  G   
Sbjct: 141 LLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG--VLKLIDFGSAKILIAGEPN 198

Query: 125 AEKVCGSPLYMAPEVL 140
              +C S  Y APE++
Sbjct: 199 VSYIC-SRYYRAPELI 213

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 95.5 bits (237), Expect = 4e-24
 Identities = 20/143 (13%), Positives = 45/143 (31%), Gaps = 13/143 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI--FLVVEFCAG------GNLSSYIRLHGRVPEQT 67
             + +       +IR+    +    +  F +              L S+   H  +    
Sbjct: 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA 212

Query: 68  ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE- 126
             +   Q+   L  L+ + ++H  L+P +I+   LD    + +  F           +  
Sbjct: 213 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIV---LDQRGGVFLTGFEHLVRDGASAVSPI 269

Query: 127 -KVCGSPLYMAPEVLQFQRYDEK 148
            +    P   A  +L F ++   
Sbjct: 270 GRGFAPPETTAERMLPFGQHHPT 292

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 96.0 bits (239), Expect = 4e-24
 Identities = 39/138 (28%), Positives = 65/138 (47%), Gaps = 9/138 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  V          
Sbjct: 266 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 325

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           Q+ + +E L   + IHR+L   N L+    ++ ++K+ADFGLS  L  G+      G+  
Sbjct: 326 QISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLS-RLMTGDTYTAHAGAKF 381

Query: 134 ---YMAPEVLQFQRYDEK 148
              + APE L + ++  K
Sbjct: 382 PIKWTAPESLAYNKFSIK 399

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 93.0 bits (232), Expect = 4e-24
 Identities = 37/133 (27%), Positives = 67/133 (50%), Gaps = 6/133 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E   +  ++HP +++ +     E  I++V E+ + G L +Y+R HG+ +      +    
Sbjct: 53  EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-PL 133
           +  G+  L SH  IHRDL   N L+     D+ +K++DFG++  +    Y   V    P+
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCLVD---RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV 169

Query: 134 -YMAPEVLQFQRY 145
            + APEV  + +Y
Sbjct: 170 KWSAPEVFHYFKY 182

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 93.0 bits (232), Expect = 5e-24
 Identities = 37/133 (27%), Positives = 63/133 (47%), Gaps = 6/133 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  I LV EF   G LS Y+R   G    +T       
Sbjct: 53  EAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 112

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-PL 133
           +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  +    Y        P+
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 169

Query: 134 -YMAPEVLQFQRY 145
            + +PEV  F RY
Sbjct: 170 KWASPEVFSFSRY 182

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 95.7 bits (238), Expect = 5e-24
 Identities = 35/152 (23%), Positives = 70/152 (46%), Gaps = 14/152 (9%)

Query: 7   KHLKSCLDCELNFLS------SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           K LK        FL        + H  +++L+     E  I++V E+ + G+L  +++  
Sbjct: 297 KTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGE 355

Query: 61  GRVPEQTAR--KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
                +  +      Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  
Sbjct: 356 TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARL 412

Query: 119 LYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEK 148
           +    Y  +     P+ + APE   + R+  K
Sbjct: 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 93.5 bits (233), Expect = 6e-24
 Identities = 38/141 (26%), Positives = 66/141 (46%), Gaps = 10/141 (7%)

Query: 15  CELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKF 71
            E+  L ++ H NI++          N I L++EF   G+L  Y+  +  ++  +   K+
Sbjct: 72  KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY 131

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVC 129
             Q+  G++ L S   +HRDL   N+L+     +  +KI DFGL+  +      Y  K  
Sbjct: 132 AVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTKAIETDKEYYTVKDD 188

Query: 130 G-SPL-YMAPEVLQFQRYDEK 148
             SP+ + APE L   ++   
Sbjct: 189 RDSPVFWYAPECLMQSKFYIA 209

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 93.5 bits (233), Expect = 7e-24
 Identities = 46/154 (29%), Positives = 70/154 (45%), Gaps = 24/154 (15%)

Query: 16  ELNFLSSV-NHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLH------------- 60
           EL  L  + +H N++ L  A  +    + ++VEFC  GNLS+Y+R               
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139

Query: 61  GRVPEQTARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
                 T    +    Q+  G+E L S   IHRDL   NILLS   +  ++KI DFGL+ 
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLAR 196

Query: 118 TLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEK 148
            +Y      +   + L   +MAPE +  + Y  +
Sbjct: 197 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 230

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 92.8 bits (231), Expect = 1e-23
 Identities = 41/140 (29%), Positives = 70/140 (50%), Gaps = 10/140 (7%)

Query: 15  CELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
            E++ L ++ H +II+            + LV+E+   G+L  Y+  H  +       F 
Sbjct: 82  QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFA 140

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-- 130
           QQ+  G+  L++ H IHRDL   N+LL    +D ++KI DFGL+  +  G+   +V    
Sbjct: 141 QQICEGMAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLAKAVPEGHEYYRVREDG 197

Query: 131 -SPL-YMAPEVLQFQRYDEK 148
            SP+ + APE L+  ++   
Sbjct: 198 DSPVFWYAPECLKEYKFYYA 217

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 92.3 bits (230), Expect = 1e-23
 Identities = 39/135 (28%), Positives = 64/135 (47%), Gaps = 9/135 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 71  EVNAMHSLDHRNLIRLY-GVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPL 133
           +  G+  L S   IHRDL   N+LL+      ++KI DFGL   L    ++        +
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186

Query: 134 ---YMAPEVLQFQRY 145
              + APE L+ + +
Sbjct: 187 PFAWCAPESLKTRTF 201

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 94.1 bits (234), Expect = 2e-23
 Identities = 31/137 (22%), Positives = 67/137 (48%), Gaps = 8/137 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
           E   +  + H  +++L+     E  I++V E+ + G+L  +++       +  +      
Sbjct: 229 EAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-P 132
           Q+ +G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y  +     P
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 344

Query: 133 L-YMAPEVLQFQRYDEK 148
           + + APE   + R+  K
Sbjct: 345 IKWTAPEAALYGRFTIK 361

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 91.9 bits (229), Expect = 2e-23
 Identities = 38/134 (28%), Positives = 69/134 (51%), Gaps = 8/134 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E N +  +++P I+R+    +AE+   LV+E    G L+ Y++ +  V ++   + + Q+
Sbjct: 68  EANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 126

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS--P 132
             G++ L   + +HRDL   N+LL         KI+DFGLS  L    NY +       P
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKAQTHGKWP 183

Query: 133 L-YMAPEVLQFQRY 145
           + + APE + + ++
Sbjct: 184 VKWYAPECINYYKF 197

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 92.3 bits (230), Expect = 2e-23
 Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 30/160 (18%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E N L  VNHP++I+L+ A   +  + L+VE+   G+L  ++R   +V            
Sbjct: 76  EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135

Query: 67  ------------TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
                       T    +    Q+  G++ L    ++HRDL   NIL++  +   M KI+
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA--EGRKM-KIS 192

Query: 112 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEK 148
           DFGLS  +Y  +   K     +   +MA E L    Y  +
Sbjct: 193 DFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ 232

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 91.9 bits (229), Expect = 2e-23
 Identities = 34/135 (25%), Positives = 65/135 (48%), Gaps = 10/135 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
           E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    +     +      
Sbjct: 58  EANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
           Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +    Y  +  G+  
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTARE-GAKF 172

Query: 134 ---YMAPEVLQFQRY 145
              + APE + +  +
Sbjct: 173 PIKWTAPEAINYGTF 187

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 91.1 bits (227), Expect = 3e-23
 Identities = 39/148 (26%), Positives = 71/148 (47%), Gaps = 12/148 (8%)

Query: 7   KHLKSCLDCELNFLS------SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           K +K     E  F+       +++H  +++L+     +  IF++ E+ A G L +Y+R  
Sbjct: 54  KMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM 113

Query: 61  -GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
             R   Q   +  + +   +E L S   +HRDL   N L++   D  ++K++DFGLS  +
Sbjct: 114 RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYV 170

Query: 120 YPGNYAEKVCGS-PL-YMAPEVLQFQRY 145
               Y   V    P+ +  PEVL + ++
Sbjct: 171 LDDEYTSSVGSKFPVRWSPPEVLMYSKF 198

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 93.8 bits (233), Expect = 3e-23
 Identities = 36/133 (27%), Positives = 67/133 (50%), Gaps = 7/133 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +   +HP+I++L         +++++E C  G L S++++    +   +   +  Q
Sbjct: 441 EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-SPL 133
           L   L  L S   +HRD+   N+L+S    +  +K+ DFGLS  +    Y +   G  P+
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556

Query: 134 -YMAPEVLQFQRY 145
            +MAPE + F+R+
Sbjct: 557 KWMAPESINFRRF 569

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 91.6 bits (228), Expect = 4e-23
 Identities = 39/135 (28%), Positives = 66/135 (48%), Gaps = 8/135 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL           +V E+   G+L +++R H G+         L+ 
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRG 159

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--- 131
           +GAG+  L+    +HRDL   N+L+     +++ K++DFGLS  L     A         
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216

Query: 132 PL-YMAPEVLQFQRY 145
           P+ + APE + F+ +
Sbjct: 217 PIRWTAPEAIAFRTF 231

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 90.8 bits (226), Expect = 5e-23
 Identities = 36/133 (27%), Positives = 67/133 (50%), Gaps = 7/133 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +   +HP+I++L         +++++E C  G L S++++    +   +   +  Q
Sbjct: 66  EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 124

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-SPL 133
           L   L  L S   +HRD+   N+L+S    +  +K+ DFGLS  +    Y +   G  P+
Sbjct: 125 LSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 181

Query: 134 -YMAPEVLQFQRY 145
            +MAPE + F+R+
Sbjct: 182 KWMAPESINFRRF 194

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 91.3 bits (227), Expect = 5e-23
 Identities = 37/140 (26%), Positives = 63/140 (45%), Gaps = 10/140 (7%)

Query: 16  ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFL 72
           E+  L +++   I++            + LV+E+   G L  +++ H  R+       + 
Sbjct: 74  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 133

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCG- 130
            Q+  G+E L S   +HRDL   NIL+     +  +KIADFGL+  L    +Y       
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAKLLPLDKDYYVVREPG 190

Query: 131 -SPL-YMAPEVLQFQRYDEK 148
            SP+ + APE L    +  +
Sbjct: 191 QSPIFWYAPESLSDNIFSRQ 210

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 90.8 bits (226), Expect = 6e-23
 Identities = 46/172 (26%), Positives = 69/172 (40%), Gaps = 28/172 (16%)

Query: 1   MLKKLNKHLKSCLD--CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           MLK  + HL        EL  LS + NH NI+ L  A        ++ E+C  G+L +++
Sbjct: 60  MLKP-SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 118

Query: 58  R---------------LHGRVPEQTARKFLQ---QLGAGLEILNSHHIIHRDLKPENILL 99
           R               +            L    Q+  G+  L S + IHRDL   NILL
Sbjct: 119 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178

Query: 100 SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEK 148
           +     +  KI DFGL+  +   +       + L   +MAPE +    Y  +
Sbjct: 179 T--HGRIT-KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE 227

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 92.5 bits (230), Expect = 6e-23
 Identities = 37/137 (27%), Positives = 68/137 (49%), Gaps = 8/137 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
           E N + ++ H  +++L  A   +  I+++ EF A G+L  +++      +   +   F  
Sbjct: 233 EANVMKTLQHDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 291

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-P 132
           Q+  G+  +   + IHRDL+  NIL+S     ++ KIADFGL+  +    Y  +     P
Sbjct: 292 QIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDNEYTAREGAKFP 348

Query: 133 L-YMAPEVLQFQRYDEK 148
           + + APE + F  +  K
Sbjct: 349 IKWTAPEAINFGSFTIK 365

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 90.9 bits (226), Expect = 7e-23
 Identities = 41/141 (29%), Positives = 67/141 (47%), Gaps = 10/141 (7%)

Query: 15  CELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKF 71
            E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+      ++
Sbjct: 91  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 150

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVC 129
             Q+  G+E L +   IHRDL   NIL+    ++  +KI DFGL+  L      Y  K  
Sbjct: 151 TSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTKVLPQDKEYYKVKEP 207

Query: 130 G-SPL-YMAPEVLQFQRYDEK 148
           G SP+ + APE L   ++   
Sbjct: 208 GESPIFWYAPESLTESKFSVA 228

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 90.4 bits (225), Expect = 7e-23
 Identities = 40/141 (28%), Positives = 67/141 (47%), Gaps = 10/141 (7%)

Query: 15  CELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKF 71
            E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+      ++
Sbjct: 60  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 119

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVC 129
             Q+  G+E L +   IHRDL   NIL+    ++  +KI DFGL+  L      +  K  
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTKVLPQDKEFFKVKEP 176

Query: 130 G-SPL-YMAPEVLQFQRYDEK 148
           G SP+ + APE L   ++   
Sbjct: 177 GESPIFWYAPESLTESKFSVA 197

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 90.8 bits (226), Expect = 8e-23
 Identities = 40/176 (22%), Positives = 76/176 (43%), Gaps = 31/176 (17%)

Query: 1   MLKK-LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           MLK+  +  +++    E   ++  ++PNI++L         + L+ E+ A G+L+ ++R 
Sbjct: 84  MLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRS 143

Query: 60  HGRVPEQTAR------------------------KFLQQLGAGLEILNSHHIIHRDLKPE 95
                  +                             +Q+ AG+  L+    +HRDL   
Sbjct: 144 MSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203

Query: 96  NILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEK 148
           N L+   ++ V+ KIADFGLS  +Y  +Y +      +   +M PE + + RY  +
Sbjct: 204 NCLVG--ENMVV-KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE 256

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 90.9 bits (226), Expect = 1e-22
 Identities = 50/159 (31%), Positives = 75/159 (47%), Gaps = 17/159 (10%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
           +KKL++  ++         EL  +  VNH NII L + F  +        +++V+E    
Sbjct: 55  IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MD 113

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            NL   I++   +  +     L Q+  G++ L+S  IIHRDLKP NI+   +  D  LKI
Sbjct: 114 ANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV---VKSDCTLKI 168

Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149
            DFGL+ T            +  Y APEV+    Y E V
Sbjct: 169 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 207

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 91.1 bits (226), Expect = 2e-22
 Identities = 51/159 (32%), Positives = 74/159 (46%), Gaps = 17/159 (10%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
           +KKL++  ++         EL  +  VNH NII L + F  +        ++LV+E    
Sbjct: 92  IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-MD 150

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            NL   I+    +  +     L Q+  G++ L+S  IIHRDLKP NI+   +  D  LKI
Sbjct: 151 ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV---VKSDCTLKI 205

Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149
            DFGL+ T            +  Y APEV+    Y E V
Sbjct: 206 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 244

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 90.1 bits (224), Expect = 2e-22
 Identities = 35/136 (25%), Positives = 67/136 (49%), Gaps = 8/136 (5%)

Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +   +HPNIIRL         + +V E+   G+L S++R H  +         L+
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154

Query: 74  QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSP 132
            + +G++ L+    +HRDL   NIL++    +++ K++DFGL   L     A     G  
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211

Query: 133 L---YMAPEVLQFQRY 145
           +   + +PE + ++++
Sbjct: 212 IPIRWTSPEAIAYRKF 227

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 88.8 bits (221), Expect = 2e-22
 Identities = 36/135 (26%), Positives = 61/135 (45%), Gaps = 9/135 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  +++P I+RL         + LV+E   GG L  ++      +P     + L Q
Sbjct: 60  EAQIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPL 133
           +  G++ L   + +HRDL   N+LL    +    KI+DFGLS  L    +Y         
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKW 175

Query: 134 ---YMAPEVLQFQRY 145
              + APE + F+++
Sbjct: 176 PLKWYAPECINFRKF 190

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 89.3 bits (222), Expect = 3e-22
 Identities = 35/135 (25%), Positives = 64/135 (47%), Gaps = 8/135 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +   +H NIIRL         + ++ E+   G L  ++R   G          L+ 
Sbjct: 96  EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC-GSPL 133
           + AG++ L + + +HRDL   NIL++    +++ K++DFGLS  L     A     G  +
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212

Query: 134 ---YMAPEVLQFQRY 145
              + APE + ++++
Sbjct: 213 PIRWTAPEAISYRKF 227

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 88.4 bits (220), Expect = 3e-22
 Identities = 34/134 (25%), Positives = 67/134 (50%), Gaps = 9/134 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   + +++HP+I++L    + E   ++++E    G L  Y+  +   +   T   +  Q
Sbjct: 63  EAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
           +   +  L S + +HRD+   NIL++       +K+ DFGLS  +   +Y  K   + L 
Sbjct: 122 ICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLSRYIEDEDY-YKASVTRLP 177

Query: 134 --YMAPEVLQFQRY 145
             +M+PE + F+R+
Sbjct: 178 IKWMSPESINFRRF 191

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 89.3 bits (222), Expect = 4e-22
 Identities = 42/161 (26%), Positives = 66/161 (40%), Gaps = 30/161 (18%)

Query: 15  CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------------- 60
            EL  ++ + +H NI+ L  A      I+L+ E+C  G+L +Y+R               
Sbjct: 97  SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156

Query: 61  -------GRVPEQTARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
                    +   T    L    Q+  G+E L     +HRDL   N+L++     V+ KI
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT--HGKVV-KI 213

Query: 111 ADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEK 148
            DFGL+  +   +       + L   +MAPE L    Y  K
Sbjct: 214 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 254

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 87.7 bits (218), Expect = 8e-22
 Identities = 29/151 (19%), Positives = 72/151 (47%), Gaps = 11/151 (7%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +L K +++         + +S ++H +++  +      +   LV EF   G+L +Y++ +
Sbjct: 47  VLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN 106

Query: 61  -GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD-----DDVMLKIADFG 114
              +      +  +QL A +  L  + +IH ++  +NILL   +     +   +K++D G
Sbjct: 107 KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG 166

Query: 115 LSCTLYPGNYAEKVCGSPL-YMAPEVLQFQR 144
           +S T+ P +  ++     + ++ PE ++  +
Sbjct: 167 ISITVLPKDILQE----RIPWVPPECIENPK 193

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 88.2 bits (219), Expect = 1e-21
 Identities = 51/168 (30%), Positives = 79/168 (47%), Gaps = 35/168 (20%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
           +KKL +  +S L       EL  L  + H N+I L D F  +         +LV+ F  G
Sbjct: 55  IKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF-MG 113

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L   ++ H ++ E   +  + Q+  GL  +++  IIHRDLKP N+    +++D  LKI
Sbjct: 114 TDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA---VNEDCELKI 169

Query: 111 ADFGLSCTLYPGNYAEKVCGSPL--------YMAPEV-LQFQRYDEKV 149
            DFGL+          +   S +        Y APEV L + RY + V
Sbjct: 170 LDFGLA----------RQADSEMTGYVVTRWYRAPEVILNWMRYTQTV 207

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 87.7 bits (218), Expect = 1e-21
 Identities = 43/154 (27%), Positives = 63/154 (40%), Gaps = 26/154 (16%)

Query: 15  CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR---- 69
            EL  L  + +HPNII L  A +    ++L +E+   GNL  ++R    +    A     
Sbjct: 74  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133

Query: 70  ------------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
                        F   +  G++ L+    IHRDL   NIL+    ++ + KIADFGLS 
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSR 190

Query: 118 TLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEK 148
                    K     L   +MA E L +  Y   
Sbjct: 191 G---QEVYVKKTMGRLPVRWMAIESLNYSVYTTN 221

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 87.7 bits (218), Expect = 1e-21
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 23/153 (15%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ-------- 66
           E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R       +        
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149

Query: 67  -----TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
                T +  +    QL  G+E L S   IHRDL   N+L++   ++ ++KIADFGL+  
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARD 206

Query: 119 LYPGNYAEKVCGSPL---YMAPEVLQFQRYDEK 148
           +   +Y +K     L   +MAPE L  + Y  +
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 239

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 88.2 bits (219), Expect = 1e-21
 Identities = 46/153 (30%), Positives = 74/153 (48%), Gaps = 23/153 (15%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ-------- 66
           E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R       +        
Sbjct: 136 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 195

Query: 67  -----TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
                T +  +    QL  G+E L S   IHRDL   N+L++  +++VM KIADFGL+  
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT--ENNVM-KIADFGLARD 252

Query: 119 LYPGNYAEKVCGSPL---YMAPEVLQFQRYDEK 148
           +   +Y +K     L   +MAPE L  + Y  +
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 285

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 88.8 bits (220), Expect = 2e-21
 Identities = 35/135 (25%), Positives = 61/135 (45%), Gaps = 9/135 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  +++P I+RL         + LV+E   GG L  ++      +P     + L Q
Sbjct: 386 EAQIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 444

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPL 133
           +  G++ L   + +HR+L   N+LL    +    KI+DFGLS  L    +Y         
Sbjct: 445 VSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKW 501

Query: 134 ---YMAPEVLQFQRY 145
              + APE + F+++
Sbjct: 502 PLKWYAPECINFRKF 516

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 88.3 bits (219), Expect = 2e-21
 Identities = 33/125 (26%), Positives = 65/125 (52%), Gaps = 14/125 (11%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
           +KK+ +  +  +DC     E+  L+ +NH +++++ D    ++      +++V+E  A  
Sbjct: 83  IKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEI-ADS 141

Query: 52  NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
           +     R    + E   +  L  L  G++ ++S  I+HRDLKP N L   ++ D  +K+ 
Sbjct: 142 DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL---VNQDCSVKVC 198

Query: 112 DFGLS 116
           DFGL+
Sbjct: 199 DFGLA 203

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 87.0 bits (216), Expect = 3e-21
 Identities = 42/153 (27%), Positives = 75/153 (49%), Gaps = 23/153 (15%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ-------- 66
           E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y++       +        
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183

Query: 67  -----TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
                +++  +    Q+  G+E L S   IHRDL   N+L++   +D ++KIADFGL+  
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARD 240

Query: 119 LYPGNYAEKVCGSPL---YMAPEVLQFQRYDEK 148
           ++  +Y +K     L   +MAPE L  + Y  +
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ 273

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 87.0 bits (216), Expect = 3e-21
 Identities = 46/160 (28%), Positives = 77/160 (48%), Gaps = 20/160 (12%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F   +        +LV+ F   
Sbjct: 54  IKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF-MQ 112

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L   +    +  E+  +  + Q+  GL+ ++S  ++HRDLKP N+    +++D  LKI
Sbjct: 113 TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLA---VNEDCELKI 167

Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKV 149
            DFGL+           V  +  Y APEV L +  Y++ V
Sbjct: 168 LDFGLARHADA-EMTGYV-VTRWYRAPEVILSWMHYNQTV 205

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 87.1 bits (216), Expect = 5e-21
 Identities = 45/182 (24%), Positives = 76/182 (41%), Gaps = 38/182 (20%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
           +KK+N+  +  +DC     E+  L+ +    IIRL+D    ++      +++V+E  A  
Sbjct: 56  IKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI-ADS 114

Query: 52  NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
           +L    +    + E+  +  L  L  G   ++   IIHRDLKP N L   L+ D  +K+ 
Sbjct: 115 DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCL---LNQDCSVKVC 171

Query: 112 DFGLSCTLYPGNYAEKVCGSPL-----------------------YMAPEV-LQFQRYDE 147
           DFGL+ T+        V                            Y APE+ L  + Y +
Sbjct: 172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTK 231

Query: 148 KV 149
            +
Sbjct: 232 SI 233

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 86.1 bits (214), Expect = 5e-21
 Identities = 35/142 (24%), Positives = 67/142 (47%), Gaps = 24/142 (16%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYI-RLHGRVPEQ 66
           E+  L  + H N++ L +  + +          I+LV +FC   +L+  +  +  +    
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS 124

Query: 67  TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
             ++ +Q L  GL  ++ + I+HRD+K  N+L   +  D +LK+ADFGL+   +  + A+
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVL---ITRDGVLKLADFGLA-RAF--SLAK 178

Query: 127 KVCGSPL--------YMAPEVL 140
               +          Y  PE+L
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELL 200

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 85.4 bits (212), Expect = 8e-21
 Identities = 34/127 (26%), Positives = 59/127 (46%), Gaps = 10/127 (7%)

Query: 24  NHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81
             PNII L D  +        LV E     +     +    + +   R ++ ++   L+ 
Sbjct: 89  GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDY 145

Query: 82  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVL 140
            +S  I+HRD+KP N+++        L++ D+GL+   +PG  Y  +V  S  +  PE+L
Sbjct: 146 CHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELL 202

Query: 141 -QFQRYD 146
             +Q YD
Sbjct: 203 VDYQMYD 209

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 85.0 bits (211), Expect = 2e-20
 Identities = 38/170 (22%), Positives = 70/170 (41%), Gaps = 28/170 (16%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
           +KK+       L       E+  L    H NII +F+  + ++      ++++ E     
Sbjct: 41  IKKIEP-FDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL-MQT 98

Query: 52  NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
           +L   I     + +   + F+ Q    +++L+  ++IHRDLKP N+L   ++ +  LK+ 
Sbjct: 99  DLHRVIS-TQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLL---INSNCDLKVC 154

Query: 112 DFGLSCTLYPGNYAEKVCGSPL-----------YMAPEV-LQFQRYDEKV 149
           DFGL+  +                         Y APEV L   +Y   +
Sbjct: 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM 204

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 84.6 bits (210), Expect = 2e-20
 Identities = 43/149 (28%), Positives = 67/149 (44%), Gaps = 19/149 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQA-------ENCIFLVVEFCAGGNLSSYIRLHGR----VP 64
            +  L+ ++HPNI++L   F         +  + +V+E+     L    R + R     P
Sbjct: 69  IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPP 127

Query: 65  EQTARKFLQQLGAGLEIL--NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
               + FL QL   +  L   S ++ HRD+KP N+L++  D    LK+ DFG +  L P 
Sbjct: 128 PILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT--LKLCDFGSAKKLSPS 185

Query: 123 N-YAEKVCGSPLYMAPEV-LQFQRYDEKV 149
                 +C S  Y APE+    Q Y   V
Sbjct: 186 EPNVAYIC-SRYYRAPELIFGNQHYTTAV 213

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 84.7 bits (210), Expect = 2e-20
 Identities = 45/168 (26%), Positives = 79/168 (47%), Gaps = 35/168 (20%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F           ++LV     G
Sbjct: 59  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-MG 117

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 118 ADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLA---VNEDCELKI 173

Query: 111 ADFGLSCTLYPGNYAEKVCGSPL--------YMAPEV-LQFQRYDEKV 149
            DFGL+          +     +        Y APE+ L +  Y++ V
Sbjct: 174 LDFGLA----------RHTADEMTGYVATRWYRAPEIMLNWMHYNQTV 211

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 83.1 bits (206), Expect = 9e-20
 Identities = 43/167 (25%), Positives = 73/167 (43%), Gaps = 29/167 (17%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
           +KK++   +    C     E+  L    H NII + D  +A        +++V +     
Sbjct: 57  IKKISP-FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL-MET 114

Query: 52  NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
           +L   ++    +       FL Q+  GL+ ++S +++HRDLKP N+L   L+    LKI 
Sbjct: 115 DLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLL---LNTTCDLKIC 170

Query: 112 DFGLSCTLYPGNYAEKVCGSPL--------YMAPEV-LQFQRYDEKV 149
           DFGL+    P    +      L        Y APE+ L  + Y + +
Sbjct: 171 DFGLARVADP----DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 213

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 83.2 bits (206), Expect = 1e-19
 Identities = 42/179 (23%), Positives = 79/179 (44%), Gaps = 36/179 (20%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVN-HPNIIRLFDAFQAENC--IFLVVEFCAGGNL 53
           +KK+    ++  D      E+  L+ ++ H NI+ L +  +A+N   ++LV ++    +L
Sbjct: 39  VKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDY-METDL 97

Query: 54  SSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
            + IR    +     +  + QL   ++ L+S  ++HRD+KP NIL   L+ +  +K+ADF
Sbjct: 98  HAVIR-ANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNIL---LNAECHVKVADF 153

Query: 114 GLSCTLYPGNYAEKVCGSPL----------------------YMAPEV-LQFQRYDEKV 149
           GLS +              +                      Y APE+ L   +Y + +
Sbjct: 154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI 212

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 82.3 bits (204), Expect = 1e-19
 Identities = 39/157 (24%), Positives = 76/157 (48%), Gaps = 31/157 (19%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC--------------IFLVVEFCAGGNLSSYIRLHG 61
           E+  +  ++H NI+++F+                     +++V E+    +L++ +   G
Sbjct: 58  EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-METDLANVLE-QG 115

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
            + E+ AR F+ QL  GL+ ++S +++HRDLKP N+ ++   +D++LKI DFGL+  + P
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLVLKIGDFGLARIMDP 173

Query: 122 GNYAEKVCGSPL--------YMAPEV-LQFQRYDEKV 149
                      L        Y +P + L    Y + +
Sbjct: 174 ----HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAI 206

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 82.7 bits (205), Expect = 1e-19
 Identities = 41/142 (28%), Positives = 65/142 (45%), Gaps = 13/142 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGRVP--EQTA 68
           E+  L+  +HPNI+ L D F          ++LV E     +L+  I    R+    Q  
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-MRTDLAQVIH-DQRIVISPQHI 136

Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
           + F+  +  GL +L+   ++HRDL P NIL   L D+  + I DF L+            
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNIL---LADNNDITICDFNLAREDTADANKTHY 193

Query: 129 CGSPLYMAPEV-LQFQRYDEKV 149
                Y APE+ +QF+ + + V
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLV 215

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 80.9 bits (200), Expect = 2e-19
 Identities = 23/114 (20%), Positives = 39/114 (34%), Gaps = 18/114 (15%)

Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL 79
           LS ++ P + R+ D         +V E+  GG+L          P    R  +Q L A  
Sbjct: 85  LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD-TSPSPVGAIR-AMQSLAAAA 142

Query: 80  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG-------------LSCTLY 120
           +  +   +      P  + +S  D DV   +A                +  +LY
Sbjct: 143 DAAHRAGVALSIDHPSRVRVSI-DGDV--VLAYPATMPDANPQDDIRGIGASLY 193

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 81.7 bits (202), Expect = 3e-19
 Identities = 43/192 (22%), Positives = 75/192 (39%), Gaps = 49/192 (25%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------------------------ 37
           LKK+ +  +     EL+ +  ++H NII+L D F                          
Sbjct: 37  LKKVLQDPRYKNR-ELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNG 95

Query: 38  --------------ENCIFLVVEFCAGGNLSSYIRLHGR----VPEQTARKFLQQLGAGL 79
                            + +++E+     L   ++   R    +P      ++ QL   +
Sbjct: 96  VNNHHKSVIVNPSQNKYLNVIMEYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154

Query: 80  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPE 138
             ++S  I HRD+KP+N+L++  D+   LK+ DFG +  L P       +C S  Y APE
Sbjct: 155 GFIHSLGICHRDIKPQNLLVNSKDNT--LKLCDFGSAKKLIPSEPSVAYIC-SRFYRAPE 211

Query: 139 V-LQFQRYDEKV 149
           + L    Y   +
Sbjct: 212 LMLGATEYTPSI 223

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 80.1 bits (198), Expect = 1e-18
 Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 20/159 (12%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC----IFLVVEFCAGGNLSSY 56
           +L+++N    +  D            +I++L D F  +      + +V E   G NL + 
Sbjct: 68  LLQRVNDADNTKEDSM-------GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLAL 119

Query: 57  IRL--HGRVPEQTARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDD---DVMLKI 110
           I+   H  +P    ++  +QL  GL+ ++    IIH D+KPEN+L+  +D     + +KI
Sbjct: 120 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKI 179

Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149
           AD G +C  +   +      +  Y +PEVL    +    
Sbjct: 180 ADLGNAC--WYDEHYTNSIQTREYRSPEVLLGAPWGCGA 216

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 78.0 bits (193), Expect = 4e-18
 Identities = 42/133 (31%), Positives = 64/133 (48%), Gaps = 16/133 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS   HP+++ L       N + L+ ++   GNL  +  L+G      +  + Q+L
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH--LYGSDLPTMSMSWEQRL 142

Query: 76  ----GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--- 126
               GA  GL  L++  IIHRD+K  NIL   LD++ + KI DFG+S             
Sbjct: 143 EICIGAARGLHYLHTRAIIHRDVKSINIL---LDENFVPKITDFGIS-KKGTELDQTHLS 198

Query: 127 -KVCGSPLYMAPE 138
             V G+  Y+ PE
Sbjct: 199 TVVKGTLGYIDPE 211

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 78.2 bits (193), Expect = 7e-18
 Identities = 46/151 (30%), Positives = 62/151 (41%), Gaps = 18/151 (11%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +L+ L K  K             N  N+I + + F   N I +  E     NL   I+ +
Sbjct: 146 ILEHLRKQDKD------------NTMNVIHMLENFTFRNHICMTFE-LLSMNLYELIKKN 192

Query: 61  G--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
                     RKF   +   L+ L+ + IIH DLKPENILL        +K+ DFG SC 
Sbjct: 193 KFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ-QGRSGIKVIDFGSSC- 250

Query: 119 LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149
            Y          S  Y APEV+   RY   +
Sbjct: 251 -YEHQRVYTYIQSRFYRAPEVILGARYGMPI 280

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 75.1 bits (185), Expect = 7e-17
 Identities = 49/153 (32%), Positives = 61/153 (39%), Gaps = 20/153 (13%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +L+ +NKH                   I+ L   F   N + LV E     NL   +R  
Sbjct: 103 LLELMNKHDTE------------MKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNT 149

Query: 61  GRVP--EQTARKFLQQLGAGLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
                     RKF QQ+   L  L +    IIH DLKPENILL        +KI DFG S
Sbjct: 150 NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSS 208

Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149
           C    G    +   S  Y +PEVL    YD  +
Sbjct: 209 C--QLGQRIYQYIQSRFYRSPEVLLGMPYDLAI 239

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 71.0 bits (175), Expect = 1e-15
 Identities = 38/139 (27%), Positives = 56/139 (40%), Gaps = 29/139 (20%)

Query: 16  ELNFLSSVNHPNIIRL--FDAFQAENCI-----FLVVEFCAGGNLSSYIRLHGRVPEQT- 67
           E+  ++   H N++ L  F               LV  +   G+L    RL         
Sbjct: 80  EIKVMAKCQHENLVELLGF-------SSDGDDLCLVYVYMPNGSLLD--RLSCLDGTPPL 130

Query: 68  --ARKFLQQLGA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
               +     GA  G+  L+ +H IHRD+K  NIL   LD+    KI+DFGL+       
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL---LDEAFTAKISDFGLA-RASEKF 186

Query: 124 YAE----KVCGSPLYMAPE 138
                  ++ G+  YMAPE
Sbjct: 187 AQTVMTSRIVGTTAYMAPE 205

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 70.7 bits (174), Expect = 2e-15
 Identities = 41/137 (29%), Positives = 60/137 (43%), Gaps = 22/137 (16%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA----RKF 71
           E+  +S   H N++RL           LV  + A G+++S   L  R   Q      ++ 
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS--CLRERPESQPPLDWPKRQ 134

Query: 72  LQQLGA--GLEILNSH-----HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
              LG+  GL  L  H      IIHRD+K  NIL   LD++    + DFGL+  L     
Sbjct: 135 RIALGSARGLAYL--HDHCDPKIIHRDVKAANIL---LDEEFEAVVGDFGLA-KLMDYKD 188

Query: 125 AE---KVCGSPLYMAPE 138
                 V G+  ++APE
Sbjct: 189 THVTTAVRGTIGHIAPE 205

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 70.4 bits (173), Expect = 3e-15
 Identities = 33/158 (20%), Positives = 59/158 (37%), Gaps = 33/158 (20%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +LKK+ +  K             N    + + D F     + +  E   G N   +++ +
Sbjct: 69  VLKKIKEKDKE------------NKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKEN 115

Query: 61  GRV--PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVM----------- 107
                P    R    QL   L  L+ + + H DLKPENIL    + + +           
Sbjct: 116 NFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175

Query: 108 -----LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL 140
                +++ADFG +   +   +   +  +  Y  PEV+
Sbjct: 176 VKNTSIRVADFGSAT--FDHEHHTTIVATRHYRPPEVI 211

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 69.2 bits (170), Expect = 6e-15
 Identities = 34/158 (21%), Positives = 62/158 (39%), Gaps = 33/158 (20%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +L+ LN    +            +    +++ + F+    I +V E   G +   +I+ +
Sbjct: 64  VLEHLNTTDPN------------STFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKEN 110

Query: 61  GRV--PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL----------------SGL 102
           G +       RK   Q+   +  L+S+ + H DLKPENIL                    
Sbjct: 111 GFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170

Query: 103 DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL 140
             +  +K+ DFG +   Y   +   +  +  Y APEV+
Sbjct: 171 LINPDIKVVDFGSAT--YDDEHHSTLVSTRHYRAPEVI 206

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 67.3 bits (165), Expect = 3e-14
 Identities = 32/154 (20%), Positives = 56/154 (36%), Gaps = 32/154 (20%)

Query: 16  ELNFLSSVNH-----PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTA 68
           E + L  + +      NI++    F   + + L+ E   G +L   I  +       +  
Sbjct: 81  EADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDI 139

Query: 69  RKFLQQLGAGLEILNSHHIIHRDLKPENILL----------------------SGLDDDV 106
           + +  ++   L  L    + H DLKPENILL                             
Sbjct: 140 KLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199

Query: 107 MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL 140
            +K+ DFG +   +  +Y   +  +  Y APEV+
Sbjct: 200 GIKLIDFGCAT--FKSDYHGSIINTRQYRAPEVI 231

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 64.6 bits (157), Expect = 4e-13
 Identities = 28/82 (34%), Positives = 42/82 (51%), Gaps = 6/82 (7%)

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
            +  Q+  G+E L S   IHRDL   NILLS   +  ++KI DFGL+  +Y      +  
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRKG 253

Query: 130 GSPL---YMAPEVLQFQRYDEK 148
            + L   +MAPE +  + Y  +
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQ 275

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 40.3 bits (94), Expect = 8e-05
 Identities = 28/136 (20%), Positives = 47/136 (34%), Gaps = 7/136 (5%)

Query: 1   MLKK-LNKHLKSCLDCELNFLSSV-NHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+         L  EL  L  + +H N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 59  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 118

Query: 58  RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
           R           K  +      +  +    I  DLK     ++           +     
Sbjct: 119 RSKRNEFVPYKTKGARF----RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174

Query: 118 TLYPGNYAEKVCGSPL 133
            +      E +    L
Sbjct: 175 DVEEEEAPEDLYKDFL 190

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 58.6 bits (142), Expect = 4e-11
 Identities = 26/117 (22%), Positives = 50/117 (42%), Gaps = 3/117 (2%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRL-FDAFQAENCIFLVVEFCAGGNLSSYIRL 59
             +++ K        E   L  +  P         F+  +  F+V+E   G +L      
Sbjct: 86  FYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ 144

Query: 60  HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           +G   + T  +   ++   LE ++ +  +H D+K  N+LL G  +   + +AD+GLS
Sbjct: 145 NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL-GYKNPDQVYLADYGLS 200

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 56.5 bits (136), Expect = 2e-10
 Identities = 38/125 (30%), Positives = 59/125 (47%), Gaps = 22/125 (17%)

Query: 2   LK--KLNKHLKSCLDCELNFLSSV-----NHPN---IIRLFDAFQAEN------CIFLVV 45
           +K  K  +H       E+  L SV     N PN   +++L D F+         C  +V 
Sbjct: 67  MKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC--MVF 124

Query: 46  EFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGL 102
           E   G +L  +I    +  +P    +K +QQ+  GL+ L++   IIH D+KPENILLS  
Sbjct: 125 EV-LGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN 183

Query: 103 DDDVM 107
           +  + 
Sbjct: 184 EQYIR 188

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 54.4 bits (131), Expect = 1e-09
 Identities = 23/133 (17%), Positives = 49/133 (36%), Gaps = 22/133 (16%)

Query: 4   KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI-------------------FLV 44
           K+       L  EL F      P  I+ +   +    +                   F++
Sbjct: 71  KVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMI 130

Query: 45  VEFCAGGNLSSYIRLHGRV-PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103
           ++   G +L      + +    +T  +   ++   LE ++ H  +H D+K  N+LL    
Sbjct: 131 MDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL-NYK 188

Query: 104 DDVMLKIADFGLS 116
           +   + + D+GL+
Sbjct: 189 NPDQVYLVDYGLA 201

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 51.3 bits (123), Expect = 2e-08
 Identities = 18/77 (23%), Positives = 39/77 (50%), Gaps = 4/77 (5%)

Query: 42  FLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL 99
           FLV+    G +L S + +  +  + E++  +   +L   LE L+ +  +H ++  ENI +
Sbjct: 134 FLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192

Query: 100 SGLDDDVMLKIADFGLS 116
              +D   + +A +G +
Sbjct: 193 -DPEDQSQVTLAGYGFA 208

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 50.4 bits (121), Expect = 2e-08
 Identities = 23/92 (25%), Positives = 41/92 (44%), Gaps = 2/92 (2%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILNS 84
             I  +       +   +V+E   G +L        R    +T      Q+ + +E ++S
Sbjct: 65  VGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 123

Query: 85  HHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
            + IHRD+KP+N L+       ++ I DFGL+
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 48.9 bits (116), Expect = 1e-07
 Identities = 22/94 (23%), Positives = 38/94 (40%), Gaps = 2/94 (2%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQLGAGLEIL 82
               I  +       +   LV++   G +L        R    +T      Q+   +E +
Sbjct: 61  GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119

Query: 83  NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
           +S   +HRD+KP+N L+        + I DFGL+
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 47.4 bits (113), Expect = 3e-07
 Identities = 25/94 (26%), Positives = 44/94 (46%), Gaps = 4/94 (4%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQLGAGLEILNS 84
             I +++          +V+E   G +L     L  R    +T      QL + +E ++S
Sbjct: 65  DGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS 123

Query: 85  HHIIHRDLKPENILL--SGLDDDVMLKIADFGLS 116
            ++I+RD+KPEN L+   G     ++ I DF L+
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 47.0 bits (112), Expect = 4e-07
 Identities = 22/94 (23%), Positives = 45/94 (47%), Gaps = 4/94 (4%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQLGAGLEILNS 84
             I  ++   Q      LV++   G +L   + L GR    +T     +Q+ A ++ ++ 
Sbjct: 66  TGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 124

Query: 85  HHIIHRDLKPENILL--SGLDDDVMLKIADFGLS 116
             +++RD+KP+N L+      +  M+ + DFG+ 
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 46.0 bits (108), Expect = 1e-06
 Identities = 22/88 (25%), Positives = 35/88 (39%), Gaps = 5/88 (5%)

Query: 38  ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL-NSHHIIHRDLKPEN 96
           ++ +F+V+EF  GG     +R         A+  L QL A L +   S    HRDL   N
Sbjct: 134 DDQLFIVLEFEFGGIDLEQMRTKLSSLAT-AKSILHQLTASLAVAEASLRFEHRDLHWGN 192

Query: 97  ILLSGLDDDVMLKIADFGLSCTLYPGNY 124
           +L   L    + K+       +    + 
Sbjct: 193 VL---LKKTSLKKLHYTLNGKSSTIPSC 217

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	154
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.98
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.98
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.98
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.98
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.98
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.98
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.98
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.98
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.98
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.98
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.98
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.98
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.98
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.98
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.98
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.98
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.98
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.98
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.98
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.98
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.98
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.98
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.98
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.98
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.98
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.98
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.97
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.97
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.97
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.97
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.97
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.97
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.97
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.97
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.97
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.97
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.97
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.97
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.97
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.97
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.97
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.97
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.97
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.97
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.97
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.97
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.97
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.97
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.97
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.97
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.97
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.97
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.97
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.97
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.97
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.97
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.97
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.97
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.97
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.97
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.97
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.97
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.97
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.97
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.97
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.97
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.97
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.97
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.97
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.97
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.97
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.97
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.97
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.97
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.97
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.97
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.97
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.97
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.97
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.97
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.97
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.97
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.97
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.97
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.97
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.97
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.97
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.97
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.97
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.97
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.96
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.96
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.96
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.94
3uqc_A	286	Probable conserved transmembrane protein; structur	99.93
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.69
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.46
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.32
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.16
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.05
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.7
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.62
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.6
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.49
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.03
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.0
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.68
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.07
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.05
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	96.95
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.49
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	95.84
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	95.21
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	94.27
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	94.01
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	93.91
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	92.89
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	91.76
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	91.07
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	90.6
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	88.86
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	88.73
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	88.26
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	87.61
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	86.5
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	85.31

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.2e-46  Score=260.34  Aligned_cols=144  Identities=31%  Similarity=0.559  Sum_probs=133.5

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+++++.++||||+++++++.+++.+|+||||++||+|.+++.+.+.+++..+..+++||+.|++|||++++
T Consensus        74 ~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~I  153 (311)
T 4aw0_A           74 NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI  153 (311)
T ss_dssp             TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            34578999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCC---CccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +||||||+||++   +..+.+||+|||+|......   ....+.+||+.|+|||++.+..|+.++|||||
T Consensus       154 iHRDlKPeNILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSl  220 (311)
T 4aw0_A          154 IHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWAL  220 (311)
T ss_dssp             ECSCCSGGGEEE---CTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHH
T ss_pred             ccCCCCHHHeEE---cCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHH
Confidence            999999999999   67889999999999876433   24456799999999999999999999999996

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.6e-45  Score=259.41  Aligned_cols=144  Identities=24%  Similarity=0.505  Sum_probs=132.2

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ....+.+.+|+.+++.++|||||+++++|.+++.+|+||||++||+|.+++.+ +.+++..+..++.|++.|++|||+++
T Consensus       112 ~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~  190 (346)
T 4fih_A          112 QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG  190 (346)
T ss_dssp             CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34467789999999999999999999999999999999999999999998874 67999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||||||+|||+   +..+.+||+|||+|...... ....+.+||+.|+|||++.+..|+.++|||||
T Consensus       191 IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSl  256 (346)
T 4fih_A          191 VIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSL  256 (346)
T ss_dssp             EECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             cccccCCHHHEEE---CCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHH
Confidence            9999999999999   67889999999999876543 34567899999999999999999999999996

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.3e-45  Score=259.33  Aligned_cols=146  Identities=25%  Similarity=0.553  Sum_probs=131.8

Q ss_pred             hhhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH
Q 031702            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      +....+.+.+|+.+++.++|||||++++++.+++.+|+||||++||+|.+++...+  .+++..++.++.|++.|++|||
T Consensus        63 ~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH  142 (350)
T 4b9d_A           63 SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH  142 (350)
T ss_dssp             CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            34567889999999999999999999999999999999999999999999997543  4789999999999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++||+||||||+|||+   +.++.+||+|||+|+...... ...+.+||+.|+|||++.+..|+.++|||||
T Consensus       143 ~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSl  211 (350)
T 4b9d_A          143 DRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWAL  211 (350)
T ss_dssp             HTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHH
T ss_pred             HCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHH
Confidence            9999999999999999   678899999999998764432 3345689999999999999999999999996

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.4e-44  Score=250.37  Aligned_cols=145  Identities=33%  Similarity=0.650  Sum_probs=128.5

Q ss_pred             hhhhHHhHHHHHHHHhhCCCCccchhhhheec----CCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHH
Q 031702            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~   81 (154)
                      +....+.|.+|+.+++.++|||||+++++|.+    ++.+|+||||++||+|.+++.+.+.+++..+..++.|++.|++|
T Consensus        65 ~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~y  144 (290)
T 3fpq_A           65 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF  144 (290)
T ss_dssp             CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Confidence            34557789999999999999999999999865    35689999999999999999988999999999999999999999


Q ss_pred             HHhCC--ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           82 LNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        82 lh~~~--~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ||+++  ++||||||+|||+.  +..+.+||+|||+|+.. ......+.+||+.|||||++. +.|+.++|||||
T Consensus       145 lH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGla~~~-~~~~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSl  215 (290)
T 3fpq_A          145 LHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLK-RASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAF  215 (290)
T ss_dssp             HHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTGGGGC-CTTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHH
T ss_pred             HHHCCCCEEecccChhheeEE--CCCCCEEEEeCcCCEeC-CCCccCCcccCccccCHHHcC-CCCCcHHHHHHH
Confidence            99998  99999999999993  24678999999999753 334556678999999999986 469999999996

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=7.8e-45  Score=251.04  Aligned_cols=143  Identities=40%  Similarity=0.763  Sum_probs=120.2

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++||||+++++++.+++.+|+||||+ +|+|.+++.+++.+++..+..+++|++.|++|||++|+
T Consensus        55 ~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~I  133 (275)
T 3hyh_A           55 DMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI  133 (275)
T ss_dssp             -CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            34567999999999999999999999999999999999999 67999999988999999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCC-cccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD-EKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Diwsl  154 (154)
                      +||||||+||++   +..+.+||+|||+|..........+.+||+.|+|||++.+..|+ .++|||||
T Consensus       134 iHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSl  198 (275)
T 3hyh_A          134 VHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC  198 (275)
T ss_dssp             CCCCCCTTTEEE---CTTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHH
T ss_pred             ccccCChHHeEE---CCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHH
Confidence            999999999999   67889999999999877666666778999999999999988874 79999996

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.8e-45  Score=258.01  Aligned_cols=148  Identities=31%  Similarity=0.474  Sum_probs=128.2

Q ss_pred             hhhhhhhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHH
Q 031702            2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (154)
Q Consensus         2 ~k~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~   81 (154)
                      +|.++..  ....+|+.+++.++|||||++++++.+++.+|+||||++||+|.+++++.+.+++..+..++.|++.|++|
T Consensus        88 iK~i~~~--~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~y  165 (336)
T 4g3f_A           88 VKKVRLE--VFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEY  165 (336)
T ss_dssp             EEEEETT--TCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             EEEECHH--HhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHH
Confidence            4555432  22357999999999999999999999999999999999999999999988999999999999999999999


Q ss_pred             HHhCCceeecCCCCcEEeecCCCCe-eEEEeecccccccCCCC------ccccccCCccccCcccccccCCCcccceecC
Q 031702           82 LNSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPGN------YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        82 lh~~~~~h~~i~p~nil~~~~~~~~-~~kl~df~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ||+++++||||||+|||+   +..+ .+||+|||+|+......      .....+||+.|||||++.+..|+.++|||||
T Consensus       166 lH~~~IiHRDlKp~NILl---~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSl  242 (336)
T 4g3f_A          166 LHTRRILHGDVKADNVLL---SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSS  242 (336)
T ss_dssp             HHTTTEECSCCCGGGEEE---CTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred             HHHCCceecccCHHHEEE---eCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHH
Confidence            999999999999999999   4554 69999999998765432      1234679999999999999999999999996

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.2e-44  Score=253.15  Aligned_cols=146  Identities=23%  Similarity=0.514  Sum_probs=131.3

Q ss_pred             hhhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-------------CCCCHHHHHHHH
Q 031702            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-------------GRVPEQTARKFL   72 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~~   72 (154)
                      +....+.|.+|+.++++++|||||++++++.+++.+|+||||+++|+|.+++.+.             ..+++.++..++
T Consensus        55 ~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~  134 (299)
T 4asz_A           55 SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIA  134 (299)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHH
T ss_pred             ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHH
Confidence            3556788999999999999999999999999999999999999999999999754             358999999999


Q ss_pred             HHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCCCccc
Q 031702           73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKV  149 (154)
Q Consensus        73 ~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~  149 (154)
                      .|++.|++|||+++++||||||+||++   +.++.+||+|||+|+......   ......||+.|+|||++.++.|+.++
T Consensus       135 ~qia~gl~yLH~~~iiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~  211 (299)
T 4asz_A          135 QQIAAGMVYLASQHFVHRDLATRNCLV---GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES  211 (299)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHH
T ss_pred             HHHHHHHHHHHhCCcccCccCHhhEEE---CCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchh
Confidence            999999999999999999999999999   778899999999998654433   22345689999999999999999999


Q ss_pred             ceecC
Q 031702          150 NFFVS  154 (154)
Q Consensus       150 Diwsl  154 (154)
                      |||||
T Consensus       212 DVwS~  216 (299)
T 4asz_A          212 DVWSL  216 (299)
T ss_dssp             HHHHH
T ss_pred             hHHHH
Confidence            99996

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=260.64  Aligned_cols=144  Identities=25%  Similarity=0.524  Sum_probs=132.2

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ....+.+.+|+.+|+.++|||||+++++|.+++.+|+|||||+||+|.+++. .+.+++..+..+++|++.||+|||++|
T Consensus       189 ~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~-~~~l~e~~~~~~~~qil~aL~ylH~~~  267 (423)
T 4fie_A          189 QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQG  267 (423)
T ss_dssp             CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3446789999999999999999999999999999999999999999999886 467999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||||||+|||+   +..+.+||+|||+|...... ....+.+||+.|||||++.+..|+.++|||||
T Consensus       268 IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSl  333 (423)
T 4fie_A          268 VIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSL  333 (423)
T ss_dssp             EECCCCSTTTEEE---CTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHH
T ss_pred             eecccCCHHHEEE---cCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHH
Confidence            9999999999999   67889999999999876543 34567899999999999999999999999996

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=9.5e-45  Score=253.66  Aligned_cols=143  Identities=36%  Similarity=0.554  Sum_probs=125.4

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ....+.+|+.++++++||||+++++++.+++.+|++|||++||+|.+++.+.+.+++..+..+++|++.|++|||++|++
T Consensus        69 ~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~Ii  148 (304)
T 3ubd_A           69 DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII  148 (304)
T ss_dssp             ECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence            34578899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ||||||+||++   +..+.+||+|||+|+..... ....+.+||+.|+|||++.+..|+.++|||||
T Consensus       149 HRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSl  212 (304)
T 3ubd_A          149 YRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSF  212 (304)
T ss_dssp             CSSCCGGGEEE---CTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHH
T ss_pred             CCCCCHHHeEE---cCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccch
Confidence            99999999999   67889999999999865443 34566789999999999999999999999996

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=250.98  Aligned_cols=146  Identities=23%  Similarity=0.482  Sum_probs=124.2

Q ss_pred             hhhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc---------------CCCCHHHHHH
Q 031702            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---------------GRVPEQTARK   70 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~---------------~~~~~~~~~~   70 (154)
                      +....+.|.+|+.++++++|||||++++++.+++.+|+||||+++|+|.+++.+.               .++++.++..
T Consensus        83 ~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~  162 (329)
T 4aoj_A           83 SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA  162 (329)
T ss_dssp             SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHH
Confidence            3556788999999999999999999999999999999999999999999998753               3489999999


Q ss_pred             HHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCCCc
Q 031702           71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDE  147 (154)
Q Consensus        71 ~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~  147 (154)
                      ++.|++.|++|||+++++||||||+||++   +..+.+||+|||+++......   ......||+.|||||++.+..|+.
T Consensus       163 i~~qia~gl~yLH~~~iiHRDLKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~  239 (329)
T 4aoj_A          163 VASQVAAGMVYLAGLHFVHRDLATRNCLV---GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTT  239 (329)
T ss_dssp             HHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCH
T ss_pred             HHHHHHHHHHHHhcCCeecccccHhhEEE---CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCc
Confidence            99999999999999999999999999999   678899999999998664432   233467899999999999999999


Q ss_pred             ccceecC
Q 031702          148 KVNFFVS  154 (154)
Q Consensus       148 ~~Diwsl  154 (154)
                      ++|||||
T Consensus       240 ~sDvwS~  246 (329)
T 4aoj_A          240 ESDVWSF  246 (329)
T ss_dssp             HHHHHHH
T ss_pred             cccccch
Confidence            9999996

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.1e-43  Score=249.25  Aligned_cols=144  Identities=23%  Similarity=0.502  Sum_probs=129.3

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc----------------CCCCHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARKF   71 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~   71 (154)
                      ...+.|.+|+.++++++|||||++++++.+++.+++||||+++|+|.+++...                ..+++..+..+
T Consensus        71 ~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i  150 (308)
T 4gt4_A           71 PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL  150 (308)
T ss_dssp             -CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHH
Confidence            34678999999999999999999999999999999999999999999999643                34889999999


Q ss_pred             HHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCCCcc
Q 031702           72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEK  148 (154)
Q Consensus        72 ~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~  148 (154)
                      +.|++.|++|||+++++||||||+||++   +..+.+||+|||+++.....+   ......||+.|+|||++.++.|+.+
T Consensus       151 ~~qia~gl~yLH~~~iiHRDLK~~NILl---~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~k  227 (308)
T 4gt4_A          151 VAQIAAGMEYLSSHHVVHKDLATRNVLV---YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID  227 (308)
T ss_dssp             HHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCccccceEE---CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCcc
Confidence            9999999999999999999999999999   788899999999998664432   2344678999999999999999999


Q ss_pred             cceecC
Q 031702          149 VNFFVS  154 (154)
Q Consensus       149 ~Diwsl  154 (154)
                      +|||||
T Consensus       228 sDVwSf  233 (308)
T 4gt4_A          228 SDIWSY  233 (308)
T ss_dssp             HHHHHH
T ss_pred             chhhhH
Confidence            999996

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.9e-43  Score=246.35  Aligned_cols=145  Identities=28%  Similarity=0.529  Sum_probs=119.6

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCC------------cEEEEEEecCCCCchHHHHHcCC---CCHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------------CIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKF   71 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------------~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~   71 (154)
                      +...+.+.+|+.+++.++||||++++++|.+.+            .+|++|||+++|+|.+++.....   .+...++.+
T Consensus        44 ~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i  123 (299)
T 4g31_A           44 ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI  123 (299)
T ss_dssp             HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHH
Confidence            345678999999999999999999999986543            47999999999999999987654   455678899


Q ss_pred             HHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc-------------cccccCCccccCcc
Q 031702           72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-------------AEKVCGSPLYMAPE  138 (154)
Q Consensus        72 ~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~-------------~~~~~~~~~y~aPE  138 (154)
                      +.|++.|++|||+++++||||||+||++   +.++.+||+|||+|+.......             ..+.+||+.|||||
T Consensus       124 ~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE  200 (299)
T 4g31_A          124 FLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPE  200 (299)
T ss_dssp             HHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCCCC--------------------------CCCTTSCHH
T ss_pred             HHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHH
Confidence            9999999999999999999999999999   6778999999999987644321             23357999999999


Q ss_pred             cccccCCCcccceecC
Q 031702          139 VLQFQRYDEKVNFFVS  154 (154)
Q Consensus       139 ~~~~~~~~~~~Diwsl  154 (154)
                      ++.+..|+.++|||||
T Consensus       201 ~~~~~~y~~~~DiwSl  216 (299)
T 4g31_A          201 QIHGNSYSHKVDIFSL  216 (299)
T ss_dssp             HHTTCCCCTHHHHHHH
T ss_pred             HHcCCCCCCHHHHHHH
Confidence            9999999999999996

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=8.3e-43  Score=244.26  Aligned_cols=144  Identities=25%  Similarity=0.459  Sum_probs=123.0

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ....+.|.+|+.++++++|||||++++++.+ +.+|+||||+++|+|.+++... ..+++.++..++.|++.|++|||++
T Consensus        73 ~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~  151 (307)
T 3omv_A           73 PEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK  151 (307)
T ss_dssp             HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4567889999999999999999999998764 5689999999999999999754 5799999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCC---CccccccCCccccCcccccc---cCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQF---QRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~---~~~~~~~Diwsl  154 (154)
                      +++||||||+|||+   +.++.+||+|||+|+.....   ......+||+.|||||++.+   +.|+.++|||||
T Consensus       152 ~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~  223 (307)
T 3omv_A          152 NIIHRDMKSNNIFL---HEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSY  223 (307)
T ss_dssp             TCBCSCCCSSSEEE---ETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHH
T ss_pred             CccCCccCHHHEEE---CCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhH
Confidence            99999999999999   67889999999999765432   23455789999999999863   468999999996

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.5e-41  Score=240.25  Aligned_cols=144  Identities=31%  Similarity=0.472  Sum_probs=126.5

Q ss_pred             hhHHhHHHHHHHHhhCCC-CccchhhhheecC-CcEEEEEEecCCCCchHHHHHc----------------CCCCHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNH-PNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTAR   69 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~----------------~~~~~~~~~   69 (154)
                      ...+.|.+|+.+++++.| ||||+++++|.++ +.+|+|||||++|+|.+++++.                ..+++..+.
T Consensus       109 ~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~  188 (353)
T 4ase_A          109 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI  188 (353)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHH
T ss_pred             HHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHH
Confidence            456789999999999965 8999999998654 6789999999999999999753                237899999


Q ss_pred             HHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCCC
Q 031702           70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYD  146 (154)
Q Consensus        70 ~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~  146 (154)
                      .++.|++.|++|||+++++||||||+||++   +.++.+||+|||+|+......   ......||+.|||||++.++.|+
T Consensus       189 ~~~~qia~gl~yLH~~~iiHRDLK~~NILl---~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~  265 (353)
T 4ase_A          189 CYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT  265 (353)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHhHhhCCeecCccCccceee---CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC
Confidence            999999999999999999999999999999   778899999999998764432   23346789999999999999999


Q ss_pred             cccceecC
Q 031702          147 EKVNFFVS  154 (154)
Q Consensus       147 ~~~Diwsl  154 (154)
                      .++|||||
T Consensus       266 ~ksDVwS~  273 (353)
T 4ase_A          266 IQSDVWSF  273 (353)
T ss_dssp             HHHHHHHH
T ss_pred             CcccEeeh
Confidence            99999996

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.5e-40  Score=233.15  Aligned_cols=150  Identities=26%  Similarity=0.358  Sum_probs=121.5

Q ss_pred             ChhhhhhhhHHhHH--HHHHHHhhCCCCccchhhhheecCC----cEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHH
Q 031702            1 MLKKLNKHLKSCLD--CELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ   74 (154)
Q Consensus         1 ~~k~~~~~~~~~~~--~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~   74 (154)
                      |+|.++....+.+.  .|+..+..++||||+++++++.+++    .+|+||||+++|+|.++++. ..+++..+..++.|
T Consensus        30 AvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~  108 (303)
T 3hmm_A           30 AVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALS  108 (303)
T ss_dssp             EEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHH
T ss_pred             EEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHH
Confidence            46666655544444  4555667889999999999997653    58999999999999999974 56899999999999


Q ss_pred             HHHHHHHHHhC--------CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-----ccccccCCccccCccccc
Q 031702           75 LGAGLEILNSH--------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQ  141 (154)
Q Consensus        75 i~~~l~~lh~~--------~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~  141 (154)
                      ++.|++|||++        +++||||||+||++   +.++.+||+|||+|+......     .....+||+.|+|||++.
T Consensus       109 ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~  185 (303)
T 3hmm_A          109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD  185 (303)
T ss_dssp             HHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHT
T ss_pred             HHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhc
Confidence            99999999987        89999999999999   788899999999997664432     223467999999999987


Q ss_pred             cc------CCCcccceecC
Q 031702          142 FQ------RYDEKVNFFVS  154 (154)
Q Consensus       142 ~~------~~~~~~Diwsl  154 (154)
                      +.      .|+.++|||||
T Consensus       186 ~~~~~~~~~~~~k~DVwS~  204 (303)
T 3hmm_A          186 DSINMKHFESFKRADIYAM  204 (303)
T ss_dssp             TCSCTTCHHHHHHHHHHHH
T ss_pred             ccccccCCccChhHhhhhH
Confidence            54      36789999996

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.3e-40  Score=236.80  Aligned_cols=143  Identities=28%  Similarity=0.487  Sum_probs=124.8

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheec------CCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~   81 (154)
                      ...+.+.+|+.+|+.++||||+++++++..      .+.+|+||||++ |+|.+++.+.+.+++..+..+++|++.||.|
T Consensus        95 ~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~y  173 (398)
T 4b99_A           95 TNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKY  173 (398)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Confidence            445778899999999999999999998754      367999999995 6899999888899999999999999999999


Q ss_pred             HHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCC-----CccccccCCccccCccccccc-CCCcccceecC
Q 031702           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        82 lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      ||++|++||||||+||++   +..+.+||+|||+|+.....     ....+.+||+.|+|||++.+. .|+.++|||||
T Consensus       174 lH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSl  249 (398)
T 4b99_A          174 MHSAQVIHRDLKPSNLLV---NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSV  249 (398)
T ss_dssp             HHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHH
T ss_pred             HHHCcCcCCCcCcccccc---CCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehh
Confidence            999999999999999999   77889999999999865432     234567899999999998765 46899999995

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.1e-39  Score=246.41  Aligned_cols=136  Identities=32%  Similarity=0.547  Sum_probs=124.1

Q ss_pred             HHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCC
Q 031702           15 CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKP   94 (154)
Q Consensus        15 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p   94 (154)
                      .++.+++.++||||++++++|.+++.+|+||||++||+|.+++.+.+.+++..++.+++||+.||+|||++||+||||||
T Consensus       241 ~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKP  320 (689)
T 3v5w_A          241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKP  320 (689)
T ss_dssp             HHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSG
T ss_pred             HHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCch
Confidence            34667778899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc-cCCCcccceecC
Q 031702           95 ENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        95 ~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      +||++   +..+.+||+|||+|...... ...+.+||+.|+|||++.+ ..|+.++|||||
T Consensus       321 eNILl---d~~G~vKL~DFGlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSL  377 (689)
T 3v5w_A          321 ANILL---DEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSL  377 (689)
T ss_dssp             GGEEE---CTTSCEEECCCTTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHH
T ss_pred             HHeEE---eCCCCEEecccceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHH
Confidence            99999   78899999999999876443 3456799999999999974 579999999996

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=6.8e-40  Score=246.45  Aligned_cols=147  Identities=29%  Similarity=0.508  Sum_probs=133.9

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ....+.+.+|+.+|+.++||||++++++|.+++.+|++|||++||+|.+++.. .+.+++..+..+++||+.||.|||++
T Consensus       195 ~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~  274 (573)
T 3uto_A          195 ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN  274 (573)
T ss_dssp             HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            45567899999999999999999999999999999999999999999998864 45799999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++||||||+||++.. +..+.+||+|||+|+...........+||+.|+|||++.+..|+.++|||||
T Consensus       275 ~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSl  342 (573)
T 3uto_A          275 NYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSV  342 (573)
T ss_dssp             TEECCCCCGGGEEESS-SSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHH
T ss_pred             CeeeccCChhhccccC-CCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHH
Confidence            9999999999999942 2347899999999998877766677899999999999999999999999995

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3e-39  Score=231.23  Aligned_cols=142  Identities=20%  Similarity=0.340  Sum_probs=121.9

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      .....+.+|+++++.+ +||||+++++++.+++++|++|||+++++|.++++   .+++..++.+++|++.|++|||++|
T Consensus        61 ~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g  137 (361)
T 4f9c_A           61 SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG  137 (361)
T ss_dssp             SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3456788999999998 79999999999999999999999999999999874   5999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-----------------------------ccccccCCccccCc
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----------------------------YAEKVCGSPLYMAP  137 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-----------------------------~~~~~~~~~~y~aP  137 (154)
                      ++||||||+||++.  ...+.+||+|||+|+......                             ...+.+||+.|+||
T Consensus       138 IiHRDiKPeNiLl~--~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~AP  215 (361)
T 4f9c_A          138 IVHRDVKPSNFLYN--RRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAP  215 (361)
T ss_dssp             EECSCCSGGGEEEE--TTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCH
T ss_pred             eEeCcCCHHHeEEe--CCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCH
Confidence            99999999999994  334789999999997543221                             12235799999999


Q ss_pred             cccccc-CCCcccceecC
Q 031702          138 EVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus       138 E~~~~~-~~~~~~Diwsl  154 (154)
                      |++.+. .|+.++||||+
T Consensus       216 E~l~~~~~y~~~~DiWSl  233 (361)
T 4f9c_A          216 EVLTKCPNQTTAIDMWSA  233 (361)
T ss_dssp             HHHTTCSCCCTHHHHHHH
T ss_pred             HHHcCCCCCCCccchhhh
Confidence            999875 48899999995

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.6e-37  Score=216.90  Aligned_cols=145  Identities=37%  Similarity=0.694  Sum_probs=133.9

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ....+.+.+|+.+++.++||||+++++++.+.+..|++|||+++++|.+++...+.+++..+..++.|++.|+.|||+++
T Consensus        55 ~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~  134 (328)
T 3fe3_A           55 PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR  134 (328)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            45567889999999999999999999999999999999999999999999988899999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCC-cccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD-EKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Diwsl  154 (154)
                      ++||||||+||++   +..+.+||+|||++............+||+.|+|||++.+..++ .++|||||
T Consensus       135 ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  200 (328)
T 3fe3_A          135 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSL  200 (328)
T ss_dssp             CCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHH
T ss_pred             EeccCCCHHHEEE---cCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhh
Confidence            9999999999999   67889999999999877666666677899999999999888775 78999996

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7.3e-37  Score=217.35  Aligned_cols=144  Identities=32%  Similarity=0.496  Sum_probs=131.6

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++||||+++++++.+.+.+|++|||+++|+|.+++.+.+.+++..++.++.|++.|++|||++|+
T Consensus        47 ~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i  126 (337)
T 1o6l_A           47 DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV  126 (337)
T ss_dssp             TCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             hHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34567889999999999999999999999999999999999999999999988899999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCC-CCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +||||||+||++   +..+.+||+|||++..... .......+||+.|+|||++.+..++.++|||||
T Consensus       127 vHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  191 (337)
T 1o6l_A          127 VYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL  191 (337)
T ss_dssp             BCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHH
T ss_pred             ecCcCCHHHEEE---CCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccc
Confidence            999999999999   6788999999999976433 334556789999999999998899999999996

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=9.9e-37  Score=218.54  Aligned_cols=148  Identities=32%  Similarity=0.509  Sum_probs=134.4

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ....+.+.+|+.+++.++||||+++++++.+++..|++|||+++++|.+++.....+++..+..++.|++.|+.|||+.+
T Consensus        69 ~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~  148 (362)
T 2bdw_A           69 ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG  148 (362)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            44567899999999999999999999999999999999999999999999987888999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||||+||++...+....+||+|||++.............||+.|+|||++.+..|+.++|||||
T Consensus       149 ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  216 (362)
T 2bdw_A          149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWAC  216 (362)
T ss_dssp             CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHH
T ss_pred             eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHH
Confidence            99999999999996544456799999999987766555566789999999999998899999999996

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.4e-36  Score=221.51  Aligned_cols=149  Identities=29%  Similarity=0.458  Sum_probs=134.6

Q ss_pred             hhhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      +....+.+.+|+.+++.++||||+++++++.+++..|++|||+.+|+|.+.+...+.+++..+..++.|++.|+.|||++
T Consensus        50 ~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~  129 (444)
T 3soa_A           50 SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM  129 (444)
T ss_dssp             HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            44567789999999999999999999999999999999999999999999999888999999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |++|+||||+||++......+.+||+|||++....... ......||+.|+|||++.+..|+.++|||||
T Consensus       130 givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSl  199 (444)
T 3soa_A          130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWAC  199 (444)
T ss_dssp             TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHH
Confidence            99999999999999654467889999999997765433 3345689999999999998899999999996

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.4e-36  Score=216.49  Aligned_cols=145  Identities=29%  Similarity=0.567  Sum_probs=131.3

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (154)
                      .+.+.+|+.+++.++||||+++++++.+++.++++|||+++++|.+++...+.+++..+..++.|++.|+.|||+.|++|
T Consensus        59 ~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH  138 (361)
T 2yab_A           59 REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH  138 (361)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            57899999999999999999999999999999999999999999999988888999999999999999999999999999


Q ss_pred             ecCCCCcEEeecCC-CCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           90 RDLKPENILLSGLD-DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        90 ~~i~p~nil~~~~~-~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +||||+||++...+ ....+||+|||++............+||+.|+|||++.+..++.++|||||
T Consensus       139 rDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  204 (361)
T 2yab_A          139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSI  204 (361)
T ss_dssp             CCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred             CCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHH
Confidence            99999999994211 122799999999987766655666789999999999998899999999996

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.1e-36  Score=213.98  Aligned_cols=154  Identities=31%  Similarity=0.533  Sum_probs=119.0

Q ss_pred             ChhhhhhhhHHhHHHHHHHHhhCC-CCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHH
Q 031702            1 MLKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL   79 (154)
Q Consensus         1 ~~k~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l   79 (154)
                      ++|.++....+.+.+|+.+++.+. ||||+++++++.+++..|++|||+++++|.+++.....+++..+..++.|++.|+
T Consensus        40 avK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l  119 (325)
T 3kn6_A           40 AVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAV  119 (325)
T ss_dssp             EEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHH
T ss_pred             EEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHH
Confidence            466677777888999999999996 9999999999999999999999999999999999888999999999999999999


Q ss_pred             HHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        80 ~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .|||+++++|+||||+||++...+....+||+|||++....... ......+|+.|+|||++.+..++.++|||||
T Consensus       120 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diwsl  195 (325)
T 3kn6_A          120 SHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSL  195 (325)
T ss_dssp             HHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------CCCCHHHHHHHH
T ss_pred             HHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHH
Confidence            99999999999999999999644444589999999997654432 3345678999999999998899999999996

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.2e-36  Score=216.63  Aligned_cols=143  Identities=31%  Similarity=0.538  Sum_probs=132.1

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++||||+++++++.+.+..|++|||+.||+|.+++.....+++..+..++.|++.|+.|||+.|++
T Consensus        58 ~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~giv  137 (384)
T 4fr4_A           58 EVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRII  137 (384)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence            35678899999999999999999999999999999999999999999999888899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc---cCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---QRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Diwsl  154 (154)
                      |+||||+||++   +..+.+||+|||++............+||+.|+|||++.+   ..|+.++|||||
T Consensus       138 HrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSl  203 (384)
T 4fr4_A          138 HRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSL  203 (384)
T ss_dssp             CCCCSGGGEEE---CTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHH
T ss_pred             eccCcHHHeEE---CCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeech
Confidence            99999999999   7788999999999987766666677889999999999874   458999999996

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.3e-36  Score=217.88  Aligned_cols=143  Identities=31%  Similarity=0.606  Sum_probs=130.6

Q ss_pred             hHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|..+++.+ +||||+++++++.+++.+|++|||+++|+|..++.+.+.+++..++.++.|++.|++|||++++
T Consensus        95 ~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~gi  174 (396)
T 4dc2_A           95 DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGI  174 (396)
T ss_dssp             -CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            345688999999887 8999999999999999999999999999999999988899999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeeccccccc-CCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +||||||+||++   +..+.+||+|||++... .........+||+.|+|||++.+..|+.++|||||
T Consensus       175 vHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~Diwsl  239 (396)
T 4dc2_A          175 IYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL  239 (396)
T ss_dssp             BCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             EeccCCHHHEEE---CCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHH
Confidence            999999999999   78889999999999763 33445566789999999999999999999999996

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.5e-36  Score=215.04  Aligned_cols=144  Identities=36%  Similarity=0.558  Sum_probs=126.8

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|..+++.+ +||||+++++++.+++.+|++|||+++|+|.+++.+.+.+++..++.++.|++.|++|||+++
T Consensus        65 ~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g  144 (353)
T 3txo_A           65 DDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG  144 (353)
T ss_dssp             TTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3456788999999998 799999999999999999999999999999999998899999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCC-CCccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++||||||+||++   +..+.+||+|||++..... .......+||+.|+|||++.+..|+.++|||||
T Consensus       145 ivHrDlkp~NILl---~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  210 (353)
T 3txo_A          145 IIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAM  210 (353)
T ss_dssp             CBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHH
T ss_pred             CcccCCCHHHEEE---CCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcc
Confidence            9999999999999   6788999999999976433 334556789999999999998899999999996

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-36  Score=212.23  Aligned_cols=141  Identities=37%  Similarity=0.635  Sum_probs=129.9

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|..+++.++||||+++++++.+.+.+|++|||+++++|.+++.+...+++..+..++.|++.|+.|||++|++
T Consensus        49 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv  128 (318)
T 1fot_A           49 QVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDII  128 (318)
T ss_dssp             CHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred             HHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            45678899999999999999999999999999999999999999999999888999999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||||+||++   +..+.+||+|||++.....  .....+||+.|+|||++.+..++.++|||||
T Consensus       129 HrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  189 (318)
T 1fot_A          129 YRDLKPENILL---DKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSF  189 (318)
T ss_dssp             CCCCCGGGEEE---CTTSCEEECCCSSCEECSS--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHH
T ss_pred             ccCCChheEEE---cCCCCEEEeecCcceecCC--ccccccCCccccCHhHhcCCCCCcccchhhh
Confidence            99999999999   6788999999999976543  2345689999999999998899999999996

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=8.7e-36  Score=212.45  Aligned_cols=144  Identities=31%  Similarity=0.607  Sum_probs=131.3

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|..+++.+ +||||+++++++.+.+.+|++|||+++++|.+++.+.+.+++..++.++.|++.|++|||+++
T Consensus        51 ~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~  130 (345)
T 3a8x_A           51 EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG  130 (345)
T ss_dssp             HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4456788999999998 899999999999999999999999999999999998889999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccC-CCCccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++||||||+||++   +..+.+||+|||++.... ........+||+.|+|||++.+..|+.++|||||
T Consensus       131 ivHrDlkp~NIll---~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  196 (345)
T 3a8x_A          131 IIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL  196 (345)
T ss_dssp             CBCCCCCGGGEEE---CTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             ceecCCCHHHEEE---CCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHH
Confidence            9999999999999   678899999999997643 3334556789999999999998899999999996

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=8.1e-36  Score=209.43  Aligned_cols=146  Identities=27%  Similarity=0.537  Sum_probs=129.7

Q ss_pred             hhhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh
Q 031702            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      +....+.+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++.. ...+++..+..++.|++.|++|||+
T Consensus        47 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~  126 (310)
T 3s95_A           47 DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS  126 (310)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            456678899999999999999999999999999999999999999999999987 4679999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc---------------ccccCCccccCcccccccCCCccc
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---------------EKVCGSPLYMAPEVLQFQRYDEKV  149 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~---------------~~~~~~~~y~aPE~~~~~~~~~~~  149 (154)
                      .+++|+||||+||++   +..+.+||+|||++.........               ....||+.|+|||++.+..++.++
T Consensus       127 ~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  203 (310)
T 3s95_A          127 MNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKV  203 (310)
T ss_dssp             TTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHH
T ss_pred             CCccCCCCCcCeEEE---CCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHH
Confidence            999999999999999   67888999999999765433211               145789999999999999999999


Q ss_pred             ceecC
Q 031702          150 NFFVS  154 (154)
Q Consensus       150 Diwsl  154 (154)
                      |||||
T Consensus       204 Di~sl  208 (310)
T 3s95_A          204 DVFSF  208 (310)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99996

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=5.9e-36  Score=213.27  Aligned_cols=143  Identities=34%  Similarity=0.557  Sum_probs=130.2

Q ss_pred             hHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+..|..+++.+ +||||+++++++.+++.+|++|||++||+|.+++.+.+.+++..+..++.|++.|++|||++|+
T Consensus        60 ~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i  139 (345)
T 1xjd_A           60 DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI  139 (345)
T ss_dssp             CHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             hHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            456788899999987 9999999999999999999999999999999999988899999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCC-CCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +||||||+||++   +..+.+||+|||++..... .......+||+.|+|||++.+..++.++|||||
T Consensus       140 vHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  204 (345)
T 1xjd_A          140 VYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSF  204 (345)
T ss_dssp             BCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             EeCCCChhhEEE---CCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHH
Confidence            999999999999   6788999999999976433 334556789999999999998899999999996

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.4e-36  Score=210.98  Aligned_cols=146  Identities=30%  Similarity=0.576  Sum_probs=131.3

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++.....+++..+..++.|++.|+.|||+.+++
T Consensus        57 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iv  136 (326)
T 2y0a_A           57 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIA  136 (326)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            35789999999999999999999999999999999999999999999998888899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCC-CCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLD-DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~-~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||+|+||++.... ....+||+|||++.............||+.|+|||++.+..++.++|||||
T Consensus       137 H~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  203 (326)
T 2y0a_A          137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSI  203 (326)
T ss_dssp             CCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHH
T ss_pred             cCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHH
Confidence            999999999994321 223799999999987765555556789999999999998899999999996

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5.2e-36  Score=209.26  Aligned_cols=145  Identities=32%  Similarity=0.549  Sum_probs=126.6

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ....+.+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++...+.+++..+..++.|++.|+.|||+.+
T Consensus        52 ~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  131 (294)
T 4eqm_A           52 EETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR  131 (294)
T ss_dssp             HHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            44567899999999999999999999999999999999999999999999998889999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||||+||++   +..+.+||+|||++.......  ......||+.|+|||++.+..++.++|||||
T Consensus       132 i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  198 (294)
T 4eqm_A          132 IVHRDIKPQNILI---DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSI  198 (294)
T ss_dssp             CCCCCCCGGGEEE---CTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHH
T ss_pred             cccCCCCHHHEEE---CCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHH
Confidence            9999999999999   677899999999997654432  2334578999999999998899999999996

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=2.2e-36  Score=227.37  Aligned_cols=142  Identities=18%  Similarity=0.210  Sum_probs=115.3

Q ss_pred             hhhhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh
Q 031702            6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ++...+.|.+|+++|+++ .|+||+++++++++++..|+||||++|++|.+.+...++++...   ++.||+.||+|+|+
T Consensus       281 ~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~~---I~~QIl~AL~ylH~  357 (569)
T 4azs_A          281 SQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDREK---ILGSLLRSLAALEK  357 (569)
T ss_dssp             HHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCHHH---HHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCHHH---HHHHHHHHHHHHHH
Confidence            345667899999999999 79999999999999999999999999999999999888888754   78999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCcccccccCCCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +||+||||||+|||+   +.++.+||+|||+|+..... ....+.+||+.|+|||++.+ .+..++|+||+
T Consensus       358 ~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~  424 (569)
T 4azs_A          358 QGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSA  424 (569)
T ss_dssp             TTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC--------------
T ss_pred             CCceeccCchHhEEE---CCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCC-CCCCccccccc
Confidence            999999999999999   67889999999999876543 34456789999999999975 46677899984

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=6e-36  Score=213.65  Aligned_cols=146  Identities=27%  Similarity=0.493  Sum_probs=128.6

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ..+.+.+|+.+++.++||||+++++++.+++..|++|||+++++|.+.+...    ..+++..+..++.|++.|+.|||+
T Consensus        69 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~  148 (351)
T 3c0i_A           69 STEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD  148 (351)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3578999999999999999999999999999999999999999998877543    248999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc-cccccCCccccCcccccccCCCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++++|+||||+||++...+....+||+|||++........ .....||+.|+|||++.+..++.++|||||
T Consensus       149 ~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  219 (351)
T 3c0i_A          149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGC  219 (351)
T ss_dssp             TTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             CCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHH
Confidence            9999999999999996444455699999999987655432 445679999999999998899999999996

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.9e-36  Score=216.11  Aligned_cols=154  Identities=21%  Similarity=0.304  Sum_probs=132.7

Q ss_pred             ChhhhhhhhHHhHHHHHHHHhhCC---CCccchhhhheecCCcEEEEEEecCCCCchHHHHH-----cCCCCHHHHHHHH
Q 031702            1 MLKKLNKHLKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-----HGRVPEQTARKFL   72 (154)
Q Consensus         1 ~~k~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~   72 (154)
                      |+|.++......+.+|..+++.++   |+|++++++++..++..|++|||+++|+|.+++..     ...+++..++.++
T Consensus        99 avK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~  178 (365)
T 3e7e_A           99 VLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA  178 (365)
T ss_dssp             EEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHH
T ss_pred             EEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHH
Confidence            356666667788899999999997   89999999999999999999999999999999974     4569999999999


Q ss_pred             HHHHHHHHHHHhCCceeecCCCCcEEeec--------CCCCeeEEEeecccccccC---CCCccccccCCccccCccccc
Q 031702           73 QQLGAGLEILNSHHIIHRDLKPENILLSG--------LDDDVMLKIADFGLSCTLY---PGNYAEKVCGSPLYMAPEVLQ  141 (154)
Q Consensus        73 ~~i~~~l~~lh~~~~~h~~i~p~nil~~~--------~~~~~~~kl~df~~~~~~~---~~~~~~~~~~~~~y~aPE~~~  141 (154)
                      .|++.|++|||+++++||||||+||++..        .+..+.+||+|||++....   .........||+.|+|||++.
T Consensus       179 ~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~  258 (365)
T 3e7e_A          179 MRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS  258 (365)
T ss_dssp             HHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHT
T ss_pred             HHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhc
Confidence            99999999999999999999999999942        1127899999999996543   223345567999999999999


Q ss_pred             ccCCCcccceecC
Q 031702          142 FQRYDEKVNFFVS  154 (154)
Q Consensus       142 ~~~~~~~~Diwsl  154 (154)
                      +..++.++|||||
T Consensus       259 ~~~~~~~~Diwsl  271 (365)
T 3e7e_A          259 NKPWNYQIDYFGV  271 (365)
T ss_dssp             TCCBSTHHHHHHH
T ss_pred             CCCCCccccHHHH
Confidence            9899999999996

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=8.4e-36  Score=211.82  Aligned_cols=141  Identities=41%  Similarity=0.759  Sum_probs=130.1

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (154)
                      .+.+.+|+.+++.++||||+++++++.+++..+++|||+ +|+|.+++...+.+++..+..++.|++.|+.|||+.|++|
T Consensus        53 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH  131 (336)
T 3h4j_B           53 HMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVH  131 (336)
T ss_dssp             SHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            457899999999999999999999999999999999999 6799999988889999999999999999999999999999


Q ss_pred             ecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCC-CcccceecC
Q 031702           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVNFFVS  154 (154)
Q Consensus        90 ~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Diwsl  154 (154)
                      +||||+||++   +..+.+||+|||++............+||+.|+|||++.+..+ +.++|||||
T Consensus       132 ~Dlkp~NIll---~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  194 (336)
T 3h4j_B          132 RDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSC  194 (336)
T ss_dssp             CCCSTTTEEE---CTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHH
T ss_pred             cCCchhhEEE---cCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHH
Confidence            9999999999   6788999999999987766666677789999999999988776 689999996

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=6.2e-36  Score=218.83  Aligned_cols=142  Identities=31%  Similarity=0.602  Sum_probs=127.6

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      .+.+.+|..+++.++||||+++++++.+++.+|+||||+++|+|.+++.+ .+.+++..++.++.|++.|+.|||+.+++
T Consensus       118 ~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gii  197 (437)
T 4aw2_A          118 TACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYV  197 (437)
T ss_dssp             TCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence            34589999999999999999999999999999999999999999999986 46799999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--cccccCCccccCccccc-----ccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ-----FQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~y~aPE~~~-----~~~~~~~~Diwsl  154 (154)
                      ||||||+||++   +..+.+||+|||++........  ....+||+.|+|||++.     ...|+.++|||||
T Consensus       198 HrDLKp~NILl---~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSl  267 (437)
T 4aw2_A          198 HRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSL  267 (437)
T ss_dssp             CCCCSGGGEEE---CTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHH
T ss_pred             ecccCHHHeeE---cCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHH
Confidence            99999999999   7888999999999976654332  23468999999999987     4568999999996

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.4e-35  Score=211.69  Aligned_cols=141  Identities=31%  Similarity=0.547  Sum_probs=130.2

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++||||+++++++.+.+.+|++|||+++++|.+++.+.+.+++..++.++.|++.|++|||++|++
T Consensus        84 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv  163 (350)
T 1rdq_E           84 QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLI  163 (350)
T ss_dssp             CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            45678899999999999999999999999999999999999999999999888999999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ||||||+||++   +..+.+||+|||++......  ....+||+.|+|||++.+..++.++|||||
T Consensus       164 HrDlkp~NIll---~~~g~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  224 (350)
T 1rdq_E          164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWAL  224 (350)
T ss_dssp             CCCCSGGGEEE---CTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             cccCccceEEE---CCCCCEEEcccccceeccCC--cccccCCccccCHHHhcCCCCCCcCCEecc
Confidence            99999999999   67889999999999865433  345679999999999998899999999996

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.4e-35  Score=210.73  Aligned_cols=144  Identities=33%  Similarity=0.564  Sum_probs=131.0

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|..+++.+ +||+|+++++++.+.+.+|++|||++||+|.+++...+.+++..++.++.|++.|++|||++|
T Consensus        62 ~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g  141 (353)
T 2i0e_A           62 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG  141 (353)
T ss_dssp             TCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3456788999999988 899999999999999999999999999999999998889999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCC-CCccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++||||||+||++   +..+.+||+|||++..... .......+||+.|+|||++.+..++.++|||||
T Consensus       142 ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  207 (353)
T 2i0e_A          142 IIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF  207 (353)
T ss_dssp             CBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHH
T ss_pred             EEeccCCHHHEEE---cCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccch
Confidence            9999999999999   6788999999999976432 334556789999999999998999999999996

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-36  Score=210.76  Aligned_cols=147  Identities=26%  Similarity=0.447  Sum_probs=131.6

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ....+.+.+|+.+++.++||||+++++++.+.+..+++|||+++++|.+++.... .+++..+..++.|++.|+.|||+.
T Consensus        42 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~  121 (321)
T 1tki_A           42 GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH  121 (321)
T ss_dssp             THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3456778999999999999999999999999999999999999999999987553 699999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |++|+||||+||++.. +..+.+||+|||++.............||+.|+|||++.+..++.++|||||
T Consensus       122 givH~Dlkp~NIl~~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  189 (321)
T 1tki_A          122 NIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSL  189 (321)
T ss_dssp             TEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHH
T ss_pred             CCCcCCCCHHHEEEcc-CCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHH
Confidence            9999999999999942 1267899999999988766655566788999999999998888999999996

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.7e-35  Score=205.95  Aligned_cols=143  Identities=29%  Similarity=0.526  Sum_probs=129.2

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++.. ..+++..+..++.|++.|+.|||+.|+
T Consensus        59 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i  137 (297)
T 3fxz_A           59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQV  137 (297)
T ss_dssp             SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            3467789999999999999999999999999999999999999999999875 469999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||||+||++   +..+.+||+|||++....... ......||+.|+|||++.+..++.++|||||
T Consensus       138 ~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  202 (297)
T 3fxz_A          138 IHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL  202 (297)
T ss_dssp             ECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHH
T ss_pred             eeCCCCHHHEEE---CCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHH
Confidence            999999999999   677899999999987765433 3445678999999999999999999999996

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.8e-35  Score=212.78  Aligned_cols=146  Identities=32%  Similarity=0.523  Sum_probs=131.4

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|+.+++.++||||+++++++.+.+..+++|||+++++|.+++... ..+++..+..++.|++.|+.|||+.+
T Consensus       128 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  207 (373)
T 2x4f_A          128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY  207 (373)
T ss_dssp             HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            45678999999999999999999999999999999999999999999888654 46999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||||+||++.. +..+.+||+|||++.............||+.|+|||++.+..++.++|||||
T Consensus       208 ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  274 (373)
T 2x4f_A          208 ILHLDLKPENILCVN-RDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSV  274 (373)
T ss_dssp             EECCCCCGGGEEEEE-TTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHH
T ss_pred             cccccCCHHHEEEec-CCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHH
Confidence            999999999999853 3456899999999987766655566779999999999998889999999996

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.6e-36  Score=214.11  Aligned_cols=146  Identities=37%  Similarity=0.557  Sum_probs=115.8

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++...+.+++..+..++.|++.|+.|||+.+++
T Consensus        91 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv  170 (349)
T 2w4o_A           91 DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV  170 (349)
T ss_dssp             --------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            45678899999999999999999999999999999999999999999998888899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||||+||++...+..+.+||+|||++.............||+.|+|||++.+..++.++|||||
T Consensus       171 H~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  236 (349)
T 2w4o_A          171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSV  236 (349)
T ss_dssp             CCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHH
T ss_pred             ecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHH
Confidence            999999999996444578999999999987655545556778999999999998899999999996

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=6.9e-35  Score=202.21  Aligned_cols=148  Identities=32%  Similarity=0.509  Sum_probs=134.2

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ....+.+.+|+.+++.++||||+++++++.+++..++++||+++++|.+.+.....+++..+..++.|++.|+.|||+.+
T Consensus        46 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  125 (284)
T 3kk8_A           46 ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG  125 (284)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            44567889999999999999999999999999999999999999999999988888999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++...+....+||+|||.+.............|++.|+|||++.+..++.++|||||
T Consensus       126 i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  193 (284)
T 3kk8_A          126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWAC  193 (284)
T ss_dssp             EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHH
Confidence            99999999999996544556699999999987766555566778999999999998899999999996

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=6.1e-35  Score=201.95  Aligned_cols=146  Identities=31%  Similarity=0.578  Sum_probs=133.2

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++.....+++..+..++.|++.|+.|||+.++
T Consensus        48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i  127 (277)
T 3f3z_A           48 EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV  127 (277)
T ss_dssp             SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            34678999999999999999999999999999999999999999999999888889999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++...+..+.++|+|||++.............+|+.|+|||++.+ .++.++|||||
T Consensus       128 ~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~sl  193 (277)
T 3f3z_A          128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSA  193 (277)
T ss_dssp             ECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHH
T ss_pred             cCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhcc-cCCchhhehhH
Confidence            9999999999996656778899999999987766666666789999999999875 48999999996

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.2e-35  Score=208.08  Aligned_cols=143  Identities=34%  Similarity=0.529  Sum_probs=121.2

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++||||+++++++.+++..|++|||+++++|.+++...+.+++..+..++.|++.|+.|||++|++
T Consensus        64 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv  143 (327)
T 3a62_A           64 DTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGII  143 (327)
T ss_dssp             -------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence            45668889999999999999999999999999999999999999999999888899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||||+||++   +..+.+||+|||++...... ......+||+.|+|||++.+..++.++|||||
T Consensus       144 H~Dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  207 (327)
T 3a62_A          144 YRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSL  207 (327)
T ss_dssp             CCCCCTTTEEE---CTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHH
T ss_pred             cccCCHHHeEE---CCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhH
Confidence            99999999999   67789999999998754332 33445678999999999998899999999996

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.2e-35  Score=210.15  Aligned_cols=145  Identities=29%  Similarity=0.451  Sum_probs=127.8

Q ss_pred             hhhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC----------------CCCHHHHH
Q 031702            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR   69 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----------------~~~~~~~~   69 (154)
                      ....+.+.+|+.+++.+ +||||+++++++.+.+.+|++|||+++|+|.+++....                .++...+.
T Consensus       127 ~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  206 (370)
T 2psq_A          127 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV  206 (370)
T ss_dssp             HHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHH
Confidence            34567899999999999 89999999999999999999999999999999997653                37889999


Q ss_pred             HHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCCC
Q 031702           70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYD  146 (154)
Q Consensus        70 ~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~  146 (154)
                      .++.|++.|++|||+++++|+||||+||++   +..+.+||+|||++.......   ......+++.|+|||++.+..++
T Consensus       207 ~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  283 (370)
T 2psq_A          207 SCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT  283 (370)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC
T ss_pred             HHHHHHHHHHHHHHhCCeeccccchhhEEE---CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC
Confidence            999999999999999999999999999999   678899999999998654432   22334567889999999988999


Q ss_pred             cccceecC
Q 031702          147 EKVNFFVS  154 (154)
Q Consensus       147 ~~~Diwsl  154 (154)
                      .++|||||
T Consensus       284 ~~~Dvwsl  291 (370)
T 2psq_A          284 HQSDVWSF  291 (370)
T ss_dssp             HHHHHHHH
T ss_pred             cHHHHHHH
Confidence            99999996

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.5e-35  Score=215.26  Aligned_cols=141  Identities=32%  Similarity=0.581  Sum_probs=127.2

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (154)
                      .+.+.+|..+++.++||||+++++++.+++.+|++|||++||+|.+++.. ..+++..+..++.|++.|++|||+.|++|
T Consensus       113 ~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givH  191 (410)
T 3v8s_A          113 SAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIH  191 (410)
T ss_dssp             CSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            45688999999999999999999999999999999999999999998874 57999999999999999999999999999


Q ss_pred             ecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCcccccccC----CCcccceecC
Q 031702           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQR----YDEKVNFFVS  154 (154)
Q Consensus        90 ~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~----~~~~~Diwsl  154 (154)
                      |||||+||++   +..+.+||+|||++.......  .....+||+.|+|||++.+..    |+.++|||||
T Consensus       192 rDLKp~NILl---~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSl  259 (410)
T 3v8s_A          192 RDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV  259 (410)
T ss_dssp             CCCSGGGEEE---CTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHH
T ss_pred             ccCCHHHeeE---CCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecc
Confidence            9999999999   788899999999998765443  234678999999999998655    7899999996

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.2e-35  Score=213.12  Aligned_cols=143  Identities=32%  Similarity=0.571  Sum_probs=128.2

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|..++..++||||+++++++.+.+.+|++|||+++|+|.+++.+.+ .+++..++.++.|++.|++|||+.++
T Consensus       104 ~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~gi  183 (412)
T 2vd5_A          104 EVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGY  183 (412)
T ss_dssp             GGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34568999999999999999999999999999999999999999999998754 79999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--cccccCCccccCccccc-------ccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ-------FQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~y~aPE~~~-------~~~~~~~~Diwsl  154 (154)
                      +||||||+||++   +..+.+||+|||++........  ....+||+.|+|||++.       ...|+.++|||||
T Consensus       184 iHrDLKp~NILl---d~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSl  256 (412)
T 2vd5_A          184 VHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWAL  256 (412)
T ss_dssp             ECCCCSGGGEEE---CTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHH
T ss_pred             eecccCHHHeee---cCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHH
Confidence            999999999999   7788999999999987654432  33468999999999987       3568999999996

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.6e-35  Score=211.11  Aligned_cols=143  Identities=34%  Similarity=0.566  Sum_probs=121.9

Q ss_pred             hHHhHHHHHHH-HhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|..+ ++.++||||+++++++.+.+.+|++|||++||+|.+++.+.+.+++..++.++.|++.|++|||++|+
T Consensus        81 ~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gi  160 (373)
T 2r5t_A           81 EEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNI  160 (373)
T ss_dssp             ----------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            34556677776 56789999999999999999999999999999999999988899999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccC-CCCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +||||||+||++   +..+.+||+|||++.... ........+||+.|+|||++.+..|+.++|||||
T Consensus       161 vHrDlkp~NIll---~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  225 (373)
T 2r5t_A          161 VYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCL  225 (373)
T ss_dssp             CCCCCCGGGEEE---CTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHH
T ss_pred             eecCCCHHHEEE---CCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHH
Confidence            999999999999   678899999999997643 3334566789999999999999999999999996

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.2e-35  Score=211.44  Aligned_cols=145  Identities=37%  Similarity=0.552  Sum_probs=118.9

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++...+.+++..++.++.|++.|+.|||++|++
T Consensus        59 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~iv  138 (361)
T 3uc3_A           59 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQIC  138 (361)
T ss_dssp             SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            35678899999999999999999999999999999999999999999998888999999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcc-cceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEK-VNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Diwsl  154 (154)
                      |+||||+||++.. +..+.+||+|||++.............||+.|+|||++.+..++.+ +|||||
T Consensus       139 H~Dlkp~Nill~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  204 (361)
T 3uc3_A          139 HRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSC  204 (361)
T ss_dssp             SCCCCGGGEEECS-SSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHH
T ss_pred             cCCCCHHHEEEcC-CCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehh
Confidence            9999999999942 2233599999999876544445556679999999999988888755 899996

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.1e-35  Score=219.86  Aligned_cols=143  Identities=33%  Similarity=0.500  Sum_probs=130.9

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ..+.+.+|+.+++.++||||+++++++.+.+.+|++|||++||+|.+++...+.  +++..+..++.|++.|++|||++|
T Consensus       227 ~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g  306 (576)
T 2acx_A          227 GEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER  306 (576)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            346688999999999999999999999999999999999999999999876543  999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++||||||+||++   +..+.+||+|||++............+||+.|+|||++.+..|+.++|||||
T Consensus       307 IvHrDLKPeNILl---d~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSL  371 (576)
T 2acx_A          307 IVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWAL  371 (576)
T ss_dssp             EECCCCCGGGEEE---CTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHH
T ss_pred             EeccCCchheEEE---eCCCCeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHH
Confidence            9999999999999   6788999999999987766555556789999999999998889999999996

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-35  Score=212.53  Aligned_cols=146  Identities=27%  Similarity=0.506  Sum_probs=130.7

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      .....+.+|+.+++.++||||+++++++.+.+..+++|||+++++|.+++.... .+++..+..++.|++.|+.|||+.+
T Consensus        90 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g  169 (387)
T 1kob_A           90 LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS  169 (387)
T ss_dssp             HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            345678999999999999999999999999999999999999999999886543 6999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||||+||++.. +..+.+||+|||++.............||+.|+|||++.+..++.++|||||
T Consensus       170 ivHrDlkp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  236 (387)
T 1kob_A          170 IVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAI  236 (387)
T ss_dssp             EECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHH
T ss_pred             eeecccchHHeEEec-CCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeH
Confidence            999999999999942 2356799999999987766555556789999999999998889999999996

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=7e-35  Score=205.83  Aligned_cols=145  Identities=27%  Similarity=0.520  Sum_probs=124.0

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCC-----------------------------------------------
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----------------------------------------------   39 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----------------------------------------------   39 (154)
                      +...+.+.+|+.+++.++||||+++++++.+.+                                               
T Consensus        45 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  124 (332)
T 3qd2_B           45 ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV  124 (332)
T ss_dssp             TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-------------------------------------
T ss_pred             hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCccccc
Confidence            345688999999999999999999999885443                                               


Q ss_pred             ----------cEEEEEEecCCCCchHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCe
Q 031702           40 ----------CIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV  106 (154)
Q Consensus        40 ----------~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~  106 (154)
                                ..+++|||+++++|.+++.....   .+...++.++.|++.|++|||+++++|+||||+||++   +..+
T Consensus       125 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~  201 (332)
T 3qd2_B          125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDD  201 (332)
T ss_dssp             -------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTC
T ss_pred             ccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCC
Confidence                      38999999999999999986544   5566789999999999999999999999999999999   6778


Q ss_pred             eEEEeecccccccCCCC-------------ccccccCCccccCcccccccCCCcccceecC
Q 031702          107 MLKIADFGLSCTLYPGN-------------YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus       107 ~~kl~df~~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .+||+|||++.......             ......||+.|+|||++.+..++.++|||||
T Consensus       202 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  262 (332)
T 3qd2_B          202 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSL  262 (332)
T ss_dssp             CEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHH
T ss_pred             CEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHH
Confidence            99999999998765432             2233568999999999998899999999996

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1e-34  Score=215.05  Aligned_cols=146  Identities=36%  Similarity=0.624  Sum_probs=130.3

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++||||+++++++.+++.+|+++||+.+++|.+.+.....+++..+..++.|++.|+.|||+.|+
T Consensus        63 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i  142 (486)
T 3mwu_A           63 KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI  142 (486)
T ss_dssp             SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34678899999999999999999999999999999999999999999999888899999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||||+||++...+..+.+||+|||++.............||+.|+|||++.+ .|+.++|||||
T Consensus       143 vH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Diwsl  208 (486)
T 3mwu_A          143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSA  208 (486)
T ss_dssp             CCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHH
T ss_pred             EeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHH
Confidence            9999999999996555667899999999987766655566789999999999875 69999999996

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.6e-35  Score=216.15  Aligned_cols=142  Identities=39%  Similarity=0.720  Sum_probs=131.3

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (154)
                      .+.+.+|+.+++.++||||+++++++.+++..|++|||+++++|.+++.+++.+++..+..++.|++.|+.|||+.+++|
T Consensus        60 ~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH  139 (476)
T 2y94_A           60 VGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVH  139 (476)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCc
Confidence            46789999999999999999999999999999999999999999999988888999999999999999999999999999


Q ss_pred             ecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCC-CcccceecC
Q 031702           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVNFFVS  154 (154)
Q Consensus        90 ~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Diwsl  154 (154)
                      +||||+||++   +..+.+||+|||++............+||+.|+|||++.+..+ +.++|||||
T Consensus       140 rDLkp~NIll---~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  202 (476)
T 2y94_A          140 RDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSS  202 (476)
T ss_dssp             SCCSGGGEEE---CTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHH
T ss_pred             ccccHHHEEE---ecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhh
Confidence            9999999999   6788999999999987766666667789999999999988765 689999996

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1e-34  Score=215.46  Aligned_cols=146  Identities=37%  Similarity=0.617  Sum_probs=132.4

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++||||+++++++.+++..|++|||+++|+|.+.+.....+++..+..++.|++.|+.|||+.|+
T Consensus        78 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  157 (494)
T 3lij_A           78 SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNI  157 (494)
T ss_dssp             CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            34677899999999999999999999999999999999999999999999888899999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||||+||++...+..+.+||+|||++.............||+.|+|||++. +.|+.++|||||
T Consensus       158 vH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~Diwsl  223 (494)
T 3lij_A          158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSI  223 (494)
T ss_dssp             ECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHH
T ss_pred             eeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHH
Confidence            999999999999654456679999999998776665566678999999999986 568999999996

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4e-35  Score=215.19  Aligned_cols=143  Identities=31%  Similarity=0.488  Sum_probs=121.0

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCc
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-HHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~   87 (154)
                      ....+.+|+.+++.++||||+++++++.+.+.+|++|||+++++|.+++.....+++..+..++.|++.|++|||+ .|+
T Consensus       191 ~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~gi  270 (446)
T 4ejn_A          191 EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV  270 (446)
T ss_dssp             ----------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCC
T ss_pred             HHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCE
Confidence            3466788999999999999999999999999999999999999999999888899999999999999999999998 999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCC-CCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||||+||++   +..+.+||+|||++..... .......+||+.|+|||++.+..|+.++|||||
T Consensus       271 iHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  335 (446)
T 4ejn_A          271 VYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL  335 (446)
T ss_dssp             CCCCCCGGGEEE---CSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHH
T ss_pred             EECCCCHHHEEE---CCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhh
Confidence            999999999999   6778999999999976433 334456789999999999998999999999996

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.3e-34  Score=204.31  Aligned_cols=142  Identities=29%  Similarity=0.578  Sum_probs=130.3

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (154)
                      .+.+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++.....+++..+..++.|++.|+.|||+.+++|
T Consensus        59 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH  138 (321)
T 2a2a_A           59 REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH  138 (321)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            57799999999999999999999999999999999999999999999988888999999999999999999999999999


Q ss_pred             ecCCCCcEEeecCCCCe----eEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           90 RDLKPENILLSGLDDDV----MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        90 ~~i~p~nil~~~~~~~~----~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +||+|+||++.   ..+    .+||+|||++.............||+.|+|||++.+..++.++|||||
T Consensus       139 ~dikp~NIl~~---~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  204 (321)
T 2a2a_A          139 FDLKPENIMLL---DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSI  204 (321)
T ss_dssp             CCCSGGGEEES---CTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred             CCCChHHEEEe---cCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHH
Confidence            99999999994   333    799999999987766555556678999999999998899999999996

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.2e-35  Score=209.63  Aligned_cols=143  Identities=34%  Similarity=0.530  Sum_probs=130.2

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCC-CchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG-NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+.+++.++||||+++++++.+.+..+++|||+.+| +|.+++.....+++..+..++.|++.|+.|||+.++
T Consensus        72 ~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i  151 (335)
T 3dls_A           72 KLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDI  151 (335)
T ss_dssp             TTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            3457788999999999999999999999999999999998766 999999988889999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCC-CcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Diwsl  154 (154)
                      +|+||||+||++   +..+.+||+|||++.............||+.|+|||++.+..+ +.++|||||
T Consensus       152 vH~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  216 (335)
T 3dls_A          152 IHRDIKDENIVI---AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSL  216 (335)
T ss_dssp             ECSCCSGGGEEE---CTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHH
T ss_pred             EEeccCHHHEEE---cCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhH
Confidence            999999999999   6778999999999987766666666789999999999987776 789999996

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.8e-35  Score=217.84  Aligned_cols=146  Identities=35%  Similarity=0.608  Sum_probs=133.2

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++||||+++++++.+.+..++++||+.+++|.+++.....+++..+..++.|++.|+.|||++++
T Consensus        68 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  147 (484)
T 3nyv_A           68 TDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKI  147 (484)
T ss_dssp             SCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             hHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34678999999999999999999999999999999999999999999999888899999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||||+||++...+..+.+||+|||++.............||+.|+|||++.+ .|+.++|||||
T Consensus       148 vH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Diwsl  213 (484)
T 3nyv_A          148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWST  213 (484)
T ss_dssp             CCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHH
T ss_pred             eeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHH
Confidence            9999999999996545678899999999987766655566789999999999875 69999999996

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=9.9e-35  Score=204.18  Aligned_cols=145  Identities=26%  Similarity=0.447  Sum_probs=120.6

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      ....+.+.+|+.+++.++||||+++++++.+.+..+++|||+++++|.+++.....   +++..+..++.|++.|++|||
T Consensus        75 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH  154 (309)
T 3p86_A           75 AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH  154 (309)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            44567889999999999999999999999999999999999999999999976543   999999999999999999999


Q ss_pred             hCC--ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           84 SHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~--~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +.+  ++|+||||+||++   +..+.+||+|||++....... ......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  225 (309)
T 3p86_A          155 NRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSF  225 (309)
T ss_dssp             TSSSCCCCTTCCGGGEEE---CTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHH
T ss_pred             cCCCCEECCCCChhhEEE---eCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHH
Confidence            999  9999999999999   678899999999987544332 2345678999999999999899999999996

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4e-35  Score=212.63  Aligned_cols=144  Identities=31%  Similarity=0.583  Sum_probs=117.8

Q ss_pred             HhHHHHHHHHhh-CCCCccchhhhheec----CCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH
Q 031702           11 SCLDCELNFLSS-VNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus        11 ~~~~~e~~~l~~-l~h~~i~~~~~~~~~----~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      ..+.+|+.++.+ .+||||+++++++..    .+.+|++|||+++|+|.+++....  .+++..+..++.|++.|+.|||
T Consensus        99 ~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH  178 (400)
T 1nxk_A           99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH  178 (400)
T ss_dssp             HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            457788888755 489999999999865    567999999999999999997653  5999999999999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +.+++|+||||+||++......+.+||+|||++............+||+.|+|||++.+..|+.++|||||
T Consensus       179 ~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  249 (400)
T 1nxk_A          179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL  249 (400)
T ss_dssp             HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHH
T ss_pred             HCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHH
Confidence            99999999999999995433378899999999987665555566788999999999998999999999996

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-34  Score=203.86  Aligned_cols=146  Identities=25%  Similarity=0.454  Sum_probs=127.7

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCC--cEEEEEEecCCCCchHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      ..+.+.+|+.+++.++||||+++++++...+  ..+++|||+++++|.+++.....   +++..++.++.|++.|+.|||
T Consensus        50 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH  129 (319)
T 4euu_A           50 PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR  129 (319)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            3577889999999999999999999987654  78999999999999999976543   999999999999999999999


Q ss_pred             hCCceeecCCCCcEEeec-CCCCeeEEEeecccccccCCCCccccccCCccccCccccc--------ccCCCcccceecC
Q 031702           84 SHHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ--------FQRYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~-~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Diwsl  154 (154)
                      +.+++|+||||+||++.. .+..+.+||+|||++.............||+.|+|||++.        +..++.++|||||
T Consensus       130 ~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Diwsl  209 (319)
T 4euu_A          130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI  209 (319)
T ss_dssp             HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHH
T ss_pred             HCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHH
Confidence            999999999999999732 3466789999999998776666556677999999999986        4678999999996

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.2e-34  Score=214.02  Aligned_cols=145  Identities=37%  Similarity=0.650  Sum_probs=131.4

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++||||+++++++.+++..|++|||+++++|.+++.....+++..+..++.|++.|+.|||+.+++
T Consensus        89 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv  168 (504)
T 3q5i_A           89 FHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIV  168 (504)
T ss_dssp             THHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            45789999999999999999999999999999999999999999999998888999999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||||+||++...+....+||+|||++.............||+.|+|||++. +.|+.++|||||
T Consensus       169 H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Diwsl  233 (504)
T 3q5i_A          169 HRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSC  233 (504)
T ss_dssp             CSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHH
T ss_pred             eCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHH
Confidence            99999999999643334579999999998776665666678999999999987 568999999996

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.2e-35  Score=209.52  Aligned_cols=148  Identities=24%  Similarity=0.349  Sum_probs=128.5

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-------CCCHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------RVPEQTARKFLQQLGAGL   79 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~i~~~l   79 (154)
                      ......+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++....       .+++..++.++.|++.|+
T Consensus       115 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL  194 (367)
T 3l9p_A          115 EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC  194 (367)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHH
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHH
Confidence            4556678999999999999999999999999999999999999999999997653       488999999999999999


Q ss_pred             HHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCC---CccccccCCccccCcccccccCCCcccceecC
Q 031702           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        80 ~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .|||++|++||||||+||++........+||+|||++......   .......+|+.|+|||++.+..++.++|||||
T Consensus       195 ~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvwsl  272 (367)
T 3l9p_A          195 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF  272 (367)
T ss_dssp             HHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHH
Confidence            9999999999999999999954335557999999999754222   23344567889999999998999999999996

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.6e-34  Score=207.48  Aligned_cols=145  Identities=25%  Similarity=0.387  Sum_probs=128.1

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ....+.+.+|+.+++.++||||+++++++.+++..|++|||+++++|.+++...  ..+++..+..++.|++.|+.|||+
T Consensus        67 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~  146 (389)
T 3gni_B           67 NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH  146 (389)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            455688899999999999999999999999999999999999999999999876  679999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCC--------CccccccCCccccCcccccc--cCCCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--------NYAEKVCGSPLYMAPEVLQF--QRYDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~--~~~~~~~Diwsl  154 (154)
                      ++++|+||||+||++   +..+.+||+|||.+......        .......||+.|+|||++.+  ..++.++|||||
T Consensus       147 ~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl  223 (389)
T 3gni_B          147 MGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV  223 (389)
T ss_dssp             TTEECCCCSGGGEEE---CTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHH
T ss_pred             CCeecCCCCHHHEEE---cCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHH
Confidence            999999999999999   67889999999987654222        12233578899999999987  578999999996

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.2e-34  Score=204.98  Aligned_cols=145  Identities=26%  Similarity=0.460  Sum_probs=126.0

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ....+.+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++... ..+++..+..++.|++.|+.|||+.
T Consensus        91 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~  170 (325)
T 3kul_A           91 ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL  170 (325)
T ss_dssp             HHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            455678999999999999999999999999999999999999999999999755 5799999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc----cccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||||+||++   +..+.+||+|||++........    .....+|+.|+|||++.+..++.++|||||
T Consensus       171 ~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl  240 (325)
T 3kul_A          171 GYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSF  240 (325)
T ss_dssp             TEECSCCSGGGEEE---CTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHH
T ss_pred             CeeCCCCCcceEEE---CCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHH
Confidence            99999999999999   6788999999999987644321    222345678999999998899999999996

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.1e-34  Score=214.32  Aligned_cols=142  Identities=35%  Similarity=0.504  Sum_probs=128.8

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      .+.+.+|..+++.++||||+++++++.+.+.+|++|||++||+|.+++...    ..+++..+..++.|++.|+.|||++
T Consensus       229 ~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~  308 (543)
T 3c4z_A          229 YQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR  308 (543)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc
Confidence            467889999999999999999999999999999999999999999998754    3599999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc-cccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |++||||||+||++   +..+.+||+|||++........ ....+||+.|+|||++.+..|+.++|||||
T Consensus       309 gIvHrDLKP~NILl---~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSl  375 (543)
T 3c4z_A          309 NIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFAL  375 (543)
T ss_dssp             TEECCCCCGGGEEE---CTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHH
T ss_pred             CCcccCCChHHEEE---eCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcc
Confidence            99999999999999   7788999999999987655433 344589999999999999899999999996

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.9e-34  Score=200.00  Aligned_cols=143  Identities=30%  Similarity=0.528  Sum_probs=124.2

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|+.+++.++||||+++++++.+++..+++|||+++ ++.+.+ ...+.+++..+..++.|++.|++|||++|
T Consensus        43 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~  121 (292)
T 3o0g_A           43 GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN  121 (292)
T ss_dssp             THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            3457788999999999999999999999999999999999976 555554 44678999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCcccccccC-CCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diwsl  154 (154)
                      ++|+||||+||++   +..+.+||+|||++...... .......+|+.|+|||++.+.. ++.++|||||
T Consensus       122 ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  188 (292)
T 3o0g_A          122 VLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA  188 (292)
T ss_dssp             EECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHH
T ss_pred             eecCCCCHHHEEE---cCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHH
Confidence            9999999999999   67889999999999766433 2334567899999999997665 7999999996

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.7e-34  Score=197.49  Aligned_cols=146  Identities=31%  Similarity=0.603  Sum_probs=126.3

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++||||+++++++.+++..++++||+++++|.+++.....+++..+..++.|++.|+.|||+.+++
T Consensus        51 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  130 (283)
T 3bhy_A           51 SREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIA  130 (283)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            36789999999999999999999999999999999999999999999998888899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCC-CCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLD-DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~-~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||+|+||++.... ....++|+|||.+.............+++.|+|||++.+..++.++|||||
T Consensus       131 H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  197 (283)
T 3bhy_A          131 HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSI  197 (283)
T ss_dssp             CSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred             CCCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhH
Confidence            999999999994321 223799999999987655554555678999999999998899999999996

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.5e-34  Score=207.90  Aligned_cols=145  Identities=23%  Similarity=0.434  Sum_probs=118.9

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ....+.+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++...+ .+++..+..++.|++.|+.|||+.
T Consensus        87 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~  166 (373)
T 2qol_A           87 EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM  166 (373)
T ss_dssp             HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4456789999999999999999999999999999999999999999999997654 699999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc----cccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||||+||++   +..+.+||+|||++........    .....+++.|+|||++.+..++.++|||||
T Consensus       167 ~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~Sl  236 (373)
T 2qol_A          167 GYVHRDLAARNILI---NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSY  236 (373)
T ss_dssp             TCCCSCCCGGGEEE---CTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHH
T ss_pred             CeeCCCCCcceEEE---cCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHH
Confidence            99999999999999   6788999999999976544321    112234678999999998899999999996

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-34  Score=204.45  Aligned_cols=145  Identities=24%  Similarity=0.474  Sum_probs=127.4

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc------------------------CC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------------------------GR   62 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~------------------------~~   62 (154)
                      ....+.+.+|+.+++.++||||+++++++.+.+..+++|||+++++|.+++...                        ..
T Consensus        91 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (343)
T 1luf_A           91 ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP  170 (343)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CC
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCC
Confidence            345678999999999999999999999999999999999999999999999764                        56


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCccc
Q 031702           63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEV  139 (154)
Q Consensus        63 ~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~  139 (154)
                      +++..++.++.|++.|+.|||+.+++|+||||+||++   +..+.+||+|||++.......   ......+++.|+|||+
T Consensus       171 l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~  247 (343)
T 1luf_A          171 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPES  247 (343)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---CCCCeEEEeecCCCcccccCccccccCCCcccceecChhh
Confidence            8999999999999999999999999999999999999   678899999999987654332   2234557888999999


Q ss_pred             ccccCCCcccceecC
Q 031702          140 LQFQRYDEKVNFFVS  154 (154)
Q Consensus       140 ~~~~~~~~~~Diwsl  154 (154)
                      +.+..++.++|||||
T Consensus       248 ~~~~~~~~~~Di~sl  262 (343)
T 1luf_A          248 IFYNRYTTESDVWAY  262 (343)
T ss_dssp             HHHCCCCHHHHHHHH
T ss_pred             hccCCcCcccccHHH
Confidence            998899999999996

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5.3e-34  Score=218.10  Aligned_cols=144  Identities=33%  Similarity=0.574  Sum_probs=131.4

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+..|..++..+ +||+|+++++++.+.+.+|+||||+++|+|.+++...+.+++..++.++.|++.|++|||+.+
T Consensus       383 ~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g  462 (674)
T 3pfq_A          383 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG  462 (674)
T ss_dssp             TTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS
T ss_pred             HHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            3456788899999988 799999999999999999999999999999999998889999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccC-CCCccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++||||||+||++   +..+.+||+|||++.... ........+||+.|+|||++.+..|+.++|||||
T Consensus       463 IiHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSl  528 (674)
T 3pfq_A          463 IIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF  528 (674)
T ss_dssp             EECCCCCSTTEEE---CSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHH
T ss_pred             eEeccCChhhEEE---cCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEech
Confidence            9999999999999   778899999999998643 3334566789999999999999999999999996

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.6e-34  Score=204.55  Aligned_cols=142  Identities=20%  Similarity=0.244  Sum_probs=126.4

Q ss_pred             hHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ..+.+.+|+.+++.+ +||||+++++++.+++..+++|||+ +++|.+++... ..+++..+..++.|++.|++|||+.+
T Consensus        47 ~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~  125 (330)
T 2izr_A           47 RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN  125 (330)
T ss_dssp             SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            356789999999999 9999999999999999999999999 89999999864 67999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCee-----EEEeecccccccCCCCc--------cccccCCccccCcccccccCCCcccceec
Q 031702           87 IIHRDLKPENILLSGLDDDVM-----LKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVNFFV  153 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~-----~kl~df~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Diws  153 (154)
                      ++|+||||+||++   +..+.     +||+|||++........        .....||+.|+|||++.+..++.++||||
T Consensus       126 iiHrDlkp~Nill---~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s  202 (330)
T 2izr_A          126 LIYRDVKPENFLI---GRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEA  202 (330)
T ss_dssp             EECCCCCGGGEEE---CCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHH
T ss_pred             eeccCCCHHHeee---ccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHH
Confidence            9999999999999   45554     99999999986544322        24567899999999999999999999999


Q ss_pred             C
Q 031702          154 S  154 (154)
Q Consensus       154 l  154 (154)
                      |
T Consensus       203 l  203 (330)
T 2izr_A          203 L  203 (330)
T ss_dssp             H
T ss_pred             H
Confidence            6

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.6e-34  Score=198.53  Aligned_cols=145  Identities=32%  Similarity=0.599  Sum_probs=123.4

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ..+.+.+|+.+++.++||||+++++++.+.+..+++|||+++++|.+++...    ..+++..+..++.|++.|+.|||+
T Consensus        63 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~  142 (285)
T 3is5_A           63 PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS  142 (285)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            3578999999999999999999999999999999999999999999988543    679999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .+++|+||+|+||++...+..+.+||+|||++.............+++.|+|||++. +.++.++|||||
T Consensus       143 ~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~sl  211 (285)
T 3is5_A          143 QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSA  211 (285)
T ss_dssp             TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHH
T ss_pred             CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehH
Confidence            999999999999999655566789999999998766655556677899999999986 568999999996

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.8e-34  Score=210.29  Aligned_cols=143  Identities=36%  Similarity=0.623  Sum_probs=118.6

Q ss_pred             HhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 031702           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR   90 (154)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~   90 (154)
                      ..+.+|+.+++.++||||+++++++.. +..+++|||+++++|.+++.....+++..+..++.|++.|+.|||+++++|+
T Consensus       185 ~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHr  263 (419)
T 3i6u_A          185 LNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHR  263 (419)
T ss_dssp             CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            468899999999999999999998854 4579999999999999998878889999999999999999999999999999


Q ss_pred             cCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc---cCCCcccceecC
Q 031702           91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---QRYDEKVNFFVS  154 (154)
Q Consensus        91 ~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Diwsl  154 (154)
                      ||||+||++...+....+||+|||++............+||+.|+|||++.+   ..++.++|||||
T Consensus       264 Dlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Diwsl  330 (419)
T 3i6u_A          264 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL  330 (419)
T ss_dssp             CCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHH
T ss_pred             CCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhH
Confidence            9999999996544566799999999987766555566789999999999853   568899999996

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.8e-34  Score=210.00  Aligned_cols=144  Identities=24%  Similarity=0.400  Sum_probs=121.8

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheec-----CCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~   81 (154)
                      ....+.+.+|+.+++.++||||+++++++..     ...+|++|||+ +++|.+++.....+++..++.++.|++.||.|
T Consensus        93 ~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~  171 (458)
T 3rp9_A           93 LIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKY  171 (458)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHH
Confidence            3456788999999999999999999999843     35799999998 56999999888889999999999999999999


Q ss_pred             HHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC----------------------------ccccccCCcc
Q 031702           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----------------------------YAEKVCGSPL  133 (154)
Q Consensus        82 lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~----------------------------~~~~~~~~~~  133 (154)
                      ||+.+++||||||+||++   +..+.+||+|||+++......                            .....+||++
T Consensus       172 LH~~~iiHrDlKp~NILl---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  248 (458)
T 3rp9_A          172 VHSAGILHRDLKPANCLV---NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRW  248 (458)
T ss_dssp             HHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCT
T ss_pred             HHhCCcCCCCCChhhEEE---CCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCccccc
Confidence            999999999999999999   678899999999997654221                            1233567999


Q ss_pred             ccCcccc-cccCCCcccceecC
Q 031702          134 YMAPEVL-QFQRYDEKVNFFVS  154 (154)
Q Consensus       134 y~aPE~~-~~~~~~~~~Diwsl  154 (154)
                      |+|||++ .+..|+.++|||||
T Consensus       249 Y~aPE~~~~~~~~~~~~DiwSl  270 (458)
T 3rp9_A          249 YRAPELILLQENYTEAIDVWSI  270 (458)
T ss_dssp             TCCHHHHTTCCCCCTHHHHHHH
T ss_pred             ccChHHhhCCCCCCcHhHHHHH
Confidence            9999986 45679999999996

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.3e-34  Score=198.41  Aligned_cols=143  Identities=25%  Similarity=0.444  Sum_probs=126.6

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++... ..+++..+..++.|++.|+.|||+.++
T Consensus        48 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i  127 (269)
T 4hcu_A           48 SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV  127 (269)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            3577999999999999999999999999999999999999999999999654 458999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||++.......  ......+++.|+|||++.+..++.++|||||
T Consensus       128 ~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  193 (269)
T 4hcu_A          128 IHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF  193 (269)
T ss_dssp             CCSCCCGGGEEE---CGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             ecCCcchheEEE---cCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHH
Confidence            999999999999   677889999999997654332  2233456778999999998899999999996

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.2e-34  Score=205.25  Aligned_cols=145  Identities=28%  Similarity=0.448  Sum_probs=128.5

Q ss_pred             hhhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC----------------CCCHHHHH
Q 031702            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR   69 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----------------~~~~~~~~   69 (154)
                      ....+.+.+|+.+++.+ +||||+++++++.+++..+++|||+++++|.+++....                .+++..++
T Consensus       115 ~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~  194 (382)
T 3tt0_A          115 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV  194 (382)
T ss_dssp             HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHH
Confidence            34557899999999999 99999999999999999999999999999999998654                48999999


Q ss_pred             HHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCCC
Q 031702           70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYD  146 (154)
Q Consensus        70 ~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~  146 (154)
                      .++.|++.|+.|||+.+++|+||||+||++   +..+.+||+|||++.......   ......+++.|+|||++.+..++
T Consensus       195 ~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  271 (382)
T 3tt0_A          195 SCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT  271 (382)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC
T ss_pred             HHHHHHHHHHHHHHhCCEecCCCCcceEEE---cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC
Confidence            999999999999999999999999999999   677899999999998664432   22334567889999999988999


Q ss_pred             cccceecC
Q 031702          147 EKVNFFVS  154 (154)
Q Consensus       147 ~~~Diwsl  154 (154)
                      .++|||||
T Consensus       272 ~~~Diwsl  279 (382)
T 3tt0_A          272 HQSDVWSF  279 (382)
T ss_dssp             HHHHHHHH
T ss_pred             chhHHHHH
Confidence            99999996

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=9.3e-34  Score=201.08  Aligned_cols=145  Identities=29%  Similarity=0.547  Sum_probs=131.7

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ....+.+.+|+.+++.++||||+++++++.+.+..+++|||+++++|.+++.....+++..+..++.|++.|+.|||+++
T Consensus        82 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  161 (335)
T 2owb_A           82 PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR  161 (335)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34578899999999999999999999999999999999999999999999988889999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.+||+|||++...... .......|++.|+|||++.+..++.++|||||
T Consensus       162 ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  227 (335)
T 2owb_A          162 VIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSI  227 (335)
T ss_dssp             EECSCCCGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHH
T ss_pred             CEecCCCchhEEE---cCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHH
Confidence            9999999999999   67788999999999776433 23445678999999999998889999999996

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.8e-35  Score=208.18  Aligned_cols=139  Identities=24%  Similarity=0.307  Sum_probs=117.7

Q ss_pred             HHhHHHHHHHHhhCC--------------------------CCccchhhhheec-------------CCcEEEEEEecCC
Q 031702           10 KSCLDCELNFLSSVN--------------------------HPNIIRLFDAFQA-------------ENCIFLVVEFCAG   50 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~--------------------------h~~i~~~~~~~~~-------------~~~~~~v~e~~~~   50 (154)
                      .+.+.+|+.+++.++                          ||||+++++++.+             ++..|++|||+++
T Consensus        67 ~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~  146 (336)
T 2vuw_A           67 FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG  146 (336)
T ss_dssp             HHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECC
T ss_pred             HHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCC
Confidence            378899999999987                          7888888888876             7889999999999


Q ss_pred             CCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-hCCceeecCCCCcEEeecCC-----------------CCeeEEEee
Q 031702           51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN-SHHIIHRDLKPENILLSGLD-----------------DDVMLKIAD  112 (154)
Q Consensus        51 ~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~~~h~~i~p~nil~~~~~-----------------~~~~~kl~d  112 (154)
                      |++.+.+. ...+++..++.++.|++.|++||| +.+++||||||+||++....                 ....+||+|
T Consensus       147 g~ll~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~D  225 (336)
T 2vuw_A          147 GIDLEQMR-TKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIID  225 (336)
T ss_dssp             CEETGGGT-TTCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECC
T ss_pred             CccHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEee
Confidence            97666654 366899999999999999999999 99999999999999996422                 123899999


Q ss_pred             cccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702          113 FGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus       113 f~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ||+++.....    ...||+.|+|||++.+.. +.++|||||
T Consensus       226 FG~a~~~~~~----~~~gt~~y~aPE~~~g~~-~~~~Diwsl  262 (336)
T 2vuw_A          226 YTLSRLERDG----IVVFCDVSMDEDLFTGDG-DYQFDIYRL  262 (336)
T ss_dssp             CTTCBEEETT----EEECCCCTTCSGGGCCCS-SHHHHHHHH
T ss_pred             ccccEecCCC----cEEEeecccChhhhcCCC-ccceehhhh
Confidence            9999865432    457899999999998665 899999995

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.4e-34  Score=209.53  Aligned_cols=143  Identities=26%  Similarity=0.440  Sum_probs=123.0

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecC-----CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL   82 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l   82 (154)
                      ...+.+.+|+.+++.++||||+++++++...     +.+|++|||++ ++|.+++.....+++..++.++.|++.|+.||
T Consensus        67 ~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~L  145 (432)
T 3n9x_A           67 IDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFI  145 (432)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            4567889999999999999999999999766     57999999995 59999998888899999999999999999999


Q ss_pred             HhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-----------------------ccccccCCccccCccc
Q 031702           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----------------------YAEKVCGSPLYMAPEV  139 (154)
Q Consensus        83 h~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-----------------------~~~~~~~~~~y~aPE~  139 (154)
                      |+.|++||||||+||++   +..+.+||+|||++.......                       ......||++|+|||+
T Consensus       146 H~~givHrDlkp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  222 (432)
T 3n9x_A          146 HESGIIHRDLKPANCLL---NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPEL  222 (432)
T ss_dssp             HHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHH
T ss_pred             HHCCCCCCCCCHHHeEE---CCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHH
Confidence            99999999999999999   678899999999998754332                       1245678999999998


Q ss_pred             c-cccCCCcccceecC
Q 031702          140 L-QFQRYDEKVNFFVS  154 (154)
Q Consensus       140 ~-~~~~~~~~~Diwsl  154 (154)
                      + ....|+.++|||||
T Consensus       223 ~~~~~~~~~~~DiwSl  238 (432)
T 3n9x_A          223 ILLQENYTKSIDIWST  238 (432)
T ss_dssp             HTTCSCCCTHHHHHHH
T ss_pred             HhcCCCCCcccccchH
Confidence            6 55679999999996

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.4e-33  Score=196.65  Aligned_cols=145  Identities=29%  Similarity=0.547  Sum_probs=131.4

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ....+.+.+|+.+++.++||||+++++++.+++..++++||+++++|.+++.....+++..+..++.|++.|+.|||+.+
T Consensus        56 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  135 (294)
T 2rku_A           56 PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR  135 (294)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34577899999999999999999999999999999999999999999999988889999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.+||+|||.+...... .......+++.|+|||++.+..++.++|||||
T Consensus       136 i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  201 (294)
T 2rku_A          136 VIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSI  201 (294)
T ss_dssp             EECCCCCGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHH
T ss_pred             ccccCCChHhEEE---cCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHH
Confidence            9999999999999   67788999999998765433 23344678999999999998889999999996

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2e-34  Score=198.49  Aligned_cols=143  Identities=26%  Similarity=0.499  Sum_probs=127.0

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++...+ .+++..+..++.|++.|+.|||+.++
T Consensus        46 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  125 (268)
T 3sxs_A           46 SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF  125 (268)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            45778999999999999999999999999999999999999999999997654 49999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--cccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||.+........  .....+++.|+|||++.+..++.++|||||
T Consensus       126 ~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  191 (268)
T 3sxs_A          126 IHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAF  191 (268)
T ss_dssp             EESSCSGGGEEE---CTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHH
T ss_pred             ecCCcCcceEEE---CCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHH
Confidence            999999999999   6788999999999976544332  223445677999999998889999999996

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.2e-34  Score=201.91  Aligned_cols=143  Identities=24%  Similarity=0.484  Sum_probs=128.7

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++||||+++++++..++..+++|||+++++|.+++. ...+++..+..++.|++.|+.|||+.++
T Consensus        84 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~~~i  162 (321)
T 2c30_A           84 QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGV  162 (321)
T ss_dssp             CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345778999999999999999999999999999999999999999999876 4579999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.+||+|||++....... ......||+.|+|||++.+..++.++|||||
T Consensus       163 vH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~sl  227 (321)
T 2c30_A          163 IHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSL  227 (321)
T ss_dssp             ECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             ecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHH
Confidence            999999999999   677899999999987665432 3345678999999999998899999999996

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.1e-34  Score=205.16  Aligned_cols=143  Identities=36%  Similarity=0.750  Sum_probs=130.7

Q ss_pred             hHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+.+++.+ +||||+++++++...+..+++|||+++++|.+++.....+++..+..++.|++.|+.|||+.|+
T Consensus       142 ~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi  221 (365)
T 2y7j_A          142 VREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNI  221 (365)
T ss_dssp             HHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            367789999999999 8999999999999999999999999999999999988889999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc------cCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF------QRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Diwsl  154 (154)
                      +|+||+|.||++   +..+.++|+|||++.............||+.|+|||++.+      ..++.++|||||
T Consensus       222 ~H~Dlkp~NIl~---~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~sl  291 (365)
T 2y7j_A          222 VHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWAC  291 (365)
T ss_dssp             ECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHH
T ss_pred             ecCCCCHHHEEE---CCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhH
Confidence            999999999999   6788999999999987766665666789999999999863      357889999996

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5.2e-35  Score=208.19  Aligned_cols=143  Identities=30%  Similarity=0.478  Sum_probs=126.2

Q ss_pred             hHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 031702           12 CLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR   90 (154)
Q Consensus        12 ~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~   90 (154)
                      ...+|++++.++ +||||+++++++.+++..|++|||+++|+|.+++...+.+++..+..++.|++.|+.|||+.|++|+
T Consensus        61 ~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHr  140 (342)
T 2qr7_A           61 DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHR  140 (342)
T ss_dssp             CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Confidence            456788999888 8999999999999999999999999999999999888889999999999999999999999999999


Q ss_pred             cCCCCcEEeecCC-CCeeEEEeecccccccCCC-CccccccCCccccCcccccccCCCcccceecC
Q 031702           91 DLKPENILLSGLD-DDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        91 ~i~p~nil~~~~~-~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ||||+||++...+ ....+||+|||++...... ......+||+.|+|||++.+..|+.++|||||
T Consensus       141 Dlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  206 (342)
T 2qr7_A          141 DLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSL  206 (342)
T ss_dssp             CCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHH
T ss_pred             cCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeH
Confidence            9999999985322 2346999999999866443 34456788999999999988889999999996

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.8e-34  Score=200.89  Aligned_cols=145  Identities=28%  Similarity=0.444  Sum_probs=127.6

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCC------------------------
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR------------------------   62 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~------------------------   62 (154)
                      ....+.+.+|+.+++.++||||+++++++.+.+..+++|||+++++|.+++.....                        
T Consensus        67 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (314)
T 2ivs_A           67 PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA  146 (314)
T ss_dssp             HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CE
T ss_pred             HHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccC
Confidence            34567899999999999999999999999999999999999999999999986543                        


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCccc
Q 031702           63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEV  139 (154)
Q Consensus        63 ~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~  139 (154)
                      +++..++.++.|++.|+.|||+++++|+||||+||++   +..+.+||+|||++.......   ......+++.|+|||+
T Consensus       147 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  223 (314)
T 2ivs_A          147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV---AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIES  223 (314)
T ss_dssp             ECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEE---cCCCCEEEccccccccccccccceeccCCCCcccccChhh
Confidence            8899999999999999999999999999999999999   567789999999997654432   2233456788999999


Q ss_pred             ccccCCCcccceecC
Q 031702          140 LQFQRYDEKVNFFVS  154 (154)
Q Consensus       140 ~~~~~~~~~~Diwsl  154 (154)
                      +.+..++.++|||||
T Consensus       224 ~~~~~~~~~~Di~sl  238 (314)
T 2ivs_A          224 LFDHIYTTQSDVWSF  238 (314)
T ss_dssp             HHHCEECHHHHHHHH
T ss_pred             hcCCCcCchhhHHHH
Confidence            998889999999996

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9.7e-35  Score=205.34  Aligned_cols=143  Identities=35%  Similarity=0.622  Sum_probs=126.4

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++||||+++++++.+++..|++|||+++++|.+++.....+++..+..++.|++.|+.|||+.|++
T Consensus        48 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~giv  127 (323)
T 3tki_A           48 CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT  127 (323)
T ss_dssp             ---CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            35778999999999999999999999999999999999999999999998777899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCC-CcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY-DEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~Diwsl  154 (154)
                      |+||||+||++   +..+.+||+|||++.......   ......||+.|+|||++.+..+ +.++|||||
T Consensus       128 H~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  194 (323)
T 3tki_A          128 HRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC  194 (323)
T ss_dssp             CSCCSGGGEEE---CTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHH
T ss_pred             ccccchHHEEE---eCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHH
Confidence            99999999999   677899999999997654322   2345678999999999987765 678999996

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=9.5e-35  Score=204.20  Aligned_cols=144  Identities=24%  Similarity=0.438  Sum_probs=120.3

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCC----cEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      ...+.+.+|+.+++.++||||+++++++....    ..|++|||+++++|.+++...+.+++..+..++.|++.|+.|||
T Consensus        54 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH  133 (311)
T 3ork_A           54 SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH  133 (311)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            44567899999999999999999999987654    34999999999999999998889999999999999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC----ccccccCCccccCcccccccCCCcccceecC
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++++|+||||+||++   +..+.+||+|||++.......    ......||+.|+|||++.+..++.++|||||
T Consensus       134 ~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  205 (311)
T 3ork_A          134 QNGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL  205 (311)
T ss_dssp             HTTCCCCCCCGGGEEE---ETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHH
T ss_pred             HCCCCcCCCCHHHEEE---cCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHH
Confidence            9999999999999999   567789999999997654432    2234568999999999998899999999996

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.8e-34  Score=211.65  Aligned_cols=142  Identities=34%  Similarity=0.481  Sum_probs=118.2

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecC------CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE   80 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~   80 (154)
                      ....+.+.+|+.+++.++||||+++++++...      ..+|++|||+++ ++.+.+.  ..+++..+..++.|++.|+.
T Consensus       102 ~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~  178 (464)
T 3ttj_A          102 QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIK  178 (464)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHH
Confidence            45567889999999999999999999999654      457999999976 5665553  45999999999999999999


Q ss_pred             HHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        81 ~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |||+.|++||||||+||++   +..+.+||+|||++.............||+.|+|||++.+..|+.++|||||
T Consensus       179 ~lH~~~iiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  249 (464)
T 3ttj_A          179 HLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV  249 (464)
T ss_dssp             HHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHH
T ss_pred             HHHHCCcccCCCChHhEEE---eCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHH
Confidence            9999999999999999999   6788999999999987766555566789999999999999999999999996

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.5e-34  Score=199.36  Aligned_cols=143  Identities=24%  Similarity=0.430  Sum_probs=127.1

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+.+++.++||||+++++++.+.+..+++|||+++++|.+++.. ...+++..+..++.|++.|+.|||++++
T Consensus        62 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  141 (283)
T 3gen_A           62 SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF  141 (283)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            357789999999999999999999999999999999999999999999976 4579999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||||+||++   +..+.++|+|||++.......  ......+++.|+|||++.+..++.++|||||
T Consensus       142 ~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  207 (283)
T 3gen_A          142 LHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF  207 (283)
T ss_dssp             CCSSCSGGGEEE---CTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHH
T ss_pred             cCCCCccceEEE---cCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHH
Confidence            999999999999   678899999999997654432  2233445778999999998899999999996

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.7e-34  Score=210.35  Aligned_cols=148  Identities=24%  Similarity=0.461  Sum_probs=125.7

Q ss_pred             hhhhhh-hhHHhHHHHHHHHhhCCCCccchhhhheecCC-cEEEEEEecCCCCchHHHHHcCC--CCHHHHHHHHHHHHH
Q 031702            2 LKKLNK-HLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGA   77 (154)
Q Consensus         2 ~k~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~   77 (154)
                      +|.++. ...+.+.+|+.+++.++||||+++++++.+.. ..|++|||+++|+|.+++.+.+.  +++..+..++.|++.
T Consensus       221 vK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~  300 (450)
T 1k9a_A          221 VKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE  300 (450)
T ss_dssp             EEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHH
T ss_pred             EEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHH
Confidence            444432 34678999999999999999999999986654 79999999999999999987654  799999999999999


Q ss_pred             HHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        78 ~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |++|||+++++|+||+|+||++   +..+.+||+|||++......  .....+++.|+|||++.+..++.++|||||
T Consensus       301 ~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwsl  372 (450)
T 1k9a_A          301 AMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSF  372 (450)
T ss_dssp             HHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTCEECC--------CCCTTTSCHHHHHSSCCCHHHHHHHH
T ss_pred             HHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCccccccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHH
Confidence            9999999999999999999999   67889999999998754332  222356788999999999999999999996

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.5e-34  Score=199.83  Aligned_cols=145  Identities=19%  Similarity=0.324  Sum_probs=124.9

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ....+.+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++..... +++..+..++.|++.|+.|||++
T Consensus        53 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~  132 (289)
T 4fvq_A           53 RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN  132 (289)
T ss_dssp             GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence            45568899999999999999999999999999999999999999999999986654 99999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCC-----CeeEEEeecccccccCCCCccccccCCccccCcccccc-cCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDD-----DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~-----~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      +++|+||||+||++.....     ...+||+|||.+......   ....+++.|+|||++.+ ..++.++|||||
T Consensus       133 ~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  204 (289)
T 4fvq_A          133 TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSF  204 (289)
T ss_dssp             TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHH
T ss_pred             CeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHH
Confidence            9999999999999953221     112999999998654332   23457888999999987 678999999996

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=8.3e-34  Score=198.71  Aligned_cols=145  Identities=33%  Similarity=0.553  Sum_probs=128.7

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++||||+++++++.+.+..+++|||+++++|.+++...+.+++..+..++.|++.|+.|||+.+++
T Consensus        49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  128 (304)
T 2jam_A           49 RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIV  128 (304)
T ss_dssp             ---HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            45678899999999999999999999999999999999999999999998888899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||+|+||++...+..+.++|+|||++..... .......|++.|+|||++.+..++.++|||||
T Consensus       129 H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  193 (304)
T 2jam_A          129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSI  193 (304)
T ss_dssp             CCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHH
T ss_pred             ccCCCHHHEEEecCCCCCCEEEccCCcceecCC-CccccccCCCCccChHHhccCCCCchhhHHHH
Confidence            999999999996545678899999999865433 23344568999999999998899999999996

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.1e-34  Score=198.74  Aligned_cols=142  Identities=30%  Similarity=0.583  Sum_probs=126.3

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheec----------------CCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHH
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQA----------------ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKF   71 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~   71 (154)
                      .+.+.+|+.+++.++||||+++++++..                ....+++|||+++++|.+++...  ..+++..+..+
T Consensus        48 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i  127 (284)
T 2a19_B           48 NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL  127 (284)
T ss_dssp             SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHH
T ss_pred             cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHH
Confidence            3567899999999999999999998854                45589999999999999999754  57999999999


Q ss_pred             HHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccce
Q 031702           72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNF  151 (154)
Q Consensus        72 ~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  151 (154)
                      +.|++.|+.|||+.+++|+||+|+||++   +..+.+||+|||++.............+++.|+|||++.+..++.++||
T Consensus       128 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  204 (284)
T 2a19_B          128 FEQITKGVDYIHSKKLINRDLKPSNIFL---VDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDL  204 (284)
T ss_dssp             HHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHH
T ss_pred             HHHHHHHHHHHHhCCeeeccCCHHHEEE---cCCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhh
Confidence            9999999999999999999999999999   5677899999999987766555556678999999999998889999999


Q ss_pred             ecC
Q 031702          152 FVS  154 (154)
Q Consensus       152 wsl  154 (154)
                      |||
T Consensus       205 ~sl  207 (284)
T 2a19_B          205 YAL  207 (284)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            996

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.2e-34  Score=196.63  Aligned_cols=142  Identities=31%  Similarity=0.607  Sum_probs=107.3

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      .+.+.+|+.+++.++||||+++++++.+.+..++++||+++++|.+++... ..+++..+..++.|++.|+.|||+.+++
T Consensus        55 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  134 (278)
T 3cok_A           55 VQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGIL  134 (278)
T ss_dssp             HHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            477899999999999999999999999999999999999999999999865 5699999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||+|+||++   +..+.++|+|||++...... .......+++.|+|||++.+..++.++|||||
T Consensus       135 H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  198 (278)
T 3cok_A          135 HRDLTLSNLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSL  198 (278)
T ss_dssp             CSSCCGGGEEE---CTTCCEEECCCTTCEECC----------------------------CTHHHHH
T ss_pred             cCCCCHHHEEE---cCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHH
Confidence            99999999999   67788999999998765432 22334678999999999998889999999996

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.3e-34  Score=212.74  Aligned_cols=143  Identities=25%  Similarity=0.429  Sum_probs=127.0

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ..+.+.+|+.+++.++||||+++++++.+.+..+++|||+++|+|.+++...  ..+++..+..++.|++.|++|||+++
T Consensus       259 ~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~  338 (495)
T 1opk_A          259 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN  338 (495)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            4678999999999999999999999999999999999999999999999864  35899999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--cccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||||+||++   +..+.+||+|||++........  .....++..|+|||++.+..++.++|||||
T Consensus       339 ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSl  405 (495)
T 1opk_A          339 FIHRNLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF  405 (495)
T ss_dssp             EECSCCSGGGEEE---CGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred             cccCCCChhhEEE---CCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhH
Confidence            9999999999999   6788999999999987644322  223345678999999998899999999996

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.7e-34  Score=207.85  Aligned_cols=145  Identities=32%  Similarity=0.532  Sum_probs=126.5

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ....+.+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++...+ .+++..+..++.|++.|++|||+.
T Consensus       153 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~  232 (377)
T 3cbl_A          153 PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK  232 (377)
T ss_dssp             HHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3456788999999999999999999999999999999999999999999997654 599999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc---ccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||+|+||++   +..+.+||+|||++.........   ....+++.|+|||++.++.++.++|||||
T Consensus       233 ~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  301 (377)
T 3cbl_A          233 CCIHRDLAARNCLV---TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSF  301 (377)
T ss_dssp             TEECSCCSGGGEEE---CTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHH
T ss_pred             CcCCcccCHHHEEE---cCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHH
Confidence            99999999999999   67789999999998764432211   12234667999999998889999999996

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=8.5e-34  Score=199.51  Aligned_cols=142  Identities=32%  Similarity=0.532  Sum_probs=123.0

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+.+++.++||||+++++++.+++..+++|||+++ +|.+++... ..+++..+..++.|++.|+.|||+.|+
T Consensus        62 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i  140 (311)
T 3niz_A           62 IPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRI  140 (311)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            356788999999999999999999999999999999999975 788777654 459999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCcccccc-cCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      +|+||||+||++   +..+.+||+|||++...... .......+|+.|+|||++.+ ..++.++|||||
T Consensus       141 vH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  206 (311)
T 3niz_A          141 LHRDLKPQNLLI---NSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSI  206 (311)
T ss_dssp             ECCCCCGGGEEE---CTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHH
T ss_pred             ccCCCchHhEEE---CCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHH
Confidence            999999999999   67789999999999876433 23344578999999999876 568999999996

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.6e-34  Score=199.75  Aligned_cols=145  Identities=26%  Similarity=0.432  Sum_probs=121.6

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheec--CCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      ....+.+.+|+.+++.++||||+++++++..  ....+++|||+++++|.+++.... .+++..+..++.|++.|+.|||
T Consensus        52 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH  131 (295)
T 3ugc_A           52 EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG  131 (295)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh
Confidence            4455789999999999999999999998854  356899999999999999997654 4999999999999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC----ccccccCCccccCcccccccCCCcccceecC
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +.+++|+||||+||++   +..+.+||+|||++.......    ......++..|+|||++.+..++.++|||||
T Consensus       132 ~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  203 (295)
T 3ugc_A          132 TKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSF  203 (295)
T ss_dssp             HTTCCCSCCSGGGEEE---EETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             cCCcccCCCCHhhEEE---cCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHH
Confidence            9999999999999999   567789999999998664432    1223446677999999998999999999996

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5.5e-34  Score=201.04  Aligned_cols=144  Identities=27%  Similarity=0.382  Sum_probs=127.4

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      ...+.+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++....    .+++..+..++.|++.|+.|||
T Consensus        77 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH  156 (321)
T 2qkw_B           77 QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH  156 (321)
T ss_dssp             SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc
Confidence            446789999999999999999999999999999999999999999999986443    4899999999999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCCCcccceecC
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++++|+||||+||++   +..+.+||+|||++.......   ......||+.|+|||++.+..++.++|||||
T Consensus       157 ~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  227 (321)
T 2qkw_B          157 TRAIIHRDVKSINILL---DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSF  227 (321)
T ss_dssp             HTTEECSCCCSTTEEE---CTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHH
T ss_pred             CCCeecCCCCHHHEEE---CCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhH
Confidence            9999999999999999   678899999999987644322   2234568899999999988899999999996

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=8e-34  Score=199.12  Aligned_cols=141  Identities=32%  Similarity=0.504  Sum_probs=124.1

Q ss_pred             HHhHHHHHHHHhhCC---CCccchhhhheecCC-----cEEEEEEecCCCCchHHHHHcCC--CCHHHHHHHHHHHHHHH
Q 031702           10 KSCLDCELNFLSSVN---HPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGL   79 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~-----~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l   79 (154)
                      ...+.+|+.+++.++   ||||+++++++.+..     ..++++|+++ ++|.+++.....  +++..+..++.|++.|+
T Consensus        55 ~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al  133 (308)
T 3g33_A           55 PISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGL  133 (308)
T ss_dssp             CHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHH
T ss_pred             chhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHH
Confidence            346777888887774   999999999997654     5899999996 599999987654  99999999999999999


Q ss_pred             HHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        80 ~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|||+.+++|+||||+||++   +..+.+||+|||++.............||+.|+|||++.+..++.++|||||
T Consensus       134 ~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  205 (308)
T 3g33_A          134 DFLHANCIVHRDLKPENILV---TSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSV  205 (308)
T ss_dssp             HHHHHTTCCCSCCCTTTEEE---CTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHH
T ss_pred             HHHHHCCcccCCCCHHHEEE---cCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHH
Confidence            99999999999999999999   6778999999999987766555666788999999999998999999999996

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.7e-33  Score=194.54  Aligned_cols=142  Identities=39%  Similarity=0.707  Sum_probs=120.3

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (154)
                      .+.+.+|+.+++.++||||+++++++.+++..++++||+++++|.+++.....+++..+..++.|++.|+.|||+.+++|
T Consensus        55 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H  134 (276)
T 2h6d_A           55 VGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVH  134 (276)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSC
T ss_pred             HHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence            46789999999999999999999999999999999999999999999988889999999999999999999999999999


Q ss_pred             ecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCC-CcccceecC
Q 031702           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVNFFVS  154 (154)
Q Consensus        90 ~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Diwsl  154 (154)
                      +||+|+||++   +..+.++|+|||++.............+++.|+|||.+.+..+ +.++|||||
T Consensus       135 ~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl  197 (276)
T 2h6d_A          135 RDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSC  197 (276)
T ss_dssp             CCCCGGGEEE---CTTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHH
T ss_pred             CCCChhhEEE---CCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHH
Confidence            9999999999   6778899999999987665555555678999999999987765 589999996

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.3e-34  Score=201.35  Aligned_cols=141  Identities=28%  Similarity=0.388  Sum_probs=126.3

Q ss_pred             HhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC-
Q 031702           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQLGAGLEILNSH-   85 (154)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lh~~-   85 (154)
                      ..+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++....    .+++..+..++.|++.|+.|||+. 
T Consensus        72 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~  151 (326)
T 3uim_A           72 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC  151 (326)
T ss_dssp             CHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSS
T ss_pred             HHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            368999999999999999999999999999999999999999999997543    389999999999999999999999 


Q ss_pred             --CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCcccccccCCCcccceecC
Q 031702           86 --HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 --~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                        +++|+||||+||++   +..+.+||+|||++.......  ......||+.|+|||++.+..++.++|||||
T Consensus       152 ~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  221 (326)
T 3uim_A          152 DPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY  221 (326)
T ss_dssp             SSCEECCCCSGGGEEE---CTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHH
T ss_pred             CCCeEeCCCchhhEEE---CCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhH
Confidence              99999999999999   677899999999998664332  2334558999999999988889999999996

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.7e-33  Score=194.92  Aligned_cols=142  Identities=32%  Similarity=0.569  Sum_probs=125.7

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++||||+++++++.+.+..+++|||+++++|.+++.....+++..+..++.|++.|+.|||+.|++
T Consensus        52 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~  131 (279)
T 3fdn_A           52 VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI  131 (279)
T ss_dssp             CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCE
T ss_pred             HHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence            35678999999999999999999999999999999999999999999998888999999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||+|+||++   +..+.++|+|||++...... ......+++.|+|||++.+..++.++|||||
T Consensus       132 H~dlkp~Nili---~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  193 (279)
T 3fdn_A          132 HRDIKPENLLL---GSAGELKIADFGWSVHAPSS-RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSL  193 (279)
T ss_dssp             ECCCCGGGEEE---CTTSCEEECSCCEESCC---------CCCCTTCCHHHHTTCCCCTTHHHHHH
T ss_pred             cccCChHhEEE---cCCCCEEEEeccccccCCcc-cccccCCCCCccCHhHhccCCCCccchhHhH
Confidence            99999999999   67889999999988654332 2344578999999999998889999999996

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.9e-33  Score=195.11  Aligned_cols=141  Identities=35%  Similarity=0.629  Sum_probs=128.8

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (154)
                      .+.+.+|+.+++.++||||+++++++.+.+..++++||+++++|.+++...+.+++..+..++.|++.|+.|||+.+++|
T Consensus        58 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H  137 (284)
T 2vgo_A           58 EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIH  137 (284)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred             HHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence            56789999999999999999999999999999999999999999999998889999999999999999999999999999


Q ss_pred             ecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        90 ~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +||+|+||++   +..+.++|+|||++...... ......|++.|+|||++.+..++.++|||||
T Consensus       138 ~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  198 (284)
T 2vgo_A          138 RDIKPENLLM---GYKGELKIADFGWSVHAPSL-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCA  198 (284)
T ss_dssp             CCCSGGGEEE---CTTCCEEECCCTTCEECSSS-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHH
T ss_pred             cCCCHHHEEE---cCCCCEEEecccccccCccc-ccccccCCCCcCCHHHhccCCCCcccchhhH
Confidence            9999999999   67788999999998655432 2345678999999999998889999999996

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.7e-33  Score=196.74  Aligned_cols=143  Identities=21%  Similarity=0.413  Sum_probs=119.1

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++||||+++++++.+++..++++||+++++|.+++.....+++..+..++.|++.|+.|||+.+++
T Consensus        77 ~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~  156 (309)
T 2h34_A           77 FRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGAT  156 (309)
T ss_dssp             HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCC
Confidence            45789999999999999999999999999999999999999999999999888999999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||+|+||++   +..+.+||+|||++.......  ......+++.|+|||++.+..++.++|||||
T Consensus       157 H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  221 (309)
T 2h34_A          157 HRDVKPENILV---SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYAL  221 (309)
T ss_dssp             CSCCCGGGEEE---CTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHH
T ss_pred             cCCCChHHEEE---cCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHH
Confidence            99999999999   677899999999987654432  2234568999999999998889999999996

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-33  Score=198.13  Aligned_cols=144  Identities=28%  Similarity=0.514  Sum_probs=123.4

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++.....+++..+..++.|++.|+.|||+.|+
T Consensus        44 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~i  123 (311)
T 4agu_A           44 VIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC  123 (311)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            44677889999999999999999999999999999999999999999998878889999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCcccccc-cCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.+||+|||.+...... .......+++.|+|||++.+ ..++.++|||||
T Consensus       124 vH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl  189 (311)
T 4agu_A          124 IHRDVKPENILI---TKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAI  189 (311)
T ss_dssp             ECCCCSGGGEEE---CTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHH
T ss_pred             cCCCCChhhEEE---cCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHH
Confidence            999999999999   67889999999999766533 23345678999999999875 568999999996

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.2e-34  Score=201.98  Aligned_cols=144  Identities=28%  Similarity=0.456  Sum_probs=125.7

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-----------------------CC
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------------------RV   63 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-----------------------~~   63 (154)
                      ...+.+.+|+.+++.+ +||||+++++++..++..+++|||+++++|.+++....                       .+
T Consensus        90 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  169 (344)
T 1rjb_A           90 SEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL  169 (344)
T ss_dssp             --CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------C
T ss_pred             HHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccC
Confidence            4567899999999999 99999999999999999999999999999999997643                       27


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccc
Q 031702           64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVL  140 (154)
Q Consensus        64 ~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~  140 (154)
                      ++..+..++.|++.|+.|||+.|++|+||||+||++   +..+.+||+|||++........   .....+|+.|+|||++
T Consensus       170 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~  246 (344)
T 1rjb_A          170 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL  246 (344)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHh
Confidence            899999999999999999999999999999999999   5678999999999976544322   2334567889999999


Q ss_pred             cccCCCcccceecC
Q 031702          141 QFQRYDEKVNFFVS  154 (154)
Q Consensus       141 ~~~~~~~~~Diwsl  154 (154)
                      .+..++.++|||||
T Consensus       247 ~~~~~~~~~Di~sl  260 (344)
T 1rjb_A          247 FEGIYTIKSDVWSY  260 (344)
T ss_dssp             HHCCCCHHHHHHHH
T ss_pred             ccCCCChhHhHHHH
Confidence            98899999999996

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.4e-34  Score=201.55  Aligned_cols=145  Identities=29%  Similarity=0.446  Sum_probs=124.3

Q ss_pred             hhhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC----------------CCCHHHHH
Q 031702            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR   69 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----------------~~~~~~~~   69 (154)
                      ....+.+.+|+.+++.+ +||||+++++++.+.+..+++|||+++++|.+++....                .+++..++
T Consensus        66 ~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (327)
T 1fvr_A           66 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL  145 (327)
T ss_dssp             ----CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHH
T ss_pred             hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHH
Confidence            34567789999999999 99999999999999999999999999999999997654                68999999


Q ss_pred             HHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCccc
Q 031702           70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV  149 (154)
Q Consensus        70 ~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  149 (154)
                      .++.|++.|+.|||+.+++|+||+|+||++   +..+.+||+|||++.............+++.|+|||++.+..++.++
T Consensus       146 ~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  222 (327)
T 1fvr_A          146 HFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS  222 (327)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHH
T ss_pred             HHHHHHHHHHHHHHhCCccCCCCccceEEE---cCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchh
Confidence            999999999999999999999999999999   67789999999998754333333445567889999999888899999


Q ss_pred             ceecC
Q 031702          150 NFFVS  154 (154)
Q Consensus       150 Diwsl  154 (154)
                      |||||
T Consensus       223 Di~sl  227 (327)
T 1fvr_A          223 DVWSY  227 (327)
T ss_dssp             HHHHH
T ss_pred             cchHH
Confidence            99996

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.5e-33  Score=195.33  Aligned_cols=145  Identities=27%  Similarity=0.451  Sum_probs=124.3

Q ss_pred             hhhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc----CCCCHHHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEI   81 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~   81 (154)
                      ......+.+|+..+..+ +||||+++++++.+++..+++|||+++++|.+++...    ..+++..+..++.|++.|+.|
T Consensus        51 ~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~  130 (289)
T 1x8b_A           51 SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY  130 (289)
T ss_dssp             SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHH
Confidence            34567788999999999 9999999999999999999999999999999999765    669999999999999999999


Q ss_pred             HHhCCceeecCCCCcEEeecCC----------------CCeeEEEeecccccccCCCCccccccCCccccCccccccc-C
Q 031702           82 LNSHHIIHRDLKPENILLSGLD----------------DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-R  144 (154)
Q Consensus        82 lh~~~~~h~~i~p~nil~~~~~----------------~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~  144 (154)
                      ||+++++|+||||+||++....                ....++|+|||.+.......   ...|++.|+|||++.+. .
T Consensus       131 lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~  207 (289)
T 1x8b_A          131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYT  207 (289)
T ss_dssp             HHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCT
T ss_pred             HHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCC
Confidence            9999999999999999995322                45579999999987654432   34589999999999865 5


Q ss_pred             CCcccceecC
Q 031702          145 YDEKVNFFVS  154 (154)
Q Consensus       145 ~~~~~Diwsl  154 (154)
                      ++.++|||||
T Consensus       208 ~~~~~Di~sl  217 (289)
T 1x8b_A          208 HLPKADIFAL  217 (289)
T ss_dssp             THHHHHHHHH
T ss_pred             CCchhhHHHH
Confidence            6689999996

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=8.2e-34  Score=200.15  Aligned_cols=145  Identities=25%  Similarity=0.426  Sum_probs=117.5

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcE------EEEEEecCCCCchHHHHHcC------CCCHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAGGNLSSYIRLHG------RVPEQTARKFLQQ   74 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------~~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~   74 (154)
                      ....+.+.+|+.+++.++||||+++++++......      ++++||+++++|.+++....      .+++..+..++.|
T Consensus        66 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~q  145 (323)
T 3qup_A           66 SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD  145 (323)
T ss_dssp             CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHH
Confidence            34567899999999999999999999999776554      99999999999999986443      5899999999999


Q ss_pred             HHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCcccce
Q 031702           75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNF  151 (154)
Q Consensus        75 i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di  151 (154)
                      ++.|+.|||+.|++|+||||+||++   +..+.+||+|||++........   .....+++.|+|||.+.+..++.++||
T Consensus       146 i~~al~~LH~~~ivH~Dikp~NIli---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  222 (323)
T 3qup_A          146 IACGMEYLSSRNFIHRDLAARNCML---AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDV  222 (323)
T ss_dssp             HHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHHHcCCcccCCCCcceEEE---cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccch
Confidence            9999999999999999999999999   6778999999999976544332   223445778999999998899999999


Q ss_pred             ecC
Q 031702          152 FVS  154 (154)
Q Consensus       152 wsl  154 (154)
                      |||
T Consensus       223 ~sl  225 (323)
T 3qup_A          223 WAF  225 (323)
T ss_dssp             HHH
T ss_pred             hhH
Confidence            996

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=8.3e-34  Score=202.62  Aligned_cols=144  Identities=31%  Similarity=0.479  Sum_probs=124.8

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheecCC-cEEEEEEecCCCCchHHHHHcCC-----------------------
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGR-----------------------   62 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~~v~e~~~~~~L~~~~~~~~~-----------------------   62 (154)
                      ...+.+.+|+.+++.+ +||||+++++++.+.+ ..+++|||+++|+|.+++.....                       
T Consensus        67 ~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (359)
T 3vhe_A           67 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP  146 (359)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------
T ss_pred             HHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccc
Confidence            4457799999999999 8999999999988764 48999999999999999976543                       


Q ss_pred             -------------------------------------------CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe
Q 031702           63 -------------------------------------------VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL   99 (154)
Q Consensus        63 -------------------------------------------~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~   99 (154)
                                                                 +++..+..++.|++.|+.|||+++++|+||||+||++
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll  226 (359)
T 3vhe_A          147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  226 (359)
T ss_dssp             -------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             hhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE
Confidence                                                       8899999999999999999999999999999999999


Q ss_pred             ecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCCCcccceecC
Q 031702          100 SGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus       100 ~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                         +..+.+||+|||++.......   ......+|+.|+|||++.+..++.++|||||
T Consensus       227 ---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl  281 (359)
T 3vhe_A          227 ---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF  281 (359)
T ss_dssp             ---CGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             ---cCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhH
Confidence               678899999999997654332   2234567888999999998899999999996

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7e-34  Score=199.88  Aligned_cols=147  Identities=33%  Similarity=0.516  Sum_probs=122.8

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|+.+++++ +||||+++++++.+++..+++|||+++++|.+++.....+++..+..++.|++.|++|||+++
T Consensus        52 ~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  131 (316)
T 2ac3_A           52 HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG  131 (316)
T ss_dssp             CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            3467889999999995 799999999999999999999999999999999998889999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--------ccccccCCccccCcccccc-----cCCCcccceec
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQF-----QRYDEKVNFFV  153 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-----~~~~~~~Diws  153 (154)
                      ++|+||||+||++...+....+||+|||++.......        ......||+.|+|||++.+     ..++.++||||
T Consensus       132 ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diws  211 (316)
T 2ac3_A          132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWS  211 (316)
T ss_dssp             CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHH
T ss_pred             ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHh
Confidence            9999999999999543333459999999987653221        1223568999999999875     56889999999


Q ss_pred             C
Q 031702          154 S  154 (154)
Q Consensus       154 l  154 (154)
                      |
T Consensus       212 l  212 (316)
T 2ac3_A          212 L  212 (316)
T ss_dssp             H
T ss_pred             H
Confidence            6

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.9e-33  Score=202.98  Aligned_cols=143  Identities=27%  Similarity=0.434  Sum_probs=121.4

Q ss_pred             hhhHHhHHHHHHHHhhCC-CCccchhhhheecC--CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      ....+.+.+|+.+++.+. ||||+++++++...  ..+|++|||++ ++|.+++.. ..+++..+..++.|++.|+.|||
T Consensus        49 ~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH  126 (388)
T 3oz6_A           49 STDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLH  126 (388)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH
Confidence            455677889999999996 99999999999754  47999999996 589988874 57999999999999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCC----------------------CccccccCCccccCccccc
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----------------------NYAEKVCGSPLYMAPEVLQ  141 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~----------------------~~~~~~~~~~~y~aPE~~~  141 (154)
                      +.|++||||||+||++   +..+.+||+|||+++.....                      ......+||++|+|||++.
T Consensus       127 ~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  203 (388)
T 3oz6_A          127 SGGLLHRDMKPSNILL---NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL  203 (388)
T ss_dssp             HTTEECCCCCGGGEEE---CTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHT
T ss_pred             hCCEEeCCCCHHHeEE---cCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhc
Confidence            9999999999999999   67889999999999765321                      1123357899999999987


Q ss_pred             c-cCCCcccceecC
Q 031702          142 F-QRYDEKVNFFVS  154 (154)
Q Consensus       142 ~-~~~~~~~Diwsl  154 (154)
                      + ..|+.++|||||
T Consensus       204 ~~~~~~~~~DiwSl  217 (388)
T 3oz6_A          204 GSTKYTKGIDMWSL  217 (388)
T ss_dssp             TCCCCCTHHHHHHH
T ss_pred             CCCCCCChhhHHHH
Confidence            6 578999999996

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.2e-33  Score=196.37  Aligned_cols=142  Identities=30%  Similarity=0.483  Sum_probs=124.5

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc------CCCCHHHHHHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------GRVPEQTARKFLQQLGAGLEIL   82 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~l   82 (154)
                      ..+.+.+|+.+++.++||||+++++++.+++..+++|||++ ++|.+++...      ..+++..+..++.|++.|+.||
T Consensus        46 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~l  124 (317)
T 2pmi_A           46 TPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC  124 (317)
T ss_dssp             SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHH
Confidence            34678899999999999999999999999999999999997 5999988654      3589999999999999999999


Q ss_pred             HhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCcccccc-cCCCcccceecC
Q 031702           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        83 h~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      |+.|++|+||||+||++   +..+.+||+|||++...... .......+|+.|+|||++.+ ..++.++|||||
T Consensus       125 H~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  195 (317)
T 2pmi_A          125 HENKILHRDLKPQNLLI---NKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSC  195 (317)
T ss_dssp             HHTTEECCCCCGGGEEE---CTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHH
T ss_pred             HHCCeeeCCCChHHeEE---cCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHH
Confidence            99999999999999999   67889999999999766433 23345678999999999876 468999999996

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=9.5e-34  Score=203.03  Aligned_cols=142  Identities=13%  Similarity=0.177  Sum_probs=120.4

Q ss_pred             HhHHHHHHHHhhCCCCccchhhhheecC----CcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702           11 SCLDCELNFLSSVNHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ..+..|+..++.++||||+++++++...    ...+++|||+ +++|.+++... ..+++..+..++.|++.|++|||+.
T Consensus        93 ~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~  171 (364)
T 3op5_A           93 PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH  171 (364)
T ss_dssp             HHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3445566777788899999999998764    5589999999 89999999876 5799999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--------cccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||||+||++.. +..+.+||+|||++........        .....||+.|+|||++.+..++.++|||||
T Consensus       172 ~iiHrDlkp~Nill~~-~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  247 (364)
T 3op5_A          172 EYVHGDIKASNLLLNY-KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEIL  247 (364)
T ss_dssp             TEECCCCCGGGEEEES-SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred             CeEEecCCHHHEEEec-CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHH
Confidence            9999999999999942 2567899999999976543321        133458999999999998899999999996

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.6e-33  Score=197.68  Aligned_cols=144  Identities=28%  Similarity=0.421  Sum_probs=127.7

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC------------------CCCHHHH
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------------RVPEQTA   68 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~------------------~~~~~~~   68 (154)
                      ...+.+.+|+.+++.+ +||||+++++++.+++..+++|||+++++|.+++....                  .+++..+
T Consensus        68 ~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (313)
T 1t46_A           68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL  147 (313)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHH
T ss_pred             HHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHH
Confidence            4568899999999999 99999999999999999999999999999999997654                  3899999


Q ss_pred             HHHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCC
Q 031702           69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRY  145 (154)
Q Consensus        69 ~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~  145 (154)
                      ..++.|++.|+.|||+.+++|+||||+||++   +..+.+||+|||++........   .....+++.|+|||++.+..+
T Consensus       148 ~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  224 (313)
T 1t46_A          148 LSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY  224 (313)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHHCCeecCCCccceEEE---cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC
Confidence            9999999999999999999999999999999   5678899999999976654332   223456778999999998899


Q ss_pred             CcccceecC
Q 031702          146 DEKVNFFVS  154 (154)
Q Consensus       146 ~~~~Diwsl  154 (154)
                      +.++|||||
T Consensus       225 ~~~~Di~sl  233 (313)
T 1t46_A          225 TFESDVWSY  233 (313)
T ss_dssp             CHHHHHHHH
T ss_pred             ChHHHHHHH
Confidence            999999996

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=5.3e-33  Score=193.92  Aligned_cols=144  Identities=39%  Similarity=0.737  Sum_probs=130.4

Q ss_pred             hhHHhHHHHHHHHhhCC-CCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|+.+++++. ||||+++++++.+++..++++||+++++|.+++.....+++..+..++.|++.|+.|||+.+
T Consensus        65 ~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  144 (298)
T 1phk_A           65 ELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN  144 (298)
T ss_dssp             HHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34678889999999995 99999999999999999999999999999999998889999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCccccc------ccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ------FQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.+||+|||++.............+++.|+|||++.      ...++.++|||||
T Consensus       145 i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~sl  215 (298)
T 1phk_A          145 IVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST  215 (298)
T ss_dssp             EECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHH
T ss_pred             cccCCCCcceEEE---cCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhH
Confidence            9999999999999   677889999999998776655556677899999999985      3467899999996

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=7.4e-34  Score=198.56  Aligned_cols=143  Identities=24%  Similarity=0.435  Sum_probs=125.1

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecC--CcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ..+.+.+|+.+++.++||||+++++++.+.  +..+++|||+++++|.+++... ..+++..+..++.|++.|++|||+.
T Consensus        66 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~  145 (302)
T 4e5w_A           66 HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR  145 (302)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC
Confidence            347789999999999999999999999876  6789999999999999999544 5699999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC----ccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||||+||++   +..+.++|+|||++.......    ......+|..|+|||++.+..++.++|||||
T Consensus       146 ~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  215 (302)
T 4e5w_A          146 QYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSF  215 (302)
T ss_dssp             TEECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred             CcccCCCchheEEE---cCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHH
Confidence            99999999999999   566789999999998765443    2334567788999999998889999999996

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.1e-33  Score=196.19  Aligned_cols=144  Identities=26%  Similarity=0.490  Sum_probs=115.3

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ....+.+.+|+.+++.++||||+++++++. .+..+++|||+++++|.+++.... .+++..+..++.|++.|+.|||+.
T Consensus        57 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  135 (281)
T 1mp8_A           57 DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK  135 (281)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            445678999999999999999999999885 456899999999999999997654 699999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--cccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||||+||++   +..+.+||+|||++........  .....+++.|+|||++.+..++.++|||||
T Consensus       136 ~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  203 (281)
T 1mp8_A          136 RFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF  203 (281)
T ss_dssp             TCCCSCCSGGGEEE---EETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHH
T ss_pred             CeecccccHHHEEE---CCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHH
Confidence            99999999999999   4667899999999976644332  223445778999999998899999999996

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.3e-33  Score=199.76  Aligned_cols=150  Identities=23%  Similarity=0.351  Sum_probs=128.4

Q ss_pred             hhhhh--hhhHHhHHHHHHHHhhCC-----CCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHH
Q 031702            2 LKKLN--KHLKSCLDCELNFLSSVN-----HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFL   72 (154)
Q Consensus         2 ~k~~~--~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~   72 (154)
                      +|.+.  ....+.+..|+.+++.++     ||||+++++++...+..+++|||+ +++|.+++....  .+++..+..++
T Consensus        65 vK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~  143 (360)
T 3llt_A           65 VKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYC  143 (360)
T ss_dssp             EEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHH
T ss_pred             EEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHH
Confidence            44443  445677888999999997     999999999999999999999999 889999997654  49999999999


Q ss_pred             HHHHHHHHHHHhCCceeecCCCCcEEeecC----------------------CCCeeEEEeecccccccCCCCccccccC
Q 031702           73 QQLGAGLEILNSHHIIHRDLKPENILLSGL----------------------DDDVMLKIADFGLSCTLYPGNYAEKVCG  130 (154)
Q Consensus        73 ~~i~~~l~~lh~~~~~h~~i~p~nil~~~~----------------------~~~~~~kl~df~~~~~~~~~~~~~~~~~  130 (154)
                      .|++.|+.|||+.+++|+||||+||++...                      ...+.+||+|||++.....  ......|
T Consensus       144 ~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~g  221 (360)
T 3llt_A          144 IEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIIN  221 (360)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCS
T ss_pred             HHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccC
Confidence            999999999999999999999999999421                      1267899999999975433  2345678


Q ss_pred             CccccCcccccccCCCcccceecC
Q 031702          131 SPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus       131 ~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+.|+|||++.+..++.++|||||
T Consensus       222 t~~y~aPE~~~~~~~~~~~Diwsl  245 (360)
T 3llt_A          222 TRQYRAPEVILNLGWDVSSDMWSF  245 (360)
T ss_dssp             CGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred             cccccCcHHHcCCCCCCccchHHH
Confidence            999999999999999999999996

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.4e-33  Score=196.27  Aligned_cols=142  Identities=30%  Similarity=0.496  Sum_probs=121.2

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+.+++.++||||+++++++.+++..+++|||+++ +|.+++... +.+++..+..++.|++.|+.|||++|+
T Consensus        43 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  121 (288)
T 1ob3_A           43 IPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV  121 (288)
T ss_dssp             CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             cchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            347788999999999999999999999999999999999975 999888754 579999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCccccccc-CCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      +|+||||+||++   +..+.+||+|||++...... .......+|+.|+|||++.+. .++.++|||||
T Consensus       122 ~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  187 (288)
T 1ob3_A          122 LHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSV  187 (288)
T ss_dssp             CCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHH
T ss_pred             ecCCCCHHHEEE---cCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHH
Confidence            999999999999   67889999999998765432 223445789999999998754 58999999996

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-33  Score=194.52  Aligned_cols=143  Identities=25%  Similarity=0.444  Sum_probs=126.6

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++... ..+++..+..++.|++.|+.+||+.++
T Consensus        46 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i  125 (267)
T 3t9t_A           46 SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV  125 (267)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            3578999999999999999999999999999999999999999999999765 468999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||++.......  ......+++.|+|||++.+..++.++|||||
T Consensus       126 ~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  191 (267)
T 3t9t_A          126 IHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF  191 (267)
T ss_dssp             CCSSCCGGGEEE---CGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             ccCCCchheEEE---CCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhh
Confidence            999999999999   677899999999987654322  2233456778999999998889999999996

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-33  Score=196.38  Aligned_cols=141  Identities=30%  Similarity=0.557  Sum_probs=122.6

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheec--CCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      .+.+.+|+.+++.++||||+++++++.+  .+..+++|||+++++|.++.. ...+++..+..++.|++.|+.|||+.++
T Consensus        80 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i  158 (298)
T 2zv2_A           80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKI  158 (298)
T ss_dssp             -CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            4678999999999999999999999986  568999999999999988654 4579999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccC---CCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR---YDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~---~~~~~Diwsl  154 (154)
                      +|+||||+||++   +..+.+||+|||++....... ......||+.|+|||++.+..   ++.++|||||
T Consensus       159 vH~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~sl  226 (298)
T 2zv2_A          159 IHRDIKPSNLLV---GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAM  226 (298)
T ss_dssp             ECCCCCGGGEEE---CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHH
T ss_pred             eccCCCHHHEEE---CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhH
Confidence            999999999999   677899999999998765432 334567899999999998655   3678999996

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.1e-32  Score=191.81  Aligned_cols=145  Identities=33%  Similarity=0.647  Sum_probs=126.5

Q ss_pred             hhhhHHhHHHHHHHHhhCCCCccchhhhheec----CCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHH
Q 031702            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~   81 (154)
                      +....+.+.+|+.+++.++||||+++++++..    ....+++|||+++++|.+++.....+++..+..++.|++.|+.|
T Consensus        65 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~  144 (290)
T 1t4h_A           65 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF  144 (290)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHH
Confidence            35567889999999999999999999998865    45689999999999999999988899999999999999999999


Q ss_pred             HHhCC--ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           82 LNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        82 lh~~~--~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ||+.+  ++|+||+|+||++.  ...+.+||+|||++..... .......|++.|+|||++. +.++.++|||||
T Consensus       145 lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~sl  215 (290)
T 1t4h_A          145 LHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAF  215 (290)
T ss_dssp             HHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHH
T ss_pred             HHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCCcccccc-cccccccCCcCcCCHHHHh-ccCCCcchHHHH
Confidence            99999  99999999999993  2677899999999865433 2334567899999999887 468999999996

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=6.8e-34  Score=209.09  Aligned_cols=142  Identities=25%  Similarity=0.459  Sum_probs=124.0

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ..+.+.+|+.+++.++||||+++++++. .+..+++|||+++|+|.+++...  ..++...+..++.|++.|++|||+++
T Consensus       226 ~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~  304 (454)
T 1qcf_A          226 SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN  304 (454)
T ss_dssp             CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            4678999999999999999999999886 56789999999999999999744  36899999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||||+||++   +..+.+||+|||++.......  ......++..|+|||++..+.++.++|||||
T Consensus       305 ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  371 (454)
T 1qcf_A          305 YIHRDLRAANILV---SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF  371 (454)
T ss_dssp             CCCSSCSGGGEEE---CTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred             ccCCCCCHHHEEE---CCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhH
Confidence            9999999999999   678899999999997654322  1223345678999999998899999999996

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.3e-33  Score=201.87  Aligned_cols=144  Identities=32%  Similarity=0.536  Sum_probs=128.5

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH-   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-   85 (154)
                      ....+.+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++...+.+++..+..++.|++.|+.|||+. 
T Consensus        72 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~  151 (360)
T 3eqc_A           72 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH  151 (360)
T ss_dssp             HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            4557889999999999999999999999999999999999999999999999888999999999999999999999996 


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||+|+||++   +..+.++|+|||++...... ......||+.|+|||++.+..++.++|||||
T Consensus       152 ~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  216 (360)
T 3eqc_A          152 KIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSM  216 (360)
T ss_dssp             CCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHH
T ss_pred             CEEcCCccHHHEEE---CCCCCEEEEECCCCcccccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHH
Confidence            99999999999999   67788999999998654322 2334578999999999998899999999996

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.6e-33  Score=199.26  Aligned_cols=143  Identities=24%  Similarity=0.368  Sum_probs=123.4

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|+.+++.++||||+++++++.+++ .++++|++.+|+|.+++... ..+++..+..++.|++.|+.|||+.+
T Consensus        59 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~  137 (327)
T 3poz_A           59 KANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR  137 (327)
T ss_dssp             -CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence            45678999999999999999999999998765 78899999999999999764 56999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||||+||++   +..+.+||+|||++........   .....+|+.|+|||++.+..++.++|||||
T Consensus       138 ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl  205 (327)
T 3poz_A          138 LVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY  205 (327)
T ss_dssp             CCCSCCCGGGEEE---EETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred             eeCCCCChheEEE---CCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhh
Confidence            9999999999999   5677899999999976644332   223445778999999999999999999996

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.9e-33  Score=198.72  Aligned_cols=149  Identities=25%  Similarity=0.408  Sum_probs=130.3

Q ss_pred             ChhhhhhhhHHhHHHHHHHHhhCC-CCccchhhhheec--CCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHH
Q 031702            1 MLKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGA   77 (154)
Q Consensus         1 ~~k~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~   77 (154)
                      ++|.++....+.+.+|+.+++.++ ||||+++++++.+  ....+++|||+++++|.+++.   .+++..+..++.|++.
T Consensus        65 avK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~  141 (330)
T 3nsz_A           65 VVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILK  141 (330)
T ss_dssp             EEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHH
T ss_pred             EEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHH
Confidence            356666667788999999999996 9999999999987  567899999999999998874   4899999999999999


Q ss_pred             HHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc-cCCCcccceecC
Q 031702           78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        78 ~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      |++|||+.|++|+||||+||++.  .....+||+|||++.............+++.|+|||++.+ ..++.++|||||
T Consensus       142 ~l~~lH~~~ivH~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  217 (330)
T 3nsz_A          142 ALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSL  217 (330)
T ss_dssp             HHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHH
T ss_pred             HHHHHHhCCeeeCCCCHHHEEEc--CCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHH
Confidence            99999999999999999999994  2344899999999987766655666788999999999876 678999999996

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=7.1e-34  Score=200.73  Aligned_cols=149  Identities=26%  Similarity=0.429  Sum_probs=124.5

Q ss_pred             hhhhh--hhhHHhHHHHHHHHhhCCCCccchhhhheecCC----cEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHH
Q 031702            2 LKKLN--KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL   75 (154)
Q Consensus         2 ~k~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i   75 (154)
                      +|.+.  ........+|+.+++.++||||+++++++.++.    .++++|||+++++|.+++.. ..+++..+..++.|+
T Consensus        52 vK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi  130 (322)
T 3soc_A           52 VKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETM  130 (322)
T ss_dssp             EEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHH
T ss_pred             EEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHH
Confidence            44443  233455667999999999999999999997754    47999999999999999975 569999999999999


Q ss_pred             HHHHHHHHhC----------CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccc
Q 031702           76 GAGLEILNSH----------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQF  142 (154)
Q Consensus        76 ~~~l~~lh~~----------~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~  142 (154)
                      +.|+.|||+.          +++|+||||+||++   +..+.+||+|||++.......   ......||+.|+|||++.+
T Consensus       131 ~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  207 (322)
T 3soc_A          131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG  207 (322)
T ss_dssp             HHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTT
T ss_pred             HHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCCCeEEEccCCcccccccccCccccccCccCccccCHhhccc
Confidence            9999999999          99999999999999   678899999999997664433   2334578999999999986


Q ss_pred             -----cCCCcccceecC
Q 031702          143 -----QRYDEKVNFFVS  154 (154)
Q Consensus       143 -----~~~~~~~Diwsl  154 (154)
                           ..++.++|||||
T Consensus       208 ~~~~~~~~~~~~Diwsl  224 (322)
T 3soc_A          208 AINFQRDAFLRIDMYAM  224 (322)
T ss_dssp             CCCCCHHHHHHHHHHHH
T ss_pred             ccccCcCCCccchhHHH
Confidence                 345678899996

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=8.8e-33  Score=194.28  Aligned_cols=142  Identities=31%  Similarity=0.468  Sum_probs=119.0

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ........|+..+..+ +||||+++++++.+++..+++|||+ +++|.+++...+ .+++..+..++.|++.|+.|||+.
T Consensus        98 ~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  176 (311)
T 3p1a_A           98 KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ  176 (311)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3344555566666555 9999999999999999999999999 668888886554 599999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||||+||++   +..+.+||+|||++.............||+.|+|||++.+ .++.++|||||
T Consensus       177 ~ivH~Dikp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Diwsl  241 (311)
T 3p1a_A          177 GLVHLDVKPANIFL---GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSL  241 (311)
T ss_dssp             TEECCCCSGGGEEE---CGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHH
T ss_pred             CEecCCCCHHHEEE---CCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHH
Confidence            99999999999999   6788999999999987766555566779999999999875 78999999996

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.9e-34  Score=198.89  Aligned_cols=150  Identities=23%  Similarity=0.369  Sum_probs=125.8

Q ss_pred             ChhhhhhhhHHhHHHHHHHHhh--CCCCccchhhhheec----CCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHH
Q 031702            1 MLKKLNKHLKSCLDCELNFLSS--VNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ   74 (154)
Q Consensus         1 ~~k~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~----~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~   74 (154)
                      |+|.++....+.+.+|.+++..  ++||||+++++++.+    ....+++|||+++++|.++++ ...+++..+..++.|
T Consensus        35 avK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~  113 (301)
T 3q4u_A           35 AVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLS  113 (301)
T ss_dssp             EEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHH
T ss_pred             EEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHH
Confidence            4666766677777888888877  799999999998644    356899999999999999995 457999999999999


Q ss_pred             HHHHHHHHH--------hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc-----cccccCCccccCccccc
Q 031702           75 LGAGLEILN--------SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQ  141 (154)
Q Consensus        75 i~~~l~~lh--------~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~  141 (154)
                      ++.|+.|||        +.+++|+||||+||++   +..+.+||+|||++........     .....||+.|+|||++.
T Consensus       114 i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  190 (301)
T 3q4u_A          114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD  190 (301)
T ss_dssp             HHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHT
T ss_pred             HHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhc
Confidence            999999999        9999999999999999   6778999999999876544322     23347899999999998


Q ss_pred             cc------CCCcccceecC
Q 031702          142 FQ------RYDEKVNFFVS  154 (154)
Q Consensus       142 ~~------~~~~~~Diwsl  154 (154)
                      +.      .++.++|||||
T Consensus       191 ~~~~~~~~~~~~~~Dvwsl  209 (301)
T 3q4u_A          191 ETIQVDCFDSYKRVDIWAF  209 (301)
T ss_dssp             TCCCTTCHHHHHHHHHHHH
T ss_pred             CcCCCCcccCCchhhHHHH
Confidence            76      44578999996

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=9.3e-34  Score=215.51  Aligned_cols=143  Identities=27%  Similarity=0.459  Sum_probs=123.0

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++||||+++++++.. +..+++|||+++++|.+++.....+++..+..++.|++.|++|||++++
T Consensus       412 ~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~i  490 (635)
T 4fl3_A          412 ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF  490 (635)
T ss_dssp             GGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            346789999999999999999999999865 4588999999999999999988889999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC----ccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||||+||++   +..+.+||+|||++.......    ......+++.|+|||++.+..++.++|||||
T Consensus       491 iHrDLkp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSl  558 (635)
T 4fl3_A          491 VHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSF  558 (635)
T ss_dssp             CCSCCSGGGEEE---EETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred             eCCCCChHhEEE---eCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHH
Confidence            999999999999   567789999999997664432    1223345778999999998899999999996

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-33  Score=200.09  Aligned_cols=141  Identities=30%  Similarity=0.505  Sum_probs=123.6

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecC------CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE   80 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~   80 (154)
                      ....+.+.+|+.+++.++||||+++++++...      ..+|++|||+ +++|.+++.. ..+++..+..++.|++.|+.
T Consensus        65 ~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~  142 (367)
T 1cm8_A           65 ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLR  142 (367)
T ss_dssp             HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Confidence            34567889999999999999999999999765      3469999999 7899998875 67999999999999999999


Q ss_pred             HHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc-cCCCcccceecC
Q 031702           81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        81 ~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      |||+.|++|+||||+||++   +..+.+||+|||++......  .....+|++|+|||++.+ ..++.++|||||
T Consensus       143 ~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  212 (367)
T 1cm8_A          143 YIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSV  212 (367)
T ss_dssp             HHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHH
T ss_pred             HHHHCCccccCcCHHHEEE---cCCCCEEEEeeecccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHH
Confidence            9999999999999999999   67889999999999765432  334578999999999876 678999999996

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.7e-33  Score=198.58  Aligned_cols=144  Identities=36%  Similarity=0.638  Sum_probs=124.7

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (154)
                      ...+.+|+.+++.++||||+++++++..++ .+++|||+++++|.+++.....+++..+..++.|++.|+.|||+.+++|
T Consensus        59 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH  137 (322)
T 2ycf_A           59 ALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIH  137 (322)
T ss_dssp             --CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            456889999999999999999999987665 8999999999999999987888999999999999999999999999999


Q ss_pred             ecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCccccc---ccCCCcccceecC
Q 031702           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVNFFVS  154 (154)
Q Consensus        90 ~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Diwsl  154 (154)
                      +||+|+||++...+....+||+|||++.............|++.|+|||++.   ...++.++|||||
T Consensus       138 ~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~sl  205 (322)
T 2ycf_A          138 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL  205 (322)
T ss_dssp             CCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHH
T ss_pred             cCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHH
Confidence            9999999999644445569999999998765544444567899999999974   4578899999996

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=9e-34  Score=201.86  Aligned_cols=143  Identities=17%  Similarity=0.174  Sum_probs=124.0

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheec----CCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      .+.+.+|+..++.++||||+++++++.+    ....|++|||+ +++|.+++...+.+++..++.++.|++.|++|||+.
T Consensus        92 ~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~  170 (345)
T 2v62_A           92 KKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN  170 (345)
T ss_dssp             CHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4457789999999999999999999987    67899999999 899999998777899999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--------ccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||||+||++.. +..+.+||+|||++.......        ......||+.|+|||++.+..++.++|||||
T Consensus       171 ~ivH~Dlkp~NIll~~-~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  246 (345)
T 2v62_A          171 EYVHGDIKAANLLLGY-KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEIL  246 (345)
T ss_dssp             TEECSCCSGGGEEEES-SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHH
T ss_pred             CeeCCCcCHHHEEEcc-CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHH
Confidence            9999999999999953 122389999999997654322        1234578999999999998889999999996

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.7e-34  Score=206.72  Aligned_cols=146  Identities=25%  Similarity=0.453  Sum_probs=126.7

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCC--cEEEEEEecCCCCchHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      ..+.+.+|+.+++.++||||+++++++.+.+  ..+++|||+++++|.+++.....   +++..++.++.|++.|+.|||
T Consensus        50 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  129 (396)
T 4eut_A           50 PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR  129 (396)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence            3577889999999999999999999987654  78999999999999999875433   999999999999999999999


Q ss_pred             hCCceeecCCCCcEEeec-CCCCeeEEEeecccccccCCCCccccccCCccccCcccccc--------cCCCcccceecC
Q 031702           84 SHHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF--------QRYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~-~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Diwsl  154 (154)
                      +++++|+||||+||++.. .+..+.+||+|||++.............||+.|+|||++.+        ..++.++|||||
T Consensus       130 ~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSl  209 (396)
T 4eut_A          130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI  209 (396)
T ss_dssp             HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHH
T ss_pred             HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHH
Confidence            999999999999999732 24667899999999987766555566779999999999865        567889999996

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-33  Score=197.21  Aligned_cols=145  Identities=23%  Similarity=0.404  Sum_probs=122.0

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ....+.+.+|+.+++.++||||+++++++.+.+..+++|||+++++|.+++... ..+++..+..++.|++.|+.|||+.
T Consensus        87 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~  166 (333)
T 1mqb_A           87 EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM  166 (333)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            345667899999999999999999999999999999999999999999999765 5699999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc----cccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||+|+||++   +..+.+||+|||++........    .....+++.|+|||++.+..++.++|||||
T Consensus       167 ~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  236 (333)
T 1mqb_A          167 NYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSF  236 (333)
T ss_dssp             TCCCSCCCGGGEEE---CTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHH
T ss_pred             CeeCCCCChheEEE---CCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHH
Confidence            99999999999999   6788999999999976544321    122345678999999998899999999996

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5.9e-33  Score=195.63  Aligned_cols=144  Identities=21%  Similarity=0.371  Sum_probs=126.2

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc----------CCCCHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------GRVPEQTARKFLQQLGA   77 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~i~~   77 (154)
                      ...+.+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++...          ..+++..+..++.|++.
T Consensus        70 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  149 (322)
T 1p4o_A           70 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD  149 (322)
T ss_dssp             HHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHH
Confidence            44567899999999999999999999999999999999999999999998653          35689999999999999


Q ss_pred             HHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCCCcccceecC
Q 031702           78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        78 ~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+.|||++|++|+||||+||++   +..+.+||+|||++.......   ......+++.|+|||++.+..++.++|||||
T Consensus       150 ~l~~lH~~~i~H~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  226 (322)
T 1p4o_A          150 GMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF  226 (322)
T ss_dssp             HHHHHHHTTCBCSCCSGGGEEE---CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHHHHCCCccCCCccceEEE---cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHH
Confidence            9999999999999999999999   677899999999987654332   1223456788999999998899999999996

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.7e-33  Score=198.96  Aligned_cols=148  Identities=24%  Similarity=0.350  Sum_probs=127.7

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-------CCCHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------RVPEQTARKFLQQLGAGL   79 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~i~~~l   79 (154)
                      ......+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++....       .+++..++.++.|++.|+
T Consensus        74 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al  153 (327)
T 2yfx_A           74 EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC  153 (327)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHH
T ss_pred             hhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHH
Confidence            4556788999999999999999999999999999999999999999999998653       488999999999999999


Q ss_pred             HHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCCCcccceecC
Q 031702           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        80 ~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .|||+.+++|+||+|+||++...+....+||+|||++.......   ......+++.|+|||++.+..++.++|||||
T Consensus       154 ~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  231 (327)
T 2yfx_A          154 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF  231 (327)
T ss_dssp             HHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHH
Confidence            99999999999999999999543356679999999987543322   2234567889999999988899999999996

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.1e-33  Score=194.21  Aligned_cols=144  Identities=26%  Similarity=0.432  Sum_probs=127.8

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ...+.+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++....  .+++..+..++.|++.|+.|||+.
T Consensus        51 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~  130 (288)
T 3kfa_A           51 MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK  130 (288)
T ss_dssp             THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC
Confidence            346788999999999999999999999999999999999999999999998643  489999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--cccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||+|+||++   +..+.++|+|||.+........  .....+++.|+|||++.+..++.++|||||
T Consensus       131 ~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  198 (288)
T 3kfa_A          131 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF  198 (288)
T ss_dssp             TCCCSCCSGGGEEE---CGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             CccCCCCCcceEEE---cCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHH
Confidence            99999999999999   6778999999999976654332  233456778999999998899999999996

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.5e-33  Score=198.46  Aligned_cols=145  Identities=28%  Similarity=0.436  Sum_probs=118.4

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++||||+++++++.+++..+++|||++ ++|.+++.....+++..+..++.|++.|+.|||+++++
T Consensus        76 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~iv  154 (329)
T 3gbz_A           76 VPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCL  154 (329)
T ss_dssp             ----CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             cchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence            35667899999999999999999999999999999999997 59999999888999999999999999999999999999


Q ss_pred             eecCCCCcEEeecC--CCCeeEEEeecccccccCCC-CccccccCCccccCccccccc-CCCcccceecC
Q 031702           89 HRDLKPENILLSGL--DDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~--~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      |+||||+||++...  +..+.+||+|||++...... .......+|+.|+|||++.+. .++.++|||||
T Consensus       155 H~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  224 (329)
T 3gbz_A          155 HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSI  224 (329)
T ss_dssp             CSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHH
T ss_pred             CCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHH
Confidence            99999999999532  24556999999999765433 233445679999999999864 48999999996

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.9e-33  Score=197.31  Aligned_cols=146  Identities=28%  Similarity=0.488  Sum_probs=124.7

Q ss_pred             hHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ..+.+.+|+.+++.+ .||||+++++++.+.+..+++|||+++++|.+++...  ..+++..+..++.|++.|++|||+.
T Consensus        71 ~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~  150 (327)
T 3lm5_A           71 CRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN  150 (327)
T ss_dssp             CHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            357889999999999 5699999999999999999999999999999988543  5699999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |++|+||+|+||++......+.+||+|||++.............||+.|+|||++.+..++.++|||||
T Consensus       151 givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  219 (327)
T 3lm5_A          151 NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNI  219 (327)
T ss_dssp             TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred             CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHH
Confidence            999999999999995333478999999999987765555556779999999999998999999999996

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.2e-33  Score=193.27  Aligned_cols=145  Identities=36%  Similarity=0.627  Sum_probs=129.8

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++||||+++++++.+.+..++++||+++++|.+++.....+++..+..++.|++.|+.+||+.+++
T Consensus        64 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~  143 (287)
T 2wei_A           64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIV  143 (287)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            46788999999999999999999999999999999999999999999998888899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||+|+||++...+....+||+|||++.............+++.|+|||++.+ .++.++|||||
T Consensus       144 H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~sl  208 (287)
T 2wei_A          144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSA  208 (287)
T ss_dssp             CSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHH
T ss_pred             ccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC-CCCCchhhHhH
Confidence            999999999996544456899999999987655554555668899999999875 58999999996

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=7.2e-33  Score=193.33  Aligned_cols=145  Identities=26%  Similarity=0.396  Sum_probs=124.6

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhhe-ecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ....+.+.+|+.+++.++||||+++++++ ..++..+++|||+++++|.+++... ..+++..+..++.|++.|+.|||+
T Consensus        67 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~  146 (298)
T 3f66_A           67 IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS  146 (298)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            34567899999999999999999999985 4556789999999999999999754 458999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-----ccccccCCccccCcccccccCCCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .+++|+||||+||++   +..+.+||+|||++.......     ......+|+.|+|||.+.+..++.++|||||
T Consensus       147 ~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  218 (298)
T 3f66_A          147 KKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF  218 (298)
T ss_dssp             TTCCCSCCSGGGEEE---CTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred             CCccCCCCchheEEE---CCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHH
Confidence            999999999999999   678899999999997654432     1233456788999999998899999999996

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.4e-33  Score=198.54  Aligned_cols=144  Identities=26%  Similarity=0.449  Sum_probs=126.6

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--------------CCCCHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------------GRVPEQTARKFL   72 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--------------~~~~~~~~~~~~   72 (154)
                      ...+.+.+|+.+++.+ +||||+++++++.+++..+++|||+++++|.+++...              ..+++..+..++
T Consensus        91 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (333)
T 2i1m_A           91 DEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS  170 (333)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHH
Confidence            4567899999999999 8999999999999999999999999999999998653              357999999999


Q ss_pred             HHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCccc
Q 031702           73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKV  149 (154)
Q Consensus        73 ~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~  149 (154)
                      .|++.|+.|||+.+++|+||+|+||++   +..+.+||+|||++........   .....+++.|+|||++.+..++.++
T Consensus       171 ~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  247 (333)
T 2i1m_A          171 SQVAQGMAFLASKNCIHRDVAARNVLL---TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQS  247 (333)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGCEE---EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHH
T ss_pred             HHHHHHHHHHhcCCcccCCcccceEEE---CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHH
Confidence            999999999999999999999999999   5678999999999976543321   2334567789999999988999999


Q ss_pred             ceecC
Q 031702          150 NFFVS  154 (154)
Q Consensus       150 Diwsl  154 (154)
                      |||||
T Consensus       248 Di~sl  252 (333)
T 2i1m_A          248 DVWSY  252 (333)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99996

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.98  E-value=1.6e-33  Score=207.10  Aligned_cols=142  Identities=20%  Similarity=0.380  Sum_probs=119.6

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ..+.+.+|+.+++.++||||+++++++.+ +..+++|||+++|+|.+++..  ...+++..+..++.|++.|++|||+++
T Consensus       222 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~  300 (452)
T 1fmk_A          222 SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN  300 (452)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            35789999999999999999999999876 668999999999999999964  356999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.+||+|||++.......  ......++..|+|||++.++.++.++|||||
T Consensus       301 ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwsl  367 (452)
T 1fmk_A          301 YVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF  367 (452)
T ss_dssp             CCCSCCSGGGEEE---CGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred             eeCCCCChhhEEE---CCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhH
Confidence            9999999999999   677899999999997654332  1223445778999999998899999999996

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.98  E-value=7e-33  Score=196.18  Aligned_cols=144  Identities=29%  Similarity=0.481  Sum_probs=123.3

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++||||+++++++.+.+..+++|||+++++|.++......+++..+..++.|++.|+.|||+.|+
T Consensus        66 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i  145 (331)
T 4aaa_A           66 MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNI  145 (331)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            44667889999999999999999999999999999999999999999888777889999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCccccccc-CCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.+||+|||++...... .......+++.|+|||++.+. .++.++|||||
T Consensus       146 vH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~sl  211 (331)
T 4aaa_A          146 IHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAI  211 (331)
T ss_dssp             CCCCCCGGGEEE---CTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHH
T ss_pred             EccCcChheEEE---cCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHH
Confidence            999999999999   67789999999999765443 233456789999999999765 68899999996

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.98  E-value=4.9e-33  Score=193.96  Aligned_cols=146  Identities=18%  Similarity=0.229  Sum_probs=126.2

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ...+.+.+|+.+++.+ +|++++++++++.++...++++||+ +++|.+++...+ .+++..+..++.|++.|++|||+.
T Consensus        47 ~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~  125 (298)
T 1csn_A           47 SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK  125 (298)
T ss_dssp             TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3456789999999999 8999999999999999999999999 899999998654 599999999999999999999999


Q ss_pred             CceeecCCCCcEEeecC--CCCeeEEEeecccccccCCCCc--------cccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGL--DDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~--~~~~~~kl~df~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||||+||++...  .....+||+|||++........        .....||+.|+|||++.+..++.++|||||
T Consensus       126 ~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  204 (298)
T 1csn_A          126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEAL  204 (298)
T ss_dssp             TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred             CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHH
Confidence            99999999999999432  1223499999999986654321        344578999999999998899999999996

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.98  E-value=6.2e-33  Score=196.68  Aligned_cols=144  Identities=30%  Similarity=0.474  Sum_probs=127.0

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC----------------CCCHHHHHH
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK   70 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----------------~~~~~~~~~   70 (154)
                      ...+.+.+|+.+++.+ +||||+++++++.+.+..+++|||+++++|.+++....                .+++..++.
T Consensus        82 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (334)
T 2pvf_A           82 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS  161 (334)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHH
Confidence            4567789999999999 99999999999999999999999999999999997653                388999999


Q ss_pred             HHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCc
Q 031702           71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE  147 (154)
Q Consensus        71 ~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~  147 (154)
                      ++.|++.|+.|||+.+++|+||||+||++   +..+.+||+|||++........   .....+++.|+|||++.+..++.
T Consensus       162 i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  238 (334)
T 2pvf_A          162 CTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH  238 (334)
T ss_dssp             HHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECH
T ss_pred             HHHHHHHHHHHHHhCCeeCCCCccceEEE---cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcCh
Confidence            99999999999999999999999999999   6788999999999976654322   22345678899999998888999


Q ss_pred             ccceecC
Q 031702          148 KVNFFVS  154 (154)
Q Consensus       148 ~~Diwsl  154 (154)
                      ++|||||
T Consensus       239 ~~Di~sl  245 (334)
T 2pvf_A          239 QSDVWSF  245 (334)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999996

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.98  E-value=8.9e-33  Score=197.10  Aligned_cols=140  Identities=33%  Similarity=0.558  Sum_probs=123.2

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|+.+++.++||||+++++++.+++..+++|||+. |++.+++. ....+++..+..++.|++.|+.|||+.+
T Consensus        96 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  174 (348)
T 1u5q_A           96 EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN  174 (348)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            445778999999999999999999999999999999999997 57877775 4567999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCccccc---ccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Diwsl  154 (154)
                      ++|+||||+||++   +..+.+||+|||++.....   .....||+.|+|||++.   .+.++.++|||||
T Consensus       175 ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Diwsl  239 (348)
T 1u5q_A          175 MIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL  239 (348)
T ss_dssp             CBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHH
T ss_pred             eeeCCCCHHHEEE---CCCCCEEEeeccCceecCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHH
Confidence            9999999999999   5678999999999876543   23457899999999984   4678999999996

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.98  E-value=1.6e-33  Score=200.21  Aligned_cols=147  Identities=32%  Similarity=0.578  Sum_probs=120.4

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--------------------------
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------------------------   60 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--------------------------   60 (154)
                      ....+.+.+|+.+++.++||||+++++++.+.+..+++|||+++++|.+++...                          
T Consensus        69 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (345)
T 3hko_A           69 PKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE  148 (345)
T ss_dssp             -CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccc
Confidence            345678999999999999999999999999999999999999999999887410                          


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---
Q 031702           61 --------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---  123 (154)
Q Consensus        61 --------------~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---  123 (154)
                                    ..+++..++.++.|++.|+.|||+.+++|+||+|+||++.. +....+||+|||++.......   
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~  227 (345)
T 3hko_A          149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGE  227 (345)
T ss_dssp             HHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC-
T ss_pred             ccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEec-CCCceEEEeeccccccccccCccc
Confidence                          11357788899999999999999999999999999999942 223389999999997653321   


Q ss_pred             --ccccccCCccccCcccccc--cCCCcccceecC
Q 031702          124 --YAEKVCGSPLYMAPEVLQF--QRYDEKVNFFVS  154 (154)
Q Consensus       124 --~~~~~~~~~~y~aPE~~~~--~~~~~~~Diwsl  154 (154)
                        ......||+.|+|||++.+  ..++.++|||||
T Consensus       228 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl  262 (345)
T 3hko_A          228 YYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA  262 (345)
T ss_dssp             -------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred             cccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence              2345678999999999865  678999999996

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.98  E-value=3.7e-33  Score=193.39  Aligned_cols=143  Identities=24%  Similarity=0.419  Sum_probs=122.0

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|+.+++.++||||+++++++.++ ..++++||+++++|.+++.... .+++..+..++.|++.|+.|||+.+
T Consensus        55 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  133 (281)
T 3cc6_A           55 DNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN  133 (281)
T ss_dssp             HHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4578899999999999999999999998754 4689999999999999997654 5999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--cccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.+||+|||++........  .....+++.|+|||++.+..++.++|||||
T Consensus       134 i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  200 (281)
T 3cc6_A          134 CVHRDIAVRNILV---ASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMF  200 (281)
T ss_dssp             CCCCCCSGGGEEE---EETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             cccCCCccceEEE---CCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHH
Confidence            9999999999999   4667899999999876544322  233456778999999998899999999996

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.98  E-value=1e-32  Score=193.63  Aligned_cols=145  Identities=30%  Similarity=0.569  Sum_probs=119.3

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH----cCCCCHHHHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEIL   82 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~l   82 (154)
                      ....+.+.+|+.+++.++||||+++++++.+.+..++++||+++++|.+++..    ...+++..++.++.|++.|+.||
T Consensus        73 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  152 (310)
T 2wqm_A           73 AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM  152 (310)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHH
Confidence            45577899999999999999999999999999999999999999999999864    35689999999999999999999


Q ss_pred             HhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        83 h~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+.+++|+||+|+||++   +..+.++|+|||++....... ......+++.|+|||++.+..++.++|||||
T Consensus       153 H~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  222 (310)
T 2wqm_A          153 HSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSL  222 (310)
T ss_dssp             HHTTCCCCCCCGGGEEE---CTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHH
T ss_pred             hhCCeeCCCCcHHHEEE---cCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHH
Confidence            99999999999999999   677899999999987654432 2334568899999999998899999999996

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=3.5e-33  Score=200.86  Aligned_cols=144  Identities=26%  Similarity=0.416  Sum_probs=116.9

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhhee-cCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ...+.+.+|+.+++.++||||+++++++. .++..+++|||+++++|.+++.... .+++..+..++.|++.|+.|||++
T Consensus       132 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~  211 (373)
T 3c1x_A          132 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK  211 (373)
T ss_dssp             HHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            45678999999999999999999999865 4567899999999999999997554 588999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc-----cccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||||+||++   +..+.+||+|||++........     .....+++.|+|||++.+..++.++|||||
T Consensus       212 ~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSl  282 (373)
T 3c1x_A          212 KFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF  282 (373)
T ss_dssp             TCCCSCCCGGGEEE---CTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred             CEecCccchheEEE---CCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHH
Confidence            99999999999999   6788999999999976543321     223456778999999998999999999996

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=3.1e-33  Score=199.87  Aligned_cols=143  Identities=29%  Similarity=0.482  Sum_probs=125.7

Q ss_pred             hHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+.+++.+ +||||+++++++.+.+..+++|||+++++|.+++.....+++..+..++.|++.|+.|||+.++
T Consensus       101 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i  180 (355)
T 1vzo_A          101 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI  180 (355)
T ss_dssp             SGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            346678899999999 7999999999999999999999999999999999988899999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCcccccc--cCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQF--QRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Diwsl  154 (154)
                      +|+||||+||++   +..+.+||+|||++.......  ......||+.|+|||++.+  ..++.++|||||
T Consensus       181 vH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dvwsl  248 (355)
T 1vzo_A          181 IYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL  248 (355)
T ss_dssp             CCCCCCGGGEEE---CTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHH
T ss_pred             ccCCCCHHHEEE---CCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHH
Confidence            999999999999   678899999999997654322  2334678999999999985  347899999996

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=1.3e-32  Score=191.90  Aligned_cols=144  Identities=24%  Similarity=0.382  Sum_probs=125.9

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcE-EEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI-FLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ...+.+.+|+.+++.++||||+++++++.+.+.. ++++||+.+++|.+++.. ...+++..+..++.|++.|++|||++
T Consensus        64 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~  143 (298)
T 3pls_A           64 QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ  143 (298)
T ss_dssp             HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4567889999999999999999999999876554 999999999999999976 35689999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-----ccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |++|+||||+||++   +..+.+||+|||++.......     ......+++.|+|||.+.+..++.++|||||
T Consensus       144 ~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  214 (298)
T 3pls_A          144 KFVHRDLAARNCML---DESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSF  214 (298)
T ss_dssp             TCCCSCCSGGGEEE---CTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHH
T ss_pred             CcccCCCCcceEEE---cCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhH
Confidence            99999999999999   677899999999997654322     2234566788999999998899999999996

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.98  E-value=4.5e-33  Score=196.82  Aligned_cols=145  Identities=24%  Similarity=0.388  Sum_probs=126.2

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhhee--cCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      ....+.+.+|+.+++.++||||+++++++.  +.+..+++|||+++++|.+++... ..+++..++.++.|++.|+.|||
T Consensus        65 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH  144 (327)
T 3lxl_A           65 PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG  144 (327)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence            455677999999999999999999999886  456799999999999999999763 56999999999999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC----ccccccCCccccCcccccccCCCcccceecC
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +.+++|+||||+||++   +..+.+||+|||++.......    ......+++.|+|||++.+..++.++|||||
T Consensus       145 ~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  216 (327)
T 3lxl_A          145 SRRCVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSF  216 (327)
T ss_dssp             HTTEECSCCSGGGEEE---EETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHH
T ss_pred             hCCccCCCCChhhEEE---CCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHH
Confidence            9999999999999999   567789999999998664432    2233457788999999998889999999996

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.98  E-value=8e-33  Score=193.56  Aligned_cols=143  Identities=27%  Similarity=0.540  Sum_probs=128.5

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++||||+++++++.+.+..+++|||+++++|.+++. .+.+++..+..++.|++.|+.|||+.|+
T Consensus        62 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i  140 (303)
T 3a7i_A           62 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKK  140 (303)
T ss_dssp             TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            346789999999999999999999999999999999999999999999886 4679999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||++....... ......|++.|+|||++.+..++.++|||||
T Consensus       141 ~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  205 (303)
T 3a7i_A          141 IHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL  205 (303)
T ss_dssp             ECCCCSGGGEEE---CTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             ccCCCChheEEE---CCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHH
Confidence            999999999999   677889999999997665433 2344578999999999998899999999996

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.98  E-value=9.3e-33  Score=199.67  Aligned_cols=143  Identities=25%  Similarity=0.515  Sum_probs=122.1

Q ss_pred             hhhHHhHHHHHHHHhhCC--CCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh
Q 031702            7 KHLKSCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ....+.+.+|+.+++.++  ||||+++++++..++.+|++|| +.+++|.+++.....+++..+..++.|++.|+.|||+
T Consensus        95 ~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~  173 (390)
T 2zmd_A           95 NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ  173 (390)
T ss_dssp             HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            455688999999999996  5999999999999999999999 5688999999988889999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccc-----------cCCCcccc
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQF-----------QRYDEKVN  150 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-----------~~~~~~~D  150 (154)
                      .+++||||||+||++.    .+.+||+|||++.......   ......||+.|+|||++.+           ..++.++|
T Consensus       174 ~~ivHrDlkp~NIll~----~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D  249 (390)
T 2zmd_A          174 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSD  249 (390)
T ss_dssp             TTCCCCCCCGGGEEES----SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHH
T ss_pred             CCeeecCCCHHHEEEE----CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhh
Confidence            9999999999999992    4679999999998764432   2345679999999999865           36889999


Q ss_pred             eecC
Q 031702          151 FFVS  154 (154)
Q Consensus       151 iwsl  154 (154)
                      ||||
T Consensus       250 iwSl  253 (390)
T 2zmd_A          250 VWSL  253 (390)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9996

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.98  E-value=3.1e-33  Score=212.02  Aligned_cols=143  Identities=25%  Similarity=0.462  Sum_probs=121.3

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|+.+++.++||||+++++++.+ +..+++|||+++|+|.+++... ..+++..+..++.|++.|++|||+++
T Consensus       378 ~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~  456 (613)
T 2ozo_A          378 ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN  456 (613)
T ss_dssp             TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            356889999999999999999999999976 5689999999999999998644 45999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc----cccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||||+||++   +..+.+||+|||++........    .....+++.|+|||++.+..++.++|||||
T Consensus       457 iiHrDlkp~NILl---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSl  525 (613)
T 2ozo_A          457 FVHRNLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSY  525 (613)
T ss_dssp             CCCSCCSGGGEEE---EETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHH
T ss_pred             EEcCcCCHHHEEE---cCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHH
Confidence            9999999999999   5677899999999987643321    122334678999999998999999999996

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.98  E-value=6.6e-33  Score=197.27  Aligned_cols=143  Identities=24%  Similarity=0.490  Sum_probs=120.6

Q ss_pred             hhhHHhHHHHHHHHhhCCC--CccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh
Q 031702            7 KHLKSCLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ....+.+.+|+.+++.++|  |||+++++++.+++..+++||+ .+++|.+++.....+++..+..++.|++.|+.|||+
T Consensus        48 ~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~  126 (343)
T 3dbq_A           48 NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ  126 (343)
T ss_dssp             HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            3455788999999999976  9999999999999999999994 578999999988899999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccc-----------cCCCcccc
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQF-----------QRYDEKVN  150 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-----------~~~~~~~D  150 (154)
                      .+++|+||||+||++.    .+.+||+|||++.......   ......||+.|+|||++.+           ..++.++|
T Consensus       127 ~~iiHrDikp~NIll~----~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D  202 (343)
T 3dbq_A          127 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD  202 (343)
T ss_dssp             TTCCCCCCCGGGEEEE----TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHH
T ss_pred             CCeecCCCCcceEEEE----CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhh
Confidence            9999999999999993    4579999999998764433   2335678999999999865           67889999


Q ss_pred             eecC
Q 031702          151 FFVS  154 (154)
Q Consensus       151 iwsl  154 (154)
                      ||||
T Consensus       203 iwsl  206 (343)
T 3dbq_A          203 VWSL  206 (343)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9996

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.98  E-value=5e-33  Score=193.70  Aligned_cols=143  Identities=26%  Similarity=0.451  Sum_probs=124.6

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++||||+++++++ ..+..++++||+++++|.+++.....+++..+..++.|++.|+.|||+.++
T Consensus        60 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i  138 (291)
T 1xbb_A           60 ALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF  138 (291)
T ss_dssp             HHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            3467899999999999999999999998 566789999999999999999988889999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc----cccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.+||+|||++........    .....+++.|+|||++.+..++.++|||||
T Consensus       139 ~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  206 (291)
T 1xbb_A          139 VHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSF  206 (291)
T ss_dssp             ECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred             EcCCCCcceEEE---eCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHH
Confidence            999999999999   4667899999999976644322    122345678999999988889999999996

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.98  E-value=3.8e-33  Score=197.16  Aligned_cols=141  Identities=24%  Similarity=0.421  Sum_probs=121.5

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      .+.+.+|+.+++.++||||+++++++. .+..++++||+.+++|.+++... +.+++..+..++.|++.|+.|||+.+++
T Consensus        59 ~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv  137 (325)
T 3kex_A           59 FQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMV  137 (325)
T ss_dssp             BCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCC
Confidence            456788999999999999999999886 45689999999999999999764 4689999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+||||+||++   +..+.+||+|||++.......   ......++..|+|||++.+..++.++|||||
T Consensus       138 H~Dikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  203 (325)
T 3kex_A          138 HRNLAARNVLL---KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSY  203 (325)
T ss_dssp             CSCCSSTTEEE---SSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHH
T ss_pred             CCccchheEEE---CCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHh
Confidence            99999999999   677889999999998765433   2234556778999999998899999999996

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.98  E-value=6e-33  Score=191.31  Aligned_cols=143  Identities=30%  Similarity=0.479  Sum_probs=117.4

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH---   86 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---   86 (154)
                      .+.+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++. ...+++..+..++.|++.|+.|||+++   
T Consensus        50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~  128 (271)
T 3dtc_A           50 IENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVP  128 (271)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSC
T ss_pred             HHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Confidence            4778999999999999999999999999999999999999999999885 567999999999999999999999999   


Q ss_pred             ceeecCCCCcEEeecCC-----CCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLD-----DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~-----~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++....     ..+.+||+|||.+....... .....|++.|+|||.+.+..++.++|||||
T Consensus       129 i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  200 (271)
T 3dtc_A          129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSY  200 (271)
T ss_dssp             CCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHH
T ss_pred             eeecCCchHHEEEecccccccccCcceEEccCCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHH
Confidence            88999999999995311     26789999999987654432 234578999999999998889999999996

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.98  E-value=1.6e-32  Score=197.22  Aligned_cols=142  Identities=33%  Similarity=0.476  Sum_probs=114.4

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCC------cEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE   80 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~   80 (154)
                      ....+.+.+|+.+++.++||||+++++++...+      ..|++|||+++ +|.+.+.  ..+++..+..++.|++.|+.
T Consensus        65 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~  141 (371)
T 2xrw_A           65 QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIK  141 (371)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHH
Confidence            345677889999999999999999999987654      78999999965 7887775  46899999999999999999


Q ss_pred             HHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        81 ~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |||++|++|+||||+||++   +..+.+||+|||++.............||+.|+|||++.+..++.++|||||
T Consensus       142 ~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  212 (371)
T 2xrw_A          142 HLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV  212 (371)
T ss_dssp             HHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHH
T ss_pred             HHHHCCeecccCCHHHEEE---cCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHH
Confidence            9999999999999999999   6778999999999987655444455678999999999998899999999996

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.98  E-value=8.4e-33  Score=190.92  Aligned_cols=144  Identities=35%  Similarity=0.618  Sum_probs=127.6

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++||||+++++++.+++..++++||+++++|.+++.....+++..+..++.|++.|+.|||+.++
T Consensus        47 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i  126 (276)
T 2yex_A           47 DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI  126 (276)
T ss_dssp             THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            34578999999999999999999999999999999999999999999999877789999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCC-CcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY-DEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||.+.......   ......|++.|+|||++.+..+ +.++|||||
T Consensus       127 ~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl  194 (276)
T 2yex_A          127 THRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC  194 (276)
T ss_dssp             ECSCCSGGGEEE---CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHH
T ss_pred             eccCCChHHEEE---ccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHH
Confidence            999999999999   677889999999987653322   2344678999999999987665 678999996

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.98  E-value=5.4e-33  Score=197.67  Aligned_cols=140  Identities=19%  Similarity=0.380  Sum_probs=125.5

Q ss_pred             HhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHH------HHH--cCCCCHHHHHHHHHHHHHHHHHH
Q 031702           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY------IRL--HGRVPEQTARKFLQQLGAGLEIL   82 (154)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~------~~~--~~~~~~~~~~~~~~~i~~~l~~l   82 (154)
                      +.+.+|+.+++.++||||+++++++.+.+..+++|||+++++|.++      +..  ...+++..++.++.|++.|+.||
T Consensus        88 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l  167 (348)
T 2pml_X           88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI  167 (348)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence            8899999999999999999999999999999999999999999998      655  46799999999999999999999


Q ss_pred             Hh-CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCccccccc-CCCc-ccceecC
Q 031702           83 NS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDE-KVNFFVS  154 (154)
Q Consensus        83 h~-~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~Diwsl  154 (154)
                      |+ .|++|+||+|+||++   +..+.++|+|||.+...... ......+++.|+|||++.+. .++. ++|||||
T Consensus       168 H~~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~sl  238 (348)
T 2pml_X          168 HNEKNICHRDVKPSNILM---DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSL  238 (348)
T ss_dssp             HHTSCEECCCCCGGGEEE---CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHH
T ss_pred             hccCCEeecCCChHhEEE---cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHH
Confidence            99 999999999999999   67789999999998765443 33446789999999999877 5666 9999996

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.98  E-value=2.7e-32  Score=191.12  Aligned_cols=143  Identities=28%  Similarity=0.436  Sum_probs=125.8

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL---HGRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ...+.+.+|+.+++.++||||+++++++.+.+..+++|||+++++|.+++..   ...+++..+..++.|++.|+.|||+
T Consensus        72 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~  151 (307)
T 2nru_A           72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE  151 (307)
T ss_dssp             THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence            4567899999999999999999999999999999999999999999999864   3458999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCCCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .+++|+||+|+||++   +..+.+||+|||++.......   ......|++.|+|||++.+ .++.++|||||
T Consensus       152 ~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~sl  220 (307)
T 2nru_A          152 NHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSF  220 (307)
T ss_dssp             TTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHH
T ss_pred             CCeecCCCCHHHEEE---cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHH
Confidence            999999999999999   678899999999987654322   2234568999999999874 58899999996

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.98  E-value=2.8e-32  Score=191.57  Aligned_cols=143  Identities=29%  Similarity=0.502  Sum_probs=128.3

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+.+++.++||||+++++++.+.+..++++||+++++|.+++. ....+++..+..++.|++.|+.|||+.|+
T Consensus        67 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i  146 (314)
T 3com_A           67 DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK  146 (314)
T ss_dssp             CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence            35778999999999999999999999999999999999999999999987 45679999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.++|+|||.+....... ......+++.|+|||++.+..++.++|||||
T Consensus       147 ~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  211 (314)
T 3com_A          147 IHRDIKAGNILL---NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSL  211 (314)
T ss_dssp             ECCCCSGGGEEE---CTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHH
T ss_pred             cCCCcCHHHEEE---CCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHH
Confidence            999999999999   677889999999997654432 2344578999999999998889999999996

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.98  E-value=1.5e-32  Score=193.01  Aligned_cols=145  Identities=28%  Similarity=0.453  Sum_probs=118.2

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCC-----cEEEEEEecCCCCchHHHHH------cCCCCHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRL------HGRVPEQTARKFLQQL   75 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~~v~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~~i   75 (154)
                      ....+.+.+|+.+++.++||||+++++++.+.+     ..++++||+++++|.+++..      ...+++..++.++.|+
T Consensus        77 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi  156 (313)
T 3brb_A           77 QREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI  156 (313)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHH
Confidence            344577999999999999999999999997654     45999999999999999843      2459999999999999


Q ss_pred             HHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCCCccccee
Q 031702           76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFF  152 (154)
Q Consensus        76 ~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diw  152 (154)
                      +.|+.|||+.+++|+||+|+||++   +..+.+||+|||++.......   ......+++.|+|||.+.+..++.++|||
T Consensus       157 ~~aL~~LH~~~ivH~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  233 (313)
T 3brb_A          157 ALGMEYLSNRNFLHRDLAARNCML---RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVW  233 (313)
T ss_dssp             HHHHHHHHTTTCCCCCCSGGGEEE---CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHH
T ss_pred             HHHHHHHHhCCcccCCCCcceEEE---cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhH
Confidence            999999999999999999999999   677899999999997654432   22334567789999999988999999999


Q ss_pred             cC
Q 031702          153 VS  154 (154)
Q Consensus       153 sl  154 (154)
                      ||
T Consensus       234 sl  235 (313)
T 3brb_A          234 AF  235 (313)
T ss_dssp             HH
T ss_pred             HH
Confidence            96

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.98  E-value=4.7e-33  Score=198.57  Aligned_cols=140  Identities=18%  Similarity=0.256  Sum_probs=120.5

Q ss_pred             HhHHHHHHHHhhCCCCccchhhh---------------heec-CCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHH
Q 031702           11 SCLDCELNFLSSVNHPNIIRLFD---------------AFQA-ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL   72 (154)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~---------------~~~~-~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~   72 (154)
                      +.+.+|+.+++.++|||++++++               ++.. ++..+++|||+ +++|.+++...  ..+++..+..++
T Consensus        87 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~  165 (352)
T 2jii_A           87 GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVA  165 (352)
T ss_dssp             STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHH
T ss_pred             chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHH
Confidence            57889999999999999998544               3333 67789999999 99999999875  679999999999


Q ss_pred             HHHHHHHHHHHhCCceeecCCCCcEEeecCCCCe--eEEEeecccccccCCCC--------ccccccCCccccCcccccc
Q 031702           73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV--MLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQF  142 (154)
Q Consensus        73 ~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~--~~kl~df~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~  142 (154)
                      .|++.|+.|||+++++|+||||+||++   +..+  .+||+|||++.......        ......||+.|+|||++.+
T Consensus       166 ~qi~~~L~~LH~~~ivH~Dikp~NIl~---~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  242 (352)
T 2jii_A          166 CRLLDALEFLHENEYVHGNVTAENIFV---DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG  242 (352)
T ss_dssp             HHHHHHHHHHHHTTCBCSCCCGGGEEE---ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT
T ss_pred             HHHHHHHHHHHhCCccCCCCCHHHEEE---cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc
Confidence            999999999999999999999999999   4555  89999999997654322        1233478999999999998


Q ss_pred             cCCCcccceecC
Q 031702          143 QRYDEKVNFFVS  154 (154)
Q Consensus       143 ~~~~~~~Diwsl  154 (154)
                      ..++.++|||||
T Consensus       243 ~~~~~~~Di~sl  254 (352)
T 2jii_A          243 CGPSRRSDLQSL  254 (352)
T ss_dssp             CCCCHHHHHHHH
T ss_pred             CCCCchhhHHHH
Confidence            899999999996

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.97  E-value=5.4e-33  Score=201.63  Aligned_cols=144  Identities=28%  Similarity=0.488  Sum_probs=115.2

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhhee--cCCcEEEEEEecCCCCchHHHHHc---------CCCCHHHHHHHHHHHHHH
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLH---------GRVPEQTARKFLQQLGAG   78 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~i~~~   78 (154)
                      .+.+.+|+.+++.++||||+++++++.  ....++++|||++ ++|.+++...         ..+++..++.++.|++.|
T Consensus        62 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a  140 (405)
T 3rgf_A           62 SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG  140 (405)
T ss_dssp             CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHH
Confidence            457889999999999999999999994  4678999999996 5888777532         148999999999999999


Q ss_pred             HHHHHhCCceeecCCCCcEEeecC-CCCeeEEEeecccccccCCC----CccccccCCccccCccccccc-CCCccccee
Q 031702           79 LEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTLYPG----NYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFF  152 (154)
Q Consensus        79 l~~lh~~~~~h~~i~p~nil~~~~-~~~~~~kl~df~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diw  152 (154)
                      +.|||+.+++|+||||+||++... +..+.+||+|||++......    .......||+.|+|||++.+. .++.++|||
T Consensus       141 l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  220 (405)
T 3rgf_A          141 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW  220 (405)
T ss_dssp             HHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHH
T ss_pred             HHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhH
Confidence            999999999999999999999543 45678999999999865432    223446789999999999874 589999999


Q ss_pred             cC
Q 031702          153 VS  154 (154)
Q Consensus       153 sl  154 (154)
                      ||
T Consensus       221 Sl  222 (405)
T 3rgf_A          221 AI  222 (405)
T ss_dssp             HH
T ss_pred             HH
Confidence            96

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.97  E-value=9.5e-33  Score=194.60  Aligned_cols=144  Identities=28%  Similarity=0.446  Sum_probs=125.4

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecC--CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ....+.+.+|+.+++.++||||+++++++.+.  ...+++|||+++++|.+++.. ..+++..+..++.|++.|+.|||+
T Consensus        74 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~  152 (318)
T 3lxp_A           74 PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHA  152 (318)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHh
Confidence            34567899999999999999999999999874  678999999999999999864 459999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC----ccccccCCccccCcccccccCCCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .+++|+||+|+||++   +..+.+||+|||++.......    ......+++.|+|||++.+..++.++|||||
T Consensus       153 ~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  223 (318)
T 3lxp_A          153 QHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSF  223 (318)
T ss_dssp             TTEECSCCSGGGEEE---CTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred             CCccCCCCchheEEE---cCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHH
Confidence            999999999999999   677899999999998765433    2233457788999999998889999999996

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.97  E-value=5.6e-33  Score=192.25  Aligned_cols=142  Identities=23%  Similarity=0.473  Sum_probs=123.7

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ..+.+.+|+.+++.++||||+++++++.+ +..++++||+++++|.+++....  .+++..+..++.|++.|+.|||+.+
T Consensus        51 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  129 (279)
T 1qpc_A           51 SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN  129 (279)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            46789999999999999999999998864 45899999999999999986443  6999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--cccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.+||+|||++........  .....+++.|+|||++.+..++.++|||||
T Consensus       130 i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  196 (279)
T 1qpc_A          130 YIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF  196 (279)
T ss_dssp             EECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHH
T ss_pred             eeccCCCHhhEEE---cCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHH
Confidence            9999999999999   6788999999999987654332  233455778999999988889999999996

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.97  E-value=7.6e-33  Score=196.41  Aligned_cols=150  Identities=26%  Similarity=0.362  Sum_probs=128.6

Q ss_pred             ChhhhhhhhHHhHHHHHHHHhh--CCCCccchhhhheecCC----cEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHH
Q 031702            1 MLKKLNKHLKSCLDCELNFLSS--VNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ   74 (154)
Q Consensus         1 ~~k~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~   74 (154)
                      ++|.++....+.+.+|.++++.  ++||||+++++++....    ..+++|||+++++|.+++.+ ..+++..++.++.|
T Consensus        69 avK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~  147 (342)
T 1b6c_B           69 AVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALS  147 (342)
T ss_dssp             EEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHH
T ss_pred             EEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHH
Confidence            4667777777888899999988  69999999999998775    79999999999999999974 57999999999999


Q ss_pred             HHHHHHHHH--------hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-----ccccccCCccccCccccc
Q 031702           75 LGAGLEILN--------SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQ  141 (154)
Q Consensus        75 i~~~l~~lh--------~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~  141 (154)
                      ++.|+.|||        +.+++|+||||+||++   +..+.+||+|||++.......     ......||+.|+|||++.
T Consensus       148 i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  224 (342)
T 1b6c_B          148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD  224 (342)
T ss_dssp             HHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHT
T ss_pred             HHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhc
Confidence            999999999        8999999999999999   677899999999997665433     234457899999999997


Q ss_pred             ccC------CCcccceecC
Q 031702          142 FQR------YDEKVNFFVS  154 (154)
Q Consensus       142 ~~~------~~~~~Diwsl  154 (154)
                      +..      ++.++|||||
T Consensus       225 ~~~~~~~~~~~~~~Di~sl  243 (342)
T 1b6c_B          225 DSINMKHFESFKRADIYAM  243 (342)
T ss_dssp             SCCCTTCHHHHHHHHHHHH
T ss_pred             ccccccccccCCcccHHHH
Confidence            652      3368999996

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.97  E-value=8.5e-33  Score=194.17  Aligned_cols=144  Identities=31%  Similarity=0.477  Sum_probs=125.3

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheecCC-cEEEEEEecCCCCchHHHHHcCC----------------CCHHHHH
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGR----------------VPEQTAR   69 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~~v~e~~~~~~L~~~~~~~~~----------------~~~~~~~   69 (154)
                      ...+.+.+|+.+++.+ +||||+++++++...+ ..++++||+++++|.+++.....                +++..+.
T Consensus        72 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (316)
T 2xir_A           72 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI  151 (316)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHH
T ss_pred             HHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHH
Confidence            4456889999999999 7999999999987654 58999999999999999986554                7899999


Q ss_pred             HHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCC
Q 031702           70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYD  146 (154)
Q Consensus        70 ~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~  146 (154)
                      .++.|++.|+.|||+.+++|+||+|+||++   +..+.+||+|||++........   .....+++.|+|||++.+..++
T Consensus       152 ~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  228 (316)
T 2xir_A          152 CYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT  228 (316)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHhCCcccccCccceEEE---CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc
Confidence            999999999999999999999999999999   6778999999999976544322   2334567889999999988999


Q ss_pred             cccceecC
Q 031702          147 EKVNFFVS  154 (154)
Q Consensus       147 ~~~Diwsl  154 (154)
                      .++|||||
T Consensus       229 ~~~Di~sl  236 (316)
T 2xir_A          229 IQSDVWSF  236 (316)
T ss_dssp             HHHHHHHH
T ss_pred             chhHHHHH
Confidence            99999996

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.97  E-value=1.9e-32  Score=192.30  Aligned_cols=147  Identities=35%  Similarity=0.577  Sum_probs=118.2

Q ss_pred             hhhhh-hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCC---CCHHHHHHHHHHHHH
Q 031702            2 LKKLN-KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQLGA   77 (154)
Q Consensus         2 ~k~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~   77 (154)
                      +|.+. ....+.+.+|+.++++++||||+++++++.+.  .+++|||+++++|.+++.....   ++...+..++.|++.
T Consensus        36 vK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~  113 (307)
T 2eva_A           36 IKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ  113 (307)
T ss_dssp             EEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHH
T ss_pred             EEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHH
Confidence            34443 34567899999999999999999999988743  7899999999999999986553   788999999999999


Q ss_pred             HHHHHHh---CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           78 GLEILNS---HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        78 ~l~~lh~---~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+.|||+   ++++|+||||+||++.  .....+||+|||++......  .....||+.|+|||++.+..++.++|||||
T Consensus       114 ~l~~LH~~~~~~ivH~dlkp~NIll~--~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  189 (307)
T 2eva_A          114 GVAYLHSMQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSW  189 (307)
T ss_dssp             HHHHHHTCSSSCCCCCCCSGGGEEEE--TTTTEEEECCCCC--------------CCTTSSCHHHHTCCCCCTHHHHHHH
T ss_pred             HHHHHHhCCCCCeecCCCChhHEEEe--CCCCEEEEcccccccccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHH
Confidence            9999999   8999999999999994  23335899999998755332  233468999999999998899999999996

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.97  E-value=3.5e-33  Score=208.89  Aligned_cols=142  Identities=20%  Similarity=0.380  Sum_probs=123.8

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ..+.+.+|+.+++.++||||+++++++.+ +..|++|||+.+++|.+++..  ...+++..+..++.|++.|++|||+++
T Consensus       305 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~  383 (535)
T 2h8h_A          305 SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN  383 (535)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            35789999999999999999999999876 668999999999999999964  356999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.+||+|||++.......  ......++..|+|||++.+..++.++|||||
T Consensus       384 ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSl  450 (535)
T 2h8h_A          384 YVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF  450 (535)
T ss_dssp             CCCSCCSGGGEEE---CGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred             eeCCCCCHhhEEE---cCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHH
Confidence            9999999999999   677899999999997654322  1223345678999999998899999999996

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=2.7e-32  Score=193.12  Aligned_cols=149  Identities=24%  Similarity=0.370  Sum_probs=122.9

Q ss_pred             hhhhhhhhHHhHHHHHHHHhhC--CCCccchhhhheecC----CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHH
Q 031702            2 LKKLNKHLKSCLDCELNFLSSV--NHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL   75 (154)
Q Consensus         2 ~k~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i   75 (154)
                      +|.+.........+|.+++..+  +||||+++++++...    +..+++|||+++++|.+++.. ..+++..+..++.|+
T Consensus        65 vK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i  143 (337)
T 3mdy_A           65 VKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSS  143 (337)
T ss_dssp             EEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHH
T ss_pred             EEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHH
Confidence            5555555556666666666665  999999999999877    679999999999999999964 479999999999999


Q ss_pred             HHHHHHHHhC--------CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc-----cccccCCccccCcccccc
Q 031702           76 GAGLEILNSH--------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQF  142 (154)
Q Consensus        76 ~~~l~~lh~~--------~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~  142 (154)
                      +.|+.|||+.        +++|+||||+||++   +..+.+||+|||++........     .....||+.|+|||++.+
T Consensus       144 ~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  220 (337)
T 3mdy_A          144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE  220 (337)
T ss_dssp             HHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccc
Confidence            9999999998        99999999999999   6778999999999976544322     234578999999999987


Q ss_pred             cCCCcc------cceecC
Q 031702          143 QRYDEK------VNFFVS  154 (154)
Q Consensus       143 ~~~~~~------~Diwsl  154 (154)
                      ..++..      +|||||
T Consensus       221 ~~~~~~~~~~~~~Diwsl  238 (337)
T 3mdy_A          221 SLNRNHFQSYIMADMYSF  238 (337)
T ss_dssp             CCCTTCTHHHHHHHHHHH
T ss_pred             ccCCccccCccccchHHH
Confidence            766654      999996

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.97  E-value=4.7e-33  Score=194.36  Aligned_cols=144  Identities=34%  Similarity=0.571  Sum_probs=114.2

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH--------cCCCCHHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQQLGAGL   79 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~i~~~l   79 (154)
                      ...+.+.+|+.+++.++||||+++++++..++..+++|||+++++|.+++..        ...+++..+..++.|++.|+
T Consensus        55 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  134 (303)
T 2vwi_A           55 TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL  134 (303)
T ss_dssp             -----------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHH
Confidence            3456788999999999999999999999999999999999999999999874        34589999999999999999


Q ss_pred             HHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC------ccccccCCccccCcccccc-cCCCccccee
Q 031702           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------YAEKVCGSPLYMAPEVLQF-QRYDEKVNFF  152 (154)
Q Consensus        80 ~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~-~~~~~~~Diw  152 (154)
                      .|||+.+++|+||+|+||++   +..+.+||+|||++.......      ......|++.|+|||++.+ ..++.++|||
T Consensus       135 ~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~  211 (303)
T 2vwi_A          135 EYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIW  211 (303)
T ss_dssp             HHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHH
T ss_pred             HHHHhCCCCCCCCChhhEEE---cCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHH
Confidence            99999999999999999999   677899999999987654321      2234568999999999875 5689999999


Q ss_pred             cC
Q 031702          153 VS  154 (154)
Q Consensus       153 sl  154 (154)
                      ||
T Consensus       212 sl  213 (303)
T 2vwi_A          212 SF  213 (303)
T ss_dssp             HH
T ss_pred             HH
Confidence            96

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.97  E-value=2e-32  Score=195.77  Aligned_cols=142  Identities=28%  Similarity=0.438  Sum_probs=113.8

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhhee-----cCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEIL   82 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~l   82 (154)
                      ..+.+.+|+.+++.++||||+++++++.     .....|++|||++ ++|.+++... ..+++..+..++.|++.|+.||
T Consensus        72 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l  150 (362)
T 3pg1_A           72 LCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVL  150 (362)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH
Confidence            3578999999999999999999999984     3346899999997 5888777644 3699999999999999999999


Q ss_pred             HhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc-cCCCcccceecC
Q 031702           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        83 h~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      |+.+++|+||||+||++   +..+.+||+|||++.............+++.|+|||++.+ ..++.++|||||
T Consensus       151 H~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  220 (362)
T 3pg1_A          151 HEAGVVHRDLHPGNILL---ADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSA  220 (362)
T ss_dssp             HHTTCCCCCCCGGGEEE---CTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHH
T ss_pred             HHCcCEecCCChHHEEE---cCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhH
Confidence            99999999999999999   6788899999999976655555556778999999999876 678999999996

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.97  E-value=5.4e-33  Score=203.22  Aligned_cols=153  Identities=32%  Similarity=0.483  Sum_probs=122.0

Q ss_pred             ChhhhhhhhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHH
Q 031702            1 MLKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAG   78 (154)
Q Consensus         1 ~~k~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~   78 (154)
                      |+|.+.....+.+.+|+.+++.+ +||||+++++++.+.+..|++|||++ ++|.+++.... ...+..+..++.|++.|
T Consensus        52 AvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~a  130 (432)
T 3p23_A           52 AVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSG  130 (432)
T ss_dssp             EEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHH
T ss_pred             EEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHH
Confidence            35666665566778999999999 89999999999999999999999996 59999987554 35555678899999999


Q ss_pred             HHHHHhCCceeecCCCCcEEeecC--CCCeeEEEeecccccccCCCC----ccccccCCccccCccccc---ccCCCccc
Q 031702           79 LEILNSHHIIHRDLKPENILLSGL--DDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQ---FQRYDEKV  149 (154)
Q Consensus        79 l~~lh~~~~~h~~i~p~nil~~~~--~~~~~~kl~df~~~~~~~~~~----~~~~~~~~~~y~aPE~~~---~~~~~~~~  149 (154)
                      +.|||+.+++||||||+||++...  +....+||+|||++.......    ......||+.|+|||++.   ...++.++
T Consensus       131 L~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~  210 (432)
T 3p23_A          131 LAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTV  210 (432)
T ss_dssp             HHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHH
T ss_pred             HHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHH
Confidence            999999999999999999999532  234568899999998765432    234467899999999997   35678899


Q ss_pred             ceecC
Q 031702          150 NFFVS  154 (154)
Q Consensus       150 Diwsl  154 (154)
                      |||||
T Consensus       211 DiwSl  215 (432)
T 3p23_A          211 DIFSA  215 (432)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99996

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.97  E-value=3.7e-33  Score=200.83  Aligned_cols=140  Identities=12%  Similarity=0.104  Sum_probs=115.7

Q ss_pred             hhHHhHHHHH---HHHhhCCCCccchhhhh-------eecCC-----------------cEEEEEEecCCCCchHHHHHc
Q 031702            8 HLKSCLDCEL---NFLSSVNHPNIIRLFDA-------FQAEN-----------------CIFLVVEFCAGGNLSSYIRLH   60 (154)
Q Consensus         8 ~~~~~~~~e~---~~l~~l~h~~i~~~~~~-------~~~~~-----------------~~~~v~e~~~~~~L~~~~~~~   60 (154)
                      ...+.+.+|+   .+++.++||||+++++.       +.+++                 ..|++|||+ +|+|.+++...
T Consensus       115 ~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~  193 (377)
T 3byv_A          115 NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL  193 (377)
T ss_dssp             THHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc
Confidence            4568899999   45555689999999944       43332                 379999999 67999999876


Q ss_pred             CCCCH-------HHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCcc
Q 031702           61 GRVPE-------QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL  133 (154)
Q Consensus        61 ~~~~~-------~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~  133 (154)
                      +.+++       ..+..++.|++.|++|||+++++|+||||+||++   +..+.+||+|||++.....  ......| +.
T Consensus       194 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~  267 (377)
T 3byv_A          194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFEHLVRDGA--RVVSSVS-RG  267 (377)
T ss_dssp             HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCGGGCEETTC--EEECCCC-TT
T ss_pred             cccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEEechhheecCC--cccCCCC-cC
Confidence            55555       7888899999999999999999999999999999   6778999999999975332  3344567 89


Q ss_pred             ccCccccccc-----------CCCcccceecC
Q 031702          134 YMAPEVLQFQ-----------RYDEKVNFFVS  154 (154)
Q Consensus       134 y~aPE~~~~~-----------~~~~~~Diwsl  154 (154)
                      |+|||++.+.           .++.++|||||
T Consensus       268 y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl  299 (377)
T 3byv_A          268 FEPPELEARRATISYHRDRRTLMTFSFDAWAL  299 (377)
T ss_dssp             CCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred             ccChhhhcccccccccccccccCChhhhHHHH
Confidence            9999999887           89999999996

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.8e-32  Score=190.58  Aligned_cols=144  Identities=25%  Similarity=0.460  Sum_probs=124.8

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ....+.+.+|+.+++.++||||+++++++ ..+..++++||+++++|.+++... ..+++..+..++.|++.|+.|||+.
T Consensus        51 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  129 (287)
T 1u59_A           51 KADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK  129 (287)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC
Confidence            35577899999999999999999999999 456689999999999999998644 4599999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc----cccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||+|+||++   +..+.++|+|||++........    .....+++.|+|||++.+..++.++|||||
T Consensus       130 ~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  199 (287)
T 1u59_A          130 NFVHRDLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSY  199 (287)
T ss_dssp             TEECCCCSGGGEEE---EETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred             CEeeCCCchheEEE---cCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHH
Confidence            99999999999999   5677899999999987644322    223445788999999988889999999996

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.97  E-value=6.5e-33  Score=191.85  Aligned_cols=146  Identities=33%  Similarity=0.631  Sum_probs=123.9

Q ss_pred             hhhhHHhHHHHHHHHhhCCCCccchhhhhee--cCCcEEEEEEecCCCCchHHHHHcC----CCCHHHHHHHHHHHHHHH
Q 031702            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQLGAGL   79 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l   79 (154)
                      +....+.+.+|+.+++.++||||+++++++.  .++..+++|||+++++|.+++....    .+++..++.++.|++.|+
T Consensus        45 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l  124 (279)
T 2w5a_A           45 TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL  124 (279)
T ss_dssp             CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHH
Confidence            3456788999999999999999999999874  4578999999999999999986542    499999999999999999


Q ss_pred             HHHHhCC-----ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceec
Q 031702           80 EILNSHH-----IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFV  153 (154)
Q Consensus        80 ~~lh~~~-----~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diws  153 (154)
                      .|||+.+     ++|+||+|+||++   +..+.+||+|||++....... ......+++.|+|||++.+..++.++||||
T Consensus       125 ~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  201 (279)
T 2w5a_A          125 KECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWS  201 (279)
T ss_dssp             HHHHHHC------CCCCCSGGGEEE---CSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHH
T ss_pred             HHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHH
Confidence            9999999     9999999999999   677889999999987654432 223456899999999999888999999999


Q ss_pred             C
Q 031702          154 S  154 (154)
Q Consensus       154 l  154 (154)
                      |
T Consensus       202 l  202 (279)
T 2w5a_A          202 L  202 (279)
T ss_dssp             H
T ss_pred             H
Confidence            6

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.97  E-value=4.2e-33  Score=196.94  Aligned_cols=139  Identities=28%  Similarity=0.470  Sum_probs=116.5

Q ss_pred             hHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 031702           12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHIIHR   90 (154)
Q Consensus        12 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~~h~   90 (154)
                      .+.+|+.+++.++||||+++++++.+++..+++|||++ ++|.+++...+ .+++..+..++.|++.|+.|||+.|++|+
T Consensus        46 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~  124 (324)
T 3mtl_A           46 TAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHR  124 (324)
T ss_dssp             CCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred             hHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence            45679999999999999999999999999999999996 58888887654 59999999999999999999999999999


Q ss_pred             cCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccc-cCCCcccceecC
Q 031702           91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        91 ~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      ||||+||++   +..+.+||+|||++....... ......+|+.|+|||++.+ ..++.++|||||
T Consensus       125 Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  187 (324)
T 3mtl_A          125 DLKPQNLLI---NERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGV  187 (324)
T ss_dssp             SCCGGGEEE---CTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHH
T ss_pred             CcCHHHEEE---CCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHH
Confidence            999999999   677899999999987654332 3344577999999999876 568999999996

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.97  E-value=3.1e-32  Score=191.54  Aligned_cols=146  Identities=27%  Similarity=0.326  Sum_probs=123.5

Q ss_pred             hhhhHHhHHHHHHHHhhCCCCccchhhhhee----cCCcEEEEEEecCCCCchHHHHH----cCCCCHHHHHHHHHHHHH
Q 031702            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGA   77 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~   77 (154)
                      +....+.+.+|+.+++.++||||+++++++.    ..+..++++||+++++|.+++..    ...+++..++.++.|++.
T Consensus        66 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~  145 (317)
T 2buj_A           66 EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR  145 (317)
T ss_dssp             SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence            3456788999999999999999999999986    34578999999999999999875    356999999999999999


Q ss_pred             HHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc----------cccccCCccccCcccccccC---
Q 031702           78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----------AEKVCGSPLYMAPEVLQFQR---  144 (154)
Q Consensus        78 ~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~---  144 (154)
                      |+.|||+.+++|+||+|+||++   +..+.+||+|||.+........          .....|++.|+|||++.+..   
T Consensus       146 ~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  222 (317)
T 2buj_A          146 GLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV  222 (317)
T ss_dssp             HHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEE
T ss_pred             HHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcC
Confidence            9999999999999999999999   6778899999998865432111          12245689999999987543   


Q ss_pred             CCcccceecC
Q 031702          145 YDEKVNFFVS  154 (154)
Q Consensus       145 ~~~~~Diwsl  154 (154)
                      ++.++|||||
T Consensus       223 ~~~~~Di~sl  232 (317)
T 2buj_A          223 IDERTDVWSL  232 (317)
T ss_dssp             ECTHHHHHHH
T ss_pred             CCchhhHHHH
Confidence            6899999996

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.97  E-value=1.5e-32  Score=191.20  Aligned_cols=144  Identities=27%  Similarity=0.450  Sum_probs=113.6

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ....+.+.+|+.+++.++||||++++++. ..+..++++||+++++|.+++.. ...+++..+..++.|++.|+.|||+.
T Consensus        61 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~  139 (289)
T 3og7_A           61 PQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK  139 (289)
T ss_dssp             HHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            45567899999999999999999999854 55668999999999999999854 35699999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCC---CccccccCCccccCccccc---ccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQ---FQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~---~~~~~~~~~~~y~aPE~~~---~~~~~~~~Diwsl  154 (154)
                      +++|+||||+||++   +..+.++|+|||++......   .......||+.|+|||++.   +..++.++|||||
T Consensus       140 ~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~sl  211 (289)
T 3og7_A          140 SIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAF  211 (289)
T ss_dssp             TCCCSCCCGGGEEE---ETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHH
T ss_pred             CcccccCccceEEE---CCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHH
Confidence            99999999999999   56779999999998755432   2234457899999999986   5678899999996

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.97  E-value=2.4e-32  Score=196.13  Aligned_cols=141  Identities=29%  Similarity=0.506  Sum_probs=110.0

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecC------CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE   80 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~   80 (154)
                      ....+.+.+|+.+++.++||||+++++++...      ...|+++|++ +++|.+++.. ..+++..+..++.|++.|+.
T Consensus        69 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~  146 (367)
T 2fst_X           69 IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLK  146 (367)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Confidence            34567888999999999999999999998654      5689999999 6899998874 67999999999999999999


Q ss_pred             HHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc-cCCCcccceecC
Q 031702           81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        81 ~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      |||+.|++|+||||+||++   +..+.+||+|||++......  .....+|+.|+|||++.+ ..++.++|||||
T Consensus       147 ~LH~~givH~Dlkp~NIll---~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  216 (367)
T 2fst_X          147 YIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSV  216 (367)
T ss_dssp             HHHHTTCCCCCCCGGGEEE---CTTCCEEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHH
T ss_pred             HHHHCCeeeCCCCHhhEEE---CCCCCEEEeecccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHH
Confidence            9999999999999999999   67889999999999764332  334578999999999876 678999999996

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.97  E-value=5.1e-33  Score=192.45  Aligned_cols=141  Identities=25%  Similarity=0.469  Sum_probs=116.4

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecC-CcEEEEEEecCCCCchHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhC
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ..+.+.+|+.+++.++||||+++++++.+. +..++++||+++++|.+++.+...  +++..+..++.|++.|+.|||+.
T Consensus        57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~  136 (278)
T 1byg_A           57 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN  136 (278)
T ss_dssp             --HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence            467889999999999999999999987544 578999999999999999976543  89999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||+|+||++   +..+.++|+|||++......  .....+++.|+|||++.+..++.++|||||
T Consensus       137 ~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  200 (278)
T 1byg_A          137 NFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSF  200 (278)
T ss_dssp             TCCCSCCSGGGEEE---CTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHH
T ss_pred             CccccCCCcceEEE---eCCCcEEEeecccccccccc--ccCCCccccccCHHHhCCCCCCchhcHHHH
Confidence            99999999999999   67789999999998754332  223456788999999998899999999996

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.97  E-value=2.2e-32  Score=193.53  Aligned_cols=144  Identities=24%  Similarity=0.364  Sum_probs=119.2

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ....+.+.+|+.+++.++||||+++++++.++. .+++++++.+++|.+++... ..+++..+..++.|++.|+.|||+.
T Consensus        58 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~  136 (327)
T 3lzb_A           58 PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR  136 (327)
T ss_dssp             CCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence            345678999999999999999999999998765 78899999999999999764 5699999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||||+||++   +..+.+||+|||++........   .....+++.|+|||++.+..++.++|||||
T Consensus       137 ~ivH~Dikp~NIl~---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl  205 (327)
T 3lzb_A          137 RLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY  205 (327)
T ss_dssp             TCCCSCCCGGGEEE---EETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred             CCcCCCCCHHHEEE---cCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHH
Confidence            99999999999999   5677899999999976644322   223445778999999999999999999996

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=2.1e-32  Score=194.89  Aligned_cols=141  Identities=34%  Similarity=0.518  Sum_probs=123.3

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      .+.+.+|+.+++.++||||+++++++.+.+..++++||+++ +|.+++.... .+++..+..++.|++.|+.|||+.+++
T Consensus        56 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv  134 (346)
T 1ua2_A           56 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL  134 (346)
T ss_dssp             CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             hHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence            35688999999999999999999999999999999999975 8888876543 589999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCccccccc-CCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      |+||||+||++   +..+.+||+|||++....... ......+|+.|+|||++.+. .++.++|||||
T Consensus       135 H~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  199 (346)
T 1ua2_A          135 HRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAV  199 (346)
T ss_dssp             CCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHH
T ss_pred             CCCCCHHHEEE---cCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhH
Confidence            99999999999   677899999999998764432 33456789999999998754 58899999996

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.97  E-value=4.4e-32  Score=193.38  Aligned_cols=141  Identities=26%  Similarity=0.456  Sum_probs=119.7

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheec--------CCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHH
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQA--------ENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLE   80 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~   80 (154)
                      ...+.+|+.+++.++||||+++++++.+        .+..+++|||+++ +|.+.+... ..+++..++.++.|++.|+.
T Consensus        60 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~  138 (351)
T 3mi9_A           60 PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLY  138 (351)
T ss_dssp             CHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999999976        3468999999975 777666543 56999999999999999999


Q ss_pred             HHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCC-----CccccccCCccccCcccccc-cCCCcccceecC
Q 031702           81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        81 ~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      |||++|++|+||||+||++   +..+.+||+|||++......     .......||+.|+|||++.+ ..++.++|||||
T Consensus       139 ~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  215 (351)
T 3mi9_A          139 YIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA  215 (351)
T ss_dssp             HHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHH
T ss_pred             HHHHCCeeCCCCCHHHEEE---cCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHH
Confidence            9999999999999999999   67789999999999765422     22344578999999999875 458999999996

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.97  E-value=1.3e-32  Score=194.91  Aligned_cols=150  Identities=29%  Similarity=0.404  Sum_probs=119.7

Q ss_pred             ChhhhhhhhHHhHHHHHHHH--hhCCCCccchhhhhe-----ecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHH
Q 031702            1 MLKKLNKHLKSCLDCELNFL--SSVNHPNIIRLFDAF-----QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ   73 (154)
Q Consensus         1 ~~k~~~~~~~~~~~~e~~~l--~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~   73 (154)
                      |+|.++....+.+..|..++  +.++||||+++++.+     .....++++|||+++++|.+++... ..++..+..++.
T Consensus        40 avK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~  118 (336)
T 3g2f_A           40 AVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAH  118 (336)
T ss_dssp             EEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHH
T ss_pred             EEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHH
Confidence            35666655556666665554  458999999998744     2334679999999999999999754 458899999999


Q ss_pred             HHHHHHHHHHhC---------CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---------ccccccCCcccc
Q 031702           74 QLGAGLEILNSH---------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---------YAEKVCGSPLYM  135 (154)
Q Consensus        74 ~i~~~l~~lh~~---------~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---------~~~~~~~~~~y~  135 (154)
                      |++.|+.|||+.         +++|+||||+||++   +..+.+||+|||++.......         ......||+.|+
T Consensus       119 qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~  195 (336)
T 3g2f_A          119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYM  195 (336)
T ss_dssp             HHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGC
T ss_pred             HHHHHHHHHHhhhccccccccceeecccccceEEE---cCCCcEEEeeccceeecccccccCccccccccccCCCcccee
Confidence            999999999999         99999999999999   677899999999997654322         122456899999


Q ss_pred             Ccccccc-------cCCCcccceecC
Q 031702          136 APEVLQF-------QRYDEKVNFFVS  154 (154)
Q Consensus       136 aPE~~~~-------~~~~~~~Diwsl  154 (154)
                      |||++.+       ..++.++|||||
T Consensus       196 aPE~~~~~~~~~~~~~~~~~~Diwsl  221 (336)
T 3g2f_A          196 APEVLEGAVNLRDXESALKQVDMYAL  221 (336)
T ss_dssp             CHHHHTTCCCGGGHHHHHHHHHHHHH
T ss_pred             CchhhcCCcccccccccccccchHHH
Confidence            9999986       456788999996

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.97  E-value=1.9e-32  Score=200.40  Aligned_cols=153  Identities=29%  Similarity=0.512  Sum_probs=119.5

Q ss_pred             ChhhhhhhhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCC-------HHHHHHHH
Q 031702            1 MLKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP-------EQTARKFL   72 (154)
Q Consensus         1 ~~k~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~-------~~~~~~~~   72 (154)
                      |+|.+.....+.+.+|+.+++.+ +||||+++++++.+++..|++|||++ ++|.+++.......       +..+..++
T Consensus        43 AvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~  121 (434)
T 2rio_A           43 AVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLL  121 (434)
T ss_dssp             EEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHH
T ss_pred             EEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHH
Confidence            35666666677889999999986 89999999999999999999999995 59999997654322       22456799


Q ss_pred             HHHHHHHHHHHhCCceeecCCCCcEEeecC----------CCCeeEEEeecccccccCCCC-----ccccccCCccccCc
Q 031702           73 QQLGAGLEILNSHHIIHRDLKPENILLSGL----------DDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAP  137 (154)
Q Consensus        73 ~~i~~~l~~lh~~~~~h~~i~p~nil~~~~----------~~~~~~kl~df~~~~~~~~~~-----~~~~~~~~~~y~aP  137 (154)
                      .|++.|++|||+++++|+||||+||++...          +....+||+|||++.......     ......||+.|+||
T Consensus       122 ~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aP  201 (434)
T 2rio_A          122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAP  201 (434)
T ss_dssp             HHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCH
T ss_pred             HHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCH
Confidence            999999999999999999999999999532          235589999999998765432     12345789999999


Q ss_pred             ccccc-------cCCCcccceecC
Q 031702          138 EVLQF-------QRYDEKVNFFVS  154 (154)
Q Consensus       138 E~~~~-------~~~~~~~Diwsl  154 (154)
                      |++.+       ..++.++|||||
T Consensus       202 E~~~~~~~~~~~~~~~~~~DiwSl  225 (434)
T 2rio_A          202 ELLEESNNLQTKRRLTRSIDIFSM  225 (434)
T ss_dssp             HHHSCCCTTSCCCCCCTHHHHHHH
T ss_pred             HHhccccccccccCcchhhhhHhH
Confidence            99975       568999999996

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.97  E-value=7e-32  Score=188.23  Aligned_cols=145  Identities=30%  Similarity=0.554  Sum_probs=119.2

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheec-------------CCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-------------ENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFL   72 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------------~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~   72 (154)
                      ....+.+.+|+.+++.++||||+++++++.+             .+..+++|||+++++|.+++.... .+++..++.++
T Consensus        43 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~  122 (303)
T 1zy4_A           43 EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF  122 (303)
T ss_dssp             HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHH
Confidence            3456788999999999999999999988754             456899999999999999997554 57889999999


Q ss_pred             HHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCC---------------CccccccCCccccCc
Q 031702           73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---------------NYAEKVCGSPLYMAP  137 (154)
Q Consensus        73 ~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~---------------~~~~~~~~~~~y~aP  137 (154)
                      .|++.|++|||+++++|+||+|+||++   +..+.+||+|||++......               .......|++.|+||
T Consensus       123 ~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  199 (303)
T 1zy4_A          123 RQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVAT  199 (303)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCCCSCTTC-------------------------CTTSCH
T ss_pred             HHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCc
Confidence            999999999999999999999999999   67788999999998765321               122345688999999


Q ss_pred             cccccc-CCCcccceecC
Q 031702          138 EVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus       138 E~~~~~-~~~~~~Diwsl  154 (154)
                      |++.+. .++.++|||||
T Consensus       200 E~~~~~~~~~~~~Di~sl  217 (303)
T 1zy4_A          200 EVLDGTGHYNEKIDMYSL  217 (303)
T ss_dssp             HHHTSCSCCCTHHHHHHH
T ss_pred             ccccCCCCCcchhhHHHH
Confidence            998754 68999999996

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=4.7e-32  Score=195.44  Aligned_cols=141  Identities=26%  Similarity=0.470  Sum_probs=120.2

Q ss_pred             HhHHHHHHHHhhCCCCccchhhhheec--------------------------------------CCcEEEEEEecCCCC
Q 031702           11 SCLDCELNFLSSVNHPNIIRLFDAFQA--------------------------------------ENCIFLVVEFCAGGN   52 (154)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~--------------------------------------~~~~~~v~e~~~~~~   52 (154)
                      +...+|+.+++.++||||+++++++..                                      ....+++|||+++ +
T Consensus        45 ~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~  123 (383)
T 3eb0_A           45 RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-T  123 (383)
T ss_dssp             TSCCHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSE-E
T ss_pred             chHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-c
Confidence            344589999999999999999998843                                      3348999999974 7


Q ss_pred             chHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccc
Q 031702           53 LSSYIR----LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV  128 (154)
Q Consensus        53 L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~  128 (154)
                      |.+.+.    ....+++..+..++.|++.|+.|||+.|++|+||||+||++.  ...+.+||+|||++............
T Consensus       124 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~  201 (383)
T 3eb0_A          124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEPSVAY  201 (383)
T ss_dssp             HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSCCCCC
T ss_pred             HHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCCCcCc
Confidence            766654    356799999999999999999999999999999999999994  25678999999999877666666667


Q ss_pred             cCCccccCccccccc-CCCcccceecC
Q 031702          129 CGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus       129 ~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      .+|+.|+|||++.+. .++.++|||||
T Consensus       202 ~~t~~y~aPE~~~~~~~~~~~~Diwsl  228 (383)
T 3eb0_A          202 ICSRFYRAPELMLGATEYTPSIDLWSI  228 (383)
T ss_dssp             CCCSSCCCHHHHTTCSSCCTHHHHHHH
T ss_pred             ccCCCccCHHHhcCCCCCCcchhhhhH
Confidence            889999999998765 48999999996

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.97  E-value=8.1e-32  Score=204.45  Aligned_cols=149  Identities=29%  Similarity=0.555  Sum_probs=131.7

Q ss_pred             hhhhHHhHHHHHHHHhhCCCCccchhhhheec------CCcEEEEEEecCCCCchHHHHHcC---CCCHHHHHHHHHHHH
Q 031702            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLG   76 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~   76 (154)
                      +....+.+.+|+.+++.++||||+++++++..      ++..+++|||+++++|.+++....   .+++..++.++.|++
T Consensus        52 ~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl  131 (676)
T 3qa8_A           52 SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS  131 (676)
T ss_dssp             CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHH
Confidence            34567889999999999999999999988765      677899999999999999998654   589999999999999


Q ss_pred             HHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        77 ~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .|+.|||+.|++|+||+|+||++...+....+||+|||.+.............|++.|+|||++.+..++.++|||||
T Consensus       132 ~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSL  209 (676)
T 3qa8_A          132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSF  209 (676)
T ss_dssp             HHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHH
T ss_pred             HHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHH
Confidence            999999999999999999999997544555799999999987766665666788999999999998999999999996

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.97  E-value=4.1e-32  Score=196.52  Aligned_cols=141  Identities=28%  Similarity=0.432  Sum_probs=118.0

Q ss_pred             hHHHHHHHHhhCCCCccchhhhheecCC------cEEEEEEecCCCCchHHH---HHcCCCCHHHHHHHHHHHHHHHHHH
Q 031702           12 CLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFLQQLGAGLEIL   82 (154)
Q Consensus        12 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~~v~e~~~~~~L~~~~---~~~~~~~~~~~~~~~~~i~~~l~~l   82 (154)
                      ...+|+.+++.++||||+++++++...+      ..+++|||++++.+....   .....+++..++.++.|++.|+.||
T Consensus        78 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L  157 (394)
T 4e7w_A           78 FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI  157 (394)
T ss_dssp             SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Confidence            3457999999999999999999985443      388999999764433322   2356799999999999999999999


Q ss_pred             HhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCccccccc-CCCcccceecC
Q 031702           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        83 h~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      |+.|++||||||+||++.  ...+.+||+|||++.............+|+.|+|||++.+. .|+.++|||||
T Consensus       158 H~~~ivHrDlkp~Nill~--~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl  228 (394)
T 4e7w_A          158 HSIGICHRDIKPQNLLLD--PPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWST  228 (394)
T ss_dssp             HHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHH
T ss_pred             HHCCccCCCCCHHHEEEc--CCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHH
Confidence            999999999999999993  26789999999999877666666667889999999998764 58999999996

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.97  E-value=2.5e-32  Score=192.99  Aligned_cols=145  Identities=26%  Similarity=0.428  Sum_probs=124.3

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecC--CcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      ....+.+.+|+.+++.++||||+++++++...  ...++++||+++++|.+++... ..+++..+..++.|++.|+.+||
T Consensus        83 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH  162 (326)
T 2w1i_A           83 EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG  162 (326)
T ss_dssp             SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence            34567899999999999999999999988654  3789999999999999999865 45999999999999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc----cccccCCccccCcccccccCCCcccceecC
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +.+++|+||+|+||++   +..+.+||+|||++........    .....++..|+|||++.+..++.++|||||
T Consensus       163 ~~~ivH~dikp~NIli---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  234 (326)
T 2w1i_A          163 TKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSF  234 (326)
T ss_dssp             HTTEECSCCCGGGEEE---EETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred             hCCEeccCCCcceEEE---cCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHH
Confidence            9999999999999999   5667899999999987654322    223446677999999998889999999996

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.97  E-value=4.1e-32  Score=186.83  Aligned_cols=141  Identities=20%  Similarity=0.307  Sum_probs=121.9

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecC--CcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEIL   82 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~l   82 (154)
                      ....+.+.+|+.+++.++||||+++++++.++  +..+++|||+++++|.+++....  .+++..+..++.|++.|+.||
T Consensus        48 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l  127 (271)
T 3kmu_A           48 TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL  127 (271)
T ss_dssp             HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence            45567899999999999999999999999877  78899999999999999998665  489999999999999999999


Q ss_pred             HhCC--ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCc---ccceecC
Q 031702           83 NSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDE---KVNFFVS  154 (154)
Q Consensus        83 h~~~--~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Diwsl  154 (154)
                      |+.+  ++|+||+|+||++   +..+.+++.||+++....    .....+|+.|+|||++.+..++.   ++|||||
T Consensus       128 H~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~sl  197 (271)
T 3kmu_A          128 HTLEPLIPRHALNSRSVMI---DEDMTARISMADVKFSFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSF  197 (271)
T ss_dssp             TTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGSCCTTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHH
T ss_pred             hcCCCceecCCCccceEEE---cCCcceeEEeccceeeec----ccCccCCccccChhhhccCCCCCCCchhhHHHH
Confidence            9999  9999999999999   677788998888765432    23346789999999998665443   7999996

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.97  E-value=7.9e-32  Score=193.08  Aligned_cols=142  Identities=27%  Similarity=0.452  Sum_probs=121.8

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecC-----CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL   82 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l   82 (154)
                      ...+.+.+|+.+++.++||||+++++++...     ...|+++|+++ ++|.+++.. ..+++..+..++.|++.|+.||
T Consensus        67 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~L  144 (364)
T 3qyz_A           67 TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYI  144 (364)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHH
Confidence            4457889999999999999999999998655     46899999996 599998864 5799999999999999999999


Q ss_pred             HhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc----cccccCCccccCcccccc-cCCCcccceecC
Q 031702           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        83 h~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      |++|++|+||||+||++   +..+.+||+|||++........    .....||+.|+|||++.+ ..++.++|||||
T Consensus       145 H~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  218 (364)
T 3qyz_A          145 HSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV  218 (364)
T ss_dssp             HHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHH
T ss_pred             HHCCeecCCCChHhEEE---CCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHH
Confidence            99999999999999999   6788899999999976543321    234578999999998754 458999999996

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.97  E-value=6.2e-32  Score=206.16  Aligned_cols=144  Identities=26%  Similarity=0.490  Sum_probs=122.4

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ....+.+.+|+.+++.++||||+++++++. .+..+++|||+++|+|.+++.... .+++..+..++.|++.|+.|||+.
T Consensus       432 ~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  510 (656)
T 2j0j_A          432 DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK  510 (656)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            345678999999999999999999999885 456899999999999999997654 689999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--cccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||||+||++   +..+.+||+|||++........  .....+++.|+|||++.+..++.++|||||
T Consensus       511 givHrDikp~NILl---~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl  578 (656)
T 2j0j_A          511 RFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF  578 (656)
T ss_dssp             TCCCSCCSGGGEEE---EETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             CccccccchHhEEE---eCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHH
Confidence            99999999999999   5677899999999987644332  223445678999999998899999999996

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.97  E-value=6.7e-32  Score=187.52  Aligned_cols=140  Identities=29%  Similarity=0.492  Sum_probs=118.1

Q ss_pred             HhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--c
Q 031702           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH--I   87 (154)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~--~   87 (154)
                      +.+.+|+.+++.++||||+++++++.+..  +++|||+++++|.+++... ..+++..+..++.|++.|+.|||+.+  +
T Consensus        68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i  145 (287)
T 4f0f_A           68 QEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPI  145 (287)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCC
T ss_pred             HHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCe
Confidence            67899999999999999999999997766  6999999999998888654 46999999999999999999999999  9


Q ss_pred             eeecCCCCcEEeecCC--CCeeEEEeecccccccCCCCccccccCCccccCccccc--ccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ--FQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~--~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Diwsl  154 (154)
                      +|+||||+||++....  ....+||+|||++.....  ......|++.|+|||++.  ...++.++|||||
T Consensus       146 vH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~sl  214 (287)
T 4f0f_A          146 VHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSF  214 (287)
T ss_dssp             BCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHH
T ss_pred             ecCCCCcceEEEeccCCCCceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHH
Confidence            9999999999994221  122489999999875433  234467899999999984  4567899999996

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.97  E-value=2.2e-32  Score=191.13  Aligned_cols=144  Identities=28%  Similarity=0.523  Sum_probs=121.7

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|+.+++.++||||+++++++.+++..++++||+++++|.+++.. ...+++..+..++.|++.|+.|||+.+
T Consensus        58 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  137 (302)
T 2j7t_A           58 EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR  137 (302)
T ss_dssp             CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence            3457888999999999999999999999999999999999999999998865 456999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCccccc-----ccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.+||+|||++...... .......|++.|+|||++.     ...++.++|||||
T Consensus       138 i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~sl  208 (302)
T 2j7t_A          138 IIHRDLKAGNVLM---TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSL  208 (302)
T ss_dssp             CCCCCCSGGGEEE---CTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHH
T ss_pred             cccCCCCHHHEEE---CCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHH
Confidence            9999999999999   67788999999987543221 1223456899999999983     5678899999996

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.97  E-value=4.8e-32  Score=188.74  Aligned_cols=145  Identities=30%  Similarity=0.484  Sum_probs=123.0

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ...+.+.+|+.+++.++||||+++++++.+.+..++++||+++++|.+++....   .+++..+..++.|++.|+.|||+
T Consensus        61 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~  140 (295)
T 2clq_A           61 RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD  140 (295)
T ss_dssp             ---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh
Confidence            446789999999999999999999999999999999999999999999997653   46788999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccC--CCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR--YDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~~Diwsl  154 (154)
                      .+++|+||+|+||++.  ...+.+||+|||.+....... ......|++.|+|||++.+..  ++.++|||||
T Consensus       141 ~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~sl  211 (295)
T 2clq_A          141 NQIVHRDIKGDNVLIN--TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSL  211 (295)
T ss_dssp             TTEECCCCSGGGEEEE--TTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHH
T ss_pred             CCEEccCCChhhEEEE--CCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHH
Confidence            9999999999999994  236789999999987654432 234457899999999997653  8899999996

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.97  E-value=3.6e-32  Score=189.00  Aligned_cols=143  Identities=28%  Similarity=0.412  Sum_probs=122.8

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|+.+++.++||||+++++++.+++ .++++||+++++|.+++... ..+++..+..++.|++.|+.|||+.+
T Consensus        63 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  141 (291)
T 1u46_A           63 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR  141 (291)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence            45678899999999999999999999998765 78999999999999998764 56999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc----cccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||+|+||++   +..+.+||+|||++........    .....+++.|+|||++.+..++.++|||||
T Consensus       142 i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  210 (291)
T 1u46_A          142 FIHRDLAARNLLL---ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMF  210 (291)
T ss_dssp             EECSCCCGGGEEE---EETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred             cccCCCchheEEE---cCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHH
Confidence            9999999999999   5667899999999877654332    223456778999999988889999999996

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.97  E-value=9.2e-32  Score=190.24  Aligned_cols=144  Identities=24%  Similarity=0.379  Sum_probs=124.1

Q ss_pred             hhHHhHHHHHHHHhhCCCCc------cchhhhheecCCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPN------IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL   79 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l   79 (154)
                      ...+.+.+|+.+++.++|++      ++++++++.+.+..+++|||+ +++|.+++...+  .+++..+..++.|++.|+
T Consensus        53 ~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l  131 (339)
T 1z57_A           53 RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSV  131 (339)
T ss_dssp             HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred             chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence            44678899999999997765      899999999999999999999 889999998765  588999999999999999


Q ss_pred             HHHHhCCceeecCCCCcEEeecCCC----------------CeeEEEeecccccccCCCCccccccCCccccCccccccc
Q 031702           80 EILNSHHIIHRDLKPENILLSGLDD----------------DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ  143 (154)
Q Consensus        80 ~~lh~~~~~h~~i~p~nil~~~~~~----------------~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  143 (154)
                      +|||+++++|+||||+||++...+.                .+.+||+|||++.....  ......||+.|+|||++.+.
T Consensus       132 ~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~  209 (339)
T 1z57_A          132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILAL  209 (339)
T ss_dssp             HHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTS
T ss_pred             HHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCC
Confidence            9999999999999999999943111                55799999999876433  23446789999999999988


Q ss_pred             CCCcccceecC
Q 031702          144 RYDEKVNFFVS  154 (154)
Q Consensus       144 ~~~~~~Diwsl  154 (154)
                      .++.++|||||
T Consensus       210 ~~~~~~Di~sl  220 (339)
T 1z57_A          210 GWSQPCDVWSI  220 (339)
T ss_dssp             CCCTHHHHHHH
T ss_pred             CCCcchhhHHH
Confidence            99999999996

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.97  E-value=1.2e-31  Score=186.32  Aligned_cols=142  Identities=26%  Similarity=0.392  Sum_probs=109.9

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ..+.+.++...++.++||||+++++++.+++..+++|||+++ +|.+++..    ...+++..+..++.|++.|+.|||+
T Consensus        49 ~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  127 (290)
T 3fme_A           49 QKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS  127 (290)
T ss_dssp             HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            344555566668888999999999999999999999999974 88777643    4679999999999999999999999


Q ss_pred             C-CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccc----cccCCCcccceecC
Q 031702           85 H-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL----QFQRYDEKVNFFVS  154 (154)
Q Consensus        85 ~-~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Diwsl  154 (154)
                      + +++|+||||+||++   +..+.+||+|||++.............||+.|+|||++    .+..++.++|||||
T Consensus       128 ~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~sl  199 (290)
T 3fme_A          128 KLSVIHRDVKPSNVLI---NALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSL  199 (290)
T ss_dssp             HSCCCCCCCSGGGCEE---CTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHH
T ss_pred             cCCeecCCCCHHHEEE---CCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHH
Confidence            8 99999999999999   67789999999999876665555556789999999996    45678999999996

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.97  E-value=1.1e-31  Score=189.72  Aligned_cols=144  Identities=26%  Similarity=0.466  Sum_probs=108.9

Q ss_pred             hhhHHhHHHHHHHHhhCC-CCccchhhhhee--------cCCcEEEEEEecCCCCchHHHHH---cCCCCHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQ--------AENCIFLVVEFCAGGNLSSYIRL---HGRVPEQTARKFLQQ   74 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--------~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~   74 (154)
                      ....+.+.+|+.+++.+. ||||+++++++.        .....++++||++ |+|.+++..   .+.+++..++.++.|
T Consensus        66 ~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~q  144 (337)
T 3ll6_A           66 EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQ  144 (337)
T ss_dssp             HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHH
Confidence            455678899999999995 999999999883        3455899999995 699888864   456999999999999


Q ss_pred             HHHHHHHHHhCC--ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc-------------cccccCCccccCccc
Q 031702           75 LGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-------------AEKVCGSPLYMAPEV  139 (154)
Q Consensus        75 i~~~l~~lh~~~--~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~-------------~~~~~~~~~y~aPE~  139 (154)
                      ++.|+.|||+.+  ++|+||||+||++   +..+.+||+|||++........             .....+|+.|+|||+
T Consensus       145 i~~~l~~LH~~~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~  221 (337)
T 3ll6_A          145 TCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEI  221 (337)
T ss_dssp             HHHHHHHHHTSSSCCBCCCCCGGGCEE---CTTSCEEBCCCTTCBCCSSCC-----------------------------
T ss_pred             HHHHHHHHHhCCCCEEEccCCcccEEE---CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhh
Confidence            999999999999  9999999999999   6778999999999976544321             114568899999999


Q ss_pred             c---cccCCCcccceecC
Q 031702          140 L---QFQRYDEKVNFFVS  154 (154)
Q Consensus       140 ~---~~~~~~~~~Diwsl  154 (154)
                      +   .+..++.++|||||
T Consensus       222 ~~~~~~~~~~~~~Dv~sl  239 (337)
T 3ll6_A          222 IDLYSNFPIGEKQDIWAL  239 (337)
T ss_dssp             --CCTTSCSSHHHHHHHH
T ss_pred             hhccccCCCChHHhHHHH
Confidence            8   56678899999996

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.97  E-value=2.3e-31  Score=187.65  Aligned_cols=141  Identities=35%  Similarity=0.529  Sum_probs=122.9

Q ss_pred             HHhHHHHHHHHhhC---CCCccchhhhhee-----cCCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHH
Q 031702           10 KSCLDCELNFLSSV---NHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL   79 (154)
Q Consensus        10 ~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l   79 (154)
                      ...+.+|+.+++.+   +||||+++++++.     .....++++||++ ++|.+++....  .+++..+..++.|++.|+
T Consensus        55 ~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l  133 (326)
T 1blx_A           55 PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGL  133 (326)
T ss_dssp             BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHH
T ss_pred             CchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHH
Confidence            34677888888777   8999999999987     5567899999997 59999997654  499999999999999999


Q ss_pred             HHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        80 ~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .|||+.|++|+||+|+||++   +..+.+||+|||++.............+++.|+|||++.+..++.++|||||
T Consensus       134 ~~lH~~gi~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  205 (326)
T 1blx_A          134 DFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSV  205 (326)
T ss_dssp             HHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHH
T ss_pred             HHHHHCCceeccCCHHHeEE---cCCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHH
Confidence            99999999999999999999   6778999999999976654444455678999999999998899999999996

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.97  E-value=1.9e-31  Score=194.50  Aligned_cols=141  Identities=28%  Similarity=0.432  Sum_probs=117.8

Q ss_pred             HhHHHHHHHHhhCCCCccchhhhheecC------CcEEEEEEecCCCCchHHHH----HcCCCCHHHHHHHHHHHHHHHH
Q 031702           11 SCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKFLQQLGAGLE   80 (154)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~   80 (154)
                      +...+|+++++.++||||+++++++...      ..+++++||+++ ++.+.+.    ....+++..++.++.|++.|+.
T Consensus        92 ~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~  170 (420)
T 1j1b_A           92 RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA  170 (420)
T ss_dssp             TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHH
Confidence            3456799999999999999999988432      247899999975 6665553    3467999999999999999999


Q ss_pred             HHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCccccccc-CCCcccceecC
Q 031702           81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        81 ~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      |||+.+++||||||+||++.  ...+.+||+|||++.............+|+.|+|||++.+. .|+.++|||||
T Consensus       171 ~LH~~~ivHrDlkp~NILl~--~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl  243 (420)
T 1j1b_A          171 YIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSA  243 (420)
T ss_dssp             HHHTTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHH
T ss_pred             HHHHCCccccCCChhhEEEe--CCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHH
Confidence            99999999999999999994  24567899999999876655555567789999999998764 78999999996

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.97  E-value=1.3e-31  Score=205.25  Aligned_cols=138  Identities=25%  Similarity=0.448  Sum_probs=117.8

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCc-----EEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~   81 (154)
                      ....+.+.+|+.+++.++||||+++++++...+.     .|+||||++|++|.+++..  .+++..+..++.|++.|+.|
T Consensus       120 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~  197 (681)
T 2pzi_A          120 AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSY  197 (681)
T ss_dssp             HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHH
Confidence            3456778999999999999999999999987655     7999999999999987753  79999999999999999999


Q ss_pred             HHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        82 lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ||++|++|+||||+||++.   . ..+||+|||++......   ....||+.|+|||++.++ ++.++|||||
T Consensus       198 lH~~giiHrDlkp~NIll~---~-~~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~sl  262 (681)
T 2pzi_A          198 LHSIGLVYNDLKPENIMLT---E-EQLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTG-PTVATDIYTV  262 (681)
T ss_dssp             HHHTTEECCCCSGGGEEEC---S-SCEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHH
T ss_pred             HHHCCCeecccChHHeEEe---C-CcEEEEecccchhcccC---CccCCCccccCHHHHcCC-CCCceehhhh
Confidence            9999999999999999993   3 38999999999765443   445789999999998754 4899999996

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.97  E-value=2.9e-31  Score=184.87  Aligned_cols=145  Identities=18%  Similarity=0.218  Sum_probs=122.8

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhhe-ecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ..+.+.+|+.+++.++|++++..+..+ .+++..+++|||+ +++|.+++.. ...+++..+..++.|++.|+.|||+++
T Consensus        47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  125 (296)
T 3uzp_A           47 KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN  125 (296)
T ss_dssp             SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            346789999999999888766665555 5667889999999 8899999974 457999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--------cccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||||+||++...+..+.+||+|||++........        .....||+.|+|||++.+..++.++|||||
T Consensus       126 ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  201 (296)
T 3uzp_A          126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESL  201 (296)
T ss_dssp             EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred             eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHH
Confidence            99999999999995334677899999999976654322        245678999999999999899999999996

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.97  E-value=2.4e-31  Score=187.71  Aligned_cols=144  Identities=31%  Similarity=0.562  Sum_probs=118.0

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheec------CCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAG   78 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~   78 (154)
                      ...+.+.+|+.+++.+ +||||+++++++..      .+..+++|||+++++|.+++...  ..+++..+..++.|++.|
T Consensus        62 ~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~  141 (326)
T 2x7f_A           62 DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG  141 (326)
T ss_dssp             STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHH
T ss_pred             ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHH
Confidence            3457889999999999 89999999999976      46789999999999999999764  469999999999999999


Q ss_pred             HHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCccccc-----ccCCCccccee
Q 031702           79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVNFF  152 (154)
Q Consensus        79 l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Diw  152 (154)
                      +.|||+.|++|+||+|+||++   +..+.+||+|||++...... .......|++.|+|||++.     +..++.++|||
T Consensus       142 l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~  218 (326)
T 2x7f_A          142 LSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLW  218 (326)
T ss_dssp             HHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHH
T ss_pred             HHHHHHCCccccCCcHHHEEE---cCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHH
Confidence            999999999999999999999   67788999999998765432 2234457899999999987     45688999999


Q ss_pred             cC
Q 031702          153 VS  154 (154)
Q Consensus       153 sl  154 (154)
                      ||
T Consensus       219 sl  220 (326)
T 2x7f_A          219 SL  220 (326)
T ss_dssp             HH
T ss_pred             HH
Confidence            96

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.97  E-value=2e-31  Score=194.82  Aligned_cols=141  Identities=30%  Similarity=0.442  Sum_probs=121.6

Q ss_pred             hhHHhHHHHHHHHhhC------CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL   79 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l   79 (154)
                      ...+.+.+|+.+++.+      .|+||+++++.+...+..+++|||+. ++|.+++....  .+++..+..++.|++.|+
T Consensus       135 ~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL  213 (429)
T 3kvw_A          135 RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCL  213 (429)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHH
Confidence            3456788899988887      56799999999999999999999995 69999887654  499999999999999999


Q ss_pred             HHHHhCCceeecCCCCcEEeecCCCCee--EEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           80 EILNSHHIIHRDLKPENILLSGLDDDVM--LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        80 ~~lh~~~~~h~~i~p~nil~~~~~~~~~--~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|||+.+++|+||||+||++   +..+.  +||+|||++.....  ......||+.|+|||++.+..++.++|||||
T Consensus       214 ~~LH~~~ivHrDlKp~NILl---~~~~~~~vkL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  285 (429)
T 3kvw_A          214 DALHKNRIIHCDLKPENILL---KQQGRSGIKVIDFGSSCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSL  285 (429)
T ss_dssp             HHHHHHTEECSCCSGGGEEE---SSTTSCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHH
T ss_pred             HHHHHCCeecCCCCHHHeEE---ccCCCcceEEeecccceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhH
Confidence            99999999999999999999   44444  99999999865433  2334678999999999999999999999996

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.97  E-value=3e-31  Score=184.66  Aligned_cols=146  Identities=18%  Similarity=0.216  Sum_probs=123.0

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhhe-ecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ...+.+.+|+.+++.++|++++..+..+ .+++..+++|||+ +++|.+++.. ...+++..+..++.|++.|+.|||+.
T Consensus        46 ~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~  124 (296)
T 4hgt_A           46 TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK  124 (296)
T ss_dssp             --CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3456789999999999888777666555 6677889999999 8899999875 45799999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--------cccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++|+||||+||++...+..+.+||+|||++........        .....||+.|+|||++.+..++.++|||||
T Consensus       125 ~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  201 (296)
T 4hgt_A          125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESL  201 (296)
T ss_dssp             TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHH
T ss_pred             CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHH
Confidence            999999999999995444677899999999986644322        234678999999999999899999999996

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.97  E-value=1.5e-31  Score=191.07  Aligned_cols=143  Identities=28%  Similarity=0.405  Sum_probs=119.1

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCC-------cEEEEEEecCCCCchHHHH----HcCCCCHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-------CIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKFLQQLGA   77 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------~~~~v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~   77 (154)
                      ..+...+|+..++.++||||+++++++.+.+       ..+++|||+++ +|.+.+.    ....+++..+..++.|++.
T Consensus        62 ~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~  140 (360)
T 3e3p_A           62 FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIR  140 (360)
T ss_dssp             CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHH
T ss_pred             ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHH
Confidence            3456677888889999999999999986543       28899999976 5544433    4456899999999999999


Q ss_pred             HHHHHH--hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCccccccc-CCCcccceecC
Q 031702           78 GLEILN--SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        78 ~l~~lh--~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      |+.|||  +.+++|+||||+||++.  ...+.+||+|||++.............||+.|+|||++.+. .++.++|||||
T Consensus       141 al~~lH~~~~~ivH~Dlkp~NIll~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl  218 (360)
T 3e3p_A          141 SIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSV  218 (360)
T ss_dssp             HHHHHTSTTTCCBCSCCCGGGEEEE--TTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHH
T ss_pred             HHHHHhCCCCCeecCcCCHHHEEEe--CCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHH
Confidence            999999  99999999999999994  23779999999999877666666667789999999998654 48999999996

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.97  E-value=1.5e-31  Score=192.98  Aligned_cols=144  Identities=31%  Similarity=0.461  Sum_probs=119.6

Q ss_pred             hhHHhHHHHHHHHhhCC--------CCccchhhhhee----cCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVN--------HPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ   73 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~----~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~   73 (154)
                      ...+.+.+|+.+++.++        |+||+++++.+.    +....+++|||+ ++++.+.+...  ..+++..++.++.
T Consensus        75 ~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~  153 (397)
T 1wak_A           75 HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQ  153 (397)
T ss_dssp             HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHH
T ss_pred             cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHH
Confidence            44678899999999995        788999999987    556899999999 55666666544  4699999999999


Q ss_pred             HHHHHHHHHHhC-CceeecCCCCcEEeecCC----------------------------------------------CCe
Q 031702           74 QLGAGLEILNSH-HIIHRDLKPENILLSGLD----------------------------------------------DDV  106 (154)
Q Consensus        74 ~i~~~l~~lh~~-~~~h~~i~p~nil~~~~~----------------------------------------------~~~  106 (154)
                      |++.|+.|||++ |++|+||||+||++....                                              ...
T Consensus       154 qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (397)
T 1wak_A          154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKL  233 (397)
T ss_dssp             HHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGC
T ss_pred             HHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccccccccccccccccccc
Confidence            999999999998 999999999999994211                                              113


Q ss_pred             eEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702          107 MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus       107 ~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .+||+|||++......  .....||+.|+|||++.+..++.++|||||
T Consensus       234 ~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  279 (397)
T 1wak_A          234 KVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSGYNTPADIWST  279 (397)
T ss_dssp             CEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSCCCTHHHHHHH
T ss_pred             ceEecccccccccccc--CccCCCCCcccCChhhcCCCCCcHHHHHHH
Confidence            7999999999765432  334578999999999998899999999996

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.97  E-value=3.8e-32  Score=195.14  Aligned_cols=141  Identities=13%  Similarity=0.089  Sum_probs=103.2

Q ss_pred             hhHHhHHHHHHHHhhC--CCCccchhhhhe-------ecC-----------------CcEEEEEEecCCCCchHHHHHcC
Q 031702            8 HLKSCLDCELNFLSSV--NHPNIIRLFDAF-------QAE-----------------NCIFLVVEFCAGGNLSSYIRLHG   61 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l--~h~~i~~~~~~~-------~~~-----------------~~~~~v~e~~~~~~L~~~~~~~~   61 (154)
                      ...+.+.+|+.+++.+  +|||+++++..+       ..+                 ...|++|||++ ++|.+++...+
T Consensus       104 ~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~  182 (371)
T 3q60_A          104 SELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD  182 (371)
T ss_dssp             HHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc
Confidence            4567788886555555  699988865333       222                 34899999998 79999997643


Q ss_pred             -CCCHHHH------HHHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccc
Q 031702           62 -RVPEQTA------RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY  134 (154)
Q Consensus        62 -~~~~~~~------~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y  134 (154)
                       .++....      ..++.|++.|++|||+++++||||||+||++   +..+.+||+|||++......  .....+++.|
T Consensus       183 ~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y  257 (371)
T 3q60_A          183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRLMLGDVSALWKVGTR--GPASSVPVTY  257 (371)
T ss_dssp             HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE---CTTSCEEECCGGGEEETTCE--EEGGGSCGGG
T ss_pred             cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEE---CCCCCEEEEecceeeecCCC--ccCccCCcCC
Confidence             3444455      6777999999999999999999999999999   67789999999999865432  2244567999


Q ss_pred             cCcccccc--cCCCcccceecC
Q 031702          135 MAPEVLQF--QRYDEKVNFFVS  154 (154)
Q Consensus       135 ~aPE~~~~--~~~~~~~Diwsl  154 (154)
                      +|||++.+  ..++.++|||||
T Consensus       258 ~aPE~~~~~~~~~~~~~DiwSl  279 (371)
T 3q60_A          258 APREFLNASTATFTHALNAWQL  279 (371)
T ss_dssp             CCHHHHTCSEEECCHHHHHHHH
T ss_pred             cChhhccCCCCCcCccccHHHH
Confidence            99999987  679999999996

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.97  E-value=8.4e-32  Score=191.18  Aligned_cols=137  Identities=31%  Similarity=0.645  Sum_probs=100.7

Q ss_pred             HHHHhhCCCCccchhhhheec----CCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 031702           17 LNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHR   90 (154)
Q Consensus        17 ~~~l~~l~h~~i~~~~~~~~~----~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~~~h~   90 (154)
                      ...++.++|||++++++++..    +...+++|||+++++|.+++....  .+++..++.++.|++.|+.|||+++++|+
T Consensus        73 ~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~  152 (336)
T 3fhr_A           73 DHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHR  152 (336)
T ss_dssp             HHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            334566799999999999976    456899999999999999998654  59999999999999999999999999999


Q ss_pred             cCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        91 ~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ||+|+||++...+..+.+||+|||++...... ......+|+.|+|||++.+..++.++|||||
T Consensus       153 dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl  215 (336)
T 3fhr_A          153 DVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSL  215 (336)
T ss_dssp             CCSGGGEEESCSSTTCCEEECCCTTCEEC-----------------------CHHHHHHHHHHH
T ss_pred             CCCHHHEEEEecCCCceEEEeccccceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHH
Confidence            99999999965445677999999998765432 3345677999999999988889999999996

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.97  E-value=7.9e-31  Score=183.44  Aligned_cols=142  Identities=30%  Similarity=0.521  Sum_probs=118.7

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhhe--ecCCcEEEEEEecCCCCchHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ..+.+.+|+.+++.++||||+++++++  .+.+..+++|||++++ +.+++..  ...+++..+..++.|++.|+.|||+
T Consensus        49 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~  127 (305)
T 2wtk_C           49 GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS  127 (305)
T ss_dssp             HHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH
Confidence            457899999999999999999999998  4556899999999775 7777765  3469999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCC---CccccccCCccccCcccccccC--CCcccceecC
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQR--YDEKVNFFVS  154 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~--~~~~~Diwsl  154 (154)
                      ++++|+||+|+||++   +..+.++|+|||.+......   .......|++.|+|||++.+..  ++.++|||||
T Consensus       128 ~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~sl  199 (305)
T 2wtk_C          128 QGIVHKDIKPGNLLL---TTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSA  199 (305)
T ss_dssp             TTEECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHH
T ss_pred             CCeeecCCCcccEEE---cCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHH
Confidence            999999999999999   67789999999999765432   2234456899999999987643  3779999996

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.97  E-value=6.7e-31  Score=187.19  Aligned_cols=142  Identities=25%  Similarity=0.457  Sum_probs=120.1

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecC-----CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL   82 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l   82 (154)
                      .....+.+|+.+++.++||||+++++++...     ...++++||++ ++|.+++.. ..+++..+..++.|++.|+.||
T Consensus        51 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~L  128 (353)
T 2b9h_A           51 LFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVL  128 (353)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHH
Confidence            4466788999999999999999999887654     67899999996 589988874 5799999999999999999999


Q ss_pred             HhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc-----------cccccCCccccCcccccc-cCCCcccc
Q 031702           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----------AEKVCGSPLYMAPEVLQF-QRYDEKVN  150 (154)
Q Consensus        83 h~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~-~~~~~~~D  150 (154)
                      |+.|++|+||+|+||++   +..+.+||+|||++........           .....||+.|+|||++.+ ..++.++|
T Consensus       129 H~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  205 (353)
T 2b9h_A          129 HGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMD  205 (353)
T ss_dssp             HHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHH
T ss_pred             HHCCeecCCCCHHHeEE---cCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhh
Confidence            99999999999999999   6788899999999976543211           123467999999998764 67899999


Q ss_pred             eecC
Q 031702          151 FFVS  154 (154)
Q Consensus       151 iwsl  154 (154)
                      ||||
T Consensus       206 i~sl  209 (353)
T 2b9h_A          206 VWSC  209 (353)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9996

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.97  E-value=1e-30  Score=183.62  Aligned_cols=144  Identities=27%  Similarity=0.543  Sum_probs=120.2

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhhee--------------cCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--------------AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL   72 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--------------~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~   72 (154)
                      ....+.+.+|+.+++.++||||+++++++.              +.+..+++|||++ ++|.+++. .+.+++..+..++
T Consensus        49 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~  126 (320)
T 2i6l_A           49 PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFM  126 (320)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHH
Confidence            455678899999999999999999998763              4467899999997 59999886 4679999999999


Q ss_pred             HHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCC----CccccccCCccccCcccccc-cCCCc
Q 031702           73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----NYAEKVCGSPLYMAPEVLQF-QRYDE  147 (154)
Q Consensus        73 ~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~  147 (154)
                      .|++.|++|||++|++|+||+|+||++.  ..++.+||+|||++......    .......+++.|+|||.+.+ ..++.
T Consensus       127 ~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  204 (320)
T 2i6l_A          127 YQLLRGLKYIHSANVLHRDLKPANLFIN--TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTK  204 (320)
T ss_dssp             HHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCH
T ss_pred             HHHHHHHHHHHhCCEecCCCCHHHEEEc--CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCc
Confidence            9999999999999999999999999994  25678999999999765432    12234567889999999865 67899


Q ss_pred             ccceecC
Q 031702          148 KVNFFVS  154 (154)
Q Consensus       148 ~~Diwsl  154 (154)
                      ++|||||
T Consensus       205 ~~Di~sl  211 (320)
T 2i6l_A          205 AIDMWAA  211 (320)
T ss_dssp             HHHHHHH
T ss_pred             hhhhHhH
Confidence            9999996

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.97  E-value=4.7e-31  Score=187.73  Aligned_cols=144  Identities=22%  Similarity=0.365  Sum_probs=122.6

Q ss_pred             hhHHhHHHHHHHHhhCCCCc------cchhhhheecCCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPN------IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL   79 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l   79 (154)
                      ...+.+.+|+.+++.++|++      ++.+.+++...+..+++|||+ ++++.+++....  .+++..+..++.|++.|+
T Consensus        58 ~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L  136 (355)
T 2eu9_A           58 KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL  136 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHH
Confidence            45678889999999998766      888889999999999999999 567777776543  699999999999999999


Q ss_pred             HHHHhCCceeecCCCCcEEeecC----------------CCCeeEEEeecccccccCCCCccccccCCccccCccccccc
Q 031702           80 EILNSHHIIHRDLKPENILLSGL----------------DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ  143 (154)
Q Consensus        80 ~~lh~~~~~h~~i~p~nil~~~~----------------~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  143 (154)
                      .|||+++++|+||||+||++...                +..+.+||+|||++.....  ......||+.|+|||++.+.
T Consensus       137 ~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~  214 (355)
T 2eu9_A          137 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILEL  214 (355)
T ss_dssp             HHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTC
T ss_pred             HHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecC
Confidence            99999999999999999999432                2467899999999876433  23446789999999999988


Q ss_pred             CCCcccceecC
Q 031702          144 RYDEKVNFFVS  154 (154)
Q Consensus       144 ~~~~~~Diwsl  154 (154)
                      .++.++|||||
T Consensus       215 ~~~~~~Di~sl  225 (355)
T 2eu9_A          215 GWAQPCDVWSI  225 (355)
T ss_dssp             CCCTHHHHHHH
T ss_pred             CCCCccchHHH
Confidence            99999999996

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.97  E-value=4.2e-31  Score=188.53  Aligned_cols=140  Identities=29%  Similarity=0.474  Sum_probs=117.5

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCc------EEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE   80 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~   80 (154)
                      ....+.+.+|+.+++.++||||+++++++...+.      .|++|||++ ++|.+++.  ..+++..+..++.|++.|+.
T Consensus        64 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~  140 (353)
T 3coi_A           64 EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLK  140 (353)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHH
Confidence            3456788999999999999999999999977653      499999996 58888764  45999999999999999999


Q ss_pred             HHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc-cCCCcccceecC
Q 031702           81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        81 ~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      |||++|++|+||+|+||++   +..+.+||+|||++......  .....+|+.|+|||++.+ ..++.++|||||
T Consensus       141 ~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~sl  210 (353)
T 3coi_A          141 YIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSV  210 (353)
T ss_dssp             HHHHTTCCCSSCCGGGEEE---CTTCCEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHH
T ss_pred             HHHHCCcccCCCCHHHEeE---CCCCcEEEeecccccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHH
Confidence            9999999999999999999   67789999999998764332  334567999999999876 678999999996

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.97  E-value=1.2e-30  Score=187.37  Aligned_cols=140  Identities=29%  Similarity=0.474  Sum_probs=117.6

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcE------EEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE   80 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~   80 (154)
                      ....+.+.+|+.+++.++||||+++++++...+..      +++|||++ ++|.+++.  ..+++..+..++.|++.|+.
T Consensus        82 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~  158 (371)
T 4exu_A           82 EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLK  158 (371)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHH
Confidence            34467889999999999999999999999877654      99999996 58877663  45999999999999999999


Q ss_pred             HHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc-cCCCcccceecC
Q 031702           81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        81 ~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      |||+.|++|+||||+||++   +..+.+||+|||++......  .....+|+.|+|||++.+ ..++.++|||||
T Consensus       159 ~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  228 (371)
T 4exu_A          159 YIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSV  228 (371)
T ss_dssp             HHHHTTCCCSCCCGGGEEE---CTTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHH
T ss_pred             HHHHCCCcCCCcCHHHeEE---CCCCCEEEEecCcccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHH
Confidence            9999999999999999999   67888999999999754332  334567999999999886 678999999996

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.97  E-value=5.9e-31  Score=194.62  Aligned_cols=145  Identities=17%  Similarity=0.186  Sum_probs=123.5

Q ss_pred             hHHhHHHHHHHHhhCCC-CccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            9 LKSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ..+.+.+|+.+++.++| ++++.+..++.+.+..+++|||+ +++|.+++.. ...+++..++.++.||+.||.|||+++
T Consensus        45 ~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g  123 (483)
T 3sv0_A           45 KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS  123 (483)
T ss_dssp             SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34578899999999976 55666666667788899999999 8899999975 457999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--------cccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|+||||+||++...+..+.+||+|||++........        .....||+.|+|||++.+..++.++|||||
T Consensus       124 IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSl  199 (483)
T 3sv0_A          124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESL  199 (483)
T ss_dssp             EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred             EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHH
Confidence            99999999999995434677899999999987654322        225678999999999999999999999996

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.97  E-value=7.9e-31  Score=185.26  Aligned_cols=142  Identities=28%  Similarity=0.464  Sum_probs=102.3

Q ss_pred             hHHhHHHHHH-HHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-----cCCCCHHHHHHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-----HGRVPEQTARKFLQQLGAGLEIL   82 (154)
Q Consensus         9 ~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~l   82 (154)
                      ....+..|.. +++.++||||+++++++.+++..+++|||+++ +|.+++..     ...+++..+..++.|++.|+.||
T Consensus        63 ~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l  141 (327)
T 3aln_A           63 EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL  141 (327)
T ss_dssp             HHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHH
Confidence            3445555665 67778999999999999999999999999975 88887763     46799999999999999999999


Q ss_pred             HhC-CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccc----cccCCCcccceecC
Q 031702           83 NSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL----QFQRYDEKVNFFVS  154 (154)
Q Consensus        83 h~~-~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Diwsl  154 (154)
                      |+. +++|+||+|+||++   +..+.+||+|||++.............|++.|+|||++    .+..++.++|||||
T Consensus       142 H~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~sl  215 (327)
T 3aln_A          142 KENLKIIHRDIKPSNILL---DRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSL  215 (327)
T ss_dssp             HHHHSCCCSCCCGGGEEE---ETTTEEEECCCSSSCC------------------------------CCSHHHHHHH
T ss_pred             hccCCEeECCCCHHHEEE---cCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHH
Confidence            999 99999999999999   57789999999999876554444455789999999998    45678999999996

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.97  E-value=8.8e-31  Score=184.01  Aligned_cols=143  Identities=25%  Similarity=0.515  Sum_probs=119.7

Q ss_pred             hhhHHhHHHHHHHHhhCC--CCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh
Q 031702            7 KHLKSCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ....+.+.+|+.+++.++  ||||+++++++.+++..+++|| +.+++|.+++.....+++..+..++.|++.|+.|||+
T Consensus        67 ~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~  145 (313)
T 3cek_A           67 NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ  145 (313)
T ss_dssp             HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            445688999999999996  5999999999999999999999 5578999999988889999999999999999999999


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccc-----------cCCCcccc
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQF-----------QRYDEKVN  150 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-----------~~~~~~~D  150 (154)
                      .+++|+||+|+||++.    .+.+||+|||++.......   ......|++.|+|||++.+           ..++.++|
T Consensus       146 ~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D  221 (313)
T 3cek_A          146 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD  221 (313)
T ss_dssp             TTCCCCCCCGGGEEEE----TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHH
T ss_pred             CCceecCCCcccEEEE----CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHH
Confidence            9999999999999993    3689999999997654432   2234568999999999875           46888999


Q ss_pred             eecC
Q 031702          151 FFVS  154 (154)
Q Consensus       151 iwsl  154 (154)
                      ||||
T Consensus       222 i~sl  225 (313)
T 3cek_A          222 VWSL  225 (313)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9996

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.97  E-value=1.6e-31  Score=188.55  Aligned_cols=141  Identities=27%  Similarity=0.443  Sum_probs=124.0

Q ss_pred             HhHHHHHHHHhhCC--CCccchhhhheecCCcEEEEEEecCC-CCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702           11 SCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus        11 ~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      +.+.+|+.+++.++  |+|++++++++.+++..++++|++.+ ++|.+++...+.+++..+..++.|++.|++|||+.++
T Consensus        91 ~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i  170 (320)
T 3a99_A           91 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGV  170 (320)
T ss_dssp             CEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            56778999999995  59999999999999999999999975 8999999988899999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCC-CcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Diwsl  154 (154)
                      +|+||+|+||++.  ...+.+||+|||++...... ......||+.|+|||++.+..+ +.++|||||
T Consensus       171 vH~Dlkp~NIll~--~~~~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl  235 (320)
T 3a99_A          171 LHRDIKDENILID--LNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL  235 (320)
T ss_dssp             ECCCCSGGGEEEE--TTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHH
T ss_pred             EeCCCCHHHEEEe--CCCCCEEEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhH
Confidence            9999999999993  25678999999998766543 2334568999999999987665 678999996

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.97  E-value=1.1e-31  Score=188.88  Aligned_cols=142  Identities=21%  Similarity=0.334  Sum_probs=119.5

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+.+++.++||||+++++++.+++..++++||+++++|.+++...+ .+++..+..++.|++.|++|||+.++
T Consensus        72 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i  151 (319)
T 2y4i_B           72 QLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI  151 (319)
T ss_dssp             CCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            34667889999999999999999999999999999999999999999997654 68999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCC------CccccccCCccccCcccccc---------cCCCccccee
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG------NYAEKVCGSPLYMAPEVLQF---------QRYDEKVNFF  152 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~---------~~~~~~~Diw  152 (154)
                      +|+||+|+||++   + .+.++|+|||++......      .......|++.|+|||++.+         ..++.++|||
T Consensus       152 ~H~dlkp~NIl~---~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~  227 (319)
T 2y4i_B          152 LHKDLKSKNVFY---D-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVF  227 (319)
T ss_dssp             CCCCCCSTTEEE---C---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHH
T ss_pred             cccCCChhhEEE---e-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHH
Confidence            999999999999   3 568999999987654321      22234568899999999874         3578899999


Q ss_pred             cC
Q 031702          153 VS  154 (154)
Q Consensus       153 sl  154 (154)
                      ||
T Consensus       228 sl  229 (319)
T 2y4i_B          228 AL  229 (319)
T ss_dssp             HH
T ss_pred             HH
Confidence            96

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.96  E-value=2.1e-31  Score=187.04  Aligned_cols=143  Identities=29%  Similarity=0.416  Sum_probs=119.7

Q ss_pred             hHHhHHHHHHHHhhC----CCCccchhhhheecCCcEEEEEEe-cCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSV----NHPNIIRLFDAFQAENCIFLVVEF-CAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l----~h~~i~~~~~~~~~~~~~~~v~e~-~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      ....+.+|+.+++.+    +||||+++++++.+.+..++++|+ +.+++|.+++...+.+++..++.++.|++.|+.|||
T Consensus        77 ~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH  156 (312)
T 2iwi_A           77 DSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH  156 (312)
T ss_dssp             --CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            345667899999998    899999999999999999999999 788999999998888999999999999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCC-cccceecC
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD-EKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Diwsl  154 (154)
                      +.+++|+||+|+||++.  ...+.+||+|||++...... ......+++.|+|||++.+..+. .++|||||
T Consensus       157 ~~~i~H~dlkp~Nil~~--~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl  225 (312)
T 2iwi_A          157 SRGVVHRDIKDENILID--LRRGCAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSL  225 (312)
T ss_dssp             HHTEECCCCSGGGEEEE--TTTTEEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHH
T ss_pred             HCCeeecCCChhhEEEe--CCCCeEEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHH
Confidence            99999999999999994  26778999999998766543 23445689999999999876665 58999996

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.96  E-value=1.7e-30  Score=186.23  Aligned_cols=144  Identities=27%  Similarity=0.439  Sum_probs=122.9

Q ss_pred             hhHHhHHHHHHHHhhCC-----------CCccchhhhheecCC----cEEEEEEecCCCCchHHHHHc--CCCCHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVN-----------HPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLH--GRVPEQTARK   70 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~~~----~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~   70 (154)
                      ...+.+.+|+.+++.++           ||||+++++++...+    ..++++|++ +++|.+++...  ..+++..+..
T Consensus        57 ~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~  135 (373)
T 1q8y_A           57 VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ  135 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHH
T ss_pred             cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHH
Confidence            34677889999999886           889999999997654    789999999 88999999764  4599999999


Q ss_pred             HHHHHHHHHHHHHhC-CceeecCCCCcEEeecC---CCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCC
Q 031702           71 FLQQLGAGLEILNSH-HIIHRDLKPENILLSGL---DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD  146 (154)
Q Consensus        71 ~~~~i~~~l~~lh~~-~~~h~~i~p~nil~~~~---~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  146 (154)
                      ++.|++.|+.|||++ |++|+||||+||++...   +..+.+||+|||++......  .....+|+.|+|||++.+..++
T Consensus       136 i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~  213 (373)
T 1q8y_A          136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWG  213 (373)
T ss_dssp             HHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCC
T ss_pred             HHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCC
Confidence            999999999999998 99999999999999532   34558999999999765432  3345789999999999988999


Q ss_pred             cccceecC
Q 031702          147 EKVNFFVS  154 (154)
Q Consensus       147 ~~~Diwsl  154 (154)
                      .++|||||
T Consensus       214 ~~~Di~sl  221 (373)
T 1q8y_A          214 CGADIWST  221 (373)
T ss_dssp             THHHHHHH
T ss_pred             chHhHHHH
Confidence            99999996

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.96  E-value=5.4e-30  Score=180.02  Aligned_cols=141  Identities=30%  Similarity=0.478  Sum_probs=108.8

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC-Cc
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH-HI   87 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~-~~   87 (154)
                      .+.+.++..+++.++||||+++++++.+++..+++|||+ ++.+..+... ...+++..+..++.|++.|+.|||+. ++
T Consensus        68 ~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i  146 (318)
T 2dyl_A           68 KRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGV  146 (318)
T ss_dssp             HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred             HHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCE
Confidence            445555666788889999999999999999999999999 5555555543 46799999999999999999999995 99


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCccccc-----ccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-----FQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Diwsl  154 (154)
                      +|+||+|+||++   +..+.+||+|||++.............+++.|+|||++.     ...++.++|||||
T Consensus       147 ~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~sl  215 (318)
T 2dyl_A          147 IHRDVKPSNILL---DERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSL  215 (318)
T ss_dssp             CCCCCCGGGEEE---CTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHH
T ss_pred             EeCCCCHHHEEE---CCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhH
Confidence            999999999999   677899999999997765554455567899999999984     4568899999996

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.96  E-value=5.1e-30  Score=184.77  Aligned_cols=143  Identities=35%  Similarity=0.453  Sum_probs=121.7

Q ss_pred             hhHHhHHHHHHHHhhCC-CC-----ccchhhhheecCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVN-HP-----NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGL   79 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l   79 (154)
                      ...+.+.+|+.+++.++ |+     +++++.+.+...+..|++|||++ ++|.+++...  ..+++..+..++.|++.|+
T Consensus        92 ~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al  170 (382)
T 2vx3_A           92 AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL  170 (382)
T ss_dssp             HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHH
Confidence            34577888999999884 55     48888999999999999999995 5999998765  3599999999999999999


Q ss_pred             HHHH--hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           80 EILN--SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        80 ~~lh--~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      .|||  ..+++|+||||+||++.. +..+.+||+|||++......  .....+|+.|+|||++.+..++.++|||||
T Consensus       171 ~~lH~~~~~ivHrDlkp~NIll~~-~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl  244 (382)
T 2vx3_A          171 LFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSL  244 (382)
T ss_dssp             HHHTSTTTCEECCCCSGGGEEESS-TTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred             HHhccCCCCEEcCCCCcccEEEec-CCCCcEEEEeccCceecccc--cccccCCccccChHHHcCCCCCcHHHHHHH
Confidence            9999  579999999999999942 34678999999999765432  344678999999999999899999999996

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=3.4e-30  Score=192.83  Aligned_cols=131  Identities=19%  Similarity=0.183  Sum_probs=113.4

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (154)
                      .+.+.+|+.++++++||||+++..++...+..|++|||+++++|.+++..        ...++.|++.++.|||+++++|
T Consensus       383 ~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiH  454 (540)
T 3en9_A          383 KSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIH  454 (540)
T ss_dssp             HHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCcc
Confidence            56789999999999999999776666677778999999999999998874        5689999999999999999999


Q ss_pred             ecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--------cccccCCccccCcccccc--cCCCcccceec
Q 031702           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQF--QRYDEKVNFFV  153 (154)
Q Consensus        90 ~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~--~~~~~~~Diws  153 (154)
                      +||||+||++   +.  .+||+|||+++.......        .....||+.|+|||++..  ..|+..+|+||
T Consensus       455 rDiKp~NILl---~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws  523 (540)
T 3en9_A          455 NDLTTSNFIF---DK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWE  523 (540)
T ss_dssp             TTCCTTSEEE---SS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHH
T ss_pred             CCCCHHHEEE---CC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHH
Confidence            9999999999   44  899999999987654321        235689999999999986  56888889997

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.94  E-value=5.5e-27  Score=163.84  Aligned_cols=124  Identities=28%  Similarity=0.560  Sum_probs=105.4

Q ss_pred             HHhHHHHHHHH-hhCCCCccchhhhheec----CCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHH
Q 031702           10 KSCLDCELNFL-SSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEIL   82 (154)
Q Consensus        10 ~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~l   82 (154)
                      .+.+.+|+.++ +..+||||+++++++..    .+..+++|||+++++|.+++....  .+++..+..++.|++.|+.||
T Consensus        54 ~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l  133 (299)
T 3m2w_A           54 CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL  133 (299)
T ss_dssp             SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence            35677899988 55599999999999876    678999999999999999998764  599999999999999999999


Q ss_pred             HhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        83 h~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+.+++|+||||+||++......+.++|+|||++....                     +..++.++|||||
T Consensus       134 H~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---------------------~~~~~~~~Diwsl  184 (299)
T 3m2w_A          134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---------------------GEKYDKSCDMWSL  184 (299)
T ss_dssp             HHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---------------------TCGGGGHHHHHHH
T ss_pred             HhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc---------------------cccCCchhhHHHH
Confidence            99999999999999999543337889999999886432                     2446778888885

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.93  E-value=2.7e-26  Score=159.67  Aligned_cols=116  Identities=16%  Similarity=0.131  Sum_probs=100.2

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++||||+++++++.+++..|++|||++|++|.++++. + ..+..+..++.|++.|+.|||++|+
T Consensus        73 ~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~gi  150 (286)
T 3uqc_A           73 DVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGV  150 (286)
T ss_dssp             HHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCC
Confidence            3457899999999999999999999999999999999999999999999853 2 4666788999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|+||||+||++   +..+.+||++++                   |++       .++.++|||||
T Consensus       151 vH~Dikp~NIll---~~~g~~kl~~~~-------------------~~~-------~~~~~~Di~sl  188 (286)
T 3uqc_A          151 ALSIDHPSRVRV---SIDGDVVLAYPA-------------------TMP-------DANPQDDIRGI  188 (286)
T ss_dssp             CCCCCSGGGEEE---ETTSCEEECSCC-------------------CCT-------TCCHHHHHHHH
T ss_pred             ccCCCCcccEEE---cCCCCEEEEecc-------------------ccC-------CCCchhHHHHH
Confidence            999999999999   567778887433                   333       36788999985

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.93  E-value=8.6e-27  Score=169.59  Aligned_cols=139  Identities=15%  Similarity=0.077  Sum_probs=106.5

Q ss_pred             hHHhHHHHHHHHhhCCC-Cccchhhhh---------------------eec-----CCcEEEEEEecCCCCchHHHHH--
Q 031702            9 LKSCLDCELNFLSSVNH-PNIIRLFDA---------------------FQA-----ENCIFLVVEFCAGGNLSSYIRL--   59 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h-~~i~~~~~~---------------------~~~-----~~~~~~v~e~~~~~~L~~~~~~--   59 (154)
                      ..+.+.+|+.+++.++| ++...+...                     +..     ....+++++.+ +++|.+++..  
T Consensus       121 ~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~  199 (413)
T 3dzo_A          121 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL  199 (413)
T ss_dssp             CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhh
Confidence            35779999999999977 433322222                     111     12357777765 6799988842  


Q ss_pred             -----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccc
Q 031702           60 -----HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY  134 (154)
Q Consensus        60 -----~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y  134 (154)
                           ...+++..+..++.|++.|++|||+++++||||||+||++   +..+.+||+|||++......  ....+| +.|
T Consensus       200 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl---~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y  273 (413)
T 3dzo_A          200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFEHLVRDGAS--AVSPIG-RGF  273 (413)
T ss_dssp             HHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCGGGCEETTEE--ECCCCC-TTT
T ss_pred             cccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEE---ecCCeEEEEeccceeecCCc--cccCCC-Cce
Confidence                 1236778899999999999999999999999999999999   67778999999998764433  344567 899


Q ss_pred             cCcccc----------cccCCCcccceecC
Q 031702          135 MAPEVL----------QFQRYDEKVNFFVS  154 (154)
Q Consensus       135 ~aPE~~----------~~~~~~~~~Diwsl  154 (154)
                      +|||++          .+..++.++|||||
T Consensus       274 ~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl  303 (413)
T 3dzo_A          274 APPETTAERMLPFGQHHPTLMTFAFDTWTL  303 (413)
T ss_dssp             CCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred             eCchhhhccccccccccCcCCCchhhHHHH
Confidence            999999          55568899999996

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=1.7e-22  Score=140.32  Aligned_cols=107  Identities=17%  Similarity=0.178  Sum_probs=87.3

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ....+.+|+.+++.++  | +++.+.+.. +..|++|||++|++|.+ +.      ......++.|++.|+.+||+.|++
T Consensus       147 ~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~gii  215 (282)
T 1zar_A          147 AIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIV  215 (282)
T ss_dssp             HHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCE
Confidence            4677999999999999  5 667765544 55699999999999988 32      123457999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF  142 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  142 (154)
                      |+||||.||++   + .+.+||+|||++..            +..+.|||.+..
T Consensus       216 HrDlkp~NILl---~-~~~vkl~DFG~a~~------------~~~~~a~e~l~r  253 (282)
T 1zar_A          216 HGDLSQYNVLV---S-EEGIWIIDFPQSVE------------VGEEGWREILER  253 (282)
T ss_dssp             CSCCSTTSEEE---E-TTEEEECCCTTCEE------------TTSTTHHHHHHH
T ss_pred             eCCCCHHHEEE---E-CCcEEEEECCCCeE------------CCCCCHHHHHHH
Confidence            99999999999   5 77899999999863            344678888753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.69  E-value=1.7e-17  Score=113.72  Aligned_cols=99  Identities=19%  Similarity=0.191  Sum_probs=75.4

Q ss_pred             HhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCC-C----CchHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-h
Q 031702           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAG-G----NLSSYIRLHGRVPEQTARKFLQQLGAGLEILN-S   84 (154)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~-~----~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-~   84 (154)
                      ..+.+|+.+++.+.|+++....-+..  +..+++|||+++ |    +|.+....   .++..+..++.|++.++.+|| .
T Consensus       115 ~~~~~E~~~l~~l~~~~i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~  189 (258)
T 1zth_A          115 IWTEKEFRNLERAKEAGVSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQE  189 (258)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHhCCCCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHH
Confidence            47889999999998876422221111  356899999942 3    56554321   234567889999999999999 9


Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeeccccccc
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  119 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~  119 (154)
                      .|++|+||||.||++   +.  .++|+|||+|...
T Consensus       190 ~givHrDlkp~NILl---~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          190 AELVHADLSEYNIMY---ID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCEECSSCSTTSEEE---SS--SEEECCCTTCEET
T ss_pred             CCEEeCCCCHHHEEE---cC--cEEEEECcccccC
Confidence            999999999999999   34  8999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.46  E-value=3.2e-14  Score=102.22  Aligned_cols=98  Identities=16%  Similarity=0.133  Sum_probs=66.7

Q ss_pred             HHHHHhhCCCCccchhhhheecCC------cEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 031702           16 ELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (154)
Q Consensus        16 e~~~l~~l~h~~i~~~~~~~~~~~------~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (154)
                      +..+.....|+|+.+++.....-+      ..+++|||++|++|.++..    .  .....+..|++.++.+||..|++|
T Consensus       155 ~~rl~A~kE~~nL~rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~----~--~~~~~l~~qll~~l~~lH~~gIVH  228 (397)
T 4gyi_A          155 LSRLAAIKEFAFMKALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSS----V--PDPASLYADLIALILRLAKHGLIH  228 (397)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCCC----C--SCHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCeeeeccCceEEEEecCCccHhhhcc----c--HHHHHHHHHHHHHHHHHHHCCCcC
Confidence            333334444555555554332211      2369999999988876532    2  233567889999999999999999


Q ss_pred             ecCCCCcEEeecCCC-------CeeEEEeeccccccc
Q 031702           90 RDLKPENILLSGLDD-------DVMLKIADFGLSCTL  119 (154)
Q Consensus        90 ~~i~p~nil~~~~~~-------~~~~kl~df~~~~~~  119 (154)
                      |||||.||++.....       ...+.++||+.+...
T Consensus       229 rDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          229 GDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             SCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            999999999953211       114789999987643

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.32  E-value=1.6e-12  Score=88.91  Aligned_cols=101  Identities=17%  Similarity=0.189  Sum_probs=80.6

Q ss_pred             hHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---
Q 031702            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS---   84 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---   84 (154)
                      ....+.+|+.+++.+ ++..+++++++..+.+..|++||+++|.++.+...     +......++.++..++..||+   
T Consensus        52 ~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~  126 (263)
T 3tm0_A           52 TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDI  126 (263)
T ss_dssp             STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCC
T ss_pred             CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCc
Confidence            345799999999999 46778899998888889999999999998876421     112234677889999999998   


Q ss_pred             --------------------------------------------------------CCceeecCCCCcEEeecCCCCeeE
Q 031702           85 --------------------------------------------------------HHIIHRDLKPENILLSGLDDDVML  108 (154)
Q Consensus        85 --------------------------------------------------------~~~~h~~i~p~nil~~~~~~~~~~  108 (154)
                                                                              ..++|+|++|.||++   +....+
T Consensus       127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~---~~~~~~  203 (263)
T 3tm0_A          127 SDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFV---KDGKVS  203 (263)
T ss_dssp             TTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEE---ETTEEE
T ss_pred             ccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEE---ECCcEE
Confidence                                                                    348899999999999   345566


Q ss_pred             EEeeccccc
Q 031702          109 KIADFGLSC  117 (154)
Q Consensus       109 kl~df~~~~  117 (154)
                      .++||+.+.
T Consensus       204 ~lIDwe~a~  212 (263)
T 3tm0_A          204 GFIDLGRSG  212 (263)
T ss_dssp             EECCCTTCE
T ss_pred             EEEEchhcc
Confidence            799998774

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.16  E-value=3.4e-11  Score=81.84  Aligned_cols=98  Identities=15%  Similarity=0.170  Sum_probs=72.3

Q ss_pred             HHhHHHHHHHHhhCCCCc--cchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC-
Q 031702           10 KSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH-   86 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~-   86 (154)
                      ...+.+|+.+++.+.+.+  ++++++...+++..+++|||++|.++.  .   .....   ..++.++...+..||... 
T Consensus        57 ~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~---~~~~~---~~~~~~l~~~l~~lh~~~~  128 (264)
T 1nd4_A           57 LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S---SHLAP---AEKVSIMADAMRRLHTLDP  128 (264)
T ss_dssp             TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--T---SCCCH---HHHHHHHHHHHHHHTTSCG
T ss_pred             chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--c---CcCCH---hHHHHHHHHHHHHHhCCCC
Confidence            356889999999995434  567888888778899999999998884  1   11221   245566666677776543 


Q ss_pred             ---------------------------------------------------------ceeecCCCCcEEeecCCCCeeEE
Q 031702           87 ---------------------------------------------------------IIHRDLKPENILLSGLDDDVMLK  109 (154)
Q Consensus        87 ---------------------------------------------------------~~h~~i~p~nil~~~~~~~~~~k  109 (154)
                                                                               ++|+|++|.||++   +.+..+.
T Consensus       129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~---~~~~~~~  205 (264)
T 1nd4_A          129 ATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMV---ENGRFSG  205 (264)
T ss_dssp             GGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEE---ETTEEEE
T ss_pred             CCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEE---ECCcEEE
Confidence                                                                     8999999999999   3455667


Q ss_pred             Eeecccccc
Q 031702          110 IADFGLSCT  118 (154)
Q Consensus       110 l~df~~~~~  118 (154)
                      ++||+.+..
T Consensus       206 liD~~~a~~  214 (264)
T 1nd4_A          206 FIDCGRLGV  214 (264)
T ss_dssp             ECCCTTCEE
T ss_pred             EEcchhccc
Confidence            999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.05  E-value=4.7e-10  Score=79.98  Aligned_cols=105  Identities=14%  Similarity=0.319  Sum_probs=80.5

Q ss_pred             HHhHHHHHHHHhhCCC--CccchhhhheecC---CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh
Q 031702           10 KSCLDCELNFLSSVNH--PNIIRLFDAFQAE---NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ...+.+|+.+++.+..  ..+++++..+.+.   +..|++||+++|.++.+.  ....+++.....+..++..++..||.
T Consensus        80 ~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~  157 (359)
T 3dxp_A           80 AHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHT  157 (359)
T ss_dssp             --CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhC
Confidence            4578899999999964  4578888887766   458999999999887541  12346788888899999999999997


Q ss_pred             ----------------------------------------------------------CCceeecCCCCcEEeecCCCCe
Q 031702           85 ----------------------------------------------------------HHIIHRDLKPENILLSGLDDDV  106 (154)
Q Consensus        85 ----------------------------------------------------------~~~~h~~i~p~nil~~~~~~~~  106 (154)
                                                                                ..++|+|++|.||++... ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~-~~~  236 (359)
T 3dxp_A          158 VDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPT-EPR  236 (359)
T ss_dssp             SCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSS-SSC
T ss_pred             CCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCC-CCc
Confidence                                                                      358999999999999421 113


Q ss_pred             eEEEeeccccc
Q 031702          107 MLKIADFGLSC  117 (154)
Q Consensus       107 ~~kl~df~~~~  117 (154)
                      .+.++||+.+.
T Consensus       237 v~~viDwe~a~  247 (359)
T 3dxp_A          237 VLAVLDWELST  247 (359)
T ss_dssp             EEEECCCTTCE
T ss_pred             EEEEECccccc
Confidence            46899999875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.62  E-value=7.5e-08  Score=67.09  Aligned_cols=107  Identities=22%  Similarity=0.262  Sum_probs=75.6

Q ss_pred             hHHhHHHHHHHHhhC-CCCc--cchhhhheecCC---cEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSV-NHPN--IIRLFDAFQAEN---CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL   82 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~--i~~~~~~~~~~~---~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l   82 (154)
                      ....+.+|..+++.+ .+..  +++++......+   ..|++|++++|.++.....  ..++..+...++.++...+..|
T Consensus        53 ~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~L  130 (304)
T 3sg8_A           53 GSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSEL  130 (304)
T ss_dssp             HHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHH
Confidence            457889999999988 4433  344444433332   3588999999988875332  3466777777778888877777


Q ss_pred             Hh----------------------------------------------------------CCceeecCCCCcEEeecCCC
Q 031702           83 NS----------------------------------------------------------HHIIHRDLKPENILLSGLDD  104 (154)
Q Consensus        83 h~----------------------------------------------------------~~~~h~~i~p~nil~~~~~~  104 (154)
                      |+                                                          ..++|+|++|.||++... .
T Consensus       131 H~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~  209 (304)
T 3sg8_A          131 HSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-K  209 (304)
T ss_dssp             HHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-T
T ss_pred             HcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-C
Confidence            75                                                          136999999999999421 1


Q ss_pred             CeeEEEeecccccc
Q 031702          105 DVMLKIADFGLSCT  118 (154)
Q Consensus       105 ~~~~kl~df~~~~~  118 (154)
                      ...+.++||+.+..
T Consensus       210 ~~~~~~iD~~~~~~  223 (304)
T 3sg8_A          210 NTICGIIDFGDAAI  223 (304)
T ss_dssp             TEEEEECCCTTCEE
T ss_pred             CCEEEEEeCCCCcc
Confidence            56788999998753

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.60  E-value=1.5e-07  Score=64.35  Aligned_cols=108  Identities=14%  Similarity=0.170  Sum_probs=75.9

Q ss_pred             hhhhhhhHHhHHHHHHHHhhCC-CCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHH
Q 031702            3 KKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (154)
Q Consensus         3 k~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~   81 (154)
                      |.-.......+.+|..+++.+. +--+++++.++.+.+..+++||+++|.++.+.....    ......+..++...+..
T Consensus        56 k~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~  131 (272)
T 4gkh_A           56 KHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRR  131 (272)
T ss_dssp             EEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHH
T ss_pred             EECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC----HHHHHHHHHHHHHHHHH
Confidence            4334455677899999999883 434778888888888999999999998877654321    11223344455555555


Q ss_pred             HHhC----------------------------------------------------------CceeecCCCCcEEeecCC
Q 031702           82 LNSH----------------------------------------------------------HIIHRDLKPENILLSGLD  103 (154)
Q Consensus        82 lh~~----------------------------------------------------------~~~h~~i~p~nil~~~~~  103 (154)
                      ||..                                                          .++|+|+.|.||++   +
T Consensus       132 Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~---~  208 (272)
T 4gkh_A          132 LHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIF---D  208 (272)
T ss_dssp             HHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEE---E
T ss_pred             hcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEE---E
Confidence            5531                                                          15899999999999   4


Q ss_pred             CCeeEEEeeccccc
Q 031702          104 DDVMLKIADFGLSC  117 (154)
Q Consensus       104 ~~~~~kl~df~~~~  117 (154)
                      ....+-|+||+.+.
T Consensus       209 ~~~~~~viDwe~a~  222 (272)
T 4gkh_A          209 EGKLIGCIDVGRVG  222 (272)
T ss_dssp             TTEEEEECCCTTCE
T ss_pred             CCeEEEEEECcccc
Confidence            55667799998775

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.49  E-value=1.7e-06  Score=60.42  Aligned_cols=108  Identities=20%  Similarity=0.227  Sum_probs=68.0

Q ss_pred             hHHhHHHHHHHHhhCCCC---ccchhhhhee-cCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh
Q 031702            9 LKSCLDCELNFLSSVNHP---NIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS   84 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   84 (154)
                      ....+.+|..+++.+.+.   .+++++.... ..+..+++||+++|.++....  -..++......+..++...+..||+
T Consensus        52 ~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~--~~~l~~~~~~~~~~~lg~~La~LH~  129 (306)
T 3tdw_A           52 GADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDG--MAVLPDDAKDRLALQLAEFMNELSA  129 (306)
T ss_dssp             HHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHH--HTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhh--hhhCCHHHHHHHHHHHHHHHHHHhc
Confidence            457889999999999643   3556665553 445678999999998887521  1122333333333333333333332


Q ss_pred             ------------------------------------------------------------CCceeecCCCCcEEeecCCC
Q 031702           85 ------------------------------------------------------------HHIIHRDLKPENILLSGLDD  104 (154)
Q Consensus        85 ------------------------------------------------------------~~~~h~~i~p~nil~~~~~~  104 (154)
                                                                                  ..++|+|++|.||++...+.
T Consensus       130 ~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~  209 (306)
T 3tdw_A          130 FPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSR  209 (306)
T ss_dssp             SCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCS
T ss_pred             CCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCC
Confidence                                                                        24689999999999942111


Q ss_pred             Ce-eEEEeecccccc
Q 031702          105 DV-MLKIADFGLSCT  118 (154)
Q Consensus       105 ~~-~~kl~df~~~~~  118 (154)
                      .+ .+.++||+.+..
T Consensus       210 ~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          210 QTPLTGIIDFGDAAI  224 (306)
T ss_dssp             SCCEEEECCCTTCEE
T ss_pred             CCceEEEEehhhcCC
Confidence            34 458999987753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.00  E-value=6.1e-06  Score=58.58  Aligned_cols=44  Identities=14%  Similarity=0.139  Sum_probs=32.6

Q ss_pred             HhHHHHHHHHhhCC-C--CccchhhhheecC---CcEEEEEEecCCCCch
Q 031702           11 SCLDCELNFLSSVN-H--PNIIRLFDAFQAE---NCIFLVVEFCAGGNLS   54 (154)
Q Consensus        11 ~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~---~~~~~v~e~~~~~~L~   54 (154)
                      ..+.+|+.+++.+. +  -.+++++....+.   +..+++||+++|.++.
T Consensus        72 ~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A           72 YRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             CCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred             hHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence            56889999999984 3  3567777776554   3568999999886654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.68  E-value=0.00015  Score=50.82  Aligned_cols=30  Identities=20%  Similarity=0.354  Sum_probs=25.6

Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeeccccc
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~  117 (154)
                      ..++|+|++|.||++   +....+.++||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~---~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLL---GENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEE---CGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEE---eCCCcEEEEehhhcc
Confidence            579999999999999   445678999998774

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.07  E-value=0.00057  Score=47.33  Aligned_cols=28  Identities=29%  Similarity=0.172  Sum_probs=22.6

Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeeccccc
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~  117 (154)
                      .++|+|+.|.||+.    ..+.+.++||..+.
T Consensus       174 ~l~HgDl~~~Nil~----~~~~~~lID~e~a~  201 (301)
T 3dxq_A          174 AACHCDPLCENFLD----TGERMWIVDWEYSG  201 (301)
T ss_dssp             EEECSCCCGGGEEE----CSSCEEECCCTTCE
T ss_pred             eeeccCCCcCCEEE----CCCCEEEEeccccc
Confidence            37999999999995    33457999998775

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.05  E-value=0.00042  Score=48.67  Aligned_cols=34  Identities=21%  Similarity=0.273  Sum_probs=25.3

Q ss_pred             CCceeecCCCCcEEeecCCC-CeeEEEeecccccc
Q 031702           85 HHIIHRDLKPENILLSGLDD-DVMLKIADFGLSCT  118 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~-~~~~kl~df~~~~~  118 (154)
                      ..++|+|+.+.||++..... ...+.++||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            46899999999999942110 25789999987753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=96.95  E-value=0.0026  Score=45.70  Aligned_cols=29  Identities=28%  Similarity=0.389  Sum_probs=23.4

Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeeccccc
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~  117 (154)
                      ..++|+|+.|.||++.   . ..++++||..+.
T Consensus       227 ~~L~HGDl~~~Nil~~---~-~~~~lID~e~a~  255 (397)
T 2olc_A          227 ETLIHGDLHTGSIFAS---E-HETKVIDPEFAF  255 (397)
T ss_dssp             CEEECSCCSGGGEEEC---S-SCEEECCCTTCE
T ss_pred             CceeeCCCCcCcEEEe---C-CCeEEEeCcccc
Confidence            5689999999999993   2 248899997664

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.49  E-value=0.0029  Score=45.52  Aligned_cols=104  Identities=20%  Similarity=0.238  Sum_probs=62.0

Q ss_pred             HHhHHHHHHHHhhCC-CCccchhhhheecCCcEEEEEEecCCCCchHH--------------HHH-c-C--C----C--C
Q 031702           10 KSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY--------------IRL-H-G--R----V--P   64 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~--------------~~~-~-~--~----~--~   64 (154)
                      ...+.+|..+++.+. +.-.+++++.+.++    +++||++|.++..-              +.+ + -  +    .  -
T Consensus        97 ~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l  172 (379)
T 3feg_A           97 VDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWL  172 (379)
T ss_dssp             HHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccH
Confidence            455668999998883 43346666665542    89999988655311              110 0 0  1    1  1


Q ss_pred             HHHHHHHHHHHHH-------------------HHHHHH----h----CCceeecCCCCcEEeecC-CCCeeEEEeecccc
Q 031702           65 EQTARKFLQQLGA-------------------GLEILN----S----HHIIHRDLKPENILLSGL-DDDVMLKIADFGLS  116 (154)
Q Consensus        65 ~~~~~~~~~~i~~-------------------~l~~lh----~----~~~~h~~i~p~nil~~~~-~~~~~~kl~df~~~  116 (154)
                      ..++..+..++-.                   .+..|.    .    ..++|+|+.+.||++... +..+.+.++||..+
T Consensus       173 ~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a  252 (379)
T 3feg_A          173 FGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYS  252 (379)
T ss_dssp             HHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTC
T ss_pred             HHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccC
Confidence            3455555544322                   223332    2    258999999999999532 12357899999887


Q ss_pred             c
Q 031702          117 C  117 (154)
Q Consensus       117 ~  117 (154)
                      .
T Consensus       253 ~  253 (379)
T 3feg_A          253 S  253 (379)
T ss_dssp             E
T ss_pred             C
Confidence            5

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=95.84  E-value=0.0094  Score=43.24  Aligned_cols=32  Identities=22%  Similarity=0.428  Sum_probs=25.6

Q ss_pred             HhCCceeecCCCCcEEeecCCCCeeEEEeecccccc
Q 031702           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  118 (154)
Q Consensus        83 h~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~  118 (154)
                      +...++|+|++|.||++.   ... +.++||+.+..
T Consensus       230 ~~~~liHGDl~~~Nil~~---~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVT---QDS-TQVIDPEFSFY  261 (420)
T ss_dssp             BCCEEECSCCSGGGEEEC---SSC-EEECCCTTCEE
T ss_pred             CCCeEEecCCCCCcEEEe---CCC-CEEEeCccccc
Confidence            456799999999999993   333 89999987753

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=95.21  E-value=0.027  Score=39.42  Aligned_cols=69  Identities=13%  Similarity=0.145  Sum_probs=51.4

Q ss_pred             hhhhhhhHHhHHHHHHHHhhCC---CCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHH
Q 031702            3 KKLNKHLKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL   79 (154)
Q Consensus         3 k~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l   79 (154)
                      |.........+..|...|+.|.   ...+++++......+..+++||++++..+..              ....++..++
T Consensus        65 K~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~~--------------~~~~~lG~~L  130 (312)
T 3jr1_A           65 KINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNKQ--------------SSFTIFAEKI  130 (312)
T ss_dssp             EEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCCT--------------THHHHHHHHH
T ss_pred             EeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCCc--------------hhHHHHHHHH
Confidence            4333445677899999999983   3568888888777788999999999876531              2345678888


Q ss_pred             HHHHhC
Q 031702           80 EILNSH   85 (154)
Q Consensus        80 ~~lh~~   85 (154)
                      +.||..
T Consensus       131 A~LH~~  136 (312)
T 3jr1_A          131 AQLHQI  136 (312)
T ss_dssp             HHHHHC
T ss_pred             HHHHcC
Confidence            899975

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=94.27  E-value=0.016  Score=40.19  Aligned_cols=30  Identities=30%  Similarity=0.598  Sum_probs=24.1

Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeeccccc
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~  117 (154)
                      .+++|+|+.|.||++.   .+..+.++||+.+.
T Consensus       187 ~~liHgDl~~~Nil~~---~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFL---GDELSGLIDFYFAC  216 (322)
T ss_dssp             EEEECSCCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred             cccCCCCCCccCEEEe---CCceEEEecchhcc
Confidence            3689999999999994   44556899998774

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=93.91  E-value=0.065  Score=37.23  Aligned_cols=28  Identities=25%  Similarity=0.191  Sum_probs=23.1

Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeeccccc
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~  117 (154)
                      ..++|+|++|.||++   + + .+.++||+.+.
T Consensus       195 ~~l~HgD~~~~Nil~---~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          195 VLRLHGDCHAGNILW---R-D-GPMFVDLDDAR  222 (328)
T ss_dssp             CEECCSSCSGGGEEE---S-S-SEEECCCTTCC
T ss_pred             eeeeeCCCCcccEeE---c-C-CCEEEECCCCC
Confidence            357899999999999   3 2 78999998764

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=92.89  E-value=0.1  Score=36.69  Aligned_cols=30  Identities=20%  Similarity=0.382  Sum_probs=24.8

Q ss_pred             CCceeecCCCCcEEeecCCCCeeEEEeeccccc
Q 031702           85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (154)
Q Consensus        85 ~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~  117 (154)
                      ..++|+|+.|.||++   +..+.+.++||+.+.
T Consensus       206 ~~~~HgD~~~~N~l~---~~~~~~~~iD~e~~~  235 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLV---GNEESIYIIDWDEPM  235 (339)
T ss_dssp             CEEECSCCCGGGEEE---CGGGCEEECCCSSCE
T ss_pred             ceeEeCCCCcCCEEE---eCCCeEEEEECCCCe
Confidence            358999999999999   445678999998764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=91.76  E-value=0.08  Score=37.55  Aligned_cols=28  Identities=32%  Similarity=0.498  Sum_probs=22.4

Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeeccccc
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~  117 (154)
                      .++|+|+.|.||++   +. ..+.++||..+.
T Consensus       213 ~l~HgDl~~~Nil~---~~-~~~~lID~e~a~  240 (369)
T 3c5i_A          213 VFCHNDLQENNIIN---TN-KCLRLIDFEYSG  240 (369)
T ss_dssp             EEECSCCCGGGEEE---CC--CEEECCCTTCE
T ss_pred             EEEeCCCCcccEEe---cC-CcEEEEEecCCC
Confidence            58999999999998   33 347899998764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=91.07  E-value=0.11  Score=38.29  Aligned_cols=36  Identities=22%  Similarity=0.264  Sum_probs=25.0

Q ss_pred             HHHHHHHhhCCCCcc-chhhhheecCCcEEEEEEecCCCCc
Q 031702           14 DCELNFLSSVNHPNI-IRLFDAFQAENCIFLVVEFCAGGNL   53 (154)
Q Consensus        14 ~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~v~e~~~~~~L   53 (154)
                      .+|..+++.|...++ +++++.+.+    ..++||++|.++
T Consensus       152 ~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l  188 (458)
T 2qg7_A          152 EREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL  188 (458)
T ss_dssp             HHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred             HHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence            589999999954444 566666632    259999987554

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=90.60  E-value=0.084  Score=38.50  Aligned_cols=39  Identities=18%  Similarity=0.192  Sum_probs=25.9

Q ss_pred             HhHHHHHHHHhhCCCCc-cchhhhheecCCcEEEEEEecCCCCc
Q 031702           11 SCLDCELNFLSSVNHPN-IIRLFDAFQAENCIFLVVEFCAGGNL   53 (154)
Q Consensus        11 ~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~v~e~~~~~~L   53 (154)
                      +.+.+|..+++.+...+ .+++++.+.+    .+++||++|.++
T Consensus       120 ~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~l  159 (429)
T 1nw1_A          120 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL  159 (429)
T ss_dssp             HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred             HHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCccc
Confidence            55668999999884333 3666665543    288999986444

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=88.86  E-value=0.23  Score=35.77  Aligned_cols=31  Identities=32%  Similarity=0.396  Sum_probs=25.0

Q ss_pred             ceeecCCCCcEEeecC---CCCeeEEEeeccccc
Q 031702           87 IIHRDLKPENILLSGL---DDDVMLKIADFGLSC  117 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~---~~~~~~kl~df~~~~  117 (154)
                      ++|+|+.+.||++...   +....+.++||..|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            6799999999999531   346679999998875

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=88.26  E-value=2.5  Score=27.97  Aligned_cols=86  Identities=13%  Similarity=0.113  Sum_probs=55.6

Q ss_pred             CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHH-HHHhCCceeecCCCCcEEeecC
Q 031702           24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE-ILNSHHIIHRDLKPENILLSGL  102 (154)
Q Consensus        24 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~-~lh~~~~~h~~i~p~nil~~~~  102 (154)
                      .||.+  -..+-.+.+.+.+.++.-++  ...+-. -...+....++++.+++.... ++  ..-++--++|+|+++   
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~--~~~f~~-i~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f---  117 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSS--FLTFAA-IRKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMF---  117 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTT--CEEHHH-HHTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEE---
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcc--cCcHHH-HHhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEE---
Confidence            46666  22333555656665554322  222221 235788888888888877655 33  455788999999999   


Q ss_pred             CCCeeEEEeeccccccc
Q 031702          103 DDDVMLKIADFGLSCTL  119 (154)
Q Consensus       103 ~~~~~~kl~df~~~~~~  119 (154)
                      +.++.+++.-.|.-..+
T Consensus       118 ~~~~~p~i~hRGi~~~l  134 (219)
T 4ano_A          118 NRALEPFFLHVGVKESL  134 (219)
T ss_dssp             CTTCCEEESCCEETTTB
T ss_pred             eCCCcEEEEEcCCcccC
Confidence            78899999987765444

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=87.61  E-value=0.08  Score=39.19  Aligned_cols=30  Identities=10%  Similarity=0.005  Sum_probs=25.9

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCC
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN   39 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   39 (154)
                      .+.|..|++.+.+++|+|+|++.++|.+..
T Consensus       323 ~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~  352 (487)
T 3oja_A          323 SETERLECERENQARQREIDALKEQYRTVI  352 (487)
T ss_dssp             --CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred             HHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence            568999999999999999999999997653

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=86.50  E-value=1.8  Score=28.55  Aligned_cols=87  Identities=11%  Similarity=0.162  Sum_probs=56.8

Q ss_pred             CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEeecCC
Q 031702           24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD  103 (154)
Q Consensus        24 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~  103 (154)
                      .||+++.. .+-.+.+.+.+.++.-  .+...|-. =...+....++++.+++....++  ..-+|--++|+|+++   +
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~--~~~~~f~~-ik~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f---~  113 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIN--DNHTPFDN-IKSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFF---T  113 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCC--TTSEEGGG-GGGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEE---C
T ss_pred             cCCcccce-EEEEcccEEEEEEEcC--cccCCHHH-HHhcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEE---c
Confidence            56766655 3444555555555533  23333221 23477888899998888877444  334688899999999   7


Q ss_pred             CCeeEEEeeccccccc
Q 031702          104 DDVMLKIADFGLSCTL  119 (154)
Q Consensus       104 ~~~~~kl~df~~~~~~  119 (154)
                      .++.+++.--|....+
T Consensus       114 ~~~~p~i~~RGik~~l  129 (215)
T 4ann_A          114 RDGLPIAKTRGLQNVV  129 (215)
T ss_dssp             TTSCEEESCCEETTTB
T ss_pred             CCCCEEEEEccCccCC
Confidence            8888999877764433

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	154
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-42
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-42
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-41
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-41
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-40
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-40
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-40
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-40
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-39
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-39
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-38
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-37
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-36
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-36
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-35
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-35
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-34
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-34
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	9e-34
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-33
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-33
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-33
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-33
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-32
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-32
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	8e-32
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-31
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-31
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-31
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-31
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-31
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	9e-31
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-30
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-30
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-30
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-30
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-29
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-29
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	9e-29
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-28
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-28
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-28
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	7e-28
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	8e-28
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-27
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-27
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-27
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-27
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-27
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-26
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-26
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-26
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-26
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-25
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	8e-25
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-23
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-23
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-23
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	9e-23
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-22
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-20
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-16
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-11

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 4e-42
 Identities = 50/157 (31%), Positives = 83/157 (52%), Gaps = 10/157 (6%)

Query: 2   LKKLNKH------LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           LK L K       ++  L  E+   S + HPNI+RL+  F     ++L++E+   G +  
Sbjct: 36  LKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR 95

Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
            ++   +  EQ    ++ +L   L   +S  +IHRD+KPEN+L   L     LKIADFG 
Sbjct: 96  ELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLL---LGSAGELKIADFGW 152

Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           S    P +    +CG+  Y+ PE+++ + +DEKV+ +
Sbjct: 153 SVHA-PSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLW 188

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  139 bits (351), Expect = 6e-42
 Identities = 52/155 (33%), Positives = 88/155 (56%), Gaps = 4/155 (2%)

Query: 2   LKKLNKHL----KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K + K      +  ++ E+  L  + HPNI+ L D +++   ++L+++  +GG L   I
Sbjct: 39  IKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI 98

Query: 58  RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
              G   E+ A + + Q+   ++ L+   I+HRDLKPEN+L   LD+D  + I+DFGLS 
Sbjct: 99  VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158

Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
              PG+     CG+P Y+APEVL  + Y + V+ +
Sbjct: 159 MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCW 193

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  139 bits (351), Expect = 2e-41
 Identities = 42/150 (28%), Positives = 79/150 (52%), Gaps = 2/150 (1%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RL 59
            +   ++  K  +  E+  +S + HP ++ L DAF+ +N + ++ EF +GG L   +   
Sbjct: 58  FVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE 117

Query: 60  HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
           H ++ E  A ++++Q+  GL  ++ ++ +H DLKPENI+ +       LK+ DFGL+  L
Sbjct: 118 HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT-TKRSNELKLIDFGLTAHL 176

Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149
            P    +   G+  + APEV + +      
Sbjct: 177 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 206

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 3e-41
 Identities = 47/150 (31%), Positives = 76/150 (50%), Gaps = 5/150 (3%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +  ++   +++ +  EL  L   N P I+  + AF ++  I + +E   GG+L   ++  
Sbjct: 39  IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 98

Query: 61  GRVPEQTARKFLQQLGAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
           GR+PEQ   K    +  GL  L   H I+HRD+KP NIL   ++    +K+ DFG+S  L
Sbjct: 99  GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL---VNSRGEIKLCDFGVSGQL 155

Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149
              + A    G+  YM+PE LQ   Y  + 
Sbjct: 156 -IDSMANSFVGTRSYMSPERLQGTHYSVQS 184

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 1e-40
 Identities = 52/156 (33%), Positives = 89/156 (57%), Gaps = 10/156 (6%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIR 58
           +KL K  +     E   L  + HPNI+R +D++++    + CI LV E    G L +Y++
Sbjct: 45  RKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK 104

Query: 59  LHGRVPEQTARKFLQQLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLS 116
               +  +  R + +Q+  GL+ L++    IIHRDLK +NI ++       +KI D GL+
Sbjct: 105 RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA 162

Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
            TL   ++A+ V G+P +MAPE+ + ++YDE V+ +
Sbjct: 163 -TLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVY 196

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  136 bits (344), Expect = 2e-40
 Identities = 42/155 (27%), Positives = 78/155 (50%), Gaps = 5/155 (3%)

Query: 2   LKKLNKHL---KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
            K +N      K  +  E++ ++ ++HP +I L DAF+ +  + L++EF +GG L   I 
Sbjct: 59  AKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA 118

Query: 59  LHG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
               ++ E     +++Q   GL+ ++ H I+H D+KPENI+         +KI DFGL+ 
Sbjct: 119 AEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLAT 177

Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
            L P    +    +  + APE++  +      + +
Sbjct: 178 KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMW 212

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (337), Expect = 6e-40
 Identities = 47/160 (29%), Positives = 81/160 (50%), Gaps = 12/160 (7%)

Query: 2   LKKLNKHL------KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K L K           +  E + +S ++HP  ++L+  FQ +  ++  + +   G L  
Sbjct: 38  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 97

Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           YIR  G   E   R +  ++ + LE L+   IIHRDLKPENIL   L++D+ ++I DFG 
Sbjct: 98  YIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGT 154

Query: 116 SCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           +  L P +    A    G+  Y++PE+L  +   +  + +
Sbjct: 155 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLW 194

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  134 bits (338), Expect = 6e-40
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 15/160 (9%)

Query: 2   LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +KK++   K   +       E+ FL  + HPN I+    +  E+  +LV+E+C G     
Sbjct: 45  IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDL 104

Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
                  + E            GL  L+SH++IHRD+K  NIL   L +  ++K+ DFG 
Sbjct: 105 LEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL---LSEPGLVKLGDFGS 161

Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVNFF 152
           +  + P N      G+P +MAPEV+      +YD KV+ +
Sbjct: 162 ASIMAPANS---FVGTPYWMAPEVILAMDEGQYDGKVDVW 198

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 5e-39
 Identities = 53/161 (32%), Positives = 86/161 (53%), Gaps = 13/161 (8%)

Query: 2   LKKLNKHLKSCLDC---ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI- 57
            K ++   +  L+    E++ L+S +HPNI++L DAF  EN +++++EFCAGG + + + 
Sbjct: 42  AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML 101

Query: 58  RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
            L   + E   +   +Q    L  L+ + IIHRDLK  NIL      D  +K+ADFG+S 
Sbjct: 102 ELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNIL---FTLDGDIKLADFGVSA 158

Query: 118 TLY-PGNYAEKVCGSPLYMAPEVLQ-----FQRYDEKVNFF 152
                    +   G+P +MAPEV+       + YD K + +
Sbjct: 159 KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVW 199

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 7e-39
 Identities = 49/149 (32%), Positives = 79/149 (53%), Gaps = 6/149 (4%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +  K        +  E+     +NH N+++ +   +  N  +L +E+C+GG L   I   
Sbjct: 38  VDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD 97

Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
             +PE  A++F  QL AG+  L+   I HRD+KPEN+L   LD+   LKI+DFGL+    
Sbjct: 98  IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL---LDERDNLKISDFGLATVFR 154

Query: 121 PGNYAE---KVCGSPLYMAPEVLQFQRYD 146
             N      K+CG+  Y+APE+L+ + + 
Sbjct: 155 YNNRERLLNKMCGTLPYVAPELLKRREFH 183

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 5e-38
 Identities = 39/155 (25%), Positives = 69/155 (44%), Gaps = 11/155 (7%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LH 60
           +             E+  L    H NI+     +     + +V ++C G +L  ++  + 
Sbjct: 40  VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIE 98

Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
            +          +Q   G++ L++  IIHRDLK  NI    L +D+ +KI DFGL+    
Sbjct: 99  TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIF---LHEDLTVKIGDFGLATVKS 155

Query: 121 PGNYAEK---VCGSPLYMAPEVLQFQR---YDEKV 149
             + + +   + GS L+MAPEV++ Q    Y  + 
Sbjct: 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 8e-37
 Identities = 49/157 (31%), Positives = 84/157 (53%), Gaps = 7/157 (4%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL    +   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 42  LKMLQDCPKARREVEL-HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 100

Query: 58  RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 101 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160

Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           +      N     C +P Y+APEVL  ++YD+  + +
Sbjct: 161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 197

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 3e-36
 Identities = 41/150 (27%), Positives = 76/150 (50%), Gaps = 5/150 (3%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
            +    +  K  +  E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +   
Sbjct: 52  QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-E 110

Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL- 119
             + E       ++    LE L+S+ +IHRD+K +NIL   L  D  +K+ DFG    + 
Sbjct: 111 TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNIL---LGMDGSVKLTDFGFCAQIT 167

Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149
              +    + G+P +MAPEV+  + Y  KV
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 3e-36
 Identities = 49/160 (30%), Positives = 81/160 (50%), Gaps = 15/160 (9%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYI-- 57
              + +  K  L  E+N L  + HPNI+R +D    +    +++V+E+C GG+L+S I  
Sbjct: 39  YGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK 98

Query: 58  --RLHGRVPEQTARKFLQQLGAGLEIL-----NSHHIIHRDLKPENILLSGLDDDVMLKI 110
             +    + E+   + + QL   L+         H ++HRDLKP N+    LD    +K+
Sbjct: 99  GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVF---LDGKQNVKL 155

Query: 111 ADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKV 149
            DFGL+  L     +A+   G+P YM+PE +    Y+EK 
Sbjct: 156 GDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKS 195

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 1e-35
 Identities = 39/151 (25%), Positives = 72/151 (47%), Gaps = 4/151 (2%)

Query: 2   LKKLNKHLKS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
            K +         +  E++ L+   H NI+ L ++F++   + ++ EF +G ++   I  
Sbjct: 35  AKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT 94

Query: 60  HG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
               + E+    ++ Q+   L+ L+SH+I H D++PENI+         +KI +FG +  
Sbjct: 95  SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQ 153

Query: 119 LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149
           L PG+    +  +P Y APEV Q        
Sbjct: 154 LKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  122 bits (306), Expect = 2e-35
 Identities = 55/147 (37%), Positives = 83/147 (56%), Gaps = 4/147 (2%)

Query: 3   KKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
            +  + L+     E++ L  V+ HPNII+L D ++     FLV +    G L  Y+    
Sbjct: 46  AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV 105

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
            + E+  RK ++ L   +  L+  +I+HRDLKPENIL   LDDD+ +K+ DFG SC L P
Sbjct: 106 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL---LDDDMNIKLTDFGFSCQLDP 162

Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEK 148
           G    +VCG+P Y+APE+++    D  
Sbjct: 163 GEKLREVCGTPSYLAPEIIECSMNDNH 189

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 4e-34
 Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 9/155 (5%)

Query: 2   LKKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRL 59
           +K +           E + ++ + H N+++L     + +  +++V E+ A G+L  Y+R 
Sbjct: 35  VKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS 94

Query: 60  HGR--VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
            GR  +      KF   +   +E L  ++ +HRDL   N+L   + +D + K++DFGL+ 
Sbjct: 95  RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL---VSEDNVAKVSDFGLTK 151

Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
                   +       + APE L+ +++  K + +
Sbjct: 152 EASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVW 184

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 8e-34
 Identities = 37/156 (23%), Positives = 73/156 (46%), Gaps = 8/156 (5%)

Query: 2   LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +K + +   S  +   E   + +++H  +++L+     +  IF++ E+ A G L +Y+R 
Sbjct: 33  IKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE 92

Query: 60  -HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
              R   Q   +  + +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  
Sbjct: 93  MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRY 149

Query: 119 LYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVNFF 152
           +    Y           +  PEVL + ++  K + +
Sbjct: 150 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 185

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 9e-34
 Identities = 39/156 (25%), Positives = 68/156 (43%), Gaps = 8/156 (5%)

Query: 2   LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY-IR 58
           +K + +   S  D   E   +  ++HP +++L+     +  I LV EF   G LS Y   
Sbjct: 34  IKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT 93

Query: 59  LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
             G    +T       +  G+  L    +IHRDL   N L   + ++ ++K++DFG++  
Sbjct: 94  QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCL---VGENQVIKVSDFGMTRF 150

Query: 119 LYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVNFF 152
           +    Y           + +PEV  F RY  K + +
Sbjct: 151 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 186

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 1e-33
 Identities = 40/154 (25%), Positives = 73/154 (47%), Gaps = 8/154 (5%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +  +  LK  L  E N +  +++P I+R+    +AE+   LV+E    G L+ Y++ +  
Sbjct: 45  EANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH 103

Query: 63  VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
           V ++   + + Q+  G++ L   + +HRDL   N+L   L      KI+DFGLS  L   
Sbjct: 104 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVL---LVTQHYAKISDFGLSKALRAD 160

Query: 123 NYAEK----VCGSPLYMAPEVLQFQRYDEKVNFF 152
               K          + APE + + ++  K + +
Sbjct: 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVW 194

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  117 bits (295), Expect = 2e-33
 Identities = 57/157 (36%), Positives = 88/157 (56%), Gaps = 11/157 (7%)

Query: 2   LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K L K +   L        E   LS V HP IIR++  FQ    IF+++++  GG L S
Sbjct: 34  MKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFS 93

Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
            +R   R P   A+ +  ++   LE L+S  II+RDLKPENIL   LD +  +KI DFG 
Sbjct: 94  LLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENIL---LDKNGHIKITDFGF 150

Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           +  +    Y   +CG+P Y+APEV+  + Y++ ++++
Sbjct: 151 AKYVPDVTY--TLCGTPDYIAPEVVSTKPYNKSIDWW 185

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 2e-33
 Identities = 44/138 (31%), Positives = 81/138 (58%), Gaps = 1/138 (0%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A +FL+Q+
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDD-DVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
             G+  L+S  I H DLKPENI+L   +     +KI DFGL+  +  GN  + + G+P +
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182

Query: 135 MAPEVLQFQRYDEKVNFF 152
           +APE++ ++    + + +
Sbjct: 183 VAPEIVNYEPLGLEADMW 200

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 5e-33
 Identities = 50/159 (31%), Positives = 83/159 (52%), Gaps = 11/159 (6%)

Query: 2   LKKLNKHLKSCLDCELNFL-------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLS 54
           +K L K +    D     +        +  HP +  +F  FQ +  +F V+E+  GG+L 
Sbjct: 32  IKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLM 91

Query: 55  SYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
            +I+   +     A  +  ++  GL+ L+S  I++RDLK +NIL   LD D  +KIADFG
Sbjct: 92  YHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL---LDKDGHIKIADFG 148

Query: 115 LSCTLYPGNYAEK-VCGSPLYMAPEVLQFQRYDEKVNFF 152
           +      G+      CG+P Y+APE+L  Q+Y+  V+++
Sbjct: 149 MCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWW 187

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  113 bits (283), Expect = 6e-32
 Identities = 35/159 (22%), Positives = 71/159 (44%), Gaps = 10/159 (6%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +     +  +     E + +   +HPN+I L         + ++ EF   G+L S++R +
Sbjct: 62  LKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN 121

Query: 61  -GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
            G+         L+ + AG++ L   + +HRDL   NIL   ++ +++ K++DFGLS  L
Sbjct: 122 DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNIL---VNSNLVCKVSDFGLSRFL 178

Query: 120 YPGNYAEKV------CGSPLYMAPEVLQFQRYDEKVNFF 152
                               + APE +Q++++    + +
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVW 217

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 7e-32
 Identities = 35/157 (22%), Positives = 68/157 (43%), Gaps = 10/157 (6%)

Query: 2   LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +K L +   S      E N +  + H  ++RL+     +  I+++ E+   G+L  +++ 
Sbjct: 42  VKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKT 100

Query: 60  HGRVP--EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
              +            Q+  G+  +   + IHRDL+  NIL   + D +  KIADFGL+ 
Sbjct: 101 PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL---VSDTLSCKIADFGLAR 157

Query: 118 TLYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVNFF 152
            +    Y  +        + APE + +  +  K + +
Sbjct: 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  112 bits (281), Expect = 8e-32
 Identities = 36/162 (22%), Positives = 69/162 (42%), Gaps = 11/162 (6%)

Query: 2   LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGG 51
           +K L   L            E    +++NHP I+ ++D  +AE       ++V+E+  G 
Sbjct: 37  VKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGV 96

Query: 52  NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDD-DVMLKI 110
            L   +   G +  + A + +      L   + + IIHRD+KP NI++S  +   VM   
Sbjct: 97  TLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFG 156

Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
               ++ +         V G+  Y++PE  +    D + + +
Sbjct: 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVY 198

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 1e-31
 Identities = 39/154 (25%), Positives = 68/154 (44%), Gaps = 9/154 (5%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           + +   K     +  E   +  +++P I+RL    QAE  + LV+E   GG L  ++   
Sbjct: 44  LKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGK 102

Query: 61  -GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
              +P     + L Q+  G++ L   + +HRDL   N+L   L +    KI+DFGLS  L
Sbjct: 103 REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVL---LVNRHYAKISDFGLSKAL 159

Query: 120 YPGNYAEK----VCGSPLYMAPEVLQFQRYDEKV 149
              +              + APE + F+++  + 
Sbjct: 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 193

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 1e-31
 Identities = 41/179 (22%), Positives = 71/179 (39%), Gaps = 30/179 (16%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           + +K +   +  L  EL  ++ + +H NI+ L  A      I+L+ E+C  G+L +Y+R 
Sbjct: 75  LKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRS 134

Query: 60  H-----------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPEN 96
                                     +  +    F  Q+  G+E L     +HRDL   N
Sbjct: 135 KREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194

Query: 97  ILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVNFF 152
           +L   +    ++KI DFGL+  +   +             +MAPE L    Y  K + +
Sbjct: 195 VL---VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 250

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  113 bits (283), Expect = 2e-31
 Identities = 43/138 (31%), Positives = 75/138 (54%), Gaps = 5/138 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
            L+ +S+ + P I+ +  AF   + +  +++   GG+L  ++  HG   E   R +  ++
Sbjct: 57  MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 116

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
             GLE +++  +++RDLKP NIL   LD+   ++I+D GL+C  +         G+  YM
Sbjct: 117 ILGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYM 172

Query: 136 APEVLQ-FQRYDEKVNFF 152
           APEVLQ    YD   ++F
Sbjct: 173 APEVLQKGVAYDSSADWF 190

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  110 bits (277), Expect = 4e-31
 Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 9/157 (5%)

Query: 2   LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +K L +      +   E   +  + HPN+++L      E   +++ EF   GNL  Y+R 
Sbjct: 47  VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE 106

Query: 60  HGR--VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
             R  V          Q+ + +E L   + IHRDL   N L   + ++ ++K+ADFGLS 
Sbjct: 107 CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL---VGENHLVKVADFGLSR 163

Query: 118 TLYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVNFF 152
            +    Y           + APE L + ++  K + +
Sbjct: 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 200

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 6e-31
 Identities = 43/169 (25%), Positives = 67/169 (39%), Gaps = 20/169 (11%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           M +  +K        EL  L  + +HPNII L  A +    ++L +E+   GNL  ++R 
Sbjct: 45  MKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK 104

Query: 60  H----------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103
                              +  Q    F   +  G++ L+    IHRDL   NIL   + 
Sbjct: 105 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL---VG 161

Query: 104 DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           ++ + KIADFGLS                 +MA E L +  Y    + +
Sbjct: 162 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVW 210

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 9e-31
 Identities = 31/140 (22%), Positives = 54/140 (38%), Gaps = 6/140 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   ++SV++P++ RL           +      G  L         +  Q    +  Q+
Sbjct: 61  EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120

Query: 76  GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSP 132
             G+  L    ++HRDL   N+L   +     +KI DFGL+  L        AE      
Sbjct: 121 AKGMNYLEDRRLVHRDLAARNVL---VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177

Query: 133 LYMAPEVLQFQRYDEKVNFF 152
            +MA E +  + Y  + + +
Sbjct: 178 KWMALESILHRIYTHQSDVW 197

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 1e-30
 Identities = 38/136 (27%), Positives = 65/136 (47%), Gaps = 6/136 (4%)

Query: 16  ELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAGG-NLSSYIRLHGRVPEQTARKFL 72
           E+  L  V+     +IRL D F+  +   L++E      +L  +I   G + E+ AR F 
Sbjct: 57  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 116

Query: 73  QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
            Q+   +   ++  ++HRD+K ENIL+    +   LK+ DFG    L          G+ 
Sbjct: 117 WQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGA-LLKDTVYTDFDGTR 173

Query: 133 LYMAPEVLQFQRYDEK 148
           +Y  PE +++ RY  +
Sbjct: 174 VYSPPEWIRYHRYHGR 189

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 2e-30
 Identities = 43/162 (26%), Positives = 69/162 (42%), Gaps = 15/162 (9%)

Query: 2   LKKLNKHLKS------CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K L   + S          E+N + S++H N+IRL+        + +V E    G+L  
Sbjct: 41  VKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLD 99

Query: 56  YIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
            +R H G     T  ++  Q+  G+  L S   IHRDL   N+L   L    ++KI DFG
Sbjct: 100 RLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL---LATRDLVKIGDFG 156

Query: 115 LSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           L   L   +      E       + APE L+ + +    + +
Sbjct: 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTW 198

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 3e-30
 Identities = 37/137 (27%), Positives = 64/137 (46%), Gaps = 7/137 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
           E   +   +HP+I++L      EN +++++E C  G L S++      +   +   +  Q
Sbjct: 58  EALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 116

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSP 132
           L   L  L S   +HRD+   N+L   +  +  +K+ DFGLS  +    Y  A K     
Sbjct: 117 LSTALAYLESKRFVHRDIAARNVL---VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173

Query: 133 LYMAPEVLQFQRYDEKV 149
            +MAPE + F+R+    
Sbjct: 174 KWMAPESINFRRFTSAS 190

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 4e-30
 Identities = 50/158 (31%), Positives = 80/158 (50%), Gaps = 10/158 (6%)

Query: 2   LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K L K +    D       E   L +  HP +  L  AFQ  + +  V+E+  GG L  
Sbjct: 35  MKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFF 94

Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           ++       E+ AR +  ++ + LE L+S  +++RD+K EN++   LD D  +KI DFGL
Sbjct: 95  HLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGL 151

Query: 116 SCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
                  G   +  CG+P Y+APEVL+   Y   V+++
Sbjct: 152 CKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 189

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  107 bits (267), Expect = 2e-29
 Identities = 36/152 (23%), Positives = 68/152 (44%), Gaps = 9/152 (5%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIR 58
           +K L    K  +  E+  L ++   PNII L D  +        LV E     +     +
Sbjct: 65  VKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ 124

Query: 59  LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
               + +   R ++ ++   L+  +S  I+HRD+KP N+++    +   L++ D+GL+  
Sbjct: 125 ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEF 179

Query: 119 LYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKV 149
            +PG        S  +  PE+ + +Q YD  +
Sbjct: 180 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSL 211

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (264), Expect = 3e-29
 Identities = 33/154 (21%), Positives = 67/154 (43%), Gaps = 10/154 (6%)

Query: 2   LKKLNKHLKS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +K L     S      E   +  + H  +++L+     E  I++V E+ + G+L  +++ 
Sbjct: 46  IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKG 104

Query: 60  HGRVP--EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
                           Q+ +G+  +   + +HRDL+  NIL   + ++++ K+ADFGL+ 
Sbjct: 105 ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL---VGENLVCKVADFGLAR 161

Query: 118 TLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKV 149
            +    Y   +       + APE   + R+  K 
Sbjct: 162 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 195

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 9e-29
 Identities = 50/161 (31%), Positives = 77/161 (47%), Gaps = 13/161 (8%)

Query: 2   LKKLNKHLKSCLD--------CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNL 53
           +KK+    +S            E+  L  ++HPNII L DAF  ++ I LV +F      
Sbjct: 28  IKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLE 87

Query: 54  SSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
                    +     + ++     GLE L+ H I+HRDLKP N+L   LD++ +LK+ADF
Sbjct: 88  VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLL---LDENGVLKLADF 144

Query: 114 GLSCTLYPGNYAEK-VCGSPLYMAPEVLQ-FQRYDEKVNFF 152
           GL+ +    N A      +  Y APE+L   + Y   V+ +
Sbjct: 145 GLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMW 185

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 5e-28
 Identities = 33/168 (19%), Positives = 68/168 (40%), Gaps = 20/168 (11%)

Query: 2   LKKLNKHL----KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K +N+      +     E + +   N  +++RL           +++E    G+L SY+
Sbjct: 55  IKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 114

Query: 58  RLHGRV----------PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVM 107
           R                     +   ++  G+  LN++  +HRDL   N +   + +D  
Sbjct: 115 RSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM---VAEDFT 171

Query: 108 LKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
           +KI DFG++  +Y  +Y     K      +M+PE L+   +    + +
Sbjct: 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVW 219

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 5e-28
 Identities = 43/161 (26%), Positives = 72/161 (44%), Gaps = 13/161 (8%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSS 55
           +KK+ +  K   + EL  +  ++H NI+RL   F      + E  + LV+++        
Sbjct: 50  IKKVLQD-KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 108

Query: 56  ---YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
              Y R    +P    + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ D
Sbjct: 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCD 166

Query: 113 FGLSCTLYPGNYAEKVCGSPLYMAP-EVLQFQRYDEKVNFF 152
           FG +  L  G        S  Y AP  +     Y   ++ +
Sbjct: 167 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVW 207

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (256), Expect = 6e-28
 Identities = 36/175 (20%), Positives = 62/175 (35%), Gaps = 27/175 (15%)

Query: 2   LKKLNKHLKSCL--DCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSS 55
           +K  +   +     + E+     + H NI+    A   +N     ++LV ++   G+L  
Sbjct: 31  VKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD 90

Query: 56  YIRLHGRVPEQTARKFLQQLGA-------GLEILNSHHIIHRDLKPENILLSGLDDDVML 108
           Y+  +    E   +  L             +       I HRDLK +NIL   +  +   
Sbjct: 91  YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL---VKKNGTC 147

Query: 109 KIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQ------FQRYDEKVNFF 152
            IAD GL+                  G+  YMAPEVL            ++ + +
Sbjct: 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIY 202

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  102 bits (255), Expect = 7e-28
 Identities = 38/182 (20%), Positives = 76/182 (41%), Gaps = 34/182 (18%)

Query: 2   LKKLNKHLKSCLDC----ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K L +   + +      E   ++  ++PNI++L         + L+ E+ A G+L+ ++
Sbjct: 48  VKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL 107

Query: 58  RLHGR------------------------VPEQTARKFLQQLGAGLEILNSHHIIHRDLK 93
           R                            +         +Q+ AG+  L+    +HRDL 
Sbjct: 108 RSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167

Query: 94  PENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVN 150
             N L   + +++++KIADFGLS  +Y  +Y +          +M PE + + RY  + +
Sbjct: 168 TRNCL---VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESD 224

Query: 151 FF 152
            +
Sbjct: 225 VW 226

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (256), Expect = 8e-28
 Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 14/162 (8%)

Query: 2   LKKLNKHLK----SCLDCELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSY 56
           +K LN+       S    E   +   +HPN++ L     ++E    +V+ +   G+L ++
Sbjct: 60  VKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 119

Query: 57  IRLHGRVP-EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           IR     P  +    F  Q+  G++ L S   +HRDL   N +   LD+   +K+ADFGL
Sbjct: 120 IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCM---LDEKFTVKVADFGL 176

Query: 116 SCTLYPGNYAEK-----VCGSPLYMAPEVLQFQRYDEKVNFF 152
           +  +Y   +              +MA E LQ Q++  K + +
Sbjct: 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 218

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  102 bits (255), Expect = 2e-27
 Identities = 48/158 (30%), Positives = 89/158 (56%), Gaps = 11/158 (6%)

Query: 2   LKKLNKHLKSCLD------CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K L+K     L        E   L +VN P +++L  +F+  + +++V+E+ AGG + S
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130

Query: 56  YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
           ++R  GR  E  AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG 
Sbjct: 131 HLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGF 187

Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFV 153
           +  +    +   +CG+P  +APE++  + Y++ V+++ 
Sbjct: 188 AKRVKGRTW--TLCGTPEALAPEIILSKGYNKAVDWWA 223

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (251), Expect = 2e-27
 Identities = 35/160 (21%), Positives = 66/160 (41%), Gaps = 12/160 (7%)

Query: 2   LKKLNKHL----KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY- 56
           +K L        +     E   +   +H NIIRL         + ++ E+   G L  + 
Sbjct: 41  IKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL 100

Query: 57  IRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
               G          L+ + AG++ L + + +HRDL   NIL   ++ +++ K++DFGLS
Sbjct: 101 REKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNIL---VNSNLVCKVSDFGLS 157

Query: 117 CTLYPGNYAEKV----CGSPLYMAPEVLQFQRYDEKVNFF 152
             L     A            + APE + ++++    + +
Sbjct: 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVW 197

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (251), Expect = 3e-27
 Identities = 47/143 (32%), Positives = 69/143 (48%), Gaps = 9/143 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTAR 69
            L  L +  HPN++RLFD         E  + LV E       +   ++    VP +T +
Sbjct: 60  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 119

Query: 70  KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
             + QL  GL+ L+SH ++HRDLKP+NIL   +     +K+ADFGL+           V 
Sbjct: 120 DMMFQLLRGLDFLHSHRVVHRDLKPQNIL---VTSSGQIKLADFGLARIYSFQMALTSVV 176

Query: 130 GSPLYMAPEVLQFQRYDEKVNFF 152
            +  Y APEVL    Y   V+ +
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLW 199

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (251), Expect = 4e-27
 Identities = 40/159 (25%), Positives = 63/159 (39%), Gaps = 25/159 (15%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR---------------- 58
           EL  LS + NH NI+ L  A        ++ E+C  G+L +++R                
Sbjct: 76  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135

Query: 59  --LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
                 +  +    F  Q+  G+  L S + IHRDL   NIL   L    + KI DFGL+
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL---LTHGRITKICDFGLA 192

Query: 117 CTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
             +   +             +MAPE +    Y  + + +
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 231

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (251), Expect = 4e-27
 Identities = 36/165 (21%), Positives = 69/165 (41%), Gaps = 17/165 (10%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--------AENCIFLVVEFCAGGNL 53
           ++   +        E+  L  + H N++ L +  +         +  I+LV +FC     
Sbjct: 45  MENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA 104

Query: 54  SSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
                +  +      ++ +Q L  GL  ++ + I+HRD+K  N+L   +  D +LK+ADF
Sbjct: 105 GLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVL---ITRDGVLKLADF 161

Query: 114 GLSCTLYPG-----NYAEKVCGSPLYMAPEVLQFQR-YDEKVNFF 152
           GL+           N       +  Y  PE+L  +R Y   ++ +
Sbjct: 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLW 206

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 99.2 bits (246), Expect = 1e-26
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 5/153 (3%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L+K ++ + S    E++ L  + H NI++L+D    +  + LV E              G
Sbjct: 36  LEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG 95

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY- 120
            +   TA+ FL QL  G+   +   ++HRDLKP+N+L   ++ +  LKIADFGL+     
Sbjct: 96  GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL---INREGELKIADFGLARAFGI 152

Query: 121 PGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVNFF 152
           P         +  Y AP+VL   ++Y   ++ +
Sbjct: 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIW 185

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =   99 bits (248), Expect = 2e-26
 Identities = 39/141 (27%), Positives = 64/141 (45%), Gaps = 12/141 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E+  L    H NII + D  +A          +V    G +L   ++    +       F
Sbjct: 56  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYF 114

Query: 72  LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEK 127
           L Q+  GL+ ++S +++HRDLKP N+L   L+    LKI DFGL+    P +    +  +
Sbjct: 115 LYQILRGLKYIHSANVLHRDLKPSNLL---LNTTCDLKICDFGLARVADPDHDHTGFLTE 171

Query: 128 VCGSPLYMAPEVLQFQRYDEK 148
              +  Y APE++   +   K
Sbjct: 172 YVATRWYRAPEIMLNSKGYTK 192

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 98.4 bits (244), Expect = 3e-26
 Identities = 28/158 (17%), Positives = 53/158 (33%), Gaps = 10/158 (6%)

Query: 2   LKKLNKHLKSC-LDCELNFLSSVNHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRL 59
           +K      K   L  E      +     I       AE +   +V+E         +   
Sbjct: 37  IKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC 96

Query: 60  HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
             +   +T      Q+ + +E ++S + IHRD+KP+N L+       ++ I DFGL+   
Sbjct: 97  SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156

Query: 120 YPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKV 149
                         + + G+  Y +           + 
Sbjct: 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRD 194

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.6 bits (242), Expect = 6e-26
 Identities = 46/146 (31%), Positives = 72/146 (49%), Gaps = 5/146 (3%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY-IRLH 60
           L    + + S    E++ L  +NHPNI++L D    EN ++LV EF              
Sbjct: 37  LDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL 96

Query: 61  GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
             +P    + +L QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+    
Sbjct: 97  TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFG 153

Query: 121 -PGNYAEKVCGSPLYMAPEVLQFQRY 145
            P         +  Y APE+L   +Y
Sbjct: 154 VPVRTYTHEVVTLWYRAPEILLGCKY 179

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 95.6 bits (237), Expect = 3e-25
 Identities = 23/160 (14%), Positives = 55/160 (34%), Gaps = 12/160 (7%)

Query: 2   LKKLNKHLKS-CLDCELNFLSSVNHPNII-RLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +K   +   +  L  E      +     I  ++   Q      LV++             
Sbjct: 35  IKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC 94

Query: 60  HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSC 117
             +   +T     +Q+ A ++ ++   +++RD+KP+N L+      +  M+ + DFG+  
Sbjct: 95  GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154

Query: 118 TLYPG--------NYAEKVCGSPLYMAPEVLQFQRYDEKV 149
                           + + G+  YM+      +    + 
Sbjct: 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRD 194

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.5 bits (234), Expect = 8e-25
 Identities = 45/172 (26%), Positives = 76/172 (44%), Gaps = 27/172 (15%)

Query: 2   LKKLNKHL----KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56
           +K L         S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y
Sbjct: 50  VKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 109

Query: 57  IRLHG----------------RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS 100
           ++                   ++  +       Q+  G+E L S   IHRDL   N+L  
Sbjct: 110 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL-- 167

Query: 101 GLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKV 149
            + +D ++KIADFGL+  ++  +Y +K         +MAPE L  + Y  + 
Sbjct: 168 -VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 218

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.6 bits (226), Expect = 1e-23
 Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 5/153 (3%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L   ++ + S    E+  L  + H NI+RL D   ++  + LV EFC       +   +G
Sbjct: 37  LDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG 96

Query: 62  RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY- 120
            +  +  + FL QL  GL   +S +++HRDLKP+N+L   ++ +  LK+A+FGL+     
Sbjct: 97  DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLL---INRNGELKLANFGLARAFGI 153

Query: 121 PGNYAEKVCGSPLYMAPEVL-QFQRYDEKVNFF 152
           P         +  Y  P+VL   + Y   ++ +
Sbjct: 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMW 186

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.8 bits (227), Expect = 2e-23
 Identities = 49/160 (30%), Positives = 75/160 (46%), Gaps = 19/160 (11%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
           +KKL +  +S L       EL  L  + H N+I L D F  +         +LV+ F   
Sbjct: 48  IKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-- 105

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
           G     +  H ++ E   +  + Q+  GL  +++  IIHRDLKP N+    +++D  LKI
Sbjct: 106 GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA---VNEDCELKI 162

Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKV 149
            DFGL+      +       +  Y APEV L + RY + V
Sbjct: 163 LDFGLARQ--ADSEMTGYVVTRWYRAPEVILNWMRYTQTV 200

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.7 bits (224), Expect = 3e-23
 Identities = 40/133 (30%), Positives = 67/133 (50%), Gaps = 6/133 (4%)

Query: 16  ELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
           E   L  +   P ++ L  AFQ E  + L++++  GG L +++    R  E   + ++ +
Sbjct: 78  ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 137

Query: 75  LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL--YPGNYAEKVCGSP 132
           +   LE L+   II+RD+K ENIL   LD +  + + DFGLS          A   CG+ 
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENIL---LDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 194

Query: 133 LYMAPEVLQFQRY 145
            YMAP++++    
Sbjct: 195 EYMAPDIVRGGDS 207

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.2 bits (220), Expect = 9e-23
 Identities = 42/176 (23%), Positives = 74/176 (42%), Gaps = 28/176 (15%)

Query: 2   LKKLNKH-----LKSCLDCELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSS 55
           +K L +       ++ +      +   +H N++ L  A  +    + ++VEFC  GNLS+
Sbjct: 48  VKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 107

Query: 56  YIRLHGR----------------VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL 99
           Y+R                    +  +    +  Q+  G+E L S   IHRDL   NIL 
Sbjct: 108 YLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL- 166

Query: 100 SGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVNFF 152
             L +  ++KI DFGL+  +Y      +         +MAPE +  + Y  + + +
Sbjct: 167 --LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 220

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.6 bits (221), Expect = 1e-22
 Identities = 48/163 (29%), Positives = 72/163 (44%), Gaps = 17/163 (10%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
           +KKL++  ++         EL  +  VNH NII L + F  +        ++LV+E    
Sbjct: 47  IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA 106

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
                   +   +  +     L Q+  G++ L+S  IIHRDLKP NI    +  D  LKI
Sbjct: 107 NLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI---VVKSDCTLKI 160

Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFV 153
            DFGL+ T            +  Y APEV+    Y E V+ + 
Sbjct: 161 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWS 203

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.0 bits (204), Expect = 3e-20
 Identities = 45/162 (27%), Positives = 81/162 (50%), Gaps = 17/162 (10%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGG 51
           +KKL++  +S +       EL  L  + H N+I L D F       E     +V    G 
Sbjct: 48  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA 107

Query: 52  NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
           +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 108 DLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLA---VNEDCELKIL 163

Query: 112 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 152
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 164 DFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 203

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 72.8 bits (177), Expect = 2e-16
 Identities = 39/155 (25%), Positives = 68/155 (43%), Gaps = 11/155 (7%)

Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGN---LSSYIRLHG 61
           K L+   D +     S+   +I++L D F     N + +V+ F   G           H 
Sbjct: 61  KLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR 120

Query: 62  RVPEQTARKFLQQLGAGLEILNSHH-IIHRDLKPENILLSGLD---DDVMLKIADFGLSC 117
            +P    ++  +QL  GL+ ++    IIH D+KPEN+L+  +D   + + +KIAD G +C
Sbjct: 121 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 180

Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 152
                        +  Y +PEVL    +    + +
Sbjct: 181 WYDEHYT--NSIQTREYRSPEVLLGAPWGCGADIW 213

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 57.9 bits (139), Expect = 1e-11
 Identities = 15/101 (14%), Positives = 33/101 (32%), Gaps = 15/101 (14%)

Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
            L  +    + +++          +++E               RV  +   + L  +   
Sbjct: 67  ALQKLQGLAVPKVYAWEG----NAVLMELIDAKE-------LYRVRVENPDEVLDMILEE 115

Query: 79  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
           +       I+H DL   N+L+     +  + I DF  S  +
Sbjct: 116 VAKFYHRGIVHGDLSQYNVLV----SEEGIWIIDFPQSVEV 152

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	154
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.97
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.93
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.8
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.09
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.97
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.45
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.3
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.57
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	93.05

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.9e-44  Score=249.13  Aligned_cols=146  Identities=34%  Similarity=0.617  Sum_probs=118.2

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++||||+++++++.+++.+|++|||++||+|.+++.+.+.+++..+..++.|++.|++|||+++++
T Consensus        50 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~ii  129 (307)
T d1a06a_          50 KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV  129 (307)
T ss_dssp             -----CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceee
Confidence            35678899999999999999999999999999999999999999999999888999999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ||||||+||++...+..+.+||+|||++..........+.+||+.|+|||++.+..|+.++|||||
T Consensus       130 HrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSl  195 (307)
T d1a06a_         130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSI  195 (307)
T ss_dssp             CSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHH
T ss_pred             eEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhh
Confidence            999999999997656678999999999987766666667789999999999999999999999996

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-43  Score=240.20  Aligned_cols=143  Identities=31%  Similarity=0.561  Sum_probs=131.7

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++||||+++++++.+++.+|++|||+++|+|.+++.+.+.+++..+..++.|++.|++|||++|+
T Consensus        48 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~i  127 (263)
T d2j4za1          48 GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV  127 (263)
T ss_dssp             TCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34577899999999999999999999999999999999999999999999988999999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +||||||+||++   +..+.+||+|||+|...... ......||+.|+|||++.+..|+.++|||||
T Consensus       128 vHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~~-~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSl  190 (263)
T d2j4za1         128 IHRDIKPENLLL---GSAGELKIADFGWSVHAPSS-RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSL  190 (263)
T ss_dssp             CCCCCCGGGEEE---CTTSCEEECCCCSCSCCCCC-CCEETTEEGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred             eeeeecccccee---cCCCCEeecccceeeecCCC-cccccCCCCcccCHHHHcCCCCCchhhhhhH
Confidence            999999999999   67789999999999765433 3455679999999999999999999999996

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-42  Score=240.81  Aligned_cols=143  Identities=29%  Similarity=0.526  Sum_probs=130.3

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++||||+++++++.+++.+|++|||++||+|.+++.+ +.+++..+..++.|++.|+.|||++|+
T Consensus        59 ~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~i  137 (293)
T d1yhwa1          59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQV  137 (293)
T ss_dssp             SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4467899999999999999999999999999999999999999999998764 579999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +||||||+||++   +..+.+||+|||++...... ......+||+.|+|||++.++.|+.++|||||
T Consensus       138 iHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  202 (293)
T d1yhwa1         138 IHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL  202 (293)
T ss_dssp             ECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHH
T ss_pred             cccCCcHHHeEE---CCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehH
Confidence            999999999999   67789999999999876543 34456789999999999999999999999996

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-43  Score=241.92  Aligned_cols=143  Identities=35%  Similarity=0.622  Sum_probs=127.7

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.++++++||||+++++++.+++..|++|||+++|+|.+++.+.+.+++..+..++.|++.|++|||++|++
T Consensus        46 ~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~Ii  125 (271)
T d1nvra_          46 CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT  125 (271)
T ss_dssp             ---CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCc
Confidence            45678999999999999999999999999999999999999999999998788899999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCC-CcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY-DEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~Diwsl  154 (154)
                      ||||||+||++   +..+.+||+|||+|.......   .....+||+.|+|||++.+..+ +.++|||||
T Consensus       126 HrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSl  192 (271)
T d1nvra_         126 HRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC  192 (271)
T ss_dssp             CSCCCGGGEEE---CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHH
T ss_pred             cCcccHHHEEE---CCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHh
Confidence            99999999999   677889999999998764332   3445789999999999988776 578999996

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-43  Score=246.22  Aligned_cols=144  Identities=33%  Similarity=0.548  Sum_probs=130.2

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-H   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~   85 (154)
                      +...+.+.+|+.+++.++||||++++++|.+++.+|+||||++||+|.+++.+.+.+++..++.++.|++.|+.|||+ +
T Consensus        45 ~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~  124 (322)
T d1s9ja_          45 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH  124 (322)
T ss_dssp             TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            455678999999999999999999999999999999999999999999999988899999999999999999999997 5


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++||||||+||++   +..+.+||+|||+|...... ...+..||+.|+|||++.+..|+.++|||||
T Consensus       125 ~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSl  189 (322)
T d1s9ja_         125 KIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSM  189 (322)
T ss_dssp             CCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHHH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHH
T ss_pred             CEEccccCHHHeeE---CCCCCEEEeeCCCccccCCC-ccccccCCccccCchHHcCCCCCcHHHHHHH
Confidence            99999999999999   67889999999999865432 3345689999999999999999999999996

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-42  Score=240.89  Aligned_cols=143  Identities=32%  Similarity=0.498  Sum_probs=133.2

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.+++.++||||+++++++.+++.+|++|||++||+|.+++.+.+.+++..++.+++|++.|++|||++|++
T Consensus        48 ~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~ii  127 (337)
T d1o6la_          48 EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV  127 (337)
T ss_dssp             CHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred             HHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCcc
Confidence            45778999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEeecCCCCeeEEEeecccccccCC-CCccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ||||||+||++   +..+.+||+|||+|+.... .......+||+.|+|||++.+..|+.++|||||
T Consensus       128 HRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSl  191 (337)
T d1o6la_         128 YRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL  191 (337)
T ss_dssp             CCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHH
T ss_pred             ccccCHHHeEe---cCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccch
Confidence            99999999999   6788999999999987644 345566889999999999999999999999996

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-42  Score=234.09  Aligned_cols=145  Identities=33%  Similarity=0.635  Sum_probs=127.5

Q ss_pred             hhhhHHhHHHHHHHHhhCCCCccchhhhheec----CCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHH
Q 031702            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~   81 (154)
                      +....+.+.+|++++++++||||+++++++.+    ++.+|++|||+++|+|.+++.+...+++..+..++.|++.|++|
T Consensus        48 ~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~y  127 (270)
T d1t4ha_          48 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF  127 (270)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHH
Confidence            34556789999999999999999999999864    35689999999999999999988899999999999999999999


Q ss_pred             HHhCC--ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           82 LNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        82 lh~~~--~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ||+++  ++||||||+||++.  +..+.+||+|||++.... ........||+.|+|||++.+ .|+.++|||||
T Consensus       128 LH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla~~~~-~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSl  198 (270)
T d1t4ha_         128 LHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAF  198 (270)
T ss_dssp             HHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGGGCC-TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHH
T ss_pred             HHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcceecc-CCccCCcccCccccCHHHhCC-CCCCcCchhhH
Confidence            99998  99999999999994  346789999999997533 334456789999999999874 69999999996

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-42  Score=239.19  Aligned_cols=144  Identities=31%  Similarity=0.562  Sum_probs=129.4

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|++++++++||||+++++++.+++.+|++|||++||+|.+++...+.+++..++.++.|++.|++|||++++
T Consensus        50 ~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~i  129 (288)
T d1uu3a_          50 NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI  129 (288)
T ss_dssp             TCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccE
Confidence            34567999999999999999999999999999999999999999999999989999999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +||||||+||++   +..+.+||+|||+|.......   .....+||+.|+|||++.+..|+.++|||||
T Consensus       130 iHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSl  196 (288)
T d1uu3a_         130 IHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWAL  196 (288)
T ss_dssp             ECSCCSGGGEEE---CTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHH
T ss_pred             EcCcCCcccccc---CCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehh
Confidence            999999999999   678899999999998764332   3345679999999999999999999999996

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.8e-42  Score=242.67  Aligned_cols=147  Identities=29%  Similarity=0.511  Sum_probs=133.6

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ....+.+.+|+.+++.++||||+++++++.+++.+|++|||++||+|.+++. ..+.+++..+..++.||+.|+.|||++
T Consensus        64 ~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~  143 (350)
T d1koaa2          64 ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN  143 (350)
T ss_dssp             HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc
Confidence            4456789999999999999999999999999999999999999999999885 445799999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |++||||||+||++.. +..+.+||+|||++.............||+.|+|||++.+..|+.++|||||
T Consensus       144 ~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSl  211 (350)
T d1koaa2         144 NYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSV  211 (350)
T ss_dssp             TEECCCCCGGGEEESS-TTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHH
T ss_pred             CCeeeeechhHeeecc-CCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhh
Confidence            9999999999999952 2357899999999988777666777889999999999999999999999996

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-42  Score=237.95  Aligned_cols=145  Identities=34%  Similarity=0.556  Sum_probs=128.1

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ....+.+.+|+++++.++||||+++++++.+++.+|++|||+++|+|.+++.+ .+.+++..+..++.|++.|+.|||++
T Consensus        50 ~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~  129 (288)
T d2jfla1          50 EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN  129 (288)
T ss_dssp             SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            45567899999999999999999999999999999999999999999998765 45699999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCccccc-----ccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Diwsl  154 (154)
                      |++||||||+||++   +.++.+||+|||+|...... .......||+.|+|||++.     +..|+.++|||||
T Consensus       130 ~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSl  201 (288)
T d2jfla1         130 KIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSL  201 (288)
T ss_dssp             TEECCCCSGGGEEE---CTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHH
T ss_pred             CEEEeecChhheeE---CCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHH
Confidence            99999999999999   67789999999998765332 2334578999999999984     4568999999996

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-41  Score=233.05  Aligned_cols=146  Identities=30%  Similarity=0.576  Sum_probs=133.3

Q ss_pred             hHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 031702            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII   88 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~   88 (154)
                      ..+.+.+|+.++++++||||+++++++.+++.+|++|||+++|+|.+++...+.+++..++.+++|++.|++|||+.+++
T Consensus        56 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~iv  135 (293)
T d1jksa_          56 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIA  135 (293)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhccee
Confidence            35789999999999999999999999999999999999999999999999888999999999999999999999999999


Q ss_pred             eecCCCCcEEeecCC-CCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           89 HRDLKPENILLSGLD-DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        89 h~~i~p~nil~~~~~-~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ||||||+||++...+ ....+|++|||++.............||+.|+|||++.+..|+.++|||||
T Consensus       136 HrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSl  202 (293)
T d1jksa_         136 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSI  202 (293)
T ss_dssp             CCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             ecccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhh
Confidence            999999999995322 233699999999988776666667789999999999998899999999996

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.3e-41  Score=235.30  Aligned_cols=142  Identities=32%  Similarity=0.524  Sum_probs=127.8

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ....+.+.+|+.++++++||||+++++++.+++.+|++|||+.+|++..+...++.+++..+..++.|++.|+.|||++|
T Consensus        56 ~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~  135 (309)
T d1u5ra_          56 NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN  135 (309)
T ss_dssp             HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            34456799999999999999999999999999999999999999999888887888999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc---cCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---QRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Diwsl  154 (154)
                      ++||||||+||++   +..+.+||+|||+|.....   .....||+.|+|||++.+   +.|+.++|||||
T Consensus       136 iiHrDiKp~NILl---~~~~~~Kl~DFG~a~~~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSl  200 (309)
T d1u5ra_         136 MIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL  200 (309)
T ss_dssp             CBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHH
T ss_pred             EeccCCCcceEEE---CCCCCEEEeecccccccCC---CCccccCccccCHHHHhccCCCCcCchhhhhhH
Confidence            9999999999999   5778999999999976543   344679999999999863   468999999996

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-41  Score=235.33  Aligned_cols=150  Identities=26%  Similarity=0.434  Sum_probs=131.6

Q ss_pred             hhhhh--hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHHHHH
Q 031702            2 LKKLN--KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGA   77 (154)
Q Consensus         2 ~k~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~   77 (154)
                      +|.++  ....+.+.+|+.++++++||||+++++++.+++..+++|||+++|+|.+++...  ..+++..+..++.|++.
T Consensus        47 vK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~  126 (287)
T d1opja_          47 VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS  126 (287)
T ss_dssp             EEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHH
T ss_pred             EEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHH
Confidence            45443  234678999999999999999999999999999999999999999999998754  46899999999999999


Q ss_pred             HHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--cccccCCccccCcccccccCCCcccceecC
Q 031702           78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        78 ~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |++|||+++++||||||+||++   +..+.+||+|||+|+.......  .....|++.|+|||++.++.|+.++|||||
T Consensus       127 gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~  202 (287)
T d1opja_         127 AMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF  202 (287)
T ss_dssp             HHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHH
T ss_pred             HHHHHHHCCcccCccccCeEEE---CCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhH
Confidence            9999999999999999999999   6788999999999987654432  233457888999999999999999999996

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7e-41  Score=234.32  Aligned_cols=142  Identities=37%  Similarity=0.626  Sum_probs=131.4

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++||||+++++++.+++.+|++|||++||+|.+++.....+++..++.++.|++.|++|||++|+
T Consensus        46 ~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i  125 (316)
T d1fota_          46 KQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI  125 (316)
T ss_dssp             TCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred             HHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcE
Confidence            34578899999999999999999999999999999999999999999999988999999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +||||||+||++   +..+.+||+|||+|......  ..+.+||+.|+|||++.+..|+.++|||||
T Consensus       126 iHrDiKp~NILl---~~~g~vkL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSl  187 (316)
T d1fota_         126 IYRDLKPENILL---DKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSF  187 (316)
T ss_dssp             ECCCCCGGGEEE---CTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHH
T ss_pred             EccccCchheeE---cCCCCEEEecCccceEeccc--cccccCcccccCHHHHcCCCCCchhhcccc
Confidence            999999999999   67889999999999876443  345789999999999999999999999996

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-41  Score=232.63  Aligned_cols=146  Identities=33%  Similarity=0.633  Sum_probs=117.6

Q ss_pred             hhhhHHhHHHHHHHHhhCCCCccchhhhheec--CCcEEEEEEecCCCCchHHHHH----cCCCCHHHHHHHHHHHHHHH
Q 031702            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGL   79 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l   79 (154)
                      ++...+.+.+|++++++++||||+++++++.+  ++.+|++|||+++|+|.+++.+    +..+++..++.++.|++.|+
T Consensus        43 ~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al  122 (269)
T d2java1          43 TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL  122 (269)
T ss_dssp             CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHH
Confidence            45556789999999999999999999999864  4668999999999999998853    35699999999999999999


Q ss_pred             HHHHhCC-----ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccCCCcccceec
Q 031702           80 EILNSHH-----IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFV  153 (154)
Q Consensus        80 ~~lh~~~-----~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diws  153 (154)
                      .|||+++     ++||||||+||++   +..+.+||+|||++....... ......||+.|+|||++.+..|+.++||||
T Consensus       123 ~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwS  199 (269)
T d2java1         123 KECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWS  199 (269)
T ss_dssp             HHHHHHCC---------CCGGGEEE---CTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHH
T ss_pred             HHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHh
Confidence            9999976     9999999999999   677899999999998765433 345678999999999999999999999999


Q ss_pred             C
Q 031702          154 S  154 (154)
Q Consensus       154 l  154 (154)
                      |
T Consensus       200 l  200 (269)
T d2java1         200 L  200 (269)
T ss_dssp             H
T ss_pred             h
Confidence            6

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.9e-41  Score=239.27  Aligned_cols=146  Identities=27%  Similarity=0.497  Sum_probs=132.7

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.+.+|+.++++++||||++++++|.+++.+|++|||++||+|.+++... .++++..++.++.||+.|+.|||++|
T Consensus        68 ~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~  147 (352)
T d1koba_          68 LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS  147 (352)
T ss_dssp             HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            44678889999999999999999999999999999999999999999877544 46999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++||||||+||++.. ...+.+||+|||+|.............||+.|+|||++.+..|+.++|||||
T Consensus       148 iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  214 (352)
T d1koba_         148 IVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAI  214 (352)
T ss_dssp             EECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHH
T ss_pred             eeecccccccccccc-cCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHH
Confidence            999999999999942 2467899999999998877777777889999999999999999999999996

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-41  Score=231.60  Aligned_cols=150  Identities=25%  Similarity=0.462  Sum_probs=122.7

Q ss_pred             hhhhh--hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHH
Q 031702            2 LKKLN--KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAG   78 (154)
Q Consensus         2 ~k~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~   78 (154)
                      +|.++  ....+.+.+|++++++++||||+++++++.+++..+++|||+++|+|.+++... ..+++..+..++.|++.|
T Consensus        34 vK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~g  113 (263)
T d1sm2a_          34 IKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG  113 (263)
T ss_dssp             EEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHH
T ss_pred             EEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHH
Confidence            44443  234578999999999999999999999999999999999999999999998655 458899999999999999


Q ss_pred             HHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--cccccCCccccCcccccccCCCcccceecC
Q 031702           79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        79 l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +.|||+++++||||||+||++   +.++.+||+|||+++.......  .....||+.|+|||++.+..|+.++|||||
T Consensus       114 l~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~  188 (263)
T d1sm2a_         114 MAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF  188 (263)
T ss_dssp             HHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHH
T ss_pred             HHhhhccceeecccchhheee---cCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcch
Confidence            999999999999999999999   7788999999999976654332  234568899999999999999999999996

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.2e-41  Score=234.54  Aligned_cols=145  Identities=24%  Similarity=0.443  Sum_probs=120.2

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ....+.|.+|+.++++++||||+++++++.+++.++++|||+++|+|.+++... +.+++.++..++.|++.|+.|||++
T Consensus        68 ~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~  147 (299)
T d1jpaa_          68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM  147 (299)
T ss_dssp             HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence            455678999999999999999999999999999999999999999999988764 4699999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCcc------ccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA------EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++||||||+||++   +.++.+||+|||+++........      ....+|+.|+|||++.++.|+.++|||||
T Consensus       148 ~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~  219 (299)
T d1jpaa_         148 NYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSY  219 (299)
T ss_dssp             TCCCSCCCGGGEEE---CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHH
T ss_pred             CCccCccccceEEE---CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccc
Confidence            99999999999999   78889999999999876543221      22456888999999999999999999996

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-41  Score=231.94  Aligned_cols=144  Identities=27%  Similarity=0.460  Sum_probs=126.7

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      +...+.+.+|+.++++++||||+++++++.++ ..++||||+++|+|.+++.+...+++..+..++.|++.|++|||+++
T Consensus        49 ~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~  127 (277)
T d1xbba_          49 PALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN  127 (277)
T ss_dssp             CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC
Confidence            34467899999999999999999999998654 57899999999999999998889999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC----ccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++||||||+||++   +..+.+|++|||+++......    ......||+.|+|||++.+..++.++|||||
T Consensus       128 iiHrDlKp~Nill---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~  196 (277)
T d1xbba_         128 FVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSF  196 (277)
T ss_dssp             EECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred             cccCCCcchhhcc---cccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccc
Confidence            9999999999999   577899999999998764432    2233568899999999999999999999996

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-41  Score=230.44  Aligned_cols=144  Identities=28%  Similarity=0.469  Sum_probs=121.6

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      +...+.|.+|+.++++++||||+++++++.+ +.++++|||+++|+|.+++... ..+++..+..++.|++.|++|||++
T Consensus        45 ~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~  123 (276)
T d1uwha_          45 PQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK  123 (276)
T ss_dssp             TTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence            4567889999999999999999999997654 5689999999999999999754 5699999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccc---cCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQF---QRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~---~~~~~~~Diwsl  154 (154)
                      +++||||||+||++   +..+.+||+|||+|.......   ......||+.|+|||++.+   +.|+.++|||||
T Consensus       124 ~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~  195 (276)
T d1uwha_         124 SIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAF  195 (276)
T ss_dssp             TCCCSCCCGGGEEE---ETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHH
T ss_pred             CEeccccCHHHEEE---cCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhh
Confidence            99999999999999   677899999999997654322   3345678999999999864   358999999996

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-41  Score=236.03  Aligned_cols=151  Identities=30%  Similarity=0.560  Sum_probs=132.1

Q ss_pred             hhhhhhhhHHhHHHHHHHHhhC-CCCccchhhhheec----CCcEEEEEEecCCCCchHHHHHc--CCCCHHHHHHHHHH
Q 031702            2 LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQ   74 (154)
Q Consensus         2 ~k~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~   74 (154)
                      +|.++.  .+.+.+|+.++.++ +||||++++++|.+    .+.+|++|||++||+|.+++.+.  ..+++..++.+++|
T Consensus        42 iK~i~~--~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~q  119 (335)
T d2ozaa1          42 LKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS  119 (335)
T ss_dssp             EEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHH
T ss_pred             EEEECC--cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHH
Confidence            455443  35678899987655 89999999999865    46799999999999999999764  36999999999999


Q ss_pred             HHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        75 i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++.|++|||++|++||||||+||++...+..+.+||+|||+|.............||+.|+|||++.+..|+.++|||||
T Consensus       120 i~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSl  199 (335)
T d2ozaa1         120 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL  199 (335)
T ss_dssp             HHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHH
T ss_pred             HHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhh
Confidence            99999999999999999999999997555677899999999988777777777889999999999999999999999996

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.5e-40  Score=232.55  Aligned_cols=142  Identities=31%  Similarity=0.545  Sum_probs=131.3

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.+++.++||||+++++++.+....++++||+.+|+|.+++.+.+.+++..++.++.||+.|+.|||++++
T Consensus        83 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~i  162 (350)
T d1rdqe_          83 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL  162 (350)
T ss_dssp             TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            33567899999999999999999999999999999999999999999999988999999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +||||||+||++   +..+.+||+|||+|+.....  .....||+.|+|||++.+..|+.++|||||
T Consensus       163 iHRDIKP~NILl---~~~g~ikL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSl  224 (350)
T d1rdqe_         163 IYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWAL  224 (350)
T ss_dssp             ECCCCSGGGEEE---CTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             ecCcCCHHHccc---CCCCCEEeeeceeeeecccc--cccccCccccCCHHHHcCCCCCccccccch
Confidence            999999999999   67789999999999876443  345789999999999999999999999996

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-40  Score=233.26  Aligned_cols=145  Identities=28%  Similarity=0.453  Sum_probs=127.0

Q ss_pred             hhhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-----------------------C
Q 031702            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------------------R   62 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-----------------------~   62 (154)
                      ....+.+.+|+.+++++ +||||+++++++.+.+.+|++|||+++|+|.+++.+..                       .
T Consensus        81 ~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (325)
T d1rjba_          81 SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV  160 (325)
T ss_dssp             ---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------
T ss_pred             HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCC
Confidence            44567789999999998 89999999999999999999999999999999997542                       3


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCccc
Q 031702           63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEV  139 (154)
Q Consensus        63 ~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~  139 (154)
                      +++..++.++.|++.|++|||+++++||||||+||++   +..+.+||+|||+|+.......   ..+..||+.|+|||+
T Consensus       161 l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~  237 (325)
T d1rjba_         161 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES  237 (325)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcccc---ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHH
Confidence            7889999999999999999999999999999999999   6788999999999976544332   234567999999999


Q ss_pred             ccccCCCcccceecC
Q 031702          140 LQFQRYDEKVNFFVS  154 (154)
Q Consensus       140 ~~~~~~~~~~Diwsl  154 (154)
                      +.++.|+.++|||||
T Consensus       238 l~~~~~~~~~DiwS~  252 (325)
T d1rjba_         238 LFEGIYTIKSDVWSY  252 (325)
T ss_dssp             HHHCCCCHHHHHHHH
T ss_pred             HcCCCCCcceeccch
Confidence            999999999999996

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-40  Score=228.82  Aligned_cols=144  Identities=26%  Similarity=0.472  Sum_probs=126.6

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ....+.|.+|++++++++||||+++++++.+ +.+|+||||+++|+|.+++.. ...+++..+..++.|++.|++|||++
T Consensus        50 ~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~  128 (285)
T d1u59a_          50 KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK  128 (285)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4556789999999999999999999999865 458999999999999998754 35799999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC----ccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++||||||+||++   +..+.+||+|||+++......    ......||+.|+|||++.++.++.++|||||
T Consensus       129 ~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~  198 (285)
T d1u59a_         129 NFVHRDLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSY  198 (285)
T ss_dssp             TEECCCCSGGGEEE---EETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred             CeecCcCchhheee---ccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcc
Confidence            99999999999999   567799999999998765433    2234567889999999998999999999996

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-40  Score=231.23  Aligned_cols=146  Identities=26%  Similarity=0.453  Sum_probs=132.0

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      .....+.+|+++++.++||||+++++++.+++.+|+||||++||+|.+++...+ .+++.++..++.|++.|++|||+.|
T Consensus        43 ~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~  122 (321)
T d1tkia_          43 TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN  122 (321)
T ss_dssp             HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence            345678899999999999999999999999999999999999999999997655 7999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++||||||+||++.. +....+|++|||++.............+++.|+|||...+..|+.++|||||
T Consensus       123 iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSl  189 (321)
T d1tkia_         123 IGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSL  189 (321)
T ss_dssp             EECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHH
T ss_pred             CCcccccccceeecC-CCceEEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhcccH
Confidence            999999999999942 2456899999999988766666667789999999999999999999999996

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-39  Score=228.11  Aligned_cols=143  Identities=35%  Similarity=0.573  Sum_probs=128.6

Q ss_pred             hHHhHHHHHHHHh-hCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+..|..++. .++||||+++++++.+++.+|+||||+++|+|.+++.....+++..++.++.|++.|++|||++++
T Consensus        45 ~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~i  124 (320)
T d1xjda_          45 DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI  124 (320)
T ss_dssp             CHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            3455667777665 689999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCcccccccCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +||||||+||++   +..+.+||+|||++...... .......||+.|+|||++.+..|+.++|||||
T Consensus       125 iHrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  189 (320)
T d1xjda_         125 VYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSF  189 (320)
T ss_dssp             BCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             eeccCcccceee---cCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhh
Confidence            999999999999   77889999999999865543 34455789999999999999999999999996

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-40  Score=227.20  Aligned_cols=149  Identities=23%  Similarity=0.437  Sum_probs=128.0

Q ss_pred             hhhhh--hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH--cCCCCHHHHHHHHHHHHH
Q 031702            2 LKKLN--KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGA   77 (154)
Q Consensus         2 ~k~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~   77 (154)
                      +|.++  ....+.|.+|+.++++++||||+++++++.+ +..+++|||+++|+|.+++..  ...+++..+..++.|++.
T Consensus        42 vK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~  120 (272)
T d1qpca_          42 VKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE  120 (272)
T ss_dssp             EEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHH
T ss_pred             EEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHH
Confidence            45543  2346789999999999999999999998755 457999999999999987643  336999999999999999


Q ss_pred             HHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCcccccccCCCcccceecC
Q 031702           78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        78 ~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+.|||+++++||||||+||++   +..+.+||+|||+|+......  ......||+.|+|||++.++.|+.++|||||
T Consensus       121 gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~  196 (272)
T d1qpca_         121 GMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF  196 (272)
T ss_dssp             HHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHH
T ss_pred             HHHHHHhCCcccCccchhheee---ecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhh
Confidence            9999999999999999999999   778899999999998765543  2344668899999999998899999999996

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.5e-39  Score=222.70  Aligned_cols=143  Identities=39%  Similarity=0.740  Sum_probs=131.2

Q ss_pred             hHHhHHHHHHHHhhCC-CCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+.++++++ ||||+++++++.+++.+|++|||+++|+|.+++..++.+++..++.++.||+.|++|||++|+
T Consensus        52 ~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~i  131 (277)
T d1phka_          52 LREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNI  131 (277)
T ss_dssp             HHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCC
Confidence            4567889999999996 999999999999999999999999999999999989999999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc------cCCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF------QRYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Diwsl  154 (154)
                      +||||||+||++   +.++.+||+|||++.............||+.|+|||.+.+      ..++.++|||||
T Consensus       132 vHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~Diwsl  201 (277)
T d1phka_         132 VHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST  201 (277)
T ss_dssp             ECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHH
T ss_pred             cccccccceEEE---cCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEccc
Confidence            999999999999   7888999999999988776656666789999999999863      246889999995

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-39  Score=224.19  Aligned_cols=145  Identities=23%  Similarity=0.406  Sum_probs=122.9

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      +...+.|.+|+.++++++||||+++++++.+++..++++||+.++++.+++... ..+++..+..++.|++.|++|||++
T Consensus        50 ~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~  129 (283)
T d1mqba_          50 EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM  129 (283)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc
Confidence            445667999999999999999999999999999999999999999999887655 5699999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC----ccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++||||||+||++   +.++.+||+|||+++......    ......||+.|+|||++.++.++.++|||||
T Consensus       130 ~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~  199 (283)
T d1mqba_         130 NYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSF  199 (283)
T ss_dssp             TCCCSCCCGGGEEE---CTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHH
T ss_pred             ccccCccccceEEE---CCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCccccccc
Confidence            99999999999999   788899999999998754432    2233467889999999999999999999996

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-39  Score=221.86  Aligned_cols=150  Identities=24%  Similarity=0.447  Sum_probs=131.3

Q ss_pred             hhhhh--hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHH
Q 031702            2 LKKLN--KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAG   78 (154)
Q Consensus         2 ~k~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~   78 (154)
                      +|.++  ....+.+.+|+.++++++||||+++++++.+++.++++|||+++|+|.+++.. ...+++..+..++.|+++|
T Consensus        33 vK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~g  112 (258)
T d1k2pa_          33 IKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA  112 (258)
T ss_dssp             EEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHH
T ss_pred             EEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHH
Confidence            44443  34467899999999999999999999999999999999999999999998654 4568999999999999999


Q ss_pred             HHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc--cccccCCccccCcccccccCCCcccceecC
Q 031702           79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        79 l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++|||+.|++|+||||+||++   +..+.+||+|||+++.......  .....+|+.|+|||.+.++.|+.++|||||
T Consensus       113 l~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~  187 (258)
T d1k2pa_         113 MEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF  187 (258)
T ss_dssp             HHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHhhcCcccccccceeEEE---cCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeeccc
Confidence            999999999999999999999   6788999999999976654432  234567889999999999999999999996

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=9.8e-39  Score=227.16  Aligned_cols=136  Identities=32%  Similarity=0.547  Sum_probs=123.2

Q ss_pred             HHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCC
Q 031702           15 CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKP   94 (154)
Q Consensus        15 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p   94 (154)
                      +|+.+++.++||||+++++++.+++.+|+||||++||+|.+++.++..+++..++.++.||+.|+.|||+++++||||||
T Consensus        56 ~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP  135 (364)
T d1omwa3          56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKP  135 (364)
T ss_dssp             HHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             HHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeecc
Confidence            34677788899999999999999999999999999999999999899999999999999999999999999999999999


Q ss_pred             CcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc-cCCCcccceecC
Q 031702           95 ENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        95 ~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      +||++   +..+.+||+|||+|+..... ......||+.|+|||++.. ..|+.++|||||
T Consensus       136 ~NILl---~~~g~iKl~DFGla~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSl  192 (364)
T d1omwa3         136 ANILL---DEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSL  192 (364)
T ss_dssp             GGEEE---CSSSCEEECCCTTCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHH
T ss_pred             ceeEE---cCCCcEEEeeeceeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHH
Confidence            99999   77889999999999866543 3445689999999999874 568999999996

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.6e-39  Score=222.80  Aligned_cols=145  Identities=23%  Similarity=0.434  Sum_probs=121.6

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCC----cEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL   82 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~l   82 (154)
                      ....+.+.+|+.+++.++||||+++++++...+    .+|++|||++|++|.+++...+.+++..+..++.|++.|++||
T Consensus        48 ~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~l  127 (277)
T d1o6ya_          48 PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS  127 (277)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence            345678999999999999999999999997653    4899999999999999999889999999999999999999999


Q ss_pred             HhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCC----CccccccCCccccCcccccccCCCcccceecC
Q 031702           83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        83 h~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |++|++||||||+||++   +..+..+++|||.+......    .......||+.|+|||++.+..|+.++|||||
T Consensus       128 H~~~iiHrDiKP~NIll---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSl  200 (277)
T d1o6ya_         128 HQNGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL  200 (277)
T ss_dssp             HHTTEECCCCSGGGEEE---ETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHH
T ss_pred             HhCCccCccccCccccc---CccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccc
Confidence            99999999999999999   57788999999988654332    23445679999999999999999999999996

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-39  Score=222.28  Aligned_cols=149  Identities=20%  Similarity=0.382  Sum_probs=122.7

Q ss_pred             hhhhhh--hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHH--cCCCCHHHHHHHHHHHHH
Q 031702            2 LKKLNK--HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGA   77 (154)
Q Consensus         2 ~k~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~   77 (154)
                      +|.++.  ...+.|.+|+.++++++||||+++++++.+ +..+++|||+++|+|..++..  .+.+++..++.++.|++.
T Consensus        46 iK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~  124 (285)
T d1fmka3          46 IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS  124 (285)
T ss_dssp             EEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHH
T ss_pred             EEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHH
Confidence            455442  335789999999999999999999999865 457899999999999988743  356999999999999999


Q ss_pred             HHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCcccccccCCCcccceecC
Q 031702           78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        78 ~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |++|||+++++||||||+||++   +.++.+||+|||+++......  ......||+.|+|||++..+.++.++|||||
T Consensus       125 gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~  200 (285)
T d1fmka3         125 GMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF  200 (285)
T ss_dssp             HHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHHhhhheecccccceEEEE---CCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcc
Confidence            9999999999999999999999   677899999999998664433  2334668999999999999999999999996

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-39  Score=224.37  Aligned_cols=142  Identities=32%  Similarity=0.449  Sum_probs=126.1

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (154)
                      .+.+.+|+.+++.++||||+++++++.+++.+|++|||+.++++..+......+++..+..+++|++.|++|||++|++|
T Consensus        44 ~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiH  123 (299)
T d1ua2a_          44 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH  123 (299)
T ss_dssp             CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceec
Confidence            35688999999999999999999999999999999999988877776666677999999999999999999999999999


Q ss_pred             ecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCccccccc-CCCcccceecC
Q 031702           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        90 ~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      |||||+||++   +..+.+||+|||++....... ......||+.|+|||++.+. .|+.++|||||
T Consensus       124 rDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  187 (299)
T d1ua2a_         124 RDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAV  187 (299)
T ss_dssp             CCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHH
T ss_pred             ccCCcceEEe---cCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhc
Confidence            9999999999   788899999999997765433 34556789999999998654 57999999996

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-38  Score=222.57  Aligned_cols=145  Identities=29%  Similarity=0.449  Sum_probs=126.5

Q ss_pred             hhhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc----------------CCCCHHHHH
Q 031702            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTAR   69 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----------------~~~~~~~~~   69 (154)
                      ....+.+.+|+.+++++ +||||+++++++.+++..++||||+++|+|.+++...                ..+++..+.
T Consensus        51 ~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~  130 (309)
T d1fvra_          51 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL  130 (309)
T ss_dssp             ----CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHH
T ss_pred             hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHH
Confidence            34567899999999999 7999999999999999999999999999999998644                468999999


Q ss_pred             HHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCccc
Q 031702           70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV  149 (154)
Q Consensus        70 ~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  149 (154)
                      .++.|++.|+.|+|+++++||||||+||++   +..+.+||+|||++.............||..|+|||.+.++.|+.++
T Consensus       131 ~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~s  207 (309)
T d1fvra_         131 HFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS  207 (309)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHH
T ss_pred             HHHHHHHHHHHhhhcCCccccccccceEEE---cCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccc
Confidence            999999999999999999999999999999   67889999999999766555455566789999999999999999999


Q ss_pred             ceecC
Q 031702          150 NFFVS  154 (154)
Q Consensus       150 Diwsl  154 (154)
                      |||||
T Consensus       208 DvwSf  212 (309)
T d1fvra_         208 DVWSY  212 (309)
T ss_dssp             HHHHH
T ss_pred             eeehh
Confidence            99996

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-38  Score=217.38  Aligned_cols=144  Identities=25%  Similarity=0.461  Sum_probs=116.4

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      +...+.+.+|+.++++++||||+++++++. .+.+|++|||+++|++.+++... ..+++..+..++.|++.|+.|||++
T Consensus        49 ~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~  127 (273)
T d1mp8a_          49 DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK  127 (273)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc
Confidence            455678999999999999999999999986 46789999999999999987654 4699999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--ccccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++||||||+||++   +..+.+||+|||+++......  ......||+.|+|||++.+..|+.++|||||
T Consensus       128 ~iiHrDlKp~NIll---~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSl  195 (273)
T d1mp8a_         128 RFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF  195 (273)
T ss_dssp             TCCCSCCSGGGEEE---EETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHH
T ss_pred             Ceeccccchhheee---cCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccc
Confidence            99999999999999   567789999999998654332  2334567899999999999999999999996

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.8e-38  Score=217.65  Aligned_cols=144  Identities=24%  Similarity=0.483  Sum_probs=127.0

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC------------------------CC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------------------RV   63 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~------------------------~~   63 (154)
                      ...+.+.+|+.++++++|||++++++++.+.+..++++||+++|+|.+++....                        .+
T Consensus        58 ~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  137 (301)
T d1lufa_          58 DMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL  137 (301)
T ss_dssp             HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCC
T ss_pred             HHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCC
Confidence            456789999999999999999999999999999999999999999999986432                        37


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccc
Q 031702           64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVL  140 (154)
Q Consensus        64 ~~~~~~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~  140 (154)
                      ++..+..++.|++.|++|||+++++||||||+||++   +..+.+||+|||++....+..   ...+..+++.|+|||.+
T Consensus       138 ~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILl---d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~  214 (301)
T d1lufa_         138 SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI  214 (301)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH
T ss_pred             CHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEE---CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHH
Confidence            888999999999999999999999999999999999   778899999999997654432   23346788899999999


Q ss_pred             cccCCCcccceecC
Q 031702          141 QFQRYDEKVNFFVS  154 (154)
Q Consensus       141 ~~~~~~~~~Diwsl  154 (154)
                      .+..||.++|||||
T Consensus       215 ~~~~~t~ksDVwS~  228 (301)
T d1lufa_         215 FYNRYTTESDVWAY  228 (301)
T ss_dssp             HHCCCCHHHHHHHH
T ss_pred             ccCCCChhhhhccc
Confidence            99999999999996

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-37  Score=218.42  Aligned_cols=144  Identities=24%  Similarity=0.364  Sum_probs=122.9

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ....+.+.+|+.++++++||||+++++++.+++ .++++|++.+++|.+++... ..+++..+..++.|++.|+.|||++
T Consensus        52 ~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~  130 (317)
T d1xkka_          52 PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR  130 (317)
T ss_dssp             -CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc
Confidence            345678999999999999999999999998754 67778889899999887654 5699999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc---cccccCCccccCcccccccCCCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +++||||||+||++   +..+.+||+|||++........   .....||+.|+|||++.++.|+.++|||||
T Consensus       131 ~iiHrDlKp~NIll---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~  199 (317)
T d1xkka_         131 RLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY  199 (317)
T ss_dssp             TCCCSCCCGGGEEE---EETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHH
T ss_pred             CcccCcchhhccee---CCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhH
Confidence            99999999999999   5778999999999987654332   233467899999999999999999999996

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-38  Score=216.55  Aligned_cols=148  Identities=23%  Similarity=0.439  Sum_probs=120.2

Q ss_pred             hhhhh-hhhHHhHHHHHHHHhhCCCCccchhhhheec-CCcEEEEEEecCCCCchHHHHHcC--CCCHHHHHHHHHHHHH
Q 031702            2 LKKLN-KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGA   77 (154)
Q Consensus         2 ~k~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~   77 (154)
                      +|.++ +...+.+.+|+.++++++||||+++++++.+ ++.+|++|||+++|+|.+++.+..  .+++..++.++.|++.
T Consensus        35 vK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~  114 (262)
T d1byga_          35 VKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE  114 (262)
T ss_dssp             EEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred             EEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHh
Confidence            45553 3456789999999999999999999998854 467899999999999999986543  4899999999999999


Q ss_pred             HHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        78 ~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+.|||+.+++|+||+|+||++   +..+.+|++|||++......  .....++..|+|||++.++.++.++|||||
T Consensus       115 al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSf  186 (262)
T d1byga_         115 AMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSF  186 (262)
T ss_dssp             HHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHH
T ss_pred             hccccccCceeccccchHhhee---cCCCCEeecccccceecCCC--CccccccccCCChHHHhCCCCChHHHHHhH
Confidence            9999999999999999999999   77889999999998764332  334567889999999999999999999996

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-37  Score=214.47  Aligned_cols=144  Identities=31%  Similarity=0.474  Sum_probs=118.4

Q ss_pred             hhHHhHHHHHHHHhhC-CCCccchhhhheecC-CcEEEEEEecCCCCchHHHHHc----------------CCCCHHHHH
Q 031702            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTAR   69 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~----------------~~~~~~~~~   69 (154)
                      ...+.+.+|..++.++ +|+||+++++++.+. +.++++|||+++|+|.+++...                ..+++..+.
T Consensus        58 ~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~  137 (299)
T d1ywna1          58 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI  137 (299)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHH
T ss_pred             HHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHH
Confidence            4456778888888887 789999999987654 5689999999999999999653                237899999


Q ss_pred             HHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCCC
Q 031702           70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYD  146 (154)
Q Consensus        70 ~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~  146 (154)
                      .++.|++.|+.|||+++++||||||+||++   +..+.+||+|||+|+......   ......||+.|+|||++.++.++
T Consensus       138 ~~~~qi~~gl~ylH~~~ivHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~  214 (299)
T d1ywna1         138 CYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT  214 (299)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHhCCCcCCcCCccceeE---CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC
Confidence            999999999999999999999999999999   678899999999997654332   23446789999999999999999


Q ss_pred             cccceecC
Q 031702          147 EKVNFFVS  154 (154)
Q Consensus       147 ~~~Diwsl  154 (154)
                      .++|||||
T Consensus       215 ~~sDiwS~  222 (299)
T d1ywna1         215 IQSDVWSF  222 (299)
T ss_dssp             HHHHHHHH
T ss_pred             cccceeeh
Confidence            99999996

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-37  Score=213.74  Aligned_cols=145  Identities=28%  Similarity=0.448  Sum_probs=129.3

Q ss_pred             hhhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC----------------CCCHHHHH
Q 031702            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR   69 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----------------~~~~~~~~   69 (154)
                      ......+.+|...+.++ +||||+++++++.+++.++++|||+.+|+|.+++....                .+++..++
T Consensus        59 ~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~  138 (299)
T d1fgka_          59 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV  138 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHH
T ss_pred             hHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHH
Confidence            45567888899999888 89999999999999999999999999999999996442                48999999


Q ss_pred             HHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCCC
Q 031702           70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYD  146 (154)
Q Consensus        70 ~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~  146 (154)
                      .++.|++.|++|||+.+++||||||+||++   +.++.+||+|||++.......   ......+++.|+|||.+.++.|+
T Consensus       139 ~~~~qi~~al~ylH~~~ivHrDiKp~NiLl---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~  215 (299)
T d1fgka_         139 SCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT  215 (299)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHhhhCCEEeeeecccceee---cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC
Confidence            999999999999999999999999999999   778899999999998664432   33446788999999999999999


Q ss_pred             cccceecC
Q 031702          147 EKVNFFVS  154 (154)
Q Consensus       147 ~~~Diwsl  154 (154)
                      .++|||||
T Consensus       216 ~k~DiwS~  223 (299)
T d1fgka_         216 HQSDVWSF  223 (299)
T ss_dssp             HHHHHHHH
T ss_pred             chhhhHHh
Confidence            99999996

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-36  Score=212.30  Aligned_cols=146  Identities=26%  Similarity=0.392  Sum_probs=127.5

Q ss_pred             hhhhHHhHHHHHHHHhhCCCCccchhhhheec-CCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH
Q 031702            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILN   83 (154)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh   83 (154)
                      +....+.|.+|++++++++||||+++++++.+ ++..+++|||+++++|.+++.... ..++..+..++.|++.|+.|+|
T Consensus        68 ~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH  147 (311)
T d1r0pa_          68 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA  147 (311)
T ss_dssp             CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc
Confidence            34566889999999999999999999999865 567999999999999999887443 5778889999999999999999


Q ss_pred             hCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-----ccccccCCccccCcccccccCCCcccceecC
Q 031702           84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        84 ~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +.+++||||||+||++   +..+.+||+|||++.......     ......||+.|+|||.+..+.++.++|||||
T Consensus       148 ~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~Sf  220 (311)
T d1r0pa_         148 SKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF  220 (311)
T ss_dssp             HTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred             ccCcccCCccHHhEeE---CCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhh
Confidence            9999999999999999   778899999999998764432     2223567889999999999999999999996

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.1e-36  Score=214.09  Aligned_cols=149  Identities=24%  Similarity=0.390  Sum_probs=130.0

Q ss_pred             ChhhhhhhhHHhHHHHHHHHhhC-CCCccchhhhheec--CCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHH
Q 031702            1 MLKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGA   77 (154)
Q Consensus         1 ~~k~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~   77 (154)
                      |+|.++....+.+.+|+++|+.+ .||||+++++++..  ...++++|||+.+++|.++   .+.+++..++.+++||+.
T Consensus        64 AiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~  140 (328)
T d3bqca1          64 VVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILK  140 (328)
T ss_dssp             EEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHH
T ss_pred             EEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHH
Confidence            46777777778899999999999 59999999999874  4579999999999999876   356999999999999999


Q ss_pred             HHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCccccccc-CCCcccceecC
Q 031702           78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        78 ~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      ||.|||++|++||||||+||++.  ..+..+|++|||+|.............+|+.|+|||.+.+. .++.++|||||
T Consensus       141 aL~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  216 (328)
T d3bqca1         141 ALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSL  216 (328)
T ss_dssp             HHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHH
T ss_pred             HHHHHhhcccccccccccceEEc--CCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhh
Confidence            99999999999999999999995  34557999999999887766666777889999999998765 57999999995

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-37  Score=211.08  Aligned_cols=143  Identities=28%  Similarity=0.407  Sum_probs=122.3

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ...+.|.+|+.++++++||||+++++++.++ ..++++||++++++.+++... +.+++..+..++.|++.|+.|||+++
T Consensus        53 ~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~  131 (273)
T d1u46a_          53 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR  131 (273)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC
Confidence            4457899999999999999999999999764 678999999999999877544 56999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCc----cccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++||||||+||++   +..+.+||+|||++........    .....++..|+|||++.+..++.++|||||
T Consensus       132 iiHrDikp~NIll---~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~  200 (273)
T d1u46a_         132 FIHRDLAARNLLL---ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMF  200 (273)
T ss_dssp             EECSCCCGGGEEE---EETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred             EeeeeecHHHhcc---ccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhh
Confidence            9999999999999   5677899999999987644332    233456788999999999999999999996

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-36  Score=211.76  Aligned_cols=143  Identities=32%  Similarity=0.540  Sum_probs=122.6

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHH-H-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-L-HGRVPEQTARKFLQQLGAGLEILNSH   85 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~-~-~~~~~~~~~~~~~~~i~~~l~~lh~~   85 (154)
                      ...+.+.+|++++++++||||+++++++.+++.+|++|||+.+ .+.+++. . ...+++..+..++.|++.|++|||++
T Consensus        43 ~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~  121 (298)
T d1gz8a_          43 GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH  121 (298)
T ss_dssp             -CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC
Confidence            3467889999999999999999999999999999999999965 4444443 2 34699999999999999999999999


Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccccCCC-CccccccCCccccCcccccccC-CCcccceecC
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  154 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diwsl  154 (154)
                      +++||||||+||++   +..+.+||+|||.|...... .......||+.|+|||+..... ++.++|||||
T Consensus       122 ~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSl  189 (298)
T d1gz8a_         122 RVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL  189 (298)
T ss_dssp             TCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHH
T ss_pred             CEEccccCchheee---cccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCcccccccc
Confidence            99999999999999   67789999999999776443 3455567999999999987665 4789999996

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-36  Score=211.87  Aligned_cols=145  Identities=28%  Similarity=0.414  Sum_probs=129.0

Q ss_pred             hhhHHhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcC------------------CCCHHH
Q 031702            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------------RVPEQT   67 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~------------------~~~~~~   67 (154)
                      ......+.+|+.+++.+ +||||+++++++.+++..+++|||+++|+|.+++....                  .+++..
T Consensus        67 ~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~  146 (311)
T d1t46a_          67 LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED  146 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHH
T ss_pred             HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHH
Confidence            34567899999999999 79999999999999999999999999999999987543                  488999


Q ss_pred             HHHHHHHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccC
Q 031702           68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQR  144 (154)
Q Consensus        68 ~~~~~~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~  144 (154)
                      +..++.||+.|++|||+++++||||||+||++   +..+.+|++|||.++......   ......||+.|+|||++.++.
T Consensus       147 ~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~---~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  223 (311)
T d1t46a_         147 LLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV  223 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC
T ss_pred             HHHHHHHHHHHHHHHHhCCeeecccccccccc---cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC
Confidence            99999999999999999999999999999999   678899999999998765432   234467899999999999999


Q ss_pred             CCcccceecC
Q 031702          145 YDEKVNFFVS  154 (154)
Q Consensus       145 ~~~~~Diwsl  154 (154)
                      ++.++|||||
T Consensus       224 ~~~~~DIwS~  233 (311)
T d1t46a_         224 YTFESDVWSY  233 (311)
T ss_dssp             CCHHHHHHHH
T ss_pred             CCCcccccch
Confidence            9999999996

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-36  Score=208.02  Aligned_cols=141  Identities=27%  Similarity=0.447  Sum_probs=123.3

Q ss_pred             HhHHHHHHHHhhCC--CCccchhhhheecCCcEEEEEEecCC-CCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702           11 SCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus        11 ~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+|+.++++++  ||||+++++++.+++..+++|||+.+ +++.+++.++..+++..++.++.|++.|++|||++++
T Consensus        52 ~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~i  131 (273)
T d1xwsa_          52 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGV  131 (273)
T ss_dssp             CEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            44678999999996  89999999999999999999999975 6788888888899999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCC-CcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Diwsl  154 (154)
                      +||||||+||++.  .+.+.+||+|||+|..... .......||+.|+|||++.+..+ +.++|||||
T Consensus       132 iHrDiKp~NIll~--~~~~~vkl~DFG~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSl  196 (273)
T d1xwsa_         132 LHRDIKDENILID--LNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL  196 (273)
T ss_dssp             ECSCCSGGGEEEE--TTTTEEEECCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHH
T ss_pred             ccccCcccceEEe--cCCCeEEECccccceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccc
Confidence            9999999999994  2457899999999976433 33455789999999999987765 567899996

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-36  Score=212.28  Aligned_cols=143  Identities=33%  Similarity=0.486  Sum_probs=122.5

Q ss_pred             hHHhHHHHHHHHhhC---CCCccchhhhheec-----CCcEEEEEEecCCCCchHHHHH-cCCCCHHHHHHHHHHHHHHH
Q 031702            9 LKSCLDCELNFLSSV---NHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGL   79 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l   79 (154)
                      ....+.+|+.+++.+   +||||+++++++..     ....++++|++.++++...... ...+++..++.++.|++.|+
T Consensus        50 ~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL  129 (305)
T d1blxa_          50 MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL  129 (305)
T ss_dssp             CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHH
Confidence            344677888887776   79999999999853     3568999999988766544433 34589999999999999999


Q ss_pred             HHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        80 ~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      +|||+++++||||||+||++   +..+.+||+|||++.............||+.|+|||++.+..|+.++|||||
T Consensus       130 ~yLH~~~ivHrDiKp~NILi---~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSl  201 (305)
T d1blxa_         130 DFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSV  201 (305)
T ss_dssp             HHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHH
T ss_pred             HHHHhCCEEecCCCccEEEE---cCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhch
Confidence            99999999999999999999   6788999999999887666666677889999999999999999999999996

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-36  Score=207.99  Aligned_cols=144  Identities=21%  Similarity=0.371  Sum_probs=127.4

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHc----------CCCCHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------GRVPEQTARKFLQQLGA   77 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~i~~   77 (154)
                      .....+.+|+.++++++||||+++++++..++..+++|||+++|+|.+++...          ..++...+..++.|++.
T Consensus        65 ~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~  144 (308)
T d1p4oa_          65 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD  144 (308)
T ss_dssp             HHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHH
Confidence            44567899999999999999999999999999999999999999999998543          23688999999999999


Q ss_pred             HHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC---ccccccCCccccCcccccccCCCcccceecC
Q 031702           78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        78 ~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |+.|||+++++||||||+||++   +....+||+|||++.......   ......+|+.|+|||.+.++.++.++|||||
T Consensus       145 gl~~LH~~~ivHrDlk~~NiLl---d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~  221 (308)
T d1p4oa_         145 GMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF  221 (308)
T ss_dssp             HHHHHHHTTCBCSCCSGGGEEE---CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHHhhCCeeeceEcCCceee---cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccH
Confidence            9999999999999999999999   788899999999997664432   2333467899999999999999999999996

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.6e-36  Score=209.62  Aligned_cols=144  Identities=28%  Similarity=0.427  Sum_probs=123.4

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ...+.+.+|+.++++++||||+++++++.+++..++++|++.++.+..+....+.+++..+..++.|++.|++|||+.++
T Consensus        42 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~I  121 (286)
T d1ob3a_          42 GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV  121 (286)
T ss_dssp             CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcE
Confidence            34678999999999999999999999999999999999999887777776767789999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCccccccc-CCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      +||||||+||++   +.++.+|++|||.+....... ......+++.|+|||.+.+. .++.++|||||
T Consensus       122 vHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~Diwsl  187 (286)
T d1ob3a_         122 LHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSV  187 (286)
T ss_dssp             CCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHH
T ss_pred             EecCCCCceeeE---cCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhc
Confidence            999999999999   678899999999997765433 34455688999999998754 56899999996

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-36  Score=209.36  Aligned_cols=150  Identities=26%  Similarity=0.349  Sum_probs=121.0

Q ss_pred             ChhhhhhhhHHhHHH--HHHHHhhCCCCccchhhhheecCC----cEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHH
Q 031702            1 MLKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ   74 (154)
Q Consensus         1 ~~k~~~~~~~~~~~~--e~~~l~~l~h~~i~~~~~~~~~~~----~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~   74 (154)
                      |+|.++....+.+.+  |+..+..++||||+++++++.+.+    .+|++|||+++|+|.+++++ ..+++.....++.|
T Consensus        30 AvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~  108 (303)
T d1vjya_          30 AVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALS  108 (303)
T ss_dssp             EEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHH
T ss_pred             EEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHH
Confidence            456665555555444  455556789999999999997553    58999999999999999975 46899999999999


Q ss_pred             HHHHHHHHHh--------CCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-----ccccccCCccccCccccc
Q 031702           75 LGAGLEILNS--------HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQ  141 (154)
Q Consensus        75 i~~~l~~lh~--------~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~  141 (154)
                      ++.|++|+|.        ++++||||||+||++   +..+.+||+|||++.......     ......||+.|+|||++.
T Consensus       109 ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  185 (303)
T d1vjya_         109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD  185 (303)
T ss_dssp             HHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHT
T ss_pred             HHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhcc
Confidence            9999999996        599999999999999   778899999999998764432     234467899999999987


Q ss_pred             cc------CCCcccceecC
Q 031702          142 FQ------RYDEKVNFFVS  154 (154)
Q Consensus       142 ~~------~~~~~~Diwsl  154 (154)
                      +.      .++.++|||||
T Consensus       186 ~~~~~~~~~~~~k~Di~S~  204 (303)
T d1vjya_         186 DSINMKHFESFKRADIYAM  204 (303)
T ss_dssp             TCSCTTCHHHHHHHHHHHH
T ss_pred             ccccccCCCcCcchhhhhh
Confidence            54      25778999996

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-36  Score=213.22  Aligned_cols=150  Identities=29%  Similarity=0.427  Sum_probs=122.1

Q ss_pred             hhhhhhhhHHhHHHHHHHHhhCCCCccchhhhheec------CCcEEEEEEecCCCCchHHH---HHcCCCCHHHHHHHH
Q 031702            2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL   72 (154)
Q Consensus         2 ~k~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~~v~e~~~~~~L~~~~---~~~~~~~~~~~~~~~   72 (154)
                      +|.+... .+.+.+|+.++++++||||++++++|..      ..++|++|||++++.+..+.   .....+++..++.++
T Consensus        50 iK~i~~~-~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~  128 (350)
T d1q5ka_          50 IKKVLQD-KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM  128 (350)
T ss_dssp             EEEEECC-SSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHH
T ss_pred             EEEECcc-chHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHH
Confidence            4544332 3345689999999999999999999843      34589999999765433332   344579999999999


Q ss_pred             HHHHHHHHHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccc-cCCCcccce
Q 031702           73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNF  151 (154)
Q Consensus        73 ~~i~~~l~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di  151 (154)
                      +|++.|++|||++|++||||||+||++.  .....+||+|||++..........+..|++.|+|||.+.+ ..|+.++||
T Consensus       129 ~qil~aL~yLH~~~IiHrDiKp~NILl~--~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DI  206 (350)
T d1q5ka_         129 YQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDV  206 (350)
T ss_dssp             HHHHHHHHHHHTTTEECCCCCGGGEEEC--TTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHH
T ss_pred             HHHHHHHHHHHhcCCcccCCCcceEEEe--cCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceee
Confidence            9999999999999999999999999993  2345899999999988777666777889999999999765 468999999


Q ss_pred             ecC
Q 031702          152 FVS  154 (154)
Q Consensus       152 wsl  154 (154)
                      |||
T Consensus       207 wSl  209 (350)
T d1q5ka_         207 WSA  209 (350)
T ss_dssp             HHH
T ss_pred             ccc
Confidence            996

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-35  Score=207.08  Aligned_cols=143  Identities=28%  Similarity=0.481  Sum_probs=120.4

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCC-----cEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~   81 (154)
                      ....+.+.+|+.+|+.++|||++++++++....     ..|++ +++.+++|.+++.. ..+++..++.++.|++.|++|
T Consensus        47 ~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~y  124 (345)
T d1pmea_          47 QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKY  124 (345)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHH
Confidence            345678899999999999999999999987653     34555 55668999999874 579999999999999999999


Q ss_pred             HHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC----ccccccCCccccCcccccc-cCCCcccceecC
Q 031702           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  154 (154)
Q Consensus        82 lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  154 (154)
                      ||++|++||||||+||++   +..+.+||+|||++.......    ......||+.|+|||++.. ..++.++||||+
T Consensus       125 LH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSl  199 (345)
T d1pmea_         125 IHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV  199 (345)
T ss_dssp             HHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHH
T ss_pred             HHHCCCcCCCCCcceEEE---CCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhcc
Confidence            999999999999999999   678899999999997654332    2345678999999999854 467899999995

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-35  Score=205.97  Aligned_cols=144  Identities=24%  Similarity=0.419  Sum_probs=121.6

Q ss_pred             hhHHhHHHHHHHHhhCCCCccchhhhheec--------CCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHH
Q 031702            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA--------ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL   79 (154)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l   79 (154)
                      ...+.+.+|+.+++.++|||++++++++..        .+..|++||+++++.+.........+++..++.+++|++.|+
T Consensus        51 ~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l  130 (318)
T d3blha1          51 GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL  130 (318)
T ss_dssp             SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHH
Confidence            345678899999999999999999998854        356899999998777766555566799999999999999999


Q ss_pred             HHHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCC-----CccccccCCccccCccccccc-CCCcccceec
Q 031702           80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFV  153 (154)
Q Consensus        80 ~~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diws  153 (154)
                      .|||++|++||||||+||++   +..+.+|++|||++......     ......+||+.|+|||++.+. .|+.++||||
T Consensus       131 ~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwS  207 (318)
T d3blha1         131 YYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWG  207 (318)
T ss_dssp             HHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHH
T ss_pred             HHhccCCEEecCcCchheee---cCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHccc
Confidence            99999999999999999999   67889999999999765432     233446789999999998765 6899999999


Q ss_pred             C
Q 031702          154 S  154 (154)
Q Consensus       154 l  154 (154)
                      |
T Consensus       208 l  208 (318)
T d3blha1         208 A  208 (318)
T ss_dssp             H
T ss_pred             C
Confidence            6

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.1e-34  Score=201.01  Aligned_cols=152  Identities=18%  Similarity=0.224  Sum_probs=127.9

Q ss_pred             hhhhh-hhhHHhHHHHHHHHhhCCC-CccchhhhheecCCcEEEEEEecCCCCchHHHHHcC-CCCHHHHHHHHHHHHHH
Q 031702            2 LKKLN-KHLKSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAG   78 (154)
Q Consensus         2 ~k~~~-~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~   78 (154)
                      +|.++ ....+.+.+|+.+++.++| ++++++++++.++...+++|||+ +++|.+++...+ .++...+..++.|++.|
T Consensus        35 vK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~  113 (293)
T d1csna_          35 IKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLAR  113 (293)
T ss_dssp             EEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHH
T ss_pred             EEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHH
Confidence            45443 2345678899999999965 89999999999999999999999 679999887654 69999999999999999


Q ss_pred             HHHHHhCCceeecCCCCcEEeecCC--CCeeEEEeecccccccCCCC--------ccccccCCccccCcccccccCCCcc
Q 031702           79 LEILNSHHIIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEK  148 (154)
Q Consensus        79 l~~lh~~~~~h~~i~p~nil~~~~~--~~~~~kl~df~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~  148 (154)
                      ++|||++|++||||||+||++....  ..+.+||+|||+|+......        ......||+.|+|||++.+..++.+
T Consensus       114 l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~  193 (293)
T d1csna_         114 VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRR  193 (293)
T ss_dssp             HHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH
T ss_pred             HHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChH
Confidence            9999999999999999999995422  35689999999998654321        2334679999999999999999999


Q ss_pred             cceecC
Q 031702          149 VNFFVS  154 (154)
Q Consensus       149 ~Diwsl  154 (154)
                      +|||||
T Consensus       194 ~DiwSl  199 (293)
T d1csna_         194 DDLEAL  199 (293)
T ss_dssp             HHHHHH
T ss_pred             HHHHHh
Confidence            999996

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.5e-35  Score=203.00  Aligned_cols=145  Identities=17%  Similarity=0.182  Sum_probs=120.0

Q ss_pred             hHHhHHHHHHHHhhCCCCccch-hhhheecCCcEEEEEEecCCCCchHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            9 LKSCLDCELNFLSSVNHPNIIR-LFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~~v~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      ..+.+..|+++++.++|++++. +...+.+++..+++|||++ +++.+.+. ....+++..+..++.|++.|++|||++|
T Consensus        45 ~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  123 (299)
T d1ckia_          45 KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN  123 (299)
T ss_dssp             TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC
Confidence            4567889999999997776554 4555677788999999994 56666554 4557999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC--------ccccccCCccccCcccccccCCCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      ++||||||+||++...+....++++|||+|.......        ......||+.|+|||+..+..++.++|||||
T Consensus       124 iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  199 (299)
T d1ckia_         124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESL  199 (299)
T ss_dssp             EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHH
T ss_pred             eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEec
Confidence            9999999999998654556789999999998764432        2344679999999999999999999999996

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-35  Score=206.23  Aligned_cols=142  Identities=32%  Similarity=0.439  Sum_probs=113.6

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheec------CCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE   80 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~   80 (154)
                      ....+.+.+|+.+++.++||||++++++|..      .+++|++|||+.++.+. .+  ...+++..++.+++|++.|+.
T Consensus        57 ~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~-~~--~~~~~~~~i~~~~~qil~gl~  133 (355)
T d2b1pa1          57 QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ-VI--QMELDHERMSYLLYQMLCGIK  133 (355)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHH-HH--TSCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHH-hh--hcCCCHHHHHHHHHHHHHHHH
Confidence            4456678999999999999999999999953      46799999999765444 33  457999999999999999999


Q ss_pred             HHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccCCCcccceecC
Q 031702           81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        81 ~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  154 (154)
                      |||++|++||||||+||++   +..+.++++|||++.............+|+.|+|||++.+..++.++||||+
T Consensus       134 ~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSl  204 (355)
T d2b1pa1         134 HLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV  204 (355)
T ss_dssp             HHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHH
T ss_pred             HhhhcccccccCCcccccc---ccccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccc
Confidence            9999999999999999999   6778899999999887766666667788999999999999999999999995

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-35  Score=206.82  Aligned_cols=143  Identities=29%  Similarity=0.481  Sum_probs=127.1

Q ss_pred             hHHhHHHHHHHHhhCCC-CccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 031702            9 LKSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI   87 (154)
Q Consensus         9 ~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~   87 (154)
                      ..+.+.+|+.++++++| |||+++++++.+....++++||+.+++|.+++...+.+++..+..+++|++.|++|+|++++
T Consensus        71 ~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~i  150 (322)
T d1vzoa_          71 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI  150 (322)
T ss_dssp             SGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCE
Confidence            45778899999999966 89999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eeecCCCCcEEeecCCCCeeEEEeecccccccCCC--CccccccCCccccCccccccc--CCCcccceecC
Q 031702           88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--NYAEKVCGSPLYMAPEVLQFQ--RYDEKVNFFVS  154 (154)
Q Consensus        88 ~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~--~~~~~~Diwsl  154 (154)
                      +||||||+||++   +..+.+||+|||++......  .......|++.|+|||.+.+.  .++.++|||||
T Consensus       151 vHrDiKp~Nill---~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSl  218 (322)
T d1vzoa_         151 IYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL  218 (322)
T ss_dssp             CCCCCCGGGEEE---CTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHH
T ss_pred             EeccCCccceee---cCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHH
Confidence            999999999999   67789999999999765433  334567889999999998754  46789999996

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-34  Score=200.59  Aligned_cols=141  Identities=31%  Similarity=0.520  Sum_probs=121.9

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCC------cEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE   80 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~   80 (154)
                      +...+.+.+|+++|+.++||||++++++|...+      .+|++|||+ +.+|..+.+ ...+++..++.+++|++.|++
T Consensus        58 ~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~  135 (346)
T d1cm8a_          58 ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLR  135 (346)
T ss_dssp             HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHH
Confidence            455678899999999999999999999997654      579999999 557777654 568999999999999999999


Q ss_pred             HHHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCccccccc-CCCcccceecC
Q 031702           81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  154 (154)
Q Consensus        81 ~lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl  154 (154)
                      |||++|++||||||+||++   +..+.+|++|||++......  .....||+.|+|||++.+. .++.++|||||
T Consensus       136 ~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl  205 (346)
T d1cm8a_         136 YIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSV  205 (346)
T ss_dssp             HHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHH
T ss_pred             HHHhCCCcccccCcchhhc---ccccccccccccceeccCCc--cccccccccccCHHHHcCCCCCCccchhhcc
Confidence            9999999999999999999   78889999999999765433  3456789999999998764 56899999996

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-34  Score=196.10  Aligned_cols=145  Identities=28%  Similarity=0.470  Sum_probs=128.8

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH   86 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   86 (154)
                      +...+.+.+|+.+++.++||||+++++++.+....+++++++.++++..+....+.+++..+..++.|++.|++|||+++
T Consensus        42 ~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~  121 (292)
T d1unla_          42 EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN  121 (292)
T ss_dssp             TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC
Confidence            34568899999999999999999999999999999999999999999998888889999999999999999999999999


Q ss_pred             ceeecCCCCcEEeecCCCCeeEEEeecccccccCCCC-ccccccCCccccCcccccccC-CCcccceecC
Q 031702           87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  154 (154)
Q Consensus        87 ~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Diwsl  154 (154)
                      ++||||||+||++   +..+.+|++|||.+....... ......+++.|+|||++.+.. ++.++|||||
T Consensus       122 IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSl  188 (292)
T d1unla_         122 VLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA  188 (292)
T ss_dssp             EECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHH
T ss_pred             EeeecccCccccc---ccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhcccc
Confidence            9999999999999   677889999999998765443 334455678899999987665 6899999996

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.2e-33  Score=196.15  Aligned_cols=142  Identities=27%  Similarity=0.433  Sum_probs=115.7

Q ss_pred             hhhHHhHHHHHHHHhhCCCCccchhhhheecC-----CcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHH
Q 031702            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI   81 (154)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~   81 (154)
                      ....+.+.+|+++++.++|||++++++++...     ...+++++++.+|+|.+++. .+.+++..++.+++|++.|++|
T Consensus        58 ~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~  136 (348)
T d2gfsa1          58 IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKY  136 (348)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHH
Confidence            34566789999999999999999999998533     23355566777999999885 4579999999999999999999


Q ss_pred             HHhCCceeecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCcccccccC-CCcccceecC
Q 031702           82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  154 (154)
Q Consensus        82 lh~~~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diwsl  154 (154)
                      ||++|++||||||+||++   +..+.+|++|||.+.....  ......|++.|+|||...+.. ++.++|||||
T Consensus       137 LH~~giiHrDiKp~NILi---~~~~~~kl~dfg~a~~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSl  205 (348)
T d2gfsa1         137 IHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV  205 (348)
T ss_dssp             HHHTTCCCCCCCGGGEEE---CTTCCEEECCC----CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHH
T ss_pred             HHhCCCcccccCCccccc---cccccccccccchhcccCc--ccccccccccccCchhhcCCccCCcccchhhh
Confidence            999999999999999999   6788999999999865432  334567889999999977654 5789999996

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.93  E-value=4.2e-27  Score=166.71  Aligned_cols=152  Identities=27%  Similarity=0.406  Sum_probs=114.4

Q ss_pred             Chhhhhh--hhHHhHHHHHHHHhhCC-----------CCccchhhhheecC--CcEEEEEEecCCCCchHH-HH--HcCC
Q 031702            1 MLKKLNK--HLKSCLDCELNFLSSVN-----------HPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSY-IR--LHGR   62 (154)
Q Consensus         1 ~~k~~~~--~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~~--~~~~~v~e~~~~~~L~~~-~~--~~~~   62 (154)
                      |+|.++.  ...+.+.+|+.+++.+.           |+||+++++++...  ...++++++...+..... ..  ....
T Consensus        42 AvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  121 (362)
T d1q8ya_          42 AMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG  121 (362)
T ss_dssp             EEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSC
T ss_pred             EEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccC
Confidence            3455432  34577889999998885           46788888877543  456666666554443332 22  2346


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEeecCC---CCeeEEEeecccccccCCCCccccccCCccccCcc
Q 031702           63 VPEQTARKFLQQLGAGLEILNS-HHIIHRDLKPENILLSGLD---DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPE  138 (154)
Q Consensus        63 ~~~~~~~~~~~~i~~~l~~lh~-~~~~h~~i~p~nil~~~~~---~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aPE  138 (154)
                      +++..++.++.|++.|++|||+ .|++||||||+||++...+   ....++++|||.+.....  ......||+.|+|||
T Consensus       122 ~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE  199 (362)
T d1q8ya_         122 IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPE  199 (362)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHH
T ss_pred             CcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc--ccccccccccccChh
Confidence            8999999999999999999998 8999999999999995321   123589999999875433  334567899999999


Q ss_pred             cccccCCCcccceecC
Q 031702          139 VLQFQRYDEKVNFFVS  154 (154)
Q Consensus       139 ~~~~~~~~~~~Diwsl  154 (154)
                      ++.+..|+.++|||||
T Consensus       200 ~~~~~~~~~~~DiwSl  215 (362)
T d1q8ya_         200 VLLGAPWGCGADIWST  215 (362)
T ss_dssp             HHHTCCCCTHHHHHHH
T ss_pred             hccccCCCccccccch
Confidence            9999999999999995

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.80  E-value=4.2e-21  Score=124.67  Aligned_cols=122  Identities=15%  Similarity=0.172  Sum_probs=88.4

Q ss_pred             HHhHHHHHHHHhhCCCCccchhhhheecCCcEEEEEEecCCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 031702           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH   89 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~h   89 (154)
                      .....+|...+.++.|.+++..++...    .+++|||+++..+.+       ++......++.|++.++.+||.+|++|
T Consensus        58 ~~~~~~e~~~l~~l~~~~v~~~~~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiH  126 (191)
T d1zara2          58 IRSARNEFRALQKLQGLAVPKVYAWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVH  126 (191)
T ss_dssp             HHHHHHHHHHHHHTTTSSSCCEEEEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHHccCCCcceEEEecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEE
Confidence            455667899999999999887764422    379999998765543       344556778999999999999999999


Q ss_pred             ecCCCCcEEeecCCCCeeEEEeecccccccCCCCccccccCCccccCc------ccccccCCCcccceecC
Q 031702           90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAP------EVLQFQRYDEKVNFFVS  154 (154)
Q Consensus        90 ~~i~p~nil~~~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~y~aP------E~~~~~~~~~~~Diwsl  154 (154)
                      +||||+||++.   . ..++++|||.|.........       .|...      +.. .+.|+..+|+||.
T Consensus       127 rDiKP~NILv~---~-~~~~liDFG~a~~~~~~~~~-------~~l~rd~~~~~~~f-~r~y~~~~d~~s~  185 (191)
T d1zara2         127 GDLSQYNVLVS---E-EGIWIIDFPQSVEVGEEGWR-------EILERDVRNIITYF-SRTYRTEKDINSA  185 (191)
T ss_dssp             SCCSTTSEEEE---T-TEEEECCCTTCEETTSTTHH-------HHHHHHHHHHHHHH-HHHHCCCCCHHHH
T ss_pred             ccCChhheeee---C-CCEEEEECCCcccCCCCCcH-------HHHHHHHHHHHHHH-cCCCCCcccHHHH
Confidence            99999999994   3 34889999998654322111       11111      111 2568889999983

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.09  E-value=4.9e-06  Score=54.82  Aligned_cols=46  Identities=9%  Similarity=0.033  Sum_probs=35.8

Q ss_pred             HHhHHHHHHHHhhCC-CCccchhhhheecCCcEEEEEEecCCCCchH
Q 031702           10 KSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSS   55 (154)
Q Consensus        10 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~   55 (154)
                      ...+.+|...++.+. +--+++++....+++..+++|++++|.++.+
T Consensus        53 ~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~   99 (263)
T d1j7la_          53 TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSE   99 (263)
T ss_dssp             TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHH
T ss_pred             hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccc
Confidence            445788999988883 4346777887888888999999999877754

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.97  E-value=2.7e-06  Score=55.87  Aligned_cols=52  Identities=17%  Similarity=0.070  Sum_probs=37.4

Q ss_pred             hhhhhhhHHhHHHHHHHHhhCCCC--ccchhhhheecCCcEEEEEEecCCCCch
Q 031702            3 KKLNKHLKSCLDCELNFLSSVNHP--NIIRLFDAFQAENCIFLVVEFCAGGNLS   54 (154)
Q Consensus         3 k~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~~v~e~~~~~~L~   54 (154)
                      |.........+..|...++.+...  .+++++....+++..+++|++++|.++.
T Consensus        41 K~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          41 KTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             EEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             EeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            333344455688899999888433  3577777777888899999999886653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.45  E-value=0.0002  Score=50.04  Aligned_cols=28  Identities=29%  Similarity=0.398  Sum_probs=23.0

Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeeccccc
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~  117 (154)
                      .++|+|+.|.||++.   . ..++++||..+.
T Consensus       224 ~LiHGDl~~gNIlv~---~-~~~~vID~E~a~  251 (392)
T d2pula1         224 TLIHGDLHTGSIFAS---E-HETKVIDPEFAF  251 (392)
T ss_dssp             EEECSCCCGGGEEEC---S-SCEEECCCTTCE
T ss_pred             ceeccCCcCCceeEc---C-CceEEechhhcc
Confidence            589999999999993   3 347999998774

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.30  E-value=0.0015  Score=45.30  Aligned_cols=40  Identities=20%  Similarity=0.170  Sum_probs=27.4

Q ss_pred             HhHHHHHHHHhhC-CCCccchhhhheecCCcEEEEEEecCCCCch
Q 031702           11 SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLS   54 (154)
Q Consensus        11 ~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   54 (154)
                      ....+|..+++.+ ++.-.+++++.+.+    ..++||++|.++.
T Consensus        89 idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l~  129 (395)
T d1nw1a_          89 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPLS  129 (395)
T ss_dssp             HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEECC
T ss_pred             hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccCC
Confidence            3456799999988 44445677776653    4789999875443

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.57  E-value=0.0021  Score=43.08  Aligned_cols=29  Identities=31%  Similarity=0.606  Sum_probs=24.9

Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeeccccc
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC  117 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~  117 (154)
                      |++|+|+.+.|+++   +.+...-++||+.+.
T Consensus       184 giIHgDl~~dNvl~---~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         184 GVIHADLFQDNVFF---LGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEECSCCCGGGEEE---ETTEEEEECCCTTCE
T ss_pred             ccccCCcchhhhhc---ccccceeEecccccc
Confidence            68999999999999   455566899999885

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=93.05  E-value=0.044  Score=36.64  Aligned_cols=28  Identities=25%  Similarity=0.264  Sum_probs=21.8

Q ss_pred             CceeecCCCCcEEeecCCCCeeEEEeecccccc
Q 031702           86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  118 (154)
Q Consensus        86 ~~~h~~i~p~nil~~~~~~~~~~kl~df~~~~~  118 (154)
                      +++|+|+.|.||++   +.+  ..++||+.++.
T Consensus       193 ~liHgDlh~~NvL~---~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILW---RDG--PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEE---SSS--EEECCCTTCCE
T ss_pred             eeecCCCCcccEEE---eCC--ceEEechhccc
Confidence            58999999999998   333  34789987753